PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lotsch, J; Dimova, V; Lieb, I; Zimmermann, M; Oertel, BG; Ultsch, A				Loetsch, Joern; Dimova, Violeta; Lieb, Isabel; Zimmermann, Michael; Oertel, Bruno G.; Ultsch, Alfred			Multimodal Distribution of Human Cold Pain Thresholds	PLOS ONE			English	Article							ION CHANNELS; SENSITIZATION; TRANSDUCTION; MECHANISMS; COMPONENTS; PROTOCOL; MENTHOL; NEURONS	Background It is assumed that different pain phenotypes are based on varying molecular pathomechanisms. Distinct ion channels seem to be associated with the perception of cold pain, in particular TRPM8 and TRPA1 have been highlighted previously. The present study analyzed the distribution of cold pain thresholds with focus at describing the multimodality based on the hypothesis that it reflects a contribution of distinct ion channels. Methods Cold pain thresholds (CPT) were available from 329 healthy volunteers (aged 18 - 37 years; 159 men) enrolled in previous studies. The distribution of the pooled and log-transformed threshold data was described using a kernel density estimation (Pareto Density Estimation (PDE)) and subsequently, the log data was modeled as a mixture of Gaussian distributions using the expectation maximization (EM) algorithm to optimize the fit. Results CPTs were clearly multi-modally distributed. Fitting a Gaussian Mixture Model (GMM) to the log-transformed threshold data revealed that the best fit is obtained when applying a three-model distribution pattern. The modes of the identified three Gaussian distributions, retransformed from the log domain to the mean stimulation temperatures at which the subjects had indicated pain thresholds, were obtained at 23.7 degrees C, 13.2 degrees C and 1.5 degrees C for Gaussian #1, #2 and #3, respectively. Conclusions The localization of the first and second Gaussians was interpreted as reflecting the contribution of two different cold sensors. From the calculated localization of the modes of the first two Gaussians, the hypothesis of an involvement of TRPM8, sensing temperatures from 25 - 24 degrees C, and TRPA1, sensing cold from 17 degrees C can be derived. In that case, subjects belonging to either Gaussian would possess a dominance of the one or the other receptor at the skin area where the cold stimuli had been applied. The findings therefore support a suitability of complex analytical approaches to detectmechanistically determined patterns from pain phenotype data.	[Loetsch, Joern; Dimova, Violeta; Lieb, Isabel; Oertel, Bruno G.] Goethe Univ, Inst Clin Pharmacol, D-60590 Frankfurt, Germany; [Loetsch, Joern; Oertel, Bruno G.] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, D-60596 Frankfurt, Germany; [Dimova, Violeta; Zimmermann, Michael] Univ Hosp Frankfurt, Dept Anesthesiol Intens Care Med & Pain Therapy, D-60590 Frankfurt, Germany; [Ultsch, Alfred] Univ Marburg, DataBion Res Grp, D-35032 Marburg, Germany	Goethe University Frankfurt; Fraunhofer Gesellschaft; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Philipps University Marburg	Lotsch, J (corresponding author), Goethe Univ, Inst Clin Pharmacol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958	"Landesoffensive zur Entwicklung wissenschaftlichokonomischer Exzellenz": "LOEWE-Schwerpunkt: Anwendungsorientierte Arzneimittelforschung"; Research Training Group Translational Research Innovation - Pharma (TRIP); European Union [602919]	"Landesoffensive zur Entwicklung wissenschaftlichokonomischer Exzellenz": "LOEWE-Schwerpunkt: Anwendungsorientierte Arzneimittelforschung"; Research Training Group Translational Research Innovation - Pharma (TRIP); European Union(European Commission)	This work was supported by the "Landesoffensive zur Entwicklung wissenschaftlichokonomischer Exzellenz": "LOEWE-Schwerpunkt: Anwendungsorientierte Arzneimittelforschung" (to JL) and the Research Training Group Translational Research Innovation - Pharma (TRIP) (to JL). The research has also received funding from the European Union Seventh Framework Programme (FP7/2007 - 2013) under grant agreement no 602919 (to JL). The funders had no role in method design, data selection and analysis, decision to publish, or preparation of the manuscript.	Altis K, 2009, PAIN, V147, P116, DOI 10.1016/j.pain.2009.08.018; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Attal N, 1998, EUR NEUROL, V40, P191, DOI 10.1159/000007979; Bouhassira D, 2014, PAIN, V155, P2171, DOI 10.1016/j.pain.2014.08.020; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chen CC, 1996, PAIN, V68, P33, DOI 10.1016/S0304-3959(96)03180-6; CROSS SA, 1994, MAYO CLIN PROC, V69, P375, DOI 10.1016/S0025-6196(12)62225-3; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Doehring A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017724; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Fluhr K, 2009, CLIN J PAIN, V25, P128, DOI 10.1097/AJP.0b013e3181817aa2; Heimann D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068654; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Lachin JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026471; LINDBLOM U, 1979, J NEUROL NEUROSUR PS, V42, P422, DOI 10.1136/jnnp.42.5.422; Lotsch J, 2013, J BIOMED INFORM, V46, P921, DOI 10.1016/j.jbi.2013.07.010; Lotsch J, 2015, PAIN; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Martel MO, 2008, PAIN, V139, P562, DOI 10.1016/j.pain.2008.06.010; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Neddermeyer TJ, 2008, PAIN, V138, P286, DOI 10.1016/j.pain.2007.12.015; Oertel BG, 2013, BRIT J PHARMACOL, V168, P534, DOI 10.1111/bph.12023; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Schutz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095592; Smidt N, 2002, ARCH PHYS MED REHAB, V83, P1145, DOI 10.1053/apmr.2002.33728; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; Ultsch A, 2003, PARETO DENSITY ESTIM; VERDUGO R, 1992, BRAIN, V115, P893, DOI 10.1093/brain/115.3.893; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Vigil JM, 2011, PAIN, V152, P2125, DOI 10.1016/j.pain.2011.05.019; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; WAHREN LK, 1989, PAIN, V38, P313, DOI 10.1016/0304-3959(89)90218-2; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108	42	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125822	10.1371/journal.pone.0125822	http://dx.doi.org/10.1371/journal.pone.0125822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992576	Green Published, Green Submitted, gold			2022-12-27	WOS:000354921400047
J	Sears, D; Mpimbaza, A; Kigozi, R; Sserwanga, A; Chang, MA; Kapella, BK; Yoon, S; Kamya, MR; Dorsey, G; Ruel, T				Sears, David; Mpimbaza, Arthur; Kigozi, Ruth; Sserwanga, Asadu; Chang, Michelle A.; Kapella, Bryan K.; Yoon, Steven; Kamya, Moses R.; Dorsey, Grant; Ruel, Theodore			Quality of Inpatient Pediatric Case Management for Four Leading Causes of Child Mortality at Six Government-Run Ugandan Hospitals	PLOS ONE			English	Article							SEVERE MALARIA; HEALTH-CARE; INFORMATION-SYSTEMS; DIARRHEA; BACTEREMIA; SERVICES; DEATHS; LEVEL; ZINC	Background A better understanding of case management practices is required to improve inpatient pediatric care in resource-limited settings. Here we utilize data from a unique health facilitybased surveillance system at six Ugandan hospitals to evaluate the quality of pediatric case management and the factors associated with appropriate care. Methods All children up to the age of 14 years admitted to six district or regional hospitals over 15 months were included in the study. Four case management categories were defined for analysis: suspected malaria, selected illnesses requiring antibiotics, suspected anemia, and diarrhea. The quality of case management for each category was determined by comparing recorded treatments with evidence-based best practices as defined in national guidelines. Associations between variables of interest and the receipt of appropriate case management were estimated using multivariable logistic regression. Results A total of 30,351 admissions were screened for inclusion in the analysis. Ninety-two percent of children met criteria for suspected malaria and 81% received appropriate case management. Thirty-two percent of children had selected illnesses requiring antibiotics and 89% received appropriate antibiotics. Thirty percent of children met criteria for suspected anemia and 38% received appropriate case management. Twelve percent of children had diarrhea and 18% received appropriate case management. Multivariable logistic regression revealed large differences in the quality of care between health facilities. There was also a strong association between a positive malaria diagnostic test result and the odds of receiving appropriate case management for comorbid non-malarial illnesses - children with a positive malaria test were more likely to receive appropriate care for anemia and less likely for illnesses requiring antibiotics and diarrhea. Conclusions Appropriate management of suspected anemia and diarrhea occurred infrequently. Pediatric quality improvement initiatives should target deficiencies in care unique to each health facility, and interventions should focus on the simultaneous management of multiple diagnoses.	[Sears, David; Dorsey, Grant] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94117 USA; [Mpimbaza, Arthur; Kigozi, Ruth; Sserwanga, Asadu] Uganda Malaria Surveillance Project, Kampala, Uganda; [Mpimbaza, Arthur] Makerere Univ, Child Hlth & Dev Ctr, Kampala, Uganda; [Chang, Michelle A.; Kapella, Bryan K.; Yoon, Steven] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA; [Yoon, Steven] Ctr Dis Control & Prevent, US Presidents Malaria Initiat, Atlanta, GA USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Ruel, Theodore] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Makerere University; University of California System; University of California San Francisco	Sears, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94117 USA.	dsears@labiomed.org		Sears, David/0000-0003-3854-6482	Malaria Initiative, U.S. Agency for International Development; Centers for Disease Control and Prevention (CDC) [1U51CK000117]; National Institutes of Health [2T32AI007641, NIH U19AI089674]; Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health [K23 HD60459]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD060459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674, T32AI007641] Funding Source: NIH RePORTER	Malaria Initiative, U.S. Agency for International Development(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The UMSP sentinel site surveillance system and this work were made possible through support provided by the President's Malaria Initiative, U.S. Agency for International Development, under the terms of an Interagency Agreement with the Centers for Disease Control and Prevention (CDC) (1U51CK000117), the National Institutes of Health (2T32AI007641, D.A.S., and NIH U19AI089674), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23 HD60459, T.D.R.) at the National Institutes of Health. The opinions expressed herein are those of the authors and do not necessarily reflect the views of CDC or the U.S. Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; Achan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017053; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Centers for Disease Control and Prevention, 2010, DISTINGUISHING PUBLI; Chandler CIR, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-13; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; Evans T, 2003, B WORLD HEALTH ORGAN, V81, P856; Gathara D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-307; Gething PW, 2006, PLOS MED, V3, P825, DOI 10.1371/journal.pmed.0030271; Hendriksen ICE, 2012, CLIN INFECT DIS, V55, P1144, DOI 10.1093/cid/cis590; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; Krug A, 2004, SAMJ S AFR MED J, V94, P202; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mangham LJ, 2012, TROP MED INT HEALTH, V17, P330, DOI 10.1111/j.1365-3156.2011.02918.x; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Nankabirwa JI, 2014, CLIN INFECT DIS, V58, P1404, DOI 10.1093/cid/ciu150; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Nyamtema AS, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-36; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; Opoka RO, 2008, PEDIATR INFECT DIS J, V27, P319, DOI 10.1097/INF.0b013e31815d74dd; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Ralston ME, 2013, LANCET, V381, P256, DOI 10.1016/S0140-6736(12)61191-X; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2008, B WORLD HEALTH ORGAN, V86, P132, DOI 10.2471/BLT.07.041723; Senn N, 2012, CLIN INFECT DIS, V54, P644, DOI 10.1093/cid/cir901; Setel PW, 2005, B WORLD HEALTH ORGAN, V83, P611; Srinivasan MG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-14; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Thomson N, 2005, RESUSCITATION, V65, P15, DOI 10.1016/j.resuscitation.2005.01.008; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Uganda Bureau of Statistics (UBOS) & ICF International Inc, 2012, UGANDA DEMOGRAPHIC A; Uganda Bureau of Statistics (UBOS) Macro International Inc. MEASURE Evaluation, 2008, UGANDA CHILD VERBAL; Uganda Ministry of Health, 2012, UGANDA CLINICAL GUID; UNICEF World Health Organization World Bank United Nations, 2013, LEVELS AND TRENDS IN; Veirum JE, 2007, ACTA PAEDIATR, V96, P1526, DOI 10.1111/j.1651-2227.2007.00467.x; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, GUID TREATM MAL, DOI [10.1186/1475-2875-9-212, DOI 10.1186/1475-2875-9-212]; World Health Organization, 2013, POCKET BOOK OF HOSPI	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127192	10.1371/journal.pone.0127192	http://dx.doi.org/10.1371/journal.pone.0127192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992620	gold, Green Submitted, Green Published			2022-12-27	WOS:000354918600054
J	Grandjean, L; Iwamoto, T; Lithgow, A; Gilman, RH; Arikawa, K; Nakanishi, N; Martin, L; Castillo, E; Alarcon, V; Coronel, J; Solano, W; Aminian, M; Guezala, C; Rastogi, N; Couvin, D; Sheen, P; Zimic, M; Moore, DAJ				Grandjean, Louis; Iwamoto, Tomotada; Lithgow, Anna; Gilman, Robert H.; Arikawa, Kentaro; Nakanishi, Noriko; Martin, Laura; Castillo, Edith; Alarcon, Valentina; Coronel, Jorge; Solano, Walter; Aminian, Minoo; Guezala, Claudia; Rastogi, Nalin; Couvin, David; Sheen, Patricia; Zimic, Mirko; Moore, David A. J.			The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru	PLOS ONE			English	Article							MICROSCOPIC-OBSERVATION; GENETIC DIVERSITY; VIRULENCE; STRAIN; ASSAY	Background The comparison of Mycobacterium tuberculosis bacterial genotypes with phenotypic, demographic, geospatial and clinical data improves our understanding of how strain lineage influences the development of drug-resistance and the spread of tuberculosis. Methods To investigate the association of Mycobacterium tuberculosis bacterial genotype with drugresistance. Drug susceptibility testing together with genotyping using both 15-loci MIRU-typing and spoligotyping, was performed on 2,139 culture positive isolates, each from a different patient in Lima, Peru. Demographic, geospatial and socio-economic data were collected using questionnaires, global positioning equipment and the latest national census. Results The Latin American Mediterranean (LAM) clade (OR 2.4, p<0.001) was significantly associated with drug-resistance and alone accounted for more than half of all drug resistance in the region. Previously treated patients, prisoners and genetically clustered cases were also significantly associated with drug-resistance (OR's 2.5, 2.4 and 1.8, p<0.001, p<0.05, p<0.001 respectively). Conclusions Tuberculosis disease caused by the LAM clade was more likely to be drug resistant independent of important clinical, genetic and socio-economic confounding factors. Explanations for this include; the preferential co-evolution of LAM strains in a Latin American population, a LAM strain bacterial genetic background that favors drug-resistance or the "founder effect" from pre-existing LAM strains disproportionately exposed to drugs.	[Grandjean, Louis] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, St Marys Campus,Norfolk Pl, London, England; [Grandjean, Louis; Lithgow, Anna; Moore, David A. J.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Grandjean, Louis; Lithgow, Anna; Moore, David A. J.] Dept Clin Res, London, England; [Grandjean, Louis; Gilman, Robert H.; Martin, Laura; Coronel, Jorge; Solano, Walter; Sheen, Patricia; Zimic, Mirko; Moore, David A. J.] Univ Peruana Cayetano Heredia, Lab Invest & Desarrollo, Lima, Peru; [Iwamoto, Tomotada; Arikawa, Kentaro; Nakanishi, Noriko] Kobe Inst Hlth, Dept Infect Dis, Chuo Ku, Kobe, Hyogo, Japan; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Castillo, Edith] DIRESA Callao, Bellavista, Callao, Peru; [Alarcon, Valentina] TB MDR, Unidad Tecn, Lima, Peru; [Aminian, Minoo] Rensselaer Polytech Inst, TB Insight Res Grp, Troy, NY USA; [Guezala, Claudia] Naval Med Res, Unit 6, Bellavista, Callao, Peru; [Rastogi, Nalin; Couvin, David] Inst Pasteur Guadeloupe, WHO, Supranat TB Reference Lab, Abymes, Guadeloupe, France	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rensselaer Polytechnic Institute; World Health Organization	Grandjean, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, St Marys Campus,Norfolk Pl, London, England.	lgrandjean@gmail.com	Iwamoto, Tomotada/I-8944-2019; RASTOGI, NALIN/AAP-1958-2020	Iwamoto, Tomotada/0000-0002-2650-0308; RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023; Moore, David/0000-0002-3748-0154; Alarcon Guizado, Valentina Antonieta/0000-0002-6381-5843; Grandjean, Louis/0000-0002-1457-8327; Coronel, Jorge/0000-0002-4580-6716	Wellcome Trust [WT088559MA, 078067/Z/05/Z]; Japanese Ministry of Health Science Research Grant [H24-SHINKO-IPPAN-011]; MEXT/JSPS KAKENHI Grant [24590845]; Wellcome Trust [WT088559MA, 078067/Z/05/Z]; Japanese Ministry of Health Science Research Grant [H24-SHINKO-IPPAN-011]; MEXT/JSPS KAKENHI Grant [24590845]; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Japanese Ministry of Health Science Research Grant; MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Wellcome Trust(Wellcome TrustEuropean Commission); Japanese Ministry of Health Science Research Grant; MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust [Grant Numbers WT088559MA, 078067/Z/05/Z] (www.wellcome.ac.uk), the Japanese Ministry of Health Science Research Grant (www.mhlw.go.jp) [Grant number H24-SHINKO-IPPAN-011] and an MEXT/JSPS KAKENHI Grant [Grant number 24590845]. The Wellcome Trust had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Dalla Costa ER, 2013, J CLIN MICROBIOL; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Dymova MA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-77; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Hsu AH, 2010, INT J TUBERC LUNG D, V14, P924; Instituto Nacional de Estadistica e Informatica INEI, 2005, 10 DE POBL V DE VIV; Instituto Nacional de Estadistica e Informatica INEI, 2007, XI DE POBLACION Y V; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Mendoza A, 2011, INT J TUBERC LUNG D, V15, P217; Mokrousov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041318; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Sebek M, 2000, INT J TUBERC LUNG D, V4, pS45; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vynnycky E, 2001, EPIDEMIOL INFECT, V126, P43, DOI 10.1017/S095026880100499X; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	30	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126271	10.1371/journal.pone.0126271	http://dx.doi.org/10.1371/journal.pone.0126271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984723	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000354917300036
J	Sudan, RJJ; Kumari, JLJ; Sudandiradoss, C				Sudan, R. Jesu Jaya; Kumari, J. Lesitha Jeeva; Sudandiradoss, C.			Ab Initio Coordination Chemistry for Nickel Chelation Motifs	PLOS ONE			English	Article							PROTEIN; CARCINOGENICITY; TOXICITY; METALS; RESIDUES; GEOMETRY; SERVER; MODEL	Chelation therapy is one of the most appreciated methods in the treatment of metal induced disease predisposition. Coordination chemistry provides a way to understand metal association in biological structures. In this work we have implemented coordination chemistry to study nickel coordination due to its high impact in industrial usage and thereby health consequences. This paper reports the analysis of nickel coordination from a large dataset of nickel bound structures and sequences. Coordination patterns predicted from the structures are reported in terms of donors, chelate length, coordination number, chelate geometry, structural fold and architecture. The analysis revealed histidine as the most favored residue in nickel coordination. The most common chelates identified were histidine based namely HHH, HDH, HEH and HH spaced at specific intervals. Though a maximum coordination number of 8 was observed, the presence of a single protein donor was noted to be mandatory in nickel coordination. The coordination pattern did not reveal any specific fold, nevertheless we report preferable residue spacing for specific structural architecture. In contrast, the analysis of nickel binding proteins from bacterial and archeal species revealed no common coordination patterns. Nickel binding sequence motifs were noted to be organism specific and protein class specific. As a result we identified about 13 signatures derived from 13 classes of nickel binding proteins. The specifications on nickel coordination presented in this paper will prove beneficial for developing better chelation strategies.	[Sudan, R. Jesu Jaya; Kumari, J. Lesitha Jeeva; Sudandiradoss, C.] VIT Univ, SBST, Bioinformat Div, Vellore 632014, Tamil Nadu, India	Vellore Institute of Technology	Sudandiradoss, C (corresponding author), VIT Univ, SBST, Bioinformat Div, Vellore 632014, Tamil Nadu, India.	csudandiradoss@vit.ac.in	R, Jesu Jaya Sudan/AAV-2228-2021	C, Sudandiradoss/0000-0001-5144-8612				Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Archibald SJ, 2011, ANNU REP PROG CHEM A, V107, P274, DOI 10.1039/c1ic90033a; Banerjee SR, 2005, NUCL MED BIOL, V32, P1, DOI 10.1016/j.nucmedbio.2004.09.001; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P239, DOI 10.1081/CLT-100102423; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; Bork P, 1996, CURR OPIN STRUC BIOL, V6, P366, DOI 10.1016/S0959-440X(96)80057-1; Briner W, 2010, INT J ENV RES PUB HE, V7, P4278, DOI 10.3390/ijerph7124278; Cempel M, 2006, POL J ENVIRON STUD, V15, P375; Chen CY, 1998, J TOXICOL ENV HEAL A, V54, P37; Csaba G, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-23; Das KK, 2008, INDIAN J MED RES, V128, P412; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deane CM, 1999, PERSPECTIVES STRUCTU, P197; Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1; Dong J, 2006, CHEM BIOL DRUG DES, V68, P107, DOI 10.1111/j.1747-0285.2006.00421.x; EMMERT DB, 1994, NUCLEIC ACIDS RES, V22, P3445, DOI 10.1093/nar/22.17.3445; Fang JW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-277; Flora SJS, 2010, INT J ENV RES PUB HE, V7, P2745, DOI 10.3390/ijerph7072745; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Hayes RB, 1997, CANCER CAUSE CONTROL, V8, P371, DOI 10.1023/A:1018457305212; Jones MM, 1994, COORDINATION CHEM AC, V565, P427; Kasampalidis IN, 2007, PROTEINS, V68, P123, DOI 10.1002/prot.21384; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kuntal BK, 2010, PROTEIN PEPTIDE LETT, V17, P765; Kuo CY, 2006, J TOXICOL ENV HEAL A, V69, P1337, DOI 10.1080/15287390500360398; LEE YW, 1995, MOL CELL BIOL, V15, P2547; Macomber L, 2011, METALLOMICS, V3, P1153, DOI 10.1039/c1mt00063b; Magaye R, 2012, EXP THER MED, V4, P551, DOI 10.3892/etm.2012.656; National Toxicology Program, 2011, Rep Carcinog, V12, P280; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Oller AR, 2002, ENVIRON HEALTH PERSP, V110, P841, DOI 10.1289/ehp.02110s5841; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Schaumloffel D, 2012, J TRACE ELEM MED BIO, V26, P1, DOI 10.1016/j.jtemb.2012.01.002; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Sudan RJJ, 2014, J COORD CHEM, V67, P1888, DOI 10.1080/00958972.2014.931945; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126787	10.1371/journal.pone.0126787	http://dx.doi.org/10.1371/journal.pone.0126787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985439	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300053
J	Dinets, A; Pernemalm, M; Kjellin, H; Sviatoha, V; Sofiadis, A; Juhlin, CC; Zedenius, J; Larsson, C; Lehtio, J; Hoog, A				Dinets, Andrii; Pernemalm, Maria; Kjellin, Hanna; Sviatoha, Vitalijs; Sofiadis, Anastasios; Juhlin, C. Christofer; Zedenius, Jan; Larsson, Catharina; Lehtio, Janne; Hoog, Anders			Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; CELL LUNG-CANCER; CYTOKERATIN 19; PROTEOMIC ANALYSIS; GALECTIN-3; PLASMA; TUMORS; BIOMARKERS; DISCOVERY; DIAGNOSIS	Cystic papillary thyroid carcinoma (cPTC) is a subgroup of PTC presenting a diagnostic challenge at fine needle aspiration biopsy (FNAB). To further investigate this entity we aimed to characterize protein profiles of cyst fluids from cPTC and benign thyroid cystic lesions. In total, 20 cPTCs and 56 benign thyroid cystic lesions were studied. Profiling by liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed on cyst fluids from a subset of cases after depletion, and selected proteins were further analyzed by Western blot (WB), immunohistochemistry (IHC) and enzyme-linked immunosorbent assay (ELISA). A total of 1,581 proteins were detected in cyst fluids, of which 841 were quantified in all samples using LC-MS/MS. Proteins with different expression levels between cPTCs and benign lesions were identified by univariate analysis (41 proteins) and multivariate analysis (59 proteins in an orthogonal partial least squares model). WB analyses of cyst fluid and IHC on corresponding tissue samples confirmed a significant up-regulation of cytokeratin 19 (CK-19/CYFRA 21-1) and S100A13 in cPTC vs. benign lesions. These findings were further confirmed by ELISA in an extended material of non-depleted cyst fluids from cPTCs (n = 17) and benign lesions (n = 55) (p<0.05). Applying a cut-off at >55 ng/ml for CK-19 resulted in 82% specificity and sensitivity. For S100A13 a cut-off at >230 pg/ml revealed a 94% sensitivity, but only 35% specificity. This is the first comprehensive catalogue of the protein content in fluid from thyroid cysts. The up-regulations of CK-19 and S100A13 suggest their possible use in FNAB based preoperative diagnostics of cystic thyroid lesions.	[Dinets, Andrii; Pernemalm, Maria; Sviatoha, Vitalijs; Sofiadis, Anastasios; Juhlin, C. Christofer; Larsson, Catharina; Lehtio, Janne; Hoog, Anders] Karolinska Inst, Dept Oncol Pathol, SE-17176 Stockholm, Sweden; [Dinets, Andrii; Sviatoha, Vitalijs; Sofiadis, Anastasios; Juhlin, C. Christofer; Larsson, Catharina; Hoog, Anders] Karolinska Inst, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden; [Dinets, Andrii; Kjellin, Hanna; Zedenius, Jan] Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Pernemalm, Maria; Kjellin, Hanna; Lehtio, Janne] Sci Life Lab, Canc Prote Mass Spectrometry, SE-17165 Stockholm, Sweden; [Sviatoha, Vitalijs; Juhlin, C. Christofer; Hoog, Anders] Karolinska Univ Hosp, Dept Pathol & Cytol, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Dinets, A (corresponding author), Bogomolets Natl Med Univ, Dept Surg 4, UA-01601 Kiev, Ukraine.	Andrii.Dinets@ki.se; Catharina.Larsson@ki.se	Dinets, Andrii/AAA-3494-2019; Juhlin, Carl Christofer/C-1125-2016	Dinets, Andrii/0000-0001-9680-7519; Juhlin, Carl Christofer/0000-0002-5945-9081; Sofiadis, Anastasios/0000-0003-4057-7739; Lehtio, Janne/0000-0002-8100-9562; Pernemalm, Maria/0000-0003-4624-031X	Swedish Cancer Society; Swedish Research Council [Vetenskapsradet 2012-5145, Vetenskapsradet K2014-66X-11622-19-3]; Cancer Society in Stockholm [Cancerfonden 140712]; Gustav V Jubilee Foundation; Stockholm County Council [20140090]; Karolinska Institute	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Gustav V Jubilee Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institute(Karolinska Institutet)	This work was supported by the Swedish Cancer Society, the Swedish Research Council (Vetenskapsradet 2012-5145, JL; Vetenskapsradet K2014-66X-11622-19-3, CL), the Cancer Society in Stockholm (Cancerfonden 140712, CL), the Gustav V Jubilee Foundation (CL), the Stockholm County Council (Stockholms Lans Landsting 20140090, AH) and Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Ren-Xian, 2008, Ai Zheng, V27, P822; Chaker S, 2013, PROTEOMICS, V13, P771, DOI 10.1002/pmic.201200356; Cheng S, 2011, CLIN CANCER RES, V17, P2385, DOI 10.1158/1078-0432.CCR-10-2837; Cochand-Priollet B, 2011, THYROID, V21, P1067, DOI 10.1089/thy.2011.0014; de Matos LL, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-97; de Matos PS, 2005, HISTOPATHOLOGY, V47, P391, DOI 10.1111/j.1365-2559.2005.02221.x; De Petris L, 2011, EUR J CANCER, V47, P131, DOI 10.1016/j.ejca.2010.08.006; DeLellis R, 2004, PATHOLOGY GENETICS T; DELOSSANTOS ET, 1990, ARCH INTERN MED, V150, P1422, DOI 10.1001/archinte.150.7.1422; Demirci H, 2007, CLIN CHEM LAB MED, V45, P1517, DOI 10.1515/CCLM.2007.293; Dinets A, 2012, EUR J ENDOCRINOL, V166, P1049, DOI 10.1530/EJE-12-0144; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eriksson H, 2008, PROTEOMICS, V8, P3008, DOI 10.1002/pmic.200800174; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Giovanella L, 2012, EUR J ENDOCRINOL, V167, P793, DOI 10.1530/EJE-12-0660; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Glasker S, 2006, CANCER BIOL THER, V5, P549; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Hebrant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037807; Ishizuka T, 2010, J BIOL CHEM, V285, P11892, DOI 10.1074/jbc.M109.072629; Isic T, 2010, J CANCER RES CLIN, V136, P1805, DOI 10.1007/s00432-010-0838-3; Jung EJ, 2010, PROTEOM CLIN APPL, V4, P528, DOI 10.1002/prca.200900063; Krause K, 2011, AM J PATHOL, V179, P3066, DOI 10.1016/j.ajpath.2011.08.033; Kristjansdottir Bjorg, 2012, Clin Proteomics, V9, P14, DOI 10.1186/1559-0275-9-14; LEADER M, 1987, HISTOPATHOLOGY, V11, P63; Lin JD, 2007, ANZ J SURG, V77, P450, DOI 10.1111/j.1445-2197.2007.04093.x; Mato E, 2014, J MOL ENDOCRINOL, V52, P289, DOI 10.1530/JME-14-0051; Nipp M, 2012, J MOL MED, V90, P163, DOI 10.1007/s00109-011-0815-6; Papotti M, 2002, EUR J ENDOCRINOL, V147, P515, DOI 10.1530/eje.0.1470515; Pernemalm M, 2008, J PROTEOME RES, V7, P2712, DOI 10.1021/pr700821k; Pernemalm M, 2009, PROTEOMICS, V9, P3414, DOI 10.1002/pmic.200800814; REHAK NN, 1993, ARCH PATHOL LAB MED, V117, P625; Ridinger K, 2000, J BIOL CHEM, V275, P8686, DOI 10.1074/jbc.275.12.8686; Rossing M, 2012, EUR THYROID J, V1, P110, DOI 10.1159/000338921; San Martin R, 2014, AM J PATHOL, V184, P1860, DOI 10.1016/j.ajpath.2014.02.021; Sharma N, 2012, ENDOCR-RELAT CANCER, V19, pR149, DOI 10.1530/ERC-12-0036; Sofiadis A, 2012, EUR J ENDOCRINOL, V166, P657, DOI 10.1530/EJE-11-0856; Sofiadis A, 2010, THYROID, V20, P1067, DOI 10.1089/thy.2009.0400; Sulaiman L, 2012, ENDOCR-RELAT CANCER, V19, P389, DOI 10.1530/ERC-11-0140; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; VIALE G, 1989, AM J SURG PATHOL, V13, P1034, DOI 10.1097/00000478-198912000-00005; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wu N, 2013, CLIN TRANSL ONCOL, V15, P106, DOI 10.1007/s12094-012-0928-6; Yang GCH, 2010, DIAGN CYTOPATHOL, V38, P721, DOI 10.1002/dc.21282; Yang XL, 2010, J PROTEOME RES, V9, P1402, DOI 10.1021/pr900932y	45	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126472	10.1371/journal.pone.0126472	http://dx.doi.org/10.1371/journal.pone.0126472			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978681	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100073
J	Dumke, J; Hinse, D; Vollmer, T; Schulz, J; Knabbe, C; Dreier, J				Dumke, Jessika; Hinse, Dennis; Vollmer, Tanja; Schulz, Jochen; Knabbe, Cornelius; Dreier, Jens			Potential Transmission Pathways of Streptococcus gallolyticus subsp gallolyticus	PLOS ONE			English	Article							SEQUENCE TYPING SCHEME; BROILER-CHICKENS; SALMONELLA CONTAMINATION; INFECTIVE ENDOCARDITIS; LAYER FLOCKS; BOVIS; COLONIZATION; GENOME; IDENTIFICATION; ENTERITIDIS	Streptococcus gallolyticus subsp. gallolyticus (S. gallolyticus subsp. gallolyticus), a member of group D streptococci, is an inhabitant of the animal and human gastrointestinal tract. Furthermore, it is a facultative pathogen which causes e.g. endocarditis, septicemia and mastitis. S. gallolyticus subsp. gallolyticus may be transmitted either directly or indirectly between animals and humans. However, the transmission routes are an unsolved issue. In this study, we present systematic analyses of an S. gallolyticus subsp. gallolyticus isolate of an infective endocarditis patient in relation to isolates of his laying hen flock. Isolates from pooled droppings of laying hens, pooled dust samples and human blood culture were characterized by using multilocus sequence typing (MLST) and DNA fingerprinting. MLST revealed the same allelic profile of isolates from the human blood culture and from the droppings of laying hens. In addition, these isolates showed clonal identity regarding a similar DNA fingerprinting pattern. For the first time, we received a hint that transmission of S. gallolyticus subsp. gallolyticus between poultry and humans may occur. This raises the question about the zoonotic potential of isolates from poultry and should be considered in future studies.	[Dumke, Jessika; Hinse, Dennis; Vollmer, Tanja; Knabbe, Cornelius; Dreier, Jens] Ruhr Univ Bochum, Inst Lab & Transfus Med, Bad Oeynhausen, Germany; [Schulz, Jochen] Univ Vet Med Hannover, Inst Anim Hyg Anim Welf & Farm Anim Behav, Hannover, Germany	Ruhr University Bochum; University of Veterinary Medicine Hannover, Foundation	Dreier, J (corresponding author), Ruhr Univ Bochum, Inst Lab & Transfus Med, Bad Oeynhausen, Germany.	jdreier@hdz-nrw.de	Vollmer, Tanja/F-1149-2013; Schulz, Jochen/AAA-7340-2021; Dreier, Jens/F-1134-2013	Vollmer, Tanja/0000-0001-7032-5423; Schulz, Jochen/0000-0002-9747-6763; Dreier, Jens/0000-0002-1337-7750	Forschungsforderung Ruhr-Universitat Medizin (FoRUM) [F739-2011]	Forschungsforderung Ruhr-Universitat Medizin (FoRUM)	This work was supported by the Forschungsforderung Ruhr-Universitat Medizin (FoRUM) F739-2011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeni Chiara, 2013, J Med Case Rep, V7, P185, DOI 10.1186/1752-1947-7-185; Boleij A, 2009, J CLIN MICROBIOL, V47, P516, DOI 10.1128/JCM.01755-08; Bordes-Benitez A, 2006, EUR J CLIN MICROBIOL, V25, P242, DOI 10.1007/s10096-006-0119-x; Carrique-Mas JJ, 2008, BRAZ J POULTRY SCI, V10, P1, DOI 10.1590/S1516-635X2008000100001; Cox NA, 2002, AVIAN DIS, V46, P535, DOI 10.1637/0005-2086(2002)046[0535:IOANSO]2.0.CO;2; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Davies R, 2003, VET REC, V152, P283, DOI 10.1136/vr.152.10.283; Davies RH, 1996, BRIT POULTRY SCI, V37, P589, DOI 10.1080/00071669608417889; DEVRIESE LA, 1990, AVIAN PATHOL, V19, P429, DOI 10.1080/03079459008418697; Dumke J, 2014, J CLIN MICROBIOL, V52, P2472, DOI 10.1128/JCM.03329-13; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; ENDTZ HP, 1993, RES MICROBIOL, V144, P703, DOI 10.1016/0923-2508(93)90034-Y; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Francois B, 1998, J CLIN MICROBIOL, V36, P2395; HEADINGS DL, 1978, J PEDIATR-US, V92, P282, DOI 10.1016/S0022-3476(78)80026-2; Hinse D, 2011, SYST APPL MICROBIOL, V34, P52, DOI 10.1016/j.syapm.2010.11.010; Hinse D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-400; Hogg R, 2009, VET REC, V165, P297, DOI 10.1136/vetrec.165.10.297-a; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kalupahana RS, 2013, APPL ENVIRON MICROB, V79, P393, DOI 10.1128/AEM.02269-12; KLEIN RS, 1977, NEW ENGL J MED, V297, P800, DOI 10.1056/NEJM197710132971503; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Millner PD, 2009, BIORESOURCE TECHNOL, V100, P5379, DOI 10.1016/j.biortech.2009.03.026; Muller W, 1987, WORLD ANIMAL SCI NET; Nemoy LL, 2005, J CLIN MICROBIOL, V43, P1776, DOI 10.1128/JCM.43.4.1776-1781.2005; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Poyart C, 1998, J CLIN MICROBIOL, V36, P41, DOI 10.1128/JCM.36.1.41-47.1998; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Sasaki E, 2004, J VET MED SCI, V66, P1467, DOI 10.1292/jvms.66.1467; Schlegel L, 2003, INT J SYST EVOL MICR, V53, P631, DOI 10.1099/ijs.0.02361-0; Schulz J, 2011, AVIAN PATHOL, V40, P243, DOI 10.1080/03079457.2010.544290; Schulz J, 2013, 16 INT C AN HYG ISAH; Sekizaki T, 2008, AVIAN DIS, V52, P183, DOI 10.1637/8048-070307-Case; Shah SS, 2001, PEDIATR INFECT DIS J, V20, P445, DOI 10.1097/00006454-200104000-00016; Shibata Y, 2014, MICROBIOL-SGM, V160, P113, DOI 10.1099/mic.0.071605-0; Sillanpaa J, 2009, J BACTERIOL, V191, P6643, DOI 10.1128/JB.00909-09; Sillanpaa J, 2008, FEMS MICROBIOL LETT, V289, P104, DOI 10.1111/j.1574-6968.2008.01378.x; Spickler AR, 2005, STREPOCOCCOSOIS; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Van Hoorebeke S, 2010, PREV VET MED, V94, P94, DOI 10.1016/j.prevetmed.2009.11.022; Wales A, 2007, AVIAN PATHOL, V36, P187, DOI 10.1080/03079450701338755	46	19	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126507	10.1371/journal.pone.0126507	http://dx.doi.org/10.1371/journal.pone.0126507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978355	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100077
J	Opstoel, K; Pion, J; Elferink-Gemser, M; Hartman, E; Willemse, B; Philippaerts, R; Visscher, C; Lenoir, M				Opstoel, Katrijn; Pion, Johan; Elferink-Gemser, Marije; Hartman, Esther; Willemse, Bas; Philippaerts, Renaat; Visscher, Chris; Lenoir, Matthieu			Anthropometric Characteristics, Physical Fitness and Motor Coordination of 9 to 11 Year Old Children Participating in a Wide Range of Sports	PLOS ONE			English	Article							MULTIDIMENSIONAL PERFORMANCE-CHARACTERISTICS; FUNDAMENTAL MOVEMENT SKILLS; ELITE; CHILDHOOD; BOYS; GYMNASTICS; COMPETENCE; STRENGTH; VALIDITY; GENES	Objectives The aim of this study was to investigate to what extent 9 to 11 year old children participating in a specific sport already exhibit a specific anthropometric, physical fitness and motor coordination profile, in line with the requirements of that particular sport. In addition, the profiles in children with a different training volume were compared and possible differences in training hours per week between children from a low, moderate, and high level of physical fitness and motor coordination were investigated. Methods and Results Data of 620 children, 347 boys and 273 girls, who participated in the Flemish Sports Compass were used. Only the primary sport of each child was considered and six groups of sports (Ball sports, Dance, Gymnastics, Martial arts, Racquet sports and Swimming) were formed based on common characteristics. Measurements consisted of 17 tests. Independent T-tests and Mann-Whitney U-tests revealed few differences between the groups of sports and the discriminant analyses with the moderate and low active group did not show any significant results (p > .05). However, when discriminating among the high active children, a 85.2 % correct classification between six groups of sports was found (Wilks' Lambda = .137 and p < .001). Finally, children performing under average on the tests spent significantly fewer hours in sport per week (2.50 +/- 1.84 hours) compared to the children performing best (3.25 +/- 2.60 hours) (p = .016) and the children performing above average (2.90 +/- 1.96 hours) (p = .029) on physical fitness and motor coordination. Discussion The study showed that in general, children at a young age do not exhibit sport-specific characteristics, except in children with a high training volume. It is possible that on the one hand, children have not spent enough time yet in their sport to develop sport-specific qualities. On the other hand, it could be possible that they do not take individual qualities into account when choosing a sport.	[Opstoel, Katrijn; Elferink-Gemser, Marije; Willemse, Bas] Univ Appl Sci Nijmegen, Fac Hlth & Social Studies, Inst Sport & Exercise Studies, Nijmegen, Netherlands; [Opstoel, Katrijn; Elferink-Gemser, Marije; Hartman, Esther; Willemse, Bas; Visscher, Chris] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Pion, Johan; Philippaerts, Renaat; Lenoir, Matthieu] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium	University of Groningen; Ghent University	Opstoel, K (corresponding author), Univ Appl Sci Nijmegen, Fac Hlth & Social Studies, Inst Sport & Exercise Studies, Nijmegen, Netherlands.	Katrijn.Opstoel@han.nl	Opstoel, Katrijn/GNH-2879-2022; Opstoel, Katrijn/AAD-7993-2020	Pion, Johan/0000-0002-2633-9120; Opstoel, Katrijn/0000-0002-3919-0513				Bailey R., 2013, INT J COACHING SCI, P56; Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; Bencke J, 2002, SCAND J MED SCI SPOR, V12, P171, DOI 10.1034/j.1600-0838.2002.01128.x; Bressel E, 2007, J ATHL TRAINING, V42, P42; Bruininks RH, 2006, BOT 2 BRUININKS OSER; Carrick FR, 2007, DISABIL REHABIL, V29, P1881, DOI 10.1080/09638280601141335; Chalip L, 1998, SOCIOL SPORT J, V15, P326, DOI 10.1123/ssj.15.4.326; Cometti G., 2007, PLIOMETRIE METHODES; Cote J, 2014, INT J SPORT IN PRESS, V6; Cote J, 2009, INT J SPORT EXERC PS, V7, P7, DOI 10.1080/1612197X.2009.9671889; Davids K, 2007, SPORTS MED, V37, P961, DOI 10.2165/00007256-200737110-00004; Duncan MJ, 2006, BRIT J SPORT MED, V40, P649, DOI 10.1136/bjsm.2005.021998; Durand-Bush N., 2001, HDB SPORT PSYCHOL, V2, P269; Elferink-Gemser MT, 2007, J SPORT SCI, V25, P481, DOI 10.1080/02640410600719945; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Europe Co, 1983, TEST PHYS FITNN EUR; Fetz F., 1993, SPORTMOTORISCHE TEST; Fisher A, 2005, MED SCI SPORT EXER, V37, P684, DOI 10.1249/01.MSS.0000159138.48107.7D; Fransen J, 2014, PEDIATR EXERC SCI, V26, P11, DOI 10.1123/pes.2013-0005; Fransen J, 2012, J SPORT SCI, V30, P379, DOI 10.1080/02640414.2011.642808; Gentier I, 2013, RES DEV DISABIL, V34, P4043, DOI 10.1016/j.ridd.2013.08.040; Green BC, 2005, J SPORT MANAGE, V19, P233, DOI 10.1123/jsm.19.3.233; Hands B, 2008, J SCI MED SPORT, V11, P155, DOI 10.1016/j.jsams.2007.02.012; JOHNSON BL, 1986, PRACTICAL MEASUREMEN; Kiphard E. J., 2007, KORPERKOORDINATIONST, V2nd; Kirkpatrick J, 2013, J STRENGTH COND RES, V27, P2414, DOI 10.1519/JSC.0b013e3182804a6d; Leone M, 2002, J SPORT SCI, V20, P443, DOI 10.1080/02640410252925116; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; Matthys SPJ, 2013, J SPORT SCI, V31, P325, DOI 10.1080/02640414.2012.733819; Okely AD, 2001, MED SCI SPORT EXER, V33, P1899, DOI 10.1097/00005768-200111000-00015; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Philippaerts RM, 2006, INT J SPORTS MED, V27, P131, DOI 10.1055/s-2005-837619; Pion J, 2014, EUR J SPORT SCI, P1, DOI DOI 10.1080/17461391.2014.944875; Pion J, 2014, ARCH BUDO, V10, P147; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; SALLIS JF, 1994, PEDIATR EXERC SCI, V6, P302; Tucker R, 2012, BRIT J SPORT MED, V46, P555, DOI 10.1136/bjsports-2011-090548; Vandendriessche JB, 2012, PEDIATR EXERC SCI, V24, P113, DOI 10.1123/pes.24.1.113; Vandorpe B, 2011, INT J SPORTS MED, V32, P591, DOI 10.1055/s-0031-1275300; Vandorpe B, 2012, J SCI MED SPORT, V15, P220, DOI 10.1016/j.jsams.2011.09.006; Vrijkotte S., 2007, FITHEIDSTESTEN JEUGD; WANKEL LM, 1985, J SPORT PSYCHOL, V7, P51, DOI 10.1123/jsp.7.1.51; Weiss M.R., 2008, ADV SPORT PSYCHOL, V3rd ed., P115; [No title captured]	45	36	37	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126282	10.1371/journal.pone.0126282	http://dx.doi.org/10.1371/journal.pone.0126282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978313	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100060
J	Rueda, M; Saiz, JCM; Morales-Castilla, I; Albuquerque, FS; Ferrero, M; Rodriguez, MA				Rueda, Marta; Moreno Saiz, Juan Carlos; Morales-Castilla, Ignacio; Albuquerque, Fabio S.; Ferrero, Mila; Rodriguez, Miguel A.			Detecting Fragmentation Extinction Thresholds for Forest Understory Plant Species in Peninsular Spain	PLOS ONE			English	Article							HABITAT FRAGMENTATION; MONOTROPA-HYPOPITYS; POPULATIONS; GERMINATION; PATTERNS; ANCIENT; ECOLOGY; HERBS	Ecological theory predicts that fragmentation aggravates the effects of habitat loss, yet empirical results show mixed evidences, which fail to support the theory instead reinforcing the primary importance of habitat loss. Fragmentation hypotheses have received much attention due to their potential implications for biodiversity conservation, however, animal studies have traditionally been their main focus. Here we assess variation in species sensitivity to forest amount and fragmentation and evaluate if fragmentation is related to extinction thresholds in forest understory herbs and ferns. Our expectation was that forest herbs would be more sensitive to fragmentation than ferns due to their lower dispersal capabilities. Using forest cover percentage and the proportion of this percentage occurring in the largest patch within UTM cells of 10-km resolution covering Peninsular Spain, we partitioned the effects of forest amount versus fragmentation and applied logistic regression to model occurrences of 16 species. For nine models showing robustness according to a set of quality criteria we subsequently defined two empirical fragmentation scenarios, minimum and maximum, and quantified species' sensitivity to forest contraction with no fragmentation, and to fragmentation under constant forest cover. We finally assessed how the extinction threshold of each species (the habitat amount below which it cannot persist) varies under no and maximum fragmentation. Consistent with their preference for forest habitats probability occurrences of all species decreased as forest cover contracted. On average, herbs did not show significant sensitivity to fragmentation whereas ferns were favored. In line with theory, fragmentation yielded higher extinction thresholds for two species. For the remaining species, fragmentation had either positive or non-significant effects. We interpret these differences as reflecting species-specific traits and conclude that although forest amount is of primary importance for the persistence of understory plants, to neglect the impact of fragmentation for some species can lead them to local extinction.	[Rueda, Marta] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Rueda, Marta; Ferrero, Mila; Rodriguez, Miguel A.] Univ Alcala, Dept Life Sci, Forest Ecol & Restorat Grp, Madrid, Spain; [Moreno Saiz, Juan Carlos] Univ Autonoma Madrid, Dept Biol Bot, Madrid, Spain; [Morales-Castilla, Ignacio] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Albuquerque, Fabio S.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA	University of California System; University of California Irvine; Universidad de Alcala; Autonomous University of Madrid; McGill University; Northern Arizona University	Rueda, M (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	mrueda.eco@gmail.com	Moreno-Saiz, Juan Carlos/C-3045-2008; Rueda, Marta/K-5024-2014; MORALES-CASTILLA, IGNACIO/J-6663-2016; Rodriguez, Miguel A/A-3409-2011; Morales-Castilla, Ignacio/AAB-2649-2019	Moreno-Saiz, Juan Carlos/0000-0002-0793-9956; Rueda, Marta/0000-0002-9754-6258; MORALES-CASTILLA, IGNACIO/0000-0002-8570-9312; Rodriguez, Miguel A/0000-0002-4082-2995; Morales-Castilla, Ignacio/0000-0002-8570-9312	Ministry of Economy and Competitiveness of Spain [CGL2010-22119]; Spanish Ministry for Education and Science [BVA-2010-0596]; Integrated Program of ICDT [1/SAESCTN/ALENT-07-0224-FEDER-001755]	Ministry of Economy and Competitiveness of Spain(Spanish Government); Spanish Ministry for Education and Science(Spanish Government); Integrated Program of ICDT	This study was sponsored by a research grant from the Ministry of Economy and Competitiveness of Spain (CGL2010-22119 to MAR). MR was funded by the Spanish Ministry for Education and Science (BVA-2010-0596). IM-C was funded by the Integrated Program of IC&DT (No. 1/SAESCTN/ALENT-07-0224-FEDER-001755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren Henrik, 1995, IALE Studies in Landscape Ecology, V2, P225; Angelstam P., 1992, ECOLOGICAL PRINCIPLE, P9, DOI DOI 10.1007/978-1-4615-3524-9_2; [Anonymous], 1997, ATLAS FLORA PIRINEO; Aranda SC, 2013, GLOBAL ECOL BIOGEOGR, V22, P483, DOI 10.1111/geb.12008; Atlegrim O, 1996, FOREST ECOL MANAG, V86, P39, DOI 10.1016/S0378-1127(96)03794-2; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; Beatty GE, 2011, ANN BOT-LONDON, V107, P663, DOI 10.1093/aob/mcr003; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Betts MG, 2014, ECOGRAPHY, V37, P517, DOI 10.1111/ecog.00740; BJORKMAN E, 1960, PHYSIOL PLANTARUM, V13, P308, DOI 10.1111/j.1399-3054.1960.tb08034.x; Bolos O, 1998, ATLAS COROLOGIC FLOR; Bolos O., 1984, FLORA DELS PAISOS CA, V1; Brunet J, 2011, FOREST ECOL MANAG, V262, P1863, DOI 10.1016/j.foreco.2011.08.007; Carranza ML, 2012, PLANT ECOL DIVERS, V5, P541, DOI 10.1080/17550874.2012.740509; Corley HV, 1967, P BOT SOC BRIT ISLES, V7, P73; Costa Tenorio M, 2005, BOSQUES IBERICOS INT; COUSENS MI, 1981, BOT GAZ, V142, P251, DOI 10.1086/337220; Didham RK, 2012, OIKOS, V121, P161, DOI 10.1111/j.1600-0706.2011.20273.x; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Freeman EA, 2008, J STAT SOFTW, V23, P1; Froborg H, 1997, J VEG SCI, V8, P395, DOI 10.2307/3237329; Gardner WA, 1921, BOT GAZ, V71, P249, DOI 10.1086/332836; Godefroid S, 2005, FOREST ECOL MANAG, V210, P39, DOI 10.1016/j.foreco.2005.02.020; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; Hanski I, 1995, MOSAIC LANDSCAPES EC, P204; Heinken Thilo, 2000, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V122, P449; Hermy M, 1999, BIOL CONSERV, V91, P9, DOI 10.1016/S0006-3207(99)00045-2; Honnay O, 2005, NEW PHYTOL, V166, P723, DOI 10.1111/j.1469-8137.2005.01352.x; Honnay O, 1998, BELG J BOT, V130, P139; HUTCHINSON TC, 1968, J ECOL, V56, P901, DOI 10.2307/2258113; INGHE O, 1985, OIKOS, V45, P400, DOI 10.2307/3565576; Izuzquiza A, 1988, FONTQUERIA, V17, P1; Jacquemyn H, 2003, ECOGRAPHY, V26, P768, DOI 10.1111/j.0906-7590.2003.03620.x; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jules ES, 2003, J VEG SCI, V14, P459, DOI 10.1111/j.1654-1103.2003.tb02172.x; Kessler M., 2010, FERN ECOLOGY, P22, DOI DOI 10.1017/CBO9780511844898.003; LANDE R, 1987, AM NAT, V130, P624, DOI 10.1086/284734; Leake JR, 2004, NEW PHYTOL, V163, P405, DOI 10.1111/j.1469-8137.2004.01115.x; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; McFadden D., 1979, BEHAV TRAVEL MODELLI, DOI DOI 10.4324/9781003156055; Montoya D, 2008, SCIENCE, V320, P1502, DOI 10.1126/science.1158404; Montoya D, 2010, OIKOS, V119, P1335, DOI 10.1111/j.1600-0706.2010.18280.x; Mutter H, 1998, NORD J BOT, V18, P267, DOI 10.1111/j.1756-1051.1998.tb01880.x; PEINADO LORCA M., 1987, VEGETACION ESPANA; Rueda M, 2013, GLOBAL ECOL BIOGEOGR, V22, P1282, DOI 10.1111/geb.12079; Salvo E, 1990, GUIA HELECHOS PENINS; SCHNELLER JJ, 1979, PLANT SYST EVOL, V132, P255, DOI 10.1007/BF00982389; Scurfield G, 1954, TRIN J ECOL, V12, P225; Secretariat of the convention on biological diversity, 2020, GLOBAL BIODIVERSITY; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; TYLER G, 1989, FOREST ECOL MANAG, V28, P101, DOI 10.1016/0378-1127(89)90063-7; von Oheimb G, 2005, EUR J FOREST RES, V124, P55, DOI 10.1007/s10342-005-0053-y; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	58	8	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126424	10.1371/journal.pone.0126424	http://dx.doi.org/10.1371/journal.pone.0126424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978329	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100068
J	Zhao, N; Zhang, Y; Liu, Q; Xiang, WP				Zhao, Na; Zhang, Yong; Liu, Qun; Xiang, Wenpei			Mfn2 Affects Embryo Development via Mitochondrial Dysfunction and Apoptosis	PLOS ONE			English	Article							ENERGY-METABOLISM; ENDOPLASMIC-RETICULUM; OXYGEN-CONSUMPTION; BCL-X; MOUSE; EXPRESSION; OOCYTE; GENE; FERTILIZATION; STRESS	Background Growth factors, energy sources, and mitochondrial function strongly affect embryo growth and development in vitro. The biological role and prospective significance of the mitofusin gene Mfn2 in the development of preimplantation embryos remain poorly understood. Our goal is to profile the role of Mfn2 in mouse embryos and determine the underlying mechanism of Mfn2 function in embryo development. Methods We transfected Mfn2-siRNA into 2-cell fertilized eggs and then examined the expression of Mfn2, the anti-apoptotic protein Bcl-2, and the apoptosis-promoting protein Bax by Western blot. Additionally, we determined the blastocyst formation rate and measured ATP levels, mtDNA levels, mitochondrial membrane potential (Delta psi m), and apoptosis in all of the embryos. Results The results indicate that the Mfn2 and Bcl-2 levels were markedly decreased, whereas Bax levels were increased in the T group (embryos transfected with Mfn2-siRNA) compared with the C group (embryos transfected with control-siRNA). The blastocyst formation rate was significantly decreased in the T group. The ATP content and the relative amounts of mtDNA and cDNA in the T group were significantly reduced compared with the C group. In the T group, Delta psi m and Ca2+ levels were reduced, and the number of apoptotic cells was increased. Conclusion Low in vitro expression of Mfn2 attenuates the blastocyst formation rate and cleavage speed in mouse zygotes and causes mitochondrial dysfunction, as confirmed by the ATP and mtDNA levels and mitochondrial membrane potential. Mfn2 deficiency induced apoptosis through the Bcl-2/Bax and Ca2+ pathways. These findings indicate that Mfn2 could affect preimplantation embryo development through mitochondrial function and cellular apoptosis.	[Zhao, Na; Liu, Qun; Xiang, Wenpei] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Family Planning Res Inst, Wuhan 430074, Hubei, Peoples R China; [Zhang, Yong] Huazhong Univ Sci & Technol, Union Hosp, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xiang, WP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Family Planning Res Inst, Wuhan 430074, Hubei, Peoples R China.	wpxiang2010@gmail.com			Natural Science Foundation of China (NSFC) [31201079]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by a grant (31201079) from the Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton BM, 2004, MOL HUM REPROD, V10, P23, DOI 10.1093/molehr/gah004; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Dimmer KS, 2006, PHYSIOLOGY, V21, P233, DOI 10.1152/physiol.00010.2006; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Gardner DK, 1998, THERIOGENOLOGY, V49, P83, DOI 10.1016/S0093-691X(97)00404-4; Gasca S, 2007, REPROD BIOMED ONLINE, V14, P175, DOI 10.1016/S1472-6483(10)60785-7; Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Houghton FD, 1996, MOL REPROD DEV, V44, P476, DOI 10.1002/(SICI)1098-2795(199608)44:4&lt;476::AID-MRD7&gt;3.0.CO;2-I; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jiang GJ, 2005, BIOCHEM BIOPH RES CO, V335, P351, DOI 10.1016/j.bbrc.2005.07.088; Kimber SJ, 2008, REPRODUCTION, V135, P635, DOI 10.1530/REP-07-0359; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; LEESE HJ, 1984, J REPROD FERTIL, V72, P9, DOI 10.1530/jrf.0.0720009; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; Pang W, 2013, PLACENTA, V34, P613, DOI 10.1016/j.placenta.2013.03.013; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Santel A, 2001, J CELL SCI, V114, P867; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Shaw L, 2012, REPRODUCTION, V144, P569, DOI 10.1530/REP-12-0047; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; Thompson JG, 1996, J REPROD FERTIL, V106, P299, DOI 10.1530/jrf.0.1060299; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260; Trimarchi JR, 2000, BIOL REPROD, V62, P1866, DOI 10.1095/biolreprod62.6.1866; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Wang WL, 2012, MED ONCOL, V29, P70, DOI 10.1007/s12032-010-9779-6; Zhang Y, 2011, METABOLISM, V60, P767, DOI 10.1016/j.metabol.2010.07.026	38	36	37	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125680	10.1371/journal.pone.0125680	http://dx.doi.org/10.1371/journal.pone.0125680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978725	Green Submitted, gold, Green Published			2022-12-27	WOS:000354916100033
J	Bansal, SK; Gupta, N; Sankhwar, SN; Rajender, S				Bansal, Sandeep Kumar; Gupta, Nishi; Sankhwar, Satya Narayan; Rajender, Singh			Differential Genes Expression between Fertile and Infertile Spermatozoa Revealed by Transcriptome Analysis	PLOS ONE			English	Article							FERTILIZATION PROMOTING PEPTIDE; HUMAN-SPERM; MESSENGER-RNA; SPERMATOGENESIS; MICROARRAY; MUTATIONS; PROTEINS; HOMOLOG; CELLS; MICE	Background It was believed earlier that spermatozoa have no traces of RNA because of loss of most of the cytoplasm. Recent studies have revealed the presence of about 3000 different kinds of mRNAs in ejaculated spermatozoa. However, the correlation of transcriptome profile with infertility remains obscure. Methods Total RNA from sperm (after exclusion of somatic cells) of 60 men consisting of individuals with known fertility (n=20), idiopathic infertility (normozoospermic patients, n=20), and asthenozoospermia (n=20) was isolated. After RNA quality check on Bioanalyzer, Affymetrix-GeneChip Human Gene 1.0 ST Array was used for expression profiling, which consisted of >30,000 coding transcripts and >11,000 long intergenic non-coding transcripts. Results Comparison between all three groups revealed that two thousand and eighty one transcripts were differentially expressed. Analysis of these transcripts showed that some transcripts [ribosomal proteins (RPS25, RPS11, RPS13, RPL30, RPL34, RPL27, RPS5), HINT1, HSP90AB1, SRSF9, EIF4G2, ILF2] were up-regulated in the normozoospermic group, but down-regulated in the asthenozoospermic group in comparison to the control group. Some transcripts were specific to the normozoospermic group (up-regulated: CAPNS1, FAM153C, ARF1, CFL1, RPL19, USP22; down-regulated: ZNF90, SMNDC1, c14orf126, HNRNPK), while some were specific to the asthenozoospermic group (up-regulated: RPL24, HNRNPM, RPL4, PRPF8, HTN3, RPL11, RPL28, RPS16, SLC25A3, C2orf24, RHOA, GDI2, NONO, PARK7; down-regulated: HNRNPC, SMARCAD1, RPS24, RPS24, RPS27A, KIFAP3). A number of differentially expressed transcripts in spermatozoa were related to reproduction (n=58) and development (n=210). Some of these transcripts were related to heat shock proteins (DNAJB4, DNAJB14), testis specific genes (TCP11, TESK1, TSPYL1, ADAD1), and Y-chromosome genes (DAZ1, TSPYL1). Conclusion A complex RNA population in spermatozoa consisted of coding and non-coding RNAs. A number of transcripts that participate in a host of cellular processes, including reproduction and development were differentially expressed between fertile and infertile individuals. Differences between comparison groups suggest that sperm RNA has strong potential of acting as markers for fertility evaluation.	[Bansal, Sandeep Kumar; Gupta, Nishi; Rajender, Singh] Cent Drug Res Inst, Div Endocrinol, Lucknow 226001, Uttar Pradesh, India; [Sankhwar, Satya Narayan] King Georges Med Univ, Dept Urol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University	Rajender, S (corresponding author), Cent Drug Res Inst, Div Endocrinol, Lucknow 226001, Uttar Pradesh, India.	rajender_singh@cdri.res.in	Singh, Rajender/ABE-3512-2020	Rajender, Singh/0000-0002-4592-6566	Department of Biotechnology (D.Bt.), Govt. of India [BT/PR13083/GBD/27/172/2009]	Department of Biotechnology (D.Bt.), Govt. of India(Department of Biotechnology (DBT) India)	This research was supported by financial grant from the Department of Biotechnology (D.Bt.), Govt. of India under Rapid Grant for Young Investigator (RGYI) scheme with reference number BT/PR13083/GBD/27/172/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CC, 2007, DEVELOPMENT, V134, P2863, DOI 10.1242/dev.003764; Bao JQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004825; Bornstein C, 2011, MOL CELL BIOL, V31, P1679, DOI 10.1128/MCB.01072-10; Chen XL, 2014, MOL REPROD DEV, V81, P908, DOI 10.1002/mrd.22386; Depa-Martynow Magdalena, 2007, Folia Histochem Cytobiol, V45 Suppl 1, pS79; Fraser LR, 1998, REV REPROD, V3, P151, DOI 10.1530/ror.0.0030151; Geisinger A, 1996, INT J DEV BIOL, V40, P385; Gibbons JG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5850; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Grunewald S, 2005, ANDROLOGIA, V37, P69, DOI 10.1111/j.1439-0272.2005.00656.x; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Held T, 2006, MOL CELL BIOL, V26, P8099, DOI 10.1128/MCB.01332-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; KANEKO S, 1986, BIOL REPROD, V35, P1059, DOI 10.1095/biolreprod35.4.1059; Kaneko T, 2010, MOL REPROD DEV, V77, P363, DOI 10.1002/mrd.21154; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; KUMAR G, 1993, CELL MOL BIOL RES, V39, P111; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Lalancette C, 2009, J MOL MED, V87, P735, DOI 10.1007/s00109-009-0485-9; Liu T, 2012, MOL MED REP, V6, P535, DOI 10.3892/mmr.2012.967; Ma YX, 2002, MOL HUM REPROD, V8, P24, DOI 10.1093/molehr/8.1.24; Martins RP, 2005, ASIAN J ANDROL, V7, P115, DOI 10.1111/j.1745-7262.2005.00048.x; Miller D, 1999, GENE, V237, P385, DOI 10.1016/S0378-1119(99)00324-8; Miller D, 2005, TRENDS MOL MED, V11, P156, DOI 10.1016/j.molmed.2005.02.006; Miller D, 2000, MOL REPROD DEV, V56, P259, DOI 10.1002/(SICI)1098-2795(200006)56:2+<259::AID-MRD10>3.0.CO;2-R; Miyagawa Y, 2005, J ANDROL, V26, P779, DOI 10.2164/jandrol.05069; Ostermeier GC, 2005, J ANDROL, V26, P70; PESSOT CA, 1989, BIOCHEM BIOPH RES CO, V158, P272, DOI 10.1016/S0006-291X(89)80208-6; Rajender Singh, 2012, Front Biosci (Schol Ed), V4, P1266; Ravel C, 2007, MOL HUM REPROD, V13, P461, DOI 10.1093/molehr/gam031; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trainor PA, 2014, BBA-MOL BASIS DIS, V1842, P769, DOI 10.1016/j.bbadis.2013.11.010; Wong CC, 2011, BLOOD, V118, P4305, DOI 10.1182/blood-2011-06-353938; World Health Organization, 1999, WHO LAB MAN EX HUM S, V4th; Yatsenko AN, 2006, HUM MOL GENET, V15, P3411, DOI 10.1093/hmg/ddl417	40	77	77	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127007	10.1371/journal.pone.0127007	http://dx.doi.org/10.1371/journal.pone.0127007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973848	gold, Green Submitted, Green Published			2022-12-27	WOS:000354545600096
J	Chen, CY; Huang, SY; Cheng, A; Chou, WC; Yao, M; Tang, JL; Tsay, W; Sheng, WH; Tien, HF				Chen, Chien-Yuan; Huang, Sheng-Yi; Cheng, Aristine; Chou, Wen-Chien; Yao, Ming; Tang, Jih-Luh; Tsay, Woei; Sheng, Wang-Huei; Tien, Hwei-Fang			High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							VIRUS HBV REACTIVATION; BONE-MARROW-TRANSPLANTATION; CYTOTOXIC CHEMOTHERAPY; CANCER-PATIENTS; HEPATOCELLULAR-CARCINOMA; DIABETES-MELLITUS; INFECTION; LYMPHOMA; CARRIERS; VACCINATION	Background Hepatitis B virus (HBV) infections are common and associated with significant morbidity and mortality in cancer patients. However, the incidence and risk factors of HBV reactivation in patients with acute myeloid leukemia (AML) are rarely investigated. Methods AML patients followed-up at the National Taiwan University Hospital between 2006 and 2012 were analyzed. The clinical characteristics and laboratory data were retrospectively reviewed. Results Four hundred and ninety patients comprising 265 men and 225 women were studied. The median age was 52 years (range, 18 - 94). Chronic HBV carriage was documented at the time of leukemia diagnosis in 57 (11.6%) patients. Forty-six (80.7%) of the 57 HBV carriers received prophylaxis with anti-HBV agents. Sixteen HBV carriers (28.1%) developed hepatitis B reactivation during or after chemotherapy, including 7 patients who had discontinued antiviral therapy. The incidence of hepatitis B reactivation among AML patients with HBV carriage was 9.5 per 100 person-years. Prophylaxis with anti-HBV agents significantly decreased the risk of hepatitis B reactivation among HBV carriers (13% vs. 61%, p<0.001). Four (2.8%) of 142 patients with initial positive anti-HBsAb and anti-HBcAb experienced hepatitis B reactivation and lost their protective anti-HBsAb. Multivariate analysis revealed that diabetes mellitus (p=0.008, odds ratio (OR) = 2.841, 95% confident interval (CI): 0.985-8.193) and carriage of HBsAg (p<0.001, OR=36.878, 95% CI: 11.770-115.547) were independent risk factors for hepatitis B reactivation in AML patients. Conclusions Hepatitis B reactivation is not uncommon in the HBsAg positive AML patients. Prophylaxis with anti-HBV agent significantly decreased the risk of hepatitis B reactivation.	[Chen, Chien-Yuan; Huang, Sheng-Yi; Chou, Wen-Chien; Yao, Ming; Tang, Jih-Luh; Tsay, Woei; Tien, Hwei-Fang] Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan; [Cheng, Aristine; Sheng, Wang-Huei] Natl Taiwan Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei 100, Taiwan; [Chou, Wen-Chien] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Tang, Jih-Luh] Natl Taiwan Univ Hosp, Tai Cheng Stem Cell Therapy Ctr, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Sheng, WH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei 100, Taiwan.	whsheng@ntu.edu.tw		SHENG, WANG-HUEI/0000-0002-5605-7853; Chen, Chien-Yuan/0000-0003-2831-8822; TIEN, HWEI-FANG/0000-0002-1384-5593; YAO, MING/0000-0003-2932-0019; CHOU, WEN-CHIEN/0000-0003-2967-698X; Cheng, Aristine/0000-0002-1182-7375; TANG, JIH-LUH/0000-0003-4021-3281	Department of Medical Research in National Taiwan University Hospital, Taiwan [103-002452]	Department of Medical Research in National Taiwan University Hospital, Taiwan	This study was supported in part by grant 103-002452, Department of Medical Research in National Taiwan University Hospital, Taiwan. No additional external funding was received for this study.	Artz AS, 2010, J CLIN ONCOL, V28, P3199, DOI 10.1200/JCO.2010.30.0673; Baden LR, 2012, J NATL COMPR CANC NE, V10, P1412, DOI 10.6004/jnccn.2012.0146; Bihl F, 2010, SWISS MED WKLY, V140, P154, DOI smw-12969; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Cetkovska P, 2002, J EUR ACAD DERMATOL, V16, P481, DOI 10.1046/j.1468-3083.2002.00395.x; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Cheng AL, 2003, HEPATOLOGY, V37, P1320, DOI 10.1053/jhep.2003.50220; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Demir M, 2008, EUR J GASTROEN HEPAT, V20, P668, DOI 10.1097/MEG.0b013e3282f55e1e; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gao C, 2010, WORLD J GASTROENTERO, V16, P4467, DOI 10.3748/wjg.v16.i35.4467; Hsu C, 2014, HEPATOLOGY, V59, P2092, DOI 10.1002/hep.26718; Ishiga K, 2001, INT J HEMATOL, V73, P115, DOI 10.1007/BF02981912; Khouri IF, 1998, J CLIN ONCOL, V16, P3803, DOI 10.1200/JCO.1998.16.12.3803; Koh C, 2013, HEPATOLOGY, V58, P2142, DOI 10.1002/hep.26578; Kojima H, 2002, EUR J HAEMATOL, V69, P101, DOI 10.1034/j.1600-0609.2002.02719.x; Koo YX, 2011, ANN HEMATOL, V90, P1219, DOI 10.1007/s00277-011-1241-0; Kusumoto S, 2011, J GASTROENTEROL, V46, P9, DOI 10.1007/s00535-010-0331-4; Liang R, 1999, J CLIN ONCOL, V17, P394, DOI 10.1200/JCO.1999.17.1.394; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Lu CY, 2004, HEPATOLOGY, V40, P1415, DOI 10.1002/hep.20490; Manzano-Alonso ML, 2011, WORLD J GASTROENTERO, V17, P1531, DOI [10.3748/wjg.v17.i12. 1531, 10.3748/wjg.v17.i12.1531]; MARTIN BA, 1995, BONE MARROW TRANSPL, V15, P145; Nakamura Y, 1996, CANCER-AM CANCER SOC, V78, P2210, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Ni YH, 2001, ANN INTERN MED, V135, P796, DOI 10.7326/0003-4819-135-9-200111060-00009; Palmore TN, 2009, CLIN GASTROENTEROL H, V7, P1130, DOI 10.1016/j.cgh.2009.06.027; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Sarrecchia Cesare, 2005, Journal of Infection and Chemotherapy, V11, P189, DOI 10.1007/s10156-005-0385-z; Shouval D, 2013, SEMIN LIVER DIS, V33, P167, DOI 10.1055/s-0033-1345722; SUNG JL, 1984, CHINESE J GASTROENTE, V1, P1; Tsutsumi Y, 2013, WORLD J HEPATOL, V5, P612, DOI 10.4254/wjh.v5.i11.612; ul-Haq N, 2003, VACCINE, V21, P3179, DOI 10.1016/S0264-410X(03)00232-9; VELASQUEZ WS, 1994, J CLIN ONCOL, V12, P1169, DOI 10.1200/JCO.1994.12.6.1169; Wang YY, 2010, METABOLISM, V59, P486, DOI 10.1016/j.metabol.2009.07.038; Wong G. C., 1996, Annals Academy of Medicine Singapore, V25, P500; Wu Chunchen, 2013, Virologica Sinica, V28, P49, DOI 10.1007/s12250-013-3285-x; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0; Yujiri T, 2014, ANN HEMATOL, V93, P351, DOI 10.1007/s00277-013-1804-3	42	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126037	10.1371/journal.pone.0126037	http://dx.doi.org/10.1371/journal.pone.0126037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973905	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600038
J	Huerta-Chagoya, A; Vazquez-Cardenas, P; Moreno-Macias, H; Tapia-Maruri, L; Rodriguez-Guillen, R; Lopez-Vite, E; Garcia-Escalante, G; Escobedo-Aguirre, F; Parra-Covarrubias, A; Cordero-Brieno, R; Manzo-Carrillo, L; Zacarias-Castillo, R; Vargas-Garcia, C; Aguilar-Salinas, C; Tusie-Luna, T				Huerta-Chagoya, Alicia; Vazquez-Cardenas, Paola; Moreno-Macias, Hortensia; Tapia-Maruri, Leonardo; Rodriguez-Guillen, Rosario; Lopez-Vite, Erika; Garcia-Escalante, Guadalupe; Escobedo-Aguirre, Fernando; Parra-Covarrubias, Adalberto; Cordero-Brieno, Roberto; Manzo-Carrillo, Lizette; Zacarias-Castillo, Rogelio; Vargas-Garcia, Carlos; Aguilar-Salinas, Carlos; Tusie-Luna, Teresa			Genetic Determinants for Gestational Diabetes Mellitus and Related Metabolic Traits in Mexican Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; COMMON VARIANTS; SUSCEPTIBILITY LOCI; SEQUENCE VARIANTS; METAANALYSIS; EXPRESSION; TCF7L2; WEIGHT; KCNQ1	Epidemiological and physiological similarities among Gestational Diabetes Mellitus (GDM) and Type 2 Diabetes (T2D) suggest that both diseases, share a common genetic background. T2D risk variants have been associated to GDM susceptibility. However, the genetic architecture of GDM is not yet completely understood. We analyzed 176 SNPs for 115 loci previously associated to T2D, GDM and body mass index (BMI), as well as a set of 118 Ancestry Informative Markers (AIMs), in 750 pregnant Mexican women. Association with GDM was found for two of the most frequently replicated T2D loci: a TCF7L2 haplotype (CTTC: rs7901695, rs4506565, rs7903146, rs12243326; P=2.16x10(-06); OR=2.95) and a KCNQ1 haplotype (TTT: rs2237892, rs163184, rs2237897; P=1.98x10(-05); OR=0.55). In addition, we found two loci associated to glycemic traits: CENTD2 (60' OGTT glycemia: rs1552224, P=0.03727) and MTNR1B (HOMA B: rs1387153, P=0.05358). Remarkably, a major susceptibility SLC16A11 locus for T2D in Mexicans was not shown to play a role in GDM risk. The fact that two of the main T2D associated loci also contribute to the risk of developing GDM in Mexicans, confirm that both diseases share a common genetic background. However, lack of association with a Native American contribution T2D risk haplotype, SLC16A11, suggests that other genetic mechanisms may be in play for GDM.	[Huerta-Chagoya, Alicia; Vazquez-Cardenas, Paola; Tapia-Maruri, Leonardo; Rodriguez-Guillen, Rosario; Tusie-Luna, Teresa] Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Inst Invest Biomed, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos] Inst Nacl Ciencias Med & Nutr Salcador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico; [Moreno-Macias, Hortensia] Univ Autonoma Metropolitana, Dept Econ, Mexico City, DF, Mexico; [Lopez-Vite, Erika] Hosp Gen OHoran, Dept Ginelocol & Obstet, Merida, Yucatan, Mexico; [Garcia-Escalante, Guadalupe] Univ Autonoma Yucatan, Dept Genet, Merida, Yucatan, Mexico; [Escobedo-Aguirre, Fernando] Ctr Med Nacl 20 Noviembre, Dept Ginecol & Med Perinatal, Mexico City, DF, Mexico; [Parra-Covarrubias, Adalberto] Inst Nacl Perinatol, Dept Endocrinol, Mexico City, DF, Mexico; [Cordero-Brieno, Roberto; Manzo-Carrillo, Lizette; Zacarias-Castillo, Rogelio] Hosp Gen Manuel Gea Gonzalez, Dept Obstet & Ginecol, Mexico City, DF, Mexico; [Vargas-Garcia, Carlos] Ctr Invest Materno Infantil GEN, Dept Obstet & Ginecol, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma de Yucatan; Universidad Nacional Autonoma de Mexico	Tusie-Luna, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Inst Invest Biomed, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico.	mttusie@gmail.com	Salinas, Carlos A Aguilar/AAL-4491-2020; del Rosario, Rodriguez-Guillen Maria/ADO-2554-2022; Vazquez-Cardenas, Paola/L-5253-2014	del Rosario, Rodriguez-Guillen Maria/0000-0002-6587-5786; Huerta-Chagoya, Alicia/0000-0001-6218-3904; Garcia Escalante, Maria Guadalupe/0000-0002-3434-7526; Vazquez-Cardenas, Paola/0000-0002-6042-9322	Fondo Sectorial de Investigacion en Salud [115250]; Consejo Nacional de Ciencia y Tecnologia (CONACyT); Carlos Slim Health Institute	Fondo Sectorial de Investigacion en Salud; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Carlos Slim Health Institute	This project was supported by the Fondo Sectorial de Investigacion en Salud, grant number: 115250. AHC and PVC received support through graduate fellowships provided by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (http://www.conacyt.mx). The SIGMA T2D Diabetes Project was conducted as part of the Slim Initiative for Genomic Medicine, a joint US-Mexico project funded by the Carlos Slim Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Chelbi ST, 2012, HUM MOL GENET, V21, P1968, DOI 10.1093/hmg/dds006; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen YC, 2013, INT J MOL SCI, V14, P5380, DOI 10.3390/ijms14035380; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Enns JE, 2011, J OBES, V2011, DOI 10.1155/2011/168659; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Evangelista AF, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-28; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Galanter JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002554; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Groop L, 2010, NAT GENET, V42, P190, DOI 10.1038/ng0310-190; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Imamura M, 2011, DIABETOLOGIA, V54, P3071, DOI 10.1007/s00125-011-2293-3; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Jimenez-Corona AA-S, 2013, SALUD PUBLICA MEXICO, V3, pS137; Kanauchi M, 2002, DIABETES CARE, V25, P1891, DOI 10.2337/diacare.25.10.1891; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Korostowski L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002956; Krishnaveni GV, 2009, DIABETOLOGIA, V52, P2350, DOI 10.1007/s00125-009-1499-0; Kulzer JR, 2014, AM J HUM GENET, V94, P186, DOI 10.1016/j.ajhg.2013.12.011; Kuzmicki M, 2011, DIABETES RES CLIN PR, V94, pE43, DOI 10.1016/j.diabres.2011.07.033; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Kwak SH, 2012, OBESITY, V20, P233, DOI 10.1038/oby.2011.253; Lacroix M, 2014, ACTA DIABETOLOGICA; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lin Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-97; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Guzman-Flores JM, 2013, J INVEST MED, V61, P265, DOI 10.2310/JIM.0b013e31827b98c9; Mao HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045882; McCarthy MI, 2013, CELL METAB, V17, P157, DOI 10.1016/j.cmet.2013.01.011; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nagorny C, 2012, CURR DIABETES REP, V12, P667, DOI 10.1007/s11892-012-0327-y; Nguyen BT, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.049; Nielsen T, 2011, DIABETOLOGIA, V54, P1052, DOI 10.1007/s00125-011-2054-3; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Papadopoulou A, 2009, DIABETOLOGIA, V52, P1339, DOI 10.1007/s00125-009-1351-6; Park S, 2013, EUR J CLIN NUTR, V67, P196, DOI 10.1038/ejcn.2012.207; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu C, 2007, PHYSIOL RES, V56, P571, DOI 10.33549/physiolres.931073; Ramirez-Torres MA, 2013, NUTR REV, V71, pS37, DOI 10.1111/nure.12070; Reyes-Lopez R, 2014, DIABETES METABOLISM; Rizzo M, 2008, DIABETIC MED, V25, P1406, DOI 10.1111/j.1464-5491.2008.02613.x; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Monroy VS, 2014, J INVEST MED, V62, P632, DOI 10.2310/JIM.0000000000000045; Sanchez-Vera I, 2007, METABOLISM, V56, P1527, DOI 10.1016/j.metabol.2007.06.020; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Souren NY, 2008, INT J OBESITY, V32, P1233, DOI 10.1038/ijo.2008.68; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; The STDC, 2013, NATURE; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Torn C, 2004, HUM IMMUNOL, V65, P1443, DOI 10.1016/j.humimm.2004.09.002; Travers ME, 2013, DIABETES, V62, P987, DOI 10.2337/db12-0819; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Urbanek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032958; Veeraswamy S, 2012, DIABETES RES CLIN PR, V97, P350, DOI 10.1016/j.diabres.2012.04.024; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026953; Watanabe RM, 2007, DIABETES, V56, P1481, DOI 10.2337/db06-1682; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Weng JP, 2002, DIABETES CARE, V25, P68, DOI 10.2337/diacare.25.1.68; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang CL, 2013, HUM REPROD UPDATE, V19, P376, DOI 10.1093/humupd/dmt013	79	48	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126408	10.1371/journal.pone.0126408	http://dx.doi.org/10.1371/journal.pone.0126408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973943	Green Submitted, gold, Green Published			2022-12-27	WOS:000354545600050
J	Kan, R; Shuen, WH; Lung, HL; Cheung, AKL; Dai, W; Kwong, DLW; Ng, WT; Lee, AWM; Yau, CC; Ngan, RKC; Tung, SY; Lung, ML				Kan, Rebecca; Shuen, Wai Ho; Lung, Hong Lok; Cheung, Arthur Kwok Leung; Dai, Wei; Kwong, Dora Lai-Wan; Wai Tong Ng; Lee, Anne Wing Mui; Yau, Chun Chung; Ngan, Roger Kai Cheong; Tung, Stewart Yuk; Lung, Maria Li			NF-kappa B p65 Subunit Is Modulated by Latent Transforming Growth Factor-beta Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; TUMOR-SUPPRESSOR GENE; EXTRACELLULAR-MATRIX; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; FACTOR-RECEPTOR; CANCER CELLS; LINES HNE-1; IKK-BETA; EXPRESSION	NF-kappa B is a well-characterized transcription factor, widely known as a key player in tumor-derived inflammation and cancer development. Herein, we present the functional and molecular relevance of the canonical NF-kappa B p65 subunit in nasopharyngeal carcinoma (NPC). Loss-and gain-of-function approaches were utilized to reveal the functional characteristics of p65 in propagating tumor growth, tumor-associated angiogenesis, and epithelial-to-mesenchymal transition in NPC cells. Extracellular inflammatory stimuli are critical factors that trigger the NF-kappa B p65 signaling; hence, we investigated the components of the tumor microenvironment that might potentially influence the p65 signaling pathway. This led to the identification of an extracellular matrix (ECM) protein that was previously reported as a candidate tumor suppressor in NPC. Our studies on the Latent Transforming Growth Factor-beta Binding Protein 2 (LTBP2) protein provides substantial evidence that it can modulate the p65 transcriptional activity. Re-expression of LTBP2 elicits tumor suppressive effects that parallel the inactivation of p65 in NPC cells. LTBP2 was able to reduce phosphorylation of p65 at Serine 536, inhibit nuclear localization of active phosphorylated p65, and impair the p65 DNA-binding ability. This results in a consequential down-regulation of p65-related gene expression. Therefore, the data suggest that the overall up-regulation of p65 expression and the loss of this candidate ECM tumor suppressor are milestone events contributing to NPC development.	[Kan, Rebecca; Shuen, Wai Ho; Lung, Hong Lok; Cheung, Arthur Kwok Leung; Dai, Wei; Kwong, Dora Lai-Wan; Lung, Maria Li] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Lung, Hong Lok; Cheung, Arthur Kwok Leung; Kwong, Dora Lai-Wan; Lung, Maria Li] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Kwong, Dora Lai-Wan; Wai Tong Ng; Lee, Anne Wing Mui; Yau, Chun Chung; Ngan, Roger Kai Cheong; Tung, Stewart Yuk; Lung, Maria Li] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Nasopharyngeal Carcinoma Res, Hong Kong, Hong Kong, Peoples R China; [Wai Tong Ng] Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Lee, Anne Wing Mui] Univ Hong Kong, Shen Zhen Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Yau, Chun Chung] Princess Margaret Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China; [Ngan, Roger Kai Cheong] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Tung, Stewart Yuk] Tuen Mun Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong; Tuen Mun Hospital	Lung, ML (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China.	mlilung@hku.hk	Ng, Wai Tong/H-9525-2019; Dai, Wei/T-8889-2019; Lung, Maria Li/C-4495-2009	Ng, Wai Tong/0000-0001-6696-3000; Dai, Wei/0000-0002-5558-0685; Lung, Maria Li/0000-0003-2559-3626	Hong Kong Research Grants Council grant [AoE/M-06/08]	Hong Kong Research Grants Council grant(Hong Kong Research Grants Council)	This work was supported by Hong Kong Research Grants Council grant, AoE/M-06/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Bashir MM, 1996, INT J BIOCHEM CELL B, V28, P531, DOI 10.1016/1357-2725(95)00167-0; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Calvo F, 2011, CURR OPIN CELL BIOL, V23, P621, DOI 10.1016/j.ceb.2011.04.010; Chan JYW, 2014, LARYNGOSCOPE, V124, P126, DOI 10.1002/lary.24193; Chan KC, 2011, INT J CANCER, V129, P1826, DOI 10.1002/ijc.25855; Chan SHK, 2011, INT J CANCER, V129, P565, DOI 10.1002/ijc.25698; Chen H, 2012, CANCER LETT, V325, P89, DOI 10.1016/j.canlet.2012.06.005; Cheung AKL, 2008, CANCER RES, V68, P8137, DOI 10.1158/0008-5472.CAN-08-0904; Cheung AKL, 2011, P NATL ACAD SCI USA, V108, P8390, DOI 10.1073/pnas.1101747108; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Ding L, 2005, INT J BIOCHEM CELL B, V37, P1881, DOI 10.1016/j.biocel.2005.04.012; Fandi Abderrahim, 1995, Current Opinion in Oncology, V7, P255, DOI 10.1097/00001622-199505000-00011; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guillemin I, 2005, PROTEOMICS, V5, P35, DOI 10.1002/pmic.200400892; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Huang S, 2000, CANCER RES, V60, P5334; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Jeyakumar A, 2006, EAR NOSE THROAT J, V85, P172; Jeyakumar A, 2006, ENT-EAR NOSE THROAT, V85, P184; Jeyakumar Anita, 2006, Ear Nose Throat J, V85, P168; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; KHACHIGIAN LM, 1995, J CLIN INVEST, V96, P1169, DOI 10.1172/JCI118106; Kiriakidis S, 2003, J CELL SCI, V116, P665, DOI 10.1242/jcs.00286; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kung CP, 2008, J VIROL, V82, P5486, DOI 10.1128/JVI.00125-08; Leung ACC, 2008, INT J CANCER, V122, P587, DOI 10.1002/ijc.23144; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo YMD, 1999, CANCER RES, V59, P1188; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lung HL, 2005, ONCOGENE, V24, P6525, DOI 10.1038/sj.onc.1208812; Lung HL, 2006, CANCER RES, V66, P9385, DOI 10.1158/0008-5472.CAN-06-0590; Lung HL, 2010, INT J CANCER, V127, P304, DOI 10.1002/ijc.25047; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Meteoglu I, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-53; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MOREN A, 1994, J BIOL CHEM, V269, P32469; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Moriuchi H, 1997, J IMMUNOL, V158, P3483; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Niedobitek G, 2000, J CLIN PATHOL-MOL PA, V53, P248, DOI 10.1136/mp.53.5.248; Rakoff-Nahoum Seth, 2006, Yale J Biol Med, V79, P123; Ren Q, 2004, LARYNGOSCOPE, V114, P855, DOI 10.1097/00005537-200405000-00012; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sun W, 2012, CARCINOGENESIS, V33, P810, DOI 10.1093/carcin/bgs027; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; Teng ZP, 1996, VIRUS GENES, V13, P53, DOI 10.1007/BF00576978; Thornburg NJ, 2007, J VIROL, V81, P12954, DOI 10.1128/JVI.01601-07; Thornburg NJ, 2003, CANCER RES, V63, P8293; Valentine R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-1; Vehvilainen P, 2003, J BIOL CHEM, V278, P24705, DOI 10.1074/jbc.M212953200; Vehvilainen P, 2009, J CELL PHYSIOL, V221, P586, DOI 10.1002/jcp.21888; Wong VCL, 2012, INT J CANCER, V130, P83, DOI 10.1002/ijc.25970; Xie TX, 2010, ONCOL REP, V23, P725, DOI 10.3892/or_00000690; Xiong HQ, 2004, INT J CANCER, V108, P181, DOI 10.1002/ijc.11562; YAO K, 1990, INT J CANCER, V45, P83, DOI 10.1002/ijc.2910450116	81	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127239	10.1371/journal.pone.0127239	http://dx.doi.org/10.1371/journal.pone.0127239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974126	Green Published, gold			2022-12-27	WOS:000354545600104
J	Telenius, EW; Engedal, K; Bergland, A				Telenius, Elisabeth Wiken; Engedal, Knut; Bergland, Astrid			Effect of a High-Intensity Exercise Program on Physical Function and Mental Health in Nursing Home Residents with Dementia: An Assessor Blinded Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; NEUROPSYCHIATRIC SYMPTOMS; ALZHEIMERS-DISEASE; PSYCHOLOGICAL SYMPTOMS; OLDER-PEOPLE; BEHAVIORAL DISTURBANCES; FALL INJURIES; CORNELL SCALE; STRENGTH; CARE	Background Dementia is among the leading causes of functional loss and disability in older adults. Research has demonstrated that nursing home patients without dementia can improve their function in activities of daily living, strength, balance and mental well being by physical exercise. The evidence on effect of physical exercise among nursing home patients with dementia is scarce and ambiguous. Thus, the primary objective of this study was to investigate the effect of a high intensity functional exercise program on the performance of balance in nursing home residents with dementia. The secondary objective was to examine the effect of this exercise on muscle strength, mobility, activities of daily living, quality of life and neuropsychiatric symptoms. Design and Methods This single blinded randomized controlled trial was conducted among 170 persons with dementia living in nursing homes. Mean age was 86.7 years (SD = 7.4) and 74% were women. The participants were randomly allocated to an intervention (n = 87) or a control group (n = 83). The intervention consisted of intensive strengthening and balance exercises in small groups twice a week for 12 weeks. The control condition was leisure activities. Results The intervention group improved the score on Bergs Balance Scale by 2.9 points, which was significantly more than the control group who improved by 1.2 points (p = 0.02). Having exercised 12 times or more was significantly associated with improved strength after intervention (p<0.05). The level of apathy was lower in the exercise group after the intervention, compared to the control group (p = 0.048). Conclusion The results from our study indicate that a high intensity functional exercise program improved balance and muscle strength as well as reduced apathy in nursing home patients with dementia.	[Telenius, Elisabeth Wiken; Bergland, Astrid] Oslo & Akershus Univ, Fac Hlth Sci, Dept Physiotherapy, Coll Appl Sci, Oslo, Norway; [Engedal, Knut] Norwegian Ctr Aging & Hlth, Vestfold Hlth Trust, Dept Psychiat, Tonsberg, Norway	Oslo Metropolitan University (OsloMet)	Telenius, EW (corresponding author), Oslo & Akershus Univ, Fac Hlth Sci, Dept Physiotherapy, Coll Appl Sci, Oslo, Norway.	elisabeth-wiken.telenius@hioa.no		Telenius, Elisabeth Wiken/0000-0003-2183-367X	Norwegian ExtraFoundation for Health and Rehabilitation; Abildso Nursing home, Oslo Municipality	Norwegian ExtraFoundation for Health and Rehabilitation; Abildso Nursing home, Oslo Municipality	This study is funded by Norwegian ExtraFoundation for Health and Rehabilitation. The exercise equipment and salary for external physiotherapists was generously sponsored by Abildso Nursing home, Oslo Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Aman E, 2009, J AM MED DIR ASSOC, V10, P271, DOI 10.1016/j.jamda.2008.12.053; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Azegami M, 2007, NURS HEALTH SCI, V9, P168, DOI 10.1111/j.1442-2018.2007.00317.x; Ballard C, 2006, COCHRANE DATABASE OF, V1; Ballard CG, 2001, J CLIN PSYCHIAT, V62, P631, DOI 10.4088/JCP.v62n0810; Barca ML, 2011, DEMENT GERIATR COGN, V31, P435, DOI 10.1159/000328969; Barca ML, 2010, DEMENT GERIATR COGN, V29, P438, DOI 10.1159/000313533; BERG K, 1989, Physiotherapy Canada, V41, P304; Bergvall N, 2011, INT PSYCHOGERIATR, V23, P73, DOI 10.1017/S1041610210000785; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Borisovskaya A, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0470-z; Bostrom G, 2014, CLIN INTERV AGING, V9, P249, DOI 10.2147/CIA.S57535; Bridle C, 2012, BRIT J PSYCHIAT, V201, P180, DOI 10.1192/bjp.bp.111.095174; Castell MV, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-86; Chaves ML, 2007, ALZHEIMERS DIS ASSOC, V21; Colantuoni E, 2010, ALZHEIMERS DEMENT, V6, P425, DOI 10.1016/j.jalz.2010.01.014; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Collin C, 1988, Int Disabil Stud, V10, P61; Craig D, 2005, AM J GERIAT PSYCHIAT, V13, P460, DOI 10.1176/appi.ajgp.13.6.460; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; de Sousa PN, 2013, J AGING PHYS ACTIV, V21, P208, DOI 10.1123/japa.21.2.208; Dechamps A, 2010, ARCH INTERN MED, V170, P162, DOI 10.1001/archinternmed.2009.489; ENGEDAL K, 1993, INT J GERIATR PSYCH, V8, P565, DOI 10.1002/gps.930080706; Feldman HH, 2005, ALZ DIS ASSOC DIS, V19, P29, DOI 10.1097/01.wad.0000157065.43282.bc; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub2; Forbes D, 2014, SAO PAULO MED J, V132, P195, DOI [10.1590/1516-3180.20141323T2, 10.1002/14651858.CD006489.pub4]; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Geldmacher DS, 2006, J NUTR HEALTH AGING, V10, P417; Glenister D, 1996, J ROY SOC HEALTH, V116, P7, DOI 10.1177/146642409611600102; Gronstedt H, 2013, GERONTOLOGY, V59, P220, DOI 10.1159/000345416; Gronstedt H, 2011, AGING CLIN EXP RES, V23, P413, DOI 10.3275/7507; Helvik AS, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-45; Hong S-Y, 2008, JOURNAL OF PHYSICAL, V5; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jensen J, 2003, J AM GERIATR SOC, V51, P627, DOI 10.1034/j.1600-0579.2003.00206.x; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Leon-Salas B, 2013, ARCH GERONTOL GERIAT, V57, P257, DOI 10.1016/j.archger.2013.04.013; Littbrand H, 2006, PHYS THER, V86, P489, DOI 10.1093/ptj/86.4.489; Littbrand H, 2011, AM J PHYS MED REHAB, V90, P495, DOI 10.1097/PHM.0b013e318214de26; Littbrand H, 2009, J AM GERIATR SOC, V57, P1741, DOI 10.1111/j.1532-5415.2009.02442.x; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Lowery D, 2014, INT J GERIATR PSYCH, V29, P819, DOI 10.1002/gps.4062; Maci T, 2012, AM J ALZHEIMERS DIS, V27, P107, DOI 10.1177/1533317512440493; MAHONEY F I, 1965, Md State Med J, V14, P61; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Munoz VM, 2010, ALZ DIS ASSOC DIS, V24, P79, DOI 10.1097/WAD.0b013e3181c78a20; Nurmi I, 2002, SCAND J PRIM HEALTH, V20, P118, DOI 10.1080/713796400; Nygaard HA, 2003, SCAND J PRIM HEALTH, V21, P148, DOI 10.1080/02813430310001798; Nygaard Harald A, 2002, Tidsskr Nor Laegeforen, V122, P823; Pitkala K, 2013, EXP GERONTOL, V48, P85, DOI 10.1016/j.exger.2012.08.008; Puthoff ML, 2007, PHYS THER, V87, P1334, DOI 10.2522/ptj.20060176; Ravona-Springer R, 2008, ROMANIAN JOURNAL OF, V8, P1; Rolland Y, 2007, J AM GERIATR SOC, V55, P158, DOI 10.1111/j.1532-5415.2007.01035.x; Ruths S, 2013, INT J GERIATR PSYCH, V28, P868, DOI 10.1002/gps.3902; Samus QM, 2005, GERONTOLOGIST, V45, P19, DOI 10.1093/geront/45.suppl_1.19; Scherder EJA, 2010, INT PSYCHOGERIATR, V22, P1203, DOI 10.1017/S1041610210001493; Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749; Selbaek G, 2013, J AM MED DIR ASSOC, V14, P161, DOI 10.1016/j.jamda.2012.09.027; Selbaek G, 2012, INT PSYCHOGERIATR, V24, P62, DOI 10.1017/S104161021100086X; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P8, DOI 10.1136/jnnp.2005.069575; Strickland JC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00753; Stubbs B, 2014, PAIN MEDICINE; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Suzuki M, 2012, DISABIL REHABIL, V34, P202, DOI 10.3109/09638288.2011.593678; Sylliaas H, 2012, AGING CLIN EXP RES, V24, P251, DOI 10.1007/BF03325253; Tagariello P, 2009, ARCH GERONTOL GERIAT, V49, P246, DOI 10.1016/j.archger.2008.09.002; Taguchi N, 2010, J EPIDEMIOL, V20, P21, DOI 10.2188/jea.JE20081033; Tappen RM, 2000, ALZ DIS ASSOC DIS, V14, P196, DOI 10.1097/00002093-200010000-00002; Thomas VS, 2002, INT J GERIATR PSYCH, V17, P128, DOI 10.1002/gps.547; Thune-Boyle ICV, 2012, INT PSYCHOGERIATR, V24, P1046, DOI 10.1017/S1041610211002365; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; van Iersel MB, 2004, Z GERONTOL GERIATR, V37, P27, DOI 10.1007/s00391-004-0176-7; Volicer L, 2013, J AM MED DIR ASSOC, V14, P417, DOI 10.1016/j.jamda.2012.12.004; Weiner M F, 2000, J Am Med Dir Assoc, V1, P114; WOLINSKY FD, 1995, GERONTOLOGIST, V35, P451, DOI 10.1093/geront/35.4.451; Zwijsen SA, 2014, INT J GERIATR PSYCH, V29, P384, DOI 10.1002/gps.4014	81	98	99	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126102	10.1371/journal.pone.0126102	http://dx.doi.org/10.1371/journal.pone.0126102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25974049	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600041
J	Young, SA; McCabe, KE; Bartakova, A; Delaney, J; Pizzo, DP; Newbury, RO; Varner, JA; Schlaepfer, DD; Stupack, DG				Young, Shanique A.; McCabe, Katelyn E.; Bartakova, Alena; Delaney, Joe; Pizzo, Donald P.; Newbury, Robert O.; Varner, Judith A.; Schlaepfer, David D.; Stupack, Dwayne G.			Integrin alpha 4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCNlow Neuroblastoma	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; ACTIVATION; APOPTOSIS; NATALIZUMAB; EXPRESSION; MIGRATION; VLA-4; MECHANISMS; THERAPY; SUBUNIT	High-risk neuroblastoma is associated with an overall survival rate of 30-50%. Neuroblastoma-expressed cell adhesion receptors of the integrin family impact cell adhesion, migration, proliferation and survival. Integrin alpha 4 is essential for neural crest cell motility during development, is highly expressed on leukocytes, and is critical for transendothelial migration. Thus, cancer cells that express this receptor may exhibit increased metastatic potential. We show that alpha 4 expression in human and murine neuroblastoma cell lines selectively enhances in vitro interaction with the alternatively spliced connecting segment 1 of fibronectin, as well as vascular cell adhesion molecule-1 and increases migration. Integrin alpha 4 expression enhanced experimental metastasis in a syngeneic tumor model, reconstituting a pattern of organ involvement similar to that seen in patients. Accordingly, antagonism of integrin alpha 4 blocked metastasis, suggesting adhesive function of the integrin is required. However, adhesive function was not sufficient, as mutants of integrin alpha 4 that conserved the matrix-adhesive and promigratory function in vitro were compromised in their metastatic capacity in vivo. Clinically, integrin alpha 4 is more frequently expressed in non-MYNC amplified tumors, and is selectively associated with poor prognosis in this subset of disease. These results reveal an unexpected role for integrin alpha 4 in neuroblastoma dissemination and identify alpha 4 as a potential prognostic indicator and therapeutic target.	[Young, Shanique A.; McCabe, Katelyn E.; Bartakova, Alena; Delaney, Joe; Schlaepfer, David D.; Stupack, Dwayne G.] UCSD Sch Med, Dept Reprod Med, Div Gynecol Oncol, La Jolla, CA 92093 USA; [Young, Shanique A.; McCabe, Katelyn E.; Delaney, Joe; Varner, Judith A.; Schlaepfer, David D.; Stupack, Dwayne G.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Pizzo, Donald P.] Univ Calif San Diego, Ctr Adv Lab Med, San Diego, CA 92121 USA; [Pizzo, Donald P.; Newbury, Robert O.; Varner, Judith A.] UCSD Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Stupack, DG (corresponding author), UCSD Sch Med, Dept Reprod Med, Div Gynecol Oncol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dstupack@ucsd.edu		Varner, Judith/0000-0002-9251-0600; Bartakova, Alena/0000-0002-1344-6103	National Institutes of Health [CA107263, CA107263 10S1]; Ford Foundation; NSF GK-12 Socrates Fellowship; National Cancer Institute of the National Institutes of Health [T32CA121938]; NATIONAL CANCER INSTITUTE [R01CA102310, R01CA126820, R01CA180769, R01CA167426, R01CA087038, T32CA121938, R01CA107263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation; NSF GK-12 Socrates Fellowship(National Science Foundation (NSF)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant numbers CA107263 (DGS) and CA107263 10S1 (DGS, SAY) (www.nih.gov); the Ford Foundation Pre-Doctoral Fellowship (SAY) (nationalacademies.org/ford); the NSF GK-12 Socrates Fellowship (SAY) (http://sciencebridge.ucsd.edu/programs/socrates/); and the National Cancer Institute of the National Institutes of Health under Award Number T32CA121938 (KEM) (www.cancer.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Beltinger C, 2001, INT J CANCER, V92, P313, DOI 10.1002/ijc.1210; Brodeur G, 2002, PRINCIPLES PRACTICE; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; Dalton CM, 2004, J NEUROL, V251, P407, DOI 10.1007/s00415-004-0332-4; DuBois SG, 1999, J PEDIAT HEMATOL ONC, V21, P181, DOI 10.1097/00043426-199905000-00005; Haack H, 2001, DEV BIOL, V233, P38, DOI 10.1006/dbio.2001.0213; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Hayashida K, 2000, J IMMUNOL, V164, P1110, DOI 10.4049/jimmunol.164.2.1110; Holzmann B, 1998, CURR TOP MICROBIOL, V231, P125; Hsia DA, 2005, MOL CELL BIOL, V25, P9700, DOI 10.1128/MCB.25.21.9700-9712.2005; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishola TA, 2007, SURG ONCOL, V16, P149, DOI 10.1016/j.suronc.2007.09.005; KASSNER PD, 1995, MOL BIOL CELL, V6, P661, DOI 10.1091/mbc.6.6.661; KASSNER PD, 1994, J BIOL CHEM, V269, P19859; Kelleher FC, 2013, NEUROBLASTOMA, P25; Kil SH, 1998, DEV BIOL, V202, P29, DOI 10.1006/dbio.1998.8985; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu S, 2000, TRENDS CARDIOVAS MED, V10, P253, DOI 10.1016/S1050-1738(00)00073-6; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; OKAHARA H, 1994, CANCER RES, V54, P3233; Pinco KA, 2002, MOL BIOL CELL, V13, P3203, DOI 10.1091/mbc.02-05-0086; Rose DM, 2002, IMMUNOL REV, V186, P118, DOI 10.1034/j.1600-065X.2002.18611.x; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Testaz S, 2001, DEV DYNAM, V222, P127, DOI 10.1002/dvdy.1181; Testaz S, 1999, J CELL SCI, V112, P4715; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; van Golen CM, 2003, ONCOGENE, V22, P2664, DOI 10.1038/sj.onc.1206362; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770	40	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0120815	10.1371/journal.pone.0120815	http://dx.doi.org/10.1371/journal.pone.0120815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973900	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600002
J	Zhou, XC; Wang, GX; Sun, Y				Zhou, Xiaochen; Wang, Gongxian; Sun, Yi			A Reliable Parameter to Standardize the Scoring of Stem Cell Spheres	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ANTITUMOR-ACTIVITY; TYROSINE KINASE; TUMOR-FORMATION; LUNG-CANCER; IN-VIVO; INHIBITOR; TARGET; ASTROCYTES; ACTIVATION	Sphere formation assay is widely used in selection and enrichment of normal stem cells or cancer stem cells (CSCs), also known as tumor initiating cells (TICs), based on their ability to grow in serum-free suspension culture for clonal proliferation. However, there is no standardized parameter to accurately score the spheres, which should be reflected by both the number and size of the spheres. Here we define a novel parameter, designated as Standardized Sphere Score (SSS), which is expressed by the total volume of selected spheres divided by the number of cells initially plated. SSS was validated in quantification of both tumor spheres from cancer cell lines and embryonic bodies (EB) from mouse embryonic stem cells with high sensitivity and reproducibility.	[Zhou, Xiaochen; Wang, Gongxian] Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Jiangxi, Peoples R China; [Zhou, Xiaochen; Sun, Yi] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA; [Sun, Yi] Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Yi] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Nanchang University; University of Michigan System; University of Michigan; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Wang, GX (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Jiangxi, Peoples R China.	wanggx-mr@126.com; sunyi@umich.edu	Sun, Yi/K-1025-2014	Sun, Yi/0000-0002-5841-4287	National Institute of Health [CA118762, CA171277]; Department of Education of Jiangxi [GJJ11360, YC2012-B010]; NATIONAL CANCER INSTITUTE [R01CA118762, R01CA171277] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education of Jiangxi; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health (www.nih.gov), CA118762 and CA171277 to YS and the Department of Education of Jiangxi (http://www.jxedu.gov.cn), GJJ11360 and YC2012-B010 to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilodeau MT, 2008, BIOORG MED CHEM LETT, V18, P3178, DOI 10.1016/j.bmcl.2008.04.074; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Chan KC, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-128; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Desiderio V, 2015, ONCOTARGET, V6, P71, DOI 10.18632/oncotarget.2698; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Ellis Arthur B, 1995, TEACHING GEN CHEM MA, V3rd; Elrod HA, 2007, MOL CANCER THER, V6, P2029, DOI 10.1158/1535-7163.MCT-07-0004; Flesken-Nikitin A, 2013, NATURE, V495, P241, DOI 10.1038/nature11979; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Galvani E, 2013, NEOPLASIA, V15, P61, DOI 10.1593/neo.121434; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Matilainen H, 2012, CANCER LETT, V323, P20, DOI 10.1016/j.canlet.2012.03.028; Motegi H, 2014, NEUROPATHOLOGY, V34, P378, DOI 10.1111/neup.12117; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Pan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013298; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Raymond E, 2000, DRUGS, V60, P15, DOI 10.2165/00003495-200060001-00002; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sahlberg SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094621; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Tirino Virginia, 2012, Methods Mol Biol, V879, P513, DOI 10.1007/978-1-61779-815-3_32; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang L, 2009, CANCER BIOL THER, V8, P543, DOI 10.4161/cbt.8.6.7695; Wang R, 2014, J THORAC DIS, V6, P829, DOI 10.3978/j.issn.2072-1439.2014.03.38; Wicha MS, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1990; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Zinner RG, 2007, CLIN CANCER RES, V13, P3006, DOI 10.1158/1078-0432.CCR-06-1958; Zou TT, 2014, ANGEW CHEM INT EDIT, V53, P5810, DOI 10.1002/anie.201400142	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127348	10.1371/journal.pone.0127348	http://dx.doi.org/10.1371/journal.pone.0127348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973895	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600110
J	Kesler, DC; Walker, RS				Kesler, Dylan C.; Walker, Robert S.			Geographic Distribution of Isolated Indigenous Societies in Amazonia and the Efficacy of Indigenous Territories	PLOS ONE			English	Article							PROTECTED AREA NETWORK; SPECIES DISTRIBUTIONS; SAMPLE-SIZE; ENTROPY; NUMBERS	The headwaters of the Amazon Basin harbor most of the world's last indigenous peoples who have limited contact with encroaching colonists. Knowledge of the geographic distribution of these isolated groups is essential to assist with the development of immediate protections for vulnerable indigenous settlements. We used remote sensing to document the locations of 28 isolated villages within the four Brazilian states of Acre, Amazonas, Roraima, and Rondonia. The sites were confirmed during previous over-flights and by image evidence of thatched-roof houses; they are estimated to host over 1,700 individuals. Locational data were used to train maximum entropy models that identified landscape and anthropogenic features associated with the occurrence of isolated indigenous villages, including elevation, proximity to streams of five different orders, proximity to roads and settlements, proximity to recent deforestation, and vegetation cover type. Isolated villages were identified at mid elevations, within 20 km of the tops of watersheds and at greater distances from existing roads and trails. We further used model results, combined with boundaries of the existing indigenous territory system that is designed to protect indigenous lands, to assess the efficacy of the existing protected area network for isolated peoples. Results indicate that existing indigenous territories encompass all of the villages we identified, and 50% of the areas with high predicted probabilities of isolated village occurrence. Our results are intended to help inform policies that can mitigate against future external threats to isolated peoples.	[Kesler, Dylan C.] Univ Missouri, Fisheries & Wildlife Sci Dept, Columbia, MO 65211 USA; [Walker, Robert S.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kesler, DC (corresponding author), Univ Missouri, Fisheries & Wildlife Sci Dept, Columbia, MO 65211 USA.	keslerd@mac.com			National Geographic Society Research and Exploration [9165- 12]; University of Missouri; United States Department of Agriculture (USDA) Agricultural Experiment Station program	National Geographic Society Research and Exploration(National Geographic Society); University of Missouri; United States Department of Agriculture (USDA) Agricultural Experiment Station program	Financial support was provided by a National Geographic Society Research and Exploration grant (#9165- 12), for background data collection and field investigations that contributed to the data set. The University of Missouri and the United States Department of Agriculture (USDA) Agricultural Experiment Station program funded the salaries for RSW and DCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay T, 2000, MICROSFOT TERRASER; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Beatty WS, 2014, BIOL CONSERV, V176, P144, DOI 10.1016/j.biocon.2014.05.018; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Bodard L, 1974, GREEN HELL MASSACRE; Brazilian Institute of Geographical Statistics (IBGE), 2014, BRAZ GEOGR STAT; Castillo BH, 2004, INDIGENOUS PEOPLES I; Drummond SP, 2010, CONSERV BIOL, V24, P441, DOI 10.1111/j.1523-1739.2009.01346.x; Efroymson R, 2009, ENVIRON MANAGE, V44, P1163, DOI 10.1007/s00267-009-9385-6; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith Jane, 2000, P39, DOI 10.1007/0-387-22648-6_4; Eva HD, 2004, GLOBAL CHANGE BIOL, V10, P731, DOI 10.1111/j.1529-8817.2003.00774.x; Fagan C, 2005, INVESTIGATION ILLEGA; Fagan C, 2007, RACE PERUS LAST MAHO; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Google Inc, 2010, GOOGL EARTH VERS 6; Hamilton MJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04541; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harte J, 2014, TRENDS ECOL EVOL, V29, P384, DOI 10.1016/j.tree.2014.04.009; Heam K, 2010, NATL GEOGRAPHIC NEWS; Hemming J., 1978, RED GOLD CONQUEST BR; Hoofeveen J, 2014, RIVERS S AM; Hu JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084529, 10.1371/journal.pone.0108582]; Hurtado M, 2001, CURR ANTHROPOL, V42, P425, DOI 10.1086/320482; JAYNES ET, 1982, P IEEE, V70, P939, DOI 10.1109/PROC.1982.12425; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morato RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092950; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pappalardo SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066293; PEARSON RG, 2007, SPECIES DISTRIBUTION; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PRODES project monitoring the Brazilian Amazon forest by satellite, 2014, PRODES PROJECT MONIT; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Ricardo B, 2011, POVOS INDIGENAS NO B; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Salisbury DS, 2011, J CULT GEOGR, V28, P147, DOI 10.1080/08873631.2011.548491; Salisbury DS, 2007, THESIS U TEXAS; Schwartzman S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0164; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; Thomson JR, 2009, ECOL APPL, V19, P817, DOI 10.1890/08-0915.1; Vaz A, 2011, ISOLADOS BRASIL POLI; Vina A, 2011, REMOTE SENS ENVIRON, V115, P3468, DOI 10.1016/j.rse.2011.08.010; Walker RS, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140246; Walker RS, 2014, AM J HUM BIOL, V26, P570, DOI 10.1002/ajhb.22552; Wallace S., 2011, UNCONQUERED SEARCH A; Welch R, 1998, IEEE T GEOSCI REMOTE, V36, P1282, DOI 10.1109/36.701078; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	56	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125113	10.1371/journal.pone.0125113	http://dx.doi.org/10.1371/journal.pone.0125113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970612	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200066
J	Lau, E; Kossidas, K; Kim, TY; Kunitomo, Y; Ziv, O; Zhen, S; Taylor, C; Schofield, L; Yammine, J; Liu, GX; Peng, XW; Qu, ZL; Koren, G; Choi, BR				Lau, Emily; Kossidas, Konstantinos; Kim, Tae Yun; Kunitomo, Yukiko; Ziv, Ohad; Zhen, Song; Taylor, Chantel; Schofield, Lorraine; Yammine, Joe; Liu, Gongxin; Peng, Xuwen; Qu, Zhilin; Koren, Gideon; Choi, Bum-Rak			Spatially Discordant Alternans and Arrhythmias in Tachypacing-Induced Cardiac Myopathy in Transgenic LQT1 Rabbits: The Importance of I-Ks and Ca2+ Cycling	PLOS ONE			English	Article							RECTIFIER POTASSIUM CURRENT; ACTION-POTENTIAL DURATION; LATE SODIUM CURRENT; LONG QT SYNDROME; HEART-FAILURE; VENTRICULAR VULNERABILITY; REPOLARIZATION RESERVE; SUDDEN-DEATH; MECHANISMS; ARRHYTHMOGENESIS	Background Remodeling of cardiac repolarizing currents, such as the downregulation of slowly activating K+ channels (I-Ks), could underlie ventricular fibrillation (VF) in heart failure (HF). We evaluated the role of I-Ks remodeling in VF susceptibility using a tachypacing HF model of transgenic rabbits with Long QT Type 1 (LQT1) syndrome. Methods and Results LQT1 and littermate control (LMC) rabbits underwent three weeks of tachypacing to induce cardiac myopathy (TICM). In vivo telemetry demonstrated steepening of the QT/RR slope in LQT1 with TICM (LQT1-TICM; pre: 0.26 +/- 0.04, post: 0.52 +/- 0.01, P<0.05). In vivo electrophysiology showed that LQT1-TICM had higher incidence of VF than LMC-TICM (6 of 11 vs. 3 of 11, respectively). Optical mapping revealed larger APD dispersion (16 +/- 4 vs. 38 +/- 6 ms, p<0.05) and steep APD restitution in LQT1-TICM compared to LQT1-sham (0.53 +/- 0.12 vs. 1.17 +/- 0.13, p<0.05). LQT1-TICM developed spatially discordant alternans (DA), which caused conduction block and higher-frequency VF (15 +/- 1 Hz in LQT1-TICM vs. 13 +/- 1 Hz in LMC-TICM, p<0.05). Ca2+ DA was highly dynamic and preceded voltage DA in LQT1-TICM. Ryanodine abolished DA in 5 out of 8 LQT1-TICM rabbits, demonstrating the importance of Ca2+ in complex DA formation. Computer simulations suggested that HF remodeling caused Ca2+-driven alternans, which was further potentiated in LQT1-TICM due to the lack of I-Ks. Conclusions Compared with LMC-TICM, LQT1-TICM rabbits exhibit steepened APD restitution and complex DA modulated by Ca2+. Our results strongly support the contention that the down-regulation of I-Ks in HF increases Ca2+ dependent alternans and thereby the risk of VF.	[Lau, Emily; Kossidas, Konstantinos; Kim, Tae Yun; Kunitomo, Yukiko; Ziv, Ohad; Taylor, Chantel; Schofield, Lorraine; Yammine, Joe; Liu, Gongxin; Koren, Gideon; Choi, Bum-Rak] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Cardiovasc Res Ctr,Div Cardiol, Providence, RI 02903 USA; [Peng, Xuwen] Penn State Univ, Coll Med, Dept Comparat Med, Hershey, PA USA; [Zhen, Song; Qu, Zhilin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Choi, BR (corresponding author), Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Cardiovasc Res Ctr,Div Cardiol, Providence, RI 02903 USA.	bum-rak_choi@brown.edu	Koren, Gideon/AAG-7726-2019; Kim, Tae Yun/AFU-8071-2022; Song, Zhen/G-4383-2017	Koren, Gideon/0000-0002-9234-0875; Kim, Tae Yun/0000-0003-0605-9575; Song, Zhen/0000-0002-3823-2646; Kunitomo, Yukiko/0000-0001-5564-8902	National Heart, Lung and Blood Institute [R01-HL-096669-04, R01-HL-046005-18A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046005, R01HL096669] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute Grants R01-HL-096669-04 to BC. and R01-HL-046005-18A1 to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Akar FG, 2003, CIRC RES, V93, P638, DOI 10.1161/01.RES.0000092248.59479.AE; Benoist D, 2012, AM J PHYSIOL-HEART C, V302, pH2381, DOI 10.1152/ajpheart.01084.2011; Bers Donald M., 2002, Basic Research in Cardiology, V97; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; CHAKKO S, 1989, CLIN CARDIOL, V12, P525, DOI 10.1002/clc.4960120910; Choi BR, 1999, CIRCULATION, V100, P51; Choi BR, 2000, J PHYSIOL-LONDON, V529, P171, DOI 10.1111/j.1469-7793.2000.00171.x; Choi BR, 2007, HEART RHYTHM, V4, P1057, DOI 10.1016/j.hrthm.2007.03.037; Decker KF, 2009, AM J PHYSIOL-HEART C, V296, pH1017, DOI 10.1152/ajpheart.01216.2008; Ebinger Matthew W, 2005, Curr Heart Fail Rep, V2, P111, DOI 10.1007/s11897-005-0018-y; Gilmour RF, 1999, J CARDIOVASC ELECTR, V10, P1087, DOI 10.1111/j.1540-8167.1999.tb00281.x; Harada M, 2011, AM J PHYSIOL-HEART C, V300, pH565, DOI 10.1152/ajpheart.00209.2010; Hayashi H, 2008, HEART RHYTHM, V5, P116, DOI 10.1016/j.hrthm.2007.08.020; Hayashi H, 2007, BIOPHYS J, V92, P448, DOI 10.1529/biophysj.106.091009; Hoeker GS, 2009, AM J PHYSIOL-HEART C, V297, pH1235, DOI 10.1152/ajpheart.01320.2008; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Jeong EM, 2012, J MOL CELL CARDIOL, V52, P454, DOI 10.1016/j.yjmcc.2011.09.018; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; Jost N, 2007, ANN NONINVAS ELECTRO, V12, P64, DOI 10.1111/j.1542-474X.2007.00140.x; Kaab S, 1996, CIRC RES, V78, P262, DOI 10.1161/01.RES.78.2.262; Karma A, 1994, CHAOS, V4, P461, DOI 10.1063/1.166024; Kim TY, 2007, P NATL ACAD SCI USA, V104, P11639, DOI 10.1073/pnas.0704204104; KJEKSHUS J, 1990, AM J CARDIOL, V65, pI42; Lammers WJ, 1986, NEW TRENDS IN ARRHYT, VII; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; Lou Q, 2012, AM J PHYSIOL-HEART C, V303, pH1426, DOI 10.1152/ajpheart.00457.2012; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Maltsev VA, 2001, J MOL CELL CARDIOL, V33, P923, DOI 10.1006/jmcc.2001.1355; Munoz V, 2007, CIRC RES, V101, P475, DOI 10.1161/CIRCRESAHA.107.149617; Nuss HB, 1999, AM J PHYSIOL-HEART C, V277, pH80, DOI 10.1152/ajpheart.1999.277.1.H80; Odening KE, 2008, AM J PHYSIOL-HEART C, V295, pH2264, DOI 10.1152/ajpheart.00680.2008; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Qu ZL, 2013, J MOL CELL CARDIOL, V58, P100, DOI 10.1016/j.yjmcc.2012.10.007; Reinecke H, 1996, CARDIOVASC RES, V31, P48, DOI 10.1016/0008-6363(95)00176-X; Restrepo JG, 2008, BIOPHYS J, V95, P3767, DOI 10.1529/biophysj.108.130419; Roden DM, 2008, CIRCULATION, V118, P981, DOI 10.1161/CIRCULATIONAHA.108.798918; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Roden DM, 2005, CIRCULATION, V112, P1376, DOI 10.1161/CIRCULATIONAHA.105.562777; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Salama G, 2005, J MEMBRANE BIOL, V208, P125, DOI 10.1007/s00232-005-0826-8; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Shannon TR, 2005, BIOPHYS J, V89, P4096, DOI 10.1529/biophysj.105.068734; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Silva J, 2005, CIRCULATION, V112, P1384, DOI 10.1161/CIRCULATIONAHA.105.543306; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; TOHSE N, 1990, AM J PHYSIOL, V258, pH1200, DOI 10.1152/ajpheart.1990.258.4.H1200; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Tsuji Y, 2006, CIRCULATION, V113, P345, DOI 10.1161/CIRCULATIONAHA.105.552968; Undrovinas AI, 2002, J MOL CELL CARDIOL, V34, P1477, DOI 10.1006/jmcc.2002.2100; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; Varro A, 2004, CURR MED CHEM, V11, P1, DOI 10.2174/0929867043456296; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Wang YG, 2010, J MOL CELL CARDIOL, V48, P619, DOI 10.1016/j.yjmcc.2010.01.009; Watanabe T, 2002, AM J PHYSIOL-HEART C, V282, pH212, DOI 10.1152/ajpheart.2002.282.1.H212; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Wilson LD, 2009, HEART RHYTHM, V6, P251, DOI 10.1016/j.hrthm.2008.11.008; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140; Ziv O, 2009, J PHYSIOL-LONDON, V587, P4661, DOI 10.1113/jphysiol.2009.175018	63	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0122754	10.1371/journal.pone.0122754	http://dx.doi.org/10.1371/journal.pone.0122754			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970695	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200007
J	Lennartsson, J; Lidstrom, N; Lindberg, C				Lennartsson, Jan; Lidstrom, Nicklas; Lindberg, Carl			Game Intelligence in Team Sports	PLOS ONE			English	Article							PENALTY KICKS; MINIMAX PLAY	We set up a game theoretic framework to analyze a wide range of situations from team sports. A fundamental idea is the concept of potential; the probability of the offense scoring the next goal minus the probability that the next goal is made by the defense. We develop categorical as well as continuous models, and obtain optimal strategies for both offense and defense. A main result is that the optimal defensive strategy is to minimize the maximum potential of all offensive strategies.	[Lennartsson, Jan] Chalmers Univ Technol, Gothenburg, Sweden; [Lennartsson, Jan] Gothenburg Univ, S-41124 Gothenburg, Sweden; [Lindberg, Carl] Second Swedish Natl Pens Fund, Stockholm, Sweden; [Lindberg, Carl] Uppsala Univ, Uppsala, Sweden; [Lidstrom, Nicklas] Independent Researcher, Vasteras, Sweden	Chalmers University of Technology; University of Gothenburg; Uppsala University	Lindberg, C (corresponding author), Second Swedish Natl Pens Fund, Stockholm, Sweden.	carl@teamsporttactics.com			Gothenburg University; Second swedish Ap fund	Gothenburg University; Second swedish Ap fund	JL was funded by Gothenburg University. CL was funded by Second swedish Ap fund. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript. NL received no funding for this work.	Alferink LA, 2009, J APPL BEHAV ANAL, V42, P595, DOI 10.1901/jaba.2009.42-595; Azar OH, 2011, APPL ECON, V43, P3591, DOI 10.1080/00036841003670747; Bailey B.J., 2012, INT J BUSINESS SOCIA, V3, P11; Buzzacchi L, 2014, APPL ECON, V46, P1067, DOI 10.1080/00036846.2013.866205; Chiappori PA, 2002, AM ECON REV, V92, P1138, DOI 10.1257/00028280260344678; Emara N, 2014, 58907 MPRA; Hsu SH, 2007, AM ECON REV, V97, P517, DOI 10.1257/aer.97.1.517; Kovash K, 2009, NBER WORKING PAPERS; Mitchell M, 2010, DYNAMIC MATCHING PEN; Monderer D, 1996, GAME ECON BEHAV, V14, P124, DOI 10.1006/game.1996.0044; Moschini GC, 2004, ECON LETT, V85, P365, DOI 10.1016/j.econlet.2004.06.003; Nash S. G., 1996, LINEAR NONLINEAR PRO, P1996; Osborne M., 2009, INTRO GAME THEORY; Palacios-Huerta I, 2003, REV ECON STUD, V70, P395, DOI 10.1111/1467-937X.00249; Skinner B, 2011, J QUANT ANAL SPORTS, V7, DOI 10.2202/1559-0410.1364; Skinner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030776; Skinner B, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1217; Walker M, 2001, AM ECON REV, V91, P1521, DOI 10.1257/aer.91.5.1521	18	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125453	10.1371/journal.pone.0125453	http://dx.doi.org/10.1371/journal.pone.0125453			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZP	25970581	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200074
J	Quan, ZF; Tian, M; Chi, P; Li, X; He, HL; Luo, C				Quan, ZheFeng; Tian, Ming; Chi, Ping; Li, Xin; He, HaiLi; Luo, Chao			Combined Use of Hyperbaric and Hypobaric Ropivacaine Significantly Improves Hemodynamic Characteristics in Spinal Anesthesia for Caesarean Section: A Prospective, Double-Blind, Randomized, Controlled Study	PLOS ONE			English	Article							CEREBROSPINAL-FLUID VOLUME; RIGHT LATERAL POSITION; EPIDURAL ANESTHESIA; BLOOD-PRESSURE; PHENYLEPHRINE INFUSION; CONTROLLED-TRIAL; DELIVERY; HYPOTENSION; BUPIVACAINE; BARICITY	Purpose To observe the hemodynamic changes of parturients in the combined use of hyperbaric (4 mg) and hypobaric (6 mg) ropivacaine during spinal anesthesia for caesarean section in this randomized double-blind study. Methods Parturients (n = 136) undergoing elective cesarean delivery were randomly and equally allocated to receive either combined hyperbaric and hypobaric ropivacaine (Group A) or hyperbaric ropivacaine (Group B). Outcome measures were: hemodynamic characteristics, maximum height of sensory block, time to achieve T8 sensory blockade level, incidence of complications, Apgar scores at 1 and 5 min, and neonatal blood gas analysis. Results Group A had a lower level of sensory blockade (T6 [T6-T7]) and longer time to achieve T8 sensory blockade level (8 +/- 1.3 min) than did patients in Group B (T3 [T2-T4] and 5 +/- 1.0 min, respectively; P < 0.001, both). The incidence rates for hypotension, nausea, and vomiting were significantly lower in Group A (13%, 10%, and 3%, respectively) than Group B (66%, 31%, and 13%; P < 0.001, P = 0.003, P = 0.028). Conclusions Combined use of hyperbaric (4 mg) and hypobaric (6 mg) ropivacaine significantly decreased the incidences of hypotension and complications in spinal anesthesia for caesarean section by extending induction time and decreasing the level of sensory blockade.	[Quan, ZheFeng; Tian, Ming; Chi, Ping; Li, Xin; He, HaiLi; Luo, Chao] Capital Med Univ, Beijing You An Hosp, Dept Anesthesiol, Beijing 100069, Peoples R China	Capital Medical University	Tian, M (corresponding author), Capital Med Univ, Beijing You An Hosp, Dept Anesthesiol, Beijing 100069, Peoples R China.	yakych@163.com						Abd El-Hakeem EE, 2011, CAN J ANESTH, V58, P1083, DOI 10.1007/s12630-011-9593-4; Akhtar MN, 2012, JCPSP-J COLL PHYSICI, V22, P747, DOI 12.2012/JCPSP.747750; Allen TK, 2010, ANESTH ANALG, V111, P1221, DOI 10.1213/ANE.0b013e3181e1db21; Apaydin Y, 2011, J ANESTH, V25, P380, DOI 10.1007/s00540-011-1111-x; Atef Hossam, 2012, Middle East Journal of Anesthesiology, V21, P591; Baghirzada L, 2012, CAN J ANESTH, V59, P1052, DOI 10.1007/s12630-012-9778-5; Banerjee A, 2010, CAN J ANAESTH, V57, P24, DOI 10.1007/s12630-009-9206-7; Cardoso MMS, 2013, EUR J ANAESTH, V30, P102, DOI 10.1097/EJA.0b013e328356676b; Carpenter RL, 1998, ANESTHESIOLOGY, V89, P24, DOI 10.1097/00000542-199807000-00007; Coppejans HC, 2006, ANESTH ANALG, V102, P243, DOI 10.1213/01.ane.0000189049.11005.26; Dalchow S, 2013, INT J OBSTET ANESTH, V22, P217, DOI 10.1016/j.ijoa.2013.04.003; Doherty A, 2012, ANESTH ANALG, V115, P1343, DOI 10.1213/ANE.0b013e31826ac3db; Dyer RA, 2009, ANESTHESIOLOGY, V111, P753, DOI 10.1097/ALN.0b013e3181b437e0; Heller AR, 2006, ANESTHESIOLOGY, V105, P346, DOI 10.1097/00000542-200608000-00018; Higuchi H, 2004, ANESTHESIOLOGY, V100, P106, DOI 10.1097/00000542-200401000-00019; HORLOCKER TT, 1993, ANESTH ANALG, V76, P1015; Kaya M, 2010, ANAESTH INTENS CARE, V38, P1002, DOI 10.1177/0310057X1003800606; Kelly JD, 2005, EUR J ANAESTH, V22, P717, DOI 10.1017/S0265021505001183; Kim JT, 2013, ANESTH ANALG, V117, P1017, DOI 10.1213/ANE.0b013e3182a1ee53; KITAHARA T, 1956, ANESTHESIOLOGY, V17, P205, DOI 10.1097/00000542-195601000-00030; Ko JS, 2007, INT J OBSTET ANESTH, V16, P8, DOI 10.1016/j.ijoa.2006.07.004; Kohler F, 2002, ACTA ANAESTH SCAND, V46, P441, DOI 10.1034/j.1399-6576.2002.460419.x; Loke GPY, 2002, ANAESTHESIA, V57, P169, DOI 10.1046/j.1365-2044.2002.02227.x; Loubert C, 2011, ANESTH ANALG, V113, P811, DOI 10.1213/ANE.0b013e3182288bf2; Mendonca C, 2003, ANAESTHESIA, V58, P428, DOI 10.1046/j.1365-2044.2003.03090.x; Miyabe M, 1997, REGION ANESTH, V22, P239, DOI 10.1016/S1098-7339(06)80008-8; Ngan Kee WD, 2013, BRIT J ANAESTH, V110, P59, DOI 10.1093/bja/aes339; Obasuyi BI, 2013, INT J OBSTET ANESTH, V22, P124, DOI 10.1016/j.ijoa.2012.12.005; Oh AY, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-36; Pan PH, 2013, ANESTHESIOLOGY, V118, P1170, DOI 10.1097/ALN.0b013e31828e156f; Rosseland LA, 2013, ANESTHESIOLOGY, V119, P541, DOI 10.1097/ALN.0b013e31829416dd; Sia ATH, 2012, ANAESTHESIA, V67, P1348, DOI 10.1111/anae.12000; Siddik-Sayyid SM, 2014, ANESTH ANALG, V118, P611, DOI 10.1213/01.ane.0000437731.60260.ce; Sujata N, 2012, INT J OBSTET ANESTH, V21, P140, DOI 10.1016/j.ijoa.2012.01.003; Sullivan JT, 2006, ANESTH ANALG, V103, P1306, DOI 10.1213/01.ane.0000240886.55044.47; Toyama S, 2013, BRIT J ANAESTH, V111, P235, DOI 10.1093/bja/aet058	36	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125014	10.1371/journal.pone.0125014	http://dx.doi.org/10.1371/journal.pone.0125014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970485	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200063
J	Woo, HD; Chiu, WA; Jo, S; Kim, J				Woo, Hae Dong; Chiu, Weihsueh A.; Jo, Seongil; Kim, Jeongseon			Benchmark Dose for Urinary Cadmium based on a Marker of Renal Dysfunction: A Meta-Analysis	PLOS ONE			English	Article							NON-POLLUTED AREA; HYBRID APPROACH; RISK-ASSESSMENT; JAPAN; EXPOSURE; LEVEL; THRESHOLD; POPULATION; TOXICITY; BETA(2)-MICROGLOBULIN	Background Low doses of cadmium can cause adverse health effects. Benchmark dose (BMD) and the one-sided 95% lower confidence limit of BMD (BMDL) to derive points of departure for urinary cadmium exposure have been estimated in several previous studies, but the methods to derive BMD and the estimated BMDs differ. Objectives We aimed to find the associated factors that affect BMD calculation in the general population, and to estimate the summary BMD for urinary cadmium using reported BMDs. Methods A meta-regression was performed and the pooled BMD/BMDL was estimated using studies reporting a BMD and BMDL, weighted by sample size, that were calculated from individual data based on markers of renal dysfunction. Results BMDs were highly heterogeneous across studies. Meta-regression analysis showed that a significant predictor of BMD was the cut-off point which denotes an abnormal level. Using the 95th percentile as a cut off, BMD5/BMDL5 estimates for 5% benchmark responses (BMR) of beta 2-microglobulinuria (beta 2-MG) estimated was 6.18/4.88 mu g/g creatinine in conventional quantal analysis and 3.56/3.13 mu g/g creatinine in the hybrid approach, and BMD5/BMDL5 estimates for 5% BMR of N-acetyl-beta-d-glucosaminidase (NAG) was 10.31/7.61 mu g/g creatinine in quantal analysis and 3.21/2.24 g/g creatinine in the hybrid approach. However, the meta-regression showed that BMD and BMDL were significantly associated with the cut-off point, but BMD calculation method did not significantly affect the results. The urinary cadmium BMDL5 of beta 2-MG was 1.9 mu g/g creatinine in the lowest cut-off point group. Conclusion The BMD was significantly associated with the cut-off point defining the abnormal level of renal dysfunction markers.	[Woo, Hae Dong; Jo, Seongil; Kim, Jeongseon] Natl Canc Ctr, Mol Epidemiol Branch, Goyang Si, South Korea; [Chiu, Weihsueh A.] US Environm Protect Agcy EPA, Natl Ctr Environm Assessment, Washington, DC USA	National Cancer Center - Korea (NCC); United States Environmental Protection Agency	Kim, J (corresponding author), Natl Canc Ctr, Mol Epidemiol Branch, Goyang Si, South Korea.	jskim@ncc.re.kr	KIM, JEONGSEON/AAA-4643-2022		Korean Food and Drug Administration [10162KFDA994]	Korean Food and Drug Administration	This research was supported by a grant from the Korean Food and Drug Administration (10162KFDA994). This funder had no role in the study design, analyses, interpretation of the data, and preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2012, TOX PROF CHROM; BARNES DG, 1995, REGUL TOXICOL PHARM, V21, P296, DOI 10.1006/rtph.1995.1043; Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9; BERNARD A, 1995, OCCUP ENVIRON MED, V52, P177, DOI 10.1136/oem.52.3.177; Chen L, 2006, TOXICOL APPL PHARM, V215, P93, DOI 10.1016/j.taap.2006.01.013; CRUMP KS, 1995, RISK ANAL, V15, P79, DOI 10.1111/j.1539-6924.1995.tb00095.x; CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6; Davis JA, 2011, TOXICOL APPL PHARM, V254, P181, DOI 10.1016/j.taap.2010.10.016; EFSA European Food Safety Authority, 2009, SCI REP-UK, V254, P1, DOI DOI 10.2903/J.EFSA.2009.254R; European Food Safety Authority (EFSA), 2009, SCI REP AFR SW UNPUB, P1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong F, 2004, BIOMETALS, V17, P573, DOI 10.1023/B:BIOM.0000045741.22924.d8; IARC, 1993, IARC SCI PUBLICATION, V58; Jarup L, 2002, NEPHROL DIAL TRANSPL, V17, P35, DOI 10.1093/ndt/17.suppl_2.35; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2011, WHO TECHN REP SER; Jin TY, 2004, BIOMETALS, V17, P525, DOI 10.1023/B:BIOM.0000045732.91261.e2; KIDO T, 1988, ARCH ENVIRON HEALTH, V43, P213, DOI 10.1080/00039896.1988.9934935; Kobayashi E, 2006, J APPL TOXICOL, V26, P351, DOI 10.1002/jat.1147; Kobayashi E, 2006, ENVIRON RES, V101, P401, DOI 10.1016/j.envres.2005.12.002; KOTSONIS FN, 1978, TOXICOL APPL PHARM, V46, P39, DOI 10.1016/0041-008X(78)90135-7; Lei LJ, 2007, TOXICOL SCI, V97, P189, DOI 10.1093/toxsci/kfm016; MORGAN H, 1984, Food Additives and Contaminants, V1, P45, DOI 10.1080/02652038409385822; Moriguchi J, 2009, TOXICOL LETT, V190, P1, DOI 10.1016/j.toxlet.2009.05.009; Murata K, 2009, J OCCUP HEALTH, V51, P1, DOI 10.1539/joh.K8003; NAKAGAWA H, 1993, ARCH ENVIRON HEALTH, V48, P428, DOI 10.1080/00039896.1993.10545965; Noonan CW, 2002, ENVIRON HEALTH PERSP, V110, P151, DOI 10.1289/ehp.02110151; Sand S, 2008, J APPL TOXICOL, V28, P405, DOI 10.1002/jat.1298; Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751; Shao B, 2007, BIOMED ENVIRON SCI, V20, P460; Shimizu A, 2006, INT J ENVIRON HEAL R, V16, P329, DOI 10.1080/09603120600869174; Suwazono Y, 2006, ENVIRON HEALTH PERSP, V114, P1072, DOI 10.1289/ehp.9028; Suwazono Y, 2011, INT J HYG ENVIR HEAL, V214, P175, DOI 10.1016/j.ijheh.2010.09.002; Suwazono Y, 2011, ENVIRON RES, V111, P312, DOI 10.1016/j.envres.2010.11.013; Suwazono Y, 2011, J APPL TOXICOL, V31, P89, DOI 10.1002/jat.1582; Uno T, 2005, SCAND J WORK ENV HEA, V31, P307, DOI 10.5271/sjweh.887; WHO, 1992, ENV HLTH CRIT, V135	37	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126680	10.1371/journal.pone.0126680	http://dx.doi.org/10.1371/journal.pone.0126680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970611	gold, Green Published, Green Submitted			2022-12-27	WOS:000354544200126
J	Sripan, P; Le Coeur, S; Amzal, B; Ingsrisawang, L; Traisathit, P; Ngo-Giang-Huong, N; McIntosh, K; Cressey, TR; Sangsawang, S; Rawangban, B; Kanjanavikai, P; Treluyer, JM; Jourdain, G; Lallemant, M; Urien, S				Sripan, Patumrat; Le Coeur, Sophie; Amzal, Billy; Ingsrisawang, Lily; Traisathit, Patrinee; Ngo-Giang-Huong, Nicole; McIntosh, Kenneth; Cressey, Tim R.; Sangsawang, Suraphan; Rawangban, Boonsong; Kanjanavikai, Prateep; Treluyer, Jean-Marc; Jourdain, Gonzague; Lallemant, Marc; Urien, Sair			Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; IMMUNODEFICIENCY-VIRUS TYPE-1; MATERNAL-INFANT TRANSMISSION; RISK-FACTORS; INTRAPARTUM TRANSMISSION; ORAL ZIDOVUDINE; COTE-DIVOIRE; NEVIRAPINE; PROPHYLAXIS; GUIDELINES	Background Antiretroviral treatments decrease HIV mother-to-child transmission through pre/post exposure prophylaxis and reduction of maternal viral load. We modeled in-utero and intra-partum HIV transmissions to investigate the preventive role of various antiretroviral treatments interventions. Methods We analysed data from 3,759 women-infant pairs enrolled in 3 randomized clinical trials evaluating (1) zidovudine monotherapy, (2) zidovudine plus perinatal single-dose nevirapine or (3) zidovudine plus lopinavir/ritonavir for the prevention of mother-to-child transmission of HIV in Thailand. All infants were formula-fed. Non-linear mixed effect modeling was used to express the viral load evolution under antiretroviral treatments and the probability of transmission. Results Median viral load was 4 log(10) copies/mL (Interquartile range: 3.36-4.56) before antiretroviral treatments initiation. An Emaxmodel described the viral load time-course during pregnancy. Half of the maximum effect of zidovudine (28% decrease) and lopinavir/ritonavir (72% decrease) were achieved after 98 and 12 days, respectively. Adjusted on viral load at baseline (Odds ratio = 1.50 [95% confidence interval: 1.34, 1.68] per log(10) copies/mL increment), anti-retroviral treatments duration (OR = 0.80 [0.75, 0.84] per week increment) but not the nature of antiretroviral treatments were associated with in-utero transmission. Adjusted on gestational age at delivery (<37 weeks, OR = 2.37 [1.37, 4.10]), baseline CD4 (Odds ratio = 0.79 [0.72, 0.88] per 100 cells/mm(3) increment) and predicted viral load at delivery (OR = 1.47 [1.25, 1.64] per log(10) copies/mL increment), single-dose nevirapine considerably reduced intra-partum transmission (OR = 0.32 [0.2, 0.51]). Conclusion These models determined the respective contributions of various antiretroviral strategies on prevention of mother-to-child transmission. This can help predict the efficacy of new antiretroviral treatments and/or prevention of mother-to-child transmission strategies particularly for women with no or late antenatal care who are at high risk of transmitting HIV to their offspring.	[Sripan, Patumrat; Ingsrisawang, Lily] Kasetsart Univ, Dept Stat, Bangkok, Thailand; [Sripan, Patumrat; Le Coeur, Sophie; Amzal, Billy; Ngo-Giang-Huong, Nicole; Cressey, Tim R.; Jourdain, Gonzague; Lallemant, Marc] IRD, PHPT, UMI 174, Marseille, France; [Sripan, Patumrat] Univ Paris 11, Ecole Doctorale Sante Publ, Paris, France; [Le Coeur, Sophie; Ngo-Giang-Huong, Nicole; Cressey, Tim R.; Jourdain, Gonzague] Chiang Mai Univ, Dept Med Technol, Chiang Mai 50000, Thailand; [Ngo-Giang-Huong, Nicole; Cressey, Tim R.; Jourdain, Gonzague] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Le Coeur, Sophie] Inst Etudes Demog, Paris, France; [Amzal, Billy] LASER Analyt, London, England; [Traisathit, Patrinee] Chiang Mai Univ, Dept Stat, Chiang Mai, Thailand; [McIntosh, Kenneth] Boston Childrens Hosp, Boston, MA USA; [McIntosh, Kenneth] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Sangsawang, Suraphan] Hlth Promot Ctr Reg 10, Chiang Mai, Thailand; [Rawangban, Boonsong] Nopparat Rajathanee Hosp, Bangkok, Thailand; [Kanjanavikai, Prateep] Banglamung Hosp, Chon Buri, Thailand; [Treluyer, Jean-Marc; Urien, Sair] Univ Paris 05, Sorbonne Paris Cite, EAU08, Paris, France; [Treluyer, Jean-Marc; Urien, Sair] Hop Tarnier, AP HP, Unite Rech Clin, Paris, France; [Treluyer, Jean-Marc; Urien, Sair] INSERM, CIC 1419, Paris, France	Kasetsart University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health; Chiang Mai University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Sripan, P (corresponding author), Kasetsart Univ, Dept Stat, Bangkok, Thailand.	patumrat.sripan@phpt.org	Cressey, Tim R./U-6428-2019; Sripan, Patumrat/HDS-9297-2022; treluyer, Jean-Marc/F-8036-2010; Urien, Saïk/G-3240-2013; Ngo-Giang-Huong, Nicole/G-2860-2017; Traisathit, Patrinee/S-4440-2017; Jourdain, Gonzague/F-9117-2017	Cressey, Tim R./0000-0002-8106-0974; Urien, Saïk/0000-0002-1065-0600; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234; Jourdain, Gonzague/0000-0002-3365-7020; Sripan, Patumrat/0000-0002-8337-9524; Traisathit, Patrinee/0000-0003-2918-1928	National Institutes of Health [PHPT-1: 5 R01 HD 33326, PHPT-2: NICHD R01 HD 39615, PHPT-5 First PhaseNICHD, R01HD052461, R01HD056953]; Agence Nationale de Recherches sur le Sida et les Hepatites Virales [PHPT-2: ANRS 1208]; French Embassy in Thailand; Science Achievement Scholarship of Thailand; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056953] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039615, R01HD033326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherches sur le Sida et les Hepatites Virales(ANRSFrench National Research Agency (ANR)); French Embassy in Thailand; Science Achievement Scholarship of Thailand; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The clinical trials containing data used in this analysis were funded by the National Institutes of Health (PHPT-1: 5 R01 HD 33326; PHPT-2: NICHD R01 HD 39615; PHPT-5 First Phase, NICHD R01HD052461, R01HD056953, USA) and the Agence Nationale de Recherches sur le Sida et les Hepatites Virales (PHPT-2: ANRS 1208). Patumrat Sripan received a scholarship from the French Embassy in Thailand and a Science Achievement Scholarship of Thailand for her PhD. Co-author Billy Amzal is employed by LASER Analytica. LASER Analytica provided support in the form of salary for author BA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; Chung MH, 2007, JAIDS-J ACQ IMM DEF, V46, P472, DOI 10.1097/QAI.0b013e3181594c1c; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cressey TR, 2005, JAIDS-J ACQ IMM DEF, V38, P283; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V58, P353, DOI 10.1097/QAI.0b013e31822d4063; HOLFORD NHG, 1981, CLIN PHARMACOKINET, V6, P429, DOI 10.2165/00003088-198106060-00002; Jourdain G, 2007, J INFECT DIS, V196, P1629, DOI 10.1086/522009; Kuhn E, 2005, COMPUT STAT DATA AN, V49, P1020, DOI 10.1016/j.csda.2004.07.002; Kuhn L, 1997, AIDS, V11, P429, DOI 10.1097/00002030-199704000-00005; Kuhn L, 1999, J INFECT DIS, V179, P52, DOI 10.1086/314551; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Lallemant M, 18 C RETR OPP INF BO; Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016; Mandelbrot L, 2001, JAMA-J AM MED ASSOC, V285, P2083, DOI 10.1001/jama.285.16.2083; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Phanuphak N, 2010, ASIAN BIOMED, V4, P529, DOI 10.2478/abm-2010-0067; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; Samson A, 2006, COMPUT STAT DATA AN, V51, P1562, DOI 10.1016/j.csda.2006.05.007; Savic RM, 2011, AAPS J, V13, P44, DOI 10.1208/s12248-010-9238-5; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Taylor GP, 2012, HIV MED, V13, P87, DOI [10.1111/j.1468-1293.2012.01030.x, 10.1111/j.1468-1293.2012.01030_2.x]; WHO, CONSOLIDATED GUIDELI; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9	32	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126647	10.1371/journal.pone.0126647	http://dx.doi.org/10.1371/journal.pone.0126647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992639	Green Published, gold			2022-12-27	WOS:000354918600038
J	Fu, QL; Ma, JX; Ou, CQ; Guo, C; Shen, SQ; Xu, G; Shi, JB				Fu, Qing-Ling; Ma, Jin-Xiang; Ou, Chun-Quan; Guo, Cui; Shen, Shuang-Quan; Xu, Geng; Shi, Jianbo			Influence of Self-Reported Chronic Rhinosinusitis on Health-Related Quality of Life: A Population-Based Survey	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; SNOT-22 QUESTIONNAIRE; DISEASE SEVERITY; SLEEP QUALITY; IMPACT; VALIDATION; VERSION; SF-36; EPIDEMIOLOGY; RELIABILITY	Chronic rhinosinusitis (CRS) is a frequently occurring chronic respiratory disease. There is evidence that effective treatment of CRS can improve patients' quality of life, but the data regarding the extent to which CRS impairs patients' quality of life (QoL) is sparse. This study aimed to evaluate the effect of self-reported CRS on health-related QoL and to determine whether the influence was associated with gender, age and socio-economic status. A four-stage random sampling method was used to select the participants from the general population in Guangzhou, China. All participants were interviewed face-to-face at their homes using a standardized questionnaire. The health-related QoL of each participant was assessed using the SF-36 Health Survey. The scores of the SF-36 after adjusting for gender, age, socioeconomic conditions, smoking and some important comorbid conditions were compared between the CRS group and the non-CRS group using analysis of covariance. A multiple linear regression model with interaction terms was established to determine whether CRS affected QoL to the same degree across the different subpopulations. Among a total of 1,411 participants aged at least 15 years, 118 persons (8.4%) had self-reported CRS. Subjects with CRS had an increased prevalence of allergic rhinitis, chronic obstructive pulmonary disease and gout than subjects without CRS. The CRS group had lower scores in all eight domains and the physical and mental component summary than those without CRS (P<0.05), and the greatest differences were in role emotional function (RE), general health (GH) and role physical function (RP). The impairments of the CRS participants in RE and RP were greater among the females than the males. Moreover, physical domains were affected to greater degrees among the elderly and those with high-level education. In conclusion, CRS is a common chronic disorder. Persons with self-reported CRS perceived themselves as having impaired QoL in both the physical andmental domains. These findings shed new light on the health burden of CRS and should be taken into account by clinicians involved in the care of CRS patients.	[Fu, Qing-Ling; Xu, Geng; Shi, Jianbo] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou 510080, Guangdong, Peoples R China; [Ma, Jin-Xiang] Guangzhou Med Univ, Sch Publ Hlth, Dept Appl Stat, Guangzhou 511436, Guangdong, Peoples R China; [Ou, Chun-Quan; Guo, Cui; Shen, Shuang-Quan] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Southern Medical University - China	Ou, CQ (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China.	ouchunquan@hotmail.com; tsjbent@163.com	guo, cui/AAR-5300-2020	guo, cui/0000-0003-0816-6534; Ou, Chun-Quan/0000-0001-6866-7213	Industry Foundation of the Ministry of Health of China [201202005]; NSFC [81322012, 81373174, 81170896, 81272062, 81273212, 81471832];  [NCET-13-0608]	Industry Foundation of the Ministry of Health of China; NSFC(National Natural Science Foundation of China (NSFC)); 	This study was funded by the Industry Foundation of the Ministry of Health of China (201202005), NCET-13-0608 and NSFC (81322012, 81373174, 81170896, 81272062, 81273212 and 81471832). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alobid I, 2008, ALLERGY, V63, P1267, DOI 10.1111/j.1398-9995.2008.01828.x; Alt JA, 2013, LARYNGOSCOPE, V123, P2364, DOI 10.1002/lary.24040; Baumann I, 2005, AM J RHINOL, V19, P282, DOI 10.1177/194589240501900312; Benninger MS, 2010, LARYNGOSCOPE, V120, P1696, DOI 10.1002/lary.21010; Bhattacharyya N, 2011, OTOLARYNG HEAD NECK, V144, P440, DOI 10.1177/0194599810391852; BOUSQUET J, 1994, AM J RESP CRIT CARE, V149, P371, DOI 10.1164/ajrccm.149.2.8306032; Colas C, 2012, CLIN EXP ALLERGY, V42, P1080, DOI 10.1111/j.1365-2222.2011.03935.x; de Loos DAED, 2013, CURR ALLERGY ASTHM R, V13, P162, DOI 10.1007/s11882-012-0334-8; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gliklich RE, 1997, OTOLARYNG HEAD NECK, V117, P12, DOI 10.1016/S0194-5998(97)70199-2; Guilemany JM, 2006, RESP MED, V100, P1997, DOI 10.1016/j.rmed.2006.02.016; Halawi AM, 2013, ALLERGY ASTHMA PROC, V34, P328, DOI 10.2500/aap.2013.34.3675; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Kluger N, 2014, CLIN ENDOCRINOL, V81, P511, DOI 10.1111/cen.12484; Lange B, 2013, CLIN OTOLARYNGOL, V38, P474, DOI 10.1111/coa.12189; Marambaia PP, 2013, BRAZ J OTORHINOLAR, V79, P54, DOI 10.5935/1808-8694.20130010; Mullol J, 2008, J INVEST ALLERG CLIN, V18, P415; Nilsson E, 2010, PATIENT-RELAT OUTCOM, V1, P153, DOI 10.2147/PROM.S13209; Pleis John R, 2002, Vital Health Stat 10, P1; Ragab SM, 2010, RHINOLOGY, V48, P305, DOI 10.4193/Rhin08.137; Schalek P, 2010, EUR ARCH OTO-RHINO-L, V267, P473, DOI 10.1007/s00405-009-1180-8; Shah A, 2014, ASIA PAC ALLERGY, V4, P131, DOI 10.5415/apallergy.2014.4.3.131; Shen B, 2014, INT J CLIN EXP MED, V7, P1585; Shi JB, 2015, ALLERGY, V70, P533, DOI 10.1111/all.12577; Thilsing T, 2012, AM J IND MED, V55, P1037, DOI 10.1002/ajim.22074; Thumboo J, 2003, SOC SCI MED, V56, P1761, DOI 10.1016/S0277-9536(02)00171-5; Thumboo J, 2000, LUPUS, V9, P708, DOI 10.1191/096120300673421268; Tomassen P, 2011, ALLERGY, V66, P556, DOI 10.1111/j.1398-9995.2010.02503.x; Wang PC, 2003, QUAL LIFE RES, V12, P443, DOI 10.1023/A:1023494025748; Ware J., 1993, SF 36 HLTH SURVEY MA; Winstead W, 1998, OTOLARYNG HEAD NECK, V119, P486, DOI 10.1016/S0194-5998(98)70106-8; Yang Z, 2012, INT J CLIN PRACT, V66, P991, DOI 10.1111/j.1742-1241.2012.02962.x; Zhou KN, 2013, J VIRAL HEPATITIS, V20, pe47, DOI 10.1111/jvh.12030	33	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126881	10.1371/journal.pone.0126881	http://dx.doi.org/10.1371/journal.pone.0126881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978550	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100112
J	Griffiths, S; Penton-Voak, IS; Jarrold, C; Munafo, MR				Griffiths, Sarah; Penton-Voak, Ian S.; Jarrold, Chris; Munafo, Marcus R.			No Own-Age Advantage in Children's Recognition of Emotion on Prototypical Faces of Different Ages	PLOS ONE			English	Article							FACIAL EXPRESSION RECOGNITION; RACE BIAS; PERCEPTION; MEMORY	We test whether there is an own-age advantage in emotion recognition using prototypical younger child, older child and adult faces displaying emotional expressions. Prototypes were created by averaging photographs of individuals from 6 different age and sex categories (male 5-8 years, male 9-12 years, female 5-8 years, female 9-12 years, adult male and adult female), each posing 6 basic emotional expressions. In the study 5-8 year old children (n = 33), 9-13 year old children (n = 70) and adults (n = 92) labelled these expression prototypes in a 6-alternative forced-choice task. There was no evidence that children or adults recognised expressions better on faces from their own age group. Instead, child facial expression prototypes were recognised as accurately as adult expression prototypes by all age groups. This suggests there is no substantial own-age advantage in children's emotion recognition.	[Griffiths, Sarah; Penton-Voak, Ian S.; Jarrold, Chris; Munafo, Marcus R.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Griffiths, Sarah; Munafo, Marcus R.] Univ Bristol, MRC IEU, Bristol, Avon, England; [Munafo, Marcus R.] Univ Bristol, UK Ctr Tobacco & Alcohol Studies, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Griffiths, S (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	sarah.griffiths@bristol.ac.uk	Munafo, Marcus/AAE-2306-2020; Griffiths, Sarah/AAG-2434-2020	Munafo, Marcus/0000-0002-4049-993X; Griffiths, Sarah/0000-0002-0720-4511; Jarrold, Christopher/0000-0001-8662-0937; Penton-Voak, Ian/0000-0003-4232-0953	University of Bristol; MRC [MC_UU_12013/7, MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [MC_UU_12013/6, MC_UU_12013/7] Funding Source: researchfish	University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Sarah Griffiths was funded by a postgraduate Science Scholarship from the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Cassia VM, 2009, Q J EXP PSYCHOL, V62, P1099, DOI 10.1080/17470210802617654; CHIRORO P, 1995, Q J EXP PSYCHOL-A, V48, P879, DOI 10.1080/14640749508401421; Dalrymple KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079131; De Sonneville LMJ, 2002, J CLIN EXP NEUROPSYC, V24, P200, DOI 10.1076/jcen.24.2.200.989; Ebner NC, 2011, COGNITION EMOTION, V25, P983, DOI 10.1080/02699931.2010.540817; Ebner NC, 2009, EMOTION, V9, P329, DOI 10.1037/a0015179; Elfenbein HA, 2002, PSYCHOL BULL, V128, P243, DOI 10.1037//0033-2909.128.2.243; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Herba CM, 2008, J CHILD PSYCHOL PSYC, V49, P201, DOI 10.1111/j-1469-7610.2007.01835.x; Herba CM, 2006, J CHILD PSYCHOL PSYC, V47, P1098, DOI 10.1111/j.1469-7610.2006.01652.x; Hills PJ, 2012, DEV PSYCHOL, V48, P499, DOI 10.1037/a0026524; Hills PJ, 2011, Q J EXP PSYCHOL, V64, P17, DOI 10.1080/17470218.2010.537926; Houstis O, 2009, EUR J ORTHODONT, V31, P459, DOI 10.1093/ejo/cjp019; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; Lobue V, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01532; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Mellion ZJ, 2013, AM J ORTHOD DENTOFAC, V143, P845, DOI 10.1016/j.ajodo.2013.01.019; Montirosso R, 2010, SOC DEV, V19, P71, DOI 10.1111/j.1467-9507.2008.00527.x; Rhodes G, 1996, SUPERPORTRAITS CARIC; Riediger M, 2011, COGNITION EMOTION, V25, P968, DOI 10.1080/02699931.2010.540812; Skinner AL, 2010, PSYCHOL SCI, V21, P1248, DOI 10.1177/0956797610380702; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Wiese H, 2013, VIS COGN, V21, P1337, DOI 10.1080/13506285.2013.823139; Yoon KL, 2008, J ABNORM PSYCHOL, V117, P680, DOI 10.1037/0021-843X.117.3.680	28	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125256	10.1371/journal.pone.0125256	http://dx.doi.org/10.1371/journal.pone.0125256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978656	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100024
J	Grundel, A; Friedrich, K; Pfeiffer, M; Jacobs, E; Dumke, R				Gruendel, Anne; Friedrich, Kathleen; Pfeiffer, Melanie; Jacobs, Enno; Dumke, Roger			Subunits of the Pyruvate Dehydrogenase Cluster of Mycoplasma pneumoniae Are Surface-Displayed Proteins that Bind and Activate Human Plasminogen	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ALPHA-ENOLASE; CELL-SURFACE; BETA-SUBUNIT; VIRULENCE; INFECTION; ADHESION; MUTATION; DOMAINS; COMPLEX	The dual role of glycolytic enzymes in cytosol-located metabolic processes and in cell surface-mediated functions with an influence on virulence is described for various microorganisms. Cell wall-less bacteria of the class Mollicutes including the common human pathogen Mycoplasma pneumoniae possess a reduced genome limiting the repertoire of virulence factors and metabolic pathways. After the initial contact of bacteria with cells of the respiratory epithelium via a specialized complex of adhesins and release of cell-damaging factors, surface-displayed glycolytic enzymes may facilitate the further interaction between host and microbe. In this study, we described detection of the four subunits of pyruvate dehydrogenase complex (PDHA-D) among the cytosolic and membrane-associated proteins of M. pneumoniae. Subunits of PDH were cloned, expressed and purified to produce specific polyclonal guinea pig antisera. Using colony blotting, fractionation of total proteins and immunofluorescence experiments, the surface localization of PDHA-C was demonstrated. All recombinant PDH subunits are able to bind to HeLa cells and human plasminogen. These interactions can be specifically blocked by the corresponding polyclonal antisera. In addition, an influence of ionic interactions on PDHC-binding to plasminogen as well as of lysine residues on the association of PDHA-D with plasminogen was confirmed. The PDHB subunit was shown to activate plasminogen and the PDHB-plasminogen complex induces degradation of human fibrinogen. Hence, our data indicate that the surface-associated PDH subunits might play a role in the pathogenesis of M. pneumoniae infections by interaction with human plasminogen.	[Gruendel, Anne; Friedrich, Kathleen; Pfeiffer, Melanie; Jacobs, Enno; Dumke, Roger] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany	Technische Universitat Dresden	Dumke, R (corresponding author), Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany.	roger.dumke@tu-dresden.de			Deutsche Forschungsgemeinschaft [DU 1280/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant DU 1280/1-1 of Deutsche Forschungsgemeinschaft (www.dfg.de) to RD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann F, 2001, HDB EXPT PHARM; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Castellino FJ, 1997, CIBA F SYMP, V212, P46; Chang PC, 2008, THROMB HAEMOSTASIS, V99, P729, DOI 10.1160/TH07-06-0403; Chen HJ, 2011, MICROB PATHOGENESIS, V51, P285, DOI 10.1016/j.micpath.2011.03.012; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; Dumke R, 2015, EMERG INFECT DIS, V21, P426, DOI 10.3201/eid2103.140927; Dumke R, 2011, MICROBIOL-SGM, V157, P2328, DOI 10.1099/mic.0.048298-0; Fernandes LGV, 2012, INFECT IMMUN, V80, P3679, DOI 10.1128/IAI.00474-12; Hames C, 2005, APPL ENVIRON MICROB, V71, P4097, DOI 10.1128/AEM.71.7.4097-4100.2005; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; Hasselbring BM, 2006, P NATL ACAD SCI USA, V103, P16478, DOI 10.1073/pnas.0608051103; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1; Hoelzle LE, 2007, MICROBES INFECT, V9, P466, DOI 10.1016/j.micinf.2007.01.004; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Layh-Schmitt G, 2000, MICROBIOL-UK, V146, P741, DOI 10.1099/00221287-146-3-741; MARTI D, 1994, EUR J BIOCHEM, V219, P455, DOI 10.1111/j.1432-1033.1994.tb19959.x; Matic JN, 2003, GENE, V319, P99, DOI 10.1016/S0378-1119(03)00798-4; Nogueira SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078150; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Regula JT, 2001, MICROBIOL-UK, V147, P1045, DOI 10.1099/00221287-147-4-1045; Sanderson-Smith ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/272148; Schmidl SR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002263; Schmidl SR, 2010, MOL CELL PROTEOMICS, V9, P1228, DOI 10.1074/mcp.M900267-MCP200; Schreiner SA, 2012, VET MICROBIOL, V156, P88, DOI 10.1016/j.vetmic.2011.10.010; Schurwanz N, 2009, INFECT IMMUN, V77, P5007, DOI 10.1128/IAI.00268-09; Song ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038836; Sun ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088328; Thomas C, 2013, MICROBIOL-SGM, V159, P352, DOI 10.1099/mic.0.061184-0; VANZONNEVELD AJ, 1986, J BIOL CHEM, V261, P14214; Vastano V, 2014, MICROBIOL RES, V169, P121, DOI 10.1016/j.micres.2013.07.013; von Baum H, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-62; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07	46	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126600	10.1371/journal.pone.0126600	http://dx.doi.org/10.1371/journal.pone.0126600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978044	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100083
J	Hou, W; Gao, W; Wang, DT; Liu, QX; Zheng, SW; Wang, YP				Hou, Wei; Gao, Wei; Wang, Datao; Liu, Qingxiu; Zheng, Siwen; Wang, Yingping			The Protecting Effect of Deoxyschisandrin and Schisandrin B on HaCaT Cells against UVB-Induced Damage	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; ULTRAVIOLET-RADIATION; KERATINOCYTES; CHINENSIS; ACTIVATION; PATHWAYS; EXTRACT; DEATH; BAILL; RATS	Schisandra chinensis is a traditional Chinese medicine that has multiple biological activities, including antioxidant, anticancer, tonic, and anti-aging effects. Deoxyschisandrin (SA) and schisandrin B (SB), the two major lignans isolated from S. chinensis, exert high antioxidant activities in vitro and in vivo by scavenging free radicals, such as reactive oxygen species (ROS). Ultraviolet B-ray (UVB) radiation induces the production of ROS and DNA damage, which eventually leads to cell death by apoptosis. However, it is unknown whether SA or SB protects cells against UVB-induced cellular DNA damage. Our study showed that both SA and SB effectively protected HaCaT cells from UVB-induced cell death by antagonizing UVB-mediated production of ROS and induction of DNA damage. Our results showed that both SA and SB significantly prevented UVB-induced loss of cell viability using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assays. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assays showed that the production of ROS following UVB exposure was inhibited by treatment with SA and SB. Moreover, SA and SB decreased the UVB-induced DNA damage in HaCaT cells by comet assays. In addition, SA and SB also prevented UVB-induced cell apoptosis and the cleavage of caspase-3, caspase-8 and caspase-9. In a word, our results imply that the antioxidants SA and SB could protect cells from UVB-induced cell damage via scavenging ROS.	[Hou, Wei; Gao, Wei; Wang, Datao; Liu, Qingxiu; Zheng, Siwen; Wang, Yingping] Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Changchun, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS	Wang, YP (corresponding author), Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Changchun, Peoples R China.	yingpingw@yeah.net			Jilin Science & Technology Development Plan [20140101125JC, YYZX201245, YYZX201286, YYZW201246, YYZX201244]; National Spark Program [2012GA660002]	Jilin Science & Technology Development Plan; National Spark Program	Funding: This work was supported by grants from the Jilin Science & Technology Development Plan (No. 20140101125JC, YYZX201245, YYZX201286, YYZW201246, and YYZX201244) and the National Spark Program (No. 2012GA660002).	Assefa Z, 2005, BBA-REV CANCER, V1755, P90, DOI 10.1016/j.bbcan.2005.04.001; Autier P, 2011, CURR OPIN ONCOL, V23, P189, DOI 10.1097/CCO.0b013e3283436e5d; Chiu PY, 2006, BIOGERONTOLOGY, V7, P199, DOI 10.1007/s10522-006-9017-y; Chiu PY, 2011, FITOTERAPIA, V82, P682, DOI 10.1016/j.fitote.2011.02.010; Cho JK, 2011, J KOREAN SOC APPL BI, V54, P583, DOI 10.3839/jksabc.2011.088; Floyd DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096239; Fu YC, 2000, J TOXICOL ENV HEAL A, V61, P177, DOI 10.1080/00984100050131323; Gu BH, 2010, INT J MOL MED, V26, P401, DOI 10.3892/ijmm_00000479; Hancke JL, 1999, FITOTERAPIA, V70, P451, DOI 10.1016/S0367-326X(99)00102-1; Huang XD, 2013, APPL MECH MATER, V423-426, P373, DOI 10.4028/www.scientific.net/AMM.423-426.373; Huyke C, 2007, PLANTA MED, V73, P1116, DOI 10.1055/s-2007-981559; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Kim W, 2010, J RADIAT RES, V51, P285, DOI 10.1269/jrr.09141; KRAMER M, 1993, J BIOL CHEM, V268, P6734; Kulms D, 2002, ONCOGENE, V21, P5844, DOI 10.1038/sj.onc.1205743; Kulms D, 2002, BIOCHEM PHARMACOL, V64, P837, DOI 10.1016/S0006-2952(02)01146-2; Kuo CT, 2008, TOXICOL LETT, V177, P48, DOI 10.1016/j.toxlet.2007.12.009; Liu CJ, 2009, NAT PROD RES, V23, P1390, DOI 10.1080/14786410902726100; Mak DHF, 1996, MOL CELL BIOCHEM, V165, P161; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Mishra R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092586; Opletal L, 2004, J CHROMATOGR B, V812, P357, DOI 10.1016/j.jchromb.2004.07.040; Panossian A, 2008, J ETHNOPHARMACOL, V118, P183, DOI 10.1016/j.jep.2008.04.020; Park K, 2007, ONCOL REP, V17, P537; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; Xu YR, 2009, J CELL BIOCHEM, V107, P873, DOI 10.1002/jcb.22195	26	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127177	10.1371/journal.pone.0127177	http://dx.doi.org/10.1371/journal.pone.0127177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978330	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100132
J	Liang, T; Alloosh, M; Bell, LN; Fullenkamp, A; Saxena, R; Van Alstine, W; Bybee, P; Werling, K; Sturek, M; Chalasani, N; Masuoka, HC				Liang, Tiebing; Alloosh, Mouhamad; Bell, Lauren N.; Fullenkamp, Allison; Saxena, Romil; Van Alstine, William; Bybee, Phelan; Werling, Klara; Sturek, Michael; Chalasani, Naga; Masuoka, Howard C.			Liver Injury and Fibrosis Induced by Dietary Challenge in the Ossabaw Miniature Swine	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; STEATOHEPATITIS; PREVALENCE; MODELS	Background Ossabaw miniature swine when fed a diet high in fructose, saturated fat and cholesterol (NASH diet) develop metabolic syndrome and nonalcoholic steatohepatitis (NASH) characterized by liver injury and fibrosis. This study was conducted to further characterize the development of NASH in this large animal model. Methods Ossabaw swine were fed standard chow (control group; n = 6) or NASH diet (n = 6) for 24 weeks. Blood and liver tissue were collected and liver histology were characterized at 0, 8, 16 and 24 weeks of dietary intervention. Hepatic apoptosis and lipid levels were assessed at week 24. Results The NASH diet group developed metabolic syndrome and progressive histologic features of NASH including: (a) hepatocyte ballooning at 8 weeks which progressed to extensive ballooning (>90% hepatocytes), (b) hepatic fibrosis at week 16, which progressed to moderate fibrosis, and (c) Kupffer cell accumulation with vacuolization at 8 weeks which progressed through week 24. The NASH diet group showed increased hepatocyte apoptosis that correlated with hepatic total and free cholesterol and free fatty acids, but not esterified cholesterol or triglycerides. Conclusions This report further characterizes the progression of diet-induced NASH in the Ossabaw swine model. In Ossabaw swine fed the NASH diet: (a) hepatocyte injury and fibrosis can occur without macrovesicular steatosis or excess triglyceride accumulation; (b) hepatocyte ballooning generally precedes the development of fibrosis; (c) there is increased hepatocyte apoptosis, and it is correlated more significantly with hepatic free cholesterol than hepatic free fatty acids and had no correlation with hepatic triglycerides.	[Liang, Tiebing; Bell, Lauren N.; Fullenkamp, Allison; Chalasani, Naga; Masuoka, Howard C.] Indiana Univ Sch Med, Dept Med, Div Gastroenterol Hepatol, Indianapolis, IN 46202 USA; [Alloosh, Mouhamad; Sturek, Michael; Chalasani, Naga; Masuoka, Howard C.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Saxena, Romil] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Van Alstine, William] Purdue Univ, Sch Vet Med, Lafayette, IN USA; [Bybee, Phelan] Purdue Univ, Sch Biomed Engn, Lafayette, IN USA; [Werling, Klara] Semmelweis Univ, Dept Med 2nd, H-1085 Budapest, Hungary	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University System; Purdue University; Semmelweis University	Masuoka, HC (corresponding author), Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, 702 Rotary Circle, Indianapolis, IN 46202 USA.	hmasuoka@iu.edu	Sturek, Michael/CAH-2948-2022	Liang, Tiebing/0000-0002-8445-3765	IU Health Values Fund Research Grant; National Institutes of Health [5R01HL062552-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA007611] Funding Source: NIH RePORTER	IU Health Values Fund Research Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Dr. Masuoka is supported by the IU Health Values Fund Research Grant. Dr. Sturek is supported by National Institutes of Health grant 5R01HL062552-11.	[Anonymous], 2011, GUIDE CARE USE LAB A; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Beymer C, 2003, ARCH SURG-CHICAGO, V138, P1240, DOI 10.1001/archsurg.138.11.1240; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; BUHLINGER CA, 1978, GROWTH, V42, P225; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; COTE PJ, 1982, J ANIM SCI, V54, P89, DOI 10.2527/jas1982.54189x; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Edwards JM, 2010, CARDIOVASC RES, V85, P631, DOI 10.1093/cvr/cvp308; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Litten-Brown JC, 2010, ANIMAL, V4, P899, DOI 10.1017/S1751731110000200; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nolen R Scott, 2011, J Am Vet Med Assoc, V239, P1269; Roberts RM, 2009, SCIENCE, V324, P468, DOI 10.1126/science.1168521; Stoll B, 2010, J NUTR, V140, P2193, DOI 10.3945/jn.110.125799; Sturek M, 2007, SWINE LAB SURG ANEST, P397; Trask AJ, 2012, J APPL PHYSIOL, V113, P1128, DOI 10.1152/japplphysiol.00604.2012; van der Laan JW, 2010, J PHARMACOL TOX MET, V62, P184, DOI 10.1016/j.vascn.2010.05.005; Varga O, 2010, OBES REV, V11, P792, DOI 10.1111/j.1467-789X.2009.00667.x; WANGSNESS PJ, 1980, GROWTH, V44, P318; Williams JL, 1997, AM J PHYSIOL-HEART C, V273, pH487, DOI 10.1152/ajpheart.1997.273.1.H487	22	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124173	10.1371/journal.pone.0124173	http://dx.doi.org/10.1371/journal.pone.0124173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978364	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100013
J	Padovan, A; Patel, HR; Chuah, A; Huttley, GA; Krause, ST; Degenhardt, J; Foley, WJ; Kulheim, C				Padovan, Amanda; Patel, Hardip R.; Chuah, Aaron; Huttley, Gavin A.; Krause, Sandra T.; Degenhardt, Joerg; Foley, William J.; Kuelheim, Carsten			Transcriptome Sequencing of Two Phenotypic Mosaic Eucalyptus Trees Reveals Large Scale Transcriptome Re-Modelling	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; BIOLOGICAL-CONTROL AGENT; GENE-EXPRESSION; SYNTHASE GENE; ISOPRENOID-BIOSYNTHESIS; MELALEUCA-QUINQUENERVIA; TERPENE SYNTHASES; MOLECULAR-BASIS; DROUGHT; LEAVES	Phenotypic mosaic trees offer an ideal system for studying differential gene expression. We have investigated two mosaic eucalypt trees from two closely related species (Eucalyptus melliodora and E. sideroxylon), which each support two types of leaves: one part of the canopy is resistant to insect herbivory and the remaining leaves are susceptible. Driving this ecological distinction are differences in plant secondary metabolites. We used these phenotypic mosaics to investigate genome wide patterns of foliar gene expression with the aim of identifying patterns of differential gene expression and the somatic mutation(s) that lead to this phenotypic mosaicism. We sequenced the mRNA pool from leaves of the resistant and susceptible ecotypes from both mosaic eucalypts using the Illumina HiSeq 2000 platform. We found large differences in pathway regulation and gene expression between the ecotypes of each mosaic. The expression of the genes in the MVA and MEP pathways is reflected by variation in leaf chemistry, however this is not the case for the terpene synthases. Apart from the terpene biosynthetic pathway, there are several other metabolic pathways that are differentially regulated between the two ecotypes, suggesting there is much more phenotypic diversity than has been described. Despite the close relationship between the two species, they show large differences in the global patterns of gene and pathway regulation.	[Padovan, Amanda; Foley, William J.; Kuelheim, Carsten] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Patel, Hardip R.; Chuah, Aaron; Huttley, Gavin A.] Australian Natl Univ, John Curtin Sch Med Res, Genome Discovery Unit, Canberra, ACT 0200, Australia; [Krause, Sandra T.; Degenhardt, Joerg] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Saale, Germany	Australian National University; Australian National University; John Curtin School of Medical Research; Martin Luther University Halle Wittenberg	Padovan, A (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia.	amanda.padovan@anu.edu.au	Huttley, Gavin A/G-5169-2015; Chuah, Aaron/G-2281-2016; Kulheim, Carsten/AAR-2734-2021; Foley, William J/C-8069-2009; Kulheim, Carsten/F-4720-2010; Patel, Hardip R/K-6376-2012	Huttley, Gavin A/0000-0001-7224-2074; Chuah, Aaron/0000-0003-3066-701X; Foley, William J/0000-0001-8587-1814; Patel, Hardip/0000-0003-3169-049X; Kulheim, Carsten/0000-0002-0798-3324	Australian Reserach Council [DP0877063]	Australian Reserach Council	This work was supported by an Australian Reserach Council (http://www.arc.gov.au/) Discovery Grant to WJF (DP0877063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S, 2012, FASTQC A QUALITY CON; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; BERKOWITZ FE, 1995, SOUTH MED J, V88, P797, DOI 10.1097/00007611-199508000-00001; Broun Pierre, 2006, Phytochemistry Reviews, V5, P27, DOI 10.1007/s11101-006-9000-x; Cai Y, 2002, PHYTOCHEMISTRY, V61, P523, DOI 10.1016/S0031-9422(02)00265-0; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Deyholos MK, 2010, PLANT CELL ENVIRON, V33, P648, DOI 10.1111/j.1365-3040.2009.02092.x; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; EDWARDS PB, 1990, NATURE, V347, P434, DOI 10.1038/347434a0; EDWARDS PB, 1993, OECOLOGIA, V95, P551, DOI 10.1007/BF00317440; Eo SH, 2012, GENE, V492, P329, DOI 10.1016/j.gene.2011.11.018; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Frenkel M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-12; Gantet P, 2002, TRENDS PHARMACOL SCI, V23, P563, DOI 10.1016/S0165-6147(02)02098-9; Gill D.E., 1986, PLANT ECOLOGY, P321; GILL DE, 1995, ANNU REV ECOL SYST, V26, P423, DOI 10.1146/annurev.es.26.110195.002231; Goodger JQD, 2009, PHYTOCHEMISTRY, V70, P1187, DOI 10.1016/j.phytochem.2009.06.004; Henery ML, 2007, NEW PHYTOL, V176, P82, DOI 10.1111/j.1469-8137.2007.02159.x; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; [Joint-Genome-Institute Center-for-Integrative-Genomics], 2006, EUCALYPTUS GRANDIS G; Keszei A, 2010, PHYTOCHEMISTRY, V71, P844, DOI 10.1016/j.phytochem.2010.03.013; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Kulheim C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1598-x; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; LEBENTHAL E, 1975, AM J CLIN NUTR, V28, P595, DOI 10.1093/ajcn/28.6.595; Licciardello C, 2008, TREE GENET GENOMES, V4, P315, DOI 10.1007/s11295-007-0111-3; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Ma DM, 2009, PLANT CELL PHYSIOL, V50, P2146, DOI 10.1093/pcp/pcp149; Matsuki M, 2011, J CHEM ECOL, V37, P286, DOI 10.1007/s10886-011-9916-5; Mayrhofer S, 2005, PLANT PHYSIOL, V139, P474, DOI 10.1104/pp.105.066373; McGregor S. E., 1976, INSECT POLLINATION O; McKay SAB, 2003, PLANT PHYSIOL, V133, P368, DOI 10.1104/pp.103.022723; Mercke P, 2004, PLANT PHYSIOL, V135, P2012, DOI 10.1104/pp.104.048116; Mewis I, 2006, PHYTOCHEMISTRY, V67, P2450, DOI 10.1016/j.phytochem.2006.09.004; Moore BD, 2014, NEW PHYTOL, V201, P733, DOI 10.1111/nph.12526; Myburg A, 2012, BMC PROC, V5, pI20; Nieuwenhuizen NJ, 2013, PLANT PHYSIOL, V161, P787, DOI 10.1104/pp.112.208249; Padovan A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-29; Padovan A, 2012, J CHEM ECOL, V38, P914, DOI 10.1007/s10886-012-0149-z; Padovan A, 2010, PHYTOCHEMISTRY, V71, P1237, DOI 10.1016/j.phytochem.2010.05.013; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Prosser I, 2004, ARCH BIOCHEM BIOPHYS, V432, P136, DOI 10.1016/j.abb.2004.06.030; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Spyropoulou EA, 2012, TRANSCRIPTION FACTOR, P181; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tholl D, 2005, PLANT J, V42, P757, DOI 10.1111/j.1365-313X.2005.02417.x; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapp SC, 2001, GENETICS, V158, P811; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van Schie CCN, 2006, CURR OPIN PLANT BIOL, V9, P203, DOI 10.1016/j.pbi.2006.01.001; Webb H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060631; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; WELIN BV, 1994, PLANT MOL BIOL, V26, P131, DOI 10.1007/BF00039526; Wheeler GS, 2006, BIOL CONTROL, V36, P121, DOI 10.1016/j.biocontrol.2005.10.005; Wheeler GS, 2005, BIOCHEM SYST ECOL, V33, P365, DOI 10.1016/j.bse.2004.10.010; WHITHAM TG, 1981, OECOLOGIA, V49, P287, DOI 10.1007/BF00347587; Xu YH, 2004, PLANT PHYSIOL, V135, P507, DOI 10.1104/pp.104.038612; Yu ZX, 2012, MOL PLANT, V5, P353, DOI 10.1093/mp/ssr087; Zini CA, 2003, J AGR FOOD CHEM, V51, P2679, DOI 10.1021/jf026047g	68	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0123226	10.1371/journal.pone.0123226	http://dx.doi.org/10.1371/journal.pone.0123226			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978451	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100007
J	Wolfertstetter, S; Reinders, J; Schwede, F; Ruth, P; Schinner, E; Schlossmann, J				Wolfertstetter, Stefanie; Reinders, Joerg; Schwede, Frank; Ruth, Peter; Schinner, Elisabeth; Schlossmann, Jens			Interaction of cCMP with the cGK, cAK and MAPK Kinases in Murine Tissues	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ANTHRACIS EDEMA FACTOR; SIGNAL-TRANSDUCTION; CELL-PROLIFERATION; BACULOVIRUS SYSTEM; GUANYLYL CYCLASE; CANCER CELLS; I-BETA; CGMP; IRAG	cAMP and cGMP are well established second messengers that are essential for numerous (patho) physiological processes. These purine cyclic nucleotides activate cAK and cGK, respectively. Recently, the existence of cCMP was described, and a possible function for this cyclic nucleotide was investigated. It was postulated that cCMP plays a role as a second messenger. However, the functions regulated by cCMP are mostly unknown. To elucidate probable functions, cCMP-binding and -activated proteins were identified using different methods. We investigated the effect of cCMP on purified cyclic nucleotide-dependent protein kinases and lung and jejunum tissues of wild type (WT), cGKI-knockout (cGKI KO) and cGKII-knockout (cGKII KO) mice. The catalytic activity of protein kinases was measured by a (gamma-P-32) ATP kinase assay. Cyclic nucleotide-dependent protein kinases (cAK, cGKI and cGKII) in WT tissue lysates were stimulated by cCMP. In contrast, there was no stimulation of phosphorylation in KO tissue lysates. Competitive binding assays identified cAK, cGKI, and cGKII as cCMP-binding proteins. An interaction between cCMP/MAPK and a protein-protein complex of MAPK/cGK were detected via cCMP affinity chromatography and co-immunoprecipitation, respectively. These complexes were abolished or reduced in jejunum tissues from cGKI KO or cGKII KO mice. In contrast, these complexes were observed in the lung tissues from WT, cGKI KO and cGKII KO mice. Moreover, cCMP was also able to stimulate the phosphorylation of MAPK. These results suggest that MAPK signaling is regulated by cGMP-dependent protein kinases upon activation by cCMP. Based on these results, we propose that additional cCMP-dependent protein kinases that are capable of modulating MAPK signaling could exist. Hence, cCMP could potentially act as a second messenger in the cAK/cGK and MAPK signaling pathways and play an important role in physiological processes of the jejunum and lung.	[Wolfertstetter, Stefanie; Schinner, Elisabeth; Schlossmann, Jens] Univ Regensburg, Inst Pharm, Dept Pharmacol & Toxicol, D-93053 Regensburg, Germany; [Reinders, Joerg] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Schwede, Frank] Biolog Life Sci Inst, Bremen, Germany; [Ruth, Peter] Univ Tubingen, Inst Pharm, Dept Pharmacol Toxicol & Clin Pharm, Tubingen, Germany	University of Regensburg; University of Regensburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schlossmann, J (corresponding author), Univ Regensburg, Inst Pharm, Dept Pharmacol & Toxicol, D-93053 Regensburg, Germany.	Jens.Schlossmann@chemie.uni-regensburg.de	Schlossmann, Jens/I-7743-2016	Schlossmann, Jens/0000-0002-2550-6839; Reinders, Joerg/0000-0003-1025-7849	Bavarian state	Bavarian state	The work was supported by the Bavarian state. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Bahre H, 2014, J CHROMATOGR B, V964, P208, DOI 10.1016/j.jchromb.2014.02.046; Bahre H, 2014, BIOCHEM BIOPH RES CO, V443, P1195, DOI 10.1016/j.bbrc.2013.12.108; Balint GA, 2001, J PHYSIOL-PARIS, V95, P243, DOI 10.1016/S0928-4257(01)00032-8; Basu N, 2014, J BIOL CHEM, V289, P581, DOI 10.1074/jbc.M113.511311; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Beste KY, 2013, BIOL CHEM, V394, P261, DOI 10.1515/hsz-2012-0282; CHENG HC, 1986, J BIOL CHEM, V261, P989; Desch M, 2010, FEBS LETT, V584, P3979, DOI 10.1016/j.febslet.2010.07.059; Desch M, 2010, CARDIOVASC RES, V86, P496, DOI 10.1093/cvr/cvq008; FEIL R, 1993, FEBS LETT, V336, P163, DOI 10.1016/0014-5793(93)81632-A; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; Geiselhoringer A, 2004, FEBS LETT, V575, P19, DOI 10.1016/j.febslet.2004.08.030; Gottle M, 2012, TOXINS, V4, P505, DOI 10.3390/toxins4070505; Gottle M, 2010, BIOCHEMISTRY-US, V49, P5494, DOI 10.1021/bi100684g; Hammerschmidt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039848; Hasan A, 2014, BIOCHEM BIOPH RES CO, V448, P236, DOI 10.1016/j.bbrc.2014.04.099; Jacob A, 2002, AM J PHYSIOL-CELL PH, V283, pC704, DOI 10.1152/ajpcell.00110.2002; Jiang L, 2013, BIOMED REP, V1, P399, DOI 10.3892/br.2013.85; Jiang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061674; Karakhanova S, 2014, PANCREAS, V43, P784, DOI 10.1097/MPA.0000000000000104; KEILBACH A, 1992, EUR J BIOCHEM, V208, P467, DOI 10.1111/j.1432-1033.1992.tb17209.x; Lan T, 2012, ONCOL REP, V27, P2039, DOI 10.3892/or.2012.1726; Nie HG, 2009, J PHYSIOL-LONDON, V587, P2663, DOI 10.1113/jphysiol.2009.170324; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; POHLER D, 1995, FEBS LETT, V374, P419, DOI 10.1016/0014-5793(95)01168-E; Ruth P, 1996, BIOL CHEM, V377, P513, DOI 10.1515/bchm3.1996.377.7-8.513; Salb Katharina, 2013, Methods Mol Biol, V1020, P147, DOI 10.1007/978-1-62703-459-3_9; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tao Y, 2012, ONCOL LETT, V4, P1104, DOI 10.3892/ol.2012.851; Thomas A, 2012, PROTEOMICS, V12, P1437, DOI 10.1002/pmic.201100628; WERNET W, 1989, FEBS LETT, V251, P191, DOI 10.1016/0014-5793(89)81453-X; Wolter S, 2014, N-S ARCH PHARMACOL, V387, P1163, DOI 10.1007/s00210-014-1042-9; Wolter S, 2011, BIOCHEM BIOPH RES CO, V415, P563, DOI 10.1016/j.bbrc.2011.10.093; Wu M, 2013, ONCOL LETT, V6, P1723, DOI 10.3892/ol.2013.1630; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129	38	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126057	10.1371/journal.pone.0126057	http://dx.doi.org/10.1371/journal.pone.0126057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978317	Green Published, gold			2022-12-27	WOS:000354916100044
J	Asiki, G; Murphy, GAV; Baisley, K; Nsubuga, RN; Karabarinde, A; Newton, R; Seeley, J; Young, EH; Kamali, A; Sandhu, MS				Asiki, Gershim; Murphy, Georgina A. V.; Baisley, Kathy; Nsubuga, Rebecca N.; Karabarinde, Alex; Newton, Robert; Seeley, Janet; Young, Elizabeth H.; Kamali, Anatoli; Sandhu, Manjinder S.			Prevalence of Dyslipidaemia and Associated Risk Factors in a Rural Population in South-Western Uganda: A Community Based Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; LOW HDL CHOLESTEROL; VEGETABLE CONSUMPTION; LIPIDS; HYPERLIPIDEMIA; HYPERTENSION; METAANALYSIS; STROKE; ADULTS	Background The burden of dyslipidaemia is rising in many low income countries. However, there are few data on the prevalence of, or risk factors for, dyslipidaemia in Africa. Methods In 2011, we used the WHO Stepwise approach to collect cardiovascular risk data within a general population cohort in rural south-western Uganda. Dyslipidaemia was defined by high total cholesterol (TC) >= 5.2mmol/L or low high density lipoprotein cholesterol (HDL-C) <1 mmol/L in men, and <1.3 mmol/L in women. Logistic regression was used to explore correlates of dyslipidaemia. Results Low HDL-C prevalence was 71.3% and high TC was 6.0%. In multivariate analysis, factors independently associated with low HDL-C among both men and women were: decreasing age, tribe (prevalence highest among Rwandese tribe), lower education, alcohol consumption (comparing current drinkers to never drinkers: men adjusted (a) OR=0.44, 95%CI=0.35-0.55; women aOR=0.51, 95%CI=0.41-0.64), consuming <5 servings of fruit/vegetable per day, daily vigorous physical activity (comparing those with none vs those with 5 days a week: men aOR=0.83 95%CI=0.67-1.02; women aOR=0.76, 95%CI=0.55-0.99), blood pressure (comparing those with hypertension to those with normal blood pressure: men aOR=0.57, 95%CI=0.43-0.75; women aOR=0.69, 95%CI=0.52-0.93) and HIV infection (HIV infected without ART vs. HIV negative: men aOR=2.45, 95%CI=1.53-3.94; women aOR=1.88, 95%CI=1.19-2.97). The odds of low HDL-C was also higher among men with high BMI or HbA1c <= 6%, and women who were single or with abdominal obesity. Among both men and women, high TC was independently associated with increasing age, non-Rwandese tribe, high waist circumference (men aOR=5.70, 95%CI=1.97-16.49; women aOR=1.58, 95%CI=1.10-2.28), hypertension (men aOR=3.49, 95%CI=1.74-7.00; women aOR=1.47, 95%CI=0.96-2.23) and HbA1c > 6% (men aOR=3.00, 95%CI=1.37-6.59; women aOR=2.74, 95%CI=1.77-4.27). The odds of high TC was also higher among married men, and women with higher education or high BMI. Conclusion Low HDL-C prevalence in this relatively young rural population is high whereas high TC prevalence is low. The consequences of dyslipidaemia in African populations remain unclear and prospective follow-up is required.	[Asiki, Gershim; Nsubuga, Rebecca N.; Karabarinde, Alex; Newton, Robert; Seeley, Janet; Kamali, Anatoli] MRC UVRI, Uganda Res Unit AIDS, Entebbe, Uganda; [Murphy, Georgina A. V.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Baisley, Kathy; Seeley, Janet; Kamali, Anatoli] London Sch Hyg & Trop Med, Oxford, England; [Young, Elizabeth H.; Sandhu, Manjinder S.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Young, Elizabeth H.; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Hinxton, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Wellcome Trust Sanger Institute	Asiki, G (corresponding author), MRC UVRI, Uganda Res Unit AIDS, Entebbe, Uganda.	gershim.asiki@mrcuganda.org	Murphy, Georgina/G-6981-2016	Murphy, Georgina/0000-0001-5978-483X; Asiki, Gershim/0000-0002-9966-1153; Seeley, Janet/0000-0002-0583-5272	Medical Research Council (MRC), UK [G0801566, G0901213-92157]; Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS core funding; British Heart Foundation [PG/08/094/26019] Funding Source: researchfish; Medical Research Council [MR/K012126/1, G0901213, MC_U950080926, G0801566] Funding Source: researchfish; MRC [G0901213, MC_U950080926, G0801566] Funding Source: UKRI	Medical Research Council (MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS core funding; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Medical Research Council (MRC), UK [grant numbers G0801566 and G0901213-92157] awarded to MSS and also Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS core funding. The URL for the funder is: http://www.mrc.ac.uk/Fundingopportunities/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Salinas CA, 2001, J LIPID RES, V42, P1298; Asiki G, 2013, INT J EPIDEMIOL, V42, P129, DOI 10.1093/ije/dys234; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Bimenya G S, 2006, Afr Health Sci, V6, P139; BRINTON EA, 1990, J CLIN INVEST, V85, P144, DOI 10.1172/JCI114405; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P304, DOI 10.1097/QAI.0b013e31815e7453; CHAIT A, 1990, ENDOCRIN METAB CLIN, V19, P259, DOI 10.1016/S0889-8529(18)30324-4; Chang MH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-62; Chang MH, 2011, CIRC-CARDIOVASC GENE, V4, P523, DOI 10.1161/CIRCGENETICS.111.959577; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; COHEN JC, 1994, J CLIN INVEST, V94, P2377, DOI 10.1172/JCI117603; CONSTANS J, 1994, EUR J CLIN INVEST, V24, P416, DOI 10.1111/j.1365-2362.1994.tb02185.x; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Davis J, 2013, ETHNIC DIS, V23, P65; DELONG DM, 1986, JAMA-J AM MED ASSOC, V256, P2372, DOI 10.1001/jama.256.17.2372; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Gottesman O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046419; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GRUNFELD C, 1989, AM J MED, V86, P27, DOI 10.1016/0002-9343(89)90225-8; Gupta R, 2012, EUR J PREV CARDIOL, V19, P1258, DOI 10.1177/1741826711424567; HAYEK T, 1993, J CLIN INVEST, V91, P1665, DOI 10.1172/JCI116375; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373; IDF, 2006, THE IDF CONSENSUS WO; Kamali A, 1996, INT J EPIDEMIOL, V25, P679, DOI 10.1093/ije/25.3.679; Kamara NT, 2010, TROP DOCT, V40, P41, DOI 10.1258/td.2009.090086; KRAUSS RM, 1982, MED CLIN N AM, V66, P403, DOI 10.1016/S0025-7125(16)31427-4; Lemic-Stojcevic N, 2001, ETHNIC HEALTH, V6, P87, DOI 10.1080/13557850120068414; Marmot M, 2006, SOCIAL DETERMINANTS; Mayanja BN, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-36; Mirmiran P, 2009, METABOLISM, V58, P460, DOI 10.1016/j.metabol.2008.11.002; Mondo CK, 2013, CARDIOVASC J AFR, V24, P52, DOI 10.5830/CVJA-2012-081; Mora S, 2008, CIRCULATION, V118, P993, DOI 10.1161/CIRCULATIONAHA.108.777334; Murphy GAV, 2013, INT J EPIDEMIOL, V42, P1740, DOI 10.1093/ije/dyt184; Mwangome MK, 2012, TROP MED INT HEALTH, V17, P622, DOI 10.1111/j.1365-3156.2012.02959.x; Njelekela M, 2001, ACTA TROP, V79, P231, DOI 10.1016/S0001-706X(01)00134-6; Nordestgaard G, 2009, CURR DRUG TARGETS, V10, P328, DOI 10.2174/138945009787846434; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Organization WH, 2011, USE OF GLYCATED HAEM; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; SPRAFKA JM, 1992, EPIDEMIOLOGY, V3, P156, DOI 10.1097/00001648-199203000-00014; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; STONE NJ, 1994, MED CLIN N AM, V78, P117, DOI 10.1016/S0025-7125(16)30179-1; WHO, 2002, QUANTIFYING SELECTED, P47; WHO, 2009, DISEASE BURDEN ESTIM; WHO, 2008, GLOBAL STRATEGY ON D; WHO, 2008, WHO EXPERT CONSULTAT; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Health Organisation, STEPS SURVEILLANCE M; World Health Organization, 2005, PREVENTING CHRONIC D; World Health Organization, 2011, USE OF GLYCATED HAEM	53	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126166	10.1371/journal.pone.0126166	http://dx.doi.org/10.1371/journal.pone.0126166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974077	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600042
J	Grigoryan, S; Yee, MB; Glick, Y; Gerber, D; Kepten, E; Garini, Y; Yang, IH; Kinchington, PR; Goldstein, RS				Grigoryan, Sergei; Yee, Michael B.; Glick, Yair; Gerber, Doron; Kepten, Eldad; Garini, Yuval; Yang, In Hong; Kinchington, Paul R.; Goldstein, Ronald S.			Direct Transfer of Viral and Cellular Proteins from Varicella-Zoster Virus-Infected Non-Neuronal Cells to Human Axons	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; VZV INFECTION; MOUSE MODEL; TRANSPORT; NEURONS; GLYCOPROTEINS; MECHANISMS; GENERATION	Varicella Zoster Virus (VZV), the alphaherpesvirus that causes varicella upon primary infection and Herpes zoster (shingles) following reactivation in latently infected neurons, is known to be fusogenic. It forms polynuclear syncytia in culture, in varicella skin lesions and in infected fetal human ganglia xenografted to mice. After axonal infection using VZV expressing green fluorescent protein (GFP) in compartmentalized microfluidic cultures there is diffuse filling of axons with GFP as well as punctate fluorescence corresponding to capsids. Use of viruses with fluorescent fusions to VZV proteins reveals that both proteins encoded by VZV genes and those of the infecting cell are transferred in bulk from infecting non-neuronal cells to axons. Similar transfer of protein to axons was observed following cell associated HSV1 infection. Fluorescence recovery after photobleaching (FRAP) experiments provide evidence that this transfer is by diffusion of proteins from the infecting cells into axons. Time-lapse movies and immunocytochemical experiments in co-cultures demonstrate that non-neuronal cells fuse with neuronal somata and proteins from both cell types are present in the syncytia formed. The fusogenic nature of VZV therefore may enable not only conventional entry of virions and capsids into axonal endings in the skin by classical entry mechanisms, but also by cytoplasmic fusion that permits viral protein transfer to neurons in bulk.	[Grigoryan, Sergei; Glick, Yair; Gerber, Doron; Goldstein, Ronald S.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Yee, Michael B.; Kinchington, Paul R.] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Yee, Michael B.; Kinchington, Paul R.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Kepten, Eldad; Garini, Yuval] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel; [Yang, In Hong] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Yang, In Hong] Natl Univ Singapore, SiNAPSE, Singapore 117548, Singapore	Bar Ilan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Bar Ilan University; Johns Hopkins University; National University of Singapore	Goldstein, RS (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	ron.goldstein@biu.ac.il	Yee, Michael/AAI-4164-2020	Yee, Michael/0000-0002-6296-7757; kepten, eldad/0000-0002-0341-5290; Garini, Yuval/0000-0002-8783-2015; Yang, In Hong/0000-0002-1020-0538	Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness; United States-Israel Binational Science Foundation [2013072]; Israel Science Foundation [238/11]; National Institutes of Health [NS082662]; CORE grant for vision research [EY08098]	Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CORE grant for vision research	This work received support from the following sources: Eye and Ear Foundation of Pittsburgh, http://www.eyeandear.org/, unrestricted, PRK; Research to Prevent Blindness, http://www. rpbusa.org/rpb/, unrestricted, PRK; United States-Israel Binational Science Foundation, http://bsf.org.il/BSFPublic/Default.aspx, 2013072, RSG, PRK; Israel Science Foundation, http://www.isf.org.il/, 238/11, RSG; National Institutes of Health, NS082662, http://www.nih.gov/, PRK, RSG; and a CORE grant for vision research, https://www.nei.nih.gov/funding/p30, EY08098, PRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinone SE, 2006, J VIROL, V80, P5494, DOI 10.1128/JVI.00026-06; Antinone SE, 2010, J VIROL, V84, P1504, DOI 10.1128/JVI.02029-09; Arvin AM, 2010, CURR TOP MICROBIOL, V342, P129, DOI 10.1007/82_2009_1; Birenboim R, 2013, J NEUROSCI METH, V214, P9, DOI 10.1016/j.jneumeth.2012.12.026; Cole NL, 2003, REV MED VIROL, V13, P207, DOI 10.1002/rmv.377; Diefenbach RJ, 2008, REV MED VIROL, V18, P35, DOI 10.1002/rmv.560; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Gershon MD, 2010, CURR TOP MICROBIOL, V342, P173, DOI 10.1007/82_2010_13; Grigoryan S, 2012, J NEUROVIROL, V18, P462, DOI 10.1007/s13365-012-0124-z; Grose C, 2010, CURR TOP MICROBIOL, V342, P113, DOI 10.1007/82_2009_4; Hafezi W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002679; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; KAPITZA HG, 1985, P NATL ACAD SCI USA, V82, P4122, DOI 10.1073/pnas.82.12.4122; Lee KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053010; Liu WW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002382; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10; McCarthy KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000640; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Ouwendijk WJD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003368; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Pugazhenthi S, 2011, J VIROL, V85, P6678, DOI 10.1128/JVI.00445-11; Reichelt M, 2008, J VIROL, V82, P3971, DOI 10.1128/JVI.02592-07; ROIZMAN B, 1987, ANNU REV MICROBIOL, V41, P543, DOI 10.1146/annurev.mi.41.100187.002551; Sloutskin A, 2014, J VIROL METHODS, V206, P128, DOI 10.1016/j.jviromet.2014.05.027; Sloutskin A, 2014, J VIROL, V88, P5079, DOI 10.1128/JVI.00252-14; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Yang E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004173; Zaichick SV, 2011, VIRUSES-BASEL, V3, P941, DOI 10.3390/v3070941; Zerboni L, 2010, CURR TOP MICROBIOL, V342, P255, DOI 10.1007/82_2009_8; Zerboni L, 2013, J VIROL, V87, P2791, DOI 10.1128/JVI.01375-12; Zerboni L, 2008, NEUROTROPIC VIRAL INFECTIONS, P225, DOI 10.1017/CBO9780511541728.016; Zhang Z, 2008, J VIROL METHODS, V148, P197, DOI 10.1016/j.jviromet.2007.11.012	34	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126081	10.1371/journal.pone.0126081	http://dx.doi.org/10.1371/journal.pone.0126081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973990	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000354545600040
J	Lee, DS; Han, K; Kim, HA; Lee, SY; Park, YH; Yim, HW; Lee, KS; Lee, WC; Park, YG; Na, KS; Park, YM				Lee, Deok-Soon; Han, Kyungdo; Kim, Hyun-Ah; Lee, Sae-Young; Park, Young-Hoon; Yim, Hyeon Woo; Lee, Kang-Sook; Lee, Won-Chul; Park, Yong Gyu; Na, Kyung-Sun; Park, Yong-Moon			The Gender-Dependent Association between Obesity and Age-Related Cataracts in Middle-Aged Korean Adults	PLOS ONE			English	Article							BODY-MASS INDEX; C-REACTIVE PROTEIN; RISK-FACTORS; OXIDATIVE STRESS; LENS OPACITIES; EYE; PREVALENCE; EXTRACTION; WOMEN; PREVENTION	The aim of this study was to investigate the association of central and abdominal obesity with the prevalence of cataracts in a middle-aged Korean population. This retrospective cross-sectional study was based on the data collected from the Korea National Health and Nutrition Examination Survey 2008-2009, in which 4,914 subjects were examined. Ophthalmological examinations were performed to determine the presence of a nuclear, cortical, or posterior subcapsular cataract. Both general obesity (a body mass index >= 25 kg/m(2)) and abdominal obesity (a waist circumference >= 90 cm for men and >= 80 cm for women) were significantly associated with the occurrence of cataracts among middle-aged women [adjusted odds ratio (aOR), 1.32; 95% confidence interval (CI), 1.03-1.69; and aOR, 1.40; 95% CI, 1.06-1.85, respectively], while abdominal obesity was significantly inversely associated with the occurrence of cataracts among middle-aged men (aOR, 0.76; 95% CI, 0.58-1.01; and aOR, 0.66; 95% CI, 0.49-0.89, respectively). We report a difference in the association between obesity and the prevalence of cataracts based on gender.	[Lee, Deok-Soon; Yim, Hyeon Woo; Lee, Kang-Sook; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Grad Sch Publ Hlth, Seoul, South Korea; [Lee, Deok-Soon] Catholic Univ Korea, Yeoeuido St Marys Hosp, Seoul, South Korea; [Han, Kyungdo; Lee, Sae-Young; Yim, Hyeon Woo; Lee, Kang-Sook; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea; [Han, Kyungdo; Park, Yong Gyu] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Kim, Hyun-Ah; Park, Young-Hoon; Na, Kyung-Sun] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Ophthalmol, Seoul, South Korea; [Lee, Sae-Young] Korea Ctr Dis Control & Prevent, Ctr Immunol & Pathol, Natl Inst Hlth, Div Aids, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC USA	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Na, KS (corresponding author), Catholic Univ Korea, Yeouido St Marys Hosp, Dept Ophthalmol, Seoul, South Korea.	drna@catholi.ac.kr; markYMpark@gmail.com	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Park, Yong Gyu/0000-0002-8721-3230	Catholic Medical Center Research Foundation; Korea Health Industry Development Institute (KHIDI) [H13C0307]	Catholic Medical Center Research Foundation; Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI))	This work was financially supported by research grants from the Catholic Medical Center Research Foundation made in the program year of 2011, and Korea Health Industry Development Institute (KHIDI), Grant number H13C0307.	Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481; Carlos GA, 2009, ARQ BRAS OFTALMOL, V72, P375, DOI 10.1590/S0004-27492009000300018; Caulfield LE, 1999, AM J CLIN NUTR, V69, P237; Ford ES, 1999, DIABETES CARE, V22, P1971, DOI 10.2337/diacare.22.12.1971; Foster PJ, 2003, BRIT J OPHTHALMOL, V87, P1112, DOI 10.1136/bjo.87.9.1112; HANKINSON SE, 1993, ARCH OPHTHALMOL-CHIC, V111, P503, DOI 10.1001/archopht.1993.01090040095040; Husain R, 2005, OPHTHALMOLOGY, V112, P1255, DOI 10.1016/j.ophtha.2005.02.015; Jacques PF, 2003, AM J CLIN NUTR, V78, P400, DOI 10.1093/ajcn/78.3.400; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Klein B E, 2001, Ophthalmic Epidemiol, V8, P251, DOI 10.1076/opep.8.4.251.1612; Klein BEK, 2006, AM J OPHTHALMOL, V141, P116, DOI 10.1016/j.ajo.2005.08.021; Kuang TM, 2005, ARCH OPHTHALMOL-CHIC, V123, P1109, DOI 10.1001/archopht.123.8.1109; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; Lindblad BE, 2008, OPHTHALMOLOGY, V115, P1687, DOI 10.1016/j.ophtha.2008.04.004; Ostberg A, 2006, OPHTHALMOLOGY, V113, P970, DOI 10.1016/j.ophtha.2006.01.067; Park S, 2013, OPTOMETRY VISION SCI, V90, P1019, DOI 10.1097/OPX.0b013e31829cae62; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Rao GN, 2011, CURR OPIN OPHTHALMOL, V22, P4, DOI 10.1097/ICU.0b013e3283414fc8; Schaumberg DA, 2000, AM J CLIN NUTR, V72, P1495; Schaumberg DA, 1999, ANN EPIDEMIOL, V9, P166, DOI 10.1016/S1047-2797(98)00049-0; SPECTOR A, 1993, EXP EYE RES, V57, P659, DOI 10.1006/exer.1993.1174; Sperduto RD, 2001, OPHTHALMOLOGY, V108, P1400; Valensi P, 1996, INT J OBESITY, V20, P574; Weintraub JM, 2002, INT J OBESITY, V26, P1588, DOI 10.1038/sj.ijo.0802158; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; Younan C, 2003, OPHTHALMIC EPIDEMIOL, V10, P227, DOI 10.1076/opep.10.4.227.15905	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0124262	10.1371/journal.pone.0124262	http://dx.doi.org/10.1371/journal.pone.0124262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974257	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600009
J	Miao, J; Bao, YQ; Ye, JQ; Shao, HX; Qian, K; Qin, AJ				Miao, Ji; Bao, Yanqing; Ye, Jianqiang; Shao, Hongxia; Qian, Kun; Qin, Aijian			Transcriptional Profiling of Host Gene Expression in Chicken Embryo Fibroblasts Infected with Reticuloendotheliosis Virus Strain HA1101	PLOS ONE			English	Article							AVIAN-LEUKOSIS VIRUS; INTERFERON-STIMULATED GENES; INFLUENZA-A VIRUS; MAREKS-DISEASE; IN-VITRO; RECEPTOR; SOCS3; IMMUNOSUPPRESSION; PATHOGENICITY; COINFECTION	Reticuloendotheliosis virus (REV), a member of the Gammaretrovirus genus in the Retroviridae family, causes an immunosuppressive, oncogenic and runting-stunting syndrome in multiple avian hosts. To better understand the host interactions at the transcriptional level, microarray data analysis was performed in chicken embryo fibroblast cells at 1, 3, 5, and 7 days after infection with REV. This study identified 1,785 differentially expressed genes that were classified into several functional groups including signal transduction, immune response, biological adhesion and endocytosis. Significant differences were mainly observed in the expression of genes involved in the immune response, especially during the later post-infection time points. These results revealed that differentially expressed genes IL6, STAT1, MyD88, TLRs, NF-kappa B, IRF-7, and ISGs play important roles in the pathogenicity of REV infection. Our study is the first to use microarray analysis to investigate REV, and these findings provide insights into the underlying mechanisms of the host antiviral response and the molecular basis of viral pathogenesis.	[Miao, Ji; Bao, Yanqing; Ye, Jianqiang; Shao, Hongxia; Qian, Kun; Qin, Aijian] Yangzhou Univ, Minist Educ Key Lab Avian Prevent Med, Yangzhou 225009, Jiangsu, Peoples R China; [Miao, Ji; Bao, Yanqing; Ye, Jianqiang; Shao, Hongxia; Qian, Kun; Qin, Aijian] Yangzhou Univ, Key Lab Jiangsu Prevent Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; [Ye, Jianqiang; Shao, Hongxia; Qian, Kun; Qin, Aijian] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University	Qin, AJ (corresponding author), Yangzhou Univ, Minist Educ Key Lab Avian Prevent Med, Yangzhou 225009, Jiangsu, Peoples R China.	aijian@yzu.edu.cn	ye, jianqiang/ABH-8988-2020		Priority Academic Program Development of Jiangsu Higher Education Institutions [2013FY113300-4]	Priority Academic Program Development of Jiangsu Higher Education Institutions	Funding provided by the Priority Academic Program Development of Jiangsu Higher Education Institutions, http://www.ec.js.edu.cn/col/col11321/index.html, AQ; 2013FY113300-4, http://www.most.gov.cn/kjjh/gjkjjh/, AQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2008, VIROLOGY, V370, P323, DOI 10.1016/j.virol.2007.09.013; Barbosa T, 2007, AVIAN DIS, V51, P33, DOI 10.1637/0005-2086(2007)051[0033:PATORV]2.0.CO;2; Barbosa T, 2007, VIRUS RES, V124, P68, DOI 10.1016/j.virusres.2006.10.002; Barton BE, 2001, CYTOKINE, V16, P251, DOI 10.1006/cyto.2001.0968; Bhattacharyya S, 2011, P NATL ACAD SCI USA, V108, P9554, DOI 10.1073/pnas.1017296108; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Cakir M, 2009, EXPERT OPIN THER TAR, V13, P1121, DOI 10.1517/14728220903170675; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Chen S, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-82; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; Cong F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-743; Crowley TM, 2011, VIRAL IMMUNOL, V24, P3, DOI 10.1089/vim.2010.0064; Cui ZZ, 2009, AVIAN PATHOL, V38, P443, DOI 10.1080/03079450903349188; CUI ZZ, 1986, J IMMUNOL, V136, P4237; Dong X, 2014, VET MICROBIOL, V172, P425, DOI 10.1016/j.vetmic.2014.06.025; Fadly AM, 1997, AVIAN DIS, V41, P695, DOI 10.2307/1592163; Gheyas AA, 2013, GENESIS, V51, P337, DOI 10.1002/dvg.22387; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Goossens KE, 2013, DEV COMP IMMUNOL, V41, P370, DOI 10.1016/j.dci.2013.05.020; Hang BL, 2014, VIRUS RES, V188, P8, DOI 10.1016/j.virusres.2014.03.009; HONDA M, 1992, J IMMUNOL, V148, P2175; Hu XM, 2013, ARCH VIROL, V158, P1787, DOI 10.1007/s00705-013-1665-z; Ishiguro H, 2005, CANCER IMMUNOL IMMUN, V54, P1191, DOI 10.1007/s00262-005-0695-0; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Jiang LL, 2013, VET MICROBIOL, V166, P68, DOI 10.1016/j.vetmic.2013.05.008; Jiang TT, 2012, J VIROL, V86, P13140, DOI 10.1128/JVI.02531-12; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Kaiser P, 2003, J VIROL, V77, P762, DOI 10.1128/JVI.77.1.762-768.2003; Karpala AJ, 2008, DEV COMP IMMUNOL, V32, P435, DOI 10.1016/j.dci.2007.08.004; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; KESHET E, 1978, P NATL ACAD SCI USA, V75, P3372, DOI 10.1073/pnas.75.7.3372; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Lee JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-445; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Liang MF, 2013, MICROB PATHOGENESIS, V54, P40, DOI 10.1016/j.micpath.2012.09.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Many AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2631; Mays JK, 2010, AVIAN PATHOL, V39, P383, DOI 10.1080/03079457.2010.510828; McDevitt HO, 2000, ANNU REV IMMUNOL, V18, P1, DOI 10.1146/annurev.immunol.18.1.1; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Mzula A, 2014, TROP ANIM HEALTH PRO, V46, P711, DOI 10.1007/s11250-014-0552-2; Ohta Y, 2011, J IMMUNOL, V186, P3563, DOI 10.4049/jimmunol.1003933; Pang P, 2010, ACTA VIROL, V54, P119, DOI 10.4149/av_2010_02_119; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Schmolke M, 2009, J IMMUNOL, V183, P5180, DOI 10.4049/jimmunol.0804198; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Seo JY, 2009, CYTOKINE, V46, P51, DOI 10.1016/j.cyto.2008.12.008; Shi L, 2014, ACTA VIROL, V58, P14, DOI 10.4149/av_2014_01_14; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Subramaniam S, 2013, J VIROL, V87, P9016, DOI 10.1128/JVI.01163-13; TEMIN HM, 1975, J GEN VIROL, V27, P267, DOI 10.1099/0022-1317-27-3-267; Wang GH, 2012, MICROB PATHOGENESIS, V53, P57, DOI 10.1016/j.micpath.2012.04.001; Wang Q, 2013, VET MICROBIOL, V162, P232, DOI 10.1016/j.vetmic.2012.10.023; Wu CT, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-159; Xue M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083918; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yu C, 2013, VET RES COMMUN, V37, P277, DOI 10.1007/s11259-013-9572-z; Zhang Z, 2005, SCI CHINA SER C, V48, P81, DOI 10.1360/03yc0270; Zheng YS, 2007, J VET MED SCI, V69, P213, DOI 10.1292/jvms.69.213	65	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126992	10.1371/journal.pone.0126992	http://dx.doi.org/10.1371/journal.pone.0126992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973612	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600094
J	Pena, MJ; Heinzel, A; Heinze, G; Alkhalaf, A; Bakker, SJL; Nguyen, TQ; Goldschmeding, R; Bilo, HJG; Perco, P; Mayer, B; de Zeeuw, D; Heerspink, HJL				Pena, Michelle J.; Heinzel, Andreas; Heinze, Georg; Alkhalaf, Alaa; Bakker, Stephan J. L.; Nguyen, Tri Q.; Goldschmeding, Roel; Bilo, Henk J. G.; Perco, Paul; Mayer, Bernd; de Zeeuw, Dick; Heerspink, Hiddo J. Lambers			A Panel of Novel Biomarkers Representing Different Disease Pathways Improves Prediction of Renal Function Decline in Type 2 Diabetes	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; ENDOTHELIAL DYSFUNCTION; YKL-40 LEVELS; NEPHROPATHY; ALBUMINURIA; PLASMA; MICROALBUMINURIA; PROGRESSION; INFLAMMATION	Objective We aimed to identify a novel panel of biomarkers predicting renal function decline in type 2 diabetes, using biomarkers representing different disease pathways speculated to contribute to the progression of diabetic nephropathy. Research Design and Methods A systematic data integration approach was used to select biomarkers representing different disease pathways. Twenty-eight biomarkers were measured in 82 patients seen at an outpatient diabetes center in The Netherlands. Median follow-up was 4.0 years. We compared the cross-validated explained variation (R-2) of two models to predict eGFR decline, one including only established risk markers, the other adding a novel panel of biomarkers. Least absolute shrinkage and selection operator (LASSO) was used for model estimation. The C-index was calculated to assess improvement in prediction of accelerated eGFR decline defined as <-3.0 mL/min/1.73m(2)/year. Results Patients' average age was 63.5 years and baseline eGFR was 77.9 mL/min/1.73m(2). The average rate of eGFR decline was -2.0 +/- 4.7 mL/min/1.73m(2)/year. When modeled on top of established risk markers, the biomarker panel including matrix metallopeptidases, tyrosine kinase, podocin, CTGF, TNF-receptor-1, sclerostin, CCL2, YKL-40, and NT-proCNP improved the explained variability of eGFR decline (R-2 increase from 37.7% to 54.6%; p=0.018) and improved prediction of accelerated eGFR decline (C-index increase from 0.835 to 0.896; p=0.008). Conclusions A novel panel of biomarkers representing different pathways of renal disease progression including inflammation, fibrosis, angiogenesis, and endothelial function improved prediction of eGFR decline on top of established risk markers in type 2 diabetes. These results need to be confirmed in a large prospective cohort.	[Pena, Michelle J.; de Zeeuw, Dick; Heerspink, Hiddo J. Lambers] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Heinzel, Andreas; Perco, Paul; Mayer, Bernd] Emergentec Biodev GmbH, Vienna, Austria; [Heinze, Georg] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Alkhalaf, Alaa; Bilo, Henk J. G.] Isala Clin, Ctr Diabet, Zwolle, Netherlands; [Alkhalaf, Alaa] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Bakker, Stephan J. L.; Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Nguyen, Tri Q.; Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	University of Groningen; Emergentec Biodevelopment GmbH; Medical University of Vienna; Isala Clinics; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center	Heerspink, HJL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	h.j.lambers.heerspink@umcg.nl	Bakker, Stephan J. L./J-4023-2015; de Zeeuw, Dick/E-9080-2014; Nguyen, Tri Q/AAN-9673-2021; Heerspink, Hiddo J Lambers/K-3358-2014; Nguyen, Tri/A-9508-2009; Perco, Paul/U-2489-2019	Bakker, Stephan J. L./0000-0003-3356-6791; de Zeeuw, Dick/0000-0003-3434-7777; Nguyen, Tri Q/0000-0001-6475-0706; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Nguyen, Tri/0000-0001-6475-0706; Perco, Paul/0000-0003-2087-5691; Pena, Michelle/0000-0003-3340-2893; Heinze, Georg/0000-0003-1147-8491	European Community [HEALTH-F2-2009-241544]; Commission of the European Communities, 6th Framework Programme Priority 1, Life Sciences, Genomics and Biotechnology [Health LSHM-CT-2005-018733]; VENI grant from the Netherlands Organisation for Scientific Research	European Community(European Commission); Commission of the European Communities, 6th Framework Programme Priority 1, Life Sciences, Genomics and Biotechnology; VENI grant from the Netherlands Organisation for Scientific Research	The work leading to this paper received funding from the European Community's Seventh Framework Programme under grant agreement no. HEALTH-F2-2009-241544 (SysKID consortium). The PREDICTIONS Study was supported by the Commission of the European Communities, 6th Framework Programme Priority 1, Life Sciences, Genomics and Biotechnology under grant agreement no. Health LSHM-CT-2005-018733. HJLH is supported by a VENI grant from the Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Agarwal R, 2014, NEPHROL DIAL TRANSPL, V29, P2293, DOI 10.1093/ndt/gfu255; Alkhalaf A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013421; Avogaro A, 2006, NUTR METAB CARDIOVAS, V16, pS39, DOI 10.1016/j.numecd.2005.10.015; Babazono T, 2009, DIABETES CARE, V32, P1518, DOI 10.2337/dc08-2151; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Ban CR, 2010, DIABETES RES CLIN PR, V87, P335, DOI 10.1016/j.diabres.2010.01.004; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Fechete R, 2011, PROTEOM CLIN APPL, V5, P354, DOI 10.1002/prca.201000136; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Hellemons ME, 2012, DIABETIC MED, V29, P567, DOI 10.1111/j.1464-5491.2011.03437.x; Hellemons ME, 2011, DIABETES CARE, V34, P2078, DOI 10.2337/dc11-0324; Lee JH, 2012, J DIABETES COMPLICAT, V26, P308, DOI 10.1016/j.jdiacomp.2012.04.012; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2014, NEPHROL DIAL TRANSPL, V29, P1037, DOI 10.1093/ndt/gft479; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Nguyen TQ, 2008, DIABETES CARE, V31, P1177, DOI 10.2337/dc07-2469; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Palmer AJ, 2004, DIABETES CARE, V27, P1897, DOI 10.2337/diacare.27.8.1897; Pena MJ, 2014, DIABETIC MED, V31, P1138, DOI 10.1111/dme.12447; Persson F, 2012, DIABETES RES CLIN PR, V96, P84, DOI 10.1016/j.diabres.2011.12.008; Persson F, 2008, SCAND J CLIN LAB INV, V68, P731, DOI 10.1080/00365510802187226; R Core Team, 2013, R A LANGUAGE AND ENV; REMUZZI G, 1990, KIDNEY INT, V38, P384, DOI 10.1038/ki.1990.217; Rondbjerg AK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-54; Roscioni SS, 2013, DIABETOLOGIA, V56, P259, DOI 10.1007/s00125-012-2755-2; Roscioni SS, 2014, KIDNEY INT, V86, P40, DOI 10.1038/ki.2013.490; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Shlipak MG, 2009, AM J NEPHROL, V30, P171, DOI 10.1159/000212381; Stelzer Gil, 2011, Human Genomics, V5, P709; Steyerberg E.W., 2009, CLIN PREDICTION MODE, P299; Tam FWK, 2009, CYTOKINE, V47, P37, DOI 10.1016/j.cyto.2009.04.001; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; US Renal Data System, 2014, 2014 ANNUAL DATA REP; van Buuren S, 2011, J STAT SOFTW, V45, P1; Verhave JC, 2013, DIABETES RES CLIN PR, V101, P333, DOI 10.1016/j.diabres.2013.07.006; Vlachopoulos C, 2010, ATHEROSCLEROSIS, V211, P649, DOI 10.1016/j.atherosclerosis.2010.03.020; Ward NL, 2002, SEMIN CELL DEV BIOL, V13, P19, DOI 10.1006/scdb.2001.0288; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; World Health Organisation, 1999, DEFINITION DIAGNOSIS	46	45	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0120995	10.1371/journal.pone.0120995	http://dx.doi.org/10.1371/journal.pone.0120995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973922	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600003
J	Sun, WY; Zhang, XM; Ding, X; Li, HQ; Geng, MY; Xie, ZQ; Wu, HM; Huang, M				Sun, Wenyi; Zhang, Xiaomin; Ding, Xu; Li, Huaiqi; Geng, Meiyu; Xie, Zuoquan; Wu, Heming; Huang, Min			Lactate Dehydrogenase B Is Associated with the Response to Neoadjuvant Chemotherapy in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; CANCER-CELLS; INDUCTION CHEMOTHERAPY; TYROSINE PHOSPHORYLATION; PHASE-III; HEAD; TAXOL; FLUOROURACIL; EXPRESSION; CISPLATIN	Oral squamous cell carcinoma (OSCC) comprises a subset of head and neck squamous cell carcinoma (HNSCC) with poor therapeutic outcomes and high glycolytic dependency. Neoadjuvant chemotherapy regimens of docetaxel, cisplatin and 5-fluorouracil (TPF) are currently accepted as standard regimens for HNSCC patients with a high risk of distant metastatic spread. However, the antitumor outcomes of TPF neoadjuvant chemotherapy in HNSCC remain controversial. This study investigated the role of lactate dehydrogenase B (LDHB), a key glycolytic enzyme catalyzing the inter-conversion between pyruvate and lactate, in determining chemotherapy response and prognosis in OSCC patients. We discovered that a high protein level of LDHB in OSCC patients was associated with a poor response to TPF regimen chemotherapy as well as poor overall survival and disease-free survival. Our in-depth study revealed that high LDHB expression conferred resistance to taxol but not 5-fluorouracil or cisplatin. LDHB deletion sensitized OSCC cell lines to taxol, whereas the introduction of LDHB decreased sensitivity to taxol treatment. Taxol induced a pronounced impact on LDHB-downregulated OSCC cells in terms of apoptosis, G2/Mphase cell cycle arrest and energy metabolism. In conclusion, our study highlighted the critical role of LDHB in OSCC and proposed that LDHB could be used as a biomarker for the stratification of patients for TPF neoadjuvant chemotherapy and the determination of prognosis in OSCC patients.	[Sun, Wenyi; Geng, Meiyu; Xie, Zuoquan; Huang, Min] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Zhang, Xiaomin; Ding, Xu; Li, Huaiqi; Wu, Heming] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Oral & Maxillofacial Surg, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Nanjing Medical University	Xie, ZQ (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	zqxie@simm.ac.cn; whmz2002@aliyun.com; mhuang@simm.ac.cn	huang, min/AAC-6965-2022	huang, min/0000-0001-6735-1612	National Natural Science Foundation of China [81222049, 81202549]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX09301001-004, 2012ZX09301001-007]; Pujiang Scholar Program Grant by the Shanghai Metropolitan Government [12PJ1410400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; Pujiang Scholar Program Grant by the Shanghai Metropolitan Government	This work was supported by the National Natural Science Foundation of China (No. 81222049, No. 81202549), the National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2012ZX09301001-004, No. 2012ZX09301001-007) and the Pujiang Scholar Program Grant by the Shanghai Metropolitan Government (No. 12PJ1410400).	Campos MS, 2009, ORAL ONCOL, V45, P121, DOI 10.1016/j.oraloncology.2008.03.019; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Dennison JB, 2013, CLIN CANCER RES, V19, P3703, DOI 10.1158/1078-0432.CCR-13-0623; Draoui N, 2011, DIS MODEL MECH, V4, P727, DOI 10.1242/dmm.007724; Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Frankel A, 1997, CANCER RES, V57, P2388; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitt R, 2005, J CLIN ONCOL, V23, P8636, DOI 10.1200/JCO.2004.00.1990; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kayser G, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-22; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2006, J CLIN ONCOL, V24, P4301, DOI 10.1200/JCO.2006.05.9501; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Lothaire P, 2006, HEAD NECK-J SCI SPEC, V28, P256, DOI 10.1002/hed.20326; Lu J, 2009, CLIN CANCER RES, V15, P1326, DOI 10.1158/1078-0432.CCR-08-0954; Ma J, 2012, ORAL ONCOL, V48, P1076, DOI 10.1016/j.oraloncology.2012.06.014; Martello LA, 2003, CANCER RES, V63, P1207; McCleland ML, 2013, CLIN CANCER RES, V19, P773, DOI 10.1158/1078-0432.CCR-12-2638; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Milane L, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel V, 2013, ORAL ONCOL, V49, P93, DOI 10.1016/j.oraloncology.2012.08.001; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Sansing HA, 2011, BIOCHEM BIOPH RES CO, V406, P171, DOI 10.1016/j.bbrc.2011.01.109; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Xu RH, 2005, CANCER RES, V65, P613; Zhong LP, 2013, J CLIN ONCOL, V31, P744, DOI 10.1200/JCO.2012.43.8820	38	26	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125976	10.1371/journal.pone.0125976	http://dx.doi.org/10.1371/journal.pone.0125976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973606	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600034
J	Yang, CY; Kim, SJ; Kim, J; Kang, TJ; Ahn, SJ				Yang, Chang Yeol; Kim, Se-Jin; Kim, Junheon; Kang, Taek-Jun; Ahn, Seung-Joon			Sex Pheromones and Reproductive Isolation in Five Mirid Species	PLOS ONE			English	Article							PLANT BUG; HEMIPTERA-MIRIDAE; IDENTIFICATION; HETEROPTERA; TORTRICIDAE	Mate location in many mirid bugs (Heteroptera: Miridae) is mediated by female-released sex pheromones. To elucidate the potential role of the pheromones in prezygotic reproductive isolation between sympatric species, we investigated differences in the pheromone systems of five mirid species, Apolygus lucorum, Apolygus spinolae, Orthops campestris, Stenotus rubrovittatus and Taylorilygus apicalis. GC/MS analyses of metathoracic scent gland extracts of virgin females showed that all five species produced mixtures of hexyl butyrate, (E)-2-hexenyl butyrate and (E)-4-oxo-2-hexenal, but in quite different ratios. (E)-2-hexenyl butyrate was the major component of A. spinolae, while hexyl butyrate was the most abundant component in the pheromone blends of the other four species. In addition to the three compounds, a fourth component, (E)-2-octenyl butyrate, was present in the gland extracts of A. lucorum and T. apicalis females. Field tests suggest that the ternary blends of hexyl butyrate, (E)-2-hexenyl butyrate and (E)-4-oxo-2-hexenal as found in the extracts of the females of each species do not inhibit attraction of conspecific males but ensure species-specificity of attraction between A. lucorum, O. campestris and T. apicalis. Furthermore, (E)-2-octenyl butyrate was essential for attraction of A. lucorum and T. apicalis males, but strongly inhibited attraction of male A. spinolae, O. campestris and S. rubrovittatus. The combined results from this study and previous studies suggest that the minor component and pheromone dose in addition to the relative ratio of the major components play an important role in reproductive isolation between mirid species.	[Yang, Chang Yeol; Kim, Se-Jin; Kang, Taek-Jun] Natl Inst Hort & Herbal Sci, Rural Dev Adm, Wonju, South Korea; [Kim, Junheon] Gyeongsang Natl Univ, Inst Agr & Life Sci BK21, Jinju, South Korea; [Ahn, Seung-Joon] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Gyeongsang National University; Max Planck Society	Yang, CY (corresponding author), Natl Inst Hort & Herbal Sci, Rural Dev Adm, Wonju, South Korea.	cyyang@korea.kr	KIM, Junheon/B-8245-2008	KIM, Junheon/0000-0001-5204-3369; Yang, Chang Yeol/0000-0001-5401-8933; Ahn, Seung-Joon/0000-0002-5980-106X	National Institute of Horticultural and Herbal Science, Rural Development Administration [PJ010213012014]	National Institute of Horticultural and Herbal Science, Rural Development Administration	This research was supported by a grant from National Institute of Horticultural and Herbal Science, Rural Development Administration (#PJ010213012014).	BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Byers JA, 2006, J CHEM ECOL, V32, P2205, DOI 10.1007/s10886-006-9140-x; Byers JA, 2013, NATURWISSENSCHAFTEN, V100, P1115, DOI 10.1007/s00114-013-1113-7; Cassis G, 2012, ANNU REV ENTOMOL, V57, P377, DOI 10.1146/annurev-ento-121510-133533; El-Sayed AM, 2015, PHEROBASE DATABASE I; Evenden ML, 2006, CHEMOECOLOGY, V16, P115, DOI 10.1007/s00049-006-0336-x; Fountain M, 2014, J CHEM ECOL, V40, P71, DOI 10.1007/s10886-013-0375-z; Gries G, 2001, J CHEM ECOL, V27, P1163, DOI 10.1023/A:1010316029165; Hayashi H., 1988, Bulletin of Hokkaido Prefectural Agricultural Experiment Stations, V51, P45; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; Kakizaki M, 2001, J CHEM ECOL, V27, P2447, DOI 10.1023/A:1013623414324; Lee Seunghwan, 2002, Korean Journal of Applied Entomology, V41, P33; Lofstedt C., 1991, Chemoecology, V2, P20, DOI 10.1007/BF01240662; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; McBrien HL, 1999, PHEROMONES OF NON-LEPIDOPTERAN INSECTS ASSOCIATED WITH AGRICULTURAL PLANTS, P277; McElfresh JS, 1999, J CHEM ECOL, V25, P2505, DOI 10.1023/A:1020826208715; Millar JG, 1997, J CHEM ECOL, V23, P1743, DOI 10.1023/B:JOEC.0000006448.01174.07; Moreira JA, 2005, J CHEM ECOL, V31, P965, DOI 10.1007/s10886-004-1978-1; ROELOFS WL, 1982, ANNU REV ECOL SYST, V13, P395, DOI 10.1146/annurev.es.13.110182.002143; SCALES AL, 1968, J ECON ENTOMOL, V61, P1466, DOI 10.1093/jee/61.5.1466; Watanabe K, 1999, PLANT PROT, V43, P56; Yang CY, 2014, J CHEM ECOL, V40, P244, DOI 10.1007/s10886-014-0407-3; Yang CY, 2011, J CHEM ECOL, V37, P1216, DOI 10.1007/s10886-011-0026-1; Yang CY, 2009, J CHEM ECOL, V35, P342, DOI 10.1007/s10886-009-9602-z; Yasuda T, 2008, APPL ENTOMOL ZOOL, V43, P219, DOI 10.1303/aez.2008.219; Yasuda T, 2013, APPL ENTOMOL ZOOL, V48, P325, DOI 10.1007/s13355-013-0191-5; YASUNAGA T, 1992, Japanese Journal of Entomology, V60, P10; Zhang T, 2015, J APPL ENTOMOL, V139, P87, DOI 10.1111/jen.12153; Zhang T, 2012, THESIS CHINESE ACAD	29	18	20	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127051	10.1371/journal.pone.0127051	http://dx.doi.org/10.1371/journal.pone.0127051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973902	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600098
J	Karakas, B; Qubbaj, W; Al-Hassan, S; Coskun, S				Karakas, Bedri; Qubbaj, Wafa; Al-Hassan, Saad; Coskun, Serdar			Noninvasive Digital Detection of Fetal DNA in Plasma of 4-Week-Pregnant Women following In Vitro Fertilization and Embryo Transfer	PLOS ONE			English	Article							MATERNAL SERUM; PCR	The discovery of cell-free fetal DNA (cfDNA) circulating in the maternal blood has provided new opportunities for noninvasive prenatal diagnosis (NIPD). However, the extremely low levels of cfDNA within a high background of the maternal DNA in maternal circulation necessitate highly sensitive molecular techniques for its reliable use in NIPD. In this proof of principle study, we evaluated the earliest possible detection of cfDNA in the maternal plasma by a bead-based emulsion PCR technology known as BEAMing (beads, emulsion, amplification, magnetics). Blood samples were collected from in vitro fertilization (IVF) patients at 2 to 6 weeks following embryo transfer (i.e., 4 to 8 week pregnancies) and plasma DNA was extracted. The genomic regions of both X and Y chromosome-specific sequences (AMELX and AMELY) were concurrently amplified in two sequential PCRs; first by conventional PCR then by BEAMing. The positive beads either for AMELX or AMELY gene sequences were counted by a flow cytometer. Our results showed that the pregnancies yielding boys had significantly higher plasma AMELY gene fractions (0.512 +/- 0.221) than the ones yielding girls (0.028 +/- 0.003) or non-pregnant women (0.020 +/- 0.005, P= 0.0059). Here, we clearly demonstrated that the BEAMing technique is capable of reliably detecting cfDNA in the blood circulation of 4-week-pregnant women, which is only two weeks after the embryo transfer. BEAMing technique can also be used to early detect fetal DNA alterations in other pregnancy-associated disorders.	[Karakas, Bedri] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [Qubbaj, Wafa; Coskun, Serdar] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia; [Al-Hassan, Saad] King Faisal Specialist Hosp & Res Ctr, Dept Obstet & Gynecol, Riyadh 11211, Saudi Arabia; [Coskun, Serdar] Alfaisal Univ, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Alfaisal University	Karakas, B (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia.	bkarakas@kfshrc.edu.sa	Coskun, Serdar/I-1470-2018; Coskun, Serdar/AAI-4625-2020	Coskun, Serdar/0000-0002-7278-0902; 	Kingdom of Saudi Arabia National Science, Technology and Innovation Plan (NSTIP) strategic technologies in the Kingdom-Award [10-BIO951-20, 10-BIO1432-20]	Kingdom of Saudi Arabia National Science, Technology and Innovation Plan (NSTIP) strategic technologies in the Kingdom-Award	This project was supported by the Kingdom of Saudi Arabia National Science, Technology and Innovation Plan (NSTIP) strategic technologies in the Kingdom-Award Nos. (10-BIO951-20 and 10-BIO1432-20). (http://www.kacst.edu.sa/en/research/pages/biotechnology.aspx) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi DW, 2012, NAT MED, V18, P1041, DOI 10.1038/nm.2829; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Castells A, 1999, J CLIN ONCOL, V17, P578, DOI 10.1200/JCO.1999.17.2.578; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Ferguson-Smith MA, 2010, PRENATAL DIAG, V30, P601, DOI 10.1002/pd.2574; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Guibert J, 2003, HUM REPROD, V18, P1733, DOI 10.1093/humrep/deg320; HERZENBERG LA, 1979, P NATL ACAD SCI USA, V76, P1453, DOI 10.1073/pnas.76.3.1453; Higgins MJ, 2012, CLIN CANCER RES, V18, P3462, DOI 10.1158/1078-0432.CCR-11-2696; Fernandez-Martinez FJ, 2012, GENET MED, V14, P101, DOI 10.1038/gim.2011.8; LEON SA, 1977, CANCER RES, V37, P646; Lippman M, 2013, NEW ENGL J MED, V368, P1249, DOI 10.1056/NEJMe1301249; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1999, CLIN CHEM, V45, P184; Poon LLM, 2000, CLIN CHEM, V46, P1832; Resta R G, 1997, J Genet Couns, V6, P81, DOI 10.1023/A:1025616019552; Simpson JL, 2013, FERTIL STERIL, V99, P1124, DOI 10.1016/j.fertnstert.2013.02.012; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Zimmermann BG, 2008, PRENATAL DIAG, V28, P1087, DOI 10.1002/pd.2150	22	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126501	10.1371/journal.pone.0126501	http://dx.doi.org/10.1371/journal.pone.0126501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970589	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200115
J	Kempsell, AT; Fieber, LA				Kempsell, Andrew T.; Fieber, Lynne A.			Aging in Sensory and Motor Neurons Results in Learning Failure in Aplysia californica	PLOS ONE			English	Article							AGE-RELATED-CHANGES; LONG-TERM SENSITIZATION; HETEROSYNAPTIC FACILITATION; INNERVATING TAIL; NERVOUS-SYSTEM; SPATIAL MEMORY; SEROTONIN; CAMP; CURRENTS; EXCITABILITY	The physiological and molecular mechanisms of age-related memory loss are complicated by the complexity of vertebrate nervous systems. This study takes advantage of a simple neural model to investigate nervous system aging, focusing on changes in learning and memory in the form of behavioral sensitization in vivo and synaptic facilitation in vitro. The effect of aging on the tail withdrawal reflex (TWR) was studied in Aplysia californica at maturity and late in the annual lifecycle. We found that short-term sensitization in TWR was absent in aged Aplysia. This implied that the neuronal machinery governing nonassociative learning was compromised during aging. Synaptic plasticity in the form of short-term facilitation between tail sensory and motor neurons decreased during aging whether the sensitizing stimulus was tail shock or the heterosynaptic modulator serotonin (5-HT). Together, these results suggest that the cellular mechanisms governing behavioral sensitization are compromised during aging, thereby nearly eliminating sensitization in aged Aplysia.	[Kempsell, Andrew T.; Fieber, Lynne A.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, Miami, FL 33149 USA	University of Miami	Fieber, LA (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	Lfieber@rsmas.miami.edu		Fieber, Lynne/0000-0002-7717-2260	National Institutes of Health [P40 OD010952]; Maytag and Korein Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maytag and Korein Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health Grant P40 OD010952, and Maytag and Korein Foundation fellowships to A.T. Kempsell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2001, J COMP NEUROL, V432, P230, DOI 10.1002/cne.1099; Akhmedov K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084793; Almaguer W, 2002, NEUROBIOL AGING, V23, P319, DOI 10.1016/S0197-4580(01)00278-0; Asanuma M, 1996, MOL BRAIN RES, V41, P210, DOI 10.1016/0169-328X(96)00098-8; Ayyagari PV, 1998, NEUROCHEM INT, V32, P107, DOI 10.1016/S0197-0186(97)00044-2; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; BARNES CA, 1992, HIPPOCAMPUS, V2, P457, DOI 10.1002/hipo.450020413; Barnes CA, 1997, NEUROBIOL AGING, V18, P445, DOI 10.1016/S0197-4580(97)00044-4; Barnes CA, 2000, NEUROBIOL AGING, V21, P613, DOI 10.1016/S0197-4580(00)00163-9; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BAXTER DA, 1990, J NEUROPHYSIOL, V64, P978, DOI 10.1152/jn.1990.64.3.978; BAXTER DA, 1989, J NEUROPHYSIOL, V62, P665, DOI 10.1152/jn.1989.62.3.665; BICKFORD PC, 1986, BRAIN RES, V385, P405, DOI 10.1016/0006-8993(86)91092-9; BICKFORDWIMER PC, 1988, NEUROBIOL AGING, V9, P173, DOI 10.1016/S0197-4580(88)80047-2; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; Carlson SL, 2012, BRAIN BEHAV, V2, P391, DOI 10.1002/brb3.60; Chin J, 1999, LEARN MEMORY, V6, P317; CLATWORTHY AL, 1993, J NEUROPHYSIOL, V70, P1181, DOI 10.1152/jn.1993.70.3.1181; Clayton DA, 2002, J NEUROSCI, V22, P3628; Clayton DA, 2001, NEUROBIOL AGING, V22, P165, DOI 10.1016/S0197-4580(00)00196-2; Cleary LJ, 1998, J NEUROSCI, V18, P5988; FELDMAN ML, 1975, ANAT EMBRYOL, V148, P279, DOI 10.1007/BF00319848; Fieber LA, 2010, BRAIN RES, V1343, P28, DOI 10.1016/j.brainres.2010.05.001; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; Gerdes R, 2006, J AM ASSOC LAB ANIM, V45, P40; Glanzman DL, 2008, PROG BRAIN RES, V169, P277, DOI 10.1016/S0079-6123(07)00017-9; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; Glisky E.L., 2007, BRAIN AGING MODELS M; GODEFROY F, 1989, NEUROBIOL AGING, V10, P187, DOI 10.1016/0197-4580(89)90029-8; GOLDSMITH BA, 1992, P NATL ACAD SCI USA, V89, P11481, DOI 10.1073/pnas.89.23.11481; Jouvenceau A, 1998, HIPPOCAMPUS, V8, P627, DOI 10.1002/(SICI)1098-1063(1998)8:6<627::AID-HIPO5>3.0.CO;2-X; Kadakkuzha BM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-880; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Kempsell AT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00084; KLEIN M, 1986, P NATL ACAD SCI USA, V83, P7994, DOI 10.1073/pnas.83.20.7994; Kumar A, 2007, BRAIN AGING MODELS M; Lee YS, 2009, P NATL ACAD SCI USA, V106, P14634, DOI 10.1073/pnas.0907502106; LEUBA G, 1983, NEUROPATH APPL NEURO, V9, P467, DOI 10.1111/j.1365-2990.1983.tb00130.x; Levenson J, 1999, J NEUROSCI, V19, P8094; LUINE V, 1990, BRAIN RES, V537, P271, DOI 10.1016/0006-8993(90)90368-L; MACKEY SL, 1989, J NEUROSCI, V9, P4227; Magnusson KR, 2002, MOL BRAIN RES, V99, P40, DOI 10.1016/S0169-328X(01)00344-8; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; MERCER AR, 1991, SCIENCE, V254, P1811, DOI 10.1126/science.1662413; Moroz LL, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.006.2010; Moser PC, 2002, J PHARMACOL EXP THER, V302, P731, DOI 10.1124/jpet.102.034249; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Newcomer JW, 2001, HIPPOCAMPUS, V11, P529, DOI 10.1002/hipo.1069.abs; Nicolle MM, 1999, J NEUROSCI, V19, P9604; Page TL, 2002, NEUROSCI LETT, V317, P37, DOI 10.1016/S0304-3940(01)02428-4; Perez-Garcia G, 2008, BEHAV BRAIN RES, V195, P139, DOI 10.1016/j.bbr.2008.07.033; Philips GT, 2011, LEARN MEMORY, V18, P272, DOI 10.1101/lm.2125311; Potier B, 2000, EXP GERONTOL, V35, P1185, DOI 10.1016/S0531-5565(00)00122-4; Power JM, 2001, J NEUROPHYSIOL, V85, P319, DOI 10.1152/jn.2001.85.1.319; RATTAN KS, 1981, J NEUROBIOL, V12, P469, DOI 10.1002/neu.480120506; Rodefer JS, 2007, BRAIN AGING MODELS M; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; Shen JM, 1996, NEUROBIOL AGING, V17, P439, DOI 10.1016/0197-4580(96)00020-6; STERN WC, 1985, NEUROBIOL AGING, V6, P245, DOI 10.1016/0197-4580(85)90058-2; Sutton MA, 2002, LEARN MEMORY, V9, P29, DOI 10.1101/lm.44802; Takahashi T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-240; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; WALTERS ET, 1987, J NEUROSCI, V7, P408; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1522, DOI 10.1152/jn.1983.50.6.1522; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; Walters ET, 2004, J COMP NEUROL, V471, P219, DOI 10.1002/cne.20042; Watkins AJ, 2010, J NEUROSCI, V30, P11028, DOI 10.1523/JNEUROSCI.1317-10.2010	69	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127056	10.1371/journal.pone.0127056	http://dx.doi.org/10.1371/journal.pone.0127056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970633	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200147
J	Larabee, FJ; Suarez, AV				Larabee, Fredrick J.; Suarez, Andrew V.			Mandible-Powered Escape Jumps in Trap-Jaw Ants Increase Survival Rates during Predator-Prey Encounters	PLOS ONE			English	Article							ODONTOMACHUS; NEUROPTERA; MYRMELEON; FLORIDA; LARVAE; KEY; DIVERSIFICATION; PERFORMANCE; HYMENOPTERA; FORMICIDAE	Animals use a variety of escape mechanisms to increase the probability of surviving predatory attacks. Antipredator defenses can be elaborate, making their evolutionary origin unclear. Trap-jaw ants are known for their rapid and powerful predatory mandible strikes, and some species have been observed to direct those strikes at the substrate, thereby launching themselves into the air away from a potential threat. This potential escape mechanism has never been examined in a natural context. We studied the use of mandible-powered jumping in Odontomachus brunneus during their interactions with a common ant predator: pit-building antlions. We observed that while trap-jaw ant workers escaped from antlion pits by running in about half of interactions, in 15% of interactions they escaped by mandible-powered jumping. To test whether escape jumps improved individual survival, we experimentally prevented workers from jumping and measured their escape rate. Workers with unrestrained mandibles escaped from antlion pits significantly more frequently than workers with restrained mandibles. Our results indicate that some trap-jaw ant species can use mandible-powered jumps to escape from common predators. These results also provide a charismatic example of evolutionary co-option, where a trait that evolved for one function (predation) has been co-opted for another (defense).	[Larabee, Fredrick J.; Suarez, Andrew V.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Larabee, Fredrick J.] Smithsonian Inst, Dept Entomol, Washington, DC 20560 USA; [Suarez, Andrew V.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Illinois System; University of Illinois Urbana-Champaign	Larabee, FJ (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	larabee@life.illinois.edu		Larabee, Fredrick/0000-0001-8404-0146	American Museum of Natural History; Society of Integrative and Comparative Biology; National Science Foundation [1407279]; National Geographic Committee for Research and Exploration [9481-14]	American Museum of Natural History; Society of Integrative and Comparative Biology; National Science Foundation(National Science Foundation (NSF)); National Geographic Committee for Research and Exploration(National Geographic Society)	Theodore Roosevelt Memorial Grant from the American Museum of Natural History was awarded to FJL (http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships); Libbie Hyman Memorial Grant from the Society of Integrative and Comparative Biology was awarded to FJL (http://sicb.org/grants/hyman/); Doctoral Dissertation Improvement Grant (Award Number 1407279) from the National Science Foundation was awarded to FJL (http://www.nsf.gov/); and National Geographic Committee for Research and Exploration (Award Number 9481-14) was awarded to AVS (http://www.nationalgeographic.com/explorers/grants-programs/cre-application/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; CARLIN N F, 1989, Psyche (Cambridge), V96, P1, DOI 10.1155/1989/96595; CARLIN N F, 1981, Psyche (Cambridge), V88, P231, DOI 10.1155/1981/59736; Cooper WE, 2006, BEHAVIOUR, V143, P1201, DOI 10.1163/156853906778691595; Devetak D, 2005, PHYSIOL ENTOMOL, V30, P82, DOI 10.1111/j.0307-6962.2005.00433.x; Deyrup M, 2004, FLA ENTOMOL, V87, P136, DOI 10.1653/0015-4040(2004)087[0136:ANSOOA]2.0.CO;2; Deyrup M, 2013, SOUTHEAST NAT, V12, P367, DOI 10.1656/058.012.0210; Domenici P, 1997, J EXP BIOL, V200, P1165; Dornhaus A, 2010, ANT ECOLOGY, P210; Ehmer Birgit, 1997, Psyche (Cambridge), V102, P215, DOI 10.1155/1995/27197; Endler J.A., 1991, P169; Gotelli NJ, 1996, ECOLOGY, V77, P630, DOI 10.2307/2265636; GRIFFITHS D, 1980, J ANIM ECOL, V49, P99, DOI 10.2307/4279; Hart LM, 2012, INSECT SOC, V59, P45, DOI 10.1007/s00040-011-0186-6; Hawlena D, 2011, FUNCT ECOL, V25, P279, DOI 10.1111/j.1365-2435.2010.01767.x; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P281, DOI 10.1016/S0169-5347(98)01375-5; Langerhans R. Brian, 2007, P177, DOI 10.1007/978-3-540-46046-6_10; Larabee FJ, 2014, MYRMECOL NEWS, V20, P25; LUCAS JR, 1982, ANIM BEHAV, V30, P651, DOI 10.1016/S0003-3472(82)80135-8; LUCAS JR, 1981, FLA ENTOMOL, V64, P207, DOI 10.2307/3494571; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Napolitano JF, 1998, FLA ENTOMOL, V81, P562, DOI 10.2307/3495960; Patek SN, 2006, P NATL ACAD SCI USA, V103, P12787, DOI 10.1073/pnas.0604290103; Raimundo RLG, 2009, ANN ENTOMOL SOC AM, V102, P1151, DOI 10.1603/008.102.0625; ROEDER K. D., 1962, ANIMAL BEHAVIOUR, V10, P300, DOI 10.1016/0003-3472(62)90053-2; Spagna JC, 2008, J EXP BIOL, V211, P2358, DOI 10.1242/jeb.015263; Spagna JC, 2009, NATURWISSENSCHAFTEN, V96, P243, DOI 10.1007/s00114-008-0473-x; Titelman J, 2003, MAR ECOL PROG SER, V247, P137, DOI 10.3354/meps247137; de Sousa VTT, 2011, BEHAV ECOL, V22, P940, DOI 10.1093/beheco/arr072; Wheeler WM, 1922, BIOL BULL-US, V42, P185, DOI 10.2307/1536521; Zettel J, 2000, EUR J ENTOMOL, V97, P41, DOI 10.14411/eje.2000.010	32	30	30	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124871	10.1371/journal.pone.0124871	http://dx.doi.org/10.1371/journal.pone.0124871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970637	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200054
J	Ohno, Y; Shimizu, S; Tatara, A; Imaoku, T; Ishii, T; Sasa, M; Serikawa, T; Kuramoto, T				Ohno, Yukihiro; Shimizu, Saki; Tatara, Ayaka; Imaoku, Takuji; Ishii, Takahiro; Sasa, Masashi; Serikawa, Tadao; Kuramoto, Takashi			Hcn1 Is a Tremorgenic Genetic Component in a Rat Model of Essential Tremor	PLOS ONE			English	Article							ACETYL-L-ASPARTATE; MICE LACKING; VARIANT; NEURONS; MOUSE; LOCALIZATION; POLYMORPHISM; ACTIVATION; EXPRESSION; SEQUENCE	Genetic factors are thought to play a major role in the etiology of essential tremor (ET); however, few genetic changes that induce ET have been identified to date. In the present study, to find genes responsible for the development of ET, we employed a rat model system consisting of a tremulous mutant strain, TRM/Kyo (TRM), and its substrain TRMR/Kyo (TRMR). The TRM rat is homozygous for the tremor (tm) mutation and shows spontaneous tremors resembling human ET. The TRMR rat also carries a homozygous tm mutation but shows no tremor, leading us to hypothesize that TRM rats carry one or more genes implicated in the development of ET in addition to the tm mutation. We used a positional cloning approach and found a missense mutation (c. 1061 C> T, p. A354V) in the hyperpolarization- activated cyclic nucleotide-gated 1 channel (Hcn1) gene. The A354V HCN1 failed to conduct hyperpolarization- activated currents in vitro, implicating it as a loss-of-function mutation. Blocking HCN1 channels with ZD7288 in vivo evoked kinetic tremors in nontremulous TRMR rats. We also found neuronal activation of the inferior olive (IO) in both ZD7288-treated TRMR and non-treated TRM rats and a reduced incidence of tremor in the IO-lesioned TRM rats, suggesting a critical role of the IO in tremorgenesis. A rat strain carrying the A354V mutation alone on a genetic background identical to that of the TRM rats showed no tremor. Together, these data indicate that body tremors emerge when the two mutant loci, tm and Hcn1(A354V), are combined in a rat model of ET. In this model, HCN1 channels play an important role in the tremorgenesis of ET. We propose that oligogenic, most probably digenic, inheritance is responsible for the genetic heterogeneity of ET.	[Ohno, Yukihiro; Shimizu, Saki; Tatara, Ayaka; Imaoku, Takuji; Serikawa, Tadao] Osaka Univ Pharmaceut Sci, Pharmacol Lab, Takatsuki, Osaka 5691094, Japan; [Ishii, Takahiro] Kyoto Univ, Grad Sch Med, Dept Physiol & Neurobiol, Kyoto 6068501, Japan; [Sasa, Masashi] Nagisa Clin, Hirakata, Osaka 5731183, Japan; [Serikawa, Tadao; Kuramoto, Takashi] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan	Osaka University of Pharmaceutical Sciences; Kyoto University; Kyoto University	Kuramoto, T (corresponding author), Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan.	tkuramot@anim.med.kyoto-u.ac.jp			Japan Society for the Promotion of Science [21300153]; Smoking Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (21300153 to T. K.) and by the Smoking Research Foundation (Y. O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aridon P, 2008, PARKINSONISM RELAT D, V14, P15, DOI 10.1016/j.parkreldis.2007.05.002; Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bal T, 1997, J NEUROPHYSIOL, V77, P3145, DOI 10.1152/jn.1997.77.6.3145; Benito-Leon J, 2006, NAT CLIN PRACT NEURO, V2, P666, DOI 10.1038/ncpneuro0347; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Boecker H, 1996, ANN NEUROL, V39, P650, DOI 10.1002/ana.410390515; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Gohma H, 2006, PHYSIOL GENOMICS, V24, P198, DOI 10.1152/PHYSIOLGENOMICS.00221.2005; Gulcher JR, 1997, NAT GENET, V17, P84, DOI 10.1038/ng0997-84; Hanaya R, 2008, BRAIN RES BULL, V75, P663, DOI 10.1016/j.brainresbull.2007.10.056; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Higgins JJ, 1997, MOVEMENT DISORD, V12, P859, DOI 10.1002/mds.870120605; Ishida S, 2012, BRAIN RES, V1435, P154, DOI 10.1016/j.brainres.2011.11.023; Ishii TM, 2001, J PHYSIOL-LONDON, V537, P93, DOI 10.1111/j.1469-7793.2001.0093k.x; Ishishita S, 2013, EXP ANIM TOKYO, V62, P219, DOI 10.1538/expanim.62.219; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Jimenez-Jimenez FJ, 2013, ACTA NEUROL SCAND, DOI 10.1111/ane.12148; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kitada K, 2000, J NEUROCHEM, V74, P2512, DOI 10.1046/j.1471-4159.2000.0742512.x; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; KONDO A, 1991, BRAIN, V114, P979, DOI 10.1093/brain/114.2.979; Kralic JE, 2005, J CLIN INVEST, V115, P774, DOI 10.1172/JCI200523625; Kuramoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043059; Kuramoto T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001262; La Salle S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095752; Lain E, 2009, J BIOL CHEM, V284, P8921, DOI 10.1074/jbc.M809491200; Lang EJ, 2003, J NEUROPHYSIOL, V89, P2259, DOI 10.1152/jn.00922.2002; LLINAS R, 1986, J PHYSIOL-LONDON, V376, P163, DOI 10.1113/jphysiol.1986.sp016147; Louis ED, 2001, MOVEMENT DISORD, V16, P822, DOI 10.1002/mds.1183; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Lucotte G, 2006, CLIN GENET, V69, P437, DOI 10.1111/j.1399-0004.2006.00600.x; Mashimo T, 2005, J APPL PHYSIOL, V98, P371, DOI 10.1152/japplphysiol.01006.2004; Mashimo T, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-19; Matalon R, 2000, J GENE MED, V2, P165; Miwa H, 2000, NEUROREPORT, V11, P2385, DOI 10.1097/00001756-200008030-00010; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nava C, 2014, NAT GENET, V46, P640, DOI 10.1038/ng.2952; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Ohno Y, 2011, NEUROBIOL DIS, V41, P261, DOI 10.1016/j.nbd.2010.09.013; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Powell KL, 2008, EPILEPSIA, V49, P1686, DOI 10.1111/j.1528-1167.2008.01593.x; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Schaffer AA, 2013, J MED GENET, V50, P641, DOI 10.1136/jmedgenet-2013-101713; Shatunov A, 2006, BRAIN, V129, P2318, DOI 10.1093/brain/awl120; Shimizu S, 2013, PROG NEURO-PSYCHOPH, V46, P86, DOI 10.1016/j.pnpbp.2013.06.016; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Stefansson H, 2009, NAT GENET, V41, P277, DOI 10.1038/ng.299; Tan EK, 2013, NEUROLOGY, V80, P1618, DOI 10.1212/WNL.0b013e31828f1903; Thier S, 2012, NEUROLOGY, V79, P243, DOI 10.1212/WNL.0b013e31825fdeed; Vitale C, 2008, EUR J NEUROL, V15, P985, DOI 10.1111/j.1468-1331.2008.02164.x; Wu YW, 2011, ACTA NEUROL SCAND, V124, P264, DOI 10.1111/j.1600-0404.2010.01466.x; YAMADA J, 1985, EXP ANIM TOKYO, V34, P183, DOI 10.1538/expanim1978.34.2_183; Yan HD, 2003, EPILEPSIA, V44, P1153, DOI 10.1046/j.1528-1157.2003.49402.x	55	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123529	10.1371/journal.pone.0123529	http://dx.doi.org/10.1371/journal.pone.0123529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970616	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200015
J	Tsai, YJ; Hao, SP; Chen, CL; Lin, BJ; Wu, WB				Tsai, Yih-Jeng; Hao, Sheng-Po; Chen, Chih-Li; Lin, Brian J.; Wu, Wen-Bin			Involvement of B2 Receptor in Bradykinin-Induced Proliferation and Proinflammatory Effects in Human Nasal Mucosa-Derived Fibroblasts Isolated from Chronic Rhinosinusitis Patients	PLOS ONE			English	Article							HUMAN LUNG FIBROBLASTS; NF-KAPPA-B; IN-VIVO; CHEMOKINE RECEPTORS; EPITHELIAL-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; B-2 RECEPTOR; POLYPS; CYCLOOXYGENASE-2	Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the sinonasal mucosa either accompanied by polyp formation (CRSwNP) or without polyps (CRSsNP). CRSsNP accounts for the majority of CRS cases and is characterized by fibrosis and neutrophilic inflammation. However, the pathogenesis of CRS, especially CRSsNP, remains unclear. Immunohistochemistry of CRSsNP specimens in the present study showed that the submucosa, perivascular areas, and the mucous glands were abundant in fibroblasts. Therefore, we investigated the effects bradykinin (BK), an autacoid known to participate in inflammation, on human CRSsNP nasal mucosa-derived fibroblasts (NMDFs). BK increased CXCL1 and -8 secretion and mRNA expression with EC50 ranging from 0.15 similar to 0.35 mu M. Moreover, BK enhanced cell proliferation and upregulated the expressions of proinflammatory molecules, including cell adhesion molecules (CAMs) and cyclooxygenase (COX)-1 and -2. These functionally caused an increase in monocyte adhesion to fibroblast monolayer. Using pharmacological intervention and BKR siRNA knockdown, we demonstrated that the BK-induced CXCL chemokine release, cell proliferation and COX and CAM expressions were mainly through the B2 receptor (B2R). Accordingly, the B2R was preferentially expressed in the NMDFs than B1R. The B2R was highly expressed in the CRSsNP than the control specimens, while the B1R and kininogen (KNG)/BK expression slightly increased in the CRSsNP mucosa. Collectively, we report here for the first time that fibroblasts, KNG/BK, and BKRs are overexpressed in CRSsNP mucosa and BK upregulates chemokine expression, proliferation, and proinflammatory molecule expression in NMDFs via B2R activation, which lead to a functional increase in monocyte-fibroblast interaction. Our findings reveal a critical role of fibroblast, KNG/BK, and BKRs in the development of CRSsNP.	[Tsai, Yih-Jeng; Hao, Sheng-Po] Shin Kong Wu Ho Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Tsai, Yih-Jeng] Fu Jen Catholic Univ, Coll Sci & Engn, Grad Inst Appl Sci & Engn, Dept Chem, New Taipei City, Taiwan; [Tsai, Yih-Jeng] Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei City, Taiwan; [Tsai, Yih-Jeng; Hao, Sheng-Po; Chen, Chih-Li; Wu, Wen-Bin] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Lin, Brian J.] NYU, Sch Med, Ronald O Perelman Dept Emergency Med, New York, NY USA	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic University; New York University	Wu, WB (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan.	wenbin@mail.fju.edu.tw	Wu, Wen-Bin/GLT-4711-2022		National Science Council [NSC 102-2320-B-030-013-MY3]; Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-102-DR-24]	National Science Council(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital	This work was supported by the grants of the National Science Council (NSC 102-2320-B-030-013-MY3) and Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302-102-DR-24).	Akbary AM, 1996, IMMUNOPHARMACOLOGY, V33, P238, DOI 10.1016/0162-3109(96)00065-3; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; AUSTIN CE, 1994, J PHYSIOL-LONDON, V478, P351, DOI 10.1113/jphysiol.1994.sp020255; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen CP, 2010, N-S ARCH PHARMACOL, V381, P401, DOI 10.1007/s00210-010-0501-1; Cheng CY, 2012, J CELL PHYSIOL, V227, P1367, DOI 10.1002/jcp.22849; Christiansen SC, 2002, J IMMUNOL, V169, P2054, DOI 10.4049/jimmunol.169.4.2054; Dykewicz MS, 2010, J ALLERGY CLIN IMMUN, V125, pS103, DOI 10.1016/j.jaci.2009.12.989; Eddleston J, 2003, J ALLERGY CLIN IMMUN, V111, P106, DOI 10.1067/mai.2003.19; Gosepath J, 2005, AM J RHINOL, V19, P111, DOI 10.1177/194589240501900201; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Haddad EB, 2000, MOL PHARMACOL, V57, P1123; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; Hayashi R, 1998, IMMUNOLOGY, V95, P507, DOI 10.1046/j.1365-2567.1998.00649.x; Hayashi R, 2000, EUR RESPIR J, V16, P452, DOI 10.1034/j.1399-3003.2000.016003452.x; Jeffe JS, 2013, LARYNGOSCOPE, V123, P2104, DOI 10.1002/lary.24016; Jung SY, 2013, AM J RHINOL ALLERGY, V27, pE17, DOI 10.2500/ajra.2013.27.3863; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Li XY, 2010, J ALLERGY CLIN IMMUN, V125, P1061, DOI 10.1016/j.jaci.2010.02.023; Lo HM, 2013, INT J MOL SCI, V14, P10090, DOI 10.3390/ijms140510090; LO SK, 1989, J IMMUNOL, V143, P3325; Marceau F, 1998, PHARMACOL REV, V50, P357; Mullol J, 2002, J ALLERGY CLIN IMMUN, V109, P824, DOI 10.1067/mai.2002.123534; Owens JM, 2006, ARCH OTOLARYNGOL, V132, P579, DOI 10.1001/archotol.132.6.579; Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009; Park SJ, 2013, J ALLERGY CLIN IMMUN, V131, P772, DOI 10.1016/j.jaci.2012.12.671; Picado C, 1999, AM J RESP CRIT CARE, V160, P291, DOI 10.1164/ajrccm.160.1.9808048; PROUD D, 1983, J CLIN INVEST, V72, P1678, DOI 10.1172/JCI111127; PROUD D, 1988, AM REV RESPIR DIS, V137, P613, DOI 10.1164/ajrccm/137.3.613; Pujols L, 2012, J PHARMACOL EXP THER, V343, P184, DOI 10.1124/jpet.111.190710; Rudack C, 2007, CLIN EXP ALLERGY, V37, P1009, DOI 10.1111/j.1365-2222.2007.02686.x; Rudack C, 2006, CLIN EXP ALLERGY, V36, P748, DOI 10.1111/j.1365-2222.2006.02501.x; Sabatini F, 2013, EUR J PHARMACOL, V710, P100, DOI 10.1016/j.ejphar.2013.03.048; Sato E, 2000, J ALLERGY CLIN IMMUN, V106, P117, DOI 10.1067/mai.2000.107400; Shirasaki H, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/102406; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Tomassen Peter, 2011, Proc Am Thorac Soc, V8, P115, DOI 10.1513/pats.201005-036RN; Turner P, 2001, J ALLERGY CLIN IMMUN, V107, P105, DOI 10.1067/mai.2001.111145; Van Bruaene N, 2011, CURR OPIN ALLERGY CL, V11, P8, DOI 10.1097/ACI.0b013e32834233ef; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Yang YC, 2012, ALLERGY, V67, P1193, DOI 10.1111/j.1398-9995.2012.02880.x; Yoshifuku K, 2007, RHINOLOGY, V45, P235; Yoshikawa M, 2013, ALLERGOL INT, V62, P495, DOI 10.2332/allergolint.13-OA-0572; Yun CB, 2002, ANN OTO RHINOL LARYN, V111, P61, DOI 10.1177/000348940211100110; Zang HR, 2009, ACTA OTO-LARYNGOL, V129, P1237, DOI 10.3109/00016480802609590	49	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126853	10.1371/journal.pone.0126853	http://dx.doi.org/10.1371/journal.pone.0126853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970620	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200137
J	Li, JJ; Ji, P; Lin, XT				Li, Jingjing; Ji, Peng; Lin, Xiaoti			Efficacy of Corneal Collagen Cross-Linking for Treatment of Keratoconus: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CLINICAL-TRIALS; ULTRAVIOLET; RIBOFLAVIN; QUALITY	Objective To evaluate the efficacy of corneal collagen cross-linking (CXL) for the treatment of keratoconus. Methods We performed a literature search for randomized controlled trials that assessed the effect of CXL in slowing progression of keratoconus. The primary outcome measures included changes of topographic parameters, visual acuity, and refraction. Efficacy estimates were evaluated by weighted mean difference (WMD) and 95% confidence interval (CI) for absolute changes of the interested outcomes. Results Significant decrease in mean keratometry value, maximum keratometry value and minimum keratometry value were demonstrated in the CXL group compared with the control group (WMD = -1.65; 95% CI: -2.51 to -0.80; P < 0.00001; WMD = -2.05; 95% CI: -3.10 to -1.00; P < 0.00001; WMD = -1.94; 95% CI: -2.63 to -1.26; P < 0.00001; respectively). Best spectacle-corrected visual acuity improved significantly in CXL group (WMD = -0.10; 95% CI: -0.15 to -0.05; P < 0.00001), whereas uncorrected visual acuity did not differ statistically. Manifest cylinder error decreased significantly in patients undergoing CXL procedure compared with control patients in sensitivity analysis (WMD = -0.388; 95% CI: -0.757 to -0. 019; P = 0.04). The changes in central corneal thickness and intraocular pressure were not statistically significant. Conclusion CXL may be an effective option in stabilizing keratoconus. Further long-term follow-up studies will be necessary to assess the persistence of CXL.	[Li, Jingjing] Hubei Univ Arts & Sci, Teaching Hosp, Xiangyang Cent Hosp, Coll Med,Dept Ophthalmol, Xiangyang, Hubei Province, Peoples R China; [Ji, Peng] Hubei Univ Chinese Med, Teaching Hosp, Xiangyang Hosp Tradit Chinese Med, Dept Operating Theatre, Xiangyang, Hubei Province, Peoples R China; [Lin, Xiaoti] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Surg, Fuzhou, Peoples R China	Hubei University of Arts & Science; Hubei University of Chinese Medicine; Fujian Medical University	Lin, XT (corresponding author), Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Surg, Fuzhou, Peoples R China.	linxt3@mail2.sysu.edu.cn	Lin, Xiaoti/AAB-7049-2021					Arbelaez Maria Clara, 2009, Oman J Ophthalmol, V2, P33, DOI 10.4103/0974-620X.48420; Caporossi A, 2010, AM J OPHTHALMOL, V149, P585, DOI 10.1016/j.ajo.2009.10.021; Craig JA, 2014, OCUL SURF, V12, P202, DOI 10.1016/j.jtos.2014.05.002; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Goldich Y, 2014, CAN J OPHTHALMOL, V49, P54, DOI 10.1016/j.jcjo.2013.09.002; Greenstein SA, 2010, J CATARACT REFR SURG, V36, P2105, DOI 10.1016/j.jcrs.2010.06.067; Henriquez MA, 2011, CORNEA, V30, P281, DOI 10.1097/ICO.0b013e3181eeaea1; Hersh PS, 2011, J CATARACT REFR SURG, V37, P149, DOI 10.1016/j.jcrs.2010.07.030; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KIRKNESS CM, 1990, EYE, V4, P673, DOI 10.1038/eye.1990.95; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Kymes SM, 2008, AM J OPHTHALMOL, V145, P611, DOI 10.1016/j.ajo.2007.11.017; Legare ME, 2013, CAN J OPHTHALMOL, V48, P64, DOI 10.1016/j.jcjo.2012.11.007; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; O'Brart David P S, 2014, J Optom, V7, P113, DOI 10.1016/j.optom.2013.12.001; O'Brart DPS, 2011, BRIT J OPHTHALMOL, V95, P1519, DOI 10.1136/bjo.2010.196493; Poli M, 2013, CORNEA, V32, P583, DOI 10.1097/ICO.0b013e31825e8414; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Renesto AD, 2012, AM J OPHTHALMOL, V153, P982, DOI 10.1016/j.ajo.2011.10.014; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Spoerl E, 1999, J REFRACT SURG, V15, P711; Tian CY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05652; Vinciguerra P, 2012, AM J OPHTHALMOL, V154, P520, DOI 10.1016/j.ajo.2012.03.020; Wittig-Silva C, 2008, J REFRACT SURG, V24, pS720, DOI 10.3928/1081597X-20080901-15; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1	27	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127079	10.1371/journal.pone.0127079	http://dx.doi.org/10.1371/journal.pone.0127079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985208	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300088
J	Lin, WT; Chao, CM; Liu, HC; Li, YJ; Lee, WJ; Lai, CC				Lin, Wei-Ting; Chao, Chien-Ming; Liu, Hsuan-Chih; Li, Yi-Ju; Lee, Wei-Jing; Lai, Chih-Cheng			Short-Term Outcomes of Hip Fractures in Patients Aged 90 Years Old and Over Receiving Surgical Intervention	PLOS ONE			English	Article							ARTHROPLASTY; MORTALITY; HEMIARTHROPLASTY; KNEE; NECK; RISK	Background The knowledge about short-term outcomes of nonagenarians undergoing surgery for hip fracture in Asian is limited. Methods The patients with hip fractures who underwent hip hemiarthroplasty and open reduction with internal fixation (ORIF) for management during the period from 2008 to 2012 were identified and their medical record was retrospectively reviewed. Results During the study period, a total of 101 patients underwent surgery formanagement of hip fractures, and the age of patients ranged from 90 to 96 years. The sites of hip fracture were intertrochanteric (n = 57, 56.4%) and the neck of the femur (n = 44, 43.6%). Most of the patients had American Society of Anesthesiologists scores of 3(n = 55) or 4 (in 44 patients). 80.2%(n = 81) underwent the operation within one day after admission; however, there were 13 patients (12.9%) that underwent surgery 48 or more hours later. ORIF and hemiarthroplasty were performed for 63 (62.4%) and 38 (37.6%) patients, respectively. Overall, the 30-day and 1-year mortality rates were 9.9%(10/101) and 17.3%(13/75), respectively. Multivariate analysis showed that the 30-day mortality was significantly associated only with end-stage renal disease (ESRD) (Odds ratio, 11.13, 95% confidence interval, 1.275-97.881, P =.029). Conclusions The short-term outcome of surgical management for Asian nonagenarians with hip fractures is favorable in selected patients.	[Lin, Wei-Ting; Liu, Hsuan-Chih; Li, Yi-Ju] Chi Mei Med Ctr, Dept Orthoped, Tainan, Taiwan; [Lin, Wei-Ting] Shu Zen Jr Coll Med & Management, Dept Phys Therapy, Kaohsiung, Taiwan; [Chao, Chien-Ming; Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Chao, Chien-Ming] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Lee, Wei-Jing] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital	Lai, CC (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	dtmed141@gmail.com	Lee, Wei-Jing/AAU-8719-2020					[Anonymous], 2005, SPIE, V5678, P16; Baker RP, 2006, J BONE JOINT SURG AM, V88A, P2583, DOI 10.2106/JBJS.E.01373; Berend ME, 2003, J ARTHROPLASTY, V18, P817, DOI 10.1016/S0883-5403(03)00338-3; Carroll C, 2011, HEALTH TECHNOL ASSES, V15, pI, DOI 10.3310/hta15360; Collins AJ, 2009, AM J KIDNEY DIS, V55, pS1; Dalrymple LS, 2012, AM J KIDNEY DIS, V59, P356, DOI 10.1053/j.ajkd.2011.07.012; Garcia-Ramiro S, 2008, HIP INT, V18, P51, DOI 10.5301/HIP.2008.184; Goldacre MJ, 2002, BRIT MED J, V325, P868, DOI 10.1136/bmj.325.7369.868; Gregory JJ, 2010, J BONE JOINT SURG BR, V92B, P1227, DOI 10.1302/0301-620X.92B9.24432; Hapuarachchi KS, 2014, J ORTHOP TRAUMATOL, V15, P13, DOI 10.1007/s10195-013-0248-9; Hopley C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2332; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Karuppiah SV, 2008, EUR J ORTHOP SURG TR, V18, P461, DOI 10.1007/s00590-008-0330-9; Krishnan E, 2007, ARTHRIT RHEUM-ARTHR, V57, P1038, DOI 10.1002/art.22888; Moja L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046175; Pagnano MW, 2003, MAYO CLIN PROC, V78, P285, DOI 10.4065/78.3.285; Shao CJ, 2009, BONE, V44, P125, DOI 10.1016/j.bone.2008.09.004; Tosun Bilgehan, 2010, Musculoskelet Surg, V94, P71, DOI 10.1007/s12306-010-0080-9; Trespalacios FC, 2002, KIDNEY INT, V62, P1799, DOI 10.1046/j.1523-1755.2002.00638.x; Wu MY, 2012, AM J KIDNEY DIS, V60, P548, DOI 10.1053/j.ajkd.2012.03.018; Yonezawa T, 2009, J ORTHOP SCI, V14, P566, DOI 10.1007/s00776-009-1380-5	21	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125496	10.1371/journal.pone.0125496	http://dx.doi.org/10.1371/journal.pone.0125496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978368	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100029
J	van Oeffelen, L; Van Roy, W; Idrissi, H; Charlier, D; Lagae, L; Borghs, G				van Oeffelen, Liesbeth; Van Roy, Willem; Idrissi, Hosni; Charlier, Daniel; Lagae, Liesbet; Borghs, Gustaaf			Ion Current Rectification, Limiting and Overlimiting Conductances in Nanopores	PLOS ONE			English	Article							TRANSPORT; SELECTIVITY; MEMBRANE	Previous reports on Poisson-Nernst-Planck (PNP) simulations of solid-state nanopores have focused on steady state behaviour under simplified boundary conditions. These are Neumann boundary conditions for the voltage at the pore walls, and in some cases also Donnan equilibrium boundary conditions for concentrations and voltages at both entrances of the nanopore. In this paper, we report time-dependent and steady state PNP simulations under less restrictive boundary conditions, including Neumann boundary conditions applied throughout the membrane relatively far away from the nanopore. We simulated ion currents through cylindrical and conical nanopores with several surface charge configurations, studying the spatial and temporal dependence of the currents contributed by each ion species. This revealed that, due to slow co-diffusion of oppositely charged ions, steady state is generally not reached in simulations or in practice. Furthermore, it is shown that ion concentration polarization is responsible for the observed limiting conductances and ion current rectification in nanopores with asymmetric surface charges or shapes. Hence, after more than a decade of collective research attempting to understand the nature of ion current rectification in solid-state nanopores, a relatively intuitive model is retrieved. Moreover, we measured and simulated current-voltage characteristics of rectifying silicon nitride nanopores presenting overlimiting conductances. The similarity between measurement and simulation shows that overlimiting conductances can result from the increased conductance of the electric double-layer at the membrane surface at the depletion side due to voltage-induced polarization charges.	[van Oeffelen, Liesbeth; Charlier, Daniel] Vrije Univ Brussel, Microbiol Res Grp, Brussels, Belgium; [van Oeffelen, Liesbeth; Van Roy, Willem; Lagae, Liesbet; Borghs, Gustaaf] IMEC, Leuven, Belgium; [Idrissi, Hosni] Univ Antwerp, Dept Phys, Electron Microscopy Mat Sci EMAT, B-2020 Antwerp, Belgium; [Idrissi, Hosni] Catholic Univ Louvain, Inst Mech Mat & Civil Engn, Louvain La Neuve, Belgium; [Lagae, Liesbet; Borghs, Gustaaf] Katholieke Univ Leuven, Dept Phys, Leuven, Belgium	Vrije Universiteit Brussel; IMEC; University of Antwerp; Universite Catholique Louvain; KU Leuven	van Oeffelen, L (corresponding author), Vrije Univ Brussel, Microbiol Res Grp, Brussels, Belgium.	Liesbeth.van.Oeffelen@vub.ac.be		Van Roy, Willem/0000-0003-3232-1987; Charlier, Daniel/0000-0002-6844-376X	Research Foundation-Flanders (FWO); IAP program of the Belgian State Federal Office for Scientific, Technical and Cultural Affairs [P7/21]	Research Foundation-Flanders (FWO)(FWO); IAP program of the Belgian State Federal Office for Scientific, Technical and Cultural Affairs	LvO has a PhD fellowship of the Research Foundation-Flanders (FWO). HI acknowledges the IAP program of the Belgian State Federal Office for Scientific, Technical and Cultural Affairs under Contract No. P7/21.	Cervera J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2179797; Chang HC, 2012, ANNU REV FLUID MECH, V44, P401, DOI 10.1146/annurev-fluid-120710-101046; Chung SH, 2005, SOFT MATTER, V1, P417, DOI 10.1039/b512455g; Daiguji H, 2005, NANO LETT, V5, P2274, DOI 10.1021/nl051646y; Daiguji H, 2004, NANO LETT, V4, P137, DOI 10.1021/nl0348185; Dimitrov V, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/6/065502; Gracheva ME, 2007, NANO LETT, V7, P1717, DOI 10.1021/nl0707104; HALL JE, 1975, J GEN PHYSIOL, V66, P531, DOI 10.1085/jgp.66.4.531; Han A, 2008, ANAL CHEM, V80, P4651, DOI 10.1021/ac7025207; Holtzel A, 2007, J SEP SCI, V30, P1398, DOI 10.1002/jssc.200600427; Kalman EB, 2009, ANAL BIOANAL CHEM, V394, P413, DOI 10.1007/s00216-008-2545-3; Kim SJ, 2010, CHEM SOC REV, V39, P912, DOI 10.1039/b822556g; Kubeil C, 2011, J PHYS CHEM C, V115, P7866, DOI 10.1021/jp111377h; Kwok H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092880; Li GB, 2009, ANAL CHIM ACTA, V650, P214, DOI 10.1016/j.aca.2009.07.044; Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/NMETH.1932, 10.1038/nmeth.1932]; Schiedt B, 2005, NUCL INSTRUM METH B, V236, P109, DOI 10.1016/j.nimb.2005.03.265; Siwy ZS, 2006, ADV FUNCT MATER, V16, P735, DOI 10.1002/adfm.200500471; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; van Oeffelen L., 2012, NAN BIOAN APPL P INT, P51; Vlassiouk I, 2008, ACS NANO, V2, P1589, DOI 10.1021/nn800306u; Vlassiouk I, 2008, NANO LETT, V8, P1978, DOI 10.1021/nl800949k; Vlassiouk I, 2007, NANO LETT, V7, P552, DOI 10.1021/nl062924b; Wei C, 1997, ANAL CHEM, V69, P4627, DOI 10.1021/ac970551g; White RJ, 2006, LANGMUIR, V22, P10777, DOI 10.1021/la061457a; Woermann D, 2004, PHYS CHEM CHEM PHYS, V6, P3130, DOI 10.1039/b316166h; Woermann D, 2002, NUCL INSTRUM METH B, V194, P458, DOI 10.1016/S0168-583X(02)00956-4; Wolfram MT, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454101; Zangle TA, 2010, CHEM SOC REV, V39, P1014, DOI 10.1039/b902074h	29	13	14	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124171	10.1371/journal.pone.0124171	http://dx.doi.org/10.1371/journal.pone.0124171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978328	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100012
J	Zhang, CW; Zhou, S; Chain, BM				Zhang, Changwang; Zhou, Shi; Chain, Benjamin M.			Hybrid Epidemics-A Case Study on Computer Worm Conficker	PLOS ONE			English	Article							INFORMATION DISSEMINATION; TRANSMISSION DYNAMICS; DISEASE TRANSMISSION; MULTIPLE ROUTES; MODEL; NETWORKS; BRUCELLOSIS; MULTISCALE; INFECTION; PATTERNS	Conficker is a computer worm that erupted on the Internet in 2008. It is unique in combining three different spreading strategies: local probing, neighbourhood probing, and global probing. We propose a mathematical model that combines three modes of spreading: local, neighbourhood, and global, to capture the worm's spreading behaviour. The parameters of the model are inferred directly from network data obtained during the first day of the Conficker epidemic. The model is then used to explore the tradeoff between spreading modes in determining the worm's effectiveness. Our results show that the Conficker epidemic is an example of a critically hybrid epidemic, in which the different modes of spreading in isolation do not lead to successful epidemics. Such hybrid spreading strategies may be used beneficially to provide the most effective strategies for promulgating information across a large population. When used maliciously, however, they can present a dangerous challenge to current internet security protocols.	[Zhang, Changwang; Zhou, Shi] UCL, Dept Comp Sci, London, England; [Zhang, Changwang] UCL, Secur Sci Doctoral Res Training Ctr, London, England; [Chain, Benjamin M.] UCL, Div Infect & Immun, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Zhang, CW (corresponding author), UCL, Dept Comp Sci, London, England.	changwang.zhang.10@ucl.ac.uk; s.zhou@ucl.ac.uk	Zhou, Shi/B-5213-2009	Zhou, Shi/0000-0001-9658-9195; Chain, Benny/0000-0002-7417-3970	Engineering and Physical Sciences Research Council of UK [EP/G037264/1]; China Scholarship Council [2010611089]; National Natural Science Foundation of China [60970034, 61170287, 61232016]	Engineering and Physical Sciences Research Council of UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported in part by the Engineering and Physical Sciences Research Council of UK (no. EP/G037264/1), the China Scholarship Council (file no. 2010611089), and the National Natural Science Foundation of China (project no. 60970034, 61170287, 61232016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben E, 2009, CONFICKER CONFLICKER; ANDERSON RM, 1991, B MATH BIOL, V53, P3, DOI 10.1016/S0092-8240(05)80039-4; Apolloni A, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-3; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Ball F, 2008, MATH BIOSCI, V212, P69, DOI 10.1016/j.mbs.2008.01.001; Ball F, 1997, ANN APPL PROBAB, V7, P46; Ball F, 2012, ADV APPL PROBAB, V44, P63, DOI 10.1239/aap/1331216645; Center for Applied Internet Data Analysis, 2008, CAIDA UCSD NETW TEL; Chen PY, 2014, IEEE T CYBERNETICS, V44, P2316, DOI 10.1109/TCYB.2014.2306781; Chiba D., 2013, J INF PROCESS, V21, P539, DOI [10.2197/ipsjjip.21.539, DOI 10.2197/IPSJJIP.21.539]; Chien E, 2010, DOWNADUP ATTEMPTS SM; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Dagon D., 2006, NDSS, P2; ESET Virusradar, 2014, WIN32 CONFICKER CHAR; Estrada E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036110; House T, 2008, MATH BIOSCI, V213, P29, DOI 10.1016/j.mbs.2008.01.011; House T, 2012, CONTEMP PHYS, V53, P213, DOI 10.1080/00107514.2011.644443; Irwin B, 2012, 2012 INFORMATION SECURITY FOR SOUTH AFRICA (ISSA); Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kiss IZ, 2006, MATH BIOSCI, V203, P124, DOI 10.1016/j.mbs.2006.03.002; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Li MT, 2014, MATH BIOSCI ENG, V11, P1115, DOI 10.3934/mbe.2014.11.1115; Ma JL, 2013, J MATH BIOL, V66, P75, DOI 10.1007/s00285-011-0502-9; Mata AS, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042820; Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Min Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057100; Moore D., 2003, IEEE Security & Privacy, V1, P33, DOI 10.1109/MSECP.2003.1219056; Moore D, 2002, IMW 2002: PROCEEDINGS OF THE SECOND INTERNET MEASUREMENT WORKSHOP, P273, DOI 10.1145/637201.637244; Newman M.E.J., 2010, NETWORKS INTRO; Nie J, 2014, J BIOL SYST, V22, P533, DOI 10.1142/S021833901450020X; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Ren Z, 2014, IEEE COMMUN LETT, V18, P1183, DOI 10.1109/LCOMM.2014.2327038; Rock K, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026602; Runheng Li, 2009, Proceedings of the Second International Symposium on Information Science and Engineering (ISISE 2009), P185, DOI 10.1109/ISISE.2009.18; Sahneh FD, 2014, MATH MODEL NAT PHENO, V9, P136, DOI 10.1051/mmnp/20149209; Shannon C, 2004, IEEE SECUR PRIV, V2, P46, DOI 10.1109/MSP.2004.59; Shin S, 2012, IEEE T INF FOREN SEC, V7, P676, DOI 10.1109/TIFS.2011.2173486; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2010, J THEOR BIOL, V264, P95, DOI 10.1016/j.jtbi.2010.01.006; Sun GQ, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/08/P08011; Sun G, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/11/P11011; Tildesley MJ, 2010, P NATL ACAD SCI USA, V107, P1041, DOI 10.1073/pnas.0909047107; Vazquez A, 2007, J THEOR BIOL, V245, P125, DOI 10.1016/j.jtbi.2006.09.018; Volz EM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002042; Wang LM, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-5; Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01468; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Wang Y, 2013, PHYSICA A, V392, P3869, DOI 10.1016/j.physa.2013.03.042; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Yu S, 2015, IEEE T KNOWL DATA EN, V27, P170, DOI 10.1109/TKDE.2014.2320725; Yu Yao, 2011, 2011 3rd International Conference on Multimedia Information Networking and Security, P431, DOI 10.1109/MINES.2011.61; Zhang C. D., 2014, PREPRINT; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108592; Zhang J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04846; Zou CC, 2006, PERFORM EVALUATION, V63, P700, DOI 10.1016/j.peva.2005.07.032	58	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127478	10.1371/journal.pone.0127478	http://dx.doi.org/10.1371/journal.pone.0127478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978309	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100148
J	Asrih, M; Altirriba, J; Rohner-Jeanrenaud, F; Jornayvaz, FR				Asrih, Mohamed; Altirriba, Jordi; Rohner-Jeanrenaud, Francoise; Jornayvaz, Francois R.			Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue	PLOS ONE			English	Article							GROWTH-FACTOR 21; INSULIN-RESISTANCE; LOW-CARBOHYDRATE; HIGH-FAT; GLUCOSE-TOLERANCE; ENERGY-EXPENDITURE; KETONE-BODIES; BETA-KLOTHO; LONG-TERM; MICE	Background/Hypothesis Beside its beneficial effects on weight loss, ketogenic diet (KD) causes dyslipidemia, a proinflammatory state involved in the development of hepatic steatosis, glucose intolerance and insulin resistance, although the latter is still being debated. Additionally, KD is known to increase fibroblast growth factor 21 (FGF21) plasma levels. However, FGF21 cannot initiate its beneficial actions on metabolism in these conditions. We therefore hypothesized and tested in the present study that KD may impair FGF21 signaling. Methods/Results Using indirect calorimetry, we found that KD-fed mice exhibited higher energy expenditure than regular chow (RC)-fed mice associated with increased Ucp1 levels in white adipose tissue (WAT), along with increased plasma FGF21 levels. We then assessed the effect of KD on FGF21 signaling in both the liver and WAT. We found that Fgfr4 and Klb (beta-klotho) were downregulated in the liver, while Fgfr1 was downregulated in WAT of KD-fed mice. Because inflammation could be one of the mechanisms linking KD to impaired FGF21 signaling, we measured the expression levels of inflammatory markers and macrophage accumulation in WAT and liver and found an increased inflammation and macrophage accumulation in the liver, but surprisingly, a reduction of inflammation in WAT. We also showed that KD enhances lipid accumulation in the liver, which may explain hepatic inflammation and impaired Fgfr4 and Klb expression. In contrast, import of lipids from the circulation was significantly reduced in WAT of KD-fed mice, as suggested by a downregulation of Lpl and Cd36. This was further associated with reduced inflammation in WAT. Conclusion Altogether, these results indicate that KD could be beneficial for a given tissue but deleterious for another.	[Asrih, Mohamed; Altirriba, Jordi; Rohner-Jeanrenaud, Francoise; Jornayvaz, Francois R.] Univ Hosp Geneva, Div Endocrinol Diabet Hypertens & Nutr, CH-1211 Geneva 14, Switzerland	University of Geneva	Jornayvaz, FR (corresponding author), Univ Hosp Geneva, Div Endocrinol Diabet Hypertens & Nutr, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	Francois.Jornayvaz@chuv.ch	Jornayvaz, François/AAL-2134-2020	Jornayvaz, Francois/0000-0001-9425-3137	Olga Mayenfisch Foundation; Hjelt Diabetes Foundation; Fondation de Reuter; Fondation Schmidheiny; Helmut Horten Foundation; SwissLife	Olga Mayenfisch Foundation; Hjelt Diabetes Foundation; Fondation de Reuter; Fondation Schmidheiny; Helmut Horten Foundation; SwissLife	This work was supported by the Olga Mayenfisch Foundation, the Hjelt Diabetes Foundation, the Fondation de Reuter, the Fondation Schmidheiny, the Helmut Horten Foundation and SwissLife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007; Asrih M, 2013, J ENDOCRINOL, V218, pR25, DOI 10.1530/JOE-13-0201; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009; Bergqvist AGC, 2012, EPILEPSY RES, V100, P261, DOI 10.1016/j.eplepsyres.2011.05.020; Bielohuby M, 2013, AM J PHYSIOL-ENDOC M, V305, pE1059, DOI 10.1152/ajpendo.00208.2013; Bisschop PH, 2001, AM J CLIN NUTR, V73, P554; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Diaz-Delfin J, 2012, ENDOCRINOLOGY, V153, P4238, DOI 10.1210/en.2012-1193; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010; Gariani K, 2013, DIABETES METAB, V39, P16, DOI 10.1016/j.diabet.2012.11.002; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Jornayvaz FR, 2011, AM J CLIN NUTR, V94, P955, DOI 10.3945/ajcn.111.019646; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Jornayvaz FR, 2010, ANNU REV NUTR, V30, P273, DOI 10.1146/annurev.nutr.012809.104726; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kossoff Eric H, 2013, Biomed J, V36, P2, DOI 10.4103/2319-4170.107152; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Murata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069330; Partsalaki I, 2012, J PEDIATR ENDOCR MET, V25, P697, DOI 10.1515/jpem-2012-0131; Peyrou M, 2015, J HEPATOL, V62, P421, DOI 10.1016/j.jhep.2014.09.012; Portincasa P, 2005, CLIN BIOCHEM, V38, P203, DOI 10.1016/j.clinbiochem.2004.10.014; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164	41	40	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126364	10.1371/journal.pone.0126364	http://dx.doi.org/10.1371/journal.pone.0126364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973847	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600048
J	Baranek, M; Cechova, J; Raddova, J; Holleinova, V; Ondrusikova, E; Pidra, M				Baranek, Miroslav; Cechova, Jana; Raddova, Jana; Holleinova, Vera; Ondrusikova, Eva; Pidra, Miroslav			Dynamics and Reversibility of the DNA Methylation Landscape of Grapevine Plants (Vitis vinifera) Stressed by In Vitro Cultivation and Thermotherapy	PLOS ONE			English	Article							TISSUE-CULTURE; GENOMIC DNA; SOMACLONAL VARIATION; PATTERNS; GENES; CELLS; TRANSCRIPTION; RESOLUTION; GROWTH	There is relatively little information concerning long-term alterations in DNA methylation following exposure of plants to environmental stress. As little is known about the ratio of non-heritable changes in DNA methylation and mitotically-inherited methylation changes, dynamics and reversibility of the DNA methylation states were investigated in grapevine plants (Vitis vinifera) stressed by in vitro cultivation. It was observed that significant part of induced epigenetic changes could be repeatedly established by exposure to particular planting and stress conditions. However, once stress conditions were discontinued, many methylation changes gradually reverted and plants returned to epigenetic states similar to those of maternal plants. In fact, in the period of one to three years after in vitro cultivation it was difficult to distinguish the epigenetic states of somaclones and maternal plants. Forty percent of the observed epigenetic changes disappeared within a year subsequent to termination of stress conditions ending and these probably reflect changes caused by transient and reversible stress-responsive acclimation mechanisms. However, sixty percent of DNA methylation diversity remained after 1 year and probably represents mitotically-inherited epimutations. Sequencing of regions remaining variable between maternal and regenerant plants revealed that 29.3% of sequences corresponded to non-coding regions of grapevine genome. Eight sequences (19.5%) corresponded to previously identified genes and the remaining ones (51.2%) were annotated as "hypothetical proteins" based on their similarity to genes described in other species, including genes likely to undergo methylation changes following exposure to stress (V. vinifera gypsy-type retrotransposon Gret1, auxin-responsive transcription factor 6-like, SAM-dependent carboxyl methyltransferase).	[Baranek, Miroslav; Cechova, Jana; Raddova, Jana; Holleinova, Vera; Ondrusikova, Eva; Pidra, Miroslav] Mendel Univ Brno, Fac Hort, Mendeleum Dept Genet, Lednice, Czech Republic	Mendel University in Brno	Baranek, M (corresponding author), Mendel Univ Brno, Fac Hort, Mendeleum Dept Genet, Lednice, Czech Republic.	baranek@mendelu.cz	Baránek, Miroslav/E-8371-2016; Ondrušikova, Eva/AAJ-4340-2021; Ondrušiková, Eva/AAO-8555-2020; Cechova, Jana/AAJ-8398-2020; Raddová, Jana/AAO-9431-2020	Baránek, Miroslav/0000-0002-1583-3588; Cechova, Jana/0000-0003-3027-6916; Raddová, Jana/0000-0002-5723-6028	Czech Ministry of Education, Youth and Sports; program Kontakt II; Development of crop stress metabolism and genomics methods in Czech Republic and China [LH12196]	Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); program Kontakt II; Development of crop stress metabolism and genomics methods in Czech Republic and China	This work was supported by the Czech Ministry of Education, Youth and Sports; program Kontakt II; project LH12196-Development of crop stress metabolism and genomics methods in Czech Republic and China. Details are available on https://www.isvav.cz/projectDetail.do?rowId=LH12196.	Alzohairy AM, 2012, LIFE SCI J, V9, P5019; Baranek M, 2012, ACTA HORTIC, V961, P73; Baranek M, 2010, PLANT CELL TISS ORG, V101, P11, DOI 10.1007/s11240-009-9656-1; Baranek M, 2009, GENET MOL BIOL, V32, P834, DOI 10.1590/S1415-47572009005000079; BRAR DS, 1998, SOMACLONAL VARIATION, P15, DOI DOI 10.1007/978-94-015-9125-6_2; Bunyan D.J., 2011, OPEN J GENET, V1, P13; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Dann AL, 2011, PLANT CELL REP, V30, P631, DOI 10.1007/s00299-010-0983-9; Diede SJ, 2010, P NATL ACAD SCI USA, V107, P234, DOI 10.1073/pnas.0907606106; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; Fraga MF, 2002, TREE PHYSIOL, V22, P813, DOI 10.1093/treephys/22.11.813; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gao GZ, 2014, BREEDING SCI, V64, P125, DOI 10.1270/jsbbs.64.125; Gao XA, 2010, J PLANT GROWTH REGUL, V29, P257, DOI 10.1007/s00344-009-9133-4; Gribaudo I, 2000, ACTA HORTIC, P231, DOI 10.17660/ActaHortic.2000.530.27; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; KAEPPLER SM, 1993, IN VITRO CELL DEV-PL, V29P, P125, DOI 10.1007/BF02632283; Kiselev KV, 2015, J PLANT PHYSIOL, V175, P59, DOI 10.1016/j.jplph.2014.10.017; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Koukalova B, 2005, PLANT PHYSIOL, V139, P275, DOI 10.1104/pp.105.061788; Kwasniewska J, 2012, ACTA BIOL CRACOV BOT, V54, P93, DOI 10.2478/v10182-012-0028-5; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Landey RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056372; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Latzel V, 2014, OIKOS, V123, P41, DOI 10.1111/j.1600-0706.2013.00537.x; Law RD, 2005, PLANT PHYSIOL BIOCH, V43, P527, DOI 10.1016/j.plaphy.2005.03.014; Li H, 2014, PLANT CELL TISS ORG, V117, P187, DOI 10.1007/s11240-014-0432-5; Li XL, 2007, PLANT CELL TISS ORG, V90, P153, DOI 10.1007/s11240-007-9224-5; Lopez CMR, 2010, NEW PHYTOL, V186, P856, DOI 10.1111/j.1469-8137.2010.03242.x; Machczynska J, 2014, PLANT CELL TISS ORG, V119, P289, DOI 10.1007/s11240-014-0533-1; MacKenzie DJ, 1997, PLANT DIS, V81, P222, DOI 10.1094/PDIS.1997.81.2.222; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Matarazzo MR, 2004, BIOTECHNIQUES, V37, P666, DOI 10.2144/04374DD02; Matsunaga W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00048; Maury S, 2012, PHYSIOL PLANTARUM, V146, P321, DOI 10.1111/j.1399-3054.2012.01634.x; Miguel C, 2011, J EXP BOT, V62, P3713, DOI 10.1093/jxb/err155; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Peredo EL, 2009, J PLANT PHYSIOL, V166, P1101, DOI 10.1016/j.jplph.2008.12.015; Popescu CF, 2002, VITIS, V41, P177; Rathore MS, 2015, PLANT GROWTH REGUL, V75, P11, DOI 10.1007/s10725-014-9926-8; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Saez-Laguna E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103145; Shi HD, 2003, CANCER RES, V63, P2164; Smulders MJM, 2011, PLANT GROWTH REGUL, V63, P137, DOI 10.1007/s10725-010-9531-4; Smulders MJM, 1995, THEOR APPL GENET, V91, P1257, DOI 10.1007/BF00220938; Smykal P, 2007, PLANT CELL REP, V26, P1985, DOI 10.1007/s00299-007-0413-9; Somers DE, 2009, TRENDS PLANT SCI, V14, P206, DOI 10.1016/j.tplants.2009.01.003; Tsaftaris AS, 2007, PLANT BREEDING REV, DOI [10.1002/9780470380130.ch2, DOI 10.1002/9780470380130.CH2]; Tyunin AP, 2013, BIOTECHNOL LETT, V35, P1525, DOI 10.1007/s10529-013-1235-1; Valledor L, 2007, PLANT CELL TISS ORG, V91, P75, DOI 10.1007/s11240-007-9262-z; Vining K, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-92; Vogel N, 2009, TRANSFUS MED HEMOTH, V36, P253, DOI 10.1159/000225089; Voronova A, 2014, TREE GENET GENOMES, V10, P937, DOI 10.1007/s11295-014-0733-1; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Xu ML, 2004, THEOR APPL GENET, V109, P899, DOI 10.1007/s00122-004-1717-6	60	28	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126638	10.1371/journal.pone.0126638	http://dx.doi.org/10.1371/journal.pone.0126638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973746	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600071
J	Deng, L; Ibanez, LI; Van den Bossche, V; Roose, K; Youssef, SA; de Bruin, A; Fiers, W; Saelens, X				Deng, Lei; Ibanez, Lorena Itat; Van den Bossche, Veronique; Roose, Kenny; Youssef, Sameh A.; de Bruin, Alain; Fiers, Walter; Saelens, Xavier			Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages	PLOS ONE			English	Article							MATRIX PROTEIN-2; M2 PROTEIN; IMMUNE-RESPONSES; EXTRACELLULAR DOMAIN; MONOCLONAL-ANTIBODY; MEMBRANE-PROTEIN; VACCINE; IMMUNIZATION; ECTODOMAIN; MUCOSAL	Human influenza viruses are responsible for annual epidemics and occasional pandemics that cause severe illness and mortality in all age groups worldwide. Matrix protein 2 (M2) of influenza A virus is a tetrameric type III membrane protein that functions as a proton-selective channel. The extracellular domain of M2 (M2e) is conserved in human and avian influenza A viruses and is being pursued as a component for a universal influenza A vaccine. To develop a M2e vaccine that is economical and easy to purify, we genetically fused M2e amino acids 2-16 to the N-terminus of pVIII, the major coat protein of filamentous bacteriophage f88. We show that the resulting recombinant f88-M2e2-16 phages are replication competent and display the introduced part of M2e on the phage surface. Immunization of mice with purified f88-M2e2-16 phages in the presence of incomplete Freund's adjuvant, induced robust M2e-specific serum IgG and protected BALB/c mice against challenge with human and avian influenza A viruses. Thus, replication competent filamentous bacteriophages can be used as efficient and economical carriers to display conserved B cell epitopes of influenza A.	[Deng, Lei; Ibanez, Lorena Itat; Van den Bossche, Veronique; Roose, Kenny; Fiers, Walter; Saelens, Xavier] Univ Ghent VIB, Ctr Med Biotechnol, Ghent, Belgium; [Deng, Lei; Ibanez, Lorena Itat; Van den Bossche, Veronique; Roose, Kenny; Fiers, Walter; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Youssef, Sameh A.; de Bruin, Alain] Univ Utrecht, Fac Vet Sci, Dept Pathobiol, Utrecht, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Utrecht University	Saelens, X (corresponding author), Univ Ghent VIB, Ctr Med Biotechnol, Technol Pk 927, Ghent, Belgium.	Xavier.Saelens@vib-Ugent.be	de Bruin, Alain/AAL-9195-2020; Saelens, Xavier/N-5728-2015	, Xavier/0000-0002-3861-6965; de Bruin, Alain/0000-0001-8579-2649	State Scholarship Fund from the China Scholarship Council [2011674067]; Belgian Federal Sciences Administration Project [BELVIR p7/45]; FP7 project FLUNIVAC; Fonds voor Wetenschappelijk Onderzoek Research Project [G052412N]; Ghent University Special Research Grant [BOF12/GOA/014]	State Scholarship Fund from the China Scholarship Council(China Scholarship Council); Belgian Federal Sciences Administration Project; FP7 project FLUNIVAC; Fonds voor Wetenschappelijk Onderzoek Research Project; Ghent University Special Research Grant	L.D. was supported by State Scholarship Fund (File No. 2011674067) from the China Scholarship Council (http://www.csc.edu.cn/) and by Belgian Federal Sciences Administration Project BELVIR p7/45 (http://www.dmipfmv.ulg.ac.be/vetimmuno/indexPAI.html). K.R. is supported by FP7 project FLUNIVAC (http://flunivac.eu/). This research was also supported by Fonds voor Wetenschappelijk Onderzoek Research Project G052412N (http://www.fwo.be/) and Ghent University Special Research Grant BOF12/GOA/014 (http://www.ugent.be/nl/onderzoek/financiering/bof). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; Baguelin M, 2012, VACCINE, V30, P3459, DOI 10.1016/j.vaccine.2012.03.019; Bastien N, 1997, VIROLOGY, V234, P118, DOI 10.1006/viro.1997.8632; Beale R, 2014, CELL HOST MICROBE, V15, P239, DOI 10.1016/j.chom.2014.01.006; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2011, J GEN VIROL, V92, P301, DOI 10.1099/vir.0.027086-0; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; der Heiden MA, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0064593PONE-D-13-00304; Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Eliasson DG, 2011, VACCINE, V29, P3951, DOI 10.1016/j.vaccine.2011.03.090; ENDEMANN H, 1995, J MOL BIOL, V250, P496, DOI 10.1006/jmbi.1995.0393; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; Frenkel D, 2000, P NATL ACAD SCI USA, V97, P11455, DOI 10.1073/pnas.97.21.11455; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Hashemi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045765; Herve PL, 2014, J VIROL, V88, P325, DOI 10.1128/JVI.01141-13; Ibanez LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059081; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Lavie V, 2004, J MOL NEUROSCI, V24, P105, DOI 10.1385/JMN:24:1:105; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Malik P, 1996, J MOL BIOL, V260, P9, DOI 10.1006/jmbi.1996.0378; MEOLA A, 1995, J IMMUNOL, V154, P3162; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Paschke M, 2006, APPL MICROBIOL BIOT, V70, P2, DOI 10.1007/s00253-005-0270-9; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Pommerenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041169; Prisco A, 2012, INT J MOL SCI, V13, P5179, DOI 10.3390/ijms13045179; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reese Kaleb A, 2013, Vet Med Int, V2013, P316926, DOI 10.1155/2013/316926; Roose K, 2009, DRUG NEWS PERSPECT, V22, P80, DOI 10.1358/dnp.2009.22.2.1334451; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schotsaert M, 2013, MUCOSAL IMMUNOL, V6, P276, DOI 10.1038/mi.2012.69; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Solomon B, 2008, J ALZHEIMERS DIS, V15, P193; Stohr K, 2003, VACCINE, V21, P1744, DOI 10.1016/S0264-410X(03)00065-3; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; van Houten NE, 2010, VACCINE, V28, P2174, DOI 10.1016/j.vaccine.2009.12.059; Wang BZ, 2014, J CONTROL RELEASE, V178, P1, DOI 10.1016/j.jconrel.2014.01.002; ZEBEDEE SL, 1985, J VIROL, V56, P502, DOI 10.1128/JVI.56.2.502-511.1985; ZEBEDEE SL, 1989, P NATL ACAD SCI USA, V86, P1061, DOI 10.1073/pnas.86.3.1061; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Zhirnov OP, 2013, J VIROL, V87, P13107, DOI 10.1128/JVI.02148-13; Zhong WM, 2014, J INFECT DIS, V209, P986, DOI 10.1093/infdis/jit811	62	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126650	10.1371/journal.pone.0126650	http://dx.doi.org/10.1371/journal.pone.0126650			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973787	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600072
J	Candon, S; Perez-Arroyo, A; Marquet, C; Valette, F; Foray, AP; Pelletier, B; Milani, C; Ventura, M; Bach, JF; Chatenoud, L				Candon, Sophie; Perez-Arroyo, Alicia; Marquet, Cindy; Valette, Fabrice; Foray, Anne-Perrine; Pelletier, Benjamin; Milani, Cristian; Ventura, Marco; Bach, Jean-Francois; Chatenoud, Lucienne			Antibiotics in Early Life Alter the Gut Microbiome and Increase Disease Incidence in a Spontaneous Mouse Model of Autoimmune Insulin-Dependent Diabetes	PLOS ONE			English	Article							TH17 CELLS; MICE; CHILDREN; MELLITUS; ASTHMA; SUSCEPTIBILITY; LACTOBACILLI; MECHANISMS; EXPOSURE; BACTERIA	Insulin-dependent or type 1 diabetes is a prototypic autoimmune disease whose incidence steadily increased over the past decades in industrialized countries. Recent evidence suggests the importance of the gut microbiota to explain this trend. Here, non-obese diabetic (NOD) mice that spontaneously develop autoimmune type 1 diabetes were treated with different antibiotics to explore the influence of a targeted intestinal dysbiosis in the progression of the disease. A mixture of wide spectrum antibiotics (i.e. streptomycin, colistin and ampicillin) or vancomycin alone were administered orally from the moment of conception, treating breeding pairs, and during the postnatal and adult life until the end of follow-up at 40 weeks. Diabetes incidence significantly and similarly increased in male mice following treatment with these two antibiotic regimens. In NOD females a slight yet not significant trend towards an increase in disease incidence was observed. Changes in gut microbiota composition were assessed by sequencing the V3 region of bacterial 16S rRNA genes. Administration of the antibiotic mixture resulted in near complete ablation of the gut microbiota. Vancomycin treatment led to increased Escherichia, Lactobacillus and Sutterella genera and decreased members of the Clostridiales order and Lachnospiraceae, Prevotellaceae and Rikenellaceae families, as compared to control mice. Massive elimination of IL-17-producing cells, both CD4+TCR alpha beta+ and TCR gamma delta+ T cells was observed in the lamina propria of the ileum and the colon of vancomycin-treated mice. These results show that a directed even partial ablation of the gut microbiota, as induced by vancomycin, significantly increases type 1 diabetes incidence in male NOD mice thus prompting for caution in the use of antibiotics in pregnant women and newborns.	[Candon, Sophie; Perez-Arroyo, Alicia; Marquet, Cindy; Valette, Fabrice; Foray, Anne-Perrine; Pelletier, Benjamin; Bach, Jean-Francois; Chatenoud, Lucienne] Univ Paris 05, Sorbonne Paris Cite, F-75475 Paris, France; [Candon, Sophie; Perez-Arroyo, Alicia; Marquet, Cindy; Valette, Fabrice; Foray, Anne-Perrine; Pelletier, Benjamin; Bach, Jean-Francois; Chatenoud, Lucienne] Hop Necker Enfants Malad, INSERM, U1151, Paris, France; [Candon, Sophie; Perez-Arroyo, Alicia; Marquet, Cindy; Valette, Fabrice; Foray, Anne-Perrine; Pelletier, Benjamin; Bach, Jean-Francois; Chatenoud, Lucienne] Hop Necker Enfants Malad, CNRS, UMR 8253, Paris, France; [Milani, Cristian; Ventura, Marco] Univ Parma, Dept Life Sci, Lab Probiogen, I-43100 Parma, Italy	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Parma	Chatenoud, L (corresponding author), Univ Paris 05, Sorbonne Paris Cite, F-75475 Paris, France.	lucienne.chatenoud@inserm.fr	Milani, Christian/ABA-8160-2020; ventura, marco/M-8230-2015	Ventura, Marco/0000-0002-4875-4560; Milani, Christian/0000-0002-5062-3164; Foray, Anne-Perrine/0000-0002-7718-8473; Perez Arroyo, Alicia/0000-0002-6129-4845	European Research Council (ERC, Hygiene) [250290]; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Juvenile Diabetes Research Foundation (JDRF); Institut Universitaire de France; Faculte Paris Descartes; Fondation Day Solvay	European Research Council (ERC, Hygiene)(European Research Council (ERC)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Institut Universitaire de France; Faculte Paris Descartes; Fondation Day Solvay(Solvay SA)	This work was supported by a grant from the European Research Council (ERC, Hygiene N<SUP>o</SUP>: 250290). Institutional support was also provided by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS) and the Faculte Paris Descartes. Additional support was provided by Fondation Day Solvay and by the Juvenile Diabetes Research Foundation (JDRF). The laboratory (INSERM U1151) is also part of the RTRS (Reseau Thematique de Recherche et de Soins) "Centaure" and of the Leducq Network. LC is supported in part by the Institut Universitaire de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam C, 2011, DIABETOLOGIA, V54, P1398, DOI 10.1007/s00125-011-2097-5; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Boerner BP, 2011, ANN NY ACAD SCI, V1243, P103, DOI 10.1111/j.1749-6632.2011.06340.x; Brown CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025792; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; FITZPATRICK F, 1991, ENDOCRINOLOGY, V129, P1382, DOI 10.1210/endo-129-3-1382; Foliaki S, 2009, J ALLERGY CLIN IMMUN, V124, P982, DOI 10.1016/j.jaci.2009.08.017; FOX HS, 1992, J EXP MED, V175, P1409, DOI 10.1084/jem.175.5.1409; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hviid A, 2009, AM J EPIDEMIOL, V169, P1079, DOI 10.1093/aje/kwp038; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Joseph J, 2012, J IMMUNOL, V188, P216, DOI 10.4049/jimmunol.1101215; King C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017049; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; Maassen CBM, 2008, VACCINE, V26, P2056, DOI 10.1016/j.vaccine.2008.02.035; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Marra F, 2009, CHEST, V136, pe30; Mikelsaar M, 2011, ANAEROBE, V17, P463, DOI 10.1016/j.anaerobe.2011.07.005; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Murk W, 2011, PEDIATRICS, V127, P1125, DOI 10.1542/peds.2010-2092; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Nylund L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-12; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; OLDSTONE MBA, 1990, J EXP MED, V171, P2077, DOI 10.1084/jem.171.6.2077; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Russell SL, 2013, GUT MICROBES, V4, P158, DOI 10.4161/gmic.23567; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Shale M, 2013, IMMUNOL REV, V252, P164, DOI 10.1111/imr.12039; Sofi MH, 2014, DIABETES, V63, P632, DOI 10.2337/db13-0981; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Wickens K, 2008, CLIN EXP ALLERGY, V38, P1318, DOI 10.1111/j.1365-2222.2008.03024.x; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	52	138	145	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125448	10.1371/journal.pone.0125448	http://dx.doi.org/10.1371/journal.pone.0125448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970503	gold, Green Published, Green Submitted			2022-12-27	WOS:000354544200073
J	Mukamal, KJ; Jensen, MK; Pers, TH; Pai, JK; Kraft, P; Rimm, EB				Mukamal, Kenneth J.; Jensen, Majken K.; Pers, Tune H.; Pai, Jennifer K.; Kraft, Peter; Rimm, Eric B.			Multilocus Heterozygosity and Coronary Heart Disease: Nested Case-Control Studies in Men and Women	PLOS ONE			English	Article							QUANTITATIVE TRAITS; ASSOCIATION; MALARIA; MARKERS; RISK	Background Generalized allelic heterozygosity has been proposed to improve reproductive fitness and has been associated with higher blood pressure, but its association with chronic disease is not well characterized. Methods Using the Affymetrix Genome-Wide Human 6.0 array, we performed whole genome scans in parallel case-control studies of coronary heart disease (CHD) nested in the Health Professionals Follow-up Study and Nurses' Health Study. We examined similar to 700,000 single nucleotide polymorphisms (SNPs) in 435 men with incident CHD and 878 matched controls and 435 women with incident CHD with 931 matched controls. We examined the relationship of genome-wide heterozygosity with risk of incident of CHD and with baseline levels of cardiovascular risk factors. Results In both cohorts, approximately 227650 (SD 2000) SNPs were heterozygous. The number of heterozygous SNPs was not related to risk of CHD in either men or women (adjusted odds ratios per 2000 heterozygous SNPs 1.01 [95% confidence interval, 0.91-1.13] in women and 0.94 [0.84-1.06] in men). We also found no consistent associations of genome-wide heterozygosity with levels of lipids, inflammatory markers, adhesion molecules, homocysteine, adiponectin, or body-mass index. Conclusions In these parallel nested case-control studies, we found no relationship of multilocus heterozygosity with risk of CHD or its major risk factors. Studies in other populations are needed to rule out associations with lower levels of heterozygosity.	[Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Jensen, Majken K.; Pai, Jennifer K.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Pers, Tune H.] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Pers, Tune H.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Pers, Tune H.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.] Broad Inst, Med & Populat Genet, Cambridge, MA USA; [Pers, Tune H.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Pai, Jennifer K.; Rimm, Eric B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Pai, Jennifer K.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Kraft, Peter; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Technical University of Denmark; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Copenhagen; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Mukamal, KJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	kmukamal@bidmc.harvard.edu	Kraft, Peter/GQH-8448-2022; Mukamal, Kenneth/GVR-7978-2022	Pers, Tune/0000-0003-0207-4831; Jensen, Majken Karoline/0000-0003-4729-7545	National Institutes of Health, Bethesda, Maryland [HL35464, CA55075, CA87969]; Merck/Rosetta Research Laboratories, North Wales, Pennsylvania; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck/Rosetta Research Laboratories, North Wales, Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lundbeck Foundation(Lundbeckfonden); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation)	This study was supported by grants HL35464, CA55075, and CA87969 from the National Institutes of Health, Bethesda, Maryland (EBR), with additional support for genotyping from Merck/Rosetta Research Laboratories, North Wales, Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri M, 2004, EXP GERONTOL, V39, P1095, DOI 10.1016/j.exger.2004.03.034; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Charpentier MJE, 2008, BEHAV GENET, V38, P151, DOI 10.1007/s10519-008-9191-6; Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602; DeVry CG, 1999, J HUM GENET, V44, P275, DOI 10.1007/s100380050161; Govindaraju DR, 2009, ANN HUM GENET, V73, P465, DOI 10.1111/j.1469-1809.2009.00514.x; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Lewis MB, 2010, PERCEPTION, V39, P136, DOI 10.1068/p6626; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Monsees GM, 2009, GENET EPIDEMIOL, V33, P717, DOI 10.1002/gepi.20424; Pai JK, 2002, CLIN CHEM, V48, P1781; Pischon T, 2003, OBES RES, V11, P1055, DOI 10.1038/oby.2003.145; PRENTICE RL, 1978, BIOMETRICS, V34, P153; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Richer J, 2005, CLIN GENET, V68, P332, DOI 10.1111/j.1399-0004.2005.00503.x; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124847	10.1371/journal.pone.0124847	http://dx.doi.org/10.1371/journal.pone.0124847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970579	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200053
J	Pham, TTM; Rodriguez, NJP; Hijri, M; Sylvestre, M				Pham, Thi Thanh My; Rodriguez, Nancy Johanna Pino; Hijri, Mohamed; Sylvestre, Michel			Optimizing Polychlorinated Biphenyl Degradation by Flavonoid-Induced Cells of the Rhizobacterium Rhodococcus erythropolis U23A	PLOS ONE			English	Article							DIOXYGENASE; BACTERIA; PCBS; RHIZOSPHERE; BIOTRANSFORMATION; BIODEGRADATION; METABOLITES; REGULATOR; TERPENES; REMOVAL	There is evidence that many plant secondary metabolites may act as signal molecules to trigger the bacterial ability to metabolize polychlorinated biphenyls (PCBs) during the rhizoremediation process. However, the bases for the PCB rhizoremediation process are still largely unknown. The rhizobacterium Rhodococcus erythropolis U23A is unable to use flavanone as a growth substrate. However, on the basis of an assay that monitors the amount of 4-chlorobenzoate produced from 4-chlorobiphenyl by cells grown co-metabolically on flavanone plus sodium acetate, this flavonoid was previously found to be a potential inducer of the U23A biphenyl catabolic pathway. In this work, and using the same assay, we identified ten other flavonoids that did not support growth, but that acted as inducers of the U23A biphenyl pathway, and we confirmed flavonoid induction of the biphenyl catabolic pathway using quantitative real-time polymerase chain reaction (RT-qPCR) on the bphAgene. We also examined the effect of the growth co-substrate on flavonoid induction. Sodium acetate was replaced by glucose, mannose, sucrose, or mannitol, which are sugars found in plant root exudates. The data showed that the level of induction of strain U23A biphenyl-degrading enzymes was significantly influenced by the nature and concentration of the flavonoid in the growth medium, as well as by the substrate used for growth. Sucrose allowed for an optimal induction response for most flavonoids. Some flavonoids, such as flavone and isoflavone, were better inducers of the biphenyl catabolic enzymes than biphenyl itself. We also found that all flavonoids tested in this work were metabolized by strain U23A during co-metabolic growth, but that the metabolite profiles, as well as the level of efficiency of degradation, differed for each flavonoid. To obtain insight into how flavonoids interact with strain U23A to promote polychlorinated biphenyl (PCB) degradation, we determined the concentration of flavanone at which optimal PCB-degrading performance of strain U23A was achieved. We showed that it corresponded to the concentration required to fully induce the biphenyl catabolic pathway of the strain. Together, our data demonstrate that optimal PCB degradation during the rhizoremediation process will require the adjustment of several parameters, including the presence of the appropriate flavonoids at the proper concentrations and the presence of proper growth substrates that positively influence the ability of flavonoids to induce the pathway.	[Pham, Thi Thanh My; Rodriguez, Nancy Johanna Pino; Sylvestre, Michel] Inst Armand Frappier, INRS, Laval, PQ, Canada; [Hijri, Mohamed] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal	Sylvestre, M (corresponding author), Inst Armand Frappier, INRS, Laval, PQ, Canada.	Michel.Sylvestre@iaf.inrs.ca	Hijri, Mohamed/ABC-5969-2021; Hijri, Mohamed/AAL-5737-2021	Hijri, Mohamed/0000-0001-6112-8372; Pino, Nancy/0000-0002-4352-8767	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/39579-2012]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (grant RGPIN/39579-2012).	Atshan SS, 2012, GENE, V494, P219, DOI 10.1016/j.gene.2011.12.010; Barriault D, 2004, J BIOL CHEM, V279, P47480, DOI 10.1074/jbc.M406805200; Barriault D, 1997, INT BIODETER BIODEGR, V39, P311, DOI 10.1016/S0964-8305(97)00027-9; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Cesco S, 2010, PLANT SOIL, V329, P1, DOI 10.1007/s11104-009-0266-9; Dudasova H, 2012, INT BIODETER BIODEGR, V69, P23, DOI 10.1016/j.ibiod.2012.01.003; Hijaz F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101830; Horsman GP, 2006, BIOCHEMISTRY-US, V45, P11071, DOI 10.1021/bi0611098; Imbeault NYR, 2000, J BIOL CHEM, V275, P12430, DOI 10.1074/jbc.275.17.12430; Kagami O, 2008, J BIOSCI BIOENG, V106, P121, DOI 10.1263/jbb.106.121; Leigh MB, 2007, ISME J, V1, P134, DOI 10.1038/ismej.2007.26; Leigh MB, 2006, APPL ENVIRON MICROB, V72, P2331, DOI 10.1128/AEM.72.4.2331-2342.2006; Leigh MB, 2002, ENVIRON SCI TECHNOL, V36, P1579, DOI 10.1021/es015702i; Luo WS, 2007, SOIL BIOL BIOCHEM, V39, P735, DOI 10.1016/j.soilbio.2006.09.019; Martin BC, 2014, SCI TOTAL ENVIRON, V472, P642, DOI 10.1016/j.scitotenv.2013.11.050; Master ER, 2001, APPL ENVIRON MICROB, V67, P2669, DOI 10.1128/AEM.67.6.2669-2676.2001; Misawa N, 2005, TETRAHEDRON, V61, P195, DOI 10.1016/j.tet.2004.10.052; Murinova S, 2014, INT BIODETER BIODEGR, V91, P52, DOI 10.1016/j.ibiod.2014.03.011; Naher U. A., 2008, Research Journal of Microbiology, V3, P580; Narasimhan K, 2003, PLANT PHYSIOL, V132, P146, DOI 10.1104/pp.102.016295; Ohtsubo Y, 2006, MOL MICROBIOL, V60, P1563, DOI 10.1111/j.1365-2958.2006.05197.x; Parnell JJ, 2010, BIODEGRADATION, V21, P147, DOI 10.1007/s10532-009-9289-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham TTM, 2012, APPL ENVIRON MICROB, V78, P3560, DOI 10.1128/AEM.00225-12; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Sambrook J., 2001, MOL CLONING LAB MANU; Seeger M, 2003, APPL ENVIRON MICROB, V69, P5045, DOI 10.1128/AEM.69.9.5045-5050.2003; Seo J, 2011, APPL MICROBIOL BIOT, V89, P1773, DOI 10.1007/s00253-010-2989-1; Singer A.C., 2006, PHYTOREMEDIATION RHI, P5; Singer AC, 2003, TRENDS BIOTECHNOL, V21, P123, DOI 10.1016/S0167-7799(02)00041-0; Slater H, 2011, CHEMOSPHERE, V84, P199, DOI 10.1016/j.chemosphere.2011.04.058; SYLVESTRE M, 1980, APPL ENVIRON MICROB, V39, P1223, DOI 10.1128/AEM.39.6.1223-1224.1980; Sylvestre M, 2013, ENVIRON MICROBIOL, V15, P907, DOI 10.1111/1462-2920.12007; Tandlich R, 2001, CHEMOSPHERE, V44, P1547, DOI 10.1016/S0045-6535(00)00523-3; Pham TTM, 2013, J BACTERIOL, V195, P3563, DOI 10.1128/JB.00161-13; Tillmann S, 2005, FEMS MICROBIOL ECOL, V52, P207, DOI 10.1016/j.femsec.2004.11.014; Toussaint JP, 2012, APPL MICROBIOL BIOT, V95, P1589, DOI 10.1007/s00253-011-3824-z; Uhlik O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040653; Uhlik O, 2009, APPL ENVIRON MICROB, V75, P6471, DOI 10.1128/AEM.00466-09; Van Aken B, 2010, ENVIRON SCI TECHNOL, V44, P2767, DOI 10.1021/es902514d; Vranova V, 2013, SCI WORLD J, DOI 10.1155/2013/524239; Watanabe T, 2003, J BACTERIOL, V185, P3575, DOI 10.1128/JB.185.12.3575-3582.2003; Xu L, 2010, SCI TOTAL ENVIRON, V408, P1007, DOI 10.1016/j.scitotenv.2009.11.031	43	22	22	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126033	10.1371/journal.pone.0126033	http://dx.doi.org/10.1371/journal.pone.0126033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970559	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000354544200094
J	Rebold, MJ; Lepp, A; Sanders, GJ; Barkley, JE				Rebold, Michael J.; Lepp, Andrew; Sanders, Gabriel J.; Barkley, Jacob E.			The Impact of Cell Phone Use on the Intensity and Liking of a Bout of Treadmill Exercise	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; COLLEGE-STUDENTS; ACADEMIC-PERFORMANCE; PEDESTRIAN SAFETY; CROSSING BEHAVIOR; SYNCHRONOUS MUSIC; DISTRACTION; TALKING; WALKING	This study used a within-subjects design to assess the effect of three common cellular telephone (cell phone) functions (texting, talking, listening to music) on planned exercise. Forty-four young adults (n = 33 females, 21.8 +/- 1.3 years) each participated in four, separate, 30-minute exercise conditions on a treadmill in a random order. During each condition, the treadmill speed display was covered and grade was fixed at zero. However, participants were able to alter treadmill speed as desired. Throughout the texting and talking conditions, research personnel used a pre-determined script to simulate cell phone conversations. During the music condition, participants used their cell phone to listen to music of their choice. Finally, participants completed a control condition with no cell phone access. For each condition, average treadmill speed, heart rate and liking (via visual analog scale) were assessed. Treadmill speed (3.4 +/- 1.3 miles.hour(-1)), heart rate (122.3 +/- 24.3 beats. min(-1)) and liking (7.5 +/- 1.5 cm) in the music condition were significantly (p <= 0.014) greater than all other conditions. Treadmill speed in the control condition (3.1 +/- 1.2 miles.hour(-1)) was significantly (p = 0.04) greater than both texting and talking (2.8 +/- 1.1 miles.hour(-1) each). Heart rate during the control condition (115.4 +/- 22.8 beats.min(-1)) was significantly (p = 0.04) greater than texting (109.9 +/- 16.4 beats.min(-1)) but not talking (112.6 +/- 16.1 beats.min(-1)). Finally, liking during the talking condition (5.4 +/- 2.2 cm) was greater (p = 0.05) than the control (4.3 +/- 2.2 cm) but not the texting (5.1 +/- 2.2 cm) conditions. In conclusion, using a cell phone for listening to music can increase the intensity (speed and heart rate) and liking of a bout of treadmill exercise. However, other common cell phone uses (texting and talking) can interfere with treadmill exercise and reduce intensity.	[Rebold, Michael J.; Lepp, Andrew; Sanders, Gabriel J.; Barkley, Jacob E.] Kent State Univ, Coll Educ Hlth & Human Serv, Kent, OH 44242 USA; [Rebold, Michael J.] Bloomsburg Univ Penn, Dept Exercise Sci, Bloomsburg, PA 17815 USA; [Sanders, Gabriel J.] No Kentucky Univ, Dept Kinesiol & Hlth, Highland Hts, KY 41099 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Pennsylvania State System of Higher Education (PASSHE); Bloomsburg University of Pennsylvania; Northern Kentucky University	Rebold, MJ (corresponding author), Kent State Univ, Coll Educ Hlth & Human Serv, Kent, OH 44242 USA.	mrebold@bloomu.edu		Lepp, Andrew/0000-0002-1077-083X				Anderson J.Q., 2012, MILLENNIALS WILL BEN; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; Dietz S, 2014, COMPUT HUM BEHAV, V36, P163, DOI 10.1016/j.chb.2014.03.045; DISHMAN RK, 1985, PUBLIC HEALTH REP, V100, P158; Edworthy J, 2006, ERGONOMICS, V49, P1597, DOI 10.1080/00140130600899104; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Foster C, 2010, EXPLORING EFFECTS MU; Gaspar JG, 2014, PSYCHOL SCI, V25, P2136, DOI 10.1177/0956797614549774; Hagberg LA, 2009, SCAND J MED SCI SPOR, V19, P740, DOI 10.1111/j.1600-0838.2008.00844.x; Hagen J, 2013, INT J SPORT PHYSIOL, V8, P104, DOI 10.1123/ijspp.8.1.104; Hancock PA, 2003, ACCIDENT ANAL PREV, V35, P501, DOI 10.1016/S0001-4575(02)00028-3; Harrison MA, 2012, SOC SCI J, V49, P513, DOI 10.1016/j.soscij.2012.05.003; Horrey WJ, 2006, HUM FACTORS, V48, P196, DOI 10.1518/001872006776412135; Hyman IE, 2010, APPL COGNITIVE PSYCH, V24, P597, DOI 10.1002/acp.1638; Jacobsen WC, 2011, CYBERPSYCH BEH SOC N, V14, P275, DOI 10.1089/cyber.2010.0135; Junco R, 2012, COMPUT EDUC, V59, P505, DOI 10.1016/j.compedu.2011.12.023; Karageorghis CI, 2009, J SPORT EXERCISE PSY, V31, P18, DOI 10.1123/jsep.31.1.18; KARVONEN J, 1988, SPORTS MED, V5, P303, DOI 10.2165/00007256-198805050-00002; KING AC, 1990, HEALTH EDUC QUART, V17, P269, DOI 10.1177/109019819001700304; Leman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067932; Lepp A, 2014, COMPUT HUM BEHAV, V31, P343, DOI 10.1016/j.chb.2013.10.049; Lepp A, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-79; MARKLAND D, 1993, PERS INDIV DIFFER, V15, P289, DOI 10.1016/0191-8869(93)90219-S; Mohammadzadeh H, 2008, J PHYS ED SPOR, V6, P67; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nasar J, 2008, ACCIDENT ANAL PREV, V40, P69, DOI 10.1016/j.aap.2007.04.005; Nasar JL, 2013, ACCIDENT ANAL PREV, V57, P91, DOI 10.1016/j.aap.2013.03.021; Neider MB, 2011, PSYCHOL AGING, V26, P260, DOI 10.1037/a0021566; Neider MB, 2010, ACCIDENT ANAL PREV, V42, P589, DOI 10.1016/j.aap.2009.10.004; Palfrey J., 2008, BORN DIGITAL UNDERST; Parr ND, 2014, J APPL BIOMECH, V30, P685, DOI 10.1123/jab.2014-0017; Priest DL, 2004, J SPORT MED PHYS FIT, V44, P77; Rakauskas ME, 2004, J SAFETY RES, V35, P453, DOI 10.1016/j.jsr.2004.06.003; Ruscello B, 2014, J SPORT MED PHYS FIT, V54, P536; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sanchez-Martinez M, 2009, CYBERPSYCHOL BEHAV, V12, P131, DOI 10.1089/cpb.2008.0164; Santos R, 2014, BRIT J SPORT MED, V48, P1508, DOI 10.1136/bjsports-2012-091610; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; Sherwood NE, 2000, ANNU REV NUTR, V20, P21, DOI 10.1146/annurev.nutr.20.1.21; Stavrinos D, 2010, PEDIATRICS, V209, pe179; Stavrinos D, 2011, J SAFETY RES, V42, P101, DOI 10.1016/j.jsr.2011.01.004; Strayer DL, 2006, HUM FACTORS, V48, P381, DOI 10.1518/001872006777724471; Terry PC, 2012, J SCI MED SPORT, V15, P52, DOI 10.1016/j.jsams.2011.06.003; Thompson LL, 2013, INJURY PREV, V19, P232, DOI 10.1136/injuryprev-2012-040601; Tindell D., 2011, COLL TEACH, P1, DOI DOI 10.1080/87567555.2011.604802; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Whaley M., 2006, ACSMS GUIDELINES EXE	49	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125029	10.1371/journal.pone.0125029	http://dx.doi.org/10.1371/journal.pone.0125029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZP	25970553	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200064
J	Yin, J; Prabhakar, M; Wang, S; Liao, SX; Peng, X; He, Y; Chen, YR; Shen, HF; Su, J; Chen, Y; Jiang, YX; Zhang, GX; Zhou, HW				Yin, Jia; Prabhakar, M.; Wang, Shan; Liao, Shuo-Xi; Peng, Xin; He, Yan; Chen, Yi-Ran; Shen, Hua-Fang; Su, Jin; Chen, Ye; Jiang, Yun-Xia; Zhang, Guo-Xia; Zhou, Hong-Wei			Different Dynamic Patterns of beta-Lactams, Quinolones, Glycopeptides and Macrolides on Mouse Gut Microbial Diversity	PLOS ONE			English	Article							FLORA; DISEASE	The adverse impact of antibiotics on the gut microbiota has attracted extensive interest, particularly due to the development of microbiome research techniques in recent years. However, a direct comparison of the dynamic effects of various types of antibiotics using the same animal model has not been available. In the present study, we selected six antibiotics from four categories with the broadest clinical usage, namely, beta-lactams (Ceftriaxone Sodium, Cefoperazone/Sulbactam and meropenem), quinolones (ofloxacin), glycopeptides (vancomycin), and macrolides (azithromycin), to treat BALB/c mice. Stool samples were collected during and after the administration of antibiotics, and microbial diversity was analyzed through Illumina sequencing and bioinformatics analyses using QIIME. Both a and beta diversity analyses showed that ceftriaxone sodium, cefoperazone/sulbactam, meropenem and vancomycin changed the gut microbiota dramatically by the second day of antibiotic administration whereas the influence of ofloxacin was trivial. Azithromycin clearly changed the gut microbiota but much less than vancomycin and the beta-lactams. In general, the community changes induced by the three beta-lactam antibiotics showed consistency in inhibiting Papillibacter, Prevotella and Alistipes while inducing massive growth of Clostridium. The low diversity and high Clostridium level might be an important cause of Clostridium difficile infection after usage of beta-lactams. Vancomycin was unique in that it inhibited Firmicutes, mainly the genus Clostridium. On the other hand, it induced the growth of Escherichia and effect lasted for months afterward. Azithromycin and meropenem induced the growth of Enterococcus. These findings will be useful for understanding the potential adverse effects of antibiotics on the gut microbiome and ensuring their better usage.	[Yin, Jia; Liao, Shuo-Xi] Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou 510515, Guangdong, Peoples R China; [Prabhakar, M.; Wang, Shan; Peng, Xin; He, Yan; Chen, Yi-Ran; Shen, Hua-Fang; Jiang, Yun-Xia; Zhang, Guo-Xia; Zhou, Hong-Wei] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Environm Hlth, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China; [Su, Jin] Southern Med Univ, Nanfang Hosp, Dept Respirat, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Ye] Southern Med Univ, Nanfang Hosp, Dept Digest Dis, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhang, GX (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Environm Hlth, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China.	guoxiazhang@126.com; biodegradation@gmail.com	Zhou, Hongwei/B-4193-2008	He, Yan/0000-0002-6611-2959	National Natural Science Foundation of China (NSFC) [31270152, 31322003, 31300114]; Program for New Century Excellent Talents in University [NCET-11-0921]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (NSFC 31270152, 31322003, 31300114), Program for New Century Excellent Talents in University (NCET-11-0921).	BALSARI A, 1982, MICROBIOLOGICA, V5, P185; Brandtzaeg P, 1997, ALIMENT PHARM THER, V11, P24; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Donald JT, 1985, PHARMACOL THERAPEUT, V27, P1; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gibson GR, 1998, BRIT J NUTR, V80, pS209, DOI 10.1017/S0007114500006048; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gismondo M.R., 1998, GASTROENTEROL INT, V11, P29; Hawrelak Jason A, 2004, Altern Med Rev, V9, P180; Hert DG, 2008, ELECTROPHORESIS, V29, P4618, DOI 10.1002/elps.200800456; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Holzapfel WH, 1998, INT J FOOD MICROBIOL, V41, P85, DOI 10.1016/S0168-1605(98)00044-0; Hove H, 1996, SCAND J GASTROENTERO, V31, P688, DOI 10.3109/00365529609009151; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Jiang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030230; John VU, 2011, FRONT BIOL, V6, P357, DOI DOI 10.1007/S11515-011-1167-X; Knecht H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089417; Linskens RK, 2001, SCAND J GASTROENTERO, V36, P29, DOI 10.1080/003655201753265082; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; MURRAY M, 1998, ENCY NATURAL MED; Noack J, 1998, J NUTR, V128, P1385, DOI 10.1093/jn/128.8.1385; NORD CE, 1990, EUR J CLIN MICROBIOL, V9, P517, DOI 10.1007/BF01964294; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Peltonen R, 1997, BRIT J RHEUMATOL, V36, P64; Peng X, 2013, J MICROBIOL METH, V95, P455, DOI 10.1016/j.mimet.2013.07.015; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sood S, 2008, INDIAN J MED RES, V128, P111; SUTO MJ, 1992, J MED CHEM, V35, P4745, DOI 10.1021/jm00103a013; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Vrieze A, 2014, J HEPATOL, V60, P824, DOI 10.1016/j.jhep.2013.11.034; WATANAKUNAKORN C, 1984, J ANTIMICROB CHEMOTH, V14, P7, DOI 10.1093/jac/14.suppl_D.7; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	39	19	22	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126712	10.1371/journal.pone.0126712	http://dx.doi.org/10.1371/journal.pone.0126712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970622	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200127
J	Inoue, S; Vasilevskis, EE; Pandharipande, PP; Girard, TD; Graves, AJ; Thompson, J; Shintani, A; Ely, EW				Inoue, Shigeaki; Vasilevskis, Eduard E.; Pandharipande, Pratik P.; Girard, Timothy D.; Graves, Amy J.; Thompson, Jennifer; Shintani, Ayumi; Ely, E. Wesley			The Impact of Lymphopenia on Delirium in ICU Patients	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; TERM COGNITIVE IMPAIRMENT; INTENSIVE-CARE UNIT; PERSISTENT INFLAMMATION; CELL-DEFICIENT; SEVERE SEPSIS; MORTALITY; STROKE; IMMUNOSUPPRESSION; PREDICTOR	Background Immunosuppressed states may predispose patients to development of acute brain injury during times of critical illness. Lymphopenia is a non-specific yet commonly used bedside marker of immunosuppressed states. Methods We examined whether lymphopenia would predict development of acute brain dysfunction (delirium and/or coma) in 518 patients enrolled in the Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors (BRAIN-ICU) study in medical and surgical ICUs of a tertiary care, university-based medical center. Utilizing proportional odds logistic regression and Cox proportional hazards survival analysis, we assessed the relationship between pre-enrollment lymphocytes and subsequent cognitive outcomes including delirium-and coma-free days (DCFDs) and 30-day mortality. Results There were no statistically significant associations between lymphocytes and DCFDs (p = 0.17); additionally, the relationship between lymphocytes and mortality was not statistically significant (p = 0.71). Among 259 patients without history of cancer or diabetes, there was no statistically significant association between lymphocytes and DCFDs (p = 0.07). Conclusion lymphopenia, a commonly used bedside marker of immunosuppression, does not appear to be a marker of risk for acute brain injury (delirium/coma) or 30-day mortality in general medical/surgical ICU patients.	[Inoue, Shigeaki] Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, Isehara, Kanagawa 25911, Japan; [Girard, Timothy D.; Ely, E. Wesley] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm Crit Care Med, Nashville, TN 37212 USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Graves, Amy J.; Thompson, Jennifer; Shintani, Ayumi] Vanderbilt Univ, Sch Med Nashville, Dept Biostat, Nashville, TN USA; [Vasilevskis, Eduard E.] Vanderbilt Univ, Sch Med, Dept Med, Div Gen Internal Med & Publ Hlth, Nashville, TN 37212 USA; [Vasilevskis, Eduard E.; Girard, Timothy D.; Ely, E. Wesley] Vanderbilt Univ, Sch Med, Vet Affairs Tennessee Valley Geriatr Res Educ & C, Nashville, TN 37212 USA	Tokai University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; Vanderbilt University	Inoue, S (corresponding author), Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, Isehara, Kanagawa 25911, Japan.	sg-inoue@is.icc.u-tokai.ac.jp	Girard, Timothy/I-3008-2019; Vasilevskis, Eduard/AAA-3065-2019; Ely, E. Wesley/Z-2018-2019	Girard, Timothy/0000-0002-9833-4871; Vasilevskis, Eduard/0000-0001-8165-5321; Ely, E. Wesley/0000-0003-3957-2172; Pandharipande, Pratik/0000-0002-1389-8580	Vanderbilt Institute for Clinical and Translational Research (VICTR); Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors (BRAIN-ICU) Study; NATIONAL INSTITUTE ON AGING [K23AG040157] Funding Source: NIH RePORTER	Vanderbilt Institute for Clinical and Translational Research (VICTR); Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors (BRAIN-ICU) Study; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the Vanderbilt Institute for Clinical and Translational Research (VICTR) and The Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors (BRAIN-ICU) Study.	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YX, 2012, METAB BRAIN DIS, V27, P487, DOI 10.1007/s11011-012-9317-7; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Girard TD, 2012, INTENS CARE MED, V38, P1965, DOI 10.1007/s00134-012-2678-x; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Golde TE, 2002, NAT MED, V8, P936, DOI 10.1038/nm0902-936; Grissom CK, 2010, DISASTER MED PUBLIC, V4, P277, DOI 10.1001/dmp.2010.40; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Huber PJ, 1967, P 5 BERK S MAHT STAT, V1, P211; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Inoue S, 2014, CRIT CARE, V18, DOI 10.1186/cc13941; Inoue S, 2013, CRIT CARE MED, V41, P810, DOI 10.1097/CCM.0b013e318274645f; Jimenez-Ibanez EO, 2012, TOHOKU J EXP MED, V226, P213, DOI 10.1620/tjem.226.213; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; MEAKINS JL, 1977, ANN SURG, V186, P241, DOI 10.1097/00000658-197709000-00002; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande PP, 2010, CRIT CARE, V14, DOI 10.1186/cc8916; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Salciccioli JD, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0731-6; Saresella M, 2010, J ALZHEIMERS DIS, V21, P927, DOI 10.3233/JAD-2010-091696; Schefold JC, 2008, CRIT CARE MED, V36, P3118, DOI 10.1097/CCM.0b013e31818bdd8f; Simone MJ, 2011, CNS NEUROSCI THER, V17, P506, DOI 10.1111/j.1755-5949.2010.00173.x; Tsuruta R, 2010, GEN HOSP PSYCHIAT, V32, P607, DOI 10.1016/j.genhosppsych.2010.09.001; Weninger SC, 2001, NAT MED, V7, P527, DOI 10.1038/87839; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126216	10.1371/journal.pone.0126216	http://dx.doi.org/10.1371/journal.pone.0126216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992641	Green Submitted, Green Published, gold			2022-12-27	WOS:000354921400058
J	Huang, CY; Hsu, TC; Kuo, WW; Liou, YF; Lee, SD; Ju, DT; Kuo, CH; Tzang, BS				Huang, Chih-Yang; Hsu, Tsai-Ching; Kuo, Wei-Wen; Liou, Yi-Fan; Lee, Shin-Da; Ju, Da-Tong; Kuo, Chia-Hua; Tzang, Bor-Show			The Root Extract of Gentiana macrophylla Pall. Alleviates Cardiac Apoptosis in Lupus Prone Mice	PLOS ONE			English	Article							RISK-FACTORS; CELL-DEATH; ERYTHEMATOSUS; CASPASES; DISEASE; GENTIOPICROSIDE; CARDIOMYOPATHY; SWERTIAMARIN; AUTOIMMUNITY; ARTHRITIS	The roots of the perennial herb Gentiana macrophylla Pall. (GM) are known as Qinjiao, which has been used for centuries to treat systemic lupus erythematosus (SLE). However, little is known about the effects of GM on cholesterol-aggravated cardiac abnormalities in SLE, and the mechanisms thereof. This study investigates whether GM exhibits anti-apoptotic effects, focusing on the left ventricle (LV) of NZB/WF1 mice fed with high-cholesterol diet. The morphology and apoptotic status of ventricular tissues were determined by microscopy and Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Levels of apoptotic biomarkers were determined by immunoblotting. The results thus obtained revealed that GM significantly reduced the cholesterol-aggravated apoptosis of LV in NZB/W F1 mice by suppressing both intrinsic and extrinsic apoptotic pathways. Additionally, GM significantly increased the cardiac insulin-like growth factors (IGF)-1 survival signaling and anti-apoptotic proteins in LV tissues. Accordingly, GM is considered to be beneficial in alleviating cholesterol-aggravated cardiac damage in SLE, and therefore constitute an alternative treatment for SLE patients with cardiac abnormalities.	[Huang, Chih-Yang; Liou, Yi-Fan] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Hsu, Tsai-Ching] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Hsu, Tsai-Ching; Tzang, Bor-Show] Chung Shan Med Univ Hosp, Clin Lab, Taichung 40201, Taiwan; [Kuo, Wei-Wen] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Lee, Shin-Da] China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan; [Ju, Da-Tong] Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan; [Kuo, Chia-Hua] Univ Taipei, Dept Sports Sci, Taipei, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; National Defense Medical Center; Tri-Service General Hospital; University of Taipei; Chung Shan Medical University; Chung Shan Medical University	Hsu, TC (corresponding author), Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan.	htc@csmu.edu.tw; bstzang@csmu.edu.tw	Yuang, Chih-Yang/O-5111-2015; Lee, Shin-Da/Q-2798-2015	Lee, Shin-Da/0000-0002-8393-8349; Kuo, Chia-Hua/0000-0002-1731-4984; Bor-Show, Tzang/0000-0003-0140-9943	National Science Council; National Science Council, Taiwan, Republic of China [NSC-99-2632-B-040-001-MY3-(8)]; Chi-Mei Medical Center and Chung-Shan Medical University [CSMU-CMMC-103-01]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	National Science Council(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Chi-Mei Medical Center and Chung-Shan Medical University; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This work was funded by the National Science Council grants, from the National Science Council, Taiwan, Republic of China (NSC-99-2632-B-040-001-MY3-(8)) and supported in part by cooperated project of Chi-Mei Medical Center and Chung-Shan Medical University (CSMU-CMMC-103-01) and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asherson RA, 2002, ANN RHEUM DIS, V61, P859, DOI 10.1136/ard.61.9.859-a; Bjornadal L, 2004, J RHEUMATOL, V31, P713; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Cao XY, 2010, PHYTOCHEM ANALYSIS, V21, P348, DOI 10.1002/pca.1206; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Greco CM, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0378-3; Hahn BH, 1993, DUBOIS LUPUS ERYTHEM, P69; Hsu TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068393; Huang CY, 2009, J AGR FOOD CHEM, V57, P8635, DOI 10.1021/jf9020625; Jahns R, 2008, AUTOIMMUNITY, V41, P454, DOI 10.1080/08916930802031603; Jia N, 2012, J ETHNOPHARMACOL, V144, P638, DOI 10.1016/j.jep.2012.10.004; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; KONDO Y, 1994, PLANTA MED, V60, P414, DOI 10.1055/s-2006-959521; Kwak WJ, 2005, BIOL PHARM BULL, V28, P750, DOI 10.1248/bpb.28.750; Li Long-yun, 2001, Zhongguo Zhongyao Zazhi, V26, P808; Lorenz HM, 2000, APOPTOSIS, V5, P443, DOI 10.1023/A:1009692902805; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; PETRI M, 1992, AM J MED, V93, P513, DOI 10.1016/0002-9343(92)90578-Y; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tincani A, 2006, RHEUMATOLOGY, V45, P8, DOI 10.1093/rheumatology/kel308; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsai CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059724; Tzang BS, 2012, J CELL MOL MED, V16, P2104, DOI 10.1111/j.1582-4934.2011.01511.x; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; WAN ASC, 1971, PLANTA MED, V19, P203, DOI 10.1055/s-0028-1099632; Xu Rui-Sheng, 2009, Zhongguo Gu Shang, V22, P920; YAMAHARA J, 1978, YAKUGAKU ZASSHI, V98, P1446, DOI 10.1248/yakushi1947.98.11_1446; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang S, 1998, DIVINE FARMERS MATER, P341; Yu FR, 2004, J ETHNOPHARMACOL, V95, P77, DOI 10.1016/j.jep.2004.06.025; Yuan Z Z, 1989, Zhong Xi Yi Jie He Za Zhi, V9, P156; Zhao P, 2009, FRONT BIOSCI-LANDMRK, V14, P1708, DOI 10.2741/3334; Zhao SG, 2004, BIOMED CHROMATOGR, V18, P10, DOI 10.1002/bmc.285	36	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127440	10.1371/journal.pone.0127440	http://dx.doi.org/10.1371/journal.pone.0127440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985203	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300125
J	Si, XF; Baselga, A; Ding, P				Si, Xingfeng; Baselga, Andres; Ding, Ping			Revealing Beta-Diversity Patterns of Breeding Bird and Lizard Communities on Inundated Land-Bridge Islands by Separating the Turnover and Nestedness Components	PLOS ONE			English	Article							FOREST FRAGMENTATION; HABITAT FRAGMENTATION; SPATIAL TURNOVER; GLOBAL PATTERNS; DISTANCE DECAY; DISSIMILARITY; DISTRIBUTIONS; EXTINCTION; RICHNESS; REGIONS	Beta diversity describes changes in species composition among sites in a region and has particular relevance for explaining ecological patterns in fragmented habitats. However, it is difficult to reveal the mechanisms if broad sense beta-diversity indices (i.e. yielding identical values under nestedness and species replacement) are used. Partitioning beta diversity into turnover (caused by species replacement from site to site) and nestedness-resultant components (caused by nested species losses) could provide a unique way to understand the variation of species composition in fragmented habitats. Here, we collected occupancy data of breeding birds and lizards on land-bridge islands in an inundated lake in eastern China. We decomposed beta diversity of breeding bird and lizard communities into spatial turnover and nestedness-resultant components to assess their relative contributions and respective relationships to differences in island area, isolation, and habitat richness. Our results showed that spatial turnover contributed more to beta diversity than the nestedness-resultant component. The degree of isolation had no significant effect on overall beta diversity or its components, neither for breeding birds nor for lizards. In turn, in both groups the nestedness-resultant component increased with larger differences in island area and habitat richness, respectively, while turnover component decreased with them. The major difference among birds and lizards was a higher relevance of nestedness-resultant dissimilarity in lizards, suggesting that they are more prone to local extinctions derived from habitat fragmentation. The dominance of the spatial turnover component of beta diversity suggests that all islands have potential conservation value for breeding bird and lizard communities.	[Si, Xingfeng; Ding, Ping] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Baselga, Andres] Univ Santiago de Compostela, Fac Biol, Dept Zool, Santiago De Compostela 15782, Spain	Zhejiang University; Universidade de Santiago de Compostela	Ding, P (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	dingping@zju.edu.cn	Ding, Ping/H-1817-2015; Si, Xingfeng/I-3957-2014; Baselga, Andres/A-6740-2008	Si, Xingfeng/0000-0003-4465-2759; Baselga, Andres/0000-0001-7914-7109	National Natural Science Foundation of China [31170397, 31210103908]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The National Natural Science Foundation of China (Nos. 31170397, 31210103908) (http://www.nsfc.gov.cn) to P.D. and the Fundamental Research Funds for the Central Universities (http://www.dost.moe.edu.cn) funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2012, GLOBAL ECOL BIOGEOGR, V21, P772, DOI 10.1111/j.1466-8238.2011.00709.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Anderson D. R., 2008, MODEL BASED INFERENC; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Angeler DG, 2013, DIVERS DISTRIB, V19, P772, DOI 10.1111/ddi.12029; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Azeria ET, 2011, RESEARCH IN BIODIVERSITY - MODELS AND APPLICATIONS, P75; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Baselga A, 2013, ECOGRAPHY, V36, P124, DOI 10.1111/j.1600-0587.2012.00124.x; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bregman TP, 2014, BIOL CONSERV, V169, P372, DOI 10.1016/j.biocon.2013.11.024; Brualdi RA, 1999, OECOLOGIA, V119, P256, DOI 10.1007/s004420050784; Calderon-Patron JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082905; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; CUTLER A, 1991, CONSERV BIOL, V5, P496, DOI 10.1111/j.1523-1739.1991.tb00357.x; Dapporto L, 2014, J BIOGEOGR, V41, P1639, DOI 10.1111/jbi.12315; Dennis RLH, 2012, J BIOGEOGR, V39, P1412, DOI 10.1111/j.1365-2699.2012.02698.x; Dennis RLH, 2011, BIOL J LINN SOC, V104, P725, DOI 10.1111/j.1095-8312.2011.01789.x; Dennis RLH, 2010, J BIOGEOGR, V37, P2291, DOI 10.1111/j.1365-2699.2010.02380.x; Diamond J.M., 1975, P342; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Fattorini S, 2010, J BIOGEOGR, V37, P1061, DOI 10.1111/j.1365-2699.2009.02252.x; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Germaine SS, 2001, BIOL CONSERV, V97, P229, DOI 10.1016/S0006-3207(00)00115-4; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Guadagnin DL, 2005, WATERBIRDS, V28, P261, DOI 10.1675/1524-4695(2005)028[0261:SATPOW]2.0.CO;2; Gutierrez-Canovas C, 2013, GLOBAL ECOL BIOGEOGR, V22, P796, DOI 10.1111/geb.12060; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Hu G, 2011, LANDSCAPE ECOL, V26, P1405, DOI 10.1007/s10980-011-9662-7; Huang M., 1987, FAUNA ZHEJIANG AMPHI; Jaeger R.G., 1994, MEASURING MONITORING, P103; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; KATTAN GH, 1994, CONSERV BIOL, V8, P138, DOI 10.1046/j.1523-1739.1994.08010138.x; Kattan GH, 2006, CONSERV BIOL, V20, P1203, DOI 10.1111/j.1523-1739.2006.00402.x; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Korfanta NM, 2012, ECOLOGY, V93, P2548, DOI 10.1890/11-1345.1; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Lens L, 2002, SCIENCE, V298, P1236, DOI 10.1126/science.1075664; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Liggins L, 2015, ECOGRAPHY, V38, P1212, DOI 10.1111/ecog.01398; Lomolino MV, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P13; Losos JB, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P1; MAC ARTHUR ROBERT H., 1967; Mac Nally R, 2002, ECOGRAPHY, V25, P651, DOI 10.1034/j.1600-0587.2002.250602.x; Matthews TJ, 2015, DIVERS DISTRIB, V21, P392, DOI 10.1111/ddi.12298; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Mouillot D, 2013, J BIOGEOGR, V40, P2228, DOI 10.1111/jbi.12194; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PIMM SL, 1993, P NATL ACAD SCI USA, V90, P10871, DOI 10.1073/pnas.90.22.10871; Pimm SL, 1991, BALANCE NATURE ECOLO; Qian H, 2009, J SYST EVOL, V47, P509, DOI 10.1111/j.1759-6831.2009.00043.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Schoereder JH, 2004, J BIOGEOGR, V31, P1219, DOI 10.1111/j.1365-2699.2004.01113.x; Si XF, 2014, J BIOGEOGR, V41, P2283, DOI 10.1111/jbi.12379; Sorensen T., 1948, BIOL SKAR, V5, P1; Terborgh J, 1997, ECOLOGY, V78, P1494, DOI 10.1890/0012-9658(1997)078[1494:BCITTL]2.0.CO;2; Terborgh John, 2008, P308; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Ulrich W, 2012, ECOL MODEL, V244, P20, DOI 10.1016/j.ecolmodel.2012.06.030; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; Weiher E, 2001, ECOLOGICAL ASSEMBLY; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI DOI 10.1098/rspb.1996.0087; Williamson M. H., 1981, ISLAND POPULATIONS; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469	89	65	72	7	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127692	10.1371/journal.pone.0127692	http://dx.doi.org/10.1371/journal.pone.0127692			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992559	Green Submitted, gold, Green Published			2022-12-27	WOS:000354917300133
J	Castello, A; Martin, M; Ruiz, A; Casas, AM; Baena-Canada, JM; Lope, V; Antolin, S; Sanchez, P; Ramos, M; Anton, A; Munoz, M; Bermejo, B; De Juan-Ferre, A; Jara, C; Chacon, JI; Jimeno, MA; Rosado, P; Diaz, E; Guillem, V; Lluch, A; Carrasco, E; Perez-Gomez, B; Vioque, J; Pollan, M				Castello, Adela; Martin, Miguel; Ruiz, Amparo; Casas, Ana M.; Baena-Canada, Jose M.; Lope, Virginia; Antolin, Silvia; Sanchez, Pedro; Ramos, Manuel; Anton, Antonio; Munoz, Montserrat; Bermejo, Begona; De Juan-Ferre, Ana; Jara, Carlos; Chacon, Jose I.; Jimeno, Maria A.; Rosado, Petra; Diaz, Elena; Guillem, Vicente; Lluch, Ana; Carrasco, Eva; Perez-Gomez, Beatriz; Vioque, Jesus; Pollan, Marina		EPiGEICAM Researchers	Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; VITAMIN-C; PREVENTION; REPRODUCIBILITY; METAANALYSIS; GUIDELINES; MORTALITY; VALIDITY; DIET; RED	Background According to the "World Cancer Research Fund" and the "American Institute of Cancer Research" (WCRF/AICR) one in four cancer cases could be prevented through a healthy diet, weight control and physical activity. Objective To explore the association between the WCRF/AICR recommendations and risk of breast cancer. Methods During the period 2006 to 2011 we recruited 973 incident cases of breast cancer and 973 controls from 17 Spanish Regions. We constructed a score based on 9 of the WCRF/AICR recommendations for cancer prevention:: 1) Maintain adequate body weight; 2) Be physically active; 3) Limit the intake of high density foods; 4) Eat mostly plant foods; 5) Limit the intake of animal foods; 6) Limit alcohol intake; 7) Limit salt and salt preserved food intake; 8) Meet nutritional needs through diet; S1) Breastfeed infants exclusively up to 6 months. We explored its association with BC by menopausal status and by intrinsic tumor subtypes (ER +/PR+ & HER2-; HER2+; ER&PR-&HER2-) using conditional and multinomial logistic models respectively. Results Our results point to a linear association between the degree of noncompliance and breast cancer risk. Taking women who met 6 or more recommendations as reference, those meeting less than 3 showed a three-fold excess risk (OR=2.98(CI95%:1.59-5.59)), especially for postmenopausal women (OR=3.60(CI95%:1.24; 10.47)) and ER+/PR+&HER2- (OR=3.60 (CI95%:1.84; 7.05)) and HER2+ (OR=4.23(CI95%:1.66;10.78)) tumors. Noncompliance of recommendations regarding the consumption of foods and drinks that promote weight gain in premenopausal women (OR=2.24(CI95%:1.18;4.28); p for interaction=0.014) and triple negative tumors (OR=2.93(CI95%:1.12-7.63)); the intake of plant foods in postmenopausal women (OR=2.35(CI95%:1.24;4.44)) and triple negative tumors (OR=3.48(CI95%:1.468.31)); and the alcohol consumption in ER+/PR+& HER2-tumors (OR=1.52 (CI95%: 1.06-2.19)) showed the strongest associations. Conclusion Breast cancer prevention might be possible by following the "World Cancer Research Fund" and the "American Institute of Cancer Research" recommendations, even in settings like Spain, where a high percentage of women already comply with many of them.	[Castello, Adela; Lope, Virginia; Perez-Gomez, Beatriz; Pollan, Marina] Inst Salud Carlos III, Natl Ctr Epidemiol, Canc Epidemiol Unit, Madrid, Spain; [Castello, Adela; Lope, Virginia; Perez-Gomez, Beatriz; Vioque, Jesus; Pollan, Marina] Inst Salud Carlos III, Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Castello, Adela; Lope, Virginia; Perez-Gomez, Beatriz; Pollan, Marina] IIS Puerta Hierro IDIPHIM, Canc Epidemiol Res Grp, Madrid, Spain; [Martin, Miguel] Univ San Carlos, Hosp Clin, Med Oncol Unit, Madrid, Spain; [Martin, Miguel; Rosado, Petra] Univ Complutense, Inst Invest Sanit Gregorio Maranon, Med Oncol Unit, E-28040 Madrid, Spain; [Ruiz, Amparo; Guillem, Vicente] Inst Valenciano Oncol, Med Oncol Unit, Valencia, Spain; [Casas, Ana M.; Diaz, Elena] Hosp Virgen Rocio, Med Oncol Unit, Seville, Spain; [Baena-Canada, Jose M.] Hosp Puerta Mar, Med Oncol Unit, Cadiz, Spain; [Antolin, Silvia] Complejo Hosp Univ A Coruna, Med Oncol Unit, La Coruna, Spain; [Sanchez, Pedro] Complejo Hosp Jaen, Med Oncol Unit, Jaen, Spain; [Ramos, Manuel] Centro Oncol Galicia, Med Oncol Unit, La Coruna, Spain; [Anton, Antonio] Hosp Univ Miguel Servet, Med Oncol Unit, Zaragoza, Spain; [Munoz, Montserrat] Hosp Clin Barcelona, Med Oncol Unit, Barcelona, Spain; [Bermejo, Begona; Lluch, Ana] Hosp Clin, Med Oncol Unit, Valencia, Spain; [De Juan-Ferre, Ana; Carrasco, Eva] Hosp Marques Valdecilla, Med Oncol Unit, Santander, Spain; [Jara, Carlos] Fdn Hosp Alcorcon, Med Oncol Unit, Alcorcon, Spain; [Chacon, Jose I.] Hosp Virgen Salud, Med Oncol Unit, Toledo, Spain; [Jimeno, Maria A.] Spanish Breast Canc Res Grp GEICAM Headquarter, Start Up Unit, Madrid, Spain; [Vioque, Jesus] Univ Miguel Hernandez, Dept Epidemiol, Sant Joan dAlacant, Spain	Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Complutense University of Madrid; Instituto Valenciano De Oncologia; Virgen del Rocio University Hospital; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Complejo Hospitalario de Jaen; Miguel Servet University Hospital; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Marques de Valdecilla (HUMV); Alcorcon Foundation University Hospital; Complejo Hospitalario de Toledo; GEICAM; Universidad Miguel Hernandez de Elche	Pollan, M (corresponding author), Inst Salud Carlos III, Natl Ctr Epidemiol, Canc Epidemiol Unit, Madrid, Spain.	mpollan@isciii.es	Perez-Gomez, Beatriz/C-4715-2012; Chacon, Jose-Ignacio/GZL-0643-2022; Pollan, Marina/M-3259-2014; Muñoz, Montserrat/AAO-9617-2020; vioque, jesus/A-1066-2008; Lluch, Ana/R-5493-2019; LOPE, VIRGINIA/S-4774-2016; Castelló, Adela/C-3829-2014; Martin, Miguel/V-6589-2019; Martin, Miguel/AAJ-9242-2020; Anton, Antonio/AAP-6563-2020; Brunet, Joan/C-5292-2018	Perez-Gomez, Beatriz/0000-0002-4299-8214; Chacon, Jose-Ignacio/0000-0002-1286-6157; Pollan, Marina/0000-0002-4328-1565; Muñoz, Montserrat/0000-0001-7772-1437; vioque, jesus/0000-0002-2284-148X; Lluch, Ana/0000-0003-2766-407X; LOPE, VIRGINIA/0000-0002-6986-4021; Castelló, Adela/0000-0002-1308-9927; Martin, Miguel/0000-0001-9237-3231; Antolin Novoa, Silvia/0000-0002-0110-3349; Adrover, Encarna/0000-0001-8676-8560; Llombart Cussac, Antonio/0000-0003-4515-8293; Brunet, Joan/0000-0003-1945-3512	Fundacion Cientifica Asociacion Espanola Contra el Cancer (AECC) (Scientific Foundation of the Spanish Association Against Cancer); Fundacion Cerveza y Salud (Beer and Health Foundation); Sociedad Espanola de Oncologia Medica (SEOM) (Spanish Society of Medical Oncology); Fondo de Investigacion Sanitaria (FIS) [CD110/00018]; Federacion de Mujeres con Cancer de Mama (FECMA) (Association of Women with Breast Cancer)	Fundacion Cientifica Asociacion Espanola Contra el Cancer (AECC) (Scientific Foundation of the Spanish Association Against Cancer); Fundacion Cerveza y Salud (Beer and Health Foundation); Sociedad Espanola de Oncologia Medica (SEOM) (Spanish Society of Medical Oncology); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Federacion de Mujeres con Cancer de Mama (FECMA) (Association of Women with Breast Cancer)	This study was funded by Fundacion Cientifica Asociacion Espanola Contra el Cancer (AECC) (Scientific Foundation of the Spanish Association Against Cancer), Fundacion Cerveza y Salud 2005 (Beer and Health Foundation 2005), Sociedad Espanola de Oncologia Medica (SEOM) (Spanish Society of Medical Oncology), Fondo de Investigacion Sanitaria (FIS) (Health Research Fund) CD110/00018, Federacion de Mujeres con Cancer de Mama (FECMA) (Association of Women with Breast Cancer). None of the funders intervened in the design, data collection and analysis, decision to publish, or preparation of the manuscript	Alexander DD, 2010, NUTR RES REV, V23, P349, DOI 10.1017/S0954422410000235; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2012, EUCAN ESTIMATED INCI; Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1; Baglietto L, 2011, BRIT J CANCER, V104, P524, DOI 10.1038/sj.bjc.6606044; Boggs DA, 2010, AM J EPIDEMIOL, V172, P1268, DOI 10.1093/aje/kwq293; Brennan SF, 2010, AM J CLIN NUTR, V91, P1294, DOI 10.3945/ajcn.2009.28796; Bristow SM, 2013, BRIT J NUTR, V110, P1384, DOI 10.1017/S0007114513001050; Castello A, 2014, BR J CANC; Catsburg C, 2014, INT J CANC; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Chlebowski RT, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2846; Eccles SA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3493; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Garcia-Arenzana N, 2012, MENOPAUSE, V19, P1121, DOI 10.1097/gme.0b013e3182544925; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Harris HR, 2013, BRIT J CANCER, V109, P257, DOI 10.1038/bjc.2013.269; Hastert TA, 2013, CANCER EPIDEM BIOMAR, V22, P1498, DOI 10.1158/1055-9965.EPI-13-0210; Inumaru LE, 2011, CAD SAUDE PUBLICA, V27, P1259, DOI 10.1590/S0102-311X2011000700002; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Lynch BM, 2011, RECENT RESULTS CANC, V186, P13, DOI 10.1007/978-3-642-04231-7_2; Pollan M, 2009, JNCI-J NATL CANCER I, V101, P1584, DOI 10.1093/jnci/djp358; Romaguera D, 2012, AM J CLIN NUTR, V96, P150, DOI 10.3945/ajcn.111.031674; Romieu I, 2011, SALUD PUBLICA MEXICO, V53, P430; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Stoll F, 2013, GYNECOL OBSTET FERTI, V41, P242, DOI 10.1016/j.gyobfe.2013.02.002; Taylor VH, 2009, BREAST CANCER RES TR, V117, P1, DOI 10.1007/s10549-009-0441-y; Thomson CA, 2014, CANCER PREV RES, V7, P42, DOI 10.1158/1940-6207.CAPR-13-0258; Vioque J, 2007, BRIT J NUTR, V97, P977, DOI 10.1017/S0007114507659017; Vioque J, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-26; WCRF/AICR, 2010, CONT UPD PROJ REP; WCRF/AICR, 2009, FOOD NUTR PHYS ACT G; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1	42	48	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126096	10.1371/journal.pone.0126096	http://dx.doi.org/10.1371/journal.pone.0126096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978407	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100047
J	Ehlken, C; Grundel, B; Michels, D; Junker, B; Stahl, A; Schlunck, G; Hansen, LL; Feltgen, N; Martin, G; Agostini, HT; Pielen, A				Ehlken, Christoph; Grundel, Bastian; Michels, Daniel; Junker, Bernd; Stahl, Andreas; Schlunck, Guenther; Hansen, Lutz L.; Feltgen, Nicolas; Martin, Gottfried; Agostini, Hansjuergen T.; Pielen, Amelie			Increased Expression of Angiogenic and Inflammatory Proteins in the Vitreous of Patients with Ischemic Central Retinal Vein Occlusion	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ETS-1; HEPATOCYTE GROWTH-FACTOR; MACULAR EDEMA; RISK-FACTORS; 10-YEAR INCIDENCE; HYPOXIA; MATRIX-METALLOPROTEINASE-9; METALLOPROTEINASES; ATHEROSCLEROSIS; ASSOCIATIONS	Background Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted retinal blood supply and a high risk of subsequent vision loss due to retinal edema and neovascular disease. This study was designed to assess the concentrations of selected signaling proteins in the vitreous and blood of patients with ischemic CRVO. Methods Vitreous and blood samples were collected from patients undergoing surgery for ischemic CRVO (radial optic neurotomy (RON), n = 13), epiretinal gliosis or macular hole (control group, n = 13). Concentrations of 40 different proteins were determined by an ELISA-type antibody microarray. Results Expression of proteins enriched in the vitreous (CCL2, IGFBP2, MMP10, HGF, TNFRSF11B (OPG)) was localized by immunohistochemistry in eyes of patients with severe ischemic CRVO followed by secondary glaucoma. Vitreal expression levels were higher in CRVO patients than in the control group (CRVO / control; p < 0.05) for ADIPOQ (13.6), ANGPT2 (20.5), CCL2 (MCP1) (3.2), HGF (4.7), IFNG (13.9), IGFBP1 (14.7), IGFBP2 (1.8), IGFBP3 (4.1), IGFBP4 (1.7), IL6 (10.8), LEP (3.4), MMP3 (4.3), MMP9 (3.6), MMP10 (5.4), PPBP (CXCL7 or NAP2) (11.8), TIMP4 (3.8), and VEGFA (85.3). In CRVO patients, vitreal levels of CCL2 (4.2), HGF (23.3), IGFBP2 (1.23), MMP10 (2.47), TNFRSF11B (2.96), and VEGFA (29.2) were higher than the blood levels (vitreous /blood, p < 0.05). Expression of CCL2, IGFBP2, MMP10, HGF, and TNFRSF11B was preferentially localized to the retina and the retinal pigment epithelium (RPE). Conclusion Proteins related to hypoxia, angiogenesis, and inflammation were significantly elevated in the vitreous of CRVO patients. Moreover, some markers known to indicate atherosclerosis may be related to a basic vascular disease underlying RVO. This would imply that local therapeutic targeting might not be sufficient for a long term therapy in a systemic disease but hypothetically reduce local changes as an initial therapeutic approach.	[Ehlken, Christoph; Grundel, Bastian; Michels, Daniel; Junker, Bernd; Stahl, Andreas; Schlunck, Guenther; Hansen, Lutz L.; Martin, Gottfried; Agostini, Hansjuergen T.; Pielen, Amelie] Univ Klinikum Freiburg, Klin Augenheilkunde, Freiburg, Germany; [Junker, Bernd; Pielen, Amelie] Hosp Eye, Hannover Med Sch, Hannover, Germany; [Feltgen, Nicolas] Univ Klinikum Gottingen, Augenklin, Gottingen, Germany	University of Freiburg; Hannover Medical School; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ehlken, C (corresponding author), Univ Klinikum Freiburg, Klin Augenheilkunde, Freiburg, Germany.	christoph.ehlken@uniklinik-freiburg.de		Pielen, Amelie/0000-0001-9401-2501	Novartis Pharma AG; Deutsche Forschungsgemeinschaft [DFG STA 1102/5-1]; Deutsche Ophthalmologische Gesellschaft	Novartis Pharma AG; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Ophthalmologische Gesellschaft	CE is supported by research grants from Novartis Pharma AG (http://www.novartis.de/); AS is supported by research grants from Deutsche Forschungsgemeinschaft (DFG STA 1102/5-1, http://dfg.de/), Deutsche Ophthalmologische Gesellschaft (http://www.dog.org/), Novartis Pharma AG; HTA is an adviser for Bayer (http://www.bayer.de/), Novartis, Allergan (http://www.allergan.de/), Zeiss (http://www.zeiss.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augoulea A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/182060; Balasubramani A, 2010, IMMUNOL REV, V238, P216, DOI 10.1111/j.1600-065X.2010.00961.x; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt E, 2000, J LEUKOCYTE BIOL, V67, P471, DOI 10.1002/jlb.67.4.471; Brown DM, 2013, AM J OPHTHALMOL, V155, P429, DOI 10.1016/j.ajo.2012.09.026; Campochiaro PA, 2011, OPHTHALMOLOGY, V118, P2041, DOI 10.1016/j.ophtha.2011.02.038; Canton A, 2000, BRIT J OPHTHALMOL, V84, P732, DOI 10.1136/bjo.84.7.732; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Ehlken C, 2011, AM J OPHTHALMOL, V152, P298, DOI 10.1016/j.ajo.2011.01.040; Elias GJ, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/164134; Epstein DL, 2012, OPHTHALMOLOGY, V119, P2587, DOI 10.1016/j.ophtha.2012.06.037; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Ha CH, 2008, ARTERIOSCL THROM VAS, V28, P1782, DOI 10.1161/ATVBAHA.108.172528; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Hasselbach HC, 2007, GRAEF ARCH CLIN EXP, V245, P1145, DOI 10.1007/s00417-006-0501-5; Hayreh SS, 2014, PROG RETIN EYE RES, V41, P1, DOI 10.1016/j.preteyeres.2014.04.001; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Kinnunen K, 2009, BRIT J OPHTHALMOL, V93, P1109, DOI 10.1136/bjo.2008.148841; Koss MJ, 2013, OPEN OPHTHALMOL J, V7, P11, DOI 10.2174/1874364101307010011; Koss MJ, 2012, ACTA OPHTHALMOL, V90, pe98, DOI 10.1111/j.1755-3768.2011.02292.x; Kruidenier L, 2006, GASTROENTEROLOGY, V130, P127, DOI 10.1053/j.gastro.2005.09.032; Mitchell P, 1996, ARCH OPHTHALMOL-CHIC, V114, P1243, DOI 10.1001/archopht.1996.01100140443012; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12; Natarajan R, 2008, J CARDIOVASC PHARM, V51, P178, DOI 10.1097/FJC.0b013e31815f248d; Noma H, 2014, RETINA-J RET VIT DIS, V34, P352, DOI 10.1097/IAE.0b013e3182993d74; Noma H, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-38; Noma H, 2010, EUR J OPHTHALMOL, V20, P402, DOI 10.1177/112067211002000222; Oikawa M, 2001, BIOCHEM BIOPH RES CO, V289, P39, DOI 10.1006/bbrc.2001.5927; Orbe J, 2011, CIRCULATION, V124, P2909, DOI 10.1161/CIRCULATIONAHA.111.047100; Orbe J, 2009, ARTERIOSCL THROM VAS, V29, P2109, DOI 10.1161/ATVBAHA.109.194589; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Pielen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078538; Prisco Domenico, 2002, Eur J Intern Med, V13, P163, DOI 10.1016/S0953-6205(02)00025-0; Radomski A, 2002, BRIT J PHARMACOL, V137, P1330, DOI 10.1038/sj.bjp.0704936; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Santos-Martinez MJ, 2008, THROMB RES, V121, P535, DOI 10.1016/j.thromres.2007.06.002; Sato Y, 2001, ANN NY ACAD SCI, V947, P117; Seitz R., 1962, NETZHAUTGEFASSE VERG; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Sodi A, 2011, RETINA-J RET VIT DIS, V31, P724, DOI 10.1097/IAE.0b013e3181eef419; Stem MS, 2013, OPHTHALMOLOGY, V120, P362, DOI 10.1016/j.ophtha.2012.07.080; Sun W, 1999, BRAIN RES, V851, P46, DOI 10.1016/S0006-8993(99)02097-1; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Tan CH, 2014, ATHEROSCLEROSIS, V232, P199, DOI 10.1016/j.atherosclerosis.2013.11.040; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158; Zhou JQ, 2013, OPHTHALMOLOGY, V120, P803, DOI 10.1016/j.ophtha.2012.09.033	56	35	39	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126859	10.1371/journal.pone.0126859	http://dx.doi.org/10.1371/journal.pone.0126859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978399	Green Published, gold			2022-12-27	WOS:000354916100109
J	Ha, LX; Shi, YH; Zhao, JL; Li, T; Chen, ZJ				Ha, Lingxia; Shi, Yuhua; Zhao, Junli; Li, Tao; Chen, Zi-Jiang			Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women	PLOS ONE			English	Article							CHROMOSOME 2P16.3; FOLLICULAR DEVELOPMENT; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; RECEPTOR; PCOS; HAN; VARIANTS; GENETICS; DENND1A	Introduction Polycystic ovary syndrome (PCOS) is one of the most common endocrine-metabolic disorders. Evidence of familial aggregation analysis and different clinical traits among different regions and ethnicities indicated that the pathogenesis of PCOS is associated with multiple genetic and environmental factors. Our previous research had identified three susceptibility loci (rs2479106, DENND1A; rs13405728, LHCGR; rs13429458, THADA) for PCOS in Han Chinese women. The overall aim of this study was to investigate the relationship between three susceptibility gene polymorphisms and PCOS in Hui ethnic women. Methods 151 patients with PCOS (case group) and 99 healthy women (control group) were recruited from the Reproductive Medicine Center of the General Hospital of Ningxia Medical University. Clinical data and serum hormone characteristics of case and control groups were collected and analyzed. The three susceptibility single-nucleotide polymorphisms have been replicated in both case and control groups. Gene polymorphisms were detected by direct sequencing after polymerase chain reaction. Results The Body Mass Index, LH, LH/FSH ratio and total testosterone were significantly elevated in PCOS patients compared to control group (P<0.05). The frequencies of genotype and allele in rs13405728 were significantly different between the PCOS and the control groups (P<0.05). Of the SNP rs13405728, the PCOS cases with TT genotype stayed at a higher level of total testosterone, TG and LDL than those with the CC and CT genotypes. In contrary, there was no statistical difference between the two groups for SNP rs13429458 and rs2479106 (P>0.05). Conclusion The present study suggested that the SNP rs13405728 in the LHCGR gene was associated with PCOS in Hui ethnic women, and its TT genotype characterized with higher level of TT, TG and LDL.	[Ha, Lingxia; Shi, Yuhua; Zhao, Junli; Li, Tao; Chen, Zi-Jiang] Shandong Univ, Ctr Reprod Med,Minist Educ,Key Lab Reprod Endocri, Prov Hosp,Reprod Med Hosp,Shandong Prov Key Lab R, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250021, Peoples R China; [Ha, Lingxia; Zhao, Junli] Ningxia Med Univ, Ctr Reprod Med, Gen Hosp, Yinchuan 75004, Peoples R China; [Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai 200000, Peoples R China	Shandong University; Ningxia Medical University; Shanghai Jiao Tong University	Chen, ZJ (corresponding author), Shandong Univ, Ctr Reprod Med,Minist Educ,Key Lab Reprod Endocri, Prov Hosp,Reprod Med Hosp,Shandong Prov Key Lab R, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250021, Peoples R China.	chenzijiang@hotmail.com	Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022; Yan, Junhao/AAH-8310-2019	Chen, Zi-Jiang/0000-0001-6637-6631	National Basic Research Program of China (973 Program) [2011CB944502]; National Key Technology R&D Program in the 12th Five year Plan of China [2012BAI32B04]; National Natural Science Foundation of China [81070461]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Technology R&D Program in the 12th Five year Plan of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program) (2011CB944502) http://www.973.gov.cn/AreaAppl.aspx, National Key Technology R&D Program in the 12th Five year Plan of China (2012BAI32B04) http://www.973.gov.cn/AreaAppl.aspx, National Natural Science Foundation of China (81070461) http://www.nsfc.gov.cn/.	Baldani DP, 2013, COLLEGIUM ANTROPOL, V37, P465; Bassiouny YA, 2014, GYNECOL ENDOCRINOL, V30, P428, DOI 10.3109/09513590.2014.895982; Castelo-Branco C, 2010, GYNECOL ENDOCRINOL, V26, P736, DOI 10.3109/09513590.2010.481025; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen Rui-min, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P631, DOI 10.3760/cma.j.issn.1003-9406.2012.06.002; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Comim FV, 2013, HUM REPROD, V28, P3086, DOI 10.1093/humrep/det352; Cui LL, 2013, HUM REPROD, V28, P538, DOI 10.1093/humrep/des424; David A, 2005, N ENGL MED, V352, P1223; El-Mazny A, 2010, INT J GYNECOL OBSTET, V109, P239, DOI 10.1016/j.ijgo.2010.01.014; Eriksen MB, 2012, EUR J OBSTET GYN R B, V163, P39, DOI 10.1016/j.ejogrb.2012.03.020; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; Glintborg D, 2010, GYNECOL ENDOCRINOL, V26, P281, DOI 10.3109/09513590903247873; Goodarzi MO, 2006, BEST PRACT RES CL EN, V20, P193, DOI 10.1016/j.beem.2006.02.005; Goodarzi MO, 2012, J MED GENET, V49, P90, DOI 10.1136/jmedgenet-2011-100427; Holte J, 1996, HUM REPROD, V11, P23; Housman E, 2014, J AM ACAD DERMATOL, V71, P847, DOI 10.1016/j.jaad.2014.05.007; Ip S, 2009, ANN INTERN MED, V150, P474, DOI 10.7326/0003-4819-150-7-200904070-00007; Kalra P, 2009, FERTIL STERIL, V91, P1437, DOI 10.1016/j.fertnstert.2008.06.037; Kauffman RP, 2006, FERTIL STERIL, V85, P1010, DOI 10.1016/j.fertnstert.2005.09.046; Kelly CJG, 2002, J CLIN ENDOCR METAB, V87, P742, DOI 10.1210/jc.87.2.742; Kim JY, 2013, ENDOCRINOLOGY, V154, P2912, DOI 10.1210/en.2013-1001; Lerchbaum E, 2011, HORM METAB RES, V43, P743, DOI 10.1055/s-0031-1286279; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menke MN, 2007, CLIN OBSTET GYNECOL, V50, P188, DOI 10.1097/GRF.0b013e3180305f7c; Mutharasan P, 2013, J CLIN ENDOCR METAB, V98, pE185, DOI 10.1210/jc.2012-2471; Paradisi G, 2001, CIRCULATION, V103, P1410, DOI 10.1161/01.CIR.103.10.1410; Scicchitano P, 2012, INT J ENDOCRINOL MET, V10, DOI 10.5812/ijem.4020; Sen A, 2014, P NATL ACAD SCI USA, V111, P3008, DOI 10.1073/pnas.1318978111; Welt CK, 2012, J CLIN ENDOCR METAB, V97, pE1342, DOI 10.1210/jc.2011-3478; WILD RA, 1995, AM J MED, V98, pS27, DOI 10.1016/S0002-9343(99)80056-4; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Williamson K, 2001, AUST NZ J OBSTET GYN, V41, P202, DOI 10.1111/j.1479-828X.2001.tb01210.x; Wu XJ, 2013, GENET TEST MOL BIOMA, V17, P104, DOI 10.1089/gtmb.2012.0256; Xita N, 2006, J CLIN ENDOCR METAB, V91, P1660, DOI 10.1210/jc.2005-2757; Xu J, 2012, INT J IMMUNOGENET, V39, P409, DOI 10.1111/j.1744-313X.2012.01103.x; Zhang Chuan, 2013, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V30, P365, DOI 10.3760/cma.j.issn.1003-9406.2013.03.025	37	34	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126505	10.1371/journal.pone.0126505	http://dx.doi.org/10.1371/journal.pone.0126505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978310	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100076
J	Hamilton, A; Basic, V; Andersson, S; Abrink, M; Ringvall, M				Hamilton, Andrew; Basic, Vladimir; Andersson, Sandra; Abrink, Magnus; Ringvall, Maria			Loss of Serglycin Promotes Primary Tumor Growth and Vessel Functionality in the RIP1-Tag2 Mouse Model for Spontaneous Insulinoma Formation	PLOS ONE			English	Article							SECRETORY GRANULE; PROTEOGLYCAN; ANGIOGENESIS; MACROPHAGES; CANCER; CELLS; LOCALIZATION; MATURATION; INFECTION; RELEASE	The serglycin proteoglycan is mainly expressed by hematopoietic cells where the major function is to retain the content of storage granules and vesicles. In recent years, expression of serglycin has also been found in different forms of human malignancies and a high serglycin expression level has been correlated with a more migratory and invasive phenotype in the case of breast cancer and nasopharyngeal carcinoma. Serglycin has also been implicated in the development of the tumor vasculature in multiple myeloma and hepatocellular carcinoma where reduced expression of serglycin was correlated with a less extensive vasculature. To further investigate the contribution of serglycin to tumor development, we have used the immunocompetent RIP1-Tag2 mouse model of spontaneous insulinoma formation crossed into serglycin deficient mice. For the first time we show that serglycin-deficiency affects orthotopic primary tumor growth and tumor vascular functionality of late stage carcinomas. RIP1-Tag2 mice that lack serglycin develop larger tumors with a higher proliferative activity but unaltered apoptosis compared to normal RIP1-Tag2 mice. The absence of serglycin also enhances the tumor vessel functionality, which is better perfused than in tumors from serglycin wild type mice. The presence of the pro-angiogenic modulators vascular endothelial growth factor and hepatocyte growth factor were decreased in the serglycin deficient mice which suggests a less pro-angiogenic environment in the tumors of these animals. Taken together, we conclude that serglycin affects multiple aspects of spontaneous tumor formation, which strengthens the theory that serglycin acts as an important mediator in the formation and progression of tumors.	[Hamilton, Andrew; Basic, Vladimir; Andersson, Sandra; Ringvall, Maria] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Abrink, Magnus] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Ringvall, M (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	maria.ringvall@imbim.uu.se	Åbrink, Magnus/AAK-8346-2020	Abrink, Magnus/0000-0002-1335-3927	Swedish Cancer Society [120507]; Swedish Research Council [90252201]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding provided Swedish Cancer Society; Grant no. 120507; MR; http://www.cancerfonden.se/; the Swedish Research Council; Grant no. 90252201; MR; http://www.vr.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; ANGERTH T, 1990, GENE, V93, P235, DOI 10.1016/0378-1119(90)90230-O; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; D'Angelo F, 2013, CLIN EXP IMMUNOL, V174, P60, DOI 10.1111/cei.12157; Fagiani E, 2011, CANCER RES, V71, P5717, DOI 10.1158/0008-5472.CAN-10-4635; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Grujic M, 2008, J IMMUNOL, V181, P1043, DOI 10.4049/jimmunol.181.2.1043; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; He L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0707-4; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Korpetinou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078157; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; McCourt M, 2001, EUR J SURG ONCOL, V27, P396, DOI 10.1053/ejso.2001.1133; McCourt M, 1999, ARCH SURG-CHICAGO, V134, P1325, DOI 10.1001/archsurg.134.12.1325; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Niemann CU, 2009, EUR J CELL BIOL, V88, P473, DOI 10.1016/j.ejcb.2009.03.002; Purushothaman A, 2014, J BIOL CHEM, V289, P5499, DOI 10.1074/jbc.M113.532143; Sawesi O, 2010, J BIOL CHEM, V285, P38005, DOI 10.1074/jbc.M110.118471; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Workman P, 1998, BRIT J CANCER, V77, P1; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200	25	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126688	10.1371/journal.pone.0126688	http://dx.doi.org/10.1371/journal.pone.0126688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978773	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100090
J	Kang, K; Ryoo, HD; Park, JE; Yoon, JH; Kang, MJ				Kang, Kwonyoon; Ryoo, Hyung Don; Park, Jung-Eun; Yoon, Jee-Hyun; Kang, Min-Ji			A Drosophila Reporter for the Translational Activation of ATF4 Marks Stressed Cells during Development	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ER-STRESS; MAMMALIAN-CELLS; GENE-EXPRESSION; MODEL; DIFFERENTIATION; DEGENERATION; MELANOGASTER; REVEALS	Eukaryotic cells have evolved signaling pathways that help to restore cellular homeostasis in response to various physiological or pathological conditions. ATF4 is a transcription factor whose mRNA translation is stimulated in response to stress-activated eIF2alpha kinases. Established conditions that activate eIF2alpha phosphorylation and ATF4 translation include excessive stress in the endoplasmic reticulum (ER) and amino acid deprivation. ATF4 is activated through a unique translational activation mechanism that involves multiple upstream open reading frames (uORFs) in the 5'-untranslated region (UTR), which is conserved from yeast to mammals. Taking advantage of this, we developed a translational activation reporter of ATF4 in Drosophila, in which the dsRed reporter coding sequence was placed downstream of the Drosophila ATF4 5' UTR. This reporter remained inactive in most tissues under normal conditions, but showed dsRed expression when starved, or when challenged with conditions that imposed ER stress. In normally developing flies, a small number of cell types showed reporter expression even without exogenous stress, which included the salivary gland, gut, the male reproductive organ, and the photoreceptor cells, suggestive of inherent stress during the normal development of these cell types. These results establish a new tool to study ATF4-mediated stress response in Drosophila development and disease.	[Kang, Kwonyoon; Park, Jung-Eun; Yoon, Jee-Hyun; Kang, Min-Ji] Univ Ulsan, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Ryoo, Hyung Don] NYU, Sch Med, Dept Cell Biol, New York, NY USA	University of Ulsan; New York University	Kang, MJ (corresponding author), Univ Ulsan, Coll Med, Dept Biomed Sci, Seoul, South Korea.	mjkang@amc.seoul.kr			Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI13C1821]; National Research Foundation of Korea [NRF-2013R1A1A1009437]; Asan Institute for Life Sciences [2014-577]; National Institutes of Health [R01 EY020866]; NATIONAL EYE INSTITUTE [R01EY020866] Funding Source: NIH RePORTER	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea); Asan Institute for Life Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (https://www.htdream.kr, HI13C1821), the National Research Foundation of Korea (https://www.nrf.re.kr, NRF-2013R1A1A1009437), the Asan Institute for Life Sciences (2014-577) to M.J.K. and the National Institutes of Health (http://www.nih.gov) grant R01 EY020866 to H.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; BRAND AH, 1993, DEVELOPMENT, V118, P401; CLEMENS MJ, 1996, COLD SPRING HARBOR M, V30, P139; Coelho DS, 2013, CELL REP, V5, P791, DOI 10.1016/j.celrep.2013.09.046; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Fischer C, 2004, BIOL REPROD, V70, P371, DOI 10.1095/biolreprod.103.021600; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hewes RS, 2000, GENETICS, V155, P1711; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Kang MJ, 2012, NAT CELL BIOL, V14, P409, DOI 10.1038/ncb2447; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Muir T, 2008, MOL REPROD DEV, V75, P1637, DOI 10.1002/mrd.20902; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Ryoo HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075774; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Sone M, 2013, CELL STRESS CHAPERON, V18, P307, DOI 10.1007/s12192-012-0383-x; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Thomas SE, 2010, DIABETES-METAB RES, V26, P611, DOI 10.1002/dmrr.1132; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang LF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004568; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996	36	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126795	10.1371/journal.pone.0126795	http://dx.doi.org/10.1371/journal.pone.0126795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978358	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100101
J	Krishnasamy, R; Isbel, NM; Hawley, CM; Pascoe, EM; Burrage, M; Leano, R; Haluska, BA; Marwick, TH; Stanton, T				Krishnasamy, Rathika; Isbel, Nicole M.; Hawley, Carmel M.; Pascoe, Elaine M.; Burrage, Matthew; Leano, Rodel; Haluska, Brian A.; Marwick, Thomas H.; Stanton, Tony			Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SPECKLE-TRACKING ECHOCARDIOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; CHRONIC HEART-FAILURE; 2-DIMENSIONAL STRAIN; ATRIAL-FIBRILLATION; DIASTOLIC FUNCTION; EUROPEAN-SOCIETY; ASSOCIATION; ABNORMALITIES	Background Echocardiographic global longitudinal strain (GLS) is increasingly recognised as a more effective technique than conventional ejection fraction (EF) in detecting subtle changes in left ventricular (LV) function. This study investigated the prognostic value of GLS over EF in patients with advanced Chronic Kidney Disease (CKD). Methods The study included 183 patients (57% male, 63% on dialysis) with CKD stage 4, 5 and 5Di-alysis (D). 112 (61%) of patients died in a follow up of 7.8 +/- 4.4 years and 41% of deaths were due to cardiovascular (CV) disease. GLS was calculated using 2-dimensional speckle tracking and EF was measured using Simpson's biplane method. Cox proportional hazard models were used to assess the association of measures of LV function and all-cause and CV mortality. Results The mean GLS at baseline was -13.6 +/- 4.3% and EF was 45 +/- 11%. GLS was a significant predictor of all-cause [ Hazard Ratio (HR) 1.09 95%; Confidence Interval (CI) 1.02-1.16; p = 0.01] and CV mortality (HR 1.16 95%; CI 1.04-1.30; p = 0.008) following adjustment for relevant clinical variables including LV mass index (LVMI) and EF. GLS also had greater predictive power for both all-cause and CV mortality compared to EF. Impaired GLS (>-16%) was associated with a 5.6-fold increased unadjusted risk of CV mortality in patients with preserved EF. Conclusions In this cohort of patients with advanced CKD, GLS is a more sensitive predictor of overall and CV mortality compared to EF. Studies of larger populations in CKD are required to confirm that GLS provides additive prognostic value in patients with preserved EF.	[Krishnasamy, Rathika; Isbel, Nicole M.; Hawley, Carmel M.] Univ Queensland, Princess Alexandra Hosp, Dept Renal Med, Brisbane, Qld, Australia; [Krishnasamy, Rathika; Isbel, Nicole M.; Hawley, Carmel M.; Pascoe, Elaine M.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Burrage, Matthew; Leano, Rodel; Haluska, Brian A.; Stanton, Tony] Univ Queensland, Princess Alexandra Hosp, Cardiovasc Imaging Res Ctr, Brisbane, Qld, Australia; [Marwick, Thomas H.] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	University of Queensland; University of Queensland; University of Queensland; University of Tasmania; Menzies Institute for Medical Research	Krishnasamy, R (corresponding author), Univ Queensland, Princess Alexandra Hosp, Dept Renal Med, Brisbane, Qld, Australia.	Rathika.Krishnasamy@health.qld.gov.au	Hawley, Carmel Mary/C-4905-2011; Isbel, Nicole M/G-5604-2011; Marwick, Thomas/AAK-3869-2021	Hawley, Carmel Mary/0000-0002-1392-5649; Marwick, Thomas/0000-0001-9065-0899; Burrage, Matthew K./0000-0003-3837-8140; Krishnasamy, Rathika/0000-0001-6974-7880	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding: This study was supported in part by a grant from the National Health and Medical Research Council of Australia. There are no additional funding sources for this study.	Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; [Anonymous], 2010, STATA J, V10, P339; Bartko PE, 2013, CIRC-CARDIOVASC IMAG, V6, P268, DOI 10.1161/CIRCIMAGING.112.980201; Belghiti H, 2008, ARCH CARDIOVASC DIS, V101, P163, DOI 10.1016/S1875-2136(08)71798-4; Bongartz LG, 2012, AM J PHYSIOL-RENAL, V303, pF1253, DOI 10.1152/ajprenal.00392.2012; Buckberg G, 2008, CIRCULATION, V118, P2571, DOI 10.1161/CIRCULATIONAHA.107.754424; Burns AT, 2010, EUR J ECHOCARDIOGR, V11, P283, DOI 10.1093/ejechocard/jep214; Bussadori C, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-8; CARABELLO BA, 1984, CIRCULATION, V69, P1058, DOI 10.1161/01.CIR.69.5.1058; Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004; Cho GY, 2009, J AM COLL CARDIOL, V54, P618, DOI 10.1016/j.jacc.2009.04.061; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; Edwards NC, 2008, J AM SOC ECHOCARDIOG, V21, P1293, DOI 10.1016/j.echo.2008.09.013; Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061; Ersboll M, 2012, J AM SOC ECHOCARDIOG, V25, P1280, DOI 10.1016/j.echo.2012.09.006; Farshid A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-280; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Hayashi SY, 2006, NEPHROL DIAL TRANSPL, V21, P125, DOI 10.1093/ndt/gfi075; Isbel NM, 2006, AM HEART J, V151, P745, DOI 10.1016/j.ahj.2005.06.017; Jenkins C, 2007, AM J CARDIOL, V99, P300, DOI 10.1016/j.amjcard.2006.08.026; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Kramann R, 2014, J AM SOC NEPHROL, V25, P2351, DOI 10.1681/ASN.2013070734; Krishnasamy R, 2014, NEPHROL DIAL TRANSPL, V29, P1218, DOI 10.1093/ndt/gfu004; Kusunose K, 2012, J AM SOC ECHOCARDIOG, V25, P953, DOI 10.1016/j.echo.2012.06.009; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu YW, 2013, CLIN J AM SOC NEPHRO, V8, P1564, DOI 10.2215/CJN.10671012; London GM, 2003, SEMIN DIALYSIS, V16, P85, DOI 10.1046/j.1525-139X.2003.16023.x; Marwick TH, 2009, JACC-CARDIOVASC IMAG, V2, P80, DOI 10.1016/j.jcmg.2007.12.007; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Otsuka T, 2009, J CARDIOL, V54, P199, DOI 10.1016/j.jjcc.2009.05.002; Otterstad JE, 1997, EUR HEART J, V18, P507; Park M, 2012, J AM SOC NEPHROL, V23, P1725, DOI 10.1681/ASN.2012020145; Park TH, 2006, AM J PHYSIOL-HEART C, V290, pH724, DOI 10.1152/ajpheart.00714.2005; Payne J, 2012, NEPHROL DIAL TRANSPL, V27, P694, DOI 10.1093/ndt/gfr282; Saito M, 2012, EUR HEART J-CARD IMG, V13, P617, DOI 10.1093/ejechocard/jer318; Solomon SD, 2004, CIRCULATION, V110, P2180, DOI 10.1161/01.CIR.0000144474.65922.AA; Stallworthy EJ, 2013, TRANSPLANTATION, V95, P1225, DOI 10.1097/TP.0b013e31828dbbbe; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Su HM, 2013, HEART, V99, P1588, DOI 10.1136/heartjnl-2013-304561; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Ternacle J, 2013, EUR HEART J-CARD IMG, V14, P77, DOI 10.1093/ehjci/jes156; Wang AYM, 2010, HYPERTENSION, V56, P210, DOI 10.1161/HYPERTENSIONAHA.110.151167; Wang J, 2008, EUR HEART J, V29, P1283, DOI 10.1093/eurheartj/ehn141; WILSON JR, 1980, AM J MED, V68, P664, DOI 10.1016/0002-9343(80)90252-1; Wu BT, 2012, ACTA CARDIOL SIN, V28, P25; Yamada S, 2010, CLIN J AM SOC NEPHRO, V5, P1793, DOI 10.2215/CJN.00050110; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Zile MR, 2010, CIRCULATION, V121, P1393, DOI 10.1161/CIRCULATIONAHA.109.909614	50	80	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127044	10.1371/journal.pone.0127044	http://dx.doi.org/10.1371/journal.pone.0127044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978372	Green Published, gold			2022-12-27	WOS:000354916100125
J	Nystrom, PK; Carlsson, AC; Leander, K; de Faire, U; Hellenius, ML; Gigante, B				Nystrom, Petter K.; Carlsson, Axel C.; Leander, Karin; de Faire, Ulf; Hellenius, Mai-Lis; Gigante, Bruna			Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study	PLOS ONE			English	Article							SAGITTAL ABDOMINAL DIAMETER; HIGH CARDIOVASCULAR RISK; BODY-MASS INDEX; ADIPOSE-TISSUE; IMPACT; PREVALENCE; ASSOCIATION; HEALTHY; HYPERTENSION; PREVENTION	Aim We aimed to investigate whether different measures of obesity could similarly predict atrial fibrillation, and whether the atrial fibrillation risk associated with obesity is dependent on presence of metabolic syndrome. Material and Methods We performed our study in a population-based longitudinal cardiovascular study, comprising 1 924 men and 2 097 women, aged 60 years, from Stockholm. Body mass index, waist circumference, sagittal abdominal diameter and components of metabolic syndrome (systolic- and diastolic blood pressure, fasting glucose, triglycerides, high-density lipoprotein-cholesterol) were recorded at baseline. Participants were classified by their body mass index (normal weight, overweight or obese), waist circumference (normal, semi-elevated or elevated), and according to presence of metabolic syndrome. Atrial fibrillation risk was estimated by Cox proportional hazards regression models, adjusted for common atrial fibrillation risk factors, expressed as HR and 95% CI. Results During a mean follow-up of 13.6 years, 285 incident atrial fibrillation cases were recorded. One standard deviation increment of each obesity measure was associated with increased atrial fibrillation risk as: bodymass index 1.25 (1.12 - 1.40), waist circumference 1.35 (1.19 - 1.54) and sagittal abdominal diameter 1.28 (1.14 - 1.44). Compared to normal weight subjects without metabolic syndrome, increased atrial fibrillation risk was noted for overweight subjects with metabolic syndrome, 1.67 (1.16 - 2.41), obese subjects without metabolic syndrome, 1.75 (1.11 - 2.74) and obese subjects withmetabolic syndrome, 1.92 (1.34 - 2.74). Compared to subjects with normal waist circumference without metabolic syndrome, subjects with elevated waist circumference and metabolic syndrome suffered increased atrial fibrillation risk, 2.03 (1.44 - 2.87). Conclusions Body mass index, waist circumference and sagittal abdominal diameter could similarly predict atrial fibrillation. Obesity was associated with an increased atrial fibrillation risk regardless of metabolic syndrome, whereas overweight and elevated waist circumference was associated with increased atrial fibrillation risk only if metabolic syndrome was present.	[Nystrom, Petter K.; Leander, Karin; de Faire, Ulf; Gigante, Bruna] Karolinska Inst, Inst Environm Med, Cardiovasc Epidemiol Unit, S-10401 Stockholm, Sweden; [Carlsson, Axel C.] Karolinska Inst, Care Sci & Soc, Dept Neurobiol, Ctr Family Med, Huddinge, Sweden; [Carlsson, Axel C.] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [de Faire, Ulf; Hellenius, Mai-Lis] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Gigante, Bruna] Karolinska Inst, Danderyds Hosp, Dept Clin Sci, Div Cardiovasc Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet	Nystrom, PK (corresponding author), Karolinska Inst, Inst Environm Med, Cardiovasc Epidemiol Unit, S-10401 Stockholm, Sweden.	nype90@gmail.com	Leander, Karin/C-7261-2017; Gigante, Bruna/I-9252-2012	Leander, Karin/0000-0002-1404-9222; Gigante, Bruna/0000-0003-4508-7990; Carlsson, Axel C/0000-0001-6113-0472	Hjart-Lung Fonden [20130220]; Karolinska Insitutet [2013Fobi38181]; Stockholms lans landsting [20130053]	Hjart-Lung Fonden; Karolinska Insitutet; Stockholms lans landsting	Funding: This work was supported by Hjart-Lung Fonden (grant n. 20130220 to Udf), URL: https://www3.hjart-lungfonden.se; Karolinska Insitutet (2013Fobi38181 to BG), URL: https://www.ki.se; Stockholms lans landsting (grant n. 20130053 to BG), URL: http://www.forskningsstod.sll.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2013, CAN J CARDIOL, V29, pS4, DOI 10.1016/j.cjca.2013.03.009; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Almgren T, 2007, J HYPERTENS, V25, P1311, DOI 10.1097/HJH.0b013e328122dd58; Alpert MA, 2014, PROG CARDIOVASC DIS, V56, P391, DOI 10.1016/j.pcad.2013.09.003; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Ayer JGJ, 2008, HEART LUNG CIRC, V17, P19, DOI 10.1016/j.hlc.2007.04.006; Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Carlsson AC, 2013, INT J OBESITY, V37, P1579, DOI 10.1038/ijo.2013.46; Carlsson AC, 2009, METAB SYNDR RELAT D, V7, P231, DOI 10.1089/met.2008.0078; Chamberlain AM, 2010, AM HEART J, V159, P850, DOI 10.1016/j.ahj.2010.02.005; Conen D, 2012, CIRCULATION, V126, P2302, DOI 10.1161/CIRCULATIONAHA.112.112300; De Schutter A, 2014, PROG CARDIOVASC DIS, V56, P401, DOI 10.1016/j.pcad.2013.08.003; de Souza NC, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-41; Ekblom-Bak E, 2014, BRIT J SPORT MED, V48, P233, DOI 10.1136/bjsports-2012-092038; Fontes JD, 2012, AM J CARDIOL, V109, P87, DOI 10.1016/j.amjcard.2011.08.008; Forslund T, 2013, INT J CARDIOL, V170, P208, DOI 10.1016/j.ijcard.2013.10.063; Frost L, 2014, OBESITY, V22, P1546, DOI 10.1002/oby.20706; Gigante B, 2012, HEART, V98, P1242, DOI 10.1136/heartjnl-2012-301852; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Go Orson, 2009, Curr Cardiol Rep, V11, P430; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Vasques ACJ, 2013, METABOLISM, V62, P1032, DOI 10.1016/j.metabol.2013.01.022; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; Lavie CJ, 2014, J AM COLL CARDIOL, V63, P1345, DOI 10.1016/j.jacc.2014.01.022; Lavie CJ, 2013, JACC-HEART FAIL, V1, P93, DOI 10.1016/j.jchf.2013.01.006; Lorenzo C, 2006, DIABETES CARE, V29, P625, DOI 10.2337/diacare.29.03.06.dc05-1755; Manolis AJ, 2012, J HYPERTENS, V30, P239, DOI 10.1097/HJH.0b013e32834f03bf; McAuley PA, 2014, PROG CARDIOVASC DIS, V56, P434, DOI 10.1016/j.pcad.2013.09.006; Menezes AR, 2013, REV CARDIOVASC MED, V14, pE73, DOI 10.3909/ricm0693; Menezes AR, 2013, MAYO CLIN PROC, V88, P394, DOI 10.1016/j.mayocp.2013.01.022; Morkedal B, 2014, J AM COLL CARDIOL, V63, P1071, DOI 10.1016/j.jacc.2013.11.035; Nordhamn K, 2000, INT J OBESITY, V24, P652, DOI 10.1038/sj.ijo.0801216; Ostgren CJ, 2004, DIABETES OBES METAB, V6, P367, DOI 10.1111/j.1462-8902.2004.00358.x; Riserus U, 2010, J OBES, V2010, DOI 10.1155/2010/757939; Rosengren A, 2009, EUR HEART J, V30, P1113, DOI 10.1093/eurheartj/ehp076; Sampaio LR, 2007, ARQ BRAS ENDOCRINOL, V51, P980, DOI 10.1590/S0004-27302007000600013; Tanner RM, 2011, AM J CARDIOL, V108, P227, DOI 10.1016/j.amjcard.2011.03.026; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Tsai CT, 2014, HEART RHYTHM, V11, P352, DOI 10.1016/j.hrthm.2013.11.014; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Verdecchia P, 2012, J HYPERTENS, V30, P1004, DOI 10.1097/HJH.0b013e3283522a51; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wanahita N, 2008, AM HEART J, V155, P310, DOI 10.1016/j.ahj.2007.10.004; Wandell PE, 2009, INT J OBESITY, V33, P577, DOI 10.1038/ijo.2009.36; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Watanabe H, 2008, CIRCULATION, V117, P1255, DOI 10.1161/CIRCULATIONAHA.107.744466; Watanabe H, 2011, CIRC J, V75, P2767, DOI 10.1253/circj.CJ-11-0780	55	45	47	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127111	10.1371/journal.pone.0127111	http://dx.doi.org/10.1371/journal.pone.0127111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978738	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100129
J	Wang, JP; Wang, SQ; Liu, XF; Xu, B; Chai, RY; Zhou, P; Ju, C; Sun, J; Brindley, PJ; Hu, W				Wang, Jipeng; Wang, Shuqi; Liu, Xiufeng; Xu, Bin; Chai, Riyi; Zhou, Pan; Ju, Chuan; Sun, Jun; Brindley, Paul J.; Hu, Wei			Intake of Erythrocytes Required for Reproductive Development of Female Schistosoma japonicum	PLOS ONE			English	Article							RNA INTERFERENCE; MANSONI INVITRO; CULTIVATION; HEMOGLOBIN; CERCARIAE; CELL; MORPHOLOGY; CULTURES; ADULTS	The reproductive development and maturation of female schistosomes are crucial since their released eggs are responsible for the host immunopathology and transmission of schistosomiasis. However, little is known about the nutrients required by female Schistosoma japonicum during its sexual maturation. We evaluated the promoting effect of several nutrients (calf serum, red blood cells (RBCs), ATP and hypoxanthine) on the reproductive development of pre-adult females at 18 days post infection (dpi) from mixed infections and at 50 dpi from unisexual infections of laboratory mice in basic medium RPMI-1640. We found RBCs, rather than other nutrients, promoted the female sexual maturation and egg production with significant morphological changes. In 27% of females (18 dpi) from mixed infections that paired with males in vitro on day 14, vitelline glands could be positively stained by Fast Blue B; and in 35% of females (50 dpi) from unisexual infections on day 21, mature vitelline cells were observed. Infertile eggs were detected among both groups. To analyze which component of mouse RBCs possesses the stimulating effect, RBCs were fractionated and included in media. However, the RBC fractions failed to stimulate development of the female reproductive organs. In addition, bovine hemoglobin hydrolysate, digested by neutral protease, was found to exhibit the promoting activity instead of untreated bovine hemoglobin. The other protein hydrolysate, lactalbumin hydrolysate, exhibited a similar effect with bovine hemoglobin hydrolysate. Using quantitative RT-PCR, we found the expression levels of four reproduction-related genes were significantly stimulated by RBCs. These data indicate that RBCs provide essential nutrients for the sexualmaturation of female S. japonicumand that the protein component of RBCs appeared to constitute the key nutrient. These findings would improve laboratory culture of pre-adult schistosomes to adult worms inmedium with well-defined components, which is important to investigate the function of genes related to female sexual maturation.	[Wang, Jipeng; Wang, Shuqi; Liu, Xiufeng; Chai, Riyi; Zhou, Pan; Hu, Wei] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China; [Xu, Bin; Ju, Chuan; Hu, Wei] Chinese Ctr Dis Control & Prevent, Inst Parasit Dis, Key Lab Parasite & Vector Biol, Minist Publ Hlth, Shanghai, Peoples R China; [Sun, Jun] Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China; [Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Res Ctr Neglected Dis Poverty, Washington, DC USA	Fudan University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; Tongji University; George Washington University; George Washington University	Hu, W (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China.	huw@fudan.edu.cn	HU, Wei/F-1004-2012; Wang, Jipeng/AAF-2575-2020	Wang, Jipeng/0000-0003-0107-424X; Wang, Shuqi/0000-0002-4460-7221; Brindley, Paul J./0000-0003-1765-0002	National Natural Science Foundation of China [81271867]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81271867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASCH PF, 1984, AM J TROP MED HYG, V33, P911, DOI 10.4269/ajtmh.1984.33.911; BASCH PF, 1981, J PARASITOL, V67, P186, DOI 10.2307/3280633; BASCH PF, 1981, J PARASITOL, V67, P179, DOI 10.2307/3280632; Beckmann S, 2010, PARASITOLOGY, V137, P497, DOI 10.1017/S0031182010000053; Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; CHEEVER AW, 1958, AM J HYG, V68, P322, DOI 10.1093/oxfordjournals.aje.a119972; CLOUGH ER, 1981, J PARASITOL, V67, P535, DOI 10.2307/3280487; CORNFORD EM, 1981, J PARASITOL, V67, P24, DOI 10.2307/3280772; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; Dalton JP, 2004, CAN J ZOOL, V82, P211, DOI [10.1139/z03-213, 10.1139/Z03-213]; ERASMUS DA, 1975, EXP PARASITOL, V38, P240, DOI 10.1016/0014-4894(75)90027-2; Fitzpatrick JM, 2004, MOL BIOCHEM PARASIT, V136, P191, DOI 10.1016/j.molbiopara.2004.03.014; GUPTA BC, 1987, J PARASITOL, V73, P481, DOI 10.2307/3282125; HASEEB MA, 1984, INT J PARASITOL, V14, P83, DOI 10.1016/0020-7519(84)90016-X; HE YX, 1980, ACTA ZOOL SINICA, V26, P32; Hoffmann KF, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-8-research0041; Holtfreter MC, 2010, PARASITOLOGY, V137, P1645, DOI 10.1017/S0031182010000405; Hua Xianxin, 1988, Acta Zoologica Sinica, V34, P297; JOHRI LN, 1956, PARASITOLOGY, V46, P107, DOI 10.1017/S003118200002638X; Jones MK, 2007, INT J BIOCHEM CELL B, V39, P1646, DOI 10.1016/j.biocel.2007.04.017; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; LAWRENCE JD, 1973, J PARASITOL, V59, P60, DOI 10.2307/3278572; LILLIE RD, 1961, J HISTOCHEM CYTOCHEM, V9, P11, DOI 10.1177/9.1.11; Liu S, 2012, MOL BIOCHEM PARASIT, V182, P75, DOI 10.1016/j.molbiopara.2011.12.007; LoVerde PT, 2004, CAN J ZOOL, V82, P357, DOI 10.1139/Z03-217; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; MEYER F, 1970, BIOCHIM BIOPHYS ACTA, V210, P257, DOI 10.1016/0005-2760(70)90170-0; Mone H, 2004, ADV PARASIT, V57, P89, DOI 10.1016/S0065-308X(04)57002-1; MOORE DV, 1956, AM J TROP MED HYG, V5, P831, DOI 10.4269/ajtmh.1956.5.831; Morales ME, 2008, MOL BIOCHEM PARASIT, V157, P160, DOI 10.1016/j.molbiopara.2007.10.009; Neves R, 2005, PARASITOL RES, V95, P43, DOI 10.1007/s00436-004-1241-2; POPIEL I, 1986, J CHEM ECOL, V12, P1745, DOI 10.1007/BF01022380; Quack T, 2010, INT J PARASITOL, V40, P991, DOI 10.1016/j.ijpara.2010.04.013; SHAW JR, 1977, EXP PARASITOL, V41, P54, DOI 10.1016/0014-4894(77)90129-1; SHAW JR, 1981, PARASITOLOGY, V82, P121, DOI 10.1017/S0031182000041913; Stefanic S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000850; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; WANG W, 1986, CHINESE MED J-PEKING, V99, P713; WANG W, 1987, ACTA ZOOL SINICA, V33, P144; Xiao SH, 2012, PARASITOL RES, V110, P2403, DOI 10.1007/s00436-011-2779-4; Yin MB, 2008, INT J PARASITOL, V38, P1681, DOI 10.1016/j.ijpara.2008.05.015; YOLLES TK, 1947, J PARASITOL, V33, P419, DOI 10.2307/3273678; Zhang WN, 2012, J HELMINTHOL, V86, P317, DOI 10.1017/S0022149X11000447; ZUSSMAN RA, 1970, J PARASITOL, V56, P75, DOI 10.2307/3277456	47	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126822	10.1371/journal.pone.0126822	http://dx.doi.org/10.1371/journal.pone.0126822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978643	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100104
J	Woods, DS; Sears, CR; Turchi, JJ				Woods, Derek S.; Sears, Catherine R.; Turchi, John J.			Recognition of DNA Termini by the C-Terminal Region of the Ku80 and the DNA-Dependent Protein Kinase Catalytic Subunit	PLOS ONE			English	Article							DAMAGE RESPONSE; STRAND; PK; PHOSPHORYLATION; ACTIVATION; REVEALS; ATM; HETERODIMER; BINDING; BREAKS	DNA double strand breaks (DSBs) can be generated by endogenous cellular processes or exogenous agents in mammalian cells. These breaks are highly variable with respect to DNA sequence and structure and all are recognized in some context by the DNA-dependent protein kinase (DNA-PK). DNA-PK is a critical component necessary for the recognition and repair of DSBs via non-homologous end joining (NHEJ). Previously studies have shown that DNA-PK responds differentially to variations in DSB structure, but how DNA-PK senses differences in DNA substrate sequence and structure is unknown. Here we explore the enzymatic mechanisms by which DNA-PK is activated by various DNA substrates and provide evidence that the DNA-PK is differentially activated by DNA structural variations as a function of the C-terminal region of Ku80. Discrimination based on terminal DNA sequence variations, on the other hand, is independent of the Ku80 C-terminal interactions and likely results exclusively from DNA-dependent protein kinase catalytic subunit interactions with the DNA. We also show that sequence differences in DNA termini can drastically influence DNA repair through altered DNA-PK activation. These results indicate that even subtle differences in DNA substrates influence DNA-PK activation and ultimately the efficiency of DSB repair.	[Woods, Derek S.; Turchi, John J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Sears, Catherine R.; Turchi, John J.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Turchi, JJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	jturchi@iu.edu		Sears, Catherine/0000-0002-5797-3458	NIH [R01CA180710, R01CA082741]; NATIONAL CANCER INSTITUTE [R01CA082741, R01CA180710] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was funded by NIH grant R01CA180710 and R01CA082741. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews BJ, 2006, J BIOL CHEM, V281, P13596, DOI 10.1074/jbc.M512787200; Bennett Sara M, 2012, Int J Biochem Mol Biol, V3, P36; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Drouet J, 2006, J BIOL CHEM, V281, P27784, DOI 10.1074/jbc.M603047200; Earley JN, 2011, ANTIOXID REDOX SIGN, V14, P2465, DOI 10.1089/ars.2010.3369; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Furuta T, 2002, GASTROENTEROLOGY, V122, pA127; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Harris R, 2004, J MOL BIOL, V335, P573, DOI 10.1016/j.jmb.2003.10.047; Hermanson IL, 2000, PROTEIN EXPRES PURIF, V19, P1, DOI 10.1006/prep.2000.1224; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Katsura Y, 2007, DNA REPAIR, V6, P639, DOI 10.1016/j.dnarep.2006.12.002; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; Lehman JA, 2008, BIOCHEMISTRY-US, V47, P4359, DOI 10.1021/bi702284c; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; Ma YM, 2001, BIOCHEMISTRY-US, V40, P9638, DOI 10.1021/bi010932v; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; Pang DL, 1997, CANCER RES, V57, P1412; Pawelczak KS, 2008, NUCLEIC ACIDS RES, V36, P4022, DOI 10.1093/nar/gkn344; Pawelczak KS, 2005, NUCLEIC ACIDS RES, V33, P152, DOI 10.1093/nar/gki157; Reitsema T, 2005, DNA REPAIR, V4, P1172, DOI 10.1016/j.dnarep.2005.06.005; Rivera-Calzada A, 2007, EMBO REP, V8, P56, DOI 10.1038/sj.embor.7400847; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Sears CR, 2012, J BIOL CHEM, V287, P24263, DOI 10.1074/jbc.M112.344911; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Strande N, 2012, J BIOL CHEM, V287, P13686, DOI 10.1074/jbc.M111.329730; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Weterings E, 2009, MOL CELL BIOL, V29, P1134, DOI 10.1128/MCB.00971-08; Willers H, 2006, RADIAT RES, V166, P567, DOI 10.1667/RR0524.1; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Woods D, 2013, CANCER BIOL THER, V14, P379, DOI 10.4161/cbt.23761	35	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127321	10.1371/journal.pone.0127321	http://dx.doi.org/10.1371/journal.pone.0127321			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978375	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100142
J	Ruiz-Benito, P; Madrigal-Gonzalez, J; Young, S; Mercatoris, P; Cavin, L; Huang, TJ; Chen, JC; Jump, AS				Ruiz-Benito, Paloma; Madrigal-Gonzalez, Jaime; Young, Sarah; Mercatoris, Pierre; Cavin, Liam; Huang, Tsurng-Juhn; Chen, Jan-Chang; Jump, Alistair S.			Climatic Stress during Stand Development Alters the Sign and Magnitude of Age-Related Growth Responses in a Subtropical Mountain Pine	PLOS ONE			English	Article							TREE-RING GROWTH; CARBON ACCUMULATION; TROPICAL FORESTS; WOOD PRODUCTION; DECLINE; TEMPERATURE; PRODUCTIVITY; LIMITATION; PHYSIOLOGY; TAIWAN	The modification of typical age-related growth by environmental changes is poorly understood, In part because there is a lack of consensus at individual tree level regarding age-dependent growth responses to climate warming as stands develop. To increase our current understanding about how multiple drivers of environmental change can modify growth responses as trees age we used tree ring data of a mountain subtropical pine species along an altitudinal gradient covering more than 2,200 m of altitude. We applied mixed-linear models to determine how absolute and relative age-dependent growth varies depending on stand development; and to quantify the relative importance of tree age and climate on individual tree growth responses. Tree age was the most important factor for tree growth in models parameterised using data from all forest developmental stages. Contrastingly, the relationship found between tree age and growth became non-significant in models parameterised using data corresponding to mature stages. These results suggest that although absolute tree growth can continuously increase along tree size when trees reach maturity age had no effect on growth. Tree growth was strongly reduced under increased annual temperature, leading to more constant age-related growth responses. Furthermore, young trees were the most sensitive to reductions in relative growth rates, but absolute growth was strongly reduced under increased temperature in old trees. Our results help to reconcile previous contrasting findings of age-related growth responses at the individual tree level, suggesting that the sign and magnitude of age-related growth responses vary with stand development. The different responses found to climate for absolute and relative growth rates suggest that young trees are particularly vulnerable under warming climate, but reduced absolute growth in old trees could alter the species' potential as a carbon sink in the future.	[Ruiz-Benito, Paloma; Mercatoris, Pierre; Cavin, Liam; Jump, Alistair S.] Univ Stirling, Sch Nat Sci, Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Madrigal-Gonzalez, Jaime] Univ Alcala, Dept Life Sci, Forest Ecol & Restorat Grp, Madrid, Spain; [Young, Sarah; Huang, Tsurng-Juhn] China Med Univ, Sch Med, Taichung, Taiwan; [Young, Sarah; Huang, Tsurng-Juhn] China Med Univ, Res Ctr Biodivers, Taichung, Taiwan; [Chen, Jan-Chang] Natl Pingtung Univ Sci & Technol, Dept Forestry, Pingtung, Taiwan	University of Stirling; Universidad de Alcala; China Medical University Taiwan; China Medical University Taiwan; National Pingtung University Science & Technology	Ruiz-Benito, P (corresponding author), Univ Stirling, Sch Nat Sci, Biol & Environm Sci, Stirling FK9 4LA, Scotland.	paloma.ruizbenito@stir.ac.uk	Madrigal-González, Jaime/B-1883-2017; Jump, Alistair/B-5746-2012; Ruiz-Benito, Paloma/E-5833-2012	Madrigal-González, Jaime/0000-0002-9522-5493; Ruiz-Benito, Paloma/0000-0002-2781-5870; Jump, Alistair/0000-0002-2167-6451	Royal Society; National Science Council of Taiwan; Leverhulme Trust [IN-2013-004]	Royal Society(Royal Society of London); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Leverhulme Trust(Leverhulme Trust)	This research was supported by an International Joint Project Grant from The Royal Society and the National Science Council of Taiwan and by Leverhulme Trust project IN-2013-004.	Anten NPR, 2011, TREE PHYSIOL-NETH, V4, P429, DOI 10.1007/978-94-007-1242-3_16; Babst F, 2013, GLOBAL ECOL BIOGEOGR, V22, P706, DOI 10.1111/geb.12023; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Binkley D, 2004, FOREST ECOL MANAG, V190, P265, DOI 10.1016/j.foreco.2003.10.018; Bunn AG, 2010, DENDROCHRONOLOGIA, V28, P251, DOI 10.1016/j.dendro.2009.12.001; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Linares JC, 2013, DENDROCHRONOLOGIA, V31, P88, DOI 10.1016/j.dendro.2012.08.003; Carrer M, 2004, ECOLOGY, V85, P730, DOI 10.1890/02-0478; Carrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022813; Caspersen JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028660; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Coomes DA, 2014, GLOBAL CHANGE BIOL, V20, P3632, DOI 10.1111/gcb.12622; Coomes DA, 2012, J ECOL, V100, P42, DOI 10.1111/j.1365-2745.2011.01920.x; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; Critchfield WB, 1966, GEOGRAPHIC DISTRIBUT; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Drake JE, 2010, PLANT CELL ENVIRON, V33, P1756, DOI 10.1111/j.1365-3040.2010.02180.x; Enquist BJ, 2001, J TROP ECOL, V17, P41, DOI 10.1017/S0266467401001031; Esper J, 2008, FOREST ECOL MANAG, V255, P3783, DOI 10.1016/j.foreco.2008.03.015; Fang JY, 2014, P NATL ACAD SCI USA, V111, P9527, DOI 10.1073/pnas.1402333111; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Foster JR, 2014, OECOLOGIA, V175, P363, DOI 10.1007/s00442-014-2881-2; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Gomez-Aparicio L, 2011, GLOBAL CHANGE BIOL, V17, P2400, DOI 10.1111/j.1365-2486.2011.02421.x; Gower ST, 1996, TRENDS ECOL EVOL, V11, P378, DOI 10.1016/0169-5347(96)10042-2; Guan BT, 2009, AGR FOREST METEOROL, V149, P281, DOI 10.1016/j.agrformet.2008.08.010; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Huang T, 2002, FLORA TAIWAN; Jump AS, 2012, ECOGRAPHY, V35, P204, DOI 10.1111/j.1600-0587.2011.06984.x; Larsson L-A, 2003, COORECORDER IMAGE CO; Lin YS, 2012, TREE PHYSIOL, V32, P219, DOI 10.1093/treephys/tpr141; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Madrigal-Gonzalez J, 2014, AGR FOREST METEOROL, V192, P18, DOI 10.1016/j.agrformet.2014.02.011; Mencuccini M, 2005, ECOL LETT, V8, P1183, DOI 10.1111/j.1461-0248.2005.00819.x; Nabuurs GJ, 2013, NAT CLIM CHANGE, V3, P792, DOI [10.1038/NCLIMATE1853, 10.1038/nclimate1853]; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Niinemets U, 2010, FOREST ECOL MANAG, V260, P1623, DOI 10.1016/j.foreco.2010.07.054; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Piper FI, 2011, ANN BOT-LONDON, V108, P907, DOI 10.1093/aob/mcr195; Prior LD, 2014, GLOBAL CHANGE BIOL, V20, P2793, DOI 10.1111/gcb.12540; R Core Team, 2021, R LANGUAGE ENV STAT; Rozas V, 2015, IFOREST, V8, P187, DOI 10.3832/ifor1249-007; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P3, DOI 10.1007/s00468-010-0480-3; Ryan MG, 2004, ECOL MONOGR, V74, P393, DOI 10.1890/03-4037; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Speer JH, 2010, FUNDAMENTALS TREE RI; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Vayreda J, 2012, GLOBAL CHANGE BIOL, V18, P1028, DOI 10.1111/j.1365-2486.2011.02606.x; Vieira J, 2009, TREES-STRUCT FUNCT, V23, P257, DOI 10.1007/s00468-008-0273-0; Vlam M, 2014, OECOLOGIA, V174, P1449, DOI 10.1007/s00442-013-2846-x; Voelker SL, 2011, TREE PHYSIOL-NETH, V4, P455, DOI 10.1007/978-94-007-1242-3_17; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Weiner J, 2001, OIKOS, V94, P374, DOI 10.1034/j.1600-0706.2001.940219.x; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Xu CY, 2012, J ECOL, V100, P428, DOI 10.1111/j.1365-2745.2011.01933.x; Zuidema PA, 2013, TRENDS PLANT SCI, V18, P413, DOI 10.1016/j.tplants.2013.05.006; Zuur Alain F., 2009, P1	65	12	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126581	10.1371/journal.pone.0126581	http://dx.doi.org/10.1371/journal.pone.0126581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973854	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600061
J	Huang, JZ; Lin, CP; Cheng, TC; Chang, BCH; Cheng, SY; Chen, YW; Lee, CY; Chin, SW; Chen, FC				Huang, Jian-Zhi; Lin, Chih-Peng; Cheng, Ting-Chi; Chang, Bill Chia-Han; Cheng, Shu-Yu; Chen, Yi-Wen; Lee, Chen-Yu; Chin, Shih-Wen; Chen, Fure-Chyi			A De Novo Floral Transcriptome Reveals Clues into Phalaenopsis Orchid Flower Development	PLOS ONE			English	Article							MADS-BOX GENES; RNA-SEQ; ORGAN IDENTITY; MOLECULAR-MECHANISMS; ARABIDOPSIS FLOWER; KNOX GENES; EXPRESSION; ROLES; PETAL; TIME	Phalaenopsis has a zygomorphic floral structure, including three outer tepals, two lateral inner tepals and a highly modified inner median tepal called labellum or lip; however, the regulation of its organ development remains unelucidated. We generated RNA-seq reads with the Illumina platform for floral organs of the Phalaenopsis wild-type and peloric mutant with a lip-like petal. A total of 43,552 contigs were obtained after de novo assembly. We used differentially expressed gene profiling to compare the transcriptional changes in floral organs for both the wild-type and peloric mutant. Pair-wise comparison of sepals, petals and labellum between peloric mutant and its wild-type revealed 1,838, 758 and 1,147 contigs, respectively, with significant differential expression. PhAGL6a (CUFF.17763), PhAGL6b (CUFF.17763.1), PhMADS1 (CUFF.36625.1), PhMADS4 (CUFF.25909) and PhMADS5 (CUFF.39479.1) were significantly upregulated in the lip-like petal of the peloric mutant. We used real-time PCR analysis of lip-like petals, lip-like sepals and the big lip of peloric mutants to confirm the five genes' expression patterns. PhAGL6a, PhAGL6b and PhMADS4 were strongly expressed in the labellum and significantly upregulated in lip-like petals and lip-like sepals of peloric-mutant flowers. In addition, PhAGL6b was significantly downregulated in the labellum of the big lip mutant, with no change in expression of PhAGL6a. We provide a comprehensive transcript profile and functional analysis of Phalaenopsis floral organs. PhAGL6a PhAGL6b, and PhMADS4 might play crucial roles in the development of the labellum in Phalaenopsis. Our study provides new insights into how the orchid labellum differs and why the petal or sepal converts to a labellum in Phalaenopsis floral mutants.	[Huang, Jian-Zhi; Cheng, Ting-Chi; Cheng, Shu-Yu; Chen, Yi-Wen; Lee, Chen-Yu; Chin, Shih-Wen; Chen, Fure-Chyi] Natl Pingtung Univ Sci & Technol, Dept Plant Ind, Pingtung 91201, Taiwan; [Lin, Chih-Peng; Chang, Bill Chia-Han] Yourgene Biosci, New Taipei City 23863, Taiwan; [Chang, Bill Chia-Han] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3010, Australia; [Lin, Chih-Peng] Ming Chuan Univ, Sch Hlth Technol, Dept Biotechnol, Taoyuan 333, Taiwan	National Pingtung University Science & Technology; University of Melbourne; Ming Chuan University	Lee, CY (corresponding author), Natl Pingtung Univ Sci & Technol, Dept Plant Ind, Pingtung 91201, Taiwan.	culee@mail.npust.edu.tw; swchin@mail.npust.edu.tw; fchen@mail.npust.edu.tw		Chang, Bill Chia-Han/0000-0001-5313-4852	Council of Agriculture, Agriculture and Food Agency, Taiwan [103AS-9.1.1-FD-Z2, 104AS-9.1.1-FD-Z2]	Council of Agriculture, Agriculture and Food Agency, Taiwan	This work was supported by grants from the Council of Agriculture, Agriculture and Food Agency, Taiwan, with the grant numbers 103AS-9.1.1-FD-Z2 and 104AS-9.1.1-FD-Z2.	Aceto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097839; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Box MS, 2012, J EXP BOT, V63, P4811, DOI 10.1093/jxb/ers152; Box MS, 2011, PLANT J, V68, P703, DOI 10.1111/j.1365-313X.2011.04721.x; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chang YY, 2010, PLANT PHYSIOL, V152, P837, DOI 10.1104/pp.109.147116; Chang YY, 2009, PLANT CELL PHYSIOL, V50, P1425, DOI 10.1093/pcp/pcp087; Chatterjee M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024752; Chen DH, 2007, PLANTA, V226, P369, DOI 10.1007/s00425-007-0488-0; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Chen YH, 2005, CELL RES, V15, P639, DOI 10.1038/sj.cr.7290334; Chen YY, 2012, PLANT CELL PHYSIOL, V53, P1053, DOI 10.1093/pcp/pcs048; Christenson EA, 2001, PHALAENOPSIS; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Corley SB, 2005, P NATL ACAD SCI USA, V102, P5068, DOI 10.1073/pnas.0501340102; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; De Paolo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102155; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Duan YL, 2012, PLANT MOL BIOL, V80, P429, DOI 10.1007/s11103-012-9958-2; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Galego L, 2002, GENE DEV, V16, P880, DOI 10.1101/gad.221002; Golz JF, 2002, CURR BIOL, V12, P515, DOI 10.1016/S0960-9822(02)00721-2; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Groszmann M, 2010, J EXP BOT, V61, P1495, DOI 10.1093/jxb/erq015; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hsiao YY, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-14; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Hsu HF, 2003, PLANT CELL PHYSIOL, V44, P783, DOI 10.1093/pcp/pcg099; Hsu HF, 2002, PLANT CELL PHYSIOL, V43, P1198, DOI 10.1093/pcp/pcf143; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Kim SY, 2007, PLANT SCI, V172, P319, DOI 10.1016/j.plantsci.2006.09.009; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Kramer EM, 2005, CURR OPIN PLANT BIOL, V8, P13, DOI 10.1016/j.pbi.2004.09.019; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Miguel C, 2011, J EXP BOT, V62, P3713, DOI 10.1093/jxb/err155; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Perez-Rodriguez M, 2005, DEVELOPMENT, V132, P359, DOI 10.1242/dev.01584; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Pridgeon AM., 2005, GENERA ORCHIDACEARUM; Raju NL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-45; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Rijpkema AS, 2009, PLANT J, V60, P1, DOI 10.1111/j.1365-313X.2009.03917.x; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Rudall PJ, 2002, BIOL REV, V77, P403, DOI 10.1017/S1464793102005936; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sedeek KEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064621; Shani E, 2009, PLANT CELL, V21, P3078, DOI 10.1105/tpc.109.068148; Skipper M, 2006, GENE, V366, P266, DOI 10.1016/j.gene.2005.08.014; Song IJ, 2006, DEV GENES EVOL, V216, P301, DOI 10.1007/s00427-005-0057-0; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; THEISSEN G, 1995, CURR OPIN GENET DEV, V5, P628, DOI 10.1016/0959-437X(95)80032-8; Theissen G, 2007, ANN BOT-LONDON, V100, P603, DOI 10.1093/aob/mcm143; Thompson BE, 2009, PLANT CELL, V21, P2578, DOI 10.1105/tpc.109.067751; Tsai WC, 2004, PLANT CELL PHYSIOL, V45, P831, DOI 10.1093/pcp/pch095; Uddenberg D, 2013, PLANT PHYSIOL, V161, P813, DOI 10.1104/pp.112.207746; Wang SY, 2011, PLANT CELL PHYSIOL, V52, P563, DOI 10.1093/pcp/pcr015; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055238; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Wu S, 2012, CURR OPIN PLANT BIOL, V15, P645, DOI 10.1016/j.pbi.2012.09.010; Xu YF, 2006, PLANT J, V46, P54, DOI 10.1111/j.1365-313X.2006.02669.x; Yu H, 2000, PLANT PHYSIOL, V123, P1325, DOI 10.1104/pp.123.4.1325; Yuan XY, 2014, APPL BIOCHEM BIOTECH, V173, P1431, DOI 10.1007/s12010-014-0951-x; Zahn LM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r101; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang JZ, 2003, CURR OPIN PLANT BIOL, V6, P430, DOI 10.1016/S1369-5266(03)00081-5; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463	94	19	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123474	10.1371/journal.pone.0123474	http://dx.doi.org/10.1371/journal.pone.0123474			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970572	Green Published, gold			2022-12-27	WOS:000354544200014
J	Mouras, H; Lelard, T; Ahmaidi, S; Godefroy, O; Krystkowiak, P				Mouras, Harold; Lelard, Thierry; Ahmaidi, Said; Godefroy, Olivier; Krystkowiak, Pierre			Freezing Behavior as a Response to Sexual Visual Stimuli as Demonstrated by Posturography	PLOS ONE			English	Article							PICTURES; AROUSAL; VALENCE; MODULATION; MOTIVATION; ERECTION; DEFENSE; ANXIETY; CORTEX	Posturographic changes in motivational conditions remain largely unexplored in the context of embodied cognition. Over the last decade, sexual motivation has been used as a good canonical working model to study motivated social interactions. The objective of this study was to explore posturographic variations in response to visual sexual videos as compared to neutral videos. Our results support demonstration of a freezing-type response in response to sexually explicit stimuli compared to other conditions, as demonstrated by significantly decreased standard deviations for (i) the center of pressure displacement along the mediolateral and anteroposterior axes and (ii) center of pressure's displacement surface. These results support the complexity of the motor correlates of sexual motivation considered to be a canonical functional context to study the motor correlates of motivated social interactions.	[Mouras, Harold; Godefroy, Olivier] Univ Picardie Jules Verne, Dept Psychol, UFR Sci Humaines Sci Sociales & Philosophie, Ctr Rech Psychol Cognit Psychisme & Organisat,EA, F-80000 Amiens, France; [Krystkowiak, Pierre] Univ Picardie Jules Verne, UFR Med, Lab Neurosci Fonct & Pathol, EA 4559, F-80000 Amiens, France; [Krystkowiak, Pierre] CHU Amiens, Serv Neurol, F-80054 Amiens 1, France; [Lelard, Thierry; Ahmaidi, Said; Godefroy, Olivier] Univ Picardie Jules Verne, UFR Sci Sport, Adaptat Physiol Exercice & Readaptat Effort, EA 3300, F-80025 Amiens, France; [Mouras, Harold; Lelard, Thierry; Ahmaidi, Said; Krystkowiak, Pierre] Univ Picardie Jules Verne, Struct Fed Rech Sante CAP Sante, F-80000 Amiens, France; [Mouras, Harold; Lelard, Thierry; Ahmaidi, Said; Krystkowiak, Pierre] Univ Reims Champagne Ardennes, F-51097 Reims, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Universite de Reims Champagne-Ardenne	Mouras, H (corresponding author), Univ Picardie Jules Verne, Dept Psychol, UFR Sci Humaines Sci Sociales & Philosophie, Ctr Rech Psychol Cognit Psychisme & Organisat,EA, F-80000 Amiens, France.	hmouras@gmail.com; godefroy.olivier@chu-amiens.fr	Mouras, Harold/L-8117-2019	Godefroy, Olivier/0000-0001-6789-6620	Regional Council of Picardy; University of Picardy Jules Verne (BQR)	Regional Council of Picardy(Region Hauts-de-France); University of Picardy Jules Verne (BQR)(Region Hauts-de-France)	This study was supported by a grant from the Regional Council of Picardy (postdoctoral grant to TL) and a grant of the University of Picardy Jules Verne (BQR) for publication fees.	Agmo A, 1999, BEHAV BRAIN RES, V105, P129, DOI 10.1016/S0166-4328(99)00088-1; Azevedo TM, 2005, PSYCHOPHYSIOLOGY, V42, P255, DOI 10.1111/j.1469-8986.2005.00287.x; BINDRA D, 1974, PSYCHOL REV, V81, P199, DOI 10.1037/h0036330; Both S, 2005, PSYCHOPHYSIOLOGY, V42, P726, DOI 10.1111/j.1469-8986.2005.00364.x; Both S, 2004, J SEX RES, V41, P242, DOI 10.1080/00224490409552232; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Brown LA, 2006, GAIT POSTURE, V24, P397, DOI 10.1016/j.gaitpost.2005.04.013; Campbell BA, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P41; Cavanagh JF, 2013, J NEUROSCI, V33, P8541, DOI 10.1523/JNEUROSCI.5754-12.2013; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; Frijda N., 1986, THE EMOTIONS; Gelat T, 2011, NEUROSCI LETT, V497, P64, DOI 10.1016/j.neulet.2011.04.030; Griebel G, 1996, PHYSIOL BEHAV, V60, P1255, DOI 10.1016/S0031-9384(96)00230-2; Guitart-Masip M, 2014, TRENDS COGN SCI, V18, P194, DOI 10.1016/j.tics.2014.01.003; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Guitart-Masip M, 2011, J NEUROSCI, V31, P7867, DOI 10.1523/JNEUROSCI.6376-10.2011; GURFINKEL E V, 1973, Agressologie, V14, P9; Halbig TD, 2011, J NEURAL TRANSM, V118, P1319, DOI 10.1007/s00702-011-0627-4; Hagenaars MA, 2014, NEUROSCI BIOBEHAV R, V47, P165, DOI 10.1016/j.neubiorev.2014.07.021; Hagenaars MA, 2014, ANXIETY STRESS COPIN, V27, P27, DOI 10.1080/10615806.2013.809420; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; Horslen BC, 2011, EXP BRAIN RES, V215, P27, DOI 10.1007/s00221-011-2867-9; Huffman JL, 2009, GAIT POSTURE, V30, P528, DOI 10.1016/j.gaitpost.2009.08.001; Kalin NH, 1997, SCI AM, P76; Lang P.J., 2005, INT AFFECTIVE PICTUR; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; LANG PJ, 1994, EMOTIONS: ESSAYS ON EMOTION THEORY, P61; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Ly V, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00237; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Mokros A, 2010, ARCH SEX BEHAV, V39, P1081, DOI 10.1007/s10508-009-9530-6; Moulier V, 2006, NEUROIMAGE, V33, P689, DOI 10.1016/j.neuroimage.2006.06.037; Mouras H, 2008, NEUROIMAGE, V42, P1142, DOI 10.1016/j.neuroimage.2008.05.051; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Naugle KM, 2010, J BIOMECH, V43, P3099, DOI 10.1016/j.jbiomech.2010.08.008; Panksepp J, 2003, BRAIN COGNITION, V52, P4, DOI 10.1016/S0278-2626(03)00003-4; Panksepp J, 2012, NORTON SERIES ON INT; Pasman EP, 2011, NEUROSCIENCE, V177, P283, DOI 10.1016/j.neuroscience.2010.12.050; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Roelofs K, 2010, PSYCHOL SCI, V21, P1575, DOI 10.1177/0956797610384746; Santtila P, 2009, LEGAL CRIMINOL PSYCH, V14, P65, DOI 10.1348/135532507X267040; Schecklmann M, 2015, SOC COGN AFFECT NEUR, V10, P1061, DOI 10.1093/scan/nsu157; Sibley KM, 2007, HUM MOVEMENT SCI, V26, P103, DOI 10.1016/j.humov.2006.09.004; Singer B., 1987, J SEX RES, V23, P481, DOI [https://doi.org/10.1080/00224498709551386, DOI 10.1080/00224498709551386]; Stins JF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-83; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Walter M, 2008, NEUROIMAGE, V40, P1482, DOI 10.1016/j.neuroimage.2008.01.040; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; WRIGHT LW, 1994, J PSYCHOPATHOL BEHAV, V16, P221, DOI 10.1007/BF02229209; Wright LW, 1999, J SEX RES, V36, P145, DOI 10.1080/00224499909551979	54	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127097	10.1371/journal.pone.0127097	http://dx.doi.org/10.1371/journal.pone.0127097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7CV	25992571	Green Published, gold, Green Submitted			2022-12-27	WOS:000354921400096
J	Lopes, BA; Emerenciano, M; Goncalves, BAA; Vieira, TM; Rossini, A; Pombo-de-Oliveira, MS				Lopes, Bruno Almeida; Emerenciano, Mariana; Aguiar Goncalves, Bruno Alves; Vieira, Tallita Meciany; Rossini, Ana; Pombo-de-Oliveira, Maria S.			Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia	PLOS ONE			English	Article							INFANT LEUKEMIA; GENE-EXPRESSION; MESSENGER-RNA; EXPOSURE; SUSCEPTIBILITY; HAPLOTYPES; VARIANT; CANCER; RISK; PCR	Based on observational studies, early age leukemia (EAL) was associated with maternal hormone exposure during pregnancy. We studied the association between genetic polymorphisms of estrogen metabolism and EAL. Using data from the Brazilian Collaborative Study Group of Infant Acute Leukemia (2000-2012), 350 cases and 404 age-matched controls and 134 mothers of cases and controls were genotyped to explore polymorphisms in genes of the estrogen metabolism pathway: CYP1B1 (c.1294C>G, rs1056836), CYP3A4 (c.-392A>G, rs2740574), CYP3A5 (c.219-237G>A, rs776746), GSTM1/GSTT1 deletions, and SULT1A1 (c.638G>A, rs9282861; and c.667A>G, rs1801030). Logistic regression was used to calculate the odds ratios (OR) with 95% confidence intervals (CIs), and unconditional logistic regression was used to estimate adjusted odds ratios (aORs) by ethnicity. Because of multiple testing, p values < 0.01 were significant after Bonferroni correction. SULT1A1 (c.638G>A) was associated to infant acute lymphoblastic leukemia and acute myeloid leukemia (AML) risk in males (additive model: aOR = 0.52; 95% CI: 0.29-0.95, p = 0.03; dominant model: aOR = 2.18; 95% CI: 1.17-4.05, p = 0.01, respectively). CYP1B1 polymorphism was associated with a decreased risk of AML either for non-white or female children (additive model: OR = 0.24; 95% CI: 0.08-0.76, p < 0.01; additive model: aOR = 0.27; 95% CI: 0.08-0.89, p = 0.03, respectively). Since polymorphisms of Cytochrome P450 genes presented gender-specific risk associations, we also investigated their expression. CYP1B1 was not expressed in 57.1% of EAL cases, and its expression varied by genotype, gender, and leukemia subtype. Maternal-fetal GSTT1 null genotype was associated with risk of EAL. This study shows that polymorphisms in genes of estrogen metabolism confer genetic susceptibility to EAL, mainly in males, and maternal susceptibility genes modify the risk for developing EAL in newborns.	[Lopes, Bruno Almeida; Emerenciano, Mariana; Aguiar Goncalves, Bruno Alves; Vieira, Tallita Meciany; Pombo-de-Oliveira, Maria S.] Inst Nacl Canc, Res Ctr, Pediat Hematol Oncol Program, Rio De Janeiro, RJ, Brazil; [Rossini, Ana] Univ Estado Rio de Janeiro, Dept Biochem, Rio De Janeiro, RJ, Brazil	National Cancer Institute (Inca); Universidade do Estado do Rio de Janeiro	Pombo-de-Oliveira, MS (corresponding author), Inst Nacl Canc, Res Ctr, Pediat Hematol Oncol Program, Rio De Janeiro, RJ, Brazil.	mpombo@inca.gov.br	Lopes, Bruno/ABC-5215-2021; EMERENCIANO, MARIANA/I-2813-2014; Emerenciano, Mariana/W-1192-2019; Pombo-de-Oliveira, Maria S./I-8884-2014	Lopes, Bruno/0000-0003-1072-470X; EMERENCIANO, MARIANA/0000-0003-2337-8420; Emerenciano, Mariana/0000-0003-2337-8420; Pombo-de-Oliveira, Maria S./0000-0002-1507-004X	Brazilian National Research Council (CNPq); Instituto Nacional de Cancer (INCA); Instituto Nacional de Ciencia e Tecnologia (INCT) para o Controle do Cancer (CNPq) [73806/2008-0, E026/170.026/2008, E-26/110.509/2010, E-26/110.823/2012]; Brazilian Ministry of Health through the Institutional Development Program Scholarship; CNPq research scholarships [309091/2007]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ [E026/101.562/2010]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Cancer (INCA)(Institut National du Cancer (INCA) France); Instituto Nacional de Ciencia e Tecnologia (INCT) para o Controle do Cancer (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Brazilian Ministry of Health through the Institutional Development Program Scholarship; CNPq research scholarships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This research was supported by the Brazilian National Research Council (CNPq) and Instituto Nacional de Cancer (INCA). The project was partially funded by grants from Instituto Nacional de Ciencia e Tecnologia (INCT) para o Controle do Cancer (CNPq #573806/2008-0, FAPERJ#E026/170.026/2008 and FAPERJ#E-26/110.509/2010; FAPERJ#E-26/110.823/2012). ME has been supported by the Brazilian Ministry of Health through the Institutional Development Program Scholarship. MSPO has been supported by CNPq research scholarships (#309091/2007) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ (#E026/101.562/2010).	AbdelRahman SZ, 1996, CANCER LETT, V107, P229, DOI 10.1016/0304-3835(96)04832-X; Alexander FE, 2001, CANCER RES, V61, P2542; Alnouti Y, 2011, XENOBIOTICA, V41, P187, DOI 10.3109/00498254.2010.535923; Ayed-Boussema I, 2011, ENVIRON TOXICOL PHAR, V31, P79, DOI 10.1016/j.etap.2010.09.008; Cavalli SA, 2001, CLIN CHEM, V47, P348; Chi AC, 2009, ORAL ONCOL, V45, P980, DOI 10.1016/j.oraloncology.2009.05.562; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Emerenciano M, 2013, BRIT J HAEMATOL, V161, P224, DOI 10.1111/bjh.12250; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Helmig S, 2010, EUR J EPIDEMIOL, V25, P867, DOI 10.1007/s10654-010-9505-x; Helmig S, 2009, DRUG METAB DISPOS, V37, P1490, DOI 10.1124/dmd.109.027060; Kotnis A, 2008, BRIT J CANCER, V99, P1340, DOI 10.1038/sj.bjc.6604683; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Landi MT, 2005, TOXICOLOGY, V207, P191, DOI 10.1016/j.tox.2004.08.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marazziti D, 1998, NEUROPSYCHOBIOLOGY, V38, P1, DOI 10.1159/000026509; Marsh S, 2007, J CLIN ONCOL, V25, P4528, DOI 10.1200/JCO.2006.10.4752; Nousome D, 2013, LEUKEMIA RES, V37, P531, DOI 10.1016/j.leukres.2013.01.020; Pacifici GM, 2005, EARLY HUM DEV, V81, P573, DOI 10.1016/j.earlhumdev.2004.10.021; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pombo-De-Oliveira MS, 2006, CANCER EPIDEM BIOMAR, V15, P2336, DOI 10.1158/1055-9965.EPI-06-0031; Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113; Raftogianis RB, 1999, BIOCHEM PHARMACOL, V58, P605, DOI 10.1016/S0006-2952(99)00145-8; Rebbeck TR, 1998, J NATL CANCER I, V90, P1225, DOI 10.1093/jnci/90.16.1225; Schnyder S, 2009, LEUKEMIA RES, V33, P1400, DOI 10.1016/j.leukres.2009.01.023; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Van Schaik RHN, 2002, CLIN CHEM, V48, P1668; Vineis P, 2007, ANN ONCOL, V18, P1230, DOI 10.1093/annonc/mdm109; Zanrosso CW, 2010, CANCER EPIDEM BIOMAR, V19, P3037, DOI 10.1158/1055-9965.EPI-10-0508	31	18	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127308	10.1371/journal.pone.0127308	http://dx.doi.org/10.1371/journal.pone.0127308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992585	gold, Green Submitted, Green Published			2022-12-27	WOS:000354917300113
J	Subelj, L; Bajec, M; Boshkoska, BM; Kastrin, A; Levnajic, Z				Subelj, Lovro; Bajec, Marko; Boshkoska, Biljana Mileva; Kastrin, Andrej; Levnajic, Zoran			Quantifying the Consistency of Scientific Databases	PLOS ONE			English	Article							DYNAMICS; SCIENCE; IMPACT	Science is a social process with far-reaching impact on our modern society. In recent years, for the first time we are able to scientifically study the science itself. This is enabled by massive amounts of data on scientific publications that is increasingly becoming available. The data is contained in several databases such as Web of Science or PubMed, maintained by various public and private entities. Unfortunately, these databases are not always consistent, which considerably hinders this study. Relying on the powerful framework of complex networks, we conduct a systematic analysis of the consistency among six major scientific databases. We found that identifying a single "best" database is far from easy. Nevertheless, our results indicate appreciable differences in mutual consistency of different databases, which we interpret as recipes for future bibliometric studies.	[Subelj, Lovro; Bajec, Marko; Levnajic, Zoran] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; [Boshkoska, Biljana Mileva; Kastrin, Andrej; Levnajic, Zoran] Fac Informat Studies Novo Mesto, Novo Mesto, Slovenia	University of Ljubljana	Subelj, L (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia.	lovro.subelj@fri.uni-lj.si	Boshkoska, Biljana Mileva/N-6298-2015; Kastrin, Andrej/AAH-9234-2021; Šubelj, Lovro/V-9106-2018	Boshkoska, Biljana Mileva/0000-0002-1137-9795; Kastrin, Andrej/0000-0002-3495-0165; Šubelj, Lovro/0000-0002-4161-2260	European Union [FISNM-3330-13-500033]; European Regional Development Fund; Slovenian Research Agency [P2-0359, P1-0383, J1-5454, L7-4119]; Slovenian Ministry of Education, Science and Sport grant [430-168/2013/91]	European Union(European Commission); European Regional Development Fund(European Commission); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovenian Ministry of Education, Science and Sport grant	The authors thank American Physical Society and Thomson Reuters for providing the data. Work supported by Creative Core FISNM-3330-13-500033 funded by the European Union and The European Regional Development Fund, by the Slovenian Research Agency via programs P2-0359, P1-0383, and via projects J1-5454, L7-4119, and by the Slovenian Ministry of Education, Science and Sport grant 430-168/2013/91. The authors thank the colleagues Dalibor Fiala, Ludo Waltman, and Nees Jan van Eck for useful comments and discussions. Thomson Reuters provided some data, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, J INFORMETR, V6, P403, DOI 10.1016/j.joi.2012.01.002; Ahmed N, 2011, 11016 PURD U; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Blagus N, 2014, PHYS A UNPUB, P17; Cook RD, 1982, RESIDUALS INFLUENCE; Cox T. F., 2010, MULTIDIMENSIONAL SCA; De Nooy W., 2005, EXPLORATORY SOCIAL N; Demsar J, 2006, J MACH LEARN RES, V7, P1; Ding Y., 2014, SPSS 211 UYGULAMALI; Easley D, 2010, NETWORKS CROWDS MARK; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; Evans TS, 2011, SCIENTOMETRICS, V89, P381, DOI 10.1007/s11192-011-0439-1; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Fiala D, 2011, SCIENTOMETRICS, V86, P553, DOI 10.1007/s11192-010-0326-1; Fisher RA, 1914, BIOMETRIKA, V10, P507; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Ginsparg P, 2011, NATURE, V476, P145, DOI 10.1038/476145a; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Kastrin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102188; Kim H, 2012, J INFORMETR, V6, P97, DOI 10.1016/j.joi.2011.05.006; Krumov L, 2011, EUR PHYS J B, V84, P535, DOI 10.1140/epjb/e2011-10746-5; Leskovec J, 2006, P 12 ACM SIGKDD INT, P631; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Ley M., 2002, String Processing and Information Retrieval. 9th International Symposium, SPIRE 2002. Proceedings (Lecture Notes in Computer Science Vol.2476), P1; Luzar B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094429; MARTINEZ W, 2004, EXPLORATORY DATA ANA; McCallum AK, 2000, INFORM RETRIEVAL, V3, P127, DOI 10.1023/A:1009953814988; Milojevic S, 2014, P NATL ACAD SCI USA, V111, P3984, DOI 10.1073/pnas.1309723111; Nemenyi P., 1963, DISTRIBUTION FREE MU; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Palmer C.R., 2002, SIGKDD, P81, DOI DOI 10.1145/775047.775059; Pan RK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04880; Pan RK, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18007; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Perc M, 2010, J INFORMETR, V4, P475, DOI 10.1016/j.joi.2010.04.003; Petersen AM, 2014, P NATL ACAD SCI USA, V111, P15316, DOI 10.1073/pnas.1323111111; PRICE DJD, 1965, SCIENCE, V149, P510; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sayama H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038747; Shen HW, 2014, P NATL ACAD SCI USA, V111, P12325, DOI 10.1073/pnas.1401992111; Soffer SN, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.057101; Subelj L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06496; Subelj L, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P527; Subelj L, 2011, EXPERT SYST APPL, V38, P1039, DOI 10.1016/j.eswa.2010.07.143; Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Yao LY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06663; Yaveroglu ON, 2014, SCI REP-UK, V4, DOI 10.1038/srep04547; Ziliak ST, 2008, CULT STAT SIGNIFICAN	56	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127390	10.1371/journal.pone.0127390	http://dx.doi.org/10.1371/journal.pone.0127390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984946	gold, Green Submitted, Green Published			2022-12-27	WOS:000354917300121
J	Ammons, MCB; Morrissey, K; Tripet, BP; Van Leuven, JT; Han, A; Lazarus, GS; Zenilman, JM; Stewart, PS; James, GA; Copie, V				Ammons, Mary Cloud B.; Morrissey, Kathryn; Tripet, Brian P.; Van Leuven, James T.; Han, Anne; Lazarus, Gerald S.; Zenilman, Jonathan M.; Stewart, Philip S.; James, Garth A.; Copie, Valerie			Biochemical Association of Metabolic Profile and Microbiome in Chronic Pressure Ulcer Wounds	PLOS ONE			English	Article							IMMUNE-RESPONSES; DIVERSITY; BIOFILMS; REPAIR	Chronic, non-healing wounds contribute significantly to the suffering of patients with co-morbidities in the clinical population with mild to severely compromised immune systems. Normal wound healing proceeds through a well-described process. However, in chronic wounds this process seems to become dysregulated at the transition between resolution of inflammation and re-epithelialization. Bioburden in the form of colonizing bacteria is a major contributor to the delayed headlining in chronic wounds such as pressure ulcers. However how the microbiome influences the wound metabolic landscape is unknown. Here, we have used a Systems Biology approach to determine the biochemical associations between the taxonomic and metabolomic profiles of wounds colonized by bacteria. Pressure ulcer biopsies were harvested from primary chronic wounds and bisected into top and bottom sections prior to analysis of microbiome by pyrosequencing and analysis of metabolome using 1H nuclear magnetic resonance (NMR) spectroscopy. Bacterial taxonomy revealed that wounds were colonized predominantly by three main phyla, but differed significantly at the genus level. While taxonomic profiles demonstrated significant variability between wounds, metabolic profiles shared significant similarity based on the depth of the wound biopsy. Biochemical association between taxonomy and metabolic landscape indicated significant wound-to-wound similarity in metabolite enrichment sets and metabolic pathway impacts, especially with regard to amino acid metabolism. To our knowledge, this is the first demonstration of a statistically robust correlation between bacterial colonization and metabolic landscape within the chronic wound environment.	[Ammons, Mary Cloud B.; Morrissey, Kathryn; Tripet, Brian P.; Copie, Valerie] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Stewart, Philip S.; James, Garth A.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; [Van Leuven, James T.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Han, Anne; Lazarus, Gerald S.; Zenilman, Jonathan M.] Johns Hopkins Med Inst, Dept Dermatol, Baltimore, MD 21205 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Montana System; University of Montana; Johns Hopkins University; Johns Hopkins Medicine	Ammons, MCB (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	mcammons@chemistry.montana.edu; vcopie@chemistry.montana.edu	Copie, Valerie/GPW-9767-2022	Copie, Valerie/0000-0002-2778-1463; Ammons, Mary Cloud/0000-0002-9717-0844; Van Leuven, James/0000-0002-2730-0287; Stewart, Philip/0000-0001-7773-8570	NIH [3P20GM103394-05S1, 8P20GM103394-05, 1KO1GM103821-01, 1RO3AR060995-01A1, R01GM109452, 1-S10RR13878-01, S10RR026659-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013878, S10RR026659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR060995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K01GM103821, R01GM109452, P20GM103394] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in part, by NIH grant 3P20GM103394-05S1, a supplement to parent grant 8P20GM103394-05 (MCBA, BPT, and VC), NIH grant 1KO1GM103821-01 (to MCBA), NIH grant 1RO3AR060995-01A1 (to MCBA), and NIH award R01GM109452 (PSS and GAJ). The NMR metabolomics experiments were performed at MSU on a 600 MHz solution NMR spectrometer purchased in part, and recently upgraded to an AVANCE III console and TCI cryoprobe with, funds from NIH grants 1-S10RR13878-01 and S10RR026659-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Alexeyev OA, 2013, EXP DERMATOL, V22, P443, DOI 10.1111/exd.12160; Ammons Mary C B, 2010, Recent Pat Antiinfect Drug Discov, V5, P10; Ammons MCB, 2014, J PROTEOME RES, V13, P2973, DOI 10.1021/pr500120c; Banks M, 2010, NUTRITION, V26, P896, DOI 10.1016/j.nut.2009.09.024; BARBUL A, 1990, SURGERY, V108, P331; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; BISTRIAN BR, 1976, JAMA-J AM MED ASSOC, V235, P1567, DOI 10.1001/jama.235.15.1567; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Gao C, 2012, J BACTERIOL, V194, P4751, DOI 10.1128/JB.00943-12; Gjersing EL, 2007, ANAL CHEM, V79, P8037, DOI 10.1021/ac070800t; Gjodsbol K, 2012, INT WOUND J, V9, P295, DOI 10.1111/j.1742-481X.2011.00883.x; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Han A, 2011, WOUND REPAIR REGEN, V19, P532, DOI 10.1111/j.1524-475X.2011.00720.x; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Kavalukas SL, 2011, PLAST RECONSTR SURG, V127, p38S, DOI 10.1097/PRS.0b013e318201256c; Keum YS, 2009, J MICROBIOL BIOTECHN, V19, P1142, DOI 10.4014/jmb.0801.465; KIRK SJ, 1993, SURGERY, V114, P155; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Raslan M, 2010, NUTRITION, V26, P721, DOI 10.1016/j.nut.2009.07.010; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Scales BS, 2013, J PATHOL, V229, P323, DOI 10.1002/path.4118; Schmidt K, 2000, VASA-J VASCULAR DIS, V29, P62, DOI 10.1024/0301-1526.29.1.62; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tielen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071845; Tredwell GD, 2011, ANAL CHEM, V83, P8683, DOI 10.1021/ac202123k; Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-91; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Williams JZ, 2002, ANN SURG, V236, P369, DOI 10.1097/00000658-200209000-00013; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418	42	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126735	10.1371/journal.pone.0126735	http://dx.doi.org/10.1371/journal.pone.0126735			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978400	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100095
J	Brolese, G; Lunardi, P; de Souza, DF; Lopes, FM; Leite, MC; Goncalves, CA				Brolese, Giovana; Lunardi, Paula; de Souza, Daniela F.; Lopes, Fernanda M.; Leite, Marina C.; Goncalves, Carlos-Alberto			Pre- and Postnatal Exposure to Moderate Levels of Ethanol Can Have Long-Lasting Effects on Hippocampal Glutamate Uptake in Adolescent Offspring	PLOS ONE			English	Article							ALCOHOL SPECTRUM DISORDERS; OXIDATIVE STRESS; NONALCOHOLIC BEER; CONSUMPTION; RECEPTORS; PREGNANCY; BEHAVIOR; ASTROCYTES; MODULATION; PLASTICITY	The developing brain is vulnerable to the effects of ethanol. Glutamate is the main mediator of excitatory signals in the brain and is probably involved in most aspects of normal brain function during development. The aim of this study was to investigate vulnerability to and the impact of ethanol toxicity on glutamate uptake signaling in adolescent rats after moderate pre and postnatal ethanol exposure. Pregnant female rats were divided into three groups and treated only with water (control), non-alcoholic beer (vehicle) or 10% (v/v) beer solution (moderate prenatal alcohol exposure-MPAE). Thirty days after birth, adolescent male offspring were submitted to hippocampal acute slice procedure. We assayed glutamate uptake and measured glutathione content and also quantified glial glutamate transporters (EAAT 1 and EAAT 2). The glutamate system vulnerability was tested with different acute ethanol doses in naive rats and compared with the MPAE group. We also performed a (lipopolysaccharide-challenge (LPS-challenge) with all groups to test the glutamate uptake response after an insult. The MPAE group presented a decrease in glutamate uptake corroborating a decrease in glutathione (GSH) content. The reduction in GSH content suggests oxidative damage after acute ethanol exposure. The glial glutamate transporters were also altered after prenatal ethanol treatment, suggesting a disturbance in glutamate signaling. This study indicates that impairment of glutamate uptake can be dose-dependent and the glutamate system has a higher vulnerability to ethanol toxicity after moderate ethanol exposure In utero. The effects of pre- and postnatal ethanol exposure can have long-lasting impacts on the glutamate system in adolescence and potentially into adulthood.	[Brolese, Giovana; Lopes, Fernanda M.; Goncalves, Carlos-Alberto] Fed Univ Rio Grande Sul UFRGS Porto Alegre, Basic Sci Hlth Inst, Dept Neurosci, Porto Alegre, RS, Brazil; [Lunardi, Paula; de Souza, Daniela F.; Leite, Marina C.; Goncalves, Carlos-Alberto] Fed Univ Rio Grande Sul UFRGS Porto Alegre, Basic Sci Hlth Inst, Dept Biochem, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Brolese, G (corresponding author), Fed Univ Rio Grande Sul UFRGS Porto Alegre, Basic Sci Hlth Inst, Dept Neurosci, Porto Alegre, RS, Brazil.	jobrolese@gmail.com		/0000-0002-1907-6051; Lopes, Fernanda/0000-0002-4853-7670	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES); Instituto Nacional de Ciencia e Tecnologia para Excitotoxicidade e Neuroprotecao (INCT)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia para Excitotoxicidade e Neuroprotecao (INCT)	Funding: This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES) and Instituto Nacional de Ciencia e Tecnologia para Excitotoxicidade e Neuroprotecao (INCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 2008, NEURON GLIA BIOL, V4, P3, DOI 10.1017/S1740925X09000064; Aschner M, 2002, BRAIN PATHOL, V12, P475; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Brocardo PS, 2011, BRAIN RES REV, V67, P209, DOI 10.1016/j.brainresrev.2011.02.001; Brolese G, 2014, BEHAV BRAIN RES, V269, P175, DOI 10.1016/j.bbr.2014.04.023; Browne R W, 1998, Methods Mol Biol, V108, P347; Chefer V, 2011, ADDICT BIOL, V16, P229, DOI 10.1111/j.1369-1600.2010.00272.x; Chu J, 2007, ACTA NEUROPATHOL, V113, P659, DOI 10.1007/s00401-007-0199-4; Dahchour A, 2003, EUR J PHARMACOL, V459, P171, DOI 10.1016/S0014-2999(02)02851-0; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dembele K, 2006, AM J PHYSIOL-REG I, V291, pR796, DOI 10.1152/ajpregu.00633.2005; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Eckardt MJ, 1998, ALCOHOL CLIN EXP RES, V22, P998, DOI 10.1111/j.1530-0277.1998.tb03695.x; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; FOLEY TD, 1992, BRAIN RES, V593, P39, DOI 10.1016/0006-8993(92)91260-L; Grant TM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.871; Guerri C, 2002, NEUROTOX RES, V4, P327, DOI 10.1080/1029842021000010884; Guerri C, 2010, ALCOHOL, V44, P15, DOI 10.1016/j.alcohol.2009.10.003; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Hamilton DA, 2014, BEHAV BRAIN RES, V269, P44, DOI 10.1016/j.bbr.2014.04.029; Hargreaves GA, 2011, ALCOHOL, V45, P485, DOI 10.1016/j.alcohol.2010.12.007; HOSLI E, 1993, PROG NEUROBIOL, V40, P477, DOI 10.1016/0301-0082(93)90019-O; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jiang T, 2014, AGING CELL, V13, P1059, DOI 10.1111/acel.12268; Kane CJM, 2012, ALCOHOL, V46, P107, DOI 10.1016/j.alcohol.2011.07.004; Karl J, 2000, BRAIN RES, V853, P32, DOI 10.1016/S0006-8993(99)02224-6; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Kumral A, 2005, DEV BRAIN RES, V160, P146, DOI 10.1016/j.devbrainres.2005.08.006; LANCASTER F, 1987, NUTR RES, V7, P375, DOI 10.1016/S0271-5317(87)80130-6; LANCASTER FE, 1992, ALCOHOL, V9, P9, DOI 10.1016/0741-8329(92)90003-S; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Loureiro SO, 2012, J NEUROIMMUNOL, V249, P8, DOI 10.1016/j.jneuroim.2012.04.004; McGregor IS, 2004, ADDICT BEHAV, V29, P1341, DOI 10.1016/j.addbeh.2004.06.011; McKenna Mary C, 2013, Front Endocrinol (Lausanne), V4, P191, DOI 10.3389/fendo.2013.00191; Melendez RI, 2005, ALCOHOL CLIN EXP RES, V29, P326, DOI 10.1097/01.ALC.0000156086.65665.4D; Nardin P, 2009, NEUROCHEM RES, V34, P1603, DOI 10.1007/s11064-009-9949-0; Orru A, 2012, PSYCHOPHARMACOLOGY, V222, P685, DOI 10.1007/s00213-012-2672-6; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Patten AR, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00093; Peadon E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-584; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Rossetti ZL, 1999, NEUROSCIENCE, V93, P1135, DOI 10.1016/S0306-4522(99)00250-X; Samson HH, 1996, ALCOHOL, V13, P365, DOI 10.1016/0741-8329(96)00010-9; Savage DD, 2002, ALCOHOL CLIN EXP RES, V26, P1752, DOI 10.1097/01.ALC.0000038265.52107.20; Scheiber IF, 2013, NEUROCHEM INT, V62, P556, DOI 10.1016/j.neuint.2012.08.017; Selim M, 1996, BRAIN RES, V716, P157, DOI 10.1016/0006-8993(95)01385-7; Smith AM, 2005, DEV BRAIN RES, V160, P231, DOI 10.1016/j.devbrainres.2005.09.004; Stevens B, 2008, NEUROSIGNALS, V16, P278, DOI 10.1159/000123038; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Valles SL, 2004, BRAIN PATHOL, V14, P365; Walker MJ, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-52; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8; Zink M, 2004, ALCOHOL CLIN EXP RES, V28, P1752, DOI 10.1097/01.ALC.0000145810.12545.B3	53	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127845	10.1371/journal.pone.0127845	http://dx.doi.org/10.1371/journal.pone.0127845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978644	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100154
J	Church, K; Wringe, A; Lewin, S; Ploubidis, GB; Fakudze, P; Mayhew, SH				Church, Kathryn; Wringe, Alison; Lewin, Simon; Ploubidis, George B.; Fakudze, Phelele; Mayhew, Susannah H.		Integra Initiative	Exploring the Feasibility of Service Integration in a Low-Income Setting: A Mixed Methods Investigation into Different Models of Reproductive Health and HIV Care in Swaziland	PLOS ONE			English	Article							FAMILY-PLANNING-SERVICES; SOUTH-AFRICA; ANTIRETROVIRAL TREATMENT; SCALE-UP; KENYA; POLICY	Integrating reproductive health (RH) with HIV care is a policy priority in high HIV prevalence settings, despite doubts surrounding its feasibility and varying evidence of effects on health outcomes. The process and outcomes of integrated RH-HIV care were investigated in Swaziland, through a comparative case study of four service models, ranging from fully integrated to fully stand-alone HIV services, selected purposively within one town. A client exit survey (n=602) measured integrated care received and unmet family planning (FP) needs. Descriptive statistics were used to assess the degree of integration per clinic and client demand for services. Logistic regression modelling was used to test the hypothesis that clients at more integrated sites had lower unmet FP needs than clients in a stand-alone site. Qualitative methods included in-depth interviews with clients and providers to explore contextual factors influencing the feasibility of integrated RH-HIV care delivery; data were analysed thematically, combining deductive and inductive approaches. Results demonstrated that clinic models were not as integrated in practice as had been claimed. Fragmentation of HIV care was common. Services accessed per provider were no higher at the more integrated clinics compared to stand-alone models (p>0.05), despite reported demand. While women at more integrated sites received more FP and pregnancy counselling than stand-alone models, they received condoms (a method of choice) less often, and there was no statistical evidence of difference in unmet FP needs by model of care. Multiple contextual factors influenced integration practices, including provider de-skilling within sub-specialist roles; norms of task-oriented routinised HIV care; perceptions of heavy client loads; imbalanced client-provider interactions hindering articulation of RH needs; and provider motivation challenges. Thus, despite institutional support, factors related to the social context of care inhibited provision of fully integrated RH-HIV services in these clinics. Programmes should move beyond simplistic training and equipment provision if integrated care interventions are to be sustained.	[Church, Kathryn; Wringe, Alison] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Lewin, Simon] Norwegian Knowledge Ctr Hlth Serv, Global Hlth Unit, Oslo, Norway; [Lewin, Simon] Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Ploubidis, George B.] Univ London, Inst Educ, Dept Quantitat Social Sci, Ctr Longitudinal Studies, London WC1N 1AZ, England; [Fakudze, Phelele] PSI, Mbabane, Eswatini; [Mayhew, Susannah H.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Norwegian Knowledge Centre for Health Services; University of London; University College London; UCL Institute of Education; University of London; London School of Hygiene & Tropical Medicine	Church, K (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England.	kathryn.church@lshtm.ac.uk	Ploubidis, George B/G-9531-2011; Lewin, Simon/HCH-1959-2022	Ploubidis, George B/0000-0002-8198-5790; /0000-0003-4491-9521; Mayhew, Susannah/0000-0002-2433-3809	Bill & Melinda Gates Foundation (through the Integra Initiative); Economic & Social Council of the UK; Medical Research Council of the UK; MRC [G0902143] Funding Source: UKRI; Medical Research Council [G0902143] Funding Source: researchfish	Bill & Melinda Gates Foundation (through the Integra Initiative); Economic & Social Council of the UK; Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was partly supported by the Bill & Melinda Gates Foundation (through the Integra Initiative) and partly by an Inter-disciplinary PhD studentship from the Economic & Social and Medical Research Councils of the UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner JN, 2014, HEALTH POLICY PLANN, V29, P570, DOI 10.1093/heapol/czt043; Church K, 2014, SEX TRANSM INFECT FO; Church K, 2011, THESIS LONDON SCH HY; Church K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17981; Church K, 2012, AIDS PATIENT CARE ST, V26, P662, DOI 10.1089/apc.2012.0191; Church K, 2009, STUD FAMILY PLANN, V40, P171, DOI 10.1111/j.1728-4465.2009.00201.x; Coovadia H, 2008, LANCET, V372, P866, DOI 10.1016/S0140-6736(08)61373-2; Dixon-Woods M, 2009, SOC SCI MED, V69, P362, DOI 10.1016/j.socscimed.2009.05.025; Dwamena F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003267.pub2; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; El-Sadr WM, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000298105.79484.62; Georgeu D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-66; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Glaser B., 1999, DISCOVERY GROUNDED T; Grossman D, 2013, AIDS, V27, pS77, DOI 10.1097/QAD.0000000000000035; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; IPPF. Positive prevention, 2010, POS PREV PREV STRAT; Leon N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-97; Lindegren ML, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010119; Lush L, 1999, B WORLD HEALTH ORGAN, V77, P771; Lush L, 2002, INT FAM PLAN PERSPEC, V28, P71, DOI 10.2307/3088238; McCoy D, 2005, AM J PUBLIC HEALTH, V95, P18, DOI 10.2105/AJPH.2004.040121; Mutemwa R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-18; Myer L, 2005, REPROD HEALTH MATTER, V13, P136, DOI 10.1016/S0968-8080(05)25185-6; NERCHA, 2009, NAT STRAT FRAM HIV A, DOI [10.1371/journal.pmed.1001641, DOI 10.1371/JOURNAL.PMED.1001641]; Pawson R, 2006, EVIDENCE BASED POLIC, P16; Rabkin M, 2009, JAIDS-J ACQ IMM DEF, V52, pS6, DOI 10.1097/QAI.0b013e3181bbcd69; Reeves S, 2010, INTERPROFESSIONAL TE; Reeves Scott, 2004, J Health Serv Res Policy, V9, P218, DOI 10.1258/1355819042250140; Reynolds HW, 2008, SEX TRANSM INFECT, V84, pII49, DOI 10.1136/sti.2008.030049; Schneider H, 2008, MODELS CARE ANTIRETR; Shelton JD, 2001, INT FAM PLAN PERSPEC, V27, P152, DOI 10.2307/2673838; Sidibe M, 2009, B WORLD HEALTH ORGAN, V87, P806, DOI 10.2471/BLT.09.071621; Smit JA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-48; Topp SM, 2013, HEALTH POLICY PLANN, V28, P347, DOI 10.1093/heapol/czs065; Uebel K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-171; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNFPA, 2004, NEW YORK CALL COMM L; Warren CE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-973; Yin R, 2003, CASE STUDY RES	40	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126144	10.1371/journal.pone.0126144	http://dx.doi.org/10.1371/journal.pone.0126144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978632	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000354916100049
J	Crompot, E; Van Damme, M; Duvillier, H; Pieters, K; Vermeesch, M; Perez-Morga, D; Meuleman, N; Mineur, P; Bron, D; Lagneaux, L; Stamatopoulos, B				Crompot, Emerence; Van Damme, Michael; Duvillier, Hugues; Pieters, Karlien; Vermeesch, Marjorie; Perez-Morga, David; Meuleman, Nathalie; Mineur, Philippe; Bron, Dominique; Lagneaux, Laurence; Stamatopoulos, Basile			Avoiding False Positive Antigen Detection by Flow Cytometry on Blood Cell Derived Microparticles: The Importance of an Appropriate Negative Control	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; CIRCULATING MICROPARTICLES; ACTIVATED PLATELETS; PERIPHERAL-BLOOD; TISSUE-FACTOR; ENDOTHELIAL MICROPARTICLES; EXTRACELLULAR VESICLES; PROTEOMIC ANALYSIS; MEMBRANE-VESICLES; LIPID RAFTS	Background Microparticles (MPs), also called microvesicles (MVs) are plasma membrane-derived fragments with sizes ranging from 0.1 to 1 mu m. Characterization of these MPs is often performed by flow cytometry but there is no consensus on the appropriate negative control to use that can lead to false positive results. Materials and Methods We analyzed MPs from platelets, B-cells, T-cells, NK-cells, monocytes, and chronic lymphocytic leukemia (CLL) B-cells. Cells were purified by positive magnetic-separation and cultured for 48h. Cells and MPs were characterized using the following monoclonal antibodies (CD19,20 for B-cells, CD3,8,5,27 for T-cells, CD16,56 for NK-cells, CD14,11c for monocytes, CD41,61 for platelets). Isolated MPs were stained with annexin-V-FITC and gated between 300nm and 900nm. The latex bead technique was then performed for easy detection of MPs. Samples were analyzed by Transmission (TEM) and Scanning Electron microscopy (SEM). Results Annexin-V positive events within a gate of 300-900nm were detected and defined as MPs. Our results confirmed that the characteristic antigens CD41/CD61 were found on platelet-derived-MPs validating our technique. However, for MPs derived from other cell types, we were unable to detect any antigen, although they were clearly expressed on the MP-producing cells in the contrary of several data published in the literature. Using the latex bead technique, we confirmed detection of CD41,61. However, the apparent expression of other antigens (already deemed positive in several studies) was determined to be false positive, indicated by negative controls (same labeling was used on MPs from different origins). Conclusion We observed that mother cell antigens were not always detected on corresponding MPs by direct flow cytometry or latex bead cytometry. Our data highlighted that false positive results could be generated due to antibody aspecificity and that phenotypic characterization of MPs is a difficult field requiring the use of several negative controls.	[Crompot, Emerence; Van Damme, Michael; Pieters, Karlien; Lagneaux, Laurence; Stamatopoulos, Basile] Univ Libre Bruxelles, Lab Clin Cell Therapy, Inst Jules Bordet, Brussels, Belgium; [Duvillier, Hugues; Meuleman, Nathalie; Bron, Dominique] Inst Jules Bordet, Dept Hematol, B-1000 Brussels, Belgium; [Vermeesch, Marjorie; Perez-Morga, David] Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, Gosselies, Belgium; [Mineur, Philippe] Grand Hop Charleroi, Dept Hematooncol, Gilly, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles; Grand Hopital De Charleroi	Crompot, E (corresponding author), Univ Libre Bruxelles, Lab Clin Cell Therapy, Inst Jules Bordet, Brussels, Belgium.	emerence.crompot@ulb.ac.be; bstamato@ulb.ac.be		Perez-Morga, David/0000-0002-7168-1865	Televie; FRSM (Fonds de la Recherche Scientifique Medicale)	Televie; FRSM (Fonds de la Recherche Scientifique Medicale)(Fonds de la Recherche Scientifique - FNRS)	Funding: This research was supported by a Televie and a FRSM (Fonds de la Recherche Scientifique Medicale) grant, both affiliated to the "Fonds National de la Recherche Scientifique - FNRS" (F.R.S-F.N.R.S.).	Aass HCD, 2011, CYTOM PART A, V79A, P990, DOI 10.1002/cyto.a.21147; Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Ayers L, 2014, J EXTRACELL VES, P3; Ayers L, 2011, THROMB RES, V127, P370, DOI 10.1016/j.thromres.2010.12.014; Baka Z, 2010, IMMUNOL LETT, V128, P124, DOI 10.1016/j.imlet.2009.12.018; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Biro E, 2005, J THROMB HAEMOST, V3, P2754, DOI 10.1111/j.1538-7836.2005.01646.x; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Boulanger CM, 2006, HYPERTENSION, V48, P180, DOI 10.1161/01.HYP.0000231507.00962.b5; Budoni M, 2013, CELL TRANSPLANT, V22, P369, DOI 10.3727/096368911X582769; Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309; Burnier L, 2009, THROMB HAEMOSTASIS, V101, P439, DOI 10.1160/TH08-08-0521; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chandler WL, 2011, J THROMB HAEMOST, V9, P1216, DOI 10.1111/j.1538-7836.2011.04283.x; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; Connor DE, 2010, THROMB HAEMOSTASIS, V103, P1044, DOI 10.1160/TH09-09-0644; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; Davizon P, 2010, SEMIN THROMB HEMOST, V36, P857, DOI 10.1055/s-0030-1267039; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Dey-Hazra E, 2010, VASC HEALTH RISK MAN, V6, P1125, DOI 10.2147/VHRM.S13236; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Fonsato V, 2012, STEM CELLS, V30, P1985, DOI 10.1002/stem.1161; Galindo-Hernandez O, 2013, ARCH MED RES, V44, P208, DOI 10.1016/j.arcmed.2013.03.002; Gheldof D, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19728; Ghosh AK, 2010, BLOOD, V115, P1755, DOI 10.1182/blood-2009-09-242719; Gyorgy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049726; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; KIM SH, 2012, PLOS NEGLECT TROP D, V6, P37036, DOI DOI 10.1371/JOURNAL.PONE.0037036; Lacroix R, 2012, HAEMATOL-HEMATOL J, V97, P1864, DOI 10.3324/haematol.2012.066167; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Liu R, 2009, EUR J HAEMATOL, V83, P220, DOI 10.1111/j.1600-0609.2009.01271.x; Macey MG, 2011, CYTOM PART B-CLIN CY, V80B, P57, DOI 10.1002/cyto.b.20551; Mahaweni NM, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22492; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Miguet L, 2006, PROTEOMICS, V6, P153, DOI 10.1002/pmic.200500133; Miguet L, 2009, J PROTEOME RES, V8, P3346, DOI 10.1021/pr801102c; Mokarizadeh A, 2012, IMMUNOL LETT, V147, P47, DOI 10.1016/j.imlet.2012.06.001; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Munoz JL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.60; Najar M, 2009, CYTOTHERAPY, V11, P570, DOI 10.1080/14653240903079377; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nielsen CT, 2012, DAN MED J, V59; Nielsen MH, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.20795; Oksvold MP, 2014, CLIN THER, V36, P847, DOI 10.1016/j.clinthera.2014.05.010; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Pisetsky DS, 2011, IMMUNOL RES, V49, P227, DOI 10.1007/s12026-010-8184-8; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Robert S, 2011, J THROMB HAEMOST, V9, P1676, DOI 10.1111/j.1538-7836.2011.04387.x; Robert S, 2012, ARTERIOSCL THROM VAS, V32, P1054, DOI 10.1161/ATVBAHA.111.244616; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Shefler I, 2010, J IMMUNOL, V185, P4206, DOI 10.4049/jimmunol.1000409; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Soriano AO, 2005, CRIT CARE MED, V33, P2540, DOI 10.1097/01.CCM.0000186414.86162.03; Szczepanski MJ, 2011, HAEMATOL-HEMATOL J, V96, P1302, DOI 10.3324/haematol.2010.039743; Tan SS, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22614; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tissot JD, 2010, CURR OPIN HEMATOL, V17, P571, DOI 10.1097/MOH.0b013e32833ec217; Trummer A, 2008, THROMB RES, V122, P691, DOI 10.1016/j.thromres.2008.01.005; Van Damme M, 2012, EPIGENETICS-US, V7, P1403, DOI 10.4161/epi.22674; van der Pol E, 2013, J THROMB HAEMOST, V11, P36, DOI 10.1111/jth.12254; van der Pol E, 2014, NANO LETT, V14, P6195, DOI 10.1021/nl503371p; van Doormaal FF, 2009, NETH J MED, V67, P266; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599	76	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127209	10.1371/journal.pone.0127209	http://dx.doi.org/10.1371/journal.pone.0127209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978814	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100138
J	Kim, B; Yang, J; Lee, YH; Kim, MH; Heo, D; Lee, E; Suh, JS; Haam, S; Huh, YM				Kim, Bongjune; Yang, Jaemoon; Lee, Young Han; Kim, Myeong-Hoon; Heo, Dan; Lee, Eugene; Suh, Jin-Suck; Haam, Seungjoo; Huh, Yong-Min			Compensatory UTE/T2W Imaging of Inflammatory Vascular Wall in Hyperlipidemic Rabbits	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; MACROPHAGE SCAVENGER RECEPTOR; CONTRAST AGENT; MAGNETIC NANOPARTICLES; ATHEROSCLEROTIC PLAQUES; DEXTRAN; MRI; PARTICLES; CELLS	Objectives To obtain compensatory ultra-short echo time (UTE) imaging and T2-weighted (T2W) imaging of Watanabe heritable hyperlipidemic (WHHL) rabbits following dextran-coated magnetic nanocluster (DMNC) injection for the effective in vivo detection of inflammatory vascular wall. Methods Magnetic nanoparticle was synthesized by thermal decomposition and encapsulated with dextran to prepare DMNC. The contrast enhancement efficiency of DMNC was investigated using UTE (repetition time [TR] = 5.58 and TE = 0.07 ms) and T2W (TR = 4000 and TE = 60 ms) imaging sequences. To confirm the internalization of DMNC into macrophages, DMNC-treated macrophages were visualized by cellular transmission electron microscope (TEM) and magnetic resonance (MR) imaging. WHHL rabbits expressing macrophage-rich plaques were subjected to UTE and T2W imaging before and after intravenous DMNC (120 mu mol Fe/kg) treatment. Ex vivo MR imaging of plaques and immunostaining studies were also performed. Results Positive and negative contrast enhancement of DMNC solutions with increasing Fe concentrations were observed in UTE and T2W imaging, respectively. The relative signal intensities of the DMNC solution containing 2.9 mM Fe were calculated as 3.53 and 0.99 in UTE and T2W imaging, respectively. DMNC uptake into the macrophage cytoplasm was visualized by electron microscopy. Cellular MR imaging of DMNC-treated macrophages revealed relative signals of 3.00 in UTE imaging and 0.98 in T2W imaging. In vivo MR images revealed significant brightening and darkening of plaque areas in the WHHL rabbit 24 h after DMNC injection in UTE and T2W imaging, respectively. Ex vivo MR imaging results agreed with these in vivo MR imaging results. Histological analysis showed that DMNCs were localized to areas of inflammatory vascular wall. Conclusions Using compensatory UTE and T2W imaging in conjunction with DMNC is an effective approach for the noninvasive in vivo imaging of atherosclerotic plaque.	[Kim, Bongjune; Kim, Myeong-Hoon; Haam, Seungjoo] Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea; [Yang, Jaemoon; Lee, Young Han; Heo, Dan; Lee, Eugene; Suh, Jin-Suck; Huh, Yong-Min] Yonsei Univ, Dept Radiol, Coll Med, Seoul 120749, South Korea; [Heo, Dan; Lee, Eugene; Suh, Jin-Suck] Yonsei Univ, Nanomed Natl Core Res Ctr, Seoul 120749, South Korea; [Yang, Jaemoon; Lee, Young Han; Suh, Jin-Suck] YUHS KRIBB Med Convergence Res Inst, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Haam, S (corresponding author), Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea.	haam@yonsei.ac.kr; ymhuh@yuhs.ac	Heo, Dan/ABB-5010-2020; Yang, Jaemoon/S-3900-2019	Yang, Jaemoon/0000-0001-7365-0395; Lee, Young Han/0000-0002-5602-391X; Suh, jin-suck/0000-0001-9455-9240; Huh, Yong-Min/0000-0002-9831-4475	Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [A085136]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MEST) [2012050077]; National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2006-2004652]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A102064]	Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MEST); National Research Foundation of Korea (NRF) grant - Korea government (MEST); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (A085136) and Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST)(2012050077) and National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2006-2004652) and Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (No. A102064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Choi R, 2010, LANGMUIR, V26, P17520, DOI 10.1021/la1029728; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Deguchi J, 2006, CIRCULATION, V114, P55, DOI 10.1161/CIRCULATIONAHA.106.619056; Flacke S, 2001, CIRCULATION, V104, P1280, DOI 10.1161/hc3601.094303; Girard OM, 2011, MAGN RESON MED, V65, P1649, DOI 10.1002/mrm.22755; Howles GP, 2009, MAGN RESON MED, V62, P1447, DOI 10.1002/mrm.22154; Jaffer FA, 2006, J AM COLL CARDIOL, V47, P1328, DOI 10.1016/j.jacc.2006.01.029; Jaffer FA, 2006, MOL IMAGING, V5, P85, DOI 10.2310/7290.2006.00009; Jarrett BR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/3/035603; KIM B, 2013, NANOSCALE RES LETT, V8, P1, DOI DOI 10.1186/1556-276X-8-1; Kim B, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-104; Kooi ME, 2003, CIRCULATION, V107, P2453, DOI 10.1161/01.CIR.0000068315.98705.CC; Korosoglou G, 2008, J AM COLL CARDIOL, V52, P483, DOI 10.1016/j.jacc.2008.03.063; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lim EK, 2012, J MATER CHEM, V22, P17518, DOI 10.1039/c2jm32277c; Lim EK, 2011, J MATER CHEM, V21, P12473, DOI 10.1039/c1jm10764j; Lim EK, 2011, ADV MATER, V23, P2436, DOI 10.1002/adma.201100351; Modo M, 2002, NEUROIMAGE, V17, P803, DOI 10.1006/nimg.2002.1194; Morishige K, 2010, CIRCULATION, V122, P1707, DOI 10.1161/CIRCULATIONAHA.109.891804; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Ruehm SG, 2001, CIRCULATION, V103, P415; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Sasaki T, 2006, ARTERIOSCL THROM VAS, V26, P1304, DOI 10.1161/01.ATV.0000219687.71607.f7; Schmitz SA, 2000, INVEST RADIOL, V35, P460, DOI 10.1097/00004424-200008000-00002; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shiomi M, 2009, ATHEROSCLEROSIS, V207, P1, DOI 10.1016/j.atherosclerosis.2009.03.024; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; Stuber M, 2007, MAGN RESON MED, V58, P1072, DOI 10.1002/mrm.21399; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; WEISSLEDER R, 1990, RADIOLOGY, V175, P494, DOI 10.1148/radiology.175.2.2326475; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; You DG, 2014, CARBOHYD POLYM, V101, P1225, DOI 10.1016/j.carbpol.2013.10.068; Zhang LJ, 2011, J MAGN RESON IMAGING, V33, P194, DOI 10.1002/jmri.22412	38	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124572	10.1371/journal.pone.0124572	http://dx.doi.org/10.1371/journal.pone.0124572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978437	Green Submitted, gold, Green Published			2022-12-27	WOS:000354916100015
J	Molina, MA; Diaz, AM; Hesse, C; Ginter, W; Gentilini, MV; Nunez, GG; Canellada, AM; Sparwasser, T; Berod, L; Castro, MS; Manghi, MA				Molina, Matias Alejandro; Diaz, Ailen Magali; Hesse, Christina; Ginter, Wiebke; Gentilini, Maria Virginia; Nunez, Guillermo Gabriel; Canellada, Andrea Mercedes; Sparwasser, Tim; Berod, Luciana; Castro, Marisa Silvia; Manghi, Marcela Alejandra			Immunostimulatory Effects Triggered by Enterococcus faecalis CECT7121 Probiotic Strain Involve Activation of Dendritic Cells and Interferon-Gamma Production	PLOS ONE			English	Article							LIPOTEICHOIC ACID; TRANSGENIC MICE; CUTTING EDGE; T-CELLS; IN-VIVO; INDUCTION; LACTOBACILLI; INFECTION; ANTIGENS; INNATE	Probiotics can modulate the immune system, conferring beneficial effects on the host. Understanding how these microorganisms contribute to improve the health status is still a challenge. Previously, we have demonstrated that Enterococcus faecalis CECT7121 implants itself and persists in the murine gastrointestinal tract, and enhances and skews the profile of cytokines towards the Th1 phenotype in several biological models. Given the importance of dendritic cells (DCs) in the orchestration of immunity, the aim of this work was to elucidate the influence of E. faecalis CECT7121 on DCs and the outcome of the immune responses. In this work we show that E. faecalis CECT7121 induces a strong dose-dependent activation of DCs and secretion of high levels of IL-12, IL-6, TNF alpha, and IL-10. This stimulation is dependent on TLR signaling, and skews the activation of T cells towards the production of IFN gamma. The influence of this activation in the establishment of Th responses in vivo shows the accumulation of specific IFN gamma-producing cells. Our findings indicate that the activation exerted by E. faecalis CECT7121 on DCs and its consequence on the cellular adaptive immune response may have broad therapeutic implications in immunomodulation.	[Molina, Matias Alejandro; Diaz, Ailen Magali; Nunez, Guillermo Gabriel; Castro, Marisa Silvia; Manghi, Marcela Alejandra] Ciudad Autonoma Buenos Aires, IDEHU CONICET UBA, Lab Modulac Respuesta Inmune, Buenos Aires, DF, Argentina; [Hesse, Christina; Ginter, Wiebke; Sparwasser, Tim; Berod, Luciana] Joint Venture Med Sch Hanover MHH, Inst Infect Immunol, TWINCORE, Ctr Expt & Clin Infect Res, Hannover, Germany; [Hesse, Christina; Ginter, Wiebke; Sparwasser, Tim; Berod, Luciana] Helmholtz Ctr Infect Res HZI, Hannover, Germany; [Gentilini, Maria Virginia] Ciudad Autonoma Buenos Aires, Inst Inmunol Genet & Metabol, INIGEM CONICET UBA, Buenos Aires, DF, Argentina; [Canellada, Andrea Mercedes] Ciudad Autonoma Buenos Aires, IDEHU CONICET UBA, Lab Anticuerpos Asimetricos & Inmunol Reprod, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Manghi, MA (corresponding author), Ciudad Autonoma Buenos Aires, IDEHU CONICET UBA, Lab Modulac Respuesta Inmune, Buenos Aires, DF, Argentina.	manghim@ffyb.uba.ar	Berod, Luciana/AAG-8095-2019; Sparwasser, Tim D/AAA-4306-2022; Sparwasser, Tim/AAF-7085-2019	Berod, Luciana/0000-0002-9677-3483; Sparwasser, Tim/0000-0001-5645-902X; Castro, Marisa/0000-0003-2129-5875	University of Buenos Aires, Argentina [20020100101002]; Institute of Infection Immunology (Twincore, Hannover, Germany); Institute of Infection Immunology (Twincore, Hannover, Germany) [PROALAR DA/10/05]; Laboratorio de Modulacion de la Respuesta Inmune, (IDEHU, CONICET-UBA, Argentina) [PROALAR DA/10/05]; Ministry of Science, Technology and Productive Innovation (MINCyT, Argentina); German Academic Exchange Service (DAAD, Germany)	University of Buenos Aires, Argentina(University of Buenos Aires); Institute of Infection Immunology (Twincore, Hannover, Germany); Institute of Infection Immunology (Twincore, Hannover, Germany); Laboratorio de Modulacion de la Respuesta Inmune, (IDEHU, CONICET-UBA, Argentina); Ministry of Science, Technology and Productive Innovation (MINCyT, Argentina); German Academic Exchange Service (DAAD, Germany)(Deutscher Akademischer Austausch Dienst (DAAD))	Funding: Our work was partly supported by University of Buenos Aires, Argentina (grant number 20020100101002) to MarAM and institutional funding from the Institute of Infection Immunology (Twincore, Hannover, Germany). This work was done in the frame of a scientific collaborative program (PROALAR DA/10/05) between the Institute of Infection Immunology (Twincore, Hannover, Germany) and the Laboratorio de Modulacion de la Respuesta Inmune, (IDEHU, CONICET-UBA, Argentina) granted to TDS and MarAM by the Ministry of Science, Technology and Productive Innovation (MINCyT, Argentina) and the German Academic Exchange Service (DAAD, Germany). The funds granted by this program were exclusively aimed to cover the costs of travel and accommodations for travel between Germany and Argentina for the researchers involved to specific project tasks. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ARAKI Y, 1972, J BIOL CHEM, V247, P6312; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Baba N, 2009, IMMUNOLOGY, V128, pe523, DOI 10.1111/j.1365-2567.2008.03022.x; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Boirivant M, 2008, MUCOSAL IMMUNOL, V1, pS47, DOI 10.1038/mi.2008.52; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Castro M., 2008, INT J PROBIOTICS PRE, V3, P25; Castro M., 2007, INT J PROBIOTICS PRE, V2, P215; Castro MS, 2012, INT ARCH ALLERGY IMM, V157, P11, DOI 10.1159/000324673; Castro MS, 2010, J APPL MICROBIOL, V109, P1234, DOI 10.1111/j.1365-2672.2010.04747.x; Cervi L, 2004, J IMMUNOL, V172, P2016, DOI 10.4049/jimmunol.172.4.2016; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Finkelman FD, 1996, J IMMUNOL, V157, P1406; Food and Agriculture Organization of the United States-World Health Organization, 2001, HLTH NUTR PROP PROB; Ganesh V, 2014, INFECT IMMUN, V82, P1052, DOI 10.1128/IAI.01378-13; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heeg K, 1998, EUR J CLIN MICROBIOL, V17, P464, DOI 10.1007/BF01691128; Hua MC, 2010, WORLD J GASTROENTERO, V16, P3529, DOI 10.3748/wjg.v16.i28.3529; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Keler T, 2004, EXPERT OPIN BIOL TH, V4, P1953, DOI 10.1517/14712598.4.12.1953; Kirjavainen PV, 1999, CLIN DIAGN LAB IMMUN, V6, P799, DOI 10.1128/CDLI.6.6.799-802.1999; Kirjavainen PV, 1999, FEMS IMMUNOL MED MIC, V26, P131, DOI 10.1111/j.1574-695X.1999.tb01380.x; Klaenhammer TR, 2012, NAT REV IMMUNOL, V12, P728, DOI 10.1038/nri3312; Kosaka A, 2012, INT IMMUNOPHARMACOL, V14, P729, DOI 10.1016/j.intimp.2012.10.007; Kruisbeek AM, 2001, CURR PROTOC IMMUNOL, V39, P313; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; MacDonald AS, 2002, J IMMUNOL, V168, P3127, DOI 10.4049/jimmunol.168.7.3127; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2012, TRENDS IMMUNOL, V33, P160, DOI 10.1016/j.it.2012.02.002; Mann ER, 2013, IMMUNOL LETT, V150, P30, DOI 10.1016/j.imlet.2013.01.007; Mayer CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00183; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059746; Plitnick LM, 2001, CLIN DIAGN LAB IMMUN, V8, P972, DOI 10.1128/CDLI.8.5.972-979.2001; Poe SL, 2013, MUCOSAL IMMUNOL, V6, P189, DOI 10.1038/mi.2012.62; Popovic ZV, 2011, J IMMUNOL, V187, P6217, DOI 10.4049/jimmunol.1003478; Schaefer M, 2008, J IMMUNOL, V180, P6836, DOI 10.4049/jimmunol.180.10.6836; Shida K, 2011, GUT MICROBES, V2, P109, DOI 10.4161/gmic.2.2.15661; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006; Weill FS, 2012, BR J NUTR, P1; Weiss G, 2011, CYTOKINE, V56, P520, DOI 10.1016/j.cyto.2011.07.024	56	38	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127262	10.1371/journal.pone.0127262	http://dx.doi.org/10.1371/journal.pone.0127262			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978357	Green Published, gold			2022-12-27	WOS:000354916100141
J	Motawae, TM; Ismail, MF; Shabayek, MI; Seleem, MM				Motawae, Tarek M.; Ismail, Manal F.; Shabayek, Marwa I.; Seleem, Mae M.			MicroRNAs 9 and 370 Association with Biochemical Markers in T2D and CAD Complication of T2D	PLOS ONE			English	Article							EXPRESSION; RISK; GENE	Background MicroRNAs (miRNAs) are small non coding RNAs with essential roles, of which any alteration leads to several conditions. Their roles in diabetes (DM) and its vascular complications have not been completely assessed. Aim to study the association of two miRNAs; 9 and 370, with biochemical parameters of type 2 diabetic (T2D), dyslipidemia and coronary artery disease (CAD). Subjects and Methods Blood samples were taken from 200 subjects of both genders, in the Outpatient clinic of Al Qasr El-Einy teaching hospitals, in which levels of both miRNAs (using real time PCR) and routine parameters were measured. Subjects were divided over four groups, 50 in each group as follows; patients with T2D, patients with CAD, patients with T2D and CAD, and healthy control subjects. Main Outcome miRNA 9 levels were expected to be over expressed in diabetic patients, while miRNA 370 levels were expected to be over expressed in those suffering from CAD and their association with CAD complication of T2D. Results miRNA 9 levels were significantly higher in T2D patients and T2D patients with CAD, (1.18 +/- 0.07, and 1.31 +/- 0.08 respectively), while miRNA 370 levels were significantly higher in T2D patients, CAD patients, and T2D patients with CAD (0.59 +/- 0.05, 1.00 +/- 0.05, and 1.20 +/- 0.06 respectively), compared to control group at p = 0.000. In addition both miRNAs were still significantly associated with each other even after conducting multiple regression analysis. Conclusion This study associates the possible role of miRNAs in the diagnosis/prognosis of CAD complication of T2D.	[Motawae, Tarek M.; Ismail, Manal F.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Shabayek, Marwa I.; Seleem, Mae M.] Future Univ, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Biochem, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Future University in Egypt	Seleem, MM (corresponding author), Future Univ, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Biochem, Cairo, Egypt.	Biochemistry.fue@gmail.com						Akinci E, 2012, BIOCHEM J, V442, P539, DOI 10.1042/BJ20111678; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bonow RO, 1996, AM J MED, V101, pA17S; da Costa Martins PA, 2010, NAT CELL BIOL, V12, P1220, DOI [10.1038/ncb2126., DOI 10.1038/NCB2126]; Herder C, 2011, CLIN PHARMACOL THER, V90, P52, DOI 10.1038/clpt.2011.93; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu Y, 2012, INT J PATHOLOGY CLIN, V5, P012; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Olszanecka-Glinianowicz Magdalena, 2005, Pol Merkur Lekarski, V18, P101; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Puri R, 2011, NAT REV CARDIOL, V8, P131, DOI 10.1038/nrcardio.2010.210; Qin B, 2012, MOL BIOL REP, V39, P4509, DOI 10.1007/s11033-011-1241-0; Rosenson RS, 2005, CURR PROB CARDIOLOGY, V30, P241, DOI 10.1016/j.cpcardiol.2004.10.001; Sacco J, 2012, CURR OPIN LIPIDOL, V23, P220, DOI 10.1097/MOL.0b013e3283534c9f; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Singh V, 2009, VASC HEALTH RISK MAN, V5, P495; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Williams MD, 2012, MICRORNAS INSULIN RE	24	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126957	10.1371/journal.pone.0126957	http://dx.doi.org/10.1371/journal.pone.0126957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978320	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100116
J	Rong, J; Li, QX; Zhang, PP; Wu, XY; Huang, JX; Li, C; Liao, ZT; Xie, YY; Lv, Q; Wei, QJ; Li, TW; Huang, JL; Cao, SY; Shen, Y; Gu, JR				Rong, Ju; Li, Qiuxia; Zhang, Pingping; Wu, Xinyu; Huang, Jinxian; Li, Chao; Liao, Zetao; Xie, Yingying; Lv, Qing; Wei, Qiujing; Li, Tianwang; Huang, Jianlin; Cao, Shuangyan; Shen, Yan; Gu, Jieruo			A Rare Co-Segregation-Mutation in the Insulin Receptor Substrate 1 Gene in One Chinese Family with Ankylosing Spondylitis	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; IRS-1; SUSCEPTIBILITY; POLYMORPHISM; RESISTANCE; VARIANT; CELLS; FORMS; LOCI; MICE	Ankylosing spondylitis (AS; MIM 106300) is a common rheumatic disease with strong genetic components affecting approximately 0.3% of the population. The exact genetic mechanism of AS remains elusive. Our previous study showed that AS could be transmitted in an autosomal dominant inheritance mode and a 6-cM candidate region located on the chromosome 2q36.1-36.3 was mapped in a Chinese family. Mutation screening was conducted within the candidate region in the family and other AS by sequencing, and the novel mutation will be further validated in other AS families, sporadic cases and healthy controls by mass spectrometry. We identified a rare non-synonymous mutation (Arg580Gly) in insulin receptor substrate 1 (IRS1) co-segregated with disease phenotype in patients of the family, which was not found in other AS families, sporadic patients and healthy controls. In the study, we found a rare non-synonymous mutation in IRS1 co-segregation in one Chinese family with AS, which indicated a new candidate disease causative gene for AS.	[Rong, Ju; Li, Qiuxia; Zhang, Pingping; Wu, Xinyu; Huang, Jinxian; Li, Chao; Liao, Zetao; Xie, Yingying; Lv, Qing; Wei, Qiujing; Li, Tianwang; Huang, Jianlin; Cao, Shuangyan; Gu, Jieruo] Sun Yat Sen Univ, Affiliated Hosp 3, Div Rheumatol, Guangzhou 510630, Guangdong, Peoples R China; [Shen, Yan] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Shen, Yan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shen, Yan] Chinese Natl Human Genome Res Ctr, Beijing 100021, Peoples R China	Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Gu, JR (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Div Rheumatol, Tianhe Rd 600, Guangzhou 510630, Guangdong, Peoples R China.	gujieruo@163.com	Huang, Jinxian/AAD-1918-2022	Li, Tian-wang/0000-0001-6438-2691	National Natural Science Foundation of China [30325019, 30571735, 30471611]; Sun Yat-Sen University [2007023]; JRG	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-Sen University; JRG	The work was supported by the following: National Natural Science Foundation of China (No. 30325019), http://www.nsfc.gov.cn, funder: JRG; National Natural Science Foundation of China (No. 30571735), http://www.nsfc.gov.cn, funder: JRG; National Natural Science Foundation of China (No. 30471611), http://www.nsfc.gov.cn, funder: JRG; and Sun Yat-Sen University clinical research 5010 program (No. 2007023), http://www.sysu.edu.cn, funder: JRG. The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMIND K, 1993, LANCET, V342, P828, DOI 10.1016/0140-6736(93)92694-O; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Berthelot JM, 2002, JOINT BONE SPINE, V69, P114, DOI 10.1016/S1297-319X(02)00371-8; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Cheng S, 2007, SEMIN ARTHRITIS RHEU, V37, P39, DOI 10.1016/j.semarthrit.2007.01.003; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Esposito DL, 2003, J CLIN ENDOCR METAB, V88, P1468, DOI 10.1210/jc.2002-020933; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Gu J, 2009, J MED GENET, V46, P657, DOI 10.1136/jmg.2009.066456; Hoshi K, 2004, J BONE MINER RES, V19, P214, DOI 10.1359/JBMR.0301221; Hribal ML, 2000, J CLIN ENDOCR METAB, V85, P2004, DOI 10.1210/jc.85.5.2004; Imai Y, 1997, J CLIN ENDOCR METAB, V82, P4201, DOI 10.1210/jc.82.12.4201; Jacobs AR, 2001, J BIOL CHEM, V276, P40795, DOI 10.1074/jbc.M105194200; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LEE CH, 1993, P NATL ACAD SCI USA, V90, P11713, DOI 10.1073/pnas.90.24.11713; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Mammarella S, 1998, Hum Mutat, V11, P411, DOI 10.1002/(SICI)1098-1004(1998)11:5<411::AID-HUMU12>3.3.CO;2-R; McGettrick AJ, 2005, J BIOL CHEM, V280, P6441, DOI 10.1074/jbc.M412300200; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; Whitehead JP, 1998, DIABETES, V47, P837, DOI 10.2337/diabetes.47.5.837; Yamaguchi M, 2005, ENDOCRINOLOGY, V146, P2620, DOI 10.1210/en.2004-1511	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126348	10.1371/journal.pone.0126348	http://dx.doi.org/10.1371/journal.pone.0126348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978640	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100065
J	Tada, M; Uchida, H; Maeda, T; Konishi, M; Umeda, S; Terasawa, Y; Nakajima, S; Mimura, M; Miyazaki, T; Takahashi, T				Tada, Mitsuhiro; Uchida, Hiroyuki; Maeda, Takaki; Konishi, Mika; Umeda, Satoshi; Terasawa, Yuri; Nakajima, Shinichiro; Mimura, Masaru; Miyazaki, Tomoyuki; Takahashi, Takuya			Fear Conditioning Induced by Interpersonal Conflicts in Healthy Individuals	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; POSTTRAUMATIC-STRESS-DISORDER; SOCIAL ANXIETY; EMOTIONAL RESPONSES; POTENTIATED STARTLE; NEURAL RESPONSES; AMYGDALA; STIMULI; CORTEX; METAANALYSIS	Psychophysiological markers have been focused to investigate the psychopathology of psychiatric disorders and personality subtypes. In order to understand neurobiological mechanisms underlying these conditions, fear-conditioning model has been widely used. However, simple aversive stimuli are too simplistic to understand mechanisms because most patients with psychiatric disorders are affected by social stressors. The objective of this study was to test the feasibility of a newly-designed conditioning experiment using a stimulus to cause interpersonal conflicts and examine associations between personality traits and response to that stimulus. Twenty-nine healthy individuals underwent the fear conditioning and extinction experiments in response to three types of stimuli: a simple aversive sound, disgusting pictures, and pictures of an actors' face with unpleasant verbal messages that were designed to cause interpersonal conflicts. Conditioned response was quantified by the skin conductance response (SCR). Correlations between the SCR changes, and personality traits measured by the Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) and Revised NEO Personality Inventory were explored. The interpersonal conflict stimulus resulted in successful conditioning, which was subsequently extinguished, in a similar manner as the other two stimuli. Moreover, a greater degree of conditioned response to the interpersonal conflict stimulus correlated with a higher ZAN-BPD total score. Fear conditioning and extinction can be successfully achieved, using interpersonal conflicts as a stimulus. Given that conditioned fear caused by the interpersonal conflicts is likely associated with borderline personality traits, this paradigm could contribute to further understanding of underlying mechanisms of interpersonal fear implicated in borderline personality disorder.	[Tada, Mitsuhiro; Uchida, Hiroyuki; Maeda, Takaki; Konishi, Mika; Nakajima, Shinichiro; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Uchida, Hiroyuki; Nakajima, Shinichiro] Ctr Addict & Mental Hlth, Geriatr Psychiat Div, Toronto, ON, Canada; [Umeda, Satoshi; Terasawa, Yuri] Keio Univ, Dept Psychol, Tokyo, Japan; [Umeda, Satoshi; Terasawa, Yuri] Keio Univ, Ctr Adv Res Log & Sensibil, Tokyo, Japan; [Terasawa, Yuri] Natl Ctr Neurol & Psychiat, Dept Psychophysiol, Tokyo, Japan; [Nakajima, Shinichiro] Ctr Addict & Mental Hlth, Res Imaging Ctr, Multimodal Imaging Grp, Toronto, ON, Canada; [Nakajima, Shinichiro] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Miyazaki, Tomoyuki; Takahashi, Takuya] Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa 232, Japan; [Takahashi, Takuya] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA	Keio University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Keio University; Keio University; National Center for Neurology & Psychiatry - Japan; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Yokohama City University; Yeshiva University	Takahashi, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa 232, Japan.	takahast@yokohama-cu.ac.jp	Nakajima, Shinichiro/V-1282-2019; Nakajima, Shinichiro/O-3011-2018; Terasawa, Yuri/HGA-1834-2022; Uchida, Hiroyuki/I-4867-2015	Terasawa, Yuri/0000-0002-2812-0544; Uchida, Hiroyuki/0000-0002-0628-7036	Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [26119524, 26350990] Funding Source: KAKEN	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project was supported by Special Coordination Funds for Promoting Science and Technology (T.T.), "Development of biomarker candidates for social behavior," carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Aviram RB, 2006, HARVARD REV PSYCHIAT, V14, P249, DOI 10.1080/10673220600975121; Barnow S, 2009, BEHAV RES THER, V47, P359, DOI 10.1016/j.brat.2009.02.003; Baskin-Sommers AR, 2012, J ABNORM PSYCHOL, V121, P477, DOI 10.1037/a0026753; Bechara A, 1999, J NEUROSCI, V19, P5473; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; Bianchin M, 2012, PHYSIOL BEHAV, V105, P925, DOI 10.1016/j.physbeh.2011.10.031; Bland Ann R, 2004, Issues Ment Health Nurs, V25, P655, DOI 10.1080/01612840490486692; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; Collimore KC, 2010, DEPRESS ANXIETY, V27, P1017, DOI [10.1002/da.20771, 10.1002/da.20759]; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Craske MG, 2009, DEPRESS ANXIETY, V26, P1066, DOI 10.1002/da.20633; DAVIDSON J, 1989, COMPR PSYCHIAT, V30, P357, DOI 10.1016/0010-440X(89)90001-1; Davis FC, 2010, CEREB CORTEX, V20, P612, DOI 10.1093/cercor/bhp126; Derogatis L, 1983, SCL 90 R ADM SCOR PR, V2nd; Dibbets P, 2012, J BEHAV THER EXP PSY, V43, P614, DOI 10.1016/j.jbtep.2011.08.006; Domes G, 2008, J PERS DISORD, V22, P135, DOI 10.1521/pedi.2008.22.2.135; Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X; Ebner-Priemer UW, 2009, J PSYCHIATR NEUROSCI, V34, P214; Fournier JC, 2012, J PSYCHIATR RES, V46, P1223, DOI 10.1016/j.jpsychires.2012.06.002; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gunderson JG, 2008, J PERS DISORD, V22, P22, DOI 10.1521/pedi.2008.22.1.22; Gunderson JG, 2007, AM J PSYCHIAT, V164, P1637, DOI 10.1176/appi.ajp.2007.07071125; Hazlett EA, 2007, BIOL PSYCHIAT, V62, P250, DOI 10.1016/j.biopsych.2006.10.028; Hecht David, 2014, Exp Neurobiol, V23, P1, DOI 10.5607/en.2014.23.1.1; Herpertz SC, 1999, AM J PSYCHIAT, V156, P1550, DOI 10.1176/ajp.156.10.1550; Herpertz SC, 2000, J PERS DISORD, V14, P339, DOI 10.1521/pedi.2000.14.4.339; Holt DJ, 2012, ARCH GEN PSYCHIAT, V69, P893, DOI 10.1001/archgenpsychiatry.2011.2310; HUBBARD JR, 1995, AM FAM PHYSICIAN, V52, P908; Inslicht SS, 2013, J PSYCHIATR RES, V47, P64, DOI 10.1016/j.jpsychires.2012.08.027; Jitsuki S, 2011, NEURON, V69, P780, DOI 10.1016/j.neuron.2011.01.016; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Johnson PA, 2003, J NEUROPSYCH CLIN N, V15, P397, DOI 10.1176/appi.neuropsych.15.4.397; Kamphausen S, 2013, WORLD J BIOL PSYCHIA, V14, P307, DOI 10.3109/15622975.2012.665174; Kuo JR, 2009, J ABNORM PSYCHOL, V118, P531, DOI 10.1037/a0016392; Lang P.J., 2008, A8 U FLOR; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2012, DEPRESS ANXIETY, V29, P257, DOI 10.1002/da.21922; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Minzenberg MJ, 2008, J PSYCHIATR RES, V42, P727, DOI 10.1016/j.jpsychires.2007.07.015; Mitsushima D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3760; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Miyazaki T, 2013, EUR J NEUROSCI, V37, P1602, DOI 10.1111/ejn.12188; Miyazaki T, 2012, J CLIN INVEST, V122, P2690, DOI 10.1172/JCI63060; MORGAN CA, 1995, BIOL PSYCHIAT, V38, P378, DOI 10.1016/0006-3223(94)00321-S; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Pavlov I.P., 1927, CONDITIONED REFLEXES; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Pine DS, 2009, DEPRESS ANXIETY, V26, P775, DOI 10.1002/da.20595; Radaelli D, 2012, PSYCHIAT RES-NEUROIM, V203, P61, DOI 10.1016/j.pscychresns.2011.09.010; Reisch T, 2008, ACTA PSYCHIAT SCAND, V118, P42, DOI 10.1111/j.1600-0447.2008.01222.x; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Ruocco AC, 2013, BIOL PSYCHIAT, V73, P153, DOI 10.1016/j.biopsych.2012.07.014; Schmahl CG, 2004, PSYCHIAT RES, V126, P33, DOI 10.1016/j.psychres.2004.01.005; Schore AN, 2014, PSYCHOTHERAPY, V51, P388, DOI 10.1037/a0037083; Sieswerda S, 2007, BEHAV RES THER, V45, P1011, DOI 10.1016/j.brat.2006.07.012; Stanley B, 2010, AM J PSYCHIAT, V167, P24, DOI 10.1176/appi.ajp.2009.09050744; Stein DJ, 2002, J CLIN PSYCHIAT, V63, P12; Unoka Z, 2011, PSYCHIAT RES, V189, P419, DOI 10.1016/j.psychres.2011.02.010; Zanarini MC, 2003, J PERS DISORD, V17, P233, DOI 10.1521/pedi.17.3.233.22147	64	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125729	10.1371/journal.pone.0125729	http://dx.doi.org/10.1371/journal.pone.0125729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978817	Green Published			2022-12-27	WOS:000354916100034
J	Daraki, V; Georgiou, V; Papavasiliou, S; Chalkiadaki, G; Karahaliou, M; Koinaki, S; Sarri, K; Vassilaki, M; Kogevinas, M; Chatzi, L				Daraki, Vasiliki; Georgiou, Vaggelis; Papavasiliou, Stathis; Chalkiadaki, Georgia; Karahaliou, Marianna; Koinaki, Stella; Sarri, Katerina; Vassilaki, Maria; Kogevinas, Manolis; Chatzi, Leda			Metabolic Profile in Early Pregnancy Is Associated with Offspring Adiposity at 4 Years of Age: The Rhea Pregnancy Cohort Crete, Greece	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; MATERNAL OBESITY; RISK-FACTORS; PLACENTAL CONTRIBUTION; CHILDHOOD OBESITY; GENE-EXPRESSION; SEX-DIFFERENCES; CHILDREN; HEALTH; DISEASE	Context Maternal pre-pregnancy obesity may increase the risk of childhood obesity but it is unknown whether other metabolic factors in early pregnancy such as lipid profile and hypertension are associated with offspring cardiometabolic traits. Objective Our objective was to investigate whether fasting lipid, glucose, and insulin levels during early pregnancy and maternal pre-pregnancy weight status, are associated with offspring adiposity measures, lipid levels and blood pressure at preschool age. Design and Methods The study included 618 mother-child pairs of the pregnancy cohort "Rhea" study in Crete, Greece. Pregnant women were recruited at the first prenatal visit (mean: 12weeks, SD: 0.7). A subset of 348 women provided fasting serum samples for glucose and lipid measurements. Outcomes measures were body mass index, abdominal circumference, sum of skin-fold thickness, and blood pressure measurements at 4 years of age. A subsample of 525 children provided non-fasting blood samples for lipid measurements. Results Pre-pregnancy overweight/obesity was associated with greater risk of offspring overweight/ obesity (RR: 1.83, 95% CI: 1.19, 2.81), central adiposity (RR: 1.97, 95% CI: 1.11, 3.49), and greater fat mass by 5.10mm (95% CI: 2.49, 7.71) at 4 years of age. These associations were more pronounced in girls. An increase of 40mg/dl in fasting serum cholesterol levels in early pregnancy was associated with greater skinfold thickness by 3.30mm (95% CI: 1.41, 5.20) at 4 years of age after adjusting for pre-pregnancy BMI and several other confounders. An increase of 10mmHg in diastolic blood pressure in early pregnancy was associated with increased risk of offspring overweight/obesity (RR: 1.22, 95% CI: 1.03, 1.45), and greater skinfold thickness by 1.71mm (95% CI: 0.57, 2.86) at 4 years of age. Conclusions Metabolic dysregulation in early pregnancy may increase the risk of obesity at preschool age.	[Daraki, Vasiliki; Georgiou, Vaggelis; Chalkiadaki, Georgia; Karahaliou, Marianna; Koinaki, Stella; Sarri, Katerina; Vassilaki, Maria; Chatzi, Leda] Univ Crete, Fac Med, Dept Social Med, Iraklion, Greece; [Daraki, Vasiliki; Papavasiliou, Stathis] Univ Hosp Crete, Clin Endocrinol, Iraklion, Greece; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis] IMIM Hosp Mar Res Inst, Barcelona, Spain; [Kogevinas, Manolis] CIBERESP, Barcelona, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece	University of Crete; University of Crete; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; National & Kapodistrian University of Athens	Chatzi, L (corresponding author), Univ Crete, Fac Med, Dept Social Med, Iraklion, Greece.	lchatzi@med.uoc.gr	Kogevinas, Manolis/C-3918-2017	Kogevinas, Manolis/0000-0002-9605-0461	Greek Ministry of Health; European project (EU FP6-2-Food-3NewGeneris); European project EU FP6. STREP Hiwate; European project EU FP7 ENV.2007.1.2.2.2. [211250 Escape]; European project EU FP7-ENV-1.2.1.4 Envirogenomarkers; European project EU FP7HEALTH-single stage CHICOS; European project EU-FP7-HEALTH [308333 HELIX]	Greek Ministry of Health(Greek Ministry of Development-GSRT); European project (EU FP6-2-Food-3NewGeneris); European project EU FP6. STREP Hiwate; European project EU FP7 ENV.2007.1.2.2.2.; European project EU FP7-ENV-1.2.1.4 Envirogenomarkers; European project EU FP7HEALTH-single stage CHICOS; European project EU-FP7-HEALTH	Rhea project was financially supported by European projects (EU FP6-2003-Food-3NewGeneris, EU FP6. STREP Hiwate, EU FP7 ENV.2007.1.2.2.2. Project No 211250 Escape, EU FP7-2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7HEALTH- 2009-single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226285 ENRIECO, EU-FP7-HEALTH-2012 Proposal No 308333 HELIX) and the Greek Ministry of Health (Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion district, Crete, Greece: 2011-2014; "Rhea Plus": Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Behl M, 2013, ENVIRON HEALTH PERSP, V121, P170, DOI 10.1289/ehp.1205404; Bekkers MBM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025533; Blair NJ, 2007, ARCH DIS CHILD, V92, P866, DOI 10.1136/adc.2007.116855; Chatzi L, 2009, AM J EPIDEMIOL, V170, P829, DOI 10.1093/aje/kwp211; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Derraik JG, 2014, CLIN ENDOCRINOL OXF; Desai M, 2015, INT J OBES LOND; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gademan MGJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094594; Gaillard R, 2014, HYPERTENSION, V63, P683, DOI 10.1161/HYPERTENSIONAHA.113.02671; Gale CR, 2007, J CLIN ENDOCR METAB, V92, P3904, DOI 10.1210/jc.2007-0088; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Jellinger PS, 2012, ENDOCR PRACT, V18, P270, DOI 10.4158/EP.18.2.269; Karachaliou M, 2014, AM J OBSTET GYNECOL; Kyle UG, 2006, CURR OPIN CLIN NUTR, V9, P388, DOI 10.1097/01.mco.0000232898.74415.42; Lampl M, 2010, AM J HUM BIOL, V22, P431, DOI 10.1002/ajhb.21014; Lawlor DA, 2012, NAT REV ENDOCRINOL, V8, P679, DOI 10.1038/nrendo.2012.176; Leventakou V, 2015, PUBLIC HEALTH NUTR, V18, P421, DOI 10.1017/S1368980014000445; Linardakis M, 2011, INT J CHLD HLTH HUMA, V3, P329; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; McCowan L, 2009, BEST PRACT RES CL OB, V23, P779, DOI 10.1016/j.bpobgyn.2009.06.003; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Napoli C, 2002, CIRCULATION, V105, P1360, DOI 10.1161/01.CIR.0000013090.96919.FA; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Oostvogels AJ, 2014, J CLIN ENDOCR METAB; Patro B, 2013, ANN NUTR METAB, V63, P32, DOI 10.1159/000350313; Perng W, 2014, ANN EPIDEMIOL; Poston L, 2012, BEST PRACT RES CL EN, V26, P627, DOI 10.1016/j.beem.2012.03.010; Poston L, 2012, CURR OPIN CLIN NUTR, V15, P252, DOI 10.1097/MCO.0b013e3283527cf2; Rasmussen KM, 2009, REEXAMINING GUIDELIN; Regnault N, 2013, DIABETES CARE, V36, P3045, DOI 10.2337/dc13-0333; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Reynolds SA, 2012, GENDER MED, V9, P424, DOI 10.1016/j.genm.2012.10.013; Seed PT, 2011, HYPERTENS PREGNANCY, V30, P58, DOI 10.3109/10641955.2010.486460; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Steiner MJ, 2011, PEDIATRICS, V128, P463, DOI 10.1542/peds.2011-0844; Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627	47	53	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126327	10.1371/journal.pone.0126327	http://dx.doi.org/10.1371/journal.pone.0126327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970502	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200103
J	Marjonen, H; Sierra, A; Nyman, A; Rogojin, V; Grohn, O; Linden, AM; Hautaniemi, S; Kaminen-Ahola, N				Marjonen, Heidi; Sierra, Alejandra; Nyman, Anna; Rogojin, Vladimir; Grohn, Olli; Linden, Anni-Maija; Hautaniemi, Sampsa; Kaminen-Ahola, Nina			Early Maternal Alcohol Consumption Alters Hippocampal DNA Methylation, Gene Expression and Volume in a Mouse Model	PLOS ONE			English	Article							PRENATAL ETHANOL EXPOSURE; INDUCED BRAIN ABNORMALITIES; LONG-TERM POTENTIATION; VOLUNTARY CONSUMPTION; SPATIAL MEMORY; ACUTE INSULT; ADOLESCENTS; PATTERNS; MICE; 5-HYDROXYMETHYLCYTOSINE	The adverse effects of alcohol consumption during pregnancy are known, but the molecular events that lead to the phenotypic characteristics are unclear. To unravel the molecular mechanisms, we have used a mouse model of gestational ethanol exposure, which is based on maternal ad libitum ingestion of 10% (v/v) ethanol for the first 8 days of gestation (GD 0.5-8.5). Early neurulation takes place by the end of this period, which is equivalent to the developmental stage early in the fourth week post-fertilization in human. During this exposure period, dynamic epigenetic reprogramming takes place and the embryo is vulnerable to the effects of environmental factors. Thus, we hypothesize that early ethanol exposure disrupts the epigenetic reprogramming of the embryo, which leads to alterations in gene regulation and life-long changes in brain structure and function. Genome-wide analysis of gene expression in the mouse hippocampus revealed altered expression of 23 genes and three miRNAs in ethanol-exposed, adolescent offspring at postnatal day (P) 28. We confirmed this result by using two other tissues, where three candidate genes are known to express actively. Interestingly, we found a similar trend of upregulated gene expression in bone marrow and main olfactory epithelium. In addition, we observed altered DNA methylation in the CpG islands upstream of the candidate genes in the hippocampus. Our MRI study revealed asymmetry of brain structures in ethanol-exposed adult offspring (P60): we detected ethanol-induced enlargement of the left hippocampus and decreased volume of the left olfactory bulb. Our study indicates that ethanol exposure in early gestation can cause changes in DNA methylation, gene expression, and brain structure of offspring. Furthermore, the results support our hypothesis of early epigenetic origin of alcohol-induced disorders: changes in gene regulation may have already taken place in embryonic stem cells and therefore can be seen in different tissue types later in life.	[Marjonen, Heidi; Nyman, Anna; Kaminen-Ahola, Nina] Univ Helsinki, Fac Med, Dept Med Genet, Helsinki, Finland; [Sierra, Alejandra; Grohn, Olli] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland; [Rogojin, Vladimir; Hautaniemi, Sampsa] Univ Helsinki, Fac Med, Inst Biomed, Helsinki, Finland; [Rogojin, Vladimir; Hautaniemi, Sampsa] Univ Helsinki, Fac Med, Genome Scale Biol Res Program, Helsinki, Finland; [Linden, Anni-Maija] Univ Helsinki, Inst Biomed Pharmacol, Helsinki, Finland	University of Helsinki; University of Eastern Finland; University of Helsinki; University of Helsinki; University of Helsinki	Kaminen-Ahola, N (corresponding author), Univ Helsinki, Fac Med, Dept Med Genet, Helsinki, Finland.	nina.kaminen@helsinki.fi	Hautaniemi, Sampsa/CAG-0362-2022; Hautaniemi, Sampsa/A-3122-2009	Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Sierra Lopez, Alejandra/0000-0001-5399-2056; Kaminen-Ahola, Nina/0000-0003-1255-4716; Linden, Anni-Maija/0000-0003-1573-8051	Academy of Finland [258304]; Pavikki and Sakari Sohlberg Foundation; Finnish Foundation for Alcohol Studies; Finnish Cultural Foundation; Orion-Farmos Research Foundation; Paulo Foundation; Biocentrum Helsinki	Academy of Finland(Academy of Finland); Pavikki and Sakari Sohlberg Foundation; Finnish Foundation for Alcohol Studies; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Orion-Farmos Research Foundation; Paulo Foundation; Biocentrum Helsinki	This work was supported by the Academy of Finland (258304), Pavikki and Sakari Sohlberg Foundation, The Finnish Foundation for Alcohol Studies, Finnish Cultural Foundation, Orion-Farmos Research Foundation and Paulo Foundation to N.J. K., The Finnish Foundation for Alcohol Studies and Finnish Cultural Foundation to H.M.M., Academy of Finland (275453) and Finnish Cultural Foundation to A.S. and Biocentrum Helsinki to S.K.H. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	ABEL EL, 1983, NEUROBEH TOXICOL TER, V5, P363; ABEL EL, 1995, NEUROTOXICOL TERATOL, V17, P445, DOI 10.1016/0892-0362(95)98055-6; Akers KG, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-29; Allan AM, 2003, ALCOHOL CLIN EXP RES, V27, P2009, DOI 10.1097/01.ALC.0000100940.95053.72; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; BARNES DE, 1981, DEV BRAIN RES, V1, P333, DOI 10.1016/0165-3806(81)90071-7; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; Biegler R, 2001, P NATL ACAD SCI USA, V98, P6941, DOI 10.1073/pnas.121034798; BLANCHARD BA, 1987, NEUROTOXICOL TERATOL, V9, P253, DOI 10.1016/0892-0362(87)90010-9; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Carnahan MN, 2013, ALCOHOL, V47, P109, DOI 10.1016/j.alcohol.2012.12.003; Chen P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr513; Choi IY, 2005, ALCOHOL CLIN EXP RES, V29, P2053, DOI 10.1097/01.alc.0000187037.02670.59; Christie BR, 2005, EUR J NEUROSCI, V21, P1719, DOI 10.1111/j.1460-9568.2005.04004.x; CLAUSING P, 1995, NEUROTOXICOL TERATOL, V17, P545, DOI 10.1016/0892-0362(95)00014-I; CLAYTON NS, 1994, P NATL ACAD SCI USA, V91, P7410, DOI 10.1073/pnas.91.16.7410; Cullen CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101482; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Edalatmanesh MA, 2013, BRAIN RES, V1526, P15, DOI 10.1016/j.brainres.2013.06.024; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; GIANOULAKIS C, 1990, BEHAV BRAIN RES, V36, P217, DOI 10.1016/0166-4328(90)90060-R; Gil-Mohapel J, 2014, NEUROSCIENCE, V273, P174, DOI 10.1016/j.neuroscience.2014.05.012; Godin EA, 2010, ALCOHOL CLIN EXP RES, V34, P98, DOI 10.1111/j.1530-0277.2009.01071.x; Guerri C, 2002, NEUROTOX RES, V4, P327, DOI 10.1080/1029842021000010884; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hanson KL, 2010, AM J DRUG ALCOHOL AB, V36, P161, DOI 10.3109/00952991003736397; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson VP, 1996, AM J MED GENET, V61, P329, DOI 10.1002/(SICI)1096-8628(19960202)61:4<329::AID-AJMG6>3.0.CO;2-P; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Kaminen-Ahola N, 2010, BIRTH DEFECTS RES A, V88, P818, DOI 10.1002/bdra.20729; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Kleiber ML, 2012, BRAIN RES, V1458, P18, DOI 10.1016/j.brainres.2012.04.016; Klingenberg CP, 2010, ALCOHOL, V44, P649, DOI 10.1016/j.alcohol.2009.10.016; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Laufer BI, 2013, DIS MODEL MECH, V6, P977, DOI 10.1242/dmm.010975; Leinders-Zufall T, 2014, J NEUROSCI, V34, P5121, DOI 10.1523/JNEUROSCI.0186-14.2014; Liu YL, 2009, EPIGENETICS-US, V4, P500, DOI 10.4161/epi.4.7.9925; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maier SE, 2001, ALCOHOL RES HEALTH, V25, P168; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MATTSON SN, 1994, NEUROTOXICOL TERATOL, V16, P283, DOI 10.1016/0892-0362(94)90050-7; MCCLEARN GE, 1959, Q J STUD ALCOHOL, V20, P691; Miller MW, 1995, ALCOHOL CLIN EXP RES, V19, P1500, DOI 10.1111/j.1530-0277.1995.tb01014.x; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Mundt C, 2006, INT IMMUNOL, V18, P163, DOI 10.1093/intimm/dxh359; Nagel BJ, 2005, PSYCHIAT RES-NEUROIM, V139, P181, DOI 10.1016/j.pscychresns.2005.05.008; O'Leary-Moore SK, 2010, BIRTH DEFECTS RES A, V88, P953, DOI 10.1002/bdra.20719; OSBORNE GL, 1980, PHARMACOL BIOCHEM BE, V12, P393, DOI 10.1016/0091-3057(80)90043-X; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Parnell SE, 2014, ALCOHOL CLIN EXP RES, V38, P2008, DOI 10.1111/acer.12464; Parnell SE, 2009, ALCOHOL CLIN EXP RES, V33, P1001, DOI 10.1111/j.1530-0277.2009.00921.x; PEREZ HD, 1991, ANN NY ACAD SCI, V625, P300; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Richardson DP, 2002, EUR J NEUROSCI, V16, P1593, DOI 10.1046/j.1460-9568.2002.02214.x; Riikonen R, 1999, DEV MED CHILD NEUROL, V41, P652, DOI 10.1017/S0012162299001358; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Sadrian B, 2014, NEUROSCIENCE, V280, P204, DOI 10.1016/j.neuroscience.2014.09.008; Sakata-Haga H, 2004, ACTA NEUROPATHOL, V108, P393, DOI 10.1007/s00401-004-0901-8; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Sokol RJ, 2003, JAMA-J AM MED ASSOC, V290, P2996, DOI 10.1001/jama.290.22.2996; Sowell ER, 2002, NEUROIMAGE, V17, P1807, DOI 10.1006/nimg.2002.1328; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Sulik KK, 2005, EXP BIOL MED, V230, P366, DOI 10.1177/15353702-0323006-04; Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401; Swayze VW, 1997, PEDIATRICS, V99, P232, DOI 10.1542/peds.99.2.232; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tata PR, 2011, NUCLEIC ACIDS RES, V39, P3574, DOI 10.1093/nar/gkq1344; Tobi EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037933; Vega MCS, 2013, BEHAV BRAIN RES, V252, P326, DOI 10.1016/j.bbr.2013.06.003; VORHEES CV, 1986, NEUROTOXICOL TERATOL, V8, P23; WEST JR, 1981, SCIENCE, V211, P957; World Health Organization, WORLD HLTH REP 2002; Zhou FC, 2003, DEV BRAIN RES, V144, P43, DOI 10.1016/S0165-3806(03)00158-5; Zhou FC, 2011, ALCOHOL CLIN EXP RES, V35, P735, DOI 10.1111/j.1530-0277.2010.01391.x; Zhou FC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-124	90	44	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124931	10.1371/journal.pone.0124931	http://dx.doi.org/10.1371/journal.pone.0124931			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970770	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200056
J	Ye, Y; Yuan, J; Chang, XJ; Yang, M; Zhang, LJ; Lu, K; Lian, XM				Ye, Ying; Yuan, Jing; Chang, Xiaojian; Yang, Meng; Zhang, Lejing; Lu, Kai; Lian, Xingming			The Phosphate Transporter Gene OsPht1;4 Is Involved in Phosphate Homeostasis in Rice	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; HIGHER-PLANTS; LIFE-CYCLE; EXPRESSION; ARABIDOPSIS; ACQUISITION; PHOSPHORUS; CELLS; TRANSLOCATION; STARVATION	A total of 13 phosphate transporters in rice (Oryza sative) have been identified as belonging to the Pht1 family, which mediates inorganic phosphate (Pi) uptake and transport. We report the biological property and physiological role of OsPht1;4 (OsPT4). Overexpressing OsPT4 resulted in significant higher Pi accumulation in roots, straw and brown rice, and suppression of OsPT4 caused decreased Pi concentration in straw and brown rice. Expression of the beta-glucuronidase reporter gene driven by the OsPT4 promoter showed that OsPT4 is expressed in roots, leaves, ligules, stamens, and caryopses under sufficient Pi conditions, consistent with the expression profile showing that OsPT4 has high expression in roots and flag leaves. The transcript level of OsPT4 increased significantly both in shoots and roots with a long time Pi starvation. OsPT4 encoded a plasma membrane-localized protein and was able to complement the function of the Pi transporter gene PHO84 in yeast. We concluded that OsPT4 is a functional Pi-influx transporter involved in Pi absorption in rice that might play a role in Pi translocation. This study will enrich our understanding about the physiological function of rice Pht1 family genes.	[Ye, Ying; Yuan, Jing; Chang, Xiaojian; Yang, Meng; Zhang, Lejing; Lu, Kai; Lian, Xingming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Ye, Ying; Yuan, Jing; Chang, Xiaojian; Yang, Meng; Zhang, Lejing; Lu, Kai; Lian, Xingming] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Lian, XM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.	xmlian@mail.hzau.edu.cn		Lian, Xingming/0000-0002-5307-2839; Yang, Meng/0000-0001-8882-1417	National Basic Research Program of China [2011CB100304]; National High Technology Research and Development Program of China [2012AA10A303]; National Natural Science Foundation of China [31172017]; transgenic project [2014ZX08001005]; Gates Foundation	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); transgenic project; Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants from the National Basic Research Program of China (2011CB100304), the National High Technology Research and Development Program of China (2012AA10A303), the National Natural Science Foundation of China (31172017), the transgenic project (2014ZX08001005) and the Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Basheer S, 2011, BIOSENS BIOELECTRON, V27, P58, DOI 10.1016/j.bios.2011.06.024; Cao Y, 2014, J PLANT PHYSIOL, V171, P340, DOI 10.1016/j.jplph.2013.07.010; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; Chrispeels MJ, 1999, PLANT CELL, V11, P661, DOI 10.1105/tpc.11.4.661; Daram P, 1998, PLANTA, V206, P225, DOI 10.1007/s004250050394; Doerner P, 2008, CURR OPIN PLANT BIOL, V11, P536, DOI 10.1016/j.pbi.2008.05.006; Goff SA, 2005, SCIENCE, V309, P879; HARRISON MJ, 1995, NATURE, V378, P626, DOI 10.1038/378626a0; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Ishiyama K, 1998, PLANTA, V204, P288, DOI 10.1007/s004250050258; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jia HF, 2011, PLANT PHYSIOL, V156, P1164, DOI 10.1104/pp.111.175240; Jouhet J, 2007, PROG LIPID RES, V46, P37, DOI 10.1016/j.plipres.2006.06.002; Karthikeyan AS, 2002, PLANT PHYSIOL, V130, P221, DOI 10.1104/pp.020007; Kumagai E, 2014, PHYSIOL PLANTARUM, V151, P533, DOI 10.1111/ppl.12145; Leggewie G, 1997, PLANT CELL, V9, P381, DOI 10.1105/tpc.9.3.381; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Liu F, 2011, MOL PLANT, V4, P1105, DOI 10.1093/mp/ssr058; Liu F, 2010, PLANT J, V62, P508, DOI 10.1111/j.1365-313X.2010.04170.x; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nagarajan VK, 2011, PLANT PHYSIOL, V156, P1149, DOI 10.1104/pp.111.174805; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Preuss CP, 2011, PLANT CELL ENVIRON, V34, P681, DOI 10.1111/j.1365-3040.2010.02272.x; Preuss CP, 2010, PLANT PHYSIOL, V152, P1431, DOI 10.1104/pp.109.152009; Raghothama KG, 2005, PLANT SOIL, V274, P37, DOI 10.1007/s11104-004-2005-6; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Remy E, 2012, NEW PHYTOL, V195, P356, DOI 10.1111/j.1469-8137.2012.04167.x; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Schunmann PHD, 2004, PLANT PHYSIOL, V136, P4205, DOI 10.1104/pp.104.045823; Seo HM, 2008, BIOTECHNOL LETT, V30, P1833, DOI 10.1007/s10529-008-9757-7; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Sun SB, 2012, PLANT PHYSIOL, V159, P1571, DOI 10.1104/pp.112.196345; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; VERSAW WK, 1995, GENE, V153, P135, DOI 10.1016/0378-1119(94)00814-9; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang XF, 2014, PLANT CELL ENVIRON, V37, P1159, DOI 10.1111/pce.12224; WEBER MJ, 1971, J BIOL CHEM, V246, P1828; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Yang M, 2014, J EXP BOT, V65, P4849, DOI 10.1093/jxb/eru259; Zhang LH, 2014, NEW PHYTOL, V201, P1183, DOI 10.1111/nph.12596; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443	46	69	80	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126186	10.1371/journal.pone.0126186	http://dx.doi.org/10.1371/journal.pone.0126186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970642	Green Submitted, Green Published, gold			2022-12-27	WOS:000354544200097
J	De Nicola, L; Provenzano, M; Chiodini, P; Borrelli, S; Garofalo, C; Pacilio, M; Liberti, ME; Sagliocca, A; Conte, G; Minutolo, R				De Nicola, Luca; Provenzano, Michele; Chiodini, Paolo; Borrelli, Silvio; Garofalo, Carlo; Pacilio, Mario; Liberti, Maria Elena; Sagliocca, Adelia; Conte, Giuseppe; Minutolo, Roberto			Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY TRIAL; ANTAGONIST LOSARTAN RENAAL; POST-HOC ANALYSIS; BLOOD-PRESSURE; PROSPECTIVE COHORT; END-POINTS; OUTCOMES; RISK; CKD; PROGRESSION	Primary kidney disease is suggested to affect renal prognosis of CKD patients; however, whether nephrology care modifies this association is unknown. We studied patients with CKD stage I-IV treated in a renal clinic and with established diagnosis of CKD cause to evaluate whether the risk of renal event (composite of end-stage renal disease and eGFR decline >= 40%) linked to the specific diagnosis is modified by the achievement or maintenance in the first year of nephrology care of therapeutic goals for hypertension (BP <= 130/80 mmHg in patients with proteinuria >= 150 mg/24h and/or diabetes and <= 140/90 in those with proteinuria < 150 mg/24h and without diabetes) anemia (hemoglobin, Hb >= 11 g/dL), and proteinuria (<= 0.5 g/24h). Survival analysis started after first year of nephrology care. We studied 729 patients (age 64 +/- 15 y; males 59.1%; diabetes 34.7%; cardiovascular disease (CVD) 44.9%; hypertensive nephropathy, HTN 53.8%; glomerulonephritis, GN 17.3%; diabetic nephropathy, DN 15.9%; tubule-interstitial nephropathy, TIN 9.5%; polycystic kidney disease, PKD 3.6%). During first year of Nephrology care, therapy was overall intensified in most patients and prevalence of main therapeutic goals generally improved. During subsequent follow up (median 3.3 years, IQR 1.9-5.1), 163 renal events occurred. Cox analysis disclosed a higher risk for PKD (Hazard Ratio 5.46, 95% Confidence Intervals 2.28-10.6) and DN (1.28,2.99-3.05), versus HTN (reference), independently of age, gender, CVD, BMI, eGFR or CKD stage, use of RAS inhibitors and achievement or maintenance in the first year of nephrology care of each of the three main therapeutic goals. No interaction was found on the risk of CKD progression between diagnostic categories and month-12 eGFR (P=0.737), as with control of BP (P=0.374), Hb (P=0.248) or proteinuria (P=0.590). Therefore, in CKD patients under nephrology care, diagnosis of kidney disease should be considered in conjunction with the main risk factors to refine renal risk stratification.	[De Nicola, Luca; Provenzano, Michele; Borrelli, Silvio; Garofalo, Carlo; Pacilio, Mario; Liberti, Maria Elena; Sagliocca, Adelia; Conte, Giuseppe; Minutolo, Roberto] Univ Naples 2, Sch Med, Div Nephrol, Naples, Italy; [Chiodini, Paolo] Univ Naples 2, Sch Med, Med Stat Unit, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	De Nicola, L (corresponding author), Univ Naples 2, Sch Med, Div Nephrol, Naples, Italy.	luca.denicola@unina2.it	Chiodini, Paolo/E-7290-2014; Garofalo, Carlo/Y-2385-2019; Borrelli, Silvio/AAH-8549-2019; De Nicola, Luca/AAB-7682-2019; Provenzano, Michele/AAG-6214-2019	Chiodini, Paolo/0000-0003-0139-2264; Garofalo, Carlo/0000-0001-9362-0281; Borrelli, Silvio/0000-0002-4414-4597; Minutolo, Roberto/0000-0001-5686-2089; Provenzano, Michele/0000-0002-2168-702X				Agarwal R, 2008, AM J NEPHROL, V28, P569, DOI 10.1159/000115291; Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Alves TP, 2010, J AM SOC NEPHROL, V21, P1361, DOI 10.1681/ASN.2009060654; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; De Nicola L, 2006, KIDNEY INT, V69, P538, DOI 10.1038/sj.ki.5000085; De Nicola L, 2014, AM J KIDNEY DIS, V64, P16, DOI 10.1053/j.ajkd.2014.02.010; De Nicola L, 2014, DRUGS, V74, P159, DOI 10.1007/s40265-013-0175-3; De Nicola L, 2012, KIDNEY INT, V82, P482, DOI 10.1038/ki.2012.174; De Nicola L, 2011, CLIN J AM SOC NEPHRO, V6, P2421, DOI 10.2215/CJN.01180211; De Nicola L, 2011, J NEPHROL, V24, P733, DOI 10.5301/JN.2011.6335; De Nicola L, 2010, AM J NEPHROL, V32, P533, DOI 10.1159/000321468; Dwyer J., 1993, NUTR KIDNEY, V2nd ed., P61; Eijkelkamp WBA, 2007, J AM SOC NEPHROL, V18, P1540, DOI 10.1681/ASN.2006050445; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ellison DH, 2014, NEW ENGL J MED, V371, P2329, DOI 10.1056/NEJMe1412586; Gentile G, 2011, J NEPHROL, V24, P673, DOI 10.5301/jn.5000052; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Harrell FE, 2001, REGRESSION MODELING; Haynes R, 2014, AM J KIDNEY DIS, V64, P40, DOI 10.1053/j.ajkd.2013.12.013; Heerspink HJL, 2014, AM J KIDNEY DIS, V63, P244, DOI 10.1053/j.ajkd.2013.09.016; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; JUNGERS P, 1995, NEPHROL DIAL TRANSPL, V10, P1353; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Lambers Heerspink HJ, 2014, J AM SOC NEPHROL; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mahnensmith RL, 2014, CLIN J AM SOC NEPHRO, V9, P831, DOI 10.2215/CJN.02480314; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Menon V, 2008, KIDNEY INT, V73, P1310, DOI 10.1038/ki.2008.67; Minutolo R, 2014, CLIN J AM SOC NEPHRO, V9, P1586, DOI 10.2215/CJN.10481013; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pohl MA, 2005, J AM SOC NEPHROL, V16, P3027, DOI 10.1681/ASN.2004110919; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Reboldi G, 2011, J HYPERTENS, V29, P1253, DOI 10.1097/HJH.0b013e3283469976; Rossing P, 2011, KIDNEY INT, V79, pS28, DOI 10.1038/ki.2010.513; Ruggenenti P, 2000, AM J KIDNEY DIS, V35, P1155, DOI 10.1016/S0272-6386(00)70054-0; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Upadhyay A, 2011, ANN INTERN MED, V154, P541, DOI 10.7326/0003-4819-154-8-201104190-00335; WIGHT JP, 1992, NEPHROL DIAL TRANSPL, V7, P379; Yang W, 2014, AM J KIDNEY DIS, V63, P236, DOI 10.1053/j.ajkd.2013.08.028	47	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127071	10.1371/journal.pone.0127071	http://dx.doi.org/10.1371/journal.pone.0127071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992629	Green Submitted, gold, Green Published			2022-12-27	WOS:000354921400093
J	Wu, HL; Lv, H; Li, L; Liu, J; Mu, SH; Li, XP; Gao, J				Wu, Huili; Lv, Hao; Li, Long; Liu, Jun; Mu, Shaohua; Li, Xueping; Gao, Jian			Genome-Wide Analysis of the AP2/ERF Transcription Factors Family and the Expression Patterns of DREB Genes in Moso Bamboo (Phyllostachys edulis)	PLOS ONE			English	Article							DNA-BINDING DOMAIN; SALT STRESS; EAR-MOTIF; FUNCTIONAL-ANALYSIS; APETALA2-LIKE GENE; SEQUENCE-ANALYSIS; ARABIDOPSIS; PROTEIN; RICE; DEHYDRATION	The AP2/ERF transcription factor family, one of the largest families unique to plants, performs a significant role in terms of regulation of growth and development, and responses to biotic and abiotic stresses. Moso bamboo (Phyllostachys edulis) is a fast-growing non-timber forest species with the highest ecological, economic and social values of all bamboos in Asia. The draft genome of moso bamboo and the available genomes of other plants provide great opportunities to research global information on the AP2/ERF family in moso bamboo. In total, 116 AP2/ERF transcription factors were identified in moso bamboo. The phylogeny analyses indicated that the 116 AP2/ERF genes could be divided into three subfamilies: AP2, RAV and ERF; and the ERF subfamily genes were divided into 11 groups. The gene structures, exons/introns and conserved motifs of the PeAP2/ERF genes were analyzed. Analysis of the evolutionary patterns and divergence showed the PeAP2/ERF genes underwent a large-scale event around 15 million years ago (MYA) and the division time of AP2/ERF family genes between rice and moso bamboo was 15-23 MYA. We surveyed the putative promoter regions of the PeDREBsand showed that largely stress-related cis-elements existed in these genes. Further analysis of expression patterns of PeDREBs revealed that the most were strongly induced by drought, low-temperature and/or high salinity stresses in roots and, in contrast, most PeDREB genes had negative functions in leaves under the same respective stresses. In this study there were two main interesting points: there were fewer members of the PeDREB subfamily in moso bamboo than in other plants and there were differences in DREB gene expression profiles between leaves and roots triggered in response to abiotic stress. The information produced from this study may be valuable in overcoming challenges in cultivating moso bamboo.	[Wu, Huili; Li, Long; Liu, Jun; Mu, Shaohua; Li, Xueping; Gao, Jian] State Forestry Adm, Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol, Beijing, Peoples R China; [Lv, Hao] Hunan Forest Bot Garden, Changsha, Hunan, Peoples R China	International Centre for Bamboo & Rattan	Li, XP (corresponding author), State Forestry Adm, Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol, Beijing, Peoples R China.	lxp@icbr.ac.cn; gaojian@icbr.ac.cn		Lv, Hao/0000-0003-4938-639X	State Forestry Administration "948" project [2014-4-74]; "Twelfth Five Year" National Science and technology plan project in rural areas [2013AA102607-4]	State Forestry Administration "948" project; "Twelfth Five Year" National Science and technology plan project in rural areas	There were two funding programs that supported the authors' work: The State Forestry Administration "948" project (2014-4-74) http://www.forestry.gov.cn/CommonAction.do?dispatch = index & colid=216); "Twelfth Five Year" National Science and technology plan project in rural areas (2013AA102607-4) (http://program.most.gov.cn/htmledit/28A92E08-6F90-BF6C-59225CCF6323ACAD.html). XPL received the funding and had a role in study design, date analysis and decision to publish.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Akhtar M, 2012, J GENET, V91, P385, DOI 10.1007/s12041-012-0201-3; Albrecht V, 2001, EMBO J, V20, P1051, DOI 10.1093/emboj/20.5.1051; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cao J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-465; Chen RY, 2003, CHROMOSOME MAPS GENO; Chu YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098334; Chu ZX, 2011, GENET MOL RES, V10, P3316, DOI 10.4238/2011.December.8.3; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Cong L, 2008, BIOCHEM BIOPH RES CO, V371, P702, DOI 10.1016/j.bbrc.2008.04.126; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Dinh TT, 2012, DEVELOPMENT, V139, P1978, DOI 10.1242/dev.077073; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Gil-Humanes J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-66; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong B, 2009, PLANT MOL BIOL, V70, P231, DOI 10.1007/s11103-009-9468-z; Hong JP, 2005, PLANTA, V220, P875, DOI 10.1007/s00425-004-1412-5; Hu LF, 2011, GENET MOL BIOL, V34, P624, DOI 10.1590/S1415-47572011005000054; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jin LG, 2008, PLANT PHYSIOL BIOCH, V46, P46, DOI 10.1016/j.plaphy.2007.10.004; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; Kagale S, 2011, EPIGENETICS-US, V6, P141, DOI 10.4161/epi.6.2.13627; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li CW, 2011, PLANT PHYSIOL, V156, P213, DOI 10.1104/pp.111.174268; Liang Chun-lai, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P556; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Licausi F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-719; Liu L, 2012, PLANT MOL BIOL REP, V30, P679, DOI 10.1007/s11105-011-0380-8; Liu L, 2011, J HORTIC SCI BIOTECH, V86, P166, DOI 10.1080/14620316.2011.11512743; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Liu SX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003790; Lobovikov M, 2007, WORLD BAMBOO RESOURC; Lynch OT, 2000, BLOOD, V95, P3541, DOI 10.1182/blood.V95.11.3541.011k11_3541_3547; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ohto MA, 2009, SEX PLANT REPROD, V22, P277, DOI 10.1007/s00497-009-0116-1; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Peng ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078944; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Rae L, 2011, PLANTA, V234, P429, DOI 10.1007/s00425-011-1414-z; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Rashotte AM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-74; Reis RR, 2014, PLANT SCI, V221, P59, DOI 10.1016/j.plantsci.2014.02.003; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Ruelland E, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.3389/fpls.2013.00307; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schmidt R, 2013, PLANT CELL, V25, P2115, DOI 10.1105/tpc.113.113068; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sohn KH, 2006, PLANT MOL BIOL, V61, P897, DOI 10.1007/s11103-006-0057-0; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian XH, 2005, J INTEGR PLANT BIOL, V47, P467, DOI 10.1111/j.1744-7909.2005.00028.x; Wagner A, 2002, GENOME BIOL, V3; Walther D, 2007, PLOS GENET, V3, P216, DOI 10.1371/journal.pgen.0030011; Wan LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025216; Wang XM, 2011, MOL BIOL REP, V38, P2801, DOI 10.1007/s11033-010-0425-3; Wessler SR, 2005, TRENDS PLANT SCI, V10, P54, DOI 10.1016/j.tplants.2004.12.007; Wu HL, 2015, GENET MOL RES; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y; Wu ZY, 2006, PHYLLOSTACHYS, V22, P163; Xu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-785; Yan HW, 2013, GENET MOL RES, V12, P2038, DOI 10.4238/2013.May.13.1; Zhang CH, 2012, GENET MOL RES, V11, P4789, DOI 10.4238/2012.October.17.6; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2011, MOL BIOL REP, V38, P745, DOI 10.1007/s11033-010-0162-7	93	74	84	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126657	10.1371/journal.pone.0126657	http://dx.doi.org/10.1371/journal.pone.0126657			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985202	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300048
J	Broekhuizen, K; Pothof, A; de Craen, AJM; Mooijaart, SP				Broekhuizen, Karen; Pothof, Axel; de Craen, Anton J. M.; Mooijaart, Simon P.			Characteristics of Randomized Controlled Trials Designed for Elderly: A Systematic Review	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; CANCER-TREATMENT TRIALS; CLINICAL-TRIALS; OLDER PATIENTS; EXCLUSION; WOMEN; UNDERREPRESENTATION; REPRESENTATION	Objectives To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly, and to assess their characteristics, as compared to RCTs not specifically designed for elderly. Design Review and synthesis of published literature. Measurements We searched PubMed for articles published in the year 2012. We included RCTs. Articles were excluded if not conducted with human subjects or if findings of secondary analyses were reported. A random sample of 10% was drawn and of this selection the following trial characteristics were extracted: sample size, disease category, age of sample, and age-related inclusion criteria. Clinical trials were defined to be specifically designed for elderly if a lower age cut-off of >= 55 years was used, or when participants had an average age of >= 70 years. Results The search strategy yielded 26,740 articles, from which a random sample was drawn, resulting in 2375 articles. After exclusion, data was extracted from 1369 publications. Of these 1369 RCTs, 96 (7%) were specifically designed for elderly. In comparison with trials not designed for older adults, trials designed for elderly contained a significantly larger median number of participants (125 vs. 80, p = 0.008) significantly more trials designed for elderly fell into the disease categories eye (6% vs. 2%, p = 0.005), musculoskeletal (13% vs. 7%, p = 0.023) and circulatory system (16% vs. 9%, p = 0.039). No significant difference was observed with regard to the other disease categories. Conclusion There is a low proportion of RCTs specifically designed for elderly. As older patients will increasingly form the majority in medical practice, there is an urgent need for stronger evidence for the formulation of treatment guidelines specifically for older adults.	[Broekhuizen, Karen; Pothof, Axel; de Craen, Anton J. M.; Mooijaart, Simon P.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Broekhuizen, Karen; Mooijaart, Simon P.] IEMO, Inst Evidence Based Med Old Age, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mooijaart, SP (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	s.p.mooijaart@lumc.nl	Mooijaart, Simon P./A-5306-2008	Mooijaart, Simon P./0000-0003-3106-3568	Dutch Ministry of Health and Welfare; ZonMw [62700.3002]	Dutch Ministry of Health and Welfare; ZonMw(Netherlands Organization for Health Research and Development)	The Institute for Evidence-Based Medicine in Old Age (IEMO) is funded by the Dutch Ministry of Health and Welfare and supported by ZonMw (project number 62700.3002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, VOLKSGEZONDHEID TOEK; [Anonymous], INT CLASS DIS ICD, V10; Cherubini A, 2011, ARCH INTERN MED, V171, P550, DOI 10.1001/archinternmed.2011.31; Dodd KS, 2011, J AM GERIATR SOC, V59, P506, DOI 10.1111/j.1532-5415.2010.03305.x; Etniciteit Definitie en gegevens, 2012, NAT KOMP VOLKSG; European Commission, 2009, AG REP 2009; Fahy N, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3815; Gijsen R, 2013, VOLKSGEZONDHEID TOEK; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.1992.03490110055029; Heiat A, 2002, ARCH INTERNAL MED, V162; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Jennens RR, 2006, INTERN MED J, V36, P216, DOI 10.1111/j.1445-5994.2006.01033.x; Konrat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033559; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; TRIMBLE EL, 1994, CANCER, V74, P2208, DOI 10.1002/1097-0142(19941001)74:7+<2208::AID-CNCR2820741737>3.0.CO;2-#	15	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126709	10.1371/journal.pone.0126709	http://dx.doi.org/10.1371/journal.pone.0126709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978312	Green Submitted, gold, Green Published			2022-12-27	WOS:000354916100092
J	Cai, JQ; Zhang, W; Yang, P; Wang, YY; Li, MY; Zhang, CB; Wang, Z; Hu, HM; Liu, Y; Li, QB; Wen, JC; Sun, B; Wang, XF; Jiang, T; Jiang, CL				Cai, Jinquan; Zhang, Wei; Yang, Pei; Wang, Yinyan; Li, Mingyang; Zhang, Chuanbao; Wang, Zheng; Hu, Huimin; Liu, Yanwei; Li, Qingbin; Wen, Jinchong; Sun, Bo; Wang, Xiaofeng; Jiang, Tao; Jiang, Chuanlu			Identification of a 6-Cytokine Prognostic Signature in Patients with Primary Glioblastoma Harboring M2 Microglia/Macrophage Phenotype Relevance	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; GROWTH-FACTOR-BETA; TGF-BETA; SUPPRESSOR-CELLS; MOLECULAR CLASSIFICATION; GENE-EXPRESSION; GLIOMA PATIENTS; RNA-SEQ; VACCINATION; MICROGLIA	Background Glioblastomas (GBM) are comprised of a heterogeneous population of tumor cells, immune cells, and extracellular matrix. Interactions among these different cell types and pro-/anti-inflammatory cytokines may promote tumor development and progression. Aims The objective of this study was to develop a cytokine-related gene signature to improve outcome prediction for patients with primary GBM. Methods Here, we used Cox regression and risk-score analysis to develop a cytokine-related gene signature in primary GBMs from the whole transcriptome sequencing profile of the Chinese Glioma Genome Atlas (CGGA) database (n=105). We also examined differences in immune cell phenotype and immune factor expression between the high-risk and low-risk groups. Results Cytokine-related genes were ranked based on their ability to predict survival in the CGGA database. The six genes showing the strongest predictive value were CXCL10, IL17R, CCR2, IL17B, IL10RB, and CCL2. Patients with a high-risk score had poor overall survival and progression-free survival. Additionally, the high-risk group was characterized by increased mRNA expression of M2 microglia/macrophage markers and elevated levels of IL10 and TGF beta 1. Conclusion The six cytokine-related gene signature is sufficient to predict survival and to identify a subgroup of primary GBM exhibiting the M2 cell phenotype.	[Cai, Jinquan; Li, Qingbin; Wen, Jinchong; Sun, Bo; Wang, Xiaofeng; Jiang, Chuanlu] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China; [Zhang, Wei; Yang, Pei; Wang, Yinyan; Li, Mingyang; Zhang, Chuanbao; Wang, Zheng; Hu, Huimin; Liu, Yanwei; Jiang, Tao] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Jiang, Tao] Beijing Inst Brain Disorders, Brain Tumor Ctr, Beijing, Peoples R China; [Zhang, Wei; Yang, Pei; Wang, Yinyan; Li, Mingyang; Zhang, Chuanbao; Wang, Zheng; Liu, Yanwei; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Cai, Jinquan; Zhang, Wei; Yang, Pei; Wang, Yinyan; Li, Mingyang; Zhang, Chuanbao; Wang, Zheng; Hu, Huimin; Liu, Yanwei; Li, Qingbin; Wen, Jinchong; Sun, Bo; Wang, Xiaofeng; Jiang, Tao; Jiang, Chuanlu] Chinese Glioma Cooperat Grp, Beijing, Peoples R China	Harbin Medical University; Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University	Jiang, T (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.	taojiang1964@163.com; jcl6688@163.com	Wang, Yinyan/AAJ-1160-2020; jiang, tao/GWC-7108-2022; Li, Mingyang/C-2324-2018	Li, Mingyang/0000-0003-1766-7867; Li, Qingbin/0000-0002-1838-3885	National High Technology Research and Development Program (863) [2012AA02A508]; International Science and Technology Cooperation Program [2012DFA30470]; National Natural Science Foundation of China [91229121, 81201993]; Ministry of Health P.R. China [w2011bx059]; National 973 program [2011CB707804]	National High Technology Research and Development Program (863)(National High Technology Research and Development Program of China); International Science and Technology Cooperation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health P.R. China; National 973 program(National Basic Research Program of China)	This work was supported by the following sources of funding: 1. National High Technology Research and Development Program (863) (No. 2012AA02A508); 2. International Science and Technology Cooperation Program (No. 2012DFA30470); 3. National Natural Science Foundation of China (No. 91229121, No. 81201993); 4. Project of Ministry of Health P.R. China (No. w2011bx059); 5. National 973 program ( No. 2011CB707804).	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cai J, 2014, ONCOTARGET; Chaplin David D., 2003, Journal of Allergy and Clinical Immunology, V111, pS442; Chen X, 2010, LUNG CANCER, V69, P348, DOI 10.1016/j.lungcan.2009.11.013; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Doucette T, 2013, CANCER IMMUNOL RES, V1, P112, DOI 10.1158/2326-6066.CIR-13-0028; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frei K, 2011, NEUROSURG REV, V34, P263; Glass R, 2014, ACTA NEUROPATHOL, V128, P347, DOI 10.1007/s00401-014-1274-2; Held-Feindt J, 2003, J NEURO-ONCOL, V63, P117, DOI 10.1023/A:1023943405292; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huettner C, 1997, ANTICANCER RES, V17, P3217; Kanu OO, 2009, EXPERT OPIN THER TAR, V13, P701, DOI [10.1517/14728220902942348 , 10.1517/14728220902942348]; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mantovani A, 2009, HUM IMMUNOL, V70, P325, DOI 10.1016/j.humimm.2009.02.008; MERZAK A, 1994, BRIT J CANCER, V70, P199, DOI 10.1038/bjc.1994.280; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishie A, 1999, CLIN CANCER RES, V5, P1107; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Penfield W, 1925, AM J PATHOL, V1, P77; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Prosniak M, 2013, CLIN CANCER RES, V19, P3776, DOI 10.1158/1078-0432.CCR-12-1940; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Rolle CE, 2012, ADV EXP MED BIOL, V746, P53, DOI 10.1007/978-1-4614-3146-6_5; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Steinke JW, 2006, J ALLERGY CLIN IMMUN, V117, pS441, DOI 10.1016/j.jaci.2005.07.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Wagner S, 1999, INT J CANCER, V82, P12, DOI 10.1002/(SICI)1097-0215(19990702)82:1<12::AID-IJC3>3.0.CO;2-O; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wick W, 2001, J NEURO-ONCOL, V53, P177, DOI 10.1023/A:1012209518843; Wilke CM, 2011, CARCINOGENESIS, V32, P643, DOI 10.1093/carcin/bgr019; YAMADA N, 1995, INT J CANCER, V62, P386, DOI 10.1002/ijc.2910620405; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yan W, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030339.WOS:000301570600034, DOI 10.1371/J0URNAL.P0NE.0030339.W0S:000301570600034]; Yan W, 2012, NEURO-ONCOLOGY, V14, P1432, DOI 10.1093/neuonc/nos263; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339; Yu JS, 2001, CANCER RES, V61, P842; Zhang CB, 2014, J CANCER RES CLIN, V140, P45, DOI 10.1007/s00432-013-1519-9; Zhang W, 2013, CANCER-AM CANCER SOC, V119, P814, DOI 10.1002/cncr.27826	58	57	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126022	10.1371/journal.pone.0126022	http://dx.doi.org/10.1371/journal.pone.0126022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978454	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100041
J	Moon, H; Kim, MJ; Son, HJ; Kweon, HJ; Kim, JT; Kim, Y; Shim, J; Suh, BC; Rhyu, MR				Moon, Hana; Kim, Min Jung; Son, Hee Jin; Kweon, Hae-Jin; Kim, Jung Tae; Kim, Yiseul; Shim, Jaewon; Suh, Byung-Chang; Rhyu, Mee-Ra			Five hTRPA1 Agonists Found in Indigenous Korean Mint, Agastache rugosa	PLOS ONE			English	Article							ION-CHANNEL TRPA1; COVALENT MODIFICATION; CAPSAICIN RECEPTOR; PUNGENT COMPOUNDS; TRPV1; ANTAGONISTS; INHIBITION; ACTIVATION; EXPRESSION; PRODUCTS	Transient receptor potential ankyrin1 (TRPA1) and transient receptor potential vanilloid 1 (TRPV1) are members of the TRP superfamily of structurally related, nonselective cation channels and mediators of several signaling pathways. Previously, we identified methyl syringate as an hTRPA1 agonist with efficacy against gastric emptying. The aim of this study was to find hTRPA1 and/or hTRPV1 activators in Agastache rugosa (Fisch. et Meyer) O. Kuntze (A. rugosa), commonly known as Korean mint to improve hTRPA1-related phenomena. An extract of the stem and leaves of A. rugosa (Labiatae) selectively activated hTRPA1 and hTRPV1. We next investigated the effects of commercially available compounds found in A. rugosa (acacetin, 4-allylanisole, p-anisaldehyde, apigenin 7-glucoside, L-carveol, beta-caryophyllene, trans-p-methoxycinnamaldehyde, methyl eugenol, pachypodol, and rosmarinic acid) on cultured hTRPA1- and hTRPV1-expressing cells. Of the ten compounds, L-carveol, trans-p-methoxycinnamaldehyde, methyl eugenol, 4-allylanisole, and p-anisaldehyde selectively activated hTRPA1, with EC50 values of 189.1 +/- 26.8, 29.8 +/- 14.9, 160.2 +/- 21.9, 1535 +/- 315.7, and 546.5 +/- 73.0 mu M, respectively. The activities of these compounds were effectively inhibited by the hTRPA1 antagonists, ruthenium red and HC-030031. Although the five active compounds showed weaker calcium responses than allyl isothiocyanate (EC50=7.2 +/- 1.4 mu M), our results suggest that these compounds from the stem and leaves of A. rugosa are specific and selective agonists of hTRPA1.	[Moon, Hana; Kim, Min Jung; Son, Hee Jin; Kim, Jung Tae; Kim, Yiseul; Shim, Jaewon; Rhyu, Mee-Ra] Korea Food Res Inst, Res Grp Food Funct, Songnam, Gyeonggi Do, South Korea; [Kweon, Hae-Jin; Suh, Byung-Chang] DGIST, Dept Brain Sci, Daegu, South Korea	Korea Food Research Institute (KFRI); Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Rhyu, MR (corresponding author), Korea Food Res Inst, Res Grp Food Funct, Songnam, Gyeonggi Do, South Korea.	mrrhyu@kfri.re.kr	Kweon, Hae-Jin/AAP-9842-2021		Korea Food Research Institute [E0131201, E0143043494]; National Research Foundation of Korea (NRF)	Korea Food Research Institute; National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	Funding: This study was supported by Korea Food Research Institute (E0131201, E0143043494), the National Research Foundation of Korea (NRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn B., 1991, Korean Journal of Food Science and Technology, V23, P582; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andrade EL, 2012, PHARMACOL THERAPEUT, V133, P189, DOI 10.1016/j.pharmthera.2011.10.008; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bevan S, 2009, CURR OPIN INVEST DR, V10, P655; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHOI KS, 1999, J KOREAN SOC FOOD SC, V28, P326; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Doihara H, 2009, N-S ARCH PHARMACOL, V380, P353, DOI 10.1007/s00210-009-0435-7; Earley S, 2010, MOL PHARMACOL, V77, P612, DOI 10.1124/mol.109.060715; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Gang DR, 2001, PLANT PHYSIOL, V125, P539, DOI 10.1104/pp.125.2.539; Geppetti P, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2008.07493.x; Hata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048072; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong JJ, 2001, FEBS LETT, V495, P142, DOI 10.1016/S0014-5793(01)02379-1; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kim M.-K., 2013, COMPUT MATH METHOD M, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0073340; Lee C, 2002, J NAT PROD, V65, P414, DOI 10.1021/np010425e; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Oh HM, 2005, ARCH PHARM RES, V28, P305, DOI 10.1007/BF02977797; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Shin S, 2003, LETT APPL MICROBIOL, V36, P111, DOI 10.1046/j.1472-765X.2003.01271.x; Shintaku M, 2012, BRAIN TUMOR PATHOL, V29, P31, DOI 10.1007/s10014-011-0057-x; Son HJ, 2012, ARCH PHARM RES, V35, P2211, DOI 10.1007/s12272-012-1220-6; Terada Y, 2011, J AGR FOOD CHEM, V59, P2627, DOI 10.1021/jf1041646; Tominaga Makoto, 2008, Brain and Nerve (Tokyo), V60, P493; Wang KC, 2009, PHYTOMEDICINE, V16, P882, DOI 10.1016/j.phymed.2009.02.016; ZAKHAROVA O I, 1979, Chemistry of Natural Compounds (English Translation of Khimiya Prirodnykh Soedinenii), V15, P561, DOI 10.1007/BF00565924; Zhang X, 2004, EXP NEUROL, V251, P12	33	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127060	10.1371/journal.pone.0127060	http://dx.doi.org/10.1371/journal.pone.0127060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978436	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100126
J	Mullins, EA; Shi, RX; Kotsch, LA; Eichman, BF				Mullins, Elwood A.; Shi, Rongxin; Kotsch, Lyle A.; Eichman, Brandt F.			A New Family of HEAT-Like Repeat Proteins Lacking a Critical Substrate Recognition Motif Present in Related DNA Glycosylases	PLOS ONE			English	Article							BASE EXCISION-REPAIR; MULTIPLE SEQUENCE ALIGNMENT; DAMAGE RECOGNITION; ELECTROSTATICS; SUPERFAMILY; MECHANISM; PDB2PQR; BINDING; MUSCLE	DNA glycosylases are important repair enzymes that eliminate a diverse array of aberrant nucleobases from the genomes of all organisms. Individual bacterial species often contain multiple paralogs of a particular glycosylase, yet the molecular and functional distinctions between these paralogs are not well understood. The recently discovered HEAT-like repeat (HLR) DNA glycosylases are distributed across all domains of life and are distinct in their specificity for cationic alkylpurines and mechanism of damage recognition. Here, we describe a number of phylogenetically diverse bacterial species with two orthologs of the HLR DNA glycosylase AlkD. One ortholog, which we designate AlkD2, is substantially less conserved. The crystal structure of Streptococcus mutans AlkD2 is remarkably similar to AlkD but lacks the only helix present in AlkD that penetrates the DNA minor groove. We show that AlkD2 possesses only weak DNA binding affinity and lacks alkylpurine excision activity. Mutational analysis of residues along this DNA binding helix in AlkD substantially reduced binding affinity for damaged DNA, for the first time revealing the importance of this structural motif for damage recognition by HLR glycosylases.	[Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	brandt.eichman@vanderbilt.edu		Shi, Rongxin/0000-0002-3930-8534; Eichman, Brandt/0000-0002-0965-2297; Mullins, Elwood/0000-0003-3834-1065	National Science Foundation [MCB-1122098]; National Institutes of Health [S10 RR026915]; U.S. Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Vanderbilt Training Program in Environmental Toxicology (NIH) [T32 ES07028]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Vanderbilt Training Program in Environmental Toxicology (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This work was funded by the National Science Foundation (MCB-1122098), http://nsf.gov. Support for the Vanderbilt Robotic Crystallization Facility was provided by the National Institutes of Health (S10 RR026915), http://www.nih.gov. Use of the Advanced Photon Source (https://www1.aps.anl.gov), an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Argonne National Laboratory, was supported by the U.S. Department of Energy (DE-AC02-06CH11357), http://energy.gov. Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (085P1000817), http://www.michiganbusiness.org/about-medc/mission/. E.A.M. was supported by the Vanderbilt Training Program in Environmental Toxicology (NIH T32 ES07028), https://my.vanderbilt.edu/toxicology/training/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adhikary S, 2013, DNA REPAIR, V12, P196, DOI 10.1016/j.dnarep.2012.12.001; Alseth I, 2006, MOL MICROBIOL, V59, P1602, DOI 10.1111/j.1365-2958.2006.05044.x; Alseth I, 2005, NUCLEIC ACIDS RES, V33, P1123, DOI 10.1093/nar/gki259; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Backe PH, 2013, J STRUCT BIOL, V183, P66, DOI 10.1016/j.jsb.2013.04.007; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Brooks SC, 2013, BBA-PROTEINS PROTEOM, V1834, P247, DOI 10.1016/j.bbapap.2012.10.005; Dalhus B, 2007, NUCLEIC ACIDS RES, V35, P2451, DOI 10.1093/nar/gkm039; Dalhus B, 2013, STRUCTURE, V21, P154, DOI 10.1016/j.str.2012.11.004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Memisoglu A, 2000, J BACTERIOL, V182, P2104, DOI 10.1128/JB.182.8.2104-2112.2000; Mullins EA, 2014, DNA REPAIR, V13, P50, DOI 10.1016/j.dnarep.2013.10.009; Mullins EA, 2013, METHODS, V64, P59, DOI 10.1016/j.ymeth.2013.07.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rubinson EH, 2008, J MOL BIOL, V381, P13, DOI 10.1016/j.jmb.2008.05.078; Rubinson EH, 2012, CURR OPIN STRUC BIOL, V22, P101, DOI 10.1016/j.sbi.2011.11.005; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Sheridan PP, 2003, GEOMICROBIOL J, V20, P1, DOI 10.1080/01490450303891; Stivers JT, 2008, CHEM-EUR J, V14, P786, DOI 10.1002/chem.200701501; Stivers JT, 2004, PROG NUCLEIC ACID RE, V77, P37, DOI 10.1016/S0079-6603(04)77002-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	37	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127733	10.1371/journal.pone.0127733	http://dx.doi.org/10.1371/journal.pone.0127733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978435	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100152
J	Ordax, M; Piquer-Salcedo, JE; Santander, RD; Sabater-Munoz, B; Biosca, EG; Lopez, MM; Marco-Noales, E				Ordax, Monica; Piquer-Salcedo, Jaime E.; Santander, Ricardo D.; Sabater-Munoz, Beatriz; Biosca, Elena G.; Lopez, Maria M.; Marco-Noales, Ester			Medfly Ceratitis capitata as Potential Vector for Fire Blight Pathogen Erwinia amylovora: Survival and Transmission	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; WIEDEMANN DIPT; PLANT-MATERIAL; TEPHRITIDAE; POPULATION; TRYPETIDAE; RECOVERY; BACTERIA; INSECTS; CALYXES	Monitoring the ability of bacterial plant pathogens to survive in insects is required for elucidating unknown aspects of their epidemiology and for designing appropriate control strategies. Erwinia amylovora is a plant pathogenic bacterium that causes fire blight, a devastating disease in apple and pear commercial orchards. Studies on fire blight spread by insects have mainly focused on pollinating agents, such as honeybees. However, the Mediterranean fruit fly (medfly) Ceratitis capitata (Diptera: Tephritidae), one of the most damaging fruit pests worldwide, is also common in pome fruit orchards. The main objective of the study was to investigate whether E. amylovora can survive and be transmitted by the medfly. Our experimental results show: i) E. amylovora can survive for at least 8 days inside the digestive tract of the medfly and until 28 days on its external surface, and ii) medflies are able to transmit the bacteria from inoculated apples to both detached shoots and pear plants, being the pathogen recovered from lesions in both cases. This is the first report on E. amylovora internalization and survival in/on C. capitata, as well as the experimental transmission of the fire blight pathogen by this insect. Our results suggest that medfly can act as a potential vector for E. amylovora, and expand our knowledge on the possible role of these and other insects in its life cycle.	[Ordax, Monica; Piquer-Salcedo, Jaime E.; Sabater-Munoz, Beatriz; Lopez, Maria M.; Marco-Noales, Ester] IVIA, Ctr Protecc Vegetal, Valencia 46113, Spain; [Santander, Ricardo D.; Biosca, Elena G.] Univ Valencia, Dept Microbiol & Ecol, E-46100 Valencia, Spain	University of Valencia	Marco-Noales, E (corresponding author), IVIA, Ctr Protecc Vegetal, Ctra Moncada Naquera,Km 4-5, Valencia 46113, Spain.	emarco@ivia.es	Santander, Ricardo Delgado/AAG-6067-2019; Sabater-Munoz, Beatriz/K-5989-2014; López, Maria M/D-2584-2015; González Biosca, Elena/F-4979-2016; Marco-Noales, Ester/A-5404-2009; Lopez, Maria/HHC-3659-2022; Marco-Noales, Ester/AAH-2322-2019; Sabater-Munoz, Beatriz/M-6021-2019	Santander, Ricardo Delgado/0000-0002-1309-2632; Sabater-Munoz, Beatriz/0000-0002-0301-215X; González Biosca, Elena/0000-0002-8590-6180; Marco-Noales, Ester/0000-0001-7973-0345; Marco-Noales, Ester/0000-0001-7973-0345; 	Spanish Agriculture Ministry [AGL2008-05723-C02-01, 02/AGR]; Horticulture Australia Ltd. (HAL) [AP07051]; Apple and Pear Australia Ltd. (APAL); University of Valencia [UV-INV-AE 112-66196]; Spanish Ministry of Education and Science (INIA-CCAA); European Social Fund; FPU of Spanish Ministry of Education and Science	Spanish Agriculture Ministry; Horticulture Australia Ltd. (HAL)(Horticulture Australia Limited); Apple and Pear Australia Ltd. (APAL); University of Valencia; Spanish Ministry of Education and Science (INIA-CCAA)(German Research Foundation (DFG)); European Social Fund(European Social Fund (ESF)); FPU of Spanish Ministry of Education and Science(National Health and Medical Research Council (NHMRC) of AustraliaGerman Research Foundation (DFG))	Funding: This study was supported by Projects AGL2008-05723-C02-01 and 02/AGR of Spanish Agriculture Ministry, MO JEPS RDG BSM EGB MML EMN; Project AP07051 of Horticulture Australia Ltd. (HAL) in partnership with Apple and Pear Australia Ltd. (APAL), MO JEPS; EUPHRESCO Phytfire project, MML EMN; Project UV-INV-AE 112-66196 of University of Valencia, RDS EGB; Spanish Ministry of Education and Science (Program INIA-CCAA) and European Social Fund, BSM EMN; Grant FPU of Spanish Ministry of Education and Science, RDS.	Agrios GN, 2009, TRANSMISSION PLANT D; Alexandrova M, 2002, ACTA HORTIC, P55, DOI 10.17660/ActaHortic.2002.590.5; Aluja M, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR; Aluja M, 1993, FRUIT FLIES BIOL MAN; Aluja M, 2008, ANNU REV ENTOMOL, V53, P473, DOI 10.1146/annurev.ento.53.103106.093350; Ark PA, 1936, PHYTOPATHOLOGY, V26, P375; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Behar Adi, 2009, P251; Billing E., 2011, Plant Pathology, V60, P178, DOI 10.1111/j.1365-3059.2010.02382.x; Biosca EG, 2008, ACTA HORTIC, V793, P83, DOI 10.17660/ActaHortic.2008.793.8; Biosca EG, 2009, CURRENT RESEARCH TOPICS IN APPLIED MICROBIOLOGY AND MICROBIAL BIOTECHNOLOGY, P88, DOI 10.1142/9789812837554_0019; Cabrefiga J, 2005, PHYTOPATHOLOGY, V95, P1430, DOI 10.1094/PHYTO-95-1430; CAYOL JP, 1994, J APPL ENTOMOL, V117, P338, DOI 10.1111/j.1439-0418.1994.tb00744.x; CAYOL JP, 1993, J APPL ENTOMOL, V116, P94, DOI 10.1111/j.1439-0418.1993.tb01172.x; Ceroni P., 2004, Bulletin OEPP, V34, P109, DOI 10.1111/j.1365-2338.2004.00705.x; Coronado-Gonzalez PA, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.7301; DUECK J, 1974, CAN J PLANT SCI, V54, P349, DOI 10.4141/cjps74-053; EMMETT BJ, 1971, PLANT PATHOL, V20, P41, DOI 10.1111/j.1365-3059.1971.tb00507.x; *EPPO, 2013, B OEPP EPPO B, V43, P21, DOI DOI 10.1111/epp.12019; EPPO European and Mediterranean Plant Protection Organization, 2010, DAT SHEETS QUAR ORG; EPPO European and Mediterranean Plant Protection Organization, 1981, OEPP EPPO B, V11, P1; Gorris M. T., 1996, Acta Horticulturae, P41; Hildebrand M, 2001, J PHYTOPATHOL, V149, P635, DOI 10.1046/j.1439-0434.2001.00685.x; Hildebrand M, 2000, J PHYTOPATHOL, V148, P251, DOI 10.1046/j.1439-0434.2000.00504.x; ISHIMARU C, 1984, PHYTOPATHOLOGY, V74, P1342, DOI 10.1094/Phyto-74-1342; Israely N, 2005, ANN ENTOMOL SOC AM, V98, P302, DOI 10.1603/0013-8746(2005)098[0302:MSDPOM]2.0.CO;2; Janisiewicz WJ, 1999, APPL ENVIRON MICROB, V65, P1; Juan-Blasco M, 2013, J APPL ENTOMOL, V137, P244, DOI 10.1111/j.1439-0418.2011.01688.x; Juan-Blasco M, 2013, PEST MANAG SCI, V69, P857, DOI 10.1002/ps.3448; KING EO, 1954, J LAB CLIN MED, V44, P301; Lelliot RA, 1967, EPPO B, V45, P27; Liao CH, 2004, PHYTOPATHOLOGY, V94, P76, DOI 10.1094/PHYTO.2004.94.1.76; Llop P, 1999, J MICROBIOL METH, V37, P23, DOI 10.1016/S0167-7012(99)00033-0; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; MCDONALD PT, 1985, ENTOMOL EXP APPL, V37, P207, DOI 10.1007/BF00191650; Meats A, 2007, J APPL ENTOMOL, V131, P518, DOI 10.1111/j.1439-0418.2007.01168.x; MILLER TD, 1972, PHYTOPATHOLOGY, V62, P1175, DOI 10.1094/Phyto-62-1175; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; Ordax M, 2009, J APPL MICROBIOL, V107, P106, DOI 10.1111/j.1365-2672.2009.04187.x; Ordax M, 2006, APPL ENVIRON MICROB, V72, P3482, DOI 10.1128/AEM.72.5.3482-3488.2006; Ordax M, 2012, TREES-STRUCT FUNCT, V26, P83, DOI 10.1007/s00468-011-0614-2; Ordax M, 2010, RES MICROBIOL, V161, P549, DOI 10.1016/j.resmic.2010.05.003; PURCELL AH, 1982, ANNU REV PHYTOPATHOL, V20, P397, DOI 10.1146/annurev.py.20.090182.002145; San Andres V, 2007, J ECON ENTOMOL, V100, P1444, DOI 10.1603/0022-0493(2007)100[1444:ANMATA]2.0.CO;2; Santander RD, 2012, TREES-STRUCT FUNCT, V26, P75, DOI 10.1007/s00468-011-0653-8; Santander RD, 2014, FEMS MICROBIOL ECOL, V90, P895, DOI 10.1111/1574-6941.12444; Santander RD, 2014, FEMS MICROBIOL ECOL, V88, P258, DOI 10.1111/1574-6941.12290; SCHROTH MN, 1974, ANNU REV PHYTOPATHOL, V12, P389, DOI 10.1146/annurev.py.12.090174.002133; Sela S, 2005, APPL ENVIRON MICROB, V71, P4052, DOI 10.1128/AEM.71.7.4052-4056.2005; SOUTHEY RFW, 1971, J APPL BACTERIOL, V34, P547, DOI 10.1111/j.1365-2672.1971.tb02317.x; Suckling DM, 2011, PEST MANAG SCI, V67, P1004, DOI 10.1002/ps.2150; Taylor RK, 2003, CROP PROT, V22, P603, DOI 10.1016/S0261-2194(02)00239-9; Taylor RK, 2001, NEW ZEAL J CROP HORT, V29, P35, DOI 10.1080/01140671.2001.9514158; Thomson SV, 2000, FIRE BLIGHT, P9, DOI 10.1079/9780851992945.0009; Tsukamoto Takanori, 2005, Research Bulletin of the Plant Protection Service Japan, P65; Van der Zwet T., 2012, FIRE BLIGHT HIST BIO, DOI [10.1111/j.1439-0434.2012.01922.x, DOI 10.1111/J.1439-0434.2012.01922.X]; Van der Zwet T, 1979, USDA AGR HDB, V510; van der Zwet T., 1995, INFORM B, V631, DOI [10.5962/bhl.title.134796, DOI 10.5962/BHL.TITLE.134796]; VANDERZWET T, 1990, PLANT DIS, V74, P711, DOI 10.1094/PD-74-0711; Vanneste JL, 2000, FIRE BLIGHT, P73, DOI 10.1079/9780851992945.0073; White I. M., 1994, FRUIT FLIES EC SIGNI	61	21	21	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127560	10.1371/journal.pone.0127560	http://dx.doi.org/10.1371/journal.pone.0127560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978369	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100149
J	Palpant, NJ; Hofsteen, P; Pabon, L; Reinecke, H; Murry, CE				Palpant, Nathan J.; Hofsteen, Peter; Pabon, Lil; Reinecke, Hans; Murry, Charles E.			Cardiac Development in Zebrafish and Human Embryonic Stem Cells Is Inhibited by Exposure to Tobacco Cigarettes and E-Cigarettes	PLOS ONE			English	Article							ELECTRONIC CIGARETTE; SMOKE EXPOSURE; TRANSMEMBRANE PROTEIN; EPICARDIUM FORMATION; AMNIOTIC-FLUID; VAPOR EXTRACT; NICOTINE; COTININE; IDENTIFICATION; METABOLITES	Background Maternal smoking is a risk factor for low birth weight and other adverse developmental outcomes. Objective We sought to determine the impact of standard tobacco cigarettes and e-cigarettes on heart development in vitro and in vivo. Methods Zebrafish (Danio rerio) were used to assess developmental effects in vivo and cardiac differentiation of human embryonic stem cells (hESCs) was used as a model for in vitro cardiac development. Results In zebrafish, exposure to both types of cigarettes results in broad, dose-dependent developmental defects coupled with severe heart malformation, pericardial edema and reduced heart function. Tobacco cigarettes are more toxic than e-cigarettes at comparable nicotine concentrations. During cardiac differentiation of hESCs, tobacco smoke exposure results in a delayed transition through mesoderm. Both types of cigarettes decrease expression of cardiac transcription factors in cardiac progenitor cells, suggesting a persistent delay in differentiation. In definitive human cardiomyocytes, both e-cigarette-and tobacco cigarette- treated samples showed reduced expression of sarcomeric genes such as MLC2v and MYL6. Furthermore, tobacco cigarette-treated samples had delayed onset of beating and showed low levels and aberrant localization of N-cadherin, reduced myofilament content with significantly reduced sarcomere length, and increased expression of the immature cardiac marker smooth muscle alpha-actin. Conclusion These data indicate a negative effect of both tobacco cigarettes and e-cigarettes on heart development in vitro and in vivo. Tobacco cigarettes are more toxic than E-cigarettes and exhibit a broader spectrum of cardiac developmental defects.	[Palpant, Nathan J.; Hofsteen, Peter; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Sch Med, Dept Bioengn, Seattle, WA USA; [Murry, Charles E.] Univ Washington, Sch Med, Dept Med Cardiol, Seattle, WA USA; [Palpant, Nathan J.; Hofsteen, Peter; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Sch Med, Ctr Cardiovasc Biol, Seattle, WA USA; [Palpant, Nathan J.; Hofsteen, Peter; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murry, CE (corresponding author), Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.	murry@uw.edu	Palpant, Nathan/B-1641-2017	Palpant, Nathan/0000-0002-9334-8107	National Institutes of Health [P01 HL094374-04S1, R01 HL084642, P01 GM81619, U01 HL100405, 5T32HL007312-35]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084642, T32HL007312, U01HL100405, P01HL094374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants P01 HL094374-04S1, R01 HL084642, P01 GM81619, and U01 HL100405 (CEM), and 5T32HL007312-35 (NJP and PH).	Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; Baeza-Loya S, 2014, B MENNINGER CLIN, V78, P243, DOI 10.1521/bumc.2014.78.3.243; Bagcchi S, 2014, LANCET ONCOL, V15, pE313, DOI 10.1016/S1470-2045(14)70297-9; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Ellis LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115305; Farsalinos KE, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-78; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Gantz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046971; Garrett BE, 2013, MMWR-MORBID MORTAL W, V62, P81; Glickman NS, 2002, SEMIN CELL DEV BIOL, V13, P507, DOI 10.1016/S1084952102001040; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Heideman W, 2005, CARDIOVASC TOXICOL, V5, P203, DOI 10.1385/CT:5:2:203; Hofsteen P, 2013, J DEV BIOL, V1, P112, DOI 10.3390/jdb1020112; Hofsteen P, 2013, MOL PHARMACOL, V84, P353, DOI 10.1124/mol.113.086413; Huang JJ, 2013, REPROD TOXICOL, V35, P89, DOI 10.1016/j.reprotox.2012.07.003; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5335; JACOB P, 1991, BIOL MASS SPECTROM, V20, P247, DOI 10.1002/bms.1200200503; JACOB P, 1981, J CHROMATOGR, V222, P61, DOI 10.1016/S0378-4347(00)81033-6; Jensen RP, 2015, NEW ENGL J MED, V372, P392, DOI 10.1056/NEJMc1413069; Kais B, 2013, AQUAT TOXICOL, V140, P229, DOI 10.1016/j.aquatox.2013.05.022; Kohler E, 2007, HUM EXP TOXICOL, V26, P535, DOI 10.1177/0960327107072391; Kohler E, 2010, HUM EXP TOXICOL, V29, P385, DOI 10.1177/0960327110363326; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee HJ, 2010, J BIOL CHEM, V285, P41549, DOI 10.1074/jbc.M110.193383; Lin S, 2010, TOXICOL SCI, V118, P202, DOI 10.1093/toxsci/kfq241; Liszewski W, 2012, DIFFERENTIATION, V83, P169, DOI 10.1016/j.diff.2011.12.005; LUCK W, 1985, DEV PHARMACOL THERAP, V8, P384, DOI 10.1159/000457063; MCCARTHY M, 2014, BMJ-BRIT MED J, V348, P95292, DOI DOI 10.1136/BMJ.G3703; Mizell M, 1997, INT J DEV BIOL, V41, P411; Palpant NJ, 2013, DEVELOPMENT, V140, P3799, DOI 10.1242/dev.094789; Parker B, 2007, ZEBRAFISH, V4, P59, DOI 10.1089/zeb.2006.9994; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Plavicki J, 2013, TOXICOL SCI, V131, P558, DOI 10.1093/toxsci/kfs301; Raimondo S, 2014, ECOTOX ENVIRON SAFE, V108, P265, DOI 10.1016/j.ecoenv.2014.07.020; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Talbot P, 2011, BIOL RES, V44, P189, DOI /S0716-97602011000200011; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Zdravkovic T, 2008, REPROD TOXICOL, V26, P86, DOI 10.1016/j.reprotox.2008.07.004; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	50	78	79	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126259	10.1371/journal.pone.0126259	http://dx.doi.org/10.1371/journal.pone.0126259			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978043	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100059
J	Saenz-Royo, C; Gracia-Lazaro, C; Moreno, Y				Saenz-Royo, Carlos; Gracia-Lazaro, Carlos; Moreno, Yamir			The Role of the Organization Structure in the Diffusion of Innovations	PLOS ONE			English	Article							NETWORKS; MODEL	Diffusion and adoption of innovations is a topic of increasing interest in economics, market research, and sociology. In this paper we investigate, through an agent based model, the dynamics of adoption of innovative proposals in different kinds of structures. We show that community structure plays an important role on the innovation diffusion, so that proposals are more likely to be accepted in homogeneous organizations. In addition, we show that the learning process of innovative technologies enhances their diffusion, thus resulting in an important ingredient when heterogeneous networks are considered. We also show that social pressure blocks the adoption process whatever the structure of the organization. These results may help to understand how different factors influence the diffusion and acceptance of innovative proposals in different communities and organizations.	[Saenz-Royo, Carlos] Ctr Univ la Def, Zaragoza 50090, Spain; [Gracia-Lazaro, Carlos; Moreno, Yamir] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain; [Moreno, Yamir] Univ Zaragoza, Dept Fis Teor, E-50009 Zaragoza, Spain; [Moreno, Yamir] Inst Sci Interchange, Complex Networks & Syst Lagrange Lab, I-10126 Turin, Italy	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Zaragoza	Gracia-Lazaro, C (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain.	cgracia@bifi.es	Gracia-Lázaro, Carlos/K-9334-2014; Royo, Carlos Sáenz/ABG-2559-2020; Sáenz, Carlos/AAA-1896-2019; Moreno, Yamir/A-1076-2009	Gracia-Lázaro, Carlos/0000-0002-9769-8796; Royo, Carlos Sáenz/0000-0001-7914-2623; Moreno, Yamir/0000-0002-0895-1893	EU FET project MULTIPLEX [317614]; Spanish Ministerio de Economia y Competitividad [FIS2012-38266-C02-01, ECO2013-48496-C4-3-R]; Diputacion General de Aragon (grupos CREVALOR, FENOL); European Social Fund (CREVALOR)	EU FET project MULTIPLEX; Spanish Ministerio de Economia y Competitividad(Spanish Government); Diputacion General de Aragon (grupos CREVALOR, FENOL); European Social Fund (CREVALOR)(European Social Fund (ESF))	The authors acknowledge financial support from EU FET project MULTIPLEX (grant 317614), from Spanish Ministerio de Economia y Competitividad (research projects FIS2012-38266-C02-01 and ECO2013-48496-C4-3-R), from Diputacion General de Aragon (grupos CREVALOR, FENOL) and from the European Social Fund (CREVALOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER PS, 1991, MANAGE SCI, V37, P267, DOI 10.1287/mnsc.37.3.267; Balasubramanian N, 2010, STRATEGIC MANAGE J, V31, P390, DOI 10.1002/smj.816; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chang MH, 2005, AM J SOCIOL, V110, P937, DOI 10.1086/426555; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Compton OW, 1992, MANUFACTURING SYSTEM, P107; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Dodds PS, 2005, J THEOR BIOL, V232, P587, DOI 10.1016/j.jtbi.2004.09.006; Katz E, 2006, PERSONAL INFLUENCE P; Kogut B, 1996, ORGAN SCI, V7, P502, DOI 10.1287/orsc.7.5.502; Latane B, 1996, J PERS SOC PSYCHOL, V70, P1218; Lazarsfeld P. F., 1948, PEOPLES CHOICE VOTER, V2nd; Liebowitz SJ, 1998, NEW PALGRAVE DICT EC, P671; Macy MW, 2002, ANNU REV SOCIOL, V28, P143, DOI 10.1146/annurev.soc.28.110601.141117; Mahajan Vijay, 2000, NEW PRODUCT DIFFUSIO; Merton R.K., 1968, SOCIAL THEORY SOCIAL, P441; MILGROM P, 1990, AM ECON REV, V80, P511; Moldoveanu MC, 2011, MANAGE SCI, V57, P393, DOI 10.1287/mnsc.1100.1279; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rogers E.M., 2010, DIFFUSION INNOVATION; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Sanz J, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041005; Sinclair G, 2000, MANAGE SCI, V46, P28, DOI 10.1287/mnsc.46.1.28.15133; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Weiss CH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041008; Yelle L. E., 1979, Decision Sciences, V10, P302, DOI 10.1111/j.1540-5915.1979.tb00026.x; Zangwill WI, 1998, MANAGE SCI, V44, P910, DOI 10.1287/mnsc.44.7.910	32	13	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126076	10.1371/journal.pone.0126076	http://dx.doi.org/10.1371/journal.pone.0126076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978360	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100045
J	Nakajima, A; Masaki, Y; Nakamura, T; Kawanami, T; Ishigaki, Y; Takegami, T; Kawano, M; Yamada, K; Tsukamoto, N; Matsui, S; Saeki, T; Okazaki, K; Kamisawa, T; Miyashita, T; Yakushijin, Y; Fujikawa, K; Yamamoto, M; Hamano, H; Origuchi, T; Hirata, S; Tsuboi, H; Sumida, T; Morimoto, H; Sato, T; Iwao, H; Miki, M; Sakai, T; Fujita, Y; Tanaka, M; Fukushima, T; Okazaki, T; Umehara, H				Nakajima, Akio; Masaki, Yasufumi; Nakamura, Takuji; Kawanami, Takafumi; Ishigaki, Yasuhito; Takegami, Tsutomu; Kawano, Mitsuhiro; Yamada, Kazunori; Tsukamoto, Norifumi; Matsui, Shoko; Saeki, Takako; Okazaki, Kazuichi; Kamisawa, Terumi; Miyashita, Taiichiro; Yakushijin, Yoshihiro; Fujikawa, Keita; Yamamoto, Motohisa; Hamano, Hideaki; Origuchi, Tomoki; Hirata, Shintaro; Tsuboi, Hiroto; Sumida, Takayuki; Morimoto, Hisanori; Sato, Tomomi; Iwao, Haruka; Miki, Miyuki; Sakai, Tomoyuki; Fujita, Yoshimasa; Tanaka, Masao; Fukushima, Toshihiro; Okazaki, Toshiro; Umehara, Hisanori			Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease	PLOS ONE			English	Article							REGULATORY T-CELLS; AUTOIMMUNE PANCREATITIS; ANTIMICROBIAL PEPTIDES; MESSENGER-RNA; TH2; GALECTIN-10; NEUTROPHIL; ACTIVATION; DEFENSINS; DIAGNOSIS	Background IgG4-related disease (IgG4-RD) is a new clinical entity of unknown etiology characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. Although aberrancies in acquired immune system functions, including increases in Th2 and Treg cytokines observed in patients with IgG4-RD, its true etiology remains unclear. To investigate the pathogenesis of IgG4-RD, this study compared the expression of genes related to innate immunity in patients with IgG4-RD and healthy controls. Materials and Methods Peripheral blood mononuclear cells (PBMCs) were obtained from patients with IgG4-RD before and after steroid therapy and from healthy controls. Total RNA was extracted and DNA microarray analysis was performed in two IgG4-RD patients to screen for genes showing changes in expression. Candidate genes were validated by real-time RT-PCR in 27 patients with IgG4-RD and 13 healthy controls. Results DNA microarray analysis identified 21 genes that showed a greater than 3-fold difference in expression between IgG4-RD patients and healthy controls and 30 genes that showed a greater than 3-fold change in IgG4-RD patients following steroid therapy. Candidate genes related to innate immunity, including those encoding Charcot-Leyden crystal protein (CLC), membrane-spanning 4-domain subfamily A member 3 (MS4A3), defensin alpha (DEFA) 3 and 4, and interleukin-8 receptors (IL8R), were validated by real-time RT-PCR. Expression of all genes was significantly lower in IgG4-RD patients than in healthy controls. Steroid therapy significantly increased the expression of DEFA3, DEFA4 and MS4A3, but had no effect on the expression of CLC, IL8RA and IL8RB. Conclusions The expression of genes related to allergy or innate immunity, including CLC, MS4A3, DEFA3, DEFA4, IL8RA and IL8RB, was lower in PBMCs from patients with IgG4-RD than from healthy controls. Although there is the limitation in the number of patients applied in DNA microarray, impaired expression of genes related to innate immunity may be involved in the pathogenesis of IgG4-RD as well as in abnormalities of acquired immunity.	[Nakajima, Akio; Masaki, Yasufumi; Nakamura, Takuji; Kawanami, Takafumi; Sato, Tomomi; Iwao, Haruka; Miki, Miyuki; Sakai, Tomoyuki; Fujita, Yoshimasa; Tanaka, Masao; Fukushima, Toshihiro; Okazaki, Toshiro; Umehara, Hisanori] Kanazawa Med Univ, Hematol & Immunol, Uchinada, Ishikawa 9200293, Japan; [Ishigaki, Yasuhito; Takegami, Tsutomu] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa 9200293, Japan; [Kawano, Mitsuhiro; Yamada, Kazunori] Kanazawa Univ Hosp, Dept Internal Med, Div Rheumatol, Kanazawa, Ishikawa 9208641, Japan; [Tsukamoto, Norifumi] Gunma Univ, Grad Sch Med, Dept Med & Clin Sci, Gunma 3718511, Japan; [Matsui, Shoko] Toyama Univ, Hlth Adm Ctr, Toyama 9300194, Japan; [Saeki, Takako] Nagaoka Red Cross Hosp, Dept Internal Med, Niigata 9402085, Japan; [Okazaki, Kazuichi] Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, Osaka 5731191, Japan; [Kamisawa, Terumi] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Tokyo 1138677, Japan; [Miyashita, Taiichiro] Natl Hosp Org Nagasaki, Med Ctr, Dept Rheumatol, Nagasaki 3808582, Japan; [Yakushijin, Yoshihiro] Ehime Grad Sch Med, Dept Clin Oncol, Toon, Ehime 7910295, Japan; [Fujikawa, Keita] Isahaya Gen Hosp, Japan Community Healthcare Org, Dept Rheumatol, Nagasaki 8548501, Japan; [Yamamoto, Motohisa] Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido 0608543, Japan; [Hamano, Hideaki] Shinshu Univ, Sch Hosp, Med Informat Div, Nagano 3908621, Japan; [Hamano, Hideaki] Shinshu Univ, Sch Hosp, Dept Internal Med Gastroenterol, Nagano 3908621, Japan; [Origuchi, Tomoki] Nagasaki Grad Sch Hlth Sci, Dept Immunol & Rheumatol, Dept Internal Med 1, Nagasaki 8528520, Japan; [Hirata, Shintaro] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Fukuoka 8078555, Japan; [Tsuboi, Hiroto; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; [Morimoto, Hisanori] Mitoyo Gen Hosp, Div Nephrol, Kagawa 7691695, Japan; [Umehara, Hisanori] Kyoto Univ, Grad Sch Med, Dept Clin Immunol, Kyoto 6068501, Japan; [Umehara, Hisanori] Kyoto Univ, Fac Med, Kyoto 6068501, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa University; Gunma University; University of Toyama; Nagaoka Red Cross Hospital; Kansai Medical University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Sapporo Medical University; Shinshu University; Shinshu University; University of Occupational & Environmental Health - Japan; University of Tsukuba; Kyoto University; Kyoto University	Nakajima, A (corresponding author), Kanazawa Med Univ, Hematol & Immunol, Uchinada, Ishikawa 9200293, Japan.	m99-0529@kanazawa-med.ac.jp; umehara606@gmail.com	Hirata, Shintaro/O-5091-2019	Hirata, Shintaro/0000-0002-2474-9943; Matsui, Shoko/0000-0002-1328-5768	Japan Society for Promotion of Science; Ministry of Health, Labor, and Welfare (MHLW) of Japan [24791011]; Japanese Ministry of Education and Science of Japan [24791011, 22249041]; Grants-in-Aid for Scientific Research [15K09511] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare (MHLW) of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education and Science of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for scientific research from the Japan Society for Promotion of Science and by the Research Program of Intractable Disease (Research on IgG4-related disease) provided by the Ministry of Health, Labor, and Welfare (MHLW) of Japan (No. 24791011 to HU) and grants from the Japanese Ministry of Education and Science of Japan No 22249041 to HU and No 24791011 to AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Adra CN, 1999, CLIN GENET, V55, P431, DOI 10.1034/j.1399-0004.1999.550606.x; Asada M, 2010, PANCREAS, V39, P224, DOI 10.1097/MPA.0b013e3181bab5e2; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Devouassoux G, 2008, ALLERGY, V63, P125, DOI 10.1111/j.1398-9995.2007.01558.x; DOR PJ, 1984, AM REV RESPIR DIS, V130, P1072; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; Guarneri F, 2005, J CELL MOL MED, V9, P741, DOI 10.1111/j.1582-4934.2005.tb00506.x; Kawano M, 2009, MOD RHEUMATOL, V19, P87, DOI 10.1007/s10165-008-0127-z; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Koyabu M, 2010, J GASTROENTEROL, V45, P732, DOI 10.1007/s00535-010-0199-3; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Kutok JL, 2011, J CELL MOL MED, V15, P86, DOI 10.1111/j.1582-4934.2009.00925.x; Laubel DM, 2006, CURR TOP MICROBIOL, V306, P153; Lin TA, 2010, BIOMARKERS, V15, P646, DOI 10.3109/1354750X.2010.511266; Liu XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-722; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Miyake K, 2008, MOD RHEUMATOL, V18, P86, DOI 10.1007/s10165-007-0010-3; Miyoshi H, 2008, PANCREAS, V36, P133, DOI 10.1097/MPA.0b013e3181577553; Okazaki K, 2008, J GASTROENTEROL, V43, P409, DOI 10.1007/s00535-008-2190-9; Okazaki K, 2009, PANCREAS, V38, P849, DOI 10.1097/MPA.0b013e3181b9ee1c; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; Sato Y, 2010, PATHOL INT, V60, P247, DOI 10.1111/j.1440-1827.2010.02524.x; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Sharma R, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-20; Siddiquee Z, 2012, CARDIOVASC PATHOL, V21, P470, DOI 10.1016/j.carpath.2012.02.001; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Watanabe T, 2012, ARTHRITIS RHEUM-US, V64, P914, DOI 10.1002/art.33386; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697	35	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126582	10.1371/journal.pone.0126582	http://dx.doi.org/10.1371/journal.pone.0126582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973893	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600062
J	Roselli, L; Basset, A				Roselli, Leonilde; Basset, Alberto			Decoding Size Distribution Patterns in Marine and Transitional Water Phytoplankton: From Community to Species Level	PLOS ONE			English	Article							CELL-SIZE; FRACTIONATED PHYTOPLANKTON; RESOURCE COMPETITION; NUTRIENT-UPTAKE; COASTAL LAGOON; TRADE-OFFS; ECOLOGY; PLANKTON; MECHANISMS; MODEL	Understanding the mechanisms of phytoplankton community assembly is a fundamental issue of aquatic ecology. Here, we use field data from transitional (e.g. coastal lagoons) and coastal water environments to decode patterns of phytoplankton size distribution into organization and adaptive mechanisms. Transitional waters are characterized by higher resource availability and shallower well-mixed water column than coastal marine environments. Differences in physico-chemical regime between the two environments have been hypothesized to exert contrasting selective pressures on phytoplankton cell morphology (size and shape). We tested the hypothesis focusing on resource availability (nutrients and light) and mixed layer depth as ecological axes that define ecological niches of phytoplankton. We report fundamental differences in size distributions of marine and freshwater diatoms, with transitional water phytoplankton significantly smaller and with higher surface to volume ratio than marine species. Here, we hypothesize that mixing condition affecting size-dependent sinking may drive phytoplankton size and shape distributions. The interplay between shallow mixed layer depth and frequent and complete mixing of transitional waters may likely increase the competitive advantage of small phytoplankton limiting large cell fitness. The nutrient regime appears to explain the size distribution within both marine and transitional water environments, while it seem does not explain the pattern observed across the two environments. In addition, difference in light availability across the two environments appear do not explain the occurrence of asymmetric size distribution at each hierarchical level. We hypothesize that such competitive equilibria and adaptive strategies in resource exploitation may drive by organism's behavior which exploring patch resources in transitional and marine phytoplankton communities.	[Roselli, Leonilde; Basset, Alberto] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy	University of Salento	Roselli, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.	lea.roselli@unisalento.it		Roselli, Leonilde/0000-0002-0002-9415	Community Initiative INTERREG IIIB CADSES TWReferenceNet; Italian Ministry of University and Research (MIUR) PRIN; POR PUGLIA Progetto Strategico	Community Initiative INTERREG IIIB CADSES TWReferenceNet; Italian Ministry of University and Research (MIUR) PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); POR PUGLIA Progetto Strategico	This work was supported by Community Initiative INTERREG IIIB CADSES TWReferenceNet, by an Italian Ministry of University and Research (MIUR) PRIN 2008. In particular, POR PUGLIA Progetto Strategico 2009-2012 funded the postdoctoral fellowship to L. Roselli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSNES DL, 1991, MAR ECOL PROG SER, V70, P65, DOI 10.3354/meps070065; Barton AD, 2013, ECOL LETT, V16, P522, DOI 10.1111/ele.12063; Basset A, 2006, AQUAT CONSERV, V16, P441, DOI 10.1002/aqc.767; Basset A, 1997, OIKOS, V78, P31, DOI 10.2307/3545797; Basset A, 2007, OIKOS, V116, P1363, DOI 10.1111/j.2007.0030-1299.15702.x; Bec B, 2005, J PLANKTON RES, V27, P881, DOI 10.1093/plankt/fbi061; Bell T, 2001, LIMNOL OCEANOGR, V46, P1243, DOI 10.4319/lo.2001.46.5.1243; Beninca E, 2008, NATURE, V451, P822, DOI 10.1038/nature06512; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CAPONE DG, 1982, SCIENCE, V217, P1140, DOI 10.1126/science.217.4565.1140; Cavender-Bares KK, 2001, LIMNOL OCEANOGR, V46, P778, DOI 10.4319/lo.2001.46.4.0778; Cermeno P, 2005, LIMNOL OCEANOGR, V50, P1438, DOI 10.4319/lo.2005.50.5.1438; Chen BZ, 2010, LIMNOL OCEANOGR, V55, P965, DOI 10.4319/lo.2010.55.3.0965; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Cloern JE, 2005, MAR ECOL PROG SER, V285, P11, DOI 10.3354/meps285011; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; CLOERN JE, 1982, MAR ECOL PROG SER, V9, P191, DOI 10.3354/meps009191; Cugier P, 2010, J MARINE SYST, V82, P21, DOI 10.1016/j.jmarsys.2010.02.013; Cullen JJ, 1998, PHYSL ECOLOGY HARMFU, V41, P1; Cullen John J., 2002, P297; Dimier C, 2009, PROTIST, V160, P397, DOI 10.1016/j.protis.2009.03.001; EPPLEY RW, 1985, J PLANKTON RES, V7, P57, DOI 10.1093/plankt/7.1.57; Estrada M., 1998, PHYSL ECOLOGY HARMFU, VG 41, P601; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Finkel ZV, 2007, P NATL ACAD SCI USA, V104, P20416, DOI 10.1073/pnas.0709381104; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Finkel ZV, 2009, P ROY SOC B-BIOL SCI, V276, P1627, DOI 10.1098/rspb.2008.1610; Finkel ZV, 2004, MAR ECOL PROG SER, V273, P269, DOI 10.3354/meps273269; Gonenc IE, 2005, COASTAL LAGOONS: ECOSYSTEM PROCESSES AND MODELING FOR SUSTAINABLE USE AND DEVELOPMENT, P371; GROVER JP, 1991, AM NAT, V138, P811, DOI 10.1086/285254; Hansen H. P., 1983, METHODS SEAWATER ANA, P368; HELCOM, 2006, BALT SEA ENV; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Hubbell Stephen P., 2001, V32, pi; Huete-Ortega M, 2012, P ROY SOC B-BIOL SCI, V279, P1815, DOI 10.1098/rspb.2011.2257; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; Huisman J, 2001, ECOL LETT, V4, P408, DOI 10.1046/j.1461-0248.2001.00256.x; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Hutchinson GE., 1957, TREATISE LIMNOLOGY G; Jiang L, 2005, AM NAT, V166, P496, DOI 10.1086/444442; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Le Moigne P, 2013, TELLUS A, V65, DOI 10.3402/tellusa.v65i0.20951; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Litchman E, 2009, P NATL ACAD SCI USA, V106, P2665, DOI 10.1073/pnas.0810891106; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Litchman E, 2010, HYDROBIOLOGIA, V653, P15, DOI 10.1007/s10750-010-0341-5; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Margalef R., 1979, P89; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Margalef R., 1958, PERSPECTIVES MARINE, P323; Mitrovic SM, 2003, J PLANKTON RES, V25, P517, DOI 10.1093/plankt/25.5.517; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; MUNK WH, 1952, J MAR RES, V11, P215; Naselli-Flores L, 2003, HYDROBIOLOGIA, V502, P133, DOI 10.1023/B:HYDR.0000004276.11436.40; Naselli-Flores L, 2007, HYDROBIOLOGIA, V578, P157, DOI 10.1007/s10750-006-2815-z; Naselli-Flores L, 2011, CRYPTOGAMIE ALGOL, V32, P157, DOI 10.7872/crya.v32.iss2.2011.157; Naselli-Flores L, 2010, HYDROBIOLOGIA, V653, P235, DOI 10.1007/s10750-010-0355-z; OFFICER CB, 1982, MAR ECOL PROG SER, V9, P203, DOI 10.3354/meps009203; Padisak J, 2003, HYDROBIOLOGIA, V506, P1, DOI 10.1023/B:HYDR.0000008630.49527.29; Paerl H. W., 2010, COASTAL LAGOONS CRIT, DOI DOI 10.1201/EBK1420088304; PASCIAK WJ, 1974, LIMNOL OCEANOGR, V19, P881, DOI 10.4319/lo.1974.19.6.0881; Peter KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049632; Pilkaityte R, 2004, HYDROBIOLOGIA, V513, P27, DOI 10.1023/B:hydr.0000018162.50270.54; RAVEN JA, 1984, NEW PHYTOL, V98, P259, DOI 10.1111/j.1469-8137.1984.tb02736.x; Raven JA, 2005, VIE MILIEU, V55, P209; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Raven JA, 1997, ADV BOT RES, V25, P59, DOI 10.1016/S0065-2296(08)60148-2; RAVEN JA, 1987, NEW PHYTOL, V106, P357, DOI 10.1111/j.1469-8137.1987.tb00149.x; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Ritchie ME, 1999, NATURE, V557, P560; Roselli L, 2009, ESTUAR COAST SHELF S, V84, P539, DOI 10.1016/j.ecss.2009.07.023; Sabetta L, 2008, AQUAT CONSERV, V18, pS76, DOI 10.1002/aqc.954; Sabetta L, 2005, ESTUAR COAST SHELF S, V63, P645, DOI 10.1016/j.ecss.2005.01.009; Sabetta L, 2008, ESTUAR COAST SHELF S, V80, P181, DOI 10.1016/j.ecss.2008.07.021; Salmaso N, 2007, HYDROBIOLOGIA, V578, P97, DOI 10.1007/s10750-006-0437-0; Schwaderer AS, 2011, LIMNOL OCEANOGR, V56, P589, DOI 10.4319/lo.2011.56.2.0589; Segura AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01037; Sin Y, 2000, J PLANKTON RES, V22, P1945, DOI 10.1093/plankt/22.10.1945; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; SOMMER U, 1984, LIMNOL OCEANOGR, V29, P633, DOI 10.4319/lo.1984.29.3.0633; Stanca E, 2013, HYDROBIOLOGIA, V701, P99, DOI 10.1007/s10750-012-1262-2; Stolte W, 1996, J PHYCOL, V32, P732, DOI 10.1111/j.0022-3646.1996.00732.x; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; SYRETT PJ, 1981, CAN B FISH AQUAT SCI, P182; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Thingstad TF, 1998, HYDROBIOLOGIA, V363, P59; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; Tomas CR, 1997, IDENTIFYING MARINE P; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Vadrucci M.R., 2007, TRANSITIONAL WATERS, V2, P83, DOI [10.1285/i1825229Xv1n2p83, DOI 10.1285/I1825229XV1N2P83]; Verdy A, 2009, MAR ECOL PROG SER, V379, P1, DOI 10.3354/meps07909; Waite A, 1997, MAR ECOL PROG SER, V157, P97, DOI 10.3354/meps157097; Wetz MS, 2002, AQUAT MICROB ECOL, V28, P87, DOI 10.3354/ame028087; Winder M, 2009, P ROY SOC B-BIOL SCI, V276, P427, DOI 10.1098/rspb.2008.1200	103	19	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127193	10.1371/journal.pone.0127193	http://dx.doi.org/10.1371/journal.pone.0127193			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974052	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600102
J	Uchiyama, T; Irie, M; Mori, H; Kurokawa, K; Yamada, T				Uchiyama, Takeru; Irie, Mitsuru; Mori, Hiroshi; Kurokawa, Ken; Yamada, Takuji			FuncTree: Functional Analysis and Visualization for Large-Scale Omics Data	PLOS ONE			English	Article							GENES; KEGG	Exponential growth of high-throughput data and the increasing complexity of omics information have been making processing and interpreting biological data an extremely difficult and daunting task. Here we developed FuncTree (http://bioviz.tokyo/functree), a web-based application for analyzing and visualizing large-scale omics data, including but not limited to genomic, metagenomic, and transcriptomic data. FuncTree allows user to map their omics data onto the "Functional Tree map", a predefined circular dendrogram, which represents the hierarchical relationship of all known biological functions defined in the KEGG database. This novel visualization method allows user to overview the broad functionality of their data, thus allowing a more accurate and comprehensive understanding of the omics information. FuncTree provides extensive customization and calculation methods to not only allow user to directly map their omics data to identify the functionality of their data, but also to compute statistically enriched functions by comparing it to other predefined omics data. We have validated FuncTree's analysis and visualization capability by mapping pan-genomic data of three different types of bacterial genera, metagenomic data of the human gut, and transcriptomic data of two different types of human cell expression. All three mapping strongly confirms FuncTree's capability to analyze and visually represent key functional feature of the omics data. We believe that FuncTree's capability to conduct various functional calculations and visualizing the result into a holistic overview of biological function, would make it an integral analysis/ visualization tool for extensive omics base research.	[Uchiyama, Takeru; Irie, Mitsuru; Mori, Hiroshi; Kurokawa, Ken; Yamada, Takuji] Tokyo Inst Technol, Dept Biol Informat, Tokyo 152, Japan; [Kurokawa, Ken] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 152, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Yamada, T (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Tokyo 152, Japan.	takuji@bio.titech.ac.jp		Mori, Hiroshi/0000-0003-0806-7704	JSPS KAKENHI [25710016]; Grants-in-Aid for Scientific Research [25292206] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant-in-Aid for Young Scientists, Grant Number 25710016. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Ahn MY, 1998, CAN J MICROBIOL, V44, P423, DOI 10.1139/cjm-44-5-423; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; FISHMAN PH, 1982, J MEMBRANE BIOL, V69, P85, DOI 10.1007/BF01872268; Garrido D, 2013, MICROBIOL-SGM, V159, P649, DOI 10.1099/mic.0.064113-0; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368; Heinaniemi M, 2013, NAT METHODS, V10, P577, DOI [10.1038/nmeth.2445, 10.1038/NMETH.2445]; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kono N, 2009, PLOS ONE, V4, pA47, DOI 10.1371/journal.pone.0007710; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Pimentel M., 2012, AM J GASTROENTEROL, V1, P28, DOI [10.1038/ajgsup.2012.6, DOI 10.1038/AJGSUP.2012.6]; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; READING C, 1977, ANTIMICROB AGENTS CH, V11, P852, DOI 10.1128/AAC.11.5.852; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73	24	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126967	10.1371/journal.pone.0126967	http://dx.doi.org/10.1371/journal.pone.0126967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974630	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600092
J	Yates, T; Davies, MJ; Henson, J; Edwardson, C; Webb, D; Bodicoat, DH; Webb, M; Howard, P; Cooper, JA; Humphries, SE; Khunti, K; Talmud, P				Yates, Thomas; Davies, Melanie J.; Henson, Joseph; Edwardson, Charlotte; Webb, David; Bodicoat, Danielle H.; Webb, M'Balu; Howard, Philip; Cooper, Jackie A.; Humphries, Steve E.; Khunti, Kamlesh; Talmud, Philippa			Effect of the PPARG2 Pro12Al alpha Polymorphism on Associations of Physical Activity and Sedentary Time with Markers of Insulin Sensitivity in Those with an Elevated Risk of Type 2 Diabetes	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; IMPAIRED GLUCOSE REGULATION; DIETARY-FAT INTAKE; GENE POLYMORPHISM; P12A POLYMORPHISM; RESISTANCE; MELLITUS; INTERACT; PEOPLE; HEALTH	Background Peroxisome proliferator-activated receptor gamma (PPAR gamma) is an important regulator of metabolic health and a common polymorphism in the PPAR-gamma 2 gene (PPARG2) may modify associations between lifestyle behaviour and health. Objective To investigate whether the PPARG2 Pro12Ala genotype modifies the associations of sedentary behaviour and moderate-to-vigorous intensity physical activity (MVPA) with common measures of insulin sensitivity. Methods Participants with a high risk of impaired glucose regulation were recruited, United Kingdom, 2010-2011. Sedentary and MVPA time were objectively measured using accelerometers. Fasting and 2-hour post-challenge insulin and glucose were assessed; insulin sensitivity was calculated using Matsuda-ISI and HOMA-IS. DNA was extracted from whole blood. Linear regression examined associations of sedentary time and MVPA with insulin sensitivity and examined interactions by PPARG2 Pro12Ala genotype. Results 541 subjects were included (average age = 65 years, female = 33%); 18% carried the Ala12 allele. Both sedentary time and MVPA were strongly associated with HOMA-IS and Matsuda-ISI after adjustment for age, sex, ethnicity, medication, smoking status and accelerometer wear time. After further adjustment for each other and BMI, only associations with Matsuda-ISI were maintained. Every 30 minute difference in sedentary time was inversely associated with a 4% (0, 8%; p = 0.043) difference in Matsuda-ISI, whereas every 30 minutes in MVPA was positively associated with a 13% (0, 26%; p = 0.048) difference. The association of MVPA with Matsuda-ISI was modified by genotype (p = 0.005) and only maintained in Ala12 allele carriers. Conversely, sedentary time was not modified by genotype and remained inversely associated with insulin sensitivity in Pro12 allele homozygotes. Conclusion The association of MVPA with Matsuda-ISI was modified by PPARG2 Pro12Ala genotype with significant associations only observed in the 18% of the population who carried the Ala12 allele, whereas associations with sedentary time were unaffected.	[Yates, Thomas; Davies, Melanie J.; Henson, Joseph; Edwardson, Charlotte; Webb, David; Bodicoat, Danielle H.; Khunti, Kamlesh] Univ Leicester, Coll Med Biol Sci & Psychol, Diabet Res Ctr, Leicester, Leics, England; [Yates, Thomas; Davies, Melanie J.; Henson, Joseph; Edwardson, Charlotte; Webb, David; Bodicoat, Danielle H.] NIHR Leicester Loughborough Diet Lifestyle & Phys, Leicester Diabet Ctr, BRU, Leicester, Leics, England; [Webb, M'Balu] Univ Hosp Leicester NHS Trust, Leicester Diabet Ctr, Leicester, Leics, England; [Howard, Philip; Cooper, Jackie A.; Humphries, Steve E.; Talmud, Philippa] UCL, British Heart Fdn Labs, Ctr Cardiovasc Genet, London, England; [Khunti, Kamlesh] NIHR, CLAHRC EM, Leicester Diabet Ctr, Leicester, Leics, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of London; University College London	Edwardson, C (corresponding author), Univ Leicester, Coll Med Biol Sci & Psychol, Diabet Res Ctr, Leicester, Leics, England.	ce95@le.ac.uk	/ABC-9527-2021	Edwardson, Charlotte/0000-0001-6485-9330; Webb, David/0000-0002-3932-3339; Talmud, Philippa/0000-0002-5560-1933; Humphries, Stephen E/0000-0002-8221-6547; Henson, Joseph/0000-0002-3898-7053; Yates, Thomas/0000-0002-5724-5178; Davies, Melanie/0000-0002-9987-9371	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for Leicestershire, Northamptonshire, and Rutland; BHF [PG 008/014]; UCL NIHR Biomedical Research Centre; NIHR Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM); NIHR Lifestyle and Physical Activity Biomedical Research Unit; University Hospitals of Leicester NHS Trust; Loughborough University; University of Leicester; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for Leicestershire, Northamptonshire, and Rutland(National Institute for Health Research (NIHR)); BHF(British Heart Foundation); UCL NIHR Biomedical Research Centre; NIHR Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM); NIHR Lifestyle and Physical Activity Biomedical Research Unit; University Hospitals of Leicester NHS Trust; Loughborough University; University of Leicester; British Heart Foundation(British Heart Foundation)	The Walking Away trial was funded by The National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for Leicestershire, Northamptonshire, and Rutland. SEH holds a Chair from the British Heart Foundation and JAC is funded by the BHF (PG 008/014). Centre for Cardiovascular Genetics, University College London, is supported by the UCL NIHR Biomedical Research Centre. The analysis reported in this paper was further supported by the NIHR Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM) and the NIHR Lifestyle and Physical Activity Biomedical Research Unit, which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University, and the University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Adamo KB, 2005, DIABETOLOGIA, V48, P1503, DOI 10.1007/s00125-005-1827-y; Brito EC, 2009, DIABETES, V58, P1411, DOI 10.2337/db08-1623; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Cooper AJM, 2014, DIABETOLOGIA, V57, P73, DOI 10.1007/s00125-013-3069-8; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc09-1521, 10.2337/dc10-0646]; Dubuquoy L, 2002, LANCET, V360, P1410, DOI 10.1016/S0140-6736(02)11395-X; Florez JC, 2007, J CLIN ENDOCR METAB, V92, P1502, DOI 10.1210/jc.2006-2275; Gouda HN, 2010, AM J EPIDEMIOL, V171, P645, DOI 10.1093/aje/kwp450; Gray LJ, 2012, DIABETOLOGIA, V55, P959, DOI 10.1007/s00125-011-2432-x; Hagberg JM, 2012, ACTA PHYSIOL, V205, P456, DOI 10.1111/j.1748-1716.2012.02455.x; Harrison SC, 2013, ATHEROSCLEROSIS, V226, P440, DOI 10.1016/j.atherosclerosis.2012.11.002; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Kahara T, 2003, METABOLISM, V52, P209, DOI 10.1053/meta.2003.50038; Kilpelainen TO, 2008, MED SCI SPORT EXER, V40, P25, DOI 10.1249/mss.0b013e318159d1cd; Luan J, 2001, DIABETES, V50, P686, DOI 10.2337/diabetes.50.3.686; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Memisoglu A, 2003, HUM MOL GENET, V12, P2923, DOI 10.1093/hmg/ddg318; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Nelson TL, 2007, METABOLISM, V56, P388, DOI 10.1016/j.metabol.2006.10.022; Ostergard T, 2005, HORM METAB RES, V37, P99, DOI 10.1055/s-2005-861174; Otten J, 2014, DIABETOLOGIA, V57, P1781, DOI 10.1007/s00125-014-3285-x; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Robitaille J, 2003, CLIN GENET, V63, P109, DOI 10.1034/j.1399-0004.2003.00026.x; Ruchat SM, 2010, DIABETOLOGIA, V53, P679, DOI 10.1007/s00125-009-1630-2; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Weiss EP, 2005, METABOLISM, V54, P97, DOI 10.1016/j.metabol.2004.08.006; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Yates T, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-46; Yates T, 2011, DIABETES RES CLIN PR, V93, P292, DOI 10.1016/j.diabres.2011.03.023	35	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0124062	10.1371/journal.pone.0124062	http://dx.doi.org/10.1371/journal.pone.0124062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974167	Green Published, gold			2022-12-27	WOS:000354545600008
J	Bergenfelz, C; Larsson, AM; von Stedingk, K; Gruvberger-Saal, S; Aaltonen, K; Jansson, S; Jernstrom, H; Janols, H; Wullt, M; Bredberg, A; Ryden, L; Leandersson, K				Bergenfelz, Caroline; Larsson, Anna-Maria; von Stedingk, Kristoffer; Gruvberger-Saal, Sofia; Aaltonen, Kristina; Jansson, Sara; Jernstrom, Helena; Janols, Helena; Wullt, Marlene; Bredberg, Anders; Ryden, Lisa; Leandersson, Karin			Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; MICROARRAY DATA-MANAGEMENT; PERIPHERAL-BLOOD CELLS; REGULATORY T-CELLS; LARGE GENE LISTS; IMMUNE SUPPRESSION; MYELOID CELLS; DENDRITIC CELLS; ENDOTOXIN TOLERANCE; LPS TOLERANCE	Myeloid-derived suppressor cells (MDSCs) are highly immunosuppressive myeloid cells, which increase in cancer patients. The molecular mechanism behind their generation and function is unclear. Whereas granulocytic-MDSCs correlate with poor overall survival in breast cancer, the presence and relevance of monocytic-MDSCs (Mo-MDSCs) is unknown. Here we report for the first time an enrichment of functional blood Mo-MDSCs in breast cancer patients before they acquire a typical Mo-MDSC surface phenotype. A clear population of Mo-MDSCs with the typical cell surface phenotype (CD14(+)HLA-DR(low/-)CD86(low/-)CD80(low/-)CD163(low/-)) increased significantly first during disease progression and correlated to metastasis to lymph nodes and visceral organs. Furthermore, monocytes, comprising the Mo-MDSC population, from patients with metastatic breast cancer resemble the reprogrammed immunosuppressive monocytes in patients with severe infections, both by their surface and functional phenotype but also at their molecular gene expression profile. Our data suggest that monitoring the Mo-MDSC levels in breast cancer patients may represent a novel and simple biomarker for assessing disease progression.	[Bergenfelz, Caroline; Leandersson, Karin] LU, SUS, Ctr Mol Pathol, Skane Univ Hosp, S-20502 Malmo, Sweden; [Larsson, Anna-Maria; von Stedingk, Kristoffer] LU, Translat Canc Res, S-22381 Lund, Sweden; [Gruvberger-Saal, Sofia; Aaltonen, Kristina; Jansson, Sara; Jernstrom, Helena] LU, Dept Clin Sci Lund, Div Oncol & Pathol, S-22185 Lund, Sweden; [Janols, Helena; Wullt, Marlene] LU, SUS, Dept Infect Dis, S-20502 Malmo, Sweden; [Bredberg, Anders] LU, SUS, Med Microbiol, S-20502 Malmo, Sweden; [Ryden, Lisa] LU, Dept Clin Sci, Div Surg, S-22185 Lund, Sweden	Lund University; Skane University Hospital	Bergenfelz, C (corresponding author), LU, SUS, Ctr Mol Pathol, Skane Univ Hosp, Jan Waldenstroms Gata 59, S-20502 Malmo, Sweden.	caroline.bergenfelz@med.lu.se	Bergenfelz, Caroline/AAQ-2660-2020	Bergenfelz, Caroline/0000-0001-9337-7285	Swedish Cancer Foundation; Medical Research Council; Malmo Allmanna Sjukhus Cancer research foundation; Gunnar Nilssons Cancer Foundation; Ollie och Elof Ericssons Foundation; Mrs Berta Kamprad Foundation; National Health Service (ALF); Gyllenstiernska Krapperups foundation	Swedish Cancer Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Malmo Allmanna Sjukhus Cancer research foundation; Gunnar Nilssons Cancer Foundation; Ollie och Elof Ericssons Foundation(Ericsson); Mrs Berta Kamprad Foundation; National Health Service (ALF); Gyllenstiernska Krapperups foundation	This work was supported by the Swedish Cancer Foundation, the Medical Research Council, Malmo Allmanna Sjukhus Cancer research foundation, Gunnar Nilssons Cancer Foundation, Ollie och Elof Ericssons Foundation, Mrs Berta Kamprad Foundation, Governmental funding of Clinical Research within the National Health Service (ALF), and the Gyllenstiernska Krapperups foundation.	Aaroe J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2472; Aneja RK, 2008, J LEUKOCYTE BIOL, V84, P1326, DOI 10.1189/jlb.0108030; Austermann J, 2014, CELL REP, V9, P2112, DOI 10.1016/j.celrep.2014.11.020; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bergenfelz C, 2012, J IMMUNOL, V188, P5448, DOI 10.4049/jimmunol.1103378; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Blot E, 2003, BRIT J CANCER, V88, P1207, DOI 10.1038/sj.bjc.6600872; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Evani SJ, 2013, FASEB J, V27, P3017, DOI 10.1096/fj.12-224824; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; FINGERLE G, 1993, BLOOD, V82, P3170; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gros A, 2012, CLIN CANCER RES, V18, P5212, DOI 10.1158/1078-0432.CCR-12-1108; Gustafson MP, 2010, NEURO-ONCOLOGY, V12, P631, DOI 10.1093/neuonc/noq001; Hadler-Olsen E, 2013, TUMOR BIOL, V34, P2041, DOI 10.1007/s13277-013-0842-8; Hotchkiss RS, 2014, NEW ENGL J MED, V371, P380, DOI 10.1056/NEJMcibr1404664; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janols H, 2014, J LEUKOCYTE BIOL, V96, P685, DOI 10.1189/jlb.5HI0214-074R; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Leek RD, 1996, CANCER RES, V56, P4625; Li SS, 2013, J SURG RES, V185, P319, DOI 10.1016/j.jss.2013.05.062; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mages J, 2007, IMMUNOBIOLOGY, V212, P723, DOI 10.1016/j.imbio.2007.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Meyer TPH, 2005, J IMMUNOL METHODS, V307, P150, DOI 10.1016/j.jim.2005.10.004; Mohamed MM, 2008, BIOL CHEM, V389, P1117, DOI 10.1515/BC.2008.117; Mougiakakos D, 2013, LEUKEMIA, V27, P377, DOI 10.1038/leu.2012.215; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Poindexter NJ, 2004, BREAST CANCER RES, V6, pR408, DOI 10.1186/bcr808; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sharma P, 2005, BREAST CANCER RES, V7, pR634, DOI 10.1186/bcr1203; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo KA, 2005, BREAST CANCER RES, V7, pR661, DOI 10.1186/bcr1261; Treilleux I, 2004, CLIN CANCER RES, V10, P7466, DOI 10.1158/1078-0432.CCR-04-0684; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vallon-Christersson J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-330; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; Xu PB, 2012, J INFECTION, V65, P380, DOI 10.1016/j.jinf.2012.08.001; Yuan XK, 2011, J INT MED RES, V39, P1381, DOI 10.1177/147323001103900424; Zhao F, 2012, IMMUNOLOGY, V136, P176, DOI 10.1111/j.1365-2567.2012.03566.x; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	56	92	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127028	10.1371/journal.pone.0127028	http://dx.doi.org/10.1371/journal.pone.0127028			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992611	Green Submitted, Green Published, gold			2022-12-27	WOS:000354921400091
J	Yang, S; Xie, JF; Hu, N; Liu, YX; Zhang, JN; Ye, XB; Liu, ZD				Yang, Sen; Xie, Jiufeng; Hu, Nan; Liu, Yixiong; Zhang, Jiner; Ye, Xiaobin; Liu, Ziduo			Bioconversion of Gibberellin Fermentation Residue into Feed Supplement and Organic Fertilizer Employing Housefly (Musca domestica L.) Assisted by Corynebacterium variabile	PLOS ONE			English	Article							SWINE MANURE; ACID PRODUCTION	The accumulation of a considerable quantity of gibberellin fermentation residue (GFR) during gibberellic acid A3 (GA3) production not only results in the waste of many resources, but also poses a potential hazard to the environment, indicating that the safe treatment of GFR has become an urgent issue for GA3 industry. The key to recycle GFR is converting it into an available resource and removing the GA3 residue. To this end, we established a co-bioconversion process in this study using house fly larvae (HFL) and microbes (Corynebacterium variabile) to convert GFR into insect biomass and organic fertilizer. About 85.5% GA3 in the GFR was removed under the following optimized solid-state fermentation conditions: 60% GFR, 40% rice straw powder, pH 8.5 and 6 days at 26 degrees C. A total of 371g housefly larvae meal and 2,064g digested residue were bio-converted from 3,500g raw GFR mixture contaning1, 400g rice straw in the unit of (calculated) dry matter. HFL meal derived from GFR contained 56.4% protein, 21.6% fat, and several essential amino acids, suggesting that it is a potential alternative animal feed protein source. Additionally, the digested GFR could be utilized as an organic fertilizer with a content of 3.2% total nitrogen, 2.0% inorganic phosphorus, 1.3% potassium and 91.5% organic matter. This novel GFR bio-conversion method can mitigate potential environmental pollution and recycle the waste resources.	[Liu, Ziduo] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hunan, Peoples R China; [Yang, Sen; Xie, Jiufeng] Henan Agr Univ, Coll Life Sci, Key Lab Enzyme Engn Agr Microbiol, Minist Agr, Zhengzhou, Henan, Peoples R China; [Hu, Nan] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Liu, Yixiong; Zhang, Jiner; Ye, Xiaobin] Jiang Xi New Reyphon Biochem Co LTD, Ji An City, Jiangxi, Peoples R China	Huazhong Agricultural University; Henan Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing Tech University	Liu, ZD (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hunan, Peoples R China.	lzd@mail.hzau.edu.cn			College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University; Hubei Province Science and Technology Support Projects [2014BBB009]; National Natural Science Foundation of China [31270162]	College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University; Hubei Province Science and Technology Support Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, and grants from the Hubei Province Science and Technology Support Projects (2014BBB009) and the National Natural Science Foundation of China (No. 31270162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2000, OFFICIAL METHODS ANA; CERDAOLMEDO E, 1994, ANTON LEEUW INT J G, V65, P217, DOI 10.1007/BF00871950; Cickova H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032798; CSABA G, 1977, ACTA BIOL MED GER, V36, P1487; Davies P.J., 2004, PLANT HORMONES BIOSY; ELMOFTY MM, 1994, NUTR CANCER, V21, P183, DOI 10.1080/01635589409514316; ELMOFTY MM, 1988, ONCOLOGY, V45, P61, DOI 10.1159/000226532; Jin Z, 2005, PRACTI PREVE MED, V2, P003; Li Q, 2012, J ANHUI SCI, V40, P13360; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; Liu X, 2010, ACTA AGR U JIANGXIEN, V3, P010; Majumder M. Z. R., 2012, Bangladesh Journal of Zoology, V40, P189; Newton G. L, 2005, BLACK SOLDIER FLY HE; OCIO E, 1979, ANIM FEED SCI TECH, V4, P227, DOI 10.1016/0377-8401(79)90016-6; [彭霄鹏 Peng Xiaopeng], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P126; Pike I, 1990, ROLE FISH MEAL DIETS, P25; Rodrigues C, 2012, CRIT REV BIOTECHNOL, V32, P263, DOI 10.3109/07388551.2011.615297; Sanchez-Muros MJ, 2014, J CLEAN PROD, V65, P16, DOI 10.1016/j.jclepro.2013.11.068; Schroder J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-545; Shukla R, 2005, PROCESS BIOCHEM, V40, P2045, DOI 10.1016/j.procbio.2004.07.017; Steel RGD, 1980, PRINCIPLES PROCEDURE; Wang H, 2013, WASTE MANAGE RES, V31, P223, DOI 10.1177/0734242X12469431; Wu ZM, 2010, ADV MATER RES-SWITZ, V113-116, P1084, DOI 10.4028/www.scientific.net/AMR.113-116.1084; Xie W, 2011, FOOD CHEM, V127, P890, DOI 10.1016/j.foodchem.2011.01.018; Yang S, 2014, RENEW ENERG, V66, P222, DOI 10.1016/j.renene.2013.11.076; Yang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045940; Zhan SX, 2008, CHINESE J HLTH LAB T, V18, P1330; Zhang ZJ, 2012, BIORESOURCE TECHNOL, V118, P563, DOI 10.1016/j.biortech.2012.05.048	28	6	6	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0110809	10.1371/journal.pone.0110809	http://dx.doi.org/10.1371/journal.pone.0110809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992605	gold, Green Published, Green Submitted			2022-12-27	WOS:000354921400001
J	Lecomte, V; Kaakoush, NO; Maloney, CA; Raipuria, M; Huinao, KD; Mitchell, HM; Morris, MJ				Lecomte, Virginie; Kaakoush, Nadeem O.; Maloney, Christopher A.; Raipuria, Mukesh; Huinao, Karina D.; Mitchell, Hazel M.; Morris, Margaret J.			Changes in Gut Microbiota in Rats Fed a High Fat Diet Correlate with Obesity-Associated Metabolic Parameters	PLOS ONE			English	Article							BACTERIAL DIVERSITY; INTESTINAL MICROBIOTA; LACTOBACILLUS-CASEI; WEIGHT-GAIN; BUTYRATE; HUMANS; COLONIZATION; INFLAMMATION; ACTIVATION; MICROFLORA	The gut microbiota is emerging as a new factor in the development of obesity. Many studies have described changes in microbiota composition in response to obesity and high fat diet (HFD) at the phylum level. In this study we used 16s RNA high throughput sequencing on faecal samples from rats chronically fed HFD or control chow (n = 10 per group, 16 weeks) to investigate changes in gut microbiota composition at the species level. 53.17% dissimilarity between groups was observed at the species level. Lactobacillus intestinalis dominated the microbiota in rats under the chow diet. However this species was considerably less abundant in rats fed HFD (P < 0.0001), this being compensated by an increase in abundance of propionate/acetate producing species. To further understand the influence of these species on the development of the obese phenotype, we correlated their abundance with metabolic parameters associated with obesity. Of the taxa contributing the most to dissimilarity between groups, 10 presented significant correlations with at least one of the tested parameters, three of them correlated positively with all metabolic parameters: Phascolarctobacterium, Proteus mirabilis and Veillonellaceae, all propionate/ acetate producers. Lactobacillus intestinalis was the only species whose abundance was negatively correlated with change in body weight and fat mass. This species decreased drastically in response to HFD, favouring propionate/ acetate producing bacterial species whose abundance was strongly correlated with adiposity and deterioration of metabolic factors. Our observations suggest that these species may play a key role in the development of obesity in response to a HFD.	[Lecomte, Virginie; Maloney, Christopher A.; Raipuria, Mukesh; Morris, Margaret J.] UNSW Australia, Sch Med Sci, Sydney, NSW, Australia; [Kaakoush, Nadeem O.; Huinao, Karina D.; Mitchell, Hazel M.] UNSW Australia, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Morris, MJ (corresponding author), UNSW Australia, Sch Med Sci, Sydney, NSW, Australia.	m.morris@unsw.edu.au	Maloney, Christopher/AAG-8599-2019; Morris, Margaret J/J-4285-2013; Kaakoush, Nadeem/ABG-9499-2020	Maloney, Christopher/0000-0002-9193-2369; Kaakoush, Nadeem Omar/0000-0003-4017-1077; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council NHMRC; University of New South Wales; National Health and Medical Research Council of Australia (NHMRC)	National Health and Medical Research Council NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Experimental costs were partially funded by a National Health and Medical Research Council NHMRC project grant (MJM). Virginie Lecomte was supported by a Vice Chancellor's Fellowship from the University of New South Wales. Nadeem O. Kaakoush was supported by an Early Career Fellowship from the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Armbruster CE, 2012, NAT REV MICROBIOL, V10, P743, DOI 10.1038/nrmicro2890; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Brooks SPJ, 2003, CAN J MICROBIOL, V49, P589, DOI 10.1139/W03-075; Burcelin R, 2012, PHYSIOLOGY, V27, P300, DOI 10.1152/physiol.00023.2012; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2013, CURR OPIN PHARMACOL, V13, P935, DOI 10.1016/j.coph.2013.09.008; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Dalby AB, 2006, APPL ENVIRON MICROB, V72, P6707, DOI 10.1128/AEM.00378-06; Davis JJ, 2013, INT J SYST EVOL MICR, V63, P2727, DOI 10.1099/ijs.0.048983-0; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Delzenne NM, 2013, BRIT J NUTR, V109, pS81, DOI 10.1017/S0007114512004047; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dowd SE, 2011, J WOUND CARE, V20, P40, DOI 10.12968/jowc.2011.20.1.40; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Drissi F, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.6; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2007, LETT APPL MICROBIOL, V44, P343, DOI 10.1111/j.1472-765X.2007.02129.x; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hernell O, 2013, BRIT J NUTR, V109, pS70, DOI 10.1017/S0007114512004059; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; JOHNSON JL, 1986, INT J SYST BACTERIOL, V36, P499, DOI 10.1099/00207713-36-4-499; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Mozes S, 2008, OBESITY, V16, P2610, DOI 10.1038/oby.2008.435; Mujico JR, 2013, BRIT J NUTR, V110, P711, DOI 10.1017/S0007114512005612; Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x; Newkirk MM, 2010, RHEUMATOLOGY, V49, P1311, DOI 10.1093/rheumatology/keq088; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Plummer JL, 2000, J GASTROEN HEPATOL, V15, P1307, DOI 10.1046/j.1440-1746.2000.02340.x; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sefcikova Z, 2010, FOLIA MICROBIOL, V55, P373, DOI 10.1007/s12223-010-0061-2; Serino M, 2012, CURR PHARM BIOTECHNO, V13, P746, DOI 10.2174/138920112799857567; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Tabuchi M, 2003, BIOSCI BIOTECH BIOCH, V67, P1421, DOI 10.1271/bbb.67.1421; Tanida M, 2008, OBES RES CLIN PRACT, V2, P159, DOI 10.1016/j.orcp.2008.04.003; Tomas Julie, 2012, Animal Health Research Reviews, V13, P54, DOI 10.1017/S1466252312000072; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vael C, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-8; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; World Health Organisation, 2013, WORLD HEALTH STATIST; Xie N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-53; Yadav H, 2007, NUTRITION, V23, P62, DOI 10.1016/j.nut.2006.09.002; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163; Zhao X, 2011, WORLD J GASTROENTERO, V17, P3151, DOI 10.3748/wjg.v17.i26.3151	86	262	275	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126931	10.1371/journal.pone.0126931	http://dx.doi.org/10.1371/journal.pone.0126931			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992554	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300067
J	Van Meter, KJ; Basu, NB				Van Meter, Kimberly J.; Basu, Nandita B.			Catchment Legacies and Time Lags: A Parsimonious Watershed Model to Predict the Effects of Legacy Storage on Nitrogen Export	PLOS ONE			English	Article							LAND-USE; MISSISSIPPI RIVER; TRANSIT-TIME; SOIL CARBON; QUALITY; INPUTS; FATE; AGROECOSYSTEMS; CHEMICALS; POLLUTION	Nutrient legacies in anthropogenic landscapes, accumulated over decades of fertilizer application, lead to time lags between implementation of conservation measures and improvements in water quality. Quantification of such time lags has remained difficult, however, due to an incomplete understanding of controls on nutrient depletion trajectories after changes in land-use or management practices. In this study, we have developed a parsimonious watershed model for quantifying catchment-scale time lags based on both soil nutrient accumulations (biogeochemical legacy) and groundwater travel time distributions (hydrologic legacy). The model accurately predicted the time lags observed in an Iowa watershed that had undergone a 41% conversion of area from row crop to native prairie. We explored the time scales of change for stream nutrient concentrations as a function of both natural and anthropogenic controls, from topography to spatial patterns of land-use change. Our results demonstrate that the existence of biogeochemical nutrient legacies increases time lags beyond those due to hydrologic legacy alone. In addition, we show that the maximum concentration reduction benefits vary according to the spatial pattern of intervention, with preferential conversion of land parcels having the shortest catchment-scale travel times providing proportionally greater concentration reductions as well as faster response times. In contrast, a random pattern of conversion results in a 1: 1 relationship between percent land conversion and percent concentration reduction, irrespective of denitrification rates within the landscape. Our modeling framework allows for the quantification of tradeoffs between costs associated with implementation of conservation measures and the time needed to see the desired concentration reductions, making it of great value to decision makers regarding optimal implementation of watershed conservation measures.	[Van Meter, Kimberly J.; Basu, Nandita B.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada; [Basu, Nandita B.] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Basu, NB (corresponding author), Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada.	nandita.basu@uwaterloo.ca		Van Meter, Kimberly/0000-0002-3698-7850	National Science Foundation Coupled Natural and Human Systems program [1114978]; National Sciences and Engineering Research Council (NSERC); Division Of Behavioral and Cognitive Sci [1114978] Funding Source: National Science Foundation	National Science Foundation Coupled Natural and Human Systems program; National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Work was supported by funds from the National Science Foundation Coupled Natural and Human Systems program, grant number 1114978 (NBB). Ongoing work is also being funded by an National Sciences and Engineering Research Council (NSERC) Strategic Grant, "Canada's Nitrogen Legacy: Combining Modeling and Isotope Approaches for Drinking Water Quality and Aquatic Ecosystem Health of Rivers" (NBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MJ, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010967; Baker LA, 2001, ECOSYSTEMS, V4, P582, DOI 10.1007/s10021-001-0031-2; Basu NB, 2012, J HYDROL, V475, P65, DOI 10.1016/j.jhydrol.2012.08.052; Basu NB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045168; Billen G, 2009, AGR ECOSYST ENVIRON, V133, P234, DOI 10.1016/j.agee.2009.04.018; Bouraoui F, 2014, SCI TOTAL ENVIRON, V468, P1267, DOI 10.1016/j.scitotenv.2013.07.066; Boyer EW, 2002, BIOGEOCHEMISTRY, V57, P137, DOI 10.1023/A:1015709302073; Chen DJ, 2014, WATER RESOUR RES, V50, P7714, DOI 10.1002/2014WR015852; Chen DJ, 2014, ENVIRON SCI TECHNOL, V48, P5683, DOI 10.1021/es500127t; Chen NW, 2008, BIOGEOCHEMISTRY, V87, P169, DOI 10.1007/s10533-007-9175-2; David MB, 2010, J ENVIRON QUAL, V39, P1657, DOI 10.2134/jeq2010.0115; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Drobney PM, 1994, ECOL RESTOR, V12, P16; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Gleeson T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045565; Grizzetti B, 2003, ECOL MODEL, V169, P25, DOI 10.1016/S0304-3800(03)00198-4; Haag D, 2000, HYLE, V6, P117; Haitjema HM., 1995, ANALYTIC ELEMENT MOD; Hamilton SK, 2012, FRESHWATER BIOL, V57, P43, DOI 10.1111/j.1365-2427.2011.02685.x; Hong BG, 2013, ENVIRON SCI TECHNOL, V47, P5199, DOI 10.1021/es303437c; Howarth RW, 2006, BIOGEOCHEMISTRY, V79, P163, DOI 10.1007/s10533-006-9010-1; Howarth RW, 2002, AMBIO, V31, P88, DOI 10.1639/0044-7447(2002)031[0088:NUITUS]2.0.CO;2; Janzen HH, 2003, NUTR CYCL AGROECOSYS, V67, P85, DOI 10.1023/A:1025195826663; Jarvie HP, 2013, J ENVIRON QUAL, V42, P295, DOI 10.2134/jeq2012.0085; Jawitz JW, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003825; Jha MK, 2007, T ASABE, V50, P479, DOI 10.13031/2013.22660; Jindal P, 2010, STUDY GROUNDWATER TR; JURY WA, 1990, WATER RESOUR RES, V26, P13, DOI 10.1029/WR026i001p00013; Kemp WM, 2009, BIOGEOSCIENCES, V6, P2985, DOI 10.5194/bg-6-2985-2009; Kling CL, 2014, EUR REV AGRIC ECON, V41, P431, DOI 10.1093/erae/jbu009; Kroeze C, 2003, NUTR CYCL AGROECOSYS, V66, P43, DOI 10.1023/A:1023339106213; Lewis DB, 2006, GLOBAL CHANGE BIOL, V12, P703, DOI 10.1111/j.1365-2486.2006.01126.x; Li CS, 2006, ECOL MODEL, V196, P116, DOI 10.1016/j.ecolmodel.2006.02.007; Liu C, 2008, NUTR CYCL AGROECOSYS, V80, P19, DOI 10.1007/s10705-007-9118-2; MacDonald GK, 2009, ECOSYSTEMS, V12, P621, DOI 10.1007/s10021-009-9246-4; MALOSZEWSKI P, 1982, J HYDROL, V57, P207; Manzoni S, 2009, SOIL BIOL BIOCHEM, V41, P1355, DOI 10.1016/j.soilbio.2009.02.031; McGuire KJ, 2006, J HYDROL, V330, P543, DOI 10.1016/j.jhydrol.2006.04.020; McMahon PB, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004417; Meals DW, 2010, J ENVIRON QUAL, V39, P85, DOI 10.2134/jeq2009.0108; Ng TL, 2010, ENVIRON SCI TECHNOL, V44, P7138, DOI 10.1021/es9039677; Osterman LE, 2009, GEO-MAR LETT, V29, P405, DOI 10.1007/s00367-009-0158-2; Pijanowski B, 2007, ECOL SOC, V12; Porporato A, 2003, ADV WATER RESOUR, V26, P45, DOI 10.1016/S0309-1708(02)00094-5; Prior J. C., 1991, LANDFORMS OF IOWA; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Rabotyagov S, 2010, ECOL APPL, V20, P1542, DOI 10.1890/08-0680.1; Sanford WE, 2013, ENVIRON SCI TECHNOL, V47, P13330, DOI 10.1021/es401334k; Schilling KE, 2007, ENVIRON GEOL, V53, P433, DOI 10.1007/s00254-007-0659-0; Schilling KE, 2012, HYDROL PROCESS, V26, P3092, DOI 10.1002/hyp.8337; Schilling KE, 2010, AGR ECOSYST ENVIRON, V135, P81, DOI 10.1016/j.agee.2009.08.013; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Sebilo M, 2013, P NATL ACAD SCI USA, V110, P18185, DOI 10.1073/pnas.1305372110; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Smith CM, 2013, J ENVIRON QUAL, V42, P219, DOI 10.2134/jeq2012.0210; Strock JS, 2004, J ENVIRON QUAL, V33, P1010, DOI 10.2134/jeq2004.1010; Swaney DP, 2012, CURR OPIN ENV SUST, V4, P203, DOI 10.1016/j.cosust.2012.03.004; Tesoriero AJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010471; Thompson SE, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009797; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Van Meter KJ, THE NITROGEN LEGACY; Veenstra JJ, 2010, FIFTY YEARS OF AGRIC; Wellen C, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011821; YOUNG RA, 1989, J SOIL WATER CONSERV, V44, P168; Zaehle S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0125; Zhang YK, 2006, J HYDROL, V324, P412, DOI 10.1016/j.jhydrol.2005.09.033	66	91	91	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125971	10.1371/journal.pone.0125971	http://dx.doi.org/10.1371/journal.pone.0125971			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985290	Green Submitted, gold, Green Published			2022-12-27	WOS:000354917300030
J	Yang, ZY; Tatham, AJ; Weinreb, RN; Medeiros, FA; Liu, T; Zangwill, LM				Yang, Zhiyong; Tatham, Andrew J.; Weinreb, Robert N.; Medeiros, Felipe A.; Liu, Ting; Zangwill, Linda M.			Diagnostic Ability of Macular Ganglion Cell Inner Plexiform Layer Measurements in Glaucoma Using Swept Source and Spectral Domain Optical Coherence Tomography	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPERATING CHARACTERISTIC CURVES; THICKNESS MEASUREMENTS; PREPERIMETRIC GLAUCOMA; STRATUS OCT; EYES; ACCURACY; TESTS; HEAD; VARIABILITY	Purpose To evaluate the diagnostic ability of macular ganglion cell and inner plexiform layer measurements in glaucoma, obtained using swept source (SS) and spectral domain (SD) optical coherence tomography (OCT) and to compare to circumpapillary retinal nerve fiber layer (cpRNFL) thickness measurements. Methods The study included 106 glaucomatous eyes of 80 subjects and 41 eyes of 22 healthy subjects from the Diagnostic Innovations in Glaucoma Study. Macular ganglion cell and inner plexiform layer (mGCIPL), macular ganglion cell complex (mGCC) and cpRNFL thickness were assessed using SS-OCT and SD-OCT, and area under the receiver operating characteristic curves (AUCs) were calculated to determine ability to differentiate glaucomatous and healthy eyes and between early glaucomatous and healthy eyes. Results Mean (+/- standard deviation) mGCIPL and mGCC thickness were thinner in both healthy and glaucomatous eyes using SS-OCT compared to using SD-OCT. Fixed and proportional biases were detected between SS-OCT and SD-OCT measures. Diagnostic accuracy (AUCs) for differentiating between healthy and glaucomatous eyes for average and sectoral mGCIPL was similar in SS-OCT (0.65 to 0.81) and SD-OCT (0.63 to 0.83). AUCs for average cpRNFL acquired using SS-OCT and SD-OCT tended to be higher (0.83 and 0.85, respectively) than for average mGCC (0.82 and 0.78, respectively), and mGCIPL (0.73 and 0.75, respectively) but these differences did not consistently reach statistical significance. Minimum SD-OCT mGCIPL and mGCC thickness (unavailable in SS-OCT) had the highest AUC (0.86) among macular measurements. Conclusion Assessment of mGCIPL thickness using SS-OCT or SD-OCT is useful for detecting glaucomatous damage, but measurements are not interchangeable for patient management decisions. Diagnostic accuracies of mGCIPL and mGCC from both SS-OCT and SD-OCT were similar to that of cpRNFL for glaucoma detection.	[Yang, Zhiyong; Tatham, Andrew J.; Weinreb, Robert N.; Medeiros, Felipe A.; Liu, Ting; Zangwill, Linda M.] Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Yang, Zhiyong; Tatham, Andrew J.; Weinreb, Robert N.; Medeiros, Felipe A.; Liu, Ting; Zangwill, Linda M.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Tatham, Andrew J.] Univ Edinburgh, Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland; [Tatham, Andrew J.] Univ Edinburgh, Dept Ophthalmol, Edinburgh, Midlothian, Scotland; [Liu, Ting] Third Mil Med Univ, Daping Hosp, Dept Ophthalmol, Chongqing, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Edinburgh; University of Edinburgh; Army Medical University	Zangwill, LM (corresponding author), Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.	lzangwill@ucsd.edu		Tatham, Andrew/0000-0003-0372-3100	National Institutes of Health/National Eye Institute [EY021818, EY11008, EY14267, EY019869, P30EY022589]; NATIONAL EYE INSTITUTE [U10EY014267, P30EY022589, R01EY011008, R01EY021818, R01EY019869] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding came from the National Institutes of Health/National Eye Institute grants (http://www.nei.nih.gov): EY021818 (F.A.M.), EY11008 (L.M.Z.), EY14267 (L.M.Z.), EY019869 (L.M.Z.), and core grant P30EY022589.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cho JW, 2011, J GLAUCOMA, V20, P15, DOI 10.1097/IJG.0b013e3181d1d332; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dodd LE, 2003, BIOMETRICS, V59, P614, DOI 10.1111/1541-0420.00071; Garas A, 2011, EYE, V25, P57, DOI 10.1038/eye.2010.139; Garcia-Martin E, 2011, ACTA OPHTHALMOL, V89, pE23, DOI 10.1111/j.1755-3768.2010.02045.x; Giovannini A, 2002, ACTA OPHTHALMOL SCAN, V80, P34, DOI 10.1034/j.1600-0420.80.s236.44.x; Greenfield DS, 2003, ARCH OPHTHALMOL-CHIC, V121, P41; Guedes V, 2003, OPHTHALMOLOGY, V110, P177, DOI 10.1016/S0161-6420(02)01564-6; Harwerth RS, 2010, PROG RETIN EYE RES, V29, P249, DOI 10.1016/j.preteyeres.2010.02.001; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Huang JJ, 2011, J GLAUCOMA, V20, P118, DOI 10.1097/IJG.0b013e3181d786f8; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Jeoung JW, 2010, INVEST OPHTH VIS SCI, V51, P938, DOI 10.1167/iovs.08-3335; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Knighton RW, 2000, J GLAUCOMA, V9, P56; Lederer DE, 2003, AM J OPHTHALMOL, V135, P838, DOI 10.1016/S0002-9394(02)02277-8; Leite MT, 2011, AM J OPHTHALMOL, V151, P85, DOI 10.1016/j.ajo.2010.06.041; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Leung CKS, 2005, OPHTHALMOLOGY, V112, P391, DOI 10.1016/j.ophtha.2004.10.020; Lisboa R, 2013, INVEST OPHTH VIS SCI, V54, P3417, DOI 10.1167/iovs.13-11676; Lisboa R, 2012, OPHTHALMOLOGY, V119, P2261, DOI 10.1016/j.ophtha.2012.06.009; Loduca AL, 2010, AM J OPHTHALMOL, V150, P849, DOI 10.1016/j.ajo.2010.06.034; Mansouri K, 2013, OPHTHALMOLOGY, V120, P2508, DOI 10.1016/j.ophtha.2013.07.040; Medeiros FA, 2005, ARCH OPHTHALMOL-CHIC, V123, P1351, DOI 10.1001/archopht.123.10.1351; Medeiros FA, 2005, AM J OPHTHALMOL, V139, P44, DOI 10.1016/j.ajo.2004.08.069; Medeiros FA, 2006, INVEST OPHTH VIS SCI, V47, P2520, DOI 10.1167/iovs.05-1441; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Mwanza JC, 2014, OPHTHALMOLOGY, V121, P849, DOI 10.1016/j.ophtha.2013.10.044; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Na JH, 2011, INVEST OPHTH VIS SCI, V52, P8094, DOI 10.1167/iovs.11-7833; Nakatani Y, 2011, J GLAUCOMA, V20, P252, DOI 10.1097/IJG.0b013e3181e079ed; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Racette L, 2010, J GLAUCOMA, V19, P167, DOI 10.1097/IJG.0b013e3181a98b85; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Schulze A, 2011, GRAEF ARCH CLIN EXP, V249, P1039, DOI 10.1007/s00417-010-1585-5; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Sung KR, 2011, BRIT J OPHTHALMOL, V95, P909, DOI 10.1136/bjo.2010.186924; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Tatham AJ, 2014, CLIN OPHTHALMOL, V8, P611, DOI 10.2147/OPTH.S44586; Wang M, 2009, ARCH OPHTHALMOL-CHIC, V127, P875, DOI 10.1001/archophthalmol.2009.145; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wollstein G, 2004, AM J OPHTHALMOL, V138, P218, DOI 10.1016/j.ajo.2004.03.019	46	47	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125957	10.1371/journal.pone.0125957	http://dx.doi.org/10.1371/journal.pone.0125957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978420	Green Published, gold			2022-12-27	WOS:000354916100040
J	Zhang, Q; Li, JH; Sang, YL; Xing, SY; Wu, QK; Liu, XJ				Zhang, Qian; Li, Jihong; Sang, Yalin; Xing, Shiyan; Wu, Qikui; Liu, Xiaojing			Identification and Characterization of MicroRNAs in Ginkgo biloba var. epiphylla Mak	PLOS ONE			English	Article							OVULE DEVELOPMENT; TRANSLATIONAL INHIBITION; PATTERN-FORMATION; EXPRESSION; PLANT; RNA; MIRNAS; MIR156; REVEALS; TARGETS	Ginkgo biloba, a dioecious plant known as a living fossil, is an ancient gymnosperm that stands distinct from other gymnosperms and angiosperms. Ginkgo biloba var. epiphylla (G. biloba var. epiphylla), with ovules borne on the leaf blade, is an unusual germplasm derived from G. biloba. MicroRNAs (miRNAs) are post-transcriptional gene regulators that play critical roles in diverse biological and metabolic processes. Currently, little is known about the miRNAs involved in the key stage of partly epiphyllous ovule germination in G. biloba var. epiphylla. Two small RNA libraries constructed from epiphyllous ovule leaves and normal leaves of G. biloba var. epiphylla were sequenced on an Illumina/Solexa platform. A total of 82 miRNA sequences belonging to 23 families and 53 putative novel miRNAs were identified in the two libraries. Differential expression analysis showed that 25 conserved and 21 novel miRNAs were differentially expressed between epiphyllous ovule leaves and normal leaves. The expression patterns of partially differentially expressed miRNAs and the transcript levels of their predicted target genes were validated by quantitative real time RTPCR. All the expression profiles of the 21 selected miRNAs were similar to those detected by Solexa deep sequencing. Additionally, the transcript levels of almost all the putative target genes of 9 selected miRNAs were opposite to those of the corresponding miRNAs. The putative target genes of the differentially expressed miRNAs were annotated with Gene Ontology terms related to reproductive process, metabolic process and responding to stimulus. This work presents a broad range of small RNA transcriptome data obtained from epiphyllous ovule and normal leaves of G. biloba var. epiphylla, which may provide insights into the miRNA-mediated regulation in the epiphyllous ovule germination process.	[Zhang, Qian; Li, Jihong; Sang, Yalin; Xing, Shiyan; Wu, Qikui; Liu, Xiaojing] Shandong Agr Univ, Coll Forestry, Key Lab Tree Germplasm Resources Res, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Xing, SY (corresponding author), Shandong Agr Univ, Coll Forestry, Key Lab Tree Germplasm Resources Res, Tai An, Shandong, Peoples R China.	xingsy@sdau.edu.cn	WU, QIKUI/AAB-9262-2020	WU, QIKUI/0000-0003-1359-9350	Natural Science Foundation of Shandong Province [2009ZRB01182]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	Funding: The study was supported by the Natural Science Foundation of Shandong Province with grant no. 2009ZRB01182. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bencivenga S, 2012, PLANT CELL, V24, P2886, DOI 10.1105/tpc.112.100164; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Hara N., 1997, GINKGO BILOBA GLOBAL, P3; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hord CLH, 2006, PLANT CELL, V18, P1667, DOI 10.1105/tpc.105.036871; Izhaki A, 2007, PLANT CELL, V19, P495, DOI 10.1105/tpc.106.047472; JANSSON S, 1994, J MOL EVOL, V39, P34, DOI 10.1007/BF00178247; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kelley DR, 2009, PLANT J, V57, P1054, DOI 10.1111/j.1365-313X.2008.03752.x; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Ko JH, 2006, NEW PHYTOL, V169, P469, DOI 10.1111/j.1469-8137.2005.01623.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li D, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1704-4; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Martin RC, 2010, SEED SCI RES, V20, P79, DOI 10.1017/S0960258510000085; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Nakao Y, 1999, J HORTIC SCI BIOTECH, V74, P768, DOI 10.1080/14620316.1999.11511186; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Oh TJ, 2008, NEW PHYTOL, V179, P67, DOI 10.1111/j.1469-8137.2008.02448.x; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; REISER L, 1995, CELL, V83, P735, DOI 10.1016/0092-8674(95)90186-8; Rothwell G. W., 1988, ORIGIN EVOLUTION GYM, P85; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; SAKISAKA MITIDI, 1929, JAPANESE JOUR BOT, V4, P219; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sieber P, 2004, DEV BIOL, V273, P321, DOI 10.1016/j.ydbio.2004.05.037; Soma S., 1997, GINKGO BILOBA GLOBAL, P51; Soma S, 1999, BUNKYO U ANN REPORT, V33, P112; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sun LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043760; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wan LC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-146; Wan LC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-132; Wang C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-122; Wang HL, 2013, PLANT MOL BIOL REP, V31, P633, DOI 10.1007/s11105-012-0525-4; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044696; Wang T, 2005, BIOTECHNOL LETT, V27, P629, DOI 10.1007/s10529-005-3629-1; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhou ZY, 2003, NATURE, V423, P821, DOI 10.1038/423821a; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	78	19	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127184	10.1371/journal.pone.0127184	http://dx.doi.org/10.1371/journal.pone.0127184			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978425	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100134
J	Basu, D; Wang, WD; Ma, SY; DeBrosse, T; Poirier, E; Emch, K; Soukup, E; Tian, L; Showalter, AM				Basu, Debarati; Wang, Wuda; Ma, Siyi; DeBrosse, Taylor; Poirier, Emily; Emch, Kirk; Soukup, Eric; Tian, Lu; Showalter, Allan M.			Two Hydroxyproline Galactosyltransferases, GALT5 and GALT2, Function in Arabinogalactan-Protein Glycosylation, Growth and Development in Arabidopsis	PLOS ONE			English	Article							SEED COAT MUCILAGE; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; PLANT-GROWTH; CELL ELONGATION; SALT TOLERANCE; YARIV REAGENT; BIOSYNTHESIS; IDENTIFICATION; THALIANA	Hydroxyproline-O-galactosyltransferase (GALT) initiates O-glycosylation of arabinogalactan-proteins (AGPs). We previously characterized GALT2 (At4g21060), and now report on functional characterization of GALT5 (At1g74800). GALT5 was identified using heterologous expression in Pichia and an in vitro GALT assay. Product characterization showed GALT5 specifically adds galactose to hydroxyproline in AGP protein backbones. Functions of GALT2 and GALT5 were elucidated by phenotypic analysis of single and double mutant plants. Allelic galt5 and galt2 mutants, and particularly galt2 galt5 double mutants, demonstrated lower GALT activities and reductions in beta-Yariv-precipitated AGPs compared to wild type. Mutant plants showed pleiotropic growth and development phenotypes (defects in root hair growth, root elongation, pollen tube growth, flowering time, leaf development, silique length, and inflorescence growth), which were most severe in the double mutants. Conditional mutant phenotypes were also observed, including salt-hypersensitive root growth and root tip swelling as well as reduced inhibition of pollen tube growth and root growth in response to beta-Yariv reagent. These mutants also phenocopy mutants for an AGP, SOS5, and two cell wall receptor-like kinases, FEI1 and FEI2, which exist in a genetic signaling pathway. In summary, GALT5 and GALT2 function as redundant GALTs that control AGP O-glycosylation, which is essential for normal growth and development.	[Basu, Debarati; Wang, Wuda; Ma, Siyi; DeBrosse, Taylor; Poirier, Emily; Emch, Kirk; Soukup, Eric; Tian, Lu; Showalter, Allan M.] Ohio Univ, Dept Environm & Plant Biol, Mol & Cellular Biol Program, Athens, OH 45701 USA	University System of Ohio; Ohio University	Showalter, AM (corresponding author), Ohio Univ, Dept Environm & Plant Biol, Mol & Cellular Biol Program, Athens, OH 45701 USA.	showalte@ohio.edu		Showalter, Allan/0000-0003-0775-4991	National Science Foundation Grant [0918661]; Ohio University Baker Grant [FN1006071]	National Science Foundation Grant(National Science Foundation (NSF)); Ohio University Baker Grant	This work was supported by a National Science Foundation Grant (grant no. 0918661) http://www.nsf.gov/ and an Ohio University Baker Grant FN1006071, http://www.ohio.edu/research/funding.cfm.	Albenne C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00111; Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; Basu D, 2013, J BIOL CHEM, V288, P10132, DOI 10.1074/jbc.M112.432609; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Baumberger N, 2003, PLANT J, V35, P71, DOI 10.1046/j.1365-313X.2003.01784.x; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cheung AY, 2002, PLANT CELL, V14, P945, DOI 10.1105/tpc.000836; Dardelle F, 2010, PLANT PHYSIOL, V153, P1563, DOI 10.1104/pp.110.158881; Dilokpimol A, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28891; Dilokpimol A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-90; Ding L, 1997, PLANTA, V203, P289, DOI 10.1007/s004250050194; Egelund J, 2011, PLANT POLYSACCHARIDE; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; FINCHER GB, 1983, ANNU REV PLANT PHYS, V34, P47, DOI 10.1146/annurev.pp.34.060183.000403; Galvan-Ampudia CS, 2011, CURR OPIN PLANT BIOL, V14, P296, DOI 10.1016/j.pbi.2011.03.019; Gao MG, 1999, PLANT J, V18, P43, DOI 10.1046/j.1365-313X.1999.00428.x; GARDINER M, 1975, PLANT PHYSIOL, V55, P536, DOI 10.1104/pp.55.3.536; Geshi N, 2013, PLANT J, V76, P128, DOI 10.1111/tpj.12281; GIBEAUT DM, 1991, PLANT PHYSIOL, V97, P551, DOI 10.1104/pp.97.2.551; Gille S, 2013, MOL PLANT, V6, P1369, DOI 10.1093/mp/sst029; Griffiths JS, 2014, PLANT PHYSIOL, V165, P991, DOI 10.1104/pp.114.239400; Harpaz-Saad S, 2011, PLANT J, V68, P941, DOI 10.1111/j.1365-313X.2011.04760.x; Hijazi May, 2014, Front Plant Sci, V5, P395, DOI 10.3389/fpls.2014.00395; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kato H, 2003, PLANTA, V217, P271, DOI 10.1007/s00425-003-0978-7; KIELISZEWSKI MJ, 1995, J BIOL CHEM, V270, P2541, DOI 10.1074/jbc.270.6.2541; Kieliszewski MJ, 2001, CELL MOL LIFE SCI, V58, P1386, DOI 10.1007/PL00000783; Kitazawa K, 2013, PLANT PHYSIOL, V161, P1117, DOI 10.1104/pp.112.211722; Knoch E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00198; Knoch E, 2013, PLANT J, V76, P1016, DOI 10.1111/tpj.12353; Kohorn BD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00088; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamport DTA, 2013, NEW PHYTOL, V197, P58, DOI 10.1111/nph.12005; Lamport DTA, 2006, NEW PHYTOL, V169, P479, DOI 10.1111/j.1469-8137.2005.01591.x; Levitin B, 2008, PLANT J, V56, P351, DOI 10.1111/j.1365-313X.2008.03607.x; Liang Y, 2013, J EXP BOT, V64, P5537, DOI 10.1093/jxb/ert321; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Mollet JC, 2002, PROTOPLASMA, V219, P89, DOI 10.1007/s007090200009; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Nikolovski N, 2012, PLANT PHYSIOL, V160, P1037, DOI 10.1104/pp.112.204263; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Oka T, 2010, PLANT PHYSIOL, V152, P332, DOI 10.1104/pp.109.146266; Pereira LG, 2006, PLANTA, V223, P374, DOI 10.1007/s00425-005-0137-4; Poulsen CP, 2014, TRAFFIC, V15, P1219, DOI 10.1111/tra.12203; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; Robinson D G, 1982, Plant Cell Rep, V1, P197, DOI 10.1007/BF00270233; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schultz C, 1998, TRENDS PLANT SCI, V3, P426, DOI 10.1016/S1360-1385(98)01328-4; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; Steinwand BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098193; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; Tan L, 2013, PLANT CELL, V25, P270, DOI 10.1105/tpc.112.107334; Tan L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00140; Tan L, 2010, J BIOL CHEM, V285, P24575, DOI 10.1074/jbc.M109.100149; Tryfona T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093291; Tryfona T, 2012, PLANT PHYSIOL, V160, P653, DOI 10.1104/pp.112.202309; van Hengel AJ, 2002, PLANT J, V32, P105, DOI 10.1046/j.1365-313X.2002.01406.x; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Willats WGT, 2001, PLANTA, V213, P37, DOI 10.1007/s004250000481; Willats WGT, 1996, PLANT J, V9, P919, DOI 10.1046/j.1365-313X.1996.9060919.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wolf S, 2012, ANNU REV PLANT BIOL, V63, P381, DOI 10.1146/annurev-arplant-042811-105449; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354; YARIV J, 1967, BIOCHEM J, V105, pC1, DOI 10.1042/bj1050001C; Youl JJ, 1998, P NATL ACAD SCI USA, V95, P7921, DOI 10.1073/pnas.95.14.7921; Zagorchev L, 2014, SCI WORLD J, DOI 10.1155/2014/764089; Zhang YZ, 2011, PLANT SIGNAL BEHAV, V6, P855, DOI 10.4161/psb.6.6.15204; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	81	47	50	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125624	10.1371/journal.pone.0125624	http://dx.doi.org/10.1371/journal.pone.0125624			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974423	Green Submitted, gold, Green Published			2022-12-27	WOS:000354545600021
J	Herre, DJ; Norman, JB; Anderson, R; Tremblay, ML; Huby, AC; de Chantemele, EJB				Herre, David J.; Norman, J. Blake; Anderson, Ruchi; Tremblay, Michel L.; Huby, Anne-Cecile; de Chantemele, Eric J. Belin			Deletion of Protein Tyrosine Phosphatase 1B (PTP1B) Enhances Endothelial Cyclooxygenase 2 Expression and Protects Mice from Type 1 Diabetes-Induced Endothelial Dysfunction	PLOS ONE			English	Article							INSULIN SENSITIVITY; SKELETAL-MUSCLE; INCREASED ABUNDANCE; MOLECULAR-CLONING; TREATED RATS; RESISTANCE; OBESITY; MECHANISMS; ACETYLCHOLINE; INHIBITION	Protein tyrosine phosphatase 1B (PTP1B) dephosphorylates receptors tyrosine kinase and acts as a molecular brake on insulin signaling pathway. Conditions ofmetabolic dysfunction increase PTP1B, when deletion of PTP1B protects against metabolic disorders by increasing insulin signaling. Although vascular insulin signaling contributes to the control of glucose disposal, little is known regarding the direct role of PTP1B in the control of endothelial function. We hypothesized that metabolic dysfunctions increase PTP1B expression in endothelial cells and that PTP1B deletion prevents endothelial dysfunction in situation of diminished insulin secretion. Type I diabetes (T1DM) was induced in wild-type (WT) and PTP1B-deficient mice (KO) with streptozotocin (STZ) injection. After 28 days of T1DM, KO mice exhibited a similar reduction in body weight and plasma insulin levels and a comparable increase in glycemia (WT: 384 +/- 20 vs. Ko: 432 +/- 29 mg/ dL), cholesterol and triglycerides, as WT mice. T1DM increased PTP1B expression and impaired endothelial NO-dependent relaxation, in mouse aorta. PTP1B deletion did not affect baseline endothelial function, but preserved endothelium- dependent relaxation, in T1DMmice. NO synthase inhibition with L-NAME abolished endothelial relaxation in control and T1DMWT mice, whereas L-NAME and the cyclooxygenases inhibitor indomethacin were required to abolish endothelium relaxation in T1DM KO mice. PTP1B deletion increased COX-2 expression and PGI(2) levels, inmouse aorta and plasma respectively, in T1DM mice. In parallel, simulation of diabetic conditions increased PTP1B expression and knockdown of PTP1B increased COX-2 but not COX-1 expression, in primary human aortic endothelial cells. Taken together these data indicate that deletion of PTP1B protected endothelial function by compensating the reduction in NO bioavailability by increasing COX-2-mediated release of the vasodilator prostanoid PGI(2), in T1DMmice.	[Herre, David J.; Norman, J. Blake; Anderson, Ruchi; Huby, Anne-Cecile; de Chantemele, Eric J. Belin] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30334 USA; [Tremblay, Michel L.] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada	University System of Georgia; Augusta University; McGill University; McGill University	de Chantemele, EJB (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30334 USA.	ebelindechanteme@gru.edu	de Chantemele, Eric J Belin/H-8923-2019	de Chantemele, Eric J Belin/0000-0002-0184-3830	American Heart Association (EB) [11SDG5060006]	American Heart Association (EB)(American Heart Association)	This work was supported by the American Heart Association 11SDG5060006 (EB).	Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552; AHMAD F, 1995, J CLIN INVEST, V95, P2806, DOI 10.1172/JCI117985; AHMAD F, 1995, METABOLISM, V44, P1175, DOI 10.1016/0026-0495(95)90012-8; Ali MI, 2009, CIRC RES, V105, P1013, DOI 10.1161/CIRCRESAHA.109.206318; Berdnikovs S, 2013, AM J PHYSIOL-LUNG C, V304, pL240, DOI 10.1152/ajplung.00375.2012; Bulut D, 2003, J HYPERTENS, V21, P1663, DOI 10.1097/00004872-200309000-00015; Cameron NE, 1999, DIABETES RES CLIN PR, V45, P137, DOI 10.1016/S0168-8227(99)00043-1; Cao ZX, 2007, CELL SIGNAL, V19, P1542, DOI 10.1016/j.cellsig.2007.01.028; Chataigneau T, 1999, BRIT J PHARMACOL, V126, P219, DOI 10.1038/sj.bjp.0702300; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Coquerel D, 2014, ARTERIOSCL THROM VAS, V34, P1032, DOI 10.1161/ATVBAHA.114.303450; Cosentino F, 1998, J CARDIOVASC PHARM, V32, pS54; DAI FX, 1993, J AM SOC NEPHROL, V4, P1327; de Chantemele EJB, 2012, HYPERTENSION, V60, P1273, DOI 10.1161/HYPERTENSIONAHA.112.196295; de Chantemele EJB, 2010, CARDIOVASC RES, V86, P516, DOI 10.1093/cvr/cvp411; de Chantemele EJB, 2009, CIRCULATION, V120, P753, DOI 10.1161/CIRCULATIONAHA.109.853077; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Elcioglu HK, 2011, EUR J PHARMACOL, V660, P476, DOI 10.1016/j.ejphar.2011.03.030; Fulton D, 2004, AM J PHYSIOL-HEART C, V287, pH2384, DOI 10.1152/ajpheart.00280.2004; Henrion D, 1997, BRIT J PHARMACOL, V121, P83, DOI 10.1038/sj.bjp.0701109; Hink U, 2001, CIRC RES, V88, pE14; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Joshua IG, 2005, J CELL BIOCHEM, V96, P1149, DOI 10.1002/jcb.20620; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lanahan AA, 2014, CIRCULATION, V130, P902, DOI 10.1161/CIRCULATIONAHA.114.009683; Maciel IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077227; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; MCGUIRE MC, 1991, DIABETES, V40, P939, DOI 10.2337/diabetes.40.7.939; Meeking DR, 2000, DIABETES CARE, V23, P1840, DOI 10.2337/diacare.23.12.1840; MIYATA A, 1994, BIOCHEM BIOPH RES CO, V200, P1728, DOI 10.1006/bbrc.1994.1652; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Norris K, 1997, FEBS LETT, V415, P243, DOI 10.1016/S0014-5793(97)01133-2; Panzhinskiy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077228; PEREIRA B, 1994, BIOCHEM BIOPH RES CO, V203, P59, DOI 10.1006/bbrc.1994.2148; Schafer A, 2004, ARTERIOSCL THROM VAS, V24, P1720, DOI 10.1161/01.ATV.0000138072.76902.dd; Stull AJ, 2012, DIABETES, V61, P1415, DOI 10.2337/db11-0744; Sun D, 1999, CIRC RES, V85, P288, DOI 10.1161/01.RES.85.3.288; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Traves PG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.90; Vercauteren M, 2006, CIRCULATION, V114, P2498, DOI 10.1161/CIRCULATIONAHA.106.630129; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Vessieres E, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00145; Wright MB, 2000, ARTERIOSCL THROM VAS, V20, P1189, DOI 10.1161/01.ATV.20.5.1189; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223	46	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126866	10.1371/journal.pone.0126866	http://dx.doi.org/10.1371/journal.pone.0126866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974252	gold, Green Submitted, Green Published			2022-12-27	WOS:000354545600090
J	Fan, J; Wang, JS; Zhao, B; Wu, LH; Zhang, CY; Zhao, XH; Gadow, KV				Fan, Juan; Wang, Jinsong; Zhao, Bo; Wu, Lianhai; Zhang, Chunyu; Zhao, Xiuhai; Gadow, Klaus V.			Effects of Manipulated Above- and Belowground Organic Matter Input on Soil Respiration in a Chinese Pine Plantation	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; CO2 EFFLUX; ABOVEGROUND LITTER; UNDERSTORY REMOVAL; MICROBIAL BIOMASS; TROPOSPHERIC O-3; TREMBLING ASPEN; PAPER BIRCH; LEAF-LITTER; FOREST	Alteration in the amount of soil organic matter input can have profound effect on carbon dynamics in forest soils. The objective of our research was to determine the response in soil respiration to above- and belowground organic matter manipulation in a Chinese pine (Pinus tabulaeformis) plantation. Five organic matter treatments were applied during a 2-year experiment: both litter removal and root trenching (LRRT), only litter removal (LR), control (CK), only root trenching (RT) and litter addition (LA). We found that either aboveground litter removal or root trenching decreased soil respiration. On average, soil respiration rate was significantly decreased in the LRRT treatment, by about 38.93% +/- 2.01% compared to the control. Soil respiration rate in the LR treatment was 30.65% +/- 1.87% and in the RT treatment 17.65% +/- 1.95% lower than in the control. Litter addition significantly increased soil respiration rate by about 25.82% +/- 2.44% compared to the control. Soil temperature and soil moisture were the main factors affecting seasonal variation in soil respiration. Up to the 59.7% to 82.9% seasonal variation in soil respiration is explained by integrating soil temperature and soil moisture within each of the various organic matter treatments. The temperature sensitivity parameter, Q(10), was higher in the RT (2.72) and LA (3.19) treatments relative to the control (2.51), but lower in the LRRT (1.52) and LR treatments (1.36). Our data suggest that manipulation of soil organic matter input can not only alter soil CO2 efflux, but also have profound effect on the temperature sensitivity of organic carbon decomposition in a temperate pine forest.	[Fan, Juan; Wang, Jinsong; Zhao, Bo; Zhang, Chunyu; Zhao, Xiuhai] Beijing Forestry Univ, Key Lab Silviculture & Conservat, Minist Educ, Beijing 100083, Peoples R China; [Wu, Lianhai] Rothamsted Res, Okehampton EX20 2SB, Devon, England; [Gadow, Klaus V.] Univ Gottingen, Fac Forestry & Forest Ecol, D-37077 Gottingen, Germany	Beijing Forestry University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Gottingen	Zhao, XH (corresponding author), Beijing Forestry Univ, Key Lab Silviculture & Conservat, Minist Educ, 35 Tsinghua East Rd, Beijing 100083, Peoples R China.	zhaoxh@bjfu.edu.cn	Wang, Jinsong/AAO-3115-2021; von Gadow, Klaus/N-6368-2015; Zhang, Chunyu/GYA-2925-2022; Zhang, Chun-yu/HDP-5776-2022	Wang, Jinsong/0000-0002-3425-7387; Zhang, Chunyu/0000-0003-3091-5060; 	National Basic Research Program of China (973 Program) [2011CB403203]; State Key Program of National Natural Science Foundation of China [41330530]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (973 Program; 2011CB403203) and the State Key Program of National Natural Science Foundation of China (41330530). Rothamsted Research receives grant aided support from the Biotechnology and Biological Science Research Council (BBSRC), UK. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Baath E, 2003, GLOBAL CHANGE BIOL, V9, P1788, DOI 10.1046/j.1365-2486.2003.00692.x; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Chapman SK, 2003, ECOLOGY, V84, P2867, DOI 10.1890/02-0046; Crow SE, 2009, FOREST ECOL MANAG, V258, P2224, DOI 10.1016/j.foreco.2009.01.014; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Feng WT, 2009, SOIL BIOL BIOCHEM, V41, P978, DOI 10.1016/j.soilbio.2008.10.002; GINTER DL, 1979, FOREST ECOL MANAG, V2, P13, DOI 10.1016/0378-1127(79)90033-1; Gottlicher SG, 2006, PLANT SOIL, V287, P85, DOI 10.1007/s11104-006-0062-8; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hartley IP, 2006, GLOBAL CHANGE BIOL, V12, P1954, DOI 10.1111/j.1365-2486.2006.01214.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; King JS, 2005, NEW PHYTOL, V168, P623, DOI 10.1111/j.1469-8137.2005.01557.x; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P425, DOI 10.1016/j.soilbio.2005.08.020; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Lee MS, 2003, PLANT SOIL, V255, P311, DOI 10.1023/A:1026192607512; Leff JW, 2012, GLOBAL CHANGE BIOL, V18, P2969, DOI 10.1111/j.1365-2486.2012.02749.x; Li YQ, 2004, SOIL BIOL BIOCHEM, V36, P2111, DOI 10.1016/j.soilbio.2004.06.003; Liu LL, 2005, TREE PHYSIOL, V25, P1511, DOI 10.1093/treephys/25.12.1511; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; MacKinney AL, 1929, ECOLOGY, V10, P312, DOI 10.2307/1929507; Matsushima M, 2007, PLANT SOIL, V292, P243, DOI 10.1007/s11104-007-9220-x; Nanjing Agricultural University, 1992, SOIL AGR CHEM ANAL, P29; Ohashi M, 1999, FOREST ECOL MANAG, V123, P105, DOI 10.1016/S0378-1127(99)00020-1; Ostertag R, 2003, ECOSYSTEMS, V6, P261, DOI 10.1007/PL00021512; Prevost-Boure NC, 2011, APPL SOIL ECOL, V46, P26; PRUDEN G, 1985, FERT RES, V6, P205, DOI 10.1007/BF01048795; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Sayer E.J., 2013, Biogeosciences, V10, P7423, DOI 10.5194/bg-10-7423; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Schaefer DA, 2009, SOIL BIOL BIOCHEM, V41, P1000, DOI 10.1016/j.soilbio.2008.11.015; Schlesinger WH, 1997, BIOGEOCHEMISTRY ANAL, P156; Scott-Denton LE, 2006, GLOBAL CHANGE BIOL, V12, P205, DOI 10.1111/j.1365-2486.2005.01064.x; Sulzman EW, 2005, BIOGEOCHEMISTRY, V73, P231, DOI 10.1007/s10533-004-7314-6; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang XL, 2011, FOREST ECOL MANAG, V261, P1053, DOI 10.1016/j.foreco.2010.12.027; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xiong YM, 2008, PLANT SOIL, V304, P179, DOI 10.1007/s11104-007-9536-6; Yu XY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016239, 10.1371/journal.pone.0028397]; Zhao J, 2011, SOIL BIOL BIOCHEM, V43, P954, DOI 10.1016/j.soilbio.2011.01.010; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	50	8	8	11	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126337	10.1371/journal.pone.0126337	http://dx.doi.org/10.1371/journal.pone.0126337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970791	Green Submitted, gold, Green Published			2022-12-27	WOS:000354544200105
J	Nugnes, F; Gebiola, M; Monti, MM; Gualtieri, L; Giorgini, M; Wang, JG; Bernardo, U				Nugnes, Francesco; Gebiola, Marco; Monti, Maurilia Maria; Gualtieri, Liberata; Giorgini, Massimo; Wang, Jianguo; Bernardo, Umberto			Genetic Diversity of the Invasive Gall Wasp Leptocybe invasa (Hymenoptera: Eulophidae) and of its Rickettsia Endosymbiont, and Associated Sex-Ratio Differences	PLOS ONE			English	Article							PNIGALIO-SOEMIUS HYMENOPTERA; SPECIES DELIMITATION; COMPLEX HYMENOPTERA; PEA APHID; EVOLUTION; POPULATIONS; WOLBACHIA; SYMBIONT; PARTHENOGENESIS; SEQUENCES	The blue-gum chalcid Leptocybe invasa Fisher & LaSalle (Hymenoptera: Eulophidae) is a gall wasp pest of Eucalyptus species, likely native to Australia. Over the past 15 years it has invaded 39 countries on all continents where eucalypts are grown. The worldwide invasion of the blue gum chalcid was attributed to a single thelytokous morphospecies formally described in 2004. Subsequently, however, males have been recorded in several countries and the sex ratio of field populations has been found to be highly variable in different areas. In order to find an explanation for such sex ratio differences, populations of L. invasa from a broad geographical area were screened for the symbionts currently known as reproductive manipulators, and both wasps and symbionts were genetically characterized using multiple genes. Molecular analyses suggested that L. invasa is in fact a complex of two cryptic species involved in the rapid and efficient spread of the wasp, the first recovered from the Mediterranean region and South America, the latter from China. All screened specimens were infected by endosymbiotic bacteria belonging to the genus Rickettsia. Two closely related Rickettsia strains were found, each infecting one of the two putative cryptic species of L. invasa and associated with different average sex ratios. Rickettsia were found to be localized in the female reproductive tissues and transovarially transmitted, suggesting a possible role of Rickettsia as the causal agent of thelytokous parthenogenesis in L. invasa. Implications for the variation of sex ratio and for the management of L. invasa are discussed.	[Nugnes, Francesco; Gebiola, Marco; Monti, Maurilia Maria; Gualtieri, Liberata; Giorgini, Massimo; Bernardo, Umberto] CNR, Ist Protez Sostenibile Piante, Portici, NA, Italy; [Gebiola, Marco] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Wang, Jianguo] Jiangxi Agr Univ, Coll Agr, Dept Plant Protect, Nanchang, Jiangxi, Peoples R China	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); University of Arizona; Jiangxi Agricultural University	Nugnes, F (corresponding author), CNR, Ist Protez Sostenibile Piante, Portici, NA, Italy.	francesconugnes82@gmail.com	Nugnes, Francesco/H-9151-2019; Gebiola, Marco/G-7560-2015; Monti, Maurilia Maria/ADQ-7727-2022; Bernardo, Umberto/P-9428-2015; GIORGINI, MASSIMO/AAX-3458-2020; Giorgini, Massimo/O-7621-2015	Nugnes, Francesco/0000-0001-9309-4007; Gebiola, Marco/0000-0002-4644-2934; Monti, Maurilia Maria/0000-0003-4508-7106; Bernardo, Umberto/0000-0001-8190-2177; GIORGINI, MASSIMO/0000-0001-8670-0945; 	Ministero dell'Istruzione, dell'Universita e della Ricerca [2010CXXHJE]; 7th FP Marie Curie Actions People International Research Staff Exchange Scheme (IRSES) (IPRABIO) [269196]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); 7th FP Marie Curie Actions People International Research Staff Exchange Scheme (IRSES) (IPRABIO)	This research activity was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca with the project titled: Insects and globalization: sustainable control of exotic species in agro-forestry ecosystems (GEISCA) PRIN, id: 2010CXXHJE; and partly by the 7th FP Marie Curie Actions People International Research Staff Exchange Scheme (IRSES) (IPRABIO, grant 269196).	Adachi-Hagimori T, 2008, P ROY SOC B-BIOL SCI, V275, P2667, DOI 10.1098/rspb.2008.0792; [Anonymous], EPPO 2013 PQR DAT; Aquino EN, 2011, LEPTOCYBE INVASA FIS, V37, P159; Asplen MK, 2014, ECOL ENTOMOL, V39, P736, DOI 10.1111/een.12153; Austin AD, 2004, AUST J ENTOMOL, V43, P216, DOI 10.1111/j.1326-6756.2004.00448.x; Aytar F, 2003, J DOA DERGISI, V9, P47; Babcock CS, 2000, ANN ENTOMOL SOC AM, V93, P738, DOI 10.1603/0013-8746(2000)093[0738:MMDEFA]2.0.CO;2; Barbosa AF, 2008, MALACOLOGIA, V50, P1, DOI 10.4002/0076-2997-50.1.1; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernardo U, 2008, BIOL CONTROL, V46, P293, DOI 10.1016/j.biocontrol.2008.05.009; Biere A, 2013, FUNCT ECOL, V27, P646, DOI 10.1111/1365-2435.12096; Bordenstein SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029106; Campbell B. C., 1993, Insect Molecular Biology, V2, P225, DOI 10.1111/j.1365-2583.1994.tb00142.x; Chen Hua-Yan, 2009, Huanjing Kunchong Xuebao, V31, P285; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colautti RI, 2004, DIVERS DISTRIB, V10, P135, DOI 10.1111/j.1366-9516.2004.00061.x; Coombs MT, 2007, ANN ENTOMOL SOC AM, V100, P736, DOI 10.1603/0013-8746(2007)100[736:PEMABI]2.0.CO;2; Cottontail VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108603; Dar SA, 2005, APPL ENVIRON MICROB, V71, P2325, DOI 10.1128/AEM.71.5.2325-2330.2005; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Dhahri S, 2010, TUNISIAN J PLANT PRO, V5, P229; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Doganlar Oguzhan, 2005, Zoology in the Middle East, V35, P112; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Ercolini D, 2004, J MICROBIOL METH, V56, P297, DOI 10.1016/j.mimet.2003.11.006; Ferrari J, 2007, OECOLOGIA, V153, P323, DOI 10.1007/s00442-007-0730-2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fournier PE, 2004, J CLIN MICROBIOL, V42, P5757, DOI 10.1128/JCM.42.12.5757-5766.2004; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gebiola M, 2012, MOL ECOL, V21, P1190, DOI 10.1111/j.1365-294X.2011.05428.x; Gebiola M, 2009, J NAT HIST, V43, P2465, DOI 10.1080/00222930903105088; Gebiola M, 2010, ZOOTAXA, P35; Gilioli G, 2013, ECOL MODEL, V263, P281, DOI 10.1016/j.ecolmodel.2013.05.011; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; Giorgini M, 2001, BIOCONTROL, V46, P427, DOI 10.1023/A:1014181431482; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; Giorgini M, 2009, HEREDITY, V102, P365, DOI 10.1038/hdy.2008.135; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hansen AK, 2007, APPL ENVIRON MICROB, V73, P7531, DOI 10.1128/AEM.01672-07; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Heraty JM, 2007, MOL PHYLOGENET EVOL, V45, P480, DOI 10.1016/j.ympev.2007.06.021; Hill K. D., 2000, Telopea, V8, P503; Huigens ME, 2003, CONT T ENT, P247; Jaenike J, 2007, EVOLUTION, V61, P2244, DOI 10.1111/j.1558-5646.2007.00180.x; Johnson DM, 2006, NATURE, V444, P361, DOI 10.1038/nature05242; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Kelly J, 2012, ZOOTAXA, P50; La Salle J, 2009, ZOOTAXA, P35, DOI 10.11646/zootaxa.2121.1.4; Lawson S, 2012, BIOL CONTROL EUCALYP; Liang Yiping, 2010, Zhongguo Senlin Bingchong, V29, P21; Lopez VM, 2014, BIOL INVASIONS, V16, P2393, DOI 10.1007/s10530-014-0672-7; McFrederick QS, 2013, MOL PHYLOGENET EVOL, V66, P847, DOI 10.1016/j.ympev.2012.11.007; Mendel Z, 2004, AUST J ENTOMOL, V43, P101, DOI 10.1111/j.1440-6055.2003.00393.x; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Orwa C., 2009, AGROFORESTREE DATABA; Paine TD, 2011, ANNU REV ENTOMOL, V56, P181, DOI 10.1146/annurev-ento-120709-144817; Perotti MA, 2006, FASEB J, V20, P2372, DOI 10.1096/fj.06-5870fje; Pham QT, 2009, SCIENCEASIA, V35, P113, DOI 10.2306/scienceasia1513-1874.2009.35.113; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reumer BM, 2012, HEREDITY, V108, P341, DOI 10.1038/hdy.2011.82; Reumer BM, 2013, MOL ECOL, V22, P4433, DOI 10.1111/mec.12397; Reumer BM, 2010, MOL ECOL, V19, P1733, DOI 10.1111/j.1365-294X.2010.04599.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouchet R, 2014, EVOLUTION, V68, P1607, DOI 10.1111/evo.12377; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Rubinoff D, 2010, PAC SCI, V64, P23, DOI 10.2984/64.1.023; Sangtongpraow B., 2011, Thai Journal of Agricultural Science, V44, P155; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stouthamer R, 1999, BIOCONTROL, V43, P421, DOI 10.1023/A:1009937108715; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Tune Gene-Sheng, 2010, Formosan Entomologist, V30, P241; Unckless RL, 2009, P ROY SOC B-BIOL SCI, V276, P2805, DOI 10.1098/rspb.2009.0287; Veneti Z, 2012, HEREDITY, V109, P306, DOI 10.1038/hdy.2012.43; Viggiani G., 2002, Informatore Agrario, V58, P86; Vitorino L, 2007, MICROBIOL-SGM, V153, P160, DOI 10.1099/mic.0.2006/001149-0; Vorburger C, 2014, INSECT SCI, V21, P251, DOI 10.1111/1744-7917.12067; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Wylie FR, 2012, INSECT PESTS IN TROPICAL FORESTRY, 2ND EDITION, P1, DOI [10.1079/9781845936365.0000, 10.1079/9781845936365.0001]; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zheng XL, 2014, AFR ENTOMOL, V22, P68, DOI 10.4001/003.022.0133; Zhu FL, 2015, AUSTRAL ENTOMOL, V54, P71, DOI 10.1111/aen.12094	93	56	60	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124660	10.1371/journal.pone.0124660	http://dx.doi.org/10.1371/journal.pone.0124660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970681	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000354544200047
J	Xu, J; Li, CF; Liu, HT; Zhou, PL; Tao, ZQ; Wang, P; Meng, QF; Zhao, M				Xu, Jie; Li, Congfeng; Liu, Huitao; Zhou, Peilu; Tao, Zhiqiang; Wang, Pu; Meng, Qingfeng; Zhao, Ming			The Effects of Plastic Film Mulching on Maize Growth and Water Use in Dry and Rainy Years in Northeast China	PLOS ONE			English	Article							USE EFFICIENCY; SOIL-TEMPERATURE; LOESS PLATEAU; WINTER-WHEAT; RIDGE-FURROW; YIELD; POTATO; IRRIGATION; MANAGEMENT; MOISTURE	Plastic film mulching (PM) has been widely used to improve maize (Zea mays L.) yields and water use efficiency (WUE) in Northeast China, but the effects of PM in a changing climate characterized by highly variable precipitation are not well understood. Six site-year field experiments were conducted in the dry and rainy years to investigate the effects of PM on maize growth, grain yield, and WUE in Northeast China. Compared to crops grown without PM treatment (control, CK), PM significantly increased the grain yield by 15-26% in the dry years, but no significant yield increase was observed in the rainy years. Yield increase in the dry years was mainly due to a large increase in dry matter accumulation pre-silking compared to the CK, which resulted from a greater dry matter accumulation rate due to the higher topsoil temperature and water content. As a result, the WUE of the crops that underwent PM (3.27 kg m(-3)) treatment was also increased by around 16% compared to the CK, although the overall evapotranspiration was similar between the two treatments. In the rainy years, due to frequent precipitation and scant sunshine, the topsoil temperature and water content in the field that received PM treatment was improved only at some stages and failed to cause higher dry matter accumulation, except at the 8th leaf stage. Consequently, the grain yield and WUE were not improved by PM in the rainy years. In addition, we found that PM caused leaf senescence at the late growth stage in both dry and rainy years. Therefore, in practice, PM should be applied cautiously, especially when in-season precipitation is taken into account.	[Xu, Jie; Li, Congfeng; Zhou, Peilu; Tao, Zhiqiang; Meng, Qingfeng; Zhao, Ming] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Liu, Huitao] Jilin Acad Agr Sci, Inst Agr Environm & Res Ctr, Changchun, Peoples R China; [Wang, Pu] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Jilin Academy of Agricultural Sciences; China Agricultural University	Meng, QF (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	Mengqfcau@gmail.com; zhaomingcau@163.net		Meng, Qingfeng/0000-0003-0047-3089	National Basic Research Program of China [2015CB150401]; Special Fund for Agriculture Profession [201203096]; Innovation Program of CAAS	National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agriculture Profession; Innovation Program of CAAS	The authors thank the National Basic Research Program of China (973, Program: 2015CB150401), Special Fund for Agriculture Profession (201203096) and the Innovation Program of CAAS.	ANDREW RH, 1976, AGRON J, V68, P422, DOI 10.2134/agronj1976.00021962006800020056x; Bu LD, 2013, AGRON J, V105, P591, DOI 10.2134/agronj2012.0459; Bu LD, 2013, AGR WATER MANAGE, V123, P71, DOI 10.1016/j.agwat.2013.03.015; Cai HG, 2014, CROP J, V2, P297, DOI 10.1016/j.cj.2014.04.006; Crowley JG, 2005, 4726 REP IR; CUTFORTH HW, 1989, CAN J PLANT SCI, V69, P121, DOI 10.4141/cjps89-014; Dong HZ, 2009, FIELD CROP RES, V111, P269, DOI 10.1016/j.fcr.2009.01.001; FISHER PD, 1995, AGR WATER MANAGE, V27, P155, DOI 10.1016/0378-3774(95)01134-5; Guo DY, 2003, J NW SCI TU AGR FOR, V2, P75; He J, 2010, AUST J SOIL RES, V48, P737, DOI 10.1071/SR09155; [侯玉虹 HOU Yuhong], 2008, [玉米科学, Maize Science], V16, P90; HUSSAIN G, 1995, AGR WATER MANAGE, V27, P143, DOI 10.1016/0378-3774(95)91233-W; Jia Y, 2006, FIELD CROP RES, V97, P167, DOI 10.1016/j.fcr.2005.09.009; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Li FM, 1999, FIELD CROP RES, V63, P79, DOI 10.1016/S0378-4290(99)00027-1; Li R, 2013, AGR WATER MANAGE, V116, P101, DOI 10.1016/j.agwat.2012.10.001; Li SX, 2013, AGR WATER MANAGE, V116, P39, DOI 10.1016/j.agwat.2012.10.004; Li SE, 2013, J HYDROL, V503, P153, DOI 10.1016/j.jhydrol.2013.07.033; Li YS, 2007, SOIL TILL RES, V93, P370, DOI 10.1016/j.still.2006.05.010; Liu CA, 2014, EUR J AGRON, V52, P103, DOI 10.1016/j.eja.2013.10.001; Liu Y, 2010, AGR FOREST METEOROL, V150, P606, DOI 10.1016/j.agrformet.2010.02.003; Lynch JP, 2014, J EXP BOT, V65, P6155, DOI 10.1093/jxb/eru162; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; McKEE GUY W., 1964, AGRON J, V56, P240; Park JH, 2010, ENVIRON INT, V36, P212, DOI 10.1016/j.envint.2009.10.008; Qin SH, 2014, AGR WATER MANAGE, V131, P87, DOI 10.1016/j.agwat.2013.09.015; Ramakrishna A, 2006, FIELD CROP RES, V95, P115, DOI 10.1016/j.fcr.2005.01.030; Ritchie S.W., 1992, 48 IOW STAT U COOP E; [宋秋华 Song Qiuhua], 2002, [生态学报, Acta Ecologica Sinica], V22, P2125; Sun Shi-jun, 2014, Shengtaixue Zazhi, V33, P2650; Tarara JM, 2000, HORTSCIENCE, V35, P169, DOI 10.21273/HORTSCI.35.2.169; Tian Y, 2003, FIELD CROP RES, V84, P385, DOI 10.1016/S0378-4290(03)00118-7; Tolk JA, 1999, SOIL TILL RES, V50, P137, DOI 10.1016/S0167-1987(99)00011-2; Wang FX, 2009, FIELD CROP RES, V110, P123, DOI 10.1016/j.fcr.2008.07.014; Wang XiQing, 1998, Acta Agronomica Sinica, V24, P348; Wang XL, 2005, AGR WATER MANAGE, V78, P181, DOI 10.1016/j.agwat.2005.02.006; Wang XH, 2014, AGR ECOSYST ENVIRON, V196, P51, DOI 10.1016/j.agee.2014.06.009; [杨迎春 Yang Yingchun], 2013, [玉米科学, Maize Science], V21, P112; Yao J.M., 2000, ACTA AGRON SIN, V26, P185; Zhang H, 1999, IRRIGATION SCI, V19, P37, DOI 10.1007/s002710050069; Zhang Q, 2011, J HYDROL, V410, P204, DOI 10.1016/j.jhydrol.2011.09.017; Zhang XY, 2005, AGRON J, V97, P783, DOI 10.2134/agronj2004.0194; Zhao J, 2014, REG ENVIRON CHANGE, V14, P17, DOI 10.1007/s10113-013-0476-9; Zhou LM, 2009, FIELD CROP RES, V113, P41, DOI 10.1016/j.fcr.2009.04.005	44	13	15	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125781	10.1371/journal.pone.0125781	http://dx.doi.org/10.1371/journal.pone.0125781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970582	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200084
J	Cardinale, EM; Marsh, AA				Cardinale, Elise M.; Marsh, Abigail A.			Impact of Psychopathy on Moral Judgments about Causing Fear and Physical Harm	PLOS ONE			English	Article							CALLOUS-UNEMOTIONAL TRAITS; CONDUCT PROBLEMS; COGNITIVE NEUROSCIENCE; PROACTIVE AGGRESSION; AMYGDALA RESPONSE; DECISION-MAKING; STARTLE REFLEX; SELF-REPORT; ATTENTION; CHILDREN	Psychopathy is a personality variable associated with persistent immoral behaviors. Despite this, attempts to link moral reasoning deficits to psychopathic traits have yielded mixed results with many findings supporting intact moral reasoning in individuals with psychopathic traits. Abundant evidence shows that psychopathy impairs responses to others' emotional distress. However, most studies of morality and psychopathy focus on judgments about causing others physical harm. Results of such studies may be inconsistent because physical harm is an imperfect proxy for emotional distress. No previous paradigm has explicitly separated judgments about physical harm and emotional distress and assessed how psychopathy affects each type of judgment. In three studies we found that psychopathy impairs judgments about causing others emotional distress (specifically fear) but minimally affects judgments about causing physical harm and that judgments about causing fear predict instrumental aggression in psychopathy. These findings are consistent with reports linking psychopathy to insensitivity to others' fear, and suggest that sensitivity to others' fear may play a fundamental role in the types of moral decision-making impaired by psychopathy.	[Cardinale, Elise M.; Marsh, Abigail A.] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA	Georgetown University	Cardinale, EM (corresponding author), Georgetown Univ, Dept Psychol, Washington, DC 20057 USA.	emc62@georgetown.edu						Aharoni E, 2012, J ABNORM PSYCHOL, V121, P484, DOI 10.1037/a0024796; Aharoni E, 2011, J RES PERS, V45, P322, DOI 10.1016/j.jrp.2011.02.005; ANISKIEWICZ AS, 1979, J CLIN PSYCHOL, V35, P60, DOI 10.1002/1097-4679(197901)35:1<60::AID-JCLP2270350106>3.0.CO;2-R; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Blair RJR, 2008, NEUROETHICS-NETH, V1, P149, DOI 10.1007/s12152-008-9016-6; Blair RJR, 2009, PSYCHOL MED, V39, P543, DOI 10.1017/S0033291708003991; Blair RJR, 2005, DEV PSYCHOPATHOL, V17, P865, DOI 10.1017/S0954579405050418; Blair RJR, 2004, PERS INDIV DIFFER, V37, P1111, DOI 10.1016/j.paid.2003.10.008; Blair RJR, 2001, PERS INDIV DIFFER, V31, P799, DOI 10.1016/S0191-8869(00)00181-1; BLAIR RJR, 1995, PERS INDIV DIFFER, V19, P741, DOI 10.1016/0191-8869(95)00087-M; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Blair RJR, 2001, J NEUROL NEUROSUR PS, V71, P727, DOI 10.1136/jnnp.71.6.727; BYRN RM, 1966, FORDHAM LAW REV, V34, P613; Cardinale EM, 2014, OXFORD STUDIES IN EX, V1; Cima M, 2010, SOC COGN AFFECT NEUR, V5, P59, DOI 10.1093/scan/nsp051; Cleckley H, 1998, THE MASK OF SANITY A, P322; Crowe SL, 2008, DEV PSYCHOPATHOL, V20, P1145, DOI 10.1017/S0954579408000540; Dadds MR, 2011, J CHILD PSYCHOL PSYC, V52, P238, DOI 10.1111/j.1469-7610.2010.02323.x; Dadds MR, 2005, J CONSULT CLIN PSYCH, V73, P400, DOI 10.1037/0022-006X.73.3.400; Dawel A, 2012, NEUROSCI BIOBEHAV R, V36, P2288, DOI 10.1016/j.neubiorev.2012.08.006; Edens JF, 2006, J ABNORM PSYCHOL, V115, P131, DOI 10.1037/0021-843X.115.1.131; Flor H, 2002, PSYCHOPHYSIOLOGY, V39, P505, DOI 10.1017/S0048577202394046; Fullam RS, 2009, BRIT J PSYCHIAT, V194, P229, DOI 10.1192/bjp.bp.108.053199; Glenn AL, 2009, MOL PSYCHIATR, V14, P909, DOI 10.1038/mp.2009.76; Glenn AL, 2009, MOL PSYCHIATR, V14, P5, DOI 10.1038/mp.2008.104; Glenn AL, 2009, J PERS DISORD, V23, P384, DOI 10.1521/pedi.2009.23.4.384; Gordon HL, 2004, BIOL PSYCHIAT, V56, P516, DOI 10.1016/j.biopsych.2004.06.030; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2009, P NATL ACAD SCI USA, V106, P12506, DOI 10.1073/pnas.0900152106; Guay JP, 2007, J ABNORM PSYCHOL, V116, P701, DOI 10.1037/0021-843X.116.4.701; HARE R D, 1970, Journal of Abnormal Psychology, V76, P370, DOI 10.1037/h0030276; HARE RD, 1966, J ABNORM PSYCHOL, V71, P25, DOI 10.1037/h0022909; Hare RD, 1993, WITHOUT CONSCIENCE T; Harenski CL, 2010, J ABNORM PSYCHOL, V119, P863, DOI 10.1037/a0020979; Herpertz SC, 2001, ARCH GEN PSYCHIAT, V58, P737, DOI 10.1001/archpsyc.58.8.737; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Kahn RE, 2013, LAW HUMAN BEHAV, V37, P87, DOI 10.1037/b0000003; Kelly D, 2007, MIND LANG, V22, P117, DOI 10.1111/j.1468-0017.2007.00302.x; Koenigs M, 2012, SOC COGN AFFECT NEUR, V7, P708, DOI 10.1093/scan/nsr048; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Krueger RF, 2005, J ABNORM PSYCHOL, V114, P537, DOI 10.1037/0021-843X.114.4.537; Levenston GK, 2000, J ABNORM PSYCHOL, V109, P373, DOI 10.1037//0021-843X.109.3.373; Lilienfeld S.O., 2005, PSYCHOPATHIC PERSONA; Lilienfeld SO, 2012, PERSONAL DISORD, V3, P327, DOI 10.1037/a0026987; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; Lykken D. T., 1995, THE ANTISOCIAL PERSO; LYKKEN DT, 1957, J ABNORM SOC PSYCH, V55, P6, DOI 10.1037/h0047232; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; Malterer MB, 2010, ASSESSMENT, V17, P3, DOI 10.1177/1073191109349743; Markon KE, 2011, PSYCHOL BULL, V137, P856, DOI 10.1037/a0023678; Marsh AA, 2013, EMPATHY IN MORALITY; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Marsh AA, 2014, SOC COGN AFFECT NEUR, V9, P3, DOI 10.1093/scan/nss097; Marsh AA, 2012, SO NEUROSCI SER, P191; Marsh AA, 2012, EMOTION, V12, P892, DOI 10.1037/a0026260; Marsh AA, 2011, J CHILD PSYCHOL PSYC, V52, P834, DOI 10.1111/j.1469-7610.2010.02353.x; Miller JD, 2012, PERSONAL DISORD, V3, P305, DOI 10.1037/a0024567; NEWMAN JP, 1986, J ABNORM PSYCHOL, V95, P252, DOI 10.1037/0021-843X.95.3.252; Nichols S, 2001, MIND LANG, V16, P425, DOI 10.1111/1468-0017.00178; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; Parkinson C, 2011, J COGNITIVE NEUROSCI, V23, P3162, DOI 10.1162/jocn_a_00017; PATRICK CJ, 1993, J ABNORM PSYCHOL, V102, P82, DOI 10.1037/0021-843X.102.1.82; POYTHRESS NG, 2010, USING THE PCL R TO H, V17, P206, DOI DOI 10.1177/1073191109351715; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rothemund Y, 2012, BIOL PSYCHOL, V90, P50, DOI 10.1016/j.biopsycho.2012.02.011; Skeem JL, 2011, PSYCHOL SCI PUBL INT, V12, P95, DOI 10.1177/1529100611426706; Sylvers P, 2011, CLIN PSYCHOL REV, V31, P122, DOI 10.1016/j.cpr.2010.08.004; Sylvers PD, 2011, PSYCHOL SCI, V22, P1280, DOI 10.1177/0956797611420730; Vanman EJ, 2003, PERS INDIV DIFFER, V35, P2007, DOI 10.1016/S0191-8869(03)00052-7; Viding E, 2007, BRIT J PSYCHIAT, V190, pS33, DOI 10.1192/bjp.190.5.s33; Viding E, 2012, AM J PSYCHIAT, V169, P1109, DOI 10.1176/appi.ajp.2012.12020191; Vieira JB, 2014, SOC COGN AFFECT NEUR, V9, P1099, DOI 10.1093/scan/nst093; Vieira JB, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00907; Vitaro F, 1998, J CHILD PSYCHOL PSYC, V39, P377, DOI 10.1017/S0021963097002102; White SF, 2012, AM J PSYCHIAT, V169, P750, DOI 10.1176/appi.ajp.2012.11081270; Woodworth M, 2002, J ABNORM PSYCHOL, V111, P436, DOI 10.1037//0021-843X.111.3.436; Young L, 2012, J ABNORM PSYCHOL, V121, P659, DOI 10.1037/a0027489; Zeier JD, 2013, ASSESSMENT, V20, P610, DOI 10.1177/1073191111415364	81	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125708	10.1371/journal.pone.0125708	http://dx.doi.org/10.1371/journal.pone.0125708			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7CV	25992566	Green Submitted, Green Published, gold			2022-12-27	WOS:000354921400042
J	Legastelois, R; Darcq, E; Wegner, SA; Lombroso, PJ; Ron, D				Legastelois, Remi; Darcq, Emmanuel; Wegner, Scott A.; Lombroso, Paul J.; Ron, Dorit			Striatal-Enriched Protein Tyrosine Phosphatase Controls Responses to Aversive Stimuli: Implication for Ethanol Drinking	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DISEASE MOUSE MODEL; MOLECULAR CHARACTERIZATION; HUNTINGTONS-DISEASE; BITTER-TASTE; BED NUCLEUS; STEP; ACTIVATION; REWARD; RATS	The STriatal-Enriched protein tyrosine Phosphatase (STEP) is a brain-specific phosphatase whose dysregulation in expression and/or activity is associated with several neuropsychiatric disorders. We recently showed that long-term excessive consumption of ethanol induces a sustained inhibition of STEP activity in the dorsomedial striatum (DMS) of mice. We further showed that down-regulation of STEP expression in the DMS, and not in the adjacent dorsolateral striatum, increases ethanol intake, suggesting that the inactivation of STEP in the DMS contributes to the development of ethanol drinking behaviors. Here, we compared the consequence of global deletion of the STEP gene on voluntary ethanol intake to the consumption of an appetitive rewarding substance (saccharin) or an aversive solution (quinine or denatonium). Whereas saccharin intake was similar in STEP knockout (KO) and wild type (WT) littermate mice, the consumption of ethanol as well as quinine and denatonium was increased in STEP KO mice. These results suggested that the aversive taste of these substances was masked upon deletion of the STEP gene. We therefore hypothesized that STEP contributes to the physiological avoidance towards aversive stimuli. To further test this hypothesis, we measured the responses of STEP KO and WT mice to lithium-induced conditioned place aversion (CPA) and found that whereas WT mice developed lithium place aversion, STEP KO mice did not. In contrast, conditioned place preference (CPP) to ethanol was similar in both genotypes. Together, our results indicate that STEP contributes, at least in part, to the protection against the ingestion of aversive agents.	[Legastelois, Remi; Darcq, Emmanuel; Wegner, Scott A.; Ron, Dorit] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Lombroso, Paul J.] Yale Univ, Sch Med, New Haven, CT USA	University of California System; University of California San Francisco; Yale University	Ron, D (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	dorit.ron@ucsf.edu	Darcq, Emmanuel/AAF-9169-2019	Darcq, Emmanuel/0000-0002-8377-8015	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism [R01AA 013438, P50 AA017072, P50 AA012870]; National Institute of Mental Health [RO1 MH052711]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072, R01AA013438, P50AA012870] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism R01AA 013438 (DR), P50 AA017072 (DR) and P50 AA012870 (PJL), and the National Institute of Mental Health RO1 MH052711 (PJL).	Baguley TD, 2013, J MED CHEM, V56, P7636, DOI 10.1021/jm401037h; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Blizard DA, 2007, BEHAV GENET, V37, P146, DOI 10.1007/s10519-006-9121-4; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Carty NC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.63; Chagniel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086988; Chiodi V, 2014, NEUROPSYCHOPHARMACOL, V39, P569, DOI 10.1038/npp.2013.229; Dabrowska J, 2013, BIOL PSYCHIAT, V74, P817, DOI 10.1016/j.biopsych.2013.07.032; Darcq E, 2014, J NEUROCHEM, V129, P1024, DOI 10.1111/jnc.12701; Darcq E, 2012, NEUROPSYCHOPHARMACOL, V37, P1288, DOI 10.1038/npp.2011.316; Deb I, 2013, J NEUROSCI, V33, P17814, DOI 10.1523/JNEUROSCI.2346-12.2013; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; Garcia J., 1975, OLFACTION TASTE, P39, DOI DOI 10.1016/B978-0-12-209750-8.50014-7; Gladding CM, 2012, HUM MOL GENET, V21, P3739, DOI 10.1093/hmg/dds154; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Goodwin FLW, 2000, PHARMACOL BIOCHEM BE, V65, P357, DOI 10.1016/S0091-3057(99)00222-1; Gracy KN, 2001, NEUROPSYCHOPHARMACOL, V24, P152, DOI 10.1016/S0893-133X(00)00186-X; Green AS, 2008, ALCOHOL, V42, P1, DOI 10.1016/j.alcohol.2007.10.005; GRILL HJ, 1978, BRAIN RES, V143, P263, DOI 10.1016/0006-8993(78)90568-1; Haack AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092701; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; Hinrichs AL, 2006, AM J HUM GENET, V78, P103, DOI 10.1086/499253; Lim JP, 2012, BRAIN BEHAV, V2, P22, DOI 10.1002/brb3.29; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Nguyen TH, 2002, J BIOL CHEM, V277, P24274, DOI 10.1074/jbc.M111683200; Nishijo H, 1998, J NEUROPHYSIOL, V79, P21, DOI 10.1152/jn.1998.79.1.21; Olausson P, 2012, NEUROSCIENCE, V225, P1, DOI 10.1016/j.neuroscience.2012.07.069; Park J, 2012, BIOL PSYCHIAT, V71, P327, DOI 10.1016/j.biopsych.2011.10.017; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Rossi M. A, 2012, CURR PROTOC NEUROSCI; Saavedra A, 2011, J NEUROSCI, V31, P8150, DOI 10.1523/JNEUROSCI.3446-10.2011; Scinska A, 2000, DRUG ALCOHOL DEPEN, V60, P199, DOI 10.1016/S0376-8716(99)00149-0; SHARMA E, 1995, MOL BRAIN RES, V32, P87, DOI 10.1016/0169-328X(95)00066-2; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spector AC, 2002, J NEUROSCI, V22, P1937, DOI 10.1523/JNEUROSCI.22-05-01937.2002; Tashev R, 2009, BIOL PSYCHIAT, V65, P637, DOI 10.1016/j.biopsych.2008.10.008; Venkitaramani DV, 2011, EUR J NEUROSCI, V33, P2288, DOI 10.1111/j.1460-9568.2011.07687.x; Verendeev A, 2013, BEHAV PHARMACOL, V24, P363, DOI 10.1097/FBP.0b013e32836413d5; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Yaka R, 2003, ALCOHOL CLIN EXP RES, V27, P1736, DOI 10.1097/01.ALC.0000095924.87729.D8; Youngentob SL, 2009, P NATL ACAD SCI USA, V106, P5359, DOI 10.1073/pnas.0809804106; Zhang YF, 2011, J NEUROCHEM, V119, P664, DOI 10.1111/j.1471-4159.2011.07450.x; Zhang YF, 2010, P NATL ACAD SCI USA, V107, P19014, DOI 10.1073/pnas.1013543107	49	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127408	10.1371/journal.pone.0127408	http://dx.doi.org/10.1371/journal.pone.0127408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992601	gold, Green Submitted, Green Published			2022-12-27	WOS:000354921400116
J	Reznik, D; Henkin, Y; Levy, O; Mukamel, R				Reznik, Daniel; Henkin, Yael; Levy, Osnat; Mukamel, Roy			Perceived Loudness of Self-Generated Sounds Is Differentially Modified by Expected Sound Intensity	PLOS ONE			English	Article							COROLLARY DISCHARGE; SUPPRESSION; SENSITIVITY; PERCEPTION; CORTEX	Performing actions with sensory consequences modifies physiological and behavioral responses relative to otherwise identical sensory input perceived in a passive manner. It is assumed that such modifications occur through an efference copy sent from motor cortex to sensory regions during performance of voluntary actions. In the auditory domain most behavioral studies report attenuated perceived loudness of self-generated auditory action-consequences. However, several recent behavioral and physiological studies report enhanced responses to such consequences. Here we manipulated the intensity of self-generated and externally-generated sounds and examined the type of perceptual modification (enhancement vs. attenuation) reported by healthy human subjects. We found that when the intensity of self-generated sounds was low, perceived loudness is enhanced. Conversely, when the intensity of self-generated sounds was high, perceived loudness is attenuated. These results might reconcile some of the apparent discrepancies in the reported literature and suggest that efference copies can adapt perception according to the differential sensory context of voluntary actions.	[Reznik, Daniel; Mukamel, Roy] Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel; [Reznik, Daniel; Henkin, Yael; Levy, Osnat; Mukamel, Roy] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Henkin, Yael] Tel Aviv Univ, Sackler Fac Med, Dept Commun Disorders, IL-69978 Tel Aviv, Israel; [Henkin, Yael] Sheba Med Ctr, Hearing Speech & Language Ctr, Ramat Gan, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Mukamel, R (corresponding author), Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel.	rmukamel@tau.ac.il	Mukamel, Roy/AAV-2900-2021	Mukamel, Roy/0000-0001-9359-8950	I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation [51/11]; Israel Science Foundation [1771/13, 2043/13]; Human Frontiers Science Project Career Development Award [CDA00078/2011-C]; Sagol School of Neuroscience; Israeli Presidential Honorary Scholarship	I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation; Israel Science Foundation(Israel Science Foundation); Human Frontiers Science Project Career Development Award; Sagol School of Neuroscience; Israeli Presidential Honorary Scholarship	The study was supported by the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (grant No. 51/11), Israel Science Foundation (grants No. 1771/13 and 2043/13), and Human Frontiers Science Project Career Development Award (CDA00078/2011-C) to RM; Sagol School of Neuroscience and the Israeli Presidential Honorary Scholarship to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley R, 2012, FRONT BEHAV NEUROSCI, V6, DOI [10.3389/fnbeh.2012.00006, DOI 10.3389/FNBEH.2012.00006]; Aliu SO, 2009, J COGNITIVE NEUROSCI, V21, P791, DOI 10.1162/jocn.2009.21055; Baess P, 2011, PSYCHOPHYSIOLOGY, V48, P1276, DOI 10.1111/j.1469-8986.2011.01196.x; Baess P, 2009, EUR J NEUROSCI, V29, P1514, DOI 10.1111/j.1460-9568.2009.06683.x; Bennett C, 2013, NEURON, V80, P350, DOI 10.1016/j.neuron.2013.08.007; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Buran BN, 2014, J NEUROSCI, V34, P4076, DOI 10.1523/JNEUROSCI.4825-13.2014; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Desantis A, 2011, CONSCIOUS COGN, V20, P1211, DOI 10.1016/j.concog.2011.02.012; Ford JM, 2008, BIOL PSYCHIAT, V63, P736, DOI 10.1016/j.biopsych.2007.09.013; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gelfand SA, 2009, ESSENTIALS AUDIOLOGY, V3rd; Holst E. von, 1954, British Journal of Animal Behaviour, V2, P89; Hughes G, 2013, PSYCHOL BULL, V139, P133, DOI 10.1037/a0028566; Hughes G, 2011, NEUROIMAGE, V56, P1632, DOI 10.1016/j.neuroimage.2011.02.057; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Reznik D, 2015, J NEUROSCI, V35, P2173, DOI 10.1523/JNEUROSCI.3723-14.2015; Reznik D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5059; Sato A, 2008, CONSCIOUS COGN, V17, P1219, DOI 10.1016/j.concog.2008.01.003; Saupe K, 2013, INT J PSYCHOPHYSIOL, V90, P300, DOI 10.1016/j.ijpsycho.2013.09.006; Simoes-Franklin C, 2011, HUM BRAIN MAPP, V32, P1067, DOI 10.1002/hbm.21091; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Weiss C, 2011, COGNITION, V121, P207, DOI 10.1016/j.cognition.2011.06.011; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	27	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127651	10.1371/journal.pone.0127651	http://dx.doi.org/10.1371/journal.pone.0127651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BG	25992603	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300131
J	Wang, F; Chai, ZG; Deng, ZX; Gao, J; Wang, H; Chen, JH				Wang, Fu; Chai, Zhiguo; Deng, Zaixi; Gao, Jing; Wang, Hui; Chen, Jihua			Effect of Heat-Pressing Temperature and Holding Time on the Microstructure and Flexural Strength of Lithium Disilicate Glass-Ceramics	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CRYSTALLIZATION; TRANSLUCENCY; P2O5; TOUGHNESS	The present study aimed to evaluate the influence of various heat-pressing procedures (different holding time and heat pressing temperature) on the microstructure and flexural strength of lithium disilicate glass ceramic. An experimental lithium silicate glass ceramic (ELDC) was prepared from the SiO2-Li2O-K2O-Al2O3-ZrO2-P2O5 system and heat-pressed following different procedures by varying temperature and holding time. The flexural strength was tested and microstructure was analyzed. The relationships between the microstructure, mechanical properties and heat-pressing procedures were discussed in-depth. Results verified the feasibility of the application of dental heat-pressing technique in processing the experimental lithium disilicate glass ceramic. Different heat-pressing procedures showed significant influence on microstructure and flexural strength. ELDC heat-pressed at 950 degrees C with holding time of 15 min achieved an almost pore-free microstructure and the highest flexural strength, which was suitable for dental restorative application.	[Wang, Fu; Chai, Zhiguo; Gao, Jing; Wang, Hui; Chen, Jihua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Med Stomatol, Xian 710032, Peoples R China; [Deng, Zaixi] Fourth Mil Med Univ, Sch Stomatol, Dept Dent Tech Lab, State Key Lab Med Stomatol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Chen, JH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Med Stomatol, Xian 710032, Peoples R China.	jhchen@fmmu.edu.cn		Chen, Ji-hua/0000-0002-1151-0693	National Natural Science Foundation of China [51472269]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	1. Funding was provided by National Natural Science Foundation of China (51472269). WF, http://isisn.nsfc.gov.cn/egrantweb/. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albakry M, 2004, J BIOMED MATER RES B, V71B, P99, DOI 10.1002/jbm.b.30066; Albakry M, 2003, J PROSTHET DENT, V89, P374, DOI 10.1067/mpr.2003.42; [Anonymous], 1995, 6872 ISO; Cattell MJ, 1999, J DENT, V27, P183, DOI 10.1016/S0300-5712(98)00047-5; Cattell MJ, 2002, J DENT, V30, P161, DOI 10.1016/S0300-5712(02)00013-1; Chai J, 2007, INT J PROSTHODONT, V20, P587; Christgau M, 1999, OPER DENT, V24, P137; Chung KH, 2009, J ORAL REHABIL, V36, P132, DOI 10.1111/j.1365-2842.2008.01909.x; Conrad HJ, 2007, J PROSTHET DENT, V98, P389, DOI 10.1016/S0022-3913(07)60124-3; Della Bona A, 2008, J AM DENT ASSOC, V139, p8S; Denry IL, 2004, J BIOMED MATER RES B, V70B, P37, DOI 10.1002/jbm.b.30010; Denry IL, 2004, J BIOMED MATER RES B, V68B, P174, DOI 10.1002/jbm.b.20018; Denry IL, 2003, J BIOMED MATER RES B, V64B, P70, DOI 10.1002/jbm.b.10514; Dong J K, 1992, Int J Prosthodont, V5, P9; Gorman CM, 2000, DENT MATER, V16, P389, DOI 10.1016/S0109-5641(00)00031-2; Gorman CM, 2003, DENT MATER, V19, P320, DOI 10.1016/S0109-5641(02)00061-1; Griggs Jason A, 2007, Dent Clin North Am, V51, P713, DOI 10.1016/j.cden.2007.04.006; Holand W, 2006, J MATER SCI-MATER M, V17, P1037, DOI 10.1007/s10856-006-0441-y; Holand W, 2006, J NON-CRYST SOLIDS, V352, P4041, DOI 10.1016/j.jnoncrysol.2006.06.039; Holand W, 2000, J BIOMED MATER RES, V53, P297, DOI 10.1002/1097-4636(2000)53:4<297::AID-JBM3>3.0.CO;2-G; Holand W, 2007, J EUR CERAM SOC, V27, P1521, DOI 10.1016/j.jeurceramsoc.2006.04.101; Iqbal Y, 1998, J NON-CRYST SOLIDS, V224, P1, DOI 10.1016/S0022-3093(97)00453-5; Kelly JR, 1996, J PROSTHET DENT, V75, P18, DOI 10.1016/S0022-3913(96)90413-8; Luo XP, 2010, J PROSTHODONT, V19, P465, DOI 10.1111/j.1532-849X.2010.00610.x; McLean JW, 2001, J PROSTHET DENT, V85, P61, DOI 10.1067/mpr.2001.112545; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Oh SC, 2000, INT J PROSTHODONT, V13, P468; Rice RW, 1996, J MATER SCI, V31, P1969, DOI 10.1007/BF00356616; Schweiger M., 1999, QUINT DENT TECHNOL, V22, P143; Soares PC, 2003, J NON-CRYST SOLIDS, V331, P217, DOI 10.1016/j.jnoncrysol.2003.08.075; Wang F, 2010, MATER DESIGN, V31, P3270, DOI 10.1016/j.matdes.2010.02.013; Wen G, 2007, ACTA MATER, V55, P3583, DOI 10.1016/j.actamat.2007.02.009; Xiong F, 2008, J PROSTHET DENT, V100, P11, DOI 10.1016/S0022-3913(08)60128-6; Yadav AK, 2014, J MATER SCI-MATER EL, V25, P5165, DOI 10.1007/s10854-014-2311-6; Yu B, 2009, ACTA ODONTOL SCAND, V67, P57, DOI 10.1080/00016350802577818; Zarone F, 2011, DENT MATER, V27, P83, DOI 10.1016/j.dental.2010.10.024; Zhao YH, 2008, INT J APPL CERAM TEC, V5, P649, DOI 10.1111/j.1744-7402.2008.02246.x; Zheng X, 2008, ACTA MATER, V56, P549, DOI 10.1016/j.actamat.2007.10.024	38	8	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126896	10.1371/journal.pone.0126896	http://dx.doi.org/10.1371/journal.pone.0126896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985206	Green Submitted, Green Published, gold			2022-12-27	WOS:000354917300062
J	Starkevic, P; Paukstyte, J; Kazanaviciute, V; Denkovskiene, E; Stanys, V; Bendokas, V; Siksnianas, T; Razanskiene, A; Razanskas, R				Starkevic, Pavel; Paukstyte, Jurgita; Kazanaviciute, Vaiva; Denkovskiene, Erna; Stanys, Vidmantas; Bendokas, Vidmantas; Siksnianas, Tadeusas; Razanskiene, Ausra; Razanskas, Raimundas			Expression and Anthocyanin Biosynthesis-Modulating Potential of Sweet Cherry (Prunus avium L.) MYB10 and bHLH Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; RED COLORATION; PERSICA L.; FRUIT; IDENTIFICATION; EVOLUTION; PATHWAY; COMPLEX; GENOME	Anthocyanins are essential contributors to fruit coloration, an important quality feature and a breed determining trait of a sweet cherry fruit. It is well established that the biosynthesis of anthocyanins is regulated by an interplay of specific transcription factors belonging to MYB and bHLH families accompanied by a WD40 protein. In this study, we isolated and analyzed PaWD40, PabHLH3, PabHLH33, and several closely related MYB10 gene variants from different cultivars of sweet cherry, analyzed their expression in fruits with different anthocyanin levels at several developmental stages, and determined their capabilities to modulate anthocyanin synthesis in leaves of two Nicotiana species. Our results indicate that transcription level of variant PaMYB10.1-1 correlates with fruit coloration, but anthocyanin synthesis in Nicotiana was induced by another variant, PaMYB10.1-3, which is moderately expressed in fruits. The analysis of two fruit-expressed bHLH genes revealed that PabHLH3 enhances MYB-induced anthocyanin synthesis, whereas PabHLH33 has strong inhibitory properties.	[Starkevic, Pavel; Paukstyte, Jurgita; Kazanaviciute, Vaiva; Denkovskiene, Erna; Razanskiene, Ausra; Razanskas, Raimundas] Vilnius State Univ, Inst Biotechnol, LT-02241 Vilnius, Lithuania; [Stanys, Vidmantas; Bendokas, Vidmantas; Siksnianas, Tadeusas] Lithuanian Res Ctr Agr & Forestry, Inst Hort, LT-54333 Kaunas, Lithuania	Vilnius University; Lithuanian Research Centre for Agriculture & Forestry	Razanskas, R (corresponding author), Vilnius State Univ, Inst Biotechnol, VA Graici 8, LT-02241 Vilnius, Lithuania.	Raimundas.Razanskas@bti.vu.lt	Bendokas, Vidmantas/AAC-6491-2020	Bendokas, Vidmantas/0000-0001-7375-7504; Razanskiene, Ausra/0000-0002-0839-1224; Paukstyte, Jurgita/0000-0003-2056-6522; Razanskas, Raimundas/0000-0003-3397-1797; Stanys, Vidmantas/0000-0003-4064-0830	Research Council of Lithuania [SVE-01/2011, SVE-06/2012]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	Funding: The project was supported by grants SVE-01/2011 and SVE-06/2012 from the Research Council of Lithuania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-569; Alkio M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.11; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jiao Y, 2014, J ZHEJIANG UNIV-SC B, V15, P809, DOI 10.1631/jzus.B1400086; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Liu Y, 2013, J PLANT GROWTH REGUL, V32, P901, DOI 10.1007/s00344-013-9355-3; Liu Y, 2011, J FOOD SCI, V76, pC633, DOI 10.1111/j.1750-3841.2011.02150.x; MARTIN C, 1991, PLANT J, V1, P37, DOI 10.1111/j.1365-313X.1991.00037.x; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Pinto FL, 2010, ANAL BIOCHEM, V397, P227, DOI 10.1016/j.ab.2009.10.022; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Rahim MA, 2014, PLANTA, V240, P913, DOI 10.1007/s00425-014-2078-2; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schaart JG, 2013, NEW PHYTOL, V197, P454, DOI 10.1111/nph.12017; Shen XJ, 2014, PLANT CELL PHYSIOL, V55, P862, DOI 10.1093/pcp/pcu013; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uematsu C, 2014, J EXP BOT, V65, P1081, DOI 10.1093/jxb/ert456; Wrolstad RE, 2005, TRENDS FOOD SCI TECH, V16, P423, DOI 10.1016/j.tifs.2005.03.019; Ying Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0388-y; Yuan KJ, 2014, MOL GENET GENOMICS, V289, P1257, DOI 10.1007/s00438-014-0886-5; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; Zhang Y, 2014, CURR OPIN PLANT BIOL, V19, P81, DOI 10.1016/j.pbi.2014.05.011	34	39	44	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126991	10.1371/journal.pone.0126991	http://dx.doi.org/10.1371/journal.pone.0126991			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978735	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100121
J	Tsuchimine, S; Saruwatari, J; Kaneda, A; Yasui-Furukori, N				Tsuchimine, Shoko; Saruwatari, Junji; Kaneda, Ayako; Yasui-Furukori, Norio			ABO Blood Type and Personality Traits in Healthy Japanese Subjects	PLOS ONE			English	Article							BETA-HYDROXYLASE ACTIVITY; MONOAMINE-OXIDASE; RISK; POLYMORPHISMS; ASSOCIATION; DIMENSIONS; EXPRESSION; LINKAGE; CANCER; COMT	There is no scientific consensus that a relationship exists between the ABO blood group and personality traits. However, a recent study hypothesized that the dopamine beta-hydroxylase (DBH) gene is in linkage with the ABO gene. The sample population consisted of 1,427 healthy Japanese subjects who completed the Temperament and Character Inventory (TCI). Each subject's ABO blood type was determined by genotyping the rs8176719 and rs8176746 ABO gene single-nucleotide polymorphisms (SNPs) using a TaqMan genotyping assay. The relationships between the six ABO genotypes or four ABO phenotypes and personality traits were examined using a multivariate analysis of covariance (MANCOVA), controlling for age and sex. The MANCOVA data showed a significant difference in TCI scores among the ABO genotype groups (F [7, 1393] = 3.354, p = 0.001). A subsequent univariate analysis showed a significant difference in the mean scores for Persistence among the genotype groups (F = 2.680, partial eta(2) = 0.010, p = 0.020). Similarly, dividing the ABO blood type into four phenotypes revealed a significant difference among the phenotype groups (F [7, 1397] = 2.529, p = 0.014). A subsequent univariate analysis showed a significant difference among the phenotype groups in the mean scores for Persistence (F = 2.952, partial eta(2)= 0.006, p = 0.032). We observed a significant association between ABO blood group genotypes and personality traits in a large number of healthy Japanese subjects. However, these results should be regarded as preliminary and should be interpreted with caution because it is possible that the association between ABO blood group genotype and the Persistence trait is relatively weak.	[Tsuchimine, Shoko; Kaneda, Ayako; Yasui-Furukori, Norio] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan; [Saruwatari, Junji] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan	Hirosaki University; Kumamoto University	Yasui-Furukori, N (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan.	yasufuru@hirosaki-u.ac.jp	Saruwatari, Junji/Q-7748-2019	Saruwatari, Junji/0000-0001-6266-1347	Asteras; Dainippon; Eli Lilly; GSK; Janssen-Pharma; Meiji. Mochida; MSD; Otsuka; Pfizer; Takada; Yoshitomi	Asteras; Dainippon; Eli Lilly(Eli Lilly); GSK(GlaxoSmithKline); Janssen-Pharma; Meiji. Mochida; MSD; Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Takada; Yoshitomi(Mitsubishi Tanabe Pharma Corporation)	The authors sincerely thank Hiroyuki Takano and all of the participants in this study. Norio Yasui-Furukori has received grant/research support or honoraria from, and been on the speakers of Asteras, Dainippon, Eli Lilly, GSK, Janssen-Pharma, Meiji. Mochida, MSD, Otsuka, Pfizer, Takada and Yoshitomi. The remaining authors declare that they have no competing interests.	[Anonymous], [No title captured]; [Anonymous], 1993, PERSONALITY DEPRESSI; Bienvenu OJ, 2003, J PERS DISORD, V17, P139, DOI 10.1521/pedi.17.2.139.23991; CATTELL RB, 1964, AM J HUM GENET, V16, P397; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cramer KM, 2002, PERS INDIV DIFFER, V32, P621, DOI 10.1016/S0191-8869(01)00064-2; Czermak C, 2004, J NEUROIMMUNOL, V150, P145, DOI 10.1016/j.jneuroim.2004.01.009; Doheny D, 2002, NEUROLOGY, V59, P1244, DOI 10.1212/WNL.59.8.1244; Flegr J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061272; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Furukawa T, 1930, J SOC PSYCHOL, V1, P494, DOI 10.1080/00224545.1930.9714153; Gerra G, 2000, PSYCHONEUROENDOCRINO, V25, P479, DOI 10.1016/S0306-4530(00)00004-4; GOLDIN LR, 1982, AM J HUM GENET, V34, P250; Grucza RA, 2005, COMPR PSYCHIAT, V46, P214, DOI 10.1016/j.comppsych.2004.08.006; GUPTA S, 1990, PERS INDIV DIFFER, V11, P317, DOI 10.1016/0191-8869(90)90246-N; Hansen PE, 2005, CANCER-AM CANCER SOC, V103, P1082, DOI 10.1002/cncr.20871; Hess C, 2009, J NEURAL TRANSM, V116, P121, DOI 10.1007/s00702-008-0138-0; Hobgood DK, 2011, MED HYPOTHESES, V77, P294, DOI 10.1016/j.mehy.2011.04.039; JOGAWAR VV, 1983, PERS INDIV DIFFER, V4, P215, DOI 10.1016/0191-8869(83)90026-0; Keller MC, 2005, BEHAV GENET, V35, P707, DOI 10.1007/s10519-005-6041-7; Kijima N., 1996, ARCH PSYCHIAT DIAGN, V7, P379, DOI DOI 10.1002/(SICI)1097-4679(199812)54:83.0.CO;2-A; LAGRANGE L, 1995, ADDICT BEHAV, V20, P93, DOI 10.1016/0306-4603(94)00049-5; LESTER D, 1987, PERS INDIV DIFFER, V8, P267, DOI 10.1016/0191-8869(87)90184-X; Liumbruno GM, 2013, BLOOD TRANSFUS-ITALY, V11, P491, DOI 10.2450/2013.0152-13; Maeda K, 2013, LEGAL MED-TOKYO, V15, P57, DOI 10.1016/j.legalmed.2012.08.009; Mao X, 1991, Hua Xi Yi Ke Da Xue Xue Bao, V22, P93; Marutham P, 1990, INDIAN J CLIN PSYCHO, V17, P79; Nawata Kengo, 2014, Shinrigaku Kenkyu, V85, P148; Noblett Kurtis L, 2005, Curr Psychiatry Rep, V7, P73, DOI 10.1007/s11920-005-0028-1; Plomin R., 2008, BEHAV GENET; RINIERIS PM, 1980, ACTA PSYCHIAT SCAND, V61, P473, DOI 10.1111/j.1600-0447.1980.tb00885.x; RINIERIS PM, 1978, ACTA PSYCHIAT SCAND, V57, P377, DOI 10.1111/j.1600-0447.1978.tb06906.x; Risch HA, 2013, AM J EPIDEMIOL, V177, P1326, DOI 10.1093/aje/kws458; Rogers M, 2003, PERS INDIV DIFFER, V34, P1099, DOI 10.1016/S0191-8869(02)00101-0; Sadahiro R, 2015, Eur Psychiatry, V30, P291, DOI 10.1016/j.eurpsy.2014.03.003; Steptoe A, 2007, HEART, V93, P783, DOI 10.1136/hrt.2006.109355; Szekely A, 2004, AM J MED GENET B, V126B, P106, DOI 10.1002/ajmg.b.20134; The Interplay of Biological Behavioral and Societal Influences, 2001, INT BIOL BEH SOC INF; Tochigi M, 2006, NEUROSCI RES, V54, P180, DOI 10.1016/j.neures.2005.11.003; Tsuchimine S, 2008, PROG NEURO-PSYCHOPH, V32, P1932, DOI 10.1016/j.pnpbp.2008.09.012; Twu YC, 2006, TRANSFUSION, V46, P1988, DOI 10.1111/j.1537-2995.2006.01007.x; Van Gestel S, 2003, MOL PSYCHIATR, V8, P840, DOI 10.1038/sj.mp.4001367; Velting DM, 1999, PERS INDIV DIFFER, V27, P943, DOI 10.1016/S0191-8869(99)00046-X; Wang JZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084749; WILSON AF, 1988, AM J HUM GENET, V42, P160; Wu KH, 2005, PERS INDIV DIFFER, V38, P797, DOI 10.1016/j.paid.2004.06.004; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Zabetian CP, 2001, AM J HUM GENET, V68, P515, DOI 10.1086/318198; Zalsman G, 2005, AM J MED GENET B, V132B, P100, DOI 10.1002/ajmg.b.30094	49	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126983	10.1371/journal.pone.0126983	http://dx.doi.org/10.1371/journal.pone.0126983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978647	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100120
J	Yarmolinsky, J; Mueller, NT; Duncan, BB; Molina, MDB; Goulart, AC; Schmidt, MI				Yarmolinsky, James; Mueller, Noel T.; Duncan, Bruce B.; Bisi Molina, Maria del Carmen; Goulart, Alessandra C.; Schmidt, Maria Ines			Coffee Consumption, Newly Diagnosed Diabetes, and Other Alterations in Glucose Homeostasis: A Cross-Sectional Analysis of the Longitudinal Study of Adult Health (ELSA-Brasil)	PLOS ONE			English	Article							DECAFFEINATED COFFEE; CHLOROGENIC ACID; ATHEROSCLEROSIS-RISK; INSULIN SENSITIVITY; TEA CONSUMPTION; TOLERANCE; METABOLISM; SECRETION; CAFFEINE	Introduction Observational studies have reported fairly consistent inverse associations between coffee consumption and risk of type 2 diabetes, but this association has been little investigated with regard to lesser degrees of hyperglycemia and other alterations in glucose homeostasis. Additionally, the association between coffee consumption and diabetes has been rarely investigated in South American populations. We examined the cross-sectional relationships of coffee intake with newly diagnosed diabetes and measures of glucose homeostasis, insulin sensitivity, and insulin secretion, in a large Brazilian cohort of middle-aged and elderly individuals. Methods We used baseline data from 12,586 participants of the Longitudinal Study of Adult Health (ELSA-Brasil). Logistic regression analyses were performed to examine associations between coffee consumption and newly diagnosed diabetes. Analysis of covariance was used to assess coffee intake in relation to two-hour glucose from an oral glucose tolerance test, fasting glucose, glycated hemoglobin, fasting and -2-hour postload insulin and measures of insulin sensitivity. Results We found an inverse association between coffee consumption and newly diagnosed diabetes, after adjusting for multiple covariates [23% and 26% lower odds of diabetes for those consuming coffee 2-3 and >3 times per day, respectively, compared to those reporting never or almost never consuming coffee, (p = .02)]. An inverse association was also found for 2-hour postload glucose [Never/almost never: 7.57 mmol/L, <= 1 time/day: 7.48 mmol/L, 2-3 times/day: 7.22 mmol/L, >3 times/day: 7.12 mol/L, p<0.0001] but not with fasting glucose concentrations (p = 0.07). Coffee was additionally associated with 2-hour postload insulin [Never/almost never: 287.2 pmol/L, <= 1 time/day: 280.1 pmol/L, 2-3 times/day: 275.3 pmol/L, >3 times/day: 262.2 pmol/L, p = 0.0005) but not with fasting insulin concentrations (p = .58). Conclusion Our present study provides further evidence of a protective effect of coffee on risk of adult-onset diabetes. This effect appears to act primarily, if not exclusively, through postprandial, as opposed to fasting, glucose homeostasis.	[Yarmolinsky, James; Mueller, Noel T.; Duncan, Bruce B.; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Mueller, Noel T.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, Med Ctr, New York, NY USA; [Mueller, Noel T.] Columbia Univ, Med Ctr, Coll Phys & Surg, Inst Human Nutr, New York, NY USA; [Mueller, Noel T.] Columbia Univ, Dept Med, Coll Phys & Surg, Med Ctr, New York, NY USA; [Bisi Molina, Maria del Carmen] Univ Fed Espirito Santo, Ctr Hlth Sci, Vitoria, ES, Brazil; [Goulart, Alessandra C.] Univ Sao Paulo, Univ Hosp, Ctr Clin & Epidemiol Res, Sao Paulo, Brazil	Universidade Federal do Rio Grande do Sul; Columbia University; Columbia University; Columbia University; Universidade Federal do Espirito Santo; Universidade de Sao Paulo	Yarmolinsky, J (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Epidemiol, Porto Alegre, RS, Brazil.	jamesyarmolinsky@gmail.com	Schmidt, Maria Inês/AGP-6441-2022; Goulart, Alessandra C/J-2845-2014; Schmidt, Maria/V-3196-2019; Joukar, Farahnaz/GMW-7238-2022; Schmidt, Maria Inês/AGT-5691-2022; Duncan, Bruce B/L-4140-2016	Schmidt, Maria Inês/0000-0002-3837-0731; Goulart, Alessandra C/0000-0003-1076-5210; Joukar, Farahnaz/0000-0003-0102-0575; Duncan, Bruce B/0000-0002-7491-2630; Mueller, Noel/0000-0002-7412-8352	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos) [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]; CNPq (The National Council for Scientific and Technological Development)	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos); CNPq (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The ELSA-Brasil study was supported by the Brazilian Ministry of Health (Science and Technology Department) (http://portalsaude.saude.gov.br/index.php/cidadao/principal/english), the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos) (http://www.mct.gov.br/), grants 01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ, and CNPq (The National Council for Scientific and Technological Development) (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; Arnlov J, 2014, JAMA-J AM MED ASSOC, V291, P1199; Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780; DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc09-1521, 10.2337/dc10-0646]; Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203; Gao DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073965; Goto A, 2011, DIABETES, V60, P269, DOI 10.2337/db10-1193; Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548; Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8; Machado LMM, 2011, INT J ENV RES PUB HE, V8, P3216, DOI 10.3390/ijerph8083216; McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037; Molina Maria del Carmen Bisi, 2013, Cad. Saúde Pública, V29, P379, DOI [10.1590/S0102-311X2013000200024, 10.1590/S0102-311X2013000600024]; Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x; Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008; Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Rebello SA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-61; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027; Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529; The IPAQ group, 2014, INT PHYS ACTIV QUEST; van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512; van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6; Vigo A, 2007, BRAZ J MED BIOL RES, V40, P933, DOI 10.1590/S0100-879X2006005000121; Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2011, US GLYC HAEM HBA1C D; Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5	35	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126469	10.1371/journal.pone.0126469	http://dx.doi.org/10.1371/journal.pone.0126469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978631	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100072
J	Di Camillo, CG; Cerrano, C				Di Camillo, Cristina Gioia; Cerrano, Carlo			Mass Mortality Events in the NW Adriatic Sea: Phase Shift from Slow- to Fast-Growing Organisms	PLOS ONE			English	Article							BENTHIC INVERTEBRATES ASCIDIANS; FILTER-FEEDING ETHOLOGY; CORAL-REEFS; POPULATION-DYNAMICS; GROWTH DYNAMICS; CNIDARIA; ANTHOZOA; STRATIFICATION; EUTROPHICATION; BIODIVERSITY	Massive outbreaks are increasing all over the world, which are likely related to climate change. The North Adriatic Sea, a sub-basin of the Mediterranean Sea, is a shallow semi-closed sea receiving high nutrients inputs from important rivers. These inputs sustain the highest productive basin of the Mediterranean Sea. Moreover, this area shows a high number of endemisms probably due to the high diversity of environmental conditions and the conspicuous food availability. Here, we documented two massive mortalities (2009 and 2011) and the pattern of recovery of the affected biocoenoses in the next two years. Results show an impressive and fast shift of the benthic assemblage from a biocoenosis mainly composed of slow-growing and long-lived species to a biocoenosis dominated by fast-growing and short-lived species. The sponge Chondrosia reniformis, one of the key species of this assemblage, which had never been involved in previous massive mortality events in the Mediterranean Sea, reduced its coverage by 70%, and only few small specimens survived. All the damaged sponges, together with many associated organisms, were detached by rough-sea conditions, leaving large bare areas on the rocky wall. Almost three years after the disease, the survived specimens of C. reniformis did not increase significantly in size, while the bare areas were colonized by fast-growing species such as stoloniferans, hydrozoans, mussels, algae, serpulids and bryozoans. Cnidarians were more resilient than massive sponges since they quickly recovered in less than one month. In the study area, the last two outbreaks caused a reduction in the filtration efficiency of the local benthic assemblage by over 60%. The analysis of the times series of wave heights and temperature revealed that the conditions in summer 2011 were not so extreme as to justify severe mass mortality, suggesting the occurrence of other factors which triggered the disease. The long-term observations of a benthic assemblage in the NW Adriatic Sea allowed us to monitor its dynamics before, during and after the mortality event. The N Adriatic Sea responds quickly to climatic anomalies and other environmental stresses because of the reduced dimension of the basin. The long-term consequences of frequent mass mortality episodes in this area could promote the shift from biocoenoses dominated by slow-growing and long-lived species to assemblages dominated by plastic and short life cycle species.	[Di Camillo, Cristina Gioia; Cerrano, Carlo] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy	Marche Polytechnic University	Di Camillo, CG (corresponding author), Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy.	c.dicamillo@univpm.it	Di Camillo, Cristina/AAI-5960-2021; Cerrano, Carlo/AAF-3557-2019	Cerrano, Carlo/0000-0001-9580-5546; Di Camillo, Cristina/0000-0002-4031-8158	PRIN project (Progetti di Ricerca di Interesse Nazionale) [2008YBEANX_002]; AMER (AMER Adriatic Marine Ecosystem Recovery)	PRIN project (Progetti di Ricerca di Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)); AMER (AMER Adriatic Marine Ecosystem Recovery)	The research has been funded by PRIN project (Progetti di Ricerca di Interesse Nazionale 2008) 2008YBEANX_002 - http://prin.miur.it/ and AMER (AMER 2013-2015. Adriatic Marine Ecosystem Recovery). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Wahab MA, 2014, J EXP MAR BIOL ECOL, V461, P162, DOI 10.1016/j.jembe.2014.08.006; [Anonymous], 2008, J ICRU, V8, P5, DOI 10.1093/jicru/ndn022; Appiotti F, 2014, REG ENVIRON CHANGE, V14, P2007, DOI 10.1007/s10113-013-0451-5; ARPA Bulletin, 2011, ARPA B; Bazairi H., 2010, MEDITERRANEAN SEA BI; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Betti F, 2012, MAR ECOL-EVOL PERSP, V33, P49, DOI [10.1111/j.1439-0485.2012.00525.x, 10.1111/j.1439-0485.2011.00456.x]; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Blasnig M, 2013, BIOGEOSCIENCES, V10, P7647, DOI 10.5194/bg-10-7647-2013; BOERO F, 1984, MAR ECOL-P S Z N I, V5, P93, DOI 10.1111/j.1439-0485.1984.tb00310.x; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; Cerrano C., 1999, Memoirs of the Queensland Museum, V44, P85; Cerrano C, 2008, CHEM ECOL, V24, P73, DOI 10.1080/02757540801979648; Cerrano C, 2006, ITAL J ZOOL, V73, P355, DOI 10.1080/11250000600911675; Cerrano C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01457; Cerrano C, 2009, ECOL STUD-ANAL SYNTH, V206, P295, DOI 10.1007/978-3-540-92704-4_21; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Crisp DJ, 1965, ECOLOGY IND SOC, P99; Cruz I., 2014, MARINE ECOLOGY, V36, P318, DOI DOI 10.1111/MAEC.12141; DALES RP, 1957, J MAR BIOL ASSOC UK, V36, P309, DOI 10.1017/S0025315400016817; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Dayton P K, 1979, BIOLOGIE SPONGIARES, P271; Desiato F, 2012, STATO AMBIENTE, V35, P162; Di Camillo CG, 2012, MAR BIOL, V159, P1593, DOI 10.1007/s00227-012-1948-z; Di Camillo CG, 2012, HYDROBIOLOGIA, V687, P299, DOI 10.1007/s10750-011-0877-z; Di Camillo CG, 2014, J EXP MAR BIOL ECOL, V461, P144, DOI 10.1016/j.jembe.2014.07.023; Diaz MC, 2001, B MAR SCI, V69, P535; Djakovac T, 2015, J MARINE SYST, V141, P179, DOI 10.1016/j.jmarsys.2014.08.001; DONS CARL, 1927, NYT MAG FOR NATURVIDENSK, V65, P111; Dubois S, 2003, CR BIOL, V326, P413, DOI 10.1016/S1631-0691(03)00124-0; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Falace A, 2010, CHEM ECOL, V26, P77, DOI 10.1080/02757541003689837; FIALAMEDIONI A, 1974, MAR BIOL, V28, P199, DOI 10.1007/BF00387298; FIALAMEDIONI A, 1978, MAR BIOL, V48, P243, DOI 10.1007/BF00397151; Fonda Umani Serena, 2008, CIESM Workshop Monographs, V35, P59; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, ESTUAR COAST SHELF S, V52, P293, DOI 10.1006/ecss.2000.0699; Giani M, 2012, ESTUAR COAST SHELF S, V115, P1, DOI 10.1016/j.ecss.2012.08.023; Gilmartin M., 1983, THALASSIA JUGOSLAVIC, V19, P173; Hadfield MG, 2001, CRC MAR SCI, P431; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; Inoue S, 2013, NAT CLIM CHANGE, V3, P683, DOI [10.1038/nclimate1855, 10.1038/NCLIMATE1855]; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; JUSTIC D, 1991, GEOL SOC SPEC PUBL, P95, DOI 10.1144/GSL.SP.1991.058.01.07; Kawaii S, 1999, BIOL BULL, V196, P45, DOI 10.2307/1543165; Koopmans M, 2008, MAR BIOTECHNOL, V10, P502, DOI 10.1007/s10126-008-9086-9; Kruzic P, 2015, CORAL REEFS, V34, P109, DOI 10.1007/s00338-014-1231-5; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Mariani S, 2005, MAR BIOL, V147, P735, DOI 10.1007/s00227-005-1616-7; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Mollmann C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0260; Moschella Paula, 2008, CIESM Workshop Monographs, V35, P47; Naumann MS, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4257-9; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; OFFICER CB, 1982, MAR ECOL PROG SER, V9, P203, DOI 10.3354/meps009203; OTT JA, 1992, OLSEN INT S, P367; Pascucci A, 2011, IL RESTO DEL CA 1102; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Ponti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102782; Puce S, 2009, MAR ECOL-EVOL PERSP, V30, P313, DOI 10.1111/j.1439-0485.2009.00283.x; Rasband W.S., 1997, IMAGEJ; REISWIG HM, 1975, CAN J ZOOL, V53, P582, DOI 10.1139/z75-072; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; REVELANTE N, 1992, ESTUAR COAST SHELF S, V35, P191, DOI 10.1016/S0272-7714(05)80113-1; Riedel B, 2008, MAR BIOL, V153, P1075, DOI 10.1007/s00227-007-0880-0; Rossi S, 2013, OCEAN COAST MANAGE, V84, P77, DOI 10.1016/j.ocecoaman.2013.07.004; Rossi S, 2012, MAR ECOL PROG SER, V467, P97, DOI 10.3354/meps09848; Scinto A., 2009, P 1 MED S CONS COR O, P136; Shellenberger JS, 1998, NORTHWEST SCI, V72, P23; Sokal RR, 1981, BIOMETRY PRINCIPLE P; Stabili L, 2012, MICROB ECOL, V64, P802, DOI 10.1007/s00248-012-0068-0; STACHOWITSCH M, 1984, PSZNI MAR ECOL, V5, P243, DOI 10.1111/j.1439-0485.1984.tb00124.x; STACHOWITSCH M, 1991, GEOL SOC SPEC PUBL, P119, DOI 10.1144/GSL.SP.1991.058.01.09; Standing J.D., 1976, P155; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Teixido N, 2009, MAR ECOL PROG SER, V375, P113, DOI 10.3354/meps07757; Teixido N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053742; Turon X, 1998, FUNCT ECOL, V12, P631, DOI 10.1046/j.1365-2435.1998.00225.x; UNEP/MAP/MED POL, 2005, TRANSB DIAGN AN TDA, V682, P1; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Vezzulli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067745; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Vilicic D, 2013, MAR ECOL-EVOL PERSP, V34, P451, DOI 10.1111/maec.12046; WEBSTER NS, 2007, CLIMATE CHANGE GREAT, P97; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2; Zenetos A, 2003, C SUST DEV MED BLACK	96	35	36	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126689	10.1371/journal.pone.0126689	http://dx.doi.org/10.1371/journal.pone.0126689			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974111	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600077
J	Hu, J; Lv, GH; Zhou, SG; Zhou, YC; Nie, BX; Duan, H; Zhang, YF; Yuan, XF				Hu, Jun; Lv, Guohua; Zhou, Shuguang; Zhou, Yucheng; Nie, Bangxu; Duan, Hong; Zhang, Yunfeng; Yuan, Xiaofeng			The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression	PLOS ONE			English	Article							PROMOTES PROLIFERATION; CIRCULATING MIR-182; LYMPHOMA INVASION; DEATH 4; METASTASIS; CANCER; OVEREXPRESSION; TARGETS; MIGRATION; MICRORNA-135B	Background Osteosarcoma is the most common primary bone malignancy in children and young adults. Increasing results suggest that discovery of microRNAs (miRNAs) might provide a novel therapeutical target for osteosarcoma. Methods MiR-182 expression level in osteosarcoma cell lines and tissues were assayed by qRT-PCR. MiRNA mimics or inhibitor were transfected for up-regulation or down-regulation of miR-182 expression. Cell function was assayed by CCK8, migration assay and invasion assay. The target genes of miR-182 were predicated by bioinformatics algorithm (TargetScan Human). Results MiR-182 was down-regulated in osteosarcoma tissues and cell lines. Overexpression of miR-182 inhibited tumor growth, migration and invasion. Subsequent investigation revealed that TIAM1 was a direct and functional target of miR-182 in osteosarcoma cells. Overexpression of miR-182 impaired TIAM1-induced inhibition of proliferation and invasion in osteosarcoma cells. Conclusions Down-expression of miR-182 in osteosarcoma promoted tumor growth, migration and invasion by targeting TIAM1. MiR-182 might act as a tumor suppressor gene whose down-regulation contributes to the progression and metastasis of osteosarcoma, providing a potential therapy target for osteosarcoma patients.	[Hu, Jun; Lv, Guohua; Zhou, Shuguang; Zhou, Yucheng] Cent South Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China; [Hu, Jun; Nie, Bangxu; Duan, Hong; Zhang, Yunfeng; Yuan, Xiaofeng] First Hosp Kunming, Dept Orthoped, Kunming, Yunnan, Peoples R China; [Zhou, Shuguang] Affiliated Hosp Hunan Univ Med, Dept Orthoped, Huaihua, Hunan, Peoples R China; [Zhou, Shuguang] Third Peoples Hosp Huaihua, Huaihua, Hunan, Peoples R China; [Zhou, Yucheng] Peoples Hosp Qingyuan, Dept Orthoped, Qingyuan, Guangdong, Peoples R China	Central South University	Lv, GH (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China.	gfq4e1@yeah.net						Althoff K, 2013, INT J CANCER, V133, P1064, DOI 10.1002/ijc.28091; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Chang SJ, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-65; Chen B, 2012, MOL MED REP, V5, P48, DOI 10.3892/mmr.2011.612; Chen JS, 2012, INT J CANCER, V130, P1302, DOI 10.1002/ijc.26117; Du BW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088022; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Fu ZC, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0164-8; Geng S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091566; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hasei J, 2013, MOL CANCER THER, V12, P314, DOI 10.1158/1535-7163.MCT-12-0869; Huang J, 2013, INT J CANCER, V132, P90, DOI 10.1002/ijc.27627; Inoue T, 2012, ONCOL REP, V27, P1759, DOI 10.3892/or.2012.1709; Jin J, 2013, ASIAN PAC J CANCER P, V14, P3681, DOI 10.7314/APJCP.2013.14.6.3681; Khatri R, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00268; Kong WQ, 2012, FEBS J, V279, P1252, DOI 10.1111/j.1742-4658.2012.08519.x; Lee JE, 2011, CELL PROLIFERAT, V44, P59, DOI 10.1111/j.1365-2184.2010.00717.x; Li CL, 2014, INT J MOL SCI, V15, P6314, DOI 10.3390/ijms15046314; Li GD, 2012, CELL PHYSIOL BIOCHEM, V30, P1481, DOI 10.1159/000343336; Li J, 2014, CELL PROLIFERAT, V47, P152, DOI 10.1111/cpr.12093; Li M, 2013, CELL PROLIFERAT, V46, P223, DOI 10.1111/cpr.12013; Li T, 2014, ONCOL REP, V31, P1699, DOI 10.3892/or.2014.3032; Li Z, 2014, GASTRIC CANCER OFFIC; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu H, 2013, INT J COLORECTAL DIS, V28, P697, DOI 10.1007/s00384-013-1674-0; Liu SG, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-69; Liu ZJ, 2012, J PATHOL, V228, P204, DOI 10.1002/path.4000; Luo CL, 2013, J INVEST DERMATOL, V133, P768, DOI 10.1038/jid.2012.357; Montanaro L, 2007, CELL PROLIFERAT, V40, P532, DOI 10.1111/j.1365-2184.2007.00448.x; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Pan WB, 2014, CELL PHYSIOL BIOCHEM, V33, P402, DOI 10.1159/000356679; Perilli L, 2014, ONCOTARGET, V5, P6611, DOI 10.18632/oncotarget.2245; Qi Y, 2009, ORL-J OTO-RHIN-LARYN, V71, P163, DOI 10.1159/000223440; Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127; Tang J, 2014, CELL PROLIFERAT, V47, P427, DOI 10.1111/cpr.12129; Tang T, 2013, GYNECOL ONCOL, V129, P199, DOI 10.1016/j.ygyno.2012.12.043; Tsuchiyama K, 2013, PROSTATE, V73, P827, DOI 10.1002/pros.22626; Wang J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-227; Wang M, 2014, TUMOR BIOL, V35, P39, DOI 10.1007/s13277-013-1004-8; Wang PY, 2013, ONCOL LETT, V6, P1681, DOI 10.3892/ol.2013.1593; Wang XH, 2014, MOL MED REP, V10, P855, DOI 10.3892/mmr.2014.2260; Wang YQ, 2013, J CELL BIOCHEM, V114, P1464, DOI 10.1002/jcb.24488; Wu ZY, 2011, MED ONCOL, V28, P1469, DOI 10.1007/s12032-010-9563-7; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Zhang LF, 2011, INT J MOL MED, V28, P381, DOI 10.3892/ijmm.2011.679; Zhao LA, 2011, J CANCER RES CLIN, V137, P393, DOI 10.1007/s00432-010-0895-7; Zhou Y, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-12; Zhu JXX, 2013, SCI CHINA CHEM, V56, P1, DOI 10.1007/s11426-012-4811-7; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023; Zhu YJ, 2014, CLIN LAB, V60, P155, DOI 10.7754/Clin.Lab.2013.121131	54	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0121175	10.1371/journal.pone.0121175	http://dx.doi.org/10.1371/journal.pone.0121175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973950	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600004
J	Bible, PW; Kanno, Y; Wei, L; Brooks, SR; O'Shea, JJ; Morasso, MI; Loganantharaj, R; Sun, HW				Bible, Paul W.; Kanno, Yuka; Wei, Lai; Brooks, Stephen R.; O'Shea, John J.; Morasso, Maria I.; Loganantharaj, Rasiah; Sun, Hong-Wei			PAPST, a User Friendly and Powerful Java Platform for ChIP-Seq Peak Co-Localization Analysis and Beyond	PLOS ONE			English	Article							READ ALIGNMENT; IDENTIFICATION; UPDATE; SITES; RNAS	Comparative co-localization analysis of transcription factors (TFs) and epigenetic marks (EMs) in specific biological contexts is one of the most critical areas of ChIP-Seq data analysis beyond peak calling. Yet there is a significant lack of user-friendly and powerful tools geared towards co-localization analysis based exploratory research. Most tools currently used for co-localization analysis are command line only and require extensive installation procedures and Linux expertise. Online tools partially address the usability issues of command line tools, but slow response times and few customization features make them unsuitable for rapid data-driven interactive exploratory research. We have developed PAPST: Peak Assignment and Profile Search Tool, a user-friendly yet powerful platform with a unique design, which integrates both gene-centric and peak-centric co-localization analysis into a single package. Most of PAPST's functions can be completed in less than five seconds, allowing quick cycles of data-driven hypothesis generation and testing. With PAPST, a researcher with or without computational expertise can perform sophisticated co-localization pattern analysis of multiple TFs and EMs, either against all known genes or a set of genomic regions obtained from public repositories or prior analysis. PAPST is a versatile, efficient, and customizable tool for genome-wide data-driven exploratory research. Creatively used, PAPST can be quickly applied to any genomic data analysis that involves a comparison of two or more sets of genomic coordinate intervals, making it a powerful tool for a wide range of exploratory genomic research. We first present PAPST's general purpose features then apply it to several public ChIP-Seq data sets to demonstrate its rapid execution and potential for cutting-edge research with a case study in enhancer analysis. To our knowledge, PAPST is the first software of its kind to provide efficient and sophisticated post peak-calling ChIP-Seq data analysis as an easy-to-use interactive application. PAPST is available at https://github.com/paulbible/papst and is a public domain work.	[Bible, Paul W.; Morasso, Maria I.] NIAMSD, Skin Biol Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Kanno, Yuka; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, Intramural Res Program, Bethesda, MD 20892 USA; [Wei, Lai] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Brooks, Stephen R.; Sun, Hong-Wei] NIAMSD, Biodata Min & Discovery Sect, Off Sci & Technol, Intramural Res Program, Bethesda, MD 20892 USA; [Loganantharaj, Rasiah] Univ Louisiana Lafayette, Ctr Adv Comp Studies, Lab Bioinformat, Lafayette, LA 70504 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Louisiana Lafayette	Bible, PW (corresponding author), NIAMSD, Skin Biol Lab, Intramural Res Program, Bethesda, MD 20892 USA.	paul.bible2@nih.gov; sunh1@mail.nih.gov	Kanno, Yuka/B-5802-2013	Kanno, Yuka/0000-0001-5668-9319	Intramural Research Program; Office of Science and Technology of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041124, ZIAAR041159, ZIAAR041171, ZIHAR041173] Funding Source: NIH RePORTER	Intramural Research Program; Office of Science and Technology of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Intramural Research Program and the Office of Science and Technology of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.	Alekseyenko AV, 2007, BIOINFORMATICS, V23, P1386, DOI 10.1093/bioinformatics/btl647; Ashoor H, 2013, BIOINFORMATICS, V29, P2979, DOI 10.1093/bioinformatics/btt524; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Chen TW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-539; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chojnowski Krzysztof, 2014, BMC Res Notes, V7, P676, DOI 10.1186/1756-0500-7-676; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kanno T, 2014, NAT STRUCT MOL BIOL, V21, P1047, DOI 10.1038/nsmb.2912; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	26	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127285	10.1371/journal.pone.0127285	http://dx.doi.org/10.1371/journal.pone.0127285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970601	Green Submitted, Green Published, gold			2022-12-27	WOS:000354544200156
J	Weinberg, SH				Weinberg, Seth H.			Membrane Capacitive Memory Alters Spiking in Neurons Described by the Fractional-Order Hodgkin-Huxley Model	PLOS ONE			English	Article							DIFFERENTIAL-EQUATIONS; DYNAMICS; PATTERNS; BEHAVIOR	Excitable cells and cell membranes are often modeled by the simple yet elegant parallel resistor-capacitor circuit. However, studies have shown that the passive properties of membranes may be more appropriately modeled with a non-ideal capacitor, in which the current-voltage relationship is given by a fractional-order derivative. Fractional-order membrane potential dynamics introduce capacitive memory effects, i.e., dynamics are influenced by a weighted sum of the membrane potential prior history. However, it is not clear to what extent fractional-order dynamics may alter the properties of active excitable cells. In this study, we investigate the spiking properties of the neuronal membrane patch, nerve axon, and neural networks described by the fractional-order Hodgkin-Huxley neuron model. We find that in the membrane patch model, as fractional-order decreases, i.e., a greater influence of membrane potential memory, peak sodium and potassium currents are altered, and spike frequency and amplitude are generally reduced. In the nerve axon, the velocity of spike propagation increases as fractional-order decreases, while in a neural network, electrical activity is more likely to cease for smaller fractional-order. Importantly, we demonstrate that the modulation of the peak ionic currents that occurs for reduced fractional-order alone fails to reproduce many of the key alterations in spiking properties, suggesting that membrane capacitive memory and fractional-order membrane potential dynamics are important and necessary to reproduce neuronal electrical activity.	Old Domin Univ, Virginia Modeling Anal & Simulat Ctr, Suffolk, VA 23435 USA		Weinberg, SH (corresponding author), Old Domin Univ, Virginia Modeling Anal & Simulat Ctr, 1030 Univ Blvd, Suffolk, VA 23435 USA.	sweinber@odu.edu		Weinberg, Seth/0000-0003-1170-0419				ANASTASIO TJ, 1994, BIOL CYBERN, V72, P69, DOI 10.1007/BF00206239; Anderson WS, 2009, EPILEPSY RES, V84, P42, DOI 10.1016/j.eplepsyres.2008.12.005; [Anonymous], 1901, ARCH ITAL BIOL; Bandeira HT, 2008, CHAOS, V18, DOI 10.1063/1.2944980; Cole KS, 1934, SCIENCE, V79, P164, DOI 10.1126/science.79.2042.164; COLE KENNETH S., 1933, COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOL, V1, P107; Cole KS, 1932, J GEN PHYSIOL, V15, P641, DOI 10.1085/jgp.15.6.641; Cole KS, 1936, P COLD SPRING HARB S, V4, P73, DOI DOI 10.1101/SQB.1936.004.01.010; Curie M. J., 1889, ANN CHIMIE PHYS 6, V18, P203; Dokoumetzidis A, 2010, J PHARMACOKINET PHAR, V37, P507, DOI 10.1007/s10928-010-9170-4; Dokoumetzidis A, 2009, J PHARMACOKINET PHAR, V36, P165, DOI 10.1007/s10928-009-9116-x; Dong J, 2014, COGN NEURODYNAMICS, V8, P167, DOI 10.1007/s11571-013-9273-x; Ford NJ, 2006, COMMUN PUR APPL ANAL, V5, P289, DOI 10.3934/cpaa.2006.5.289; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Goychuk I, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051915; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kerner Z, 2000, ELECTROCHIM ACTA, V46, P207, DOI 10.1016/S0013-4686(00)00574-0; Koch C., 2004, BIOPHYSICS COMPUTATI; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Leszczynski J, 2002, LECT NOTES COMPUT SC, V2328, P695; LIEBOVITCH LS, 1987, MATH BIOSCI, V84, P37, DOI 10.1016/0025-5564(87)90042-3; Lin YM, 2007, J COMPUT PHYS, V225, P1533, DOI 10.1016/j.jcp.2007.02.001; Lowen SB, 1999, PHYS REV E, V59, P5970, DOI 10.1103/PhysRevE.59.5970; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Magin RL, 2008, J VIB CONTROL, V14, P1431, DOI 10.1177/1077546307087439; Magin R.-L., 2006, FRACTIONAL CALCULUS; Magin Richard L., 2004, Critical Reviews in Biomedical Engineering, V32, P1, DOI 10.1615/CritRevBiomedEng.v32.10; Magin RL, 2010, COMPUT MATH APPL, V59, P1586, DOI 10.1016/j.camwa.2009.08.039; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; Moaddy K, 2012, COMPUT MATH APPL, V64, P3329, DOI 10.1016/j.camwa.2012.01.005; Momani S, 2007, CHAOS SOLITON FRACT, V31, P1248, DOI 10.1016/j.chaos.2005.10.068; Nagy AM, 2014, PHYS LETT A, V378, P1980, DOI 10.1016/j.physleta.2014.06.012; Nernst W, 1908, ARCH GESAMTE PHYSIOL, V122, P275, DOI 10.1007/BF01677956; Petras I, 2011, COMMUN NONLINEAR SCI, V16, P4588, DOI 10.1016/j.cnsns.2011.02.012; Podlubny I., 1998, FRACTIONAL DIFFERENT; Radwan AG, 2009, CHAOS SOLITON FRACT, V40, P2317, DOI 10.1016/j.chaos.2007.10.033; RINZEL J, 1980, MATH BIOSCI, V49, P27, DOI 10.1016/0025-5564(80)90109-1; Scherer R, 2011, COMPUT MATH APPL, V62, P902, DOI 10.1016/j.camwa.2011.03.054; Sherief H, 2012, FRACTIONAL DYNAMICS, P275, DOI DOI 10.1007/978-1-4614-0457-6_23; Shi M, 2014, COMMUN NONLINEAR SCI, V19, P1956, DOI 10.1016/j.cnsns.2013.10.032; Siwy Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031907; Stanislavsky AA, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021111; Tan WC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2805208; Teka W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003526; Varanda WA, 2000, J THEOR BIOL, V206, P343, DOI 10.1006/jtbi.2000.2131; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; Weinberg S, 2008, BIOPHYS J, V95, P1138, DOI 10.1529/biophysj.107.128207; Weinberg SH, 2014, BIOPHYS J, V106, P2693, DOI 10.1016/j.bpj.2014.04.045; Weinberg SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081402; Weinberg SH, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/897371; WESTERLUND S, 1994, IEEE T DIELECT EL IN, V1, P826, DOI 10.1109/94.326654; Yao K, 2009, CHAOS SOLITON FRACT, V41, P2538, DOI 10.1016/j.chaos.2008.09.053	55	36	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126629	10.1371/journal.pone.0126629	http://dx.doi.org/10.1371/journal.pone.0126629			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970534	gold, Green Submitted, Green Published			2022-12-27	WOS:000354544200124
J	Alex, A; Antunes, A				Alex, Anoop; Antunes, Agostinho			Pyrosequencing Characterization of the Microbiota from Atlantic Intertidal Marine Sponges Reveals High Microbial Diversity and the Lack of Co-Occurrence Patterns	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; VERTICAL TRANSMISSION; BACTERIAL COMMUNITIES; SYMBIOTIC BACTERIA; THEONELLA-SWINHOEI; CHEMICAL ECOLOGY; PHYLOGENY; ABUNDANCE; ARCHAEA; MICROORGANISMS	Sponges are ancient metazoans that host diverse and complex microbial communities. Sponge-associated microbial diversity has been studied from wide oceans across the globe, particularly in subtidal regions, but the microbial communities from intertidal sponges have remained mostly unexplored. Here we used pyrosequencing to characterize the microbial communities in 12 different co-occurring intertidal marine sponge species sampled from the Atlantic coast, revealing a total of 686 operational taxonomic units (OTUs) at 97% sequence similarity. Taxonomic assignment of 16S ribosomal RNA tag sequences estimated altogether 26 microbial groups, represented by bacterial (75.5%) and archaeal (22%) domains. Proteobacteria (43.4%) and Crenarchaeota (20.6%) were the most dominant microbial groups detected in all the 12 marine sponge species and ambient seawater. The Crenarchaeota microbes detected in three Atlantic Ocean sponges had a close similarity with Crenarchaeota from geographically separated subtidal Red Sea sponges. Our study showed that most of the microbial communities observed in sponges (73%) were also found in the surrounding ambient seawater suggesting possible environmental acquisition and/or horizontal transfer of microbes. Beyond the microbial diversity and community structure assessments (NMDS, ADONIS, ANOSIM), we explored the interactions between the microbial communities coexisting in sponges using the checkerboard score (C-score). Analyses of the microbial association pattern (co-occurrence) among intertidal sympatric sponges revealed the random association of microbes, favoring the hypothesis that the sponge-in-habiting microbes are recruited from the habitat mostly by chance or influenced by environmental factors to benefit the hosts.	[Alex, Anoop; Antunes, Agostinho] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, P-4050123 Porto, Portugal; [Alex, Anoop; Antunes, Agostinho] Univ Porto, Fac Sci, Dept Biol, P-4169007 Porto, Portugal	Universidade do Porto; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, Rua Bragas 177, P-4050123 Porto, Portugal.	aantunes@ciimar.up.pt		Alex, Anoop/0000-0001-5788-1089; Antunes, Agostinho/0000-0002-1328-1732	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/62356/2009, SFRH/BPD/99251/2013]; FCT [PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029), PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490), PEst-C/MAR/LA0015/2013]; European Regional Development Fund (ERDF) through COMPETE - Operational Competitiveness Program	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Fund (ERDF) through COMPETE - Operational Competitiveness Program	Anoop Alex was funded by the Fundacao para a Ciencia e a Tecnologia (FCT) (SFRH/BD/62356/2009 and SFRH/BPD/99251/2013 grants). Agostinho Antunes was funded in part by the FCT projects PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029), PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490) and partially supported by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Program and national funds through FCT under the project PEst-C/MAR/LA0015/2013.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; Alex A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080653; Alex A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051834; Anderson SA, 2010, FEMS MICROBIOL ECOL, V72, P328, DOI 10.1111/j.1574-6941.2010.00869.x; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; BLOCHL E, 1995, WORLD J MICROB BIOT, V11, P9, DOI 10.1007/BF00339133; Bruck WM, 2008, ISME J, V2, P335, DOI 10.1038/ismej.2007.91; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chanas B, 1997, J EXP MAR BIOL ECOL, V208, P185, DOI 10.1016/S0022-0981(96)02653-6; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Croue J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02583; de Caralt S, 2007, J MAR BIOL ASSOC UK, V87, P1693, DOI 10.1017/S0025315407056846; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DELONG EF, 1994, NATURE, V371, P695, DOI 10.1038/371695a0; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Ereskovsky AV, 2005, MAR BIOL, V146, P869, DOI 10.1007/s00227-004-1489-1; Erwin PM, 2012, FEMS MICROBIOL ECOL, V79, P619, DOI 10.1111/j.1574-6941.2011.01243.x; Fan L, 2013, ISME J, V7, P991, DOI 10.1038/ismej.2012.165; Fieseler L, 2004, APPL ENVIRON MICROB, V70, P3724, DOI 10.1128/aem.70.6.3724-3732.2004; Fuchs T, 1996, SYST APPL MICROBIOL, V18, P560; Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, ECOSIM NULL MODELS S; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88; Lee EY, 2003, BIOMOL ENG, V20, P299, DOI 10.1016/S1389-0344(03)00034-0; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lee OO, 2009, APPL ENVIRON MICROB, V75, P3513, DOI 10.1128/AEM.00002-09; Lemloh Marie-Louise, 2009, BMC Ecology, V9, P4, DOI 10.1186/1472-6785-9-4; Li ZY, 2006, J EXP MAR BIOL ECOL, V329, P75, DOI 10.1016/j.jembe.2005.08.014; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MCINERNEY JO, 1995, APPL ENVIRON MICROB, V61, P1646, DOI 10.1128/AEM.61.4.1646-1648.1995; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ren TT, 2013, ENVIRON MICROBIOL, V15, P535, DOI 10.1111/1462-2920.12000; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Soberon J, 2015, J BIOGEOGR, V42, P807, DOI 10.1111/jbi.12475; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005; Steindler L, 2002, SYMBIOSIS, V33, P263; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Taylor MW, 2007, ISME J, V1, P187, DOI 10.1038/ismej.2007.32; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkinson C.R., 1980, P157; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1978, MAR BIOL, V49, P161, DOI 10.1007/BF00387115; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Zhu P, 2008, MICROB ECOL, V55, P406, DOI 10.1007/s00248-007-9285-3	85	24	24	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127455	10.1371/journal.pone.0127455	http://dx.doi.org/10.1371/journal.pone.0127455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992625	Green Published, gold, Green Submitted			2022-12-27	WOS:000354921400119
J	Cohen, Y; Rubin, AE				Cohen, Yigal; Rubin, Avia E.			Daytime Solar Heating Controls Downy Mildew Peronospora belbahrii in Sweet Basil	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS; SPORANGIA; SURVIVAL; TABACINA; TEMPERATURE; PATHOGENS; SAGE	The biotrophic oomycete Peronospora belbahrii causes a devastating downy mildew disease in sweet basil. Due to the lack of resistant cultivars current control measures rely heavily on fungicides. However, resistance to fungicides and strict regulation on their deployment greatly restrict their use. Here we report on a 'green' method to control this disease. Growth chamber studies showed that P. belbahrii could hardly withstand exposure to high temperatures; exposure of spores, infected leaves, or infected plants to 35-45 degrees C for 6-9 hours suppressed its survival. Therefore, daytime solar heating was employed in the field to control the downy mildew disease it causes in basil. Covering growth houses of sweet basil already infected with downy mildew with transparent infra-red-impermeable, transparent polyethylene sheets raised the daily maximal temperature during sunny hours by 11-22 degrees C reaching 40-58 degrees C (greenhouse effect). Such coverage, applied for a few hours during 1-3 consecutive days, had a detrimental effect on the survival of P. belbahrii: killing the pathogen and/or suppressing disease progress while enhancing growth of the host basil plants.	[Cohen, Yigal; Rubin, Avia E.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel	Bar Ilan University	Cohen, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel.	yigal.cohen1@gmail.com			Plant Council Israel	Plant Council Israel	This work was supported by the Plant Council Israel.	BASHI E, 1983, PHYTOPATHOLOGY, V73, P1135, DOI 10.1094/Phyto-73-1135; Belbahri L, 2005, MYCOL RES, V109, P1276, DOI 10.1017/S0953756205003928; Bitton S, 2014, PLANT PROTECTION MAN; Cohen Y, 2013, PLANT DIS, V97, P692, DOI 10.1094/PDIS-12-12-1126-PDN; COHEN Y, 1974, CAN J BOT, V52, P447, DOI 10.1139/b74-058; Cohen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081282; Elad Y, 2014, ACTA HORTIC, V1015, P89; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; ROTEM J, 1970, PHYTOPATHOLOGY, V60, P54, DOI 10.1094/Phyto-60-54; ROTEM J, 1974, PHYTOPATHOLOGY, V64, P711, DOI 10.1094/Phyto-64-711; Sukanya SL, 2013, CROP PROT, V51, P14, DOI 10.1016/j.cropro.2013.03.015; Thines M, 2009, MYCOL RES, V113, P532, DOI 10.1016/j.mycres.2008.12.005; Wu BM, 2000, PHYTOPATHOLOGY, V90, P827, DOI 10.1094/PHYTO.2000.90.8.827	14	12	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126103	10.1371/journal.pone.0126103	http://dx.doi.org/10.1371/journal.pone.0126103			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992649	Green Published, Green Submitted, gold			2022-12-27	WOS:000354921400053
J	Leving, MT; Vegter, RJK; Hartog, J; Lamoth, CJC; de Groot, S; van der Woude, LHV				Leving, Marika T.; Vegter, Riemer J. K.; Hartog, Johanneke; Lamoth, Claudine J. C.; de Groot, Sonja; van der Woude, Lucas H. V.			Effects of Visual Feedback-Induced Variability on Motor Learning of Handrim Wheelchair Propulsion	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MECHANICAL EFFICIENCY; SHOULDER PAIN; USERS; REHABILITATION; PERFORMANCE; BIOFEEDBACK; STRATEGIES; TREADMILL; FORCE	Background It has been suggested that a higher intra-individual variability benefits the motor learning of wheelchair propulsion. The present study evaluated whether feedback-induced variability on wheelchair propulsion technique variables would also enhance the motor learning process. Learning was operationalized as an improvement in mechanical efficiency and propulsion technique, which are thought to be closely related during the learning process. Methods 17 Participants received visual feedback-based practice (feedback group) and 15 participants received regular practice (natural learning group). Both groups received equal practice dose of 80 min, over 3 weeks, at 0.24 W/kg at a treadmill speed of 1.11 m/s. To compare both groups the pre- and post-test were performed without feedback. The feedback group received real-time visual feedback on seven propulsion variables with instruction to manipulate the presented variable to achieve the highest possible variability (1st 4-min block) and optimize it in the prescribed direction (2nd 4-min block). To increase motor exploration the participants were unaware of the exact variable they received feedback on. Energy consumption and the propulsion technique variables with their respective coefficient of variation were calculated to evaluate the amount of intra-individual variability. Results The feedback group, which practiced with higher intra-individual variability, improved the propulsion technique between pre- and post-test to the same extent as the natural learning group. Mechanical efficiency improved between pre- and post-test in the natural learning group but remained unchanged in the feedback group. Conclusion These results suggest that feedback-induced variability inhibited the improvement in mechanical efficiency. Moreover, since both groups improved propulsion technique but only the natural learning group improved mechanical efficiency, it can be concluded that the improvement in mechanical efficiency and propulsion technique do not always appear simultaneously during the motor learning process. Their relationship is most likely modified by other factors such as the amount of the intra-individual variability.	[Leving, Marika T.; Vegter, Riemer J. K.; Hartog, Johanneke; Lamoth, Claudine J. C.; de Groot, Sonja; van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [de Groot, Sonja] Amsterdam Rehabil Res Ctr Reade, Amsterdam, Netherlands; [van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands	University of Groningen; University of Groningen	Vegter, RJK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	r.j.k.vegter@umcg.nl	van der Woude, Lucas H/E-7986-2018; JK, Vegter Riemer/N-3385-2013; Lamoth, Claudine JC/N-4325-2013	van der Woude, Lucas H/0000-0002-8472-334X; JK, Vegter Riemer/0000-0002-4294-6086; Lamoth, Claudine JC/0000-0002-6495-2823; de Groot, Sonja/0000-0001-8463-2563				Almasbakk B, 2001, BIOL CYBERN, V84, P75, DOI 10.1007/s004229900075; BAYLEY JC, 1987, J BONE JOINT SURG AM, V69A, P676, DOI 10.2106/00004623-198769050-00006; Brose SW, 2008, ARCH PHYS MED REHAB, V89, P2086, DOI 10.1016/j.apmr.2008.05.015; Croft L, 2013, EUR J PHYS REHAB MED, V49, P865; de Groot S, 2002, CLIN BIOMECH, V17, P219, DOI 10.1016/S0268-0033(02)00005-0; de Groot S, 2008, CLIN BIOMECH, V23, P434, DOI 10.1016/j.clinbiomech.2007.11.001; de Groot S, 2007, INT J SPORTS MED, V28, P880, DOI 10.1055/s-2007-964900; de Groot S, 2006, MED ENG PHYS, V28, P604, DOI 10.1016/j.medengphy.2005.09.004; de Groot S, 2005, ARCH PHYS MED REHAB, V86, P1452, DOI 10.1016/j.apmr.2004.11.025; de Groot S, 2003, AM J PHYS MED REHAB, V82, P504, DOI 10.1097/01.PHM.0000069941.77921.AA; de Groot S, 2002, MED SCI SPORT EXER, V34, P756, DOI 10.1097/00005768-200205000-00005; Degroot KK, 2009, DISABIL REHABIL-ASSI, V4, P86, DOI 10.1080/17483100802613685; Frank TD, 2008, BIOL CYBERN, V98, P19, DOI 10.1007/s00422-007-0193-x; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; Kilkens OJE, 2005, J REHABIL RES DEV, V42, P65, DOI 10.1682/JRRD.2004.08.0093; Kotajarvi BR, 2006, ARCH PHYS MED REHAB, V87, P510, DOI 10.1016/j.apmr.2005.12.033; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Mercer JL, 2006, CLIN BIOMECH, V21, P781, DOI 10.1016/j.clinbiomech.2006.04.010; Moon Y, 2013, CLIN BIOMECH, V28, P967, DOI 10.1016/j.clinbiomech.2013.10.004; PENTLAND WE, 1991, PARAPLEGIA, V29, P521, DOI 10.1038/sc.1991.75; Powers S.K., 2012, EXERCISE PHYSL THEOR, V8th; Ranganathan R, 2013, EXERC SPORT SCI REV, V41, P64, DOI 10.1097/JES.0b013e318259beb5; Ranganathan R, 2010, J MOTOR BEHAV, V42, P307, DOI 10.1080/00222895.2010.510542; Ranganathan R, 2009, J MOTOR BEHAV, V41, P317, DOI 10.3200/JMBR.41.4.317-330; Rice I, 2010, J SPINAL CORD MED, V33, P33, DOI 10.1080/10790268.2010.11689672; Rice IM, 2014, ARCH PHYS MED REHAB, V95, P699, DOI 10.1016/j.apmr.2013.11.005; Richter WM, 2011, ARCH PHYS MED REHAB, V92, P572, DOI 10.1016/j.apmr.2010.11.001; SPARROW WA, 1983, J MOTOR BEHAV, V15, P237; Sparrow WA, 1998, PSYCHON B REV, V5, P173, DOI 10.3758/BF03212943; SPARROW WA, 1987, J MOTOR BEHAV, V19, P240; VANDERWOUDE LHV, 1986, ERGONOMICS, V29, P1561, DOI 10.1080/00140138608967269; VEEGER D, 1989, Journal of Rehabilitation Research and Development, V26, P37; Vegter RJK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089729; Vegter RJK, 2014, IEEE T NEUR SYS REH, V22, P104, DOI 10.1109/TNSRE.2013.2280301; Vegter RJK, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-9; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; Ziegler MD, 2010, J NEUROSCI, V30, P10720, DOI 10.1523/JNEUROSCI.1938-10.2010	37	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127311	10.1371/journal.pone.0127311	http://dx.doi.org/10.1371/journal.pone.0127311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992626	Green Published, gold, Green Submitted			2022-12-27	WOS:000354921400105
J	Hougaard, A; Jensen, BH; Amin, FM; Rostrup, E; Hoffmann, MB; Ashina, M				Hougaard, Anders; Jensen, Bettina Hagstrom; Amin, Faisal Mohammad; Rostrup, Egill; Hoffmann, Michael B.; Ashina, Messoud			Cerebral Asymmetry of fMRI-BOLD Responses to Visual Stimulation	PLOS ONE			English	Article							PERCEPTUAL ASYMMETRIES; STATISTICAL-ANALYSIS; UNILATERAL NEGLECT; INFERIOR PARIETAL; HEMISPHERE STROKE; SPATIAL NEGLECT; ANATOMY; BISECTION; CORTEX; BRAIN	Hemispheric asymmetry of a wide range of functions is a hallmark of the human brain. The visual system has traditionally been thought of as symmetrically distributed in the brain, but a growing body of evidence has challenged this view. Some highly specific visual tasks have been shown to depend on hemispheric specialization. However, the possible lateralization of cerebral responses to a simple checkerboard visual stimulation has not been a focus of previous studies. To investigate this, we performed two sessions of blood-oxygenation level dependent (BOLD) functional magnetic resonance imaging (fMRI) in 54 healthy subjects during stimulation with a black and white checkerboard visual stimulus. While carefully excluding possible non-physiological causes of left-to-right bias, we compared the activation of the left and the right cerebral hemispheres and related this to grey matter volume, handedness, age, gender, ocular dominance, interocular difference in visual acuity, as well as line-bisection performance. We found a general lateralization of cerebral activation towards the right hemisphere of early visual cortical areas and areas of higher-level visual processing, involved in visuospatial attention, especially in top-down (i.e., goal-oriented) attentional processing. This right hemisphere lateralization was partly, but not completely, explained by an increased grey matter volume in the right hemisphere of the early visual areas. Difference in activation of the superior parietal lobule was correlated with subject age, suggesting a shift towards the left hemisphere with increasing age. Our findings suggest a right-hemispheric dominance of these areas, which could lend support to the generally observed leftward visual attentional bias and to the left hemifield advantage for some visual perception tasks.	[Hougaard, Anders; Jensen, Bettina Hagstrom; Amin, Faisal Mohammad; Ashina, Messoud] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Danish Headache Ctr, Glostrup, Denmark; [Hougaard, Anders; Jensen, Bettina Hagstrom; Amin, Faisal Mohammad; Ashina, Messoud] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Dept Neurol, Glostrup, Denmark; [Rostrup, Egill] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Funct Imaging Unit, Glostrup, Denmark; [Rostrup, Egill] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Dept Diagnost, Glostrup, Denmark; [Hoffmann, Michael B.] Univ Magdeburg, Ophthalm Dept, Visual Proc Lab, D-39106 Magdeburg, Germany	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Otto von Guericke University	Ashina, M (corresponding author), Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Danish Headache Ctr, Glostrup, Denmark.	ashina@dadlnet.dk	Rostrup, Egill/D-8622-2017; Hoffmann, Michael/E-9115-2010; Ashina, Messoud/AFU-1246-2022	Rostrup, Egill/0000-0001-5015-5244; Hoffmann, Michael/0000-0002-6452-9638; Ashina, Messoud/0000-0003-0951-5804; Amin, Faisal Mohammad/0000-0003-3803-3599	University of Copenhagen; Lundbeck Foundation Center for Neurovascular Signalling (LUCENS); Danish Council for Independent Research-Medical Sciences (FSS); Novo Nordisk Foundation; Research Foundation of the Capital Region of Denmark; Novo Nordisk Fonden [NNF11OC1014333] Funding Source: researchfish	University of Copenhagen; Lundbeck Foundation Center for Neurovascular Signalling (LUCENS)(Lundbeck Corporation); Danish Council for Independent Research-Medical Sciences (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Foundation of the Capital Region of Denmark; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by the University of Copenhagen, the Lundbeck Foundation Center for Neurovascular Signalling (LUCENS), the Danish Council for Independent Research-Medical Sciences (FSS), the Novo Nordisk Foundation and the Research Foundation of the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulhorn E, 1972, Ber Zusammenkunft Dtsch Ophthalmol Ges, V71, P487; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Baciu M, 2005, EUR J RADIOL, V55, P209, DOI 10.1016/j.ejrad.2004.11.004; Beis JM, 2004, NEUROLOGY, V63, P1600, DOI 10.1212/01.WNL.0000142967.60579.32; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Caminiti R, 1996, CEREB CORTEX, V6, P319, DOI 10.1093/cercor/6.3.319; Cavezian C, 2012, BRAIN RES, V1437, P89, DOI 10.1016/j.brainres.2011.12.002; Corballis PM, 2002, NEUROPSYCHOLOGIA, V40, P401, DOI 10.1016/S0028-3932(01)00100-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Culham JC, 2001, CURRENT OPINION NEUR; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hougaard A, 2015, CEPHALALGIA, V35, P3, DOI 10.1177/0333102414532378; Hougaard A, 2014, HUM BRAIN MAPP, V35, P2714, DOI 10.1002/hbm.22361; Hugdahl K., 2005, EUR REV, V13, P119, DOI DOI 10.1017/S1062798705000700; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Jonas J, 2014, HUM BRAIN MAPP, V35, P3360, DOI 10.1002/hbm.22407; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; LUH KE, 1994, BRAIN COGNITION, V25, P141, DOI 10.1006/brcg.1994.1028; Mattingley JB, 1998, NATURE, V392, P179, DOI 10.1038/32413; Mendola JD, 2007, NEUROSCI LETT, V414, P30, DOI 10.1016/j.neulet.2006.12.012; Miles WR, 1930, J GEN PSYCHOL; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Nicholls MER, 1999, NEUROPSYCHOLOGIA, V37, P307, DOI 10.1016/S0028-3932(98)00074-8; Oakes TR, 2007, NEUROIMAGE; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oshio R, 2010, NEUROIMAGE, V49, P1108, DOI 10.1016/j.neuroimage.2009.07.034; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Shapiro K, 2002, CURR BIOL, V12, P1320, DOI 10.1016/S0960-9822(02)01040-0; Singh-Curry V, 2009, NEUROPSYCHOLOGIA; Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Toosy AT, 2001, NEUROIMAGE, V14, P632, DOI 10.1006/nimg.2001.0851; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Verleger Rolf, 2009, J Cogn Neurosci, V21, P474, DOI 10.1162/jocn.2009.21038; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Watkins KE, 2001, CEREB CORTEX, V11, P868, DOI 10.1093/cercor/11.9.868; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1; Wolynski B, 2009, NEUROPSYCHOLOGIA, V47, P1313, DOI 10.1016/j.neuropsychologia.2009.01.027	43	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126477	10.1371/journal.pone.0126477	http://dx.doi.org/10.1371/journal.pone.0126477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985078	Green Submitted, gold, Green Published			2022-12-27	WOS:000354917300042
J	Lin, YC; Lu, PL; Lin, KH; Chu, PY; Wang, CF; Lin, JH; Liu, HF				Lin, Yung-Cheng; Lu, Po-Liang; Lin, Kuei-Hsiang; Chu, Pei-Yu; Wang, Chu-Feng; Lin, Jih-Hui; Liu, Hsin-Fu			Molecular Epidemiology and Phylogenetic Analysis of Human Adenovirus Caused an Outbreak in Taiwan during 2011	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; GENOME TYPES; RESPIRATORY-INFECTIONS; HOSPITALIZED CHILDREN; FATAL PNEUMONIA; SEROTYPE 7; SEQUENCES; DISEASE; TYPE-7; PERFORMANCE	An outbreak of adenovirus has been surveyed in Taiwan in 2011. To better understand the evolution and epidemiology of adenovirus in Taiwan, full-length sequence of hexon and fiber coapsid protein was analyzed using series of phylogenetic and dynamic evolution tools. Six different serotypes were identified in this outbreak and the species B was predominant (HAdV-3, 71.50%; HAdV-7, 15.46%). The most frequent diagnosis was acute tonsillitis (54.59%) and bronchitis (47.83%). Phylogenetic analysis revealed that hexon protein gene sequences were highly conserved for HAdV-3 and HAdV-7 circulation in Taiwan. However, comparison of restriction fragment length polymorphism (RFLP) analysis and phylogenetic trees of fiber gene in HAdV-7 clearly indicated that the predominant genotype in Taiwan has shifted from 7b to 7d. Several positive selection sites were observed in hexon protein. The estimated nucleotide substitution rates of hexon protein of HAdV-3 and HAdV-7 were 0.234x10(-3) substitutions/site/year (95% HPD: 0.387 similar to 0.095x10(-3)) and 1.107x10(-3) (95% HPD: 0.541 similar to 1.604) respectively; those of the fiber protein of HAdV-3 and HAdV-7 were 1.085x10(-3) (95% HPD: 1.767 similar to 0.486) and 0.132x10(-3) (95% HPD: 0.283 similar to 0.014) respectively. Phylodynamic analysis by Bayesian skyline plot (BSP) suggested that using individual gene to evaluate the effective population size might possibly cause miscalculation. In summary, the virus evolution is ongoing, and continuous surveillance of this virus evolution will contribute to the control of the epidemic.	[Lin, Yung-Cheng; Liu, Hsin-Fu] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Lin, Yung-Cheng; Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Kuei-Hsiang] Kaohsiung Med Univ, Dept Clin Lab, Kaohsiung, Taiwan; [Chu, Pei-Yu] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Wang, Chu-Feng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Lin, Jih-Hui] Ctr Res Diagnost & Vaccine Dev, Ctr Dis Control, Taipei, Taiwan; [Liu, Hsin-Fu] Natl Taipei Univ Nursing & Hlth Sci, Ctr Gen Educ, Taipei, Taiwan	National Taiwan Ocean University; Mackay Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Centers For Disease Control - Taiwan; National Taipei University of Nursing & Health Science (NTUNHS)	Lin, JH (corresponding author), Ctr Res Diagnost & Vaccine Dev, Ctr Dis Control, Taipei, Taiwan.	jeffy320@cdc.gov.tw; hsinfu@mmh.org.tw	Liu, Hsin-Fu/AAR-5960-2020; Lu, Po-Liang/D-4499-2009	Liu, Hsin-Fu/0000-0003-0082-2269; Lu, Po-Liang/0000-0002-7423-6783	Ministry of Science and Technology, Taiwan [102-2314-B-195-013-MY2]; Mackay Memorial Hospital, Taiwan [MMH-101113, MMH-10226]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital, Taiwan	This work was supported by the Ministry of Science and Technology, Taiwan (grant 102-2314-B-195-013-MY2) (http://www.most.gov.tw/mp.aspx?mp=7), Mackay Memorial Hospital, Taiwan (grant MMH-101113 and MMH-10226)(http://eng.mmh.org.tw/dnn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi K, 2011, JPN J INFECT DIS, V64, P353; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Azar R, 1998, J MED VIROL, V54, P291, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;291::AID-JMV9&gt;3.0.CO;2-#; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Biere B, 2010, J CLIN VIROL, V47, P366, DOI 10.1016/j.jcv.2010.01.005; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Cheng CC, 2008, EUR J PEDIATR, V167, P633, DOI 10.1007/s00431-007-0562-4; Choi EH, 2006, J MED VIROL, V78, P379, DOI 10.1002/jmv.20550; Choi EH, 2006, J CLIN VIROL, V35, P388, DOI 10.1016/j.jcv.2006.01.001; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ferreyra L J, 2015, Epidemiol Infect, V143, P1427, DOI 10.1017/S0950268814002192; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Houng HSH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-116; Ikeda Y, 2003, J MED VIROL, V69, P215, DOI 10.1002/jmv.10287; Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09; Kajon AE, 1996, VIROLOGY, V215, P190, DOI 10.1006/viro.1996.0022; Kolavic-Gray SA, 2002, CLIN INFECT DIS, V35, P808, DOI 10.1086/342573; Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451; Lee WJ, 2015, J MED VIROL, V87, P10, DOI 10.1002/jmv.23984; Li QG, 1996, J MED VIROL, V49, P170, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;170::AID-JMV3&gt;3.0.CO;2-1; Li QG, 1999, ARCH VIROL, V144, P1739, DOI 10.1007/s007050050701; Lin K H, 1986, Gaoxiong Yi Xue Ke Xue Za Zhi, V2, P774; Lin KH, 2004, J MED VIROL, V73, P274, DOI 10.1002/jmv.20087; Lin YC, 2010, ARCH VIROL, V155, P287, DOI 10.1007/s00705-009-0575-6; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Poon AFY, 2009, METHODS MOL BIOL, V537, P163, DOI 10.1007/978-1-59745-251-9_8; Rebelo-De-Andrade H, 2010, J CLIN MICROBIOL, V48, P1391, DOI 10.1128/JCM.02019-09; Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; SaitohInagawa W, 1996, J CLIN MICROBIOL, V34, P2113, DOI 10.1128/JCM.34.9.2113-2116.1996; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Tabain I, 2012, PEDIATR INFECT DIS J, V31, P680, DOI 10.1097/INF.0b013e318256605e; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang LY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-23; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; Tsou TP, 2012, EMERG INFECT DIS, V18, P1825, DOI 10.3201/eid1811.120629; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Xie L, 2012, J CLIN MICROBIOL, V50, P1879, DOI 10.1128/JCM.06523-11; Yamamoto D, 2014, JPN J INFECT DIS, V67, P105, DOI 10.7883/yoken.67.105; Yusof MA, 2012, EMERG INFECT DIS, V18, P852, DOI 10.3201/eid1805.110865	45	13	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127377	10.1371/journal.pone.0127377	http://dx.doi.org/10.1371/journal.pone.0127377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992619	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300118
J	Morabito, M; Crisci, A; Gioli, B; Gualtieri, G; Toscano, P; Di Stefano, V; Orlandini, S; Gensini, GF				Morabito, Marco; Crisci, Alfonso; Gioli, Beniamino; Gualtieri, Giovanni; Toscano, Piero; Di Stefano, Valentina; Orlandini, Simone; Gensini, Gian Franco			Urban-Hazard Risk Analysis: Mapping of Heat-Related Risks in the Elderly in Major Italian Cities	PLOS ONE			English	Article							LAND-SURFACE TEMPERATURE; HEALTH; MORTALITY; CLIMATE; VULNERABILITY; ISLAND	Background Short-term impacts of high temperatures on the elderly are well known. Even though Italy has the highest proportion of elderly citizens in Europe, there is a lack of information on spatial heat-related elderly risks. Objectives Development of high-resolution, heat-related urban risk maps regarding the elderly population (>= 65). Methods A long time-series (2001-2013) of remote sensing MODIS data, averaged over the summer period for eleven major Italian cities, were downscaled to obtain high spatial resolution (100 m) daytime and night-time land surface temperatures (LST). LST was estimated pixel-wise by applying two statistical model approaches: 1) the Linear Regression Model (LRM); 2) the Generalized Additive Model (GAM). Total and elderly population density data were extracted from the Joint Research Centre population grid (100 m) from the 2001 census (Eurostat source), and processed together using "Crichton's Risk Triangle" hazard-risk methodology for obtaining a Heat-related Elderly Risk Index (HERI). Results The GAM procedure allowed for improved daytime and night-time LST estimations compared to the LRM approach. High-resolution maps of daytime and night-time HERI levels were developed for inland and coastal cities. Urban areas with the hazardous HERI level (very high risk) were not necessarily characterized by the highest temperatures. The hazardous HERI level was generally localized to encompass the city-centre in inland cities and the inner area in coastal cities. The two most dangerous HERI levels were greater in the coastal rather than inland cities. Conclusions This study shows the great potential of combining geospatial technologies and spatial demographic characteristics within a simple and flexible framework in order to provide high-resolution urban mapping of daytime and night-time HERI. In this way, potential areas for intervention are immediately identified with up-to-street level details. This information could support public health operators and facilitate coordination for heat-related emergencies.	[Morabito, Marco; Crisci, Alfonso; Gioli, Beniamino; Gualtieri, Giovanni; Toscano, Piero] CNR, Inst Biometeorol, Florence, Italy; [Morabito, Marco; Orlandini, Simone; Gensini, Gian Franco] Univ Florence, Interdept Ctr Bioclimatol, Florence, Italy; [Di Stefano, Valentina] Fdn Clima & Sostenibilita, Florence, Italy; [Orlandini, Simone] Univ Florence, Dept Agrifood Prod & Environm Sci, Florence, Italy; [Gensini, Gian Franco] Univ Florence, Clin Medica & Cardiol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); University of Florence; University of Florence; University of Florence	Morabito, M (corresponding author), CNR, Inst Biometeorol, Florence, Italy.	marco.morabito@unifi.it	Gioli, Beniamino/A-1251-2009; Morabito, Marco/AAX-7261-2020; Crisci, Alfonso/AAX-3314-2020; orlandini, simone/L-7880-2015	Gioli, Beniamino/0000-0001-7631-2623; Morabito, Marco/0000-0002-8799-4866; Gualtieri, Giovanni/0000-0002-5293-2315; Toscano, Piero/0000-0001-9184-0707; Crisci, Alfonso/0000-0002-5495-6695; orlandini, simone/0000-0001-6290-9752	Regional MeteoSalute Project, Regional Health System of Tuscany; Smart HealthyENV Project "Smart Monitoring Integrated System for a Healthy Urban ENVironment in Smart Cities", POR CReO FESR	Regional MeteoSalute Project, Regional Health System of Tuscany; Smart HealthyENV Project "Smart Monitoring Integrated System for a Healthy Urban ENVironment in Smart Cities", POR CReO FESR	This study was supported and funded by the Regional MeteoSalute Project, Regional Health System of Tuscany and the Smart HealthyENV Project "Smart Monitoring Integrated System for a Healthy Urban ENVironment in Smart Cities", POR CReO FESR 2007/2013.	Anniballe R, 2014, REMOTE SENS ENVIRON, V150, P163, DOI 10.1016/j.rse.2014.05.005; [Anonymous], 2018, WORLD POPULATION DAY; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Buscail C, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-38; Collins TW, 2009, APPL GEOGR, V29, P448, DOI 10.1016/j.apgeog.2008.10.005; Crichton D., 1999, NATURAL DISASTER MAN, P102; Di Gregorio A, 1996, FED GEOGR DAT COMM M; Gallego FJ, 2010, POPUL ENVIRON, V31, P460, DOI 10.1007/s11111-010-0108-y; Goggins WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038551; Gronlund CJ, 2014, ENVIRON HEALTH PERSP, V122, P1187, DOI 10.1289/ehp.1206132; Hajat S, 2010, J EPIDEMIOL COMMUN H, V64, P753, DOI 10.1136/jech.2009.087999; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Karnieli A, 2010, J CLIMATE, V23, P618, DOI 10.1175/2009JCLI2900.1; Kestens Y, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-7; Lindley SJ, 2006, J RISK RES, V9, P543, DOI 10.1080/13669870600798020; Lindley SJ, 2007, BUILT ENV, V33, P46, DOI DOI 10.2148/BENV.33.1.46; McCarthy MP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042845; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Morabito M, 2012, SCI TOTAL ENVIRON, V441, P28, DOI 10.1016/j.scitotenv.2012.09.056; Morabito M, 2012, INT J BIOMETEOROL, V56, P801, DOI 10.1007/s00484-011-0481-y; Nichol J, 2005, PHOTOGRAMM ENG REM S, V71, P613, DOI 10.14358/PERS.71.5.613; Ozelkan E, 2014, EUR J REMOTE SENS, V47, P655, DOI 10.5721/EuJRS20144737; Peng SS, 2012, ENVIRON SCI TECHNOL, V46, P696, DOI 10.1021/es2030438; Reid CE, 2009, ENVIRON HEALTH PERSP, V117, P1730, DOI 10.1289/ehp.0900683; Rikkert MGMO, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2663; Schifano P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-58; Sun DL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031485; Tan JG, 2008, INT J EPIDEMIOL, V37, P318, DOI 10.1093/ije/dyn023; Tomlinson CJ, 2011, METEOROL APPL, V18, P296, DOI 10.1002/met.287; Tomlinson CJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-42; United Nations (UN) Department of Economic and Social Affairs Population Division, 2014, STESASERA352 UN DEP; White-Newsome JL, 2013, ENVIRON HEALTH PERSP, V121, P925, DOI 10.1289/ehp.1206176; Wilhelmi O.V., 2004, NAT HAZARDS REV, V5, P147, DOI [10.1061/(ASCE)1527-6988(2004)5:3(147)., DOI 10.1061/(ASCE)1527-6988(2004)5:3(147)]; Williams S, 2012, SCI TOTAL ENVIRON, V414, P126, DOI 10.1016/j.scitotenv.2011.11.038; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]; Yue W, 2007, INT J REMOTE SENS, V28, P3205, DOI 10.1080/01431160500306906; Zhao L, 2014, NATURE, V511, P216, DOI 10.1038/nature13462	37	47	47	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127277	10.1371/journal.pone.0127277	http://dx.doi.org/10.1371/journal.pone.0127277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985204	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300108
J	Bastiaansen, JA; Cummins, TDR; Riese, H; van Roon, AM; Nolte, IM; Oldehinkel, AJ; Bellgrove, MA				Bastiaansen, Jojanneke A.; Cummins, Tarrant D. R.; Riese, Harriette; van Roon, Arie M.; Nolte, Ilja M.; Oldehinkel, Albertine J.; Bellgrove, Mark A.			A Population Based Study of the Genetic Association between Catecholamine Gene Variants and Spontaneous Low-Frequency Fluctuations in Reaction Time	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; O-METHYLTRANSFERASE COMT; DEFICIT HYPERACTIVITY DISORDER; INDIVIDUAL-LIVES SURVEY; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; RESPONSE VARIABILITY; SUSTAINED ATTENTION; PREFRONTAL CORTEX; HUMAN BRAIN	The catecholamines dopamine and noradrenaline have been implicated in spontaneous low-frequency fluctuations in reaction time, which are associated with attention deficit hyperactivity disorder (ADHD) and subclinical attentional problems. The molecular genetic substrates of these behavioral phenotypes, which reflect frequency ranges of intrinsic neuronal oscillations (Slow-4: 0.027-0.073 Hz; Slow-5: 0.010-0.027 Hz), have not yet been investigated. In this study, we performed regression analyses with an additive model to examine associations between low-frequency fluctuations in reaction time during a sustained attention task and genetic markers across 23 autosomal catecholamine genes in a large young adult population cohort (n = 964), which yielded greater than 80% power to detect a small effect size (f(2) = 0.02) and 100% power to detect a small/medium effect size (f(2) = 0.15). At significance levels corrected for multiple comparisons, none of the gene variants were associated with the magnitude of low-frequency fluctuations. Given the study's strong statistical power and dense coverage of the catecholamine genes, this either indicates that associations between low-frequency fluctuation measures and catecholamine gene variants are absent or that they are of very small effect size. Nominally significant associations were observed between variations in the alpha-2A adrenergic receptor gene (ADRA2A) and the Slow-5 band. This is in line with previous reports of an association between ADRA2A gene variants and general reaction time variability during response selection tasks, but the specific association of these gene variants and low-frequency fluctuations requires further confirmation. Pharmacological challenge studies could in the future provide convergent evidence for the noradrenergic modulation of both general and time sensitive measures of intra-individual variability in reaction time.	[Bastiaansen, Jojanneke A.; Riese, Harriette; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Cummins, Tarrant D. R.; Bellgrove, Mark A.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Riese, Harriette; Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Roon, Arie M.] Univ Groningen, Univ Med Ctr Groningen, Dept Vasc Med, NL-9713 AV Groningen, Netherlands	University of Groningen; Monash University; University of Groningen; University of Groningen	Bastiaansen, JA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	j.bastiaansen@umcg.nl	Bellgrove, Mark/AAB-3114-2019; Riese, Harriëtte/E-7234-2012; Cummins, Tarrant/I-3086-2014; Bastiaansen, Jojanneke/F-4849-2013	Riese, Harriëtte/0000-0003-3661-3151; Cummins, Tarrant/0000-0003-2324-3366; Bastiaansen, Jojanneke/0000-0003-4831-6402; Bellgrove, Mark/0000-0003-0186-8349	Netherlands Organization for Scientific Research NWO (Medical Research Council) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant) [100-001-004]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behaviour and Dependence) [60-60600-97-118]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health) [261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council) [GB-MaGW 480-01-006, GB-MaGW 480-07-001, GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO [175.010.2003.005]; Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding) [481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; Accare Center for Child and Adolescent Psychiatry; VICI grant from the Netherlands Organization for Scientific Research [NWO Vici 016.001/002]; Australian Research Council (ARC)	Netherlands Organization for Scientific Research NWO (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behaviour and Dependence); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health); Netherlands Organization for Scientific Research NWO (Social Sciences Council)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Justice (WODC); European Science Foundation(European Science Foundation (ESF)European Commission); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; Accare Center for Child and Adolescent Psychiatry; VICI grant from the Netherlands Organization for Scientific Research; Australian Research Council (ARC)(Australian Research Council)	This research is part of the TRacking Adolescents' Individual Lives Survey (TRAILS). Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behaviour and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), the participating universities, and Accare Center for Child and Adolescent Psychiatry. AJO is supported by a VICI grant from the Netherlands Organization for Scientific Research (NWO Vici 016.001/002). MAB is supported by a Future Fellowship from the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Bastiaansen JA, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.03.005; Bellgrove MA, 2006, CORTEX, V42, P838, DOI 10.1016/S0010-9452(08)70426-X; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cummins TDR, 2014, MOL PSYCHIATR, V19, P1031, DOI 10.1038/mp.2013.140; Cummins TDR, 2012, MOL PSYCHIATR, V17, P1086, DOI 10.1038/mp.2011.104; Dang LC, 2012, J NEUROSCI, V32, P9582, DOI 10.1523/JNEUROSCI.0909-12.2012; de Sonneville LMJ, 1999, COMP PSYCH, V6, P187; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; DESONNEVILLE LMJ, 1994, J CLIN EXP NEUROPSYC, V16, P877, DOI 10.1080/01688639408402700; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; Dietrich A, 2006, J HYPERTENS, V24, P345, DOI 10.1097/01.hjh.0000200517.27356.47; Epstein JN, 2011, NEUROPSYCHOPHARMACOL, V36, P1060, DOI 10.1038/npp.2010.243; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Goldman David, 2009, Biol Psychiatry, V65, pe1, DOI 10.1016/j.biopsych.2008.07.032; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; Johnson KA, 2008, NEUROPSYCHOLOGIA, V46, P1532, DOI 10.1016/j.neuropsychologia.2008.01.002; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; Karalunas SL, 2013, J CHILD PSYCHOL PSYC, V54, P536, DOI 10.1111/jcpp.12028; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Konrad K, 2004, J AM ACAD CHILD PSY, V43, P191, DOI 10.1097/00004583-200402000-00015; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Liddle EB, 2011, J CHILD PSYCHOL PSYC, V52, P761, DOI 10.1111/j.1469-7610.2010.02333.x; Liu B, 2010, J NEUROSCI, V30, P64, DOI 10.1523/JNEUROSCI.3941-09.2010; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Marchetta NDJ, 2008, J ATTEN DISORD, V11, P664, DOI 10.1177/1087054707305108; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nandam LS, 2011, BIOL PSYCHIAT, V69, P902, DOI 10.1016/j.biopsych.2010.11.014; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Nolte IM, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P423, DOI 10.1007/978-0-387-09488-5_29; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Sambataro F, 2009, BIOL PSYCHIAT, V66, P540, DOI 10.1016/j.biopsych.2009.04.014; Smith A, 1996, NATURE, V380, P291, DOI 10.1038/380291a0; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Tomasi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006102; Tunbridge EM, 2013, NEUROIMAGE, V68, P49, DOI 10.1016/j.neuroimage.2012.11.059; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; Yordanova J, 2011, BRAIN, V134, P1740, DOI 10.1093/brain/awr107; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	53	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126461	10.1371/journal.pone.0126461	http://dx.doi.org/10.1371/journal.pone.0126461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978426	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100070
J	Feng, XM; Maze, M; Koch, LG; Britton, SL; Hellman, J				Feng, Xiaomei; Maze, Mervyn; Koch, Lauren G.; Britton, Steven L.; Hellman, Judith			Exaggerated Acute Lung Injury and Impaired Antibacterial Defenses During Staphylococcus aureus Infection in Rats with the Metabolic Syndrome	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; BLOOD-STREAM INFECTIONS; RISK-FACTORS; SEVERE SEPSIS; ARTIFICIAL SELECTION; SEPTIC SHOCK; ACUTE-INFLAMMATION; MEDICAL PROGRESS; MORTALITY; OUTCOMES	Rats with Metabolic Syndrome (MetaS) have a dysregulated immune response to the aseptic trauma of surgery. We hypothesized that rats with MetaS would have dysregulated inflammation, increased lung injury, and less effective antibacterial defenses during Staphylococcus (S.) aureus sepsis as compared to rats without MetaS. Low capacity runner (LCR; a model of MetaS) and high capacity runner (HCR) rats were challenged intravenously with S. aureus bacteria. After 48 h, inflammatory mediators and bacteria were quantified in the blood, bronchoalveolar lavage fluid (BALF), and lung homogenates. Lungs were analyzed histologically. BALF protein and lung wet-dry ratios were quantified to assess for vascular leak. Endpoints were compared in infected LCR vs HCR rats. LCR rats had higher blood and lung S. aureus counts, as well as higher levels of IL-6 in plasma, lungs and BALF, MIP-2 in plasma and lung, and IL-17A in lungs. Conversely, LCR rats had lower levels of IL-10 in plasma and lungs. Although lactate levels, and liver and renal function tests were similar between groups, LCR rats had higher BALF protein and lung wet-dry ratios, and more pronounced acute lung injury histologically. During S. aureus bacteremia, as compared with HCR rats, LCR (MetaS) rats have heightened pro-inflammatory responses, accompanied by increased acute lung injury and vascular leak. Notably, despite an augmented pro-inflammatory phenotype, LCR rats have higher bacterial levels in their blood and lungs. The MetaS state may exacerbate lung injury and vascular leak by attenuating the inflammation-resolving response, and by weakening antimicrobial defenses.	[Feng, Xiaomei; Maze, Mervyn; Hellman, Judith] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Feng, Xiaomei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Koch, Lauren G.; Britton, Steven L.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI USA	University of California System; University of California San Francisco; Shanghai Jiao Tong University; University of Michigan System; University of Michigan	Maze, M (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	mervyn.maze@ucsf.edu			National Institutes of Health [R01 GM104194]; NIH [R24 OD010950, R01 DK077200]; San Francisco Foundation; Department of Anesthesia and Perioperative Care, University of California, San Francisco; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK077200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104194] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); San Francisco Foundation(American Cancer Society); Department of Anesthesia and Perioperative Care, University of California, San Francisco; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Institutes of Health (R01 GM104194) to MM. The LCR-HCR rat model system was supported by NIH grants to LK (R24 OD010950) and to SB (R24 OD010950 and R01 DK077200). Additional funding was provided by the San Francisco Foundation and the Department of Anesthesia and Perioperative Care, University of California, San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Biron A, 2012, AIDS RES HUM RETROV, V28, P1672, DOI [10.1089/aid.2012.0048, 10.1089/AID.2012.0048]; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chen S, 2009, CLIN ORTHOP RELAT R, V467, P1670, DOI 10.1007/s11999-009-0740-y; Cheng XQ, 2012, INFLAMMATION, V35, P1715, DOI 10.1007/s10753-012-9489-7; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; Das DK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-348; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Edwards KL, 2008, OBESITY, V16, P1596, DOI 10.1038/oby.2008.236; Elgalib A, 2011, CURR MED RES OPIN, V27, P63, DOI 10.1185/03007995.2010.537212; Everhart JS, 2013, CLIN ORTHOP RELAT R, V471, P3112, DOI 10.1007/s11999-013-2923-9; Fang A, 2005, SPINE, V30, P1460, DOI 10.1097/01.brs.0000166532.58227.4f; Feng XM, 2013, ANESTHESIOLOGY, V118, P1098, DOI 10.1097/ALN.0b013e318286d0c9; Fitch K, 2012, AIDS, V26, P587, DOI 10.1097/QAD.0b013e32834f33cc; Fullerton JN, 2014, TRENDS IMMUNOL, V35, P12, DOI 10.1016/j.it.2013.10.008; Hogue CW, 2009, INTENS CARE MED, V35, P1152, DOI 10.1007/s00134-009-1424-5; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hoyert D. L., 2008, NATL VITAL STAT REP, V56, P1; Hudetz JA, 2011, J ANESTH, V25, P337, DOI 10.1007/s00540-011-1137-0; Hudetz JA, 2011, J CARDIOTHOR VASC AN, V25, P282, DOI 10.1053/j.jvca.2010.06.008; Huttunen R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-13; Joy T, 2008, CURR DIABETES REP, V8, P141, DOI 10.1007/s11892-008-0025-y; Kajimoto K, 2009, J THORAC CARDIOV SUR, V137, P658, DOI 10.1016/j.jtcvs.2008.11.043; Kao CH, 2011, J MICROBIOL IMMUNOL, V44, P215, DOI 10.1016/j.jmii.2011.01.023; Kaye KS, 2011, J AM GERIATR SOC, V59, P622, DOI 10.1111/j.1532-5415.2010.03289.x; Kivela R, 2010, FASEB J, V24, P4565, DOI 10.1096/fj.10-157313; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Konrad FM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/740987; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Liu LJ, 2014, AM J CARDIOL, V113, P84, DOI 10.1016/j.amjcard.2013.08.042; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luzzaro F, 2011, DIAGN MICR INFEC DIS, V69, P363, DOI 10.1016/j.diagmicrobio.2010.10.016; Naber CK, 2009, CLIN INFECT DIS, V48, pS231, DOI 10.1086/598189; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Oliveros H, 2008, OBESITY, V16, P515, DOI 10.1038/oby.2007.102; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Prescott HC, 2014, CRIT CARE MED, V42, P1766, DOI 10.1097/CCM.0000000000000336; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Ren YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077588; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Schimmel JJP, 2010, EUR SPINE J, V19, P1711, DOI 10.1007/s00586-010-1421-y; Schreiber MP, 2011, J CRIT CARE, V26, P395, DOI 10.1016/j.jcrc.2010.09.002; Serdar ZA, 2011, CUTAN OCUL TOXICOL, V30, P221, DOI 10.3109/15569527.2011.554482; Simons LA, 2011, HEART LUNG CIRC, V20, P214, DOI 10.1016/j.hlc.2010.12.005; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Su X, 2012, MOL MED, V18, P1481, DOI 10.2119/molmed.2012.00351; Tadros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075171; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; Uslan DZ, 2007, ARCH INTERN MED, V167, P834, DOI 10.1001/archinte.167.8.834; Walker J, 2011, SHOCK, V36, P410, DOI 10.1097/SHK.0b013e31822798c1; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177	62	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126906	10.1371/journal.pone.0126906	http://dx.doi.org/10.1371/journal.pone.0126906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978669	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100113
J	Haist, K; Ziegler, C; Botten, J				Haist, Kelsey; Ziegler, Christopher; Botten, Jason			Strand-Specific Quantitative Reverse Transcription-Polymerase Chain Reaction Assay for Measurement of Arenavirus Genomic and Antigenomic RNAs	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HEPATITIS-C VIRUS; IN-SITU HYBRIDIZATION; DEFORMED-WING VIRUS; RT-PCR; LOW-LEVEL; S RNA; REPLICATION; CELLS; SEQUENCE	Arenaviruses are bi-segmented, single-stranded RNA viruses that cause significant human disease. The manner in which they regulate the replication of their genome is not well-understood. This is partly due to the absence of a highly sensitive assay to measure individual species of arenavirus replicative RNAs. To overcome this obstacle, we designed a quantitative reverse transcription (RT)-PCR assay for selective quantitation of each of the lymphocytic choriomeningitis virus (LCMV) genomic or antigenomic RNAs. During the course of assay design, we identified a nonspecific priming phenomenon whereby, in the absence of an RT primer, cDNAs complementary to each of the LCMV replicative RNA species are generated during RT. We successfully circumvented this nonspecific priming event through the use of biotinylated primers in the RT reaction, which permitted affinity purification of primer-specific cDNAs using streptavidin-coated magnetic beads. As proof of principle, we used the assay to map the dynamics of LCMV replication at acute and persistent time points and to determine the quantities of genomic and antigenomic RNAs that are incorporated into LCMV particles. This assay can be adapted to measure total S or L segment-derived viral RNAs and therefore represents a highly sensitive diagnostic platform to screen for LCMV infection in rodent and human tissue samples and can also be used to quantify viruscell attachment.	[Haist, Kelsey; Botten, Jason] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Haist, Kelsey; Ziegler, Christopher; Botten, Jason] Univ Vermont, Dept Med, Div Immunobiol, Burlington, VT USA	University of Vermont; University of Vermont	Botten, J (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	jbotten@uvm.edu			NIH [AI065359, P20RR021905, F32 AI056827, 1R21AI88059-1A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, T32AI055402, R21AI088059, F32AI056827] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge NIH grants AI065359, P20RR021905, F32 AI056827, and 1R21AI88059-1A1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton LL, 2002, AM J OBSTET GYNECOL, V187, P1715, DOI 10.1067/mob.2002.126297; Bessaud M, 2008, J VIROL METHODS, V153, P182, DOI 10.1016/j.jviromet.2008.07.010; Besselsen DG, 2003, COMPARATIVE MED, V53, P65; Boncristiani HF, 2009, J VIROL METHODS, V161, P147, DOI 10.1016/j.jviromet.2009.06.006; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Botten J, 2007, J VIROL, V81, P2307, DOI 10.1128/JVI.02063-06; Bowen MD, 1997, MOL PHYLOGENET EVOL, V8, P301, DOI 10.1006/mpev.1997.0436; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; BUCHMEIER MJ, 1999, LYMPHOCYTIC CHORIOME; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; BURNS JW, 1991, VIROLOGY, V183, P620, DOI 10.1016/0042-6822(91)90991-J; CHAVES RL, 1994, NUCLEIC ACIDS RES, V22, P1919, DOI 10.1093/nar/22.10.1919; Childs J.E., 1993, ARENAVIRIDAE, P331, DOI DOI 10.1007/978-1-4615-3028-2_19; Cordey S, 2011, J VIROL METHODS, V177, P118, DOI 10.1016/j.jviromet.2011.06.018; Craggs JK, 2001, J VIROL METHODS, V94, P111, DOI 10.1016/S0166-0934(01)00281-6; Emonet S, 2007, EMERG INFECT DIS, V13, P472, DOI 10.3201/eid1303.061141; Escaffre O, 2010, J VIROL METHODS, V170, P1, DOI 10.1016/j.jviromet.2010.07.009; EVANS CF, 1994, J VIROL, V68, P7367, DOI 10.1128/JVI.68.11.7367-7373.1994; FAZAKERLEY JK, 1991, J GEN VIROL, V72, P1611, DOI 10.1099/0022-1317-72-7-1611; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670; FRANCIS SJ, 1988, J VIROL, V62, P1251, DOI 10.1128/JVI.62.4.1251-1257.1988; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Horsington J, 2007, J VIROL METHODS, V144, P149, DOI 10.1016/j.jviromet.2007.05.002; Hosking MP, 2013, J IMMUNOL, V191, P4211, DOI 10.4049/jimmunol.1300920; HOTCHIN J, 1973, NATURE-NEW BIOL, V241, P270, DOI 10.1038/newbio241270a0; HOTCHIN J, 1974, PROG MED VIROL, V18, P81; JOHNSON KM, 1964, P SOC EXP BIOL MED, V118, P113; Kaiser P, 2006, J INFECT DIS, V194, P1713, DOI 10.1086/508431; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Klaus JP, 2013, CELL HOST MICROBE, V14, P522, DOI 10.1016/j.chom.2013.10.010; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; Lehmann- Grube F, 1971, VIROLOGY MONOGRAPHS; Lin L, 2002, J VIROL METHODS, V100, P97, DOI 10.1016/S0166-0934(01)00399-8; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Mellor J, 1998, J GEN VIROL, V79, P705, DOI 10.1099/0022-1317-79-4-705; Meyer BJ, 2002, CURR TOP MICROBIOL, V262, P139; MEYER BJ, 1994, J VIROL, V68, P7659, DOI 10.1128/JVI.68.11.7659-7664.1994; Meyer BJ, 1997, J VIROL, V71, P6757, DOI 10.1128/JVI.71.9.6757-6764.1997; MEYER BJ, 1993, J VIROL, V67, P2621, DOI 10.1128/JVI.67.5.2621-2627.1993; Neuman BW, 2005, J VIROL, V79, P3822, DOI 10.1128/JVI.79.6.3822-3830.2005; OLDSTONE MBA, 1982, NATURE, V300, P360, DOI 10.1038/300360a0; Park JY, 1997, J MED VIROL, V51, P107, DOI 10.1002/(SICI)1096-9071(199702)51:2&lt;107::AID-JMV4&gt;3.0.CO;2-B; Parodi AS, 1958, DIA MED, V30, P62; Peyrefitte CN, 2003, J VIROL METHODS, V113, P19, DOI 10.1016/S0166-0934(03)00218-0; Purcell MK, 2006, J VIROL METHODS, V132, P18, DOI 10.1016/j.jviromet.2005.08.017; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; Roberts TJ, 2004, J IMMUNOL, V172, P3454, DOI 10.4049/jimmunol.172.6.3454; ROMANOWSKI V, 1985, VIRUS RES, V3, P101, DOI 10.1016/0168-1702(85)90001-2; SALAS R, 1991, LANCET, V338, P1033, DOI 10.1016/0140-6736(91)91899-6; Salazar-Bravo J, 2002, CURR TOP MICROBIOL, V262, P25; SALVATO MS, 1992, VIRUS RES, V22, P185, DOI 10.1016/0168-1702(92)90050-J; SALVATO MS, 1989, VIROLOGY, V173, P1, DOI 10.1016/0042-6822(89)90216-X; Sanchez AB, 2006, VIROLOGY, V350, P370, DOI 10.1016/j.virol.2006.01.012; SOUTHERN PJ, 1987, VIROLOGY, V157, P145, DOI 10.1016/0042-6822(87)90323-0; SOUTHERN PJ, 1984, NATURE, V312, P555, DOI 10.1038/312555a0; WEBER C, 1983, ARCH VIROL, V77, P271, DOI 10.1007/BF01309275; WELSH RM, 1979, VIROLOGY, V96, P503, DOI 10.1016/0042-6822(79)90107-7; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	59	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0120043	10.1371/journal.pone.0120043	http://dx.doi.org/10.1371/journal.pone.0120043			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978311	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100004
J	Jin, PF; Chen, YB; Lv, LX; Yang, JZ; Lu, HF; Li, LJ				Jin, Pengfeng; Chen, Yunbo; Lv, Longxian; Yang, Jianzhuan; Lu, Haifeng; Li, Lanjuan			Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-alpha Expression and Liver Injury via an IL-10-and PGE(2)-EP4-Dependent Mechanism	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED RECEPTOR-GAMMA; BACTERIAL TRANSLOCATION; KUPFFER CELLS; INTESTINAL EPITHELIUM; DAMAGE; COX-2; BIFIDOBACTERIUM; INTERLEUKIN-10; INFLAMMATION	Lipopolysaccharide (LPS) has essential role in the pathogenesis of D-galactosamine-sensitized animal models and alcoholic liver diseases of humans, by stimulating release of pro-inflammatory mediators that cause hepatic damage and intestinal barrier impairment. Oral pretreatment of probiotics has been shown to attenuate LPS-induced hepatic injury, but it is unclear whether the effect is direct or due to improvement in the intestinal barrier. The present study tested the hypothesis that pretreatment with probiotics enables the liver to withstand directly LPS-induced hepatic injury and inflammation. In a mouse model of LPS-induced hepatic injury, the levels of hepatic tumor necrosis factor-alpha (TNF-alpha) and serum alanine aminotransferase (ALT) of mice with depleted intestinal commensal bacteria were not significantly different from that of the control models. Pre-feeding mice for 10 days with Lactobacillus fermentum ZYL0401 (LF41), significantly alleviated LPS-induced hepatic TNF-alpha expression and liver damage. After LF41 pretreatment, mice had dramatically more L. fermentum-specific DNA in the ileum, significantly higher levels of ileal cyclooxygenase (COX)-2 and interleukin 10 (IL-10) and hepatic prostaglandin E2 (PGE(2)). However, hepatic COX-1, COX-2, and IL-10 protein levels were not changed after the pretreatment. There were also higher hepatic IL-10 protein levels after LPS challenge in LF41-pretreaed mice than in the control mice. Attenuation of hepatic TNF-alpha was mediated via the PGE(2)/E prostanoid 4 (EP4) pathway, and serum ALT levels were attenuated in an IL-10-dependent manner. A COX-2 blockade abolished the increase in hepatic PGE(2) and IL-10 associated with LF41. In LF41-pretreated mice, a blockade of IL-10 caused COX-2-dependent promotion of hepatic PGE(2), without affecting hepatic COX-2levels. In LF41-pretreatedmice, COX2 prevented enhancing TNF-alpha expression in both hepatic mononuclear cells and the ileum, and averted TNF-alpha-mediated increase in intestinal permeability. Together, we demonstrated that LF41 pre-feeding enabled the liver to alleviate LPS-induced hepatic TNF-alpha expression and injury via a PGE(2)-EP4-and IL-10-dependent mechanism.	[Jin, Pengfeng; Chen, Yunbo; Lv, Longxian; Yang, Jianzhuan; Lu, Haifeng; Li, Lanjuan] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Pengfeng; Chen, Yunbo; Lv, Longxian; Yang, Jianzhuan; Lu, Haifeng; Li, Lanjuan] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Li, LJ (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			National Basic Research Program of China [2013CB531401]; National Natural Science Foundation of China [81330011]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (No. 2013CB531401)(973 program; http://www.973.gov.cn/English/Index.aspx) and the key Program of the National Natural Science Foundation of China (No. 81330011) (http://www.nsfc.gov.cn/). LJ Li receives these two fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adawi D, 2001, INT J FOOD MICROBIOL, V70, P213, DOI 10.1016/S0168-1605(01)00550-5; Adawi D, 1997, HEPATOLOGY, V25, P642, DOI 10.1002/hep.510250325; Brandt K, 2003, INT J FOOD MICROBIOL, V84, P189, DOI 10.1016/S0168-1605(02)00419-1; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Ciorba MA, 2012, GUT, V61, P829, DOI 10.1136/gutjnl-2011-300367; Enomoto N, 2000, J GASTROEN HEPATOL, V15, pD20; Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, P1360, DOI 10.1111/j.1530-0277.2001.tb02359.x; Ewaschuk J, 2007, HEPATOLOGY, V46, P841, DOI 10.1002/hep.21750; Fennekohl A, 2002, J HEPATOL, V36, P328, DOI 10.1016/S0168-8278(01)00277-X; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Fukui H, 2005, ALCOHOL CLIN EXP RES, V29, p172S, DOI 10.1097/01.alc.0000189278.30237.e9; Guarner F, 1998, INT J FOOD MICROBIOL, V39, P237, DOI 10.1016/S0168-1605(97)00136-0; Hartmann P, 2012, GASTROENTEROLOGY, V143, P1330, DOI 10.1053/j.gastro.2012.07.099; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Jobin C, 1998, IMMUNOLOGY, V95, P537; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kasravi FB, 1996, HEPATOLOGY, V23, P97, DOI 10.1053/jhep.1996.v23.pm0008550055; Khailova L, 2010, AM J PHYSIOL-GASTR L, V299, pG1118, DOI 10.1152/ajpgi.00131.2010; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; Kudo H, 2009, J HEPATOL, V51, P168, DOI 10.1016/j.jhep.2009.02.032; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Li YT, 2010, J TRAUMA, V68, P76, DOI 10.1097/TA.0b013e31818ba467; Loguercio C, 2005, J CLIN GASTROENTEROL, V39, P540, DOI 10.1097/01.mcg.0000165671.25272.0f; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Napolitano LM, 1996, SHOCK, V5, P202, DOI 10.1097/00024382-199603000-00006; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Otte JM, 2009, NUTR CANCER, V61, P103, DOI 10.1080/01635580802372625; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; STRASSMANN G, 1994, J EXP MED, V180, P2365, DOI 10.1084/jem.180.6.2365; Trifan OC, 2002, CANCER RES, V62, P5778; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971; Uchimura K, 2001, HEPATOLOGY, V33, P91, DOI 10.1053/jhep.2001.21145; Uesugi T, 2002, J IMMUNOL, V168, P2963, DOI 10.4049/jimmunol.168.6.2963; Wang YH, 2012, AM J PHYSIOL-GASTR L, V303, pG32, DOI 10.1152/ajpgi.00024.2012; Weaver SA, 2001, GASTROENTEROLOGY, V120, P1117, DOI 10.1053/gast.2001.23257; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018	47	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126520	10.1371/journal.pone.0126520	http://dx.doi.org/10.1371/journal.pone.0126520			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978374	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100078
J	Okoth, SA; Abdallah, JF; Ceron, N; Adhin, MR; Chandrabose, J; Krishnalall, K; Huber, CS; Goldman, IF; de Oliveira, AM; Barnwell, JW; Udhayakumar, V				Okoth, Sheila Akinyi; Abdallah, Joseph F.; Ceron, Nicolas; Adhin, Malti R.; Chandrabose, Javin; Krishnalall, Karanchand; Huber, Curtis S.; Goldman, Ira F.; de Oliveira, Alexandre Macedo; Barnwell, John W.; Udhayakumar, Venkatachalam			Variation in Plasmodium falciparum Histidine-Rich Protein 2 (Pfhrp2) and Plasmodium falciparum Histidine-Rich Protein 3 (Pfhrp3) Gene Deletions in Guyana and Suriname	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; MICROSATELLITE MARKERS; MALARIA; RESISTANCE; INFERENCE; PARASITES; ORIGIN; REGION	Guyana and Suriname have made important progress in reducing the burden of malaria. While both countries use microscopy as the primary tool for clinical diagnosis, malaria rapid diagnostic tests (RDTs) are useful in remote areas of the interior where laboratory support may be limited or unavailable. Recent reports indicate that histidine-rich protein 2 (PfHRP2)-based diagnostic tests specific for detection of P. falciparum may provide false negative results in some parts of South America due to the emergence of P. falciparum parasites that lack the pfhrp2 gene, and thus produce no PfHRP2 antigen. Pfhrp2 and pfhrp3 genes were amplified in parasite isolates collected from Guyana and Suriname to determine if there were circulating isolates with deletions in these genes. Pfhrp3 deletions were monitored because some monoclonal antibodies utilized in PfHRP2-based RDTs cross-react with the PfHRP3 protein. We found that all 97 isolates from Guyana that met the inclusion criteria were both pfhrp2- and pfhrp3-positive. In Suriname (N = 78), 14% of the samples tested were pfhrp2-negative while 4% were pfhrp3-negative. Furthermore, analysis of the genomic region proximal to pfhrp2 and pfhrp3 revealed that genomic deletions extended to the flanking genes. We also investigated the population substructure of the isolates collected to determine if the parasites that had deletions of pfhrp2 and pfhrp3 belonged to any genetic subtypes. Cluster analysis revealed that there was no predominant P. falciparum population substructure among the isolates from either country, an indication of genetic admixture among the parasite populations. Furthermore, the pfhrp2-deleted parasites from Suriname did not appear to share a single, unique genetic background.	[Okoth, Sheila Akinyi; Abdallah, Joseph F.; Huber, Curtis S.; Goldman, Ira F.; de Oliveira, Alexandre Macedo; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA 30322 USA; [Okoth, Sheila Akinyi] Atlanta Res & Educ Fdn, Decatur, GA USA; [Ceron, Nicolas] Pan Amer Hlth Org Guyana, Georgetown, Guyana; [Adhin, Malti R.] Univ Suriname, Dept Biochem, Anton Kom ADEK, Paramaribo, Suriname; [Chandrabose, Javin; Krishnalall, Karanchand] Guyana Minist Hlth, Georgetown, Guyana	Centers for Disease Control & Prevention - USA; Pan American Health Organization; Anton de Kom Universiteit van Suriname	Udhayakumar, V (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA 30322 USA.	vxu0@cdc.gov			Amazon Malaria Initiative of the United States Agency for International Development; American Society for Microbiology/CDC Fellowship; Atlanta Research and Education Foundation	Amazon Malaria Initiative of the United States Agency for International Development(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); American Society for Microbiology/CDC Fellowship; Atlanta Research and Education Foundation	This study was funded by the Amazon Malaria Initiative of the United States Agency for International Development. SAO was supported by the American Society for Microbiology/CDC Fellowship and the Atlanta Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Adhin MR, 2013, AM J TROP MED HYG, V89, P311, DOI 10.4269/ajtmh.12-0695; Adhin MR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-322; Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; [Anonymous], 2002, GUY BUR STAT MOF; BARNES ST, 1972, SOC SCI MED, V6, P1; Martha RCD, 2007, MEM I OSWALDO CRUZ, V102, P293, DOI 10.1590/S0074-02762007005000044; Derks T, 2006, OND NAAR BEH OPL TOT; Dharia NV, 2010, GENOME RES, V20, P1534, DOI 10.1101/gr.105163.110; Earl DA, 2011, CONSERVATION GENETIC; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Hiwat H, 2010, T ROY SOC TROP MED H, V104, P207, DOI 10.1016/j.trstmh.2009.07.007; Hiwat H, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-10; Hoffmann EHE, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-24; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kumar N, 2012, ACTA TROP; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Pan American Health Organization, 2013, SIT MAL REG AM 2000; Pritchard JK, 2000, GENETICS, V155, P945; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; SCHERF A, 1992, NUCLEIC ACIDS RES, V20, P1491, DOI 10.1093/nar/20.7.1491; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Statistiek/Censuskantoor ABvd, 2005, ZEV ALG VOLKS WON SU; Trouvay M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074269; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2010, REP SIT MAL AM 2008; World Health Organization, 2013, REP SIT MAL AM 2011; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	37	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126805	10.1371/journal.pone.0126805	http://dx.doi.org/10.1371/journal.pone.0126805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978499	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100103
J	Ren, XW; Li, YF; Liu, XN; Shen, XP; Gao, WL; Li, JS				Ren, Xiaowei; Li, Yuefeng; Liu, Xiaoning; Shen, Xiping; Gao, Wenlong; Li, Juansheng			Computational Identification of Antigenicity-Associated Sites in the Hemagglutinin Protein of A/H1N1 Seasonal Influenza Virus	PLOS ONE			English	Article							A VIRUSES; VARIANTS; H1N1; EVOLUTION; INHIBITION; POSITIONS	The antigenic variability of influenza viruses has always made influenza vaccine development challenging. The punctuated nature of antigenic drift of influenza virus suggests that a relatively small number of genetic changes or combinations of genetic changes may drive changes in antigenic phenotype. The present study aimed to identify antigenicity-associated sites in the hemagglutinin protein of A/H1N1 seasonal influenza virus using computational approaches. Random Forest Regression (RFR) and Support Vector Regression based on Recursive Feature Elimination (SVR-RFE) were applied to H1N1 seasonal influenza viruses and used to analyze the associations between amino acid changes in the HA1 polypeptide and antigenic variation based on hemagglutination-inhibition (HI) assay data. Twenty-three and twenty antigenicity-associated sites were identified by RFR and SVR-RFE, respectively, by considering the joint effects of amino acid residues on antigenic drift. Our proposed approaches were further validated with the H3N2 dataset. The prediction models developed in this study can quantitatively predict antigenic differences with high prediction accuracy based only on HA1 sequences. Application of the study results can increase understanding of H1N1 seasonal influenza virus antigenic evolution and accelerate the selection of vaccine strains.	[Ren, Xiaowei; Liu, Xiaoning; Shen, Xiping; Gao, Wenlong; Li, Juansheng] Lanzhou Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Lanzhou, Gansu, Peoples R China; [Li, Yuefeng] Natl Hlth & Family Planning Commiss, Ctr Stat & Informat, Beijing, Peoples R China	Lanzhou University	Ren, XW (corresponding author), Lanzhou Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Lanzhou, Gansu, Peoples R China.	renxw@lzu.edu.cn	LI, Yue/GRS-8071-2022		National Natural Science Foundation of China [81102205]; Fundamental Research Funds for the Central Universities [lzujbky-2012-155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (No. 81102205) to XR and by the Fundamental Research Funds for the Central Universities (No. lzujbky-2012-155) to XR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Wkly Epidemiol Rec, V74, P321; ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Awad M, 2015, EFFICIENT LEARNING M, P67, DOI DOI 10.1007/978-1-4302-5990-9_4; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; Centers for Disease Control and Prevention, 2004, INF VACC REL BIOL PR, P9; Centers for Disease Control and Prevention, 2008, PREL INF VACC REL BI, P13; Centers for Disease Control and Prevention, 2009, FEBR 18 19 VRPBAC M, P12; Centers for Disease Control and Prevention, 2006, PREL INF VACC REL BI, P9; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen SH, 2008, GENET EPIDEMIOL, V32, P152, DOI 10.1002/gepi.20272; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chi XS, 2005, J CLIN MICROBIOL, V43, P6130, DOI 10.1128/JCM.43.12.6130-6132.2005; Dewey KG, 2006, ACTA PAEDIATR, V95, P27, DOI 10.1080/08035320500495456; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Huang JW, 2012, VACCINE, V30, P6327, DOI 10.1016/j.vaccine.2012.07.079; Huang JW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S41; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Lee MS, 2007, VACCINE, V25, P8133, DOI 10.1016/j.vaccine.2007.09.039; Lee MS, 2004, EMERG INFECT DIS, V10, P1385, DOI 10.3201/eid1008.040107; Li Y, 2013, J VIROL, V87, P9904, DOI 10.1128/JVI.01023-13; Li Yang, 2011, LIBSVM FARUTOULTIMAT; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; McQuarrie A. D, 1998, REGRESSION TIME SERI; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; Ren XW, 2011, J MED VIROL, V83, P1113, DOI 10.1002/jmv.22078; Rossi T, 2008, THESIS U TRIESTE; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Soundararajan V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00200; Sun HL, 2013, MBIO, V4, DOI 10.1128/mBio.00230-13; Svetnik V, 2004, LECT NOTES COMPUT SC, V3077, P334; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHO, 2007, INT GEND CURR HLTH P, P3	38	21	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126742	10.1371/journal.pone.0126742	http://dx.doi.org/10.1371/journal.pone.0126742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978416	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100096
J	Smirnov, A; Esnault, C; Prigent, M; Holland, IB; Virolle, MJ				Smirnov, Aleksey; Esnault, Catherine; Prigent, Magali; Holland, Ian Barry; Virolle, Marie-Joelle			Phosphate Homeostasis in Conditions of Phosphate Proficiency and Limitation in the Wild Type and the phoP Mutant of Streptomyces lividans	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; PROTEOMIC ANALYSIS; COELICOLOR; METABOLISM; PPK; EXPRESSION; SURVIVAL; REVEALS	Phosphate, as a constituent of the high energy molecules, ATP/GTP and polyphosphate, plays a crucial role in most of the metabolic processes of living organisms. Therefore, the adaptation to low Pi availability is a major challenge for bacteria. In Streptomyces, this adaptation is tightly controlled by the two component PhoR/PhoP system. In this study, the free intracellular Pi, ATP, ADP and polyP content of the wild type and the phoP mutant strain of S. lividans TK24 were analyzed at discrete time points throughout growth in Pi replete and limited media. PolyP length and content was shown to be directly related to the Pi content of the growth medium. In Pi repletion, ATP and high molecular weight (HMW) polyP contents were higher in the phoP mutant than in the WT strain. This supports the recently proposed repressive effect of PhoP on oxidative phosphorylation. High oxidative phosphorylation activity might also have a direct or indirect positive impact on HMW polyP synthesis. In Pi sufficiency as in Pi limitation, the degradation of these polymers was shown to be clearly delayed in the phoP mutant, indicating PhoP dependent expression of the enzymes involved in this degradation. The efficient storage of Pi as polyphosphate and/or its inefficient degradation in Pi in the phoP mutant resulted in low levels of free Pi and ATP that are likely to be, at least in part, responsible for the very poor growth of this mutant in Pi limitation. Furthermore, short polyP was shown to be present outside the cell, tightly bound to the mycelium via electrostatic interactions involving divalent cations. Less short polyP was found to be associated with the mycelium of the phoP mutant than with that of the WT strain, indicating that generation and externalization of these short polyP molecules was directly or indirectly dependent on PhoP.	[Smirnov, Aleksey] Univ Paris 11, Inst Integrat Biol Cell I2BC, Energet Metab Streptomyces, CEA,CNRS, Orsay, France; [Esnault, Catherine; Virolle, Marie-Joelle] Univ Paris 11, Inst Integrat Biol Cell I2BC, Energet Metab Streptomyces, Orsay, France; [Esnault, Catherine] Univ Paris 06, Sorbonne Univ, UFR927, Sci Vie, Paris, France; [Prigent, Magali] Univ Paris 11, Inst Integrat Biol Cell I2BC, Genom Struct & Translat, Orsay, France; [Holland, Ian Barry] Univ Paris 11, Inst Integrat Biol Cell I2BC, Orsay, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Virolle, MJ (corresponding author), Univ Paris 11, Inst Integrat Biol Cell I2BC, Energet Metab Streptomyces, Orsay, France.	marie-joelle.virolle@igmors.u-psud.fr	Smirnov, Alexey/AAB-2521-2020	Smirnov, Alexey/0000-0001-5361-8232; virolle, marie-joelle/0000-0001-9509-4115	University Paris-Sud; CNRS; FP6 European program [ActinoGEN LSHM-CT-2004-005224]	University Paris-Sud; CNRS(Centre National de la Recherche Scientifique (CNRS)); FP6 European program	This work was supported by the University Paris-Sud, the CNRS and the FP6 European program ActinoGEN LSHM-CT-2004-005224: (http://ec.europa.eu/research/health/infectious-diseases/antimicrobial-drug-resistance/projects/019_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Allenby NEE, 2012, NUCLEIC ACIDS RES, V40, P9543, DOI 10.1093/nar/gks766; Apel AK, 2007, MICROBIOL-SGM, V153, P3527, DOI 10.1099/mic.0.2007/007070-0; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Ault-Riche D, 1999, Prog Mol Subcell Biol, V23, P241; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Casey WT, 2013, ENV MICROBIOL REP, V5, P740, DOI 10.1111/1758-2229.12076; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Ghorbel S, 2006, J BACTERIOL, V188, P677, DOI 10.1128/JB.188.2.677-686.2006; Ghorbel S, 2006, J BACTERIOL, V188, P6269, DOI 10.1128/JB.00202-06; Hopwood D. A., 1985, GENETIC MANIPULATION; HOPWOOD DA, 1983, J GEN MICROBIOL, V129, P2257; Kornberg A, 1999, Prog Mol Subcell Biol, V23, P1; Le Marechal P, 2013, APPL ENVIRON MICROB, V79, P5907, DOI 10.1128/AEM.02280-13; Martin JF, 2004, J BACTERIOL, V186, P5197, DOI 10.1128/JB.186.16.5197-5201.2004; Martin JF, 2012, APPL MICROBIOL BIOT, V95, P61, DOI 10.1007/s00253-012-4129-6; Motomura K, 2014, APPL ENVIRON MICROB, V80, P2602, DOI 10.1128/AEM.03971-13; Motomura K, 2011, FEMS MICROBIOL LETT, V320, P25, DOI 10.1111/j.1574-6968.2011.02285.x; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Rao N N, 1999, Prog Mol Subcell Biol, V23, P183; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; Rodriguez-Garcia A, 2009, NUCLEIC ACIDS RES, V37, P3230, DOI 10.1093/nar/gkp162; Santos-Beneit F, 2008, MICROBIOL-SGM, V154, P2356, DOI 10.1099/mic.0.2008/019539-0; SHARFSTEIN ST, 1994, ANN NY ACAD SCI, V745, P77; TIJSSEN JPF, 1984, BIOCHEM BIOPH RES CO, V119, P447, DOI 10.1016/S0006-291X(84)80269-7; Tomaschevsky AA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1052, DOI 10.1134/S0006297910080158; Vagabov VM, 2000, BIOCHEMISTRY-MOSCOW+, V65, P349; Van Dien SJ, 1999, BIOTECHNOL PROGR, V15, P587, DOI 10.1021/bp990067u	32	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126221	10.1371/journal.pone.0126221	http://dx.doi.org/10.1371/journal.pone.0126221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978423	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100056
J	Xiang, Y; Tang, YP; Ma, BQ; Yan, HC; Jiang, J; Tian, XY				Xiang, Yun; Tang, Yi-ping; Ma, Bao-qing; Yan, Hang-chen; Jiang, Jun; Tian, Xu-yuan			Remote Safety Monitoring for Elderly Persons Based on Omni-Vision Analysis	PLOS ONE			English	Article							SYSTEM	Remote monitoring service for elderly persons is important as the aged populations in most developed countries continue growing. To monitor the safety and health of the elderly population, we propose a novel omni-directional vision sensor based system, which can detect and track object motion, recognize human posture, and analyze human behavior automatically. In this work, we have made the following contributions: (1) we develop a remote safety monitoring system which can provide real-time and automatic health care for the elderly persons and (2) we design a novel motion history or energy images based algorithm for motion object tracking. Our system can accurately and efficiently collect, analyze, and transfer elderly activity information and provide health care in real-time. Experimental results show that our technique can improve the data analysis efficiency by 58.5% for object tracking. Moreover, for the human posture recognition application, the success rate can reach 98.6% on average.	[Xiang, Yun; Tang, Yi-ping; Ma, Bao-qing; Yan, Hang-chen] Zhejiang Univ Technol, Coll Informat Engn, Hangzhou, Zhejiang, Peoples R China; [Jiang, Jun; Tian, Xu-yuan] Zhejiang Univ Technol, Coll Comp Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology; Zhejiang University of Technology	Tang, YP (corresponding author), Zhejiang Univ Technol, Coll Informat Engn, Hangzhou, Zhejiang, Peoples R China.	typ@zjut.edu.cn			China National Science Foundation [61070134]	China National Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the China National Science Foundation (Number: 61070134) (YT) (www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew S, 2004, IEEE PERVAS COMPUT, V3, P42, DOI [10.1109/MPRV.2004.1316817, DOI 10.1109/MPRV.2004.1316817]; Auvinet E, 2011, IEEE T INF TECHNOL B, V15, P290, DOI 10.1109/TITB.2010.2087385; Foroughi H, 2008, 2008 11TH INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION TECHNOLOGY: ICCIT 2008, VOLS 1 AND 2, P540; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Guan T, 2011, IEEE COMPUT GRAPH, V31, P56, DOI 10.1109/MCG.2010.23; Han JH, 2008, GAIT DETECTION FROM; Hynes M, 2010, INTERNATIONAL CONFER; Jang SI, 2015, PATTERN RECOGN, V48, P126, DOI 10.1016/j.patcog.2014.07.020; Ji R, 2012, IEEE TRANSACTIONS ON; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Kass M., 1987, Proceedings of the First International Conference on Computer Vision (Cat. No.87CH2465-3), P259, DOI 10.1007/BF00133570; Kim SH, 2012, SENSOR LETT, V10, P5; Li WY, 2014, NEUROCOMPUTING; Lin HY, 2005, AUTOMATIC CONTROL CO; MicksiK B, 2004, THESIS; Nasution A, 2007, IEEE WORKSHOP MULTIM; Paul C, 2003, PROCEEDINGS OF 2003, P183; Scaramuzza Davide, 2007, Vision Systems- Applications, P297; Tang Yi-ping, 2007, Chinese Journal of Sensors and Actuators, V20, P1316; Tang YP, 2006, P INT JOINT C SICE I, P3850; Tang YP, 2006, CHINESE JOURNAL OF C, V43, P211; Taylor ME, 2012, AGE AGEING, V41, P665, DOI 10.1093/ageing/afs057; Wang H, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY, VOLS 1-6, P1; Xu C, 2015, ASILO MAR CONF SIGNA, P483; Yilmaz A, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1177352.1177355; Yoo J, 2009, IEEE T INF TECHNOL B, V13, P897, DOI 10.1109/TITB.2009.2033053; Yoshida T, 2006, PROCEEDINGS OF THE T, DOI [10.1109/DDHH.2006.1624793, DOI 10.1109/DDHH.2006.1624793]; Zhou ZN, 2009, IEEE ENG MED BIO, P6115, DOI 10.1109/IEMBS.2009.5334915	30	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124068	10.1371/journal.pone.0124068	http://dx.doi.org/10.1371/journal.pone.0124068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978761	Green Submitted, gold, Green Published			2022-12-27	WOS:000354916100010
J	Cerritelli, F; Pizzolorusso, G; Renzetti, C; Cozzolino, V; D'Orazio, M; Lupacchini, M; Marinelli, B; Accorsi, A; Lucci, C; Lancellotti, J; Ballabio, S; Castelli, C; Molteni, D; Besana, R; Tubaldi, L; Perri, FP; Fusilli, P; D'Incecco, C; Barlafante, G				Cerritelli, Francesco; Pizzolorusso, Gianfranco; Renzetti, Cinzia; Cozzolino, Vincenzo; D'Orazio, Marianna; Lupacchini, Mariacristina; Marinelli, Benedetta; Accorsi, Alessandro; Lucci, Chiara; Lancellotti, Jenny; Ballabio, Silvia; Castelli, Carola; Molteni, Daniela; Besana, Roberto; Tubaldi, Lucia; Perri, Francesco Paolo; Fusilli, Paola; D'Incecco, Carmine; Barlafante, Gina			A Multicenter, Randomized, Controlled Trial of Osteopathic Manipulative Treatment on Preterms	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; HEART-RATE-VARIABILITY; QUALITY-IMPROVEMENT; BIRTH; PREMATURE; COLLABORATION; MATURATION; CULTURE; HEALTH	Background Despite some preliminary evidence, it is still largely unknown whether osteopathic manipulative treatment improves preterm clinical outcomes. Materials and Methods The present multi-center randomized single blind parallel group clinical trial enrolled newborns who met the criteria for gestational age between 29 and 37 weeks, without any congenital complication from 3 different public neonatal intensive care units. Preterm infants were randomly assigned to usual prenatal care (control group) or osteopathic manipulative treatment (study group). The primary outcome was the mean difference in length of hospital stay between groups. Results A total of 695 newborns were randomly assigned to either the study group (n=352) or the control group (n=343). A statistical significant difference was observed between the two groups for the primary outcome (13.8 and 17.5 days for the study and control group respectively, p<0.001, effect size: 0.31). Multivariate analysis showed a reduction of the length of stay of 3.9 days (95% CI -5.5 to -2.3, p<0.001). Furthermore, there were significant reductions with treatment as compared to usual care in cost (difference between study and control group: 1,586.01(sic); 95% CI 1,087.18 to 6,277.28; p<0.001) but not in daily weight gain. There were no complications associated to the intervention. Conclusions Osteopathic treatment reduced significantly the number of days of hospitalization and is cost-effective on a large cohort of preterm infants.	[Cerritelli, Francesco; Accorsi, Alessandro; Lucci, Chiara] COME Collaborat, Ctr Osteopath Med, Clin Based Human Res Dept, Pescara, Italy; [Cerritelli, Francesco; Pizzolorusso, Gianfranco; Renzetti, Cinzia; Cozzolino, Vincenzo; D'Orazio, Marianna; Lupacchini, Mariacristina; Marinelli, Benedetta; Accorsi, Alessandro; Lucci, Chiara; Lancellotti, Jenny; Barlafante, Gina] Accademia Italiana Osteopatia Tradiz, Pescara, Italy; [Ballabio, Silvia; Castelli, Carola; Molteni, Daniela; Besana, Roberto] Desio Publ Hosp, Neonatal Intens Care Unit, Desio, Italy; [Tubaldi, Lucia; Perri, Francesco Paolo] Macerata Publ Hosp, Neonatal Intens Care Unit, Macerata, Italy; [Fusilli, Paola; D'Incecco, Carmine] Pescara Publ Hosp, Neonatal Intens Care Unit, Pescara, Italy		Cerritelli, F (corresponding author), COME Collaborat, Ctr Osteopath Med, Clin Based Human Res Dept, Pescara, Italy.	francesco.cerritelli@gmail.com	Cerritelli, Francesco/AAJ-5003-2020; Cerritelli, Francesco/O-8416-2015	Cerritelli, Francesco/0000-0002-2963-9620				[Anonymous], 2007, PRETERM BIRTH CAUSES; Bakewell-Sachs S, 2009, PEDIATRICS, V123, pE878, DOI 10.1542/peds.2008-2568; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Berghella Vincenzo, 2010, PRETERM BIRTH PREVEN; Bodeker G, 2007, TRADITIONAL, COMPLEMENTARY AND ALTERNATIVE MEDICINE: POLICY AND PUBLIC HEALTH PERSPECTIVES, P1; Brodsky D, 2013, BMJ QUAL SAF, V22, P374, DOI 10.1136/bmjqs-2012-000909; Brown MS, 2003, PEDIATRICS, V111; Cerritelli F, 2014, CHIROPR MAN THER, V22, DOI 10.1186/2045-709X-22-18; Cerritelli F, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-65; Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009; Degenhardt BF, 2007, J AM OSTEOPATH ASSOC, V107, P387; FASDAC, 2012, NOM TAR; Giles PD, 2013, J ALTERN COMPLEM MED, V19, P92, DOI 10.1089/acm.2011.0031; Goldenberg RL, 2010, PRETERM BIRTH, V22; Horbar JD, 2001, PEDIATRICS, V107, P14, DOI 10.1542/peds.107.1.14; Italian Ministry of Health, 2012, RAPP ANN ATT RIC OSP; Jackson DJ, 2003, AM J PUBLIC HEALTH, V93, P999, DOI 10.2105/AJPH.93.6.999; Keller M, 2010, ACTA PAEDIATR, V99, P1624, DOI 10.1111/j.1651-2227.2010.01894.x; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lemons JA, 1998, PEDIATRICS, V102, P411; Longin E, 2006, J PERINAT MED, V34, P303, DOI 10.1515/JPM.2006.058; Narendran V, 2010, PEDIATR RES, V67, P382, DOI 10.1203/PDR.0b013e3181d00b73; Ohlinger J, 2003, PEDIATRICS, V111; Pizzolorusso G, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/243539; Pizzolorusso G, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-15; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Rogowski JA, 2001, PEDIATRICS, V107, P23, DOI 10.1542/peds.107.1.23; Silber JH, 2009, HEALTH SERV RES, V44, P444, DOI 10.1111/j.1475-6773.2008.00938.x; Visscher M, 2013, PEDIATRICS, V131, pE1950, DOI 10.1542/peds.2012-1626; WHO March of Dimes PMNCH Save the Children, 2012, BORN SOON GLOB ACT R, DOI [10.1186/1742-4755-10-S1-S1, DOI 10.1186/1742-4755-10-S1-S1]	31	32	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127370	10.1371/journal.pone.0127370	http://dx.doi.org/10.1371/journal.pone.0127370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974071	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600113
J	Connor, JR; Zhang, XS; Nixon, AM; Webb, B; Perno, JR				Connor, James R.; Zhang, Xuesheng; Nixon, Anne M.; Webb, Becky; Perno, Joseph R.			Comparative Evaluation of Nephrotoxicity and Management by Macrophages of Intravenous Pharmaceutical Iron Formulations	PLOS ONE			English	Article							DEFICIENCY ANEMIA; INJURY; STRESS; HEMODIALYSIS; MECHANISMS; STABILITY; FERRITIN; CELLS; POOL	Background There is a significant clinical need for effective treatment of iron deficiency. A number of compounds that can be administered intravenously have been developed. This study examines how the compounds are handled by macrophages and their relative potential to provoke oxidative stress. Methods Human kidney (HK-2) cells, rat peritoneal macrophages and renal cortical homogenates were exposed to pharmaceutical iron preparations. Analyses were performed for indices of oxidative stress and cell integrity. In addition, in macrophages, iron uptake and release and cytokine secretion was monitored. Results HK-2 cell viability was decreased by iron isomaltoside and ferumoxytol and all compounds induced lipid peroxidation. In the renal cortical homogenates, lipid peroxidation occurred at lowest concentrations with ferric carboxymaltose, iron dextran, iron sucrose and sodium ferric gluconate. In the macrophages, iron sucrose caused loss of cell viability. Iron uptake was highest for ferumoxytol and iron isomaltoside and lowest for iron sucrose and sodium ferric gluconate. Iron was released as secretion of ferritin or as ferrous iron via ferroportin. The latter was blocked by hepcidin. Exposure to ferric carboxymaltose and iron dextran resulted in release of tumor necrosis factor alpha. Conclusions Exposure to iron compounds increased cell stress but was tissue and dose dependent. There was a clear difference in the handling of iron from the different compounds by macrophages that suggests in vivo responses may differ.	[Connor, James R.; Zhang, Xuesheng; Nixon, Anne M.; Webb, Becky] MS Hershey Penn State Univ, Coll Med, MS Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Perno, Joseph R.] Luitpold Pharmaceut Inc, Norristown, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Connor, JR (corresponding author), MS Hershey Penn State Univ, Coll Med, MS Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA.	jconnor@hmc.psu.edu			Luitpold Pharmaceuticals Inc.	Luitpold Pharmaceuticals Inc.	Funding for this work was provided by Luitpold Pharmaceuticals Inc. The funder provided support in the form of salaries for authors JP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio P, 2007, AM J PHYSIOL-CELL PH, V293, pC641; Bayraktar UD, 2010, WORLD J GASTROENTERO, V16, P2720, DOI 10.3748/wjg.v16.i22.2720; Bishu K, 2006, CLIN J AM SOC NEPHRO, V1, pS19, DOI 10.2215/CJN.01420406; Breborowicz A, 2007, TRANSL RES, V149, P304, DOI 10.1016/j.trsl.2006.11.003; Cavdar C, 2003, SCAND J UROL NEPHROL, V37, P77, DOI 10.1080/00365590310008758; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Fisher J, 2007, AM J PHYSIOL-CELL PH, V293, pC641, DOI 10.1152/ajpcell.00599.2006; Ganz T, 2006, BBA-MOL CELL RES, V1763, P690, DOI 10.1016/j.bbamcr.2006.03.014; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Garrick MD, 2009, BBA-GEN SUBJECTS, V1790, P309, DOI 10.1016/j.bbagen.2009.03.018; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Johnson ACM, 2010, AM J PHYSIOL-RENAL, V299, pF426, DOI 10.1152/ajprenal.00248.2010; Jomova K., 2010, MOL CELL BIOCH; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kovesdy CP, 2009, J RENAL CARE, V35, P14, DOI 10.1111/j.1755-6686.2009.00125.x; Lyseng-Williamson KA, 2009, DRUGS, V69, P739, DOI 10.2165/00003495-200969060-00007; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Michelis R, 2003, NEPHROL DIAL TRANSPL, V18, P924, DOI 10.1093/ndt/gfg031; Preza GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058934; Recalcati S, 2012, AUTOIMMUN REV, V11, P883, DOI 10.1016/j.autrev.2012.03.003; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; Rozen-Zvi B, 2008, AM J KIDNEY DIS, V52, P897, DOI 10.1053/j.ajkd.2008.05.033; SHINOBU LA, 1997, METALS OXIDATIVE DAM, P237; Sturm B, 2003, EUR J BIOCHEM, V270, P3731, DOI 10.1046/j.1432-1033.2003.03759.x; Sullivan JL, 2007, EXP BIOL MED, V232, P1014, DOI 10.3181/0703-MR-54; Ternes N, 2007, NEPHROL DIAL TRANSPL, V22, P2824, DOI 10.1093/ndt/gfm315; Tolouian R, 2013, CLIN NEPHROL, V79, P237, DOI 10.5414/CN107361; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vogel S C, 1998, ANNA J, V25, P625; Walter PB, 2009, ACTA HAEMATOL-BASEL, V122, P174, DOI 10.1159/000243802; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Zager RA, 2002, AM J KIDNEY DIS, V40, P90, DOI 10.1053/ajkd.2002.33917; Zager RA, 2005, AM J PHYSIOL-RENAL, V289, pF289, DOI 10.1152/ajprenal.00023.2005; Zager RA, 2004, KIDNEY INT, V66, P144, DOI 10.1111/j.1523-1755.2004.00716.x	38	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125272	10.1371/journal.pone.0125272	http://dx.doi.org/10.1371/journal.pone.0125272			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973894	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600014
J	Ettema, EM; Kuipers, J; Assa, S; Bakker, SJL; Groen, H; Westerhuis, R; Gaillard, CAJM; Gansevoort, RT; Franssen, CFM				Ettema, Esmee M.; Kuipers, Johanna; Assa, Solmaz; Bakker, Stephan J. L.; Groen, Henk; Westerhuis, Ralf; Gaillard, Carlo A. J. M.; Gansevoort, Ron T.; Franssen, Casper F. M.			Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; BLOOD-PRESSURE; FLUID REMOVAL; DIALYSIS; HYPOTENSION; PEPTIDE; PRECURSOR	Objectives Plasma levels of copeptin, a surrogate marker for the vasoconstrictor hormone arginine vasopressin (AVP), are increased in hemodialysis patients. Presently, it is unknown what drives copeptin levels in hemodialysis patients. We investigated whether the established physiological stimuli for copeptin release, i.e. plasma osmolality, blood volume and mean arterial pressure (MAP), are operational in hemodialysis patients. Methods One hundred and eight prevalent, stable hemodialysis patients on a thrice-weekly dialysis schedule were studied during hemodialysis with constant ultrafiltration rate and dialysate conductivity in this observational study. Plasma levels of copeptin, sodium, MAP, and blood volume were measured before, during and after hemodialysis. Multivariate analysis was used to determine the association between copeptin (dependent variable) and the physiological stimuli plasma sodium, MAP, excess weight as well as NT-pro-BNP immediately prior to dialysis and between copeptin and changes of plasma sodium, MAP and blood volume with correction for age, sex and diabetes during dialysis treatment. Results Patients were 63 +/- 15.6 years old and 65% were male. Median dialysis vintage was 1.6 years (IQR 0.7-4.0). Twenty-three percent of the patients had diabetes and 82% had hypertension. Median predialysis copeptin levels were 141.5 pmol/L (IQR 91.0-244.8 pmol/L). Neither predialysis plasma sodium levels, nor NT-proBNP levels, nor MAP were associated with predialysis copeptin levels. During hemodialysis, copeptin levels rose significantly (p<0.01) to 163.0 pmol/L (96.0-296.0 pmol/L). Decreases in blood volume and MAP were associated with increases in copeptin levels during dialysis, whereas there was no significant association between the change in plasma sodium levels and the change in copeptin levels. Conclusions Plasma copeptin levels are elevated predialysis and increase further during hemodialysis. Volume stimuli, i.e. decreases in MAP and blood volume, rather than osmotic stimuli, are associated with change in copeptin levels during hemodialysis.	[Ettema, Esmee M.; Assa, Solmaz; Bakker, Stephan J. L.; Gaillard, Carlo A. J. M.; Gansevoort, Ron T.; Franssen, Casper F. M.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [Kuipers, Johanna; Westerhuis, Ralf] Dialysis Ctr Groningen, Groningen, Netherlands; [Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen	Ettema, EM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands.	e.m.ettema@umcg.nl	Gaillard, Carlo/AAC-6729-2022; Bakker, Stephan J. L./J-4023-2015; Groen, Henk/B-2163-2013	Gaillard, Carlo/0000-0002-8964-0236; Bakker, Stephan J. L./0000-0003-3356-6791; Groen, Henk/0000-0002-6629-318X; Franssen, Casper/0000-0003-1004-9994	Dutch Kidney Foundation (Nierstichting) [C08.2279]	Dutch Kidney Foundation (Nierstichting)	A grant of the Dutch Kidney Foundation (Nierstichting) supported this work. The grant number is C08.2279. The URL of the funder's website is www.nierstichting.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artunc F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086148; Assa S, 2012, CLIN J AM SOC NEPHRO, V7, P1615, DOI 10.2215/CJN.00850112; Balanescu S, 2011, J CLIN ENDOCR METAB, V96, P1046, DOI 10.1210/jc.2010-2499; Barrett LK, 2007, CRIT CARE MED, V35, P33, DOI 10.1097/01.CCM.0000251127.45385.CD; Bhandari SS, 2009, CLIN SCI, V116, P257, DOI 10.1042/CS20080140; Cernaro V, 2012, BLOOD PURIFICAT, V33, P317, DOI 10.1159/000337104; Dabla PK, 2011, CLIN CHIM ACTA, V412, P22, DOI 10.1016/j.cca.2010.09.034; Ettema EM, 2014, AM J NEPHROL, V39, P100, DOI 10.1159/000358203; Fenske W, 2011, J AM SOC NEPHROL, V22, P782, DOI 10.1681/ASN.2010070691; Flythe JE, 2011, KIDNEY INT, V79, P250, DOI 10.1038/ki.2010.383; IITAKE K, 1985, ACTA ENDOCRINOL-COP, V110, P207, DOI 10.1530/acta.0.1100207; Li X, 2013, CHINESE MED J-PEKING, V126, P823, DOI 10.3760/cma.j.issn.0366-6999.20122497; MARTINEZVEA A, 1985, CLIN NEPHROL, V24, P316; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Morgenthaler Nils G, 2010, Congest Heart Fail, V16 Suppl 1, pS37, DOI 10.1111/j.1751-7133.2010.00177.x; Mutlu GM, 2004, INTENS CARE MED, V30, P1276, DOI 10.1007/s00134-004-2283-8; Nakayama M, 1998, NEPHRON, V79, P488, DOI 10.1159/000045104; Nord E, 1979, Proc Eur Dial Transplant Assoc, V16, P238; Park J, 2013, KIDNEY INT, V84, P795, DOI 10.1038/ki.2013.237; Ronco C, 2001, INT J ARTIF ORGANS, V24, P726, DOI 10.1177/039139880102401005; Santoro A, 2007, NAT CLIN PRACT NEPHR, V3, P362, DOI 10.1038/ncpneph0509; Sauerbrei W, 1999, J ROY STAT SOC C-APP, V48, P313, DOI 10.1111/1467-9876.00155; Schneditz D, 2012, ASAIO J, V58, P160, DOI 10.1097/MAT.0b013e318243660f; Sharman A, 2008, BJA EDUC, V8, P134, DOI 10.1093/bjaceaccp/mkn021; Shoji T, 2004, KIDNEY INT, V66, P1212, DOI 10.1111/j.1523-1755.2004.00812.x; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; van der Zee S, 2007, KIDNEY INT, V71, P318, DOI 10.1038/sj.ki.5001885; YAMADA K, 1993, REGUL PEPTIDES, V45, P91, DOI 10.1016/0167-0115(93)90188-E; ZOCCALI C, 1991, NEPHROL DIAL TRANSPL, V6, P631, DOI 10.1093/ndt/6.9.631	30	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127116	10.1371/journal.pone.0127116	http://dx.doi.org/10.1371/journal.pone.0127116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973954	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600100
J	Pappas, ML; Steppuhn, A; Geuss, D; Topalidou, N; Zografou, A; Sabelis, MW; Broufas, GD				Pappas, Maria L.; Steppuhn, Anke; Geuss, Daniel; Topalidou, Nikoleta; Zografou, Aliki; Sabelis, Maurice W.; Broufas, George D.			Beyond Predation: The Zoophytophagous Predator Macrolophus pygmaeus Induces Tomato Resistance against Spider Mites	PLOS ONE			English	Article							INDUCED PLANT-RESISTANCE; NICOTIANA-ATTENUATA; PROTEINASE-INHIBITOR; PROTEASE INHIBITORS; VOLATILE EMISSIONS; JASMONIC ACID; HERBIVORE; DEFENSE; RESPONSES; CONSEQUENCES	Many predatory insects that prey on herbivores also feed on the plant, but it is unknown whether plants affect the performance of herbivores by responding to this phytophagy with defence induction. We investigate whether the prior presence of the omnivorous predator Macrolophus pygmaeus (Rambur) on tomato plants affects plant resistance against two different herbivore species. Besides plant-mediated effects of M. pygmaeus on herbivore performance, we examined whether a plant defence trait that is known to be inducible by herbivory, proteinase inhibitors (PI), may also be activated in response to the interactions of this predator with the tomato plant. We show that exposing tomato plants to the omnivorous predator M. pygmaeus reduced performance of a subsequently infesting herbivore, the two-spotted spider mite Tetranychus urticae Koch, but not of the greenhouse whitefly Trialeurodes vaporariorum (Westwood). The spider-mite infested tomato plants experience a lower herbivore load, i.e., number of eggs deposited and individuals present, when previously exposed to the zoophytophagous predator. This effect is not restricted to the exposed leaf and persists on exposed plants for at least two weeks after the removal of the predators. The decreased performance of spider mites as a result of prior exposure of the plant to M. pygmaeus is accompanied by a locally and systemically increased accumulation of transcripts and activity of proteinase inhibitors that are known to be involved in plant defence. Our results demonstrate that zoophytophagous predators can induce plant defence responses and reduce herbivore performance. Hence, the suppression of populations of certain herbivores via consumption may be strengthened by the induction of plant defences by zoophytophagous predators.	[Pappas, Maria L.; Topalidou, Nikoleta; Zografou, Aliki; Broufas, George D.] Democritus Univ Thrace, Dept Agr Dev, Orestiada, Greece; [Steppuhn, Anke; Geuss, Daniel] Free Univ Berlin, Dahlem Ctr Plant Sci, Inst Biol, Berlin, Germany; [Sabelis, Maurice W.] Univ Amsterdam, Sect Populat Biol, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Democritus University of Thrace; Free University of Berlin; University of Amsterdam	Pappas, ML (corresponding author), Democritus Univ Thrace, Dept Agr Dev, Orestiada, Greece.	mpappa@agro.duth.gr	Steppuhn, Anke/G-5263-2013; Pappas, Maria L./G-1540-2010	Steppuhn, Anke/0000-0001-6801-997X; Pappas, Maria L./0000-0003-4563-3023; Broufas, George/0000-0003-3604-2109; Geuss, Daniel/0000-0002-1874-5823	Greek State Scholarships Foundation; German Academic Exchange Office; Onassis Foundation [R-ZJ 003]	Greek State Scholarships Foundation(Greek Ministry of Development-GSRT); German Academic Exchange Office(Deutscher Akademischer Austausch Dienst (DAAD)); Onassis Foundation	This project was partially funded by the Greek State Scholarships Foundation (http://www.iky. gr/en/) and the German Academic Exchange Office (https://www.daad.de/en/) under a joint bilateral agreement between Greece and Germany (IKYDA 2011 awarded to AS and GDB). MLP was supported by the Onassis Foundation (http://www.onassis.gr/en/, grant number R-ZJ 003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, CURR OPIN PLANT BIOL, V3, P329, DOI 10.1016/S1369-5266(00)00089-3; Agrawal AA, 2000, J ANIM ECOL, V69, P525, DOI 10.1046/j.1365-2656.2000.00416.x; Alba JM, 2015, NEW PHYTOL, V205, P828, DOI 10.1111/nph.13075; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; Armer CA, 1998, ENTOMOL EXP APPL, V86, P109, DOI 10.1023/A:1003168909489; Bode RF, 2013, PLANTA, V237, P1287, DOI 10.1007/s00425-013-1845-9; Bruce TJ, 2007, CURR OPIN PLANT BIOL, V10, P387, DOI 10.1016/j.pbi.2007.05.002; Calvo FJ, 2012, BIOCONTROL, V57, P809, DOI 10.1007/s10526-012-9455-1; Castane C, 2011, BIOL CONTROL, V59, P22, DOI 10.1016/j.biocontrol.2011.03.007; De Puysseleyr V, 2011, ARTHROPOD-PLANT INTE, V5, P71, DOI 10.1007/s11829-010-9117-0; Dicke M, 2000, J CHEM ECOL, V26, P1497, DOI 10.1023/A:1005543910683; Eubanks MD, 2000, ECOLOGY, V81, P936, DOI 10.2307/177168; Eubanks Micky D., 2005, P148, DOI 10.1017/CBO9780511542220.007; Gaquerel E, 2012, NEW PHYTOL, V196, P574, DOI 10.1111/j.1469-8137.2012.04286.x; Gillespie D. R., 2012, Psyche: A Journal of Entomology, V2012, P495805, DOI 10.1155/2012/495805; Estrada-Hernandez MG, 2009, PHYSIOL PLANTARUM, V137, P44, DOI 10.1111/j.1399-3054.2009.01260.x; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Hartl M, 2010, PLANT CELL, V22, P4158, DOI 10.1105/tpc.109.073395; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Hilker M, 2015, ANNU REV ENTOMOL, V60, P493, DOI 10.1146/annurev-ento-010814-020620; Hori K, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P11; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Janssen A, 2003, J ANIM ECOL, V72, P478, DOI 10.1046/j.1365-2656.2003.00717.x; Kant MR, 2008, P R SOC B, V275, P443, DOI 10.1098/rspb.2007.1277; KARBAN R, 1984, SCIENCE, V225, P53, DOI 10.1126/science.225.4657.53; Karban R, 1997, ECOL APPL, V7, P183, DOI 10.1890/1051-0761(1997)007[0183:MVFSMO]2.0.CO;2; KARBAN R, 1997, INDUCED RESPONSES TO; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2004, PLANT J, V38, P639, DOI 10.1111/j.1365-313X.2004.02076.x; Kessler A, 2007, CURR OPIN PLANT BIOL, V10, P409, DOI 10.1016/j.pbi.2007.06.001; Lefcheck JS, 2013, ECOLOGY, V94, P565, DOI 10.1890/12-0192.1; Li CY, 2002, PLANT PHYSIOL, V130, P494, DOI 10.1104/pp.005314; Mouttet R, 2013, OECOLOGIA, V173, P1379, DOI 10.1007/s00442-013-2716-6; Pallipparambil GR, 2015, J EXP BOT, V66, P549, DOI 10.1093/jxb/eru361; Perez-Hedo M, 2015, J PEST SCI IN PRESS, DOI [10.1007/s10340-10014-10640-10340, DOI 10.1007/S10340-10014-10640-10340]; Puthoff DP, 2010, J CHEM ECOL, V36, P1271, DOI 10.1007/s10886-010-9868-1; R Core Team, 2014, R A LANGUAGE AND ENV; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Sampson C., 1999, IOBC-WPRS Bulletin, V22, P213; Sanchez-Hernandez C, 2006, PLANT CELL ENVIRON, V29, P546, DOI 10.1111/j.1365-3040.2005.01431.x; Singer MS, 2003, ECOLOGY, V84, P2532, DOI 10.1890/02-0397; Spence KO, 2007, ENVIRON ENTOMOL, V36, P623, DOI 10.1603/0046-225X(2007)36[623:FOFAPI]2.0.CO;2; Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Thaler JS, 2002, J CHEM ECOL, V28, P1131, DOI 10.1023/A:1016225515936; Torres JB, 2010, ARTHROPOD-PLANT INTE, V4, P219, DOI 10.1007/s11829-010-9095-2; Trottin-Caudal Y., 2012, Bulletin OEPP, V42, P234, DOI 10.1111/epp.2560; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106; Zhi JR, 2006, ENTOMOL EXP APPL, V121, P59, DOI 10.1111/j.1570-8703.2006.00456.x	55	62	62	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127251	10.1371/journal.pone.0127251	http://dx.doi.org/10.1371/journal.pone.0127251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974207	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600105
J	Lao-Kaim, NP; Fonville, L; Giampietro, VP; Williams, SCR; Simmons, A; Tchanturia, K				Lao-Kaim, Nick P.; Fonville, Leon; Giampietro, Vincent P.; Williams, Steven C. R.; Simmons, Andrew; Tchanturia, Kate			Aberrant Function of Learning and Cognitive Control Networks Underlie Inefficient Cognitive Flexibility in Anorexia Nervosa: A Cross-Sectional fMRI Study	PLOS ONE			English	Article							GENERIC BRAIN ACTIVATION; EATING-DISORDERS; SET; ARCHITECTURE; ATTENTION; DEFAULT; WOMEN	Objectives People with Anorexia Nervosa exhibit difficulties flexibly adjusting behaviour in response to environmental changes. This has previously been attributed to problematic behavioural shifting, characterised by a decrease in fronto-striatal activity. Additionally, alterations of instrumental learning, which relies on fronto-striatal networks, may contribute to the observation of inflexible behaviour. The authors sought to investigate the neural correlates of cognitive flexibility and learning in Anorexia Nervosa. Method Thirty-two adult females with Anorexia Nervosa and thirty-two age-matched female control participants completed the Wisconsin Card Sorting Task whilst undergoing functional magnetic resonance imaging. Event-related analysis permitted the comparison of cognitive shift trials against those requiring maintenance of rule-sets and allowed assessment of trials representing learning. Results Although both groups performed similarly, we found significant interactions in the left middle frontal gyrus, precuneus and superior parietal lobule whereby blood-oxygenated-level dependent response was higher in Anorexia Nervosa patients during shifting but lower when maintaining rule-sets, as compared to healthy controls. During learning, posterior cingulate cortex activity in healthy controls decreased whilst increasing in the Anorexia Nervosa group, whereas the right precuneus exhibited the opposite pattern. Furthermore, learning was associated with lower blood-oxygenated-level dependent response in the caudate body, as compared to healthy controls. Conclusions People with Anorexia Nervosa display widespread changes in executive function. Whilst cognitive flexibility appears to be associated with aberrant functioning of the fronto-parietal control network that mediates between internally and externally directed cognition, fronto-striatal alterations, particularly within the caudate body, were associated with instrumental learning. Together, this shows how perseverative tendencies could be a substrate of multiple high-order processes that may contribute to the maintenance of Anorexia Nervosa.	[Lao-Kaim, Nick P.; Fonville, Leon; Tchanturia, Kate] Kings Coll London, Inst Psychiat, Dept Psychol Med, London, England; [Giampietro, Vincent P.; Williams, Steven C. R.; Simmons, Andrew] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London, England; [Williams, Steven C. R.; Simmons, Andrew] Kings Coll London, South London & Maudsley NHS Fdn Trust, NIHR Biomed Res Ctr Mental Hlth, London, England; [Williams, Steven C. R.; Simmons, Andrew] Kings Coll London, Inst Psychiat, London, England	University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London	Tchanturia, K (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med, London, England.	kate.tchanturia@kcl.ac.uk	Tchanturia, Kate/H-1474-2011; Giampietro, Vincent P/D-1279-2011; Williams, Steve C/D-6979-2011; Simmons, Andrew/B-8848-2008; Fonville, Leon/F-7790-2019	Tchanturia, Kate/0000-0001-8988-3265; Giampietro, Vincent P/0000-0002-9381-8201; Williams, Steve C/0000-0003-4299-1941; Simmons, Andrew/0000-0003-2306-5811; Fonville, Leon/0000-0001-8874-7843; Lao-Kaim, Nicholas Piyachati/0000-0002-0241-7630; opoku, anita/0000-0001-7243-8157	Swiss Anorexia Foundation; Psychiatry Research Trust; NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	Swiss Anorexia Foundation; Psychiatry Research Trust; NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	This work was supported by the Swiss Anorexia Foundation, the Psychiatry Research Trust, the NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; [Anonymous], 2011, SPSS STAT WIND VERS; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Barcelo F, 2002, NEUROPSYCHOLOGIA, V40, P349, DOI 10.1016/S0028-3932(01)00110-5; Blinder BJ, 2006, PSYCHOSOM MED, V68, P454, DOI 10.1097/01.psy.0000221254.77675.f5; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Cowdrey FA, 2011, BIOL PSYCHIAT, V70, P736, DOI 10.1016/j.biopsych.2011.05.028; Dang LC, 2012, J NEUROSCI, V32, P9582, DOI 10.1523/JNEUROSCI.0909-12.2012; Eliassen JC, 2012, BRAIN RES, V1458, P56, DOI 10.1016/j.brainres.2012.04.010; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; First M. B., 1997, STRUCTURED CLIN INTE; Friman O, 2003, NEUROIMAGE, V19, P837, DOI 10.1016/S1053-8119(03)00077-6; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Holliday J, 2005, AM J PSYCHIAT, V162, P2269, DOI 10.1176/appi.ajp.162.12.2269; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Kothari R, 2013, PSYCHOL MED, V43, P1543, DOI 10.1017/S0033291712002188; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; MARTIN MM, 1995, PSYCHOL REP, V76, P623, DOI 10.2466/pr0.1995.76.2.623; Muhlau M, 2007, AM J PSYCHIAT, V164, P1850, DOI 10.1176/appi.ajp.2007.06111861; Nagahama Y, 2005, J NEUROL NEUROSUR PS, V76, P169, DOI 10.1136/jnnp.2004.039818; Nelson HE., 1991, REVISED NATL ADULT R; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061108; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Shott ME, 2012, NEUROPSYCHOLOGY, V26, P191, DOI 10.1037/a0026771; Simmons A, 1999, MAGNET RESON MED, V41, P1274, DOI 10.1002/(SICI)1522-2594(199906)41:6<1274::AID-MRM27>3.0.CO;2-1; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Talairach I., 1988, COPLANAR STEREOTACTI; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Tchanturia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020462; Tenconi E, 2010, WORLD J BIOL PSYCHIA, V11, P813, DOI 10.3109/15622975.2010.483250; Titova OE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-110; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; YETERIAN EH, 1993, J COMP NEUROL, V332, P175, DOI 10.1002/cne.903320204; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	41	41	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124027	10.1371/journal.pone.0124027	http://dx.doi.org/10.1371/journal.pone.0124027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970523	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200024
J	Sanchez, S; Payet, C; Lifante, JC; Polazzi, S; Chollet, F; Carty, MJ; Duclos, A				Sanchez, Stephane; Payet, Cecile; Lifante, Jean-Christophe; Polazzi, Stephanie; Chollet, Francois; Carty, Matthew J.; Duclos, Antoine			Surgical Risks Associated with Winter Sport Tourism	PLOS ONE			English	Article							INJURIES; MORTALITY; SURVIVAL; VOLUME	Background Mass tourism during winter in mountain areas may cause significant clustering of body injuries leading to increasing emergency admissions at hospital. We aimed at assessing if surgical safety and efficiency was maintained in this particular context. Methods We selected all emergency admissions of open surgery performed in French hospitals between 2010 and 2012. After identifying mountain areas with increasing volume of surgical stays during winter, we considered seasonal variations in surgical outcomes using a difference-in-differences study design. We computed multilevel regressions to evaluate whether significant increase in emergency cases had an effect on surgical mortality, complications and length of stay. Clustering effect of patients within hospitals was integrated in analysis and surgical outcomes were adjusted for both patient and hospital characteristics. Results A total of 381 hospitals had 559,052 inpatient stays related to emergency open surgery over 3 years. Compared to other geographical areas, a significant peak of activity was noted during winter in mountainous hospitals (Alps, Pyrenees, Vosges), ranging 6-77% volume increase. Peak was mainly explained by tourists' influx (+124.5%, 4,351/3,496) and increased need for orthopaedic procedures (+36.8%, 4,731/12,873). After controlling for potential confounders, patients did not experience increased risk for postoperative death (ratio of OR 1.01, 95% CI 0.89-1.14, p = 0.891), thromboembolism (0.95, 0.77-1.17, p = 0.621) or sepsis (0.98, 0.85-1.12, p = 0.748). Length of stay was unaltered (1.00, 0.99-1.02, p = 0.716). Conclusion Surgical outcomes are not compromised during winter in French mountain areas despite a substantial influx of major emergencies.	[Sanchez, Stephane; Payet, Cecile; Polazzi, Stephanie; Chollet, Francois; Duclos, Antoine] Hosp Civils Lyon, Pole Informat Med Evaluat Rech, Lyon, Rhone, France; [Sanchez, Stephane] Univ Lyon 1, Fac Med Lyon Est, F-69365 Lyon, Rhone, France; [Lifante, Jean-Christophe] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Chirurg Gen & Endocrinienne, Pierre Benite, Rhone, France; [Lifante, Jean-Christophe] Univ Lyon 1, Fac Med Lyon Sud, F-69365 Lyon, Rhone, France; [Carty, Matthew J.; Duclos, Antoine] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Duclos, Antoine] Univ Lyon 1, EAM Sante Individu Soc 4128, F-69365 Lyon, Rhone, France; [Lifante, Jean-Christophe; Polazzi, Stephanie; Duclos, Antoine] Hlth Serv & Performance Res Lab, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Harvard University; Brigham & Women's Hospital; Harvard Medical School; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Sanchez, S (corresponding author), Hosp Civils Lyon, Pole Informat Med Evaluat Rech, Lyon, Rhone, France.	stephane.sanchez@chu-lyon.fr	Lifante, Jean-Christophe/AAX-2606-2020; Sanchez, Stephane/ABD-3014-2020; Duclos, Antoine/N-3756-2016	Sanchez, Stephane/0000-0002-0925-6948; Duclos, Antoine/0000-0002-8915-4203; Polazzi, Stephanie/0000-0003-4622-7983	Hospices Civils de Lyon teaching hospital	Hospices Civils de Lyon teaching hospital	All authors had financial support from Hospices Civils de Lyon teaching hospital for conducting the submitted work independently.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bergstrom KA, 1999, SCAND J MED SCI SPOR, V9, P110; Chantry AA, 2011, J CLIN EPIDEMIOL, V64, P1014, DOI 10.1016/j.jclinepi.2010.11.015; Corra S, 2004, INJ CONTROL SAF PROM, V11, P281; Duclos A, 2013, MED CARE, V51, P1085, DOI 10.1097/MLR.0b013e3182a97c54; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; FIENNES A, 1990, BRIT MED J, V300, P659, DOI 10.1136/bmj.300.6725.659; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Girardi P, 2010, KNEE SURG SPORT TR A, V18, P1804, DOI 10.1007/s00167-010-1133-1; Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Harrison EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3330; Hasler RM, 2009, BRIT J SPORT MED, V43, P1020, DOI 10.1136/bjsm.2009.064741; Ingraham AM, 2011, J AM COLL SURGEONS, V212, P20, DOI 10.1016/j.jamcollsurg.2010.09.026; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Kocher MS, 1996, AM J SPORT MED, V24, P665, DOI 10.1177/036354659602400517; Koehle MS, 2002, SPORTS MED, V32, P785, DOI 10.2165/00007256-200232120-00003; Langran M, 2002, BRIT J SPORT MED, V36, P135, DOI 10.1136/bjsm.36.2.135; Leppanen M, 2014, SPORTS MED, V44, P473, DOI 10.1007/s40279-013-0136-8; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Matter-Walstra K, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-25; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; McDonald KM, 2002, AHRQ PUBLICATION, V02-0038; Mullins PM, 2014, AM J EMERG MED; Murray IR, 2011, INJURY, V42, P687, DOI 10.1016/j.injury.2010.12.012; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; RALIS ZA, 1988, LANCET, V1, P589; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Ruedl G, 2010, BRIT J SPORT MED, V44, P204, DOI 10.1136/bjsm.2009.066779; Ruedl G, 2012, BRIT J SPORT MED, V46, P1091, DOI 10.1136/bjsports-2012-091374; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Shadish W., 2001, EXPT QUASIEXPERIMENT; Shen YC, 2011, JAMA-J AM MED ASSOC, V305, P2440, DOI 10.1001/jama.2011.811; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Steventon A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-377; Veille info tourisme, 2012, VEILL INF TOUR	40	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124644	10.1371/journal.pone.0124644	http://dx.doi.org/10.1371/journal.pone.0124644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970625	Green Submitted, Green Published, gold			2022-12-27	WOS:000354544200046
J	Guertin, KA; Gu, FY; Wacholder, S; Freedman, ND; Panagiotou, OA; Reyes-Guzman, C; Caporaso, NE				Guertin, Kristin A.; Gu, Fangyi; Wacholder, Sholom; Freedman, Neal D.; Panagiotou, Orestis A.; Reyes-Guzman, Carolyn; Caporaso, Neil E.			Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial	PLOS ONE			English	Article							NICOTINE DEPENDENCE PHENOTYPE; FAGERSTROM TEST; LUNG HEALTH; SMOKING; DIAGNOSIS; COPD; QUESTIONNAIRE; PREVALENCE; PREDICTORS; SYMPTOMS	Background Time to first cigarette (TTFC) after waking is an indicator of nicotine dependence. The association between TTFC and chronic obstructive pulmonary disease (COPD), the third leading cause of death in the United States, has not yet been reported. Methods We investigated the cross-sectional association between TTFC and prevalent COPD among 6,108 current smokers in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. COPD was defined as a self-reported diagnosis of emphysema, chronic bronchitis, or both. Current smokers in PLCO reported TTFC, the amount of time they typically waited before smoking their first cigarette of the day after waking, in four categories: <= 5, 6-30, 31-60, or >60 minutes. We used logistic regression models to investigate the association between TTFC and prevalent COPD with adjustments for age, gender, race, education, and smoking (cigarettes/day, years smoked during lifetime, pack-years, age at smoking initiation), and prior lung cancer diagnosis. Results COPD was reported by 19% of these 6,108 smokers. Individuals with the shortest TTFC had the greatest risk of COPD; compared to those with the longest TTFC (>60 minutes) the adjusted odds ratios (OR) and 95% confidence intervals (CI) for COPD were 1.48 (95% CI, 1.15-1.91), 1.64 (95% CI, 1.29-2.08), 2.18 (95% CI, 1.65-2.87) for those with TTFC 31-60 minutes, 6-30 minutes, and <= 5 minutes, respectively (P-trend <0.0001). The association between TTFC and emphysema was similar to that for bronchitis, albeit the ORs were slightly stronger for chronic bronchitis; comparing TTFC <= 5 minutes to >60 minutes, the adjusted OR (95% CI) was 2.29 (1.69-3.12) for emphysema and 2.99 (1.95-4.59) for chronic bronchitis. Conclusions Current smokers with shorter TTFC have increased risk of COPD compared to those with longer TTFC, even after comprehensive adjustment for established smoking covariates. Future epidemiologic studies, including prospective designs, should incorporate TTFC to better assess disease risk and evaluate the potential utility of TTFC as a COPD screening tool for smokers in the clinical setting.	[Guertin, Kristin A.; Freedman, Neal D.] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Gu, Fangyi; Reyes-Guzman, Carolyn; Caporaso, Neil E.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Wacholder, Sholom; Panagiotou, Orestis A.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Guertin, KA (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	kristin.guertin@nih.gov; Caporaso@nih.gov	Panagiotou, Orestis/AAI-1268-2021; Panagiotou, Orestis A/I-5934-2015; Freedman, Neal David/B-9741-2015	Panagiotou, Orestis A/0000-0001-9604-8380; Freedman, Neal David/0000-0003-0074-1098; Guertin, Kristin/0000-0003-2255-3928; Reyes-Guzman, Carolyn/0000-0001-5027-8228	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; Berlin I, 2008, PREV MED, V47, P447, DOI 10.1016/j.ypmed.2008.06.008; Bernstein SL, 2008, NICOTINE TOB RES, V10, P1277, DOI 10.1080/14622200802239272; Branstetter SA, 2013, CANCER EPIDEM BIOMAR, V22, P615, DOI 10.1158/1055-9965.EPI-12-0842; Centers for Disease Control and Prevention, 2014, CURR CIG SMOK AD US; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Gu FY, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju118; Hatsukami DK, 2006, CANCER EPIDEM BIOMAR, V15, P2355, DOI 10.1158/1055-9965.EPI-06-0240; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HECHT SS, 1993, NEW ENGL J MED, V329, P1543, DOI 10.1056/NEJM199311183292105; HERNING RI, 1983, CLIN PHARMACOL THER, V33, P84, DOI 10.1038/clpt.1983.12; Jimemez-Ruiz CA, 2004, NICOTINE TOB RES, V6, P649, DOI 10.1080/14622200410001727948; Ruiz CAJ, 2012, NICOTINE TOB RES, V14, P1035, DOI 10.1093/ntr/nts001; Jimenez-Ruiz CA, 2001, CHEST, V119, P1365, DOI 10.1378/chest.119.5.1365; Kanner RE, 1999, AM J MED, V106, P410, DOI 10.1016/S0002-9343(99)00056-X; Kim DK, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-9; Kubik A, 2008, NEOPLASMA, V55, P192; Kunze U, 2007, NICOTINE TOB RES, V9, P625, DOI 10.1080/14622200601096998; Murgia N, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-49; Muscat JE, 2012, CANCER CAUSE CONTROL, V23, P497, DOI 10.1007/s10552-012-9909-x; Muscat JE, 2011, CANCER-AM CANCER SOC, V117, P5370, DOI 10.1002/cncr.26236; Muscat JE, 2009, CANCER EPIDEM BIOMAR, V18, P3415, DOI 10.1158/1055-9965.EPI-09-0737; National Heart Lung and Blood Institute, 2012, MORB MORT 2012 CHART; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI DOI 10.1016/S0197-2456(00)00098-2; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rostron BL, 2014, JAMA INTERN MED, V174, P1922, DOI 10.1001/jamainternmed.2014.5219; Schnoll RA, 2013, ADDICTION, V108, P1989, DOI 10.1111/add.12285; Shahab L, 2006, THORAX, V61, P1043, DOI 10.1136/thx.2006.064410; Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence, 2007, Nicotine Tob Res, V9 Suppl 4, pS555, DOI 10.1080/14622200701673480; van der Meer RM., 2003, COCHRANE DB SYST REV, V2003, pCd002999, DOI DOI 10.1002/14651858.CD002999; Vozoris NT, 2011, RESP MED, V105, P477, DOI 10.1016/j.rmed.2010.08.011	33	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125973	10.1371/journal.pone.0125973	http://dx.doi.org/10.1371/journal.pone.0125973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985429	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300031
J	Niizato, T; Gunji, YP				Niizato, Takayuki; Gunji, Yukio-Pegio			Ongoing Processes in a Fitness Network Model under Restricted Resources	PLOS ONE			English	Article							EMERGENCE; POWER	In real networks, the resources that make up the nodes and edges are finite. This constraint poses a serious problem for network modeling, namely, the compatibility between robustness and efficiency. However, these concepts are generally in conflict with each other. In this study, we propose a new fitness-driven network model for finite resources. In our model, each individual has its own fitness, which it tries to increase. The main assumption in fitness-driven networks is that incomplete estimation of fitness results in a dynamical growing network. By taking into account these internal dynamics, nodes and edges emerge as a result of exchanges between finite resources. We show that our network model exhibits exponential distributions in the in- and out-degree distributions and a power law distribution of edge weights. Furthermore, our network model resolves the trade-off relationship between robustness and efficiency. Our result suggests that growing and anti-growing networks are the result of resolving the trade-off problem itself.	[Niizato, Takayuki] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Gunji, Yukio-Pegio] Waseda Univ, Sch Fundamental Sci & Engn, Tokyo, Japan	University of Tsukuba; Waseda University	Niizato, T (corresponding author), Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan.	t_niizato@yahoo.co.jp			Grants-in-Aid for Scientific Research [25280091] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Achliopatas D, 2009, SCIENCE, V1453, P323; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Antal T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026103; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066149; Bianconi G, 2005, EUROPHYS LETT, V71, P1029, DOI 10.1209/epl/i2005-10167-2; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; D'Souza RM, 2007, EUR PHYS J B, V59, P535, DOI 10.1140/epjb/e2007-00310-5; Dorogovtsev S. N., 2009, LECT COMPLEX NETWORK; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Emmerson M, 2004, P ROY SOC B-BIOL SCI, V271, P397, DOI 10.1098/rspb.2003.2592; Ergun G, 2002, PHYSICA A, V303, P261, DOI 10.1016/S0378-4371(01)00408-3; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Li X, 2003, PHYSICA A, V328, P274, DOI 10.1016/S0378-4371(03)00604-6; Mandelbrot B., 1953, COMMUN THEOR, P486; Meusel R, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P427, DOI 10.1145/2567948.2576928; Niizato T, 2013, BIOSYSTEMS, V111, P145, DOI 10.1016/j.biosystems.2012.12.003; Oka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060398; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Stouffer DB, 2010, FUNCT ECOL, V24, P44, DOI 10.1111/j.1365-2435.2009.01644.x; Tong JY, 2011, PHYSICA A, V390, P1826, DOI 10.1016/j.physa.2010.12.024; Ulanowicz R.E., 1997, ECOLOGY ASCENDENT PE; Ulanowicz RE, 2002, BIOSYSTEMS, V64, P13, DOI 10.1016/S0303-2647(01)00170-8; Vega YM, 2004, PHYSICA A, V343, P279, DOI 10.1016/j.physa.2004.05.033; Wen GH, 2011, PHYSICA A, V390, P4012, DOI 10.1016/j.physa.2011.06.027; Xu XJ, 2010, PHYSCS PROC, V3, P1795, DOI 10.1016/j.phpro.2010.07.021; Zheng DF, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.040102; Zhengping Fan, 2004, Journal of Control Theory and Applications, V1, P60	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127284	10.1371/journal.pone.0127284	http://dx.doi.org/10.1371/journal.pone.0127284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985301	Green Submitted, Green Published, gold			2022-12-27	WOS:000354917300110
J	Abdullah, KG; Ramayya, A; Thawani, JP; Macyszyn, L; Martinez-Lage, M; O'Rourke, DM; Brem, S				Abdullah, Kalil G.; Ramayya, Ashwin; Thawani, Jayesh P.; Macyszyn, Lukasz; Martinez-Lage, Maria; O'Rourke, Donald M.; Brem, Steven			Factors Associated with Increased Survival after Surgical Resection of Glioblastoma in Octogenarians	PLOS ONE			English	Article							RADIOTHERAPY PLUS CONCOMITANT; ELDERLY-PATIENTS; ADJUVANT TEMOZOLOMIDE; PERFORMANCE STATUS; RADIATION-THERAPY; OLDER PATIENTS; MULTIFORME; OUTCOMES; EXTENT; AGE	Elderly patients with glioblastoma represent a clinical challenge for neurosurgeons and oncologists. The data available on outcomes of patients greater than 80 undergoing resection is limited. In this study, factors linked to increased survival in patients over the age of 80 were analyzed. A retrospective chart review of all patients over the age of 80 with a new diagnosis of glioblastoma and who underwent surgical resection with intent for maximal resection were examined. Patients who had only stereotactic biopsies were excluded. Immunohistochemical expression of oncogenic drivers (p53, EGFR, IDH-1) and a marker of cell proliferation (Ki-67 index) performed upon routine neuropathological examination were recorded. Stepwise logistic regression and Kaplan Meier survival curves were plotted to determine correlations to overall survival. Fifty-eight patients fit inclusion criteria with a mean age of 83 (range 80-93 years). The overall median survival was 4.2 months. There was a statistically significant correlation between Karnofsky Performance Status (KPS) and overall survival (P < 0.05). There was a significantly longer survival among patients undergoing either radiation alone or radiation and chemotherapy compared to those who underwent no postoperative adjuvant therapy (p < 0.05). There was also an association between overall survival and lack of p53 expression (p < 0.001) and lack of EGFR expression (p < 0.05). In this very elderly population, overall survival advantage was conferred to those with higher preoperative KPS, postoperative adjuvant therapy, and lack of protein expression of EGFR and p53. These findings may be useful in clinical decision analysis for management of patients with glioblastoma who are octogenarians, and also validate the critical role of EGFR and p53 expression in oncogenesis, particularly with advancing age.	[Abdullah, Kalil G.; Ramayya, Ashwin; Thawani, Jayesh P.; Macyszyn, Lukasz; O'Rourke, Donald M.; Brem, Steven] Univ Penn, Dept Neurosurg, Perelman Sch Med, Hosp Univ Penn, Philadelphia, PA 19104 USA; [Martinez-Lage, Maria] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Hosp Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Brem, S (corresponding author), Univ Penn, Dept Neurosurg, Perelman Sch Med, Hosp Univ Penn, Philadelphia, PA 19104 USA.	Steven.Brem@uphs.upenn.edu	Martinez-Lage, Maria/S-6665-2019; Brem, Steven/HIK-3353-2022; O'Rourke, Donald/AAC-3376-2021	O'Rourke, Donald/0000-0002-8479-7314; Martinez-Lage, Maria/0000-0002-5859-7562				Arvold ND, 2014, NEURO-ONCOLOGY, V16, P1530, DOI 10.1093/neuonc/nou060; Bauchet L, 2014, NEUROONCOL; Chaichana KL, 2011, J NEUROSURG, V114, P587, DOI 10.3171/2010.8.JNS1081; Combs SE, 2008, INT J RADIAT ONCOL, V70, P987, DOI 10.1016/j.ijrobp.2007.07.2368; Coppola D, 2014, J GERIATR ONCOL, V5, P389, DOI 10.1016/j.jgo.2014.08.003; Ewelt C, 2011, J NEURO-ONCOL, V103, P611, DOI 10.1007/s11060-010-0429-9; Fiorentino A, 2013, AM J CLIN ONCOL; Gzell C, 2014, J NEURO-ONCOL, V119, P187, DOI 10.1007/s11060-014-1472-8; Hoffermann M, 2015, CLIN NEUROL NEUROSUR, V128, P60, DOI 10.1016/j.clineuro.2014.11.006; Iwamoto FM, 2008, ANN NEUROL, V64, P628, DOI 10.1002/ana.21521; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Kita D, 2009, NEUROEPIDEMIOLOGY, V33, P17, DOI 10.1159/000210017; Kumthekar PU, 2014, AM J CANCER RES, V4, P436; Lee JH, 2013, J CLIN NEUROSCI, V20, P503, DOI 10.1016/j.jocn.2012.03.044; Marko NF, 2014, J CLIN ONCOL, V32, P774, DOI 10.1200/JCO.2013.51.8886; Minniti G, 2014, INT J RAD ONCOL BIOL; Minniti G, 2012, INT J RADIAT ONCOL, V83, P93, DOI 10.1016/j.ijrobp.2011.06.1992; Nagpal J, 2006, ANTICANCER RES, V26, P4633; Oszvald A, 2012, J NEUROSURG, V116, P357, DOI 10.3171/2011.8.JNS102114; Roa W, 2004, J CLIN ONCOL, V22, P1583, DOI 10.1200/JCO.2004.06.082; Ruano Y, 2009, AM J CLIN PATHOL, V131, P257, DOI 10.1309/AJCP64YBDVCTIRWV; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Stockhammer Florian, 2014, CNS Oncol, V3, P159, DOI 10.2217/cns.14.11; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Uzuka T, 2014, J NEURO-ONCOL, V116, P299, DOI 10.1007/s11060-013-1291-3	25	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127202	10.1371/journal.pone.0127202	http://dx.doi.org/10.1371/journal.pone.0127202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978638	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100136
J	Din, NU; Ukoumunne, OC; Rubin, G; Hamilton, W; Carter, B; Stapley, S; Neal, RD				Din, Nafees U.; Ukoumunne, Obioha C.; Rubin, Greg; Hamilton, William; Carter, Ben; Stapley, Sal; Neal, Richard D.			Age and Gender Variations in Cancer Diagnostic Intervals in 15 Cancers: Analysis of Data from the UK Clinical Practice Research Datalink	PLOS ONE			English	Article							PRIMARY-CARE; BREAST-CANCER; RISK-FACTORS; SYMPTOMS; OVARIAN; DELAY; LUNG; VALIDATION; AWARENESS; PROSTATE	Background Time from symptomatic presentation to cancer diagnosis (diagnostic interval) is an important, and modifiable, part of the patient's cancer pathway, and can be affected by various factors such as age, gender and type of presenting symptoms. The aim of this study was to quantify the relationships of diagnostic interval with these variables in 15 cancers diagnosed between 2007 and 2010 using routinely collected data from the Clinical Practice Research Datalink (CPRD) in the UK. Methods Symptom lists for each cancer were prepared from the literature and by consensus amongst the clinician researchers, which were then categorised into either NICE qualifying (NICE) or not (non-NICE) based on NICE Urgent Referral Guidelines for Suspected Cancer criteria. Multivariable linear regression models were fitted to examine the relationship between diagnostic interval (outcome) and the predictors: age, gender and symptom type. Results 18,618 newly diagnosed cancer patients aged >= 40 who had a recorded symptom in the preceding year were included in the analysis. Mean diagnostic interval was greater for older patients in four disease sites (difference in days per 10 year increase in age; 95% CI): bladder (10.3; 5.5 to 15.1; P<0.001), kidney (11.0; 3.4 to 18.6; P=0.004), leukaemia (18.5; 8.8 to 28.1; P<0.001) and lung (10.1; 6.7 to 13.4; P<0.001). There was also evidence of longer diagnostic interval in older patients with colorectal cancer (P<0.001). However, we found that mean diagnostic interval was shorter with increasing age in two cancers: gastric (-5.9; -11.7 to -0.2; P=0.04) and pancreatic (-6.0; -11.2 to -0.7; P=0.03). Diagnostic interval was longer for females in six of the gender non-specific cancers (mean difference in days; 95% CI): bladder (12.2; 0.8 to 23.6; P=0.04), colorectal (10.4; 4.3 to 16.5; P=0.001), gastric (14.3; 1.1 to 27.6; P=0.03), head and neck (31.3; 6.2 to 56.5; P=0.02), lung (8.0; 1.2 to 14.9; P=0.02), and lymphoma (19.2; 3.8 to 34.7; P=0.01). Evidence of longer diagnostic interval was found for patients presenting with non-NICE symptoms in 10 of 15 cancers (mean difference in days; 95% CI): bladder (62.9; 48.7 to 77.2; P<0.001), breast (115.1; 105.9 to 124.3; P<0.001), cervical (60.3; 31.6 to 89.0; P<0.001), colorectal (25.8; 19.6 to 31.9; P<0.001), gastric (24.1; 3.4 to 44.8; P=0.02), kidney (22.1; 4.5 to 39.7; P=0.01), oesophageal (67.0; 42.1 to 92.0; P<0.001), pancreatic (48.6; 28.1 to 69.1; P<0.001), testicular (36.7; 17.0 to 56.4; P<0.001), and endometrial (73.8; 60.3 to 87.3; P<0.001). Pooled analysis across all cancers demonstrated highly significant evidence of differences overall showing longer diagnostic intervals with increasing age (7.8 days; 6.4 to 9.1; P<0.001); for females (8.9 days; 5.5 to 12.2; P<0.001); and in non-NICE symptoms (27.7 days; 23.9 to 31.5; P<0.001). Conclusions We found age and gender-specific inequalities in time to diagnosis for some but not all cancer sites studied. Whilst these need further explanation, these findings can inform the development and evaluation of interventions intended to achieve timely diagnosis and improved cancer outcomes, such as to provide equity across all age and gender groupings.	[Din, Nafees U.; Neal, Richard D.] Bangor Univ, Coll Hlth & Behav Sci, North Wales Ctr Primary Care Res, Wrexham, Wales; [Ukoumunne, Obioha C.] Univ Exeter, Sch Med, NIHR CLAHRC South West Peninsula, Exeter, Devon, England; [Rubin, Greg] Univ Durham, Wolfson Res Inst, Sch Med Pharm & Hlth, Durham, England; [Hamilton, William; Stapley, Sal] Univ Exeter, Sch Med, Exeter, Devon, England; [Carter, Ben] Cardiff Univ, Cardiff Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales	Bangor University; University of Exeter; Durham University; University of Exeter; Cardiff University	Din, NU (corresponding author), Bangor Univ, Coll Hlth & Behav Sci, North Wales Ctr Primary Care Res, Wrexham, Wales.	n.u.din@bangor.ac.uk	Stapley, Sal/L-7897-2019; Din, Nafees U/B-5301-2008	Stapley, Sal/0000-0001-9893-2794; Din, Nafees U/0000-0001-5739-1207; Carter, Ben/0000-0003-0318-8865; Hamilton, William/0000-0003-1611-1373	National Cancer Action Team in England, UK; Department of Health Cancer Policy Team in England, UK; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust; Betsi Cadwaladr University Health Board; Public Health Wales	National Cancer Action Team in England, UK; Department of Health Cancer Policy Team in England, UK; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust; Betsi Cadwaladr University Health Board; Public Health Wales	Funding: This research was funded by the National Cancer Action Team and the Department of Health Cancer Policy Team in England, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views contained in it are those of the authors and do not represent those of the National Health Service (NHS), the National Institute for Health Research (NIHR) or the Department of Health policy (DoH) in England. OCU is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust. RDN has received funding from both Betsi Cadwaladr University Health Board and Public Health Wales.	Aapro M, 2012, ANN ONCOL SUPPL 6, V23, pvi52; Allgar VL, 2006, BRIT J GEN PRACT, V56, P355; Allgood P, 2011, BRIT J CANCER, V104, DOI [10.1038/bjc.2011.198, DOI 10.1038/BJC.2011.198]; American Cancer Society, 2014, HER CANC FAM CANC SY; [Anonymous], 2009, AGEISM AGE DISCRIMIN; Astin Margaret, 2011, Br J Gen Pract, V61, pe231, DOI 10.3399/bjgp11X572427; Banks J, 2014, LANCET ONCOL, V15, P232, DOI 10.1016/S1470-2045(13)70588-6; Baughan P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606591; Cancer Care Ontario, 2009, DIAGN ASS PROGR ENV; Cancer Research UK, 2011, CANC INC AG 2009 201; Cancer Research UK, 2014, HIGH RISK GROUPS BOW; Chapman KR, 2001, CHEST, V119; Corner J, 2005, THORAX, V60, P314, DOI 10.1136/thx.2004.029264; Davison AC, 1997, BOOTSTRAP METHODS TH; Dawson SJ, 2009, BRIT J CANCER, V101, P1338, DOI 10.1038/sj.bjc.6605317; Department of Health, 2012, 2 ANN REP 2012; Dommett RM, 2012, BRIT J CANCER, V106, P982, DOI 10.1038/bjc.2011.600; Eden B, 2010, PRIMARY CARE CANC AU; Ek S, 2015, HEALTH PROMOT INT, V30, P736, DOI 10.1093/heapro/dat063; Forbes LJL, 2013, BRIT J CANCER, V108, P292, DOI 10.1038/bjc.2012.542; Hamilton W, 2009, BRIT J CANCER, V101, pS80, DOI 10.1038/sj.bjc.6605396; Hamilton W, 2010, BRIT J GEN PRACT, V60, P121, DOI 10.3399/bjgp10X483175; Hamilton WT, 2003, BRIT J GEN PRACT, V53, P929; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660724; Jones CEL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006944; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Khakbazan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110262; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lyratzopoulos G, 2013, ANN ONCOL, V24, P843, DOI 10.1093/annonc/mds526; Lyratzopoulos G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002861; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; Macdonald S, 2006, BRIT J CANCER, V94, P1272, DOI 10.1038/sj.bjc.6603089; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Macmillan Cancer Support, 2022, CANC INF SUPP; National Institute of Health and Care Excellence, 2005, REF GUID SUSP CANC; Neal RD, 2014, BRIT J CANCER, V110, P584, DOI 10.1038/bjc.2013.791; Neal RD, 2009, BRIT J CANCER, V101, pS9, DOI 10.1038/sj.bjc.6605384; Neal RD, 2005, BRIT J CANCER, V92, P1971, DOI 10.1038/sj.bjc.6602623; Nieder AM, 2010, UROL ONCOL-SEMIN ORI, V28, P500, DOI 10.1016/j.urolonc.2008.10.018; O'Mahony M, 2013, EUR J ONCOL NURS, V17, P632, DOI 10.1016/j.ejon.2013.03.012; Office for National Statistics, 2014, STAT B; Olesen F, 2009, BRIT J CANCER, V101, pS5, DOI 10.1038/sj.bjc.6605383; Pancreatic Cancer UK, 2011, STUD SURV 2011; Pilote L, 2007, CMAJ, V176; Potter S, 2007, BMJ-BRIT MED J, V335, P288, DOI 10.1136/bmj.39258.688553.55; Prades J, 2011, BRIT J CANCER, V105, P753, DOI 10.1038/bjc.2011.308; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Rarer Cancer Foundation, 2011, PRIM CAUS AUD EXP PR; Richards MA, 2009, BRIT J CANCER, V101, pS1, DOI 10.1038/sj.bjc.6605382; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Ritvo P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-500; Royal College of General Practitioners, 2011, NAT AUD CANC DIAGN P; Tate AR, 2010, BRIT J CANCER, V102, P947, DOI 10.1038/sj.bjc.6605593; Tate AR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000025; Torring ML, 2011, BRIT J CANCER, V104, P934, DOI 10.1038/bjc.2011.60; Vlassoff C, 2007, J HEALTH POPUL NUTR, V25, P47; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68	58	60	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127717	10.1371/journal.pone.0127717	http://dx.doi.org/10.1371/journal.pone.0127717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978414	Green Published, Green Accepted, gold			2022-12-27	WOS:000354916100151
J	Park, DU; Choi, YY; Ahn, JJ; Lim, HK; Kim, SK; Roh, S; Cheong, HK; Leem, JH; Koh, DH; Jung, HJ; Lee, KM; Lee, JH; Kim, YH; Lim, SY; Paek, DM; Lim, CM; Hong, SJ				Park, Dong-Uk; Choi, Ye-Yong; Ahn, Jong-Ju; Lim, Heung-Kyu; Kim, Sun-Kyung; Roh, Hyun-Suk; Cheong, Hae-Kwan; Leem, Jong-Han; Koh, Dong-Hee; Jung, Hye-Jung; Lee, Kyoung-Mu; Lee, Jong-Hyeon; Kim, Yong-Hwa; Lim, Sin-Ye; Paek, Do-Myung; Lim, Chae-Man; Hong, Soo-Jong			Relationship between Exposure to Household Humidifier Disinfectants and Risk of Lung Injury: A Family-Based Study	PLOS ONE			English	Article							HEALTH	Background In South Korea, a cluster of acute lung disease patients included lung injury disease suspected of being caused by the use of humidifier disinfectants. We examined the relationship between humidifier disinfectant exposure and clinically diagnosed humidifier disinfectant-associated lung injury (HDLI) in a family-based study. Methods This case-control study included 169 clinically confirmed HDLI cases and 303 family controls who lived with the HDLI patients. A range of information on exposure to humidifier disinfectants was obtained using a structured questionnaire and field investigations. Odds ratios (ORs) and confidence intervals (CIs) were estimated using unconditional logistic regression models that were adjusted for age, sex, presence of a factory within 1 km of residence, and the number of household chemical products used. Results HDLI risk increased approximately two-fold or more among the highest quartile compared with the lowest quartile in terms of the hours sleeping in a room with an operating humidifier treated with disinfectant (adjusted OR = 2.0, 95% CI = 1.1-3.7), average hours of disinfectant-treated humidifier use per day (adjusted OR = 2.1, 95% CI = 1.0-4.5), airborne disinfectant intensity (adjusted OR = 2.6, 95% CI = 1.2-5.3), and cumulative disinfectant inhalation level (adjusted OR = 2.0, 95% CI = 1.0-4.1). HDLI risk increased as the distance of the bed from humidifier gets shorter; compared with longer distance (>1 m), the odds ratio was 2.7 for 0.5 to 1 m (95% CI = 1.5-5.1) and 13.2 for <0.5 m (95 % CI = 2.4-73.0). Conclusions The use of household humidifier disinfectants was associated with HDLI risk in a dose-response manner.	[Park, Dong-Uk; Jung, Hye-Jung; Lee, Kyoung-Mu] Korea Natl Open Univ, Dept Environm Hlth, Seoul 110791, South Korea; [Choi, Ye-Yong; Ahn, Jong-Ju; Lim, Heung-Kyu; Kim, Sun-Kyung] Asian Citizens Ctr Environm & Hlth, Seoul 110460, South Korea; [Roh, Hyun-Suk] Data Analyt Team, Tiny Labs, Seoul 140822, South Korea; [Cheong, Hae-Kwan] Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Suwon 440746, South Korea; [Leem, Jong-Han] Inha Univ Hosp, Dept Occupat & Environm Med, Inchon, South Korea; [Koh, Dong-Hee] Catholic Kwandong Univ, Int St Marys Hosp, Dept Occupat & Environm Med, Inchon 210701, South Korea; [Lee, Jong-Hyeon] NeoEnBiz Co, Inst Environm Safety & Protect, Bucheon 420806, South Korea; [Kim, Yong-Hwa] Korea Inst Toxicol, Daejeon 305343, South Korea; [Lim, Sin-Ye] Kyung Hee Univ, Coll Med, Dept Occupat & Environm Med, Seoul 130791, South Korea; [Paek, Do-Myung] Seoul Natl Univ, Sch Publ Hlth, Seoul 151742, South Korea; [Lim, Chae-Man] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Pulm Med & Crit Care Med, Seoul, South Korea; [Hong, Soo-Jong] Univ Ulsan, Asan Med Ctr, Childhood Asthma Atopy Ctr, Coll Med,Dept Pediat, Seoul, South Korea	Korea National Open University; Sungkyunkwan University (SKKU); Inha University; Inha University Hospital; Catholic Kwandong University; Korea Institute of Toxicology; Kyung Hee University; Seoul National University (SNU); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Park, DU (corresponding author), Korea Natl Open Univ, Dept Environm Hlth, Seoul 110791, South Korea.	pdw545@gmail.com	Hong, Soo-Jong/AAR-1788-2020; Paek, Domyung/D-5747-2012; Roh, Seong Woon/C-7688-2011	Hong, Soo-Jong/0000-0003-1409-2113; Roh, Seong Woon/0000-0003-0609-6130; Cheong, Hae-Kwan/0000-0003-2758-9399	Korea Center for Disease Control and Prevention (KCDC) [4851-300-210-13]	Korea Center for Disease Control and Prevention (KCDC)	This study was supported by the Korea Center for Disease Control and Prevention (KCDC) (4851-300-210-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprea C, 2000, ENVIRON HEALTH PERSP, V108, P521, DOI 10.2307/3454613; Bhatia P, 2000, POSTGRAD MED J, V76, P683, DOI 10.1136/pmj.76.901.683; Brandlistuen RE, 2013, INT J EPIDEMIOL, V42, P1702, DOI 10.1093/ije/dyt183; Dearry A, 1999, CHILDRENS ENV HLTH D; Etzel R, 1999, ENVIRON HEALTH PERSP, V107, P463; Hong S. B., 2014, THORAX; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P17, DOI 10.1159/000318264; KCDC, 2011, INT REP EP INV LUNG; KCDC, 2011, AN RES CHEM COMP VAR AN RES CHEM COMP VAR; KCDC, 2011, HOSP BAS CAS CONTR S; Kim HJ, 2014, THORAX; Kim KW, 2014, AM J RESP CRIT CARE, V189, P48, DOI 10.1164/rccm.201306-1088OC; Kim YB, 2013, 2013 ANN M; KSEH, 2012, CAS HLTH PROBL DUE U; LEBOWITZ MD, 1995, SCI TOTAL ENVIRON, V168, P109, DOI 10.1016/0048-9697(95)04614-7; Lee E, 2013, J KOREAN MED SCI, V28, P915, DOI 10.3346/jkms.2013.28.6.915; Lee JH, 2012, ENVIRON SCI TECHNOL, V46, P2498, DOI 10.1021/es300567j; Milne RL, 2011, INT J EPIDEMIOL, V40, P1342, DOI 10.1093/ije/dyr110; Park D, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-70; Park DU, 2014, INDOOR AIR; SHIUE ST, 1990, NEW YORK STATE J MED, V90, P263; SUDA T, 1995, CHEST, V107, P711, DOI 10.1378/chest.107.3.711; Thornburg KL, 2000, HEMODYNAMIC CHANGES; WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P1257, DOI 10.1001/jama.269.10.1257; Yang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064430	25	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124610	10.1371/journal.pone.0124610	http://dx.doi.org/10.1371/journal.pone.0124610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978522	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100016
J	Schuld, NJ; Hussong, SA; Kapphahn, RJ; Lehmann, U; Roehrich, H; Rageh, AA; Heuss, ND; Bratten, W; Gregerson, DS; Ferrington, DA				Schuld, Nathan J.; Hussong, Stacy A.; Kapphahn, Rebecca J.; Lehmann, Ute; Roehrich, Heidi; Rageh, Abrar A.; Heuss, Neal D.; Bratten, Wendy; Gregerson, Dale S.; Ferrington, Deborah A.			Immunoproteasome Deficiency Protects in the Retina after Optic Nerve Crush	PLOS ONE			English	Article							GANGLION-CELL DEATH; SELECTIVE INHIBITOR; OXIDATIVE STRESS; SUBUNITS MECL-1; AXONAL INJURY; UP-REGULATION; IGF-I; PROTEASOME; ACTIVATION; INDUCTION	The immunoproteasome is upregulated by disease, oxidative stress, and inflammatory cytokines, suggesting an expanded role for the immunoproteasome in stress signaling that goes beyond its canonical role in generating peptides for antigen presentation. The signaling pathways that are regulated by the immunoproteasome remain elusive. However, previous studies suggest a role for the immunoproteasome in the regulation of PTEN and NF-kappa B signaling. One well-known pathway upstream of NF-kappa B and downstream of PTEN is the Akt signaling pathway, which is responsible for mediating cellular survival and is modulated after optic nerve crush (ONC). This study investigated the role of retinal immunoproteasome after injury induced by ONC, focusing on the Akt cell survival pathway. Retinas or retinal pigment epithelial (RPE) cells from wild type (WT) and knockout (KO) mice lacking either one (LMP2) or two (LMP7 and MECL-1) catalytic subunits of the immunoproteasome were utilized in this study. We show that mRNA and protein levels of the immunoproteasome subunits are significantly upregulated in WT retinas following ONC. Mice lacking the immunoproteasome subunits show either a delayed or dampened apoptotic response as well as altered Akt signaling, compared to WT mice after ONC. Treatment of the RPE cells with insulin growth factor-1 (IGF-1) to stimulate Akt signaling confirmed that the immunoproteasome modulates this pathway, and most likely modulates parallel pathways as well. This study links the inducible expression of the immunoproteasome following retinal injury to Akt signaling, which is important in many disease pathways.	[Schuld, Nathan J.; Hussong, Stacy A.; Kapphahn, Rebecca J.; Lehmann, Ute; Rageh, Abrar A.; Heuss, Neal D.; Bratten, Wendy; Gregerson, Dale S.; Ferrington, Deborah A.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; [Hussong, Stacy A.] Univ Minnesota, Grad Program Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Lehmann, Ute] Univ Minnesota, Grad Program Microbiol Immunol & Canc Biol, Minneapolis, MN USA; [Roehrich, Heidi] Univ Minnesota, Histol Core Vis Res, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ferrington, DA (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.	ferri013@umn.edu		Ferrington, Deborah/0000-0003-2561-7464; Gregerson, Dale/0000-0001-5769-796X	National Institutes of Health [AG032391, EY013623, EY011542, P30-EY11374, T32-AG029796, T32-EY07133]; Research to Prevent Blindness; Minnesota Lions Clubs; NATIONAL EYE INSTITUTE [R01EY021003, P30EY011374, R01EY013623, R01EY011542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032391, T32AG029796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Minnesota Lions Clubs; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health AG032391 (DAF), EY013623 (DAF), EY011542 (DSG), P30-EY11374 (Core Grant for Vision Research), T32-AG029796 (NS and SH, Training Grant: Functional Proteomics of Aging), T32-EY07133 (UL, Training Grant for Vision Science), an unrestricted grant from the Research to Prevent Blindness to the Dept OVNS, and the Minnesota Lions Clubs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian A, 2014, J NEUROSCI, V34, P10582, DOI 10.1523/JNEUROSCI.1912-14.2014; ALLCUTT D, 1984, DEV BRAIN RES, V16, P231, DOI 10.1016/0165-3806(84)90028-2; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Cai ZP, 2008, FASEB J, V22, P4248, DOI 10.1096/fj.08-105940; Caudill CM, 2006, J IMMUNOL, V176, P4075, DOI 10.4049/jimmunol.176.7.4075; Chen A, 2002, GLIA, V38, P115, DOI 10.1002/glia.10061; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Cui Q, 2009, NEUROSCIENCE, V158, P1039, DOI 10.1016/j.neuroscience.2008.07.036; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; Ferrer I, 2004, J NEUROPATH EXP NEUR, V63, P484, DOI 10.1093/jnen/63.5.484; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Ferrington DA, 2006, EXP EYE RES, V83, P638, DOI 10.1016/j.exer.2006.03.003; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Frank M, 1996, GLIA, V16, P227, DOI 10.1002/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Gregerson DS, 2006, INVEST OPHTH VIS SCI, V47, P5385, DOI 10.1167/iovs.06-0636; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Hayashi Takuma, 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/476498; Heuss ND, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0143-1; HIRSCHBERG DL, 1994, J NEUROIMMUNOL, V50, P9, DOI 10.1016/0165-5728(94)90209-7; Homma K, 2007, NEUROCHEM INT, V50, P741, DOI 10.1016/j.neuint.2007.01.011; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Hussong SA, 2011, INVEST OPHTH VIS SCI, V52, P714, DOI 10.1167/iovs.10-6032; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jang ER, 2012, MOL BIOSYST, V8, P2295, DOI 10.1039/c2mb25125f; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kapphahn RJ, 2007, EXP EYE RES, V84, P646, DOI 10.1016/j.exer.2006.12.002; Kapphahn RJ, 2006, EXP EYE RES, V83, P165, DOI 10.1016/j.exer.2005.11.017; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Koriyama Y, 2007, NEUROCHEM INT, V50, P749, DOI 10.1016/j.neuint.2007.01.012; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Lehmann U, 2010, NEUROBIOL DIS, V40, P177, DOI 10.1016/j.nbd.2010.05.022; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Levin LA, 1998, INVEST OPHTH VIS SCI, V39, P157; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Louie JL, 2002, EXP EYE RES, V75, P271, DOI 10.1006/exer.2002.2022; Maldonado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056187; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; McPherson SW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0205-4; McPherson SW, 2006, GLIA, V53, P457, DOI 10.1002/glia.20298; Meiners S, 2014, ANTIOXIDANTS REDOX S; Miller Z, 2013, CURR PHARM DESIGN, V19, P4140, DOI 10.2174/1381612811319220018; Minghetti L, 2005, BRAIN RES REV, V48, P251, DOI 10.1016/j.brainresrev.2004.12.015; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Nakazawa T, 2003, CURR EYE RES, V26, P55, DOI 10.1076/ceyr.26.1.55.14254; Ostrowska H, 2006, INT J BIOCHEM CELL B, V38, P1778, DOI 10.1016/j.biocel.2006.04.011; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Gavilan MP, 2009, AGING CELL, V8, P654, DOI 10.1111/j.1474-9726.2009.00519.x; PETERS JM, 1994, TRENDS BIOCHEM SCI, V19, P377, DOI 10.1016/0968-0004(94)90115-5; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; REIER PJ, 1974, J NEUROCYTOL, V3, P591, DOI 10.1007/BF01097626; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Schuld NJ, 2014, J BIOL CHEM, V289, P6862, DOI 10.1074/jbc.M113.527192; Schuld NJ, 2014, CELL CYCLE, V13, P941, DOI 10.4161/cc.27804; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Smallwood HS, 2011, BIOCHEMISTRY-US, V50, P9911, DOI 10.1021/bi2011866; Teoh CY, 2004, ARCH BIOCHEM BIOPHYS, V423, P88, DOI 10.1016/j.abb.2003.12.001; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Vorwerk CK, 2004, BRAIN RES BULL, V62, P485, DOI 10.1016/S0361-9230(03)00075-3; Walker Chandler L, 2013, Front Biol (Beijing), V8, DOI 10.1007/s11515-013-1255-1; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Wehenkel M, 2012, BRIT J CANCER, V107, P53, DOI 10.1038/bjc.2012.243; Zaiss DMW, 2011, J IMMUNOL, V187, P2302, DOI 10.4049/jimmunol.1101003; Zu LY, 2010, J MOL CELL CARDIOL, V49, P5, DOI 10.1016/j.yjmcc.2010.02.007	80	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126768	10.1371/journal.pone.0126768	http://dx.doi.org/10.1371/journal.pone.0126768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978061	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100099
J	Baez, S; Malizia, A; Carilla, J; Blundo, C; Aguilar, M; Aguirre, N; Aquirre, Z; Alvarez, E; Cuesta, F; Duque, A; Farfan-Rios, W; Garcia-Cabrera, K; Grau, R; Homeier, J; Linares-Palomino, R; Malizia, LR; Cruz, OM; Osinaga, O; Phillips, OL; Reynel, C; Silman, MR; Feeley, KJ				Baez, Selene; Malizia, Agustina; Carilla, Julieta; Blundo, Cecilia; Aguilar, Manuel; Aguirre, Nikolay; Aquirre, Zhofre; Alvarez, Esteban; Cuesta, Francisco; Duque, Alvaro; Farfan-Rios, William; Garcia-Cabrera, Karina; Grau, Ricardo; Homeier, Juergen; Linares-Palomino, Reynaldo; Malizia, Lucio R.; Cruz, Omar Melo; Osinaga, Oriana; Phillips, Oliver L.; Reynel, Carlos; Silman, Miles R.; Feeley, Kenneth J.			Large-Scale Patterns of Turnover and Basal Area Change in Andean Forests	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; TROPICAL RAIN-FOREST; TREE MORTALITY; CLIMATE-CHANGE; CARBON BALANCE; TEMPERATURE; DYNAMICS; RATES; PRECIPITATION; GRADIENTS	General patterns of forest dynamics and productivity in the Andes Mountains are poorly characterized. Here we present the first large-scale study of Andean forest dynamics using a set of 63 permanent forest plots assembled over the past two decades. In the North-Central Andes tree turnover (mortality and recruitment) and tree growth declined with increasing elevation and decreasing temperature. In addition, basal area increased in Lower Montane Moist Forests but did not change in Higher Montane Humid Forests. However, at higher elevations the lack of net basal area change and excess of mortality over recruitment suggests negative environmental impacts. In North-Western Argentina, forest dynamics appear to be influenced by land use history in addition to environmental variation. Taken together, our results indicate that combinations of abiotic and biotic factors that vary across elevation gradients are important determinants of tree turnover and productivity in the Andes. More extensive and longer-term monitoring and analyses of forest dynamics in permanent plots will be necessary to understand how demographic processes and woody biomass are responding to changing environmental conditions along elevation gradients through this century.	[Baez, Selene; Cuesta, Francisco] Consorcio El Desarrollo Sostenible Ecoreg Andina, Quito, Ecuador; [Baez, Selene] Univ Tecn Particular Loja, Loja, Ecuador; [Malizia, Agustina; Carilla, Julieta; Blundo, Cecilia; Grau, Ricardo] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Malizia, Agustina; Carilla, Julieta; Blundo, Cecilia; Osinaga, Oriana] Univ Nacl Tucuman, IER, San Miguel De Tucuman, Argentina; [Aguilar, Manuel; Linares-Palomino, Reynaldo; Reynel, Carlos] Univ Nacl Agraria Molina, Fac Ciencias Forest, Lima, Peru; [Aguirre, Nikolay; Aquirre, Zhofre] Univ Nacl Loja, Loja, Ecuador; [Alvarez, Esteban] Lab Serv Ecosistem & Cambio Climat, Jardin Bot Medellin, Medellin, Colombia; [Duque, Alvaro] Univ Nacl Colombia, Dept Ciencias Forest, Medellin, Colombia; [Farfan-Rios, William; Garcia-Cabrera, Karina] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Homeier, Juergen] Univ Gottingen, Plant Ecol, D-37073 Gottingen, Germany; [Malizia, Lucio R.] Univ Nacl Jujuy, Fac Ciencias Agr, San Salvador De Jujuy, Argentina; [Malizia, Lucio R.] Fdn ProYungas, San Salvador De Jujuy, Argentina; [Cruz, Omar Melo] Univ Tolima, Grp Invest Biodiversidad & Dinam Ecosistemas Trop, Bogota, Colombia; [Phillips, Oliver L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Feeley, Kenneth J.] Florida Int Univ, Int Ctr Trop Bot, Dept Biol Sci, Miami, FL 33199 USA	Universidad Tecnica Particular de Loja; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; University Nacional Agraria La Molina; Universidad Nacional de Colombia; Wake Forest University; University of Gottingen; Universidad del Tolima; University of Leeds; State University System of Florida; Florida International University	Baez, S (corresponding author), Consorcio El Desarrollo Sostenible Ecoreg Andina, Quito, Ecuador.	selene.baez@condesan.org	Farfan-Rios, William/J-9881-2015; Linares-Palomino, Reynaldo/AAI-1023-2020; Phillips, Oliver/A-1523-2011; Alvarez-Davila, Esteban/AAP-4231-2020; Feeley, Kenneth James/A-7631-2009; Homeier, Jürgen/G-1662-2011	Farfan-Rios, William/0000-0002-3196-0317; Linares-Palomino, Reynaldo/0000-0002-7631-5549; Phillips, Oliver/0000-0002-8993-6168; Alvarez-Davila, Esteban/0000-0001-9032-0099; Feeley, Kenneth James/0000-0002-3618-1144; Homeier, Jürgen/0000-0001-5676-3267; Reynel, Carlos/0000-0002-6173-9023; Cuesta, Francisco/0000-0002-5150-073X	Swiss International Cooperation (COSUDE); German International Cooperation (GIZ) through the Proyecto Tri-Nacional; Federal Ministry of Education and Science of Germany (BMBF); Gordon and Betty Moore Foundation; National Science Foundation (NSF) [0743666]; US National Science Foundation [DEB-1257655]; French Fund for the Environment; NSF (USA); ProYungas Foundation; Secretary of Environment and Sustainable Development of Argentina (National Fund for Enrichment and Conservation of Native Forests); National Environment Research Council (NERC) [ESPA/NE20025291]; European Research Council; Royal Society; Proyecto Prometeo, Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion de la Republica del Ecuador (SENESCYT); NERC [NE/D01025X/1] Funding Source: UKRI; Natural Environment Research Council [NE/B503384/1, NE/D01025X/1] Funding Source: researchfish; Division Of Environmental Biology [1257655] Funding Source: National Science Foundation	Swiss International Cooperation (COSUDE); German International Cooperation (GIZ) through the Proyecto Tri-Nacional; Federal Ministry of Education and Science of Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); US National Science Foundation(National Science Foundation (NSF)); French Fund for the Environment; NSF (USA)(National Science Foundation (NSF)); ProYungas Foundation; Secretary of Environment and Sustainable Development of Argentina (National Fund for Enrichment and Conservation of Native Forests); National Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Proyecto Prometeo, Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion de la Republica del Ecuador (SENESCYT); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This paper has been developed thanks to the financial support of the Swiss International Cooperation (COSUDE, www.cooperacionsuizaenperu.org.pe) to the CIMA project conducted by CONDESAN. The German International Cooperation (GIZ, www.giz.de) through the Proyecto Tri-Nacional supported the workshop where the idea of this study was conceived. AM, JC, RG thank the Consejo Nacional de Ciencias de Investigaciones Cientificas y Tecnicas of Argentina (CONICET, www.conicet.gov.ar). EA OMC thank COLCIENCIAS (www.colciencias.gov.co) and the Jardin Botanico de Medellin (aggreement No. 393 year 2012). JH thanks the Federal Ministry of Education and Science of Germany (BMBF, www.bmbf.de) for financial support within the project "ProBenefit" for establishing permanent plots in Ecuador. MRS, KJF, KGC and WF thank the Andes Biodiversity and Ecosystems Research Group (http://www.andesconservation.org/). MRS and WFR thank the support from Gordon and Betty Moore Foundation's Andes to Amazon initiative (www.moore.org) and National Science Foundation (NSF, www.nsf.gov) (No. 0743666). KJF is supported by the US National Science Foundation (DEB-1257655). LM thanks the NSF (USA), French Fund for the Environment, ProYungas Foundation (www.proyungas.org.ar) and Secretary of Environment and Sustainable Development of Argentina (National Fund for Enrichment and Conservation of Native Forests) that provided support for the establishment of northern subtropical plots. NA, ZA, SB are grateful to the National Environment Research Council (NERC, www.nerk.ac.uk) Project ESPA/NE20025291 for funding field work. RLP, CR and MA thank APRODES (Asociacion Peruana para la Promocion del Desarrollo Sostenible). The first author has also received additional funding to complete this study: Proyecto Prometeo, Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion de la Republica del Ecuador (SENESCYT). SB thanks Proyecto Prometeo, Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion de la Republica del Ecuador (SENESCYT). OLP was supported by a European Research Council Advanced Grant and a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Bellingham PJ, 2009, J ECOL, V97, P472, DOI 10.1111/j.1365-2745.2009.01479.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruijnzeel LA, 1998, ECOLOGY, V79, P3, DOI 10.1890/0012-9658(1998)079[0003:CCATMF]2.0.CO;2; Buytaert W, 2010, HYDROL EARTH SYST SC, V14, P1247, DOI 10.5194/hess-14-1247-2010; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Chazdon RL, 2005, ECOLOGY, V86, P1808, DOI 10.1890/04-0572; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Clark DA, 2004, PHILOS T R SOC B, V359, P477, DOI 10.1098/rstb.2003.1426; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Delaney M, 1997, J TROP ECOL, V13, P697, DOI 10.1017/S0266467400010877; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; Grau HR, 2008, ECOL SOC, V13; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hilker T, 2014, P NATL ACAD SCI USA, V111, P16041, DOI 10.1073/pnas.1404870111; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Huasco WH, 2014, PLANT ECOL DIVERS, V7, P125, DOI 10.1080/17550874.2013.819042; Inc SI, 1989, JMP; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; Leuschner C., 2013, ECOSYSTEM SERVICES B, V221, P117, DOI DOI 10.1007/978-3-642-38137-9_10; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lewis SL, 2004, J ECOL, V92, P929, DOI 10.1111/j.0022-0477.2004.00923.x; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Malhi Y, 2010, CURR OPIN ENV SUST, V2, P237, DOI 10.1016/j.cosust.2010.08.002; Malizia A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073546; Mora DE, 2014, HYDROL EARTH SYST SC, V18, P631, DOI 10.5194/hess-18-631-2014; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pena MA, 2013, FOREST ECOL MANAG, V302, P54, DOI 10.1016/j.foreco.2013.03.025; Phillips O, 2002, SIXTH FRAMEWORK PROG; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; Pitman NCA, 2011, TROP CONSERV SCI, V4, P64, DOI 10.1177/194008291100400107; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; Rivas-Martinez S., 2008, WORLDWIDE BIOCLIMATI; Ruiz D, 2008, SCI TOTAL ENVIRON, V398, P122, DOI 10.1016/j.scitotenv.2008.02.038; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; Silva CE, 2013, GLOBAL CHANGE BIOL, V19, P3423, DOI 10.1111/gcb.12312; Spracklen DV, 2014, BIOGEOSCIENCES, V11, P2741, DOI 10.5194/bg-11-2741-2014; Stephenson NL, 2011, ECOL MONOGR, V81, P527, DOI 10.1890/10-1077.1; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Sundqvist MK, 2013, ANNU REV ECOL EVOL S, V44, P261, DOI 10.1146/annurev-ecolsys-110512-135750; Unger M, 2012, OECOLOGIA, V170, P263, DOI 10.1007/s00442-012-2295-y; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Wolf K, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003876; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	53	27	30	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126594	10.1371/journal.pone.0126594	http://dx.doi.org/10.1371/journal.pone.0126594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973977	Green Published, gold			2022-12-27	WOS:000354545600064
J	Krishnamoorthy, S; Alli, P				Krishnamoorthy, Somasundaram; Alli, P.			RETRACTED: A Novel Image Recuperation Approach for Diagnosing and Ranking Retinopathy Disease Level Using Diabetic Fundus Image(Retracted article. See vol.12, art no. e0181891, 2017)	PLOS ONE			English	Article; Retracted Publication								Retinal fundus images are widely used in diagnosing and providing treatment for several eye diseases. Prior works using retinal fundus images detected the presence of exudation with the aid of publicly available dataset using extensive segmentation process. Though it was proved to be computationally efficient, it failed to create a diabetic retinopathy feature selection system for transparently diagnosing the disease state. Also the diagnosis of diseases did not employ machine learning methods to categorize candidate fundus images into true positive and true negative ratio. Several candidate fundus images did not include more detailed feature selection technique for diabetic retinopathy. To apply machine learning methods and classify the candidate fundus images on the basis of sliding window a method called, Diabetic Fundus Image Recuperation (DFIR) is designed in this paper. The initial phase of DFIR method select the feature of optic cup in digital retinal fundus images based on Sliding Window Approach. With this, the disease state for diabetic retinopathy is assessed. The feature selection in DFIR method uses collection of sliding windows to obtain the features based on the histogram value. The histogram based feature selection with the aid of Group Sparsity Non-overlapping function provides more detailed information of features. Using Support Vector Model in the second phase, the DFIR method based on Spiral Basis Function effectively ranks the diabetic retinopathy diseases. The ranking of disease level for each candidate set provides a much promising result for developing practically automated diabetic retinopathy diagnosis system. Experimental work on digital fundus images using the DFIR method performs research on the factors such as sensitivity, specificity rate, ranking efficiency and feature selection time.	[Krishnamoorthy, Somasundaram] PSNA Coll Engn & Technol, Dept Comp Sci & Engn, Dindigul, Tamil Nadu, India; [Alli, P.] Velammal Coll Engn & Technol, Dept Comp Sci & Engn, Madurai, Tamil Nadu, India	PSNA College of Engineering & Technology	Krishnamoorthy, S (corresponding author), PSNA Coll Engn & Technol, Dept Comp Sci & Engn, Dindigul, Tamil Nadu, India.	soma@psnacet.edu.in	P, Alli/AFJ-7184-2022	P, Alli/0000-0001-6131-6250				Aibinu AM, 2010, COMPUT BIOL MED, V40, P81, DOI 10.1016/j.compbiomed.2009.11.004; Akara S, 2011, PROCEEDINGS OF THE W; Akara SK., 2008, ELSEVIER JOURNAL, V32, P720; Akram MU, 2013, ENG COMPUT-GERMANY, V29, P165, DOI 10.1007/s00366-011-0253-7; Atul K, 2012, SECOND INTERNATIONAL; Deepak KS, 2012, IEEE T MED IMAGING, V31, P766, DOI 10.1109/TMI.2011.2178856; Dorota RN, 2014, MEDIAT INFLAMM, V14, P1; Giancardo L, 2012, MED IMAGE ANAL, V16, P216, DOI 10.1016/j.media.2011.07.004; Girish SR, 2011, EXPERT SYST APPL, V39, P1141; Jaya K C, 2012, PROCEDIA ENGINEERING, V30, P297; Jianfei X, 2014, INT J ENDOCRINOL, V14, P65; Kung YH, 2010, J CHIN MED ASSOC, V73, P396, DOI 10.1016/S1726-4901(10)70085-X; Midena E, 2011, SAUDI J OPHTHALMOL, V25, P131, DOI 10.1016/j.sjopt.2011.01.010; Ponnalagu M, 2014, PLOS ONE, V10, P1; Shraddha T, 2013, INT J ENGG TECH, V13, P85; Tomi K, 2013, COMP MATH MATH PHYS, V13, P1; Usman AM, 2012, PATTERN RECOGN, V12, P319	17	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125542	10.1371/journal.pone.0125542	http://dx.doi.org/10.1371/journal.pone.0125542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974230	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600019
J	Xu, ML; Zhang, D; Yang, Y; Liu, Y; Yuan, ZY; Qin, QQ				Xu, Menglong; Zhang, Dong; Yang, Yan; Liu, Yu; Yuan, Zhiyong; Qin, Qianqing			A Split-and-Merge-Based Uterine Fibroid Ultrasound Image Segmentation Method in HIFU Therapy	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; GRAPH-BASED SEGMENTATION; NATURAL IMAGES; BREAST-TUMORS; CLASSIFICATION; TEXTURE; SURGERY	High-intensity focused ultrasound (HIFU) therapy has been used to treat uterine fibroids widely and successfully. Uterine fibroid segmentation plays an important role in positioning the target region for HIFU therapy. Presently, it is completed by physicians manually, reducing the efficiency of therapy. Thus, computer-aided segmentation of uterine fibroids benefits the improvement of therapy efficiency. Recently, most computer-aided ultrasound segmentation methods have been based on the framework of contour evolution, such as snakes and level sets. These methods can achieve good performance, although they need an initial contour that influences segmentation results. It is difficult to obtain the initial contour automatically; thus, the initial contour is always obtained manually in many segmentation methods. A split-and-merge-based uterine fibroid segmentation method, which needs no initial contour to ensure less manual intervention, is proposed in this paper. The method first splits the image into many small homogeneous regions called superpixels. A new feature representation method based on texture histogram is employed to characterize each superpixel. Next, the superpixels are merged according to their similarities, which are measured by integrating their Quadratic-Chi texture histogram distances with their space adjacency. Multiway Ncut is used as the merging criterion, and an adaptive scheme is incorporated to decrease manual intervention further. The method is implemented using Matlab on a personal computer (PC) platform with Intel Pentium Dual-Core CPU E5700. The method is validated on forty-two ultrasound images acquired from HIFU therapy. The average running time is 9.54 s. Statistical results showed that SI reaches a value as high as 87.58%, and normHD is 5.18% on average. It has been demonstrated that the proposed method is appropriate for segmentation of uterine fibroids in HIFU pre-treatment imaging and planning.	[Xu, Menglong; Zhang, Dong; Yang, Yan; Liu, Yu] Wuhan Univ, Sch Phys & Technol, Wuhan 430072, Hubei, Peoples R China; [Yuan, Zhiyong] Wuhan Univ, Sch Comp, Wuhan 430072, Hubei, Peoples R China; [Qin, Qianqing] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Zhang, D (corresponding author), Wuhan Univ, Sch Phys & Technol, Wuhan 430072, Hubei, Peoples R China.	dongz@whu.edu.cn		Zhang, Dong/0000-0003-4006-2698	National Basic Research Program of China [2011CB707900]	National Basic Research Program of China(National Basic Research Program of China)	The authors gratefully acknowledge that this research work was supported by funding from the National Basic Research Program of China under grant no. 2011CB707900 (http://www.973.gov.cn/AreaAppl.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Archip N, 2005, ULTRASOUND MED BIOL, V31, P1485, DOI 10.1016/j.ultrasmedbio.2005.07.005; Belaid A, 2011, IEEE T INF TECHNOL B, V15, P138, DOI 10.1109/TITB.2010.2090889; Cheng HD, 2010, PATTERN RECOGN, V43, P299, DOI 10.1016/j.patcog.2009.05.012; Cong JY, 2014, BIO-MED MATER ENG, V24, P3231, DOI 10.3233/BME-141145; Destrempes F, 2010, ULTRASOUND MED BIOL, V36, P1037, DOI 10.1016/j.ultrasmedbio.2010.04.001; Dutt V, 1996, J ACOUST SOC AM, V99, P3817, DOI 10.1121/1.414999; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Gao L, 2012, MED PHYS, V39, P3299, DOI 10.1118/1.4718565; Garnier C, 2011, IEEE T MED IMAGING, V30, P792, DOI 10.1109/TMI.2010.2095465; Golub G. H., 1989, MATRIX COMPUTATION; Hassan M, 2014, COMPUT METH PROG BIO, V113, P593, DOI 10.1016/j.cmpb.2013.10.012; Huang J, 2013, J VIS COMMUN IMAGE R, V24, P937, DOI 10.1016/j.jvcir.2013.05.013; Huang QH, 2012, ULTRASONICS, V52, P266, DOI 10.1016/j.ultras.2011.08.011; Huang QH, 2014, NEUROCOMPUTING, V129, P216, DOI 10.1016/j.neucom.2013.09.038; Jensen J. A., 1996, Medical & Biological Engineering & Computing, V34, P351; JENSEN JA, 1992, IEEE T ULTRASON FERR, V39, P262, DOI 10.1109/58.139123; Kennedy JE, 2005, NAT REV CANCER, V5, P321, DOI 10.1038/nrc1591; Kennedy JE, 2003, BRIT J RADIOL, V76, P590, DOI 10.1259/bjr/17150274; LEE DT, 1984, IEEE T COMPUT, V33, P1072, DOI 10.1109/TC.1984.1676388; Levinshtein A, 2009, IEEE T PATTERN ANAL, V31, P2290, DOI 10.1109/TPAMI.2009.96; Liu B, 2010, PATTERN RECOGN, V43, P2028, DOI 10.1016/j.patcog.2010.01.002; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Malik J, 2001, INT J COMPUT VISION, V43, P7, DOI 10.1023/A:1011174803800; Mavrelos D, 2010, ULTRASOUND OBST GYN, V35, P238, DOI 10.1002/uog.7482; Mobahi H, 2011, INT J COMPUT VISION, V95, P86, DOI 10.1007/s11263-011-0444-0; Noble JA, 2006, IEEE T MED IMAGING, V25, P987, DOI 10.1109/TMI.2006.877092; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Pele O, 2010, LECT NOTES COMPUT SC, V6312, P749, DOI 10.1007/978-3-642-15552-9_54; Ren XL, 2007, J ULTRAS MED, V26, P201, DOI 10.7863/jum.2007.26.2.201; Shan J, 2012, ULTRASOUND MED BIOL, V38, P262, DOI 10.1016/j.ultrasmedbio.2011.10.022; Shankar PM, 2000, IEEE T ULTRASON FERR, V47, P727, DOI 10.1109/58.842062; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Slabaugh G, 2009, ULTRASOUND MED BIOL, V35, P781, DOI 10.1016/j.ultrasmedbio.2008.10.014; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Tvakkoli J, 2011, THERAPEUTIC ULTRASOU, P137; Varma M, 2003, PROC CVPR IEEE, P691; Wang W, 2012, EUR RADIOL, V22, P2553, DOI 10.1007/s00330-012-2517-z; Weiss Y., 1999, COMP VIS 1999 P 7 IE, V2, P975; Wong A, 2011, IEEE T INF TECHNOL B, V15, P900, DOI 10.1109/TITB.2011.2163724; Wu F, 2004, ULTRASOUND MED BIOL, V30, P245, DOI 10.1016/j.ultrasmedbio.2003.10.010; Yang AY, 2008, COMPUT VIS IMAGE UND, V110, P212, DOI 10.1016/j.cviu.2007.07.005; Yu SX, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P313, DOI 10.1109/iccv.2003.1238361	44	4	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125738	10.1371/journal.pone.0125738	http://dx.doi.org/10.1371/journal.pone.0125738			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973906	Green Submitted, gold, Green Published			2022-12-27	WOS:000354545600026
J	Li, P; Wang, YH; Dai, XY; Zhang, R; Jiang, Z; Jiang, DW; Wang, S; Jiang, HC; Wang, YX; Dong, HL				Li, Ping; Wang, Yanhong; Dai, Xinyue; Zhang, Rui; Jiang, Zhou; Jiang, Dawei; Wang, Shang; Jiang, Hongchen; Wang, Yanxin; Dong, Hailiang			Microbial Community in High Arsenic Shallow Groundwater Aquifers in Hetao Basin of Inner Mongolia, China	PLOS ONE			English	Article							REDUCING BACTERIA; HUHHOT BASIN; SEDIMENTS; MOBILIZATION; PLAIN; IRON; DIVERSITY; GEOCHEMISTRY; SPECIATION; REDUCTION	A survey was carried out on the microbial community of 20 groundwater samples (4 low and 16 high arsenic groundwater) and 19 sediments from three boreholes (two high arsenic and one low arsenic boreholes) in a high arsenic groundwater system located in Hetao Basin, Inner Mongolia, using the 454 pyrosequencing approach. A total of 233,704 sequence reads were obtained and classified into 12-267 operational taxonomic units (OTUs). Groundwater and sediment samples were divided into low and high arsenic groups based on measured geochemical parameters and microbial communities, by hierarchical clustering and principal coordinates analysis. Richness and diversity of the microbial communities in high arsenic sediments are higher than those in high arsenic groundwater. Microbial community structure was significantly different either between low and high arsenic samples or between groundwater and sediments. Acinetobacter, Pseudomonas, Psychrobacter and Alishewanella were the top four genera in high arsenic groundwater, while Thiobacillus, Pseudomonas, Hydrogenophaga, Enterobacteriaceae, Sulfuricurvum and Arthrobacter dominated high arsenic sediments. Archaeal sequences in high arsenic groundwater were mostly related to methanogens. Biota-environment matching and co-inertia analyses showed that arsenic, total organic carbon, SO42-, SO42-/total sulfur ratio, and Fe2+ were important environmental factors shaping the observed microbial communities. The results of this study expand our current understanding of microbial ecology in high arsenic groundwater aquifers and emphasize the potential importance of microbes in arsenic transformation in the Hetao Basin, Inner Mongolia.	[Li, Ping; Wang, Yanhong; Dai, Xinyue; Zhang, Rui; Jiang, Zhou; Jiang, Dawei; Jiang, Hongchen; Wang, Yanxin; Dong, Hailiang] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Wang, Yanhong; Jiang, Zhou; Wang, Yanxin] China Univ Geosci, Sch Environm Studies, Wuhan 430074, Peoples R China; [Wang, Shang] China Univ Geosci, Inst Earth Sci, Beijing BEIJING, Peoples R China; [Dong, Hailiang] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA	China University of Geosciences; China University of Geosciences; China University of Geosciences; University System of Ohio; Miami University	Wang, YX (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China.	yx.wang@cug.edu.cn; dongh@miamioh.edu	wang, yi/GVT-8516-2022; Jiang, Hongchen/I-5838-2016; Jiang, Hongchen/Y-9471-2018; Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022	Jiang, Hongchen/0000-0003-1271-7028; Jiang, Zhou/0000-0002-1716-113X; Dong, Hailiang/0000-0002-7468-1350	National Natural Science Foundation of China [41372348, 41120124003]; Specialized Research Fund for the Doctoral Program of Higher Education of China [2013T60757]; Fundamental Research Funds for the Central Universities [CUG140505]; State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences [GBL11204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences	This research was financially supported by National Natural Science Foundation of China (Grant Nos. 41372348, 41120124003), Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 2013T60757), Fundamental Research Funds for the Central Universities (Grant No. CUG140505) and State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences (Grant No. GBL11204).	Al Lawati WM, 2012, APPL GEOCHEM, V27, P315, DOI 10.1016/j.apgeochem.2011.09.030; Antwis RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085563; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen Chien-Jen, 2014, Reviews on Environmental Health, V29, P13, DOI 10.1515/reveh-2014-0007; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Deng YM, 2011, ENVIRON EARTH SCI, V64, P2001, DOI 10.1007/s12665-011-1020-1; Deng YM, 2009, APPL GEOCHEM, V24, P587, DOI 10.1016/j.apgeochem.2008.12.018; Deng YM, 2009, ENVIRON GEOL, V56, P1467, DOI 10.1007/s00254-008-1243-y; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fan H, 2008, J APPL MICROBIOL, V105, P529, DOI 10.1111/j.1365-2672.2008.03790.x; Fendorf S, 2010, SCIENCE, V328, P1123, DOI 10.1126/science.1172974; Freikowski D, 2010, APPL MICROBIOL BIOT, V88, P1363, DOI 10.1007/s00253-010-2856-0; Garcia-Dominguez E, 2008, FEMS MICROBIOL ECOL, V66, P401, DOI 10.1111/j.1574-6941.2008.00569.x; Giral M, 2010, ENVIRON POLLUT, V158, P1890, DOI 10.1016/j.envpol.2009.10.041; Guo HM, 2013, J GEOCHEM EXPLOR, V135, P130, DOI 10.1016/j.gexplo.2012.06.010; Guo HM, 2013, GEOCHIM COSMOCHIM AC, V112, P130, DOI 10.1016/j.gca.2013.02.031; Guo HM, 2011, ENVIRON POLLUT, V159, P876, DOI 10.1016/j.envpol.2010.12.029; Guo HM, 2008, APPL GEOCHEM, V23, P3267, DOI 10.1016/j.apgeochem.2008.07.010; Haaijer SCM, 2006, FEMS MICROBIOL ECOL, V58, P439, DOI 10.1111/j.1574-6941.2006.00178.x; Handley KM, 2014, ENVIRON MICROBIOL, V16, P3443, DOI 10.1111/1462-2920.12453; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; Herbert KJ, 2012, CHEM-BIOL INTERACT, V198, P38, DOI 10.1016/j.cbi.2012.05.004; Hery M, 2010, GEOBIOLOGY, V8, P155, DOI 10.1111/j.1472-4669.2010.00233.x; Hou WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053350; Jiang Z, 2014, ENVIRON EARTH SCI, V71, P311, DOI 10.1007/s12665-013-2435-7; Jun He, 2009, Frontiers of Earth Science in China, V3, P63, DOI 10.1007/s11707-009-0004-x; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kocar BD, 2010, GEOCHIM COSMOCHIM AC, V74, P980, DOI 10.1016/j.gca.2009.10.023; Larose C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079972; Li P, 2014, GEOMICROBIOL J, V31, P802, DOI 10.1080/01490451.2014.893181; Li P, 2013, GEOMICROBIOL J, V30, P897, DOI 10.1080/01490451.2013.791354; Liao VHC, 2011, J CONTAM HYDROL, V123, P20, DOI 10.1016/j.jconhyd.2010.12.003; Lim KT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/503784; Lin NF, 2002, ENVIRON GEOCHEM HLTH, V24, P249, DOI 10.1023/A:1016079216654; Luo JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108185; Michael HA, 2013, SCIENCE, V341, P852, DOI 10.1126/science.1242212; Muehe EM, 2013, ENVIRON SCI TECHNOL, V47, P8297, DOI 10.1021/es400801z; Mukherjee A, 2009, APPL GEOCHEM, V24, P1835, DOI 10.1016/j.apgeochem.2009.06.005; Mumford AC, 2012, WATER RES, V46, P2859, DOI 10.1016/j.watres.2012.02.044; Neidhardt H, 2012, ENVIRON POLLUT, V163, P8, DOI 10.1016/j.envpol.2011.12.033; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Rawlings DE, 2001, HYDROMETALLURGY, V59, P187, DOI 10.1016/S0304-386X(00)00182-1; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rodriguez-Lado L, 2013, SCIENCE, V341, P866, DOI 10.1126/science.1237484; Ruiz-Chancho MJ, 2007, ANAL BIOANAL CHEM, V387, P627, DOI 10.1007/s00216-006-0939-7; Seabaugh JL, 2006, CLAY CLAY MINER, V54, P67, DOI 10.1346/CCMN.2006.0540109; Shah R, 2013, CHEM ECOL, V29, P427, DOI 10.1080/02757540.2013.774379; Smedley PL, 2003, APPL GEOCHEM, V18, P1453, DOI 10.1016/S0883-2927(03)00062-3; Sultana M, 2011, GEOMICROBIOL J, V28, P198, DOI 10.1080/01490451.2010.490078; Sutton NB, 2009, WATER RES, V43, P1720, DOI 10.1016/j.watres.2009.01.006; vanden Hoven RN, 2004, BBA-BIOENERGETICS, V1656, P148, DOI 10.1016/j.bbabio.2004.03.001; Wade TJ, 2009, INT J ENV RES PUB HE, V6, P1107, DOI 10.3390/ijerph6031107; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062901; Wang YH, 2014, GEOMICROBIOL J, V31, P338, DOI 10.1080/01490451.2013.835886; World Health Organization, 2006, GUIDELINES FOR DRINK; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029593; Xia YJ, 2009, INT J ENV RES PUB HE, V6, P1010, DOI 10.3390/ijerph6031010; Xie XJ, 2011, J GEOCHEM EXPLOR, V110, P155, DOI 10.1016/j.gexplo.2011.05.006; Xiong JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050507; [周文树 Zhou Wenshu], 2008, [分析仪器, Analytical Instrumentation], P18	62	42	46	12	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125844	10.1371/journal.pone.0125844	http://dx.doi.org/10.1371/journal.pone.0125844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970606	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200085
J	Li, Y; Song, YG; Yan, LB; Chen, T; An, ZS				Li, Yun; Song, Yougui; Yan, Libin; Chen, Tao; An, Zhisheng			Timing and Spatial Distribution of Loess in Xinjiang, NW China	PLOS ONE			English	Article							ATMOSPHERIC CIRCULATION PATTERNS; TIEN-SHAN; LIUPAN SHAN; TARIM BASIN; ILI BASIN; DEPOSITS; PROVENANCE; MOUNTAINS; CLIMATE; LUMINESCENCE	Central Asia is one of the most significant loess regions on Earth, with an important role in understanding Quaternary climate and environmental change. However, in contrast to the widely investigated loess deposits in the Chinese Loess Plateau, the Central Asian loess-paleosol sequences are still insufficiently known and poorly understood. Through field investigation and review of the previous literature, the authors have investigated the distribution, thickness and age of the Xinjiang loess, and analyzed factors that control these parameters in the Xinjiang in northwest China, Central Asia. The loess sediments cover river terraces, low uplands, the margins of deserts and the slopes of the Tianshan Mountains and Kunlun Mountains and are also present in the Ili Basin. The thickness of the Xinjiang loess deposits varies from several meters to 670 m. The variation trend of the sand fraction (>63 mu m) grain-size contour can indicate the local major wind directions, so we conclude that the NW and NE winds are the main wind directions in the North and South Xinjiang, and the westerly wind mainly transport dust into the Ili basin. We consider persistent drying, adequate regional wind energy and well-developed river terraces to be the main factors controlling the distribution, thickness and formation age of the Xinjiang loess. The well-outcropped loess sections have mainly developed since the middle Pleistocene in Xinjiang, reflecting the appearance of the persistent drying and the present air circulation system. However, the oldest loess deposits are as old as the beginning of the Pliocene in the Tarim Basin, which suggests that earlier aridification occurred in the Tarim Basin rather than in the Ili Basin and the Junggar Basin.	[Li, Yun; Song, Yougui; Yan, Libin; Chen, Tao; An, Zhisheng] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710061, Peoples R China; [Song, Yougui] Joint Ctr Global Change Studies, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Earth Environment, CAS	Song, YG (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710061, Peoples R China.	ygsong@loess.llqg.ac.cn	Song, yougui/I-8813-2014; AN, Zhisheng/F-8834-2012	Song, yougui/0000-0003-0064-3260; an, zhi sheng/0000-0002-9538-9826	National Basic Research Program of China, Institute of Earth Environment and Scientific and Technological Innovation Team of Chinese Academy of Sciences [2013CB95594, 2010CB833406, ZZBS1301]	National Basic Research Program of China, Institute of Earth Environment and Scientific and Technological Innovation Team of Chinese Academy of Sciences	This study is funded by the National Basic Research Program of China (No. 2013CB95594, 2010CB833406), Institute of Earth Environment (ZZBS1301) and Scientific and Technological Innovation Team of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen EM, 2001, INT J CLIMATOL, V21, P535, DOI 10.1002/joc.626; Aizen VB, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003894; An Z.S., 1990, QUATERN INT, V7, P91, DOI DOI 10.1016/1040-6182(90)90042-3; An ZS, 2000, QUATERNARY SCI REV, V19, P171, DOI 10.1016/S0277-3791(99)00060-8; [Anonymous], 2005, THESIS; Aubekerov B, 2003, PAGES NEWS, V11, P24; ChongYi E, 2012, QUAT GEOCHRONOL, V10, P50, DOI 10.1016/j.quageo.2012.04.022; Deng S, 2013, J DESERT RES, V31, P848; Ding ZL, 2002, EARTH PLANET SC LETT, V200, P387, DOI 10.1016/S0012-821X(02)00637-4; Dodonov AE, 1995, QUATERNARY SCI REV, V14, P707, DOI 10.1016/0277-3791(95)00054-2; Fang XM, 2002, CHINESE SCI BULL, V47, P1381, DOI 10.1360/02tb9305; Fang XM, 2002, SCI CHINA SER D, V45, P289, DOI 10.1360/02yd9031; Feng ZD, 2011, QUATERN INT, V240, P156, DOI 10.1016/j.quaint.2010.10.019; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hao QZ, 2012, NATURE, V490, P393, DOI 10.1038/nature11493; HELLER F, 1984, GEOPHYS J ROY ASTR S, V77, P125, DOI 10.1111/j.1365-246X.1984.tb01928.x; Jia J, 2013, QUATERN INT, V296, P141, DOI 10.1016/j.quaint.2012.10.029; Jia J, 2012, QUATERN INT, V250, P84, DOI 10.1016/j.quaint.2011.06.018; Li B, 1989, GEOL REV, p[423, 493]; Li B, 1993, SCI CHINA SER B, P644; Li B, 2008, QUAT SCI, P140; Li B, 1988, CHINESE SCI BULL, P140; Li B. S., 1998, ACTA GEOL SINICA, V72, P83; Li G, 2013, MAR GEOL QUAT GEOL, P183; Li J, 2000, TREE RING HYDROLOGY; Li JF, 1991, CLIMATE IN XINJIANG; Li XZ, 2013, J GEOPHYS RES-ATMOS, V118, P7481, DOI 10.1002/jgrd.50611; Li Y, 2013, J EARTH SCI-CHINA, V24, P506, DOI 10.1007/s12583-013-0353-y; Liang LJ, 2013, J ASIAN EARTH SCI, V69, P177, DOI 10.1016/j.jseaes.2012.12.015; LIU TS, 1965, LOESS DEPOSITS CHINA; Liu TS., 1985, LOESS ENV; Lu H, 2010, GEOL SOC SPEC PUBL, V342, P29, DOI 10.1144/SP342.4; Lu HH, 2010, PALAEOGEOGR PALAEOCL, V285, P343, DOI 10.1016/j.palaeo.2009.11.031; Machalett B, 2006, QUATERN INT, V152, P192, DOI 10.1016/j.quaint.2005.12.014; Obruchev VA, 1958, QUESTIONS ORIGIN LOE; Pan BT, 2014, BOREAS, V43, P121, DOI 10.1111/bor.12026; Porter SC, 2001, EARTH-SCI REV, V54, P115, DOI 10.1016/S0012-8252(01)00043-5; Pye K, 1995, QUATERNARY SCI REV, V14, P653, DOI 10.1016/0277-3791(95)00047-X; Qiao Y, 1987, 14C GEOCHRONOLOGY LA, P214; Song Y., 2005, J MT SCI-ENGL, V2, P137, DOI [10.1007/BF02918329, DOI 10.1007/BF02918329]; Song Y.G., 2012, ADV SCI LETT, V6, P167; Song YG, 2001, SCI CHINA SER D, V44, P176, DOI 10.1007/BF02911985; Song YG, 2008, INT GEOSC REM SENS S, V2, P1227; Song YG, 2014, QUATERN INT, V334, P61, DOI 10.1016/j.quaint.2013.12.053; Song YG, 2012, QUAT GEOCHRONOL, V10, P2, DOI 10.1016/j.quageo.2012.04.005; Song YG, 2010, SCI CHINA EARTH SCI, V53, P419, DOI 10.1007/s11430-010-0011-5; Sun JM, 2002, EARTH PLANET SC LETT, V203, P845, DOI 10.1016/S0012-821X(02)00921-4; Sun JM, 2002, QUATERNARY RES, V58, P341, DOI 10.1006/qres.2002.2381; Sun YB, 2006, QUATERNARY SCI REV, V25, P33, DOI 10.1016/j.quascirev.2005.07.005; Sun YB, 2010, EARTH PLANET SC LETT, V289, P171, DOI 10.1016/j.epsl.2009.10.038; Tang ZH, 2009, ENVIRON GEOL, V58, P1703, DOI 10.1007/s00254-008-1670-9; Vandenberghe J, 1997, GEOLOGY, V25, P35, DOI 10.1130/0091-7613(1997)025<0035:NATSFT>2.3.CO;2; Wang F, 1992, GEOLOGY GLOBE CHAN 3, P108; Wei HT, 2013, CHINESE J GEOPHYS-CH, V56, P150, DOI 10.6038/cjg20130115; Xia DS, 2012, J ARID ENVIRON, V78, P73, DOI 10.1016/j.jaridenv.2011.10.012; Xinjiang integrated Expedition Team and Institute of Botany CASS, 1978, VEG ITS UT XINJ; Xiong SF, 2010, QUATERNARY SCI REV, V29, P1911, DOI 10.1016/j.quascirev.2010.04.009; [徐茜 XU Qian], 2007, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V21, P116; Yang SL, 2014, QUAT GEOCHRONOL, V20, P78, DOI 10.1016/j.quageo.2013.11.004; Yang XP, 1999, QUAT SCI, P373; Yang XP, 2000, ARID LAND GEOG, P13; Ye Wei, 1999, Arid Land Geography, V22, P9; Youn JH, 2014, CATENA, V117, P81, DOI 10.1016/j.catena.2013.09.007; Yuan QD, 2009, ACTA GEOL SIN-ENGL, V83, P648, DOI 10.1111/j.1755-6724.2009.00059.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zan J., 2010, THESIS LANZHOU U; Zan JB, 2014, PHYS EARTH PLANET IN, V229, P82, DOI 10.1016/j.pepi.2014.01.010; Zan JB, 2013, QUATERN INT, V313, P210, DOI 10.1016/j.quaint.2013.03.012; Zan JB, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004251; Zan JB, 2011, CHINESE SCI BULL, V56, P290, DOI 10.1007/s11434-010-4210-4; Zan JB, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007184; Zhang H, 1987, ASPECTS LOESS RES, P52; Zhang J, 2013, QUAT SCI, P889; Zhang WX, 2013, ENVIRON EARTH SCI, V70, P2191, DOI 10.1007/s12665-013-2323-1; Zhu R, 2009, ARID LAND GEOG, V28, P167	75	26	27	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125492	10.1371/journal.pone.0125492	http://dx.doi.org/10.1371/journal.pone.0125492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970617	gold, Green Published, Green Submitted			2022-12-27	WOS:000354544200076
J	Li, LP; Liu, W; Liu, H; Zhu, F; Zhang, DZ; Shen, H; Xu, Z; Qi, YP; Zhang, SQ; Chen, SM; He, LJ; Cao, XJ; Huang, X; Zhang, JD; Yan, L; An, MM; Jiang, YY				Li, Li Ping; Liu, Wei; Liu, Hong; Zhu, Fang; Zhang, Da Zhi; Shen, Hui; Xu, Zheng; Qi, Yun Peng; Zhang, Shi Qun; Chen, Si Min; He, Li Juan; Cao, Xin Ju; Huang, Xin; Zhang, Jun Dong; Yan, Lan; An, Mao Mao; Jiang, Yuan Ying			Synergistic Antifungal Activity of Berberine Derivative B-7b and Fluconazole	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CANDIDA-ALBICANS RESISTANT; IN-VITRO SYNERGISM; FUNGAL-INFECTIONS; AMPHOTERICIN-B; EPIDEMIOLOGY; INHIBITION; GROWTH; AZOLES; COMBINATION	Our previous study demonstrated berberine (BBR) and fluconazole (FLC) used concomitantly exhibited a synergism against FLC-resistant Candida albicans in vitro. We also suggested BBR played a major antifungal role in the synergism of FLC and BBR, while FLC increased intracellular BBR concentrations. Our following systematic structural modification and reconstruction of BBR core identified the novel scaffold of N-(2-(benzo[d][1,3]dioxol-5-yl) ethyl)-2-(substituted phenyl) acet-amide derivatives 7a-i, including B-7b and B-7d exhibiting remarkable synergistic antifungal activity and low cytotoxicity. Here, the study mainly investigated the synergistic activity of FLC and B-7b and the underlying mechanism. In vitro interaction of FLC and B-7b was investigated against 30 FLC-resistant clinical isolates of C. albicans and non-C. albicans species, including Candida tropicalis, Candida parapsilosis, Candida glabrata, Candida krusei and Cryptococcus neoformans. The potent synergistic activity of B-7b in combination with FLC against FLC-resistant C. albicans was found through the checkerboard microdilution assay. The findings of agar diffusion tests and time-kill curves confirmed its better synergism with FLC. And as expected, B-7b exhibited much lower cytotoxicity than BBR to human umbilical vein endothelial cells. In contrast to BBR, we found that endogenous ROS augmentation was not involved in the synergism of FLC and B-7b. According to the results from our present comparative proteomic study, it seemed that the disruption of protein folding and processing and the weakening of cells' self-defensive ability contributed to the synergism of FLC and B-7b. Together, these results suggested novel scaffold BBR derivative B-7b could be a promising synergist in combination with FLC for the treatment of invasive fungal infections.	[Li, Li Ping; Liu, Wei; Zhu, Fang; Shen, Hui; Zhang, Shi Qun; Chen, Si Min; Huang, Xin; Zhang, Jun Dong; An, Mao Mao; Jiang, Yuan Ying] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Li, Li Ping; Liu, Wei; Zhu, Fang; Shen, Hui; Zhang, Shi Qun; Chen, Si Min; Huang, Xin; Zhang, Jun Dong; An, Mao Mao; Jiang, Yuan Ying] Tongji Univ, Sch Med, Dept Pharmacol, Shanghai 200092, Peoples R China; [Liu, Hong; Zhang, Da Zhi; Xu, Zheng; Qi, Yun Peng; He, Li Juan; Cao, Xin Ju; Yan, Lan; Jiang, Yuan Ying] Second Mil Med Univ, New Drug Res & Dev Ctr, Sch Pharm, Shanghai, Peoples R China	Tongji University; Tongji University; Naval Medical University	Yan, L (corresponding author), Second Mil Med Univ, New Drug Res & Dev Ctr, Sch Pharm, Shanghai, Peoples R China.	ylan20001228@sina.com; anmaomao@tongji.edu.cn; 13761575178@163.com	jiang, anyi/GPT-0379-2022	Zhang, Shiqun/0000-0003-1299-6848; Huang, Xin/0000-0002-5690-1575	National Science Foundation of China [81330083, 81202563, 81471924]; National Key Basic Research Program of China [2013CB531602]; National Science and Technology Major Project for the Creation of New Drugs [2013ZX09103001-014, 2013ZX09J13108-03B]; Shanghai Science and Technology Support Program [14401902200, 14431902200]; Shanghai Manufacture-Education-Research-Medical Cooperative Project [12DZ1930505]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project for the Creation of New Drugs; Shanghai Science and Technology Support Program; Shanghai Manufacture-Education-Research-Medical Cooperative Project	This study was supported by the National Science Foundation of China (81330083,81202563,81471924), National Key Basic Research Program of China (No 2013CB531602), National Science and Technology Major Project for the Creation of New Drugs (No 2013ZX09103001-014), the Shanghai Science and Technology Support Program (No 14401902200, No 14431902200), National Science and Technology Major Project for the Creation of New Drugs (No 2013ZX09J13108-03B); the Shanghai Manufacture-Education-Research-Medical Cooperative Project (No 12DZ1930505).	Bertram G, 1996, YEAST, V12, P115, DOI 10.1002/(SICI)1097-0061(199602)12:2<115::AID-YEA889>3.0.CO;2-E; Carlsson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052094; Ckless K, 1995, J PHARM PHARMACOL, V47, P1029, DOI 10.1111/j.2042-7158.1995.tb03291.x; Copping VMS, 2005, J ANTIMICROB CHEMOTH, V55, P645, DOI 10.1093/jac/dki088; Desalermos A, 2012, EXPERT OPIN PHARMACO, V13, P783, DOI 10.1517/14656566.2012.658773; Devasahayam G, 2002, GENETICS, V160, P37; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fu ZJ, 2011, BIOL PHARM BULL, V34, P214, DOI 10.1248/bpb.34.214; Gaspari M, 2011, METHODS MOL BIOL, V790, P115, DOI 10.1007/978-1-61779-319-6_9; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Han Y, 2005, BIOL PHARM BULL, V28, P541, DOI 10.1248/bpb.28.541; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Henry KW, 2000, ANTIMICROB AGENTS CH, V44, P2693, DOI 10.1128/AAC.44.10.2693-2700.2000; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang S, 2008, BIOL PHARM BULL, V31, P2234, DOI 10.1248/bpb.31.2234; Iizuka N, 2000, CANCER LETT, V148, P19, DOI 10.1016/S0304-3835(99)00264-5; Iwazaki RS, 2010, ANTON LEEUW INT J G, V97, P201, DOI 10.1007/s10482-009-9394-8; KANEDA Y, 1991, ANN TROP MED PARASIT, V85, P417, DOI 10.1080/00034983.1991.11812586; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kibbler CC, 2003, J HOSP INFECT, V54, P18, DOI 10.1016/S0195-6701(03)00085-9; Klotz SA, 2001, MICROBIOL-SGM, V147, P3159, DOI 10.1099/00221287-147-11-3159; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; Lehrnbecher T, 2010, J INFECTION, V61, P259, DOI 10.1016/j.jinf.2010.06.018; Li DD, 2013, ANTIMICROB AGENTS CH, V57, P6016, DOI 10.1128/AAC.00499-13; Liu H, 2014, CHEMMEDCHEM, V9, P207, DOI 10.1002/cmdc.201300332; Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Morace G, 2010, MINERVA ANESTESIOL, V76, P950; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mulu A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-82; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Orfila L, 2000, J ETHNOPHARMACOL, V71, P449, DOI 10.1016/S0378-8741(00)00177-X; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P4419, DOI 10.1128/JCM.42.10.4419-4431.2004; Quan H, 2006, ANTIMICROB AGENTS CH, V50, P1096, DOI 10.1128/AAC.50.3.1096-1099.2006; Sanchez-Martinez C, 2001, CURR OPIN MICROBIOL, V4, P214, DOI 10.1016/S1369-5274(00)00191-0; SanchezChapula J, 1996, BRIT J PHARMACOL, V117, P1427, DOI 10.1111/j.1476-5381.1996.tb15302.x; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Sun LM, 2010, J APPL MICROBIOL, V108, P341, DOI 10.1111/j.1365-2672.2009.04429.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAYLOR CT, 1995, BRIT J PHARMACOL, V116, P2667, DOI 10.1111/j.1476-5381.1995.tb17224.x; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Vorisek J, 2002, YEAST, V19, P449, DOI 10.1002/yea.845; Wei GX, 2011, ARCH ORAL BIOL, V56, P565, DOI 10.1016/j.archoralbio.2010.11.021; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; WITTEKIND M, 1990, MOL CELL BIOL, V10, P2049, DOI 10.1128/MCB.10.5.2049; Xu Y, 2009, J PROTEOME RES, V8, P5296, DOI 10.1021/pr9005074; Yapar N, 2011, MED MYCOL, V49, P26, DOI 10.3109/13693786.2010.501344; Yin ZK, 2004, PROTEOMICS, V4, P2425, DOI 10.1002/pmic.200300760; Zirkel J, 2012, MED MYCOL, V50, P50, DOI 10.3109/13693786.2011.587211	52	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126393	10.1371/journal.pone.0126393	http://dx.doi.org/10.1371/journal.pone.0126393			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992630	Green Published, gold, Green Submitted			2022-12-27	WOS:000354918600033
J	Presaghi, F; Manca, M; Rodriguez-Franco, L; Curcio, G				Presaghi, Fabio; Manca, Maura; Rodriguez-Franco, Luis; Curcio, Giuseppe			A Questionnaire for the Assessment of Violent Behaviors in Young Couples: The Italian Version of Dating Violence Questionnaire (DVQ)	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; FEMALE; ADOLESCENT	In the last years, intimate partner violence (IPV) became a relevant problem for community and for social life, particularly in young people. Its correct assessment and evaluation in the population is mandatory. Our objectives were: Confirm factor structure of Dating Violence Questionnaire (DVQ) and investigate its convergent and divergent validity. The DVQ along with other personality measures were filled by a sample of 418 university students (Females = 310) of average age of 23 y.o. (SD = 4.71). A subsample of participants (223 students) consented in being involved also in retest and filled also the Revised Eysenck Personality Questionnaire (short form) and a brief scale for describing the behavior of the (past) partner after the breaking of the relationship (BRS). The 8-factor structure, with respect to the two other competing models, reported better fit indexes and showed significant correlations with other personality measures. Personality traits, both Neuroticism and Psychoticism, correlated with Sexual Violence, while Detachment correlated only with Neuroticism and Coercion, Humiliation and Physical Violence correlated with only Psychoticism. Extraversion did not report significant relationships with any of the 8 DVQ factors. Also the predictive validity of DVQ was satisfactory with the partner violent reaction to the break of relationship predicted positively predicted by Coercion (b = 0.22) and by Humiliation (b = 0.20) and negatively by Emotional Punishment (b = -0.18). The present results indicate a good factor structure of the questionnaire, and interesting correlations with personality traits, allowing to identify psychological aspects with a predisposing role for anti-social aggressive behaviors. Further studies will be aimed at ascertaining other possible determinants of intimate partner violence and the weight of cultural aspects.	[Presaghi, Fabio] Univ Roma La Sapienza, Dept Social & Dev Psychol, I-00185 Rome, Italy; [Rodriguez-Franco, Luis] Univ Seville, Dept Personal Assessment & Psychol Treatment, Seville, Spain; [Manca, Maura; Curcio, Giuseppe] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy	Sapienza University Rome; University of Sevilla; University of L'Aquila	Presaghi, F (corresponding author), Univ Roma La Sapienza, Dept Social & Dev Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	fabio.presaghi@uniroma1.it; giuseppe.curcio@univaq.it	Presaghi, Fabio/P-3845-2015; rodriguez-franco, luis/D-3095-2019; Presaghi, Fabio/N-1590-2019	Presaghi, Fabio/0000-0001-7880-6715; rodriguez-franco, luis/0000-0001-8638-8170; Presaghi, Fabio/0000-0001-7880-6715; Curcio, Giuseppe/0000-0003-2248-781X				Asparouhov A, 2007, P 2007 JSM M SALT LA; Bonomi AE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-637; Bonomi AE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-821; Caetano R, 2005, ALCOHOL CLIN EXP RES, V29, P98, DOI 10.1097/01.ALC.0000150015.84381.63; Cale EM, 2006, J RES PERS, V40, P250, DOI 10.1016/j.jrp.2005.01.001; Capaldi DM, 2007, J FAM VIOLENCE, V22, P101, DOI 10.1007/s10896-007-9067-1; Ayala MDC, 2014, INT J CLIN HLTH PSYC, V14, P39; Cunradi CB, 2002, J FAM VIOLENCE, V17, P377, DOI 10.1023/A:1020374617328; Esquivel-Santovena EE, 2013, PARTN ABUSE, V4, P6, DOI 10.1891/1946-6560.4.1.6; European Union Agency for Fundamental Rights, 2014, VIOL WOM EU WID SURV; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; Fabelo HE, 2012, INT FAM VIOL CHILD V, pV; FRANCO LR, 2009, PSICOTHEMA, V21, P248; Furman W, 2003, ADOLESCENT ROMANTIC REALTIONS AND SEXUAL BEHAVIOR: THEORY, RESEARCH, AND PRACTICAL IMPLICATIONS, P3; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU, P204; Gil-Gonzalez D, 2008, J PUBLIC HEALTH-UK, V30, P14, DOI 10.1093/pubmed/fdm071; Halpern CT, 2009, J ADOLESCENT HEALTH, V45, P508, DOI 10.1016/j.jadohealth.2009.03.011; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; ISTAT, 2007, VIOL MALTR CONTR DON; Jackson SM, 1999, AGGRESS VIOLENT BEH, V4, P233, DOI 10.1016/S1359-1789(97)00049-9; Koeppel MDH, 2014, WOMEN CRIM JUSTICE, V24, P126, DOI 10.1080/08974454.2013.842517; Krantz G, 2005, J EPIDEMIOL COMMUN H, V59, P818, DOI 10.1136/jech.2004.022756; Langhinrichsen-Rohling J, 2005, J INTERPERS VIOLENCE, V20, P108, DOI 10.1177/0886260504268602; Lewis SF, 2001, CLIN PSYCHOL REV, V21, P105, DOI 10.1016/S0272-7358(99)00042-2; Lopez-Cepero J, RIDEP REV I IN PRESS; Menesini E, 2008, GIORNALE ITALIANO PS, V35, P407, DOI DOI 10.1421/27217; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Rodriguez Franco L, 2007, VIOLENCIA GENERO REL; Rodriguez-Franco L, 2012, INT J CLIN HLTH PSYC; Rodriguez-Franco L., 2010, ANNUCLINHEALTH PSYCH, V6, P43; Shortt JW, 2013, J YOUTH ADOLESCENCE, V42, P619, DOI 10.1007/s10964-013-9911-y; Smith PH, 2003, AM J PUBLIC HEALTH, V93, P1104, DOI 10.2105/AJPH.93.7.1104; Stockl H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-751; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Straus MA, 2008, CHILD YOUTH SERV REV, V30, P252, DOI 10.1016/j.childyouth.2007.10.004; Williams JR, 2008, TRAUMA VIOLENCE ABUS, V9, P227, DOI 10.1177/1524838008324418; World Health Organization, WHO MULT STUD WOM HL; Yu CY, 2002, EVALUATING CUTOFF CR	40	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126089	10.1371/journal.pone.0126089	http://dx.doi.org/10.1371/journal.pone.0126089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BT	25992602	gold, Green Published			2022-12-27	WOS:000354918600026
J	David, M; Borde, T; Brenne, S; Henrich, W; Breckenkamp, J; Razum, O				David, Matthias; Borde, Theda; Brenne, Silke; Henrich, Wolfgang; Breckenkamp, Juergen; Razum, Oliver			Caesarean Section Frequency among Immigrants, Second- and Third-Generation Women, and Non-Immigrants: Prospective Study in Berlin/Germany	PLOS ONE			English	Article							MIGRANTS; DELIVERY; OUTCOMES; BIRTH; RATES; RISK; AUSTRALIA; ETHNICITY; BORN	Objective The frequency of caesarean section delivery varies between countries and social groups. Among other factors, it is determined by the quality of obstetrics care. Rates of elective (planned) and emergency (in-labor) caesareans may also vary between immigrants (first generation), their offspring (second- and third-generation women), and non-immigrants because of access and language barriers. Other important points to be considered are whether caesarean section indications and the neonatal outcomes differ in babies delivered by caesarean between immigrants, their offspring, and non-immigrants. Methods A standardized interview on admission to delivery wards at three Berlin obstetric hospitals was performed in a 12-month period in 2011/2012. Questions on socio-demographic and care aspects and on migration (immigrated herself vs. second- and third-generation women vs. non-immigrant) and acculturation status were included. Data was linked with information from the expectant mothers' antenatal records and with perinatal data routinely documented in the hospital. Regression modeling was used to adjust for age, parity and socio-economic status. Results The caesarean section rates for immigrants, second- and third-generation women, and non-immigrant women were similar. Neither indications for caesarean section delivery nor neonatal outcomes showed statistically significant differences. The only difference found was a somewhat higher rate of crash caesarean sections per 100 births among first generation immigrants compared to non-immigrants. Conclusion Unlike earlier German studies and current studies from other European countries, this study did not find an increased rate of caesarean sections among immigrants, as well as second- and third-generation women, with the possible exception of a small high-risk group. This indicates an equally high quality of perinatal care for women with and without a migration history.	[David, Matthias; Brenne, Silke] Charite, Clin Gynaecol, D-13353 Berlin, Germany; [Borde, Theda] Berlin Univ Appl Sci, Alice Salomon Hsch, Berlin, Germany; [Henrich, Wolfgang] Charite, Obstet Clin, D-13353 Berlin, Germany; [Breckenkamp, Juergen; Razum, Oliver] Univ Bielefeld, Sch Publ Hlth, Dept Epidemiol & Int Publ Hlth, D-33615 Bielefeld, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bielefeld	David, M (corresponding author), Charite, Clin Gynaecol, Campus Virchow Klinikum, D-13353 Berlin, Germany.	matthias.david@charite.de		Razum, Oliver/0000-0002-1244-7649; David, Matthias/0000-0002-6901-5636; Henrich, Wolfgang/0000-0002-0759-832X				Anderson NH, 2013, AUST NZ J OBSTET GYN, V53, P258, DOI 10.1111/ajo.12036; [Anonymous], 1985, LANCET, V2, P436; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Bollini P, 2009, SOC SCI MED, V68, P452, DOI 10.1016/j.socscimed.2008.10.018; Bongard S, 2002, J PSYCHOSOM RES, V53, P795, DOI 10.1016/S0022-3999(02)00347-1; BRAVEMAN P, 1995, AM J PUBLIC HEALTH, V85, P625, DOI 10.2105/AJPH.85.5.625; Dahlen HG, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-100; Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24; Diani F, 2003, J Obstet Gynaecol, V23, P615, DOI 10.1080/01443610310001604367; Federal Statistical Offices, CENS DAT CENS 2011; Gissler M, 2009, ACTA OBSTET GYN SCAN, V88, P134, DOI 10.1080/00016340802603805; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; Ibison JM, 2005, EUR J OBSTET GYN R B, V118, P199, DOI 10.1016/j.ejogrb.2004.05.002; Institute for Social Research Survey Research Center, 2014, IVEWARE IMP VAR EST; Kabir AA, 2005, OBSTET GYNECOL, V105, P710, DOI 10.1097/01.AOG.0000154154.02581.ce; Lavender T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004660.pub3; Loew D, 1966, Zentralbl Gynakol, V88, P23; Margioula-Siarkou C, 2013, J IMMIGR MINOR HEALT, V15, P249, DOI 10.1007/s10903-012-9727-y; McCourt C, 2007, BIRTH-ISS PERINAT C, V34, P65, DOI 10.1111/j.1523-536X.2006.00147.x; Merry L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-27; Merten S, 2007, INT J PUBLIC HEALTH, V52, P210, DOI 10.1007/s00038-007-6035-8; Oberaigner W, 2013, WIEN KLIN WOCHENSCHR, V125, P34, DOI 10.1007/s00508-012-0312-0; Razum O, 2011, GESUNDHEIT SCHWANGER; Rio I, 2010, EUR J PUBLIC HEALTH, V20, P524, DOI 10.1093/eurpub/ckq067; Rizzo N, 2004, EUR J OBSTET GYN R B, V116, P170, DOI 10.1016/j.ejogrb.2004.02.018; Schenk L, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P853, DOI 10.1007/s00103-006-0018-4; Sorbye IK, 2014, EUR J PUBLIC HLTH; Vangen S, 2000, ACTA OBSTET GYN SCAN, V79, P553, DOI 10.1034/j.1600-0412.2000.079007553.x; von Katterfeld B, 2012, INT J GYNECOL OBSTET, V116, P153, DOI 10.1016/j.ijgo.2011.09.012; Walsh J, 2011, BJOG-INT J OBSTET GY, V118, P713, DOI 10.1111/j.1471-0528.2010.02878.x; Wright P., MARGINAL PROBABILITI; Zeitlin JA, EUROPEAN PERINATAL H; Zich K., 2012, KAISERSCHNITTGEBURTE; Zizza A, 2011, J Prev Med Hyg, V52, P161	34	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127489	10.1371/journal.pone.0127489	http://dx.doi.org/10.1371/journal.pone.0127489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BG	25985437	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300127
J	Li, JJ; Han, SH; Ding, XL; He, TT; Dai, JY; Yang, SP; Gai, JY				Li, Jiajia; Han, Shaohuai; Ding, Xianlong; He, Tingting; Dai, Jinying; Yang, Shouping; Gai, Junyi			Comparative Transcriptome Analysis between the Cytoplasmic Male Sterile Line NJCMS1A and Its Maintainer NJCMS1B in Soybean (Glycine max (L.) Merr.)	PLOS ONE			English	Article							CELL-DEATH; OXIDATIVE STRESS; GENE-EXPRESSION; CALCIUM; IDENTIFICATION; METABOLISM; COTTON; CMS; ANNOTATION; CALMODULIN	Background The utilization of soybean heterosis is probably one of the potential approaches in future yield breakthrough as was the situation in rice breeding in China. Cytoplasmic male sterility (CMS) plays an important role in the production of hybrid seeds. However, the molecular mechanism of CMS in soybean remains unclear. Results The comparative transcriptome analysis between cytoplasmic male sterile line NJCMS1A and its near-isogenic maintainer NJCMS1B in soybean was conducted using Illumina sequencing technology. A total of 88,643 transcripts were produced in Illumina sequencing. Then 56,044 genes were obtained matching soybean reference genome. Three hundred and sixty five differentially expressed genes (DEGs) between NJCMS1A and NJCMS1B were screened by threshold, among which, 339 down-regulated and 26 up-regulated in NJCMS1A compared to in NJCMS1B. Gene Ontology (GO) annotation showed that 242 DEGs were annotated to 19 functional categories. Clusters of Orthologous Groups of proteins (COG) annotation showed that 265 DEGs were classified into 19 categories. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that 46 DEGs were assigned to 33 metabolic pathways. According to functional and metabolic pathway analysis combined with reported literatures, the relations between some key DEGs and the male sterility of NJCMS1A were discussed. qRT-PCR analysis validated that the gene expression pattern in RNA-Seq was reliable. Finally, enzyme activity assay showed that energy supply was decreased in NJCMS1A compared to in NJCMS1B. Conclusions We concluded that the male sterility of NJCMS1A might be related to the disturbed functions and metabolism pathways of some key DEGs, such as DEGs involved in carbohydrate and energy metabolism, transcription factors, regulation of pollen development, elimination of reactive oxygen species (ROS), cellular signal transduction, and programmed cell death (PCD) etc. Future research will focus on cloning and transgenic function validation of possible candidate genes associated with soybean CMS.	[Li, Jiajia; Han, Shaohuai; Ding, Xianlong; He, Tingting; Dai, Jinying; Yang, Shouping; Gai, Junyi] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, MOA Key Lab Biol & Genet Improvement Soybean Gen, Soybean Res Inst,Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, SP (corresponding author), Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, MOA Key Lab Biol & Genet Improvement Soybean Gen, Soybean Res Inst,Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China.	spyung@126.com; sri@njau.edu.cn	han, shaohuai/AAT-5334-2021		National Hightech R & D Program of China [2011AA10A105]; National Transgene Science and Technology Major Program of China [2011ZX08004-005, 2013ZX08004-005, 2014ZX08004-005]; National Key Basic Research Program of China [2011CB109301]; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT13073]	National Hightech R & D Program of China(National High Technology Research and Development Program of China); National Transgene Science and Technology Major Program of China; National Key Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Hightech R & D Program of China (2011AA10A105), the National Transgene Science and Technology Major Program of China (2011ZX08004-005, 2013ZX08004-005, 2014ZX08004-005), the National Key Basic Research Program of China (2011CB109301), and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT13073). The funders had no role in study design, data collection and analysis, decision or preparation of the manuscript.	Alche JD, 2004, PLANT CELL PHYSIOL, V45, P1149, DOI 10.1093/pcp/pch127; An H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-258; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman P, 2000, PLANT MOL BIOL, V42, P531, DOI 10.1023/A:1006388814458; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding DR, 2002, EUPHYTICA, V124, P85, DOI 10.1023/A:1015683526982; Ding DR, 1999, CHINESE SCI BULL, V44, P191, DOI 10.1007/BF02884752; Dorion S, 1996, PLANT PHYSIOL, V111, P137, DOI 10.1104/pp.111.1.137; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Fan JM, 2003, THESIS NANJING AGR U; Gai J. Y., 1995, Soybean Genetics Newsletter, V22, P55; Ge XC, 2005, EMBO REP, V6, P282, DOI 10.1038/sj.embor.7400357; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Havey MJ, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P623, DOI 10.1007/978-1-4020-3166-3_23; Hu B, 2014, ACTA PHYSIOL PLANT, V36, P2203, DOI 10.1007/s11738-014-1597-6; Jiang PD, 2007, PLANT CELL REP, V26, P1627, DOI 10.1007/s00299-007-0351-6; Jiang SY, 2005, DNA RES, V12, P167, DOI 10.1093/dnares/dsi005; Kater MM, 1998, PLANT CELL, V10, P171, DOI 10.1105/tpc.10.2.171; Li SQ, 2004, FUNCT PLANT BIOL, V31, P369, DOI 10.1071/FP03224; Li XB, 2010, J EXP BOT, V61, P41, DOI 10.1093/jxb/erp280; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; MEANS AR, 1988, CELL CALCIUM, V9, P313, DOI 10.1016/0143-4160(88)90012-7; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Rato C, 2004, PLANT J, V38, P887, DOI 10.1111/j.1365-313X.2004.02091.x; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sheoran IS, 2010, BOTANY, V88, P217, DOI 10.1139/B09-085; SIEDOW JN, 1995, PLANT CELL, V7, P821, DOI 10.1105/tpc.7.7.821; Suzuki H, 2013, PLANT CELL REP, V32, P1531, DOI 10.1007/s00299-013-1465-7; Tadege M, 1997, PLANT MOL BIOL, V35, P343, DOI 10.1023/A:1005837112653; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Teixeira RT, 2005, J EXP BOT, V56, P1245, DOI 10.1093/jxb/eri120; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841; Wei MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-97; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu ZM, 2013, INT J MOL SCI, V14, P22982, DOI 10.3390/ijms141122982; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhang GY, 2010, PLANTA, V231, P1323, DOI 10.1007/s00425-010-1136-7; Zhu J., 2013, CHIN J NAT, V35, P112, DOI [10.3969/j.issn.0253-9608.2013.02.005, DOI 10.3969/J.ISSN.0253-9608.2013.02.005]	51	22	28	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126771	10.1371/journal.pone.0126771	http://dx.doi.org/10.1371/journal.pone.0126771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985300	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300052
J	Bourgault, P; Lacasse, A; Marchand, S; Courtemanche-Harel, R; Charest, J; Gaumond, I; de Souza, JB; Choiniere, M				Bourgault, Patricia; Lacasse, Anais; Marchand, Serge; Courtemanche-Harel, Roxanne; Charest, Jacques; Gaumond, Isabelle; de Souza, Juliana Barcellos; Choiniere, Manon			Multicomponent Interdisciplinary Group Intervention for Self-Management of Fibromyalgia: A Mixed-Methods Randomized Controlled Trial	PLOS ONE			English	Article							PAIN CLINICAL-TRIALS; PATIENT GLOBAL IMPRESSION; QUALITY-OF-LIFE; COPING STRATEGIES; PHYSICAL-THERAPY; PROGRAM; METAANALYSIS; INTENSITY; EXERCISE; SCALE	Background This study evaluated the efficacy of the PASSAGE Program, a structured multicomponent interdisciplinary group intervention for the self-management of FMS. Methods A mixed-methods randomized controlled trial (intervention (INT) vs. waitlist (WL)) was conducted with patients suffering from FMS. Data were collected at baseline (T-0), at the end of the intervention (T-1), and 3 months later (T-2). The primary outcome was change in pain intensity (0-10). Secondary outcomes were fibromyalgia severity, pain interference, sleep quality, pain coping strategies, depression, health-related quality of life, patient global impression of change (PGIC), and perceived pain relief. Qualitative group interviews with a subset of patients were also conducted. Complete data from T-0 to T-2 were available for 43 patients. Results The intervention had a statistically significant impact on the three PGIC measures. At the end of the PASSAGE Program, the percentages of patients who perceived overall improvement in their pain levels, functioning and quality of life were significantly higher in the INT Group (73%, 55%, 77% respectively) than in the WL Group (8%, 12%, 20%). The same differences were observed 3 months post-intervention (Intervention group: 62%, 43%, 38% vs Waitlist Group: 13%, 13%, 9%). The proportion of patients who reported >= 50% pain relief was also significantly higher in the INT Group at the end of the intervention (36% vs 12%) and 3 months post-intervention (33% vs 4%). Results of the qualitative analysis were in line with the quantitative findings regarding the efficacy of the intervention. The improvement, however, was not reflected in the primary outcome and other secondary outcome measures. Conclusion The PASSAGE Program was effective in helping FMS patients gain a sense of control over their symptoms. We suggest including PGIC in future clinical trials on FMS as they appear to capture important aspects of the patients' experience.	[Bourgault, Patricia] Univ Sherbrooke, Fac Med & Sci Sante, Ecole Sci Infirmieres, Sherbrooke, PQ J1K 2R1, Canada; [Bourgault, Patricia; Marchand, Serge; Courtemanche-Harel, Roxanne; Gaumond, Isabelle; de Souza, Juliana Barcellos] Univ Sherbrooke, Ctr Hosp, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ J1K 2R1, Canada; [Bourgault, Patricia; Lacasse, Anais; Choiniere, Manon] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Lacasse, Anais; Charest, Jacques] Univ Quebec Abitibi Temiscamingue, Dept Sci Sante, Rouyn Noranda, PQ, Canada; [Marchand, Serge] Univ Sherbrooke, Fac Med & Sci Sante, Dept Neurochirurg, Sherbrooke, PQ J1K 2R1, Canada; [Choiniere, Manon] Univ Montreal, Fac Med, Dept Anesthesiol, Montreal, PQ H3C 3J7, Canada	University of Sherbrooke; University of Sherbrooke; Universite de Montreal; University of Quebec; University Quebec Abitibi-Temiscamingue; University of Sherbrooke; Universite de Montreal	Choiniere, M (corresponding author), Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada.	manon.choiniere@umontreal.ca		Barcellos de Souza, Juliana/0000-0003-4657-052X; Marchand, Serge/0000-0002-4234-5977	Canadian Institutes of Health Research [86787]; AstraZeneca Canada Inc [86787]; Pfizer Canada Inc.; Quebec Rehabilitation Research Network - Fonds de la recherche en sante du Quebec; Fonds de la recherche en sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca Canada Inc(AstraZeneca); Pfizer Canada Inc.; Quebec Rehabilitation Research Network - Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	MC, PB and SM received a team research grant-Community Alliances for Health Research and Knowledge Exchange in Pain-of the Canadian Institutes of Health Research in partnership with AstraZeneca Canada Inc (Grant #86787) (http://www.cihr-irsc.gc.ca) to carry out the study. MC and PB also received an unrestricted research grant from Pfizer Canada Inc. (http://www.pfizer.ca) for the same research project. During the study, PB was the recipient of a postdoctoral research award from the Quebec Rehabilitation Research Network (http://www.repar.ca) which is itself funded by the Fonds de la recherche en sante du Quebec (http:www.frqs.gouv.qc.ca), and AL was the recipient of a postdoctoral research award from the Fonds de la recherche en sante du Quebec (http:www.frqs.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles AM, 2007, ANN INTERN MED, V146, P726, DOI 10.7326/0003-4819-146-10-200705150-00006; Affleck G, 1996, PAIN, V68, P363, DOI 10.1016/S0304-3959(96)03226-5; Amris K, 2014, PAIN; Barcellos de Souza J, 2007, DOULEUR ANALG, V20, P213; Beal CC, 2009, CAN J NURS RES, V41, P16; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Bennett R, 2006, NAT CLIN PRACT RHEUM, V2, P416, DOI 10.1038/ncprheum0245; Bieber C, 2008, J PSYCHOSOM RES, V64, P13, DOI 10.1016/j.jpsychores.2007.05.009; Bigatti SM, 2008, ARTHRIT RHEUM-ARTHR, V59, P961, DOI 10.1002/art.23828; Birnie KA, 2012, PAIN, V153, P2311, DOI 10.1016/j.pain.2012.07.033; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Branco JC, 2010, SEMIN ARTHRITIS RHEU, V39, P448, DOI 10.1016/j.semarthrit.2008.12.003; Brosseau L, 2008, PHYS THER, V88, P857, DOI 10.2522/ptj.20070200; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Busch Angela J., 2008, Physiotherapy Theory and Practice, V24, P151, DOI 10.1080/09593980701686872; Cedraschi C, 2004, ANN RHEUM DIS, V63, P290, DOI 10.1136/ard.2002.004945; Charest J, 1996, LOMBALGIE ECOLE INTE, DOI [10.1016/j.rehab.2014.06.006, DOI 10.1016/J.REHAB.2014.06.006]; Charest J, 1994, RHUMATOLOGIE, V48, P221; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Dworkin RH, 2009, PAIN, V146, P238, DOI 10.1016/j.pain.2009.08.019; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; Fitzcharles MA, 2013, J RHEUMATOL, V40, P1388, DOI 10.3899/jrheum.130127; Fitzcharles MA, 2013, PAIN RES MANAG, V18, P119, DOI 10.1155/2013/918216; French DJ, 2005, CAN J BEHAV SCI, V37, P181, DOI 10.1037/h0087255; Gauthier J, 1982, REV QUEBEC PSYCHOL, V3, P1; Geisser ME, 2010, PAIN, V149, P373, DOI 10.1016/j.pain.2010.02.043; Glombiewski JA, 2010, PAIN, V151, P280, DOI 10.1016/j.pain.2010.06.011; Gran JT, 2003, BEST PRACT RES CL RH, V17, P547, DOI 10.1016/S1521-6942(03)00042-1; Hadhazy VA, 2000, J RHEUMATOL, V27, P2911; Hauser W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3002; Hauser W, 2009, JAMA-J AM MED ASSOC, V301, P198, DOI 10.1001/jama.2008.944; Han C, 2011, DRUG TODAY, V47, P539, DOI 10.1358/dot.2011.47.7.1603503; Hauser W, 2008, GER MED SCI, V9, P6; Havermark AM, 2006, SCAND J CARING SCI, V20, P315, DOI 10.1111/j.1471-6712.2006.00410.x; Haythornthwaite JA, 2001, HDB PAIN ASSESSMENT; Hudson JI, 2009, J RHEUMATOL, V36, P2517, DOI 10.3899/jrheum.090139; Irachabal S, 2008, ENCEPHALE, V34, P47, DOI 10.1016/j.encep.2006.11.002; Jensen MP., 2003, VALIDITY RELIABILITY; Jensen MP., 1992, HDB PAIN ASSESSMENT, P19; JICK TD, 1979, ADMIN SCI QUART, V24, P602, DOI 10.2307/2392366; Kosinski M, 2007, CLIN THER, V29, P2562, DOI 10.1016/j.clinthera.2007.12.001; McGillion MH, 2008, J PAIN SYMPTOM MANAG, V36, P126, DOI 10.1016/j.jpainsymman.2007.09.015; Moore RA, 2010, PAIN, V149, P360, DOI 10.1016/j.pain.2010.02.039; Mucchielli R., 2006, ANAL CONTENU DOCUMEN; Nijs J, 2010, PHYS THER, V90, P1815, DOI 10.2522/ptj.20100046; Oldfield, 2013, WOMENS HLTH URBAN LI, V12, P39; Perrot S, 2003, J RHEUMATOL, V30, P1054; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Ramel J, 2009, CURR RHEUMATOL REV, V5, P188, DOI 10.2174/157339709790192459; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Rossy LA, 1999, ANN BEHAV MED, V21, P180, DOI 10.1007/BF02908299; Scascighini L, 2008, RHEUMATOLOGY, V47, P670, DOI 10.1093/rheumatology/ken021; Sim J, 2002, CLIN J PAIN, V18, P324, DOI 10.1097/00002508-200209000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thieme Kati, 2009, Curr Rheumatol Rep, V11, P443; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Tyler EJ, 2002, ARCH PHYS MED REHAB, V83, P236, DOI 10.1053/apmr.2002.27466; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; White KP, 1999, J RHEUMATOL, V26, P1570; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	65	47	48	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126324	10.1371/journal.pone.0126324	http://dx.doi.org/10.1371/journal.pone.0126324			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978402	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000354916100063
J	Fukasaka, M; Asari, D; Kiyotoh, E; Okazaki, A; Gomi, Y; Tanimoto, T; Takeuchi, O; Akira, S; Hori, M				Fukasaka, Masahiro; Asari, Daisuke; Kiyotoh, Eiji; Okazaki, Arimichi; Gomi, Yasuyuki; Tanimoto, Takeshi; Takeuchi, Osamu; Akira, Shizuo; Hori, Mitsuhiko			A Lipopolysaccharide from Pantoea Agglomerans Is a Promising Adjuvant for Sublingual Vaccines to Induce Systemic and Mucosal Immune Responses in Mice via TLR4 Pathway	PLOS ONE			English	Article							INFLUENZA-VIRUS; DENDRITIC CELLS; CHOLERA-TOXIN; CUTTING EDGE; IMMUNIZATION; VACCINATION; MACROPHAGE; INFECTION; IP-PA1; PERSPECTIVES	A lipopolysaccharide from Pantoea agglomerans (LPSpa) has been applied to various fields for human use as a Toll-like receptor 4 ligand and its safety has been confirmed. Here, we showed for the first time the application of LPSpa as an effective mucosal adjuvant for activating vaccine-induced antigen specific immune responses. Mice sublingually immunized with influenza vaccine (HA split vaccine) with LPSpa induced both HA-specific IgG (systemic) and IgA (mucosal) antibody responses, which led to a significant increase in survival rate against lethal influenza virus challenge compared with subcutaneous vaccination. After sublingual administration of ovalbumin with LPSpa, ovalbumin-specific mucosal IgA responses were induced at both mucosal surfaces close to the immunized site and at remote mucosal surfaces. Sublingual administration of LPSpa evoked local antigen-uptake by dendritic cells in cervical lymph nodes. LPSpa induced cytokine production and the maturation and proliferation of innate immune cells via Toll-like receptor 4 in dendritic cells. Collectively, these results suggest that LPSpa can be used as an effective mucosal adjuvant to stimulate and activate local innate immune cells to improve and enhance mucosal vaccine potency against various pathogens.	[Fukasaka, Masahiro; Asari, Daisuke; Kiyotoh, Eiji; Okazaki, Arimichi; Hori, Mitsuhiko] Nitto Denko Corp, Corp Res & Dev Div, Life Sci Res Ctr, Ibaraki, Osaka, Japan; [Gomi, Yasuyuki; Tanimoto, Takeshi] Osaka Univ, Res Fdn Microbial Dis, Res & Prod Technol Dept, Kanonji, Kagawa, Japan; [Takeuchi, Osamu] Kyoto Univ, Lab Infect & Prevent, Inst Virus Res, Sakyo Ku, Kyoto, Japan; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, WPI Immunol Frontier Res Ctr IFReC, Host Def Lab, Suita, Osaka 565, Japan	Nitto Denko Corporation; Osaka University; Kyoto University; Osaka University	Fukasaka, M (corresponding author), Nitto Denko Corp, Corp Res & Dev Div, Life Sci Res Ctr, Ibaraki, Osaka, Japan.	masahiro_fukasaka@gg.nitto.co.jp; mitsuhiko_hori@gg.nitto.co.jp	Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; 	Nitto Denko Corporation	Nitto Denko Corporation	Nitto Denko Corporation provided support in the form of salaries for authors MF, DA, EK, AO, and MH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ainai A, 2010, J MED VIROL, V82, P476, DOI 10.1002/jmv.21694; Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Alecsandru D, 2011, CLIN EXP IMMUNOL, V164, P100, DOI 10.1111/j.1365-2249.2011.04320.x; Allam JP, 2011, ALLERGY, V66, P532, DOI 10.1111/j.1398-9995.2010.02510.x; Appledorn DM, 2011, CLIN VACCINE IMMUNOL, V18, P150, DOI 10.1128/CVI.00341-10; Asahi Y, 2002, J IMMUNOL, V168, P2930, DOI 10.4049/jimmunol.168.6.2930; Bayne ACV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061790; Buffa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050529; Ciabattini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019346; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; Frati F, 2010, DRUG DES DEV THER, V4, P99; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Fukasaka M, 2013, J IMMUNOL, V190, P5702, DOI 10.4049/jimmunol.1203155; Fukushi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042419; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hebishima T, 2011, EXP ANIM TOKYO, V60, P101, DOI 10.1538/expanim.60.101; Hebishima T, 2010, ANTICANCER RES, V30, P3113; Hervouet C, 2014, MUCOSAL IMMUNOL, V7, P280, DOI 10.1038/mi.2013.45; Huang CF, 2008, J PEDIATR GASTR NUTR, V46, P262, DOI 10.1097/MPG.0b013e318156050d; Inagawa H, 1997, ANTICANCER RES, V17, P2153; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kandasamy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003115; Kobiyama K, 2014, P NATL ACAD SCI USA, V111, P3086, DOI 10.1073/pnas.1319268111; Kohchi C, 2006, J BIOSCI BIOENG, V102, P485, DOI 10.1263/jbb.102.485; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Maroof A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003875; MCGHEE JR, 1993, INFECT AGENT DIS, V2, P55; MCGHEE JR, 1993, SEMIN HEMATOL, V30, P3; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moingeon P, 2006, ALLERGY, V61, P151, DOI 10.1111/j.1398-9995.2006.01002.x; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; NISHIZAWA T, 1992, CHEM PHARM BULL, V40, P479, DOI 10.1248/cpb.40.479; Ottsjo LS, 2013, INFECT IMMUN, V81, P1532, DOI 10.1128/IAI.01407-12; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Raghavan S, 2010, INFECT IMMUN, V78, P4251, DOI 10.1128/IAI.00536-10; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; Shim BS, 2013, J MICROBIOL, V51, P130, DOI 10.1007/s12275-013-2399-z; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Song JH, 2009, J IMMUNOL, V182, P6851, DOI 10.4049/jimmunol.0803568; Takahashi Y, 2000, FISH SHELLFISH IMMUN, V10, P555, DOI 10.1006/fsim.2000.0268; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Taniguchi Y, 2009, ANTICANCER RES, V29, P859; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Weldon WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041501; Yoshida A, 2009, ANTICANCER RES, V29, P4867; Yuki Y, 2003, REV MED VIROL, V13, P293, DOI 10.1002/rmv.398; Zunt SL, 2009, CLIN EXP IMMUNOL, V156, P285, DOI 10.1111/j.1365-2249.2009.03854.x	51	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126849	10.1371/journal.pone.0126849	http://dx.doi.org/10.1371/journal.pone.0126849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978818	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100106
J	Szafron, LM; Balcerak, A; Grzybowska, EA; Pienkowska-Grela, B; Felisiak-Golabek, A; Podgorska, A; Kulesza, M; Nowak, N; Pomorski, P; Wysocki, J; Rubel, T; Dansonka-Mieszkowska, A; Konopka, B; Lukasik, M; Kupryjanczyk, J				Szafron, Lukasz Michal; Balcerak, Anna; Grzybowska, Ewa Anna; Pienkowska-Grela, Barbara; Felisiak-Golabek, Anna; Podgorska, Agnieszka; Kulesza, Magdalena; Nowak, Natalia; Pomorski, Pawel; Wysocki, Juliusz; Rubel, Tymon; Dansonka-Mieszkowska, Agnieszka; Konopka, Bozena; Lukasik, Martyna; Kupryjanczyk, Jolanta			The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues	PLOS ONE			English	Article							KEYHOLE LIMPET HEMOCYANIN; RNA ACTIVATOR SRA; NONCODING RNAS; BREAST-CANCER; ANTIGENIC DETERMINANTS; PROTEIN-STRUCTURE; SF3B1 MUTATIONS; I-TASSER; EXPRESSION; CELLS	CRNDE, recently described as the lncRNA-coding gene, is overexpressed at RNA level in human malignancies. Its role in gametogenesis, cellular differentiation and pluripotency has been suggested as well. Herein, we aimed to verify our hypothesis that the CRNDE gene may encode a protein product, CRNDEP. By using bioinformatics methods, we identified the 84-amino acid ORF encoded by one of two CRNDEtranscripts, previously described by our research team. This ORF was cloned into two expression vectors, subsequently utilized in localization studies in HeLa cells. We also developed a polyclonal antibody against CRNDEP. Its specificity was confirmed in immunohistochemical, cellular localization, Western blot and immunoprecipitation experiments, as well as by showing a statistically significant decrease of endogenous CRNDEP expression in the cells with transient shRNA-mediated knockdown of CRNDE. Endogenous CRNDEP localizes predominantly to the nucleus and its expression seems to be elevated in highly proliferating tissues, like the parabasal layer of the squamous epithelium, intestinal crypts or spermatocytes. After its artificial overexpression in HeLa cells, in a fusion with either the EGFP or DsRed Monomer fluorescent tag, CRNDEP seems to stimulate the formation of stress granules and localize to them. Although the exact role of CRNDEP is unknown, our preliminary results suggest that it may be involved in the regulation of the cell proliferation. Possibly, CRNDEP also participates in oxygen metabolism, considering our in silico results, and the correlation between its enforced overexpression and the formation of stress granules. This is the first report showing the existence of a peptide encoded by the CRNDE gene.	[Szafron, Lukasz Michal; Pienkowska-Grela, Barbara; Felisiak-Golabek, Anna; Podgorska, Agnieszka; Kulesza, Magdalena; Dansonka-Mieszkowska, Agnieszka; Konopka, Bozena; Lukasik, Martyna; Kupryjanczyk, Jolanta] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol & Lab Diagnost, Warsaw, Poland; [Balcerak, Anna; Grzybowska, Ewa Anna; Wysocki, Juliusz] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Mol & Translat Oncol, Warsaw, Poland; [Nowak, Natalia] Nencki Inst Expt Biol, Lab Imaging Tissue Struct & Funct, Neurobiol Ctr, Warsaw, Poland; [Pomorski, Pawel] Nencki Inst Expt Biol, NanoBioGeo Consortium, Multimodal Lab Cell Adhes & Motil, Warsaw, Poland; [Pomorski, Pawel] Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Dept Biochem, Warsaw, Poland; [Rubel, Tymon] Warsaw Univ Technol, Inst Radioelect, Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Warsaw University of Technology	Szafron, LM (corresponding author), Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol & Lab Diagnost, Warsaw, Poland.	lukszafron@gmail.com	Grzybowska, Ewa/F-2711-2013; Pomorski, Pawel/AAC-3993-2020; Nowak, Natalia/P-9617-2016; Pomorski, Paweł/R-4170-2016; Rubel, Tymon/L-6861-2017	Pomorski, Pawel/0000-0002-1658-7649; Nowak, Natalia/0000-0003-3140-2056; Pomorski, Paweł/0000-0002-1658-7649; Rubel, Tymon/0000-0002-1342-414X; Kupryjanczyk, Jolanta/0000-0001-5820-0214; Lukasik, Martyna/0000-0001-8102-129X; Konopka, Bozena/0000-0003-1187-3504; Balcerak, Anna/0000-0003-3698-6046; Dansonka-Mieszkowska, Agnieszka/0000-0002-2482-6523; Podgorska, Agnieszka/0000-0002-6915-3334; Grzybowska, Ewa/0000-0003-3148-2439; Szafron, Lukasz/0000-0003-1670-0274	Polish Ministry of Science and Higher Education [N N401 2361 34, N N407 0272 38]; NanoFun Project [POIG.02.02.00-00-025/09]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NanoFun Project	Funding: This study was supported by the grants no. N N401 2361 34 and N N407 0272 38 of the Polish Ministry of Science and Higher Education. URL: (http://www.nauka.gov.pl/en/). Immunofluorescence imaging was performed in Multimodal Laboratory of Cell Adhesion and Motility in Nencki Institute of Experimental Biology PAS, supported by the NanoFun Project POIG.02.02.00-00-025/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; BRZEZINSKABLASZCZYK E, 1980, ARCH IMMUNOL THER EX, V28, P533; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen LL, 2010, WIRES RNA, V1, P2, DOI 10.1002/wrna.5; Cooper C, 2009, NUCLEIC ACIDS RES, V37, P4518, DOI 10.1093/nar/gkp441; Ellis BC, 2014, BBA-MOL CELL RES, V1843, P372, DOI 10.1016/j.bbamcr.2013.10.016; Ellis Blake C., 2012, Frontiers in Genetics, V3, P270, DOI 10.3389/fgene.2012.00270; Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Graham Lloyd D, 2011, Genes Cancer, V2, P829, DOI 10.1177/1947601911431081; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Harris JR, 2000, EUR UROL, V37, P24, DOI 10.1159/000052389; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80; Hube F, 2006, DNA CELL BIOL, V25, P418, DOI 10.1089/dna.2006.25.418; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Maguire SL, 2015, J PATHOL, V235, P571, DOI 10.1002/path.4483; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Nagaraj SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-35; Ollagnier S, 1996, J BIOL CHEM, V271, P9410, DOI 10.1074/jbc.271.16.9410; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sambrook J., 2001, MOL CLONING LAB MANU; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Szafron L, 2013, EUR J CANCER, V49, pS215; Szafron L, 2009, INT J MOL MED, V24, pS40; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Wahlstrom T, 2014, BIOCHIM BIOPHYS ACTA, V1849, P563, DOI [10.1016/j.bbagrm.2014.07.004, DOI 10.1016/J.BBAGRM.2014.07.004]; WARBURG O, 1956, SCIENCE, V124, P269; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Zhang XQ, 2012, NEUROBIOL DIS, V48, P1, DOI 10.1016/j.nbd.2012.06.004; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	48	27	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127475	10.1371/journal.pone.0127475	http://dx.doi.org/10.1371/journal.pone.0127475			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978564	Green Submitted, gold, Green Published			2022-12-27	WOS:000354916100146
J	Wells-Berlin, AM; Perry, MC; Kohn, RA; Paynter, KT; Ottinger, MA				Wells-Berlin, Alicia M.; Perry, Matthew C.; Kohn, Richard A.; Paynter, Kennedy T., Jr.; Ottinger, Mary Ann			Composition, Shell Strength, and Metabolizable Energy of Mulinia lateralis and Ischadium recurvum as Food for Wintering Surf Scoters (Melanitta perspicillata)	PLOS ONE			English	Article							CHESAPEAKE BAY; SOMATERIA-MOLLISSIMA; MYTILUS-EDULIS; SIZE SELECTION; COMMON EIDERS; BLUE MUSSELS; AYTHYA-FULIGULA; BLACK DUCKS; NUTRIENT; HABITAT	Decline in surf scoter (Melanitta perspicillata) waterfowl populations wintering in the Chesapeake Bay has been associated with changes in the availability of benthic bivalves. The Bay has become more eutrophic, causing changes in the benthos available to surf scoters. The subsequent decline in oyster beds (Crassostrea virginica) has reduced the hard substrate needed by the hooked mussel (Ischadium recurvum), one of the primary prey items for surf scoters, causing the surf scoter to switch to a more opportune species, the dwarf surfclam (Mulinia lateralis). The composition (macronutrients, minerals, and amino acids), shell strength (N), and metabolizable energy (kJ) of these prey items were quantified to determine the relative foraging values for wintering scoters. Pooled samples of each prey item were analyzed to determine composition. Shell strength (N) was measured using a shell crack compression test. Total collection digestibility trials were conducted on eight captive surf scoters. For the prey size range commonly consumed by surf scoters (6-12 mm for M. lateralis and 18-24 mm for I. recurvum), I. recurvum contained higher ash, protein, lipid, and energy per individual organism than M. lateralis. I. recurvum required significantly greater force to crack the shell relative to M. lateralis. No difference in metabolized energy was observed for these prey items in wintering surf scoters, despite I. recurvum's higher ash content and harder shell than M. lateralis. Therefore, wintering surf scoters were able to obtain the same amount of energy from each prey item, implying that they can sustain themselves if forced to switch prey.	[Wells-Berlin, Alicia M.; Perry, Matthew C.] USGS, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [Kohn, Richard A.; Ottinger, Mary Ann] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Paynter, Kennedy T., Jr.] Univ Maryland, Marine & Estuarine Environm Sci Program, College Pk, MD 20742 USA	United States Department of the Interior; United States Geological Survey; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Wells-Berlin, AM (corresponding author), USGS, Patuxent Wildlife Res Ctr, 12100 Beech Forest Rd, Laurel, MD 20708 USA.	aberlin@usgs.gov		Chiaradia, Andre/0000-0002-6178-4211	USGS Chesapeake Bay Program; Seaduck Joint Venture; Friends of Patuxent Wildlife Research Center	USGS Chesapeake Bay Program; Seaduck Joint Venture; Friends of Patuxent Wildlife Research Center	The USGS Chesapeake Bay Program, Seaduck Joint Venture, and Friends of Patuxent Wildlife Research Center and Research Refuge provided the financial support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	AOAC International, 2006, AOAC OFFICIAL METHOD; Bustnes JO, 1998, CAN J ZOOL, V76, P1787, DOI 10.1139/cjz-76-9-1787; BUSTNES JO, 1990, CAN J ZOOL, V68, P2280, DOI 10.1139/z90-318; DAUER DM, 1992, ESTUARIES, V15, P384, DOI 10.2307/1352785; Dauer DM, 2000, ESTUARIES, V23, P80, DOI 10.2307/1353227; DELEEUW JJ, 1992, ARDEA, V80, P353; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; DRAULANS D, 1982, J ANIM ECOL, V51, P943, DOI 10.2307/4015; GRANDY JW, 1972, AUK, V89, P189; Hamilton DJ, 1999, AUK, V116, P403, DOI 10.2307/4089374; HOCKEY PAR, 1984, ARDEA, V72, P111; HOLLAND AF, 1977, CHESAPEAKE SCI, V18, P370, DOI 10.2307/1350592; Holland AF, 1985, ESTUARIES, V8, P91; JORDE DG, 1988, J WILDLIFE MANAGE, V52, P209, DOI 10.2307/3801224; Karasov WH, 1990, STUDIES AVIAN BIOL, P391; Karasov WH, 2007, PHYSL ECOLOGY ANIMAL, P117; Kemp W.M., 1992, OXYGEN DYNAMICS CHES, P149; KENWARD RE, 1977, J APPL ECOL, V14, P815, DOI 10.2307/2402813; Kidwell DM, 2007, THESIS U MARYLAND CO; KLASING K. C., 1998, COMP AVIAN NUTR; Malone CR, 1965, J WILDLIFE MANAGE, V17, P197; OFFICER CB, 1984, SCIENCE, V223, P22, DOI 10.1126/science.223.4631.22; PAINE RT, 1966, LIMNOL OCEANOGR, V11, P126, DOI 10.4319/lo.1966.11.1.0126; Perry MC, 2007, WATERBIRDS, V30, P4, DOI 10.1675/1524-4695(2007)030[0004:TCOPAT]2.0.CO;2; Petersen C, 1988, AM NAT, V131, P437; PETERSON CH, 1988, AM NAT, V131, P257, DOI 10.1086/284788; Richman SE, 2004, ECOL APPL, V14, P1217, DOI 10.1890/03-5032; Richman SE, 2003, MAR ECOL PROG SER, V261, P283, DOI 10.3354/meps261283; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; SAS, 2003, SAS STAT SOFTW VERS; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; SELIGER HH, 1985, SCIENCE, V228, P70, DOI 10.1126/science.228.4695.70; Sibald IR, 1982, CANADIAN J ANIMAL SC, V62, P983; SUGDEN L G, 1971, Canadian Wildlife Service Progress Notes, V24, P1; TITUS HW, 1959, POULTRY SCI, V38, P1114, DOI 10.3382/ps.0381114; Townsend C.R., 1981, P86; Tuttle J. H., 1987, CONTAMINANT PROBLEMS, P442; U.S. Department of Agriculture Agricultural Research Service, 2012, DAT USDA NAT NUTR DA; ZWARTS L, 1992, MAR ECOL PROG SER, V83, P113, DOI 10.3354/meps083113; [No title captured]	40	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0119839	10.1371/journal.pone.0119839	http://dx.doi.org/10.1371/journal.pone.0119839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978636	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100002
J	Huang, HR; Fan, LC; Rajbanshi, B; Xu, JF				Huang, Hua-Rong; Fan, Li-Chao; Rajbanshi, Bhavana; Xu, Jin-Fu			Evaluation of a New Cryptococcal Antigen Lateral Flow Immunoassay in Serum, Cerebrospinal Fluid and Urine for the Diagnosis of Cryptococcosis: A Meta-Analysis and Systematic Review	PLOS ONE			English	Review							MENINGITIS; ASSAY; ACCURACY	Background A new lateral flow immunoassay (LFA) for the detection of cryptococcal antigen was developed. Objective We aimed to systematically review all relevant studies to evaluate the diagnostic accuracy of the cryptococcal antigen LFA on serum, CSF and urine specimens. Methods We searched public databases including PubMed, Web of Science, Elsevier Science Direct and Cochrane Library for the English-language literature published up to September 2014. We conducted meta-analyses of sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR) and diagnostic odds ratios (DOR) and SROC of LFA in serum and CSF, respectively. The sensitivity of LFA in urine was also analyzed. Subgroup analyses were carried out to analyze the potential heterogeneity. Results 12 studies were included in this study. The pooled sensitivity and specificity values of LFA in serum were 97.6%(95% CI, 95.6% to 98.9%) and 98.1%(95% CI, 97.4% to 98.6%), respectively. The average PLR of LFA in serum was 43.787 (95% CI, 22.60-84.81) and the NLR was 0.03 (95% CI, 0.01-0.09). The pooled DOR was 2180.30 (95% CI, 868.92-5471.00) and the AUC was 0.9968. The pooled sensitivity and specificity values of LFA in CSF were 98.9% (95% CI, 97.9% to 99.5%) and 98.9% (95% CI, 98.0% to 99.5%), respectively. The average PLR of LFA in serum was 48.83 (95% CI, 21.59-110.40) and the NLR was 0.02 (95% CI, 0.01-0.04). The pooled DOR was 2931.10 (95% CI, 1149.20-7475.90) and the AUC was 0.9974. The pooled sensitivity value of LFA in urine was 85.0% (95% CI, 78.7% to 90.1%) Conclusions The study demonstrates a very high accuracy of LFA in serum and CSF for the diagnosis of cryptococcosis in patients at risk. LFA in urine can be a promising sample screening tool for early diagnosis of cryptococcosis.	[Huang, Hua-Rong; Fan, Li-Chao; Rajbanshi, Bhavana; Xu, Jin-Fu] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Resp Med, Shanghai 200092, Peoples R China	Tongji University	Xu, JF (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Resp Med, Shanghai 200092, Peoples R China.	jfxucn@gmail.com	Xu, Jin-fu/AAC-6980-2020	Xu, Jin-fu/0000-0002-8039-8973	National Science Foundation of China [NSFC81170003, 81370109]; STCSM [12PJD004, 134119a6400, 12JC1402300, XYQ2011006]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); STCSM(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Science Foundation of China (NSFC81170003, 81370109); Projects from STCSM (12PJD004, 134119a6400, 12JC1402300 and XYQ2011006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binnicker MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1988, DOI 10.1128/CVI.00446-12; Boulware DR, 2014, EMERG INFECT DIS, V20, P45, DOI 10.3201/eid2001.130906; Clarke S, 2012, AUST SOC MICR SAN FR; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Escandon P, 2013, MED MYCOL, V51, P765, DOI 10.3109/13693786.2013.781692; Hansen J, 2013, CLIN VACCINE IMMUNOL, V20, P52, DOI 10.1128/CVI.00536-12; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Kabanda T, 2014, CLIN INFECT DIS, V58, P113, DOI 10.1093/cid/cit641; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Lindsley MD, 2011, CLIN INFECT DIS, V53, P321, DOI 10.1093/cid/cir379; McMullan BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049541; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Rolfes M, 2012, 19 C RETR OPP INF SE; Rugemalila J, 2013, TROP MED INT HEALTH, V18, P1075, DOI 10.1111/tmi.12157; Saha DC, 2009, J MED MICROBIOL, V58, P1098, DOI 10.1099/jmm.0.007328-0; Vijayan T., 2012, TEST PERFORMANCE NOV; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	21	38	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127117	10.1371/journal.pone.0127117	http://dx.doi.org/10.1371/journal.pone.0127117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974018	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600101
J	Kondo, HM; Nomura, M; Kashino, M				Kondo, Hirohito M.; Nomura, Michio; Kashino, Makio			Different Roles of COMT and HTR2A Genotypes in Working Memory Subprocesses	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; ANTERIOR CINGULATE CORTEX; INDIVIDUAL-DIFFERENCES; SEROTONIN TRANSPORTER; VAL(158)MET GENOTYPE; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; NEURAL MECHANISMS; GENETIC-VARIATION; INTELLIGENCE	Working memory is linked to the functions of the frontal areas, in which neural activity is mediated by dopaminergic and serotonergic tones. However, there is no consensus regarding how the dopaminergic and serotonergic systems influence working memory subprocesses. The present study used an imaging genetics approach to examine the interaction between neurochemical functions and working memory performance. We focused on functional polymorphisms of the catechol-O-methyltransferase (COMT) Val158Met and serotonin 2A receptor (HTR2A) -1438G/A genes, and devised a delayed recognition task to isolate the encoding, retention, and retrieval processes for visual information. The COMT genotypes affected recognition accuracy, whereas the HTR2A genotypes were associated with recognition response times. Activations specifically related to working memory were found in the right frontal and parietal areas, such as the middle frontal gyrus (MFG), inferior frontal gyrus (IFG), anterior cingulate cortex (ACC), and inferior parietal lobule (IPL). MFG and ACC/IPL activations were sensitive to differences between the COMT genotypes and between the HTR2A genotypes, respectively. Structural equation modeling demonstrated that stronger connectivity in the ACC-MFG and ACC-IFG networks is related to better task performance. The behavioral and fMRI results suggest that the dopaminergic and serotonergic systems play different roles in the working memory subprocesses and modulate closer cooperation between lateral and medial frontal activations.	[Kondo, Hirohito M.; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa 2430198, Japan; [Kondo, Hirohito M.] Osaka Univ, Dept Child Dev, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan; [Nomura, Michio] Kyoto Univ, Grad Sch Educ, Div Cognit Psychol Educ, Kyoto 6068501, Japan; [Kashino, Makio] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Informat Proc, Yokohama, Kanagawa 2268503, Japan	Nippon Telegraph & Telephone Corporation; Osaka University; Kyoto University; Tokyo Institute of Technology	Kondo, HM (corresponding author), NTT Corp, NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa 2430198, Japan.	kondo.hirohito@lab.ntt.co.jp	Kondo, Hirohito/H-3646-2011	Kondo, Hirohito/0000-0002-7444-4996; Nomura, Michio/0000-0003-1043-2811				Aghajanian GK, 1997, NEUROPHARMACOLOGY, V36, P589, DOI 10.1016/S0028-3908(97)00051-8; Baddeley A., 2009, CURR BIOL, V20, pR136, DOI DOI 10.1016/J.CUB.2009.12.014; Baddeley A. D, 1986, WORKING MEMORY; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Blokland GAM, 2011, J NEUROSCI, V31, P10882, DOI 10.1523/JNEUROSCI.5334-10.2011; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter OL, 2005, J COGNITIVE NEUROSCI, V17, P1497, DOI 10.1162/089892905774597191; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cooper J., 2003, BIOCH BASIS NEUROPHA; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Ettinger U, 2008, NEUROPSYCHOPHARMACOL, V33, P3046, DOI 10.1038/sj.npp.1301658; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Glabus MF, 2003, CEREB CORTEX, V13, P1352, DOI 10.1093/cercor/bhg082; Glahn DC, 2002, NEUROIMAGE, V17, P201, DOI 10.1006/nimg.2002.1161; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; HAIER RJ, 1992, INTELLIGENCE, V16, P415, DOI 10.1016/0160-2896(92)90018-M; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Jakab RL, 1998, P NATL ACAD SCI USA, V95, P735, DOI 10.1073/pnas.95.2.735; Jha AP, 2000, J COGNITIVE NEUROSCI, V12, P90, DOI 10.1162/089892900564091; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Koizumi A, 2010, NEUROREPORT, V21, P422, DOI 10.1097/WNR.0b013e32833833f0; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Kondo H, 2004, JPN PSYCHOL RES, V46, P86, DOI 10.1111/j.0021-5368.2004.00239.x; Kondo H, 2004, NEUROIMAGE, V21, P2, DOI 10.1016/j.neuroimage.2003.09.046; Kondo HM, 2007, NEUROIMAGE, V36, P123, DOI 10.1016/j.neuroimage.2007.02.024; Kondo HM, 2012, CEREB CORTEX, V22, P1915, DOI 10.1093/cercor/bhr266; Kondo HM, 2009, J NEUROSCI, V29, P12695, DOI 10.1523/JNEUROSCI.1549-09.2009; Lane HY, 2008, J PSYCHIATR NEUROSCI, V33, P47; Larson GE, 1995, INTELLIGENCE, V21, P267, DOI 10.1016/0160-2896(95)90017-9; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Narayanan NS, 2005, NEUROPSYCHOLOGY, V19, P223, DOI 10.1037/0894-4105.19.2.223; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Nomura M, 2006, ANN NY ACAD SCI, V1086, P134, DOI 10.1196/annals.1377.004; Osaka M, 2003, NEUROIMAGE, V18, P789, DOI 10.1016/S1053-8119(02)00032-0; Osaka N, 2004, NEUROIMAGE, V21, P623, DOI 10.1016/j.neuroimage.2003.09.069; Osaka R, 1972, KYOTO U SX15 INELLIG; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; Parsons MJ, 2004, BIOL PSYCHIAT, V56, P406, DOI 10.1016/j.biopsych.2004.06.020; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Reuter M, 2008, BIOL PSYCHOL, V79, P111, DOI 10.1016/j.biopsycho.2007.12.002; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Sambataro F, 2009, BIOL PSYCHIAT, V66, P540, DOI 10.1016/j.biopsych.2009.04.014; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Tsubomi H, 2013, J NEUROSCI, V33, P8257, DOI 10.1523/JNEUROSCI.5348-12.2013; Tsubomi H, 2009, NEUROIMAGE, V45, P587, DOI 10.1016/j.neuroimage.2008.11.028; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vollenweider FX, 1997, NEUROPSYCHOPHARMACOL, V16, P357, DOI 10.1016/S0893-133X(96)00246-1; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279; Zarahn E, 2005, CEREB CORTEX, V15, P303, DOI 10.1093/cercor/bhh132	78	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126511	10.1371/journal.pone.0126511	http://dx.doi.org/10.1371/journal.pone.0126511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974269	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600056
J	Nhampossa, T; Mandomando, I; Acacio, S; Quinto, L; Vubil, D; Ruiz, J; Nhalungo, D; Sacoor, C; Nhabanga, A; Nhacolo, A; Aide, P; Machevo, S; Sigauque, B; Nhama, A; Kotloff, K; Farag, T; Nasrin, D; Bassat, Q; Macete, E; Levine, MM; Alonso, P				Nhampossa, Tacilta; Mandomando, Inacio; Acacio, Sozinho; Quinto, Llorenc; Vubil, Delfino; Ruiz, Joaquin; Nhalungo, Delino; Sacoor, Charfudin; Nhabanga, Arnaldo; Nhacolo, Ariel; Aide, Pedro; Machevo, Sonia; Sigauque, Betuel; Nhama, Abel; Kotloff, Karen; Farag, Tamer; Nasrin, Dilruba; Bassat, Quique; Macete, Eusebio; Levine, Myron M.; Alonso, Pedro			Diarrheal Disease in Rural Mozambique: Burden, Risk Factors and Etiology of Diarrheal Disease among Children Aged 0-59 Months Seeking Care at Health Facilities	PLOS ONE			English	Article							GLOBAL ENTERIC MULTICENTER; DEVELOPING-COUNTRIES; MATERNAL EDUCATION; GIARDIA-LAMBLIA; NATIONAL CAUSES; YOUNG-CHILDREN; COMMUNITY; GEMS; EPIDEMIOLOGY; ASSOCIATION	Background Diarrheal disease remains a leading cause of illness and death, particularly in low-income countries. Its burden, microbiological causes and risk factors were examined in children aged 0-59 months living in Manhica, rural southern Mozambique. Methods Trends of diarrhea-related burden of disease were estimated during the period 2001-2012. A prospective, age-stratified and matched (by age, gender and geographical origin), case-control study was conducted during 2007-2011. Clinical, epidemiology, anthropometric measurement and fecal samples obtained from recruited children were used to estimate moderate-to-severe diarrhea (MSD) weighted attributable fractions. Results Over the last decade the incidence of acute diarrhea has dropped by about 80%. Incidence of MSD per 100 child years at risk for the period 2007-2011 was 9.85, 7.73 and 2.10 for children aged 0-11, 12-23 and 24-59 months respectively. By adjusted population attributable fractions, most cases of MSD were due to rotavirus, Cryptosporidium, ETEC ST (ST only or ST/LT), Shigella and Adenovirus 40/41. Washing hands and having facilities to dispose child's stools were associated with a reduced risk of MSD, while giving stored water to the child was associated with an increased risk of MSD. Conclusions Despite the predominantly decreasing trends observed throughout the last decade, diarrheal diseases remain today a major cause of morbidity among children aged 0-59 months living in this rural Mozambican area. Rotavirus, cryptosporidium, Shigella, ETEC ST and Adenovirus 40/41 were the most important aetiologies of MSD. Thus, well-known preventive strategies such as washing hands, improving the treatment of stored water, having facilities to dispose children stools, and accelerating the introduction of the rotavirus vaccine should be promoted on a wider scale to reduce the current burden of diarrheal diseases.	[Nhampossa, Tacilta; Mandomando, Inacio; Acacio, Sozinho; Vubil, Delfino; Nhalungo, Delino; Sacoor, Charfudin; Nhabanga, Arnaldo; Nhacolo, Ariel; Aide, Pedro; Machevo, Sonia; Sigauque, Betuel; Nhama, Abel; Bassat, Quique; Macete, Eusebio; Alonso, Pedro] CISM, Maputo, Mozambique; [Nhampossa, Tacilta; Mandomando, Inacio; Acacio, Sozinho; Nhacolo, Ariel; Aide, Pedro; Sigauque, Betuel; Nhama, Abel; Macete, Eusebio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Machevo, Sonia] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Quinto, Llorenc; Ruiz, Joaquin; Bassat, Quique; Alonso, Pedro] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Kotloff, Karen; Farag, Tamer; Nasrin, Dilruba; Levine, Myron M.] Univ Maryland, CVD, Sch Med, Baltimore, MD USA	Centro de Investigacao em Saude de Manhica; Eduardo Mondlane University; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University System of Maryland; University of Maryland Baltimore	Nhampossa, T (corresponding author), CISM, Maputo, Mozambique.	taciltanha@yahoo.com	Mandomando, Inacio/ABD-8007-2020; Alonso, Pedro L/AAZ-3645-2020; kotloff, karen l/E-7768-2012; Bassat, Quique/P-2341-2016; Aide, Pedro/D-8771-2018; Ruiz, Joaquim/D-2704-2013	Mandomando, Inacio/0000-0002-1078-2187; Alonso, Pedro L/0000-0003-3292-3443; kotloff, karen l/0000-0003-1808-6431; Bassat, Quique/0000-0003-0875-7596; Ruiz, Joaquim/0000-0002-4431-2036; Farag, Tamer/0000-0003-1826-6600; Quinto, Llorenc/0000-0001-9992-6951	Bill & Melinda Gates Foundation; Spanish Agency for International Cooperation and development (AECID); Calouste Gulbenkian Foundation (Portugal); program Miguel Servet of the ISCIII (Spain) [CP11/00269]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Spanish Agency for International Cooperation and development (AECID); Calouste Gulbenkian Foundation (Portugal); program Miguel Servet of the ISCIII (Spain)	This work was supported by the Bill & Melinda Gates Foundation. CISM received core funding from the Spanish Agency for International Cooperation and development (AECID). TN (corresponding author) is supported by a PhD scholarship from the Calouste Gulbenkian Foundation (Portugal). QB has a fellowship from the program Miguel Servet of the ISCIII (grant number: CP11/00269; Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragaw Mer'awi, 2011, Ethiop Med J, V49, P341; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; Bessong PO, 2009, J HEALTH POPUL NUTR, V27, P652; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788; Boadi KO, 2005, J ENVIRON HEALTH, V68, P32; Brown KH, 2003, J NUTR, V133, p328S, DOI 10.1093/jn/133.1.328S; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Cama VA, 2008, EMERG INFECT DIS, V14, P1567, DOI 10.3201/eid1410.071273; Checkley W, 2004, LANCET, V363, P112, DOI 10.1016/S0140-6736(03)15261-0; DARGENTMOLINA P, 1994, SOC SCI MED, V38, P343, DOI 10.1016/0277-9536(94)90404-9; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Dgedge M, 2001, B WORLD HEALTH ORGAN, V79, P546; El-Hakim M A, 1996, J Egypt Public Health Assoc, V71, P439; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FRASER D, 1994, ISRAEL J MED SCI, V30, P356; García Coralith, 2006, Rev. gastroenterol. Perú, V26, P21; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Keusch GT, 2006, DIARRHEAL DISEASES; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761; Levine MM, 2012, CLIN INFECT DIS, V55, pS303, DOI 10.1093/cid/cis789; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; MacLennan CA, 2013, EXPERT REV ANTI-INFE, V11, P443, DOI [10.1586/ERI.13.27, 10.1586/eri.13.27]; Mandomando I, 2007, PEDIATR INFECT DIS J, V26, P1059, DOI 10.1097/INF.0b013e31812e55a2; Mandomando I, 2009, TROP MED INT HEALTH, V14, P1467, DOI 10.1111/j.1365-3156.2009.02399.x; Mandomando IM, 2007, AM J TROP MED HYG, V76, P522, DOI 10.4269/ajtmh.2007.76.522; MISAU. Ministerio da Saude, MANUAL DE PREVENCAO; Moyo SJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-19; Muhsen K, 2012, CLIN INFECT DIS, V55, pS271, DOI 10.1093/cid/cis762; Nel ED, 2011, J TROP PEDIATRICS, V57, P289, DOI 10.1093/tropej/fmq094; Newman RD, 1999, J INFECT DIS, V180, P167, DOI 10.1086/314820; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; Rappelli P, 2005, FEMS IMMUNOL MED MIC, V43, P67, DOI 10.1016/j.femsim.2004.07.006; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sacarlal J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-67; Smith HV, 2010, EXP PARASITOL, V124, P61, DOI 10.1016/j.exppara.2009.05.014; Snelling WJ, 2007, J INFECT DEV COUNTR, V1, P242, DOI 10.3855/jidc.360; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6	44	51	52	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0119824	10.1371/journal.pone.0119824	http://dx.doi.org/10.1371/journal.pone.0119824			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25973880	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600001
J	Procopio, TF; Fernandes, KM; Pontual, EV; Ximenes, RM; de Oliveira, ARC; Souza, CD; Melo, AMMD; Navarro, DMDF; Paiva, PMG; Martins, GF; Napoleao, TH				Procopio, Thamara Figueiredo; Fernandes, Kenner Morais; Pontual, Emmanuel Viana; Ximenes, Rafael Matos; Cardoso de Oliveira, Aline Rafaella; Souza, Carolina de Santana; Mendonca de Albuquerque Melo, Ana Maria; do Amaral Ferraz Navarro, Daniela Maria; Guedes Paiva, Patricia Maria; Martins, Gustavo Ferreira; Napoleao, Thiago Henrique			Schinus terebinthifolius Leaf Extract Causes Midgut Damage, Interfering with Survival and Development of Aedes aegypti Larvae	PLOS ONE			English	Article							MYRACRODRUON-URUNDEUVA; INSECTICIDE RESISTANCE; DIPTERA-CULICIDAE; ESSENTIAL OILS; CELLS; DENGUE; METAMORPHOSIS; ALBOPICTUS; INHIBITOR; APOPTOSIS	In this study, a leaf extract from Schinus terebinthifolius was evaluated for effects on survival, development, and midgut of A. aegypti fourth instar larvae (L4), as well as for toxic effect on Artemia salina. Leaf extract was obtained using 0.15 M NaCl and evaluated for phytochemical composition and lectin activity. Early L4 larvae were incubated with the extract (0.3-1.35%, w/v) for 8 days, in presence or absence of food. Polymeric proanthocyanidins, hydrolysable tannins, heterosid and aglycone flavonoids, cinnamic acid derivatives, traces of steroids, and lectin activity were detected in the extract, which killed the larvae at an LC50 of 0.62% (unfed larvae) and 1.03% (fed larvae). Further, the larvae incubated with the extract reacted by eliminating the gut content. No larvae reached the pupal stage in treatments at concentrations between 0.5% and 1.35%, while in the control (fed larvae), 61.7% of individuals emerged as adults. The extract (1.0%) promoted intense disorganization of larval midgut epithelium, including deformation and hypertrophy of cells, disruption of microvilli, and vacuolization of cytoplasms, affecting digestive, enteroendocrine, regenerative, and proliferating cells. In addition, cells with fragmented DNA were observed. Separation of extract components by solid phase extraction revealed that cinnamic acid derivatives and flavonoids are involved in larvicidal effect of the extract, being the first most efficient in a short time after larvae treatment. The lectin present in the extract was isolated, but did not show deleterious effects on larvae. The extract and cinnamic acid derivatives were toxic to A. salina nauplii, while the flavonoids showed low toxicity. S. terebinthifolius leaf extract caused damage to the midgut of A. aegypti larvae, interfering with survival and development. The larvicidal effect of the extract can be attributed to cinnamic acid derivatives and flavonoids. The data obtained using A. salina indicates that caution should be used when employing this extract as a larvicidal agent.	[Procopio, Thamara Figueiredo; Pontual, Emmanuel Viana; Cardoso de Oliveira, Aline Rafaella; Souza, Carolina de Santana; Guedes Paiva, Patricia Maria; Napoleao, Thiago Henrique] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Bioquim, BR-50670420 Recife, PE, Brazil; [Fernandes, Kenner Morais; Martins, Gustavo Ferreira] Univ Fed Vicosa, Dept Biol Geral, BR-36570900 Vicosa, MG, Brazil; [Pontual, Emmanuel Viana] Univ Fed Rural Pernambuco, Dept Morfol & Fisiol Anim, BR-52171900 Recife, PE, Brazil; [Ximenes, Rafael Matos] Univ Fed Pernambuco, Dept Antibiot, BR-50670420 Recife, PE, Brazil; [Mendonca de Albuquerque Melo, Ana Maria] Univ Fed Pernambuco, Dept Biofis & Radiobiol CCB, BR-50670420 Recife, PE, Brazil; [do Amaral Ferraz Navarro, Daniela Maria] Univ Fed Pernambuco, Ctr Ciencias Exatas & Nat, Dept Quim Fundamental, BR-50740560 Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Vicosa; Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Napoleao, TH (corresponding author), Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Bioquim, Cidade Univ, BR-50670420 Recife, PE, Brazil.	thiagohn86@yahoo.com.br	Ximenes, Rafael/AAG-9874-2021; Napoleao, Thiago Henrique/P-2364-2019; Martins, Gustavo Ferreira/AAL-7744-2020; Navarro, Daniela Maria do Amaral Ferraz/GXM-4019-2022; Martins, Gustavo F/L-9107-2015; de Albuquerque Melo, Ana Maria Mendonça/AAG-3879-2021; Pontual, Emmanuel/AAQ-8097-2020; Procópio, Thamara Figueiredo/AAZ-5811-2020; Navarro, Daniela Maria do Amaral Ferraz/C-4975-2013; Ximenes, Rafael M/J-3247-2012; Paiva, Patricia Maria Guedes/S-4038-2019; Morais, Kenner/Z-1667-2019	Ximenes, Rafael/0000-0002-2011-2865; Napoleao, Thiago Henrique/0000-0002-0065-2602; Martins, Gustavo F/0000-0003-0614-8551; de Albuquerque Melo, Ana Maria Mendonça/0000-0002-7223-6472; Pontual, Emmanuel/0000-0002-4399-3650; Navarro, Daniela Maria do Amaral Ferraz/0000-0003-0158-7221; Ximenes, Rafael M/0000-0002-2011-2865; Paiva, Patricia Maria Guedes/0000-0003-3467-708X; Morais, Kenner/0000-0003-0576-8185	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco [APQ-0137-2.08/12, BCT-0421-2.08/12, BIC-0312-2.08/13, APQ-0330-2.08/13]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PNPD CAPES-FACEPE) [CAPES/PVE 88881.030429/2013-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [132375/2013-3, 472546/2012-0, 446902/2014-4]; Brazilian Ministry for Science, Technology and Innovation (MCTI) [01200.003711/2011-11]	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PNPD CAPES-FACEPE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry for Science, Technology and Innovation (MCTI)	This work was supported by the Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (APQ-0137-2.08/12 and BCT-0421-2.08/12 to E.V.P.; BIC-0312-2.08/13 for A.R.C.O. and T.H.N.; APQ-0330-2.08/13 for P.M.G.P.; www.facepe.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PVE 88881.030429/2013-01 for K.M.F.; PNPD CAPES-FACEPE for E.V.P.; www.capes.gov.br), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (132375/2013-3 for T.F.P.; 472546/2012-0 for P.M.G.P.; 446902/2014-4 for T.H.N.), and the Brazilian Ministry for Science, Technology and Innovation (MCTI; 01200.003711/2011-11 for P.M.G.P.; www.mcti.gov.br). P.M.G.P. and G.F.M. are investigators of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEDI Z. H., 1961, ANN ENT SOC AMER, V54, P539, DOI 10.1093/aesa/54.4.539; Agra-Neto AC, 2014, PARASITOL RES, V113, P175, DOI 10.1007/s00436-013-3640-8; Aiub Claudia Alessandra Fortes, 2002, Genetics and Molecular Research, V1, P159; Al-Mehmadi R. M., 2010, Journal of King Saud University Science, V22, P77, DOI 10.1016/j.jksus.2010.02.004; Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3; [Anonymous], 1981, World Health Organ Tech Rep Ser, V657, P1; [Anonymous], 2013, LECTINS TRYPSIN INHI; [Anonymous], 1998, BUSINESS MEDIA, DOI DOI 10.1007/978-94-009-5570-7; [Anonymous], 1996, PLANT DRUG ANAL; Arruda Walquíria, 2003, Rev. Soc. Bras. Med. Trop., V36, P17, DOI 10.1590/S0037-86822003000100004; ASHIDA M, 1983, BIOCHEM BIOPH RES CO, V113, P562, DOI 10.1016/0006-291X(83)91762-X; Balbachas A, 1959, AS PLANTAS CURAM; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BROWN MR, 1985, TISSUE CELL, V17, P709, DOI 10.1016/0040-8166(85)90006-0; BRUSCA GJ, 2003, INVERTEBRATES; Cavalher-Machado SC, 2008, INT IMMUNOPHARMACOL, V8, P1552, DOI 10.1016/j.intimp.2008.06.012; Cheng SS, 2004, J AGR FOOD CHEM, V14, P4935; Coelho AAM, 2009, BIOASSAY, V4, P3; Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022; Costa MS, 2012, NEOTROP ENTOMOL, V41, P311, DOI 10.1007/s13744-012-0050-z; Costa MS, 2014, TOXINS, V6, P1169, DOI 10.3390/toxins6041169; Deletre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082103; Fernandes KM, 2010, SOCIOBIOLOGY, V56, P489; Fernandes KM, 2014, PARASITOL INT, V63, P506, DOI 10.1016/j.parint.2014.01.004; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gomes FS, 2013, J APPL MICROBIOL, V114, P672, DOI 10.1111/jam.12086; Gusmao DS, 2002, MEM I OSWALDO CRUZ, V97, P371, DOI 10.1590/S0074-02762002000300017; JAIN MK, 1995, PHYTOCHEMISTRY, V39, P537, DOI 10.1016/0031-9422(94)00960-2; Kamiabi Fatemeh, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P767, DOI 10.1016/S2221-1691(13)60153-7; Levi T, 2014, ACTA TROP, V133, P42, DOI 10.1016/j.actatropica.2014.02.001; Lindenmaier D. S., 2008, ETNOBOTANICA COMUNID; LORENZI H., 2016, ARVORES BRASILEIRAS, V1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424; Matsuo AL, 2011, BIOCHEM BIOPH RES CO, V411, P449, DOI 10.1016/j.bbrc.2011.06.176; Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015; MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236; MITCHELL MJ, 1993, INSECT BIOCHEM MOLEC, V23, P65, DOI 10.1016/0965-1748(93)90083-5; Murray T, 2013, NATURAL INSECTICIDES; Napoleao TH, 2012, PARASITOL RES, V110, P609, DOI 10.1007/s00436-011-2529-7; Navarro DMDF, 2013, NAT PROD J, V3, P268, DOI 10.2174/221031550304140328113732; Navarro DMAF, 2003, J APPL ENTOMOL, V127, P46, DOI 10.1046/j.1439-0418.2003.00690.x; Nishiura JT, 2003, J MED ENTOMOL, V40, P498, DOI 10.1603/0022-2585-40.4.498; Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007; Ochieng C.O., 2010, RES J PHARM, V4, P45, DOI [10.3923/rjpharm.2010.45.50, DOI 10.3923/RJPHARM.2010.45.50]; Pawlowski A, 2012, S AFR J BOT, V80, P96, DOI 10.1016/j.sajb.2012.03.003; Perumalsamy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080226; Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005; Pontual EV, 2014, PARASITOL RES, V113, P727, DOI 10.1007/s00436-013-3702-y; Pontual EV, 2012, ARCH INSECT BIOCHEM, V79, P135, DOI 10.1002/arch.21012; Pratti DLA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0746-0; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Ray K, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.5501; ROBERTS E. A. H., 1956, Journal of the Science of Food and Agriculture, V7, P637, DOI 10.1002/jsfa.2740071003; ROWLEY AF, 1990, J INVERTEBR PATHOL, V56, P31, DOI 10.1016/0022-2011(90)90141-R; Sa RA, 2009, COMP BIOCHEM PHYS C, V149, P300, DOI 10.1016/j.cbpc.2008.08.004; Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Silva AG, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-79; Silva C. C. A., 2002, BIOTECNOL CIEN DESEN, V2, P68; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; Zhang YE, 2012, J ECON ENTOMOL, V105, P1034, DOI 10.1603/EC11287	62	52	55	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126612	10.1371/journal.pone.0126612	http://dx.doi.org/10.1371/journal.pone.0126612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974067	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600066
J	Velmurugan, P; Rao, JR; Nair, BU				Velmurugan, Punitha; Rao, Jonnalagadda Raghava; Nair, Balachandran Unni			Engineering D-Amino Acid Containing Collagen Like Peptide at the Cleavage Site of Clostridium histolyticum Collagenase for Its Inhibition	PLOS ONE			English	Article							TRIPLE-HELICAL PEPTIDES; CIRCULAR-DICHROISM SPECTRA; X-Y TRIPLETS; ASPARTIC-ACID; HOST-GUEST; CONFORMATIONAL STABILITY; OSTEOGENESIS IMPERFECTA; ALZHEIMERS-DISEASE; ASP(23) RESIDUE; RACEMIZATION	Collagenase is an important enzyme which plays an important role in degradation of collagen in wound healing, cancer metastasis and even in embryonic development. However, the mechanism of this degradation has not yet been completely understood. In the field of biomedical and protein engineering, the design and development of new peptide based materials is of main concern. In the present work an attempt has been made to study the effect of DAla in collagen like peptide (imino-poor region of type I collagen) on the structure and stability of peptide against enzyme hydrolysis. Effect of replacement of DAla in the collagen like peptide has been studied using circular dichroic spectroscopy (CD). Our findings suggest that, DAla substitution leads to conformational changes in the secondary structure and favours the formation of polyproline II conformation than its L-counterpart in the imino-poor region of collagen like peptides. Change in the chirality of alanine at the cleavage site of collagenase in the imino-poor region inhibits collagenolytic activity. This may find application in design of peptides and peptidomimics for enzyme-substrate interaction, specifically with reference to collagen and other extra cellular matrix proteins.	[Velmurugan, Punitha; Rao, Jonnalagadda Raghava; Nair, Balachandran Unni] Cent Leather Res Inst, CSIR, Chem Lab, Chennai 600020, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI)	Rao, JR (corresponding author), Cent Leather Res Inst, CSIR, Chem Lab, Chennai 600020, Tamil Nadu, India.	jrrao@clri.res.in	Rao, Jonnalagadda Raghava/V-6803-2018; velmurugan, punitha/B-8072-2009	Rao, Jonnalagadda Raghava/0000-0001-5191-3182; 	CSIR, INDIA	CSIR, INDIA(Council of Scientific & Industrial Research (CSIR) - India)	VP-Senior Research Fellowship from CSIR, INDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2; BADA JL, 1973, NATURE, V245, P308, DOI 10.1038/245308a0; Bansal PS, 2008, J BIOL CHEM, V283, P8969, DOI 10.1074/jbc.M709762200; Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f; Chan VC, 1997, J BIOL CHEM, V272, P31441, DOI 10.1074/jbc.272.50.31441; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.3.CO;2-Z; Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Friedman M, 1999, J AGR FOOD CHEM, V47, P3457, DOI 10.1021/jf990080u; FRIEDMAN M, 1984, J FOOD SCI, V49, P1282, DOI 10.1111/j.1365-2621.1984.tb14970.x; Friedman M, 1999, J AGR FOOD CHEM, V47, P1295, DOI 10.1021/jf981000+; Fujii N, 2004, CHEM REC, V4, P267, DOI 10.1002/tcr.20020; FUJII N, 1994, J BIOCHEM-TOKYO, V116, P663, DOI 10.1093/oxfordjournals.jbchem.a124577; Fujii N, 2002, BIOCHEM BIOPH RES CO, V294, P1047, DOI 10.1016/S0006-291X(02)00597-1; Garner William H., 1978, P NATL ACAD SCI USA, V75, P3618; Gineyts E, 2000, BIOCHEM J, V345, P481, DOI 10.1042/0264-6021:3450481; GOODFRIEND GA, 1992, NATURE, V357, P399, DOI 10.1038/357399a0; Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Horng JC, 2007, PROTEIN SCI, V16, P208, DOI 10.1110/ps.062560107; Jacobsen RB, 1999, J PEPT RES, V54, P93, DOI 10.1034/j.1399-3011.1999.00093.x; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; Khew ST, 2007, J CHROMATOGR B, V858, P79, DOI 10.1016/j.jchromb.2007.08.020; Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005; Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; Krause E, 2000, J AM CHEM SOC, V122, P4865, DOI 10.1021/ja9940524; Kreil G, 1997, ANNU REV BIOCHEM, V66, P337, DOI 10.1146/annurev.biochem.66.1.337; Krishna OD, 2009, BIOMACROMOLECULES, V10, P2626, DOI 10.1021/bm900551c; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lee DL, 2004, J PEPT RES, V63, P69, DOI 10.1046/j.1399-3011.2003.00106.x; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V17, P275; Oda A, 2011, J CHROMATOGR B, V879, P3337, DOI 10.1016/j.jchromb.2011.08.011; OGINO T, 1988, J DENT RES, V67, P1319, DOI 10.1177/00220345880670101501; OKUYAMA K, 1972, J MOL BIOL, V72, P571, DOI 10.1016/0022-2836(72)90175-1; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Persikov AV, 2003, J AM CHEM SOC, V125, P11500, DOI 10.1021/ja036673+; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342; Pires MM, 2012, LANGMUIR, V28, P1993, DOI 10.1021/la203848r; Przybyla DE, 2008, J AM CHEM SOC, V130, P12610, DOI 10.1021/ja804942w; Punitha V, 2009, J PHYS CHEM B, V113, P8983, DOI 10.1021/jp808690m; Punitha V, 2012, ADV BIOSCI BIOTECHNO, V3, P900; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Raman SS, 2008, J PHYS CHEM B, V112, P1533, DOI 10.1021/jp0728297; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; RICHTER K, 1987, SCIENCE, V238, P200, DOI 10.1126/science.3659910; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Sakai-Kato K, 2007, BIOCHEM BIOPH RES CO, V364, P464, DOI 10.1016/j.bbrc.2007.10.014; Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y; Shah NK, 1999, BIOPOLYMERS, V49, P297; Shao Q, 2011, J PHYS CHEM B, V115, P8627, DOI 10.1021/jp203344u; SHIKATA Y, 1995, J BIOL CHEM, V270, P16719, DOI 10.1074/jbc.270.28.16719; SOYEZ D, 1994, J BIOL CHEM, V269, P18295; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; Tanihara M, 2005, BIOPOLYMERS, V3, P163; TOMIYAMA T, 1994, J BIOL CHEM, V269, P10205; Torres AM, 2002, FEBS LETT, V524, P172, DOI 10.1016/S0014-5793(02)03050-8; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Xu P, 2008, BIOMACROMOLECULES, V9, P1551, DOI 10.1021/bm701365x; Yang W, 1997, J BIOL CHEM, V272, P28837, DOI 10.1074/jbc.272.46.28837; Yao JM, 2004, J BIOCHEM, V136, P643, DOI 10.1093/jb/mvh172; Yu M, 2011, AGE, V33, P131, DOI [10.1007/s11357-010-9171-7, DOI 10.1007/S11357-010-9171-7]	74	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0124398	10.1371/journal.pone.0124398	http://dx.doi.org/10.1371/journal.pone.0124398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973613	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600010
J	Lanuti, M; Talamonti, E; Maccarrone, M; Chiurchiu, V				Lanuti, Mirko; Talamonti, Emanuela; Maccarrone, Mauro; Chiurchiu, Valerio			Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; POTENTIAL ROLE; KAPPA-B; CELLS; ATHEROSCLEROSIS; EXPRESSION; RELEASE; LYSOPHOSPHATIDYLINOSITOL; CD36; GENE	The G protein-coupled receptor GPR55 has been proposed as a new cannabinoid receptor associated with bone remodelling, nervous system excitability, vascular homeostasis as well as in several pathophysiological conditions including obesity and cancer. However, its physiological role and underlying mechanism remain unclear. In the present work, we demonstrate for the first time its presence in human macrophages and its increased expression in ox-LDL-induced foam cells. In addition, pharmacological activation of GPR55 by its selective agonist O-1602 increased CD36-and SRB-I-mediated lipid accumulation and blocked cholesterol efflux by downregulating ATP-binding cassette (ABC) transporters ABCA1 and ABCG1, as well as enhanced cytokine-and pro-metalloprotease-9 (pro-MMP-9)-induced proinflammatory responses in foam cells. Treatment with cannabidiol, a selective antagonist of GPR55, counteracted these pro-atherogenic and proinflammatory O-1602-mediated effects. Our data suggest that GPR55 could play deleterious role in ox-LDL-induced foam cells and could be a novel pharmacological target to manage atherosclerosis and other related cardiovascular diseases.	[Lanuti, Mirko; Talamonti, Emanuela; Maccarrone, Mauro; Chiurchiu, Valerio] Santa Lucia Fdn, European Ctr Brain Res CERC, IRCCS, Rome, Italy; [Talamonti, Emanuela; Maccarrone, Mauro; Chiurchiu, Valerio] Univ Rome, Ctr Integrated Res, Rome, Italy	IRCCS Santa Lucia; Sapienza University Rome	Maccarrone, M (corresponding author), Santa Lucia Fdn, European Ctr Brain Res CERC, IRCCS, Rome, Italy.	m.maccarrone@unicampus.it; v.chiurchiu@hsantalucia.it	Maccarrone, Mauro/K-5398-2012; Chiurchiu, Valerio/G-6227-2011	Maccarrone, Mauro/0000-0002-3990-2963; Chiurchiu, Valerio/0000-0002-0316-7311	Ministero dell'Istruzione, dell'Universita e della Ricerca	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This investigation was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca [grant PRIN 2010-2011] to MM.	[Anonymous], 2010, PROBE REPORTS NIH MO; Arjuman A, 2013, DIABETES VASC DIS RE, V10, P442, DOI 10.1177/1479164113489042; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Beltowski J, 2009, CURR DRUG SAF, V4, P209, DOI 10.2174/157488609789006949; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Boyle JJ, 2003, ARTERIOSCL THROM VAS, V23, P1553, DOI 10.1161/01.ATV.0000086961.44581.B7; Cantarella G, 2011, BIOCHEM PHARMACOL, V82, P380, DOI 10.1016/j.bcp.2011.05.004; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Chiurchitiu V, 2011, PEPTIDES, V32, P80, DOI 10.1016/j.peptides.2010.09.024; Chiurchiu V, 2008, REGUL PEPTIDES, V148, P26, DOI 10.1016/j.regpep.2008.02.009; Chiurchiu V, 2015, INT IMMUNOL, V27, P153, DOI 10.1093/intimm/dxu097; Chiurchiu V, 2014, ATHEROSCLEROSIS, V233, P55, DOI 10.1016/j.atherosclerosis.2013.12.042; Chiurchiu V, 2013, ANN NEUROL, V73, P626, DOI 10.1002/ana.23875; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Costet P, 2000, J BIOL CHEM, V275, P28240; de la Llera-Moya M, 2001, J LIPID RES, V42, P1969; Delsing DJM, 2011, OPEN CARDIOVASC MED, V5, P15, DOI 10.2174/1874192401105010015; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Diaz-Arteaga A, 2012, DIABETES OBES METAB, V14, P234, DOI 10.1111/j.1463-1326.2011.01515.x; Dol-Gleizes F, 2009, ARTERIOSCL THROM VAS, V29, P12, DOI 10.1161/ATVBAHA.108.168757; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; Halvorsen B, 2014, BIOCHEM BIOPH RES CO, V450, P1525, DOI 10.1016/j.bbrc.2014.07.036; Han CY, 2000, BIOCHEM J, V350, P829, DOI 10.1042/0264-6021:3500829; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Hoyer FF, 2011, J MOL CELL CARDIOL, V51, P1007, DOI 10.1016/j.yjmcc.2011.08.008; Izzi V, 2008, INT J IMMUNOPATH PH, V21, P833, DOI 10.1177/039463200802100408; Izzi V, 2009, INT J ONCOL, V34, P543, DOI 10.3892/ijo_00000180; Kargl J, 2013, J PHARMACOL EXP THER, V346, P54, DOI 10.1124/jpet.113.204180; Li K, 2013, NEUROPHARMACOLOGY, V71, P255, DOI 10.1016/j.neuropharm.2013.03.029; Li YK, 2006, J BIOL CHEM, V281, P6707, DOI 10.1074/jbc.M510579200; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lipina C, 2010, DIABETES, V59, P375, DOI 10.2337/db09-0979; Lipsky RH, 1997, RECEPT SIGNAL TRANS, V7, P1; Mach F, 2008, J NEUROENDOCRINOL, V20, P53, DOI 10.1111/j.1365-2826.2008.01685.x; MAINI RN, 1995, CLIN EXP IMMUNOL, V101, P207; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Massaro M, 2010, CARDIOVASC RES, V86, P311, DOI 10.1093/cvr/cvp375; McHugh D, 2009, VITAM HORM, V81, P337, DOI 10.1016/S0083-6729(09)81013-3; McKillop AM, 2013, BRIT J PHARMACOL, V170, P978, DOI 10.1111/bph.12356; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Netherland CD, 2010, ATHEROSCLEROSIS, V213, P102, DOI 10.1016/j.atherosclerosis.2010.07.060; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Pacher P, 2009, ARTERIOSCL THROM VAS, V29, P7, DOI 10.1161/ATVBAHA.108.178129; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Sabol SL, 2005, J LIPID RES, V46, P2151, DOI 10.1194/jlr.M500080-JLR200; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Simcocks AC, 2014, DRUG DISCOV TODAY, V19, P1145, DOI 10.1016/j.drudis.2013.12.005; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Steffens S, 2012, BRIT J PHARMACOL, V167, P313, DOI 10.1111/j.1476-5381.2012.02042.x; Sylantyev S, 2013, P NATL ACAD SCI USA, V110, P5193, DOI 10.1073/pnas.1211204110; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Xu MZ, 2009, BIOCHEM BIOPH RES CO, V390, P1349, DOI 10.1016/j.bbrc.2009.10.152; Zhang X, 2010, BRIT J PHARMACOL, V160, P1583, DOI 10.1111/j.1476-5381.2010.00841.x	56	19	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126839	10.1371/journal.pone.0126839	http://dx.doi.org/10.1371/journal.pone.0126839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970609	gold, Green Published			2022-12-27	WOS:000354544200136
J	Rothan, HA; Bahrani, H; Mohamed, Z; Teoh, TC; Shankar, EM; Rahman, NA; Yusof, R				Rothan, Hussin A.; Bahrani, Hirbod; Mohamed, Zulqarnain; Teoh, Teow Chong; Shankar, Esaki M.; Rahman, Noorsaadah A.; Yusof, Rohana			A Combination of Doxycycline and Ribavirin Alleviated Chikungunya Infection	PLOS ONE			English	Article							ANTIVIRAL ACTIVITY; IN-VITRO; HEPATITIS-C; VIRUS; DISEASE; MICE; ANTIBIOTICS; VIVO; TETRACYCLINE; ENCEPHALITIS	Lack of vaccine and effective antiviral drugs against chikungunya virus (CHIKV) outbreaks have led to significant impact on health care in the developing world. Here, we evaluated the antiviral effects of tetracycline (TETRA) derivatives and other common antiviral agents against CHIKV. Our results showed that within the TETRA derivatives group, Doxycycline (DOXY) exhibited the highest inhibitory effect against CHIKV replication in Vero cells. On the other hand, in the antiviral group Ribavirin (RIBA) showed higher inhibitory effects against CHIKV replication compared to Aciclovir (ACIC). Interestingly, RIBA inhibitory effects were also higher than all but DOXY within the TETRA derivatives group. Docking studies of DOXY to viral cysteine protease and E2 envelope protein showed non-competitive interaction with docking energy of -6.6 +/- 0.1 and -6.4 +/- 0.1 kcal/mol respectively. The 50% effective concentration (EC50) of DOXY and RIBA was determined to be 10.95 +/- 2.12 mu M and 15.51 +/- 1.62 mu M respectively, while DOXY+RIBA (1:1 combination) showed an EC50 of 4.52 +/- 1.42 mu M. When compared, DOXY showed higher inhibition of viral infectivity and entry than RIBA. In contrast however, RIBA showed higher inhibition against viral replication in target cells compared to DOXY. Assays using mice as animal models revealed that DOXY+RIBA effectively inhibited CHIKV replication and attenuated its infectivity in vivo. Further experimental and clinical studies are warranted to investigate their potential application for clinical intervention of CHIKV disease.	[Rothan, Hussin A.; Bahrani, Hirbod; Yusof, Rohana] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia; [Mohamed, Zulqarnain; Teoh, Teow Chong] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia; [Shankar, Esaki M.] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia; [Rahman, Noorsaadah A.] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Rothan, HA (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia.	rothan@um.edu.my	TEOH, TEOW CHONG/B-9950-2010; Rahman, Noorsaadah Abd./B-9291-2010; Muthu, Shankar Esaki/B-3132-2019; Mohamed, Zahurin/C-1112-2010; YUSOF, ROHANA/B-9589-2010; Shankar, EM/G-6444-2011; ROTHAN, HUSSIN/D-5490-2016; MOHAMED, ZULQARNAIN/C-1158-2010	Rahman, Noorsaadah Abd./0000-0001-5847-8961; Muthu, Shankar Esaki/0000-0002-7866-9818; Mohamed, Zahurin/0000-0002-4396-0517; YUSOF, ROHANA/0000-0002-6591-3236; MOHAMED, ZULQARNAIN/0000-0001-7311-0356; ROTHAN, HUSSIN/0000-0002-7300-6388	University of Malaya, UMRG [RG309-14AFR, BK-0432014]	University of Malaya, UMRG(Universiti Malaya)	Support was provided by the University of Malaya, UMRG Grant RG309-14AFR AND BK-0432014.	Bajak A, 2014, NATURE, V512, P124, DOI 10.1038/512124a; Bizollon T, 2005, TRANSPLANTATION, V79, P325, DOI 10.1097/01.TP.0000149499.78996.B3; Braschi I, 2010, J HAZARD MATER, V178, P218, DOI 10.1016/j.jhazmat.2010.01.066; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Chao Y, 2011, CHEM ENG J, V243, P60; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Darr S, 2008, CLIN INFECT DIS, V47, P731, DOI 10.1086/590970; Fuster D, 2005, ANTIVIR THER, V10, P841; Homem V, 2011, J ENVIRON MANAGE, V92, P2304, DOI 10.1016/j.jenvman.2011.05.023; Jeulin H, 2008, INT J PHARMACEUT, V357, P148, DOI 10.1016/j.ijpharm.2008.01.043; Ji LL, 2010, ENVIRON SCI TECHNOL, V44, P3116, DOI 10.1021/es903716s; Kirchner JT, 2000, POSTGRAD MED, V107, P55, DOI 10.3810/pgm.2000.01.815; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lawitz E, 2008, J HEPATOL, V49, P163, DOI 10.1016/j.jhep.2008.03.027; Macdougall C, 2011, GOODMAN GILMANS PHAR, P1537; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Mary JA, 2013, J BIOMOL STRUCT DYN, V31, P1077, DOI 10.1080/07391102.2012.721496; Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018; Ng HH, 2012, EXP MOL PATHOL, V92, P287, DOI 10.1016/j.yexmp.2012.03.003; Panigrahi R, 2014, J VIROL, V22, DOI [10.1186/1687-9856-2014-22, DOI 10.1186/1687-9856-2014-22]; Parashar D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002405; Pastorino BAM, 2008, VIRUS RES, V131, P293, DOI 10.1016/j.virusres.2007.09.009; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Polat KY, 2012, TRANSPL INFECT DIS, V14, P326, DOI 10.1111/j.1399-3062.2011.00709.x; Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; QUISPELAIME AM, 2010, J INTENSIVE CARE MED, V36, P33; Rothan HA, 2013, TROP BIOMED, V30, P681; Rothan HA, 2014, ARCH VIROL, V159, P711, DOI 10.1007/s00705-013-1880-7; Rowe T, 2010, J GEN VIROL, V91, P2898, DOI 10.1099/vir.0.024323-0; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sebastian L, 2012, LETT APPL MICROBIOL, V55, P234, DOI 10.1111/j.1472-765X.2012.03282.x; Skulason S, 2012, J ORAL PATHOL MED, V41, P61, DOI 10.1111/j.1600-0714.2011.01037.x; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Sturtz FG, 1998, METHOD FIND EXP CLIN, V20, P643, DOI 10.1358/mf.1998.20.8.487489; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Walter MS, 2014, DENT MATER, V30, P200, DOI 10.1016/j.dental.2013.11.006; WYDE PR, 1986, ANTIMICROB AGENTS CH, V30, P942, DOI 10.1128/AAC.30.6.942; Yang JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000428; Yao HW, 2012, VIROLOGY, V433, P116, DOI 10.1016/j.virol.2012.07.018; Zhu JH, 2014, SPECTROCHIM ACTA A, V124, P237, DOI 10.1016/j.saa.2013.12.114	43	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126360	10.1371/journal.pone.0126360	http://dx.doi.org/10.1371/journal.pone.0126360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970853	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200107
J	Weissgerber, T; Rader, T; Baumann, U				Weissgerber, Tobias; Rader, Tobias; Baumann, Uwe			Impact of a Moving Noise Masker on Speech Perception in Cochlear Implant Users	PLOS ONE			English	Article							DIRECTIONAL-MICROPHONE; COCKTAIL-PARTY; NORMAL-HEARING; INTELLIGIBILITY; MASKING; STIMULATION; BENEFIT; AID; LOCALIZATION; RECOGNITION	Objectives Previous studies investigating speech perception in noise have typically been conducted with static masker positions. The aim of this study was to investigate the effect of spatial separation of source and masker (spatial release from masking, SRM) in a moving masker setup and to evaluate the impact of adaptive beamforming in comparison with fixed directional microphones in cochlear implant (CI) users. Design Speech reception thresholds (SRT) were measured in S0N0 and in a moving masker setup (S0Nmove) in 12 normal hearing participants and 14 CI users (7 subjects bilateral, 7 bimodal with a hearing aid in the contralateral ear). Speech processor settings were a moderately directional microphone, a fixed beamformer, or an adaptive beamformer. The moving noise source was generated by means of wave field synthesis and was smoothly moved in a shape of a half-circle from one ear to the contralateral ear. Noise was presented in either of two conditions: continuous or modulated. Results SRTs in the S0Nmove setup were significantly improved compared to the S0N0 setup for both the normal hearing control group and the bilateral group in continuous noise, and for the control group in modulated noise. There was no effect of subject group. A significant effect of directional sensitivity was found in the S0Nmove setup. In the bilateral group, the adaptive beamformer achieved lower SRTs than the fixed beamformer setting. Adaptive beamforming improved SRT in both CI user groups substantially by about 3 dB (bimodal group) and 8 dB (bilateral group) depending on masker type. Conclusions CI users showed SRM that was comparable to normal hearing subjects. In listening situations of everyday life with spatial separation of source and masker, directional microphones significantly improved speech perception with individual improvements of up to 15 dB SNR. Users of bilateral speech processors with both directional microphones obtained the highest benefit.	[Weissgerber, Tobias; Rader, Tobias; Baumann, Uwe] Univ Hosp Frankfurt, ENT Dept, Audiol Acoust, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Weissgerber, T (corresponding author), Univ Hosp Frankfurt, ENT Dept, Audiol Acoust, Frankfurt, Germany.	tobias.weissgerber@kgu.de	Baumann, Uwe/AAE-5640-2019; Weissgerber, Tobias/AAN-3688-2021; Rader, Tobias/N-4203-2017	Weissgerber, Tobias/0000-0002-0327-1274; Rader, Tobias/0000-0001-7250-2833; Baumann, Uwe/0000-0002-1295-2661	Cochlear RD Ltd.	Cochlear RD Ltd.	This work was funded by Cochlear R&D Ltd. The study was designed in collaboration with Cochlear R&D Ltd. The funders had no role in data collection and analysis and decision to publish or preparation of the manuscript.	Bentler R, 2006, J AM ACAD AUDIOL, V17, P179, DOI 10.3766/jaaa.17.3.4; BERKHOUT AJ, 1988, J AUDIO ENG SOC, V36, P977; Blauert J., 1997, SPATIAL HEARING PSYC, DOI [10.7551/mitpress/6391.001.0001, DOI 10.7551/MITPRESS/6391.001.0001]; Brand T, 2002, J ACOUST SOC AM, V111, P2801, DOI 10.1121/1.1479152; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Buechner A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095542; CARHART R, 1969, J ACOUST SOC AM, V45, P694, DOI 10.1121/1.1911445; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Ching TYC, 2004, EAR HEARING, V25, P9, DOI 10.1097/01.AUD.0000111261.84611.C8; Chung K, 2006, J ACOUST SOC AM, V120, P2216, DOI 10.1121/1.2258500; Chung K, 2009, HEARING RES, V250, P27, DOI 10.1016/j.heares.2009.01.005; Cooke M, 2006, J ACOUST SOC AM, V119, P1562, DOI 10.1121/1.2166600; Culling JF, 2012, EAR HEARING, V33, P673, DOI 10.1097/AUD.0b013e3182587356; Fastl H., 1987, Audiologische Akustik, V26, P2; Geier M, 2008, P 124 CONV AUD ENG S; GeiSSler Gunnar, 2015, Cochlear Implants Int, V16, P69, DOI 10.1179/1754762814Y.0000000088; GLASBERG BR, 1987, J ACOUST SOC AM, V81, P1546, DOI 10.1121/1.394507; GRIFFITHS LJ, 1982, IEEE T ANTENN PROPAG, V30, P27, DOI 10.1109/TAP.1982.1142739; HAHLBROCK K H, 1953, Arch Ohren Nasen Kehlkopfheilkd, V162, P394, DOI 10.1007/BF02105664; Hamacher V, 1997, AM J OTOL, V18, P46; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; Hersbach AA, 2012, EAR HEARING, V33, pE13, DOI 10.1097/AUD.0b013e31824b9e21; Hoevel H Vom, 1980, FORTSCHRITTE AKUSTIK, P615; Huygens C, 1960, TRAITE LUMIERE; Kokkinakis K, 2010, J ACOUST SOC AM, V127, P3136, DOI 10.1121/1.3372727; Kompis M, 2001, J ACOUST SOC AM, V109, P1134, DOI 10.1121/1.1338558; Loizou PC, 2009, J ACOUST SOC AM, V125, P372, DOI 10.1121/1.3036175; Misurelli SM, 2012, J ACOUST SOC AM, V132, P380, DOI 10.1121/1.4725760; Patrick James F, 2006, Trends Amplif, V10, P175, DOI 10.1177/1084713806296386; PLOMP R, 1981, ACUSTICA, V48, P325; Rader T, 2013, EAR HEARING, V34, P324, DOI 10.1097/AUD.0b013e318272f189; Ricketts T, 2002, INT J AUDIOL, V41, P100, DOI 10.3109/14992020209090400; Schleich P, 2004, EAR HEARING, V25, P197, DOI 10.1097/01.AUD.0000130792.43315.97; Spors S., 2008, P THE AUDIO ENG SOC; Spriet A, 2007, EAR HEARING, V28, P62, DOI 10.1097/01.aud.0000252470.54246.54; THEILE G, 1977, J AUDIO ENG SOC, V25, P196; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; van Wieringen A, 2008, INT J AUDIOL, V47, P348, DOI 10.1080/14992020801895144; Vandali AE, 2000, EAR HEARING, V21, P608, DOI 10.1097/00003446-200012000-00008; VANHOESEL RJM, 1995, J ACOUST SOC AM, V97, P2498, DOI 10.1121/1.411970; Wagener K.C., 1999, Z AUDIOL, V38, P4; Wagener K.C., 1999, Z AUDIOL, V38, P44, DOI DOI 10.3109/00206099909073001; Wagener KC, 2005, INT J AUDIOL, V44, P144, DOI 10.1080/14992020500057517; Wierstorf H., 2012, P 132 CONV AUD ENG S; WILSON BS, 1993, J REHABIL RES DEV, V30, P110; Wolfe J, 2012, OTOL NEUROTOL, V33, P553, DOI 10.1097/MAO.0b013e31825367a5; Wouters J, 2001, EAR HEARING, V22, P420, DOI 10.1097/00003446-200110000-00006	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126133	10.1371/journal.pone.0126133	http://dx.doi.org/10.1371/journal.pone.0126133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970594	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200095
J	Seong, JM; Choi, NK; Shin, JY; Chang, Y; Kim, YJ; Lee, J; Kim, JY; Park, BJ				Seong, Jong-Mi; Choi, Nam-Kyong; Shin, Ju-Young; Chang, Yoosoo; Kim, Ye-Jee; Lee, Joongyub; Kim, Ju-Young; Park, Byung-Joo			Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study	PLOS ONE			English	Article							PATIENTS PRESCRIBED SITAGLIPTIN; ORAL ANTIHYPERGLYCEMIC AGENTS; BLOOD-PRESSURE; MELLITUS; METAANALYSIS; SAFETY; DPP-4	Background/Objectives Data on the comparative effectiveness of oral antidiabetics on cardiovascular outcomes in a clinical practice setting are limited. This study sought to determine whether a differential risk of cardiovascular disease (CVD) exists for the combination of a dipeptidyl peptidase-4 (DPP-4) inhibitor plus metformin versus a sulfonylurea derivative plus metformin or pioglitazone plus metformin. Methods We conducted a cohort study of 349,476 patients who received treatment with a DPP-4 inhibitor, sulfonylurea, or pioglitazone plus metformin for type 2 diabetes using the Korean national health insurance claims database. The incidence of total CVD and individual outcomes of myocardial infarction (MI), heart failure (HF), and ischemic stroke (IS) were assessed using the hazard ratios (HRs) estimated from a Cox proportional-hazards model weighted for a propensity score. Results During follow-up, 3,881 patients developed a CVD, including 428 MIs, 212 HFs, and 1,487 ISs. The adjusted HR with 95% confidence interval (CI) for a sulfonylurea derivative plus metformin compared with a DPP-4 inhibitor plus metformin was 1.20 (1.09-1.32) for total CVD; 1.14 (1.04-1.91) for MI; 1.07 (0.71-1.62) for HF; and 1.51 (1.28-1.79) for IS. The HRs with 95% CI for total CVD, MI, HF, and IS for pioglitazone plus metformin were 0.89 (0.810.99), 1.05 (0.76-1.46), 4.81 (3.53-6.56), and 0.81 (0.67-0.99), respectively. Conclusions Compared with a DPP-4 inhibitor plus metformin, treatment with a sulfonylurea drug plus metformin was associated with increased risks of total CVD, MI, and IS, whereas the use of pioglitazone plus metformin was associated with decreased total CVD and IS risks.	[Seong, Jong-Mi; Park, Byung-Joo] Korea Inst Drug Safety & Risk Management, Off Drug Safety Informat 2, Seoul, South Korea; [Seong, Jong-Mi; Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Choi, Nam-Kyong; Lee, Joongyub] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Div Clin Epidemiol,Med Res Collaborating Ctr, Seoul, South Korea; [Choi, Nam-Kyong] Seoul Natl Univ, Med Res Ctr, Seoul, South Korea; [Shin, Ju-Young; Park, Byung-Joo] Korea Inst Drug Safety & Risk Management, Off Drug Utilizat Review, Seoul, South Korea; [Chang, Yoosoo] Sungkyunkwan Univ, Sch Med, Dept Occupat & Environm Med, Kangbuk Samsung Hosp, Seoul, South Korea; [Kim, Ye-Jee; Park, Byung-Joo] Korea Inst Drug Safety & Risk Management, Off Drug Safety Informat 1, Seoul, South Korea; [Kim, Ju-Young] Seoul Natl Univ, Dept Family Med, Bundang Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital	Park, BJ (corresponding author), Korea Inst Drug Safety & Risk Management, Off Drug Safety Informat 2, Seoul, South Korea.	bjpark@snu.ac.kr	Kim, Ju Young/AAV-3029-2020	Kim, Ju Young/0000-0001-6018-3337; Chang, Yoosoo/0000-0002-6945-9050; Choi, Nam-Kyong/0000-0003-1153-9928; Shin, Ju-Young/0000-0003-1010-7525				[Anonymous], 2008, ACT PIOGL HYDR PROD; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cai B, 2010, INT J CLIN PRACT, V64, P1601, DOI 10.1111/j.1742-1241.2010.02516.x; Choi NK, 2007, ANN PHARMACOTHER, V41, P667, DOI 10.1345/aph.1H247; Deacon CF, 2004, DIABETES, V53, P2181, DOI 10.2337/diabetes.53.9.2181; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Fadini GP, 2011, VASC PHARMACOL, V55, P10, DOI 10.1016/j.vph.2011.05.001; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Frederich R, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.05.2138; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Johansen OE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-3; Kimm H, 2012, KOREAN CIRC J, V42, P10, DOI 10.4070/kcj.2012.42.1.10; Korean Diabetes Association Health Insurance Review & Assessment Service, 2007, REP TASK FORC TEAM B; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Matikainen N, 2006, DIABETOLOGIA, V49, P2049, DOI 10.1007/s00125-006-0340-2; Mistry GC, 2008, J CLIN PHARMACOL, V48, P592, DOI 10.1177/0091270008316885; Monami M, 2011, CURR MED RES OPIN, V27, P57, DOI 10.1185/03007995.2011.602964; Ogawa S, 2011, TOHOKU J EXP MED, V223, P133, DOI 10.1620/tjem.223.133; Park B., 2003, REPORT EVALUATION VA, P19; Park JK, 2000, KOREAN J PREV MED, V33, P76, DOI DOI 10.1161/01.STR.0000078562.82918.F6; Patrick AR, 2011, PHARMACOEPIDEM DR S, V20, P551, DOI 10.1002/pds.2098; Phung OJ, 2010, JAMA-J AM MED ASSOC, V303, P1410, DOI 10.1001/jama.2010.405; Pratley RE, 2007, CURR MED RES OPIN, V23, P919, DOI 10.1185/030079906X162746; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Selva DM, 2009, ENDOCRINOLOGY, V150, P2183, DOI 10.1210/en.2008-1289; Seong JM, 2011, PHARMACOEPIDEM DR S, V20, P344, DOI 10.1002/pds.2112; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Sikka R, 2005, AM J MANAG CARE, V11, P453; Starcke S, 2006, GENES NUTR, V1, P177, DOI 10.1007/BF02829967; Tremblay AJ, 2011, DIABETES OBES METAB, V13, P366, DOI 10.1111/j.1463-1326.2011.01362.x; van Poppel PCM, 2011, DIABETES CARE, V34, P2072, DOI 10.2337/dc10-2421; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001; Zhang QY, 2010, CURR MED RES OPIN, V26, P1697, DOI 10.1185/03007995.2010.489029	40	46	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0124287	10.1371/journal.pone.0124287	http://dx.doi.org/10.1371/journal.pone.0124287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992614	Green Published, Green Submitted, gold			2022-12-27	WOS:000354921400016
J	Jacobs, S; Jager, S; Jansen, E; Peter, A; Stefan, N; Boeing, H; Schulze, MB; Kroger, J				Jacobs, Simone; Jaeger, Susanne; Jansen, Eugene; Peter, Andreas; Stefan, Norbert; Boeing, Heiner; Schulze, Matthias B.; Kroeger, Janine			Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study	PLOS ONE			English	Article							ATTENUATION PARAMETER CAP; DESATURASE ACTIVITY; INSULIN-RESISTANCE; HEPATIC STEATOSIS; PALMITOLEIC ACID; RISK; PLASMA; DISEASE; FETUIN; CARBOHYDRATE	Background Biomarker fatty acids (FAs) reflecting de novo lipogenesis (DNL) are strongly linked to the risk of cardiometabolic diseases. Liver fat accumulation could mediate this relation. There is very limited data from human population-based studies that have examined this relation. Objective The aim of this study was to investigate the relation between specific FAs in the DNL pathway and liver fat accumulation in a large population-based study. Methods We conducted a cross-sectional analysis of a subsample (n = 1,562) of the EPIC-Potsdam study, which involves 27,548 middle-aged men and women. Baseline blood samples have been analyzed for proportions of 32 FAs in erythrocyte membranes (determined by gas chromatography) and biomarker concentrations in plasma. As indicators for DNL, the DNL-index (16: 0 / 18:2n-6) and proportions of individual blood FAs in the DNL pathway were used. Plasma parameters associated with liver fat content (fetuin-A, ALT, and GGT) and the algorithm-based fatty liver index (FLI) were used to reflect liver fat accumulation. Results The DNL-index tended to be positively associated with the FLI and was positively associated with GGT activity in men (p for trend: 0.12 and 0.003). Proportions of 14: 0 and 16: 0 in erythrocytes were positively associated with fetuin-A, whereas 16:1n-7 were positively associated with the FLI and GGT activity (all p for trends in both sexes at least 0.004). Furthermore, the proportion of 16:1n-7 was positively related to fetuin-A in women and ALT activity in men (all p for trend at least 0.03). The proportion of 16:1n-9 showed positive associations with the FLI and GGT activity in men and fetuin-A in both sexes, whereas 18:1n-7 was positively associated with GGT activity in men (all p for trend at least 0.048). Conclusion Findings from this large epidemiological study suggest that liver fat accumulation could link erythrocyte FAs in the DNL pathway to the risk of cardiometabolic diseases.	[Jacobs, Simone; Jaeger, Susanne; Schulze, Matthias B.; Kroeger, Janine] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Jacobs, Simone; Jaeger, Susanne; Peter, Andreas; Stefan, Norbert; Schulze, Matthias B.; Kroeger, Janine] German Ctr Diabet Res DZD, Dusseldorf, Germany; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, Bilthoven, Netherlands; [Peter, Andreas; Stefan, Norbert] Univ Tubingen, Univ Hosp, Dept Internal Med, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, Tubingen, Germany; [Peter, Andreas; Stefan, Norbert] Univ Tubingen IDM, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Netherlands National Institute for Public Health & the Environment; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Kroger, J (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany.	kroeger@dife.de	Schulze, Matthias B/AAH-6906-2021	Schulze, Matthias B/0000-0002-0830-5277; Jager, Susanne/0000-0001-6619-0861; Kroger, Janine/0000-0002-7496-3665; Stefan, Norbert/0000-0002-2186-9595	Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; German Research Foundation (DFG) [SCHU 1516/5-1]	Federal Ministry of Science, Germany; European Union(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401) and the European Union (SOC 95201408 05F02). The present study was also supported by a grant from the German Research Foundation (DFG, SCHU 1516/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arregui M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048338; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Carvalho JAM, 2011, ANN MED, V43, P487, DOI 10.3109/07853890.2011.554428; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Djousse L, 2012, CIRC-HEART FAIL, V5, P703, DOI 10.1161/CIRCHEARTFAILURE.112.967802; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Haukeland JW, 2012, EUR J ENDOCRINOL, V166, P503, DOI 10.1530/EJE-11-0864; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jacobs S, 2014, AM J CLIN NUTR, V100, P891, DOI 10.3945/ajcn.113.080317; Kim JH, 2011, LIVER INT, V31, P1600, DOI 10.1111/j.1478-3231.2011.02580.x; King IB, 2006, AM J CLIN NUTR, V83, P227; Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; LaBrecque DR, 2014, J CLIN GASTROENTEROL, V48, P467, DOI 10.1097/MCG.0000000000000116; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Lee JJ, 2015, AM J CLIN NUTR, V101, P34, DOI 10.3945/ajcn.114.092262; Lee WNP, 1998, J BIOL CHEM, V273, P20929, DOI 10.1074/jbc.273.33.20929; Lemaitre RN, 2010, METABOLISM, V59, P1029, DOI 10.1016/j.metabol.2009.10.026; Ma WJ, 2015, AM J CLIN NUTR, V101, P153, DOI 10.3945/ajcn.114.092601; Meffert PJ, 2014, AM J GASTROENTEROL, V109, P1404, DOI 10.1038/ajg.2014.155; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Peter A, 2009, CLIN CHEM, V55, P2113, DOI 10.1373/clinchem.2009.127274; Petersson H, 2010, DIABETES RES CLIN PR, V87, P379, DOI 10.1016/j.diabres.2009.11.019; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Siegert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076813; Silbernagel G, 2012, J CLIN ENDOCR METAB, V97, pE2288, DOI 10.1210/jc.2012-2152; Siler SQ, 1999, AM J CLIN NUTR, V70, P928; SIMON JA, 1995, AM J EPIDEMIOL, V142, P469, DOI 10.1093/oxfordjournals.aje.a117662; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; Thamer C, 2005, HORM METAB RES, V37, P246, DOI 10.1055/s-2005-861411; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Wang L, 2003, AM J CLIN NUTR, V78, P91; Wu JHY, 2011, AM J CLIN NUTR, V94, P431, DOI 10.3945/ajcn.111.012054; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Zelber-Sagi S, 2013, WORLD J GASTROENTERO, V19, P57, DOI 10.3748/wjg.v19.i1.57; Zong G, 2013, AM J CLIN NUTR, V98, P319, DOI 10.3945/ajcn.113.061218	53	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127368	10.1371/journal.pone.0127368	http://dx.doi.org/10.1371/journal.pone.0127368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984792	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300117
J	Letouzey, V; Tan, KS; Deane, JA; Ulrich, D; Gurung, S; Ong, YR; Gargett, CE				Letouzey, Vincent; Tan, Ker Sin; Deane, James A.; Ulrich, Daniela; Gurung, Shanti; Ong, Y. Rue; Gargett, Caroline E.			Isolation and Characterisation of Mesenchymal Stem/Stromal Cells in the Ovine Endometrium	PLOS ONE			English	Article							LABEL-RETAINING CELLS; HUMAN BONE-MARROW; STEM-CELLS; STROMAL CELLS; MARKERS; TISSUE; IDENTIFICATION; ANTIBODIES; CD271	Objective Mesenchymal stem/stromal cells (MSC) were recently discovered in the human endometrium. These cells possess key stem cell properties and show promising results in small animal models when used for preclinical tissue engineering studies. A small number of surface markers have been identified that enrich for MSC from bone marrow and human endometrium, including the Sushi Domain-containing 2 (SUSD2; W5C5) and CD271 markers. In preparation for developing a large animal preclinical model for urological and gynecological tissue engineering applications we aimed to identify and characterise MSC in ovine endometrium and determine surface markers to enable their prospective isolation. Materials and Methods Ovine endometrium was obtained from hysterectomised ewes following progesterone synchronisation, dissociated into single cell suspensions and tested for MSC surface markers and key stem cell properties. Purified stromal cells were obtained by flow cytometry sorting with CD49f and CD45 to remove epithelial cells and leukocytes respectively, and MSC properties investigated. Results There was a small population CD271(+) stromal cells (4.5 +/- 2.3%) in the ovine endometrium. Double labelling with CD271 and CD49f showed that the sorted CD271(+)CD49f(-) stromal cell population possessed significantly higher cloning efficiency, serial cloning capacity and a qualitative increased ability to differentiate into 4 mesodermal lineages (adipocytic, smooth muscle, chondrocytic and osteoblastic) than CD271(-)CD49f(-) cells. Immunolabelling studies identified an adventitial perivascular location for ovine endometrial CD271(+) cells. Conclusion This is the first study to characterise MSC in the ovine endometrium and identify a surface marker profile identifying their location and enabling their prospective isolation. This knowledge will allow future preclinical studies with a large animal model that is well established for pelvic organ prolapse research.	[Letouzey, Vincent; Tan, Ker Sin; Deane, James A.; Ulrich, Daniela; Gurung, Shanti; Ong, Y. Rue; Gargett, Caroline E.] MIMR PHI Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Ulrich, Daniela; Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research; Monash University	Gargett, CE (corresponding author), MIMR PHI Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	caroline.gargett@mimr-phi.org	Deane, James A/G-3592-2011; Gargett, Caroline E/Q-7911-2019; Gold, Daniela/ABE-4818-2020; Gargett, Caroline Eve/I-4895-2019	Deane, James A/0000-0001-8409-0303; Gargett, Caroline E/0000-0002-3590-2077; Gold, Daniela/0000-0002-7196-454X; Ong, Yih Rue/0000-0003-0574-3762; Gurung, Shanti/0000-0002-9003-652X	National Health and Medical Research Council of Australia grant [1021126]; National Health and Medical Research Council of Australia Senior Research Fellowship [1042298]; South East Melbourne Alliance for Regenerative Therapies; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia grant(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); South East Melbourne Alliance for Regenerative Therapies; Victorian Government's Operational Infrastructure Support Program	This work was supported by National Health and Medical Research Council of Australia grant (1021126) (CEG) and National Health and Medical Research Council of Australia Senior Research Fellowship (1042298) (CEG) (http://www.nhmrc.gov.au/), South East Melbourne Alliance for Regenerative Therapies (CEG) and Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.038; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Buhring HJ, 2007, ANN NY ACAD SCI, V1106, P262, DOI 10.1196/annals.1392.000; Casey R, 2000, HUM REPROD, V15, P1469, DOI 10.1093/humrep/15.7.1469; Cervello I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021221; Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2012, REPROD SCI, V19, P102, DOI 10.1177/1933719111414207; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Couri Bruna M, 2012, Expert Rev Obstet Gynecol, V7, P249; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Gronthos S, 2009, STEM CELLS DEV, V18, P1253, DOI 10.1089/scd.2008.0400; Li Zhanghua, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P62; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; McCarty RC, 2009, J CELL PHYSIOL, V219, P324, DOI 10.1002/jcp.21670; Miernik K, 2012, REPRODUCTION, V143, P203, DOI 10.1530/REP-11-0202; Miyazaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050749; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Rhodes NP, 2004, J MATER SCI-MATER M, V15, P397, DOI 10.1023/B:JMSM.0000021109.21807.f0; Rozemuller H, 2010, STEM CELLS DEV, V19, P1911, DOI 10.1089/scd.2009.0510; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; SIMMONS PJ, 1991, BLOOD, V78, P55; Sivasubramaniyan K, 2013, STEM CELLS DEV, V22, P1944, DOI 10.1089/scd.2012.0584; Sobiesiak M, 2010, STEM CELLS DEV, V19, P669, DOI 10.1089/scd.2009.0290; Ulrich D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104972; Ulrich D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093172; Ulrich D, 2014, TISSUE ENG PT A, V20, P785, DOI 10.1089/ten.TEA.2013.0170; Ulrich D, 2013, EXPERT OPIN BIOL TH, V13, P1387, DOI 10.1517/14712598.2013.826187; Watson JT, 2013, CELLS TISSUES ORGANS, V197, P496, DOI 10.1159/000348794; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	40	30	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127531	10.1371/journal.pone.0127531	http://dx.doi.org/10.1371/journal.pone.0127531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992577	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300130
J	Malheiro, R; Casal, S; Cunha, SC; Baptista, P; Pereira, JA				Malheiro, Ricardo; Casal, Susana; Cunha, Sara C.; Baptista, Paula; Pereira, Jose Alberto			Olive Volatiles from Portuguese Cultivars Cobrancosa, Madural and Verdeal Transmontana: Role in Oviposition Preference of Bactrocera oleae (Rossi) (Diptera: Tephritidae)	PLOS ONE			English	Article							DACUS-OLEAE; FLY; OIL; SUSCEPTIBILITY; VARIETIES; QUALITY; LEAVES; GMEL	The olive fly, Bactrocera oleae (Rossi), a serious threat to the olive crop worldwide, displays ovipositon preference for some olive cultivars but the causes are still unclear. In the present work, three Portuguese olive cultivars with different susceptibilities to olive fly (Cobrancosa, Madural, and Verdeal Transmontana) were studied, aiming to determine if the olive volatiles are implicated in this interaction. Olive volatiles were assessed by SPME-GC-MS in the three cultivars during maturation process to observe possible correlations with olive fly infestation levels. Overall, 34 volatiles were identified in the olives, from 7 chemical classes (alcohols, aldehydes, aromatic hydrocarbons, esters, ketones, sesquiterpenes, and terpenes). Generally, total volatile amounts decrease during maturation but toluene, the main compound, increased in all cultivars, particularly in those with higher susceptibility to olive fly. Sesquiterpenes also raised, mainly alpha-copaene. Toluene and alpha-copaene, recognized oviposition promoters to olive fly, were correlated with the infestation level of cvs. Madural and Verdeal Trasnmontana (intermediate and highly susceptible cultivars respectively), while no correlations were established with cv. Cobrancosa (less susceptible). No volatiles with inverse correlation were observed. Volatile composition of olives may be a decisive factor in the olive fly choice to oviposit and this could be the basis for the development of new control strategies for this pest.	[Malheiro, Ricardo; Baptista, Paula; Pereira, Jose Alberto] Polytech Inst Braganca, Sch Agr, Mt Res Ctr CIMO, P-5301855 Braganca, Portugal; [Malheiro, Ricardo; Casal, Susana; Cunha, Sara C.] Univ Porto, Fac Pharm, Lab Bromatol & Hydrol, LAQV REQUIMTE, P-4050313 Oporto, Portugal	Instituto Politecnico de Braganca; Universidade do Porto	Casal, S (corresponding author), Univ Porto, Fac Pharm, Lab Bromatol & Hydrol, LAQV REQUIMTE, P-4050313 Oporto, Portugal.	sucasal@ff.up.pt; jpereira@ipb.pt	Baptista, Paula/AAO-4888-2020; Casal, Susana/D-6603-2011; Pereira, José A./L-6798-2014; Cunha, S.C./D-6652-2013	Casal, Susana/0000-0002-1686-3850; Pereira, José A./0000-0002-2260-0600; Cunha, S.C./0000-0003-4320-2318	European Union (FEDER funds through COMPETE); National Funds (FCT, Fundacao para a Ciencia e Tecnologia) [EXCL/AGR-PRO/0591/2012, Pest-C/EQB/LA0006/2013]; FCT; POPH-QREN (Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional); FSE (Fundo Social Europeu) [SFRH/BD/74675/2010]	European Union (FEDER funds through COMPETE); National Funds (FCT, Fundacao para a Ciencia e Tecnologia); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH-QREN (Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional); FSE (Fundo Social Europeu)(European Social Fund (ESF))	This work received financial support from the European Union (FEDER funds through COMPETE) and National Funds (FCT, Fundacao para a Ciencia e Tecnologia) through projects EXCL/AGR-PRO/0591/2012 "Olive crop protection in sustainable production under global climatic changes: linking ecological infrastructures to ecosystem functions" and Pest-C/EQB/LA0006/2013. Ricardo Malheiro thanks FCT, POPH-QREN (Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional) and FSE (Fundo Social Europeu) for PhD grant (SFRH/BD/74675/2010).	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; BIEDERMANN M, 1995, Z LEBENSM UNTERS FOR, V200, P266, DOI 10.1007/BF01187517; Bueno AM, 2002, IOBC WPRS B, V25, P1; Burrack HJ, 2008, J ECON ENTOMOL, V101, P750, DOI 10.1603/0022-0493(2008)101[750:OFFDTO]2.0.CO;2; Canale A, 2013, CHEMOECOLOGY, V23, P155, DOI 10.1007/s00049-013-0131-4; Carpita A, 2012, NATURWISSENSCHAFTEN, V99, P77, DOI 10.1007/s00114-011-0868-y; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; de Alfonso I, 2014, J AGR FOOD CHEM, V62, P11976, DOI 10.1021/jf504821a; ERCOLANI GL, 1991, MICROBIAL ECOL, V21, P35, DOI 10.1007/BF02539143; FAOSTAT. Food and Agriculture Organization, 2015, FAOSTAT DAT 2015; Flamini G, 2003, J AGR FOOD CHEM, V51, P1382, DOI 10.1021/jf020854y; Goncalves MF, 2012, SCI HORTIC-AMSTERDAM, V145, P127, DOI 10.1016/j.scienta.2012.08.002; Hermoso M., 2001, CULTIVO OLIVO, P153; Iannotta N, 2007, J ENVIRON SCI HEAL B, V42, P789, DOI 10.1080/03601230701551426; Iraqi R, 2005, J AGR FOOD CHEM, V53, P1179, DOI 10.1021/jf040349w; Kalua CM, 2007, FOOD CHEM, V100, P273, DOI 10.1016/j.foodchem.2005.09.059; Kiralan M, 2012, EUR J LIPID SCI TECH, V114, P552, DOI 10.1002/ejlt.201100289; Latinovic J, 2013, CROP PROT, V48, P35, DOI 10.1016/j.cropro.2013.02.004; Liscia A, 2013, J INSECT PHYSIOL, V59, P705, DOI 10.1016/j.jinsphys.2013.04.008; Malheiro R, 2013, FOOD RES INT, V54, P186, DOI 10.1016/j.foodres.2013.06.010; Masi E, 2014, J SCI FOOD IN PRESS; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Navrozidis E, 2007, PHYTOPARASITICA, V35, P429, DOI 10.1007/BF03020599; NEUENSCHWANDER P, 1980, Z ANGEW ENTOMOL, V89, P514; Pereira JA, 2004, ITAL J FOOD SCI, V16, P355; Sacchetti P, 2008, J APPL ENTOMOL, V132, P682, DOI 10.1111/j.1439-0418.2008.01334.x; Salas JJ, 1998, PHYTOCHEMISTRY, V48, P35, DOI 10.1016/S0031-9422(97)01097-2; Salas JJ, 1999, J AM OIL CHEM SOC, V76, P1163, DOI 10.1007/s11746-999-0090-7; Sansone-Land A, 2014, FOOD CHEM, V149, P285, DOI 10.1016/j.foodchem.2013.10.090; Scarpati ML, 1996, J CHEM ECOL, V22, P1027, DOI 10.1007/BF02029952; SCARPATI ML, 1993, J CHEM ECOL, V19, P881, DOI 10.1007/BF00985017; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X	32	33	33	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125070	10.1371/journal.pone.0125070	http://dx.doi.org/10.1371/journal.pone.0125070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985460	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300013
J	Vashishtha, S; Broderick, G; Craddock, TJA; Fletcher, MA; Klimas, NG				Vashishtha, Saurabh; Broderick, Gordon; Craddock, Travis J. A.; Fletcher, Mary Ann; Klimas, Nancy G.			Inferring Broad Regulatory Biology from Time Course Data: Have We Reached an Upper Bound under Constraints Typical of In Vivo Studies?	PLOS ONE			English	Article							DYNAMIC BAYESIAN NETWORK; ENGINEERING GENE NETWORKS; IMPROVED RECONSTRUCTION; MUTUAL INFORMATION; COMPOUND-MODE; INFERENCE; EXPRESSION; IDENTIFICATION; ALGORITHM; KNOCKOUT	There is a growing appreciation for the network biology that regulates the coordinated expression of molecular and cellular markers however questions persist regarding the identifiability of these networks. Here we explore some of the issues relevant to recovering directed regulatory networks from time course data collected under experimental constraints typical of in vivo studies. NetSim simulations of sparsely connected biological networks were used to evaluate two simple feature selection techniques used in the construction of linear Ordinary Differential Equation (ODE) models, namely truncation of terms versus latent vector projection. Performance was compared with ODE-based Time Series Network Identification (TSNI) integral, and the information-theoretic Time-Delay ARACNE (TD-ARACNE). Projection-based techniques and TSNI integral outperformed truncation-based selection and TD-ARACNE on aggregate networks with edge densities of 10-30%, i.e. transcription factor, protein-protein cliques and immune signaling networks. All were more robust to noise than truncation-based feature selection. Performance was comparable on the in silico 10-node DREAM 3 network, a 5-node Yeast synthetic network designed for In vivo Reverse-engineering and Modeling Assessment (IRMA) and a 9-node human HeLa cell cycle network of similar size and edge density. Performance was more sensitive to the number of time courses than to sample frequency and extrapolated better to larger networks by grouping experiments. In all cases performance declined rapidly in larger networks with lower edge density. Limited recovery and high false positive rates obtained overall bring into question our ability to generate informative time course data rather than the design of any particular reverse engineering algorithm.	[Vashishtha, Saurabh; Broderick, Gordon] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Broderick, Gordon; Craddock, Travis J. A.; Fletcher, Mary Ann; Klimas, Nancy G.] Nova SE Univ, Inst Neuroimmune Med, Ft Lauderdale, FL 33314 USA; [Broderick, Gordon; Craddock, Travis J. A.] Nova SE Univ, Ctr Psychol Studies, Ft Lauderdale, FL 33314 USA; [Fletcher, Mary Ann; Klimas, Nancy G.] Miami Vet Affairs Med Ctr, Miami, FL USA	University of Alberta; Nova Southeastern University; Nova Southeastern University	Broderick, G (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	gbroderick@nova.edu	Vashishtha, Saurabh/Q-2824-2017	Vashishtha, Saurabh/0000-0001-5565-0500; Craddock, Travis/0000-0001-7244-6317	US National Institutes of Health (NIH) [1R01AR057853-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057853] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding was provided by US National Institutes of Health (NIH) 1R01AR057853-01 to NGK PI, GJB Co-PI, MAF Co-PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Akutsu T, 1999, Pac Symp Biocomput, P17; Akutsu T, 2000, BIOINFORMATICS, V16, P727, DOI 10.1093/bioinformatics/16.8.727; Bansal M, 2007, IET SYST BIOL, V1, P306, DOI 10.1049/iet-syb:20060079; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bartlett MS, 1950, B J PSYCHOL-STAT SEC, V3, P77, DOI 10.1111/j.2044-8317.1950.tb00285.x; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Camacho D, 2007, ANN NY ACAD SCI, V1115, P73, DOI 10.1196/annals.1407.006; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chai LE, 2014, COMPUT BIOL MED, V48, P55, DOI 10.1016/j.compbiomed.2014.02.011; Cho KH, 2007, IET SYST BIOL, V1, P149, DOI 10.1049/iet-syb:20060075; Chowdhury AR, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-196; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Di Camillo B, 2009, ANN NY ACAD SCI, V1158, P125, DOI 10.1111/j.1749-6632.2008.03756.x; Dojer N, 2013, BIOINFORMATICS, V29, P2068, DOI 10.1093/bioinformatics/btt323; Dong CY, 2012, BIOINFORMATICS, V28, P2146, DOI 10.1093/bioinformatics/bts354; Dong CY, 2010, J MATH BIOL, V60, P285, DOI 10.1007/s00285-009-0263-x; Draper N, 1998, STEPWISE REGRESSION, P307; ElBakry O, 2013, IEEE ACM T COMPUT BI, V10, P671, DOI 10.1109/TCBB.2013.73; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Frankenstein Z, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-32; FRONTIER S, 1976, J EXP MAR BIOL ECOL, V25, P67, DOI 10.1016/0022-0981(76)90076-9; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gollee H, 2012, BIOL CYBERN, V106, P359, DOI 10.1007/s00422-012-0503-9; Greenfield A, 2013, BIOINFORMATICS, V29, P1060, DOI 10.1093/bioinformatics/btt099; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Henderson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094003; Hendrickx DM, 2011, MOL BIOSYST, V7, P511, DOI 10.1039/c0mb00083c; Hickman Graham J., 2009, Journal of Bioinformatics and Computational Biology, V7, P1013, DOI 10.1142/S0219720009004448; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Huynh-Thu VA, 2015, BIOINFORMATICS; Jackson J.E., 1991, USERS GUIDE PRINCIPA, P26, DOI 10.1002/0471725331.ch2; Jackson JE, 1991, SINGULAR VALUE DECOM, P189; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kawada T, 2000, JPN J PHYSIOL, V50, P371, DOI 10.2170/jjphysiol.50.371; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Kim Sun Yong, 2003, Briefings in Bioinformatics, V4, P228, DOI 10.1093/bib/4.3.228; Kim Y, 2013, BRIEF BIOINFORM; Li P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S13; Li X, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-26; Li Z, 2011, BIOINFORMATICS, V27, P2686, DOI 10.1093/bioinformatics/btr454; Liang S, 1998, Pac Symp Biocomput, P18; Lozano AC, 2009, BIOINFORMATICS, V25, pI110, DOI 10.1093/bioinformatics/btp199; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Marbach D, 2010, P NATL ACAD SCI US; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2010, IET SYST BIOL, V4, P428, DOI 10.1049/iet-syb.2010.0009; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2007, ANN NY ACAD SCI, V1115, P51, DOI 10.1196/annals.1407.019; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Vinh NX, 2012, BBA-PROTEINS PROTEOM, V1824, P1434, DOI 10.1016/j.bbapap.2012.05.017; Vinh NX, 2011, BIOINFORMATICS, V27, P2765, DOI 10.1093/bioinformatics/btr457; Penfold CA, 2011, INTERFACE FOCUS; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rawlings JO, 1988, APPL REGRESSION ANAL, P273; Sambo F, 2008, 8 WORKSH NETW TOOLS, P134; Sauer U, 2007, SCIENCE, V316, P550, DOI 10.1126/science.1142502; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Schmidt MD, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055011; Schulz MH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-104; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Shojaie A, 2010, BIOINFORMATICS, V26, pi517, DOI 10.1093/bioinformatics/btq377; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Thomas MC, 2006, ELEMENTS INFORM THEO; Villaverde AF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0505; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilczynski B, 2009, BIOINFORMATICS, V25, P286, DOI 10.1093/bioinformatics/btn505; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P131, DOI 10.1016/S0169-7439(01)00156-3; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Yip KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008121; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhu J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000671; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154; Zou CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-122; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	92	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127364	10.1371/journal.pone.0127364	http://dx.doi.org/10.1371/journal.pone.0127364			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984725	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300116
J	Zhang, DH; Wen, XM; Wu, W; Guo, Y; Cui, W				Zhang, Donghong; Wen, Xuemei; Wu, Wei; Guo, Ye; Cui, Wei			Elevated Homocysteine Level and Folate Deficiency Associated with Increased Overall Risk of Carcinogenesis: Meta-Analysis of 83 Case-Control Studies Involving 35,758 Individuals	PLOS ONE			English	Article							COLORECTAL-CANCER RISK; CARBON METABOLISM BIOMARKERS; SQUAMOUS-CELL CARCINOMA; REDUCTASE MTHFR C677T; METHYLENETETRAHYDROFOLATE REDUCTASE; BREAST-CANCER; PROSTATE-CANCER; FOLIC-ACID; LUNG-CANCER; PLASMA HOMOCYSTEINE	Background Results of the association of folate metabolism and carcinogenesis are conflicting. We performed a meta-analysis to examine the effect of the interaction of serum concentration of homocysteine (Hcy), folate, and vitamin B12 and 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphism on risk of cancer overall. Method Two reviewers independently searched for all published studies of Hcy and cancer in PubMed, EMBASE-MEDLINE and Chinese databases. Pooled results were reported as odds ratios (ORs) and mean differences and presented with 95% confidence intervals (95% CIs) and 2-sided probability values. Results We identified 83 eligible studies of 15,046 cases and 20,712 controls. High level of Hcy but low level of folate was associated with risk of cancer overall, with little effect by type of cancer or ethnicity. Vitamin B12 level was inversely associated with only urinary-system and gastrointestinal carcinomas and for Asian and Middle Eastern patients. As well, MTHFR C677T, A1298C and G1793A polymorphisms were related to elevated serum level of Hcy, and folate and vitamin B12 deficiency. However, only MTHFR C677T homogeneity/wildtype (TT/CC) polymorphism was positively associated with overall risk of cancer. Conclusion Elevated serum Hcy level and folate deficiency are associated with increased overall risk of cancer.	[Zhang, Donghong; Wu, Wei; Guo, Ye; Cui, Wei] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100021, Peoples R China; [Zhang, Donghong; Wu, Wei; Guo, Ye; Cui, Wei] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wen, Xuemei] Fudan Univ, Ctr Canc, Dept Clin Lab, Shanghai 200433, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Fudan University	Cui, W (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100021, Peoples R China.	cuiw@pumch.cn			Peking Union Medical College; Chinese Academy of Medical Sciences Youth Fund; Fundamental Research Funds for the Central Universities [3332013004]	Peking Union Medical College; Chinese Academy of Medical Sciences Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Peking Union Medical College and the Chinese Academy of Medical Sciences Youth Fund and the Fundamental Research Funds for the Central Universities (no. 3332013004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 2005, CANCER-AM CANCER SOC, V103, P284, DOI 10.1002/cncr.20772; Almadori G, 2002, CANCER, V94, P1006, DOI 10.1002/cncr.10343; Bai JL, 2009, EUR J CANCER, V45, P1443, DOI 10.1016/j.ejca.2009.01.020; Baltar VT, 2013, EUR J EPIDEMIOL, V28, P677, DOI 10.1007/s10654-013-9793-z; Bao Y, 2011, JNCI-J NATL CANCER I, V103, P1840, DOI 10.1093/jnci/djr431; Battistelli S, 2006, WORLD J GASTROENTERO, V12, P6128, DOI 10.3748/wjg.v12.i38.6128; Bystrom P, 2009, UPSALA J MED SCI, V114, P160, DOI 10.1080/03009730903027172; Chandy S, 2008, INDIAN J CLIN BIOCHE, V23, P258, DOI 10.1007/s12291-008-0058-7; Chen XC, 2012, JOURNAL OF RADIOIMMU, V25, P187; Chung CJ, 2010, CANCER CAUSE CONTROL, V21, P1605, DOI 10.1007/s10552-010-9589-3; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Collin SM, 2010, CANCER EPIDEM BIOMAR, V19, P1632, DOI 10.1158/1055-9965.EPI-10-0180; de Vogel S, 2013, INT J EPIDEMIOL, V42, P201, DOI 10.1093/ije/dys199; Deng YanLing, 2012, Modern Preventive Medicine, V39, P1754; Deng YL, 2012, MODERN PREVENTIVE ME, V34, P87; Ding HB, 2011, JOURNAL OF RADIOIMMU, V24, P639; Du Xian, 2012, Modern Preventive Medicine, V39, P3379; Duthie SJ, 2011, J INHERIT METAB DIS, V34, P101, DOI 10.1007/s10545-010-9128-0; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Eklof V, 2008, SCAND J CLIN LAB INV, V68, P393, DOI 10.1080/00365510701805431; Eleftheriadou A, 2006, ANTICANCER RES, V26, P2345; Eroglu A, 2009, CENT EUR J MED, V4, P450, DOI 10.2478/s11536-009-0020-y; Falvoa N, 2007, REV MED INTERNE, V28, P520, DOI 10.1016/j.revmed.2007.04.003; Fang YC, 2009, CHINESE JOURNAL OF H, V19, P2875; Ferroni P, 2009, ANTICANCER RES, V29, P4131; Figueiredo JC, 2013, MOL NUTR FOOD RES, V57, P607, DOI 10.1002/mnfr.201200278; Figueiredo JC, 2009, JNCI-J NATL CANCER I, V101, P432, DOI 10.1093/jnci/djp019; Fu ZB, 2010, MODERN ONCOLOGY, V18, P767; Gatt A, 2007, INT J LAB HEMATOL, V29, P421, DOI 10.1111/j.1751-553X.2007.00907.x; Ge YB, 2012, JOURNAL OF RADIOIMMU, V25, P12, DOI [10.1186/1687-9856-2012-25, DOI 10.1186/1687-9856-2012-25]; Gibson TM, 2010, CANCER CAUSE CONTROL, V21, P1061, DOI 10.1007/s10552-010-9534-5; Gorgulu O, 2010, J INT MED RES, V38, P2047, DOI 10.1177/147323001003800619; Guo AiZhen, 2009, Academic Journal of Second Military Medical University, V30, P420, DOI 10.3724/SP.J.1008.2009.00420; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; He BH, 2010, JOURNAL OF RADIOIMMU, V23, P491; He BH, 2012, JOURNAL OF RADIOIMMU, V25, P500; He HM, 2010, MEDICAL JOURNAL OF T, V21, P485; He HM, 2010, MEDICAL JOURNAL OF T, V21, P481; Hegele RA, 1997, LANCET, V349, P1221, DOI 10.1016/S0140-6736(05)62414-2; [黄义强 HUANG Yiqiang], 2011, [中国现代医学杂志, China Journal of Modern Medicine], V21, P1359; Hultdin J, 2005, INT J CANCER, V113, P819, DOI 10.1002/ijc.20646; Hwang Nam Cheol, 2005, Korean J Gastroenterol, V45, P97; Ishihara J, 2007, J NUTR, V137, P1808, DOI 10.1093/jn/137.7.1808; Jang HR, 2005, J NUTR, V135, p2967S, DOI 10.1093/jn/135.12.2967S; Jatoi A, 2001, J SURG ONCOL, V77, P247, DOI 10.1002/jso.1104; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji YJ, 2008, JOURNAL OF RADIOIMMU, V12, P512; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Kedzierska M, 2013, MOL CELL BIOCHEM, V372, P47, DOI 10.1007/s11010-012-1444-2; Kedzierska M, 2011, MOL CELL BIOCHEM, V355, P193, DOI 10.1007/s11010-011-0854-x; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Ko KH, 2006, ANTICANCER RES, V26, P4229; Kohaar I, 2010, BIOMARKERS, V15, P61, DOI 10.3109/13547500903295881; Komlosi V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-525; Lamônica-Garcia Vânia Cristina, 2008, Arq. Gastroenterol., V45, P199, DOI 10.1590/S0004-28032008000300006; Lan LD, 2011, CHINESE AND FOREIGN, V9, P53; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Le Marchand L, 2009, CANCER EPIDEM BIOMAR, V18, P2195, DOI 10.1158/1055-9965.EPI-09-0141; Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1197, DOI 10.1158/1055-9965.EPI-08-1001; Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P89, DOI 10.1158/1055-9965.EPI-09-0727; Li HL, 2012, CHINESE JOURNAL OF P, V19, P3208; Lin J, 2010, CANCER RES, V70, P2397, DOI 10.1158/0008-5472.CAN-09-3648; [刘巍 LIU Wei], 2006, [肿瘤防治研究, Cancer Research on Prevention and Treatment], V33, P191; Liu YL, 2011, J CHINESE PLA POSTGR, V32, P1085; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Ma JG, 2011, JOURNAL OF RADIOIMMU, V24, P502; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Miller JW, 2013, AM J CLIN NUTR, V97, P827, DOI 10.3945/ajcn.112.049932; Mohammad NS, 2011, MOL CELL BIOCHEM, V349, P159, DOI 10.1007/s11010-010-0670-8; Must A, 2003, J NUTR, V133, P2643, DOI 10.1093/jn/133.8.2643; Nacci A, 2008, ARCH OTOLARYNGOL, V134, P1328, DOI 10.1001/archotol.134.12.1328; Ozkan Y, 2007, ANTICANCER RES, V27, P1185; Park SY, 2014, INT J CANCER, V134, P1504, DOI 10.1002/ijc.28476; Pathak S, 2012, MOL CELL BIOCHEM, V369, P1, DOI 10.1007/s11010-012-1362-3; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Qiao R, 2006, J MOD LAB MED, V21, P7; Qiao R, 2009, CHIN J MISDIAGN, V9, P2773; Ragasudha PN, 2012, NUTR CANCER, V64, P550, DOI 10.1080/01635581.2012.675618; Rock CL, 2000, ANNU REV PUBL HEALTH, V21, P47, DOI 10.1146/annurev.publhealth.21.1.47; Safarinejad MR, 2012, CLIN ONCOL-UK, V24, P269, DOI 10.1016/j.clon.2011.03.005; Safarinejad MR, 2011, MED ONCOL, V28, pS398, DOI 10.1007/s12032-010-9723-9; Safarinejad MR, 2010, PROSTATE, V70, P1645, DOI 10.1002/pros.21200; Samonakis DN, 2004, DIGEST DIS SCI, V49, P854, DOI 10.1023/B:DDAS.0000030099.13397.28; Schernhammer E, 2007, CANCER RES, V67, P5553, DOI 10.1158/0008-5472.CAN-06-4463; Schroecksnadel K, 2007, CLIN CHEM LAB MED, V45, P47, DOI 10.1515/CCLM.2007.012; Sciacca FL, 2004, CLIN CANCER RES, V10, P1312, DOI 10.1158/1078-0432.CCR-03-0198; Slattery ML, 1999, CANCER EPIDEM BIOMAR, V8, P513; Song J, 2000, CANCER RES, V60, P5434; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Tai YH, 2009, JOURNAL OF HUAIHAI M, V27, P195; Ubbink JB, 1996, J NUTR, V126, pS1254, DOI 10.1093/jn/126.suppl_4.1254S; UBBINK JB, 1995, AM J CLIN NUTR, V62, P802, DOI 10.1093/ajcn/62.4.802; Ulrich CM, 2008, CANCER EPIDEM BIOMAR, V17, P1822, DOI 10.1158/1055-9965.EPI-07-2937; Voevodina O, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-203; [王莉娜 WANG Lina], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P528; Wang LY, 2012, INTERNATIONAL JOURNA, V39, P752; Wang R, 2011, CHINESE JOURNAL OF S, V03, P341; Wang SG, 2011, CHINA MEDICAL HERALD, V8, P157; Wang TC, 2012, J HAZARD MATER, V213, P440, DOI 10.1016/j.jhazmat.2012.02.024; Wang XY, 2011, JOURNAL OF RADIOIMMU, V24, P622; Wei K, 2012, INT J LAB MED, V33, P699, DOI DOI 10.3969/J.ISSN.1673-4130.2012.06.028; Weinstein SJ, 2008, CANCER EPIDEM BIOMAR, V17, P3233, DOI 10.1158/1055-9965.EPI-08-0459; Williams EA, 2013, EUR J NUTR, V52, P1801, DOI 10.1007/s00394-012-0483-5; Wu K, 2009, AM J CLIN NUTR, V90, P1623, DOI 10.3945/ajcn.2009.28319; Xu J, 2000, CHINA ONCOLOGY, V10, P78; Yang CX, 2008, JOURNAL OF RADIOIMMU, V21, P116; Yin GC, 2012, ONCOL LETT, V4, P365, DOI 10.3892/ol.2012.740; Zacho J, 2011, INT J CANCER, V128, P644, DOI 10.1002/ijc.25375; Zhang CX, 2011, BRIT J NUTR, V106, P936, DOI 10.1017/S0007114511001140; Zhang CY, 2012, JOURNAL OF RADIOIMMU, V25, P406; Zhang SH, 2012, MODERN ONCOLOGY, V20, P2580; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373; Zhang XQ, 2010, JOURNAL OF CLINICAL, V15, P1433; Zhang Y, 2012, MOL BIOL REP, V39, P6203, DOI 10.1007/s11033-011-1439-1; Zhang YL, 2012, CANCER RESEARCH AND, V24, P550; Zhou LH, 2011, LABORATORY MEDICINE, V08, P687; Zhu PM, 2007, JOURNAL OF RADIOIMMU, V20, P587; Zhu WX, 2011, JOURNAL OF RADIOIMMU, V24, P132	119	50	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0123423	10.1371/journal.pone.0123423	http://dx.doi.org/10.1371/journal.pone.0123423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985325	Green Submitted, gold, Green Published			2022-12-27	WOS:000354917300006
J	Baldo, L; Riera, JL; Tooming-Klunderud, A; Alba, MM; Salzburger, W				Baldo, Laura; Lluis Riera, Joan; Tooming-Klunderud, Ave; Mar Alba, M.; Salzburger, Walter			Gut Microbiota Dynamics during Dietary Shift in Eastern African Cichlid Fishes	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; EVOLUTION; PHYLOGENY; DIVERSITY; CONVERGENCE; PHYSIOLOGY; HISTORY; TRACT; SHAPE; CARP	The gut microbiota structure reflects both a host phylogenetic history and a signature of adaptation to the host ecological, mainly trophic niches. African cichlid fishes, with their array of closely related species that underwent a rapid dietary niche radiation, offer a particularly interesting system to explore the relative contribution of these two factors in nature. Here we surveyed the host intra-and interspecific natural variation of the gut microbiota of five cichlid species from the monophyletic tribe Perissodini of lake Tanganyika, whose members transitioned from being zooplanktivorous to feeding primarily on fish scales. The outgroup riverine species Astatotilapia burtoni, largely omnivorous, was also included in the study. Fusobacteria, Firmicutes and Proteobacteria represented the dominant components in the gut microbiota of all 30 specimens analysed according to two distinct 16S rRNA markers. All members of the Perissodini tribe showed a homogenous pattern of microbial alpha and beta diversities, with no significant qualitative differences, despite changes in diet. The recent diet shift between zooplantkon-and scale-eaters simply reflects on a significant enrichment of Clostridium taxa in scale-eaters where they might be involved in the scale metabolism. Comparison with the omnivorous species A. burtoni suggests that, with increased host phylogenetic distance and/or increasing herbivory, the gut microbiota begins differentiating also at qualitative level. The cichlids show presence of a large conserved core of taxa and a small set of core OTUs (average 13-15%), remarkably stable also in captivity, and putatively favoured by both restricted microbial transmission among related hosts (putatively enhanced by mouthbrooding behavior) and common host constraints. This study sets the basis for a future large-scale investigation of the gut microbiota of cichlids and its adaptation in the process of the host adaptive radiation.	[Baldo, Laura; Salzburger, Walter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Baldo, Laura; Lluis Riera, Joan] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Tooming-Klunderud, Ave] Univ Oslo, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Mar Alba, M.] Inst Hosp Mar Invest Med IMIM, Evolutionary Genom Grp, Barcelona, Spain; [Mar Alba, M.] UPF, Barcelona, Spain; [Mar Alba, M.] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	University of Basel; University of Barcelona; University of Oslo; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; ICREA	Baldo, L (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	baldo.laura@ub.edu	Baldo, Laura/R-4921-2018; Gasull, Martina/J-4076-2019; Alba, Mar/B-4793-2009	Baldo, Laura/0000-0003-4528-6674; Alba, Mar/0000-0002-7963-7375; Riera Rey, Joan Lluis/0000-0002-2810-2581	European Research Council (ERC; INTERGENADAPT); Swiss National Science Foundation; ICREA Funding Source: Custom	European Research Council (ERC; INTERGENADAPT)(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ICREA(ICREA)	Funding: This work was supported by the European Research Council (ERC; Starting Grant "INTERGENADAPT") and the Swiss National Science Foundation to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolnick DI, 2014, MOL ECOL, V23, P4831, DOI 10.1111/mec.12846; Bolnick DI, 2014, ECOL LETT, V17, P979, DOI 10.1111/ele.12301; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cayrou C, 2013, APMIS, V121, P1082, DOI 10.1111/apm.12087; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clements KD, 2014, MOL ECOL, V23, P1891, DOI 10.1111/mec.12699; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Day JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001730; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Delsuc F, 2014, MOL ECOL, V23, P1301, DOI 10.1111/mec.12501; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Franchini P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095027; Fryer G, 1972, CICHLID FISHES GREAT, Vxvi; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; GROSS J, 1974, BIOCHEM BIOPH RES CO, V61, P605, DOI 10.1016/0006-291X(74)91000-6; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Koblmueller Stephan, 2007, Molecular Phylogenetics and Evolution, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Lankau EW, 2012, MOL ECOL, V21, P1779, DOI 10.1111/j.1365-294X.2012.05502.x; Larsen AM, 2014, J APPL MICROBIOL, V116, P1396, DOI 10.1111/jam.12475; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li XM, 2014, J APPL MICROBIOL, V117, P1245, DOI 10.1111/jam.12626; Li XM, 2012, J MICROBIOL, V50, P29, DOI 10.1007/s12275-012-1340-1; Llewellyn MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00207; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MACLENNAN JD, 1953, J CLIN INVEST, V32, P1317, DOI 10.1172/JCI102860; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Meyer BS, 2015, MOL PHYLOGENET EVOL, V83, P56, DOI 10.1016/j.ympev.2014.10.009; Miyake S, 2015, MOL ECOL, V24, P656, DOI 10.1111/mec.13050; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Muschick M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0605; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Navarrete P, 2009, MICROB ECOL, V57, P550, DOI 10.1007/s00248-008-9448-x; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Phillips CD, 2012, MOL ECOL, V21, P2617, DOI 10.1111/j.1365-294X.2012.05568.x; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Star B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-248; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Sullam KE, 2015, ISME J, V9, P1508, DOI 10.1038/ismej.2014.231; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Takahashi R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-195; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x; van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41; Ward NL, 2009, EXTREMOPHILES, V13, P679, DOI 10.1007/s00792-009-0252-4; Wong S, 2013, APPL ENVIRON MICROB, V79, P4974, DOI 10.1128/AEM.00924-13; Xing MX, 2013, FEMS MICROBIOL ECOL, V86, P432, DOI 10.1111/1574-6941.12174; Ye L, 2014, ISME J, V8, P541, DOI 10.1038/ismej.2013.181; Yeoman CJ, 2011, ENTROPY-SWITZ, V13, P570, DOI 10.3390/e13030570; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhu DJ, 2012, ADV ENG MATER, V14, pB185, DOI 10.1002/adem.201180057; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	58	71	72	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127462	10.1371/journal.pone.0127462	http://dx.doi.org/10.1371/journal.pone.0127462			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978452	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100145
J	Corbelli, JM; Zurita, GA; Filloy, J; Galvis, JP; Vespa, NI; Bellocq, I				Corbelli, Julian Martin; Zurita, Gustavo Andres; Filloy, Julieta; Galvis, Juan Pablo; Vespa, Natalia Isabel; Bellocq, Isabel			Integrating Taxonomic, Functional and Phylogenetic Beta Diversities: Interactive Effects with the Biome and Land Use across Taxa	PLOS ONE			English	Article							TYRANT FLYCATCHERS; ECOSYSTEM-FUNCTION; COMMUNITY ECOLOGY; EARLY EVOLUTION; BIRDS; AVES; DIVERSIFICATION; BIODIVERSITY; REGRESSION; PATTERNS	The spatial distribution of species, functional traits and phylogenetic relationships at both the regional and local scales provide complementary approaches to study patterns of biodiversity and help to untangle the mechanisms driving community assembly. Few studies have simultaneously considered the taxonomic (TBD), functional (FBD) and phylogenetic (PBD) facets of beta diversity. Here we analyze the associations between TBD, FBD, and PBD with the biome (representing different regional species pools) and land use, and investigate whether TBD, FBD and PBD were correlated. In the study design we considered two widely used indicator taxa (birds and ants) from two contrasting biomes (subtropical forest and grassland) and land uses (tree plantations and cropfields) in the southern Neotropics. Non-metric multidimensional scaling showed that taxonomic, functional and phylogenetic distances were associated to biome and land use; study sites grouped into four groups on the bi-dimensional space (cropfields in forest and grassland, and tree plantations in forest and grassland), and that was consistent across beta diversity facets and taxa. Mantel and PERMANOVA tests showed that TBD, FBD and PBD were positively correlated for both bird and ant assemblages; in general, partial correlations were also significant. Some of the functional traits considered here were conserved along phylogeny. Our results will contribute to the development of sound land use planning and beta diversity conservation.	[Corbelli, Julian Martin; Filloy, Julieta; Vespa, Natalia Isabel; Bellocq, Isabel] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, IEGEBA,CONICET UBA, RA-1428 Buenos Aires, DF, Argentina; [Zurita, Gustavo Andres; Vespa, Natalia Isabel] Univ Nacl Misiones, CONICET, Inst Biol Subtrop, Fac Ciencias Forest, RA-3770 Pto Iguazu, Misiones, Argentina; [Galvis, Juan Pablo] Univ Nacl La Plata, Museo Ciencias Nat La Plata, Fac Ciencias Nat & Museo FCNyM, Div Paleozool Invertebrados, RA-1900 La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Bellocq, I (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, IEGEBA,CONICET UBA, Ciudad Univ,Pabellon 2,Piso 4, RA-1428 Buenos Aires, DF, Argentina.	bellocq@ege.fcen.ba.ar		Corbett, Jack/0000-0003-2005-7162	PICT [2008-0416]	PICT(ANPCyT)	This work was supported by PICT 2008-0416 (www.agencia.mincyt.gob.ar).	Allen AP, 2000, J BIOGEOGR, V27, P889, DOI 10.1046/j.1365-2699.2000.00453.x; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2004, PERMDISP A FORTRAN C; Baker AJ, 2009, THE TIMETREE OF LIFE; Bibby C, 1998, EXPEDITION FIELD TEC; Bihn JH, 2010, ECOLOGY, V91, P782, DOI 10.1890/08-1276.1; Bilenca D, 2004, IDENTIFICACION DE AR; Bininda-Emonds ORP, 2004, TRENDS ECOL EVOL, V19, P315, DOI 10.1016/j.tree.2004.03.015; Birdsley JS, 2002, AUK, V119, P715, DOI 10.1642/0004-8038(2002)119[0715:POTTFT]2.0.CO;2; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bolton Barry, 2003, Memoirs of the American Entomological Institute (Gainesville), V71, P1; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brandao C. Roberto F., 2007, Memoirs of the American Entomological Institute (Gainesville), V80, P72; Brown JW, 2007, THE TREE OF LIFE WEB; Brown JW, 2009, THE TIMETREE OF LIFE; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cianciaruso MV, 2011, FRONTIERS BIOGEOGR, V3, P87; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cody ML, 1985, HABITAT SELECTION IN; Cofre HL, 2007, DIVERS DISTRIB, V13, P203, DOI 10.1111/j.1472-4642.2006.00312.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diniz JAF, 2011, FUNCT ECOL, V25, P735, DOI 10.1111/j.1365-2435.2011.01836.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ericson PGP, 2006, MOL PHYLOGENET EVOL, V40, P471, DOI 10.1016/j.ympev.2006.03.031; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Feeley KJ, 2007, ANIM CONSERV, V10, P493, DOI 10.1111/j.1469-1795.2007.00140.x; Fernandez F, 2003, INTRODUCCION A LAS H; Filloy J, 2010, ACTA OECOL, V36, P333, DOI 10.1016/j.actao.2010.02.007; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Fischer J, 2006, FRONT ECOL ENVIRON, V4, P80, DOI 10.1890/1540-9295(2006)004[0080:BEFART]2.0.CO;2; Fjeldsa J, 2005, J ORNITHOL, V146, P1, DOI 10.1007/s10336-004-0054-5; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Galindo-Leal C, 2003, THE ATLANTIC FOREST; Gibb H, 2010, OECOLOGIA, V164, P1061, DOI 10.1007/s00442-010-1703-4; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harshman J, 2008, THE TREE OF LIFE WEB; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hedges SB, 2008, THE TIMETREE OF LIFE; Henwood W. D., 1998, PARKS, V8, P3; INBIO, 2009, INSTITUTO DE BIOTECN; Irestedt M, 2006, J AVIAN BIOL, V37, P260, DOI 10.1111/j.2006.0908-8857.03612.x; Irestedt M, 2002, MOL PHYLOGENET EVOL, V23, P499, DOI 10.1016/S1055-7903(02)00034-9; Jonsson KA, 2006, ZOOL SCR, V35, P149, DOI 10.1111/j.1463-6409.2006.00221.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; Leibold MA, 1998, EVOL ECOL, V12, P95, DOI 10.1023/A:1006511124428; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; LEON R J C, 1984, Phytocoenologia, V12, P201; Lerner HRL, 2006, THE TREE OF LIFE WEB; Linksvayer TA, 2009, SYST RES BEHAV SCI, V26, P315, DOI 10.1002/sres.928; Lopez-Lanus B, 2008, CATEGORIZACION DE LA; MacArthur R.H., 1972, pvii; MANTEL N, 1967, CANCER RES, V27, P209; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Mindell DP, 2008, THE TREE OF LIFE WEB; Moore WS, 2009, THE TIMETREE OF LIFE; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Morrone JJ, 2001, MANUALES Y TESIS SEA, V3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Orme D, 2011, R PACKAGE VERSION 04; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Pausas JG, 2008, ECOLOGY, V89, P2181, DOI 10.1890/07-1737.1; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Purschke O, 2013, J ECOL, V101, P857, DOI 10.1111/1365-2745.12098; Quinn GP, 2002, EXPERIMENTAL DESIGN; Ricotta C, 2008, PRESLIA, V80, P61; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Soriano A., 1991, ECOSYSTEMS WORLD A, P367; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Sutherland WJ., 1996, ECOLOGICAL CENSUS TE, V2, DOI DOI 10.1017/CBO9780511790508; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Tree of Life Web Project, 2007, COLUMBIFORMES COLUMB; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2008, PHYLOCOM SOFTWARE FO; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wild AL, 2009, SYST ENTOMOL, V34, P49, DOI 10.1111/j.1365-3113.2008.00435.x; Wilson E.O., 1971, INSECT SOC; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	100	35	37	6	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126854	10.1371/journal.pone.0126854	http://dx.doi.org/10.1371/journal.pone.0126854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978319	Green Published, gold			2022-12-27	WOS:000354916100108
J	Khorsandi, SE; Quaglia, A; Salehi, S; Jassem, W; Vilca-Melendez, H; Prachalias, A; Srinivasan, P; Heaton, N				Khorsandi, Shirin Elizabeth; Quaglia, Alberto; Salehi, Siamak; Jassem, Wayel; Vilca-Melendez, Hector; Prachalias, Andreas; Srinivasan, Parthi; Heaton, Nigel			The microRNA Expression Profile in Donation after Cardiac Death (DCD) Livers and Its Ability to Identify Primary Non Function	PLOS ONE			English	Article							REGENERATION; RETRANSPLANTATION; OUTCOMES; TARGETS; CANCER	Donation after cardiac death (DCD) livers are marginal organs for transplant and their use is associated with a higher risk of primary non function (PNF) or early graft dysfunction (EGD). The aim was to determine if microRNA (miRNA) was able to discriminate between DCD livers of varying clinical outcome. DCD groups were categorized as PNF retransplanted within a week (n=7), good functional outcome (n=7) peak aspartate transaminase (AST) <= 1000 IU/L and EGD (n=9) peak AST >= 2500 IU/L. miRNA was extracted from archival formalin fixed post-perfusion tru-cut liver biopsies. High throughput expression analysis was performed using miRNA arrays. Bioinformatics for expression data analysis was performed and validated with real time quantitative PCR (RT-qPCR). The function of miRNA of interest was investigated using computational biology prediction algorithms. From the array analysis 16 miRNAs were identified as significantly different (p<0.05). On RT-qPCR miR-155 and miR-940 had the highest expression across all three DCD clinical groups. Only one miRNA, miR-22, was validated with marginal significance, to have differential expression between the three groups (p=0.049). From computational biology miR-22 was predicted to affect signalling pathways that impact protein turnover, metabolism and apoptosis/cell cycle. In conclusion, microRNA expression patterns have a low diagnostic potential clinically in discriminating DCD liver quality and outcome.	[Khorsandi, Shirin Elizabeth; Quaglia, Alberto; Salehi, Siamak; Jassem, Wayel; Vilca-Melendez, Hector; Prachalias, Andreas; Srinivasan, Parthi; Heaton, Nigel] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Heaton, N (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 8RX, England.	nigel.heaton@nhs.net	Salehi, Albert/F-7768-2018; khorsandi, shirin elizabeth/I-2699-2019; Heaton, Nigel/AAK-8363-2020	Salehi, Albert/0000-0001-6120-3539; khorsandi, shirin elizabeth/0000-0003-1624-4467; Jassem, Wayel/0000-0003-2918-5232				Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Biggar KK, 2009, CURR GENOMICS, V10, P573, DOI 10.2174/138920209789503905; Boutz DR, 2011, J BIOL CHEM, V286, P18066, DOI 10.1074/jbc.M110.196451; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Castro RE, 2010, AM J PHYSIOL-GASTR L, V299, pG887, DOI 10.1152/ajpgi.00216.2010; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen XL, 2011, TRANSPLANTATION, V91, P293, DOI 10.1097/TP.0b013e318204756c; CLAVIEN PA, 1994, ANN SURG, V220, P109, DOI 10.1097/00000658-199408000-00002; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Farid WRR, 2011, AM J TRANSPLANT, V11, P210; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Kren BT, 2009, AM J PHYSIOL-GASTR L, V297, pG1181, DOI 10.1152/ajpgi.90636.2008; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Mas VR, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/j.1600-6143.2012.04313.x; Morozova N, 2012, RNA, V18, P1635, DOI 10.1261/rna.032284.112; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Roubelakis MG, 2009, BMC BIOINFORMATICS, V10, pS6, DOI [10.1186/1471-2105-10-S15-S6, DOI 10.1186/1471-2105-10-S15-S6]; Salehi S, 2013, AM J TRANSPLANT, V13, P1282, DOI 10.1111/ajt.12183; Schug J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-264; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selck FW, 2008, ANN SURG, V248, P599, DOI 10.1097/SLA.0b013e31818a080e; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shapiro MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023011; Tan GY, 2012, BIOCHEM BIOPH RES CO, V417, P546, DOI 10.1016/j.bbrc.2011.11.160; Uemura T, 2007, LIVER TRANSPLANT, V13, P227, DOI 10.1002/lt.20992; Verhoeven CJ, 2013, J HEPATOL, V59, P1231, DOI [10.1016/j.jhep.2013.07.034, 10.1016/j.jhep.2017.09.001]; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127073	10.1371/journal.pone.0127073	http://dx.doi.org/10.1371/journal.pone.0127073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978529	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100127
J	Kohyama, T; Moriyama, K; Kanai, R; Kotani, M; Uzawa, K; Satoh, T; Yorozu, T				Kohyama, Tomoki; Moriyama, Kiyoshi; Kanai, Riichiro; Kotani, Mariko; Uzawa, Kohji; Satoh, Toru; Yorozu, Tomoko			Accuracy of Pulse Oximeters in Detecting Hypoxemia in Patients with Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							OXYGEN-SATURATION	Purpose Pulse oximetry is routinely used to continuously and non-invasively monitor arterial oxygen saturation (SaO(2)). When oxygen saturation by pulse oximeter (SpO(2)) overestimates SaO(2), hypoxemia may be overlooked. We compared the SpO(2) - SaO(2) differences among three pulse oximeters in patients with chronic thromboembolic pulmonary hypertension (CTEPH) who spent their daily lives in a poor oxygen state. Material and Method This prospective observational study recruited 32 patients with CTEPH undergoing elective cardiac catheterization. As we collected arterial blood samples in the catheter laboratory, SpO(2) values were simultaneously recorded. Three pulse oximeters were used on each patient, and SpO(2) values were compared with oximetry readings using a blood gas analyzer. To determine the optimal SpO(2) value by which to detect hypoxemia (SaO(2)<= 90%), we generated receiver operating characteristic (ROC) curves for each pulse oximeter. Result The root mean square of each pulse oximeter was 1.79 (OLV-3100), 1.64 (N-BS), and 2.50 (Masimo Radical). The mean bias (SpO(2) - SaO(2)) for the 90%-95% saturation range was significantly higher for Masimo Radical (0.19 +/- 1.78% [OLV-3100], 0.18 +/- 1.63% [N-BS], and 1.61 +/- 1.91%[Masimo Radical]; p < 0.0001). The optimal SpO(2) value to detect hypoxemia (SaO(2)<= 90%) was 89% for OLV-3100, 90% for N-BS, and 92% for Masimo Radical. Conclusion We found that the biases and precision with which to detect hypoxemia differed among the three pulse oximeters. To avoid hypoxemia, the optimal SpO(2) should be determined for each pulse oximeter.	[Kohyama, Tomoki; Moriyama, Kiyoshi; Kanai, Riichiro; Kotani, Mariko; Uzawa, Kohji; Yorozu, Tomoko] Kyorin Univ, Sch Med, Dept Anesthesiol, Tokyo, Japan; [Satoh, Toru] Kyorin Univ, Sch Med, Dept Internal Med 2, Div Cardiol, Tokyo, Japan	Kyorin University; Kyorin University	Moriyama, K (corresponding author), Kyorin Univ, Sch Med, Dept Anesthesiol, Tokyo, Japan.	mokiyo@ks.kyorin-u.ac.jp	Moriyama, Kiyoshi/AAA-3764-2022	Moriyama, Kiyoshi/0000-0002-0387-5406				Feiner JR, 2007, ANESTH ANALG, V105, pS18, DOI 10.1213/01.ane.0000285988.35174.d9; Ghayumi SMA, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.15449; Ikeda K, 2014, ANESTH ANALG, V119, P1381, DOI 10.1213/ANE.0000000000000463; JUBRAN A, 1990, CHEST, V97, P1420, DOI 10.1378/chest.97.6.1420; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kataoka M, 2012, CIRC-CARDIOVASC INTE, V5, P756, DOI 10.1161/CIRCINTERVENTIONS.112.971390; Majumdar SR, 2011, CLIN INFECT DIS, V52, P325, DOI 10.1093/cid/ciq076; Perkins GD, 2003, CRIT CARE, V7, pR67, DOI 10.1186/cc2339; Secker C, 1997, ANAESTHESIA, V52, P127, DOI 10.1111/j.1365-2044.1997.32-az0062.x; Seguin P, 2000, CRIT CARE MED, V28, P703, DOI 10.1097/00003246-200003000-00017; Suzuki S, 2014, CRIT CARE MED, V42, P1414, DOI 10.1097/CCM.0000000000000219; Vadasz I, 2011, AM J RESP CRIT CARE, V183, P1147, DOI 10.1164/rccm.201102-0327UP; Van de Louw A, 2001, INTENS CARE MED, V27, P1606; Wilson BJ, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-9	14	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126979	10.1371/journal.pone.0126979	http://dx.doi.org/10.1371/journal.pone.0126979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978517	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100119
J	Wang, LL; Xue, HP; Li, LP; Zhao, X				Wang, Liangliang; Xue, Huping; Li, Longping; Zhao, Xin			Characterization of Insertion Sequence ISSau2 in the Human and Livestock-Associated Staphylococcus aureus	PLOS ONE			English	Article							TRANSPOSITION; HOST	Mobile genetic elements play important roles in evolution and diversification of bacterial genomes. ISSau2 is 1660bp in length with terminal 5'-TG and CA-3' dinucleotides and has two overlapping reading frames orfA and orfB. It has been found in a wide range of S. aureus, such as HA-MRSA252, LGA251, MRSA S0385 and ED133. To determine distribution of ISSau2, 164 S. aureus isolates from milk samples of mastitic cows from our laboratory and all the S. aureus strains from the National Center for Biotechnology Information (NCBI) database were screened for the presence of ISSau2. Next, in order to explore a potential relationship among S. aureus ISSau2-containing strains and isolates, a relationship among 10 ISSau2-positive S. aureus isolates and 27 ISSau2-positive S. aureus strains was investigated by a phylogenetic analysis. These ISSau2 isolates and strains could be classified into four groups (A, B, C and D). The strains or isolates in Group D were all isolated from mammary glands, suggesting tissue specificity. All strains in Group B had an identical ISSau2 derivative, termed ISSau2(1628), with 32bp deletion at the 3' terminus. ISSau2(1628) in strain ST398 from Group B was closely related to ISSau2 in strain LGA251 from Group D.	[Wang, Liangliang; Xue, Huping; Li, Longping; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Montreal, PQ H3A 2T5, Canada	Northwest A&F University - China; McGill University	Zhao, X (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China.	xin.zhao@mcgill.ca	Zhao, Xin/M-4312-2015; Wang, Liangliang/ADF-9017-2022	Zhao, Xin/0000-0002-1078-7332; 	National Science Foundation of China [31372282]; China Thousand Talents program; University Scientific Research Fund project [Z111021305]; Natural Science and Engineering Research Council of Canada	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Thousand Talents program; University Scientific Research Fund project; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: This study was financially supported by a grant from National Science Foundation of China (31372282), the China Thousand Talents program, and a University Scientific Research Fund project (Fund No. Z111021305). This work was also partially supported from a discovery grant by Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; Baptiste KE, 2005, EMERG INFECT DIS, V11, P1942, DOI 10.3201/eid1112.050241; CHANDLER M, 1993, MOL MICROBIOL, V7, P497, DOI 10.1111/j.1365-2958.1993.tb01140.x; DOOLITTLE WF, 1984, NATURE, V307, P501, DOI 10.1038/307501b0; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Izsvak Z, 2002, J BIOL CHEM, V277, P34581, DOI 10.1074/jbc.M204001200; Jamrozy DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040458; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116699; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; McGavin MJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00048; POLARD P, 1991, J MOL BIOL, V222, P465, DOI 10.1016/0022-2836(91)90490-W; Rousseau P, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-16; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; SEKINE Y, 1994, J MOL BIOL, V235, P1406, DOI 10.1006/jmbi.1994.1097; Sekine Y, 1997, GENES CELLS, V2, P547, DOI 10.1046/j.1365-2443.1997.1440342.x; Siguier P, 2014, FEMS MICROBIOL REV, V10, P1574; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VOGELE K, 1991, NUCLEIC ACIDS RES, V19, P4377, DOI 10.1093/nar/19.16.4377; Xue HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020332	24	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127183	10.1371/journal.pone.0127183	http://dx.doi.org/10.1371/journal.pone.0127183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978410	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100133
J	Fak, F; Jakobsdottir, G; Kulcinskaja, E; Marungruang, N; Matziouridou, C; Nilsson, U; Stalbrand, H; Nyman, M				Fak, Frida; Jakobsdottir, Greta; Kulcinskaja, Evelina; Marungruang, Nittaya; Matziouridou, Chrysoula; Nilsson, Ulf; Stalbrand, Henrik; Nyman, Margareta			The Physico-Chemical Properties of Dietary Fibre Determine Metabolic Responses, Short-Chain Fatty Acid Profiles and Gut Microbiota Composition in Rats Fed Low- and High-Fat Diets	PLOS ONE			English	Article							INTESTINAL-TRACT; BETA-MANNANASE; GUAR GUM; VISCOSITY; DEGRADATION; PECTIN; GALACTOGLUCOMANNAN; ABSORPTION; ADIPOSITY; ENZYMES	The aim of this study was to investigate how physico-chemical properties of two dietary fibres, guar gum and pectin, affected weight gain, adiposity, lipid metabolism, short-chain fatty acid (SCFA) profiles and the gut microbiota in male Wistar rats fed either low- or high-fat diets for three weeks. Both pectin and guar gum reduced weight gain, adiposity, liver fat and blood glucose levels in rats fed a high-fat diet. Methoxylation degree of pectin (low, LM and high (HM)) and viscosity of guar gum (low, medium or high) resulted in different effects in the rats, where total blood and caecal amounts of SCFA were increased with guar gum (all viscosities) and with high methoxylated (HM) pectin. However, only guar gum with medium and high viscosity increased the levels of butyric acid in caecum and blood. Both pectin and guar gum reduced cholesterol, liver steatosis and blood glucose levels, but to varying extent depending on the degree of methoxylation and viscosity of the fibres. The medium viscosity guar gum was the most effective preparation for prevention of diet-induced hyperlipidaemia and liver steatosis. Caecal abundance of Akkermansia was increased with high-fat feeding and with HM pectin and guar gum of all viscosities tested. Moreover, guar gum had distinct bifidogenic effects independent of viscosity, increasing the caecal abundance of Bifidobacterium ten-fold. In conclusion, by tailoring the viscosity and possibly also the degree of methoxylation of dietary fibre, metabolic effects may be optimized, through a targeted modulation of the gut microbiota and its metabolites.	[Fak, Frida; Jakobsdottir, Greta; Marungruang, Nittaya; Matziouridou, Chrysoula; Nilsson, Ulf; Nyman, Margareta] Lund Univ, Food Hlth Sci Ctr, Lund, Sweden; [Kulcinskaja, Evelina; Stalbrand, Henrik] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden	Lund University; Lund University	Fak, F (corresponding author), Lund Univ, Food Hlth Sci Ctr, Lund, Sweden.	frida.fak@food-health-science.lu.se	Nyman, Margareta/AAY-9466-2020	Nyman, Margareta/0000-0003-3660-2364; Kulcinskaja, Evelina/0000-0002-0557-7672; Marungruang, Nittaya/0000-0001-9769-7980; Jakobsdottir, Greta/0000-0002-0109-6871	VINNOVA VINN Excellence Center Antidiabetic Food Centre; VINNOVA Biostream project; Direktor Albert Pahlsson Foundation; Sparbank Foundation Fars och Frosta; FLAK (The Swedish Research School of Pharmaceutical Sciences); FORMAS [213-2011-1620]; Swedish Nutrition Foundation (SNF)	VINNOVA VINN Excellence Center Antidiabetic Food Centre(Vinnova); VINNOVA Biostream project(Vinnova); Direktor Albert Pahlsson Foundation; Sparbank Foundation Fars och Frosta; FLAK (The Swedish Research School of Pharmaceutical Sciences); FORMAS(Swedish Research Council Formas); Swedish Nutrition Foundation (SNF)	This research was funded by the VINNOVA VINN Excellence Center Antidiabetic Food Centre (MN, FF), the VINNOVA Biostream project (HS), the Direktor Albert Pahlsson Foundation (FF), the Sparbank Foundation Fars och Frosta (GJ), FLAK (The Swedish Research School of Pharmaceutical Sciences) (EK), FORMAS (213-2011-1620) (HS), and by the Swedish Nutrition Foundation (SNF) (GJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar F., 2010, Biotechnology, V9, P25; Ademark P, 1998, J BIOTECHNOL, V63, P199, DOI 10.1016/S0168-1656(98)00086-8; Antov M, 2006, J CHROMATOGR A, V1123, P53, DOI 10.1016/j.chroma.2006.05.021; BALASCIO JR, 1981, J FOOD BIOCHEM, V5, P271, DOI 10.1111/j.1745-4514.1981.tb00679.x; Berger K, 2014, J AGR FOOD CHEM, V62, P8169, DOI 10.1021/jf502343v; Brockman DA, 2014, J NUTR, V144, P1415, DOI 10.3945/jn.114.191577; Brouns F, 2012, EUR J CLIN NUTR, V66, P591, DOI 10.1038/ejcn.2011.208; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CROCIANI F, 1994, INT J FOOD MICROBIOL, V24, P199, DOI 10.1016/0168-1605(94)90119-8; CUMMINGS JH, 1979, BRIT J NUTR, V41, P477, DOI 10.1079/BJN19790062; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; De Vuyst L, 2011, INT J FOOD MICROBIOL, V149, P73, DOI 10.1016/j.ijfoodmicro.2011.03.003; den Besten G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107392; Dongowski G, 2002, J NUTR, V132, P1935, DOI 10.1093/jn/132.7.1935; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Hamaker BR, 2014, J MOL BIOL, V426, P3838, DOI 10.1016/j.jmb.2014.07.028; Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Jakobsdottir G, 2013, BRIT J NUTR, V110, P1565, DOI 10.1017/S0007114513000809; Karlsson CLJ, 2011, PEDIATR RES, V70, P282, DOI 10.1203/PDR.0b013e318225f765; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kulcinskaja E, 2013, APPL ENVIRON MICROB, V79, P133, DOI 10.1128/AEM.02118-12; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lundqvist J, 2002, CARBOHYD POLYM, V48, P29, DOI 10.1016/S0144-8617(01)00210-7; Lundqvist J, 2003, CARBOHYD POLYM, V51, P203, DOI 10.1016/S0144-8617(02)00111-X; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; NYMAN M, 1986, BRIT J NUTR, V55, P487, DOI 10.1079/BJN19860056; Ohashi Y, 2014, BENEF MICROBES, P1, DOI [10.3920/BM2013.x001, DOI 10.3920/BM2013.X001]; OKUBO T, 1994, BIOSCI BIOTECH BIOCH, V58, P1364, DOI 10.1271/bbb.58.1364; Pasquier B, 1996, BIOCHEM J, V314, P269, DOI 10.1042/bj3140269; Sanchez D, 2011, PHARMACOL RES, V64, P31, DOI 10.1016/j.phrs.2011.02.005; Santas J, 2012, LIPIDS, V47, P697, DOI 10.1007/s11745-012-3682-1; Schroeder N, 2013, NUTRIENTS, V5, P2093, DOI 10.3390/nu5062093; Shinohara K, 2010, ANAEROBE, V16, P510, DOI 10.1016/j.anaerobe.2010.03.005; SVANBERG SJM, 1995, J AGR FOOD CHEM, V43, P2692, DOI 10.1021/jf00058a026; Vuksan V, 2011, BRIT J NUTR, V106, P1349, DOI 10.1017/S0007114511001711; Yamamoto Y, 2000, BIOSCI BIOTECH BIOCH, V64, P2165, DOI 10.1271/bbb.64.2165; Yang J, 2013, ANAEROBE; Yang JY, 2013, ANAEROBE, V23, P74, DOI 10.1016/j.anaerobe.2013.06.012	42	52	55	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127252	10.1371/journal.pone.0127252	http://dx.doi.org/10.1371/journal.pone.0127252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973610	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600106
J	Kim, R; Schell, MJ; Teer, JK; Greenawalt, DM; Yang, ML; Yeatman, TJ				Kim, Richard; Schell, Michael J.; Teer, Jamie K.; Greenawalt, Danielle M.; Yang, Mingli; Yeatman, Timothy J.			Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era	PLOS ONE			English	Article							CLONAL EVOLUTION; PERSONALIZED MEDICINE; PRIMARY TUMOR; EXPRESSION; HETEROGENEITY; CARCINOMA; MUTATIONS; P53; DNA	Introduction Metastasis is thought to be a clonal event whereby a single cell initiates the development of a new tumor at a distant site. However the degree to which primary and metastatic tumors differ on a molecular level remains unclear. To further evaluate these concepts, we used next generation sequencing (NGS) to assess the molecular composition of paired primary and metastatic colorectal cancer tissue specimens. Methods 468 colorectal tumor samples from a large personalized medicine initiative were assessed by targeted gene sequencing of 1,321 individual genes. Eighteen patients produced genomic profiles for 17 paired primary: metastatic (and 2 metastatic: metastatic) specimens. Results An average of 33.3 mutations/tumor were concordant (shared) between matched samples, including common well-known genes (APC, KRAS, TP53). An average of 2.3 mutations/tumor were discordant (unshared) among paired sites. KRAS mutational status was always concordant. The overall concordance rate for mutations was 93.5%; however, nearly all (18/ 19 (94.7%)) paired tumors showed at least one mutational discordance. Mutations were seen in: TTN, the largest gene (5 discordant pairs), ADAMTS20, APC, MACF1, RASA1, TP53, and WNT2 (2 discordant pairs), SMAD2, SMAD3, SMAD4, FBXW7, and 66 others (1 discordant pair). Conclusions Whereas primary and metastatic tumors displayed little variance overall, co-evolution produced incremental mutations in both. These results suggest that while biopsy of the primary tumor alone is likely sufficient in the chemotherapy-naive patient, additional biopsies of primary or metastatic disease may be necessary to precisely tailor therapy following chemotherapy resistance or insensitivity in order to adequately account for tumor evolution.	[Kim, Richard] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA; [Schell, Michael J.; Teer, Jamie K.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA; [Greenawalt, Danielle M.] Merck Co Inc, Boston, MA USA; [Yang, Mingli; Yeatman, Timothy J.] Gibbs Canc Ctr & Res Inst, Spartanburg, SC 29303 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Merck & Company	Yeatman, TJ (corresponding author), Gibbs Canc Ctr & Res Inst, Spartanburg, SC 29303 USA.	yeatman@gibbscc.org		Yang, Mingli/0000-0002-4781-690X	National Institutes of Health (NIH) [U01CA157960]; Merck Co, Inc/AstraZeneca; NATIONAL CANCER INSTITUTE [P30CA076292, U01CA157960] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Co, Inc/AstraZeneca; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by National Institutes of Health (NIH) nih.gov U01CA157960 (TJY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck Co, Inc/AstraZeneca provided support in the form of salaries for the author [DMG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Bissig H, 1999, AM J PATHOL, V155, P267, DOI 10.1016/S0002-9440(10)65120-6; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Fenstermacher DA, 2011, CANCER J, V17, P528, DOI 10.1097/PPO.0b013e318238216e; Forslund A, 2001, J CLIN ONCOL, V19, P2829, DOI 10.1200/JCO.2001.19.11.2829; Gartner JJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-505; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Iacopetta B, 2003, HUM MUTAT, V21, P271, DOI 10.1002/humu.10175; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Khan ZAJ, 2000, CLIN CANCER RES, V6, P3499; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090459; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Montel V, 2006, INT J CANCER, V119, P251, DOI 10.1002/ijc.21757; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Suzuki M, 2007, MOL ONCOL, V1, P172, DOI 10.1016/j.molonc.2007.03.005; Urquidi V, 2002, CLIN CANCER RES, V8, P61; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; Vignot S, 2013, J CLIN ONCOL, V31, P2167, DOI 10.1200/JCO.2012.47.7737; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yeatman TJ, 2008, CANCER RES, V68, P7250, DOI 10.1158/0008-5472.CAN-08-1374	29	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126670	10.1371/journal.pone.0126670	http://dx.doi.org/10.1371/journal.pone.0126670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974029	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600075
J	Portevin, D; Moukambi, F; Mpina, M; Bauer, A; Haraka, F; Chachage, M; Metzger, P; Saathoff, E; Clowes, P; Ntinginya, NE; Rachow, A; Hoelscher, M; Reither, K; Daubenberger, CA; Geldmacher, C				Portevin, Damien; Moukambi, Felicien; Mpina, Maxmillian; Bauer, Asli; Haraka, Frederick; Chachage, Mkunde; Metzger, Philipp; Saathoff, Elmar; Clowes, Petra; Ntinginya, Nyanda E.; Rachow, Andrea; Hoelscher, Michael; Reither, Klaus; Daubenberger, Claudia A.; Geldmacher, Christof			Maturation and Mip-1 beta Production of Cytomegalovirus-Specific T Cell Responses in Tanzanian Children, Adolescents and Adults: Impact by HIV and Mycobacterium tuberculosis Co-Infections	PLOS ONE			English	Article							DAY-CARE; CD4(+); INFECTION; MEMORY; EXPRESSION; DYNAMICS; VIRUS; DEATH; LIFE	It is well accepted that aging and HIV infection are associated with quantitative and functional changes of CMV-specific T cell responses. We studied here the expression of Mip-1 beta and the T cell maturation marker CD27 within CMVpp65-specific CD4(+) and CD8(+) T cells in relation to age, HIV and active Tuberculosis (TB) co-infection in a cohort of Tanzanian volunteers (<= 16 years of age, n = 108 and >= 18 years, n = 79). Independent of HIV co-infection, IFN gamma(+) CMVpp65-specific CD4(+) T cell frequencies increased with age. In adults, HIV co-infection further increased the frequencies of these cells. A high capacity for Mip-1 beta production together with a CD27(low) phenotype was characteristic for these cells in children and adults. Interestingly, in addition to HIV co-infection active TB disease was linked to further down regulation of CD27 and increased capacity of Mip-1 beta production in CMVpp65-specific CD4(+) T cells. These phenotypic and functional changes of CMVpp65-specific CD4(+) T cells observed during HIV infection and active TB could be associated with increased CMV reactivation rates.	[Portevin, Damien; Metzger, Philipp; Reither, Klaus; Daubenberger, Claudia A.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Portevin, Damien; Reither, Klaus; Daubenberger, Claudia A.] Univ Basel, Basel, Switzerland; [Moukambi, Felicien; Bauer, Asli; Chachage, Mkunde; Clowes, Petra; Ntinginya, Nyanda E.] NIMR Mbeya Med Res Ctr, Mbeya, Tanzania; [Moukambi, Felicien; Bauer, Asli; Saathoff, Elmar; Clowes, Petra; Rachow, Andrea; Hoelscher, Michael; Geldmacher, Christof] Univ Munich, Med Ctr, Dept Infect Dis & Trop Med, Munich, Germany; [Mpina, Maxmillian; Haraka, Frederick; Reither, Klaus] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Saathoff, Elmar; Rachow, Andrea; Hoelscher, Michael; Geldmacher, Christof] German Ctr Infect Res DZIF, Munich, Germany	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Munich; Ifakara Health Institute; German Center for Infection Research	Portevin, D (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	damien.portevin@unibas.ch; geldmacher@lrz.uni-muenchen.de	Portevin, Damien/ABB-4546-2021; Metzger, Philipp/D-7539-2017; Hoelscher, Michael/D-3436-2012	Portevin, Damien/0000-0003-2949-9557; Metzger, Philipp/0000-0001-8741-3139; Daubenberger, Claudia/0000-0001-7136-0642; Chachage, Mkunde/0000-0003-2196-1073; Reither, Klaus/0000-0001-6195-8237	European and Developing Countries Clinical Trials Partnership (EDCTP), as part of the TB CHILD project [IP.2009.32040.007]; German Federal Ministry of Education and Research (BMBF) [01KA1006]; Swiss National Science Foundation [32EC30_131192/1]; German Research Foundation (DFG) [SA 1878/1-1]; German Center for Infection Research (DZIF); Basel University (Forderung exzellenter junger Forschender); German Academic Exchange Service (DAAD); PROMOS scholarship	European and Developing Countries Clinical Trials Partnership (EDCTP), as part of the TB CHILD project; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for Infection Research (DZIF); Basel University (Forderung exzellenter junger Forschender); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); PROMOS scholarship	The authors gratefully acknowledge funding from the European and Developing Countries Clinical Trials Partnership (EDCTP) for this study as part of the TB CHILD project (IP.2009.32040.007). Co-funding was provided by the German Federal Ministry of Education and Research (BMBF Grant 01KA1006), the Swiss National Science Foundation (32EC30_131192/1) and the German Research Foundation (DFG, grant SA 1878/1-1). Christof Geldmacher's salary is funded by the German Center for Infection Research (DZIF). Damien Portevin's salary was funded by the Basel University (Forderung exzellenter junger Forschender). Philipp Metzger was supported by the German Academic Exchange Service (DAAD) with a PROMOS scholarship.	ADLER SP, 1989, NEW ENGL J MED, V321, P1290, DOI 10.1056/NEJM198911093211903; BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366; Brantsaeter AB, 2012, INT J INFECT DIS, V16, pE879, DOI 10.1016/j.ijid.2012.08.003; Brenchley JM, 2006, J VIROL, V80, P6801, DOI 10.1128/JVI.00070-06; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Bronke C, 2005, J INFECT DIS, V191, P873, DOI 10.1086/427828; Cannon MJ, 2011, REV MED VIROL, V21, P240, DOI 10.1002/rmv.695; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Casazza JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000646; Chachage M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002755; Edwards ESJ, 2014, IMMUNOL CELL BIOL, V92, P181, DOI 10.1038/icb.2013.88; Faist B, 2010, CLIN VACCINE IMMUNOL, V17, P986, DOI 10.1128/CVI.00455-09; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Hanna-Wakim R, 2009, J INFECT DIS, V200, P1921, DOI 10.1086/648375; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Henry Masur JEK, GUIDELINES PREVENTIO; Kaye S, 2008, J INFECT DIS, V197, P1307, DOI 10.1086/586715; Libri V, 2011, IMMUNOLOGY, V132, P326, DOI 10.1111/j.1365-2567.2010.03386.x; Lugo-Villarino G, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00405; Miles DJC, 2008, J INFECT DIS, V197, P658, DOI 10.1086/527418; Pera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088538; Portevin D, 2014, LANCET INFECT DIS, V14, P931, DOI 10.1016/S1473-3099(14)70884-9; Ritter M, 2013, EUR J IMMUNOL, V43, P1099, DOI 10.1002/eji.201243100; Schuetz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027284; Sinclair J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00389; Soares AP, 2013, J INFECT DIS, V207, P1084, DOI 10.1093/infdis/jis941; STAGNO S, 1994, P NATL ACAD SCI USA, V91, P2384, DOI 10.1073/pnas.91.7.2384; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Waller ECP, 2008, MED MICROBIOL IMMUN, V197, P83, DOI 10.1007/s00430-008-0082-5; White GP, 2002, J IMMUNOL, V168, P2820, DOI 10.4049/jimmunol.168.6.2820; WILSON CB, 1986, J CLIN INVEST, V77, P860, DOI 10.1172/JCI112383	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126716	10.1371/journal.pone.0126716	http://dx.doi.org/10.1371/journal.pone.0126716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974183	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000354545600078
J	Rangarajan, N; Kulkarni, P; Hannenhalli, S				Rangarajan, Nivedita; Kulkarni, Prakash; Hannenhalli, Sridhar			Evolutionarily Conserved Network Properties of Intrinsically Disordered Proteins	PLOS ONE			English	Article							GENOMIC ANALYSIS; DATABASE; CENTRALITY; CLASSIFICATION; ESSENTIALITY; MODULARITY	Background Intrinsically disordered proteins (IDPs) lack a stable tertiary structure in isolation. Remarkably, however, a substantial portion of IDPs undergo disorder-to-order transitions upon binding to their cognate partners. Structural flexibility and binding plasticity enable IDPs to interact with a broad range of partners. However, the broader network properties that could provide additional insights into the functional role of IDPs are not known. Results Here, we report the first comprehensive survey of network properties of IDP-induced sub-networks in multiple species from yeast to human. Our results show that IDPs exhibit greater- than-expected modularity and are connected to the rest of the protein interaction network (PIN) via proteins that exhibit the highest betweenness centrality and connect to fewer-than- expected IDP communities, suggesting that they form critical communication links from IDP modules to the rest of the PIN. Moreover, we found that IDPs are enriched at the top level of regulatory hierarchy. Conclusion Overall, our analyses reveal coherent and remarkably conserved IDP-centric network properties, namely, modularity in IDP-induced network and a layer of critical nodes connecting IDPs with the rest of the PIN.	[Rangarajan, Nivedita] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Kulkarni, Prakash] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA; [Hannenhalli, Sridhar] Univ Maryland, Dept Cell Biol & Mol Genet, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Indian Institute of Science Education & Research (IISER) Pune; University System of Maryland; University of Maryland College Park	Hannenhalli, S (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	sridhar@umiacs.umd.edu			National Institutes of Health [R01GM100335]; INSPIRE Scholarship from the Department of Science and Technology, Government of India; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSPIRE Scholarship from the Department of Science and Technology, Government of India; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SH was supported by National Institutes of Health grant R01GM100335. NR was supported by an INSPIRE Scholarship from the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Di Domenico T, 2012, BIOINFORMATICS, V28, P2080, DOI 10.1093/bioinformatics/bts327; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Goh KI, 2002, P NATL ACAD SCI USA, V99, P12583, DOI 10.1073/pnas.202301299; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Gursoy A, 2008, BIOCHEM SOC T, V36, P1398, DOI 10.1042/BST0361398; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Mahmoudabadi G, 2013, CELL CYCLE, V12, P26, DOI 10.4161/cc.23178; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Pasquaretta C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07600; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; Rodrigues FA, 2011, MOL BIOSYST, V7, P1263, DOI 10.1039/c0mb00256a; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shimizu K, 2009, J MOL BIOL, V392, P1253, DOI 10.1016/j.jmb.2009.07.088; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Uhart M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00010; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vacic V, 2012, MOL BIOSYST, V8, P27, DOI 10.1039/c1mb05251a; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Vishnoi A, 2011, MOL BIOL EVOL, V28, P2615, DOI 10.1093/molbev/msr085; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Wuchty S, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-8; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zeng Y, 2011, J BIOL CHEM, V286, P13985, DOI 10.1074/jbc.M110.210765	54	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126729	10.1371/journal.pone.0126729	http://dx.doi.org/10.1371/journal.pone.0126729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974317	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600079
J	Silverstone, PH; Bercov, M; Suen, VYM; Allen, A; Cribben, I; Goodrick, J; Henry, S; Pryce, C; Langstraat, P; Rittenbach, K; Chakraborty, S; Engels, RC; McCabe, C				Silverstone, Peter H.; Bercov, Marni; Suen, Victoria Y. M.; Allen, Andrea; Cribben, Ivor; Goodrick, Jodi; Henry, Stu; Pryce, Catherine; Langstraat, Pieter; Rittenbach, Katherine; Chakraborty, Samprita; Engels, Rutger C.; McCabe, Christopher			Initial Findings from a Novel School-Based Program, EMPATHY, Which May Help Reduce Depression and Suicidality in Youth	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PATIENT HEALTH QUESTIONNAIRE-9; INTERNET-BASED PREVENTION; MENTAL-HEALTH; SELF-HARM; SUBTHRESHOLD-DEPRESSION; SUBSTANCE MISUSE; HOSPITAL ANXIETY; YOUNG-PEOPLE; RISK-FACTORS	We describe initial pilot findings froma novel school-based approach to reduce youth depression and suicidality, the Empowering a Multimodal Pathway Towards Healthy Youth (EMPATHY) program. Here we present the findings from the pilot cohort of 3,244 youth aged 11-18 (Grades 6-12). They were screened for depression, suicidality, anxiety, use of drugs, alcohol, or tobacco (DAT), quality-of-life, and self-esteem. Additionally, all students in Grades 7 and 8 (mean ages 12.3 and 13.3 respectively) also received an 8-session cognitive-behavioural therapy (CBT) based program designed to increase resiliency to depression. Following screening there were rapid interventions for the 125 students (3.9%) who were identified as being actively suicidal, as well as for another 378 students (11.7%) who were felt to be at higher-risk of self-harm based on a combination of scores from all the scales. The intervention consisted of an interview with the student and their family followed by offering a guided internet-based CBT program. Results from the 2,790 students who completed scales at both baseline and 12-week follow-up showed significant decreases in depression and suicidality. Importantly, there was a marked decrease in the number of students who were actively suicidal (from n = 125 at baseline to n = 30 at 12-weeks). Of the 503 students offered the CBT program 163 (32%) took part, and this group had significantly lower depression scores compared to those who didn't take part. There were no improvements in self-esteem, quality-of- life, or the number of students using DAT. Only 60 students (2% of total screened) required external referral during the 24-weeks following study initiation. These results suggest that a multimodal school-based program may provide an effective and pragmatic approach to help reduce youth depression and suicidality. Further research is required to determine longer-term efficacy, reproducibility, and key program elements.	[Silverstone, Peter H.] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada; [Silverstone, Peter H.; Bercov, Marni; Suen, Victoria Y. M.; Allen, Andrea; Pryce, Catherine; Rittenbach, Katherine] Alberta Hlth Serv, Strateg Clin Network Addict & Mental Hlth, Edmonton, AB, Canada; [Silverstone, Peter H.; Cribben, Ivor] Univ Alberta, Dept Finance & Stat Anal, Edmonton, AB, Canada; [Goodrick, Jodi; Henry, Stu; Langstraat, Pieter] Red Deer Publ Sch, Red Deer, AB, Canada; [Chakraborty, Samprita] Univ Alberta, Dept Econ, Fac Art, Edmonton, AB T6G 2E1, Canada; [Engels, Rutger C.] Trimbos Inst, NL-3500 BN Utrecht, Netherlands; [McCabe, Christopher] Dept Emergency Med & Publ Hlth, Edmonton, AB, Canada	University of Alberta; Alberta Health Services (AHS); University of Alberta; University of Alberta; Trimbos Institute	Silverstone, PH (corresponding author), Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.	peter.silverstone@ualberta.ca		Engels, Rutger/0000-0003-1944-9126	Alberta Health Services Grant [002479]	Alberta Health Services Grant	Alberta Health Services Grant-002479 provided funding for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 2014, J CHILD PSYCHOL PSYC, V55, P1390, DOI 10.1111/jcpp.12248; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Balazs J, 2013, J CHILD PSYCHOL PSYC, V54, P670, DOI 10.1111/jcpp.12016; Beghi M, 2010, CURR OPIN PSYCHIATR, V23, P349, DOI 10.1097/YCO.0b013e32833ad783; Bertha EA, 2013, EUR CHILD ADOLES PSY, V22, P589, DOI 10.1007/s00787-013-0411-0; Bond L, 2007, J ADOLESCENT HEALTH, V40, DOI DOI 10.1016/J.JADOHEALTH.2006.10.013; Bor W, 2014, AUST NZ J PSYCHIAT, V48, P606, DOI 10.1177/0004867414533834; Bouwmans C, 2014, EUR J HEALTH ECON, V15, P967, DOI 10.1007/s10198-013-0540-x; Briere FN, 2014, BEHAV RES THER, V53, P55, DOI 10.1016/j.brat.2013.12.005; Burns J, 2005, AUST NZ J PSYCHIAT, V39, P121, DOI 10.1111/j.1440-1614.2005.01532.x; Calear AL, 2010, MED J AUSTRALIA, V192, pS12; Calear AL, 2010, J ADOLESCENCE, V33, P429, DOI 10.1016/j.adolescence.2009.07.004; Carli V, 2014, WORLD PSYCHIATRY, V13, P78, DOI 10.1002/wps.20088; Carrard I, 2011, BEHAV RES THER, V49, P482, DOI 10.1016/j.brat.2011.05.004; Chung T, 2000, J STUD ALCOHOL, V61, P579, DOI 10.15288/jsa.2000.61.579; Clifford AC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-463; Costello EJ, 2005, J AM ACAD CHILD PSY, V44, P972, DOI 10.1097/01.chi.0000172552.41596.6f; Cutuli JJ, 2013, INT J EMOT EDUC, V5, P67; Daniel SS, 2009, SUICIDE LIFE-THREAT, V39, P252, DOI 10.1521/suli.2009.39.3.252; Davies EB, 2014, J MED INTERNET RES, V16, P18, DOI 10.2196/jmir.3142; Dever BV, 2013, WEST J EMERG MED, V14, P1, DOI 10.5811/westjem.2013.2.15349; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Eaton DK, 2011, YOUTH RISK BEHAV SUR, V61; Elison S, 2014, DRUGS ALCOHOL TODAY, V14, P207, DOI 10.1108/DAT-05-2014-0025; Erhart M, 2009, INT J PUBLIC HEALTH, V54, P160, DOI 10.1007/s00038-009-5407-7; Everett BG, 2014, J AM PSYCHIAT NURSES, V20, P42, DOI 10.1177/1078390313510319; Friedmann H, 2008, SUICIDE LIFE-THREAT, V38, P287, DOI 10.1521/suli.2008.38.3.287; Ganguly S, 2013, J ADOLESCENT HEALTH, V52, P546, DOI 10.1016/j.jadohealth.2012.09.012; Gillham JE, 2007, J CONSULT CLIN PSYCH, V75, P9, DOI 10.1037/0022-006x.75.1.9; Gillham JE, 2012, J CLIN CHILD ADOLESC, V41, P621, DOI 10.1080/15374416.2012.706517; Gillham JE, 1999, PSYCHOL SCI, V10, P461, DOI 10.1111/1467-9280.00188; Goldman S, 2012, CHILD ADOL PSYCH CL, V21, P217, DOI 10.1016/j.chc.2011.12.002; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; JAYCOX LH, 1994, BEHAV RES THER, V32, P801, DOI 10.1016/0005-7967(94)90160-0; Khajehdaluee M, 2013, IRAN RED CRESCENT ME, V15, DOI 10.5812/ircmj.7682; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Kindt KCM, 2014, INT J ENV RES PUB HE, V11, P5273, DOI 10.3390/ijerph110505273; Kindt KCM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-212; King, 2006, PREVENTION RES, V13, P8; Knight JR, 2003, ALCOHOL CLIN EXP RES, V27, P67, DOI 10.1097/01.ALC.0000046598.59317.3A; Kutcher S, 2012, CURR OPIN PSYCHIATR, V25, P311, DOI 10.1097/YCO.0b013e3283543976; Lillevoll KR, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-14; Lima-Serrano M, 2014, GAC SANIT, V28, P411, DOI 10.1016/j.gaceta.2014.05.003; Merry SN, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003380.pub3; Nardi B, 2013, EUR REV MED PHARMACO, V17, P1546; O'Leary-Barrett M, 2013, J AM ACAD CHILD PSY, V52, P911, DOI 10.1016/j.jaac.2013.05.020; Perou R, 2013, MMWR SURVEILL SUM S2, V62, P1; Postel MG, 2008, TELEMED J E-HEALTH, V14, P707, DOI 10.1089/tmj.2007.0111; Puskar KR, 2010, CONTEMP NURSE, V34, P190, DOI 10.5172/conu.2010.34.2.190; Ravens-Sieberer U, 2010, QUAL LIFE RES, V19, P1487, DOI 10.1007/s11136-010-9706-5; Richardson LP, 2012, PEDIATRICS, V130, pE1541, DOI 10.1542/peds.2012-0450; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Robinson J, 2014, EARLY INTER IN PRESS; Robinson J, 2014, AUST HEALTH REV, V38, P18, DOI 10.1071/AH13058; Robinson J, 2011, AUST NZ J PSYCHIAT, V45, P3, DOI 10.3109/00048674.2010.511147; Rose K, 2014, J CONSULT CLIN PSYCH, V82, P510, DOI 10.1037/a0035827; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rudd MD, 2006, SUICIDE LIFE-THREAT, V36, P255, DOI 10.1521/suli.2006.36.3.255; Sander JB, 2005, CLIN CHILD FAM PSYCH, V8, P203, DOI 10.1007/s10567-005-6666-3; Saunders K, 2014, EMERG MED J, V31, P796, DOI 10.1136/emermed-2013-202781; Sawyer MG, 2010, J CHILD PSYCHOL PSYC, V51, P199, DOI 10.1111/j.1469-7610.2009.02136.x; Sheffield JK, 2006, J CONSULT CLIN PSYCH, V74, P66, DOI 10.1037/0022-006X.74.1.66; Shochet I, 2014, INT J ENV RES PUB HE, V11, P5541, DOI 10.3390/ijerph110505541; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Skogen JC, 2013, ADDICT BEHAV, V38, P2500, DOI 10.1016/j.addbeh.2013.05.002; Spence SH, 2005, J CONSULT CLIN PSYCH, V73, P160, DOI 10.1037/0022-006X.73.1.160; Spence SH, 2007, J CHILD PSYCHOL PSYC, V48, P526, DOI 10.1111/j.1469-7610.2007.01738.x; Spence SH, 2014, INT J ENV RES PUB HE, V11, P5113, DOI 10.3390/ijerph110505113; Spirito A, 2006, ANNU REV CLIN PSYCHO, V2, P237, DOI 10.1146/annurev.clinpsy.2.022305.095323; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steele MM, 2007, CAN J PSYCHIAT S1, V52, p5S; Strunk CM, 2014, HEALTH EDUC BEHAV, V41, P605, DOI 10.1177/1090198114531774; Sullivan B J, 1978, Diabetes Care, V1, P18, DOI 10.2337/diacare.1.1.18; Tak YR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-21; Teesson M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-32; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; van der Geest IMM, 2013, J PEDIAT HEMATOL ONC, V35, P525, DOI 10.1097/MPH.0b013e31829f2799; van Zoonen K, 2014, INT J EPIDEMIOL, V43, P318, DOI 10.1093/ije/dyt175; Wahl MS, 2014, INT J ENV RES PUB HE, V11, P5294, DOI 10.3390/ijerph110505294; Weare K, 2011, HEALTH PROMOT INT, V26, pI29, DOI 10.1093/heapro/dar075; Wei YF, 2012, CHILD ADOL PSYCH CL, V21, P11, DOI 10.1016/j.chc.2011.09.005; Wen L, 2015, CELL BIOCHEM BIOPHYS, V71, P1083, DOI 10.1007/s12013-014-0312-y; Wiefferink CH, 2006, PREV SCI, V7, P127, DOI 10.1007/s11121-005-0021-2; Wijnhoven LAMW, 2014, J ABNORM CHILD PSYCH, V42, P217, DOI 10.1007/s10802-013-9773-5; Wiklund M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-993; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	87	25	25	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125527	10.1371/journal.pone.0125527	http://dx.doi.org/10.1371/journal.pone.0125527			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25974146	Green Submitted, gold, Green Published			2022-12-27	WOS:000354545600018
J	Streja, E; Miller, JE; Wu, CS; Bech, BH; Pedersen, LH; Schendel, DE; Uldall, P; Olsen, J				Streja, Elani; Miller, Jessica E.; Wu, Chunsen; Bech, Bodil H.; Pedersen, Lars Henning; Schendel, Diana E.; Uldall, Peter; Olsen, Jorn			Disproportionate Fetal Growth and the Risk for Congenital Cerebral Palsy in Singleton Births	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; ABDOMEN CIRCUMFERENCE RATIO; ADVERSE PERINATAL OUTCOMES; INTRAUTERINE GROWTH; PARENTAL AGE; PLACENTAL PATHOLOGY; PONDERAL INDEX; CHILDREN BORN; PRETERM BIRTH; WEIGHT	Objective To investigate the association between proportionality of fetal and placental growth measured at birth and the risk for congenital cerebral palsy (CP). Study Design We identified all live-born singletons born in Denmark between 1995 and 2003 and followed them from 1 year of age until December 31st, 2008. Information on four indices of fetal growth: ponderal index, head circumference/abdominal circumference ratio, cephalization index and birth weight/placenta weight ratio was collected. Cox proportional hazards regression models were used to estimate adjusted hazard ratios (aHR) and 95% confidence intervals (CI). All measurements were evaluated as gestational age and sex specific z-scores and in z-score percentile groups, adjusted for potential confounders, and stratified on gestational age groups (< 32, 32-36, 37-38, 39, 40, >= 41 weeks). Results We identified 503,784 singleton births, of which 983 were confirmed cases of CP. Head/abdominal circumference ratio (aHR: 1.12; 95% CI: 1.07-1.16) and cephalization index (aHR: 1.14; 95% CI: 1.11-1.16) were associated with the risk of CP irrespective of gestational age. Birth weight-placental weight ratio was also associated with CP in the entire cohort (aHR: 0.90; 95% CI: 0.83-0.97). Ponderal index had a u-shaped association with CP, where both children with low and high ponderal index were at higher risk of CP. Conclusions CP is associated with disproportions between birth weight, birth length, placental weight and head circumference suggesting pre and perinatal conditions contribute to fetal growth restriction in children with CP.	[Streja, Elani; Miller, Jessica E.; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Wu, Chunsen; Pedersen, Lars Henning; Olsen, Jorn] Aarhus Univ Hosp, Inst Clin Med, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Bech, Bodil H.; Pedersen, Lars Henning; Schendel, Diana E.; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Schendel, Diana E.] Aarhus Univ, Dept Econ & Business, Natl Ctr Register Based Res, Aarhus, Denmark; [Schendel, Diana E.] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Uldall, Peter] Southern Univ, Natl Inst Publ Hlth, Danish Cerebral Palsy Registry, Copenhagen, Denmark; [Uldall, Peter] Univ Copenhagen, Rigshosp, Dept Pediat, DK-2100 Copenhagen, Denmark	University of California System; University of California Los Angeles; Aarhus University; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Rigshospitalet; University of Copenhagen	Streja, E (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.	elani@ucla.edu	Bech, Bodil Hammer/B-9646-2016	Bech, Bodil Hammer/0000-0002-0287-3687; Miller, Jessica/0000-0002-1806-1894; Schendel, Diana/0000-0002-8588-1227	Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; Lundbeck Foundation(Lundbeckfonden)	Funding for this project was provided by the Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.	Alio AP, 2012, AM J MENS HEALTH, V6, P427, DOI 10.1177/1557988312440718; BLAIR E, 1992, EARLY HUM DEV, V28, P91, DOI 10.1016/0378-3782(92)90104-O; Bleker OP, 2006, PLACENTA, V27, P1052, DOI 10.1016/j.placenta.2006.01.001; Bollepalli S, 2010, AM J PERINAT, V27, P603, DOI 10.1055/s-0030-1249362; CAMPBELL S, 1977, BRIT J OBSTET GYNAEC, V84, P165, DOI 10.1111/j.1471-0528.1977.tb12550.x; Cheung YB, 2002, ACTA PAEDIATR, V91, P447, DOI 10.1080/080352502317371706; Collier SA, 2007, MATERN CHILD HLTH J, V11, P65, DOI 10.1007/s10995-006-0085-z; Cox P, 2009, BEST PRACT RES CL OB, V23, P751, DOI 10.1016/j.bpobgyn.2009.06.006; Dahlseng MO, 2014, DEV MED CHILD NEUROL, V56, P53, DOI 10.1111/dmcn.12293; DAVID C, 1995, ULTRASOUND OBST GYN, V5, P256, DOI 10.1046/j.1469-0705.1995.05040256.x; Dolk H, 2001, PAEDIATR PERINAT EP, V15, P359, DOI 10.1046/j.1365-3016.2001.00351.x; Fattal-Valevski A, 1999, J CHILD NEUROL, V14, P724, DOI 10.1177/088307389901401107; FLETCHER NA, 1993, J MED GENET, V30, P44, DOI 10.1136/jmg.30.1.44; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Gray PH, 1999, DEV MED CHILD NEUROL, V41, P16, DOI 10.1017/S0012162299000043; Greenland S, 2003, EPIDEMIOLOGY, V14, P300, DOI 10.1097/00001648-200305000-00009; Greenwood C, 2005, ARCH DIS CHILD-FETAL, V90, P141, DOI 10.1136/adc.2004.052860; HAREL S, 1985, BRAIN DEV-JPN, V7, P580, DOI 10.1016/S0387-7604(85)80005-X; Heinonen S, 2001, PLACENTA, V22, P399, DOI 10.1053/plac.2001.0630; Hjern A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-49; Iwayama M, 2011, PEDIATR INT, V53, P709, DOI 10.1111/j.1442-200X.2011.03331.x; Jarvis S, 2005, ARCH DIS CHILD, V90, P474, DOI 10.1136/adc.2004.052670; Jarvis S, 2006, CLIN PERINATOL, V33, P285, DOI 10.1016/j.clp.2006.03.009; Jorgensen FS, 1999, ACTA OBSTET GYNECOL, V78, P305; Kinzler WL, 2002, PAEDIATR PERINAT EP, V16, P320, DOI 10.1046/j.1365-3016.2002.00449.x; Knudsen LB, 1998, DAN MED BULL, V45, P221; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Landmann E, 2006, J MATERN-FETAL NEO M, V19, P157, DOI 10.1080/14767050600624786; Lao TT, 1999, PLACENTA, V20, P723, DOI 10.1053/plac.1999.0432; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Lin CC, 1998, OBSTET GYNECOL, V92, P1044, DOI 10.1016/S0029-7844(98)00328-7; Nardozza LMM, 2012, ARCH GYNECOL OBSTET, V286, P1, DOI 10.1007/s00404-012-2330-6; McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x; Nelson KB, 2008, CURR OPIN NEUROL, V21, P129, DOI 10.1097/WCO.0b013e3282f4958b; NELSON KB, 1985, AM J DIS CHILD, V139, P1031, DOI 10.1001/archpedi.1985.02140120077032; Nielsen LF, 2008, BJOG-INT J OBSTET GY, V115, P1518, DOI 10.1111/j.1471-0528.2008.01896.x; Nieto Anibal, 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P540; O'Callaghan ME, 2011, OBSTET GYNECOL, V118, P576, DOI 10.1097/AOG.0b013e31822ad2dc; Ozturk A, 2007, BRAIN DEV-JPN, V29, P39, DOI 10.1016/j.braindev.2006.05.011; Pedersen CB, 2006, DAN MED BULL, V53, P441; Raisanen S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-28; Ravn SH, 2010, EUR J PAEDIATR NEURO, V14, P214, DOI 10.1016/j.ejpn.2009.06.001; Redline RW, 2006, CLIN PERINATOL, V33, P503, DOI 10.1016/j.clp.2006.03.007; Salafia CM, 2008, PAEDIATR PERINAT EP, V22, P229, DOI 10.1111/j.1365-3016.2008.00935.x; SAS, 2002, SAS 9 2; Scholl T O, 1992, Ann Epidemiol, V2, P565; Sebayang SK, 2012, TROP MED INT HEALTH, V17, P938, DOI 10.1111/j.1365-3156.2012.03039.x; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Streja E, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.023; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Topp M, 1996, EARLY HUM DEV, V44, P27, DOI 10.1016/0378-3782(96)82791-5; Uldall P, 2001, DAN MED BULL, V48, P161; van Batenburg-Eddes T, 2010, PEDIATR RES, V67, P132, DOI 10.1203/PDR.0b013e3181c2dc76; WALTHER FJ, 1982, J PERINAT MED, V10, P42, DOI 10.1515/jpme.1982.10.1.42; Wen SW, 2003, PAEDIATR PERINAT EP, V17, P347, DOI 10.1046/j.1365-3016.2003.00513.x; Whitcomb BW, 2009, PAEDIATR PERINAT EP, V23, P394, DOI 10.1111/j.1365-3016.2009.01053.x; Williams MC, 1996, DEV MED CHILD NEUROL, V38, P661	58	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126743	10.1371/journal.pone.0126743	http://dx.doi.org/10.1371/journal.pone.0126743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974407	gold, Green Published			2022-12-27	WOS:000354545600080
J	Zhao, SG; Shilkrut, M; Speers, C; Liu, ML; Wilder-Romans, K; Lawrence, TS; Pierce, LJ; Feng, FY				Zhao, Shuang G.; Shilkrut, Mark; Speers, Corey; Liu, Meilan; Wilder-Romans, Kari; Lawrence, Theodore S.; Pierce, Lori J.; Feng, Felix Y.			Development and Validation of a Novel Platform-Independent Metastasis Signature in Human Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; CELL-LINES; TGF-BETA; CHEMOTHERAPY; LYMPHOCYTES; RECURRENCE; INHIBITORS; PREDICTOR; PATHWAYS; PATTERNS	Purpose The molecular drivers of metastasis in breast cancer are not well understood. Therefore, we sought to identify the biological processes underlying distant progression and define a prognostic signature for metastatic potential in breast cancer. Experimental design In vivo screening for metastases was performed using Chick Chorioallantoic Membrane assays in 21 preclinical breast cancer models. Expressed genes associated with metastatic potential were identified using high-throughput analysis. Correlations with biological function were determined using the Database for Annotation, Visualization and Integrated Discovery. Results We identified a broad range of metastatic potential that was independent of intrinsic breast cancer subtypes. 146 genes were significantly associated with metastasis progression and were linked to cancer-related biological functions, including cell migration/adhesion, Jak-STAT, TGF-beta, and Wnt signaling. These genes were used to develop a platform-independent gene expression signature (M-Sig), which was trained and subsequently validated on 5 independent cohorts totaling nearly 1800 breast cancer patients with all p-values < 0.005 and hazard ratios ranging from approximately 2.5 to 3. On multivariate analysis accounting for standard clinicopathologic prognostic variables, M-Sig remained the strongest prognostic factor for metastatic progression, with p-values < 0.001 and hazard ratios > 2 in three different cohorts. Conclusion M-Sig is strongly prognostic for metastatic progression, and may provide clinical utility in combination with treatment prediction tools to better guide patient care. In addition, the platform-independent nature of the signature makes it an excellent research tool as it can be directly applied onto existing, and future, datasets.	[Zhao, Shuang G.; Shilkrut, Mark; Speers, Corey; Liu, Meilan; Wilder-Romans, Kari; Lawrence, Theodore S.; Pierce, Lori J.; Feng, Felix Y.] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Lawrence, Theodore S.; Pierce, Lori J.; Feng, Felix Y.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Feng, Felix Y.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feng, FY (corresponding author), Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.	ffeng@med.umich.edu	Speers, Corey/J-4937-2019; zhao, shuangling/HCI-6255-2022; Shilkrut, Mark/ABA-6217-2020	Speers, Corey/0000-0002-2362-2860; 	Susan G. Komen For The Cure [N012788]	Susan G. Komen For The Cure(Susan G. Komen Breast Cancer Foundation)	This work was supported by a grant from Susan G. Komen For The Cure (grant number N012788, ww5.komen.org) for author LJP. The funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; [Anonymous], 2013, R LANG ENV STAT COMP; Asangani IA, 2013, MOL CELL, V49, P80, DOI 10.1016/j.molcel.2012.10.008; Banfield RE, 2007, IEEE T PATTERN ANAL, V29, P173, DOI 10.1109/TPAMI.2007.250609; Berman AT, 2013, CLIN BREAST CANCER, V13, P88, DOI 10.1016/j.clbc.2012.11.001; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Denkert C, 2013, J CLIN ONCOL, V31, P836, DOI 10.1200/JCO.2012.47.1698; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hanks BA, 2013, J CLIN INVEST, V123, P3925, DOI 10.1172/JCI65745; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Mook Stella, 2007, Cancer Genomics & Proteomics, V4, P147; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Prensner JR, 2014, CANCER RES, V74, P1651, DOI 10.1158/0008-5472.CAN-13-3159; PRICE JE, 1990, CANCER RES, V50, P717; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Ribatti D, 2014, EXP CELL RES; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van der Horst EH, 2004, BIOTECHNIQUES, V37, P940, DOI 10.2144/04376ST02; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zhao S, 2014, TRANSL ONCOL	46	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126631	10.1371/journal.pone.0126631	http://dx.doi.org/10.1371/journal.pone.0126631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974184	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600068
J	Dagher, RK; Chen, J; Thomas, SB				Dagher, Rada K.; Chen, Jie; Thomas, Stephen B.			Gender Differences in Mental Health Outcomes before, during, and after the Great Recession	PLOS ONE			English	Article							EXPENDITURE PANEL SURVEY; ECONOMIC RECESSION; DEPRESSION; ANXIETY; UNEMPLOYMENT; TRENDS; TIMES; MODEL; CARE	We examined gender differences in mental health outcomes during and post-recession versus pre-recession. We utilized 2005-2006, 2008-2009, and 2010-2011 data from the Medical Expenditure Panel Survey. Females had lower odds of depression diagnoses during and post-recession and better mental health during the recession, but higher odds of anxiety diagnoses post-recession. Males had lower odds of depression diagnoses and better mental health during and post-recession and lower Kessler 6 scores post-recession. We conducted stratified analyses, which confirmed that the aforementioned findings were consistent across the four different regions of the U.S., by employment status, income and health care utilization. Importantly, we found that the higher odds of anxiety diagnoses among females after the recession were mainly prominent among specific subgroups of females: those who lived in the Northeast or the Midwest, the unemployed, and those with low household income. Gender differences in mental health in association with the economic recession highlight the importance of policymakers taking these differences into consideration when designing economic and social policies to address economic downturns. Future research should examine the reasons behind the decreased depression diagnoses among both genders, and whether they signify decreased mental healthcare utilization or increased social support and more time for exercise and leisure activities.	[Dagher, Rada K.; Chen, Jie; Thomas, Stephen B.] Univ Maryland, Sch Publ Hlth, Dept Hlth Serv Adm, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Dagher, RK (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Hlth Serv Adm, College Pk, MD 20742 USA.	rdagher1@umd.edu			NIH-NIMHD P20 Research Center of Excellence on Race, Ethnicity and Health Disparities Research [5P20MD006737-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006737] Funding Source: NIH RePORTER	NIH-NIMHD P20 Research Center of Excellence on Race, Ethnicity and Health Disparities Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Dr. Stephen B. Thomas is supported by the NIH-NIMHD P20 Research Center of Excellence on Race, Ethnicity and Health Disparities Research (5P20MD006737-04, Thomas, SB, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, MED EXP PAN SURV MEP; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Bambra C., 2011, WORK WORKLESSNESS PO, DOI [10.1136/jech.2009.102103, DOI 10.1136/JECH.2009.102103]; Bambra C, 2010, J EPIDEMIOL COMMUN H, V64, P213, DOI 10.1136/jech.2009.090621; Bezruchka S, 2009, CAN MED ASSOC J, V181, P281, DOI 10.1503/cmaj.090553; BRENNER MH, 1969, J NERV MENT DIS, V148, P31, DOI 10.1097/00005053-196901000-00004; Brenner MH, 1973, MENT ILLN EC; Business Cycle Dating Committee of the National Bureau of Economic Research, 2008, DET DEC 2007 PEAK EC; CATALANO R, 1991, AM J PUBLIC HEALTH, V81, P1148, DOI 10.2105/AJPH.81.9.1148; Catalano R, 1979, MENTAL HLTH EC, P321; Cheak-Zamora NC, 2009, QUAL LIFE RES, V18, P727, DOI 10.1007/s11136-009-9483-1; Chen J, 2016, J BEHAV HEALTH SER R, V43, P187, DOI 10.1007/s11414-014-9403-1; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Cohen JW, 2009, MED CARE, V47, pS44, DOI 10.1097/MLR.0b013e3181a23e3a; Cohen SB, 1999, 5 AG HEALTHC RES QUA; Davis SJ, 2011, BROOKINGS PAP ECO AC, P1; Durkheim E., 1897, SUICIDE STUDY SOCIOL; Edmiston K., 2013, ECON REV, V98, P33; Fleishman JA, 2007, MED CARE, V45, P602, DOI 10.1097/MLR.0b013e31803bb4b0; Garcia RA, 2010, J LEGAL MED, V31, P137, DOI 10.1080/01947641003598328; Goldman-Mellor S, 2010, INT J MENT HLTH, V39, P6, DOI DOI 10.2753/IMH0020-7411390201; Greene H., 2003, ECONOMETRIC ANAL; Hacker JS, 2011, EC SECURITY GREAT RE; Katikireddi SV, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001790; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Le Cook B, 2009, HEALTH SERV RES, V44, P1603, DOI 10.1111/j.1475-6773.2009.01004.x; Levit KR, 2013, HEALTH AFFAIR, V32, P952, DOI 10.1377/hlthaff.2012.1065; Looney A, 2011, UNEMPLOYMENT EARNING; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Olfson M, 2002, JAMA-J AM MED ASSOC, V287, P203, DOI 10.1001/jama.287.2.203; Organization WH, 2016, GLOBAL STATUS REPORT; Pearlin L. I., 1999, HDB SOCIOLOGY MENTAL, P395, DOI DOI 10.1007/0-387-36223-1_19; Reeves A, 2014, BRIT J PSYCHIAT, V205, P246, DOI 10.1192/bjp.bp.114.144766; Ruhm CJ, 2005, INT J EPIDEMIOL, V34, P1206, DOI 10.1093/ije/dyi143; Ruhm CJ, 2005, J HEALTH ECON, V24, P341, DOI 10.1016/j.jhealeco.2004.09.007; Ruhm CJ, 2003, J HEALTH ECON, V22, P637, DOI 10.1016/S0167-6296(03)00041-9; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Tausig M, 1999, J HEALTH SOC BEHAV, V40, P1, DOI 10.2307/2676375; Taylor P, 2010, WOMEN MEN NEW EC MAR; Toossi M, 2012, MON LABOR REV, V135, P43; United States Department of Labor, 2009, EMPL SIT JUN 2009; Uutela A, 2010, CURR OPIN PSYCHIATR, V23, P127, DOI 10.1097/YCO.0b013e328336657d; Viinamaki H, 1996, EUR J PSYCHIAT, V10, P215; Viinamaki H, 2000, NORD J PSYCHIAT, V54, P177, DOI 10.1080/080394800750019079; Ware J. E. J., 2002, SCORE VERSION 2 SF 1	45	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124103	10.1371/journal.pone.0124103	http://dx.doi.org/10.1371/journal.pone.0124103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZP	25970634	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200027
J	King, WJ; Forsyth, DM; Coulson, G; Festa-Bianchet, M				King, Wendy J.; Forsyth, David M.; Coulson, Graeme; Festa-Bianchet, Marco			Adoption in Eastern Grey Kangaroos: A Consequence of Misdirected Care?	PLOS ONE			English	Article							MACROPUS-GIGANTEUS SHAW; HAWAIIAN MONK SEALS; FOSTERING BEHAVIOR; EVOLUTION; GROWTH; REPRODUCTION; SIZE	Adoption is rare in animals and is usually attributed to kin selection. In a 6-year study of eastern grey kangaroos (Macropus giganteus), 11 of 326 juveniles were adopted. We detected eight adoptions by observing behavioural associations and nursing between marked mothers and young and three more by analysing the relatedness of mothers and young using microsatellite DNA. Four adoptions involved reciprocal switches and three were by mothers whose own pouch young were known to subsequently disappear. Adoptive mothers were not closely related to each other or to adoptees but adoptive mothers and young associated as closely as did biological pairs, as measured by half-weight indices. Switch mothers did not associate closely. Maternal age and body condition did not influence the likelihood of adoption but females were more likely to adopt in years with high densities of females with large pouch young. Adoption did not improve juvenile survival. We conclude that adoptions in this wild population were potentially costly and likely caused by misdirected care, suggesting that eastern grey kangaroos may have poorly developed mother-offspring recognition mechanisms.	[King, Wendy J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Forsyth, David M.; Coulson, Graeme; Festa-Bianchet, Marco] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia; [Festa-Bianchet, Marco] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Queensland; University of Melbourne; University of Sherbrooke	King, WJ (corresponding author), Bishops Univ, Dept Biol, Sherbrooke, PQ, Canada.	wendy.king@uqconnect.edu	King, Wendy J./N-2728-2013; King, Wendy J/GXN-1167-2022	King, Wendy J./0000-0002-5832-0088; Forsyth, David/0000-0001-5356-9573; Festa-Bianchet, Marco/0000-0002-2352-3379	NSERC of Canada; Holsworth Wildlife Research Endowment; Senate Research Committee of Bishop's University	NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Holsworth Wildlife Research Endowment; Senate Research Committee of Bishop's University	Funding was received from NSERC of Canada, the Holsworth Wildlife Research Endowment and the Senate Research Committee of Bishop's University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Banks PB, 2000, AUSTRAL ECOL, V25, P283, DOI 10.1046/j.1442-9993.2000.01039.x; Best EC, 2014, ANIM BEHAV, V89, P1, DOI 10.1016/j.anbehav.2013.12.011; BONESS DJ, 1990, BEHAV ECOL SOCIOBIOL, V27, P113, DOI 10.1007/BF00168454; Boness DJ, 1998, J MAMMAL, V79, P1060, DOI 10.2307/1383115; Crawley MJ., 2007, STAT PAP, V2, DOI [10.1002/9780470515075, DOI 10.1002/9780470515075]; Deane E.M., 1988, P190; Eymann Jutta, 2007, Australian Mammalogy, V29, P63; Gelin U, 2015, J ANIM ECOL, V84, P239, DOI 10.1111/1365-2656.12266; Gelin U, 2013, ANIM BEHAV, V86, P885, DOI 10.1016/j.anbehav.2013.08.016; Glass R, 2013, THESIS U MELBOURNE; Gorrell JC, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1022; Green B., 1988, P41; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; INNS RW, 1980, SEARCH, V11, P118; JARMAN PJ, 1987, ANIM BEHAV, V35, P1044, DOI 10.1016/S0003-3472(87)80161-6; JARMAN PJ, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P527; King W. J., 2011, Australian Mammalogy, V33, P47, DOI 10.1071/AM10029; King WJ, ECOL EVOL IN PRESS; KONIG B, 1994, ANIM BEHAV, V48, P1449, DOI 10.1006/anbe.1994.1381; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; MacLeod KJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0378; MCCRACKEN GF, 1991, ETHOLOGY, V89, P305; Menzies BR, 2007, REPROD FERT DEVELOP, V19, P976, DOI 10.1071/RD07142; MERCHANT J. C., 1966, AUSTRALIAN J ZOOL, V14, P593, DOI 10.1071/ZO9660593; PEARSE RJ, 1981, AUST WILDLIFE RES, V8, P229; POOLE WE, 1982, AUST WILDLIFE RES, V9, P9; POOLE WE, 1975, AUST J ZOOL, V23, P333, DOI 10.1071/ZO9750333; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; QUIN DG, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P787; R Development Core Team, 2012, R LANG ENV STAT COMP; RIEDMAN ML, 1982, BEHAV ECOL SOCIOBIOL, V11, P203, DOI 10.1007/BF00300063; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Roulin A, 2002, ANIM BEHAV, V63, P201, DOI 10.1006/anbe.2001.1895; Roulin A, 1999, ECOL LETT, V2, P319, DOI 10.1046/j.1461-0248.1999.00091.x; RUSSELL EM, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P549; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Taggart DA, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P263; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Oorschot RAH, 1988, AUST MAMMAL, V12, P83; Whitehead H, 2008, ANAL ANIMAL SOC QUAN; Zenger KR, 2001, MOL ECOL NOTES, V1, P98, DOI 10.1046/j.1471-8278.2001.00044.x; Zenger KR, 2001, ANIM GENET, V32, P166, DOI 10.1046/j.1365-2052.2001.0723d.x	45	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125182	10.1371/journal.pone.0125182	http://dx.doi.org/10.1371/journal.pone.0125182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970624	Green Published, gold			2022-12-27	WOS:000354544200067
J	Lee, J; Moir, RD; Willis, IM				Lee, Jaehoon; Moir, Robyn D.; Willis, Ian M.			Differential Phosphorylation of RNA Polymerase III and the Initiation Factor TFIIIB in Saccharomyces cerevisiae	PLOS ONE			English	Article							CASEIN KINASE-II; TRANSCRIPTION FACTOR-IIIB; TATA-BINDING PROTEIN; IN-VITRO; GENE-TRANSCRIPTION; HUMAN-CELLS; MAF1; REPRESSION; YEAST; COMPLEX	The production of ribosomes and tRNAs for protein synthesis has a high energetic cost and is under tight transcriptional control to ensure that the level of RNA synthesis is balanced with nutrient availability and the prevailing environmental conditions. In the RNA polymerase (pol) III system in yeast, nutrients and stress affect transcription through a bifurcated signaling pathway in which protein kinase A (PKA) and TORC1 activity directly or indirectly, through downstream kinases, alter the phosphorylation state and function of the Maf1 repressor and Rpc53, a TFIIF-like subunit of the polymerase. However, numerous lines of evidence suggest greater complexity in the regulatory network including the phosphoregulation of other pol III components. To address this issue, we systematically examined all 17 subunits of pol III along with the three subunits of the initiation factor TFIIIB for evidence of differential phosphorylation in response to inhibition of TORC1. A relatively high stoichiometry of phosphorylation was observed for several of these proteins and the Rpc82 subunit of the polymerase and the Bdp1 subunit of TFIIIB were found to be differentially phosphorylated. Bdp1 is phosphorylated on four major sites during exponential growth and the protein is variably dephosphorylated under conditions that inhibit tRNA gene transcription. PKA, the TORC1-regulated kinase Sch9 and protein kinase CK2 are all implicated in the phosphorylation of Bdp1. Alanine substitutions at the four phosphosites cause hyper-repression of transcription indicating that phosphorylation of Bdp1 opposes Maf1-mediated repression. The new findings suggest an integrated regulatory model for signaling events controlling pol III transcription.	[Lee, Jaehoon; Moir, Robyn D.; Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Moir, RD (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	robyn.moir@einstein.yu.edu; ian.willis@einstein.yu.edu		Willis, Ian/0000-0001-6599-2395	National Institutes of Health Grant [GM085177]; Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085177] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health Grant GM085177 to IMW and funds from the Albert Einstein College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athineos D, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-21; Bachman N, 2005, GENE DEV, V19, P955, DOI 10.1101/gad.1299105; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Cabart P, 2008, J BIOL CHEM, V283, P36108, DOI 10.1074/jbc.M807538200; Chedin S, 1998, COLD SPRING HARB SYM, V63, P381, DOI 10.1101/sqb.1998.63.381; Cloutier TE, 2001, P NATL ACAD SCI USA, V98, P9581, DOI 10.1073/pnas.161292298; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P331, DOI 10.1016/j.bbagrm.2012.10.009; Fairley JA, 2003, EMBO J, V22, P5841, DOI 10.1093/emboj/cdg544; Fairley JA, 2012, MOL CELL, V45, P541, DOI 10.1016/j.molcel.2011.11.030; Felton-Edkins ZA, 2003, EMBO J, V22, P2422, DOI 10.1093/emboj/cdg240; Gerber J, 2008, NUCLEIC ACIDS RES, V36, P793, DOI 10.1093/nar/gkm1093; Ghavidel A, 2001, CELL, V106, P575, DOI 10.1016/S0092-8674(01)00473-1; Ghavidel A, 1997, GENE DEV, V11, P2780, DOI 10.1101/gad.11.21.2780; Gjidoda A, 2013, BBA-GENE REGUL MECH, V1829, P385, DOI 10.1016/j.bbagrm.2012.09.011; Graczyk D, 2011, P NATL ACAD SCI USA, V108, P4926, DOI 10.1073/pnas.1010010108; Hockman DJ, 1996, MOL CELL BIOL, V16, P892; Hu P, 2004, MOL CELL, V16, P81, DOI 10.1016/j.molcel.2004.09.008; Hu P, 2003, MOL CELL, V12, P699, DOI 10.1016/j.molcel.2003.08.011; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; HUIBREGTSE JM, 1989, MOL CELL BIOL, V9, P3244, DOI 10.1128/MCB.9.8.3244; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnston IM, 2002, MOL CELL BIOL, V22, P3757, DOI 10.1128/MCB.22.11.3757-3768.2002; Kim HS, 2014, CELL REP, V6, P892, DOI 10.1016/j.celrep.2014.01.029; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Kumar Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-402; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Lee J, 2012, MOL CELL, V45, P836, DOI 10.1016/j.molcel.2012.01.018; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Li Y, 2000, MOL CELL BIOL, V20, P3843, DOI 10.1128/MCB.20.11.3843-3851.2000; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Milliman EJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-728; Moir RD, 2004, ADV PROTEIN CHEM, V67, P93; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Moir RD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002890; Moir RD, 2012, J BIOL CHEM, V287, P30833, DOI 10.1074/jbc.M112.378828; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Sanchez-Casalongue ME, 2015, J BIOL CHEM, V290, P7221, DOI 10.1074/jbc.M114.626523; SETHY I, 1995, J BIOL CHEM, V270, P28463; Sethy-Coraci I, 1998, NUCLEIC ACIDS RES, V26, P2344, DOI 10.1093/nar/26.10.2344; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Stark C, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap026; Tavenet A, 2009, P NATL ACAD SCI USA, V106, P14265, DOI 10.1073/pnas.0900162106; Towpik J, 2008, J BIOL CHEM, V283, P17168, DOI 10.1074/jbc.M709157200; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; Wei YH, 2009, CELL CYCLE, V8, P4085, DOI 10.4161/cc.8.24.10170; WERNER M, 1993, J BIOL CHEM, V268, P20721; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Willis IM, 2012, CELL CYCLE, V11, P2769, DOI 10.4161/cc.21257; Woiwode A, 2008, MOL CELL BIOL, V28, P4204, DOI 10.1128/MCB.01912-07; Wu CC, 2012, P NATL ACAD SCI USA, V109, P19232, DOI 10.1073/pnas.1211665109; Zhang QS, 2013, CARCINOGENESIS, V34, P28, DOI 10.1093/carcin/bgs316; Zhong SP, 2009, P NATL ACAD SCI USA, V106, P12682, DOI 10.1073/pnas.0904843106	67	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127225	10.1371/journal.pone.0127225	http://dx.doi.org/10.1371/journal.pone.0127225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970584	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200155
J	Ehrlich, LE; Feig, JSG; Schiffres, SN; Malen, JA; Rabin, Y				Ehrlich, Lili E.; Feig, Justin S. G.; Schiffres, Scott N.; Malen, Jonathan A.; Rabin, Yoed			Large Thermal Conductivity Differences between the Crystalline and Vitrified States of DMSO with Applications to Cryopreservation	PLOS ONE			English	Article							VITRIFICATION; STRESS; GLYCOL; ICE	Thermal conductivity of dimethyl-sulfoxide (DMSO) solution is measured in this study using a transient hot wire technique, where DMSO is a key ingredient in many cryoprotective agent (CPA) cocktails. Characterization of thermal properties of cryoprotective agents is essential to the analysis of cryopreservation processes, either when evaluating experimental data or for the design of new protocols. Also presented are reference measurements of thermal conductivity for pure water ice and glycerol. The thermal conductivity measurement setup is integrated into the experimentation stage of a scanning cryomacroscope apparatus, which facilitates the correlation of measured data with visualization of physical events. Thermal conductivity measurements were conducted for a DMSO concentration range of 2M and 10M, in a temperature range of -180 degrees C and 25 degrees C. Vitrified samples showed decreased thermal conductivity with decreasing temperature, while crystalline samples showed increased thermal conductivity with decreasing temperature. These different behaviors result in up to a tenfold difference in thermal conductivity at -180 degrees C. Such dramatic differences can drastically impact heat transfer during cryopreservation and their quantification is therefore critical to cryobiology.	[Ehrlich, Lili E.; Feig, Justin S. G.; Schiffres, Scott N.; Malen, Jonathan A.; Rabin, Yoed] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Rabin, Y (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	rabin@cmu.edu	Malen, Jonathan/D-5954-2013	Malen, Jonathan/0000-0003-4560-4476; Schiffres, Scott/0000-0003-1847-7715	National Center for Research Resources (NCRR) [R21RR026210]; National Institute of General Medical Sciences (NIGMS) [R21GM103407]; NSF CAREER Award [ENG-1149374]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR026210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM103407] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been supported in part by Award Number R21RR026210 from the National Center for Research Resources (NCRR), and Award Number R21GM103407 from the National Institute of General Medical Sciences (NIGMS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Jonathan Malen acknowledges support from the NSF CAREER Award (ENG-1149374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINABHAVI TM, 1995, J CHEM ENG DATA, V40, P856, DOI 10.1021/je00020a026; [Anonymous], [No title captured]; Baudot A, 2000, CRYOBIOLOGY, V40, P151, DOI 10.1006/cryo.2000.2234; BIRGE NO, 1986, PHYS REV B, V34, P1631, DOI 10.1103/PhysRevB.34.1631; CAHILL DG, 1987, PHYS REV B, V35, P4067, DOI 10.1103/PhysRevB.35.4067; CAHILL DG, 1989, SOLID STATE COMMUN, V70, P927, DOI 10.1016/0038-1098(89)90630-3; Choi J, 2010, CRYOBIOLOGY, V60, P52, DOI 10.1016/j.cryobiol.2009.11.004; Devireddy RV, 2002, J HEAT TRANS-T ASME, V124, P365, DOI 10.1115/1.1445134; Eisenberg DP, 2014, CRYOGENICS, V64, P86, DOI 10.1016/j.cryogenics.2014.09.005; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; FAHY GM, 1986, CRYOBIOLOGY, V23, P1, DOI 10.1016/0011-2240(86)90013-1; Feig JSG, 2014, CRYOGENICS, V62, P118, DOI 10.1016/j.cryogenics.2014.04.017; FUKUSAKO S, 1990, INT J THERMOPHYS, V11, P353, DOI 10.1007/BF01133567; Hammerschmidt U, 2000, INT J THERMOPHYS, V21, P1255, DOI 10.1023/A:1006649209044; HEALY JJ, 1976, PHYSICA B & C, V82, P392, DOI 10.1016/0378-4363(76)90203-5; Hopkins JB, 2012, CRYOBIOLOGY, V65, P169, DOI 10.1016/j.cryobiol.2012.05.010; Incropera F.P., 2006, FUNDAMENTALS HEAT MA; MACGREGO.WS, 1967, ANN NY ACAD SCI, V141, P3, DOI 10.1111/j.1749-6632.1967.tb34860.x; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; MERYMAN HT, 1971, CRYOBIOLOGY, V8, P173, DOI 10.1016/0011-2240(71)90024-1; NAGASAKA Y, 1981, J PHYS E SCI INSTRUM, V14, P1435, DOI 10.1088/0022-3735/14/12/020; Plitz J., 2004, CELL PRESERV TECHNOL, V2, P215, DOI [10.1089/cpt.2004.2.215, DOI 10.1089/CPT.2004.2.215]; Rabin Y, 2000, CRYO-LETT, V21, P163; RASMUSSEN DH, 1968, NATURE, V220, P1315, DOI 10.1038/2201315a0; Rios JLJ, 2006, CRYOBIOLOGY, V52, P284, DOI 10.1016/j.cryobiol.2005.12.006; Sakazume S., 1978, B JSME, V44, P2059; Steif PS, 2007, CELL PRESERV TECHNOL, V5, P104, DOI 10.1089/cpt.2007.9994; Taylor MJ, 2004, VITRIFICATION TISSUE, P603; Wang JF, 2006, INT J HEAT MASS TRAN, V49, P3075, DOI 10.1016/j.ijheatmasstransfer.2006.02.007	29	20	20	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125862	10.1371/journal.pone.0125862	http://dx.doi.org/10.1371/journal.pone.0125862			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985058	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300027
J	Kambiz, S; van Neck, JW; Cosgun, SG; van Velzen, MHN; Janssen, JAMJL; Avazverdi, N; Hovius, SER; Walbeehm, ET				Kambiz, Shoista; van Neck, Johan W.; Cosgun, Saniye G.; van Velzen, Marit H. N.; Janssen, Joop A. M. J. L.; Avazverdi, Naim; Hovius, Steven E. R.; Walbeehm, Erik T.			An Early Diagnostic Tool for Diabetic Peripheral Neuropathy in Rats	PLOS ONE			English	Article							SKIN BLOOD-FLOW; INFRARED THERMOGRAPHY; EPIDERMAL THICKNESS; NERVE INJURY; STREPTOZOTOCIN; MELLITUS; GLUCOSE; PAIN; FOOT; MICROCIRCULATION	The skin's rewarming rate of diabetic patients is used as a diagnostic tool for early diagnosis of diabetic neuropathy. At present, the relationship between microvascular changes in the skin and diabetic neuropathy is unclear in streptozotocin (STZ) diabetic rats. The aim of this study was to investigate whether the skin rewarming rate in diabetic rats is related to microvascular changes and whether this is accompanied by changes observed in classical diagnostic methods for diabetic peripheral neuropathy. Computer-assisted infrared thermography was used to assess the rewarming rate after cold exposure on the plantar skin of STZ diabetic rats' hind paws. Peripheral neuropathy was determined by the density of intra-epidermal nerve fibers (IENFs), mechanical sensitivity, and electrophysiological recordings. Data were obtained in diabetic rats at four, six, and eight weeks after the induction of diabetes and in controls. Four weeks after the induction of diabetes, a delayed rewarming rate, decreased skin blood flow and decreased density of IENFs were observed. However, the mechanical hyposensitivity and decreased motor nerve conduction velocity (MNCV) developed 6 and 8 weeks after the induction of diabetes. Our study shows that the skin rewarming rate is related to microvascular changes in diabetic rats. Moreover, the skin rewarming rate is a non-invasive method that provides more information for an earlier diagnosis of peripheral neuropathy than the classical monofilament test and MNCV in STZ induced diabetic rats.	[Kambiz, Shoista; van Neck, Johan W.; Cosgun, Saniye G.; Avazverdi, Naim; Hovius, Steven E. R.; Walbeehm, Erik T.] Erasmus Univ, Med Ctr, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands; [Kambiz, Shoista; Cosgun, Saniye G.] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands; [van Velzen, Marit H. N.] Erasmus Univ, Med Ctr, Lab Expt Anesthesiol, Dept Anesthesiol, Rotterdam, Netherlands; [Janssen, Joop A. M. J. L.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Kambiz, S (corresponding author), Erasmus Univ, Med Ctr, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands.	s.kambiz@erasmusmc.nl	Janssen, Joseph A.M.J.L./AAU-5133-2021	Janssen, Joseph A.M.J.L./0000-0002-9363-6408	Nuts Ohra [1201-054]	Nuts Ohra	This work was supported by Nuts Ohra: 1201-054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DG, 1997, PHYS THER, V77, P169, DOI 10.1093/ptj/77.2.169; Balbinot LF, 2012, CLINICS, V67, P1419, DOI 10.6061/clinics/2012(12)12; Barriga ES, 2012, IEEE ENG MED BIO, P1486, DOI 10.1109/EMBC.2012.6346222; Beckert S, 2004, DIABETES CARE, V27, P2863, DOI 10.2337/diacare.27.12.2863; Chao CYL, 2012, DIABETES TECHNOL THE, V14, P602, DOI 10.1089/dia.2011.0301; Coppey L J, 2000, Int J Exp Diabetes Res, V1, P131, DOI 10.1155/EDR.2000.131; DITZEL J, 1975, ACTA MED SCAND, P49; Duraku LS, 2013, EXP NEUROL, V241, P13, DOI 10.1016/j.expneurol.2012.11.029; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; Gargiulo S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-255; Gong CY, 2013, INT J OPHTHALMOL-CHI, V6, P573, DOI 10.3980/j.issn.2222-3959.2013.05.03; Gonzalez de Zarate J, 2000, REV ESP ANESTESIOL R, V47, P287; Hasegawa O, 1999, No To Shinkei, V51, P863; Holiner I, 2013, PEDIATR NEUROL, V49, P171, DOI 10.1016/j.pediatrneurol.2013.03.014; Huang IT, 1999, NEUROSCIENCE, V94, P965, DOI 10.1016/S0306-4522(99)00210-9; Jasmin L, 1998, PAIN, V75, P367, DOI 10.1016/S0304-3959(98)00017-7; Jin HY, 2012, EXP CLIN ENDOCR DIAB, V120, P451, DOI 10.1055/s-0032-1306350; Kambiz S, 2014, J NEUROSURG IN PRESS; Kambiz S, 2013, J PLAST RECONSTR AES; KLEEMANN R, 1993, FEBS LETT, V328, P9, DOI 10.1016/0014-5793(93)80954-S; KUHLMANN WD, 1986, HISTOCHEMISTRY, V85, P13, DOI 10.1007/BF00508648; Liu Ming-sheng, 2005, Zhonghua Nei Ke Za Zhi, V44, P173; Marangoni MN, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-11; Mazilu Georgiana, 2011, Rev Med Chir Soc Med Nat Iasi, V115, P1007; Mori Taketoshi, 2013, J Diabetes Sci Technol, V7, P1102; Muhammed SJ, 2012, DIABETES OBES METAB, V14, P1010, DOI 10.1111/j.1463-1326.2012.01632.x; Narayanaswamy H, 2012, J CLIN NEUROSCI, V19, P1490, DOI 10.1016/j.jocn.2011.12.026; Oltman CL, 2011, EUR J PHARMACOL, V650, P556, DOI 10.1016/j.ejphar.2010.10.047; Peleshok JC, 2011, J COMP NEUROL, V519, P49, DOI 10.1002/cne.22500; Pisarev VB, 2009, B EXP BIOL MED+, V148, P937, DOI 10.1007/s10517-010-0856-9; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; RENDELL MS, 1993, DIABETOLOGIA, V36, P907, DOI 10.1007/BF02374471; Rondi S, 2014, J ADV PHARM TECHNOL, V5, P78, DOI 10.4103/2231-4040.133429; Rotter R, 2012, J TRAUMA ACUTE CARE, V73, P73, DOI 10.1097/TA.0b013e31824afddd; SEYERHANSEN K, 1976, CLIN SCI MOL MED, V51, P551, DOI 10.1042/cs0510551; Sivanandam S, 2013, MOL CELL ENDOCRINOL, V367, P57, DOI 10.1016/j.mce.2012.12.017; Smits ES, 2013, J PLAST RECONSTR AES, V66, P1279, DOI 10.1016/j.bjps.2013.04.004; Tong M, 2012, DIABETES, V61, P2633, DOI 10.2337/db11-1329; Tuncer S, 2011, MUSCLE NERVE, V43, P237, DOI 10.1002/mus.21837; Verdu E, 1997, EXP NEUROL, V146, P187, DOI 10.1006/exnr.1997.6517; WEISS RB, 1982, CANCER TREAT REP, V66, P427; Werdin F, 2009, J NEUROSCI METH, V182, P71, DOI 10.1016/j.jneumeth.2009.05.017; Zhang J, 2013, J PHYSIOL-LONDON, V591, P1097, DOI 10.1113/jphysiol.2012.242115; Zotter H, 2003, J PEDIATR ENDOCR MET, V16, P1257; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	45	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126892	10.1371/journal.pone.0126892	http://dx.doi.org/10.1371/journal.pone.0126892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984949	Green Published, gold			2022-12-27	WOS:000354917300060
J	Taylor, KS; Heneghan, CJ; Stevens, RJ; Adams, EC; Nunan, D; Ward, A				Taylor, Kathryn S.; Heneghan, Carl J.; Stevens, Richard J.; Adams, Emily C.; Nunan, David; Ward, Alison			Heterogeneity of Prognostic Studies of 24-Hour Blood Pressure Variability: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CLINICAL-VALUE; HOME; REPRODUCIBILITY; HYPERTENSION; PATTERNS; DISEASE; AWAKE; SURGE	In addition to mean blood pressure, blood pressure variability is hypothesized to have important prognostic value in evaluating cardiovascular risk. We aimed to assess the prognostic value of blood pressure variability within 24 hours. Using MEDLINE, EMBASE and Cochrane Library to April 2013, we conducted a systematic review of prospective studies of adults, with at least one year follow-up and any day, night or 24-hour blood pressure variability measure as a predictor of one or more of the following outcomes: all-cause mortality, cardiovascular mortality, all cardiovascular events, stroke and coronary heart disease. We examined how blood pressure variability is defined and how its prognostic use is reported. We analysed relative risks adjusted for covariates including the appropriate mean blood pressure and considered the potential for meta-analysis. Our analysis of methods included 24 studies and analysis of predictions included 16 studies. There were 36 different measures of blood pressure variability and 13 definitions of night-and day-time periods. Median follow-up was 5.5 years (interquartile range 4.2-7.0). Comparing measures of dispersion, coefficient of variation was less well researched than standard deviation. Night dipping based on percentage change was the most researched measure and the only measure for which data could be meaningfully pooled. Night dipping or lower night-time blood pressure was associated with lower risk of cardiovascular events. The interpretation and use in clinical practice of 24-hour blood pressure variability, as an important prognostic indicator of cardiovascular events, is hampered by insufficient evidence and divergent methodologies. We recommend greater standardisation of methods.	[Taylor, Kathryn S.; Heneghan, Carl J.; Stevens, Richard J.; Nunan, David; Ward, Alison] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Adams, Emily C.] Univ Oxford, Hosp Trust, Oxford, England	University of Oxford; University of Oxford	Taylor, KS (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	kathryn.taylor@phc.ox.ac.uk	Taylor, Kathryn/ABG-1422-2020	Stevens, Richard/0000-0002-9258-4060	National Institute for Health Research (NIHR) [RP-PG-0407-10347]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This project presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10347). The views expressed in this paper are those of the authors and not necessarily of the NHS, the NIHR or the Department of Health.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Asayama K, 2014, CLIN EXP PHARMACOL P, V41, P1, DOI 10.1111/1440-1681.12091; Fagard R, 1996, J HYPERTENS, V14, P557, DOI 10.1097/00004872-199605000-00003; FAGARD R, 1995, J HYPERTENS, V13, P823, DOI 10.1097/00004872-199508000-00002; Franklin SS, 1997, CIRCULATION, V96, P308; Grove JS, 1997, AM J EPIDEMIOL, V145, P771, DOI 10.1093/oxfordjournals.aje.a009169; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; Heneghan C, 2006, EVIDENCE BASED MEDIC; KANNEL WB, 1980, CIRCULATION, V61, P1183, DOI 10.1161/01.CIR.61.6.1183; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Krakoff LR, 2014, HYPERTENSION, V63, P670, DOI 10.1161/HYPERTENSIONAHA.113.02886; Kukla C, 1998, ARCH NEUROL-CHICAGO, V55, P683, DOI 10.1001/archneur.55.5.683; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; Mancia G, 2012, HYPERTENSION, V60, P512, DOI 10.1161/HYPERTENSIONAHA.112.194340; Manios E, 2011, J HYPERTENS, V29, P1109, DOI 10.1097/HJH.0b013e3283454ff4; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; Mochizuki Y, 1998, AM J HYPERTENS, V11, P403, DOI 10.1016/S0895-7061(97)00497-4; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; National Institute for Clinical Excellence, 2011, HYPERTENSION CLINICA; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Omboni S, 1998, J HYPERTENS, V16, P733, DOI 10.1097/00004872-199816060-00003; Parati G, 2003, BLOOD PRESS MONIT, V8, P31, DOI 10.1097/00126097-200302000-00007; Parati G, 2008, AM J HYPERTENS, V21, P123, DOI 10.1038/ajh.2007.27; PEIXOTO AJ, 1995, AM J HYPERTENS, V8, P676, DOI 10.1016/0895-7061(95)00211-7; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Sega R, 1998, J HYPERTENS, V16, P1585, DOI 10.1097/00004872-199816110-00004; Stergiou GS, 2008, HYPERTENS RES, V31, P1589, DOI 10.1291/hypres.31.1589; Stergiou GS, 2011, HYPERTENSION, V57, P1041, DOI 10.1161/HYPERTENSIONAHA.111.172924; The Cochrane Collaboration, COCHRANE HANDBOOK FO; VANITTERSUM FJ, 1995, J HYPERTENS, V13, P1053, DOI 10.1097/00004872-199509000-00017; Ward AM, 2012, J HYPERTENS, V30, P449, DOI 10.1097/HJH.0b013e32834e4aed; Wetzler Marie-Laure, 2003, Blood Press Monit, V8, P229, DOI 10.1097/00126097-200312000-00002; Wong SSL, 2006, J MED LIBR ASSOC, V94, P41	41	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126375	10.1371/journal.pone.0126375	http://dx.doi.org/10.1371/journal.pone.0126375			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984791	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300038
J	Ahmed, AM; Good, B; Hanrahan, JP; McGettigan, P; Browne, J; Keane, OM; Bahar, B; Mehta, J; Markey, B; Lohan, A; Sweeney, T				Ahmed, Albin M.; Good, Barbara; Hanrahan, James P.; McGettigan, Paul; Browne, John; Keane, Orla M.; Bahar, Bojlul; Mehta, Jai; Markey, Bryan; Lohan, Amanda; Sweeney, Torres			Variation in the Ovine Abomasal Lymph Node Transcriptome between Breeds Known to Differ in Resistance to the Gastrointestinal Nematode	PLOS ONE			English	Article							FECAL EGG COUNTS; GENE-EXPRESSION; RIG-I; MULTIPLE-SCLEROSIS; SHEEP; RNA; RECOGNITION; PROTEIN; ALLELE; POPULATION	Texel lambs are known to be more resistant to gastrointestinal nematode (GIN) infection than Suffolk lambs, with a greater ability to limit infection. The objectives of this study were to: 1) profile the whole transcriptome of abomasal lymph node tissue of GIN-free Texel and Suffolk lambs; 2) identify differentially expressed genes and characterize the immune-related biological pathways and networks associated with these genes. Abomasal lymph nodes were collected from Texel (n = 6) and Suffolk (n = 4) lambs aged 19 weeks that had been GIN-free since 6 weeks of age. Whole transcriptome profiling was performed using RNAseq on the Illumina platform. At the time of conducting this study, a well annotated Ovine genome was not available and hence the sequence reads were aligned with the Bovine (UMD3.1) genome. Identification of differentially expressed genes was followed by pathway and network analysis. The Suffolk breed accounted for significantly more of the differentially expressed genes, (276 more highly expressed in Suffolk v 162 in Texel; P < 0.001). The four most significant differentially expressed pathways were all related to immunity and were classified as: Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Activation of IRF by Cytosolic Pattern Recognition Receptors, Role of RIG-I-like Receptors in Antiviral Innate Immunity, and Interferon Signaling. Of significance is the fact that all of these four pathways were more highly expressed in the Suffolk. These data suggest that in a GIN-free environment, Suffolk lambs have a more active immune profile relative to the Texel: this immune profile may contribute to the poorer efficiency of response to a GIN challenge in the Suffolk breed compared to the Texel breed.	[Ahmed, Albin M.; McGettigan, Paul; Browne, John; Bahar, Bojlul; Markey, Bryan; Sweeney, Torres] Univ Coll Dublin, Vet Sci Ctr, Sch Vet Med, Dublin 4, Ireland; [Ahmed, Albin M.; Good, Barbara; Hanrahan, James P.] Teagasc Anim & Grassland Res & Innovat Ctr, Athenry, Co Galway, Ireland; [Keane, Orla M.] Teagasc Anim & Grassland Res & Innovat Ctr, Grange, Co Meath, Ireland; [Mehta, Jai; Lohan, Amanda] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland	University College Dublin; Teagasc; Teagasc; University College Dublin	Sweeney, T (corresponding author), Univ Coll Dublin, Vet Sci Ctr, Sch Vet Med, Dublin 4, Ireland.	torres.sweeney@ucd.ie	KEANE, ORLA/AAQ-1148-2021	Sweeney, Torres/0000-0003-2639-395X; Keane, Orla/0000-0002-9507-2191	Teagasc Walsh Fellowship	Teagasc Walsh Fellowship	This research has been funded by a Teagasc Walsh Fellowship (www.teagasc.ie). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2015, VET RES, V46, DOI 10.1186/s13567-014-0137-0; Amarante AFT, 2004, VET PARASITOL, V120, P91, DOI 10.1016/j.vetpar.2003.12.004; [Anonymous], QUALITY CONTROL TOOL; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Baruah P, 2009, BLOOD, V113, P3485, DOI 10.1182/blood-2008-06-164392; Biacchesi S, 2009, J VIROL, V83, P7815, DOI 10.1128/JVI.00404-09; Buitkamp J, 1996, PARASITOL RES, V82, P693, DOI 10.1007/s004360050187; Cagliani R, 2012, HUM GENET, V131, P87, DOI 10.1007/s00439-011-1053-2; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Coltman DW, 2001, PARASITOLOGY, V122, P571, DOI 10.1017/S0031182001007570; CRAWFORD AM, 1998, Patent No. 330201; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Good B, 2006, VET PARASITOL, V136, P317, DOI 10.1016/j.vetpar.2005.12.001; Hassan M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-46; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hollmig ST, 2009, GLYCOBIOLOGY, V19, P568, DOI 10.1093/glycob/cwp032; Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawamoto S, 2004, J CLIN INVEST, V114, P399, DOI 10.1172/jci200419082; Keane OM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-42; Keane OM, 2007, PHYSIOL GENOMICS, V30, P253, DOI 10.1152/physiolgenomics.00273.2006; Kraus TA, 2003, J BIOL CHEM, V278, P13033, DOI 10.1074/jbc.M212972200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mugambi JM, 1997, VET PARASITOL, V69, P265, DOI 10.1016/S0304-4017(96)01128-4; O'Brien M, 2010, NEUROLOGY, V75, P411, DOI 10.1212/WNL.0b013e3181ebdd2b; Pemberton JM, 2011, MOL ECOL, V20, P910, DOI 10.1111/j.1365-294X.2010.04992.x; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rios JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010537; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Sayers G, 2008, PARASITOLOGY, V135, P71, DOI 10.1017/S0031182007003630; Sayers G., 2005, Animal Health Research Reviews, V6, P159, DOI 10.1079/AHR2005108; Scherer CA, 2009, EP Patent, Patent No. [2,083,089, 2083089]; SCHWAIGER FW, 1995, INT J PARASITOL, V25, P815, DOI 10.1016/0020-7519(94)00216-B; Spencer TE, 2012, ANIM REPROD SCI, V134, P95, DOI 10.1016/j.anireprosci.2012.08.016; Stear MJ, 1996, INT J PARASITOL, V26, P423, DOI 10.1016/0020-7519(96)00002-1; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tryland M, 2012, VETERINARY MICROBIOL; Uematsu S, 2006, EXPERT OPIN BIOL TH, V6, P203, DOI 10.1517/14712598.6.3.203; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366	45	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124823	10.1371/journal.pone.0124823	http://dx.doi.org/10.1371/journal.pone.0124823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978040	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000354916100019
J	Rodriguez, MC; Loaces, I; Amarelle, V; Senatore, D; Iriarte, A; Fabiano, E; Noya, F				Cecilia Rodriguez, Maria; Loaces, Ines; Amarelle, Vanesa; Senatore, Daniella; Iriarte, Andres; Fabiano, Elena; Noya, Francisco			Est10: A Novel Alkaline Esterase Isolated from Bovine Rumen Belonging to the New Family XV of Lipolytic Enzymes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; METAGENOMIC LIBRARY; CRYSTAL-STRUCTURE; GASTRIC LIPASE; SWISS-MODEL; CLASSIFICATION; IDENTIFICATION; DIVERSITY; ACCURACY; SEDIMENT	A metagenomic fosmid library from bovine rumen was used to identify clones with lipolytic activity. One positive clone was isolated. The gene responsible for the observed phenotype was identified by in vitro transposon mutagenesis and sequencing and was named est10. The 367 amino acids sequence harbors a signal peptide, the conserved secondary structure arrangement of alpha/beta hydrolases, and a GHSQG pentapeptide which is characteristic of esterases and lipases. Homology based 3D-modelling confirmed the conserved spatial orientation of the serine in a nucleophilic elbow. By sequence comparison, Est10 is related to hydrolases that are grouped into the non-specific Pfam family DUF3089 and to other characterized esterases that were recently classified into the new family XV of lipolytic enzymes. Est10 was heterologously expressed in Escherichia coli as a His-tagged fusion protein, purified and biochemically characterized. Est10 showed maximum activity towards C4 aliphatic chains and undetectable activity towards C10 and longer chains which prompted its classification as an esterase. However, it was able to efficiently catalyze the hydrolysis of aryl esters such as methyl phenylacetate and phenyl acetate. The optimum pH of this enzyme is 9.0, which is uncommon for esterases, and it exhibits an optimal temperature at 40 degrees C. The activity of Est10 was inhibited by metal ions, detergents, chelating agents and additives. We have characterized an alkaline esterase produced by a still unidentified bacterium belonging to a recently proposed new family of esterases.	[Cecilia Rodriguez, Maria; Loaces, Ines; Amarelle, Vanesa; Fabiano, Elena; Noya, Francisco] Inst Invest Biol Clemente Estable, Dept Bioquim & Genom Microbianas, Montevideo, Uruguay; [Senatore, Daniella] Inst Invest Biol Clemente Estable, Lab Ecol Microbiana, Montevideo, Uruguay; [Iriarte, Andres] Inst Invest Biol Clemente Estable, Dept Genom, Montevideo, Uruguay	Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay	Noya, F (corresponding author), Inst Invest Biol Clemente Estable, Dept Bioquim & Genom Microbianas, Montevideo, Uruguay.	fnoya@iibce.edu.uy	Amarelle, Vanesa/AAY-7871-2020	Fabiano, Elena/0000-0003-2868-6393; Amarelle, Vanesa/0000-0003-0405-3321; Iriarte, Andres/0000-0002-5862-0152	ANII (National Agency for Research and Innovation, Uruguay) [PR_FSE_2010_23]; PEDECIBA; INIA, Uruguay [FPTA 256]	ANII (National Agency for Research and Innovation, Uruguay); PEDECIBA; INIA, Uruguay(Instituto de Investigacion Agropecuaria (INIA))	This work was supported by ANII (National Agency for Research and Innovation, Uruguay) #PR_FSE_2010_23, PEDECIBA and INIA #FPTA 256, Uruguay.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Bayer S, 2010, J MOL MICROB BIOTECH, V18, P181, DOI 10.1159/000315459; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Biver S, 2013, J IND MICROBIOL BIOT, V40, P191, DOI 10.1007/s10295-012-1217-7; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Couto GH, 2010, GENET MOL RES, V9, P514, DOI 10.4238/vol9-1gmr738; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekkers DM, 2012, APPL MICROBIOL BIOT, V93, P1005, DOI 10.1007/s00253-011-3804-3; Elend C, 2006, APPL ENVIRON MICROB, V72, P3637, DOI 10.1128/AEM.72.5.3637-3645.2006; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Esteban-Torres M, 2013, APPL ENVIRON MICROB, V79, P5130, DOI 10.1128/AEM.01523-13; Faoro H, 2011, ENV MICROBIOL REP, V3, P750, DOI 10.1111/j.1758-2229.2011.00295.x; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jeon JH, 2009, MAR BIOTECHNOL, V11, P307, DOI 10.1007/s10126-008-9145-2; Jeong GT, 2008, APPL BIOCHEM BIOTECH, V148, P131, DOI 10.1007/s12010-007-8050-x; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kim EY, 2009, APPL ENVIRON MICROB, V75, P257, DOI 10.1128/AEM.01400-08; Kim MK, 2012, J MICROBIOL BIOTECHN, V22, P1044, DOI 10.4014/jmb.1201.12070; Kim YJ, 2006, PROTEIN EXPRES PURIF, V45, P315, DOI 10.1016/j.pep.2005.06.008; Ko KC, 2012, J IND MICROBIOL BIOT, V39, P681, DOI 10.1007/s10295-011-1080-y; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Lee MH, 2006, APPL ENVIRON MICROB, V72, P7406, DOI 10.1128/AEM.01157-06; Lee MH, 2010, APPL MICROBIOL BIOT, V88, P1125, DOI 10.1007/s00253-010-2729-6; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Nacke H, 2012, BIOTECHNOL LETT, V34, P663, DOI 10.1007/s10529-011-0830-2; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prakash T, 2012, BRIEF BIOINFORM, V13, P711, DOI 10.1093/bib/bbs033; Rhee JK, 2005, APPL ENVIRON MICROB, V71, P817, DOI 10.1128/AEM.71.2.817-825.2005; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang SD, 2013, J MOL CATAL B-ENZYM, V95, P1, DOI 10.1016/j.molcatb.2013.05.015; Yoshihisa T, 1996, J BIOL CHEM, V271, P9429, DOI 10.1074/jbc.271.16.9429	54	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126651	10.1371/journal.pone.0126651	http://dx.doi.org/10.1371/journal.pone.0126651			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973851	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600073
J	Delwaide, AC; Nalley, LL; Dixon, BL; Danforth, DM; Nayga, RM; Van Loo, EJ; Verbeke, W				Delwaide, Anne-Cecile; Nalley, Lawton L.; Dixon, Bruce L.; Danforth, Diana M.; Nayga, Rodolfo M., Jr.; Van Loo, Ellen J.; Verbeke, Wim			Revisiting GMOs: Are There Differences in European Consumers' Acceptance and Valuation for Cisgenically vs Transgenically Bred Rice?	PLOS ONE			English	Article							ORGANISMS; CORN	Both cisgenesis and transgenesis are plant breeding techniques that can be used to introduce new genes into plant genomes. However, transgenesis uses gene(s) from a non-plant organism or from a donor plant that is sexually incompatible with the recipient plant while cisgenesis involves the introduction of gene(s) from a crossable-sexually compatible-plant. Traditional breeding techniques could possibly achieve the same results as those from cisgenesis, but would require a much larger timeframe. Cisgenesis allows plant breeders to enhance an existing cultivar more quickly and with little to no genetic drag. The current regulation in the European Union (EU) on genetically modified organisms (GMOs) treats cisgenic plants the same as transgenic plants and both are mandatorily labeled as GMOs. This study estimates European consumers' willingness-to-pay (WTP) for rice labeled as GM, cisgenic, with environmental benefits (which cisgenesis could provide), or any combination of these three attributes. Data were collected from 3,002 participants through an online survey administered in Belgium, France, the Netherlands, Spain and the United Kingdom in 2013. Censored regression models were used to model consumers' WTP in each country. Model estimates highlight significant differences in WTP across countries. In all five countries, consumers are willing-to-pay a premium to avoid purchasing rice labeled as GM. In all countries except Spain, consumers have a significantly higher WTP to avoid consuming rice labeled as GM compared to rice labeled as cisgenic, suggesting that inserting genes from the plant's own gene pool is more acceptable to consumers. Additionally, French consumers are willing-to-pay a premium for rice labeled as having environmental benefits compared to conventional rice. These findings suggest that not all GMOs are the same in consumers' eyes and thus, from a consumer preference perspective, the differences between transgenic and cisgenic products are recommended to be reflected in GMO labeling and trade policies.	[Delwaide, Anne-Cecile; Nalley, Lawton L.; Dixon, Bruce L.; Danforth, Diana M.; Nayga, Rodolfo M., Jr.] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Delwaide, Anne-Cecile; Van Loo, Ellen J.; Verbeke, Wim] Univ Ghent, Dept Agr Econ, B-9000 Ghent, Belgium; [Nayga, Rodolfo M., Jr.] Korea Univ, Seoul, South Korea; [Van Loo, Ellen J.; Verbeke, Wim] Norwegian Agr Econ Res Inst, Oslo, Norway	University of Arkansas System; University of Arkansas Fayetteville; Ghent University; Korea University	Nalley, LL (corresponding author), Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA.	llnalley@uark.edu	Verbeke, Wim/F-8373-2010; Nalley, Lawton/AAN-7643-2021; Van Loo, Ellen J./A-9008-2012	Verbeke, Wim/0000-0002-9967-7104; Van Loo, Ellen J./0000-0002-0162-1760	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture [2013-68004-20378]	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-68004-20378 from the United States Department of Agriculture National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerni P, 2011, FOOD POLICY, V36, P830, DOI 10.1016/j.foodpol.2011.08.002; Anderson S, 2007, APPL ECON, V39, P675, DOI 10.1080/00036840500462046; Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2561; [Anonymous], 2014, NAT BIOTECHNOL, V32, P1169, DOI 10.1038/nbt.3094; [Anonymous], 2001, HARMONICON, DOI DOI 10.1016/S0167-5729(00)00007-8; [Anonymous], 2008, MAIZE MON 810 FRANCE; Bruner DM, 2011, APPL ECON LETT, V18, P417, DOI 10.1080/13504851003724242; Eriksson D, 2014, NAT BIOTECHNOL, V32, P727, DOI 10.1038/nbt.2980; European Commission, 2010, EUROBAROMETER 341 TH; European Commission, 2014, ATTITUDES OF EUROPEA; European Commission, 2014, NEW BREEDING TECHNIQ; Fischer T, 2014, ACIAR MONOGRAPH, P158; Frewer LJ, 1998, PESTIC SCI, V52, P388, DOI 10.1002/(SICI)1096-9063(199804)52:4&lt;388::AID-PS740&gt;3.0.CO;2-F; Gaskell G, 2006, EUROPEANS AND BIOTEC; Gaskell G, 2010, EUR 24537 EUROPEANS; Greer CA, 2001, PLANT DIS, V85, P1096, DOI 10.1094/PDIS.2001.85.10.1096; Harrison G.W., 2008, HDB EXPT EC RESULTS, P752, DOI 10.1016/s1574-0722(07)00081-9; Heiman Amir, 2011, International Journal of Biotechnology, V12, P50, DOI 10.1504/IJBT.2011.042681; High-Level Expert Forum, 2009, FEED WORLD 2050; Holme IB, 2013, PLANT BIOTECHNOL J, V11, P395, DOI 10.1111/pbi.12055; International Research Associates (INRA), 2000, EUROBAROMETER 52 1 T; Knight JG, 2007, NAT BIOTECHNOL, V25, P507, DOI 10.1038/nbt0507-507; Kronberger N, 2014, SCI COMMUN, V36, P106, DOI 10.1177/1075547013500773; Lusk JL, 2003, AM J AGR ECON, V85, P840, DOI 10.1111/1467-8276.00492; Lusk JL, 2003, AM J AGR ECON, V85, P16, DOI 10.1111/1467-8276.00100; Mielby H, 2013, AGR HUM VALUES, V30, P471, DOI 10.1007/s10460-013-9430-1; Mielby H, 2013, PUBLIC UNDERST SCI, V22, P155, DOI 10.1177/0963662511430577; Mohanty S, 2013, TRENDS IN GLOBAL RIC; Myskja BK, 2006, J AGR ENVIRON ETHIC, V19, P225, DOI 10.1007/s10806-005-6164-0; Nielsen KM, 2003, NAT BIOTECHNOL, V21, P227, DOI 10.1038/nbt0303-227; Schouten HJ, 2006, EMBO REP, V7, P750, DOI 10.1038/sj.embor.7400769; Telem RS, 2013, CURR GENOMICS, V14, P468, DOI 10.2174/13892029113146660013	32	68	68	0	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126060	10.1371/journal.pone.0126060	http://dx.doi.org/10.1371/journal.pone.0126060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25973946	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600039
J	Li, ZK; Huo, XY; Zhang, SY; Lu, J; Li, CL; Guo, M; Fu, R; He, ZM; Du, XY; Chen, ZW				Li, Zhenkun; Huo, Xueyun; Zhang, Shuangyue; Lu, Jing; Li, Changlong; Guo, Meng; Fu, Rui; He, Zhengming; Du, Xiaoyan; Chen, Zhenwen			Selection of Genes Associated with Variations in the Circle of Willis in Gerbils Using Suppression Subtractive Hybridization	PLOS ONE			English	Article							CYSTATIN-C; GROWTH; IDENTIFICATION; CONFIGURATION; ANGIOGENESIS; EXPRESSION; MUTATIONS; PROTEIN; ARTERY; ROLES	Deformities in the Circle of Willis (CoW) can significantly increase the risk of cerebrovascular disease in humans. However, the molecular mechanisms underlying these deformities have not been understood. Based on our previous studies, variations in the CoW of gerbils are hereditary. A normal CoW is observed in approximately 60% of gerbils, a percentage that also applies to humans. Thus, gerbil is an ideal experimental model for studying variations in the CoW. To study the mechanisms underlying these variations, we selected genes associated with different types of the CoW using suppression subtractive hybridization (SSH). After evaluating the efficiency of SSH using quantitative real-time polymerase chain reaction (qPCR) on subtracted and unsubtracted cDNA and Southern blotting on SSH PCR products, 12 SSH libraries were established. We identified 4 genes (CST3, GNAS, GPx4 and PFN2) associated with variations in the CoW. These genes were identified with qPCR and Western blotting using 70 expressed sequence tags from the SSH libraries. Cloning and sequencing allowed us to demonstrate that the 4 genes were closely related to mouse genes. We may assume that these 4 genes play an important role in the development of variations in the CoW. This study provides a foundation for further research of genes related to development of variations in the CoW and the mechanisms of dysmorphosis of cerebral vessels.	[Li, Zhenkun; Huo, Xueyun; Zhang, Shuangyue; Lu, Jing; Li, Changlong; Guo, Meng; Du, Xiaoyan; Chen, Zhenwen] Capital Med Univ, Sch Basic Med Sci, Dept Lab Anim Sci, Beijing 100069, Peoples R China; [Fu, Rui; He, Zhengming] Natl Inst Food & Drug Control, Inst Lab Anim Resources, Beijing 100050, Peoples R China	Capital Medical University; National Institute of Food & Drug Control - China	Du, XY (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Lab Anim Sci, Beijing 100069, Peoples R China.	duduyan@ccmu.edu.cn; czwen@ccmu.edu.cn	Li, Changlong/AAJ-4483-2020; Du, Xiaoyan/ABD-3167-2021	Du, Xiaoyan/0000-0002-4030-7299; Yang, Li/0000-0002-5484-0895	National Science Foundation of China [31372272, 31172168, 31272393]; Key Projects in the National Science & Technology Pillar Program [2015BAI09B01]; Beijing Natural Science Foundation [5122005, 7141002]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was funded by the National Science Foundation of China (Nos. 31372272, ZC; 31172168, ZC; 31272393, XD), the website is http://www.nsfc.gov.cn/Portal0/default152.htm; Key Projects in the National Science & Technology Pillar Program (No. 2015BAI09B01, ZC); Beijing Natural Science Foundation (No. 5122005, XD; 7141002, ZC), the website is http://www.bjnsf.org. All of the funders are aimed at finding out genes associated with Variations in the Circle of Willis in Gerbils in this study.	Alam MA, 2014, GENET MOL RES, V13, P4289, DOI 10.4238/2014.June.9.15; Balseiro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023140; Chuang YM, 2013, J CRIT CARE, V28, P166, DOI 10.1016/j.jcrc.2012.08.018; Cimerman N, 2000, CLIN CHIM ACTA, V300, P83, DOI 10.1016/S0009-8981(00)00298-9; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; del Valle-Perez B, 2004, FEBS LETT, V569, P105, DOI 10.1016/j.febslet.2004.05.058; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Dreilich M, 2005, MED ONCOL, V22, P29, DOI 10.1385/MO:22:1:029; Du Xiao Yan, 2011, ILAR J, V52, pE1; Du XY, 2010, J HERED, V101, P710, DOI 10.1093/jhered/esq066; Gardmo C, 2002, MOL CELL ENDOCRINOL, V190, P125, DOI 10.1016/S0303-7207(02)00004-7; Gasparotti R, 2005, EUR RADIOL, V15, P441, DOI 10.1007/s00330-004-2614-8; Ghosh S., 2013, PLOS ONE, V8; Hayward DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026411; He NH, 2004, FISH SHELLFISH IMMUN, V17, P121, DOI 10.1016/j.fsi.2003.11.008; Hendrikse J, 2001, STROKE, V32, P2768, DOI 10.1161/hs1201.099892; Kapoor K, 2008, ANAT SCI INT, V83, P96, DOI [10.1111/j.1447-073X.2007.00216.x, 10.1111/j.1447-073x.2007.00216.x]; Khadka DK, 2009, DEV BIOL, V332, P396, DOI 10.1016/j.ydbio.2009.06.008; Kris-Etherton PM, 2014, AM J CLIN NUTR, V99, P9; LEVINE S, 1966, EXP NEUROL, V16, P255, DOI 10.1016/0014-4886(66)90062-8; Li GQ, 2014, BIOMED ENVIRON SCI, V27, P169, DOI 10.3967/bes2014.038; Li Q, 2011, J CLIN NEUROSCI, V18, P379, DOI 10.1016/j.jocn.2010.07.137; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Portal O, 2011, PLANT CELL REP, V30, P913, DOI 10.1007/s00299-011-1008-z; Sahebi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/971985; Schneider M, 2010, NEOPLASIA, V12, P254, DOI 10.1593/neo.91782; SCHOMER DF, 1994, NEW ENGL J MED, V330, P1565, DOI 10.1056/NEJM199406023302204; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Stojanovic N, 2009, VOJNOSANIT PREGL, V66, P711, DOI 10.2298/VSP0909711S; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Turan S, 2013, HORM RES PAEDIAT, V80, P229, DOI 10.1159/000355384; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Xu JW, 2012, MOL BIOL REP, V39, P3603, DOI 10.1007/s11033-011-1134-2; Yang K, 2013, DEV BIOL, V381, P107, DOI 10.1016/j.ydbio.2013.06.007; Zhang J, 2010, J INT MED RES, V38, P1389, DOI 10.1177/147323001003800421	36	112	116	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127355	10.1371/journal.pone.0127355	http://dx.doi.org/10.1371/journal.pone.0127355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973917	Green Submitted, gold, Green Published			2022-12-27	WOS:000354545600111
J	Schara, U; Busse, M; Timmann, D; Gerwig, M				Schara, Ulrike; Busse, Melanie; Timmann, Dagmar; Gerwig, Marcus			Cerebellar-Dependent Associative Learning Is Preserved in Duchenne Muscular Dystrophy: A Study Using Delay Eyeblink Conditioning	PLOS ONE			English	Article							COGNITIVE-AFFECTIVE SYNDROME; DEFICIENT MDX MICE; PURKINJE-CELLS; MOUSE; RESPONSES; LESIONS; MEMORY; INVOLVEMENT; EXTINCTION; CHILDREN	Objective Besides progressive muscle weakness cognitive deficits have been reported in patients with Duchenne muscular dystrophy (DMD). Cerebellar dysfunction has been proposed to explain cognitive deficits at least in part. In animal models of DMD disturbed Purkinje cell function has been shown following loss of dystrophin. Furthermore there is increasing evidence that the lateral cerebellum contributes to cognitive processing. In the present study cerebellar-dependent delay eyeblink conditioning, a form of associative learning, was used to assess cerebellar function in DMD children. Methods Delay eyeblink conditioning was examined in eight genetically defined male patients with DMD and in ten age-matched control subjects. Acquisition, timing and extinction of conditioned eyeblink responses (CR) were assessed during a single conditioning session. Results Both groups showed a significant increase of CRs during the course of learning (block effect p < 0.001). CR acquisition was not impaired in DMD patients (mean total CR incidence 37.4 +/- 17.6%) as compared to control subjects (36.2 +/- 17.3%; group effect p = 0.89; group by block effect p = 0.38; ANOVA with repeated measures). In addition, CR timing and extinction was not different from controls. Conclusions Delay eyeblink conditioning was preserved in the present DMD patients. Because eyeblink conditioning depends on the integrity of the intermediate cerebellum, this older part of the cerebellum may be relatively preserved in DMD. The present findings agree with animal model data showing that the newer, lateral cerebellum is primarily affected in DMD.	[Schara, Ulrike; Busse, Melanie] Univ Duisburg Essen, Dept Neuropediat Dev Neurol & Social Pediat, Essen, Germany; [Timmann, Dagmar; Gerwig, Marcus] Univ Duisburg Essen, Dept Neurol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Gerwig, M (corresponding author), Univ Duisburg Essen, Dept Neurol, Essen, Germany.	marcus.gerwig@uk-essen.de						Anderson JL, 2010, MUSCLE NERVE, V41, P329, DOI 10.1002/mus.21467; Anderson JL, 2004, BRAIN RES, V1019, P289, DOI 10.1016/j.brainres.2004.06.011; Belmeguenai A, 2010, J NEUROSCI, V30, P13630, DOI 10.1523/JNEUROSCI.3226-10.2010; Billard C, 1998, DEV MED CHILD NEUROL, V40, P12, DOI 10.1111/j.1469-8749.1998.tb15351.x; BILLARD C, 1992, NEUROMUSCULAR DISORD, V2, P371, DOI 10.1016/S0960-8966(06)80008-8; Bracha V, 2000, BRAIN RES, V860, P87, DOI 10.1016/S0006-8993(00)01995-8; Brown KL, 2014, LEARN MEMORY, V21, P696, DOI 10.1101/lm.036103.114; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Cheng DT, 2010, PSYCHOL AGING, V25, P684, DOI 10.1037/a0017978; Coffin JM, 2005, CORTEX, V41, P389, DOI 10.1016/S0010-9452(08)70275-2; Cotton S, 2001, DEV MED CHILD NEUROL, V43, P497, DOI 10.1017/S0012162201000913; Cyrulnik SE, 2008, NEUROSCI BIOBEHAV R, V32, P486, DOI 10.1016/j.neubiorev.2007.09.001; DAUM I, 1993, BEHAV NEUROSCI, V107, P748, DOI 10.1037/0735-7044.107.5.748; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; Delgado-Garcia JM, 2006, TRENDS NEUROSCI, V29, P330, DOI 10.1016/j.tins.2006.05.003; Dichgans J, 2001, CEREBELLAR FUNCTIONS, P126; Duchenne G., 1868, ARCH GEN MED, V11, P5; EMERY AEH, 1993, NEUROMUSCULAR DISORD, V3, P263, DOI 10.1016/0960-8966(93)90018-F; Frings M, 2010, EXP BRAIN RES, V201, P167, DOI 10.1007/s00221-009-2020-1; Gerwig M, 2007, CEREBELLUM, V6, P38, DOI 10.1080/14734220701225904; Gerwig M, 2005, J NEUROSCI, V25, P3919, DOI 10.1523/JNEUROSCI.0266-05.2005; Gerwig M, 2003, BRAIN, V126, P71, DOI 10.1093/brain/awg011; Gerwig M, 2014, CEPHALALGIA, V34, P904, DOI 10.1177/0333102414523844; Gerwig M, 2010, BEHAV BRAIN RES, V212, P143, DOI 10.1016/j.bbr.2010.04.007; Hinton VJ, 2007, DEV MED CHILD NEUROL, V49, P123, DOI 10.1111/j.1469-8749.2007.00123.x; Hinton VJ, 2000, NEUROLOGY, V54, P2127, DOI 10.1212/WNL.54.11.2127; Jacobson SW, 2011, ALCOHOL CLIN EXP RES, V35, P250, DOI 10.1111/j.1530-0277.2010.01341.x; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; KIM TW, 1992, P NATL ACAD SCI USA, V89, P11642, DOI 10.1073/pnas.89.23.11642; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kreis R, 2011, NMR BIOMED, V24, P253, DOI 10.1002/nbm.1582; Kronenbuerger M, 2007, BRAIN, V130, P1538, DOI 10.1093/brain/awm081; Kueh SLL, 2011, NEUROBIOL DIS, V43, P558, DOI 10.1016/j.nbd.2011.05.002; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; Marini A, 2007, BRAIN LANG, V102, P1, DOI 10.1016/j.bandl.2007.02.003; Medical Research Council, 1976, 45 MED RES COUNC, V45; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Nicolson RI, 2002, EXP BRAIN RES, V143, P42, DOI 10.1007/s00221-001-0969-5; Parames SF, 2014, NEUROSCIENCE, V269, P173, DOI 10.1016/j.neuroscience.2014.03.050; PERRETT SP, 1993, J NEUROSCI, V13, P1708; Rasch B., 2010, QUANTITATIVE METHODE, V2; Robleto K, 2004, LEARN MEMORY, V11, P517, DOI 10.1101/lm.80004; Schara U, 2001, J Clin Neuromuscul Dis, V2, P179, DOI 10.1097/00131402-200106000-00002; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Snow WM, 2014, NEUROBIOL LEARN MEM, V107, P19, DOI 10.1016/j.nlm.2013.10.017; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Snow WM, 2013, CELL MOL NEUROBIOL, V33, P513, DOI 10.1007/s10571-013-9917-8; Timmann D, 2005, EXP BRAIN RES, V162, P332, DOI 10.1007/s00221-004-2181-x; Timmann D, 2007, CEREBELLUM, V6, P159, DOI 10.1080/14734220701496448; TOPKA H, 1993, BRAIN, V116, P961, DOI 10.1093/brain/116.4.961; Vaillend C, 2004, NEUROBIOL DIS, V17, P10, DOI 10.1016/j.nbd.2004.05.004; WOODRUFFPAK DS, 1988, PSYCHOL AGING, V3, P219, DOI 10.1037/0882-7974.3.3.219; WoodruffPak DS, 1996, NEUROPSYCHOLOGY, V10, P443	57	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126528	10.1371/journal.pone.0126528	http://dx.doi.org/10.1371/journal.pone.0126528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973604	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600058
J	Song, ZW; Schlatter, D; Kennedy, P; Kinkel, LL; Kistler, HC; Nguyen, N; Bates, ST				Song, Zewei; Schlatter, Dan; Kennedy, Peter; Kinkel, Linda L.; Kistler, H. Corby; Nhu Nguyen; Bates, Scott T.			Effort versus Reward: Preparing Samples for Fungal Community Characterization in High-Throughput Sequencing Surveys of Soils	PLOS ONE			English	Article							DNA EXTRACTION METHODS; TIME PCR ASSAY; ENVIRONMENTAL DNA; DIVERSITY; PURIFICATION; GRADIENT; BIODIVERSITY; PATHOGEN; DRIVERS	Next generation fungal amplicon sequencing is being used with increasing frequency to study fungal diversity in various ecosystems; however, the influence of sample preparation on the characterization of fungal community is poorly understood. We investigated the effects of four procedural modifications to library preparation for high-throughput sequencing (HTS). The following treatments were considered: 1) the amount of soil used in DNA extraction, 2) the inclusion of additional steps (freeze/thaw cycles, sonication, or hot water bath incubation) in the extraction procedure, 3) the amount of DNA template used in PCR, and 4) the effect of sample pooling, either physically or computationally. Soils from two different ecosystems in Minnesota, USA, one prairie and one forest site, were used to assess the generality of our results. The first three treatments did not significantly influence observed fungal OTU richness or community structure at either site. Physical pooling captured more OTU richness compared to individual samples, but total OTU richness at each site was highest when individual samples were computationally combined. We conclude that standard extraction kit protocols are well optimized for fungal HTS surveys, but because sample pooling can significantly influence OTU richness estimates, it is important to carefully consider the study aims when planning sampling procedures.	[Song, Zewei; Schlatter, Dan; Kinkel, Linda L.; Kistler, H. Corby; Bates, Scott T.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Kennedy, Peter; Nhu Nguyen] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Kistler, H. Corby] USDA ARS, Cereal Dis Lab, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA)	Song, ZW (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA.	songx208@umn.edu	Kistler, Harold/AAC-1645-2019	Kistler, Harold/0000-0001-5312-6297; Bates, Scott/0000-0002-6184-4296	United States Department of Agriculture grant [2011-67019-30200]; University of Minnesota MnDrive grant; National Science Foundation [EF 12-41895]; National Science Foundation (Long-Term Ecological Research Network) [0620652]	United States Department of Agriculture grant; University of Minnesota MnDrive grant; National Science Foundation(National Science Foundation (NSF)); National Science Foundation (Long-Term Ecological Research Network)(National Science Foundation (NSF))	Funding was received from United States Department of Agriculture (2011-67019-30200 http:// nifa.usda.gov/grants) grant to LLK & HCK; University of Minnesota MnDrive (http://mndrive.umn.edu/) grant to LLK & STB; and National Science Foundation (Grants EF 12-41895 grant to LLK and Long-Term Ecological Research Network 0620652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2011, GLOBAL CHANGE BIOL, V17, P3546, DOI 10.1111/j.1365-2486.2011.02484.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Boine B, 2014, EUR J PLANT PATHOL, V140, P745, DOI 10.1007/s10658-014-0506-6; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Branco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078295; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carrigg C, 2007, APPL MICROBIOL BIOT, V77, P955, DOI 10.1007/s00253-007-1219-y; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Dickie IA, 2010, NEW PHYTOL, V187, P475, DOI 10.1111/j.1469-8137.2010.03277.x; Dijkstra FA, 2009, FOREST ECOL MANAG, V257, P1112, DOI 10.1016/j.foreco.2008.11.014; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Francesconi A, 2008, J CLIN MICROBIOL, V46, P1978, DOI 10.1128/JCM.02246-07; Fredricks DN, 2005, J CLIN MICROBIOL, V43, P5122, DOI 10.1128/JCM.43.10.5122-5128.2005; Goldschmidt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094886; He JZ, 2005, SOIL BIOL BIOCHEM, V37, P2337, DOI 10.1016/j.soilbio.2005.04.016; Jang Chang Soon, 2010, Mycobiology, V38, P33, DOI 10.4489/MYCO.2010.38.1.033; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Karakousis A, 2006, J MICROBIOL METH, V65, P38, DOI 10.1016/j.mimet.2005.06.008; Kemler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081718; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lakay FM, 2007, J APPL MICROBIOL, V102, P265, DOI 10.1111/j.1365-2672.2006.03052.x; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058020; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nguyen NH, 2015, NEW PHYTOL, V205, P1389, DOI 10.1111/nph.12923; Oksanen J., **DATA OBJECT**; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Roh C, 2006, APPL BIOCHEM BIOTECH, V134, P97, DOI 10.1385/ABAB:134:2:97; Sagova-Mareckova M, 2008, APPL ENVIRON MICROB, V74, P2902, DOI 10.1128/AEM.02161-07; Sanchez B, 2008, J FOOD PROTECT, V71, P2497, DOI 10.4315/0362-028X-71.12.2497; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekiguchi H, 2001, BIOTECHNOL LETT, V23, P1205, DOI 10.1023/A:1010517117046; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Than DJ, 2013, FOREST PATHOL, V43, P324, DOI 10.1111/efp.12034; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vishnivetskaya TA, 2014, FEMS MICROBIOL ECOL, V87, P217, DOI 10.1111/1574-6941.12219; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Woodhall JW, 2012, EUR J PLANT PATHOL, V134, P467, DOI 10.1007/s10658-012-0025-2; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Xu LH, 2012, SOIL BIOL BIOCHEM, V46, P26, DOI 10.1016/j.soilbio.2011.11.010	55	33	33	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127234	10.1371/journal.pone.0127234	http://dx.doi.org/10.1371/journal.pone.0127234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974078	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600103
J	Sudao, B; Wang, XM				Sudao, Bilige; Wang, Xiaomin			A Generalized Simplest Equation Method and Its Application to the Boussinesq-Burgers Equation	PLOS ONE			English	Article							TRAVELING-WAVE SOLUTIONS; NONLINEAR EVOLUTION-EQUATIONS; FINDING EXACT-SOLUTIONS; DARBOUX TRANSFORMATION; ELLIPTIC FUNCTION; SOLITON-SOLUTIONS	In this paper, a generalized simplest equation method is proposed to seek exact solutions of nonlinear evolution equations (NLEEs). In the method, we chose a solution expression with a variable coefficient and a variable coefficient ordinary differential auxiliary equation. This method can yield a Backlund transformation between NLEEs and a related constraint equation. By dealing with the constraint equation, we can derive infinite number of exact solutions for NLEEs. These solutions include the traveling wave solutions, non-traveling wave solutions, multi-soliton solutions, rational solutions, and other types of solutions. As applications, we obtained wide classes of exact solutions for the Boussinesq-Burgers equation by using the generalized simplest equation method.	[Sudao, Bilige; Wang, Xiaomin] Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University of Technology	Sudao, B (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China.	inmathematica@126.com			Natural Science Foundation of Inner Mongolia Autonomous Region of China [2014MS0114, 2014BS0105]; High Education Science Research Program of Inner Mongolia of China [NJZY12056]	Natural Science Foundation of Inner Mongolia Autonomous Region of China; High Education Science Research Program of Inner Mongolia of China	This work is supported by Natural Science Foundation of Inner Mongolia Autonomous Region of China (2014MS0114, 2014BS0105) and High Education Science Research Program of Inner Mongolia of China (NJZY12056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablowitz M.J, 1991, SOLITONS NONLINEAR E; Antonova AO, 2014, COMMUN NONLINEAR SCI, V19, P4037, DOI 10.1016/j.cnsns.2014.03.035; Bilige S, 2013, APPL MATH COMPUT, V224, P517, DOI 10.1016/j.amc.2013.08.083; Bilige S, 2010, APPL MATH COMPUT, V216, P3146, DOI 10.1016/j.amc.2010.04.029; Chen AH, 2006, CHAOS SOLITON FRACT, V27, P43, DOI 10.1016/j.chaos.2004.09.116; Fan EG, 2000, PHYS LETT A, V277, P212, DOI 10.1016/S0375-9601(00)00725-8; Fan EG, 2003, APPL MATH COMPUT, V141, P351, DOI 10.1016/S0096-3003(02)00260-6; Gao L, 2007, PHYS LETT A, V366, P411, DOI 10.1016/j.physleta.2007.02.040; He JH, 2006, CHAOS SOLITON FRACT, V30, P700, DOI 10.1016/j.chaos.2006.03.020; Hirota R., 2004, DIRECT METHOD SOLITO; Jafari H, 2012, COMPUT MATH APPL, V64, P2084, DOI 10.1016/j.camwa.2012.04.004; Khalfallah M, 2009, MATH COMPUT MODEL, V49, P666, DOI 10.1016/j.mcm.2008.08.004; Kudryashov NA, 2005, PHYS LETT A, V342, P99, DOI 10.1016/j.physleta.2005.05.025; Kudryashov NA, 2005, CHAOS SOLITON FRACT, V24, P1217, DOI 10.1016/j.chaos.2004.09.109; Kudryashov NA, 2012, COMMUN NONLINEAR SCI, V17, P2248, DOI 10.1016/j.cnsns.2011.10.016; Li X, 2007, PHYS LETT A, V361, P115, DOI 10.1016/j.physleta.2006.09.022; Li XM, 2005, PHYS LETT A, V342, P413, DOI 10.1016/j.physleta.2005.05.083; Liu SK, 2001, PHYS LETT A, V289, P69, DOI 10.1016/S0375-9601(01)00580-1; Lou SY., 2006, NONLINEAR MATH PHYS; Matveev V B, 1991, DARBOUX TRANSFORMATI; Miura R. M., 1978, BACKLUND TRANSFORMAT; Naher H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064618; Rady ASA, 2010, COMMUN NONLINEAR SCI, V15, P886, DOI 10.1016/j.cnsns.2009.05.039; Sirendaoreji, 2003, PHYS LETT A, V309, P387, DOI 10.1016/S0375-9601(03)00196-8; Vitanov NK, 2013, APPL MATH COMPUT, V219, P7480, DOI 10.1016/j.amc.2013.01.035; Wang ML, 2008, PHYS LETT A, V372, P417, DOI 10.1016/j.physleta.2007.07.051; Wang ML, 1996, PHYS LETT A, V216, P67, DOI 10.1016/0375-9601(96)00283-6; Wang ZY, 2007, CHINESE PHYS, V16, P1233, DOI 10.1088/1009-1963/16/5/011; WEISS J, 1983, J MATH PHYS, V24, P522, DOI 10.1063/1.525721; WEISS J, 1984, PHYS LETT A, V102, P329, DOI 10.1016/0375-9601(84)90289-5; Zhang L, 2008, CHINESE PHYS B, V17, P403, DOI 10.1088/1674-1056/17/2/009; Zhou YB, 2003, PHYS LETT A, V308, P31, DOI 10.1016/S0375-9601(02)01775-9	32	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126635	10.1371/journal.pone.0126635	http://dx.doi.org/10.1371/journal.pone.0126635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973605	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600070
J	Hwang, SA; Crucian, B; Sams, C; Actor, JK				Hwang, Shen-An; Crucian, Brian; Sams, Clarence; Actor, Jeffrey K.			Post-Spaceflight (STS-135) Mouse Splenocytes Demonstrate Altered Activation Properties and Surface Molecule Expression	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD LEUKOCYTES; SHORT-DURATION; LACTOFERRIN MODULATION; CYTOKINE PRODUCTION; EPIGENETIC CHANGES; APPLIED PHYSIOLOGY; GENETIC MODELS; C57BL/6 MOUSE; SPACE	Alterations in immune function have been documented during or post-spaceflight and in ground based models of microgravity. Identification of immune parameters that are dysregulated during spaceflight is an important step in mitigating crew health risks during deep space missions. The in vitro analysis of leukocyte activity post-spaceflight in both human and animal species is primarily focused on lymphocytic function. This report completes a broader spectrum analysis of mouse lymphocyte and monocyte changes post 13 days orbital flight (mission STS-135). Analysis includes an examination in surface markers for cell activation, and antigen presentation and co-stimulatory molecules. Cytokine production was measured after stimulation with T-cell mitogen or TLR-2, TLR-4, or TLR-5 agonists. Splenocyte surface marker analysis immediate post-spaceflight and after in vitro culture demonstrated unique changes in phenotypic populations between the flight mice and matched treatment ground controls. Post-spaceflight splenocytes (flight splenocytes) had lower expression intensity of CD4(+)CD25(+) and CD8(+)CD25(+) cells, lower percentage of CD11c(+)MHC II+ cells, and higher percentage of CD11c(+)MHC I+ populations compared to ground controls. The flight splenocytes demonstrated an increase in phagocytic activity. Stimulation with ConA led to decrease in CD4(+) population but increased CD4(+)CD25(+) cells compared to ground controls. Culturing with TLR agonists led to a decrease in CD11c(+) population in splenocytes isolated from flight mice compared to ground controls. Consequently, flight splenocytes with or without TLR-agonist stimulation showed a decrease in CD11c+MHC I+, CD11c(+)MHC II+, and CD11c(+)CD86(+) cells compared to ground controls. Production of IFN-gamma was decreased and IL-2 was increased from ConA stimulated flight splenocytes. This study demonstrated that expression of surface molecules can be affected by conditions of spaceflight and impaired responsiveness persists under culture conditions in vitro.	[Hwang, Shen-An; Actor, Jeffrey K.] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Crucian, Brian] NASA, Lyndon B Johnson Space Ctr, Div Biomed & Environm Sci, Houston, TX 77058 USA; [Sams, Clarence] NASA, Lyndon B Johnson Space Ctr, Space & Clin Operat Div, Houston, TX 77058 USA	University of Texas System; University of Texas Health Science Center Houston; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Actor, JK (corresponding author), Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA.	Jeffrey.K.Actor@uth.tmc.edu		Actor, Jeffrey/0000-0002-9265-7012				ALLEBBAN Z, 1994, J LEUKOCYTE BIOL, V55, P209, DOI 10.1002/jlb.55.2.209; ARMSTRONG JW, 1995, EXP CELL RES, V216, P160, DOI 10.1006/excr.1995.1020; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; Blutt SE, 2004, AVIAT SPACE ENVIR MD, V 75, P215; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; CHAPES SK, 1992, J LEUKOCYTE BIOL, V52, P104, DOI 10.1002/jlb.52.1.104; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; Crucian B. S., 2014, J INTERFERON CYTOKIN; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2014, BRAIN BEHAV IMMUN, V39, P23, DOI 10.1016/j.bbi.2014.01.011; Crucian B, 2013, J CLIN IMMUNOL, V33, P456, DOI 10.1007/s10875-012-9824-7; Crucian B, 2011, AVIAT SPACE ENVIR MD, V82, P857, DOI 10.3357/ASEM.3047.2011; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; Cubano LA, 2000, EXP GERONTOL, V35, P389, DOI 10.1016/S0531-5565(00)00090-5; Dresch C, 2012, TRENDS IMMUNOL, V33, P381, DOI 10.1016/j.it.2012.04.009; Grenon SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8124; Gridley DS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075097, 10.1371/annotation/e66bdc4e-2409-4582-b163-7bc182db275e]; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gridley DS, 2003, J APPL PHYSIOL, V94, P2095, DOI 10.1152/japplphysiol.01053.2002; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Hawkins W R, 1975, CLIN ASPECTS CREW HL; Hwang SA, 2007, MED MICROBIOL IMMUN, V196, P171, DOI 10.1007/s00430-007-0041-6; Hwang SA, 2009, INT IMMUNOL, V21, P1185, DOI 10.1093/intimm/dxp084; Hwang SA, 2009, VACCINE, V27, P3026, DOI 10.1016/j.vaccine.2009.03.036; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Ishihara A, 2014, MUSCLE NERVE; Kim W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062437; KIMZEY SL, 1975, ACTA ASTRONAUT, V2, P141, DOI 10.1016/0094-5765(75)90050-8; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Latchney SE, 2014, J APPL PHYSIOL, V116, P1593, DOI 10.1152/japplphysiol.01174.2013; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Maile R, 2006, EUR J IMMUNOL, V36, P397, DOI 10.1002/eji.200535064; Maile R, 2005, J IMMUNOL, V174, P619, DOI 10.4049/jimmunol.174.2.619; Mao XW, 2014, FREE RADICAL RES, V48, P890, DOI 10.3109/10715762.2014.920086; Mao XW, 2013, RADIAT RES, V180, P340, DOI 10.1667/RR3309.1; MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236; MEEHAN RT, 1992, IMMUNOLOGY, V76, P491; Mehta SK, 2013, CYTOKINE, V61, P205, DOI 10.1016/j.cyto.2012.09.019; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Mehta SK, 2014, BRAIN BEHAV IMMUN; Mifsud EJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00079; NASH PV, 1992, EXP CELL RES, V202, P125, DOI 10.1016/0014-4827(92)90411-Z; NASH PV, 1992, J APPL PHYSIOL, V73, pS186; Ou XF, 2010, GENOME, V53, P524, DOI [10.1139/G10-030, 10.1139/g10-030]; Ou XF, 2009, MUTAT RES-FUND MOL M, V662, P44, DOI 10.1016/j.mrfmmm.2008.12.004; Payne DA, 1999, AVIAT SPACE ENVIR MD, V70, P1211; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; RYKOVA MP, 1992, J APPL PHYSIOL, V73, pS196, DOI 10.1152/jappl.1992.73.2.S196; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; SONNENFELD G, 1988, ACTA MICROBIOL HUNG, V35, P411; SONNENFELD G, 1990, AVIAT SPACE ENVIR MD, V61, P648; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; STEIN TP, 1994, AM J PHYSIOL, V266, pE448, DOI 10.1152/ajpendo.1994.266.3.E448; Stodieck LS, 2013, 2013 INT SPAC STAT R; Stowe RP, 2003, AVIAT SPACE ENVIR MD, V74, P1281; Stowe RP, 2001, PSYCHOSOM MED, V63, P891, DOI 10.1097/00006842-200111000-00007; TAYLOR GR, 1986, AVIAT SPACE ENVIR MD, V57, P213; TAYLOR GR, 1992, J LEUKOCYTE BIOL, V51, P129, DOI 10.1002/jlb.51.2.129	63	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124380	10.1371/journal.pone.0124380	http://dx.doi.org/10.1371/journal.pone.0124380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970640	Green Submitted, Green Published, gold			2022-12-27	WOS:000354544200037
J	Panoli, A; Martin, MV; Alandete-Saez, M; Simon, M; Neff, C; Swarup, R; Bellido, A; Yuan, L; Pagnussat, GC; Sundaresan, V				Panoli, Aneesh; Martin, Maria Victoria; Alandete-Saez, Monica; Simon, Marissa; Neff, Christina; Swarup, Ranjan; Bellido, Andres; Yuan, Li; Pagnussat, Gabriela C.; Sundaresan, Venkatesan			Auxin Import and Local Auxin Biosynthesis Are Required for Mitotic Divisions, Cell Expansion and Cell Specification during Female Gametophyte Development in Arabidopsis thaliana	PLOS ONE			English	Article							PATHWAY; TRYPTOPHAN; TRANSPORT; FAMILY	The female gametophyte of flowering plants, called the embryo sac, develops from a haploid cell named the functional megaspore, which is specified after meiosis by the diploid sporophyte. In Arabidopsis, the functional megaspore undergoes three syncitial mitotic divisions followed by cellularization to form seven cells of four cell types including two female gametes. The plant hormone auxin is important for sporophytic developmental processes, and auxin levels are known to be regulated by biosynthesis and transport. Here, we investigated the role of auxin biosynthetic genes and auxin influx carriers in embryo sac development. We find that genes from the YUCCA/TAA pathway (YUC1, YUC2, YUC8, TAA1, TAR2) are expressed asymmetrically in the developing ovule and embryo sac from the two-nuclear syncitial stage until cellularization. Mutants for YUC1 and YUC2 exhibited defects in cell specification, whereas mutations in YUC8, as well as mutations in TAA1 and TAR2, caused defects in nuclear proliferation, vacuole formation and anisotropic growth of the embryo sac. Additionally, expression of the auxin influx carriers AUX1 and LAX1 were observed at the micropylar pole of the embryo sac and in the adjacent cells of the ovule, and the aux1 lax1 lax2 triple mutant shows multiple gametophyte defects. These results indicate that both localized auxin biosynthesis and auxin import, are required for mitotic divisions, cell expansion and patterning during embryo sac development.	[Panoli, Aneesh; Alandete-Saez, Monica; Simon, Marissa; Neff, Christina; Yuan, Li; Sundaresan, Venkatesan] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Alandete-Saez, Monica] Univ Calif Davis, PIPRA, Davis, CA 95616 USA; [Martin, Maria Victoria; Bellido, Andres; Pagnussat, Gabriela C.] Univ Nacl Mar Del Plata, CONICET, Inst Biol Res IIB, RA-7600 Mar Del Plata, Argentina; [Swarup, Ranjan] Univ Nottingham, Nottingham NG7 2RD, England; [Sundaresan, Venkatesan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; University of Nottingham; University of California System; University of California Davis	Pagnussat, GC (corresponding author), Univ Nacl Mar Del Plata, CONICET, Inst Biol Res IIB, RA-7600 Mar Del Plata, Argentina.	gpagnussat@mdp.edu.ar; sundar@ucdavis.edu	Yuan, Li/D-6069-2015; martin, viky/GMX-1010-2022	Yuan, Li/0000-0003-1803-6661; Sundaresan, Venkatesan/0000-0002-4670-0630; swarup, Ranjan/0000-0002-6438-9188; Pagnussat, Gabriela/0000-0002-6836-3495; Martin, Maria Victoria/0000-0001-6015-7059; Panoli, Aneesh/0000-0002-4906-3622	National Science Foundation [IOS-1051951]; HHMI International Early Career grant [55007430]; PICT grant from the Argentinean ANPCyT [1809]; Direct For Biological Sciences [1051951] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); HHMI International Early Career grant; PICT grant from the Argentinean ANPCyT; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grant IOS-1051951 to V.S. from the National Science Foundation (http://www.nsf.gov/), HHMI International Early Career grant 55007430 to GCP (http://www.hhmi.org/node/11337) and PICT grant 1809 from the Argentinean ANPCyT to GCP (http://www.agencia.mincyt.gob.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett TA, 2014, CURR BIOL, V24, P2776, DOI 10.1016/j.cub.2014.09.054; Berger F, 2011, ANNU REV PLANT BIOL, V62, P461, DOI 10.1146/annurev-arplant-042110-103824; Ceccato L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066148; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Drews Gary N, 2011, Arabidopsis Book, V9, pe0155, DOI 10.1199/tab.0155; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Friedman WE, 2003, EVOLUTION, V57, P216, DOI 10.1111/j.0014-3820.2003.tb00257.x; Hofmann NR, 2011, PLANT CELL, V23, P3869, DOI 10.1105/tpc.111.231112; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; Kagi C, 2010, EUR J CELL BIOL, V89, P258, DOI 10.1016/j.ejcb.2009.11.005; Lituiev DS, 2013, DEVELOPMENT, V140, P4544, DOI 10.1242/dev.098301; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Peret B, 2012, PLANT CELL, V24, P2874, DOI 10.1105/tpc.112.097766; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Prigge MJ, 2010, CURR BIOL, V20, P1907, DOI 10.1016/j.cub.2010.08.050; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Sundaresan V, 2010, DEVELOPMENT, V137, P179, DOI 10.1242/dev.030346; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Ugartechea-Chirino Y, 2010, ANN BOT-LONDON, V105, P277, DOI 10.1093/aob/mcp287; Viaene T, 2014, CURR BIOL, V24, P2786, DOI 10.1016/j.cub.2014.09.056; Won C, 2011, P NATL ACAD IN PRESS; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Yang WC, 2010, ANNU REV PLANT BIOL, V61, P89, DOI 10.1146/annurev-arplant-042809-112203; Yu HJ, 2005, PLANT PHYSIOL, V139, P1853, DOI 10.1104/pp.105.067314; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	33	56	58	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126164	10.1371/journal.pone.0126164	http://dx.doi.org/10.1371/journal.pone.0126164			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970627	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200096
J	Kuzelova, K; Brodska, B; Fuchs, O; Dobrovolna, M; Soukup, P; Cetkovsky, P				Kuzelova, Katerina; Brodska, Barbora; Fuchs, Ota; Dobrovolna, Marie; Soukup, Petr; Cetkovsky, Petr			Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia	PLOS ONE			English	Article							NPM1 MUTATIONS; NUCLEAR EXPORT; AML; PEPTIDES; MUTANTS	Nucleophosmin 1 (NPM1) mutations are frequently found in patients with acute myeloid leukemia (AML) and the newly generated sequences were suggested to induce immune response contributing to the relatively favorable outcome of patients in this AML subset. We hypothesized that if an efficient immune response against mutated nucleophosmin can be induced in vivo, the individuals expressing HLA alleles suitable for presenting NPM-derived peptides should be less prone to developing AML associated with NPM1 mutation. We thus compared HLA class I frequencies in a cohort of patients with mutated NPM1 (63 patients, NPMc+), a cohort of patients with wild-type NPM1 (94 patients, NPMwt) and in normal individuals (large datasets available from Allele Frequency Net Database). Several HLA allelic groups were found to be depleted in NPMc+ patients, but not in NPMwt compared to the normal distribution. The decrease was statistically significant for HLA B*07, B*18, and B*40. Furthermore, statistically significant advantage in the overall survival was found for patients with mutated NPM1 expressing at least one of the depleted allelic groups. The majority of the depleted alleles were predicted to bind potent NPM-derived immunopeptides and, importantly, these peptides were often located in the unmutated part of the protein. Our analysis suggests that individuals expressing specific HLA allelic groups are disposed to develop an efficient anti-AML immune response thanks to aberrant cytoplasmic localization of the mutated NPM protein.	[Kuzelova, Katerina; Brodska, Barbora] Inst Hematol & Blood Transfus, Dept Prote, CR-12820 Prague, Czech Republic; [Fuchs, Ota] Inst Hematol & Blood Transfus, Dept Genom, CR-12820 Prague, Czech Republic; [Dobrovolna, Marie] Inst Hematol & Blood Transfus, Dept HLA, CR-12820 Prague, Czech Republic; [Soukup, Petr; Cetkovsky, Petr] Inst Hematol & Blood Transfus, Clin Dept, CR-12820 Prague, Czech Republic	Institute of Hematology Prague; Institute of Hematology Prague; Institute of Hematology Prague; Institute of Hematology Prague	Kuzelova, K (corresponding author), Inst Hematol & Blood Transfus, Dept Prote, CR-12820 Prague, Czech Republic.	Katerina.Kuzelova@uhkt.cz	Kuzelova, Katerina/ADE-8303-2022	Kuzelova, Katerina/0000-0002-9628-6255; Brodska, Barbora/0000-0002-3703-594X	Ministry of Health of the Czech Republic (Project for conceptual development of research organization) [00023736]	Ministry of Health of the Czech Republic (Project for conceptual development of research organization)	The work was supported by the Ministry of Health of the Czech Republic (Project for conceptual development of research organization No 00023736). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidwell J, 2000, HISTOCOMPATIBILITY T; BORTIN MM, 1987, BLOOD, V70, P227; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Fernandez-Torres J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/705862; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Greiner J, 2013, BLOOD, V122, P1087, DOI 10.1182/blood-2013-04-496844; Greiner J, 2012, BLOOD, V120, P1282, DOI 10.1182/blood-2011-11-394395; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Liso A, 2008, LEUKEMIA, V22, P1285, DOI 10.1038/sj.leu.2405045; Liso A, 2008, LEUKEMIA, V22, P424, DOI 10.1038/sj.leu.2404887; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Martelli MP, 2013, BLOOD REV, V27, P13, DOI 10.1016/j.blre.2012.11.001; Nakagawa M, 2005, NEW ENGL J MED, V352, P1819; NAVARRETE C, 1986, J IMMUNOGENET, V13, P77; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Ozdilli K, 2010, J INT MED RES, V38, P1835, DOI 10.1177/147323001003800531; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Pfeiffer T, 2013, HAEMATOLOGICA, V98, P518, DOI 10.3324/haematol.2012.070235; Pitiot AS, 2007, LEUKEMIA, V21, P1564, DOI 10.1038/sj.leu.2404679; Posthuma EFM, 2000, LEUKEMIA, V14, P859, DOI 10.1038/sj.leu.2401774; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Swoboda RK, 2010, INT J CANCER, V127, P1124, DOI 10.1002/ijc.25133; Yuan Y, 2014, BIORESOURCE TECHNOL, V174, P1, DOI 10.1016/j.biortech.2014.07.104	26	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127637	10.1371/journal.pone.0127637	http://dx.doi.org/10.1371/journal.pone.0127637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992555	Green Published, Green Submitted, gold			2022-12-27	WOS:000354921400128
J	Sturrock, AM; Wikert, JD; Heyne, T; Mesick, C; Hubbard, AE; Hinkelman, TM; Weber, PK; Whitman, GE; Glessner, JJ; Johnson, RC				Sturrock, Anna M.; Wikert, J. D.; Heyne, Timothy; Mesick, Carl; Hubbard, Alan E.; Hinkelman, Travis M.; Weber, Peter K.; Whitman, George E.; Glessner, Justin J.; Johnson, Rachel C.			Reconstructing the Migratory Behavior and Long-Term Survivorship of Juvenile Chinook Salmon under Contrasting Hydrologic Regimes	PLOS ONE			English	Article							SIZE-SELECTIVE MORTALITY; ONCORHYNCHUS-TSHAWYTSCHA; CENTRAL VALLEY; PACIFIC SALMON; OTOLITH MICROSTRUCTURE; DEPENDENT MORTALITY; SR ISOTOPES; RIVER; CALIFORNIA; GROWTH	The loss of genetic and life history diversity has been documented across many taxonomic groups, and is considered a leading cause of increased extinction risk. Juvenile salmon leave their natal rivers at different sizes, ages and times of the year, and it is thought that this life history variation contributes to their population sustainability, and is thus central to many recovery efforts. However, in order to preserve and restore diversity in life history traits, it is necessary to first understand how environmental factors affect their expression and success. We used otolith 87Sr/86Sr in adult Chinook salmon (Oncorhynchus tsha-wytcha) returning to the Stanislaus River in the California Central Valley (USA) to reconstruct the sizes at which they outmigrated as juveniles in a wetter (2000) and drier (2003) year. We compared rotary screw trap-derived estimates of outmigrant timing, abundance and size with those reconstructed in the adults from the same cohort. This allowed us to estimate the relative survival and contribution of migratory phenotypes (fry, parr, smolts) to the adult spawning population under different flow regimes. Juvenile abundance and outmigration behavior varied with hydroclimatic regime, while downstream survival appeared to be driven by size- and time-selective mortality. Although fry survival is generally assumed to be negligible in this system, >20% of the adult spawners from outmigration year 2000 had outmigrated as fry. In both years, all three phenotypes contributed to the spawning population, however their relative proportions differed, reflecting greater fry contributions in the wetter year (23% vs. 10%) and greater smolt contributions in the drier year (13% vs. 44%). These data demonstrate that the expression and success of migratory phenotypes vary with hydrologic regime, emphasizing the importance of maintaining diversity in a changing climate.	[Sturrock, Anna M.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Wikert, J. D.; Mesick, Carl] US Fish & Wildlife Serv, Lodi, CA USA; [Heyne, Timothy] Calif Dept Fish & Wildlife, Tuolumne River Restorat Ctr, La Grange, CA USA; [Hubbard, Alan E.] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA; [Hinkelman, Travis M.] Cramer Fish Sci, Auburn, CA USA; [Weber, Peter K.] Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA USA; [Whitman, George E.; Johnson, Rachel C.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Glessner, Justin J.] Univ Calif Davis, Interdisciplinary Ctr Plasma Mass Spectrometry, Dept Geol, Davis, CA 95616 USA; [Johnson, Rachel C.] Natl Marine Fisheries Serv, Southwest Fisheries Sci Ctr, Santa Cruz, CA USA	University of California System; University of California Santa Cruz; United States Department of the Interior; US Fish & Wildlife Service; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; University of California System; University of California Davis; National Oceanic Atmospheric Admin (NOAA) - USA	Sturrock, AM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	a.sturrock@berkeley.edu	Weber, Peter Kilian/AAP-9517-2020; Hinkelman, Travis M/B-3296-2009	Weber, Peter Kilian/0000-0001-6022-6050; Sturrock, Anna/0000-0001-9423-9845; Hinkelman, Travis/0000-0002-8157-8407	United States Fish and Wildlife Service funding under United States Bureau of Reclamation Agreement [R09AC20043]; United States Department of Energy [DE-AC52-07NA27344]	United States Fish and Wildlife Service funding under United States Bureau of Reclamation Agreement; United States Department of Energy(United States Department of Energy (DOE))	United States Fish and Wildlife Service funding under United States Bureau of Reclamation Agreement R09AC20043 was awarded to RCJ. Work at LLNL by PKW was performed under the auspices of the United States Department of Energy, Contract DE-AC52-07NA27344.	Achord S, 2003, ECOL LETT, V6, P335, DOI 10.1046/j.1461-0248.2003.00438.x; Barnett-Johnson R, 2005, CAN J FISH AQUAT SCI, V62, P2425, DOI 10.1139/F05-194; Barnett-Johnson R, 2008, LIMNOL OCEANOGR, V53, P1633, DOI 10.4319/lo.2008.53.4.1633; Barnett-Johnson R, 2007, CAN J FISH AQUAT SCI, V64, P1683, DOI 10.1139/F07-129; Barnett-Johnson R, 2010, ENVIRON BIOL FISH, V89, P533, DOI 10.1007/s10641-010-9662-5; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Beckman Brian R., 1998, North American Journal of Fisheries Management, V18, P537, DOI 10.1577/1548-8675(1998)018<0537:ROFSAG>2.0.CO;2; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Berejikian BA, 1999, T AM FISH SOC, V128, P832, DOI 10.1577/1548-8659(1999)128<0832:CDBNEO>2.0.CO;2; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Brandes P., 2001, FISH B, P39; BURNS JW, 1971, CALIF FISH GAME, V57, P44; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Carlson SM, 2011, CAN J FISH AQUAT SCI, V68, P1579, DOI 10.1139/F2011-084; Cavallo B, 2013, ENVIRON BIOL FISH, V96, P393, DOI 10.1007/s10641-012-9993-5; Cramer Fish Sciences, 2012, JUV SALM OUT MIGR MO; Cramer Fish Sciences, 2006, 2006 STAN RIV DAT RE; Demko D, 2003, SJRGA 2003 ANN TECHN; DWR, 2010, CLIM CHANG CHAR AN C; Ewing RD, 2002, AQUACULTURE, V209, P139, DOI 10.1016/S0044-8486(01)00755-4; FISHER FW, 1994, CONSERV BIOL, V8, P870, DOI 10.1046/j.1523-1739.1994.08030863-5.x; Genz A., 2014, MULTIVARIATE NORMAL; Good SP, 2001, CAN J FISH AQUAT SCI, V58, P1187, DOI 10.1139/cjfas-58-6-1187; Gray A, 2012, STANISLAUS RIVER JUV; Greene CM, 2004, CAN J FISH AQUAT SCI, V61, P590, DOI 10.1139/F04-024; Greene CM, 2011, MONITORING POPULATIO; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; Gregory RS, 1998, T AM FISH SOC, V127, P275, DOI 10.1577/1548-8659(1998)127<0275:TRPOMJ>2.0.CO;2; Guignard J, 2008, ADDENDUM STANISLAUS; Guignard J, 2007, ADDENDUM STANISLAUS; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hauer FR, 2004, AQUAT SCI, V66, P388, DOI 10.1007/s00027-004-0724-7; Healey M.C., 1991, P311; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Ingram BL, 1999, GEOLOGY, V27, P851; Jager HI, 2003, N AM J FISH MANAGE, V23, P1, DOI 10.1577/1548-8675(2003)023<0001:DOFPFF>2.0.CO;2; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Kennedy BP, 2002, CAN J FISH AQUAT SCI, V59, P925, DOI [10.1139/f02-070, 10.1139/F02-070]; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; Kjelson M., 1981, P NAT S FRESHW INFL, P88; Kjelson M.A., 1982, ESTUARINE COMP, P393; Kondolf G. M., 2001, RECONNAISSANCE LEVEL; Kormos B., 2012, RECOVERY CODED WIRE; Lindley S.T., 2009, WHAT CAUSED SACRAMEN; MacFarlane RB, 2002, FISH B-NOAA, V100, P244; Marine KR, 2004, N AM J FISH MANAGE, V24, P198, DOI 10.1577/M02-142; Marston D., 2012, SAN FRANC ESTUARY WA, V10; Mesick C, 2010, PROPORTION IN PRESS; Mesick C, 2009, ESTIMATING RECRUITME; Miller JA, 2010, MAR ECOL PROG SER, V408, P227, DOI 10.3354/meps08613; Montgomery DR, 2000, GEOLOGY, V28, P1107, DOI 10.1130/0091-7613(2000)28<1107:COTPSA>2.0.CO;2; Moyle P, 2008, SALMON STEELHEAD TRO; MOYLE PB, 1994, CONSERV BIOL, V8, P869, DOI 10.1046/j.1523-1739.1994.08030863-4.x; Myrick CA, 2004, REV FISH BIOL FISHER, V14, P113, DOI 10.1007/s11160-004-2739-5; NEILSON JD, 1982, CAN J FISH AQUAT SCI, V39, P1340, DOI 10.1139/f82-180; Perry RW, 2013, ENVIRON BIOL FISH, V96, P381, DOI 10.1007/s10641-012-9984-6; PFMC, 2014, APP TABL A1 5 STOCK; PSMFC, 2014, JUV SALM EM MON LOW; Reisenbichler RR, 1982, RELATION SIZE CHINOO; Ruckelshaus MH, 2002, ANNU REV ECOL SYST, V33, P665, DOI 10.1146/annurev.ecolsys.33.010802.150504; Satterthwaite WH, 2014, MAR ECOL PROG SER, V511, P237, DOI 10.3354/meps10934; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schneider KS, 2000, CHANNEL FLOODPLAIN D, V94720, P165; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; Selective Fisheries Evaluation Committee S, 2012, SUMM MASS MARK ACT M; Semhi K, 2000, CHEM GEOL, V168, P173, DOI 10.1016/S0009-2541(00)00226-6; [SJRGA San Joaquin River Group Authority], 2013, SJRGA 2011 ANN TECHN; SJRGA, 2003, SALM SMOLT SURV INV; SJRGA, 2000, VAMP 2000 SALM SMOLT; SJRGA, 2011, SJRGA 2010 ANN TECHN; Sogard SM, 1997, B MAR SCI, V60, P1129; Speegle J, 2013, ANN REPORT JUVENILE; Spence BC, 2010, CAN J FISH AQUAT SCI, V67, P1316, DOI 10.1139/F10-060; Stearns S.C., 1992, pi; Sturrock AM, 2012, J FISH BIOL, V81, P766, DOI 10.1111/j.1095-8649.2012.03372.x; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Titus RG, 2004, AM FISH S S, V39, P181; Unwin MJ, 1997, FISH B-NOAA, V95, P812; US Environmental Protection Agency, 2003, EPA REG 10 GUID PAC; USFWS, 2014, CHIN DAT UNPUB; Van Belle G., 2008, STAT RULES THUMB; Vasques J, 2001, 1999 2000 GRAYSON SC; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Waples RS, 2004, EVOLUTION, V58, P386, DOI 10.1111/j.0014-3820.2004.tb01654.x; Weitkamp LA, 2010, T AM FISH SOC, V139, P147, DOI 10.1577/T08-225.1; Wells BK, 2007, FISH OCEANOGR, V16, P363, DOI 10.1111/j.1365-2419.2007.00437.x; Williams J.G, 2006, SAN FRANC ESTUARY WA, V4, P3, DOI [10.15447/sfews.2006v4iss3art2, DOI 10.15447/SFEWS.2006V4ISS3ART2]; WILLIAMS JG, 2012, SAN FRANC ESTUARY WA, V10; Wood CC, 2008, EVOL APPL, V1, P207, DOI 10.1111/j.1752-4571.2008.00028.x; Woodson LE, 2013, MAR ECOL PROG SER, V487, P163, DOI 10.3354/meps10353; Yoshiyama R.M., 2001, FISH B-NOAA, V179, P71; Yoshiyama Ronald M., 1998, North American Journal of Fisheries Management, V18, P487, DOI 10.1577/1548-8675(1998)018<0487:HAADOC>2.0.CO;2; Zabel RW, 2010, ENVIRON BIOL FISH, V89, P267, DOI 10.1007/s10641-010-9678-x; Zeug SC, 2014, FISHERIES MANAGEMENT	96	37	38	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0122380	10.1371/journal.pone.0122380	http://dx.doi.org/10.1371/journal.pone.0122380			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992556	Green Published, gold, Green Submitted			2022-12-27	WOS:000354921400006
J	Davies, JS; Stewart, HA; Narayanaswamy, BE; Jacobs, C; Spicer, J; Golding, N; Howell, KL				Davies, Jaime S.; Stewart, Heather A.; Narayanaswamy, Bhavani E.; Jacobs, Colin; Spicer, John; Golding, Neil; Howell, Kerry L.			Benthic Assemblages of the Anton Dohrn Seamount (NE Atlantic): Defining Deep-Sea Biotopes to Support Habitat Mapping and Management Efforts with a Focus on Vulnerable Marine Ecosystems	PLOS ONE			English	Article							CORAL LOPHELIA-PERTUSA; FOOD-SUPPLY MECHANISMS; ROCKALL TROUGH MARGIN; COLD-WATER CORALS; LE-DANOIS BANK; COMMUNITY STRUCTURE; XENOPHYOPHORES PROTISTA; PORCUPINE SEABIGHT; CARBONATE-MOUND; MORPHOLOGY	In 2009 the NW and SE flanks of Anton Dohrn Seamount were surveyed using multibeam echosounder and video ground-truthing to characterise megabenthic biological assemblages (biotopes) and assess those which clearly adhere to the definition of Vulnerable Marine Ecosystems, for use in habitat mapping. A combination of multivariate analysis of still imagery and video ground-truthing defined 13 comprehensive descriptions of biotopes that function as mapping units in an applied context. The data reveals that the NW and SE sides of Anton Dohrn Seamount (ADS) are topographically complex and harbour diverse biological assemblages, some of which agree with current definitions of 'listed' habitats of conservation concern. Ten of these biotopes could easily be considered Vulnerable Marine Ecosystems; three coral gardens, four cold-water coral reefs, two xenophyophore communities and one sponge dominated community, with remaining biotopes requiring more detailed assessment. Coral gardens were only found on positive geomorphic features, namely parasitic cones and radial ridges, found both sides of the seamount over a depth of 1311-1740 m. Two cold-water coral reefs (equivalent to summit reef) were mapped on the NW side of the seamount; Lophelia pertusa reef associated with the cliff top mounds at a depth of 747-791 m and Solenosmilia variabilis reef on a radial ridge at a depth of 1318-1351 m. Xenophyophore communities were mapped from both sides of the seamount at a depth of 1099-1770 m and were either associated with geomorphic features or were in close proximity (< 100 m) to them. The sponge dominated community was found on the steep escarpment either side of the seamount over at a depth of 854-1345 m. Multivariate diversity revealed the xenophyophore biotopes to be the least diverse, and a hard substratum biotope characterised by serpulids and the sessile holothurian, Psolus squamatus, as the most diverse.	[Davies, Jaime S.; Spicer, John; Howell, Kerry L.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Stewart, Heather A.] British Geol Survey, Edinburgh EH9 3LA, Midlothian, Scotland; [Narayanaswamy, Bhavani E.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Jacobs, Colin] Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Golding, Neil] Joint Nat Conservat Comm, Peterborough PE1 1JY, Cambs, England	University of Plymouth; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; UHI Millennium Institute; NERC National Oceanography Centre; University of Southampton	Davies, JS (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	jaime.davies@plymouth.ac.uk		Howell, Kerry/0000-0003-3359-1778; Stewart, Heather Ann/0000-0002-5590-6972; Narayanaswamy, Bhavani/0000-0002-5810-9127	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Deep Sea Forum; Scottish Funding Council [HR09011]; Joint Nature Conservation Committee; NERC [bgs05015, noc010011] Funding Source: UKRI; Natural Environment Research Council [noc010011, bgs05015] Funding Source: researchfish	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Deep Sea Forum; Scottish Funding Council; Joint Nature Conservation Committee; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work received funding from the MASTS pooling initiative, (The Marine Alliance for Science and Technology for Scotland), specifically from the Deep Sea Forum and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council, (grant reference HR09011) and contributing institutions. The work was funded by the Joint Nature Conservation Committee; they had some input in the study design to meet their survey objectives.	[Anonymous], 2007, M WORK GROUP MAR PRO; [Anonymous], 2009, FAO INT GUID MAN DEE; Barham E. G., 1968, Underwater Naturalist, V5, P24; Bett BJ, 2001, CONT SHELF RES, V21, P917, DOI 10.1016/S0278-4343(00)00119-9; Bruntse G, 2001, MARINE BIOL INVESTIG, P80; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Cairns Stephen D., 1992, Scientia Marina, V56, P125; CARPINE C, 1975, Bulletin de l'Institut Oceanographique (Monaco), V71, P1; CBD, 2008, 920 CBD; Chivers AJ, 2013, BIOGEOSCIENCES, V10, P3535, DOI 10.5194/bg-10-3535-2013; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, PRIMER V6 2006 USER; Coggan R, 2007, RECOMMENDED OEPRATIN; Convention on Biological Diversity (CBD), 2004, TECHN ADV EST MAN NA; Dahl Friedr., 1908, Zoologischer Anzeiger Leipzig, V33; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; Davies C.E., 2004, EUNIS HABITAT CLASSI, DOI DOI 10.1051/ACAROLOGIA/20162245; Davies JS, 2014, DEEP-SEA RES PT II, V104, P208, DOI 10.1016/j.dsr2.2014.02.001; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; de Haas H, 2009, FACIES, V55, P1, DOI 10.1007/s10347-008-0157-1; De Mol B, 2002, MAR GEOL, V188, P193, DOI 10.1016/S0025-3227(02)00281-5; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; Duran Munoz P, 2007, 2007A01 ICES CM, P17; ELLETT DJ, 1986, P ROY SOC EDINB B, V88, P61, DOI 10.1017/S0269727000004474; FREDERIKSEN R, 1992, SARSIA, V77, P157, DOI 10.1080/00364827.1992.10413502; Freiwald A, 2004, UN ENV PROGRAMME WOR, V22, P84; GAGE JD, 1986, P ROY SOC EDINB B, V88, P159, DOI 10.1017/S026972700000453X; Garcia-Alegre A, 2014, DEEP-SEA RES PT II, V106, P151, DOI 10.1016/j.dsr2.2013.12.012; GOODAY A, 1984, SARSIA, V69, P45, DOI 10.1080/00364827.1984.10420588; GOODAY AJ, 1983, DEEP-SEA RES, V30, P591, DOI 10.1016/0198-0149(83)90038-9; GOODAY AJ, 1991, J FORAMIN RES, V21, P197, DOI 10.2113/gsjfr.21.3.197; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; GRASSHOFF M, 1981, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V3, P731; GRASSHOFF M, 1981, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V3, P941; Grasshoff M., 1977, Meteor Forschungsergebnisse Reihe D - Biologie, V27D, P5; Grasshoff M., 1973, Meteor ForschErgebn (Biol), VNo. 13, P1; GRASSHOFF M, 1972, Meteor Forschungsergebnisse Reihe D - Biologie, V10, P73; GRASSHOFF M, 1981, Steenstrupia, V7, P213; GRASSHOFF M, 1985, Senckenbergiana Maritima, V17, P65; Greene HG, 1999, OCEANOL ACTA, V22, P663, DOI 10.1016/S0399-1784(00)88957-4; HAEDRICH RL, 1980, MAR BIOL, V57, P165, DOI 10.1007/BF00390735; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hayek L.C., 1997, SURVEYING NATURAL PO; Heap AD, 2008, AUST J EARTH SCI, V55, P555, DOI 10.1080/08120090801888669; Heifetz J, 2005, FISH OCEANOGR, V14, P131, DOI 10.1111/j.1365-2419.2005.00371.x; Hellmann JJ, 1999, ECOL APPL, V9, P824, DOI 10.1890/1051-0761(1999)009[0824:BPAAOF]2.0.CO;2; Henry LA, 2007, DEEP-SEA RES PT I, V54, P654, DOI 10.1016/j.dsr.2007.01.005; Howell KL, 2010, J MAR BIOL ASSOC UK, V90, P33, DOI 10.1017/S0025315409991299; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Howell KL, 2010, BIOL CONSERV, V143, P1041, DOI 10.1016/j.biocon.2010.02.001; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; Howell KL, 2010, MAR ECOL S1, V31, P1; Howell KL, 2007, STRATEGIC ENV ASSESS, P163; Howell KL, 2010, DEEP SEA SPECIES CAT; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; Hughes DJ, 2004, PROG OCEANOGR, V63, P29, DOI 10.1016/j.pocean.2004.09.002; Hughes JA, 2002, NEWSLETTER MICROPALA, V66, P15; ICES, 2008, ICES ADVICE, P1; JENSEN A, 1992, SARSIA, V77, P53, DOI 10.1080/00364827.1992.10413492; Johnson C, 2010, DEEP-SEA RES PT I, V57, P1153, DOI 10.1016/j.dsr.2010.07.006; JONES EJW, 1994, OCEANOL ACTA, V17, P237; JONES EJW, 1974, NATURE, V251, P129, DOI 10.1038/251129a0; Kenyon NH, 2003, MAR GEOL, V195, P5, DOI 10.1016/S0025-3227(02)00680-1; KINZIE RA, 1973, B MAR SCI, V23, P93; Lande R, 2000, OIKOS, V89, P601, DOI 10.1034/j.1600-0706.2000.890320.x; Larsson AI, 2011, MAR POLLUT BULL, V62, P1159, DOI 10.1016/j.marpolbul.2011.03.041; Laubier L., 1985, CAMPAGNE BIOGAS, P629; Le Danois E., 1948; LEVIN LA, 1994, PALAIOS, V9, P32, DOI 10.2307/3515076; LEVIN LA, 1986, MAR ECOL PROG SER, V29, P99, DOI 10.3354/meps029099; LEVIN LA, 1991, AM ZOOL, V31, P886; LEVIN LA, 1988, DEEP-SEA RES, V35, P2003, DOI 10.1016/0198-0149(88)90122-7; LONSDALE P, 1979, OCEANOL ACTA, V2, P91; Ludwig J.A., 1998, STAT ECOLOGY PRIMER, P337; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; Mienis F, 2009, DEEP-SEA RES PT I, V56, P1026, DOI 10.1016/j.dsr.2009.01.006; Moore Jon A., 2008, Bulletin of the Peabody Museum of Natural History, V49, P31, DOI 10.3374/0079-032X(2008)49[31:FBNHIT]2.0.CO;2; Mortensen PB, 2008, DEEP-SEA RES PT II, V55, P142, DOI 10.1016/j.dsr2.2007.09.018; Mortensen PB, 2009, NORW J GEOL, V89, P163; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Narayanaswamy BE, 2006, STRATEGIC ENV ASSESS, P178; Narayanaswamy BE, 2013, DEEP-SEA RES PT II, V92, P79, DOI 10.1016/j.dsr2.2013.03.004; NEAFC. North East Atlantic Fisheries Commission, 2007, REC N E ATL FISH COM; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; OSPAR, 2010, BIOD SER, P38; OSPAR, 2009, M OSPAR COMM OSPAR B; Parin NV, 1997, ADV MAR BIOL, V32, P145; Paterson G.L.J., 1985, P491; Pfannkuche O., 2004, GEOBIOLOGICAL INVEST; Rex M.A., 1983, SEA, P453; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Richardson PL., 1980, J GEOPHYS RES, V96; ROBERTS DG, 1974, DEEP-SEA RES, V21, P175, DOI 10.1016/0011-7471(74)90057-6; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2003, MAR POLLUT BULL, V46, P7, DOI 10.1016/S0025-326X(02)00259-X; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rowe GT, 1983, SEA, P97; Sanchez F, 2008, J MARINE SYST, V72, P64, DOI 10.1016/j.jmarsys.2007.04.008; Sanchez F, 2009, CONT SHELF RES, V29, P1174, DOI 10.1016/j.csr.2009.01.004; Sanchez F, 2014, DEEP-SEA RES PT II, V106, P118, DOI 10.1016/j.dsr2.2013.12.014; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2010.00396.x; Shank TM, 2010, OCEANOGRAPHY, V23, P108, DOI 10.5670/oceanog.2010.65; SHIRES R, 1994, J FORAMIN RES, V24, P214, DOI 10.2113/gsjfr.24.4.214; SIBUET M, 1977, DEEP-SEA RES, V24, P549, DOI 10.1016/0146-6291(77)90527-6; Stewart H, JNCC OFFSHORE NATURA; Stewart HA, 2014, DEEP-SEA RES PT II, V104, P230, DOI 10.1016/j.dsr2.2013.08.018; STODDART DR, 1969, BIOL REV, V44, P433, DOI 10.1111/j.1469-185X.1969.tb00609.x; Tendal O.S., 1972, GALATHEA REP, V12, P7; Thiem O, 2006, J MARINE SYST, V60, P207, DOI 10.1016/j.jmarsys.2005.12.004; Tracey DM, 2011, MAR ECOL PROG SER, V430, P1, DOI 10.3354/meps09164; Turnewitsch R, 2013, EARTH-SCI REV, V127, P203, DOI 10.1016/j.earscirev.2013.10.005; Wheeler AJ, 2007, INT J EARTH SCI, V96, P37, DOI 10.1007/s00531-006-0130-6; White M, 2005, ERLANGEN EARTH CONF, P503, DOI 10.1007/3-540-27673-4_25; Wienberg C, 2008, FACIES, V54, P1, DOI 10.1007/s10347-007-0118-0; WILSON JB, 1979, J MAR BIOL ASSOC UK, V59, P165, DOI 10.1017/S0025315400046257	117	36	36	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0124815	10.1371/journal.pone.0124815	http://dx.doi.org/10.1371/journal.pone.0124815			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992572	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000354917300010
J	Perez-Cruz, M; Costa, C; Manez, R				Perez-Cruz, Magdiel; Costa, Cristina; Manez, Rafael			Divergence of the Response Induced by Xenogenic Immunization in the Sepsis Survival of Rats	PLOS ONE			English	Article							NATURAL ANTIBODIES; LEPTIN; IMMUNOGLOBULIN; LIPOPOLYSACCHARIDE; INFLAMMATION; MACROPHAGES; CLEARANCE; MORTALITY; BACTERIA; HUMANS	We have previously described that boosted natural xenoantibodies in rats cross-react to bacteria by targeting carbohydrate antigens. This type of immunization is associated with reduced survival after cecal ligation and puncture (CLP). In the present study, we investigated further this phenomenon by immunizing Lewis rats with three intraperitoneal injections, every other day, of hamster blood compared to saline-injected control animals. One day after the last injection, CLP was performed to produce a low-grade sepsis. Induction of xenoantibodies was associated with a reduction in animal survival after CLP relative to controls (45% vs. 90%, p<0.01). No bacterial blood load was observed after CLP in this model either with or without xenoantibody enhancement, indicating that the augmented mortality was not mediated by a direct effect of boosted xenoantibodies over blood bacteria. Nevertheless, the xenoimmunization produced a systemic inflammatory response in all rats. Additionally, a lack of weight gain at the time of CLP was present in animals that died after the procedure, which was not observed in surviving rats and controls. The cytokine profile at the time of CLP in animals that died after the procedure was characterized by an increase in the serum level of several cytokines, particularly adipokines. In contrast, the cytokine profile at CLP of xenoimmunized rats that survived the procedure was characterized by a reduction in the level of cytokines. In conclusion, this study failed to show a direct effect of boosted xenoantibodies over blood bacterial isolates as cause for the decreased survival after CLP. However, it evidenced that non-infectious systemic inflammation may lead to a pattern of augmented cytokines, particularly adipokines, which impairs survival after subsequent CLP. Therefore, the profile of cytokines existing before the infectious insult appears more crucial than that resulting from the condition for the outcome of sepsis.	[Perez-Cruz, Magdiel; Costa, Cristina; Manez, Rafael] Hosp Llobregat, Bellvitge Biomed Res Inst IDIBELL, Infect Dis & Transplantat Div, Barcelona, Spain; [Manez, Rafael] Hosp Llobregat, Bellvitge Univ Hosp, Dept Intens Care, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Manez, R (corresponding author), Hosp Llobregat, Bellvitge Biomed Res Inst IDIBELL, Infect Dis & Transplantat Div, Barcelona, Spain.	rmanez@bellvitgehospital.cat	Pérez-Cruz, Magdiel/AAC-6164-2020; Costa, Cristina/AAP-4005-2020	Pérez-Cruz, Magdiel/0000-0003-1215-2100; Costa, Cristina/0000-0002-1837-4268; Manez, Rafael/0000-0002-0884-5564	"Fondo de Investigaciones Sanitarias" (FIS) from Carlos III Health Institute [PI05/0861, PI10/01727]; Spanish Ministry of Health; European Commission's Seventh Framework Programme grant TRANSLINK Collaborative Project [HEALTH-F4-2013-603049]; IDIBELL; Ramon y Cajal program from the Spanish Ministry of Education and Science	"Fondo de Investigaciones Sanitarias" (FIS) from Carlos III Health Institute; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Commission's Seventh Framework Programme grant TRANSLINK Collaborative Project; IDIBELL; Ramon y Cajal program from the Spanish Ministry of Education and Science(German Research Foundation (DFG))	This work was supported by "Fondo de Investigaciones Sanitarias" (FIS) grants PI05/0861 and PI10/01727 from Carlos III Health Institute, Spanish Ministry of Health (www.isciii.es), and European Commission's Seventh Framework Programme grant HEALTH-F4-2013-603049 TRANSLINK Collaborative Project (www.ec.europa.eu/research/fp7). MPC was funded by an IDIBELL fellowship (www.idibell.cat) and CC by the Ramon y Cajal program from the Spanish Ministry of Education and Science (www.idi.mineco.gob.es) and IDIBELL.	Barbier M, 1998, GUT, V43, P783, DOI 10.1136/gut.43.6.783; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Cai BL, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/642462; Chen YF, 2009, J IMMUNOL, V183, P1346, DOI 10.4049/jimmunol.0900948; Cramer DV, 2000, XENOTRANSPLANTATION, V7, P83, DOI 10.1034/j.1399-3089.2000.00061.x; Cui XZ, 2006, J INFECT DIS, V193, P829, DOI 10.1086/500468; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Ebong S, 1999, INFECT IMMUN, V67, P6603; Ebong SJ, 1999, SHOCK, V12, P118, DOI 10.1097/00024382-199908000-00005; Elinav E, 2006, J AM GERIATR SOC, V54, P1719, DOI 10.1111/j.1532-5415.2006.00921.x; Fjell CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079207; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GALILI U, 1993, BLOOD, V82, P2485, DOI 10.1182/blood.V82.8.2485.bloodjournal8282485; GALILI U, 1988, INFECT IMMUN, V56, P1730, DOI 10.1128/IAI.56.7.1730-1737.1988; HAMADEH RM, 1992, J CLIN INVEST, V89, P1223, DOI 10.1172/JCI115706; Heimberger O, 1999, NEPHROL DIAL TRANSPL, V14, P723, DOI 10.1093/ndt/14.3.723; HRISCHEV P, 2012, J BIOSCI BIOTECHNO S, V1, P63; Kaveri SV, 2012, J IMMUNOL, V188, P939, DOI 10.4049/jimmunol.1102107; Kolonko A, 2008, PERITON DIALYSIS INT, V28, P527; Krempler F, 2000, ARTERIOSCL THROM VAS, V20, P443, DOI 10.1161/01.ATV.20.2.443; Lvovschi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028870; Manez R, 2001, XENOTRANSPLANTATION, V8, P15, DOI 10.1034/j.1399-3089.2001.00082.x; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Osuchowski MF, 2009, CRIT CARE MED, V37, P1567, DOI 10.1097/CCM.0b013e31819df06b; Perez-Cruz M, 2014, J INNATE IMMUN, V6, P140, DOI 10.1159/000355305; Perez-Fontan M, 2006, AM J KIDNEY DIS, V48, P972; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Saadia R, 1999, J ACCID EMERG MED, V16, P163; Schwartz-Albiez R, 2009, CLIN EXP IMMUNOL, V158, P43, DOI [10.1111/j.1365-2249.2009.04026.X, 10.1111/j.1365-2249.2009.04026.x]; Shapiro NI, 2010, J IMMUNOL, V185, P517, DOI 10.4049/jimmunol.0903975; Skurnik D, 2012, CLIN INFECT DIS, V55, P1188, DOI 10.1093/cid/cis624; Sterns T, 2005, INFECT IMMUN, V73, P4905, DOI 10.1128/IAI.73.8.4905-4912.2005; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Xiao HY, 2006, INFECT IMMUN, V74, P5227, DOI 10.1128/IAI.01220-05; Yamanaka YJ, 2013, TRENDS IMMUNOL, V34, P59, DOI 10.1016/j.it.2012.10.006; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Zhang Y, 2009, J IMMUNOL, V182, P554, DOI 10.4049/jimmunol.182.1.554	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125472	10.1371/journal.pone.0125472	http://dx.doi.org/10.1371/journal.pone.0125472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984763	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300017
J	Yang, CW; Sun, XF; Li, C; Ni, HJ; Zhu, XD; Yang, SC; Li, M				Yang, Changwei; Sun, Xiaofei; Li, Chao; Ni, Haijian; Zhu, Xiaodong; Yang, Shichang; Li, Ming			Could CCI or FBCI Fully Eliminate the Impact of Curve Flexibility When Evaluating the Surgery Outcome for Thoracic Curve Idiopathic Scoliosis Patient? A Retrospective Study	PLOS ONE			English	Article							PEDICLE-SCREW; HYBRID INSTRUMENTATION; LUMBAR SCOLIOSIS; THORACOLUMBAR; CONSTRUCTS; PREDICTION; FUSION; INDEX; HOOKS; WIRES	Purpose To clarify if CCI or FBCI could fully eliminate the influence of curve flexibility on the coronal correction rate. Methods We reviewed medical record of all thoracic curve AIS cases undergoing posterior spinal fusion with all pedicle screw systems from June 2011 to July 2013. Radiographical data was collected and calculated. Student t test, Pearson correlation analysis and linear regression analysis were used to analyze the data. Results 60 were included in this study. The mean age was 14.7y (10-18y) with 10 males (17%) and 50 females (83%). The average Risser sign was 2.7. The mean thoracic Cobb angle before operation was 51.9 degrees. The mean bending Cobb angle was 27.6 degrees and the mean fulcrum bending Cobb angle was 17.4 degrees. The mean Cobb angle at 2 week after surgery was 16.3 degrees. The Pearson correlation coefficient r between CCI and BFR was -0.856(P<0.001), and between FBCI and FFR was -0.728 (P<0.001). A modified FBCI (M-FBCI) = (CR-0.513)/BFR or a modified CCI (M-CCI) = (CR-0.279)/FFR was generated by curve estimation has no significant correlation with FFR (r=-0.08, p=0.950) or with BFR (r=0.123, p=0.349). Conclusions Fulcrum-bending radiographs may better predict the outcome of AIS coronal correction than bending radiographs in thoracic curveAIS patients. Neither CCI nor FBCI can fully eliminate the impact of curve flexibility on the outcome of correction. A modified CCI or FBCI can better evaluating the corrective effects of different surgical techniques or instruments.	[Yang, Changwei; Sun, Xiaofei; Li, Chao; Ni, Haijian; Zhu, Xiaodong; Li, Ming] Second Mil Med Univ, Changhai Hosp, Dept Spine Surg, Shanghai 200433, Peoples R China; [Li, Chao] 304 Hosp Peoples Liberat Army, Dept Orthoped, Beijing 100048, Peoples R China; [Yang, Shichang] Gen Hosp Peoples Liberat Army, Dept Nerve Internal Med, Beijing 100853, Peoples R China; [Yang, Shichang] Fourth Mil Med Univ, Xijing Hosp, Dept Nerve Internal Med, Xian 710032, Peoples R China	Naval Medical University; Chinese People's Liberation Army General Hospital; Air Force Military Medical University	Li, M (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Spine Surg, Shanghai 200433, Peoples R China.	limingch@21cn.com			"1255" Project Foundation of Changhai Hospital, Shanghai, China	"1255" Project Foundation of Changhai Hospital, Shanghai, China	This study was funded by "1255" Project Foundation of Changhai Hospital, Shanghai, China.	Barr SJ, 1997, SPINE, V22, P1369, DOI 10.1097/00007632-199706150-00016; Cheng I, 2005, SPINE, V30, P2104, DOI 10.1097/01.brs.0000179261.70845.b7; Cheung KMC, 1997, J BONE JOINT SURG AM, V79A, P1144, DOI 10.2106/00004623-199708000-00005; Cheung WY, 2010, SPINE, V35, P557, DOI 10.1097/BRS.0b013e3181b9cfa9; de Gauzy JS, 2011, J CHILD ORTHOP, V5, P273, DOI 10.1007/s11832-011-0357-z; Dobbs MB, 2006, SPINE, V31, P2386, DOI 10.1097/01.brs.0000238965.81013.c5; Dobbs MB, 2006, SPINE, V31, P2400, DOI 10.1097/01.brs.0000240212.31241.8e; Kaneda K, 1996, SPINE, V21, P1250, DOI 10.1097/00007632-199605150-00021; Karatoprak O, 2008, INT ORTHOP, V32, P523, DOI 10.1007/s00264-007-0359-0; Kim YJ, 2006, SPINE, V31, P291, DOI 10.1097/01.brs.0000197865.20803.d4; KING HA, 1983, J BONE JOINT SURG AM, V65, P1302, DOI 10.2106/00004623-198365090-00012; Klepps S J, 2001, Spine (Phila Pa 1976), V26, pE74, DOI 10.1097/00007632-200103010-00002; Lowenstein JE, 2007, SPINE, V32, P448, DOI 10.1097/01.brs.0000255030.78293.fd; LUK KDK, 1989, SPINE, V14, P275, DOI 10.1097/00007632-198903000-00006; Luk KDK, 1998, SPINE, V23, P2303, DOI 10.1097/00007632-199811010-00011; Mazda K, 2009, EUR SPINE J, V18, P158, DOI 10.1007/s00586-008-0839-y; Sun YQ, 2011, EUR SPINE J, V20, P144, DOI 10.1007/s00586-010-1534-3; Vora V, 2007, SPINE, V32, P1869, DOI 10.1097/BRS.0b013e318108b912; Watanabe K, 2008, SPINE, V33, P1084, DOI 10.1097/BRS.0b013e31816f5f3a; WOJCIK AS, 1989, SPINE, V14, P625, DOI 10.1097/00007632-198906000-00016; Yang CW, 2012, ARCH ORTHOP TRAUM SU, V132, P633, DOI 10.1007/s00402-011-1454-7	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126380	10.1371/journal.pone.0126380	http://dx.doi.org/10.1371/journal.pone.0126380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984945	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300039
J	Lin, CM; Huang, HL; Chu, FY; Fan, HC; Chen, HA; Chu, DM; Wu, LW; Wang, CC; Chen, WL; Lin, SH; Ho, SY				Lin, Chien-Ming; Huang, Hui-Ling; Chu, Fang-Ying; Fan, Hueng-Chuen; Chen, Hung-An; Chu, Der-Ming; Wu, Li-Wei; Wang, Chung-Ching; Chen, Wei-Liang; Lin, Shih-Hua; Ho, Shinn-Ying			Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER-RISK; IN-VIVO; METFORMIN; INSULIN; GROWTH; LIVER; INCREASES; MORTALITY; TAIWANESE	Background The relationship between diabetes mellitus (DM) and cancer incidence has been evaluated in limited kinds of cancer. The effect of anti-diabetic therapy (ADT) on carcinogenesis among diabetic patients is also unclear. Materials and Methods Using population-based representative insurance claims data in Taiwan, 36,270 DM patients and 145,080 comparison subjects without DM were identified from claims from 2005 to 2010. The association between the top ten leading causes of cancer-related death in Taiwan and DM was evaluated. Whether ADT altered the risk of developing cancer was also investigated. Results Incidence of cancer at any site was significantly higher in patients with DM than in those without (p<0.001). The risk of carcinogenesis imparted by DM was greatest in gastroenterological malignancies (liver, pancreas, and colorectal cancer) as well as lung, breast and oral cancer (p<0.001). Among the oral types of ADT, metformin decreased the risk of lung and liver cancer, but had less effect on reducing the risk of colorectal cancer. alpha-glucosidase inhibitor decreased the risk of developing liver, colorectal, and breast cancer. Apart from intermediateacting insulin, rapid-acting, long-acting, and combination insulin treatment significantly reduced the overall cancer risk among all DM patients. In subgroup analysis, long-acting insulin treatment significantly decreased the risk of lung, liver, and colorectal cancer. Conclusion Our results supported the notion that pre-existing DM increases the incidence of gastroenterological cancer. ADT, especially metformin, alpha-glucosidase inhibitor, and long-acting insulin treatment, may protect patients with DM against these malignancies. It is crucial that oncologists should closely collaborate with endocrinologists to provide an optimal cancerspecific therapy and diabetic treatment to patients simultaneously with cancer and DM.	[Lin, Chien-Ming; Fan, Hueng-Chuen; Chu, Der-Ming] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pediat, Taipei, Taiwan; [Lin, Chien-Ming; Wu, Li-Wei; Wang, Chung-Ching; Chen, Wei-Liang] Grad Inst Med Sci, Natl Def Med Ctr, Taipei, Taiwan; [Huang, Hui-Ling; Chu, Fang-Ying; Chen, Hung-An; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Huang, Hui-Ling; Ho, Shinn-Ying] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Wu, Li-Wei; Wang, Chung-Ching; Chen, Wei-Liang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Family & Community Med, Taipei, Taiwan; [Lin, Shih-Hua] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Nephrol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Ho, SY (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	syho@mail.nctu.edu.tw	Ho, Shinn-Ying/AFD-8402-2022; Ho, Shinn-Ying/AAE-9394-2022	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353	Tri-Service General Hospital [(TSGH)-C103-019]; National Science Council of Taiwan [NSC-103-2221-E009-117-]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. [103W962]; USTUCSD International Center of Excellence in Advanced Bioengineering - Taiwan National Science Council I-RiCE Program [NSC-103-2911-I-009-101]	Tri-Service General Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C.; USTUCSD International Center of Excellence in Advanced Bioengineering - Taiwan National Science Council I-RiCE Program	This work was supported by grant number Tri-Service General Hospital (TSGH)-C103-019. This work was also funded by National Science Council of Taiwan under the contract number NSC-103-2221-E009-117-, and "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. for the project 103W962. This work was also supported in part by the USTUCSD International Center of Excellence in Advanced Bioengineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC-103-2911-I-009-101.	Algire C, 2008, ENDOCR-RELAT CANCER, V15, P833, DOI 10.1677/ERC-08-0038; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Donadon V, 2009, WORLD J GASTROENTERO, V15, P2506, DOI 10.3748/wjg.15.2506; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hassan MM, 2010, CANCER-AM CANCER SOC, V116, P1938, DOI 10.1002/cncr.24982; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; HEUSON JC, 1972, CANCER RES, V32, P226; Jiang Y., 2009, Plant Biology (Rockville), V2009, P111; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Lee MY, 2012, METABOLISM, V61, P242, DOI 10.1016/j.metabol.2011.06.020; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; Ministry of Health and Welfare Taiwan, 2012, CAUS DEATH STAT; Monami M, 2009, ACTA DIABETOL, V46, P279, DOI 10.1007/s00592-008-0083-2; Pinheiro SP, 2005, CANCER EPIDEM BIOMAR, V14, P2147, DOI 10.1158/1055-9965.EPI-04-0944; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Welfare MoHa Taiwan, 2010, CANC REG ANN REP; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhang H, 2007, CANCER RES, V67, P391, DOI 10.1158/0008-5472.CAN-06-1712	34	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125421	10.1371/journal.pone.0125421	http://dx.doi.org/10.1371/journal.pone.0125421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978841	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100026
J	Lintott, PR; Bunnefeld, N; Minderman, J; Fuentes-Montemayor, E; Mayhew, RJ; Olley, L; Park, KJ				Lintott, Paul R.; Bunnefeld, Nils; Minderman, Jeroen; Fuentes-Montemayor, Elisa; Mayhew, Rebekah J.; Olley, Lena; Park, Kirsty J.			Differential Responses to Woodland Character and Landscape Context by Cryptic Bats in Urban Environments	PLOS ONE			English	Article							2 PHONIC TYPES; PIPISTRELLUS-PIPISTRELLUS; INSECTIVOROUS BATS; ECHOLOCATION CALLS; HABITAT SELECTION; SPECIES RICHNESS; BIODIVERSITY; URBANIZATION; MORPHOLOGY; BEHAVIOR	Urbanisation is one of the most dramatic forms of land use change which relatively few species can adapt to. Determining how and why species respond differently to urban habitats is important in predicting future biodiversity loss as urban areas rapidly expand. Understanding how morphological or behavioural traits can influence species adaptability to the built environment may enable us to improve the effectiveness of conservation efforts. Although many bat species are able to exploit human resources, bat species richness generally declines with increasing urbanisation and there is considerable variation in the responses of different bat species to urbanisation. Here, we use acoustic recordings from two cryptic, and largely sympatric European bat species to assess differential responses in their use of fragmented urban woodland and the surrounding urban matrix. There was a high probability of P. pygmaeus activity relative to P. pipistrellus in woodlands with low clutter and understory cover which were surrounded by low levels of built environment. Additionally, the probability of recording P. pygmaeus relative to P. pipistrellus was considerably higher in urban woodland interior or edge habitat in contrast to urban grey or non-wooded green space. These results show differential habitat use occurring between two morphologically similar species; whilst the underlying mechanism for this partitioning is unknown it may be driven by competition avoidance over foraging resources. Their differing response to urbanisation indicates the difficulties involved when attempting to assess how adaptable a species is to urbanisation for conservation purposes.	[Lintott, Paul R.; Bunnefeld, Nils; Fuentes-Montemayor, Elisa; Mayhew, Rebekah J.; Olley, Lena; Park, Kirsty J.] Univ Stirling, Sch Nat Sci, Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Minderman, Jeroen] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of Stirling; University of St Andrews	Lintott, PR (corresponding author), Univ Stirling, Sch Nat Sci, Biol & Environm Sci, Stirling FK9 4LA, Scotland.	p.r.lintott@stir.ac.uk		Fuentes-Montemayor, Elisa/0000-0002-5550-9432; Minderman, Jeroen/0000-0002-8451-5540; Park, Kirsty/0000-0001-6080-7197; Mayhew, Rebekah J./0000-0003-4463-0787; Bunnefeld, Nils/0000-0002-1349-4463; Lintott, Paul/0000-0003-1594-1850	University of Stirling; British Ecological Society [3266 / 4045]	University of Stirling; British Ecological Society	This research was funded by the University of Stirling (www.stir.ac.uk) and the British Ecological Society (Grant number: 3266 / 4045; http://www.britishecologicalsociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; Barlow KE, 1997, ANIM BEHAV, V53, P991, DOI 10.1006/anbe.1996.0398; Barlow KE, 1997, J ZOOL, V243, P597, DOI 10.1111/j.1469-7998.1997.tb02804.x; Barlow KE, 1997, P ROY SOC B-BIOL SCI, V264, P1695, DOI 10.1098/rspb.1997.0235; Barlow KE, 1999, Z SAUGETIERKD, V64, P257; Bates D., 2013, LME4 LINEAR MIXED EF; Corben C., 2006, ANALOOKW BAT CALL AN; Cornelis J, 2004, LANDSCAPE URBAN PLAN, V69, P385, DOI 10.1016/j.landurbplan.2003.10.038; Croci S, 2008, LANDSCAPE ECOL, V23, P1171, DOI 10.1007/s10980-008-9257-0; Davidson-Watts I, 2006, J ZOOL, V268, P55, DOI 10.1111/j.1469-7998.2005.00016.x; Davidson-Watts I, 2006, BIOL CONSERV, V133, P118, DOI 10.1016/j.biocon.2006.05.027; EDINA Digimap Ordnance Survey Service, 2014, OS MAST TOP LAYER; ESRI Inc, 2014, ARCGIS 10; Faraway JJ., 2005, EXTENDING LINEAR MOD; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; Fischer JD, 2015, CONSERV BIOL, V29, P1246, DOI 10.1111/cobi.12451; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Fuentes-Montemayor E, 2013, AGR ECOSYST ENVIRON, V172, P6, DOI 10.1016/j.agee.2013.03.019; Fuentes-Montemayor E, 2011, BIOL CONSERV, V144, P2233, DOI 10.1016/j.biocon.2011.05.015; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; Gehrt SD, 2003, ECOL APPL, V13, P939, DOI 10.1890/02-5188; Gelman A., 2007, DATA ANAL USING REGR; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hale JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033300; Haussler U, 1999, EXTERNAL CHARACTERS, V37, P27; James P, 2009, URBAN FOR URBAN GREE, V8, P65, DOI 10.1016/j.ufug.2009.02.001; Johnson Joshua B., 2008, Urban Ecosystems, V11, P227, DOI 10.1007/s11252-008-0055-x; JONES G, 1993, P ROY SOC B-BIOL SCI, V251, P119, DOI 10.1098/rspb.1993.0017; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; KALKO EKV, 1993, BEHAV ECOL SOCIOBIOL, V33, P415; Lacki M.J., 2007, BATS FORESTS CONSERV; Lane DJW, 2006, BIOL CONSERV, V131, P584, DOI 10.1016/j.biocon.2006.03.005; Li YY, 2014, BEHAV ECOL SOCIOBIOL, V68, P657, DOI 10.1007/s00265-013-1680-9; Lintott PR, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140200; Lintott PR, 2013, WILDLIFE RES, V40, P675, DOI 10.1071/WR13153; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Mathews F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0124; Matsuoka RH, 2008, LANDSCAPE URBAN PLAN, V84, P7, DOI 10.1016/j.landurbplan.2007.09.009; McGarigal K., 2002, FRAGSTATS SPATIAL PA; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Muller J, 2013, FOREST ECOL MANAG, V306, P179, DOI 10.1016/j.foreco.2013.06.043; Nicholls B, 2006, BEHAV ECOL SOCIOBIOL, V61, P131, DOI 10.1007/s00265-006-0244-7; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Roche N, 2011, ANIM CONSERV, V14, P642, DOI 10.1111/j.1469-1795.2011.00470.x; Russ JM, 2002, BIOL CONSERV, V108, P49, DOI 10.1016/S0006-3207(02)00089-7; Russo D, 2014, Z SAUGETIER IN PRESS; Sachteleben J, 2006, ACTA CHIROPTEROL, V8, P391, DOI 10.3161/1733-5329(2006)8[391:SBAMSO]2.0.CO;2; Safi K, 2004, CONSERV BIOL, V18, P1293, DOI 10.1111/j.1523-1739.2004.00155.x; Smith DA, 2010, RESTOR ECOL, V18, P914, DOI 10.1111/j.1526-100X.2009.00538.x; Threlfall CG, 2012, BIOL CONSERV, V146, P41, DOI 10.1016/j.biocon.2011.11.026; Vaughan N, 1997, J APPL ECOL, V34, P716, DOI 10.2307/2404918; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; Zipperer WC, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P298; Zuur Alain F., 2009, P1	56	18	18	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126850	10.1371/journal.pone.0126850	http://dx.doi.org/10.1371/journal.pone.0126850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978034	Green Published, gold			2022-12-27	WOS:000354916100107
J	Liu, X; Zuo, HY; Wang, DW; Peng, RY; Song, T; Wang, SM; Xu, XP; Gao, YB; Li, Y; Wang, SX; Wang, LF; Zhao, L				Liu, Xiao; Zuo, Hongyan; Wang, Dewen; Peng, Ruiyun; Song, Tao; Wang, Shuiming; Xu, Xinping; Gao, Yabing; Li, Yang; Wang, Shaoxia; Wang, Lifeng; Zhao, Li			Improvement of Spatial Memory Disorder and Hippocampal Damage by Exposure to Electromagnetic Fields in an Alzheimer's Disease Rat Model	PLOS ONE			English	Article							MAGNETIC-FIELD; NEURODEGENERATIVE DISEASES; MESSENGER-RNA; BRAIN; CELLS; TAU; CONSOLIDATION; NEUROGENESIS; DYSFUNCTION; POPULATION	Although some epidemiological investigations showed a potential association between long-term exposure of extremely low frequency electromagnetic fields (ELF-EMF) and Alzheimer's disease (AD), no reasonable mechanism can explain this association, and the related animal experiments are rare. In this study, ELF-EMF exposure (50Hz 400 mu T 60d) combined with D-galactose intraperitoneal (50mg/kg, q.d., 42d) and A beta(25-35) hippocampal (5 mu l/unilateral, bilateral, single-dose) injection was implemented to establish a complex rat model. Then the effects of ELF-EMF exposure on AD development was studied by using the Morris water maze, pathological analysis, and comparative proteomics. The results showed that ELF-EMF exposure delayed the weight gain of rats, and partially improved cognitive and clinicopathologic symptoms of AD rats. The differential proteomic analysis results suggest that synaptic transmission, oxidative stress, protein degradation, energy metabolism, Tau aggregation, and inflammation involved in the effects mentioned above. Therefore, our findings indicate that certain conditions of ELF-EMF exposure could delay the development of AD in rats.	[Liu, Xiao; Zuo, Hongyan; Wang, Dewen; Peng, Ruiyun; Wang, Shuiming; Xu, Xinping; Gao, Yabing; Li, Yang; Wang, Shaoxia; Wang, Lifeng; Zhao, Li] Beijing Inst Radiat Med, Dept Expt Pathol, Beijing, Peoples R China; [Song, Tao] Chinese Acad Sci, Inst Elect Engn, Beijing Key Lab Bioelectromagnetism, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese Academy of Sciences; Institute of Electrical Engineering, CAS	Zuo, HY (corresponding author), Beijing Inst Radiat Med, Dept Expt Pathol, 27 Taiping Rd, Beijing, Peoples R China.	zuohy2005@126.com; wangdewen1938@126.com	Zuo, Hongyan/ABD-5614-2020; Song, Tao/AAE-2145-2022	song, tao/0000-0001-7070-7819	National Natural Science Foundation of China [51037006, 51307181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (51037006; 51307181).	Andel R, 2010, J GERONTOL A-BIOL, V65, P1220, DOI 10.1093/gerona/glq112; [Anonymous], 2011, HLTH PHYS, V100, P112; Aydin S, 2012, BIOGERONTOLOGY, V13, P251, DOI 10.1007/s10522-011-9370-3; Bai WF, 2013, CYTOTHERAPY, V15, P961, DOI 10.1016/j.jcyt.2013.03.001; Balassa T, 2009, ACTA PHYSIOL HUNG, V96, P437, DOI 10.1556/APhysiol.96.2009.4.4; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Barsam T, 2012, IRAN J ENVIRON HEALT, V9, DOI 10.1186/1735-2746-9-15; Broussard G. Joseph, 2012, Inflammopharmacology, V20, P109, DOI 10.1007/s10787-012-0130-z; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Dong SZ, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-18; Ferrer-Acosta Y, 2013, J NEUROCHEM, V125, P921, DOI 10.1111/jnc.12155; Foldi Istvan, 2011, J Neurochem, V117, P691, DOI 10.1111/j.1471-4159.2011.07238.x; Foroozandeh E, 2011, J AM SCI, V7, P58; Foroozandeh E, 2013, TOXICOL IND HEALTH, V29, P293, DOI 10.1177/0748233711433931; Furuya TK, 2012, NEUROSCIENCE, V220, P41, DOI 10.1016/j.neuroscience.2012.06.035; Garcia AM, 2008, INT J EPIDEMIOL, V37, P329, DOI 10.1093/ije/dym295; Goemaere J, 2012, J COMP NEUROL, V520, P258, DOI 10.1002/cne.22689; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Guo Li-li, 2011, Zhong Yao Cai, V34, P237; Hakansson N, 2003, EPIDEMIOLOGY, V14, P420, DOI 10.1097/01.EDE.0000078446.76859.c9; He YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076495; Huang JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067284; Hug K, 2006, SOZ PRAVENTIV MED, V51, P210, DOI 10.1007/s00038-006-5096-4; Huss A, 2009, AM J EPIDEMIOL, V169, P167, DOI 10.1093/aje/kwn297; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Jadidi M, 2007, NEUROBIOL LEARN MEM, V88, P387, DOI 10.1016/j.nlm.2007.07.010; Kumar S, 2013, ELECTROMAGN BIOL MED, V32, P471, DOI 10.3109/15368378.2012.743907; Lemeshko BY, 2005, MEAS TECH+, V48, P536; Liu S, 2013, NEURAL REGEN RES, V8, P2800, DOI 10.3969/j.issn.1673-5374.2013.30.002; Liu X, 2013, AEROSP MANUF TECHNOL, V1, P1, DOI DOI 10.1109/TNNLS.2013.2287275; Manczak M, 2013, J ALZHEIMERS DIS, V36, P285, DOI 10.3233/JAD-130275; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Morabito C, 2010, CELL PHYSIOL BIOCHEM, V26, P947, DOI 10.1159/000324003; Park SA, 2010, NEUROCHEM INT, V56, P886, DOI 10.1016/j.neuint.2010.03.014; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Ravera S, 2010, BIOELECTROMAGNETICS, V31, P270, DOI 10.1002/bem.20563; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Suszynski K, 2014, ELECTROMAGN BIOL MED, V33, P198, DOI 10.3109/15368378.2013.801351; Szemerszky R, 2010, BRAIN RES BULL, V81, P92, DOI 10.1016/j.brainresbull.2009.10.015; Tajes M, 2013, HISTOL HISTOPATHOL, V28, P43, DOI 10.14670/HH-28.43; Tasset I, 2012, NEUROSCIENCE, V209, P54, DOI 10.1016/j.neuroscience.2012.02.034; Vitale M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/728178; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang XS, 2013, BIOELECTROMAGNETICS, V34, P275, DOI 10.1002/bem.21775; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; World Health Organization, 2007, EXTR LOW FREQ FIELDS; Yang Y, 2012, NEUROSCI LETT, V516, P15, DOI 10.1016/j.neulet.2012.03.022; Yin YY, 2013, PHARMACOL BIOCHEM BE, V106, P77, DOI 10.1016/j.pbb.2013.03.005; Young JK, 2013, HIPPOCAMPUS, V23, P1476, DOI 10.1002/hipo.22200; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071087	52	32	35	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126963	10.1371/journal.pone.0126963	http://dx.doi.org/10.1371/journal.pone.0126963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978363	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100117
J	Yu, P; Li, XX; White, PJ; Li, CJ				Yu, Peng; Li, Xuexian; White, Philip J.; Li, Chunjian			A Large and Deep Root System Underlies High Nitrogen-Use Efficiency in Maize Production	PLOS ONE			English	Article							REDUCING ENVIRONMENTAL RISK; PHENOTYPIC PLASTICITY; SHOOT RATIOS; YIELD; NUTRIENT; MANAGEMENT; HYBRIDS; TRENDS; GROWTH; CHINA	Excessive N fertilization results in low N-use efficiency (NUE) without any yield benefits and can have profound, long-term environmental consequences including soil acidification, N leaching and increased production of greenhouse gases. Improving NUE in crop production has been a longstanding, worldwide challenge. A crucial strategy to improve NUE is to enhance N uptake by roots. Taking maize as a model crop, we have compared root dry weight (RDW), root/shoot biomass ratio (R/S), and NUE of maize grown in the field in China and in western countries using data from 106 studies published since 1959. Detailed analysis revealed that the differences in the RDW and R/S of maize at silking in China and the western countries were not derived from variations in climate, geography, and stress factors. Instead, NUE was positively correlated with R/S and RDW; R/S and NUE of maize varieties grown in western countries were significantly greater than those grown in China. We then testified this conclusion by conducting field trials with representative maize hybrids in China (ZD958 and XY335) and the US (P32D79). We found that US P32D79 had a better root architecture for increased N uptake and removed more mineral N than Chinese cultivars from the 0-60 cm soil profile. Reported data and our field results demonstrate that a large and deep root, with an appropriate architecture and higher stress tolerance (higher plant density, drought and N deficiency), underlies high NUE in maize production. We recommend breeding for these traits to reduce the N-fertilizer use and thus N-leaching in maize production and paying more attention to increase tolerance to stresses in China.	[Yu, Peng; Li, Xuexian; Li, Chunjian] China Agr Univ, Coll Resources & Environm Sci, Dept Plant Nutr, Beijing 100193, Peoples R China; [White, Philip J.] James Hutton Inst, Ecol Sci, Dundee DD2 5DA, Scotland	China Agricultural University; James Hutton Institute	Li, CJ (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Dept Plant Nutr, Beijing 100193, Peoples R China.	lichj@cau.edu.cn	White, Philip John/C-5860-2008	White, Philip John/0000-0003-0827-288X	National Natural Science Foundation of China [31272232]; State Key Basic Research and Development Plan of China [2013CB127402]; Chinese Universities Scientific Fund [2012YJ039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Plan of China(National Basic Research Program of China); Chinese Universities Scientific Fund	The research is supported by the National Natural Science Foundation of China (No: 31272232), the State Key Basic Research and Development Plan of China (No. 2013CB127402), and Chinese Universities Scientific Fund (No. 2012YJ039).	Aikio S, 2002, EVOL ECOL, V16, P67, DOI 10.1023/A:1016096309637; Amos B, 2006, SOIL SCI SOC AM J, V70, P1489, DOI 10.2136/sssaj2005.0216; Bohm W., 1979, METHODS STUDYING ROO; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; CARTER P R, 1988, Journal of Production Agriculture, V1, P295; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Chen G.P., 2009, J MAIZE SCI, V17, P89; Chen XC, 2013, GLOBAL CHANGE BIOL, V19, P923, DOI 10.1111/gcb.12093; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chen YanLing, 2012, Plant Nutrition and Fertilizer Science, V18, P52; Ci XK, 2011, CROP SCI, V51, P13, DOI 10.2135/cropsci2010.04.0207; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Dawson CJ, 2011, FOOD POLICY, V36, pS14, DOI 10.1016/j.foodpol.2010.11.012; Den Herder G, 2010, TRENDS PLANT SCI, V15, P600, DOI 10.1016/j.tplants.2010.08.009; Dunbabin V, 2003, PLANT CELL ENVIRON, V26, P835, DOI 10.1046/j.1365-3040.2003.01015.x; Dunbabin VM, 2002, PLANT SOIL, V239, P39, DOI 10.1023/A:1014952728942; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; Dwyer LM, 1996, CAN J SOIL SCI, V76, P23, DOI 10.4141/cjss96-004; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gedroc JJ, 1996, FUNCT ECOL, V10, P44, DOI 10.2307/2390260; Gewin V, 2010, NATURE, V466, P552, DOI 10.1038/466552a; Grassini P, 2012, P NATL ACAD SCI USA, V109, P1074, DOI 10.1073/pnas.1116364109; Grassini P, 2011, FIELD CROP RES, V120, P142, DOI 10.1016/j.fcr.2010.09.012; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; HAMBLIN AP, 1985, AUST J AGR RES, V36, P63, DOI 10.1071/AR9850063; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; HILBERT DW, 1990, ANN BOT-LONDON, V66, P91, DOI 10.1093/oxfordjournals.aob.a088005; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043507; Li L, 2006, OECOLOGIA, V147, P280, DOI 10.1007/s00442-005-0256-4; Li ShaoKun, 2009, Scientia Agricultura Sinica, V42, P1941; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Ma BL, 2003, CAN J PLANT SCI, V83, P241, DOI 10.4141/P02-052; Marschener H, 1998, FIELD CROP RES, V56, P203, DOI 10.1016/S0378-4290(97)00131-7; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; MCCULLY ME, 1988, PLANT SOIL, V111, P159, DOI 10.1007/BF02139932; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x; Ning P, 2014, FIELD CROP RES, V166, P66, DOI 10.1016/j.fcr.2014.06.009; OSAKI M, 1995, SOIL SCI PLANT NUTR, V41, P635, DOI 10.1080/00380768.1995.10417014; Peng YF, 2010, FIELD CROP RES, V115, P85, DOI 10.1016/j.fcr.2009.10.006; SIDDIQUE KHM, 1990, PLANT SOIL, V121, P89, DOI 10.1007/BF00013101; Sun QingQuan, 2003, Acta Agronomica Sinica, V29, P641; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; VARNEY GT, 1991, ANN BOT-LONDON, V67, P357; Waines JG, 2007, ANN BOT-LONDON, V100, P991, DOI 10.1093/aob/mcm180; Waisel Y, 2002, PLANT ROOTS HIDDEN H, P243; Wang K.J., 2001, ACTA PHYS SIN-CH ED, V25, P472; Wang TY, 2011, CROP SCI, V51, P512, DOI 10.2135/cropsci2010.06.0383; White PJ, 2013, ANN BOT-LONDON, V112, P207, DOI 10.1093/aob/mct123; WHITE PJ, 2012, APPL ENVIRON SOIL SC; Wu YongChang, 1998, Acta Agronomica Sinica, V24, P595; Yang X, 2007, CLIMATIC CHANGE, V84, P45, DOI 10.1007/s10584-007-9265-0; Yu P, 2014, PLANTA, V240, P667, DOI 10.1007/s00425-014-2150-y; Zhang FS, 2013, NATURE, V497, P33, DOI 10.1038/497033a; Zhang FS, 2012, ADV AGRON, V116, P1, DOI 10.1016/B978-0-12-394277-7.00001-4; Zhang FS, 2011, J ENVIRON QUAL, V40, P1051, DOI 10.2134/jeq2010.0292; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	64	44	48	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126293	10.1371/journal.pone.0126293	http://dx.doi.org/10.1371/journal.pone.0126293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978356	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100061
J	Carallo, C; Scavelli, FB; Cipolla, M; Merante, V; Medaglia, V; Irace, C; Gnasso, A				Carallo, Claudio; Scavelli, Faustina Barbara; Cipolla, Maurizio; Merante, Valentina; Medaglia, Valeria; Irace, Concetta; Gnasso, Agostino		Progetto Diabete Calabria	Management of Type 2 Diabetes Mellitus through Telemedicine	PLOS ONE			English	Article							HEALTH	Background Type 2 diabetes mellitus T2DM has a huge and growing burden on public health, whereas new care models are not implemented into clinical practice; in fact the purpose of this study was to test the effectiveness of a program of integrated care for T2DM, compared with ordinary diligence. Methods "Progetto Diabete Calabria" is a new organizational model for the management of patients with diabetes mellitus, based on General Practitioners (GPs) empowerment and the use of a web-based electronic health record, shared in remote consultations among GPs and Hospital Consultants. One-year change in glucose and main cardiovascular risk factors control in 104 patients (Cases) following this integrated care program has been evaluated and compared with that of 208 control patients (Controls) matched for age, gender, and cardiometabolic profile, and followed in an ordinary outpatient medical management by the Consultants only. Both patient groups had Day Hospitals before and after the study period. Results The mean number of accesses to the Consultants during the study was 0.6 +/- 0.9 for Cases, and 1.3 +/- 1.5 for Controls (p<0.0001). At follow-up, glycated hemoglobin (HbA1c) significantly decreased from 58 +/- 6 to 54 +/- 8 mmol/ mol in Cases only (p=0.01); LDL cholesterol decreased in both groups; body mass index decreased in Cases only, from 31.0 +/- 4.8 to 30.5 +/- 4.6 kg/m(2) (p=0.03). Conclusions The present study demonstrates that a health care program based on GPs empowerment and taking care plus remote consultation with Consultants is at least as effective as standard outpatient management, in order to improve the control of T2DM.	[Carallo, Claudio; Scavelli, Faustina Barbara; Merante, Valentina; Medaglia, Valeria; Irace, Concetta; Gnasso, Agostino; Progetto Diabete Calabria] Magna Graecia Univ Catanzaro, Mater Domini Hosp, Dept Clin & Expt Med, Metab Dis Unit, Catanzaro, Italy; [Cipolla, Maurizio] Natl Hlth Serv, Catanzaro, Italy	Magna Graecia University of Catanzaro	Gnasso, A (corresponding author), Magna Graecia Univ Catanzaro, Mater Domini Hosp, Dept Clin & Expt Med, Metab Dis Unit, Catanzaro, Italy.	gnasso@unicz.it	Irace, Concetta/AAC-7796-2022	IRACE, Concetta/0000-0001-5182-5473; Carallo, Claudio/0000-0002-3958-3245				Abrahamian H, 2002, J TELEMED TELECARE, V8, P350, DOI 10.1258/135763302320939248; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2005, PREV CHRON DIS VIT I; Aprile V, 2007, 0710ISTISAN; Bruno G, 2011, NUTR METAB CARDIOVAS, V21, P302, DOI 10.1016/j.numecd.2010.08.009; Druss BG, 2005, J MED LIBR ASSOC, V93, P499; Egan BM, 2013, CIRCULATION, V128, P29, DOI 10.1161/CIRCULATIONAHA.112.000500; Gomez EJ, 1996, MED INFORM, V21, P283, DOI 10.3109/14639239608999290; Home P, 2008, BRIT MED J, V336, P1306, DOI 10.1136/bmj.39560.442095.AD; IDF Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB; Irace C, 2009, CORONARY ARTERY DIS, V20, P94, DOI 10.1097/MCA.0b013e3283219e76; ISTAT, ANN STAT IT; Kumar S, 2013, AM J PREV MED, V45, P228, DOI 10.1016/j.amepre.2013.03.017; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Progetto Diabete Calabria Study Workgroup, 2013, GIDM, V33, P155, DOI [10.3265/Nefrologia.pre2013, DOI 10.3265/NEFROLOGIA.PRE2013]; Progetto IGEA, 2008, GEST INT DIAB MELL T; Progetto IGEA, 2012, GEST INT DIAB MELL T	17	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126858	10.1371/journal.pone.0126858	http://dx.doi.org/10.1371/journal.pone.0126858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974092	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600088
J	Curk, F; Ancillo, G; Ollitrault, F; Perrier, X; Jacquemoud-Collet, JP; Garcia-Lor, A; Navarro, L; Ollitrault, P				Curk, Franck; Ancillo, Gema; Ollitrault, Frederique; Perrier, Xavier; Jacquemoud-Collet, Jean-Pierre; Garcia-Lor, Andres; Navarro, Luis; Ollitrault, Patrick			Nuclear Species-Diagnostic SNP Markers Mined from 454 Amplicon Sequencing Reveal Admixture Genomic Structure of Modern Citrus Varieties	PLOS ONE			English	Article							BAC-END SEQUENCES; GENETIC DIVERSITY; POPULATION-STRUCTURE; ASCERTAINMENT BIAS; SSR MARKERS; CULTIVATED CITRUS; LINKAGE MAP; ORIGIN; RUTACEAE; GENERA	Most cultivated Citrus species originated from interspecific hybridisation between four ancestral taxa (C. reticulata, C. maxima, C. medica, and C. micrantha) with limited further interspecific recombination due to vegetative propagation. This evolution resulted in admixture genomes with frequent interspecific heterozygosity. Moreover, a major part of the phenotypic diversity of edible citrus results from the initial differentiation between these taxa. Deciphering the phylogenomic structure of citrus germplasm is therefore essential for an efficient utilization of citrus biodiversity in breeding schemes. The objective of this work was to develop a set of species-diagnostic single nucleotide polymorphism (SNP) markers for the four Citrus ancestral taxa covering the nine chromosomes, and to use these markers to infer the phylogenomic structure of secondary species and modern cultivars. Species-diagnostic SNPs were mined from 454 amplicon sequencing of 57 gene fragments from 26 genotypes of the four basic taxa. Of the 1,053 SNPs mined from 28,507 kb sequence, 273 were found to be highly diagnostic for a single basic taxon. Species-diagnostic SNP markers (105) were used to analyse the admixture structure of varieties and rootstocks. This revealed C. maxima introgressions in most of the old and in all recent selections of mandarins, and suggested that C. reticulata x C. maxima reticulation and introgression processes were important in edible mandarin domestication. The large range of phylogenomic constitutions between C. reticulata and C. maxima revealed in mandarins, tangelos, tangors, sweet oranges, sour oranges, grapefruits, and orangelos is favourable for genetic association studies based on phylogenomic structures of the germplasm. Inferred admixture structures were in agreement with previous hypotheses regarding the origin of several secondary species and also revealed the probable origin of several acid citrus varieties. The developed species-diagnostic SNP marker set will be useful for systematic estimation of admixture structure of citrus germplasm and for diverse genetic studies.	[Curk, Franck] INRA, Ctr Inra Corse, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, F-20230 San Giuliano, Corsica, France; [Curk, Franck; Ancillo, Gema; Ollitrault, Frederique; Garcia-Lor, Andres; Navarro, Luis; Ollitrault, Patrick] Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, Valencia 46113, Spain; [Perrier, Xavier; Jacquemoud-Collet, Jean-Pierre] Ctr Cooperat Int Rech Agron Dev Cirad, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, F-34398 Montpellier 5, France; [Ollitrault, Patrick] Ctr Cooperat Int Rech Agron Dev Cirad, Stn Roujol, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Petit Bourg 97170, Guadeloupe, France	INRAE; Instituto Valenciano de Investigaciones Agrarias (IVIA); CIRAD; CIRAD	Navarro, L (corresponding author), Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, Valencia 46113, Spain.	lnavarro@ivia.es; ollitrault@cirad.fr	Lor, Andres García/B-1246-2016; Navarro, Luis/D-1001-2012; Ancillo, Gema/ABF-8990-2020	Lor, Andres García/0000-0002-5625-5470; Navarro, Luis/0000-0001-5163-5960; JACQUEMOUD-COLLET, Jean-Pierre/0000-0001-8754-565X; CURK, Franck/0000-0003-0737-4104; PERRIER, Xavier/0000-0002-0092-003X; Ollitrault, Patrick/0000-0002-9456-5517	Ministry of 'Economia y Competitividad' [AGL2011-26490]; 'Fondo Europeo de Desarrollo Regional' (FEDER); Generalitat Valenciana, Spain [Prometeo II/2013/008]; Ministry of 'Economia y Competitividad' [AGL2011-26490]; 'Fondo Europeo de Desarrollo Regional' (FEDER); Generalitat Valenciana, Spain [Prometeo II/2013/008]	Ministry of 'Economia y Competitividad'; 'Fondo Europeo de Desarrollo Regional' (FEDER)(European CommissionSpanish Government); Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Ministry of 'Economia y Competitividad'; 'Fondo Europeo de Desarrollo Regional' (FEDER)(European CommissionSpanish Government); Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	This work was supported by a grant [AGL2011-26490] from the Ministry of 'Economia y Competitividad', 'Fondo Europeo de Desarrollo Regional' (FEDER) and a grant [Prometeo II/2013/008] from the Generalitat Valenciana, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barkley NA, 2009, PLANT SYST EVOL, V282, P71, DOI 10.1007/s00606-009-0208-2; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Belkhir K, 1996, 5000 CNRS UMR; Biswas MK, 2012, MOL BIOL REP, V39, P5373, DOI 10.1007/s11033-011-1338-5; Bradbury IR, 2011, MOL ECOL RESOUR, V11, P218, DOI 10.1111/j.1755-0998.2010.02949.x; Breto MP, 2001, MOL PHYLOGENET EVOL, V21, P285, DOI 10.1006/mpev.2001.1008; Carlson CS, 2006, HUM MOL GENET, V15, P1931, DOI 10.1093/hmg/ddl115; Chen D, 2008, NAT METHODS, V5, P323, DOI [10.1038/NMETH.1191, 10.1038/nmeth.1191]; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Cuppen Edwin, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4841; Curk F, BMC GENETIC IN PRESS; Curk F, 2012, ACTA HORTIC IN PRESS; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; de Moraes AP, 2007, CHROMOSOME RES, V15, P115, DOI 10.1007/s10577-006-1101-2; Dereeper A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-134; DNASTAR Inc, 2014, DNASTAR SOFTW LIF SC; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fanciullino AL, 2006, J AGR FOOD CHEM, V54, P4397, DOI 10.1021/jf0526644; Federici CT, 1998, THEOR APPL GENET, V96, P812, DOI 10.1007/s001220050807; Fluidigm Corp, 2014, ACC ARR SYST; Froelicher Y, 2011, TREE GENET GENOMES, V7, P49, DOI 10.1007/s11295-010-0314-x; Garcia-Lor A, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200406; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; Garcia-Lor A, 2012, MOL GENET GENOMICS, V287, P77, DOI 10.1007/s00438-011-0658-4; Gulsen O., 2001, Bahce, V30, P53; Gulsen O, 2001, J AM SOC HORTIC SCI, V126, P309, DOI 10.21273/JASHS.126.3.309; Herrero R, 1996, THEOR APPL GENET, V93, P1327, DOI 10.1007/BF00223466; Kijas JMH, 1997, THEOR APPL GENET, V94, P701, DOI 10.1007/s001220050468; Krueger RR, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P45, DOI 10.1079/9780851990194.0045; Life Sciences Corp, 2009, TECHN B GEN SEQ FLX, V005, P1; Life Sciences Corp, 2010, 454 SEQ SYST SOFTW M, P2; Liu SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075149; Luro F, 2011, PLANT GENET RESOUR-C, V9, P218, DOI 10.1017/S1479262111000189; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Mabberley D. J., 1997, Telopea, V7, P167; McCouch SR, 2010, BREEDING SCI, V60, P524, DOI 10.1270/jsbbs.60.524; Negrini R, 2010, 9 WORLD C GEN APPL L; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Nicolosi E, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P19, DOI 10.1079/9780851990194.0019; Ollitrault F, 2010, AM J BOT, V97, pE124, DOI 10.3732/ajb.1000280; Ollitrault P, 2014, ACTA HORTICULTURAE; Ollitrault Patrick, 2003, P193; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-593; Ollitrault P, 2012, HANDB PLANT BREED, V8, P623, DOI 10.1007/978-1-4419-0763-9_16; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Perrier X., 2006, DARWIN SOFTWARE; PRINSEQ, 2012, PREPROCESSING INFORM; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard Lab SU, 2014, STRUCT SOFTW; Ramadugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068410; Roose ML, 2009, 2 INT CITR BIOT S 28; Rosenblum EB, 2007, J HERED, V98, P331, DOI 10.1093/jhered/esm031; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Swingle W T, 1967, CITRUS IND, P190; Tanaka T, 1961, CITOLOGIA SEMICENTEN; Trask JAS, 2011, PRIMATES, V52, P129, DOI 10.1007/s10329-010-0232-4; Troggio M, 2007, GENETICS, V176, P2637, DOI 10.1534/genetics.106.067462; United States Department of Agriculture Agricultural Research Service Beltsville Area, 2014, GRIN TAX PLANTS; United States Department of Agriculture Agricultural Research Service Beltsville Area, 2013, GRIN TAX PLANTS; Uzun A, 2009, SCI HORTIC-AMSTERDAM, V121, P306, DOI 10.1016/j.scienta.2009.02.018; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Webber H.J., 1967, CITRUS IND, V1, P1; Webber HJ, 1943, CITRUS IND, V1, P475; Wright S., 1978, ANONYMOUS EVOLUTION; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472	73	58	58	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125628	10.1371/journal.pone.0125628	http://dx.doi.org/10.1371/journal.pone.0125628			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973611	Green Published, gold			2022-12-27	WOS:000354545600022
J	Khajuria, YP; Saxena, MS; Gaur, R; Chattopadhyay, D; Jain, M; Parida, SK; Bhatia, S				Khajuria, Yash Paul; Saxena, Maneesha S.; Gaur, Rashmi; Chattopadhyay, Debasis; Jain, Mukesh; Parida, Swarup K.; Bhatia, Sabhyata			Development and Integration of Genome-Wide Polymorphic Microsatellite Markers onto a Reference Linkage Map for Constructing a High-Density Genetic Map of Chickpea	PLOS ONE			English	Article							CICER-ARIETINUM L.; SEQUENCE; DIVERSITY; RESOURCE; DESIGN; CROP	The identification of informative in silico polymorphic genomic and genic microsatellite markers by comparing the genome and transcriptome sequences of crop genotypes is a rapid, cost-effective and non-laborious approach for large-scale marker validation and genotyping applications, including construction of high-density genetic maps. We designed 1494 markers, including 1016 genomic and 478 transcript-derived microsatellite markers showing in-silico fragment length polymorphism between two parental genotypes (Cicer arietinum ICC4958 and C. reticulatum PI489777) of an inter-specific reference mapping population. High amplification efficiency (87%), experimental validation success rate (81%) and polymorphic potential (55%) of these microsatellite markers suggest their effective use in various applications of chickpea genetics and breeding. Intra-specific polymorphic potential (48%) detected by microsatellite markers in 22 desi and kabuli chickpea genotypes was lower than inter-specific polymorphic potential (59%). An advanced, high-density, integrated and inter-specific chickpea genetic map (ICC4958 x PI489777) having 1697 map positions spanning 1061.16 cM with an average inter-marker distance of 0.625 cM was constructed by assigning 634 novel informative transcript-derived and genomic microsatellite markers on eight linkage groups (LGs) of our prior documented, 1063 marker-based genetic map. The constructed genome map identified 88, including four major (7-23 cM) longest high-resolution genomic regions on LGs 3, 5 and 8, where the maximum number of novel genomic and genic microsatellite markers were specifically clustered within 1 cM genetic distance. It was for the first time in chickpea that in silico FLP analysis at genome-wide level was carried out and such a large number of microsatellite markers were identified, experimentally validated and further used in genetic mapping. To best of our knowledge, in the presently constructed genetic map, we mapped highest number of new sequence-based robust microsatellite markers (634) which is an advancement over the previously documented (similar to 300 markers) inter-specific genetic maps. This advanced high-density map will serve as a foundation for large-scale marker validation and genotyping applications, including identification and targeted mapping of trait-specific genes/QTLs (quantitative trait loci) with sub-optimal use of resources and labour in chickpea.	[Khajuria, Yash Paul; Saxena, Maneesha S.; Gaur, Rashmi; Chattopadhyay, Debasis; Jain, Mukesh; Parida, Swarup K.; Bhatia, Sabhyata] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Bhatia, S (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	sabhyatabhatia@nipgr.ac.in		Jain, Mukesh/0000-0002-7622-1083; Bhatia, Sabhyata/0000-0003-0811-219X; Chattopadhyay, Debasis/0000-0002-5754-4987	National Institute of Plant Genome Research, New Delhi; Department of Biotechnology, Ministry of Science and Technology, Government of India	National Institute of Plant Genome Research, New Delhi; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This study was funded by the National Institute of Plant Genome Research, New Delhi and the Department of Biotechnology, Ministry of Science and Technology, Government of India.	Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; Anuradha C, 2011, EUPHYTICA, V182, P1, DOI 10.1007/s10681-011-0394-1; BECKMANN JS, 1990, BIO-TECHNOL, V8, P930, DOI 10.1038/nbt1090-930; Bharadwaj C, 2011, J GENET, V90, pE94, DOI 10.1007/s12041-011-0114-6; Choudhary S, 2012, THEOR APPL GENET, V124, P1449, DOI 10.1007/s00122-012-1800-3; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Gaur R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-117; Grover A, 2007, MOL GENET GENOMICS, V277, P469, DOI 10.1007/s00438-006-0204-y; Gujaria N, 2011, THEOR APPL GENET, V122, P1577, DOI 10.1007/s00122-011-1556-1; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Kujur A, 2013, DNA RES, V20, P355, DOI 10.1093/dnares/dst015; Kumar J, 2011, PLANT BREEDING, V130, P297, DOI 10.1111/j.1439-0523.2011.01851.x; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Nayak SN, 2010, THEOR APPL GENET, V120, P1415, DOI 10.1007/s00122-010-1265-1; Parida SK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-251; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Parida SK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-140; Radhika P, 2007, THEOR APPL GENET, V115, P209, DOI 10.1007/s00122-007-0556-7; Sethy NK, 2006, THEOR APPL GENET, V112, P1416, DOI 10.1007/s00122-006-0243-0; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027275; Vadez V, 2012, MOL BREEDING, V30, P9, DOI 10.1007/s11032-011-9594-6; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Winter P, 2000, THEOR APPL GENET, V101, P1155, DOI 10.1007/s001220051592; Zhang ZH, 2007, DNA RES, V14, P37, DOI 10.1093/dnares/dsm005	29	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125583	10.1371/journal.pone.0125583	http://dx.doi.org/10.1371/journal.pone.0125583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974327	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600020
J	Lee, JG; McKinney, KQ; Lee, YY; Chung, HN; Pavlopoulos, AJ; Jung, KY; Kim, WK; Kuroda, MJ; Han, DK; Hwang, S				Lee, Jin-Gyun; McKinney, Kimberly Q.; Lee, Yong-Yook; Chung, Hae-Na; Pavlopoulos, Antonis J.; Jung, Kook Y.; Kim, Woong-Ki; Kuroda, Marcelo J.; Han, David K.; Hwang, Sunil			A Draft Map of Rhesus Monkey Tissue Proteome for Biomedical Research	PLOS ONE			English	Article							HUMAN-GENOME-PROJECT; DATABASE; IDENTIFICATION; PROTEINS; MODEL; DISEASE	Though the rhesus monkey is one of the most valuable non-human primate animal models for various human diseases because of its manageable size and genetic and proteomic similarities with humans, proteomic research using rhesus monkeys still remains challenging due to the lack of a complete protein sequence database and effective strategy. To investigate the most effective and high-throughput proteomic strategy, comparative data analysis was performed employing various protein databases and search engines. The UniProt databases of monkey, human, bovine, rat and mouse were used for the comparative analysis and also a universal database with all protein sequences from all available species was tested. At the same time, de novo sequencing was compared to the SEQUEST search algorithm to identify an optimal work flow for monkey proteomics. Employing the most effective strategy, proteomic profiling of monkey organs identified 3,481 proteins at 0.5% FDR from 9 male and 10 female tissues in an automated, high-throughput manner. Data are available via ProteomeXchange with identifier PXD001972. Based on the success of this alternative interpretation of MS data, the list of proteins identified from 12 organs of male and female subjects will benefit future rhesus monkey proteome research.	[Lee, Jin-Gyun; McKinney, Kimberly Q.; Lee, Yong-Yook; Chung, Hae-Na; Pavlopoulos, Antonis J.; Jung, Kook Y.; Hwang, Sunil] Carolinas HealthCare Syst, Prote Lab Clin & Translat Res, Charlotte, NC 28232 USA; [Kim, Woong-Ki] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Kuroda, Marcelo J.] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Han, David K.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA; [Han, David K.] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT USA	Carolinas HealthCare System; Eastern Virginia Medical School; Tulane University; University of Connecticut; University of Connecticut	Han, DK (corresponding author), Carolinas HealthCare Syst, Prote Lab Clin & Translat Res, Charlotte, NC 28232 USA.	sunil.hwang@carolinas.org			Carolinas HealthCare System Cannon Research Grant [CRG 08-026]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	Carolinas HealthCare System Cannon Research Grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a Carolinas HealthCare System Cannon Research Grant (CRG 08-026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama K, 2011, BBA-PROTEINS PROTEOM, V1814, P265, DOI 10.1016/j.bbapap.2010.10.009; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cuny E, 2008, NEUROBIOL DIS, V30, P151, DOI 10.1016/j.nbd.2007.12.011; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Freeman WM, 2006, PROTEOMICS, V6, P3109, DOI 10.1002/pmic.200500717; Guttmacher AE, 2003, NEW ENGL J MED, V349, P996, DOI 10.1056/NEJMe038132; Korir CC, 2006, INFECT GENET EVOL, V6, P75, DOI 10.1016/j.meegid.2005.01.003; Muth T, 2010, PROTEOMICS, V10, P1522, DOI 10.1002/pmic.200900759; Nasrabadi D, 2009, J PROTEOME RES, V8, P1527, DOI 10.1021/pr800880v; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Connor CM, 2007, CURR TOP MICROBIOL, V312, P43; Oikawa S, 2009, FREE RADICAL BIO MED, V46, P1472, DOI 10.1016/j.freeradbiomed.2009.02.029; Pan C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-118; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ponten F, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.93; Sadygov RG, 2004, NAT METHODS, V1, P195, DOI 10.1038/NMETH725; Savitski MM, 2005, J PROTEOME RES, V4, P2348, DOI 10.1021/pr050288x; Tannu NS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-270; Taylor JA, 1997, RAPID COMMUN MASS SP, V11, P1067, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1067::AID-RCM953>3.0.CO;2-L; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wiederin JL, 2010, J PROTEOME RES, V9, P4721, DOI 10.1021/pr1004345; Yan L, 2004, J MOL CELL CARDIOL, V37, P921, DOI 10.1016/j.yjmcc.2004.06.012; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975	27	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126243	10.1371/journal.pone.0126243	http://dx.doi.org/10.1371/journal.pone.0126243			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974132	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600043
J	Liu, Y; Ye, J; Ogawa, LS; Inoue, T; Huang, Q; Chu, J; Bates, RC; Ying, W; Sonderfan, AJ; Rao, PE; Zhou, D				Liu, Yuan; Ye, Josephine; Ogawa, Luisa Shin; Inoue, Takayo; Huang, Qin; Chu, John; Bates, Richard C.; Ying, Weiwen; Sonderfan, Andrew J.; Rao, Patricia E.; Zhou, Dan			The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; T-CELLS; ELEVATED LEVELS; ACTIVATION; MICE; AUTOANTIBODIES; INFLAMMATION; INNATE; SAFETY; IL-6	Systemic lupus erythematosus (SLE) is a complex, systemic autoimmune disease with a diverse range of immunological and clinical manifestations. The introduction of broad spectrum immunosuppressive therapies and better management of acute disease exacerbations have improved outcomes for lupus patients over recent years. However, these regimens are burdened by substantial toxicities and confer significantly higher risks of infection, thus there remains a significant and unmet medical need for alternative treatment options, particularly those with improved safety profiles. Heat shock protein 90 (HSP90) is a ubiquitously expressed molecular chaperone that acts as an important modulator of multiple innate and adaptive inflammatory processes. Of note, accumulating clinical and experimental evidence has implicated a role for HSP90 in the pathogenesis of SLE. Here we evaluated the potential of HSP90 as a therapeutic target for this disease using the selective small molecule inhibitor ganetespib in the well-characterized MRL/lpr autoimmune mouse model. In both the prophylactic and therapeutic dosing settings, ganetespib treatment promoted dramatic symptomatic improvements in multiple disease parameters, including suppression of autoantibody production and the preservation of renal tissue integrity and function. In addition, ganetespib exerted profound inhibitory effects on disease-related lymphadenopathy and splenomegaly, and reduced pathogenic T and B cell lineage populations in the spleen. Ganetespib monotherapy was found to be equally efficacious and tolerable when compared to an effective weekly dosing regimen of the standard-of-care immunosuppressive agent cyclophosphamide. Importantly, co-treatment of ganetespib with a sub-optimal, intermittent dosing schedule of cyclophosphamide resulted in superior therapeutic indices and maximal disease control. These findings highlight the potential of HSP90 inhibition as an alternative, and potentially complementary, strategy for therapeutic intervention in SLE. Such approaches may have important implications for disease management, particularly for limiting or preventing treatment-related toxicities, a major confounding factor in current SLE therapy.	[Liu, Yuan; Ye, Josephine; Ogawa, Luisa Shin; Inoue, Takayo; Chu, John; Bates, Richard C.; Ying, Weiwen; Sonderfan, Andrew J.; Rao, Patricia E.; Zhou, Dan] Synta Pharmaceut Corp, Lexington, MA 02421 USA; [Huang, Qin] VA Boston Healthcare Syst, Dept Pharmacol & Lab Med, West Roxbury, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Zhou, D (corresponding author), Synta Pharmaceut Corp, Lexington, MA 02421 USA.	DZhou@syntapharma.com			Synta Pharmaceuticals Corp	Synta Pharmaceuticals Corp	The author(s) received no specific funding for this work. Synta Pharmaceuticals Corp provided support in the form of salaries for authors YL, JY, LSO, TI, JC, RB, WY, AS, PR and DZ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section".	Bae J, 2013, J IMMUNOL, V190, P1360, DOI 10.4049/jimmunol.1200593; Choi JY, 2006, ARTHRITIS RHEUM, V54, P3277, DOI 10.1002/art.22119; CONROY SE, 1994, BRIT J RHEUMATOL, V33, P923; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Dello Russo C, 2006, J NEUROCHEM, V99, P1351, DOI 10.1111/j.1471-4159.2006.04221.x; DHILLON VB, 1993, ANN RHEUM DIS, V52, P436, DOI 10.1136/ard.52.6.436; FAULDS G, 1995, BRIT J RHEUMATOL, V34, P610; FRAISER LH, 1991, DRUGS, V42, P781, DOI 10.2165/00003495-199142050-00005; Goldman JW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-152; He SQ, 2014, INVEST NEW DRUG, V32, P577, DOI 10.1007/s10637-014-0095-4; He SQ, 2013, INT J ONCOL, V42, P35, DOI 10.3892/ijo.2012.1698; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Katsifis GE, 2004, LUPUS, V13, P673, DOI 10.1191/0961203304lu2012oa; Kenderov A, 2002, CLIN EXP IMMUNOL, V129, P169, DOI 10.1046/j.1365-2249.2002.01887.x; Koga T, 2014, J CLIN INVEST, V124, P2234, DOI 10.1172/JCI73411; Kulkarni O, 2009, J PHARMACOL EXP THER, V328, P371, DOI 10.1124/jpet.108.142711; Lacotte S, 2010, J IMMUNOL, V184, P3937, DOI 10.4049/jimmunol.0902595; Lateef A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3919; Lisi L, 2013, J NEUROIMMUNOL, V255, P1, DOI 10.1016/j.jneuroim.2012.10.008; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Marian V, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3917; Mehal WZ, 1998, J IMMUNOL, V161, P1686; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; NORTON PM, 1989, J AUTOIMMUN, V2, P187, DOI 10.1016/0896-8411(89)90154-6; Oglesby A, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/347520; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; Proia DA, 2014, CANCER RES, V74, P1294, DOI 10.1158/0008-5472.CAN-13-3263; Putterman C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/437282; Rice JW, 2008, ARTHRITIS RHEUM-US, V58, P3765, DOI 10.1002/art.24047; Ripley BJM, 2001, J AUTOIMMUN, V17, P341, DOI 10.1006/jaut.2001.0549; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; Schnaider T, 2000, CELL STRESS CHAPERON, V5, P52, DOI 10.1379/1466-1268(2000)005<0052:THSIGS>2.0.CO;2; Seavey MM, 2011, CURR PROTOC PHARM, P60; Shimp SK, 2012, CELL MOL IMMUNOL, V9, P255, DOI 10.1038/cmi.2012.5; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stephanou A, 1998, SEMIN ARTHRITIS RHEU, V28, P155, DOI 10.1016/S0049-0172(98)80032-2; Stephanou A, 1998, J AUTOIMMUN, V11, P249, DOI 10.1006/jaut.1998.0194; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takada K, 2001, LUPUS, V10, P154, DOI 10.1191/096120301671376017; Tamura Y, 2012, CURR MOL MED, V12, P1198, DOI 10.2174/156652412803306710; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tukaj S, 2014, EXP DERMATOL, V23, P585, DOI 10.1111/exd.12476; Tukaj S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-10; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whitesell L, 2003, CURR CANCER DRUG TAR, V3, P349, DOI 10.2174/1568009033481787; Yildirim-Toruner C, 2011, J ALLERGY CLIN IMMUN, V127, P303, DOI 10.1016/j.jaci.2010.12.1087; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Yun TJ, 2011, J IMMUNOL, V186, P563, DOI 10.4049/jimmunol.1000222	53	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127361	10.1371/journal.pone.0127361	http://dx.doi.org/10.1371/journal.pone.0127361			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974040	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600112
J	Orsini, C; Avendano, M				Orsini, Chiara; Avendano, Mauricio			Macro-Economic Conditions and Infant Health: A Changing Relationship for Black and White Infants in the United States	PLOS ONE			English	Article							BIRTH-WEIGHT; DELAYED CHILDBEARING; RECESSIONS GOOD; MATERNAL AGE; MORTALITY; ECONOMY; OLDER; RISK	We study whether the relationship between the state unemployment rate at the time of conception and infant health, infant mortality and maternal characteristics in the United States has changed over the years 1980-2004. We use microdata on births and deaths for years 1980-2004 and find that the relationship between the state unemployment rate at the time of conception and infant mortality and birthweight changes over time and is stronger for blacks than whites. For years 1980-1989 increases in the state unemployment rate are associated with a decline in infant mortality among blacks, an effect driven by mortality from gestational development and birth weight, and complications of placenta while in utero. In contrast, state economic conditions are unrelated to black infant mortality in years 1990-2004 and white infant mortality in any period, although effects vary by cause of death. We explore potential mechanisms for our findings and, including mothers younger than 18 in the analysis, uncover evidence of age-related maternal selection in response to the business cycle. In particular, in years 1980-1989 an increase in the unemployment rate at the time of conception is associated with fewer babies born to young mothers. The magnitude and direction of the relationship between business cycles and infant mortality differs by race and period. Age-related selection into motherhood in response to the business cycle is a possible explanation for this changing relationship.	[Orsini, Chiara; Avendano, Mauricio] London Sch Econ & Polit Sci, London WC2A 2AE, England; [Avendano, Mauricio] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	University of London; London School Economics & Political Science; Harvard University; Harvard T.H. Chan School of Public Health	Orsini, C (corresponding author), London Sch Econ & Polit Sci, Cowdray House,Houghton St, London WC2A 2AE, England.	chrorsini@gmail.com	Avendano, Mauricio/C-9658-2018	Avendano, Mauricio/0000-0002-7295-2911	European Research Council (ERC) [263684]; National Institute of Ageing [R01AG037398, R01AG040248]; NATIONAL INSTITUTE ON AGING [R01AG040248, R01AG037398] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)); National Institute of Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Starting Researcher grant from the European Research Council (ERC) (grant No 263684). Mauricio Avendano is additionally supported by National Institute of Ageing (grants R01AG037398 and R01AG040248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Aparicio A, 2014, 8031 IZA DP; Ariizumi H, 2012, SOC SCI MED, V74, P1224, DOI 10.1016/j.socscimed.2011.12.038; Becker G.S., 1960, DEMOGRAPHIC EC CHANG, P209; Behrman JR, 2004, REV ECON STAT, V86, P586, DOI 10.1162/003465304323031139; Bitler M, J LABOR EC IN PRESS; Black SE, 2007, Q J ECON, V122, P409, DOI 10.1162/qjec.122.1.409; CNATTINGIUS S, 1992, JAMA-J AM MED ASSOC, V268, P886; Dehejia R, 2004, Q J ECON, V119, P1091, DOI 10.1162/0033553041502216; FRIEDE A, 1988, OBSTET GYNECOL, V72, P152; FRIEDE A, 1987, PUBLIC HEALTH REP, V102, P192; Granados JAT, 2005, INT J EPIDEMIOL, V34, P1194, DOI 10.1093/ije/dyi141; Greenstone M, MIT DEP EC WORKING P, V12, P27; Headley AJ, 2004, J NATL MED ASSOC, V96, P987; Hoynes H, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.3.27; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; McInerney M, 2012, J HEALTH ECON, V31, P744, DOI 10.1016/j.jhealeco.2012.06.002; Menclova AK, 2013, J FAM ECON ISS, V34, P400, DOI 10.1007/s10834-012-9339-7; Miller DL, 2009, AM ECON REV, V99, P122, DOI 10.1257/aer.99.2.122; Neumayer E, 2004, SOC SCI MED, V58, P1037, DOI 10.1016/S0277-9536(03)00276-4; Ruhm CJ, 2007, DEMOGRAPHY, V44, P829, DOI 10.1007/BF03208384; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Ruhm CJ, 2015, 19287 NBER; Sullivan FM, 2001, PAEDIATR PERINAT EP, V15, P144	25	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0123501	10.1371/journal.pone.0123501	http://dx.doi.org/10.1371/journal.pone.0123501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25974070	Green Published, Green Accepted, gold			2022-12-27	WOS:000354545600006
J	Rossi, AH; Farias, A; Fernandez, JE; Bonomi, HR; Goldbaum, FA; Berguer, PM				Rossi, Andres H.; Farias, Ana; Fernandez, Javier E.; Bonomi, Hernan R.; Goldbaum, Fernando A.; Berguer, Paula M.			Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; POLYMERIC BACTERIAL PROTEIN; BACILLUS-CALMETTE-GUERIN; DENDRITIC CELLS; TUMOR-CELLS; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; MULTIPLE DISPLAY; PHASE-III; EXPRESSION	Brucella Lumazine Synthase (BLS) is a highly immunogenic decameric protein which can accept the fusion of foreign proteins at its ten N-termini. These chimeras are very efficient to elicit systemic and oral immunity without adjuvants. BLS signaling via Toll-Like Receptor 4 (TLR4) regulates innate and adaptive immune responses, inducing dendritic cell maturation and CD8+ T-cell cytotoxicity. In this work we study the effect induced by BLS in TLR4-expressing B16 melanoma. In order to evaluate the effectiveness of BLS as a preventive vaccine, C57BL/6J mice were immunized with BLS or BLS-OVA, and 35 days later were subcutaneously inoculated with B16-OVA melanoma. BLS or BLS-OVA induced a significant inhibition of tumor growth, and 50% of mice immunized with the highest dose of BLS did not develop visible tumors. This effect was not observed in TLR4-deficient mice. For treatment experiments, mice were injected with BLS or BLS-OVA 2 days after the inoculation of B16 cells. Both treatments induced significant and equal tumor growth delay and increased survival. Moreover, BLS and BLS-OVA stimulation were also effective in TLR4-deficient mice. In order to study whether BLS has a direct effect on tumor cells, B16 cells were preincubated with BLS, and after 48h, cells were inoculated. Tumors induced by BLS-stimulated cells had inhibited growth and survival was increased. In the BLS group, 40% of mice did not develop tumors. This effect was abolished by the addition of TLR4/MD2 blocking antibody to cells before BLS stimulation. Our work demonstrates that BLS immunization induces a preventive antitumor response that depends on mice TLR4. We also show that BLS generates a therapeutic effect in mice inoculated with B16 cells. Our results show that BLS acts directly in cultured tumor cells via TLR4, highly suggesting that BLS elicits its therapeutic effects acting on the TLR4 from B16 melanoma cells.	[Rossi, Andres H.; Farias, Ana; Fernandez, Javier E.; Bonomi, Hernan R.; Goldbaum, Fernando A.; Berguer, Paula M.] Consejo Nacl Invest Cient & Tecn, IIBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Berguer, PM (corresponding author), Consejo Nacl Invest Cient & Tecn, IIBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina.	pauberguer@gmail.com	Berguer, Paula/AAI-6353-2020; Farias, Ana Rita/K-1944-2015; Bonomi, Hernán Ruy/D-8826-2019	Farias, Ana Rita/0000-0002-7686-4046; Bonomi, Hernán Ruy/0000-0002-1550-6181; Goldbaum, Fernando/0000-0001-6235-3002	Agencia Nacional para la Promocion Cientifica y Tecnologica ANPCyT [PICT 2011-2672, PICT 2013-0355, PICT 2010-1969]	Agencia Nacional para la Promocion Cientifica y Tecnologica ANPCyT(ANPCyT)	This work was supported in part by grants from the Agencia Nacional para la Promocion Cientifica y Tecnologica ANPCyT (http://www.agencia.gov.ar) to PMB (PICT 2011-2672 and PICT 2013-0355) and to FAG (PICT 2010-1969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2009, IMMUNOTHERAPY-UK, V1, P949, DOI [10.2217/imt.09.70, 10.2217/IMT.09.70]; Anderson C M, 1995, Oncology (Williston Park), V9, P1149; Anderson CM, 1995, ONCOLOGY WILLISTON P, V9, P67; Anderson CM, 1995, ONCOLOGY WILLISTON P, V9, P63; Andreani V, 2007, CANCER RES, V67, P10519, DOI 10.1158/0008-5472.CAN-07-0079; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Arkenau HT, 2011, BRIT J CANCER, V104, P392, DOI 10.1038/sj.bjc.6606030; Asprodites N, 2008, FASEB J, V22, P3628, DOI 10.1096/fj.08-108274; Atefi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028973; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Bellone M, 2000, J IMMUNOL, V165, P2651, DOI 10.4049/jimmunol.165.5.2651; Bergner PM, 2006, J IMMUNOL, V176, P2366, DOI 10.4049/jimmunol.176.4.2366; Berguer PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045705; Braden BC, 2000, J MOL BIOL, V297, P1031, DOI 10.1006/jmbi.2000.3640; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Craig PO, 2005, PROTEINS, V61, P1089, DOI 10.1002/prot.20635; Curti BD, 2015, MOL IMMUNOL, V67, P18, DOI 10.1016/j.molimm.2015.01.025; DELPRETE SA, 1984, CANCER TREAT REP, V68, P1403; Dennis LK, 1999, ARCH DERMATOL, V135, P275, DOI 10.1001/archderm.135.3.275; Earl TM, 2009, ANN SURG ONCOL, V16, P1043, DOI 10.1245/s10434-009-0325-8; Eiro N, 2013, ARCH DERMATOL RES, V305, P59, DOI 10.1007/s00403-012-1300-y; FIDLER IJ, 1976, CANCER RES, V36, P3608; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Furumoto K, 2004, J CLIN INVEST, V113, P774, DOI 10.1172/JCI200419762; Goldbaum FA, 1999, J MED MICROBIOL, V48, P833, DOI 10.1099/00222615-48-9-833; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Nunez NG, 2012, CANCER RES, V72, P592, DOI 10.1158/0008-5472.CAN-11-0534; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Jego G, 2006, LEUKEMIA, V20, P1130, DOI 10.1038/sj.leu.2404226; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Laplagne DA, 2004, PROTEINS, V57, P820, DOI 10.1002/prot.20248; Legha SS, 1997, SEMIN ONCOL, V24, pS39; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Mac Keon S, 2010, VACCINE, V28, P8162, DOI 10.1016/j.vaccine.2010.09.095; McCarthy Edward F, 2006, Iowa Orthop J, V26, P154; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Palucka K, 2009, ANN NY ACAD SCI, V1174, P88, DOI 10.1111/j.1749-6632.2009.05000.x; Panelli MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r8; Park HD, 2011, ONCOGENE, V30, P201, DOI 10.1038/onc.2010.401; Paulos CM, 2007, CLIN CANCER RES, V13, P5280, DOI 10.1158/1078-0432.CCR-07-1378; Rosas G, 2006, MICROBES INFECT, V8, P1277, DOI 10.1016/j.micinf.2005.12.006; Roux S, 2008, J CLIN INVEST, V118, P3751, DOI 10.1172/JCI35890; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Sato Y, 2009, CANCER MICROENVIRON, V2, pS205, DOI 10.1007/s12307-009-0022-y; Sautes-Fridman C, 2011, CANCER METAST REV, V30, P13, DOI 10.1007/s10555-011-9279-y; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Sciutto E, 2005, VACCINE, V23, P2784, DOI 10.1016/j.vaccine.2004.11.043; Seegenschmiedt MH, 1999, INT J RADIAT ONCOL, V44, P607, DOI 10.1016/S0360-3016(99)00066-8; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sheyhidin I, 2011, WORLD J GASTROENTERO, V17, P3745, DOI 10.3748/wjg.v17.i32.3745; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Spagnolo F, 2012, ARCH DERMATOL RES, V304, P177, DOI 10.1007/s00403-012-1223-7; Starska K, 2009, FOLIA HISTOCHEM CYTO, V47, P401, DOI 10.2478/v10042-009-0075-2; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tawbi HA, 2007, SEMIN ONCOL, V34, P532, DOI 10.1053/j.seminoncol.2007.09.008; Tewari R, 2012, J MOL MED, V90, P67, DOI 10.1007/s00109-011-0807-6; Thotathil Z, 2007, EXPERT OPIN INV DRUG, V16, P1391, DOI 10.1517/13543784.16.9.1391; Tillman DK, 2007, CUTIS, V79, P241; Tsan MF, 2006, SEMIN CANCER BIOL, V16, P32, DOI 10.1016/j.semcancer.2005.07.004; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Urosevic M, 2005, J NATL CANCER I, V97, P1143, DOI 10.1093/jnci/dji207; Von Euw EM, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-6; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Weiss SA, 2014, CURR TREAT OPTION ON, V15, P269, DOI 10.1007/s11864-014-0283-7; Yoo KH, 2012, EXP THER MED, V3, P221, DOI 10.3892/etm.2011.400; Zylberman V, 2004, J BIOL CHEM, V279, P8093, DOI 10.1074/jbc.M312035200	85	15	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126827	10.1371/journal.pone.0126827	http://dx.doi.org/10.1371/journal.pone.0126827			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973756	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600083
J	Watanabe, M; Ueda, T; Shibata, Y; Kumamoto, N; Shimada, S; Ugawa, S				Watanabe, Masaya; Ueda, Takashi; Shibata, Yasuhiro; Kumamoto, Natsuko; Shimada, Shoichi; Ugawa, Shinya			Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons	PLOS ONE			English	Article							RAT SENSORY NEURONS; INDUCED MECHANICAL HYPERALGESIA; NEUROPATHIC PAIN; CA2+ CHANNELS; PERIPHERAL NOCICEPTORS; DIABETIC-NEUROPATHY; CAPSAICIN RECEPTOR; REDOX MODULATION; HYDROGEN-SULFIDE; TRPV1 CHANNELS	The Cav3.2 isoform of the T-type calcium channel is expressed in primary sensory neurons of the dorsal root ganglion (DRG), and these channels contribute to nociceptive and neuropathic pain in rats. However, there are conflicting reports on the roles of these channels in pain processing in rats and mice. In addition, the function of T-type channels in persistent inflammatory hyperalgesia is poorly understood. We performed behavioral and comprehensive histochemical analyses to characterize Cav3.2-expressing DRG neurons and examined the regulation of T-type channels in DRGs from C57BL/6 mice with carrageenan-induced inflammatory hyperalgesia. We show that approximately 20% of mouse DRG neurons express Cav3.2 mRNA and protein. The size of the majority of Cav3.2-positive DRG neurons (69 +/- 8%) ranged from 300 to 700 mu m2 in cross-sectional area and 20 to 30 mu m in estimated diameter. These channels co-localized with either neurofilament-H (NF-H) or peripherin. The peripherin-positive cells also overlapped with neurons that were positive for isolectin B4 (IB4) and calcitonin gene-related peptide (CGRP) but were distinct from transient receptor potential vanilloid 1 (TRPV1)-positive neurons during normal mouse states. In mice with carrageenan-induced inflammatory hyperalgesia, Cav3.2 channels, but not Cav3.1 or Cav3.3 channels, were upregulated in ipsilateral DRG neurons during the sub-acute phase. The increased Cav3.2 expression partially resulted from an increased number of Cav3.2-immunoreactive neurons; this increase in number was particularly significant for TRPV1-positive neurons. Finally, preceding and periodic intraplantar treatment with the T-type calcium channel blockers mibefradil and NNC 55-0396 markedly reduced and reversed mechanical hyperalgesia during the acute and sub-acute phases, respectively, in mice. These data suggest that Cav3.2 T-type channels participate in the development of inflammatory hyperalgesia, and this channel might play an even greater role in the sub-acute phase of inflammatory pain due to increased co-localization with TRPV1 receptors compared with that in the normal state.	[Watanabe, Masaya; Ueda, Takashi; Shibata, Yasuhiro; Kumamoto, Natsuko; Ugawa, Shinya] Nagoya City Univ, Grad Sch Med Sci, Dept Anat & Neurosci, Nagoya, Aichi, Japan; [Shimada, Shoichi] Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, Suita, Osaka, Japan	Nagoya City University; Osaka University	Ueda, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Anat & Neurosci, Nagoya, Aichi, Japan.	tueda@med.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24590281]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The research was supported in part by Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 24590281 (TU). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLEAKMAN D, 1990, BRIT J PHARMACOL, V101, P423, DOI 10.1111/j.1476-5381.1990.tb12725.x; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Btesh J, 2013, J NEUROSCI, V33, P9184, DOI 10.1523/JNEUROSCI.4991-12.2013; CARDENAS CG, 1995, J NEUROPHYSIOL, V74, P1870, DOI 10.1152/jn.1995.74.5.1870; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Choi S, 2007, GENES BRAIN BEHAV, V6, P425, DOI 10.1111/j.1601-183X.2006.00268.x; Choucair-Jaafar N, 2009, BRIT J PHARMACOL, V158, P1683, DOI 10.1111/j.1476-5381.2009.00510.x; Comunanza V, 2011, PFLUG ARCH EUR J PHY, V462, P709, DOI 10.1007/s00424-011-1023-5; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Dogrul A, 2003, PAIN, V105, P159, DOI 10.1016/S0304-3959(03)00177-5; Escoffier J, 2007, J CELL PHYSIOL, V212, P753, DOI 10.1002/jcp.21075; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Haanpaa M, 2012, EUR NEUROL, V68, P264, DOI 10.1159/000339944; Helyes Z, 2009, P NATL ACAD SCI USA, V106, P13088, DOI 10.1073/pnas.0900681106; Heppenstall PA, 2006, CELL CALCIUM, V40, P165, DOI 10.1016/j.ceca.2006.04.021; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; JANCSO G, 1990, NEUROSCIENCE, V39, P501, DOI 10.1016/0306-4522(90)90286-D; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kawabata A, 2007, PAIN, V132, P74, DOI 10.1016/j.pain.2007.01.026; Khomula EV, 2013, BBA-MOL BASIS DIS, V1832, P636, DOI 10.1016/j.bbadis.2013.01.017; Mantyh PW, 1998, NEURON, V21, P644, DOI 10.1016/S0896-6273(00)80575-9; Menendez L, 2004, LIFE SCI, V74, P3235, DOI 10.1016/j.lfs.2003.11.019; Nelson MT, 2005, J NEUROSCI, V25, P8766, DOI 10.1523/JNEUROSCI.2527-05.2005; Obradovic AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091467; Okubo K, 2012, BRIT J PHARMACOL, V166, P1738, DOI 10.1111/j.1476-5381.2012.01886.x; Orozco OE, 2001, EUR J NEUROSCI, V13, P2177, DOI 10.1046/j.0953-816x.2001.01596.x; Pathirathna S, 2005, PAIN, V117, P326, DOI 10.1016/j.pain.2005.06.019; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PETERSEN M, 1989, N-S ARCH PHARMACOL, V339, P184; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; Rose KE, 2013, NEUROSCIENCE, V250, P263, DOI 10.1016/j.neuroscience.2013.07.005; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; Sekiguchi F, 2013, J PHARMACOL SCI, V122, P244, DOI 10.1254/jphs.13R05CP; Shikano M, 2011, NEUROGASTROENT MOTIL, V23, P1020, DOI 10.1111/j.1365-2982.2011.01767.x; Shin JB, 2003, NAT NEUROSCI, V6, P724, DOI 10.1038/nn1076; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Takahashi T, 2010, PAIN, V150, P183, DOI 10.1016/j.pain.2010.04.022; Talley EM, 1999, J NEUROSCI, V19, P1895; Tang L, 2007, J PHARMACOL EXP THER, V321, P791, DOI 10.1124/jpet.106.117572; Todorovic SM, 2006, CNS NEUROL DISORD-DR, V5, P639, DOI 10.2174/187152706779025490; Todorovic SM, 2013, PFLUG ARCH EUR J PHY, V465, P921, DOI 10.1007/s00424-012-1211-y; Todorovic SM, 2011, BRIT J PHARMACOL, V163, P484, DOI 10.1111/j.1476-5381.2011.01256.x; Todorovic SM, 2004, PAIN, V109, P328, DOI 10.1016/j.pain.2004.01.026; Todorovic SM, 2001, NEURON, V31, P75, DOI 10.1016/S0896-6273(01)00338-5; Trevino CL, 2004, FEBS LETT, V563, P87, DOI 10.1016/S0014-5793(04)00257-1; Ueda T, 2001, MOL BRAIN RES, V93, P36, DOI 10.1016/S0169-328X(01)00179-6; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010; Wang R, 2011, J PHYSIOL-LONDON, V589, P2229, DOI 10.1113/jphysiol.2010.203463; Watanabe M, 2015, NEUROREPORT, V26, P173, DOI 10.1097/WNR.0000000000000322; Wu SW, 2000, J PHARMACOL EXP THER, V292, P939; Yen YT, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-1; Yue J, 2013, SPINE, V38, P463, DOI 10.1097/BRS.0b013e318272fbf8	56	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127572	10.1371/journal.pone.0127572	http://dx.doi.org/10.1371/journal.pone.0127572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974104	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600114
J	Kuprewicz, EK				Kuprewicz, Erin K.			Scatter Hoarding of Seeds Confers Survival Advantages and Disadvantages to Large-Seeded Tropical Plants at Different Life Stages	PLOS ONE			English	Article							NEOTROPICAL RAIN-FOREST; DIPTERYX-PANAMENSIS; PREDATION; TREE; DISPERSAL; RODENTS; PALM; RECRUITMENT; DYNAMICS; PANAMA	Scatter hoarding of seeds by animals contributes significantly to forest-level processes, including plant recruitment and forest community composition. However, the potential positive and negative effects of caching on seed survival, germination success, and seedling survival have rarely been assessed through experimental studies. Here, I tested the hypothesis that seed burial mimicking caches made by scatter hoarding Central American agoutis (Dasyprocta punctate) enhances seed survival, germination, and growth by protecting seeds from seed predators and providing favorable microhabitats for germination. In a series of experiments, I used simulated agouti seed caches to assess how hoarding affects seed predation by ground-dwelling invertebrates and vertebrates for four plant species. I tracked germination and seedling growth of intact and beetle-infested seeds and, using exclosures, monitored the effects of mammals on seedling survival through time. All experiments were conducted over three years in a lowland wet forest in Costa Rica. The majority of hoarded palm seeds escaped predation by both invertebrates and vertebrates while exposed seeds suffered high levels of infestation and removal. Hoarding had no effect on infestation rates of D. panamensis, but burial negatively affected germination success by preventing endocarp dehiscence. Non-infested palm seeds had higher germination success and produced larger seedlings than infested seeds. Seedlings of A. alatum and I. deltoidea suffered high mortality by seed-eating mammals. Hoarding protected most seeds from predators and enhanced germination success (except for D. panamensis) and seedling growth, although mammals killed many seedlings of two plant species; all seedling deaths were due to seed removal from the plant base. Using experimental caches, this study shows that scatter hoarding is beneficial to most seeds and may positively affect plant propagation in tropical forests, although tradeoffs in seed survival do exist.	[Kuprewicz, Erin K.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	University of Miami	Kuprewicz, EK (corresponding author), Natl Museum Nat Hist, Smithsonian Inst, Dept Bot, Washington, DC 20560 USA.	erinkuprewicz@gmail.com			Organization for Tropical Studies; University of Miami	Organization for Tropical Studies; University of Miami	Funding for this project was provided by the Organization for Tropical Studies, http://ots.ac.cr/ (Emily P. Foster Fund and Rowe Family Fellowship) and the University of Miami, http://www.miami.edu/ (Curtis Plant Sciences Scholarship, Kushlan Fund, and Center for Latin American Studies Doctoral Research Fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2005, ECOL LETT, V8, P438, DOI 10.1111/j.1461-0248.2005.00741.x; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Asquith NM, 1997, ECOLOGY, V78, P941, DOI 10.1890/0012-9658(1997)078[0941:DMCCCR]2.0.CO;2; Beck Harald, 2005, P77, DOI 10.1079/9780851998060.0077; Brewer SW, 2001, OIKOS, V93, P32, DOI 10.1034/j.1600-0706.2001.930103.x; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Cintra R, 1997, J TROP ECOL, V13, P709, DOI 10.1017/S0266467400010889; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; CLARK DB, 1985, ECOLOGY, V66, P1884, DOI 10.2307/2937384; CLARK DB, 1989, OIKOS, V55, P225, DOI 10.2307/3565426; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; CONNELL J H, 1971, P298; DeMattia EA, 2006, BIOTROPICA, V38, P196, DOI 10.1111/j.1744-7429.2006.00117.x; DESTEVEN D, 1984, OIKOS, V43, P207, DOI 10.2307/3544770; Donatti CI, 2009, ECOL RES, V24, P1187, DOI 10.1007/s11284-009-0601-x; Forget PM, 1996, J TROP ECOL, V12, P751, DOI 10.1017/S0266467400009998; FORGET PM, 1993, OECOLOGIA, V94, P255, DOI 10.1007/BF00341325; Galvez D, 2007, J TROP ECOL, V23, P381, DOI 10.1017/S0266467407003975; Galvez D, 2009, ANIM BEHAV, V78, P1327, DOI 10.1016/j.anbehav.2009.08.015; GUREVITCH J, 2006, ECOLOGY PLANTS; HALLWACHS W, 1986, FRUGIVORES SEED DISP, P285, DOI DOI 10.1007/978-94-009-4812-9_25; HAMRICK JL, 1987, AM J BOT, V74, P451, DOI 10.2307/2443821; Holdridge L.R., 1971, FOREST ENV TROPICAL; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hulme Philip E., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P32, DOI 10.1078/1433-8319-00050; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kirkendall Lawrence R., 1997, P181; Kuprewicz EK, 2013, BIOTROPICA, V45, P333, DOI 10.1111/btp.12014; Kuprewicz EK, 2010, J TROP ECOL, V26, P263, DOI 10.1017/S0266467410000039; Mack AL, 1998, BIOTROPICA, V30, P604, DOI 10.1111/j.1744-7429.1998.tb00100.x; McDade L.A., 1994, SELVA ECOLOGY NATURA; Mendoza E, 2009, AM J BOT, V96, P1255, DOI 10.3732/ajb.0800297; Notman Evan M., 2005, P55, DOI 10.1079/9780851998060.0055; Peres CA, 1997, J TROP ECOL, V13, P69, DOI 10.1017/S0266467400010269; Pyare S, 2000, OECOLOGIA, V122, P66, DOI 10.1007/PL00008837; Romero A, 2013, J MAMMAL, V94, P771, DOI 10.1644/12-MAMM-A-266.1; Schupp E. W., 2007, Seed dispersal: theory and its application in a changing world, P445, DOI 10.1079/9781845931650.0445; Silman MR, 2003, ECOLOGY, V84, P431, DOI 10.1890/0012-9658(2003)084[0431:PROADR]2.0.CO;2; Silvius KM, 2002, J ECOL, V90, P1024, DOI 10.1046/j.1365-2745.2002.00728.x; SMYTHE N, 1989, BIOTROPICA, V21, P50, DOI 10.2307/2388441; Smythe N., 1978, NATURAL HIST CENTRAL; Vallejo-Marin M, 2006, AM J BOT, V93, P369, DOI 10.3732/ajb.93.3.369; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Wenny DG, 2001, EVOL ECOL RES, V3, P51	46	12	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124932	10.1371/journal.pone.0124932	http://dx.doi.org/10.1371/journal.pone.0124932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970832	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200057
J	O'Neill, K; Bradley, JM; Johnston, E; McGrath, S; McIlreavey, L; Rowan, S; Reid, A; Bradbury, I; Einarsson, G; Elborn, JS; Tunney, MM				O'Neill, Katherine; Bradley, Judy M.; Johnston, Elinor; McGrath, Stephanie; McIlreavey, Leanne; Rowan, Stephen; Reid, Alastair; Bradbury, Ian; Einarsson, Gisli; Elborn, J. Stuart; Tunney, Michael M.			Reduced Bacterial Colony Count of Anaerobic Bacteria Is Associated with a Worsening in Lung Clearance Index and Inflammation in Cystic Fibrosis	PLOS ONE			English	Article							RISK-FACTORS; DISEASE; SPIROMETRY; MARKERS; AIRWAYS; ADULTS	Anaerobic bacteria have been identified in abundance in the airways of cystic fibrosis (CF) subjects. The impact their presence and abundance has on lung function and inflammation is unclear. The aim of this study was to investigate the relationship between the colony count of aerobic and anaerobic bacteria, lung clearance index (LCI), spirometry and C-Reactive Protein (CRP) in patients with CF. Sputum and blood were collected from CF patients at a single cross-sectional visit when clinically stable. Community composition and bacterial colony counts were analysed using extended aerobic and anaerobic culture. Patients completed spirometry and a multiple breath washout (MBW) test to obtain LCI. An inverse correlation between colony count of aerobic bacteria (n = 41, r = -0.35; p = 0.02), anaerobic bacteria (n = 41, r = -0.44, p = 0.004) and LCI was observed. There was an inverse correlation between colony count of anaerobic bacteria and CRP (n = 25, r = -0.44, p = 0.03) only. The results of this study demonstrate that a lower colony count of aerobic and anaerobic bacteria correlated with a worse LCI. A lower colony count of anaerobic bacteria also correlated with higher CRP levels. These results indicate that lower abundance of aerobic and anaerobic bacteria may reflect microbiota disruption and disease progression in the CF lung.	[O'Neill, Katherine; Johnston, Elinor; McGrath, Stephanie; McIlreavey, Leanne; Rowan, Stephen; Einarsson, Gisli; Elborn, J. Stuart; Tunney, Michael M.] Queens Univ Belfast, CF & Airways Microbiol Res Grp, Belfast, Antrim, North Ireland; [O'Neill, Katherine; Johnston, Elinor; Rowan, Stephen; Einarsson, Gisli; Elborn, J. Stuart] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Bradley, Judy M.; Bradbury, Ian] Univ Ulster, Ctr Hlth & Rehabil Technol, Belfast, Antrim, North Ireland; [McGrath, Stephanie; McIlreavey, Leanne; Tunney, Michael M.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Reid, Alastair] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Ulster University; Queens University Belfast	O'Neill, K (corresponding author), Queens Univ Belfast, CF & Airways Microbiol Res Grp, Belfast, Antrim, North Ireland.	k.oneill@qub.ac.uk; s.elborn@qub.ac.uk; m.tunney@qub.ac.uk	; O'Neill, Katherine/I-6878-2018	Bradley, Judy/0000-0002-7423-135X; elborn, joseph/0000-0002-2323-442X; O'Neill, Katherine/0000-0002-7080-9791; Einarsson, Gisli/0000-0003-1353-950X; TUNNEY, MICHAEL/0000-0002-7433-7074	HSC Research and Development, Public Health Agency, Northern Ireland; Medical Research Council through a US-Ireland Partnership Grant; Public Health Agency [CDV/3650/07, STL/3713/07] Funding Source: researchfish	HSC Research and Development, Public Health Agency, Northern Ireland; Medical Research Council through a US-Ireland Partnership Grant; Public Health Agency	This work was funded by HSC Research and Development, Public Health Agency, Northern Ireland and the Medical Research Council through a US-Ireland Partnership Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Aurora P, 2004, THORAX, V59, P1068, DOI 10.1136/thx.2004.022590; Belessis Y, 2012, AM J RESP CRIT CARE, V185, P862, DOI 10.1164/rccm.201109-1631OC; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; Davies J, 2013, LANCET RESP MED, V1, P630, DOI 10.1016/S2213-2600(13)70182-6; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Downey DG, 2007, PEDIATR PULM, V42, P216, DOI 10.1002/ppul.20553; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Hannon D, 2014, BMJ OPEN RESPIRATORY, P1; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Horsley AR, 2008, THORAX, V63, P135, DOI 10.1136/thx.2007.082628; Horsley AR, 2013, THORAX, V68, P532, DOI 10.1136/thoraxjnl-2012-202538; Kent L, 2014, J CYST FIBROS, V13, P123, DOI 10.1016/j.jcf.2013.09.005; Konstan MW, 2012, J CYST FIBROS, V11, P405, DOI 10.1016/j.jcf.2012.03.009; Kraemer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-138; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Sherrard LJ, 2013, J ANTIMICROB CHEMOTH, V68, P2369, DOI 10.1093/jac/dkt191; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Ulrich M, 2010, THORAX, V65, P978, DOI 10.1136/thx.2010.137745; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Vermeulen F, 2014, THORAX, V69, P39, DOI 10.1136/thoraxjnl-2013-203807; Zakharkina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068302; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	33	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126980	10.1371/journal.pone.0126980	http://dx.doi.org/10.1371/journal.pone.0126980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992575	gold, Green Published, Green Submitted			2022-12-27	WOS:000354921400087
J	Santos, JE; Santos, FR; Silveira, FA				Santos Junior, Jose Eustaquio; Santos, Fabricio R.; Silveira, Fernando A.			Hitting an Unintended Target: Phylogeography of Bombus brasiliensis Lepeletier, 1836 and the First New Brazilian Bumblebee Species in a Century (Hymenoptera: Apidae)	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MITOCHONDRIAL CYTOCHROME-B; ATLANTIC FOREST; PHYLOGENETIC-RELATIONSHIPS; BEES BOMBUS; DNA; CONSERVATION; PATTERNS; DECLINE; DIVERGENCE	This work tested whether or not populations of Bombus brasiliensis isolated on mountain tops of southeastern Brazil belonged to the same species as populations widespread in lowland areas in the Atlantic coast and westward along the Parana-river valley. Phylogeographic and population genetic analyses showed that those populations were all conspecific. However, they revealed a previously unrecognized, apparently rare, and potentially endangered species in one of the most threatened biodiversity hotspots of the World, the Brazilian Atlantic Forest. This species is described here as Bombus bahiensis sp. n., and included in a revised key for the identification of the bumblebee species known to occur in Brazil. Phylogenetic analyses based on two mtDNA markers suggest this new species to be sister to B. brasiliensis, from which its workers and queens can be easily distinguished by the lack of a yellow hair-band on the first metasomal tergum. The results presented here are consistent with the hypothesis that B. bahiensis sp. n. may have originated from an ancestral population isolated in an evergreen-forest refuge (the so-called Bahia refuge) during cold, dry periods of the Pleistocene. This refuge is also known as an important area of endemism for several animal taxa, including other bees. Secondary contact between B. bahiensis and B. brasiliensis may be presently prevented by a strip of semi-deciduous forest in a climate zone characterized by relatively long dry seasons. Considering the relatively limited range of this new species and the current anthropic pressure on its environment, attention should be given to its conservation status.	[Santos Junior, Jose Eustaquio; Santos, Fabricio R.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Silveira, Fernando A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Silveira, FA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil.	f.a.silveira.ufmg@gmail.com	Santos, Fabrício Rodrigues/H-2370-2011	Santos, Fabrício Rodrigues/0000-0001-9088-1750	Fundacao de Amparo a Pesquisa de Minas Gerais; Conselho Nacional de Pesquisas	Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Pesquisas	This study was suported by grants from the Fundacao de Amparo a Pesquisa de Minas Gerais (http://www.fapemig.br/) to FAS and Conselho Nacional de Pesquisas (http://www.cnpq.br/) to FRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamovich Alberto H., 2002, Biota Colombiana, V3, P199; Abrahamovich Alberto H., 2004, Acta Zool. Mex, V20, P99; [Anonymous], 2007, CATALOGUE BEES HYMEN; Azevedo AA, 2008, MEGADIVERSIDADE, V4, P67; Bandelt HJ, 1999, MOL BIOL EVOL, V48, P16, DOI DOI 10.1093/0XF0RDJ0URNALS.M0LBEV.A026036; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Bertsch A, 2005, INSECT SOC, V52, P45, DOI 10.1007/s00040-004-0761-1; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Cameron SA, 2003, MOL PHYLOGENET EVOL, V28, P552, DOI 10.1016/S1055-7903(03)00056-3; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1461; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; da Silva JMC, 2003, STATE HOTS, P43; Dick CW, 2004, MOL ECOL, V13, P3775, DOI 10.1111/j.1365-294X.2004.02374.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2000, EVOLUTION, V54, P1839; Ellis J.S., 2005, Journal of Insect Conservation, V9, P75, DOI 10.1007/s10841-004-4168-0; Ellis JS, 2006, MOL ECOL NOTES, V6, P540, DOI 10.1111/j.1471-8286.2006.01231.x; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faria LRR, 2012, ZOOLOGIA-CURITIBA, V29, P349, DOI 10.1590/S1984-46702012000400008; Gibbs J, 2009, ZOOTAXA, P1; Gjershaug JO, 2013, ZOOTAXA, V3716, P431, DOI 10.11646/zootaxa.3716.3.6; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kim Min Jee, 2009, Journal of Asia-Pacific Entomology, V12, P133, DOI 10.1016/j.aspen.2009.02.003; Koulianos S, 1999, ANN ENTOMOL SOC AM, V92, P355, DOI 10.1093/aesa/92.3.355; Koulianos S, 2000, MOL PHYLOGENET EVOL, V14, P335, DOI 10.1006/mpev.1999.0621; Lecocq T, 2011, SYST ENTOMOL, V36, P453, DOI 10.1111/j.1365-3113.2011.00576.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martins AC, 2010, J INSECT CONSERV, V14, P207, DOI 10.1007/s10841-009-9237-y; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Michener CD, 2007, BEES WORLD, V1016, P2; MILLIRON HE, 1973, MEM ENTOMOL SOC CAN, P81, DOI 10.4039/entm10589fv; Moure J. S., 1962, Studia Entomologica Petropolis (NS), V5, P65; Moure Jesus S., 1995, Revista Brasileira de Zoologia, V12, P467, DOI 10.1590/S0101-81751995000300002; Nei M., 2005, MOL EVOLUTION PHYLOG; Nemesio A, 2011, ZOOTAXA, P12; Nemesio A, 2013, ZOOTAXA, V3609, P568, DOI 10.11646/zootaxa.3609.6.2; Nemesio A, 2012, ZOOKEYS, P47, DOI 10.3897/zookeys.222.3382; Nemesio A, 2012, J INSECT CONSERV, V16, P745, DOI 10.1007/s10841-012-9459-2; Packer L, 2000, CONSERVATION ECOLOGY; Pirounakis K, 1998, EUR J ENTOMOL, V95, P27; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Resende HC, 2010, BIOL J LINN SOC, V101, P949, DOI 10.1111/j.1095-8312.2010.01534.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Sambrook J., 2001, MOL CLONING LAB MANU; Shao ZY, 2004, J HERED, V95, P46, DOI 10.1093/jhered/esh008; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; SILVEIRA FA, 1993, STUD NEOTROP FAUNA E, V28, P47, DOI 10.1080/01650529309360887; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchaicka L, 2007, MOL ECOL, V16, P819, DOI 10.1111/j.1365-294X.2006.03185.x; Widmer A, 1998, HEREDITY, V81, P563, DOI 10.1046/j.1365-2540.1998.00407.x; Widmer A, 1999, MOL ECOL, V8, P387, DOI 10.1046/j.1365-294X.1999.00584.x; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiley EO, 2011, PHYLOGENETICS THEORY; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; Williams PH, 2013, APIDOLOGIE, V44, P121, DOI 10.1007/s13592-012-0161-x; Williams PH, 2012, SYST BIODIVERS, V10, P21, DOI 10.1080/14772000.2012.664574; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Williams Paul H., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P79; Wolf S, 2010, APIDOLOGIE, V41, P45, DOI 10.1051/apido/2009048	73	23	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125847	10.1371/journal.pone.0125847	http://dx.doi.org/10.1371/journal.pone.0125847			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992624	gold, Green Published, Green Submitted			2022-12-27	WOS:000354921400048
J	Rantalainen, M; Lindgren, CM; Holmes, CC				Rantalainen, Mattias; Lindgren, Cecilia M.; Holmes, Christopher C.			Robust Linear Models for Cis-eQTL Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; ASSOCIATION	Expression Quantitative Trait Loci (eQTL) analysis enables characterisation of functional genetic variation influencing expression levels of individual genes. In outbread populations, including humans, eQTLs are commonly analysed using the conventional linear model, adjusting for relevant covariates, assuming an allelic dosage model and a Gaussian error term. However, gene expression data generally have noise that induces heavy-tailed errors relative to the Gaussian distribution and often include atypical observations, or outliers. Such departures from modelling assumptions can lead to an increased rate of type II errors (false negatives), and to some extent also type I errors (false positives). Careful model checking can reduce the risk of type-I errors but often not type II errors, since it is generally too time-consuming to carefully check all models with a non-significant effect in large-scale and genome-wide studies. Here we propose the application of a robust linear model for eQTL analysis to reduce adverse effects of deviations from the assumption of Gaussian residuals. We present results from a simulation study as well as results from the analysis of real eQTL data sets. Our findings suggest that in many situations robust models have the potential to provide more reliable eQTL results compared to conventional linear models, particularly in respect to reducing type II errors due to non-Gaussian noise. Post-genomic data, such as that generated in genome-wide eQTL studies, are often noisy and frequently contain atypical observations. Robust statistical models have the potential to provide more reliable results and increased statistical power under non-Gaussian conditions. The results presented here suggest that robust models should be considered routinely alongside other commonly used methodologies for eQTL analysis.	[Rantalainen, Mattias; Holmes, Christopher C.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Rantalainen, Mattias; Lindgren, Cecilia M.; Holmes, Christopher C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Holmes, Christopher C.] MRC Harwell, MRC Mammalian Genet Unit, Harwell, Berks, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; MRC Harwell	Holmes, CC (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	cholmes@stats.ox.ac.uk		Holmes, Christopher/0000-0002-6667-4943; Lindgren, Cecilia/0000-0002-4903-9374	Wellcome Trust [086596/Z/08/Z]; Medical Research Council [G0802460]; MRC [G0802460] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CML is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z). MR is a MRC biomedical informatics fellow (Medical Research Council, fellowship G0802460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Copt S, 2007, BIOMETRICS, V63, P1045, DOI 10.1111/j.1541-0420.2007.00804.x; Croux C, 2003, RES REPORT; Dermitzakis ET, 2006, MAMM GENOME, V17, P503, DOI 10.1007/s00335-006-0005-y; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Drake TA, 2006, MAMM GENOME, V17, P466, DOI 10.1007/s00335-005-0175-z; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Harrell FE, 2001, REGRESSION MODELING; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; Maronna R.A., 2006, ROBUST STAT; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Min JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022070; Montgomery DC, 2012, WILEY SERIES PROBABI; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Rousseeuw P.J., 1984, LECTURE NOTES STATIS, V26, P256, DOI DOI 10.1007/978-1-4615-7821-5_15; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger Barbara E., 2005, Human Genomics, V2, P126; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127882	10.1371/journal.pone.0127882	http://dx.doi.org/10.1371/journal.pone.0127882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992607	Green Published, gold			2022-12-27	WOS:000354917300135
J	Bryson, BD; White, FM				Bryson, Bryan D.; White, Forest M.			Quantitative Profiling of Lysine Acetylation Reveals Dynamic Crosstalk between Receptor Tyrosine Kinases and Lysine Acetylation	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; SIGNALING NETWORKS; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; CANCER; PHOSPHORYLATION; MECHANISMS	Lysine acetylation has been primarily investigated in the context of transcriptional regulation, but a role for acetylation in mediating other cellular responses has emerged. Multiple studies have described global lysine acetylation profiles for particular biological states, but none to date have investigated the temporal dynamics regulating cellular response to perturbation. Reasoning that lysine acetylation may be altered in response to growth factors, we implemented quantitative mass spectrometry-based proteomics to investigate the temporal dynamics of lysine acetylation in response to growth factor stimulation in cultured carcinoma cell lines. We found that lysine acetylation changed rapidly in response to activation of several different receptor tyrosine kinases by their respective ligands. To uncover the effects of lysine acetylation dynamics on tyrosine phosphorylation signaling networks, cells were treated with an HDAC inhibitor. This short-term pharmacological inhibition of histone deacetylase activity modulated signaling networks involving phosphorylated tyrosine and thereby altered the response to receptor tyrosine kinase activation. This result highlights the interconnectivity of lysine acetylation and tyrosine phosphorylation signaling networks and suggests that HDAC inhibition may influence cellular responses by affecting both types of post-translational modifications.	[Bryson, Bryan D.; White, Forest M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Bryson, Bryan D.; White, Forest M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	White, FM (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fwhite@mit.edu		White, Forest/0000-0002-1545-1651	NIH [R24DK090963, R01CA118705, U54CA112967, U24CA159988, P30CA14051]; Charles S. Krakauer Fellowship; Hugh Hampton Young Fellowship; NATIONAL CANCER INSTITUTE [P30CA014051, U54CA112967, R01CA118705, U24CA159988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090963] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles S. Krakauer Fellowship; Hugh Hampton Young Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R24DK090963, R01CA118705, U54CA112967, U24CA159988 and P30CA14051. BDB has been supported by the Charles S. Krakauer and Hugh Hampton Young Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Curran TG, 2013, METHODS, V61, P219, DOI 10.1016/j.ymeth.2013.03.004; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Johnson H, 2012, MOL CELL PROTEOMICS, V11, P1724, DOI 10.1074/mcp.M112.019984; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Lammers R, 1998, BIOCHEM BIOPH RES CO, V242, P32, DOI 10.1006/bbrc.1997.7906; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; Naegle KM, 2010, MOL CELL PROTEOMICS, V9, P2558, DOI 10.1074/mcp.M110.001206; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Norvell A, 2010, SCIENCE, V327, P964, DOI 10.1126/science.1187159; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Song H, 2011, BIOCHEM BIOPH RES CO, V404, P68, DOI 10.1016/j.bbrc.2010.11.064; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	41	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126242	10.1371/journal.pone.0126242	http://dx.doi.org/10.1371/journal.pone.0126242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978619	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100058
J	Jacobson, K; van Diepeningen, A; Evans, S; Fritts, R; Gemmel, P; Marsho, C; Seely, M; Wenndt, A; Yang, XX; Jacobson, P				Jacobson, Kathryn; van Diepeningen, Anne; Evans, Sarah; Fritts, Rachel; Gemmel, Philipp; Marsho, Chris; Seely, Mary; Wenndt, Anthony; Yang, Xiaoxuan; Jacobson, Peter			Non-Rainfall Moisture Activates Fungal Decomposition of Surface Litter in the Namib Sand Sea	PLOS ONE			English	Article							FILAMENTOUS FUNGI; ENDOPHYTIC FUNGI; EVOLUTION-CANYON; STANDING LITTER; SOIL; DESERT; DIVERSITY; COMMUNITY; FUSARIUM; WATER	The hyper-arid western Namib Sand Sea (mean annual rainfall 0-17 mm) is a detritus-based ecosystem in which primary production is driven by large, but infrequent rainfall events. A diverse Namib detritivore community is sustained by minimal moisture inputs from rain and fog. The decomposition of plant material in the Namib Sand Sea (NSS) has long been assumed to be the province of these detritivores, with beetles and termites alone accounting for the majority of litter losses. We have found that a mesophilic Ascomycete community, which responds within minutes to moisture availability, is present on litter of the perennial Namib dune grass Stipagrostis sabulicola. Important fungal traits that allow survival and decomposition in this hyper-arid environment with intense desiccation, temperature and UV radiation stress are darkly-pigmented hyphae, a thermal range that includes the relatively low temperature experienced during fog and dew, and an ability to survive daily thermal and desiccation stress at temperatures as high as 50 degrees C for five hours. While rainfall is very limited in this area, fog and high humidity provide regular periods (>= 1 hour) of sufficient moisture that can wet substrates and hence allow fungal growth on average every 3 days. Furthermore, these fungi reduce the C/N ratio of the litter by a factor of two and thus detritivores, like the termite Psammotermes allocerus, favor fungal-infected litter parts. Our studies show that despite the hyper-aridity of the NSS, fungi are a key component of energy flow and biogeochemical cycling that should be accounted for in models addressing how the NSS ecosystem will respond to projected climate changes which may alter precipitation, dew and fog regimes.	[Jacobson, Kathryn; Fritts, Rachel; Gemmel, Philipp; Marsho, Chris; Wenndt, Anthony; Yang, Xiaoxuan; Jacobson, Peter] Grinnell Coll, Dept Biol, Grinnell, IA 50112 USA; [van Diepeningen, Anne] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Evans, Sarah] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Seely, Mary] Gobabeb Res & Training Ctr, Gobabeb, Namibia	Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Michigan State University	Jacobson, K (corresponding author), Grinnell Coll, Dept Biol, Grinnell, IA 50112 USA.	jacobsok@grinnell.edu	Seely, Mary Kathryn/AAI-1072-2019	Gemmel, Philipp/0000-0003-0281-7682	Grinnell College	Grinnell College	Grinnell College provided funding for the research to KJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Azeem AM, 2012, MYCOSPHERE, V3, P900, DOI 10.5943/mycosphere/3/6/4; Abrams MM, 1997, J ARID ENVIRON, V35, P29, DOI 10.1006/jare.1995.0139; Abu-Ghosh S, 2014, ENV MICROBIOL REP, P382; Al-Hazmi NA, 2010, AFR J BIOTECHNOL, V9, P5590; Ananda K, 2002, CAN J MICROBIOL, V48, P871, DOI 10.1139/W02-080; Andre HM, 1997, J AFRICAN ZOOLOGY, P517; Arquette TJ, 2013, FLA ENTOMOL, V96, P1186, DOI 10.1653/024.096.0362; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Badali H, 2011, J CLIN MICROBIOL, V49, P2336, DOI 10.1128/JCM.02648-10; Balmas V, 2012, MYCOLOGIA, P812; BARLOCHER F, 1985, BOT J LINN SOC, V91, P83, DOI 10.1111/j.1095-8339.1985.tb01137.x; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Brune A, 2011, BIOL TERMITES MODERN, P476, DOI [10.1093/jis/14.1.81, DOI 10.1093/JIS/14.1.81]; Bultman MW, 2013, ESSENTIALS MED GEOLO, P477, DOI 10.1007/978-94-007-4375-5_20; Bushula VS, 2008, NATIVE FUSARIUM SPEC; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Cavalcanti Maria Auxiliadora de Queiroz, 2006, Acta Bot. Bras., V20, P831, DOI 10.1590/S0102-33062006000400008; Coaton WGH, 1973, CIMBEBASIA, P19; Collins SL, 2008, J ECOL, V96, P413, DOI 10.1111/j.1365-2745.2008.01362.x; Crawford C. S., 1994, Journal of African Zoology, V108, P49; CRAWFORD CS, 1984, S AFR J SCI, V80, P170; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; Deacon JW, 2006, FUNGAL BIOL-UK; Dighton J, 2002, FUNGI ECOSYSTEM PROC; Dirks I, 2010, GLOBAL CHANGE BIOL, V16, P2799, DOI 10.1111/j.1365-2486.2010.02172.x; Ebner M, 2011, J ARID ENVIRON, V75, P524, DOI 10.1016/j.jaridenv.2011.01.004; Eckardt FD, 2013, J ARID ENVIRON, V93, P7, DOI 10.1016/j.jaridenv.2012.01.011; El-Maghraby OMO, 2010, ENDOPHYTIC FUNGI 3 L; El-Zayat SA, 2008, J BASIC MICROB, V48, P82, DOI 10.1002/jobm.200700107; Elkhateeb W, 2014, EGYPT PHARM J, V13, P58, DOI DOI 10.4103/1687-4315.135598; Emeis KC, 2009, INT J EARTH SCI, V98, P309, DOI 10.1007/s00531-007-0236-5; FRANKLAND JC, 1976, BOT J LINN SOC, V73, P133, DOI 10.1111/j.1095-8339.1976.tb02018.x; Gliksman D, 2014, EGU GEN ASS 2014; GOCHENAUR S E, 1970, Mycopathologia et Mycologia Applicata, V42, P259, DOI 10.1007/BF02051953; GOCHENAUR SE, 1975, MYCOPATHOLOGIA, V57, P155, DOI 10.1007/BF00551422; Gorbushina AA, 2008, STUD MYCOL, P91, DOI 10.3114/sim.2008.61.09; Gostincar C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-549; Gostincar C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00390; Grishkan I, 2006, EUR J SOIL BIOL, V42, P33, DOI 10.1016/j.ejsobi.2005.09.014; Grishkan I, 2007, BIOL J LINN SOC, V90, P263, DOI 10.1111/j.1095-8312.2007.00722.x; Grishkan I, 2013, EUR J SOIL BIOL, V56, P107, DOI 10.1016/j.ejsobi.2013.03.005; Grishkan I, 2010, FUNGAL ECOL, V3, P326, DOI 10.1016/j.funeco.2010.01.003; Henschel JR, 2008, ATMOS RES, V87, P362, DOI 10.1016/j.atmosres.2007.11.015; Hong SB, 2006, INT J SYST EVOL MICR, V56, P477, DOI 10.1099/ijs.0.63980-0; Huang L-D, 2004, NZ PLANT PROTECTION, P124; HUDSON HJ, 1968, NEW PHYTOL, V67, P837, DOI 10.1111/j.1469-8137.1968.tb06399.x; Jacobson K, 1996, MCILVAINEA, V12, P21; Jacobson KM, 1998, J ARID ENVIRON, V38, P571, DOI 10.1006/jare.1997.0358; Jacobson KM, 1997, J ARID ENVIRON, V35, P59, DOI 10.1006/jare.1995.0140; Jamali S, 2012, J CROP PROT, P41; JOFFE AZ, 1977, PHYTOPARASITICA, V5, P119, DOI 10.1007/BF02981151; Jurgens JA, 2010, FUNGAL BIODIVERSITY, P264; Kallio JP, 2011, FEBS J, V278, P2283, DOI 10.1111/j.1742-4658.2011.08146.x; Kamna Sharma, 2010, Indian Phytopathology, V63, P452; Kaseke KF, 2012, PURE APPL GEOPHYS, V169, P2217, DOI 10.1007/s00024-012-0469-5; Kis-Papo T, 2001, MYCOL RES, V105, P749, DOI 10.1017/S0953756201004129; Klittich CJR, 1997, MYCOLOGIA, V89, P643, DOI 10.2307/3761002; Kuehn KA, 1999, MICROBIAL ECOL, V38, P50, DOI 10.1007/s002489900154; Kuehn KA, 1998, FRESHWATER BIOL, V40, P717, DOI 10.1046/j.1365-2427.1998.00374.x; Kusari S, 2009, J NAT PROD, V72, P1825, DOI 10.1021/np9002977; LANCASTER J, 1984, Madoqua, V14, P5; Latiffah Z, 2007, MALAYS J MICROBIOL, V3, P27, DOI 10.21161/mjm.00407; Le Roux GJ, 1970, MICROBIOLOGY SAND DU; Leduc G, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044353; Leslie JF, 2000, COMPENDIUM SORGHUM D, P30; Liden M, 2010, PLANT CELL ENVIRON, V33, P851, DOI 10.1111/j.1365-3040.2009.02111.x; Louw G.N., 1972, Symposia Zool Soc Lond, VNo. 31, P297; LOUW GN, 1980, S AFR J SCI, V76, P38; Mandeel Q, 1999, PHARM BIOL, V37, P181, DOI 10.1076/phbi.37.3.181.6301; Mandeel QA, 2006, J BASIC MICROB, V46, P480, DOI 10.1002/jobm.200510128; Manitchotpisit P, 2009, MYCOL RES, V113, P1107, DOI 10.1016/j.mycres.2009.07.008; MARTIN MM, 1979, BIOL REV, V54, P1, DOI 10.1111/j.1469-185X.1979.tb00865.x; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Montana C, 1988, J ARID ENVIRON, P60; Moslem MA, 1999, PAKISTAN J BIOL SCI, V2, P647; Mouchacca J, 2005, J ARID ENVIRON, V60, P359, DOI 10.1016/j.jaridenv.2004.06.007; Mouchacca J, 2007, WORLD J MICROB BIOT, V23, P1755, DOI 10.1007/s11274-007-9426-3; Nazim K, 2013, TURK J BOT, V37, P735, DOI 10.3906/bot-1008-22; O'Donnell K, 2010, J CLIN MICROBIOL, V48, P3708, DOI 10.1128/JCM.00989-10; Odum EP, 1984, AM NAT, P376; Oliveira LG, 2013, J ARID ENVIRON, V95, P49, DOI 10.1016/j.jaridenv.2013.03.007; ONYIKE NBN, 1992, MYCOLOGIA, V84, P452, DOI 10.2307/3760198; Polis G.A., 1991, P383; Raz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034689; Robertson GP, 1999, LT EC RES NETWK SER, V2, P258; ROSSI L, 1979, OIKOS, V32, P380, DOI 10.2307/3544749; Rubini MR, 2005, INT J BIOL SCI, V1, P24; SANTOS PF, 1981, ECOLOGY, V62, P654, DOI 10.2307/1937733; Schuurman G, 2005, ECOLOGY, V86, P1236, DOI 10.1890/03-0570; Seely M, 2008, NAMIB SECRETS DESERT; Seely M.K., 1991, P348; SEELY MK, 1980, J ARID ENVIRON, V3, P25, DOI 10.1016/S0140-1963(18)31673-2; Seely MK, 1978, MADOQUA, V9, P5; Sherman C, 2014, PEDOSPHERE, V24, P437, DOI 10.1016/S1002-0160(14)60030-8; Singaravelan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002993; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Southgate RI, 1996, J ARID ENVIRON, V33, P267, DOI 10.1006/jare.1996.0064; Stchigel AM, 2002, MYCOL RES, V106, P975, DOI 10.1017/S0953756202006299; Steiman R, 1997, ANTON LEEUW INT J G, V72, P261, DOI 10.1023/A:1000441705073; Sterflinger K, 2012, FUNGAL ECOL, V5, P453, DOI 10.1016/j.funeco.2011.12.007; Stomeo F, 2013, EXTREMOPHILES, V17, P329, DOI 10.1007/s00792-013-0519-7; Sun Y, 2012, MYCOL PROG, V11, P781, DOI 10.1007/s11557-011-0790-x; Suryanarayanan TS, 2005, MYCOL RES, V109, P635, DOI 10.1017/S0953756205002753; Throop Heather L., 2009, V70, P171, DOI 10.1007/978-3-540-68421-3_8; van Diepeningen AD, 2004, MYCOL RES, V108, P919, DOI 10.1017/S0953756204000747; Webster J.W., 1995, FUNGAL ECOL; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; Wright MS, 2005, MICROB ECOL, V49, P536, DOI 10.1007/s00248-004-0052-4; Wright TMMG, 2011, AFRICAN J PLANT SCI, V5, P33	110	50	51	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126977	10.1371/journal.pone.0126977	http://dx.doi.org/10.1371/journal.pone.0126977			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978429	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100118
J	Jeong, JR; Kim, S; Jo, SR; Joh, JY; Kim, YP				Jeong, Ju-Ri; Kim, Sun; Jo, So-Ra; Joh, Ju-Youn; Kim, Yeon-Pyo			Health Behaviors of Breast Cancer Survivors with Hypertension: A Propensity Analysis of KNHANES III-V (2005-2012)	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; SALT INTAKE; RISK; METAANALYSIS; COMORBIDITY; CONSUMPTION; DIAGNOSIS; SODIUM; STAGE	Objective This study examines health behaviors of breast cancer survivors with hypertension and compares them with those of non-cancer individuals with hypertension. Methods In this cross-sectional study, a total of 10,996 hypertensive adults (>= 19 years) who participated in the 2005-2012 Korean National Health and Nutrition Examination Survey (KNHANES) were considered. Data on alcohol consumption, smoking, physical activity, antihypertensive medication adherence, self-reported diet control, and sodium intake were collected through self-report questionnaire. A total of 64 breast cancer survivors with hypertension and 10,932 non-cancer participants with hypertension were identified. To better compare health behaviors of the two groups, 56 breast cancer survivors and 280 non-cancer participants were selected through the 1: 5 nearest available matching based on estimated propensity scores. Multivariate analysis was conducted to determine any differences between the two groups. Results According to multivariate analysis, breast cancer survivors with hypertension (n = 56) were significantly less likely to consume alcohol (odds ratio (OR): 3.75; 95% confidence interval (CI): 1.06-13.29) but significantly more likely to have sodium intake of more than 2400 mg (OR: 2.98; 95% CI: 1.27-6.97) than the propensity-matched control group (n = 280). There was no significant difference in other health behaviors between the two groups. Conclusions Breast cancer survivors require active interventions for healthy behaviors related to the management of comorbid conditions such as hypertension to reduce the risk of cardiovascular disease and improve their overall survival rate.	[Jeong, Ju-Ri; Kim, Sun; Jo, So-Ra; Joh, Ju-Youn; Kim, Yeon-Pyo] Hwasun Chonnam Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Jeong, Ju-Ri; Kim, Sun; Jo, So-Ra; Joh, Ju-Youn] Hwasun Chonnam Natl Univ Hosp, Clin Life Canc Treatment LACT Clin, Seoul, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University Hospital	Kim, YP (corresponding author), Hwasun Chonnam Natl Univ Hosp, Dept Family Med, Seoul, South Korea.	ypkim@jnu.ac.kr		Jeong, Ju Ri/0000-0003-3544-2522				Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bernardi JLD, 2011, P NUTR SOC, V70, pE148, DOI 10.1017/S0029665111001996; Braithwaite D, 2009, INT J CANCER, V124, P1213, DOI 10.1002/ijc.24054; BROWN BW, 1993, J NATL CANCER I, V85, P979, DOI 10.1093/jnci/85.12.979; Caliendo M., 2005, 1588 IZA; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; D'Elia L, 2012, CLIN NUTR, V31, P489, DOI 10.1016/j.clnu.2012.01.003; Demark-Wahnefried W, 2000, CANCER-AM CANCER SOC, V88, P674, DOI 10.1002/(SICI)1097-0142(20000201)88:3&lt;674::AID-CNCR26&gt;3.0.CO;2-R; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; DuGoff EH, 2014, HEALTH SERV RES, V49, P284, DOI 10.1111/1475-6773.12090; Earle CC, 2004, CANCER, V101, P1712, DOI 10.1002/cncr.20560; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Grimm P, 2011, SOCIAL DESIRABILITY; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; JANSSON B, 1990, CANCER DETECT PREV, V14, P563; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jung KW, 2013, CANCER RES TREAT, V45, P162, DOI 10.4143/crt.2013.45.3.162; Karimi Z, 2014, PUBLIC HEALTH NUTR, V17, P1098, DOI 10.1017/S1368980013001018; Kim RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057598; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Korean Ministry of Health and Welfare, 2014, KOR NAT HLTH NUTR EX; Kwan ML, 2010, J CLIN ONCOL, V28, P4410, DOI 10.1200/JCO.2010.29.2730; Lindsey AM, 2004, WESTERN J NURS RES, V26, P872, DOI 10.1177/0193945903261274; LONGNECKER MP, 1994, CANCER CAUSE CONTROL, V5, P73, DOI 10.1007/BF01830729; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Ogle KS, 2000, CANCER, V88, P653, DOI 10.1002/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1; Park JH, 2013, CANC FACTS FIGURES 2; Park JH, 2014, J KOREAN MED SCI, V29, pS131, DOI 10.3346/jkms.2014.29.S2.S131; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; Paxton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061854; Pierce JP, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt359; Reeve BB, 2008, HEALTH CARE FINANC R, V29, P69; Rock CL, 2012, CA-CANCER J CLIN, V62, P243, DOI 10.3322/caac.21142; Shin DW, 2014, PSYCHO-ONCOLOGY, V23, P585, DOI 10.1002/pon.3460; Shin DW, 2011, SUPPORT CARE CANCER, V19, P211, DOI 10.1007/s00520-009-0802-4; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Takachi R, 2010, AM J CLIN NUTR, V91, P456, DOI 10.3945/ajcn.2009.28587; Thoemmes F., 2012, ARXIV12016385; Weaver KE, 2013, J CANCER SURVIV, V7, P253, DOI 10.1007/s11764-013-0267-9; Williams K, 2013, BRIT J CANCER, V108, P2407, DOI 10.1038/bjc.2013.254; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	43	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127346	10.1371/journal.pone.0127346	http://dx.doi.org/10.1371/journal.pone.0127346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978401	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100143
J	Kang, SJ; Jang, HC; Jung, SI; Choe, PG; Park, WB; Kim, CJ; Song, KH; Kim, ES; Kim, HB; Oh, MD; Kim, NJ; Park, KH				Kang, Seung-Ji; Jang, Hee-Chang; Jung, Sook-In; Choe, Pyoeng Gyun; Park, Wan Beom; Kim, Chung-Jong; Song, Kyoung-Ho; Kim, Eu Suk; Kim, Hong Bin; Oh, Myoung-Don; Kim, Nam Joong; Park, Kyung-Hwa			Clinical Characteristics and Risk Factors of Pyogenic Spondylitis Caused by Gram-Negative Bacteria	PLOS ONE			English	Article							HEMATOGENOUS VERTEBRAL OSTEOMYELITIS; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; OUTCOMES	Background There are limited data describing the clinical characteristics of pyogenic spondylitis caused by Gram-negative bacteria (GNB). The aim of this study was to investigate the predisposing factors and clinical characteristics of pyogenic spondylitis caused by GNB compared to Gram-positive cocci (GPC). Methods We performed a retrospective review of medical records from patients with culture-confirmed pyogenic spondylitis at four tertiary teaching hospitals over an 8-year period. Results A total of 344 patients with culture-confirmed pyogenic spondylitis were evaluated. There were 62 patients (18.0%) with pyogenic spondylitis caused by GNB and the most common organism was Escherichia coli (n = 35, 10.2%), followed by Pseudomonas aeruginosa (n = 10, 2.9%). Pyogenic spondylitis caused by GNB was more frequently associated with the female gender (64.5 vs. 35.5%, P < 0.01), preexisting or synchronous genitourinary tract infection (32.3 vs. 2.1%, P < 0.01), and intra-abdominal infection (12.9 vs. 0.4%, P < 0.01) compared to patients with GPC. Although pyogenic spondylitis caused by GNB presented with severe sepsis more frequently (24.2 vs. 11.3%, P = 0.01), the mortality rate (6.0 vs. 5.2%) and the proportion of patients with residual disability (6.0 vs. 9.0%), defined as grade 3 or 4 (P = 0.78) 3 months after completion of treatment, were not significantly different compared to GPC patients. Conclusion GNB should be considered as the etiologic organism when infectious spondylitis develops in a patient with preexisting or synchronous genitourinary tract and intra-abdominal infection. In addition, the mortality rate and clinical outcomes are not significantly different between pyogenic spondylitis caused by GNB and GPC.	[Kang, Seung-Ji; Jang, Hee-Chang; Jung, Sook-In; Park, Kyung-Hwa] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Gwangju, South Korea; [Choe, Pyoeng Gyun; Park, Wan Beom; Kim, Chung-Jong; Song, Kyoung-Ho; Kim, Eu Suk; Kim, Hong Bin; Oh, Myoung-Don; Kim, Nam Joong] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Chonnam National University; Seoul National University (SNU)	Kim, NJ (corresponding author), Chonnam Natl Univ, Sch Med, Dept Infect Dis, Gwangju, South Korea.	molder@unitel.co.kr; iammedkid@naver.com	Bin Kim, Hong/J-5452-2012; Park, Wan Beom/AGO-0374-2022; Park, Wan Beom/GLU-9886-2022	Bin Kim, Hong/0000-0001-6262-372X; Park, Wan Beom/0000-0003-0022-9625; Kang, Seung ji/0000-0002-3298-0520; Choe, Pyoeng Gyun/0000-0001-6794-7918; Jang, Hee-Chang/0000-0002-3407-8493; Song, Kyoung-Ho/0000-0002-4517-3840				Belzunegui J, 2000, CLIN RHEUMATOL, V19, P344, DOI 10.1007/PL00011175; Bhavan KP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-158; Carragee EJ, 1997, J BONE JOINT SURG AM, V79A, P874, DOI 10.2106/00004623-199706000-00011; Cheng AG, 2011, TRENDS MICROBIOL, V19, P225, DOI 10.1016/j.tim.2011.01.007; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cottle L, 2008, J INFECTION, V56, P401, DOI 10.1016/j.jinf.2008.02.005; Darouiche RO, 2006, NEW ENGL J MED, V355, P2012, DOI 10.1056/NEJMra055111; Gasbarrini A L, 2005, Eur Rev Med Pharmacol Sci, V9, P53; Graham SM, 2013, EUR SPINE J, V22, P1845, DOI 10.1007/s00586-013-2750-4; Grammatico L, 2008, EPIDEMIOL INFECT, V136, P653, DOI 10.1017/S0950268807008850; Hadjipavlou AG, 2000, SPINE, V25, P1668, DOI 10.1097/00007632-200007010-00010; Kim CJ, 2010, SPINE, V35, pE1096, DOI 10.1097/BRS.0b013e3181e04dd3; Lora-Tamayo J, 2011, SEMIN ARTHRITIS RHEU, V41, P247, DOI 10.1016/j.semarthrit.2011.04.002; Luzzati R, 2009, J INFECTION, V58, P259, DOI 10.1016/j.jinf.2009.02.006; McHenry MC, 2002, CLIN INFECT DIS, V34, P1342, DOI 10.1086/340102; Mylona E, 2009, SEMIN ARTHRITIS RHEU, V39, P10, DOI 10.1016/j.semarthrit.2008.03.002; Nolla JM, 2002, SEMIN ARTHRITIS RHEU, V31, P271, DOI 10.1053/sarh.2002.29492; Park KH, 2014, J INFECTION, V69, P42, DOI 10.1016/j.jinf.2014.02.009; Park KH, 2014, INT J INFECT DIS, V23, P8, DOI 10.1016/j.ijid.2013.12.021; PERRONNE C, 1994, CLIN INFECT DIS, V19, P746, DOI 10.1093/clinids/19.4.746; Scudeller L, 2009, ARCH INTERN MED, V169, P1720, DOI 10.1001/archinternmed.2009.307; Tice AD, 2003, AM J MED, V114, P723, DOI 10.1016/S0002-9343(03)00231-6; Yoon SH, 2010, EUR SPINE J, V19, P575, DOI 10.1007/s00586-009-1216-1	23	17	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127126	10.1371/journal.pone.0127126	http://dx.doi.org/10.1371/journal.pone.0127126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978839	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100130
J	Noguchi-Shinohara, M; Ono, K; Hamaguchi, T; Iwasa, K; Nagai, T; Kobayashi, S; Nakamura, H; Yamada, M				Noguchi-Shinohara, Moeko; Ono, Kenjiro; Hamaguchi, Tsuyoshi; Iwasa, Kazuo; Nagai, Toshitada; Kobayashi, Shoko; Nakamura, Hiroyuki; Yamada, Masahito			Pharmacokinetics, Safety and Tolerability of Melissa officinalisExtract which Contained Rosmarinic Acid in Healthy Individuals: A Randomized Controlled Trial	PLOS ONE			English	Article							PERILLA-FRUTESCENS; ALZHEIMERS-DISEASE; MODULATION; OLIGOMERS; EXTRACT; MEMORY; MOOD; SAGE	The aim of this study was to evaluate the safety, tolerability and pharmacokinetics of single dose of Melissa officinalis extract which contained rosmarinic acid, including food-effects in healthy individuals. A total of eleven healthy individuals were randomly assigned to treatment arms in the two studies [Study 1 (fasted state) and Study 2 (fed state)]. Rosmarinic acid in serum was measured by a coulometric detection method using High-Performance Liquid Chromatography electrochemical detector. The serum concentration of total rosmarinic acid peaked at 1 hour after administration of Melissa officinalisextract containing 500mg rosmarinic acid in fasted state, with a maximum serum concentration 162.20 nmol/L. The area under the curve for intact rosmarinic acid was calculated from the serum concentration-time profile to be 832.13 nmol. hour/L. Food intake increases area under the curve and delayed time at which the maximum serum concentration. Rosmarinic acid supplementation did not affect liver, kidney, or blood cell function parameters. No adverse event was reported by any of the participants due to the study treatment. Single dose of Melissa officinalisextract containing 500 mg rosmarinic acid appears to be safe and tolerable in healthy individuals. Food intake increased the exposure of rosmarinic acid and delayed absorption of rosmarinic acid in healthy individuals.	[Noguchi-Shinohara, Moeko; Ono, Kenjiro; Hamaguchi, Tsuyoshi; Iwasa, Kazuo; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Nagai, Toshitada] Takasaki Univ Hlth & Welf, Dept Food & Life Sci, Gunma, Japan; [Kobayashi, Shoko] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan	Kanazawa University; University of Tokyo; Kanazawa University	Yamada, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan.	m-yamada@med.kanazawa-u.ac.jp		Nagai, Toshitada/0000-0002-9152-0073	Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour, and Welfare, Japan; Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO)	Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO)	This work was supported in part by a Grant-in-Aid Scientific Research from the Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MY, MN-S), a grant to the Amyloidosis Research Committee from the Ministry of Health, Labour, and Welfare, Japan (MY), and Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO) (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondzadeh S, 2003, J NEUROL NEUROSUR PS, V74, P863, DOI 10.1136/jnnp.74.7.863; Al-Sereiti M. R., 1999, Indian Journal of Experimental Biology, V37, P124; Alkam T, 2007, BEHAV BRAIN RES, V180, P139, DOI 10.1016/j.bbr.2007.03.001; Areias F, 2000, J AGR FOOD CHEM, V48, P6081, DOI 10.1021/jf000440+; Baba S, 2005, EUR J NUTR, V44, P1, DOI 10.1007/s00394-004-0482-2; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Carnat A., 1998, PHARM ACTA HELV, V72, P301, DOI DOI 10.1016/S0031-6865(97)00026-5; Center for Drug Evaluation and Research (CDER), 2000, WAIV IN VIV BIOAV BI; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Faustmen EM, 1996, CASARETT DOULLS TOXI, P75; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iuvone T, 2006, J PHARMACOL EXP THER, V317, P1143, DOI 10.1124/jpet.105.099317; Kennedy DO, 2003, NEUROPSYCHOPHARMACOL, V28, P1871, DOI 10.1038/sj.npp.1300230; Kennedy DO, 2002, PHARMACOL BIOCHEM BE, V72, P953, DOI 10.1016/S0091-3057(02)00777-3; Konishi Y, 2005, J AGR FOOD CHEM, V53, P4740, DOI 10.1021/jf0478307; Konishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P583, DOI 10.1271/bbb.69.583; Makino T, 1998, PLANTA MED, V64, P541, DOI 10.1055/s-2006-957510; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; Stahringer SS, 2012, GENOME RES, V22, P2146, DOI 10.1101/gr.140608.112; Usansky J. I., 2011, PK FUNCTIONS MICROSO	26	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126422	10.1371/journal.pone.0126422	http://dx.doi.org/10.1371/journal.pone.0126422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978046	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100067
J	Delibes, M; Blazquez, MC; Fedriani, JM; Granados, A; Soriano, L; Delgado, A				Delibes, Miguel; Carmen Blazquez, Ma; Maria Fedriani, Jose; Granados, Arsenio; Soriano, Laura; Delgado, Antonio			Isotopic Niche Variation in a Higher Trophic Level Ectotherm: Highlighting the Role of Succulent Plants in Desert Food Webs	PLOS ONE			English	Article							STABLE-ISOTOPES; CARBON; NITROGEN; ECOLOGY; POPULATION; LIZARDS; DIET; ACQUISITION; DELTA-C-13; ABUNDANCE	Stable isotope analysis of animal tissues allows description of isotopic niches, whose axes in an n-dimensional space are the isotopic ratios, compared to a standard, of different isotope systems (e.g. delta C-13, delta N-15). Isotopic niches are informative about where an animal, population or species lives and about what it consumes. Here we describe inter-and intra-population isotopic niche (bidimensional delta C-13-delta N-15 space) of the Orange-throated whiptail (Aspidoscelis hyperythra), an arthropodivorous small lizard, in ten localities of Baja California Sur (Mexico). These localities range from extreme arid to subtropical conditions. Between 13 and 20 individuals were sampled at each locality and 1 cm of tail-tip was collected for isotope analysis. As expected, interpopulation niche width variation was much larger than intrapopulation one. Besides, isotopic variation was not related to age, sex or individual size of lizards. This suggests geographic variation of the isotopic niche was related to changes in the basal resources that fuel the trophic web at each locality. The position of Bayesian isotope ellipses in the delta-space indicated that whiptails in more arid localities were enriched in C-13, suggesting most of the carbon they ingested came from CAM succulent plants (cacti, agaves) and in minor degree in C-4 grasses. Contrarily, whiptails in subtropical areas were depleted in C-13, as they received more carbon from C-3 scrubs and trees. Localities closer to sea-level tended to be enriched in N-15, but a clear influence of marine subsidies was detected only at individual level. The study contributes to identify the origin and pathways through which energy flows across the trophic webs of North American deserts.	[Delibes, Miguel; Maria Fedriani, Jose; Soriano, Laura] CSIC, Estn Biol Donana, Dept Conservat Biol, Seville 41092, Spain; [Carmen Blazquez, Ma] Ctr Invest Biol Noroeste, La Paz 23090, Bcs, Mexico; [Maria Fedriani, Jose] Helmholtz Ctr Environm Res GmbH UFZ, Dept Ecol Modelling, D-04318 Leipzig, Germany; [Maria Fedriani, Jose] Univ Tecn Lisboa, Inst Agron, Ctr Appl Ecol, P-1349017 Lisbon, Portugal; [Granados, Arsenio; Delgado, Antonio] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada 18100, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada	Blazquez, MC (corresponding author), Ctr Invest Biol Noroeste, Avda Politecn Nacl 195, La Paz 23090, Bcs, Mexico.	blazquez@cibnor.mx	Delibes, Miguel/K-2744-2014; Fedriani, Jose/R-1328-2018; Huertas, Antonio Delgado/F-6866-2011	Delibes, Miguel/0000-0002-3569-567X; Fedriani, Jose/0000-0002-1581-2621; Huertas, Antonio Delgado/0000-0002-7240-1570; Granados Torres, Arsenio/0000-0002-3147-3471; Blazquez, M Carmen/0000-0002-0810-749X	Semarnat-CONACYT [2002-C01-0318]; Mexico-Spain FOMIX-CONACYT-AECI [J200-450/2004, 156/03/05]; AECID-CONACYT [J110-374/2007];  [SEP-CONACyT-80219]	Semarnat-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Mexico-Spain FOMIX-CONACYT-AECI; AECID-CONACYT; 	Several projects about different aspects of Aspidoscelis spp. in California's Gulf region supported this study: SEP-CONACyT-80219, Semarnat-CONACYT 2002-C01-0318, mixed fund Mexico-Spain FOMIX-CONACYT-AECI, J200-450/2004, 156/03/05 and AECID-CONACYT J110-374/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; ASPLUND KK, 1967, AM MIDL NAT, V77, P462, DOI 10.2307/2423352; Awkerman JA, 2007, CAN J ZOOL, V85, P273, DOI 10.1139/Z06-202; Barrett K, 2005, OIKOS, V109, P145, DOI 10.1111/j.0030-1299.2005.13728.x; Bearhop S, 1999, J APPL ECOL, V36, P75, DOI 10.1046/j.1365-2664.1999.00378.x; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bocher P, 2000, MAR ECOL PROG SER, V208, P249, DOI 10.3354/meps208249; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bostic D. L., 1965, Southwestern Naturalist, V10, P278, DOI 10.2307/3669303; BOSTIC DENNIS L., 1966, HERPETOLOGICA, V22, P23; Brown J.H, 1991, FDN ECOLOGY CLASSIC, P177, DOI DOI 10.7208/CHICAGO/9780226182100.001.0001; Castillo LP, 2007, RAPID COMMUN MASS SP, V21, P4125, DOI 10.1002/rcm.3305; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Comas M, 2014, BASIC APPL ECOL, V15, P362, DOI 10.1016/j.baae.2014.05.005; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Delaney KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012767; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; FLEMING TH, 1993, OECOLOGIA, V94, P72, DOI 10.1007/BF00317304; Galina P, 1994, THESIS CIBNOR LA PAZ; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Gillespie JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053041; Grenot Claude J., 1995, Amphibia-Reptilia, V16, P11, DOI 10.1163/156853895X00154; Grocke DR, 1997, EARTH PLANET SC LETT, V153, P279, DOI 10.1016/S0012-821X(97)00189-1; HEATON THE, 1986, NATURE, V322, P822, DOI 10.1038/322822a0; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Hubbell S.P., 2001, MG POP BIOL, V32; Hutchinson G.E., 1978, INTRO POPULATION ECO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; INEGI (Instituto Nacional de Estadistica Geografia e Informatica), 2003, CART US ACT SUEL V 3, VIII; Insightful, 2001, S PLUS 6 WIND GUID S; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; KARASOV WH, 1984, ECOLOGY, V65, P235, DOI 10.2307/1939476; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Langkilde T, 2006, J EXP BIOL, V209, P1035, DOI 10.1242/jeb.02112; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; Lin ZH, 2005, J COMP PHYSIOL B, V175, P567, DOI 10.1007/s00360-005-0017-z; Little RC, 2006, SAS MIXED MODELS; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Magnusson WE, 1999, OECOLOGIA, V119, P91, DOI 10.1007/PL00008821; Magnusson WE, 2001, ECOLOGY, V82, P1772, DOI 10.2307/2679817; Mann J., 1969, Bulletin United States National Museum, VNo. 256, P1; Marquez-Ferrando R, 2009, ARCH ENVIRON CON TOX, V56, P276, DOI 10.1007/s00244-008-9189-3; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; McCue MD, 2008, RAPID COMMUN MASS SP, V22, P2307, DOI 10.1002/rcm.3615; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Peinado M., 1994, Anales del Jardin Botanico de Madrid, V51, P255; Polis GA, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P200; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Reich KJ, 2008, OECOLOGIA, V155, P651, DOI 10.1007/s00442-007-0949-y; Roberts N. C., 1989, BAJA CALIFORNIA PLAN; Rosenblatt AE, 2013, PHYSIOL BIOCHEM ZOOL, V86, P137, DOI 10.1086/668295; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; SHREVE F., 1942, BOT REV, V8, P195, DOI 10.1007/BF02882228; SIMS PL, 1978, J ECOL, V66, P251, DOI 10.2307/2259192; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; THACKERAY JF, 1993, S AFR J SCI, V89, P458; TIESZEN LL, 1991, J ARCHAEOL SCI, V18, P227, DOI 10.1016/0305-4403(91)90063-U; Tieszen LL, 1980, P 7 N AM PRAIR C, P165; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Vazquez-Reyes CJ, 2006, THESIS CTR INVESTIGA; Warne RW, 2010, ECOLOGY, V91, P1628, DOI 10.1890/08-1471.1; Warne RW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P608, DOI 10.1086/651585; Wiegand T, 2014, CH HALL CRC APP ENV, P1; Willson JD, 2010, OIKOS, V119, P1161, DOI 10.1111/j.1600-0706.2009.17939.x; Wolf BO, 2003, ISOT ENVIRON HEALT S, V39, P53, DOI 10.1080/1025601031000102198; Wolf BO, 2002, ECOLOGY, V83, P1286, DOI 10.1890/0012-9658(2002)083[1286:SIRTSF]2.0.CO;2	76	5	5	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126814	10.1371/journal.pone.0126814	http://dx.doi.org/10.1371/journal.pone.0126814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973609	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600082
J	Jacob, SR; Tyagi, V; Agrawal, A; Chakrabarty, SK; Tyagi, RK				Jacob, Sherry R.; Tyagi, Vandana; Agrawal, Anuradha; Chakrabarty, Shyamal K.; Tyagi, Rishi K.			Indian Plant Germplasm on the Global Platter: An Analysis	PLOS ONE			English	Article							GENETIC-RESOURCES; CONSERVATION; BIODIVERSITY	Food security is a global concern amongst scientists, researchers and policy makers. No country is self-sufficient to address food security issues independently as almost all countries are inter-dependent for availability of plant genetic resources (PGR) in their national crop improvement programmes. Consultative Group of International Agricultural Research (CGIAR; in short CG) centres play an important role in conserving and distributing PGR through their genebanks. CG genebanks assembled the germplasm through collecting missions and acquisition the same from national genebanks of other countries. Using the Genesys Global Portal on Plant Genetic Resources, the World Information and Early Warning System (WIEWS) on Plant Genetic Resources for Food and Agriculture and other relevant databases, we analysed the conservation status of Indian-origin PGR accessions (both cultivated and wild forms possessed by India) in CG genebanks and other national genebanks, including the United States Department of Agriculture (USDA) genebanks, which can be considered as an indicator of Indian contribution to the global germplasm collection. A total of 28,027,770 accessions are being conserved world-wide by 446 organizations represented in Genesys; of these, 3.78% (100,607) are Indian-origin accessions. Similarly, 62,920 Indian-origin accessions (8.73%) have been conserved in CG genebanks which are accessible to the global research community for utilization in their respective crop improvement programmes. A total of 60 genebanks including 11 CG genebanks have deposited 824,625 accessions of PGR in the Svalbard Global Seed Vault (SGSV) as safety duplicates; the average number of accessions deposited by each genebank is 13,744, and amongst them there are 66,339 Indian-origin accessions. In principle, India has contributed 4.85 times the number of germplasm accessions to SGSV, in comparison to the mean value (13,744) of any individual genebank including CG genebanks. More importantly, about 50% of the Indian-origin accessions deposited in SGSV are traditional varieties or landraces with defined traits which form the backbone of any crop gene pool. This paper is also attempting to correlate the global data on Indian-origin germplasm with the national germplasm export profile. The analysis from this paper is discussed with the perspective of possible implications in the access and benefit sharing regime of both the International Treaty on Plant Genetic Resources for Food and Agriculture and the newly enforced Nagoya Protocol under the Convention on Biological Diversity.	[Jacob, Sherry R.; Tyagi, Rishi K.] ICAR Natl Bur Plant Genet Resources, Div Germplasm Conservat, New Delhi 110012, India; [Tyagi, Vandana] ICAR Natl Bur Plant Genet Resources, Germplasm Exchange Unit, New Delhi 110012, India; [Agrawal, Anuradha] ICAR Natl Bur Plant Genet Resources, Tissue Culture & Cryopreservat Unit, New Delhi 110012, India; [Chakrabarty, Shyamal K.] ICAR Natl Bur Plant Genet Resources, Reg Stn, Hyderabad 500030, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Tyagi, RK (corresponding author), ICAR Natl Bur Plant Genet Resources, Div Germplasm Conservat, New Delhi 110012, India.	rktyagi@nbpgr.ernet.in	Agrawal, Anuradha/AAC-7619-2021; Agrawal, Anuradha/AAB-8589-2019	Agrawal, Anuradha/0000-0003-1499-8572; 				Agrawal RC, 2013, ROADMAP IMPLEMENTING, P35; [Anonymous], 1976, ANN REP; Bjornstad A, 2013, GENET RESOUR CROP EV, V60, P1959, DOI 10.1007/s10722-013-0029-6; Datta SK, 2013, ROADMAP IMPLEMENTING, P56; Dauda B, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-36; Dulloo ME, 2013, CROP SCI, V53, P1217, DOI 10.2135/cropsci2012.04.0219; FAO, 2010, 2 FAO; Fowler C, 2001, GFAR IPGRI STRENGTHE, P86; Global Crop Diversity Trust, 2014, GEN; Halewood M, 2014, INTELLECTUAL PROPERT, P288; Khanna S.S., 1989, SURVEY INDIAN AGR, P28; Khoshbakht K, 2008, GENET RESOUR CROP EV, V55, P925, DOI 10.1007/s10722-008-9368-0; Lopez-Noriega I., 2012, CCAFS Working Paper; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NBPGR, 2011, NBPGR COMP ACH; NordGen, 2014, SVALB GLOB SEED VAUL; Noriega IL, 2013, RESOURCES-BASEL, V2, P231, DOI 10.3390/resources2030231; Plucknett DL, 1987, GENE BANKS WORLDS FO; Ungricht S, 2004, TAXON, V53, P481, DOI 10.2307/4135626; Vernooy R, 2012, 1 PROJ PLANN WORKSH, DOI [10.1016/j.jep.2011.05.027, DOI 10.1016/J.JEP.2011.05.027]; Westengen OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064146; Zeven A. C., 1982, Dictionary of cultivated plants and their regions of diversity.; Zhang JM, 2014, ACTA HORTIC, V1039, P309	24	11	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126634	10.1371/journal.pone.0126634	http://dx.doi.org/10.1371/journal.pone.0126634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974270	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600069
J	Kaylor, JJ; Radu, RA; Bischoff, N; Makshanoff, J; Hu, J; Lloyd, M; Eddington, S; Bianconi, T; Bok, D; Travis, GH				Kaylor, Joanna J.; Radu, Roxana A.; Bischoff, Nicholas; Makshanoff, Jacob; Hu, Jane; Lloyd, Marcia; Eddington, Shannan; Bianconi, Tran; Bok, Dean; Travis, Gabriel H.			Diacylglycerol O-Acyltransferase Type-1 Synthesizes Retinyl Esters in the Retina and Retinal Pigment Epithelium	PLOS ONE			English	Article							VITAMIN-A; BINDING-PROTEIN; MULLER CELLS; ISOMERASE; RPE65; LECITHIN; ISOMEROHYDROLASE; IDENTIFICATION; ISOMERIZATION; ACCUMULATION	Retinyl esters represent an insoluble storage form of vitamin A and are substrates for the retinoid isomerase (Rpe65) in cells of the retinal pigment epithelium (RPE). The major retinyl-ester synthase in RPE cells is lecithin: retinol acyl-transferase (LRAT). A second palmitoyl coenzyme A-dependent retinyl-ester synthase activity has been observed in RPE homogenates but the protein responsible has not been identified. Here we show that diacylglycerol O-acyltransferase-1 (DGAT1) is expressed in multiple cells of the retina including RPE and Muller glial cells. DGAT1 catalyzes the synthesis of retinyl esters from multiple retinol isomers with similar catalytic efficiencies. Loss of DGAT1 in dgat1(-/-) mice has no effect on retinal anatomy or the ultrastructure of photoreceptor outer-segments (OS) and RPE cells. Levels of visual chromophore in dgat1(-/-) mice were also normal. However, the normal build-up of all-trans-retinyl esters (all-trans-RE's) in the RPE during the first hour after a deep photobleach of visual pigments in the retina was not seen in dgat1(-/-) mice. Further, total retinyl-ester synthase activity was reduced in both dgat1(-/-) retina and RPE.	[Kaylor, Joanna J.; Radu, Roxana A.; Bischoff, Nicholas; Makshanoff, Jacob; Hu, Jane; Lloyd, Marcia; Eddington, Shannan; Bianconi, Tran; Bok, Dean; Travis, Gabriel H.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Bok, Dean] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kaylor, JJ (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	kaylor@jsei.ucla.edu	Travis, Gabriel Harvey/AIF-1062-2022; Kaylor, Joanna/Y-5184-2019; Radu, Roxana A./K-8924-2019	Travis, Gabriel Harvey/0000-0003-4020-9493; Radu, Roxana/0000-0002-5064-6403	National Institute of Health (NIH); NIH [R01-EY11713, P30-EY00331]; NATIONAL EYE INSTITUTE [P30EY000331, R01EY011713] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by the National Institute of Health (NIH), NIH Grants # R01-EY11713 and # P30-EY00331, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY RJ, 1989, J BIOL CHEM, V264, P9231; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; DeVita RJ, 2013, J MED CHEM, V56, P9820, DOI 10.1021/jm4007033; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P5809, DOI 10.1021/bi0341004; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Kaschula CH, 2006, EXP EYE RES, V82, P111, DOI 10.1016/j.exer.2005.05.010; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kaylor JJ, 2014, PROC NATL ACAD SCI U; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Leenheer APD, 2000, MODERN CHROMATOGRAPH; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Mata NL, 2005, BIOCHEMISTRY-US, V44, P11715, DOI 10.1021/bi050942m; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Muniz A, 2007, EXP EYE RES, V85, P175, DOI 10.1016/j.exer.2007.05.003; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; RODRIGUEZ KA, 1989, AM J PHYSIOL, V256, pR255, DOI 10.1152/ajpregu.1989.256.1.R255; Ruiz A, 2007, INVEST OPHTH VIS SCI, V48, P5377, DOI 10.1167/iovs.07-0673; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Tsilou E, 1997, ARCH BIOCHEM BIOPHYS, V346, P21, DOI 10.1006/abbi.1997.0276; WAKAKURA M, 1988, INVEST OPHTH VIS SCI, V29, P892; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200	36	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125921	10.1371/journal.pone.0125921	http://dx.doi.org/10.1371/journal.pone.0125921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974161	gold, Green Published			2022-12-27	WOS:000354545600032
J	Krishnakumar, S; Gaudana, SB; Vinh, NX; Viswanathan, GA; Chetty, M; Wangikar, PP				Krishnakumar, S.; Gaudana, Sandeep B.; Vinh, Nguyen X.; Viswanathan, Ganesh A.; Chetty, Madhu; Wangikar, Pramod P.			Coupling of Cellular Processes and Their Coordinated Oscillations under Continuous Light in Cyanothece sp ATCC 51142, a Diazotrophic Unicellular Cyanobacterium	PLOS ONE			English	Article							CIRCADIAN GENE-EXPRESSION; RNA HELICASE; MESSENGER-RNA; SIGMA-FACTORS; RHYTHM; IDENTIFICATION; METABOLISM; PROTEIN; CARBON; CLOCK	Unicellular diazotrophic cyanobacteria such as Cyanothece sp. ATCC 51142 (henceforth Cyanothece), temporally separate the oxygen sensitive nitrogen fixation from oxygen evolving photosynthesis not only under diurnal cycles (LD) but also in continuous light (LL). However, recent reports demonstrate that the oscillations in LL occur with a shorter cycle time of similar to 11 h. We find that indeed, majority of the genes oscillate in LL with this cycle time. Genes that are upregulated at a particular time of day under diurnal cycle also get upregulated at an equivalent metabolic phase under LL suggesting tight coupling of various cellular events with each other and with the cell's metabolic status. A number of metabolic processes get upregulated in a coordinated fashion during the respiratory phase under LL including glycogen degradation, glycolysis, oxidative pentose phosphate pathway, and tricarboxylic acid cycle. These precede nitrogen fixation apparently to ensure sufficient energy and anoxic environment needed for the nitrogenase enzyme. Photosynthetic phase sees upregulation of photosystem II, carbonate transport, carbon concentrating mechanism, RuBisCO, glycogen synthesis and light harvesting antenna pigment biosynthesis. In Synechococcus elongates PCC 7942, a non-nitrogen fixing cyanobacteria, expression of a relatively smaller fraction of genes oscillates under LL condition with the major periodicity being 24 h. In contrast, the entire cellular machinery of Cyanothece orchestrates coordinated oscillation in anticipation of the ensuing metabolic phase in both LD and LL. These results may have important implications in understanding the timing of various cellular events and in engineering cyanobacteria for biofuel production.	[Krishnakumar, S.; Gaudana, Sandeep B.; Viswanathan, Ganesh A.; Wangikar, Pramod P.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India; [Viswanathan, Ganesh A.; Wangikar, Pramod P.] Indian Inst Technol, DBT Pan IIT Ctr Bioenergy, Bombay 400076, Maharashtra, India; [Wangikar, Pramod P.] Indian Inst Technol, Wadhwani Res Ctr Bioengn, Bombay 400076, Maharashtra, India; [Vinh, Nguyen X.; Chetty, Madhu] Federat Univ Australia, Sch Informat Technol, Mt Helen, Vic 3841, Australia	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; DBT-Pan IIT Centre for Bioenergy; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Federation University Australia	Wangikar, PP (corresponding author), Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.	wangikar@iitb.ac.in		Chetty, Madhu/0000-0001-7052-0413; Viswanathan, Ganesh A/0000-0001-6424-0765	Australia-India strategic research (AISRF) grant; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/Indo-Aus/04/04/2009]	Australia-India strategic research (AISRF) grant(Australian GovernmentDepartment of Industry, Innovation and Science); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The work was partially funded by an Australia-India strategic research (AISRF) grant to PPW and MC. The grant to the Indian side was provided by Department of Biotechnology, Ministry of Science and Technology, Government of India, grant number: BT/Indo-Aus/04/04/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagesan S, 2013, PHOTOSYNTH RES, V118, P191, DOI 10.1007/s11120-013-9911-5; Angermayr SA, 2012, APPL ENVIRON MICROB, V78, P7098, DOI 10.1128/AEM.01587-12; Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cerveny J, 2013, P NATL ACAD SCI USA, V110, P13210, DOI 10.1073/pnas.1301171110; Cerveny J, 2009, J BIOL RHYTHM, V24, P295, DOI 10.1177/0748730409338367; Charollais J, 2004, NUCLEIC ACIDS RES, V32, P2751, DOI 10.1093/nar/gkh603; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; Ditty JL, 2003, ANNU REV GENET, V37, P513, DOI 10.1146/annurev.genet.37.110801.142716; Elvitigala T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-226; Elvitigala TR, 2009, P AMER CONTR CONF, P343, DOI 10.1109/ACC.2009.5159968; Gaudana SB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00374; Golden SS, 2003, NAT REV MICROBIOL, V1, P191, DOI 10.1038/nrmicro774; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Imamura S, 2003, FEBS LETT, V554, P357, DOI 10.1016/S0014-5793(03)01188-8; Imamura S, 2003, J MOL BIOL, V325, P857, DOI 10.1016/S0022-2836(02)01242-1; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ivleva NB, 2006, P NATL ACAD SCI USA, V103, P17468, DOI 10.1073/pnas.0606639103; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; JERRI AJ, 1977, P IEEE, V65, P1565, DOI 10.1109/PROC.1977.10771; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Jones AC, 2011, P NATL ACAD SCI USA, V108, P8815, DOI 10.1073/pnas.1101137108; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Katayama M, 2003, J BACTERIOL, V185, P1415, DOI 10.1128/JB.185.4.1415-1422.2003; Kim YI, 2012, P NATL ACAD SCI USA, V109, P17765, DOI 10.1073/pnas.1216401109; Krishnakumar S, 2013, BIOTECHNOL BIOENG, V110, P2371, DOI 10.1002/bit.24882; Kujat SL, 2000, PLANT PHYSIOL, V124, P703, DOI 10.1104/pp.124.2.703; Lehmann R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-133; Li H, 2001, ARCH MICROBIOL, V176, P9, DOI 10.1007/s002030100281; Liberton M, 2011, PLANT PHYSIOL, V155, P1656, DOI 10.1104/pp.110.165332; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Mackey SR, 2008, J BACTERIOL, V190, P3738, DOI 10.1128/JB.01721-07; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Memon D, 2013, ANTON LEEUW INT J G, V103, P331, DOI 10.1007/s10482-012-9813-0; Nigam A, 2012, BIORESOURCE TECHNOL, V114, P484, DOI 10.1016/j.biortech.2012.03.007; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Rosana ARR, 2012, PLANT CELL PHYSIOL, V53, P646, DOI 10.1093/pcp/pcs020; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; Samartzidou H, 1998, PLANT PHYSIOL, V117, P225, DOI 10.1104/pp.117.1.225; Sherman LA, 2010, ADV EXP MED BIOL, V675, P275, DOI 10.1007/978-1-4419-1528-3_16; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Stockel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056887; Taniguchi Y, 2012, FEBS LETT, V586, P753, DOI 10.1016/j.febslet.2012.01.035; Taniuchi Y, 2008, MICROBIOL-SGM, V154, P1859, DOI 10.1099/mic.0.2008/018689-0; Toepel J, 2008, J BACTERIOL, V190, P3904, DOI 10.1128/JB.00206-08; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Wang WX, 2011, IEEE ACM T COMPUT BI, V8, P108, DOI 10.1109/TCBB.2009.37; Yen UC, 2004, PLANT SCI, V166, P949, DOI 10.1016/j.plantsci.2003.12.005; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zhou J, 2012, METAB ENG, V14, P394, DOI 10.1016/j.ymben.2012.03.005	54	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125148	10.1371/journal.pone.0125148	http://dx.doi.org/10.1371/journal.pone.0125148			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973856	Green Published, gold			2022-12-27	WOS:000354545600013
J	Zhang, WT; Gu, YX; Sun, QL; Siegel, DS; Tolias, P; Yang, Z; Lee, WY; Zilberberg, J				Zhang, Wenting; Gu, Yexin; Sun, Qiaoling; Siegel, David S.; Tolias, Peter; Yang, Zheng; Lee, Woo Y.; Zilberberg, Jenny			Ex Vivo Maintenance of Primary Human Multiple Myeloma Cells through the Optimization of the Osteoblastic Niche	PLOS ONE			English	Article							MEDIATED DRUG-RESISTANCE; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; EXPRESSION PROFILES; GENE-EXPRESSION; GROWTH-FACTORS; BONE-DISEASE; CANCER CELLS; N-CADHERIN; MARROW	We previously reported a new approach for culturing difficult-to-preserve primary patient-derived multiple myeloma cells (MMC) using an osteoblast (OSB)-derived 3D tissue scaffold constructed in a perfused microfluidic environment and a culture medium supplemented with patient plasma. In the current study, we used this biomimetic model to show, for the first time, that the long-term survival of OSB is the most critical factor in maintaining the ex vivo viability and proliferative capacity of MMC. We found that the adhesion and retention of MMC to the tissue scaffold was meditated by osteoblastic N-cadherin, as one of potential mechanisms that regulate MMC-OSB interactions. However, in the presence of MMC and patient plasma, the viability and osteogenic activity of OSB became gradually compromised, and consequently MMC could not remain viable over 3 weeks. We demonstrated that the long-term survival of both OSB and MMC could be enhanced by: (1) optimizing perfusion flow rate and patient-derived plasma composition in the culture medium and (2) replenishing OSB during culture as a practical means of prolonging MMC's viability beyond several weeks. These findings were obtained using a high-throughput well plate-based perfusion device from the perspective of optimizing the ex vivo preservation of patient- derived MM biospecimens for downstream use in biological studies and chemosensitivity analyses.	[Zhang, Wenting; Gu, Yexin; Sun, Qiaoling; Lee, Woo Y.] Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA; [Siegel, David S.; Zilberberg, Jenny] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ 07601 USA; [Tolias, Peter] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA; [Tolias, Peter] Stevens Inst Technol, Ctr Healthcare Innovat, Hoboken, NJ 07030 USA; [Yang, Zheng; Zilberberg, Jenny] Hackensack Univ, Med Ctr, Res Dept, Hackensack, NJ 07601 USA	Stevens Institute of Technology; Hackensack University Medical Center; Stevens Institute of Technology; Stevens Institute of Technology; Hackensack University Medical Center	Zilberberg, J (corresponding author), Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ 07601 USA.	JZilberberg@HackensackUMC.org			NHI/NCI Innovative Molecular Analysis Technologies Program grant [R21CA174543]; Provost Office of the Stevens Institute of Technology (Stevens); John Theurer Cancer Center at Hackensack University Medical Center (HackensackUMC); NATIONAL CANCER INSTITUTE [R21CA174543] Funding Source: NIH RePORTER	NHI/NCI Innovative Molecular Analysis Technologies Program grant; Provost Office of the Stevens Institute of Technology (Stevens); John Theurer Cancer Center at Hackensack University Medical Center (HackensackUMC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the NHI/NCI Innovative Molecular Analysis Technologies Program grant R21CA174543 (to W.Y.L and J.Z), the Provost Office of the Stevens Institute of Technology (Stevens), and the John Theurer Cancer Center at Hackensack University Medical Center (HackensackUMC).	Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; BATAILLE R, 1989, J CLIN ONCOL, V7, P1909, DOI 10.1200/JCO.1989.7.12.1909; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; Brenne AT, 2002, BLOOD, V99, P3756, DOI 10.1182/blood.V99.10.3756; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Fryer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057641; Fu JX, 2010, ARCH MED SCI, V6, P496, DOI 10.5114/aoms.2010.14459; Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007; Giuliani N, 2006, BLOOD, V108, P3992, DOI 10.1182/blood-2006-05-026112; Giuliani N, 2009, EXP HEMATOL, V37, P879, DOI 10.1016/j.exphem.2009.04.004; Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5; Groen RWJ, 2011, HAEMATOL-HEMATOL J, V96, P1653, DOI 10.3324/haematol.2010.038133; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Gurkan UA, 2008, ANN BIOMED ENG, V36, P1978, DOI 10.1007/s10439-008-9577-x; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Karadag A, 2000, BRIT J HAEMATOL, V108, P383; Kirshner J, 2008, BLOOD, V112, P2935, DOI 10.1182/blood-2008-02-142430; Lawson MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119546; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; Porat Z, 2011, J CELL PHYSIOL, V226, P3197, DOI 10.1002/jcp.22680; Rajkumar SV, 2013, AM J HEMATOL, V88, P225, DOI 10.1002/ajh.23390; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Ramachandran IR, 2013, J IMMUNOL, V190, P3815, DOI 10.4049/jimmunol.1203373; Reagan MR, 2014, BLOOD, V124, P3250, DOI 10.1182/blood-2014-02-558007; Roodman GD, 2011, BONE, V48, P135, DOI 10.1016/j.bone.2010.06.016; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Schmidmaier R, 2006, INT J BIOL MARKER, V21, P218, DOI 10.1177/172460080602100404; Shiirevnyamba A, 2011, BRIT J CANCER, V104, P505, DOI 10.1038/sj.bjc.6606070; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Vejlgaard T, 1997, EUR J HAEMATOL, V58, P104; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Yata K, 2007, LEUKEMIA, V18, P1891; Zhang WT, 2014, TISSUE ENG PART C-ME, V20, P663, DOI [10.1089/ten.TEC.2013.0490, 10.1089/ten.tec.2013.0490]; Zlei M, 2007, EXP HEMATOL, V35, P1550, DOI 10.1016/j.exphem.2007.06.016	40	29	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125995	10.1371/journal.pone.0125995	http://dx.doi.org/10.1371/journal.pone.0125995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973790	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600036
J	Dantas-Ferreira, RF; Dumont, S; Gourmelen, S; Cipolla-Neto, J; Simonneaux, V; Pevet, P; Challet, E				Dantas-Ferreira, Rosana F.; Dumont, Stephanie; Gourmelen, Sylviane; Cipolla-Neto, Jose; Simonneaux, Valerie; Pevet, Paul; Challet, Etienne			Food-Anticipatory Activity in Syrian Hamsters: Behavioral and Molecular Responses in the Hypothalamus According to Photoperiodic Conditions	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; SUPRACHIASMATIC NUCLEUS; SKELETON PHOTOPERIODS; NEURONAL ACTIVATION; LOCOMOTOR-ACTIVITY; ENTRAINED RATS; BODY-WEIGHT; EXPRESSION; LIGHT; PACEMAKER	When food availability is restricted, animals adjust their behavior according to the timing of food access. Most rodents, such as rats and mice, and a wide number of other animals express before timed food access a bout of activity, defined as food-anticipatory activity (FAA). One notable exception amongst rodents is the Syrian hamster, a photoperiodic species that is not prone to express FAA. The present study was designed to understand the reasons for the low FAA in that species. First, we used both wheel-running activity and general cage activity to assess locomotor behavior. Second, the possible effects of photoperiod was tested by challenging hamsters with restricted feeding under long (LP) or short (SP) photoperiods. Third, because daytime light may inhibit voluntary activity, hamsters were also exposed to successive steps of full and skeleton photoperiods (two 1-h light pulses simulating dawn and dusk). When hamsters were exposed to skeleton photoperiods, not full photoperiod, they expressed FAA in the wheel independently of daylength, indicating that FAA in the wheel is masked by daytime light under full photoperiods. During FAA under skeleton photoperiods, c-Fos expression was increased in the arcuate nuclei independently of the photoperiod, but differentially increased in the ventromedial and dorsomedial hypothalamic nuclei according to the photoperiod. FAA in general activity was hardly modulated by daytime light, but was reduced under SP. Together, these findings show that food-restricted Syrian hamsters are not prone to display FAA under common laboratory conditions, because of the presence of light during daytime that suppresses FAA expression in the wheel.	[Dantas-Ferreira, Rosana F.; Dumont, Stephanie; Gourmelen, Sylviane; Cipolla-Neto, Jose; Simonneaux, Valerie; Pevet, Paul; Challet, Etienne] Univ Strasbourg, UPR CNRS 3212, Inst Cellular & Integrat Neurosci, Dept Neurobiol Rhythms, Strasbourg, France; [Dantas-Ferreira, Rosana F.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade de Sao Paulo	Challet, E (corresponding author), Univ Strasbourg, UPR CNRS 3212, Inst Cellular & Integrat Neurosci, Dept Neurobiol Rhythms, Strasbourg, France.	challet@inci-cnrs.unistra.fr	Cipolla-Neto, Jose/B-1619-2009; Challet, Etienne/ABF-7553-2020	Cipolla-Neto, Jose/0000-0003-3748-3731; Challet, Etienne/0000-0001-9416-9496	Fundacao de Amparo a Pesquisa do Estado do Sao Paulo (Sao Paulo State, Brazil); Centre National de la Recherche Scientifique (France); University of Strasbourg (France)	Fundacao de Amparo a Pesquisa do Estado do Sao Paulo (Sao Paulo State, Brazil); Centre National de la Recherche Scientifique (France)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg (France)	This work was supported by doctoral scholarship from Fundacao de Amparo a Pesquisa do Estado do Sao Paulo (Sao Paulo State, Brazil) to RFDF, and by Centre National de la Recherche Scientifique and University of Strasbourg (France) to EC, VS and PP.	ABE H, 1992, AM J PHYSIOL, V263, pR116, DOI 10.1152/ajpregu.1992.263.1.R116; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Ahima RS, 2004, PHYSIOL BEHAV, V81, P223, DOI 10.1016/j.physbeh.2004.02.014; Ancel C, 2012, ENDOCRINOLOGY, V153, P1352, DOI 10.1210/en.2011-1622; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; BARTNESS TJ, 1985, NEUROSCI BIOBEHAV R, V9, P599, DOI 10.1016/0149-7634(85)90006-5; Blum ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036117; Bradley SP, 2014, HORM BEHAV, V66, P159, DOI 10.1016/j.yhbeh.2013.10.008; Carneiro BTS, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00083; Challet E, 2004, NEUROSCI LETT, V355, P131, DOI 10.1016/j.neulet.2003.10.041; Challet E, 2000, J NEUROENDOCRINOL, V12, P69; Challet E, 2003, J NEUROSCI RES, V72, P629, DOI 10.1002/jnr.10616; CONN CA, 1995, J APPL PHYSIOL, V78, P458, DOI 10.1152/jappl.1995.78.2.458; Davidson AJ, 2000, AM J PHYSIOL-REG I, V278, pR1296, DOI 10.1152/ajpregu.2000.278.5.R1296; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Edelstein K, 1999, J NEUROSCI, V19, P372, DOI 10.1523/JNEUROSCI.19-01-00372.1999; ELLIS GB, 1983, HORM BEHAV, V17, P66, DOI 10.1016/0018-506X(83)90016-8; Horton TH, 2000, HORM BEHAV, V37, P388, DOI 10.1006/hbeh.2000.1592; Hsu JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011802; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Kiessling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092959; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Menet JS, 2005, AM J PHYSIOL-REG I, V288, pR234, DOI 10.1152/ajpregu.00029.2004; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; MISTLBERGER RE, 1992, BEHAV NEUROSCI, V106, P192, DOI 10.1037/0735-7044.106.1.192; MISTLBERGER RE, 1991, PHYSIOL BEHAV, V50, P1257, DOI 10.1016/0031-9384(91)90592-C; MISTLBERGER RE, 1993, PHYSIOL BEHAV, V53, P509, DOI 10.1016/0031-9384(93)90145-6; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1984, PHYSIOL BEHAV, V33, P227, DOI 10.1016/0031-9384(84)90104-5; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Morin LP, 2013, EXP NEUROL, V243, P4, DOI 10.1016/j.expneurol.2012.06.026; Morin LP, 2001, STEREOTAXIC ATLAS GO; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Nakamura TJ, 2004, NEUROSCI LETT, V371, P244, DOI 10.1016/j.neulet.2004.09.005; Novak CM, 2012, NEUROSCI BIOBEHAV R, V36, P1001, DOI 10.1016/j.neubiorev.2011.12.012; PERSONS JE, 1993, PHYSIOL BEHAV, V54, P55, DOI 10.1016/0031-9384(93)90043-F; Poulin AM, 2008, BRAIN RES, V1227, P128, DOI 10.1016/j.brainres.2008.06.039; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; Revel FG, 2008, ENDOCRINOLOGY, V149, P902, DOI 10.1210/en.2007-0848; Ribeiro AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023364; Ribeiro AC, 2009, EUR J NEUROSCI, V30, P1730, DOI 10.1111/j.1460-9568.2009.06969.x; ROSENWASSER AM, 1983, PHYSIOL BEHAV, V30, P353, DOI 10.1016/0031-9384(83)90138-5; RUSAK B, 1988, J COMP PHYSIOL A, V164, P165, DOI 10.1007/BF00603948; Scarbrough K, 1997, AM J PHYSIOL-REG I, V272, pR1219, DOI 10.1152/ajpregu.1997.272.4.R1219; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Simonneaux V, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00022; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; WADE GN, 1986, PHYSIOL BEHAV, V37, P863, DOI 10.1016/S0031-9384(86)80005-1; Yan L, 2008, EUR J NEUROSCI, V28, P2108, DOI 10.1111/j.1460-9568.2008.06493.x	52	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126519	10.1371/journal.pone.0126519	http://dx.doi.org/10.1371/journal.pone.0126519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970608	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200116
J	McKenney, EA; Rodrigo, A; Yoder, AD				McKenney, Erin A.; Rodrigo, Allen; Yoder, Anne D.			Patterns of Gut Bacterial Colonization in Three Primate Species	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; VARECIA-VARIEGATA; MICROBIOTA; DIET; DIVERSITY; ECOLOGY; HEALTH; IMPACT	Host fitness is impacted by trillions of bacteria in the gastrointestinal tract that facilitate development and are inextricably tied to life history. During development, microbial colonization primes the gut metabolism and physiology, thereby setting the stage for adult nutrition and health. However, the ecological rules governing microbial succession are poorly understood. In this study, we examined the relationship between host lineage, captive diet, and life stage and gut microbiota characteristics in three primate species (infraorder, Lemuriformes). Fecal samples were collected from captive lemur mothers and their infants, from birth to weaning. Microbial DNA was extracted and the v4 region of 16S rDNA was sequenced on the Illumina platform using protocols from the Earth Microbiome Project. Here, we show that colonization proceeds along different successional trajectories in developing infants from species with differing dietary regimes and ecological profiles: frugivorous (fruit-eating) Varecia variegata, generalist Lemur catta, and folivorous (leaf-eating) Propithecus coquereli. Our analyses reveal community membership and succession patterns consistent with previous studies of human infants, suggesting that lemurs may serve as a useful model of microbial ecology in the primate gut. Each lemur species exhibits distinct species-specific bacterial diversity signatures correlating to life stages and life history traits, implying that gut microbial community assembly primes developing infants at species-specific rates for their respective adult feeding strategies.	[McKenney, Erin A.; Rodrigo, Allen; Yoder, Anne D.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Rodrigo, Allen] Natl Evolutionary Synth Ctr, Durham, NC USA; [Yoder, Anne D.] Duke Univ, Duke Lemur Ctr, Durham, NC USA	Duke University; The National Evolutionary Synthesis Center; Duke University	McKenney, EA (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	erin.mckenney@duke.edu	Rodrigo, Allen/E-8905-2015	Rodrigo, Allen/0000-0002-8327-7317; McKenney, Erin/0000-0001-9874-1146	Duke Biology Department; Duke Lemur Center Director's Fund; Direct For Social, Behav & Economic Scie [1455848] Funding Source: National Science Foundation	Duke Biology Department; Duke Lemur Center Director's Fund; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Duke Biology Department Grant-in-Aid; Duke Lemur Center Director's Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2005, PERMUTATIONAL MULTIV; [Anonymous], 2011, ARONESTY E ARONESTY; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Borries C, 2011, AM J PHYS ANTHROPOL, V144, P286, DOI 10.1002/ajpa.21403; Britt A, 1998, ZOO BIOL, V17, P379, DOI 10.1002/(SICI)1098-2361(1998)17:5<379::AID-ZOO3>3.3.CO;2-O; Campbell JL, 2000, AM J PRIMATOL, V52, P133, DOI 10.1002/1098-2345(200011)52:3<133::AID-AJP2>3.0.CO;2-#; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Frey JC, 2006, APPL ENVIRON MICROB, V72, P3788, DOI 10.1128/AEM.72.5.3788-3792.2006; Godfrey LR, 2001, AM J PHYS ANTHROPOL, V114, P192, DOI 10.1002/1096-8644(200103)114:3<192::AID-AJPA1020>3.0.CO;2-Q; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hemingway CA, 1998, INT J PRIMATOL, V19, P355, DOI 10.1023/A:1020344018670; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jones JH, 2011, CURR BIOL, V21, pR708, DOI 10.1016/j.cub.2011.08.025; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McKenney EA, 2014, INTEGR ZOOL, V9, P557, DOI 10.1111/1749-4877.12112; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; READ AF, 1989, J ZOOL, V219, P329, DOI 10.1111/j.1469-7998.1989.tb02584.x; Sanz Y, 2011, AM J CLIN NUTR, V94, p2000S, DOI 10.3945/ajcn.110.001172; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056565; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x	48	43	46	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124618	10.1371/journal.pone.0124618	http://dx.doi.org/10.1371/journal.pone.0124618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970595	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200045
J	Tsai, WC; Ou, TT; Yen, JH; Wu, CC; Tung, YC				Tsai, Wen-Chan; Ou, Tsan-Teng; Yen, Jeng-Hsien; Wu, Cheng-Chin; Tung, Yi-Ching			Long-Term Frequent Use of Non-Steroidal Anti-Inflammatory Drugs Might Protect Patients with Ankylosing Spondylitis from Cardiovascular Diseases: A Nationwide CaseControl Study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; GASTROINTESTINAL TOXICITY; RADIOGRAPHIC PROGRESSION; MYOCARDIAL-INFARCTION; INCEPTION COHORT; CLINICAL-TRIAL; INCREASED RISK; EVENTS; ROFECOXIB; OSTEOARTHRITIS	The objective of this case-control study was to investigate the risk of cardiovascular disease (CVD) following non-steroidal anti-inflammatory drug (NSAID) use in patients with ankylosing spondylitis (AS). A total of 10,763 new AS patients were identified from the National Taiwan Health Insurance claims database during the period from 1997 to 2008. In all, 421 AS patients with CVD were recruited as cases, and up to 2-fold as many sex- and age-matched controls were selected. Logistic regression models were used to estimate the odds ratio (OR) between NSAID use and CVD incidence. The medication possession rate (MPR) was used to evaluate NSAID exposure during the study period. AS patients had increased risk of CVD (OR, 1.68; 95% confidence interval (CI), 1.57 to 1.80). Among frequent (MPR >= 80%) COX II users, the risks for all types of CVD were ten times lower than those among non-users at 24 months (OR, 0.08; 95% CI, 0.01 to 0.92). Among frequent NSAID users, the risks of major adverse cardiac event (MACE) were significantly lower at 12 months (OR, 0.23; 95% CI, 0.07 to 0.76)-a trend showing that longer exposure correlated with lower risk. Regarding non-frequent NSAID users (MPR<80%), short-term exposure did carry higher risk (for 6 months: OR, 1.41; 95% CI, 1.07 to 1.86), but after 12 months, the risk no longer existed. We conclude that long-term frequent use of NSAIDs might protect AS patients from CVD; however, NSAIDs still carried higher short-term risk in the non-frequent users.	[Tsai, Wen-Chan; Ou, Tsan-Teng; Yen, Jeng-Hsien; Wu, Cheng-Chin] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tung, Yi-Ching] Kaohsiung Med Univ, Coll Med, Dept Publ Hlth & Environm Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Tung, YC (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Publ Hlth & Environm Med, Kaohsiung, Taiwan.	yctung@kmu.edu.tw	Yen, Jeng-Hsien/A-1335-2010	Yen, Jeng-Hsien/0000-0002-1291-1739				Bili A, 2014, ARTHRIT CARE RES, V66, P355, DOI 10.1002/acr.22166; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bremander A, 2011, ARTHRIT CARE RES, V63, P550, DOI 10.1002/acr.20408; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; Goodson NJ, 2009, ANN RHEUM DIS, V68, P367, DOI 10.1136/ard.2007.076760; Greenberg JD, 2011, ANN RHEUM DIS, V70, P576, DOI 10.1136/ard.2010.129916; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; Han CL, 2006, J RHEUMATOL, V33, P2167; Haroon N, 2012, ANN RHEUM DIS, V71, P1593, DOI 10.1136/annrheumdis-2012-201844; Hennekens CH, 2008, J CARDIOVASC PHARM T, V13, P41, DOI 10.1177/1074248407312990; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kitas GD, 2003, RHEUMATOLOGY, V42, P607, DOI 10.1093/rheumatology/keg175; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Kroon F, 2012, ANN RHEUM DIS, V71, P1623, DOI 10.1136/annrheumdis-2012-201370; Lader E, 2013, ANN INTERN MED, V159, DOI 10.7326/0003-4819-159-8-201310150-02012; Lindhardsen J, 2014, ANN RHEUM DIS, V73, P1515, DOI 10.1136/annrheumdis-2012-203137; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Pincus T, 2000, J RHEUMATOL, V27, P1020; Poddubnyy D, 2012, ANN RHEUM DIS, V71, P1616, DOI 10.1136/annrheumdis-2011-201252; Salpeter SR, 2006, AM J MED, V119, P552, DOI 10.1016/j.amjmed.2005.10.056; Schoenfeld SR, 2013, SEMIN ARTHRITIS RHEU, V43, P77, DOI 10.1016/j.semarthrit.2012.12.002; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Stevens Robert J., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009154; Szabo SM, 2011, ARTHRITIS RHEUM-US, V63, P3294, DOI 10.1002/art.30581; Wanders A, 2005, ARTHRITIS RHEUM-US, V52, P1756, DOI 10.1002/art.21054; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105; Wolfe F, 2000, ARTHRITIS RHEUM-US, V43, P378, DOI 10.1002/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	36	26	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126347	10.1371/journal.pone.0126347	http://dx.doi.org/10.1371/journal.pone.0126347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970845	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200106
J	Gownaris, NJ; Pikitch, EK; Ojwang, WO; Michener, R; Kaufman, L				Gownaris, Natasha J.; Pikitch, Ellen K.; Ojwang, William O.; Michener, Robert; Kaufman, Les			Predicting Species' Vulnerability in a Massively Perturbed System: The Fishes of Lake Turkana, Kenya	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSES; FOOD-WEB STRUCTURE; TROPHIC POSITION; LIPID EXTRACTION; NILE PERCH; INDIVIDUAL SPECIALIZATION; BIOTIC HOMOGENIZATION; SYNODONTIS-SCHALL; INTESTINE LENGTH; LATES-NILOTICUS	Background and Trophic Diversity Study Lake Turkana is an understudied desert lake shared by Kenya and Ethiopia. This system is at the precipice of large-scale changes in ecological function due to climate change and economic development along its major inflowing river, the Omo River. To anticipate response by the fish community to these changes, we quantified trophic diversity for seven ecological disparate species (Alestes baremose, Hydrocynus forskalli, Labeo horie, Lates niloticus, Oreochromis niloticus, Synodontis schall, and Tilapia zillii) using stable isotopes. Based on their marked morphological differentiation, we postulated that dietary niches of these species would be similar in size but show little overlap. The degree of trophic diversity varied greatly among the species studied, refuting our hypothesis regarding dietary niche size. Oreochromis niloticus and L. niloticus had the highest trophic diversity and significantly larger dietary niches than T. zillii, A. baremose and H. forskalli. Low overlap among the dietary niches of the seven species, with the exception of the synodontid catfish S. schall, is consistent with our second hypothesis. Predicting Species' Vulnerability Breeding vulnerability was highest among those species with the lowest trophic diversity. We predict that in suffering two strikes against them, A. baremose, H. forskalli, T. zillii, and L. horiewill be most affected by the highly altered Lake Turkana ecosystem and that O. niloticus, L. niloticus and S. schall will be least affected. Low vulnerability among O. niloticus and L. niloticus is promising for the future of the lake's fishery, but the third most important fishery species (L. horie) will be highly vulnerable to impending ecosystem change. T. zillii should be treated as separate from O. niloticus in the fishery given higher sensitivity and a different ecological role. We see potential for expansion of the fishery for S. schallbut don't recommend the development of a fishery for A. baremose and H. forskalli.	[Gownaris, Natasha J.; Pikitch, Ellen K.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA; [Ojwang, William O.] Kenya Marine & Fisheries Res Inst, Kisumu, Kenya; [Michener, Robert; Kaufman, Les] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Kaufman, Les] Conservat Int, Arlington, VA USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Boston University; Conservation International	Gownaris, NJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA.	ngownaris@gmal.com			Turkana Basin Institute Graduate Fellowship; small Young Explorer's Grant through National Geographic Society	Turkana Basin Institute Graduate Fellowship; small Young Explorer's Grant through National Geographic Society	Funding was provided by a Turkana Basin Institute Graduate Fellowship (http://www.turkanabasin.org/) and a small Young Explorer's Grant through National Geographic Society (http://www.nationalgeographic.com/). Private funds were also provided by donors of the Institute for Ocean Conservation Science, including Pamela Thye, J.F. Thye, Daniel H. Cohen, and donors who wish to remain anonymous. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann KL, 1996, J EXP BIOL, V199, P1743; Agostinho AA, 2008, BRAZ J BIOL, V68, P1119, DOI 10.1590/S1519-69842008000500019; Agostinho AA, 2004, REV FISH BIOL FISHER, V14, P11, DOI 10.1007/s11160-004-3551-y; Akombo P, 2014, INT J FISH AQUAT STU, V1, P42; Araoye PA, 1999, REV BIOL TROP, V47, P1061; Araujo MS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1855, DOI 10.1007/s00265-007-0425-z; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Avery S. T., 2012, LAKE TURKANA LOWER O; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Binning SA, 2009, J FISH BIOL, V75, P1683, DOI 10.1111/j.1095-8649.2009.02421.x; Binning SA, 2010, INTEGR ZOOL, V5, P241, DOI 10.1111/j.1749-4877.2010.00209.x; Bishaw Y, 2012, EVALUATION CLIMATE C; Bogh C, 2003, B ENTOMOL RES, V93, P279, DOI 10.1079/BER2003239; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Bootsma HA, 1996, ECOLOGY, V77, P1286, DOI 10.2307/2265598; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Campbell LM, 2005, ENVIRON BIOL FISH, V74, P247, DOI 10.1007/s10641-005-3190-8; Campbell LM, 2003, J GREAT LAKES RES, V29, P267, DOI 10.1016/S0380-1330(03)70554-1; Campbell LM, 2003, J GREAT LAKES RES, V29, P243, DOI 10.1016/S0380-1330(03)70552-8; Canonico GC, 2005, AQUAT CONSERV, V15, P463, DOI 10.1002/aqc.699; Cheung WH, 2008, INT J CLIMATOL, V28, P1723, DOI 10.1002/joc.1623; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Cline W., 2007, GLOBAL WARMING AGR I; COHEN AS, 1986, HYDROBIOLOGIA, V141, P179, DOI 10.1007/BF00014214; Cummings DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040539; Dadebo E, 2012, ETHIOP J BIOL SCI, V11, P117; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; GIRGIS S, 1952, J MORPHOL, V90, P281, DOI 10.1002/jmor.1050900206; GOLDSCHMIDT T, 1993, CONSERV BIOL, V7, P686, DOI 10.1046/j.1523-1739.1993.07030686.x; Grant M, 2014, ECOL ENTOMOL, V39, P109, DOI 10.1111/een.12075; Grey J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042575; Gu BH, 1997, ECOLOGY, V78, P2263, DOI 10.1890/0012-9658(1997)078[2263:IFDIBT]2.0.CO;2; Hussey NE, 2011, CAN J FISH AQUAT SCI, V68, P2029, DOI 10.1139/F2011-115; Hutchinson G.E., 1978, INTRO POPULATION ECO; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2013, ECOL FRESHW FISH, V22, P654, DOI 10.1111/eff.12063; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; Joordens JC, 2011, POWER PLACE CLIMATE; Jul-Larsen E., 2003, MANAGEMENT COMANAGEM; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Kaijage AS, 2009, SOCIOECONOMIC ANAL P; Kallqvist T., 1988, LAKE TURKANA LIMNOLO; KMFRI, 2008, LAK TURK FISH PEOPL; KMFRI, 2010, PREL OV FISH BREED A; KNBS Kenya National Bureau of Statistics, 2012, QUANT VAL FISH LAND; Kolding J., 1995, IMPACT SPECIES CHANG, P335, DOI 10.1007/978-94-011-0563-7_16; Kolding J, 1993, TROPHIC MODELS AQUAT, P116; Kolding J., 1989, FISH RESOURCES LAKE, P262; Kolding J, 1992, MITT INT VER LIMNOL, V23, P25; KRAMER DL, 1995, ENVIRON BIOL FISH, V42, P129, DOI 10.1007/BF00001991; Laleye P, 2006, BELG J ZOOL, V136, P193; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LEVINS RICHARD, 1968; LIEM KF, 1980, AM ZOOL, V20, P295; LIEM KF, 1990, AM ZOOL, V30, P209; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Lowe-McConnell R. H., 1987, ECOLOGICAL STUDIES T; Lu KH, 2006, HYDROBIOLOGIA, V568, P111, DOI 10.1007/s10750-006-0023-5; Machena C., 1993, TROPHIC MODELS AQUAT, P130; Matthews B, 2010, ECOLOGY, V91, P1025, DOI 10.1890/09-0235.1; Mbabazi D, 2010, AFR J ECOL, V48, P667, DOI 10.1111/j.1365-2028.2009.01163.x; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MINISTRY OF ENERGY, 1972, SED STUD LAT DAM LAK; MKUMBO OC, 1992, HYDROBIOLOGIA, V232, P79, DOI 10.1007/BF00014615; MoFLD, 2008, FISH ANN STAT B 2004; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Murry BA, 2006, CAN J FISH AQUAT SCI, V63, P2167, DOI 10.1139/F06-116; Muska M, 2012, J GREAT LAKES RES, V38, P98, DOI 10.1016/j.jglr.2011.11.014; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Norden J, 2013, J ECOL, V101, P701, DOI 10.1111/1365-2745.12085; Ojuok J, 2008, AFR J ECOL, V46, P445, DOI 10.1111/j.1365-2028.2007.00841.x; Ojwang WO, 2010, AQUAT ECOSYST HEALTH, V13, P269, DOI 10.1080/14634988.2010.504140; Ojwang WO, ENCY WETLAN IN PRESS, V4; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olin JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077567; Paugy D., 2007, FRESH BRACKISH WATER, V1, P348; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Development Team, 2013, R LANG ENV STAT COMP; RIBBLE DO, 1983, GROWTH, V47, P292; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Ryan C, 2013, MAR ECOL PROG SER, V479, P251, DOI 10.3354/meps10231; Schwartz JDM, 2006, AFR J ECOL, V44, P145, DOI 10.1111/j.1365-2028.2006.00579.x; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; SOMIYA H, 1980, MAR ECOL PROG SER, V2, P9, DOI 10.3354/meps002009; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; Stewart KM, 2003, ECOSCIENCE, V10, P297, DOI 10.1080/11956860.2003.11682777; Street-Perrott FA, 1983, VARIATIONS GLOBAL WA, P331; Sweeting CJ, 2006, RAPID COMMUN MASS SP, V20, P595, DOI 10.1002/rcm.2347; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; TREWAVAS E, 1982, AQUACULTURE, V27, P79, DOI 10.1016/0044-8486(82)90112-0; Van der Veken S, 2004, FLORA, V199, P516, DOI 10.1078/0367-2530-00180; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Velpuri NM, 2012, HYDROL EARTH SYST SC, V16, P3561, DOI 10.5194/hess-16-3561-2012; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Wagner CE, 2009, FUNCT ECOL, V23, P1122, DOI 10.1111/j.1365-2435.2009.01589.x; Weiner CN, 2014, ECOLOGY, V95, P466, DOI 10.1890/13-0436.1; WIENS JA, 1977, AM SCI, V65, P590; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; WOOD RB, 1988, HYDROBIOLOGIA, V158, P29, DOI 10.1007/BF00026266; Yongo EO, 2010, AQUAT ECOSYST HEALTH, V13, P28, DOI 10.1080/14634980903578308; Zanden M. Jake Vander, 1999, Ecology (Washington D C), V80, P1395, DOI 10.1890/0012-9658(1999)080[1395:PCCANA]2.0.CO;2	117	21	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127027	10.1371/journal.pone.0127027	http://dx.doi.org/10.1371/journal.pone.0127027			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992561	Green Submitted, Green Published, gold			2022-12-27	WOS:000354918600048
J	Long, LE; Anderson, P; Frank, E; Shaw, A; Liu, SJ; Huang, XF; Pinault, D; Karl, T; O'Brien, TJ; Weickert, CS; Jones, NC				Long, Leonora E.; Anderson, Paul; Frank, Elisabeth; Shaw, Alex; Liu, Shijie; Huang, Xu-Feng; Pinault, Didier; Karl, Tim; O'Brien, Terence J.; Weickert, Cynthia Shannon; Jones, Nigel C.			Neuregulin 1 Expression and Electrophysiological Abnormalities in the Neuregulin 1 Transmembrane Domain Heterozygous Mutant Mouse	PLOS ONE			English	Article							HIPPOCAMPAL GAMMA OSCILLATIONS; DORSOLATERAL PREFRONTAL CORTEX; SCHIZOPHRENIA-LIKE PHENOTYPES; WORKING-MEMORY; CELL-SURFACE; GENE NEUREGULIN-1; NERVOUS-SYSTEM; BASE-LINE; MICE; RECEPTOR	Background The Neuregulin 1 transmembrane domain heterozygous mutant (Nrg1 TM HET) mouse is used to investigate the role of Nrg1 in brain function and schizophrenia-like behavioural phenotypes. However, the molecular alterations in brain Nrg1 expression that underpin the behavioural observations have been assumed, but not directly determined. Here we comprehensively characterise mRNA Nrg1 transcripts throughout development of the Nrg1 TM HET mouse. In addition, we investigate the regulation of high-frequency (gamma) electrophysiological oscillations in this mutant mouse to associate molecular changes in Nrg1 with a schizophrenia-relevant neurophysiological profile. Methods Using exonic probes spanning the cysteine-rich, epidermal growth factor (EGF)-like, transmembrane and intracellular domain encoding regions of Nrg1, mRNA levels were measured using qPCR in hippocampus and frontal cortex from male and female Nrg1TM HET and wild type-like (WT) mice throughout development. We also performed electrophysiological recordings in adult mice and analysed gamma oscillatory at baseline, in responses to auditory stimuli and to ketamine. Results In both hippocampus and cortex, Nrg1 TM HET mice show significantly reduced expression of the exon encoding the transmembrane domain of Nrg1compared with WT, but unaltered mRNA expression encoding the extracellular bioactive EGF-like and the cysteine-rich (type III) domains, and development-specific and region-specific reductions in the mRNA encoding the intracellular domain. Hippocampal Nrg1 protein expression was not altered, but NMDA receptor NR2B subunit phosphorylation was lower in Nrg1TM HET mice. We identified elevated ongoing and reduced sensory-evoked gamma power in Nrg1 TM HET mice. Interpretation We found no evidence to support the claim that the Nrg1 TM HET mouse represents a simple haploinsufficient model. Further research is required to explore the possibility that mutation results in a gain of Nrg1 function.	[Long, Leonora E.; Frank, Elisabeth; Shaw, Alex; Huang, Xu-Feng; Karl, Tim; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Sydney, NSW, Australia; [Long, Leonora E.; Shaw, Alex; Karl, Tim; Weickert, Cynthia Shannon] Neurosci Res Australia, Randwick, NSW, Australia; [Long, Leonora E.; Karl, Tim] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Anderson, Paul; Liu, Shijie; O'Brien, Terence J.; Jones, Nigel C.] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Med, Parkville, Vic 3052, Australia; [Frank, Elisabeth; Huang, Xu-Feng] Univ Wollongong, Wollongong, NSW, Australia; [Pinault, Didier] Univ Strasbourg, FMTS, INSERM,U1114, Psychopathol Cognit & Physiopathol Schizophrenie, Strasbourg, France; [Weickert, Cynthia Shannon] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Royal Melbourne Hospital; University of Melbourne; University of Wollongong; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of New South Wales Sydney	Weickert, CS (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	cyndi@neura.edu.au; ncjones@unimelb.edu.au	Long, Leonora/D-2576-2010; Huang, Xu-Feng/H-7408-2015; Pinault, Didier/H-7816-2016; Didier, Pinault/E-5090-2013; O'Brien, Terence/L-8102-2013; Karl, Tim/E-2088-2011; Huang, Xu-Feng/D-6053-2013; Anderson, Paul/M-8341-2016; O'Brien, Terence/AAU-5525-2021	Long, Leonora/0000-0002-1759-4138; Huang, Xu-Feng/0000-0002-5895-2253; Pinault, Didier/0000-0003-3807-4817; O'Brien, Terence/0000-0002-7198-8621; Karl, Tim/0000-0001-9904-8482; Huang, Xu-Feng/0000-0002-5895-2253; Anderson, Paul/0000-0003-2716-6556; Shannon Weickert, Cynthia/0000-0002-4560-0259; Jones, Nigel/0000-0002-1080-8439	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales and Neuroscience Research Australia; Australian Rotary Health Ian Scott PhD Scholarship; Motor Neuron Disease Research Institute of Australia (Mick Rodger Benalla MND Research Grant); NHMRC [1045643, 1003886]; Senior Research Fellowship from the National Health and Medical Research Council (NHMRC) [1021970]; Future Fellowship from the Australian Research Council (ARC) [130100100]	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales and Neuroscience Research Australia; Australian Rotary Health Ian Scott PhD Scholarship; Motor Neuron Disease Research Institute of Australia (Mick Rodger Benalla MND Research Grant); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Senior Research Fellowship from the National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Future Fellowship from the Australian Research Council (ARC)(Australian Research Council)	This work was supported by the Schizophrenia Research Institute (utilising infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales and Neuroscience Research Australia. PA is supported by an Australian Rotary Health Ian Scott PhD Scholarship. TK is supported by the Motor Neuron Disease Research Institute of Australia (Mick Rodger Benalla MND Research Grant) and a career development fellowship (1045643) and a project grant (1003886) from the NHMRC. CSW is supported by a Senior Research Fellowship (1021970) from the National Health and Medical Research Council (NHMRC). NCJ is supported by a Future Fellowship (130100100) from the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2014, CELL REP, V8, P1130, DOI 10.1016/j.celrep.2014.07.026; Andersson RH, 2012, P NATL ACAD SCI USA, V109, P13118, DOI 10.1073/pnas.1201011109; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Barz CS, 2014, BRAIN STRUCT FUCT; Bitanihirwe BKY, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-71; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Boucher AA, 2007, NEUROSCIENCE, V149, P861, DOI 10.1016/j.neuroscience.2007.08.020; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Boucher AA, 2011, INT J NEUROPSYCHOPH, V14, P631, DOI 10.1017/S146114571000091X; BURGESS TL, 1995, J BIOL CHEM, V270, P19188, DOI 10.1074/jbc.270.32.19188; Chesworth R, 2012, BEHAV BRAIN RES, V226, P218, DOI 10.1016/j.bbr.2011.09.019; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Curley AA, 2012, J PHYSIOL-LONDON, V590, P715, DOI 10.1113/jphysiol.2011.224659; Deakin IH, 2012, CEREB CORTEX, V22, P1520, DOI 10.1093/cercor/bhr223; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dillman AA, 2013, NAT NEUROSCI, V16, P499, DOI 10.1038/nn.3332; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gonzalez-Burgos G, 2012, SCHIZOPHRENIA BULL, V38, P950, DOI 10.1093/schbul/sbs010; Hakami T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006755; Harris LW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-28; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2003, J NEUROSCI, V23, P6315; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jones NC, 2010, NEUROBIOL DIS, V39, P116, DOI 10.1016/j.nbd.2010.02.001; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2011, BEHAV BRAIN RES, V223, P336, DOI 10.1016/j.bbr.2011.04.051; Karl T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00018; Kulikova SP, 2012, EUR J NEUROSCI, V36, P3407, DOI 10.1111/j.1460-9568.2012.08263.x; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li KX, 2012, NAT NEUROSCI, V15, P267, DOI 10.1038/nn.3006; Liu XH, 2011, J NEUROSCI, V31, P8491, DOI 10.1523/JNEUROSCI.5317-10.2011; Loeb JA, 1998, MOL CELL NEUROSCI, V11, P77, DOI 10.1006/mcne.1998.0676; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; Long LE, 2013, INT J NEUROPSYCHOPH, V16, P163, DOI 10.1017/S1461145711001854; Long LE, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034129, 10.1371/journal.pone.0051782]; Long LE, 2010, PSYCHOPHARMACOLOGY, V211, P277, DOI 10.1007/s00213-010-1896-6; Luo XY, 2014, BIOL PSYCHIAT, V76, P120, DOI 10.1016/j.biopsych.2013.09.026; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Meyer D, 1997, DEVELOPMENT, V124, P3575; Montero JC, 2007, MOL BIOL CELL, V18, P380, DOI 10.1091/mbc.E06-06-0511; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Saunders JA, 2012, NEUROBIOL DIS, V46, P93, DOI 10.1016/j.nbd.2011.12.049; Spencer JR, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00015; Spencer KM, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00190; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tamura H, 2012, J NEUROSCI, V32, P12657, DOI 10.1523/JNEUROSCI.2542-12.2012; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V12, P1383, DOI 10.1017/S1461145709000388; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Walss-Bass C, 2006, BIOL PSYCHIAT, V60, P548, DOI 10.1016/j.biopsych.2006.03.017; Wang CZ, 2008, NEUROPSYCHOPHARMACOL, V33, P2442, DOI 10.1038/sj.npp.1301647; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Weickert CS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.25; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Williams NM, 2003, MOL PSYCHIATR, V8, P485, DOI 10.1038/sj.mp.4001348; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Woo TUW, 2010, HARVARD REV PSYCHIAT, V18, P173, DOI 10.3109/10673221003747609; Yamamoto J, 2014, CELL, V157, P845, DOI 10.1016/j.cell.2014.04.009; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Zhao X, 2004, J MED GENET, V41, P31, DOI 10.1136/jmg.2003.014977	82	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0124114	10.1371/journal.pone.0124114	http://dx.doi.org/10.1371/journal.pone.0124114			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BT	25992564	Green Published, gold, Green Submitted			2022-12-27	WOS:000354918600008
J	Han, YC; Lv, P; Hou, SL; Li, SY; Ji, GS; Ma, X; Du, RH; Liu, GQ				Han, Yucui; Lv, Peng; Hou, Shenglin; Li, Suying; Ji, Guisu; Ma, Xue; Du, Ruiheng; Liu, Guoqing			Combining Next Generation Sequencing with Bulked Segregant Analysis to Fine Map a Stem Moisture Locus in Sorghum (Sorghum bicolor L. Moench)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ENERGY-RELATED TRAITS; SWEET SORGHUM; GENETIC-IMPROVEMENT; SNP DISCOVERY; QTLS; GENOME; SUGAR; IDENTIFICATION; POPULATIONS	Sorghum is one of the most promising bioenergy crops. Stem juice yield, together with stem sugar concentration, determines sugar yield in sweet sorghum. Bulked segregant analysis (BSA) is a gene mapping technique for identifying genomic regions containing genetic loci affecting a trait of interest that when combined with deep sequencing could effectively accelerate the gene mapping process. In this study, a dry stem sorghum landrace was characterized and the stem water controlling locus, qSW6, was fine mapped using QTL analysis and the combined BSA and deep sequencing technologies. Results showed that: (i) In sorghum variety Jiliang 2, stem water content was around 80% before flowering stage. It dropped to 75% during grain filling with little difference between different internodes. In landrace G21, stem water content keeps dropping after the flag leaf stage. The drop from 71% at flowering time progressed to 60% at grain filling time. Large differences exist between different internodes with the lowest (51%) at the 7th and 8th internodes at dough stage. (ii) A quantitative trait locus (QTL) controlling stem water content mapped on chromosome 6 between SSR markers Ch6-2 and gpsb069 explained about 34.7-56.9% of the phenotypic variation for the 5th to 10th internodes, respectively. (iii) BSA and deep sequencing analysis narrowed the associated region to 339 kb containing 38 putative genes. The results could help reveal molecular mechanisms underlying juice yield of sorghum and thus to improve total sugar yield.	[Han, Yucui; Du, Ruiheng; Liu, Guoqing] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Dept Biotechnol, Key Lab Minor Cereal Crops Hebei Prov, Shijiazhuang, Peoples R China; [Lv, Peng; Hou, Shenglin; Li, Suying; Ji, Guisu; Ma, Xue; Du, Ruiheng; Liu, Guoqing] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Natl Sorghum Improvement Center, Dept Sorghum Breeding,Hebei Branch, Shijiazhuang, Peoples R China	Hebei Academy of Agricultural & Forestry Sciences; Hebei Academy of Agricultural & Forestry Sciences	Liu, GQ (corresponding author), Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Dept Biotechnol, Key Lab Minor Cereal Crops Hebei Prov, Shijiazhuang, Peoples R China.	guoqingliu@hotmail.com			Agricultural Science, Technology and Innovation in Hebei, China [2014128978]	Agricultural Science, Technology and Innovation in Hebei, China	Support was provided by 2014128978, a special fund for Agricultural Science, Technology and Innovation in Hebei, China to GL.	BEKAVAC G., 2002, GENETIKA, V34, P33; Bian YunLong, 2006, Agricultural Sciences in China, V5, P736, DOI 10.1016/S1671-2927(06)60118-1; Brown PJ, 2006, THEOR APPL GENET, V113, P931, DOI 10.1007/s00122-006-0352-9; Corn RJ, 2009, HETEROSIS COMPOSITIO; Doyle J. J., 1987, PHYTOCHEM B, P11; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Felderhoff TJ, 2012, CROP SCI, V52, P2040, DOI 10.2135/cropsci2011.11.0618; Feltus FA, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-80; Guan YA, 2011, EUPHYTICA, V182, P431, DOI 10.1007/s10681-011-0528-5; Hart GE, 2001, THEOR APPL GENET, V103, P1232, DOI 10.1007/s001220100582; Hilson G., 1916, AGR J INDIA, V11, P150; Jackson DR, 2008, RES REPORT DEV SWEET, V1; Kao CH, 1997, BIOMETRICS, V53, P653, DOI 10.2307/2533965; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lekgari AL, 2010, GENETIC MAPPING QUAN; Li RH, 2005, GENETICS, V169, P1699, DOI 10.1534/genetics.104.033993; Lincoln S.E., 1993, CONSTRUCTING GENETIC, V3rd Edn; Livaja M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-628; Lv P, 2013, EUPHYTICA, V193, P419, DOI 10.1007/s10681-013-0962-7; Mangelsdorf A.J., 1958, ISSCT SUGARCANE BREE, V3, P23; Massman J, 2011, MOL BREEDING, V27, P439, DOI 10.1007/s11032-010-9442-0; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Murray SC, 2009, PLANT GENOME-US, V2, P48, DOI 10.3835/plantgenome2008.10.0011; Murray SC, 2008, CROP SCI, V48, P2165, DOI 10.2135/cropsci2008.01.0016; Murray SC, 2008, CROP SCI, V48, P2180, DOI 10.2135/cropsci2008.01.0068; Natoli A, 2002, MAYDICA, V47, P311; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Ritter KB, 2007, EUPHYTICA, V157, P161, DOI 10.1007/s10681-007-9408-4; Shiringani AL, 2010, THEOR APPL GENET, V121, P323, DOI 10.1007/s00122-010-1312-y; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Sun ZiQi, 2013, Acta Agronomica Sinica, V39, P1, DOI 10.3724/SP.J.1006.2013.00001; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Wang F, 2009, ENERG FUEL, V23, P4137, DOI 10.1021/ef900317s; WING RA, 1994, MOL GEN GENET, V242, P681, DOI 10.1007/BF00283423; Wu XR, 2010, IND CROP PROD, V31, P164, DOI 10.1016/j.indcrop.2009.10.006; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433	38	25	34	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127065	10.1371/journal.pone.0127065	http://dx.doi.org/10.1371/journal.pone.0127065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984727	gold, Green Submitted, Green Published			2022-12-27	WOS:000354917300083
J	Kuehne, M; Heimrath, K; Heinze, HJ; Zaehle, T				Kuehne, Maria; Heimrath, Kai; Heinze, Hans-Jochen; Zaehle, Tino			Transcranial Direct Current Stimulation of the Left Dorsolateral Prefrontal Cortex Shifts Preference of Moral Judgments	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; DECISION-MAKING; AUDITORY-CORTEX; NEURAL BASIS; PSYCHOPATHY; CONSEQUENCES; NEUROBIOLOGY; NEUROSCIENCE; COGNITION; AMYGDALA	Attitude to morality, reflecting cultural norms and values, is considered unique to human social behavior. Resulting moral behavior in a social environment is controlled by a widespread neural network including the dorsolateral prefrontal cortex (DLPFC), which plays an important role in decision making. In the present study we investigate the influence of neurophysiological modulation of DLPFC reactivity by means of transcranial direct current stimulation (tDCS) on moral reasoning. For that purpose we administered anodal, cathodal, and sham stimulation of the left DLPFC while subjects judged the appropriateness of hard moral personal dilemmas. In contrast to sham and cathodal stimulation, anodal stimulation induced a shift in judgment of personal moral dilemmas towards more non-utilitarian actions. Our results demonstrate that alterations of left DLPFC activity can change moral judgments and, in consequence, provide a causal link between left DLPFC activity and moral reasoning. Most important, the observed shift towards non-utilitarian actions suggests that moral decision making is not a permanent individual trait but can be manipulated; consequently individuals with boundless, uncontrollable, and maladaptive moral behavior, such as found in psychopathy, might benefit from neuromodulation-based approaches.	[Kuehne, Maria; Heimrath, Kai; Heinze, Hans-Jochen; Zaehle, Tino] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany	Otto von Guericke University	Zaehle, T (corresponding author), Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany.	tino.zaehle@ovgu.de	Zaehle, Tino/A-5088-2019	Zaehle, Tino/0000-0003-3673-4869	German Research Foundation (DFG) [SFB/TR 31, SFB 779]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG, SFB/TR 31 and SFB 779).	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Blair RJR, 2003, BRIT J PSYCHIAT, V182, P5, DOI 10.1192/bjp.182.1.5; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Chen JC, 2013, CLIN NEUROPHYSIOLOGY; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; Foot, 1967, OXFORD REV, V5, P5, DOI DOI 10.1093/0199252866.003.0002; Fox D, 2011, NATURE, V472, P156, DOI 10.1038/472156a; Freeman W., 1942, BULL NEW YORK ACAD MED, V18, P794; Glenn AL, 2009, MOL PSYCHIATR, V14, P5, DOI 10.1038/mp.2008.104; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2007, TRENDS COGN SCI, V11, P322, DOI 10.1016/j.tics.2007.06.004; Heekeren HR, 2005, NEUROIMAGE, V24, P887, DOI 10.1016/j.neuroimage.2004.09.026; Heimrath K, 2014, NEUROSCIENCE, V261, P68, DOI 10.1016/j.neuroscience.2013.12.031; Howard-Snyder Frances, 2011, STANFORD ENCY PHILOS; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jeurissen D, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00018; Kadosh RC, 2012, CURR BIOL, V22, pR108, DOI 10.1016/j.cub.2012.01.013; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Krause B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00602; Luber B, 2009, BEHAV SCI LAW, V27, P191, DOI 10.1002/bsl.860; Marsh AA, 2011, PSYCHIAT RES-NEUROIM, V194, P279, DOI 10.1016/j.pscychresns.2011.07.008; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moll J, 2011, NEUROIMAGE, V54, P1735, DOI 10.1016/j.neuroimage.2010.08.026; Monte-Silva K, 2009, J NEUROSCI, V29, P6124, DOI 10.1523/JNEUROSCI.0728-09.2009; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Passingham RE, 2010, TRENDS COGN SCI, V14, P16, DOI 10.1016/j.tics.2009.11.001; Prehn K, 2008, SOC COGN AFFECT NEUR, V3, P33, DOI 10.1093/scan/nsm037; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Tassy S, 2012, SOC COGN AFFECT NEUR, V7, P282, DOI 10.1093/scan/nsr008; THOMSON JJ, 1985, YALE LAW J, V94, P1395, DOI 10.2307/796133; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Woermann FG, 2000, J NEUROL NEUROSUR PS, V68, P162, DOI 10.1136/jnnp.68.2.162; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107; Zaehle T, 2011, EXP BRAIN RES, V215, P135, DOI 10.1007/s00221-011-2879-5	36	26	26	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127061	10.1371/journal.pone.0127061	http://dx.doi.org/10.1371/journal.pone.0127061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985442	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300082
J	Uchida, Y; Kanagawa, C; Takenishi, A; Harada, A; Okawa, K; Yabuno, H				Uchida, Yukiko; Kanagawa, Chie; Takenishi, Ako; Harada, Akira; Okawa, Kiyotake; Yabuno, Hiromi			How Did the Media Report on the Great East Japan Earthquake? Objectivity and Emotionality Seeking in Japanese Media Coverage	PLOS ONE			English	Article							AMERICAN; CULTURE	The Great East Japan Earthquake was a tragic event requiring critical media involvement. Since the media played an important role in conveying factual information, journalists expressed feeling that it was difficult to guarantee the objectivity of their coverage. As media coverage constructs a socio-culturally shared reality among its audience, an examination of the objectivity and emotionality of the contents of the news coverage is needed. In Study 1, we conducted an exploratory content analysis of TV and newspaper coverage from the six month period following the March 11, 2011 disaster, finding that the news media generally reported neutral and objective factual information about the event, with emotionality shown only in the commentary. In order to examine how media coverage was constructed and evaluated by journalists, in Study 2 we conducted an online survey of 115 journalists working for mass media organizations. We found that that the journalists' orientations tended to be more objective than emotional, which is consistent with the findings of Study 1. However, their evaluations of the objectivity of the published articles were low, especially for the coverage of the nuclear power plant accident, which was an accident of an unprecedented nature. The negative emotions that journalists experienced during their investigations negatively affected subsequent evaluations of the objectivity of their reporting.	[Uchida, Yukiko] Kyoto Univ, Kokoro Res Ctr, Kyoto, Kyoto, Japan; [Kanagawa, Chie; Harada, Akira; Yabuno, Hiromi] Otemon Gakukun Univ, Fac Management, Ibaraki, Osaka, Japan; [Takenishi, Ako] Hyogo Univ Teachers Educ, Kato City, Hyogo, Japan; [Okawa, Kiyotake] Teikyo Univ, Fac Liberal Arts, Hachioji, Tokyo, Japan	Kyoto University; Hyogo University of Teacher Education; Teikyo University	Uchida, Y (corresponding author), Kyoto Univ, Kokoro Res Ctr, Kyoto, Kyoto, Japan.	uchida.yukiko.6m@kyoto-u.ac.jp		Uchida, Yukiko/0000-0002-8336-2423	Kokoro Research Center Project Grant	Kokoro Research Center Project Grant	This research was supported by Kokoro Research Center Project Grant.	Dickinson R, 2007, CULT SOCIOL-LONDON, V1, P189, DOI 10.1177/1749975507078187; Erigawa S., 2011, 39 BEH SOC JAP; Hatanaka M, 2010, J TRAUMA STRESS, V23, P173, DOI 10.1002/jts.20496; Hommerich C, 2012, INT J JPN SOCIOL, V21, P46, DOI 10.1111/j.1475-6781.2012.01169.x; Koshiro E, 1997, THE HANSHIN AWAJI EA; Markus HR, 2006, PSYCHOL SCI, V17, P103, DOI 10.1111/j.1467-9280.2006.01672.x; Morling B, 2008, PERS SOC PSYCHOL REV, V12, P199, DOI 10.1177/1088868308318260; MORRIS MW, 1994, J PERS SOC PSYCHOL, V67, P949, DOI 10.1037/0022-3514.67.6.949; Niwa Y, 2013, TREMBLING MEDIA TV R; Nomura Research Institute, 2011, SURVEY RESEARCH ON M; Quarantelli EL, 1990, PRELIMINARY PAPER 14; Quarantelli EL, 1987, PRELIMINARY PAPER 11; Tanihara K, 2011, JOURNALISM, V6; Uchida Y, 2001, Shinrigaku Kenkyu, V72, P275; Uchida Y, 2014, J HAPPINESS STUD, V15, P207, DOI 10.1007/s10902-013-9463-6; Ueno N, 2007, 22 JAP SOC SCI POL R; Yabuno H, 2013, OTEMON BUSINESS MANA, V19, P281; Yamanaka S, 2011, JOURNALISM, P6	18	5	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125966	10.1371/journal.pone.0125966	http://dx.doi.org/10.1371/journal.pone.0125966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BG	25985193	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300029
J	Brogan, WR; Relyea, RA				Brogan, William R., III; Relyea, Rick A.			Submerged Macrophytes Mitigate Direct and Indirect Insecticide Effects in Freshwater Communities	PLOS ONE			English	Article							MALATHIONS ACUTE TOXICITY; ZOOPLANKTON COMMUNITIES; AMPHIBIAN DECLINES; HABITAT COMPLEXITY; PREDATOR IDENTITY; HYLA-SQUIRELLA; PLANTS REDUCE; PESTICIDE; QUALITY; GROWTH	Understanding how ecological interactions mitigate the impacts of perturbations such as pesticides in biological communities is an important basic and applied question for ecologists. In aquatic ecosystems, new evidence from microcosm experiments suggests that submerged macrophytes can buffer cladocerans from pulse exposures to the widely used insecticide malathion, and that mitigation increases with macrophyte density. However, whether these results scale up to more complex aquatic communities where ecological interactions such as competition can alter toxicity is unknown. Further, macrophyte abilities to mitigate different insecticide exposure scenarios (i.e. single versus repeated pulses) have never been tested. To address these gaps, we performed a factorial mesocosm experiment examining the influence of four macrophyte treatments (0, 10, 50, or 100 Elodea Canadensis shoots planted per mesocosm) crossed with three malathion exposure scenarios (no insecticide, single pulse, repeated pulses) on aquatic communities containing zooplankton, phytoplankton, periphyton, two snail species, and larval amphibians. In the absence of macrophytes, single malathion pulses caused short-term declines in cladoceran abundance followed by their rapid recovery, which precluded any indirect effects (i.e. trophic cascades). However, repeated malathion pulses caused cladoceran extinctions, resulting in persistent phytoplankton blooms and reduced abundance of one snail species. In contrast, with macrophytes present, even at low density, malathion had no effect on any taxa. We also discovered novel effects of macrophytes on the benthic food web. In the two highest macrophyte treatments, we observed trends of reduced periphyton biomass, decreased abundance of one snail species, and decreased amphibian time to and mass at metamorphosis. To our knowledge, this is the first evidence of negative submerged macrophyte effects on amphibians, a taxa of global conservation concern. Our findings suggest that facilitating macrophytes could be an important strategy for buffering freshwater communities from insecticides, though consideration of their impacts on animal species is necessary.	[Brogan, William R., III] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Relyea, Rick A.] Rensselaer Polytech Inst, Troy, NY 12180 USA	Smithsonian Institution; Smithsonian Environmental Research Center; Rensselaer Polytechnic Institute	Brogan, WR (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	wbrogan@gmail.com			Sigma Xi [G20090315100640]; Society for Wetland Scientists; L.K. Darbaker Award (University of Pittsburgh); National Science Foundation [NSF DEB 05-18250]	Sigma Xi; Society for Wetland Scientists; L.K. Darbaker Award (University of Pittsburgh); National Science Foundation(National Science Foundation (NSF))	WRBIII funded this research in part from: 1. Sigma Xi Grants-in-aid-of-research: Funding #: G20090315100640, website - https://www.sigmaxi.org/programs/grants-in-aid, 2. Society for Wetland Scientists: Funding #: N/A, website - http://www.sws.org/, 3. L.K. Darbaker Award (University of Pittsburgh): Funding #: N/A, website - http://biology.pitt.edu/facilities/pymatuning/research-grants. RAR funded this research in part from: National Science Foundation: Funding #: NSF DEB 05-18250, website - http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg R, 2003, EVOLUTION, V57, P872; [Anonymous], 2007, ASTM STANDARD E729; Babbitt KJ, 1997, J HERPETOL, V31, P128, DOI 10.2307/1565342; Baber MJ, 2004, COPEIA, P173, DOI 10.1643/CE-03-056R1; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Blaustein AR, 2010, ANN NY ACAD SCI, V1223, P108; Boone MD, 2001, CONSERV BIOL, V15, P228, DOI 10.1046/j.1523-1739.2001.99475.x; Boone MD, 2001, OECOLOGIA, V129, P518, DOI 10.1007/s004420100749; Boone MD, 2007, ECOL APPL, V17, P291, DOI 10.1890/1051-0761(2007)017[0291:MSIACE]2.0.CO;2; Brogan WR, 2014, CHEMOSPHERE, V108, P405, DOI 10.1016/j.chemosphere.2014.02.041; Brogan WR, 2013, ENVIRON TOXICOL CHEM, V32, P1535, DOI 10.1002/etc.2233; Brogan WR, 2013, ENVIRON TOXICOL CHEM, V32, P699, DOI 10.1002/etc.2080; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; CARTER V, 1988, J FRESHWATER ECOL, V4, P493, DOI 10.1080/02705060.1988.9665199; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; DUARTE CM, 1990, HYDROBIOLOGIA, V196, P17, DOI 10.1007/BF00008889; Duggan IC, 2001, FRESHWATER BIOL, V46, P777, DOI 10.1046/j.1365-2427.2001.00718.x; FAIRCHILD JF, 1992, ENVIRON TOXICOL CHEM, V11, P115, DOI 10.1002/etc.5620110111; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Forbes VE, 2008, ENVIRON TOXICOL CHEM, V27, P1987, DOI 10.1897/08-029.1; FRODGE JD, 1990, AQUAT BOT, V38, P231, DOI 10.1016/0304-3770(90)90008-9; Gosner K. L., 1960, Herpetologica, V16, P183; Grube A, 2011, PESTICIDE INDUSTRY S; HANAZATO T, 1987, ENVIRON POLLUT, V48, P145, DOI 10.1016/0269-7491(87)90093-5; Hanazato T, 2001, ENVIRON POLLUT, V112, P1, DOI 10.1016/S0269-7491(00)00110-X; Hanazato T, 1998, ENVIRON POLLUT, V101, P361, DOI 10.1016/S0269-7491(98)00053-0; Hilt S, 2008, BASIC APPL ECOL, V9, P422, DOI 10.1016/j.baae.2007.04.003; Jones IJ, 2000, FRESHWATER BIOL, V43, P591, DOI 10.1046/j.1365-2427.2000.t01-1-00538.x; Jones JI, 1999, OECOLOGIA, V120, P463, DOI 10.1007/s004420050879; Kegley S., 2010, PAN PESTICIDE DATABA; Kiely T, 2004, PESTICIDE INDUSTRY S, DOI [10.1093/toxsci/kfs297, DOI 10.1093/T0XSCI/KFS297]; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; Kufel L, 2004, POL J ECOL, V52, P261; LODGE DM, 1985, FRESHWATER BIOL, V15, P695, DOI 10.1111/j.1365-2427.1985.tb00243.x; LODGE DM, 1991, AQUAT BOT, V41, P195, DOI 10.1016/0304-3770(91)90044-6; Mills NE, 2004, ECOL APPL, V14, P1041, DOI 10.1890/02-5134; Mitsch WJ, 1986, VAN NOSTRAND REINHOL; MORIN PJ, 1983, ECOL MONOGR, V53, P119, DOI 10.2307/1942491; Newhardt K, 2006, ENVIRONMENTAL FATE O; Newman MC, 2010, FUNDAMENTALS OF ECOT; Nurminen L, 2003, ANN BOT FENN, V40, P199; Nystrom P, 1998, HYDROBIOLOGIA, V368, P201, DOI 10.1023/A:1003266603371; Odenkirchen E, 2007, RISKS OF MALATHION U; Organisation for Economic Co-operation and Development Guideline 202, 1984, ORGANISATION FOR ECO; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Purrenhage JL, 2009, HERPETOLOGICA, V65, P14, DOI 10.1655/08-017R1.1; Raspopov Igor Mikhajlovich, 2002, Preslia (Prague), V74, P315; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; Relyea RA, 2008, OIKOS, V117, P1647, DOI 10.1111/j.1600-0706.2008.16933.x; Relyea RA, 2008, ECOL APPL, V18, P1728, DOI 10.1890/08-0454.1; SANDJENSEN K, 1988, OIKOS, V53, P332, DOI 10.2307/3565533; SANDJENSEN K, 1991, AQUAT BOT, V41, P137, DOI 10.1016/0304-3770(91)90042-4; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tarr TL, 2002, AMPHIBIA-REPTILIA, V23, P13, DOI 10.1163/156853802320877591; TCHOUNWOU PB, 1991, ARCH ENVIRON CON TOX, V21, P351, DOI 10.1007/BF01060355; Turner AM, 2010, ECOL APPL, V20, P2089, DOI 10.1890/10-0208.1; Vadeboncoeur Y, 2001, ECOLOGY, V82, P1065, DOI 10.1890/0012-9658(2001)082[1065:WLFEOD]2.0.CO;2; van Donk E, 2002, AQUAT BOT, V72, P261, DOI 10.1016/S0304-3770(01)00205-4; WANG T, 1991, B ENVIRON CONTAM TOX, V47, P238, DOI 10.1007/BF01688646; Wetzel RG., 2001, LIMNOLOGY LAKE RIVER; WOLFE NL, 1977, ENVIRON SCI TECHNOL, V11, P88, DOI 10.1021/es60124a001; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449	65	14	14	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126677	10.1371/journal.pone.0126677	http://dx.doi.org/10.1371/journal.pone.0126677			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978686	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100089
J	Chiu, KW; Nakano, T; Chen, KD; Hsu, LW; Lai, CY; Huang, CY; Cheng, YF; Goto, S; Chen, CL				Chiu, King-Wah; Nakano, Toshiaki; Chen, Kuang-Den; Hsu, Li-Wen; Lai, Chia-Yun; Huang, Ching-Yin; Cheng, Yu-Fan; Goto, Shigeru; Chen, Chao-Long			Repeated-Measures Implication of Hepatocellular Carcinoma Biomarkers in Living Donor Liver Transplantation	PLOS ONE			English	Article							CYP2C19 GENOTYPES; GROWTH-FACTOR; CELL BLOCKS; GRAFT; RECIPIENTS; EXPRESSION; SURVIVIN	Objective Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver transplantation (LDLT). Several biomarkers have been used to investigate this event. We conducted a prospective controlled study to determine the activities of the basic fibroblast growth factor (FGF-2), survivin, Ki67, endostatin, and vascular endothelial growth factor (VEGF) in different conditions before, early after, and late after LDLT with and without HCC recurrence. Methods Fifty patients with virus-related HCC who underwent LDLT were enrolled in this 2-year cross-sectional study. During the study period, recurrent HCC was identified in 9 patients (study group, n = 9) and 41 patients (control group, n = 41) had no recurrence after LDLT. The mean time to HCC recurrence was 587.11 +/- 398.64 days (range, 90-1352 days). Microvascular invasion (MVI) was found in 66.7% (6/9) of the recipients, as determined on pathological examination. The serum biomarkers were investigated by using enzyme-linked immunosorbent assay at the different LDLT stages. Results The serum levels of the biomarkers significantly correlated with LDLT and HCC recurrence in the repeated-measures analysis (F = 31.676, P = 0.000). Significant differences were observed in the effects of all biomarkers (F = 85.313, P = 0.000) and the time to HCC recurrence after LDLT (F = 3.178, P = 0.046). The biomarkers, ordered by the observed power of the test for HCC recurrence after LDLT, were FGF-2 (1.000) > survivin (0.999) > Ki67 (0.949) > endostatin (0.411) > VEGF (0.305). Conclusions Different biomarker activities may be implicated in the pathogenesis of HCC recurrence after LDLT. Oncogenes may not exist in the new graft but may still be present in the peripheral blood. The timing of HCC recurrence and impact of MVI in the explanted liver requires confirmation in larger studies with a longer follow-up.	[Chiu, King-Wah; Nakano, Toshiaki; Chen, Kuang-Den; Hsu, Li-Wen; Lai, Chia-Yun; Huang, Ching-Yin; Cheng, Yu-Fan; Goto, Shigeru; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan; [Chiu, King-Wah; Nakano, Toshiaki; Cheng, Yu-Fan; Chen, Chao-Long] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chiu, KW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan.	c471026@ms6.hinet.net		Chiu, King-Wah/0000-0003-2108-6539; Nakano, Toshiaki/0000-0003-3701-3449	Chang Gung Memorial Hospital of Taiwan [CMRPG8B0921]	Chang Gung Memorial Hospital of Taiwan(Chang Gung Memorial Hospital)	This work was supported by grant number CMRPG8B0921 from the Chang Gung Memorial Hospital of Taiwan.	Adolf J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00883; Chen CL, 2013, NAT REV GASTRO HEPAT, V10, P746, DOI 10.1038/nrgastro.2013.194; Chen CL, 2010, J HEPATO-BIL-PAN SCI, V17, P555, DOI 10.1007/s00534-009-0166-7; Cheng YF, 2009, AM J TRANSPLANT, V9, P1382, DOI 10.1111/j.1600-6143.2009.02626.x; Chiu KW, 2013, WORLD J HEPATOL, V5, P642, DOI 10.4254/wjh.v5.i11.642; Chiu KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071314; Chiu KW, 2012, EUR J CLIN INVEST, V42, P352, DOI 10.1111/j.1365-2362.2011.02589.x; Chiu KW, 2010, ANN TRANSPL, V15, P38; Chiu KW, 2010, CLIN TRANSPLANT, V24, P830, DOI 10.1111/j.1399-0012.2010.01220.x; Chiu KW, 2005, HEPATO-GASTROENTEROL, V52, P1825; CHIU KW, 1994, HEPATO-GASTROENTEROL, V41, P30; Chiu KW, 2002, HEPATO-GASTROENTEROL, V49, P1386; Colakoglu T, 2007, J SURG RES, V143, P337, DOI 10.1016/j.jss.2007.02.001; Digklia Antonia, 2014, World J Exp Med, V4, P58; El-Attar HA, 2010, ASIAN PAC J CANCER P, V11, P897; Harding James J, 2014, Hepatobiliary Surg Nutr, V3, P168, DOI 10.3978/j.issn.2304-3881.2014.07.03; KOCH I, 1990, ONCOGENE, V5, P839; Lu LS, 2012, HEPATO-GASTROENTEROL, V59, P1586, DOI 10.5754/hge10856; Martyn Shuttleworth, 2009, REPEATED MEASURES DE; Nishio T, 2014, ANN SURG ONCOL; Or YYY, 2014, MOL MED REP, V10, P2025, DOI 10.3892/mmr.2014.2413; Sandhu DS, 2014, HEPATOLOGY, V59, P1166, DOI 10.1002/hep.26679; Schmilovitz-Weiss H, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-121; Sharma BK, 2013, MOL CELL BIOCHEM, V383, P103, DOI 10.1007/s11010-013-1759-7; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Sohn W, 2014, J VIRAL HEPAT; Suh YG, 2014, DIGEST DIS, V32, P725, DOI 10.1159/000368010; Wang Z, 2009, J CANCER RES CLIN, V135, P715, DOI 10.1007/s00432-008-0506-z; Xin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085308; Zhang W, 2014, LIVER TRANSPL	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124943	10.1371/journal.pone.0124943	http://dx.doi.org/10.1371/journal.pone.0124943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978323	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100020
J	Gervas-Arruga, J; Cebolla, JJ; de Blas, I; Roca, M; Pocovi, M; Giraldo, P				Gervas-Arruga, Javier; Cebolla, Jorge Javier; de Blas, Ignacio; Roca, Mercedes; Pocovi, Miguel; Giraldo, Pilar			The Influence of Genetic Variability and Proinflammatory Status on the Development of Bone Disease in Patients with Gaucher Disease	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; INFLAMMATORY PROTEIN (MIP)-1-ALPHA; MINERAL DENSITY; OSTEOPROTEGERIN GENE; TURNOVER MARKERS; POLYMORPHISMS; FRACTURE; RISK; OSTEOCLASTOGENESIS; OSTEOPOROSIS	Gaucher disease, the most common lysosomal storage disorder, is caused by alpha-glucocerebrosidase deficiency. Bone complications are the major cause of morbidity in patients with type 1 Gaucher disease (GD1). Genetic components strongly influence bone remodelling. In addition, chronic inflammation produced by Gaucher cells induces the production of several cytokines, which leads to direct changes in the bone remodelling process and can also affect the process indirectly through other immune cells. In this study, we analysed the association between bone mineral density (BMD), bone marrow burden score, and relevant genetic polymorphisms related to bone metabolism, as well as profiles of proinflammatory cytokines in a GD1 cohort. This study included 83 patients distributed according to bone status. BMD was measured with DXA and broadband ultrasound attenuation; bone marrow involvement was evaluated using MRI. We also analysed 26 SNPs located in 14 genes related to bone metabolism. To assess proinflammatory status, we analysed IL-4, IL-6, IL-7, IL-10, IL-13, MIP-1 alpha, MIP-1 alpha, and TNF alpha in plasma samples from 71 control participants and GD1 patients. SNP genotype proportions and BMD differed significantly between ESRI c.453-397T>C and VDR c. 1024+283G>A variants. We also observed significant associations between GD1 genotypes and bone affectation. When patients were stratified by spleen status, we observed significant correlations between non-/splenectomized groups and Spanish MRI (S-MRI) score. Across genotype proportions of non-/splenectomized patients and S-MRI, we observed significant differences in ESRI c. 453-397T>C, VDR c.-8325988G>A, and TNFRSF11B c.9C>G polymorphisms. We observed different significant proinflammatory profiles between control participants, treatment-naive patients, and patients on enzyme replacement therapy (ERT); between non-/splenectomized patients (between untreated and ERT-treated patients) and among those with differing GBA genotypes. The data suggest that patients with GD1 have increased susceptibility to developing bone disease owing to the coexistence of genetic variants, and that genetic background in GD1 is fundamental to regulate the impact of proinflammatory status on the development of bone disease.	[Gervas-Arruga, Javier; Giraldo, Pilar] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Zaragoza, Spain; [Gervas-Arruga, Javier; Giraldo, Pilar] Miguel Servet Univ Hosp, Translat Res Unit, Zaragoza, Spain; [Gervas-Arruga, Javier; Cebolla, Jorge Javier; Roca, Mercedes; Giraldo, Pilar] Spanish Gaucher Dis Fdn FEETEG, Zaragoza, Spain; [Gervas-Arruga, Javier; Pocovi, Miguel; Giraldo, Pilar] Inst Aragones Ciencias Salud, Zaragoza, Spain; [Cebolla, Jorge Javier; Pocovi, Miguel] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain; [de Blas, Ignacio] Univ Zaragoza, Fac Vet, Unidad Patol Infecciosa & Epidemiol, Zaragoza, Spain; [Roca, Mercedes] Int Skeletal Society, Radiodiagnost Ctr, Zaragoza, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Miguel Servet University Hospital; University of Zaragoza; University of Zaragoza	Gervas-Arruga, J (corresponding author), Ctr Invest Biomed Red Enfermedades Raras CIBERER, Zaragoza, Spain.	gervas.j@gmail.com	Gervas-Arruga, Javier/AAE-4641-2020; Cebolla, Jorge Javier/I-4191-2015; de Blas, Ignacio/E-2125-2013	Cebolla, Jorge Javier/0000-0001-8727-9179; de Blas, Ignacio/0000-0002-1204-4356	Genzyme-Sanofi; grant FIS [PI 09/02556, FIS PS12/01219]; FEETEG	Genzyme-Sanofi(Sanofi-AventisGenzyme Corporation); grant FIS; FEETEG	This work was financed by Genzyme-Sanofi and supported by grant FIS (PI 09/02556, FIS PS12/01219) and by FEETEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, BLOOD, V100, P2195, DOI 10.1182/blood.V100.6.2195.h81802002195_2195_2202; Akatsu T, 1998, BIOCHEM BIOPH RES CO, V250, P229, DOI 10.1006/bbrc.1998.9294; ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19; Arai H, 2001, J BONE MINER RES, V16, P1256, DOI 10.1359/jbmr.2001.16.7.1256; Arko B, 2005, MATURITAS, V51, P270, DOI 10.1016/j.maturitas.2004.08.006; Bagger YZ, 2006, OSTEOPOROSIS INT, V17, P471, DOI 10.1007/s00198-005-0009-6; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bustamante M, 2007, OSTEOPOROSIS INT, V18, P235, DOI 10.1007/s00198-006-0225-8; Campeau PM, 2009, BLOOD, V114, P3181, DOI 10.1182/blood-2009-02-205708; Carrascosa A, 2008, Endocrinol Nutr, V55, P484, DOI 10.1016/S1575-0922(08)75845-5; Cummings SR, 1998, NEW ENGL J MED, V339, P733, DOI 10.1056/NEJM199809103391104; CUMMINGS SR, 1994, J BONE MINER RES, V9, P1429; Cunningham JL, 1996, BRIT J RADIOL, V69, P25, DOI 10.1259/0007-1285-69-817-25; Deegan PB, 2005, BLOOD CELL MOL DIS, V35, P259, DOI 10.1016/j.bcmd.2005.05.005; DeMayo RF, 2008, AM J ROENTGENOL, V191, P115, DOI 10.2214/AJR.07.3550; Eriksen E, 1994, BONE HISTOMORPHOMETR, P33; Gennari L, 2005, AM J EPIDEMIOL, V161, P307, DOI 10.1093/aje/kwi055; Giraldo P, 2000, HAEMATOLOGICA, V85, P792; Giraldo P, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-17; Giuffrida G, 2012, HEMATOL REP, V4, P70, DOI 10.4081/hr.2012.e21; Goltzman D, 2001, J CLIN INVEST, V107, P1219, DOI 10.1172/JCI13073; Greenwood A, 2010, CLIN RHEUMATOL, V29, P1037, DOI 10.1007/s10067-010-1464-9; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Kacher Y, 2009, BLOOD CELL MOL DIS, V43, P134, DOI 10.1016/j.bcmd.2009.03.006; Khan A, 2012, J BONE MINER RES, V27, P1839, DOI 10.1002/jbmr.1680; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Langdahl BL, 2002, J BONE MINER RES, V17, P1245, DOI 10.1359/jbmr.2002.17.7.1245; Langdahl BL, 2000, EUR J CLIN INVEST, V30, P608; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Mucci JM, 2012, GENE, V509, P51, DOI 10.1016/j.gene.2012.07.071; Nguyen TV, 2000, J BONE MINER RES, V15, P392, DOI 10.1359/jbmr.2000.15.3.392; Pavlova EV, 2011, BLOOD CELL MOL DIS, V46, P27, DOI 10.1016/j.bcmd.2010.10.010; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Roca M, 2007, EUR J RADIOL, V62, P132, DOI 10.1016/j.ejrad.2006.11.024; SIBILLE A, 1993, AM J HUM GENET, V52, P1094; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sosa M, 2002, OSTEOPOROSIS INT, V13, P487, DOI 10.1007/s001980200059; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Toth Judit, 2003, Orvosi Hetilap, V144, P749; van Breemen MJ, 2007, BBA-MOL BASIS DIS, V1772, P788, DOI 10.1016/j.bbadis.2007.04.002; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wenstrup RJ, 2002, BRIT J RADIOL, V75, pA2, DOI 10.1259/bjr.75.suppl_1.750002; Yamamoto H, 1999, J BONE MINER RES, V14, P240, DOI 10.1359/jbmr.1999.14.2.240	47	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126153	10.1371/journal.pone.0126153	http://dx.doi.org/10.1371/journal.pone.0126153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978039	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100051
J	Kwon, WA; Kim, SH; Kim, S; Joung, JY; Chung, J; Lee, KH; Lee, SJ; Seo, HK				Kwon, Whi-An; Kim, Sung Han; Kim, Sohee; Joung, Jae Young; Chung, Jinsoo; Lee, Kang Hyun; Lee, Sang-Jin; Seo, Ho Kyung			Changes in Urination According to the Sound of Running Water Using a Mobile Phone Application	PLOS ONE			English	Article							LOWER URINARY-TRACT; BENIGN PROSTATIC HYPERPLASIA; HEALTH-CARE; SYMPTOMS; BLADDER; EFFICACY; TAMSULOSIN; TERAZOSIN; GENDER; SAFETY	Objective The sound of running water (SRW) has been effectively used for toilet training during toddlerhood. However, the effect of SRW on voiding functions in adult males with lower urinary tract symptoms (LUTS) has not been evaluated. To determine the effect of SRW on urination in male patients with LUTS, multiple voiding parameters of uroflowmetry with postvoid residual urine (PVR) were assessed according to the presence of SRW played by a mobile application. Methods Eighteen consecutive male patients with LUTS were prospectively enrolled between March and April 2014. Uroflowmetry with PVR measured by a bladder scan was randomly performed once weekly for two consecutive weeks with and without SRW in a completely sealed room after pre-checked bladder volume was scanned to be more than 150 cc. SRW was played with river water sounds amongst relaxed melodies from a smartphone mobile application. Results The mean age of enrolled patients and their mean International Prostate Symptom Score (IPSS) were 58.9 +/- 7.7 years (range: 46-70) and 13.1 +/- 5.9, respectively. All patients had not been prescribed any medications, including alpha-blockers or anti-muscarinic agents, in the last 3 months. There was a significant increase in mean peak flow rate (PFR) with SRW in comparison to without SRW (15.7 mL/s vs. 12.3 mL/s, respectively, p = 0.0125). However, there were no differences in other uroflowmetric parameters, including PVR. Conclusions The study showed that SRW from a mobile phone application may be helpful in facilitating voiding functions by increasing PFR in male LUTS patients.	[Kwon, Whi-An] Wonkwang Univ, Sanbon Hosp, Inst Wonkwang Med Sci, Sch Med,Dept Urol, Gunpo, Gyeonggi Do, South Korea; [Kim, Sung Han; Joung, Jae Young; Chung, Jinsoo; Lee, Kang Hyun; Seo, Ho Kyung] Natl Canc Ctr, Ctr Prostate Canc, Goyang, South Korea; [Kim, Sohee] Natl Canc Ctr, Dept Biometr Res, Goyang, South Korea; [Lee, Sang-Jin] Natl Canc Ctr, Genitourinary Canc Branch, Goyang, South Korea	Wonkwang University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Seo, HK (corresponding author), Natl Canc Ctr, Ctr Prostate Canc, Goyang, South Korea.	seohk@ncc.re.kr		Kim, Sohee/0000-0003-4660-6043; Kwon, Whi-An/0000-0002-7833-5981; KIM, Sung Han/0000-0002-1689-5203	Wonkwang University	Wonkwang University	This study was supported by Wonkwang University in 2014.	ALSOP RF, 1974, NEW ENGL J MED, V290, P808; Araki I, 2003, J UROLOGY, V170, P1901, DOI 10.1097/01.ju.0000092942.87643.27; Azam U, 2001, DRUG AGING, V18, P213, DOI 10.2165/00002512-200118030-00006; Carrera PM, 2014, MATURITAS, V77, P37, DOI 10.1016/j.maturitas.2013.10.022; Coyne KS, 2009, BJU INT, V103, P4, DOI 10.1111/j.1464-410X.2009.08371.x; DEGROAT WC, 1981, J AUTONOM NERV SYST, V3, P135, DOI 10.1016/0165-1838(81)90059-X; DEGROAT WC, 1993, AUTONOMIC NERVOUS SY, V3, P227; Dong ZL, 2009, SYST BIOL REPROD MED, V55, P129, DOI 10.1080/19396360902833235; Ellsworth P, 2013, INT J CLIN PRACT, V67, P397, DOI 10.1111/ijcp.12127; Largo RH, 1999, EUR J PEDIATR, V158, P115; Largo RH, 1996, DEV MED CHILD NEUROL, V38, P1106; Lepor H, 1996, NEW ENGL J MED, V335, P533, DOI 10.1056/NEJM199608223350801; Madersbacher S, 1998, UROLOGY, V51, P206, DOI 10.1016/S0090-4295(97)00616-X; Mosa AM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-67; Nickel JC, 2008, INT J CLIN PRACT, V62, P1547, DOI 10.1111/j.1742-1241.2008.01880.x; Nickel J Curtis, 2006, Curr Urol Rep, V7, P282, DOI 10.1007/s11934-996-0007-z; Nordling J, 2002, EXP GERONTOL, V37, P991, DOI 10.1016/S0531-5565(02)00094-3; Oelke M, 2012, EUR UROL, V61, P917, DOI 10.1016/j.eururo.2012.01.013; Ozdalga E, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1994; RESCORLA RA, 1967, PSYCHOL REV, V74, P71, DOI 10.1037/h0024109; Schonwald A, 2004, PEDIATRICS, V113, P1753, DOI 10.1542/peds.113.6.1753; Schum TR, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.3.e48; Singla S, 2014, J CLIN DIAGNOSTIC RE, V8, pNC01; van Kerrebroeck P, 2002, EUR UROL, V41, P54, DOI 10.1016/S0302-2838(01)00016-1; Wilt TJ, 2003, COCHRANE DB SYST REV	25	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126798	10.1371/journal.pone.0126798	http://dx.doi.org/10.1371/journal.pone.0126798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978378	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100102
J	Melekhov, VV; Shvyreva, US; Timchenko, AA; Tutukina, MN; Preobrazhenskaya, EV; Burkova, DV; Artiukhov, VG; Ozoline, ON; Antipov, SS				Melekhov, Vladislav V.; Shvyreva, Uliana S.; Timchenko, Alexander A.; Tutukina, Maria N.; Preobrazhenskaya, Elena V.; Burkova, Diana V.; Artiukhov, Valiriy G.; Ozoline, Olga N.; Antipov, Sergey S.			Modes of Escherichia coli Dps Interaction with DNA as Revealed by Atomic Force Microscopy	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEIN; BINDING PROTEIN; H-NS; CRYSTAL-STRUCTURE; STATIONARY-PHASE; PROTECTION; STRESS; IRON; TRANSCRIPTION; PROMOTER	Multifunctional protein Dps plays an important role in iron assimilation and a crucial role in bacterial genome packaging. Its monomers form dodecameric spherical particles accumulating similar to 400 molecules of oxidized iron ions within the protein cavity and applying a flexible N-terminal ends of each subunit for interaction with DNA. Deposition of iron is a well-studied process by which cells remove toxic Fe2+ ions from the genetic material and store them in an easily accessible form. However, the mode of interaction with linear DNA remained mysterious and binary complexes with Dps have not been characterized so far. It is widely believed that Dps binds DNA without any sequence or structural preferences but several lines of evidence have demonstrated its ability to differentiate gene expression, which assumes certain specificity. Here we show that Dps has a different affinity for the two DNA fragments taken from the dps gene regulatory region. We found by atomic force microscopy that Dps predominantly occupies thermodynamically unstable ends of linear double-stranded DNA fragments and has high affinity to the central part of the branched DNA molecule self-assembled from three single-stranded oligonucleotides. It was proposed that Dps prefers binding to those regions in DNA that provide more contact pads for the triad of its DNA-binding bundle associated with one vertex of the protein globule. To our knowledge, this is the first study revealed the nucleoid protein with an affinity to branched DNA typical for genomic regions with direct and inverted repeats. As a ubiquitous feature of bacterial and eukaryotic genomes, such structural elements should be of particular care, but the protein system evolutionarily adapted for this function is not yet known, and we suggest Dps as a putative component of this system.	[Melekhov, Vladislav V.; Tutukina, Maria N.; Ozoline, Olga N.; Antipov, Sergey S.] Pushchino State Inst Nat Sci, Dept Cell Biol, Pushchino, Moscow Region, Russia; [Melekhov, Vladislav V.] Russian Acad Sci, Inst Biol Instrumentat, Lab New Methods Biol, Pushchino 142292, Moscow Region, Russia; [Shvyreva, Uliana S.; Tutukina, Maria N.; Ozoline, Olga N.; Antipov, Sergey S.] Russian Acad Sci, Inst Cell Biophys, Dept Funct Genom & Cellular Stress, Pushchino 142292, Moscow Region, Russia; [Timchenko, Alexander A.] Russian Acad Sci, Inst Prot Res, Dept Phys Nucleoproteids, Pushchino 142292, Moscow Region, Russia; [Preobrazhenskaya, Elena V.; Burkova, Diana V.; Artiukhov, Valiriy G.; Antipov, Sergey S.] Voronezh State Univ, Dept Biophys & Biotechnol, Voronezh 394693, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Voronezh State University	Ozoline, ON (corresponding author), Pushchino State Inst Nat Sci, Dept Cell Biol, Pushchino, Moscow Region, Russia.	ozoline@rambler.ru	Antipov, Sergei S/U-1798-2017; Antipov, Sergei/AAD-6556-2019; Timchenko, Alexander/N-6023-2014	Antipov, Sergei S/0000-0003-3244-1428; Antipov, Sergei/0000-0003-3244-1428; Tutukina, Maria/0000-0001-8876-4707	Russian Scientific Foundation [14-04-00985]; Ministry of Education and Science of the Russian Federation [2504]; Russian Foundation for basic reseach [13-04-00997]; Russian Science Foundation [14-14-00985] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for basic reseach(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The work has been supported by Russian Scientific Foundation (ONO, grant 14-04-00985, http://rscf.ru/node/8), by the Ministry of Education and Science of the Russian Federation (SSA, project. 2504, http://xn-80abucjiibhv9a.xn-p1ai) and Russian Foundation for basic reseach (ONO, 13-04-00997, http://www.rfbr.ru/rffi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Antipov SS, 2013, QUESTIONS BIOLOGICAL, V7, P24; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; BONNEFOY E, 1994, J MOL BIOL, V242, P116, DOI 10.1006/jmbi.1994.1563; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Calhoun LN., 2011, INT J MICROBIOL RES, V3, P136, DOI [10.9735/0975-5276.3.3.136-147, DOI 10.9735/0975-5276.3.3.136-147]; CASTAING B, 1995, J BIOL CHEM, V270, P10291, DOI 10.1074/jbc.270.17.10291; Ceci P, 2005, J BIOL CHEM, V280, P34776, DOI 10.1074/jbc.M502343200; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Ceci P, 2007, NUCLEIC ACIDS RES, V35, P2247, DOI 10.1093/nar/gkm077; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; de los Rios S, 2007, J MOL BIOL, V366, P1589, DOI 10.1016/j.jmb.2006.12.032; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Frenkiel-Krispin D, 2004, MOL MICROBIOL, V51, P395, DOI 10.1046/j.1365-2958.2003.03855.x; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Frenkiel-Krispin D, 2006, J STRUCT BIOL, V156, P311, DOI 10.1016/j.jsb.2006.05.014; Ghatak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016019; Goodman SD, 1999, J BACTERIOL, V181, P3246, DOI 10.1128/JB.181.10.3246-3255.1999; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Huergo LF, 2013, J BACTERIOL, V195, P1970, DOI 10.1128/JB.00059-13; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ilari A, 2002, J BIOL CHEM, V277, P37619, DOI 10.1074/jbc.M206186200; Ingleston SM, 2002, EUR J BIOCHEM, V269, P1525, DOI 10.1046/j.1432-1033.2002.02805.x; Iwahori K, 2007, CHEM MATER, V19, P3105, DOI 10.1021/cm0628799; Kawamura T, 2011, J MOL BIOL, V409, P311, DOI 10.1016/j.jmb.2011.01.058; Khomyakova EB, 1998, FEBS LETT, V422, P265, DOI 10.1016/S0014-5793(98)00022-2; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Lavoie BD, 1996, CELL, V85, P761, DOI 10.1016/S0092-8674(00)81241-6; Machulin A. V., 2012, Biophysics, V57, P314, DOI 10.1134/S0006350912030128; Maniatis T, 1982, MOLECULAR CLONING A; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Purtov YA, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014410066; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rogulin EA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1123, DOI 10.1023/B:BIRY.0000046886.19428.d5; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Shvyreva U. S., 2011, Biophysics, V56, P795, DOI 10.1134/S0006350911050204; Sonnenfield JM, 2001, BIOCHIMIE, V83, P243, DOI 10.1016/S0300-9084(01)01232-9; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Stillman TJ, 2005, MOL MICROBIOL, V57, P1101, DOI 10.1111/j.1365-2958.2005.04757.x; Tutukina MN, 2010, MOL BIOL+, V44, P439, DOI 10.1134/S002689331003012X; UEGUCHI C, 1994, P NATL ACAD SCI USA, V91, P1054, DOI 10.1073/pnas.91.3.1054; Wolf SG, 1999, NATURE, V400, P83, DOI 10.1038/21918; YUAN HS, 1991, P NATL ACAD SCI USA, V88, P9558, DOI 10.1073/pnas.88.21.9558; Zeth K, 2012, BIOCHEM J, V445, P297, DOI 10.1042/BJ20120514	55	11	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126504	10.1371/journal.pone.0126504	http://dx.doi.org/10.1371/journal.pone.0126504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978038	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100075
J	Muller, C; Cacaci, M; Sauvageot, N; Sanguinetti, M; Rattei, T; Eder, T; Giard, JC; Kalinowski, J; Hain, T; Hartke, A				Muller, Cecile; Cacaci, Margherita; Sauvageot, Nicolas; Sanguinetti, Maurizio; Rattei, Thomas; Eder, Thomas; Giard, Jean-Christophe; Kalinowski, Joern; Hain, Torsten; Hartke, Axel			The Intraperitoneal Transcriptome of the Opportunistic Pathogen Enterococcus faecalis in Mice	PLOS ONE			English	Article							OXIDATIVE-STRESS-RESPONSE; RNA-SEQ; DIFFERENTIAL EXPRESSION; DEPENDENT REGULATION; VIRULENCE; IDENTIFICATION; RESISTANCE; INFECTION; PROTEIN; MOUSE	Enterococcus faecalis is a Gram-positive lactic acid intestinal opportunistic bacterium with virulence potential. For a better understanding of the adapation of this bacterium to the host conditions, we performed a transcriptome analysis of bacteria isolated from an infection site (mouse peritonitis) by RNA-sequencing. We identified a total of 211 genes with significantly higher transcript levels and 157 repressed genes. Our in vivo gene expression database reflects well the infection process since genes encoding important virulence factors like cytolysin, gelatinase or aggregation substance as well as stress response proteins, are significantly induced. Genes encoding metabolic activities are the second most abundant in vivo induced genes demonstrating that the bacteria are metabolically active and adapt to the special nutrient conditions of the host. alpha- and beta-glucosides seem to be important substrates for E. faecalis inside the host. Compared to laboratory conditions, the flux through the upper part of glycolysis seems to be reduced and more carbon may enter the pentose phosphate pathway. This may reflect the need of the bacteria under infection conditions to produce more reducing power for biosynthesis. Another important substrate is certainly glycerol since both pathways of glycerol catabolism are strongly induced. Strongly in vivo induced genes should be important for the infection process. This assumption has been verified in a virulence test using well characterized mutants affected in glycerol metabolism. This showed indeed that mutants unable to metabolize this sugar alcohol are affected in organ colonisation in a mouse model.	[Muller, Cecile; Cacaci, Margherita; Sauvageot, Nicolas; Giard, Jean-Christophe; Hartke, Axel] Univ Caen Basse Normandie, Stress & Virulence U2RM, EA4655, F-14032 Caen, France; [Cacaci, Margherita; Sanguinetti, Maurizio] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy; [Rattei, Thomas; Eder, Thomas] Univ Vienna, Dept Microbiol & Ecosyst Sci, CUBE Div Computat Syst Biol, A-1090 Vienna, Austria; [Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, D-33594 Bielefeld, Germany; [Hain, Torsten] Univ Giessen, Inst Med Microbiol, D-35392 Giessen, Germany	Universite de Caen Normandie; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Vienna; University of Bielefeld; Justus Liebig University Giessen	Muller, C (corresponding author), Univ Caen Basse Normandie, Stress & Virulence U2RM, EA4655, F-14032 Caen, France.	cecile.muller@unicaen.fr; axel.hartke@unicaen.fr	Rattei, Thomas/F-1366-2011; Sanguinetti, Maurizio/A-1453-2019; cacaci, margherita/K-9051-2016	Rattei, Thomas/0000-0002-0592-7791; Sanguinetti, Maurizio/0000-0002-9780-7059; cacaci, margherita/0000-0002-5433-9400; giard, jean-christophe/0000-0001-8588-2732; Eder, Thomas/0000-0002-0932-2052; Muller, Cecile/0000-0003-3078-1920	Agence Nationale de la Recherche [ANR-08-PATH-008-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was supported by grants from the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr) in the frame of a transnational ERA-NET PathoGenoMics program (ANR-08-PATH-008-01), and the funding was received by AH, TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Bizzini A, 2010, J BACTERIOL, V192, P779, DOI 10.1128/JB.00959-09; Chaudhuri S, 2013, MBIO, V4, DOI 10.1128/mBio.00617-12; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2008, INFECT IMMUN, V76, P5668, DOI 10.1128/IAI.00930-08; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Dupont H, 1998, INFECT IMMUN, V66, P2570, DOI 10.1128/IAI.66.6.2570-2575.1998; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Febrer M, 2011, TRENDS BIOTECHNOL, V29, P586, DOI 10.1016/j.tibtech.2011.06.004; Frank KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115839; Frankenberg L, 2002, J BACTERIOL, V184, P6351, DOI 10.1128/JB.184.22.6351-6356.2002; Garsin D.A., 2014, ENTEROCOCCI COMMENSA; Giard JC, 1996, CURR MICROBIOL, V32, P264, DOI 10.1007/s002849900048; Gilmore MS, 2013, CURR OPIN MICROBIOL, V16, P10, DOI 10.1016/j.mib.2013.01.006; Gopal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010349; Hanin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011879; Hannon G, FASTX TOOLKIT; Hendrickx APA, 2009, TRENDS MICROBIOL, V17, P423, DOI 10.1016/j.tim.2009.06.004; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Jorth P, 2013, J BACTERIOL, V195, P4991, DOI 10.1128/JB.00875-13; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; Leendertse M, 2009, INFECT IMMUN, V77, P485, DOI 10.1128/IAI.00863-08; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindenstrauss AG, 2014, ARCH MICROBIOL, V196, P423, DOI 10.1007/s00203-014-0982-2; Low YL, 2003, J MED MICROBIOL, V52, P113, DOI 10.1099/jmm.0.05039-0; LOWE AM, 1995, INFECT IMMUN, V63, P703, DOI 10.1128/IAI.63.2.703-706.1995; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matos RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003539; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; Nallapareddy SR, 2005, J BACTERIOL, V187, P5709, DOI 10.1128/JB.187.16.5709-5718.2005; Pinkston KL, 2011, J BACTERIOL, V193, P4317, DOI 10.1128/JB.05026-11; Podbielski A, 2004, INT J INFECT DIS, V8, P81, DOI 10.1016/j.ijid.2003.04.003; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Rana NF, 2013, INFECT IMMUN, V81, P2662, DOI 10.1128/IAI.01299-12; Riboldi GP, 2011, BBA-PROTEINS PROTEOM, V1814, P1910, DOI 10.1016/j.bbapap.2011.06.016; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rince A, 2003, INT J FOOD MICROBIOL, V88, P207, DOI 10.1016/S0168-1605(03)00182-X; Rince A, 2002, MICROBIOL-SGM, V148, P703, DOI 10.1099/00221287-148-3-703; Rince A, 2001, J BACTERIOL, V183, P1482, DOI 10.1128/JB.183.4.1482-1488.2001; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rochat T, 2012, PROTEOMICS, V12, P1792, DOI 10.1002/pmic.201100465; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Schonert S, 2006, J BACTERIOL, V188, P3911, DOI 10.1128/JB.00213-06; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sherman JM, 1938, J BACTERIOL, V35, P81, DOI 10.1128/JB.35.2.81-93.1938; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Singh KV, 1998, J INFECT DIS, V178, P1416, DOI 10.1086/314453; Skvortsov TA, 2013, ACTA NATURAE, V5, P62, DOI 10.32607/20758251-2013-5-2-62-69; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Taveirne ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073586; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Van Tyne D, 2013, TOXINS, V5, P895, DOI 10.3390/toxins5050895; Verneuil N, 2005, MICROBIOL-SGM, V151, P3997, DOI 10.1099/mic.0.28325-0; Verneuil N, 2005, FEMS MICROBIOL LETT, V252, P137, DOI 10.1016/j.femsle.2005.08.043; Verneuil N, 2006, MICROBIOL-SGM, V152, P2579, DOI 10.1099/mic.0.28922-0; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Werner G, 2008, EURO SURVEILL B EUR, V13; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zarb P, 2012, EUROSURVEILLANCE, V17, P4; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072285; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	71	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126143	10.1371/journal.pone.0126143	http://dx.doi.org/10.1371/journal.pone.0126143			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978463	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100048
J	Studer, E; Naslund, J; Andersson, E; Nilsson, S; Westberg, L; Eriksson, E				Studer, Erik; Naslund, Jakob; Andersson, Erik; Nilsson, Staffan; Westberg, Lars; Eriksson, Elias			Serotonin Depletion-Induced Maladaptive Aggression Requires the Presence of Androgens	PLOS ONE			English	Article							SEX-DIFFERENCES; BEHAVIORAL DISINHIBITION; INTERMALE AGGRESSION; PREFRONTAL CORTEX; RECEPTOR GENE; TESTOSTERONE; BRAIN; VIOLENCE; MICE; CHLOROPHENYLALANINE	The sex hormone testosterone and the neurotransmitter serotonin exert opposite effects on several aspects of behavior including territorial aggression. It is however not settled if testosterone exerts its pro-aggressive effects by reducing serotonin transmission and/or if the anti-aggressive effect of serotonin requires the presence of the androgen. Using the resident intruder test, we now show that administration of the serotonin synthesis inhibitor parachlorophenylalanine (300 mg/kg x 3 days) increases the total time of attack as well as the percentage amount of social behavior spent on attack but not that spent on threat - i.e. that it induces a pattern of unrestricted, maladaptive aggression - in gonadectomized C57Bl/6 male mice receiving testosterone replacement; in contrast, it failed to reinstate aggression in those not given testosterone. Whereas these results suggest the pro-aggressive effect of testosterone to be independent of serotonin, and not caused by an inhibition of serotonergic activity, the pCPA-induced induction of maladaptive aggression appears to require the presence of the hormone. In line with these findings, pCPA enhanced the total time of attack as well the relative time spent on attacks but not threats also in wild-type gonadally intact male C57Bl/6 mice, but failed to reinstate aggression in mice rendered hypo-aggressive by early knock-out of androgen receptors in the brain (AR(NesDel) mice). We conclude that androgenic deficiency does not dampen aggression by unleashing an anti-aggressive serotonergic influence; instead serotonin seems to modulate aggressive behavior by exerting a parallel-coupled inhibitory role on androgen-driven aggression, which is irrelevant in the absence of the hormone, and the arresting of which leads to enhanced maladaptive aggression.	[Studer, Erik; Naslund, Jakob; Andersson, Erik; Westberg, Lars; Eriksson, Elias] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, SE-40530 Gothenburg, Sweden; [Nilsson, Staffan] Chalmers Univ Technol, Math Sci, SE-41296 Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology	Eriksson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, POB 431, SE-40530 Gothenburg, Sweden.	elias.eriksson@neuro.gu.se	Näslund, Jakob/I-7491-2019	Nilsson, Staffan/0000-0003-4748-0446; Naslund, Jakob/0000-0003-2782-5160	Swedish Science Council [K2010-61x-4961-01-3]; Soderberg's Foundation [MT30/09]; Hallsten's Foundation; Brain Foundation [FO2011-0293]	Swedish Science Council; Soderberg's Foundation; Hallsten's Foundation; Brain Foundation	Financial support was obtained from the Swedish Science Council (EE, K2010-61x-4961-01-3) http://www.vr.se/, Soderberg's Foundation (EE, MT30/09) http://ragnarsoderbergsstiftelse.se/, Hallsten's Foundation (EE), and the Brain Foundation (EE, FO2011-0293) http://www.hjarnfonden.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambar G, 2009, GENES BRAIN BEHAV, V8, P161, DOI 10.1111/j.1601-183X.2008.00458.x; BARKLEY MS, 1977, HORM BEHAV, V9, P32, DOI 10.1016/0018-506X(77)90048-4; BATTY J, 1980, PHARMACOL BIOCHEM BE, V12, P181, DOI 10.1016/0091-3057(80)90352-4; Bernhardt PC, 1997, CURR DIR PSYCHOL SCI, V6, P44, DOI 10.1111/1467-8721.ep11512620; Bethea CL, 2013, BEHAV NEUROSCI, V127, P400, DOI 10.1037/a0032016; Bing O, 1998, EUR NEUROPSYCHOPHARM, V8, P321, DOI 10.1016/S0924-977X(97)00095-3; Birger M, 2003, ISR MED ASSOC J, V5, P653; BONSON KR, 1994, PHARMACOL BIOCHEM BE, V49, P313, DOI 10.1016/0091-3057(94)90427-8; Bourghardt J, 2010, ENDOCRINOLOGY, V151, P5428, DOI 10.1210/en.2010-0663; Caramaschi D, 2008, BEHAV BRAIN RES, V189, P263, DOI 10.1016/j.bbr.2008.01.003; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Cologer-Clifford A, 1999, PHYSIOL BEHAV, V65, P823; CologerClifford A, 1997, PHARMACOL BIOCHEM BE, V58, P425, DOI 10.1016/S0091-3057(97)00295-5; Daly RC, 2001, ARCH GEN PSYCHIAT, V58, P172, DOI 10.1001/archpsyc.58.2.172; de Boer SF, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.052.2009; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Gao XM, 2001, BRAIN RES, V892, P63, DOI 10.1016/S0006-8993(00)03221-2; Higley JD, 1996, BIOL PSYCHIAT, V40, P1067, DOI 10.1016/S0006-3223(95)00675-3; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Keleta YB, 2007, BRAIN RES, V1132, P129, DOI 10.1016/j.brainres.2006.10.097; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; Kubala KH, 2008, BRAIN RES, V1232, P21, DOI 10.1016/j.brainres.2008.07.065; Kuepper Y, 2010, BEHAV BRAIN RES, V206, P93, DOI 10.1016/j.bbr.2009.09.006; Liu Y, 2011, NATURE, V472, P95, DOI 10.1038/nature09822; Lu SF, 1998, ENDOCRINOLOGY, V139, P1594, DOI 10.1210/en.139.4.1594; MARTINEZCONDE E, 1985, COMP BIOCHEM PHYS C, V80, P411, DOI 10.1016/0742-8413(85)90077-5; Michelsen KA, 2007, BRAIN RES REV, V55, P329, DOI 10.1016/j.brainresrev.2007.01.002; Naslund J, 2013, PSYCHOPHARMACOLOGY, V230, P29, DOI 10.1007/s00213-013-3133-6; Natarajan D, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00009; Natarajan D, 2009, BEHAV GENET, V39, P73, DOI 10.1007/s10519-008-9230-3; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Ogawa S, 1997, P NATL ACAD SCI USA, V94, P1476, DOI 10.1073/pnas.94.4.1476; Olivier B, 2005, EUR J PHARMACOL, V526, P207, DOI 10.1016/j.ejphar.2005.09.066; Olivier B, 2011, CURR TOP BEHAV NEURO, V8, P15, DOI 10.1007/7854_2010_116; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Sundblad C, 1997, EUR NEUROPSYCHOPHARM, V7, P253, DOI 10.1016/S0924-977X(97)00031-X; Svensson AI, 2003, PHARMACOL BIOCHEM BE, V75, P481, DOI 10.1016/S0091-3057(03)00137-0; Takahashi A, 2011, PSYCHOPHARMACOLOGY, V213, P183, DOI 10.1007/s00213-010-2000-y; Wu MV, 2011, CURR OPIN NEUROBIOL, V21, P116, DOI 10.1016/j.conb.2010.09.014; Zhang L, 1999, NEUROSCIENCE, V94, P251, DOI 10.1016/S0306-4522(99)00234-1	42	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126462	10.1371/journal.pone.0126462	http://dx.doi.org/10.1371/journal.pone.0126462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978464	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100071
J	Tutor, JD; Srinivasan, S; Gosa, MM; Spentzas, T; Stokes, DC				Tutor, James D.; Srinivasan, Saumini; Gosa, Memorie M.; Spentzas, Thomas; Stokes, Dennis C.			Pulmonary Function in Infants with Swallowing Dysfunction	PLOS ONE			English	Article							LUNG-FUNCTION; GASTROESOPHAGEAL REFLUX; AIRWAY FUNCTION; VOLUME; DYSPHAGIA; CHILDREN	Background Swallowing dysfunction can lead to recurring aspiration and is frequently associated with chronic symptoms such as cough and wheezing in infants. Our objective was to describe the characteristics of infants with swallowing dysfunction, determine if pulmonary function abnormalities are detectable, and if they improve after therapy. Methods We studied 38 infants with a history of coughing and wheezing who had pulmonary function tests performed within two weeks of their diagnosis of swallowing dysfunction. The raised lung volume rapid thoracoabdominal compression technique was used. After 6 months of therapy, 17 of the infants repeated the tests. Results Initially, 25 had abnormal spirometry, 18 had abnormal plethysmography, and 15 demonstrated bronchodilator responsiveness. Six months later test were repeated for seventeen patients. Ten patients had continued abnormal spirometry, two patients remained normal, three patients' abnormal spirometry had normalized, and two patients' previously normal studies became abnormal. Eight of the 17 patients had continued abnormal plethysmography, six had continued normal plethysmography, and three patients' normal plethysmography became abnormal. After 6 months of treatment, eight patients demonstrated bronchodilator responsiveness, of which five continued to demonstrate bronchodilator responsiveness and three developed responsiveness. The remainder either continued to be non-bronchodilator responsive (two) or lost responsiveness (three.) The findings of the abnormal tests in most infants tested is complicated by frequent occurrence of other co-morbidities in this population, including gastroesophageal reflux in 23 and passive smoke exposure in 13 of the infants. Conclusions The interpretation of lung function changes is complicated by the frequent association of swallowing dysfunction with gastroesophageal reflux and passive smoke exposure in this population. Six months of medical therapy for swallowing dysfunction/gastroesophageal reflux did not significantly improve pulmonary function in these infants. Long-term studies will be necessary to determine which of these changes persists into adulthood.	[Tutor, James D.; Srinivasan, Saumini; Stokes, Dennis C.] Univ Tennessee, Hlth Sci Ctr, Program Pediat Pulm Med, Le Bonheur Childrens Hosp, Memphis, TN 38163 USA; [Tutor, James D.; Srinivasan, Saumini; Stokes, Dennis C.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Gosa, Memorie M.] Le Bonheur Childrens Hosp, Dept Speech Language Pathol, Rehabil Serv, Memphis, TN USA; [Spentzas, Thomas] Univ Tennessee, Hlth Sci Ctr, Le Bonheur Childrens Hosp, Dept Pediat & Prevent Med, Memphis, TN USA; [Gosa, Memorie M.] Univ Alabama, Dept Communicat Disorders, Tuscaloosa, AL USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Tuscaloosa	Tutor, JD (corresponding author), Univ Tennessee, Hlth Sci Ctr, Program Pediat Pulm Med, Le Bonheur Childrens Hosp, Memphis, TN 38163 USA.	jtutor@uthsc.edu		Stokes, Dennis/0000-0002-1162-9192	Methodist/Le Bonheur Healthcare Small Research Grant	Methodist/Le Bonheur Healthcare Small Research Grant	This study was funded by a Methodist/Le Bonheur Healthcare Small Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Speech-Language-Hearing Association, 2004, ASHA S, V24, P77, DOI DOI 10.1044/POLICY.GL2004-00050; American Thoracic Society, 2005, Am J Respir Crit Care Med, V172, P1463; ARVEDSON J, 1994, INT J PEDIATR OTORHI, V28, P173, DOI 10.1016/0165-5876(94)90009-4; Behrman RE, 2011, NELSON TXB PEDIAT, V19th, P1266; Castile RG, 2004, PEDIATR PULM, V37, P461, DOI 10.1002/ppul.10446; Dezateux C, 2004, THORAX, V59, P60; EID NS, 1994, PEDIATR PULM, V18, P39, DOI 10.1002/ppul.1950180110; Feher A, 1985, J APPL PHYSIOL, V80, P2019; Friedrich L, 2007, AM J RESP CRIT CARE, V176, P1269, DOI 10.1164/rccm.200703-476OC; Garcia JM, 2010, AM J NURS, V110, P26, DOI 10.1097/01.NAJ.0000390519.83887.02; Goldstein AB, 2001, AM J RESP CRIT CARE, V164, P447, DOI 10.1164/ajrccm.164.3.2005080; HAMPTON FJ, 1991, ARCH DIS CHILD, V66, P848, DOI 10.1136/adc.66.7.848; Hiorns MP, 2006, PEDIATR RADIOL, V36, P911, DOI 10.1007/s00247-006-0124-3; Jones M, 2000, AM J RESP CRIT CARE, V161, P353, DOI 10.1164/ajrccm.161.2.9903026; Le Souef PN, 1996, INFANT RESP FUNCTION, P379; Leiter AF, 1996, AJ MED SPEECH LANG P, V4, P289; Linnane BM, 2008, AM J RESP CRIT CARE, V178, P1238, DOI 10.1164/rccm.200804-551OC; Low J, 2001, DYSPHAGIA, V16, P123, DOI 10.1007/s004550011002; Lum S, 2007, THORAX, V62, P341, DOI 10.1136/thx.2006.068262; Lum S, 2010, PEDIATR PULM, V45, P906, DOI 10.1002/ppul.21255; Newman L A, 2000, Semin Speech Lang, V21, P281, DOI 10.1055/s-2000-8382; Ranganathan SC, 2004, AM J RESP CRIT CARE, V169, P928, DOI 10.1164/rccm.200309-1344OC; Rao N, 2003, J APPL RES, V3, P1; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Sheikh S, 1999, PEDIATR PULM, V27, P236, DOI 10.1002/(SICI)1099-0496(199904)27:4<236::AID-PPUL3>3.0.CO;2-I; Stocks J, 2001, EUR RESPIR J, V17, P302, DOI 10.1183/09031936.01.17203020; Stocks J., 2006, KENDIGS DISORDERS RE, P129; TANIGUCHI MH, 1994, DEV MED CHILD NEUROL, V36, P495; Tepper RS, 2005, AM J RESP CRIT CARE, V171, P78, DOI 10.1164/rccm.200406-711OC; TURNER DJ, 1995, AM J RESP CRIT CARE, V151, P1441, DOI 10.1164/ajrccm.151.5.7735598; Tutor JD, 2012, PEDIATR PULM, V47, P321, DOI 10.1002/ppul.21576	31	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0123125	10.1371/journal.pone.0123125	http://dx.doi.org/10.1371/journal.pone.0123125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978396	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100006
J	Miranda, MM; Panis, C; Cataneo, AHD; da Silva, SS; Kawakami, NY; Lopes, LGD; Morey, AT; Yamauchi, LM; Andrade, CGTD; Cecchini, R; da Silva, JJN; Sforcin, JM; Conchon-Costa, I; Pavanelli, WR				Miranda, Milena Menegazzo; Panis, Carolina; Depieri Cataneo, Allan Henrique; da Silva, Suelen Santos; Kawakami, Natalia Yoshie; de Franca Lopes, Luiz Gonzaga; Morey, Alexandre Tadachi; Yamauchi, Lucy Megumi; Tardelli de Jesus Andrade, Celia Guadalupe; Cecchini, Rubens; Nogueira da Silva, Jean Jerley; Sforcin, Jose Maurcio; Conchon-Costa, Ivete; Pavanelli, Wander Rogerio			Nitric Oxide and Brazilian Propolis Combined Accelerates Tissue Repair by Modulating Cell Migration, Cytokine Production and Collagen Deposition in Experimental Leishmaniasis	PLOS ONE			English	Article							IN-VITRO; CUTANEOUS LEISHMANIASIS; IMMUNE-RESPONSE; T-CELLS; EXPRESSION; VIVO; SYNTHASE; PROLIFERATION; ACCUMULATION; CHEMOTHERAPY	The fact that drugs currently used in the treatment of Leishmania are highly toxic and associated with acquired resistance has promoted the search for new therapies for treating American tegumentary leishmaniasis (ATL). In this study, BALB/c mice were injected in the hind paw with Leishmania (Leishmania) amazonensis and subsequently treated with a combination of nitric oxide (NO) donor (cis-[Ru(bpy)(2)imN(NO)](PF6)(3)) (Ru-NO), given by intraperitoneal injection, and oral Brazilian propolis for 30 days. Ru-NO reached the center of the lesion and increased the NO level in the injured hind paw without lesion exacerbation. Histological and immunological parameters of chronic inflammation showed that this combined treatment increased the efficacy of macrophages, determined by the decrease in the number of parasitized cells, leading to reduced expression of proinflammatory and tissue damage markers. In addition, these drugs in combination fostered wound healing, enhanced the number of fibroblasts, pro-healing cytokines and induced collagen synthesis at the lesion site. Overall, our findings suggest that the combination of the NO donor Ru-NO and Brazilian propolis alleviates experimental ATL lesions, highlighting a new therapeutic option that can be considered for further in vivo investigations as a candidate for the treatment of cutaneous leishmaniasis.	[Miranda, Milena Menegazzo; Depieri Cataneo, Allan Henrique; da Silva, Suelen Santos; Kawakami, Natalia Yoshie; Cecchini, Rubens; Conchon-Costa, Ivete; Pavanelli, Wander Rogerio] Univ Estadual Londrina, Ctr Biol Sci, Dept Pathol Sci, Londrina, Parana, Brazil; [Panis, Carolina] State Univ Western Parana, Lab Inflammatory Mediators, Francisco Beltrao, Parana, Brazil; [de Franca Lopes, Luiz Gonzaga] Univ Fed Ceara, Dept Organ & Inorgan Chem, Fortaleza, Ceara, Brazil; [Morey, Alexandre Tadachi; Yamauchi, Lucy Megumi] Univ Estadual Londrina, Ctr Biol Sci, Dept Microbiol, Londrina, Parana, Brazil; [Tardelli de Jesus Andrade, Celia Guadalupe] Univ Estadual Londrina, Ctr Biol Sci, Dept Gen Biol, Lab Electron Microscopy & Microanal, Londrina, Parana, Brazil; [Nogueira da Silva, Jean Jerley] State Univ Roraima, Dept Chem, Boa Vista, Roraima, Brazil; [Sforcin, Jose Maurcio] Sao Paulo State Univ, Biosci Inst, Dept Microbiol & Immunol, Botucatu, SP, Brazil	Universidade Estadual de Londrina; Universidade Federal do Ceara; Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Roraima (UERR); Universidade Estadual Paulista	Miranda, MM (corresponding author), Univ Estadual Londrina, Ctr Biol Sci, Dept Pathol Sci, Londrina, Parana, Brazil.	milenamenegazzo@yahoo.com.br	Miranda-Sapla, Milena M/D-1231-2017; da Silva, Suelen Santos/AAS-5789-2020; Cataneo, Allan/AAB-7997-2020; Miranda-Sapla, Milena Menegazzo/AAU-6241-2021; Lopes, Luiz G F/J-4385-2015; Cecchini, Rubens/D-9811-2013; PANIS, CAROLINA/O-1490-2015; Costa, Ivete/AAM-7309-2021; PANIS, CAROLINA/AAM-7214-2021; Sforcin, José/AGN-6459-2022	Miranda-Sapla, Milena M/0000-0001-8324-9642; da Silva, Suelen Santos/0000-0002-6251-0386; Cataneo, Allan/0000-0002-3567-7471; Miranda-Sapla, Milena Menegazzo/0000-0001-8324-9642; Lopes, Luiz G F/0000-0002-3641-1835; Cecchini, Rubens/0000-0001-9941-2344; PANIS, CAROLINA/0000-0002-0104-4369; PANIS, CAROLINA/0000-0002-0104-4369; 				Ahsan H, 2013, HUM IMMUNOL, V74, P1392, DOI 10.1016/j.humimm.2013.06.009; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Amarante MK, 2012, J PHARM PHARMACOL, V64, P154, DOI 10.1111/j.2042-7158.2011.01385.x; Ayres DC, 2007, MEM I OSWALDO CRUZ, V102, P215, DOI 10.1590/S0074-02762007005000020; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Barbosa MH, 2009, ACTA PAUL ENFERM, V22, P318, DOI 10.1590/S0103-21002009000300013; BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536; Bogdan C, 1999, PARASITOL TODAY, V15, P22, DOI 10.1016/S0169-4758(98)01362-3; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; CANDOLFI E, 1994, INFECT IMMUN, V62, P1995, DOI 10.1128/IAI.62.5.1995-2001.1994; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054055; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; da Silva SS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/673058; Dal Secco D, 2003, NITRIC OXIDE-BIOL CH, V9, P153, DOI 10.1016/j.niox.2003.11.001; Daleprane JB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/175135; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Davidson RN, 2000, T ROY SOC TROP MED H, V94, P319, DOI 10.1016/S0035-9203(00)90341-9; Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123; Costa ISF, 2014, J ANTIMICROB CHEMOTH, V69, P2302, DOI 10.1093/jac/dku223; Frank S, 2002, KIDNEY INT, V61, P882, DOI 10.1046/j.1523-1755.2002.00237.x; Gao HW, 2004, J IMMUNOL, V172, P7703, DOI 10.4049/jimmunol.172.12.7703; Gao WN, 2014, J CLIN BIOCHEM NUTR, V55, P7, DOI 10.3164/jcbn.13-70; Genestra M, 2008, CELL BIOCHEM FUNCT, V26, P709, DOI 10.1002/cbf.1496; Giorgio S, 1996, PHOTOCHEM PHOTOBIOL, V63, P750, DOI 10.1111/j.1751-1097.1996.tb09626.x; Guedes PMM, 2010, BRIT J PHARMACOL, V160, P270, DOI 10.1111/j.1476-5381.2009.00576.x; Hickey MJ, 2001, CLIN SCI, V100, P1, DOI 10.1042/CS20000135; Hosnuter M, 2004, BURNS, V30, P121, DOI 10.1016/j.burns.2003.09.022; Hu FL, 2005, J ETHNOPHARMACOL, V100, P276, DOI 10.1016/j.jep.2005.02.044; Khorasgani EM, 2010, PAK VET J, V30, P72; KIKUCHI K, 1993, J BIOL CHEM, V268, P23106; Kolankaya D, 2002, FOOD CHEM, V78, P213, DOI 10.1016/S0308-8146(01)00400-9; da Silva MFL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034022; Leaper D., 2011, WOUNDS, V7, P4; Lemesre JL, 1997, EXP PARASITOL, V86, P58, DOI 10.1006/expr.1997.4151; LIEW FY, 1994, IMMUNOL LETT, V43, P95, DOI 10.1016/0165-2478(94)00157-X; Lira R, 2000, INFECT IMMUN, V68, P5176, DOI 10.1128/IAI.68.9.5176-5182.2000; Lopez-Jaramillo P, 2010, AM J TROP MED HYG, V83, P97, DOI 10.4269/ajtmh.2010.09-0287; Pereira JCM, 2010, EUR J MED CHEM, V45, P4180, DOI 10.1016/j.ejmech.2010.06.010; MILLER GL, 1959, ANAL CHEM, V31, P964, DOI 10.1021/ac60149a611; Missima F, 2008, EVID-BASED COMPL ALT, V5, P71, DOI 10.1093/ecam/nel112; Muscara MN, 2000, BRIT J PHARMACOL, V129, P681, DOI 10.1038/sj.bjp.0703112; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P15143, DOI 10.1073/pnas.191498798; Nicolas L, 2002, J CLIN MICROBIOL, V40, P1666, DOI 10.1128/JCM.40.5.1666-1669.2002; Silva JJN, 2010, BRIT J PHARMACOL, V160, P260, DOI 10.1111/j.1476-5381.2009.00524.x; O'Connor RA, 2000, INFECT IMMUN, V68, P6101, DOI 10.1128/IAI.68.11.6101-6107.2000; Olczyk P, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/423809; Olczyk P, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/290675; Olekhnovitch R, 2014, J CLIN INVEST, V124, P1711, DOI 10.1172/JCI72058; Oliveira F, 2011, AM J TROP MED HYG, V85, P70, DOI 10.4269/ajtmh.2011.10-0680; Oliveira WN, 2014, CYTOKINE, V66, P127, DOI 10.1016/j.cyto.2013.12.016; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Orsatti CL, 2010, PHYTOTHER RES, V24, P1141, DOI 10.1002/ptr.3086; Orsatti CL, 2010, J ETHNOPHARMACOL, V129, P314, DOI 10.1016/j.jep.2010.03.030; Orsi R. O., 2000, Journal of Venomous Animals and Toxins including Tropical Diseases, V6, P205, DOI 10.1590/S0104-79302000000200006; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Panis C, 2011, EXP PARASITOL, V127, P58, DOI 10.1016/j.exppara.2010.06.030; Pavanelli WR, 2011, MYCOPATHOLOGIA, V172, P95, DOI 10.1007/s11046-011-9416-8; Pearl JE, 2012, EUR J IMMUNOL, V42, P3267, DOI 10.1002/eji.201142158; Pizzatti L, 2012, PROTEOMICS, V12, P2618, DOI 10.1002/pmic.201200066; Pontin K, 2008, PARASITOL RES, V103, P487, DOI 10.1007/s00436-008-0970-z; Ramos AFN, 2007, J VENOM ANIM TOXINS, V13, P697, DOI 10.1590/S1678-91992007000400002; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rim WJH, 1998, ARCH PHARM RES, V21, P487, DOI 10.1007/BF02975363; Sa-Nunes A, 2003, J ETHNOPHARMACOL, V87, P93, DOI 10.1016/S0378-8741(03)00121-1; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sakthianandeswaren A, 2005, P NATL ACAD SCI USA, V102, P15551, DOI 10.1073/pnas.0505630102; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sforcin JM, 2007, J ETHNOPHARMACOL, V113, P1, DOI 10.1016/j.jep.2007.05.012; Sforcin JM, 2005, J ETHNOPHARMACOL, V98, P301, DOI 10.1016/j.jep.2005.01.042; Sforcin JM, 2009, PROPOLIS IMUNIDADE C, P67; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Shi HP, 2000, SURGERY, V128, P374, DOI 10.1067/msy.2000.107372; Silva FON, 2006, EUR J INORG CHEM, P2020, DOI 10.1002/ejic.200500871; Silva FON, 2011, J INORG BIOCHEM, V105, P624, DOI 10.1016/j.jinorgbio.2011.02.004; Soneja A, 2005, PHARMACOL REP, V57, P108; Spiecker M, 1998, J LEUKOCYTE BIOL, V63, P732, DOI 10.1002/jlb.63.6.732; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Thornton FJ, 1998, BIOCHEM BIOPH RES CO, V246, P654, DOI 10.1006/bbrc.1998.8681; Toledo JC, 2005, COORDIN CHEM REV, V249, P419, DOI 10.1016/j.ccr.2004.09.016; Valdez RH, 2012, ANTIMICROB AGENTS CH, V56, P507, DOI 10.1128/AAC.05575-11; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; Wanasen N, 2008, IMMUNOL RES, V41, P15, DOI 10.1007/s12026-007-8012-y	85	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125101	10.1371/journal.pone.0125101	http://dx.doi.org/10.1371/journal.pone.0125101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973801	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600012
J	Chen, L; Tai, WCS; Brar, MS; Leung, FCC; Hsiao, WLW				Chen, Lei; Tai, William C. S.; Brar, Manreetpal S.; Leung, Frederick C. C.; Hsiao, W. L. Wendy			Tumor Grafting Induces Changes of Gut Microbiota in Athymic Nude Mice in the Presence and Absence of Medicinal Gynostemma Saponins	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; ABERRANT CRYPT FOCI; INTESTINAL MICROBIOTA; BETA-GLUCURONIDASE; ALLERGIC DISEASES; TOXICITY; DIETARY; OBESITY; CELLS; MICROFLORA	Recent findings have revealed that gut microbiota plays a substantial role in modulating diseases such as autism, rheumatoid arthritis, allergies, and cancer that occur at sites distant to the gut. Athymic nude mice have been employed for tumorigenic research for decades; however, the relationships between the gut microbiome and host's response in drug treatment to the grafted tumors have not been explored. In this study, we analyzed the fecal microbiome of nonxenograft and xenograft nude mice treated with phytosaponins from a popular medicinal plant, Gynostemma pentaphyllum (Gp). Analysis of enterobacterial repetitive intergenic consensus (ERIC)-PCR data showed that the microbiota profile of xenograft mice departed from that of the nonxenograft mice. After ten days of treatment with Gp saponins (GpS), the microbiota of the treated mice was closer to the microbiota at Day 0 before the implantation of the tumor. Data obtained from 16S pyrosequencing of fecal samples reiterates the differences in microbiome between the nonxenograft and xenograft mice. GpS markedly increased the relative abundance of Clostridium cocleatum and Bacteroides acidifaciens, for which the beneficial effects on the host have been well documented. This study, for the first time, characterizes the properties of gut microbiome in nude mice responding to tumor implant and drug treatment. We also demonstrate that dietary saponins such as GpS can potentially regulate the gut microbial ecosystem by increasing the number of symbionts. Interestingly, this regulation of the gut ecosystem might, at least in part, be responsible for or contribute to the anticancer effect of GpS.	[Hsiao, W. L. Wendy] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Chen, Lei; Tai, William C. S.; Hsiao, W. L. Wendy] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Kowloon, Hong Kong, Peoples R China; [Brar, Manreetpal S.; Leung, Frederick C. C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Macau University of Science & Technology; Hong Kong Baptist University; University of Hong Kong	Hsiao, WLW (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	wlhsiao@must.edu.mo			Research Grants Council of Hong Kong [GRF260413]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was partially supported by Research Grants Council of Hong Kong under GRF260413 to W. L. Wendy Hsiao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2000, J PHARM PHARMACOL, V52, P1563, DOI 10.1211/0022357001777621; Almeida J, 2006, WORLD J GASTROENTERO, V12, P1493, DOI 10.3748/wjg.v12.i10.1493; Attawish A, 2004, FITOTERAPIA, V75, P539, DOI 10.1016/j.fitote.2004.04.010; BOUREAU H, 1993, RES MICROBIOL, V144, P405, DOI 10.1016/0923-2508(93)90198-B; BROWN JF, 1978, APPL ENVIRON MICROB, V36, P144, DOI 10.1128/AEM.36.1.144-159.1978; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiranthanut N, 2013, J ETHNOPHARMACOL, V149, P228, DOI 10.1016/j.jep.2013.06.027; Clavel T, 2007, SYST APPL MICROBIOL, V30, P16, DOI 10.1016/j.syapm.2006.02.003; Critchfield JW, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/161358; Delihas N, 2007, GENE REGUL SYST BIO, V1, P191; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; FREEMAN AE, 1967, P NATL ACAD SCI USA, V58, P1205, DOI 10.1073/pnas.58.3.1205; Goto S, 1996, CANCER IMMUNOL IMMUN, V42, P255, DOI 10.1007/s002620050279; Hormannsperger G, 2012, J ALLERGY CLIN IMMUN, V129, P1452, DOI 10.1016/j.jaci.2011.12.993; Hsiao WLW, 2004, CARCINOGENESIS, V25, P1177, DOI 10.1093/carcin/bgh119; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ishikawa H, 2005, INT J CANCER, V116, P762, DOI 10.1002/ijc.21115; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kong J., 2006, ASIAN J TRAD MED, V1, P1; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Malinen E, 2010, WORLD J GASTROENTERO, V16, P4532, DOI 10.3748/wjg.v16.i36.4532; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; Miyamoto Y, 2000, INT J SYST EVOL MICR, V50, P145, DOI 10.1099/00207713-50-1-145; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Ott SJ, 2006, GUT, V55, P1207; Peng Y, 2009, WORLD J GASTROENTERO, V15, P2220, DOI 10.3748/wjg.15.2220; Pierre F, 1997, CANCER RES, V57, P225; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rao CV, 1998, CARCINOGENESIS, V19, P1815, DOI 10.1093/carcin/19.10.1815; RAO GR, 1977, J RETICULOENDOTH SOC, V21, P13; Razmovski-Naumovsld V., 2005, PHYTOCHEMISTRY, V14, P197, DOI DOI 10.1007/S11101-005-3754-4; Renouf M, 2011, J NUTR, V141, P1120, DOI 10.3945/jn.111.140988; Russell SL, 2012, CURR OPIN GASTROEN, V28, P563, DOI 10.1097/MOG.0b013e3283573017; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sengottuvelan M, 2006, BBA-GEN SUBJECTS, V1760, P1175, DOI 10.1016/j.bbagen.2006.03.008; Stringer AM, 2013, NUTRIENTS, V5, P1488, DOI 10.3390/nu5051488; Stringer AM, 2008, CANCER BIOL THER, V7, P1919, DOI 10.4161/cbt.7.12.6940; Takasuna K, 1996, CANCER RES, V56, P3752; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015; Wang YL, 2005, J AGR FOOD CHEM, V53, P191, DOI 10.1021/jf0403282; Wilson LA, 2006, MOL BIOL EVOL, V23, P1156, DOI 10.1093/molbev/msj125; Wu PK, 2011, FOOD CHEM, V128, P70, DOI 10.1016/j.foodchem.2011.02.078; Yanagibashi T, 2013, IMMUNOBIOLOGY, V218, P645, DOI 10.1016/j.imbio.2012.07.033; Yu K, 2012, CURR DRUG METAB, V13, P577, DOI 10.2174/1389200211209050577	52	31	33	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126807	10.1371/journal.pone.0126807	http://dx.doi.org/10.1371/journal.pone.0126807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992551	Green Published, Green Submitted, gold			2022-12-27	WOS:000354921400078
J	Patel, R; Shetty, H; Jackson, R; Broadbent, M; Stewart, R; Boydell, J; McGuire, P; Taylor, M				Patel, Rashmi; Shetty, Hitesh; Jackson, Richard; Broadbent, Matthew; Stewart, Robert; Boydell, Jane; McGuire, Philip; Taylor, Matthew			Delays before Diagnosis and Initiation of Treatment in Patients Presenting to Mental Health Services with Bipolar Disorder	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; SCHIZOAFFECTIVE DISORDER; ILLNESS; DURATION; OPPORTUNITIES; ASSOCIATION; MORTALITY; LONDON; MANIA; ONSET	Background Bipolar disorder is a significant cause of morbidity and mortality. Although existing treatments are effective, there is often a substantial delay before diagnosis and treatment initiation. We sought to investigate factors associated with the delay before diagnosis of bipolar disorder and the onset of treatment in secondary mental healthcare. Method Retrospective cohort study using anonymised electronic mental health record data from the South London and Maudsley NHS Foundation Trust (SLaM) Biomedical Research Centre (BRC) Case Register on 1364 adults diagnosed with bipolar disorder between 2007 and 2012. The following predictor variables were analysed in a multivariable Cox regression analysis: age, gender, ethnicity, compulsory admission to hospital under the UK Mental Health Act, marital status and other diagnoses prior to bipolar disorder. The outcomes were time to recorded diagnosis from first presentation to specialist mental health services (the diagnostic delay), and time to the start of appropriate therapy (treatment delay). Results The median diagnostic delay was 62 days (interquartile range: 17-243) and median treatment delay was 31 days (4-122). Compulsory hospital admission was associated with a significant reduction in both diagnostic delay (hazard ratio 2.58, 95% CI 2.18-3.06) and treatment delay (4.40, 3.63-5.62). Prior diagnoses of other psychiatric disorders were associated with increased diagnostic delay, particularly alcohol (0.48, 0.33-0.41) and substance misuse disorders (0.44, 0.31-0.61). Prior diagnosis of schizophrenia and psychotic depression were associated with reduced treatment delay. Conclusions Some individuals experience a significant delay in diagnosis and treatment of bipolar disorder after initiation of specialist mental healthcare, particularly those who have prior diagnoses of alcohol and substance misuse disorders. These findings highlight a need for further study on strategies to better identify underlying symptoms and offer appropriate treatment sooner in order to facilitate improved clinical outcomes, such as developing specialist early intervention services to identify and treat people with bipolar disorder.	[Patel, Rashmi; Boydell, Jane; McGuire, Philip; Taylor, Matthew] Kings Coll London, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England; [Shetty, Hitesh; Broadbent, Matthew] South London & Maudsley NHS Fdn Trust, Biomed Res Ctr Nucleus, London, England; [Jackson, Richard; Stewart, Robert] Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London	Patel, R (corresponding author), Kings Coll London, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England.	plosone@rpatel.co.uk	Stewart, Robert/B-1667-2010; Patel, Rashmi/O-1327-2013	Stewart, Robert/0000-0002-4435-6397; Patel, Rashmi/0000-0002-9259-8788; Taylor, Matthew/0000-0003-4716-4662; Jackson, Richard/0000-0002-3278-8547; McGuire, Philip/0000-0003-4381-0532	Medical Research Council Clinical Research Training Fellowship; National Institute for Health Research (NIHR) Biomedical Research Centre - Dementia Biomedical Research Unit at South London; National Institute for Health Research (NIHR) Biomedical Research Centre - Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre - King's College London; Medical Research Council [MR/K002813/1] Funding Source: researchfish; MRC [MR/K002813/1] Funding Source: UKRI	Medical Research Council Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre - Dementia Biomedical Research Unit at South London(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Biomedical Research Centre - Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre - King's College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RP is supported by a Medical Research Council Clinical Research Training Fellowship. All other authors are funded by the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London, which also supports the development and maintenance of the CRIS data resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura AC, 2010, EUR ARCH PSY CLIN N, V260, P385, DOI 10.1007/s00406-009-0085-2; Altshuler LL, 2006, AM J PSYCHIAT, V163, P313, DOI 10.1176/appi.ajp.163.2.313; Baca-Garcia E, 2007, ACTA PSYCHIAT SCAND, V115, P473, DOI 10.1111/j.1600-0447.2006.00984.x; Bauer MS, 2005, J AFFECT DISORDERS, V85, P301, DOI 10.1016/j.jad.2004.11.009; Berk M, 2007, J AFFECT DISORDERS, V103, P181, DOI 10.1016/j.jad.2007.01.027; Berk M, 2007, J AFFECT DISORDERS, V100, P279, DOI 10.1016/j.jad.2007.03.007; Berk M, 2010, J MENT HEALTH, V19, P113, DOI 10.3109/09638230903469111; Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Drancourt N, 2013, ACTA PSYCHIAT SCAND, V127, P136, DOI 10.1111/j.1600-0447.2012.01917.x; Fernandes AC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-71; Funk M., 2008, INT MENT HLTH PRIM C; Goldberg JF, 2003, BIPOLAR DISORD, V5, P407, DOI 10.1046/j.1399-5618.2003.00067.x; Goldberg JF, 2002, J CLIN PSYCHIAT, V63, P985, DOI 10.4088/JCP.v63n1105; Goldstein BI, 2010, J CLIN PSYCHIAT, V71, P348, DOI 10.4088/JCP.09r05222gry; Goodwin GM, 2009, J PSYCHOPHARMACOL, V23, P346, DOI 10.1177/0269881109102919; Gorrell G., 2013, P NLP MED BIOL WORK, P9; Hayes RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044613; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Kessing LV, 2004, ACTA PSYCHIAT SCAND, V109, P339, DOI 10.1046/j.1600-0447.2003.00266.x; Lagerberg TV, 2010, J NERV MENT DIS, V198, P628, DOI 10.1097/NMD.0b013e3181ef3ef4; Lawton-Smith M, 2008, COST MENTAL HLTH CAR; McCraw S, 2014, J AFFECT DISORDERS, V168, P422, DOI 10.1016/j.jad.2014.07.025; Merikangas KR, 2008, ARCH GEN PSYCHIAT, V65, P47, DOI 10.1001/archgenpsychiatry.2007.18; National Institute for Health and Care Excellence, 2016, SEVERE MENTAL ILLNES; NHS England, 2014, UND NEW NHS; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Pagel T, 2013, BIPOLAR DISORD, V15, P229, DOI 10.1111/bdi.12057; Peralta V, 2005, SOC PSYCH PSYCH EPID, V40, P345, DOI 10.1007/s00127-005-0905-2; Pettinati HM, 2013, AM J PSYCHIAT, V170, P23, DOI 10.1176/appi.ajp.2012.12010112; Pilling S, 2011, BMJ, V342; Post RM, 2010, J CLIN PSYCHIAT, V71, P864, DOI 10.4088/JCP.08m04994yel; Smith DJ, 2011, BRIT J PSYCHIAT, V199, P49, DOI 10.1192/bjp.bp.110.083840; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Suppes T, 2001, J AFFECT DISORDERS, V67, P45, DOI 10.1016/S0165-0327(01)00432-3; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	40	38	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126530	10.1371/journal.pone.0126530	http://dx.doi.org/10.1371/journal.pone.0126530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7CV	25992560	Green Published, gold, Green Submitted			2022-12-27	WOS:000354921400065
J	Geng, LN; Xu, JK; Ye, LJ; Zhou, WJ; Zhou, KX				Geng, Liuna; Xu, Jingke; Ye, Lijuan; Zhou, Wenjun; Zhou, Kexin			Connections with Nature and Environmental Behaviors	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; SOCIAL COGNITION; SELF-ESTEEM; EXPLICIT; CONNECTEDNESS; ATTITUDE; DETERMINANTS; METAANALYSIS; MOTIVATION; SCALE	The influence of environmental attitudes on environmental behaviors has long been discussed. However, few studies have addressed the foundation of such attitudes. In the present study, we explored primitive belief underlying environmental attitudes, i.e., connections with nature, and its relationship with pro-environmental behaviors. Specifically, we used scales, a computerized Implicit Association Test, and a situational simulation experiment to examine both explicit and implicit connections with nature, both deliberate and spontaneous environmental behaviors, and to find correlations between environmental connectedness and environmental behaviors. Results showed that explicit connectedness was positively correlated with deliberate environmental behaviors, while implicit connectedness was positively correlated with spontaneous environmental behaviors. Additionally, explicit and implicit connectedness was independent of each other. In conclusion, the current study confirms the positive role played by connections with nature in promoting environmental behavior, and accordingly suggests means to encourage pro-environmental behavior by enhancing people's connectedness to nature.	[Geng, Liuna; Ye, Lijuan; Zhou, Wenjun] Nanjing Univ, Dept Psychol, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Jingke] Nanjing Univ, Kuang Yaming Honors Sch, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Kexin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Zhou, KX (corresponding author), Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China.	zhoukexin@aliyun.com			National Social Science Foundation of China [11CSH045]; Fundamental Research Funds for the Central Universities [2062014333]	National Social Science Foundation of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study described in this report was supported by11CSH045 National Social Science Foundation of China (LNG, http://www.npopss-cn.gov.cn/), and 2062014333 the Fundamental Research Funds for the Central Universities (LNG, http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; Asendorpf JB, 2002, J PERS SOC PSYCHOL, V83, P380, DOI 10.1037//0022-3514.83.2.380; Bamberg S, 2003, J ENVIRON PSYCHOL, V23, P21, DOI 10.1016/S0272-4944(02)00078-6; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002; Bruni CM, 2010, J ENVIRON PSYCHOL, V30, P95, DOI 10.1016/j.jenvp.2009.10.004; Clayton S., 2003, IDENTITY NATURAL ENV; Conrey FR, 2005, J PERS SOC PSYCHOL, V89, P469, DOI 10.1037/0022-3514.89.4.469; d'Adda G, 2011, ECOL ECON, V70, P2083, DOI 10.1016/j.ecolecon.2011.06.006; Diekmann A, 1998, RATION SOC, V10, P79, DOI 10.1177/104346398010001004; DUNLAP RE, 1978, J ENVIRON EDUC, V9, P10, DOI 10.1080/00958964.1978.10801875; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Friese M, 2008, BRIT J SOC PSYCHOL, V47, P397, DOI 10.1348/014466607X241540; Friese M, 2008, EUR REV SOC PSYCHOL, V19, P285, DOI 10.1080/10463280802556958; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Howell AJ, 2011, PERS INDIV DIFFER, V51, P166, DOI 10.1016/j.paid.2011.03.037; Kaiser FG, 2007, J ENVIRON PSYCHOL, V27, P242, DOI 10.1016/j.jenvp.2007.06.004; Karpinski A, 2001, J PERS SOC PSYCHOL, V81, P774, DOI 10.1037/0022-3514.81.5.774; Kidner D, 2001, IATURE PSYCHE RADICA; Korpela KM, 2008, HEALTH PLACE, V14, P636, DOI 10.1016/j.healthplace.2007.10.008; Leopold Aldo, 1949, S COUNTY ALMANAC; Marsh KL, 2001, Z EXP PSYCHOL, V48, P161; Mayer FS, 2009, ENVIRON BEHAV, V41, P607, DOI 10.1177/0013916508319745; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; Milfont TL, 2010, J ENVIRON PSYCHOL, V30, P80, DOI 10.1016/j.jenvp.2009.09.001; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Ohtomo S, 2014, RESOUR CONSERV RECY, V84, P57, DOI 10.1016/j.resconrec.2013.12.014; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; Perrin JL, 2009, J ENVIRON PSYCHOL, V29, P434, DOI 10.1016/j.jenvp.2009.03.003; Perugini M, 2011, HDB IMPLICIT SOCIAL, P255; Ponting C., 1991, GREEN HIST WORLD ENV; Schultz P.W., 2002, PSYCHOL SUSTAINABLE, P61, DOI DOI 10.1007/978-1-4615-0995-0_4; Schultz PW, 2007, J APPL SOC PSYCHOL, V37, P1219, DOI 10.1111/j.1559-1816.2007.00210.x; Schultz PW, 2004, J ENVIRON PSYCHOL, V24, P31, DOI 10.1016/S0272-4944(03)00022-7; Schultz PW, 2001, J ENVIRON PSYCHOL, V21, P327; Schultz PW, 2000, J SOC ISSUES, V56, P391, DOI 10.1111/0022-4537.00174; Shen LJ, 2008, THESIS SHANXI U; Sherman JW, 2008, PSYCHOL REV, V115, P314, DOI 10.1037/0033-295X.115.2.314; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; Tam KP, 2013, J ENVIRON PSYCHOL, V34, P64, DOI 10.1016/j.jenvp.2013.01.004	45	81	84	9	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127247	10.1371/journal.pone.0127247	http://dx.doi.org/10.1371/journal.pone.0127247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BG	25985075	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300106
J	Hosseini, I; Gama, L; Mac Gabhann, F				Hosseini, Iraj; Gama, Lucio; Mac Gabhann, Feilim			Multiplexed Component Analysis to Identify Genes Contributing to the Immune Response during Acute SIV Infection	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; METABOLOMICS DATA; VIRAL LOAD; EXPRESSION; CLASSIFICATION; CHEMOMETRICS; REPLICATION; REGRESSION; INDUCTION; MODEL	Immune response genes play an important role during acute HIV and SIV infection. Using an SIV macaque model of AIDS and CNS disease, our overall goal was to assess how the expression of genes associated with immune and inflammatory responses are longitudinally changed in different organs or cells during SIV infection. To compare RNA expression of a panel of 88 immune-related genes across time points and among three tissues - spleen, mesenteric lymph nodes (MLN) and peripheral blood mononuclear cells (PBMC) - we designed a set of Nanostring probes. To identify significant genes during acute SIV infection and to investigate whether these genes are tissue-specific or have global roles, we introduce a novel multiplexed component analysis (MCA) method. This combines multivariate analysis methods with multiple preprocessing methods to create a set of 12 "judges"; each judge emphasizes particular types of change in gene expression to which cells could respond, for example, the absolute or relative size of expression change from baseline. Compared to bivariate analysis methods, our MCA method improved classification rates. This analysis allows us to identify three categories of genes: (a) consensus genes likely to contribute highly to the immune response; (b) genes that would contribute highly to the immune response only if certain assumptions are met - e.g. that the cell responds to relative expression change rather than absolute expression change; and (c) genes whose contribution to immune response appears to be modest. We then compared the results across the three tissues of interest; some genes are consistently highly-contributing in all tissues, while others are specific for certain tissues. Our analysis identified CCL8, CXCL10, CXCL11, MxA, OAS2, and OAS1 as top contributing genes, all of which are stimulated by type I interferon. This suggests that the cytokine storm during acute SIV infection is a systemic innate immune response against viral replication. Furthermore, these genes have approximately equal contributions to all tissues, making them possible candidates to be used as non-invasive biomarkers in studying PBMCs instead of MLN and spleen during acute SIV infection experiments. We identified clusters of genes that co-vary together and studied their correlation with regard to other gene clusters. We also developed novel methods to faithfully visualize multi-gene correlations on two-dimensional polar plots, and to visualize tissue specificity of gene expression responses.	[Hosseini, Iraj; Mac Gabhann, Feilim] Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21287 USA; [Gama, Lucio] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Hosseini, I (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21287 USA.	ihossei1@jhu.edu; lucio@jhmi.edu		Gama, Lucio/0000-0001-9511-012X	Ruth H. Aranow fellowship; Siebel Scholarship; Willowcroft Foundation grant; NIH [P01 MH070306, U19 AI096113]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [P40 RR019995]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR019995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD013117] Funding Source: NIH RePORTER	Ruth H. Aranow fellowship; Siebel Scholarship; Willowcroft Foundation grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Ruth H. Aranow fellowship (IH), Siebel Scholarship (IH), Willowcroft Foundation grant (FMG), NIH (www.nih.gov) grants P01 MH070306 and U19 AI096113 (LG), National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Grant number P40 RR019995 (LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Brereton RG, 1990, CHEMOMETRICS APPLICA; Bro R, 2003, J CHEMOMETR, V17, P16, DOI 10.1002/cem.773; Clements JE, 2011, CURR OPIN HIV AIDS, V6, P37, DOI 10.1097/COH.0b013e3283412413; Crawford MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001199; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; den Haan JMM, 2012, J INNATE IMMUN, V4, P437, DOI 10.1159/000335216; Einax JW, 1997, CHEMOMETRICS IN ENVI; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; HARTEMINK AJ, 2001, P SOC PHOTO-OPT INS, V2, P132; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Hoefsloot HCJ, 2006, J CHEMOMETR, V20, P120, DOI 10.1002/cem.996; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; HORI G, 2001, GEN INFORM, V12, P255; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Jackson J.E, 2005, USERS GUIDE PRINCIPA, V587; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Keun HC, 2003, ANAL CHIM ACTA, V490, P265, DOI 10.1016/S0003-2670(03)00094-1; Krzanowski W., 1988, PRINCIPLES OF MULTIV; KVALHEIM OM, 1994, ANAL CHEM, V66, P43, DOI 10.1021/ac00073a010; Lackner AA, 2007, ANNU REV MED, V58, P461, DOI 10.1146/annurev.med.58.082405.094316; Maritz J. S., 1995, DISTRIBUTION FREE ST, V2nd; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Moreda-Pineiro A, 2001, J ENVIRON MONITOR, V3, P352, DOI 10.1039/b103658k; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Myers JL, 2010, RES DESIGN STAT ANAL; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; Rivet CA, 2011, MOLECULAR CELLULAR P, V10; Saccenti E, 2013, METABOLOMICS, P1; Seber G.A.F., 2004, MULTIVARIATE OBSERVA; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Timmerman H., 2008, CHEMOMETRIC METHODS; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Wise BM, 1996, J PROCESS CONTR, V6, P329, DOI 10.1016/0959-1524(96)00009-1; Witwer KW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008129; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999	45	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126843	10.1371/journal.pone.0126843	http://dx.doi.org/10.1371/journal.pone.0126843			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984721	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300056
J	Moosmann, J; Uebe, S; Dittrich, S; Ruffer, A; Ekici, AB; Toka, O				Moosmann, Julia; Uebe, Steffen; Dittrich, Sven; Rueffer, Andre; Ekici, Arif B.; Toka, Okan			Novel Loci for Non-Syndromic Coarctation of the Aorta in Sporadic and Familial Cases	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; CONGENITAL HEART-DISEASE; COPY-NUMBER VARIANTS; RING CHROMOSOME-X; KABUKI-SYNDROME; TURNER-SYNDROME; LINKAGE ANALYSIS; CARDIOVASCULAR MALFORMATIONS; 8P22-8P23.1 DUPLICATION; 3 GENERATIONS	Backround Coarctation of the aorta (CoA) accounts for 5-8% of all congenital heart defects. CoA can be detected in up to 20% of patients with Ullrich-Turner syndrome (UTS), in which a part or all of one of the X chromosomes is absent. The etiology of non-syndromic CoA is poorly understood. In the present work, we test the hypothesis that rare copy number variation (CNV) especially on the gonosomes, contribute to the etiology of non-syndromic CoA. Methods We performed high-resolution genome-wide CNV analysis using the Affymetrix SNP 6.0 microarray platform for 70 individuals with sporadic CoA, 3 families with inherited CoA (n=13) and 605 controls. Our analysis comprised genome wide association, CNV burden and linkage. CNV was validated by multiplex ligation-dependent probe amplification. Results We identified a significant abundance of large (>100 kb) CNVs on the X chromosome in males with CoA (p=0.005). 11 out of 51 (similar to 22%) male cases had these large CNVs. Association analysis in the sporadic cohort revealed 14 novel loci for CoA. The locus on 21q22.3 in the sporadic CoA cohort overlapped with a gene locus identified in all familial cases of CoA (candidate gene TRPM2). We identified one CNV locus within a locus with high multipoint LOD score from a linkage analysis of the familial cases (SEPT9); another locus overlapped with a region implicated in Kabuki syndrome. In the familial cases, we identified a total of 7 CNV loci that were exclusively present in cases but not in unaffected family members. Conclusion Of all candidate loci identified, the TRPM2 locus was the most frequently implicated autosomal locus in sporadic and familial cases. However, the abundance of large CNVs on the X chromosome of affected males suggests that gonosomal aberrations are not only responsible for syndromic CoA but also involved in the development of sporadic and non-syndromic CoA and their male dominance.	[Moosmann, Julia; Dittrich, Sven; Toka, Okan] Univ Erlangen Nurnberg, Dept Pediat Cardiol, D-91054 Erlangen, Germany; [Uebe, Steffen; Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Rueffer, Andre] Univ Erlangen Nurnberg, Dept Pediat Cardiac Surg, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Toka, O (corresponding author), Univ Erlangen Nurnberg, Dept Pediat Cardiol, Loschgestr 15, D-91054 Erlangen, Germany.	okan.toka@uk-erlangen.de	Dittrich, Sven/T-2753-2019; Ekici, Arif B/C-3971-2013	Dittrich, Sven/0000-0002-8455-3416; Ekici, Arif B/0000-0001-6099-7066; Moosmann, Julia/0000-0002-8843-7084	Competence Network for Congenital Heart Defects - Federal Ministry of Education and Research (BMBF) [FKZ 01GI0601]	Competence Network for Congenital Heart Defects - Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Competence Network for Congenital Heart Defects funded by the Federal Ministry of Education and Research (BMBF), FKZ 01GI0601. The support was non-financial and included the allocation of human tissue samples only.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Alesi V, 2012, GENE, V505, P384, DOI 10.1016/j.gene.2012.05.031; Barriot R, 2010, GENOME MED, V2, DOI 10.1186/gm137; Boucher CA, 2001, J MED GENET, V38, P591, DOI 10.1136/jmg.38.9.591; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Digilio MC, 2001, AM J MED GENET, V100, P269, DOI 10.1002/ajmg.1265; Du XN, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-62; GERBONI S, 1993, J MED GENET, V30, P328, DOI 10.1136/jmg.30.4.328; GOTZSCHE CO, 1994, ARCH DIS CHILD, V71, P433, DOI 10.1136/adc.71.5.433; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Hecquet CM, 2014, CIRC RES, V114, P469, DOI 10.1161/CIRCRESAHA.114.302414; Hitz MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002903; Hoffman JD, 2005, J MED GENET, V42, P49, DOI 10.1136/jmg.2004.024372; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Kimberley KW, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-46; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lacka Katarzyna, 2005, Endokrynol Pol, V56, P986; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lindstrand A, 2014, AM J HUM GENET, V94, P745, DOI 10.1016/j.ajhg.2014.03.017; Liu XF, 2014, INTEGR BIOL-UK, V6, P511, DOI 10.1039/c3ib40265g; Lugtenberg D, 2010, AM J MED GENET A, V152A, P638, DOI 10.1002/ajmg.a.33292; Marino B, 2000, CARDIOVASC PATHOL, V9, P303, DOI 10.1016/S1054-8807(00)00050-8; McGinniss MJ, 1997, AM J MED GENET, V70, P37, DOI 10.1002/(SICI)1096-8628(19970502)70:1<37::AID-AJMG8>3.3.CO;2-F; Miller BA, 2014, J BIOL CHEM, V289, P7615, DOI 10.1074/jbc.M113.533851; Milunsky JM, 2003, CLIN GENET, V64, P509, DOI 10.1046/j.1399-0004.2003.00189.x; Miyake T, 2014, BIOCHEM BIOPH RES CO, V444, P212, DOI 10.1016/j.bbrc.2014.01.022; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OGATA T, 1993, HUM GENET, V91, P551; Ogata T, 2001, J CLIN ENDOCR METAB, V86, P5498, DOI 10.1210/jc.86.11.5498; Ranke MB, 2001, LANCET, V358, P309, DOI 10.1016/S0140-6736(01)05487-3; Sanlaville D, 2005, EUR J HUM GENET, V13, P690, DOI 10.1038/sj.ejhg.5201383; Shieh JTC, 2006, AM J MED GENET A, V140A, P170, DOI 10.1002/ajmg.a.31036; Silversides CK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002843; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Stankiewicz P, 2001, AM J MED GENET, V102, P286, DOI 10.1002/ajmg.1462; Stoll C, 1999, ANN GENET-PARIS, V42, P174; Sybert VP, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e11; Tagariello A, 2012, CURR MOL MED, V12, P199, DOI 10.2174/156652412798889027; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Turner C, 2005, EUR J HUM GENET, V13, P716, DOI 10.1038/sj.ejhg.5201377; Tzancheva M, 1999, J MED GENET, V36, P549; Veerappa AM, 2013, AM J MED GENET B, V162, P889, DOI 10.1002/ajmg.b.32199; Volkl TMK, 2005, CLIN CARDIOL, V28, P88, DOI 10.1002/clc.4960280209; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; Wellesley D G, 1994, Clin Dysmorphol, V3, P297; Xie L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096471; Yoshida K, 1999, GENOMICS, V62, P540, DOI 10.1006/geno.1999.6042; Younkin SG, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-24; Zahnleiter D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003365	55	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126873	10.1371/journal.pone.0126873	http://dx.doi.org/10.1371/journal.pone.0126873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984793	Green Submitted, Green Published, gold			2022-12-27	WOS:000354917300058
J	Rouxel, P; Tsakos, G; Demakakos, P; Zaninotto, P; Chandola, T; Watt, RG				Rouxel, Patrick; Tsakos, Georgios; Demakakos, Panayotes; Zaninotto, Paola; Chandola, Tarani; Watt, Richard Geddie			Is Social Capital a Determinant of Oral Health among Older Adults? Findings from the English Longitudinal Study of Ageing	PLOS ONE			English	Article							SELF-RATED HEALTH; MULTIPLE IMPUTATION; DENTAL STATUS; LATER LIFE; PARTICIPATION; PROGRAM; SUPPORT; WELL	There are a number of studies linking social capital to oral health among older adults, although the evidence base mainly relies on cross-sectional study designs. The possibility of reverse causality is seldom discussed, even though oral health problems could potentially lead to lower social participation. Furthermore, few studies clearly distinguish between the effects of different dimensions of social capital on oral health. The objective of the study was to examine the longitudinal associations between individual social capital and oral health among older adults. We analyzed longitudinal data from the 3(rd) and 5(th) waves of the English Longitudinal Study of Ageing (ELSA). Structural social capital was operationalized using measures of social participation, and volunteering. Number of close ties and perceived emotional support comprised the functional dimension of social capital. Oral health measures were having no natural teeth (edentate vs. dentate), self-rated oral health and oral health-related quality of life. Time-lag and autoregressive models were used to explore the longitudinal associations between social capital and oral health. We imputed all missing data, using multivariate imputation by chained equations. We found evidence of bi-directional longitudinal associations between self-rated oral health, volunteering and functional social capital. Functional social capital was a strong predictor of change in oral health-related quality of life - the adjusted odds ratio of reporting poor oral health-related quality of life was 1.75 (1.33-2.30) for older adults with low vs. high social support. However in the reverse direction, poor oral health-related quality of life was not associated with changes in social capital. This suggests that oral health may not be a determinant of social capital. In conclusion, social capital may be a determinant of subjective oral health among older adults rather than edentulousness, despite many cross-sectional studies on the latter.	[Rouxel, Patrick; Tsakos, Georgios; Demakakos, Panayotes; Zaninotto, Paola; Watt, Richard Geddie] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Chandola, Tarani] Univ Manchester, Sch Social Sci, CMIST, Manchester, Lancs, England	University of London; University College London; University of Manchester	Rouxel, P (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London, England.	patrick.rouxel.09@ucl.ac.uk	Rouxel, Patrick/AGH-0663-2022; Chandola, Tarani/I-3192-2013	Rouxel, Patrick/0000-0003-0330-554X; Chandola, Tarani/0000-0002-1864-3413; Tsakos, Georgios/0000-0002-5086-235X; Demakakos, Panayotes/0000-0002-7663-2122; Watt, Richard/0000-0001-6229-8584	NIA NIH HHS [R01 AG017644] Funding Source: Medline; ESRC [ES/J019119/1] Funding Source: UKRI; Economic and Social Research Council [ES/J019119/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aida J, 2011, COMMUNITY DENT ORAL, V39, P239, DOI 10.1111/j.1600-0528.2010.00590.x; Aida J, 2011, SOC SCI MED, V73, P1561, DOI 10.1016/j.socscimed.2011.09.005; Aida J, 2009, SOC SCI MED, V69, P512, DOI 10.1016/j.socscimed.2009.06.003; Banks J, 2011, LONGITUD LIFE COURSE, V2, P101, DOI 10.14301/llcs.v2i2.115; Benyamini Y, 2004, SOC SCI MED, V59, P1109, DOI 10.1016/j.socscimed.2003.12.021; Borgonovi F, 2008, SOC SCI MED, V66, P2321, DOI 10.1016/j.socscimed.2008.01.011; Casiday R, 2008, VOLUNTEERING HLTH WH; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Demakakos P, 2008, SOC SCI MED, V67, P330, DOI 10.1016/j.socscimed.2008.03.038; Eisele M, 2012, BMC GERIATR, V12, P26, DOI [10.1186/1471-2318-12-26, DOI 10.1186/1471-2318-12-26]; Fujiwara Y, 2009, J INTERGENER RELATSH, V7, P17, DOI 10.1080/15350770802628901; Gilbert GH, 1998, MED CARE, V36, P988, DOI 10.1097/00005650-199807000-00006; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Harper R, 2003, MEASURING SOCIAL CAP; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Ichida Y, 2013, SOC SCI MED, V94, P83, DOI 10.1016/j.socscimed.2013.05.006; Jenkinson CE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-773; Li YQ, 2006, SOC FORCES, V85, P497, DOI 10.1353/sof.2006.0132; Lindstrom, 2006, INT J EQUITY HEALTH, V5, P1, DOI DOI 10.1186/1475-9276-5-3; Locker D, 2005, J PUBLIC HEALTH DENT, V65, P146; McMunn A, 2009, AGEING SOC, V29, P765, DOI 10.1017/S0144686X08008350; Merchant AT, 2003, J AM DENT ASSOC, V134, P1591, DOI 10.14219/jada.archive.2003.0104; Murayama H, 2013, GLOBAL PERSPECTIVES, P205; Nyqvist F, 2013, SOCIAL INDICATORS RE, V116, P545; Oksanen T, 2009, ANN U TURKUENSIS D; Petersen PE, 2005, COMMUNITY DENT ORAL, V33, P81, DOI 10.1111/j.1600-0528.2004.00219.x; PETERSEN PE, 1994, J PUBLIC HEALTH DENT, V54, P73, DOI 10.1111/j.1752-7325.1994.tb01185.x; Rodrigues SM, 2012, INT J ENV RES PUB HE, V9, P100, DOI 10.3390/ijerph9010100; Rouxel PL, 2014, COMMUNITY DENT ORAL; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Sabbah W, 2011, J CLIN PERIODONTOL, V38, P547, DOI 10.1111/j.1600-051X.2011.01713.x; Singh Archana, 2009, Ind Psychiatry J, V18, P51, DOI 10.4103/0972-6748.57861; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Steffick D. E., 2000, DR005 HRSAHEAD; Takeuchi K, 2013, PLOS ONE, V8, P1; Tsakos G, 2001, Gerodontology, V18, P121, DOI 10.1111/j.1741-2358.2001.00121.x; Tsakos G, 2013, PSYCHOSOM MED, V75, P178, DOI 10.1097/PSY.0b013e31827d221b; Tsakos G, 2011, AM J PUBLIC HEALTH, V101, P1892, DOI 10.2105/AJPH.2011.300215; Twisk JWR, 2003, APPL LONGITUDINAL DA; Uphoff N, 2000, SOCIAL CAPITAL, P215; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wu B, 2011, J AGING HEALTH, V23, P267, DOI 10.1177/0898264310382135	42	22	22	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125557	10.1371/journal.pone.0125557	http://dx.doi.org/10.1371/journal.pone.0125557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BG	25992569	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300021
J	Sun, WY; Sun, J; Zou, LL; Shen, KN; Zhong, DR; Zhou, DB; Sun, W; Li, J				Sun, Weiyi; Sun, Jian; Zou, Lili; Shen, Kaini; Zhong, Dingrong; Zhou, Daobin; Sun, Wei; Li, Jian			The Successful Diagnosis and Typing of Systemic Amyloidosis Using A Microwave-Assisted Filter-Aided Fast Sample Preparation Method and LC/MS/MS Analysis	PLOS ONE			English	Article							SPECTROMETRY-BASED PROTEOMICS; MASS-SPECTROMETRY; MEMBRANE PROTEOME; CONGO RED; MICRODISSECTION; DIGESTION; ABUNDANCE; TISSUES; EMPAI	Laser microdissection followed by mass spectrometry has been successfully used for amyloid typing. However, sample contamination can interfere with proteomic analysis, and overnight digestion limits the analytical throughput. Moreover, current quantitative analysis methods are based on the spectrum count, which ignores differences in protein length and may lead to misdiagnoses. Here, we developed a microwave-assisted filter-aided sample preparation (maFASP) method that can efficiently remove contaminants with a 10-kDa cutoff ultrafiltration unit and can accelerate the digestion process with the assistance of a microwave. Additionally, two parameters (P-and D-scores) based on the exponentially modified protein abundance index were developed to define the existence of amyloid deposits and those causative proteins with the greatest abundance. Using our protocol, twenty cases of systemic amyloidosis that were well-typed according to clinical diagnostic standards (training group) and another twenty-four cases without subtype diagnoses (validation group) were analyzed. Using this approach, sample preparation could be completed within four hours. We successfully subtyped 100% of the cases in the training group, and the diagnostic success rate in the validation group was 91.7%. This maFASP-aided proteomic protocol represents an efficient approach for amyloid diagnosis and subtyping, particularly for serum-contaminated samples.	[Sun, Weiyi; Zou, Lili; Sun, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Core Facility Instrument, Beijing 100730, Peoples R China; [Sun, Weiyi; Shen, Kaini; Zhou, Daobin; Li, Jian] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Hematol, Beijing, Peoples R China; [Sun, Weiyi; Sun, Jian; Shen, Kaini; Zhong, Dingrong; Zhou, Daobin; Li, Jian] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Sun, Jian; Zhong, Dingrong] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Pathol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Sun, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Core Facility Instrument, Beijing 100730, Peoples R China.	sunwei1018@hotmail.com; lijian@pumch.cn		Li, Jian/0000-0002-4549-0694; Sun, Jian/0000-0003-4997-2604	National Nature Science Foundation of China [81370672]; Beijing Municipal Science & Technology Commission [Z131107002213050]; Peking Union Medical College New Star; National Public Health Grand Research Foundation [201202017]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Peking Union Medical College New Star; National Public Health Grand Research Foundation	This work was funded by the National Nature Science Foundation of China (81370672, for Jian Li), Beijing Municipal Science & Technology Commission (Z131107002213050, for Jian Li), Peking Union Medical College New Star (2011, for Jian Li), and the National Public Health Grand Research Foundation (201202017, for Jian Li).	Brambilla F, 2012, BLOOD, V119, P1844, DOI 10.1182/blood-2011-07-365510; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Giorgadze TA, 2004, DIAGN CYTOPATHOL, V31, P300, DOI 10.1002/dc.20131; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jenner E, 2014, CLIN CHIM ACTA, V427, P15, DOI 10.1016/j.cca.2013.08.018; Kebbel A, 2006, AM J SURG PATHOL, V30, P673, DOI 10.1097/00000478-200606000-00002; Klein CJ, 2011, ARCH NEUROL-CHICAGO, V68, P195, DOI 10.1001/archneurol.2010.261; Lavatelli F, 2011, AMYLOID, V18, P177, DOI 10.3109/13506129.2011.630762; Magy BN, 2008, CLIN EXP RHEUMATOL, V26, P1074; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Nishimura T, 2010, J PROTEOMICS, V73, P1100, DOI 10.1016/j.jprot.2009.11.010; Picken MM, 2007, CURR OPIN NEPHROL HY, V16, P196, DOI 10.1097/MNH.0b013e3280bdc0db; Picken MM, 2013, KIDNEY INT, V83, P353, DOI 10.1038/ki.2012.433; Pramanik BN, 2002, PROTEIN SCI, V11, P2676, DOI 10.1110/ps.0213702; Rodriguez FJ, 2008, LAB INVEST, V88, P1024, DOI 10.1038/labinvest.2008.72; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Sethi S, 2012, KIDNEY INT, V82, P226, DOI 10.1038/ki.2012.108; Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Sprung RW, 2012, J PROTEOME RES, V11, P3498, DOI 10.1021/pr300130t; Sun W, 2006, MOL CELL PROTEOMICS, V5, P769, DOI 10.1074/mcp.T500022-MCP200; Vrana JA, 2014, HAEMATOLOGICA, V99, P1239, DOI 10.3324/haematol.2013.102764; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Winiewski JR., 2013, J VIS EXP; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu C, 2012, BIOPHYS J, V103, P550, DOI 10.1016/j.bpj.2012.07.008; Yu YB, 2012, ANAL CHEM, V84, P9008, DOI 10.1021/ac300134e	28	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127180	10.1371/journal.pone.0127180	http://dx.doi.org/10.1371/journal.pone.0127180			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984759	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300099
J	Yang, YS; Zhao, QY; Cai, ZJ; Cheng, GP; Chen, M; Wang, JL; Zhong, HJ				Yang, Yunshan; Zhao, Qiyu; Cai, Zhijian; Cheng, Guoping; Chen, Ming; Wang, Jiaoli; Zhong, Haijun			Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin	PLOS ONE			English	Article							CELLS; EXPRESSION; CD95; APOPTOSIS; ROLES; ACTIVATION; MECHANISM; STAT3; PROLIFERATION; INVASIVENESS	Background Fas signaling-activated signal transducers and activators of transcription 3 (STAT3) is required for Fascin upregulation. As an actin-bundling protein, Fascin can mediate gastric cancer (GC) cell migration. Methods Gastric cancer AGS cells were treated with anti-Fas (5 mu g/ml) for 2 h, in order to stimulate the activation of the Fas signaling. The in vitro migration of Fas signaling-activated AGS cells was assessed using Transwell chambers. The levels of Fascin and phosphorylated STAT3 were detected by Western blotting analyses. Nude mice were injected intravenously with AGS cells treated with anti-Fas or treated with STAT3 inhibitor without anti-Fas; tumor pulmonary metastases were measured. Fascin protein expression in tumor tissues was detected by immunohistochemistry. The Fas and Fascin mRNA levels in tumor tissues from patients with GC were measured by real-time PCR and their correlation was analyzed. Results The activation of Fas signaling promoted cell migration and resulted in STAT3-dependent Fascin upregulation in AGS cells. STAT3 enhanced Fascin levels in vivo. Fascin was the mediator of Fas signaling-induced AGS cell migration in vitro and in vivo. Furthermore, there was a positive correlation between Fas and Fascin mRNA levels in tumor tissues from GC patients. Conclusions Fas signaling promotes GC metastasis through the STAT3/Fascin pathway, which may provide a new target for GC therapy.	[Yang, Yunshan; Cheng, Guoping; Zhong, Haijun] Zhejiang Canc Hosp, Dept Chemotherapy, Hangzhou 310022, Zhejiang, Peoples R China; [Zhao, Qiyu] Zhejiang Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Hepatobiliary & Pancreat Intervent Ctr,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Cai, Zhijian] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Ming] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Otolaryngol, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Jiaoli] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Med Oncol, Affiliated Hangzhou Hosp, Hangzhou 310006, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang University; Zhejiang University; Zhejiang University; Nanjing Medical University	Wang, JL (corresponding author), Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Med Oncol, Affiliated Hangzhou Hosp, Hangzhou 310006, Zhejiang, Peoples R China.	wangjl230@sina.com; zhonghaijun1712@sohu.com			National Natural Science Foundation of China [81200014]; Natural Science Foundation of Zhejiang Province [LY14H160011, LY12C08002, LY12H13003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China No. 81200014 to JLW (http://www.nsfc.gov.cn/); the Natural Science Foundation of Zhejiang Province No. LY14H160011 to YSY; No. LY12C08002 to ZJC and No. LY12H13003 to MC (http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Cai ZJ, 2012, J IMMUNOL, V188, P5954, DOI 10.4049/jimmunol.1103466; Cai ZJ, 2012, CELL RES, V22, P607, DOI 10.1038/cr.2011.196; Chen HJ, 2014, EUR J MED CHEM, V82, P195, DOI 10.1016/j.ejmech.2014.05.049; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Choi C, 2002, J NEURO-ONCOL, V56, P13, DOI 10.1023/A:1014467626314; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Deng XW, 2014, BIOMATERIALS, V35, P4333, DOI 10.1016/j.biomaterials.2014.02.006; Groner B, 2000, BREAST CANCER RES, V2, P149, DOI 10.1186/bcr47; Gryko M, 2014, ADV MED SCI-POLAND, V59, P47, DOI 10.1016/j.advms.2013.07.005; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee JK, 2003, APOPTOSIS, V8, P151, DOI 10.1023/A:1022918625509; Li HC, 2008, AM J PHYSIOL-GASTR L, V294, pG263, DOI 10.1152/ajpgi.00267.2007; Li HC, 2009, GASTROENTEROLOGY, V137, P934, DOI 10.1053/j.gastro.2009.06.004; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Mejias-Luque R, 2008, BBA-MOL CELL RES, V1783, P1728, DOI 10.1016/j.bbamcr.2008.05.020; Okamoto W, 2011, BRIT J CANCER, V105, P407, DOI 10.1038/bjc.2011.246; OWENSCHAUB LB, 1993, J IMMUNOTHER, V14, P234, DOI 10.1097/00002371-199310000-00011; OWENSCHAUB LB, 1994, CANCER RES, V54, P1580; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Shinohara H, 2000, CANCER RES, V60, P1766; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Snyder M, 2011, J BIOL CHEM, V286, P38886, DOI 10.1074/jbc.M111.286245; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Su CC, 2013, CELL IMMUNOL, V281, P101, DOI 10.1016/j.cellimm.2013.03.002; Sun WJ, 2001, DRUGS, V61, P1545, DOI 10.2165/00003495-200161110-00002; Symes JC, 2008, MOL CANCER THER, V7, P3018, DOI 10.1158/1535-7163.MCT-08-0335; Trauzold A, 2005, FASEB J, V19, P620, DOI 10.1096/fj.04-2984fje; Woo S, 2011, PATHOBIOLOGY, V78, P295, DOI 10.1159/000321696; Xiao C, 2005, EXP CELL RES, V304, P244, DOI 10.1016/j.yexcr.2004.11.002; Yao J, 2014, ONCOL LETT, V7, P902, DOI 10.3892/ol.2014.1804; Zhang J, 2004, IUBMB LIFE, V56, P395, DOI 10.1080/15216540400008929	37	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125132	10.1371/journal.pone.0125132	http://dx.doi.org/10.1371/journal.pone.0125132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992623	Green Submitted, gold, Green Published			2022-12-27	WOS:000354917300014
J	Hagstrom, AEV; Garvey, G; Paterson, AS; Dhamane, S; Adhikari, M; Estes, MK; Strych, U; Kourentzi, K; Atmar, RL; Willson, RC				Hagstroem, Anna E. V.; Garvey, Gavin; Paterson, Andrew S.; Dhamane, Sagar; Adhikari, Meena; Estes, Mary K.; Strych, Ulrich; Kourentzi, Katerina; Atmar, Robert L.; Willson, Richard C.			Sensitive Detection of Norovirus Using Phage Nanoparticle Reporters in Lateral-Flow Assay	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; RAPID DETECTION; IMMUNOCHROMATOGRAPHIC ASSAY; NORWALK VIRUS; GOLD; INFECTION; GASTROENTERITIS; EPIDEMIOLOGY; IMMUNOASSAY; BIOSENSOR	Noroviruses are recognized worldwide as the principal cause of acute, non-bacterial gastroenteritis, resulting in 19-21 million cases of disease every year in the United States. Noroviruses have a very low infectious dose, a short incubation period, high resistance to traditional disinfection techniques and multiple modes of transmission, making early, point-of-care detection essential for controlling the spread of the disease. The traditional diagnostic tools, electron microscopy, RT-PCR and ELISA require sophisticated and expensive instrumentation, and are considered too laborious and slow to be useful during severe outbreaks. In this paper we describe the development of a new, rapid and sensitive lateral-flow assay using labeled phage particles for the detection of the prototypical norovirus GI. 1 (Norwalk), with a limit of detection of 107 virus-like particles per mL, one hundredfold lower than a conventional gold nanoparticle lateral-flow assay using the same antibody pair.	[Hagstroem, Anna E. V.; Garvey, Gavin; Paterson, Andrew S.; Kourentzi, Katerina; Willson, Richard C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77004 USA; [Dhamane, Sagar; Adhikari, Meena; Strych, Ulrich; Willson, Richard C.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Estes, Mary K.; Atmar, Robert L.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Estes, Mary K.; Atmar, Robert L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Willson, Richard C.] Houston Methodist Res Inst, Houston, TX USA; [Willson, Richard C.] Ctr Biotecnol FEMSA, Tecnol Monterrey, Dept Biotecnol & Ingn Alimentos, Monterrey, Nuevo Leon, Mexico	University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Tecnologico de Monterrey	Willson, RC (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77004 USA.	willson@uh.edu	Willson, richard/AAD-4832-2019; Hagstrom, Anna/G-2928-2012; Paterson, Andrew/N-2702-2016; Atmar, Robert/AFQ-5392-2022	Hagstrom, Anna/0000-0001-9001-565X; Paterson, Andrew/0000-0001-7627-2393; Atmar, Robert/0000-0001-9989-6772; Strych, Ulrich/0000-0001-9455-7683	Cancer Prevention & Research Institute of Texas [RP110360]; National Institute of Allergy and Infectious Diseases; National Institutes of Health [AI057156]; RCE Programs Office, NIAID; NIH; National Science Foundation [0840889]; Olle Engkvist Byggmastare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, P01AI057788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	Cancer Prevention & Research Institute of Texas; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RCE Programs Office, NIAID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Olle Engkvist Byggmastare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded in part by grants to RCW from the Cancer Prevention & Research Institute of Texas, www.cprit.state.tx.us, (Grant RP110360), and National Institute of Allergy and Infectious Diseases, National Institutes of Health, http://www.niaid.nih.gov/, (Grant U54 AI057156). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the RCE Programs Office, NIAID, or NIH. G.G. was supported by the National Science Foundation, www.nsf.gov, (Grant Number 0840889). AEVH's postdoctoral studies were funded by the Olle Engkvist Byggmastare Foundation, www.engkviststiftelserna.se, and the Carl Trygger Foundation, www.carltryggersstiftelse.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari M, 2013, ANALYST, V138, P5584, DOI 10.1039/c3an00891f; Ambert-Balay K, 2013, J CLIN VIROL, V56, P194, DOI 10.1016/j.jcv.2012.11.001; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Bally M, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-4; Battaglioli G, 2012, J CLIN VIROL, V53, P262, DOI 10.1016/j.jcv.2011.12.007; Brooks BD, 2008, ANAL BIOCHEM, V382, P60, DOI 10.1016/j.ab.2008.07.009; Cho IH, 2013, ANAL BIOANAL CHEM, V405, P3313, DOI 10.1007/s00216-013-6742-3; Connelly JT, 2012, ANAL BIOANAL CHEM, V402, P315, DOI 10.1007/s00216-011-5381-9; Geginat G, 2012, EUR J CLIN MICROBIOL, V31, P733, DOI 10.1007/s10096-011-1366-z; Gilpatrick SG, 2000, J VIROL METHODS, V90, P69, DOI 10.1016/S0166-0934(00)00220-2; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hale AD, 1999, CLIN DIAGN LAB IMMUN, V6, P142, DOI 10.1128/CDLI.6.1.142-145.1999; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hardy ME, 1996, VIROLOGY, V217, P252, DOI 10.1006/viro.1996.0112; He YQ, 2011, BIOSENS BIOELECTRON, V26, P2018, DOI 10.1016/j.bios.2010.08.079; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Kim HS, 2012, J VIROL METHODS, V186, P94, DOI 10.1016/j.jviromet.2012.08.014; Kitamoto N, 2002, J CLIN MICROBIOL, V40, P2459, DOI 10.1128/JCM.40.7.2459-2465.2002; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Lee HM, 2013, J FOOD PROTECT, V76, P707, DOI 10.4315/0362-028X.JFP-12-343; Leon JS, 2011, APPL ENVIRON MICROB, V77, P5476, DOI 10.1128/AEM.02801-10; Leonardi GP, 2013, J VIROL METHODS, V189, P379, DOI 10.1016/j.jviromet.2013.02.008; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Mao X, 2009, ANAL CHEM, V81, P1660, DOI 10.1021/ac8024653; Mashayekhi F, 2010, ANAL BIOANAL CHEM, V398, P2955, DOI 10.1007/s00216-010-4213-7; Nash MA, 2012, ACS NANO, V6, P6776, DOI 10.1021/nn3015008; Okitsu-Negishi S, 2006, J CLIN MICROBIOL, V44, P3784, DOI 10.1128/JCM.01373-06; Park KS, 2012, ANN LAB MED, V32, P79, DOI 10.3343/alm.2012.32.1.79; Parolo C, 2013, BIOSENS BIOELECTRON, V40, P412, DOI 10.1016/j.bios.2012.06.049; Rasband W., 2006, IMAGEJ; Rhinehart E, 2012, AM J INFECT CONTROL, V40, P2, DOI 10.1016/j.ajic.2011.10.003; Riddle MS, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-9; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Sambrook J, 2001, WORKING BACTERIOPHAG, P31; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Wong RC, 2009, LATERAL FLOW IMMUNOASSAY, P1, DOI 10.1007/978-1-59745-240-3; Xie QY, 2014, BIOSENS BIOELECTRON, V54, P262, DOI 10.1016/j.bios.2013.11.002; Zhao P, 2014, NANOSCALE, V6, P3804, DOI 10.1039/c3nr06549a	42	28	30	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126571	10.1371/journal.pone.0126571	http://dx.doi.org/10.1371/journal.pone.0126571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978622	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100081
J	AlBacha, JD; Khoury, M; Mouawad, C; Haddad, K; Hamoui, S; Azar, A; Fajloun, Z; Makdissy, N				AlBacha, Jeanne d'Arc; Khoury, Mira; Mouawad, Charbel; Haddad, Katia; Hamoui, Samar; Azar, Albert; Fajloun, Ziad; Makdissy, Nehman			High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; PLASMINOGEN-ACTIVATOR INHIBITOR-1; CORONARY-ARTERY-DISEASE; R506Q MUTATION-LEIDEN; FACTOR-XIII GENE; INSERTION/DELETION POLYMORPHISM; BLOOD-PRESSURE; RISK-FACTORS; LEBANESE POPULATION; VENOUS THROMBOSIS	Cardiovascular diseases (CVDs) are significantly high in the Lebanese population with the two most predominant forms being atherosclerosis and venous thrombosis. The purpose of our study was to assess the association of a spectrum of CVD related genes and combined state of hypertension hypercholesterolemia (HH) in unrelated Lebanese. Twelve polymorphisms were studied by multiplex PCR and reverse hybridization of DNA from 171 healthy individuals and 144 HH subjects. Two genes were significantly associated with HH: ACE (OR: 9.20, P<0.0001) and PAI-1 (OR: 2.29, P = 0.007), respectively with the occurrence of the risky alleles "Del" and "4G". The frequencies of the Del and 4G alleles were found to be 0.98 and 0.90 in the HH group versus 0.84 and 0.79 in the healthy group, respectively. Serum ACE activity and PAI-I increased significantly with Del/Del and 4G/5G genotypes. The co-expression of Del/4G(+/+) was detected in 113 out of 171 (66.0%) controls and 125 out of 144 (86.8%) HH subjects. Del/4G(-/-) was detected in only 6 (3.5%) controls and undetected in the HH group. Three venous thrombosis related genes [FV(Leiden), MTHFR (A1298C) and FXIII(V34L)] were significantly related to the prominence of the co-expression of Del/4G(+/+). A range of 2 to 8 combined polymorphisms co-expressed per subject where 5 mutations were the most detected. In Del/4G(+/+) subjects, peripheral blood mononuclear cells (PBMCs) produced significant elevated levels of IFN-gamma and TNF-alpha contrary to IL-10, and no variations occurred for IL-4. ACE inhibitor (ramipril) in combination with statin (atorvastatin) and not alone reversed significantly the situation. This first report from Lebanon sheds light on an additional genetic predisposition of a complex spectrum of genes involved in CVD and suggests that the most requested gene FVL by physicians may not be sufficient to diagnose eventual future problems that can occur in the cardiovascular system. Subjects expressing the double mutations (Del/4G) are at high risk for the onset of CVDs.	[AlBacha, Jeanne d'Arc; Khoury, Mira; Azar, Albert; Fajloun, Ziad; Makdissy, Nehman] Middle East Inst Hlth Hosp, Ctr Human Genet, Reviva Regenerat Med Ctr, Bsalim, Lebanon; [AlBacha, Jeanne d'Arc; Fajloun, Ziad] Lebanese Univ, Doctoral Sch Sci & Technol, Azm Ctr Res Biotechnol & Applicat, Lab Appl Biotechnol, Tripoli, Lebanon; [Mouawad, Charbel; Haddad, Katia; Hamoui, Samar; Makdissy, Nehman] Lebanese Univ, Sect 3, Fac Sci, Dept Biol, El Kobeh, Lebanon	Lebanese University	Makdissy, N (corresponding author), Middle East Inst Hlth Hosp, Ctr Human Genet, Reviva Regenerat Med Ctr, Bsalim, Lebanon.	n.makdissy@revivamedical.com	Fajloun, Ziad/AAO-8595-2021		National Council for Scientific Research (CNRS-Lebanon); Francophone University Agency (AUF)	National Council for Scientific Research (CNRS-Lebanon)(Centre National de la Recherche Scientifique (CNRS)); Francophone University Agency (AUF)	The authors are deeply appreciative to the National Council for Scientific Research (CNRS-Lebanon) and Francophone University Agency (AUF) for the financial support and the funding of their work.	Abd El-Aziz TA, 2012, GENE, V498, P270, DOI 10.1016/j.gene.2012.02.033; Agachan B, 2003, EXP MOL MED, V35, P545, DOI 10.1038/emm.2003.71; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Alghasham A, 2012, INT J HEALTH SCI-IJH, V6, P3, DOI 10.12816/0005968; Alharbi KK, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-177; Andersson B, 1996, J AM COLL CARDIOL, V28, P162, DOI 10.1016/0735-1097(96)00098-8; [Anonymous], 1998, Circulation, V97, P2202; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Ariens RAS, 2000, BLOOD, V96, P988, DOI 10.1182/blood.V96.3.988.015k57_988_995; Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; Aydenian H, 1999, ANN BIOL CLIN-PARIS, V57, P697; Bae Y, 2007, J HUM HYPERTENS, V21, P159, DOI 10.1038/sj.jhh.1002110; Barley J, 1996, J HUM HYPERTENS, V10, P31; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Biller H, 2006, EUR RESPIR J, V28, P1085, DOI 10.1183/09031936.00050106; Blaschke S, 2009, SCAND J RHEUMATOL, V38, P235, DOI 10.1080/03009740802572475; Boncoraglio GB, 2006, CEREBROVASC DIS, V22, P191, DOI 10.1159/000093604; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Chen F, 2013, CLIN APPL THROMB HEM; Corsetti JP, 2008, ARTERIOSCL THROM VAS, V28, P548, DOI 10.1161/ATVBAHA.107.155556; Daniels PR, 2004, AM J MED, V116, P676, DOI 10.1016/j.amjmed.2003.12.032; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Di Pasquale P, 2004, EUR J HEART FAIL, V6, P11, DOI 10.1016/j.ejheart.2003.07.009; Egan BM, 2013, CIRCULATION, V128, P29, DOI 10.1161/CIRCULATIONAHA.112.000500; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Fahed AC, 2011, MOL GENET METAB, V102, P181, DOI 10.1016/j.ymgme.2010.11.006; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Franchini M, 2012, BLOOD TRANSFUS-ITALY, V10, P257, DOI 10.2450/2012.0095-12; Francis CW, 2002, ARCH PATHOL LAB MED, V126, P1391; Gesang L, 2002, HYPERTENS RES, V25, P481, DOI 10.1291/hypres.25.481; Gohil R, 2009, THROMB HAEMOSTASIS, V102, P360, DOI 10.1160/TH09-01-0013; Goodman CS, 2006, AM J REPROD IMMUNOL, V56, P230, DOI 10.1111/j.1600-0897.2006.00419.x; Guney AI, 2013, GENET MOL RES, V12, P6895, DOI 10.4238/2013.December.19.8; Haber M, 2012, ANN HUM GENET, V76, P1, DOI 10.1111/j.1469-1809.2011.00682.x; Ilhan N, 2008, ARCH MED RES, V39, P125, DOI 10.1016/j.arcmed.2007.07.009; Ince FDA, 2010, ANATOL J CARDIOL, V10, P202, DOI 10.5152/akd.2010.058; Irani-Hakime N, 2001, J THROMB THROMBOLYS, V11, P111, DOI 10.1023/A:1011268531377; Ismail M, 2004, J BIOCHEM MOL BIOL, V37, P552; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Kawashiri M, 2000, AM J CARDIOL, V86, P840, DOI 10.1016/S0002-9149(00)01103-6; Keavney B, 2000, LANCET, V355, P434; Kim DK, 1997, ARTERIOSCL THROM VAS, V17, P3242, DOI 10.1161/01.ATV.17.11.3242; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Kohler HP, 1998, THROMB HAEMOSTASIS, V79, P8, DOI 10.1055/s-0037-1614250; Koupepidou P, 2005, INT ANGIOL, V24, P287; Kwak B, 2001, SWISS MED WKLY, V131, P41; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lin PT, 2008, INT J VITAM NUTR RES, V78, P33, DOI 10.1024/0300-9831.78.1.33; Loew M, 2006, EUR J CARDIOV PREV R, V13, P449; Mahfouz RAR, 2008, MOL BIOL REP, V35, P375, DOI 10.1007/s11033-007-9096-0; Mahfouz RAR, 2006, MOL BIOL REP, V33, P145, DOI 10.1007/s11033-006-6260-x; Margaglione M, 1997, ARTERIOSCL THROM VAS, V17, P2082, DOI 10.1161/01.ATV.17.10.2082; Margaglione M, 1998, ARTERIOSCL THROM VAS, V18, P152, DOI 10.1161/01.ATV.18.2.152; Markan S, 2007, MOL CELL BIOCHEM, V302, P125, DOI 10.1007/s11010-007-9434-5; Mein CA, 2004, HUM MOL GENET, V13, pR169, DOI 10.1093/hmg/ddh078; Minihane AM, 2007, P NUTR SOC, V66, P183, DOI 10.1017/S0029665107005435; Niemiec P, 2007, GENET TEST, V11, P353, DOI 10.1089/gte.2007.0005; O'Malley JP, 1998, CIRCULATION, V97, P1780, DOI 10.1161/01.CIR.97.18.1780; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saab YB, 2011, J RENIN-ANGIO-ALDO S, V12, P588, DOI 10.1177/1470320311408465; Sabbagh AS, 2007, TRANSFUSION MED, V17, P473, DOI 10.1111/j.1365-3148.2007.00792.x; Sabbagh AS, 2008, GENET TEST, V12, P75, DOI 10.1089/gte.2007.0064; Sabbagh AS, 2007, MOL BIOL REP, V34, P267, DOI 10.1007/s11033-006-9041-7; Sabbagh AS, 2007, MOL BIOL REP, V34, P47, DOI 10.1007/s11033-006-9013-y; Samani NJ, 1996, CIRCULATION, V94, P708, DOI 10.1161/01.CIR.94.4.708; SAWA H, 1993, CIRC RES, V73, P671, DOI 10.1161/01.RES.73.4.671; Schmidt-Ott KM, 2000, REGUL PEPTIDES, V93, P65, DOI 10.1016/S0167-0115(00)00178-6; Shammaa DMR, 2008, MOL BIOL REP, V35, P453, DOI 10.1007/s11033-007-9106-2; Shammaa DMR, 2008, MOL BIOL REP, V35, P307, DOI 10.1007/s11033-007-9087-1; SMITH GD, 1992, JAMA-J AM MED ASSOC, V267, P70, DOI 10.1001/jama.267.1.70; Smith SC, 2004, CIRCULATION, V109, P2613, DOI 10.1161/01.CIR.0000128519.60762.84; Snieder H, 2003, HYPERTENSION, V41, P1196, DOI 10.1161/01.HYP.0000072269.19820.0D; Strey RF, 2005, PATHOPHYSIOL HAEMO T, V34, P279, DOI 10.1159/000093108; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Thomas DP, 1996, BLOOD COAGUL FIBRIN, V7, P583, DOI 10.1097/00001721-199609000-00001; Thomas GN, 2001, DIABETES CARE, V24, P356, DOI 10.2337/diacare.24.2.356; Todoroki M, 2003, J HUM HYPERTENS, V17, P713, DOI 10.1038/sj.jhh.1001601; Tohme RA, 2005, J HUM HYPERTENS, V19, P861, DOI 10.1038/sj.jhh.1001909; Tripathi Gaurav, 2006, BMC Nephrol, V7, P15, DOI 10.1186/1471-2369-7-15; Tsantes AE, 2007, THROMB HAEMOSTASIS, V97, P907, DOI 10.1160/TH06-12-0745; Vargas-Alarcon G, 2003, HUM BIOL, V75, P889, DOI 10.1353/hub.2004.0012; Wang Y, 2011, BIOMED PHARMACOTHER, V65, P118, DOI 10.1016/j.biopha.2010.12.005; Weiss D, 2001, AM J CARDIOL, V87, p25C; Yang BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087497; Ye S, 2003, HEART, V89, P1195, DOI 10.1136/heart.89.10.1195; Zaatari GS, 2006, PATHOLOGY, V38, P442, DOI 10.1080/00313020600922934; Zhang AY, 2010, CARDIOL RES, V1, P8, DOI 10.4021/cr108e; Zhang Yu-ling, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1681; Zhu XF, 2003, HYPERTENSION, V41, P1027, DOI 10.1161/01.HYP.0000068681.69874.CB	93	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127266	10.1371/journal.pone.0127266	http://dx.doi.org/10.1371/journal.pone.0127266			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973747	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600107
J	Pfeil, AM; Reich, O; Guerra, IM; Cure, S; Negro, F; Mullhaupt, B; Lavanchy, D; Schwenkglenks, M				Pfeil, Alena M.; Reich, Oliver; Guerra, Ines M.; Cure, Sandrine; Negro, Francesco; Muellhaupt, Beat; Lavanchy, Daniel; Schwenkglenks, Matthias			Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; GENOTYPE 1; PEGYLATED INTERFERON; TRIPLE THERAPY; PLUS RIBAVIRIN; PEGINTERFERON; TELAPREVIR; INFECTION; EPIDEMIOLOGY; RETREATMENT	In clinical trials, sofosbuvir showed high antiviral activity in patients infected with hepatitis C virus (HCV) across all genotypes. We aimed to determine the cost-effectiveness of sofosbuvir-based treatment compared to current standard treatment in mono-infected patients with chronic hepatitis C (CHC) genotypes 1-4 in Switzerland. Cost-effectiveness was modelled from the perspective of the Swiss health care system using a lifetime Markov model. Incremental cost-effectiveness ratios (ICERs) used an endpoint of cost per quality-adjusted life year (QALY) gained. Treatment characteristics, quality of life, and transition probabilities were obtained from published literature. Country-specific model inputs such as patient characteristics, mortality and costs were obtained from Swiss sources. We performed extensive sensitivity analyses. Costs and effects were discounted at 3% (range: 0-5%) per year. Sofosbuvir-containing treatment in mixed cohorts of cirrhotic and non-cirrhotic patients with CHC genotypes 1-4 showed ICERs between CHF 10,337 and CHF 91,570 per QALY gained. In subgroup analyses, sofosbuvir dominated telaprevir-and boceprevir-containing treatment in treatment-naive genotype 1 cirrhotic patients. ICERs of sofosbuvir were above CHF 100,000 per QALY in treatment-naIve, interferon eligible, non-cirrhotic patients infected with genotypes 2 or 3. In deterministic and probabilistic sensitivity analyses, results were generally robust. From a Swiss health care system perspective, treatment of mixed cohorts of cirrhotic and non-cirrhotic patients with CHC genotypes 1-4 with sofosbuvir-containing treatment versus standard treatment would be cost-effective if a threshold of CHF 100,000 per QALY was assumed.	[Pfeil, Alena M.; Schwenkglenks, Matthias] Univ Basel, Inst Pharmaceut Med ECPM, Basel, Switzerland; [Reich, Oliver] Helsana Grp, Dept Hlth Sci, Zurich, Switzerland; [Guerra, Ines M.; Cure, Sandrine] OPTUMInsight, Uxbridge, Middx, England; [Negro, Francesco] Univ Hosp Geneva, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland; [Muellhaupt, Beat] Univ Zurich Hosp, Swiss HPB Hepatopancreatobiliary Ctr, CH-8091 Zurich, Switzerland; [Muellhaupt, Beat] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Lavanchy, Daniel] African Union, WHO, Denges Vd, Switzerland	University of Basel; Optum; University of Geneva; University of Geneva; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; World Health Organization	Pfeil, AM (corresponding author), Univ Basel, Inst Pharmaceut Med ECPM, Basel, Switzerland.	alena.pfeil@unibas.ch	Negro, Francesco/E-2183-2012; Mullhaupt, Beat/O-3744-2016	Schwenkglenks, Matthias/0000-0001-7217-1173; Mullhaupt, Beat/0000-0002-9020-8192	Gilead Switzerland; Helsana Group; OPTUMInsight	Gilead Switzerland(Gilead Sciences); Helsana Group; OPTUMInsight	The study was funded by Gilead Switzerland. The sponsor participated, but did not make final decisions regarding the design, conduct or reporting of the study and had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Helsana Group and OPTUMInsight provided support in the form of salaries for the authors OR, IMG, and SC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	AASLD/IDSA/IAS-USA, RECOMMENDATIONS FOR; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], TARMED SUISSE TARMED; [Anonymous], ORGANISATION FOR ECO; [Anonymous], 2000, ORGANISATION FOR ECO; [Anonymous], 2011, BIOETHICA FORUM, V4; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bichoupan K, 2014, HEPATOLOGY, V60, P1187, DOI 10.1002/hep.27340; Brennan T, 2014, JAMA-J AM MED ASSOC, V312, P593, DOI 10.1001/jama.2014.8897; Briggs A, 2010, VALUE HEALTH, V13, pS22, DOI 10.1111/j.1524-4733.2010.00751.x; Bundesamt fur Statistik, 2014, BRUTTOINLANDPRODUKT; Carroll John, 2014, Manag Care, V23, P12; Casey LC, 2013, CURR OPIN GASTROEN, V29, P243, DOI 10.1097/MOG.0b013e32835ff972; Chambers JD, 2010, MED DECIS MAKING, V30, pE14, DOI 10.1177/0272989X10371134; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Dedes KJ, 2009, EUR J CANCER, V45, P1397, DOI 10.1016/j.ejca.2008.12.016; Deuffic-Burban S, 2014, J HEPATOL, V61, P7, DOI 10.1016/j.jhep.2014.03.011; European Association for the Study of the Liver, 2014, EASL RECOMMENDATIONS; Federal Office of Public Health (FOPH), 2014, ANALYSENLISTE AL GES; Federal Office of Public Health (FOPH), SPEZIALITATENLISTE S; Feld JJ, 2014, ANTIVIRAL RES; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gilead, 2014, EUROPEAN COMMISSION; Grishchenko M, 2009, INT J TECHNOL ASSESS, V25, P171, DOI 10.1017/S0266462309090229; Hartwell D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15170; Hill A, 2014, SCIENCE, V345, P141, DOI 10.1126/science.1257737; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kim CW, 2013, CLIN MOL HEPATOL, V19, P17, DOI 10.3350/cmh.2013.19.1.17; Kim H, 2014, BRIT J CLIN PHARMACO, V77, P116, DOI 10.1111/bcp.12150; Knies S, 2009, PHARMACOECONOMICS, V27, P767, DOI 10.2165/11314120-000000000-00000; Lagging M, 2013, SCAND J GASTROENTERO, V48, P839, DOI 10.3109/00365521.2013.793389; Lalezari JP, 2013, ONCE DAILY SOFOSBUVI; Lawitz E, 2012, BOCEPREVIR BOC COMBI; Lawitz E, 2013, SOFOSBUVIR IN COMBIN; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Leleu H, 2014, J VIRAL HEPAT; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martinot-Peignoux M, 2010, HEPATOLOGY, V51, P1122, DOI 10.1002/hep.23444; Matter-Walstra K, 2014, PHARMACOECONOMICS, V32, P591, DOI 10.1007/s40273-014-0151-0; Matter-Walstra K, 2012, VALUE HEALTH, V15, P65, DOI 10.1016/j.jval.2011.08.1737; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Papatheodoridis G, 2012, BEST PRACT RES CL GA, V26, P371, DOI 10.1016/j.bpg.2012.09.012; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Pfeil Alena M, 2012, Swiss Med Wkly, V142, pw13676, DOI 10.4414/smw.2012.13676; Pol S, 2012, CONTRIB NEPHROL, V176, P1, DOI 10.1159/000332374; Prasad L, 2007, INT J EPIDEMIOL, V36, P731, DOI 10.1093/ije/dym096; Saab S, 2014, ALIMENT PHARMACOL TH; San Miguel R, 2014, GUT; Schad M, 2012, EUR J HEALTH ECON, V13, P127, DOI 10.1007/s10198-010-0292-9; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Swiss Federal Statistical Office, 2005, BAG; Swissmedic, 2014, SOVALDI; Thomson BJ, 2008, J VIRAL HEPATITIS, V15, P271, DOI 10.1111/j.1365-2893.2007.00941.x; Tran Tram T, 2012, Am J Manag Care, V18, pS335; Umar M, 2014, J CLIN GASTROENTEROL, V48, P204, DOI 10.1097/MCG.0000000000000050; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Zeuzem S, 2014, N ENGL J MED	64	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126984	10.1371/journal.pone.0126984	http://dx.doi.org/10.1371/journal.pone.0126984			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974722	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600093
J	Santarpia, G; De Rosa, S; Polimeni, A; Giampa, S; Micieli, M; Curcio, A; Indolfi, C				Santarpia, Giuseppe; De Rosa, Salvatore; Polimeni, Alberto; Giampa, Salvatore; Micieli, Mariella; Curcio, Antonio; Indolfi, Ciro			Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis	PLOS ONE			English	Article							PERIPROCEDURAL ANTICOAGULATION; PERIABLATION ANTICOAGULATION; BLEEDING COMPLICATIONS; DABIGATRAN ETEXILATE; WARFARIN; RIVAROXABAN; THERAPY; STROKE; THROMBOEMBOLISM; MANAGEMENT	Background Use of the non-vitamin K antagonist oral anticoagulants (NOACs) is endorsed by current guidelines for stroke prevention in patients with atrial fibrillation (AF). However efficacy and safety of NOACs in patients undergoing catheter ablation (RFCA) of AF has not been well established yet. Objectives To perform a meta-analysis of all studies comparing NOACs and vitamin K antagonist oral anticoagulants (VKAs) in patients undergoing RFCA. Data Sources Studies were searched for in PubMed and Google Scholar databases. Study Eligibility Criteria Studies were considered eligible if: they evaluated the clinical impact of NOACs versus VKAs; they specifically analyzed the use of anticoagulants during periprocedural phase of RFCA; they reported clinical outcome data. Study Appraisal and Synthesis Methods 25 studies were selected, including 9881 cases. The summary measure used was the risk ratio (RR) with 95% confidence interval (CI). The random-effects or the fixed effect model were used to synthesize results from the selected studies. Results There was no significant difference in thromboembolic complications (RR 1.39; p=0.13). Bleeding complications were significantly lower in the NOACs-treated arm as compared to VKAs (RR=0.67, p<0.001). Interestingly, a larger number of thromboembolic events was found in the VKAs-treated arm in those studies where VKAs had been interrupted during the periprocedural phase (RR=0.68; p=ns). In this same subgroup a significantly higher incidence of both minor (RR=0.54; p=0.002) and major bleeding (RR=0.41; p=0.01) events was recorded. Conversely, the incidence of thromboembolic events in the VKAs-treated arm was significantly lower in those studies with uninterrupted periprocedural anticoagulation treatment (RR=1.89; p=0.02). Limitations As with every meta-analysis, no patients-level data were available. Conclusions and Implications The use of NOACs in patients undergoing RFCA is safe, given the lower incidence of bleedings observed with NOACs. On the other side, periprocedural interruption of VKAs and bridging with heparin is associated with a higher bleeding rate with no significant benefit on onset of thromboembolic events.	[Santarpia, Giuseppe; De Rosa, Salvatore; Polimeni, Alberto; Giampa, Salvatore; Micieli, Mariella; Curcio, Antonio; Indolfi, Ciro] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Div Cardiol, Catanzaro, Italy; [Indolfi, Ciro] CNR, URT CNR, Dept Med, Catanzaro, Italy	Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR)	Indolfi, C (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Div Cardiol, Catanzaro, Italy.	indolfi@unicz.it	De Rosa, Salvatore/J-6350-2012; Polimeni, Alberto AP/K-4731-2018; Curcio, Antonio/K-4822-2018; Polimeni, Alberto/M-9243-2019	De Rosa, Salvatore/0000-0001-5388-942X; Polimeni, Alberto AP/0000-0002-9166-3031; Polimeni, Alberto/0000-0002-9166-3031; INDOLFI, Ciro/0000-0003-1241-6487; Curcio, Antonio/0000-0003-3213-4436	Italian Ministry of Education, University and Research (MIUR) [PON01_02833]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant of the Italian Ministry of Education, University and Research (MIUR): PON01_02833 "CARDIO-TECH". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad A, 2014, PACE, V37, P665, DOI 10.1111/pace.12401; Bassiouny M, 2013, CIRC-ARRHYTHMIA ELEC, V6, P460, DOI 10.1161/CIRCEP.113.000320; Bernard M, 2013, J AM COLL CARDIOL, V61, pE276, DOI 10.1016/S0735-1097(13)60276-4; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; De Rosa S, 2014, J AM COLL CARDIOL, V63, P1340, DOI 10.1016/j.jacc.2013.08.1662; De Rosa S, 2014, INT J CARDIOL, V171, P66, DOI 10.1016/j.ijcard.2013.11.046; De Rosa S, 2013, INT J CARDIOL, V168, P1298, DOI 10.1016/j.ijcard.2012.12.003; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Biase L, 2014, CIRCULATION, V129, P2638, DOI 10.1161/CIRCULATIONAHA.113.006426; Dillier R, 2014, CIRC-ARRHYTHMIA ELEC, V7, P576, DOI 10.1161/CIRCEP.114.001586; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Haines DE, 2013, J INTERV CARD ELECTR, V37, P233, DOI 10.1007/s10840-013-9800-z; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hohnloser SH, 2013, EUROPACE, V15, P1407, DOI 10.1093/europace/eut241; Ichiki H, 2013, PACE, V36, P1328, DOI 10.1111/pace.12195; Imamura K, 2013, J INTERV CARD ELECTR, V37, P223, DOI 10.1007/s10840-013-9801-y; Kaess BM, 2015, AM J CARDIOL, V115, P47, DOI 10.1016/j.amjcard.2014.10.005; Kaiser DW, 2013, J INTERV CARD ELECTR, V37, P241, DOI 10.1007/s10840-013-9793-7; Karasoy D, 2015, EUR HEART J, V36, P307, DOI 10.1093/eurheartj/ehu421; Kaseno K, 2012, CIRC J, V76, P2337, DOI 10.1253/circj.CJ-12-0498; Kim JS, 2013, HEART RHYTHM, V10, P483, DOI 10.1016/j.hrthm.2012.12.011; Konduru SV, 2012, J INTERV CARD ELECTR, V35, P277, DOI 10.1007/s10840-012-9719-9; Lakkireddy D, 2012, J AM COLL CARDIOL, V59, P1168, DOI 10.1016/j.jacc.2011.12.014; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Maddox W, 2013, J CARDIOVASC ELECTR, V24, P861, DOI 10.1111/jce.12143; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mendoza I, 2012, HEART RHYTHM, V9, pS270; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nin T, 2013, PACE, V36, P172, DOI 10.1111/pace.12036; Parvathaneni SV, 2012, HEART RHYTHM, V9, P1218, DOI 10.1016/j.hrthm.2012.03.049; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pavaci H, 2012, EUR HEART J, V33, P60; Piccini JP, 2013, J AM COLL CARDIOL, V61, P1998, DOI 10.1016/j.jacc.2013.02.025; Providencia R, 2014, EUROPACE, V16, P1137, DOI 10.1093/europace/euu007; Providencia R, 2014, HEART, V100, P324, DOI 10.1136/heartjnl-2013-304386; Rowley CP, 2012, HEART RHYTHM S1, V9, pS201; Samsa GP, 2000, ARCH INTERN MED, V160, P967, DOI 10.1001/archinte.160.7.967; Sardar P, 2014, AM J CARDIOL, V113, P1173, DOI 10.1016/j.amjcard.2013.12.027; Shurrab M, 2013, CAN J CARDIOL, V29, P1203, DOI 10.1016/j.cjca.2013.07.005; Snipelisky D, 2012, J INTERV CARD ELECTR, V35, P29, DOI 10.1007/s10840-012-9708-z; Stepanyan G, 2014, J INTERV CARD ELECTR, V40, P33, DOI 10.1007/s10840-014-9888-9; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Winkle RA, 2014, EUROPACE, V16, P1443, DOI 10.1093/europace/euu196; Yamaji H, 2013, CLIN DRUG INVEST, V33, P409, DOI 10.1007/s40261-013-0081-1	46	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126512	10.1371/journal.pone.0126512	http://dx.doi.org/10.1371/journal.pone.0126512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974377	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600057
J	Bureau, HR; Merz, DR; Hershkovits, E; Quirk, S; Hernandez, R				Bureau, Hailey R.; Merz, Dale R., Jr.; Hershkovits, Eli; Quirk, Stephen; Hernandez, Rigoberto			Constrained Unfolding of a Helical Peptide: Implicit versus Explicit Solvents	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY DIFFERENCES; SPACE OVERLAP MEASURES; JARZYNSKIS EQUALITY; NONEQUILIBRIUM MEASUREMENTS; WATER; ALANINE; SOLVATION; MODELS; THERMODYNAMICS	Steered Molecular Dynamics (SMD) has been seen to provide the potential of mean force (PMF) along a peptide unfolding pathway effectively but at significant computational cost, particularly in all-atom solvents. Adaptive steered molecular dynamics (ASMD) has been seen to provide a significant computational advantage by limiting the spread of the trajectories in a staged approach. The contraction of the trajectories at the end of each stage can be performed by taking a structure whose nonequilibrium work is closest to the Jarzynski average (in naive ASMD) or by relaxing the trajectories under a no-work condition (in full-relaxation ASMD-namely, FR-ASMD). Both approaches have been used to determine the energetics and hydrogen-bonding structure along the pathway for unfolding of a benchmark peptide initially constrained as an a-helix in a water environment. The energetics are quite different to those in vacuum, but are found to be similar between implicit and explicit solvents. Surprisingly, the hydrogen-bonding pathways are also similar in the implicit and explicit solvents despite the fact that the solvent contact plays an important role in opening the helix.	[Bureau, Hailey R.; Merz, Dale R., Jr.; Hershkovits, Eli; Hernandez, Rigoberto] Georgia Inst Technol, Sch Chem & Biochem, Ctr Computat & Mol Sci & Technol, Atlanta, GA 30332 USA; [Quirk, Stephen] Kimberly Clark Inc, Atlanta, GA 30076 USA	University System of Georgia; Georgia Institute of Technology; Kimberly-Clark	Hernandez, R (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Ctr Computat & Mol Sci & Technol, Atlanta, GA 30332 USA.	hernandez@gatech.edu	Hernandez, Rigoberto/A-8793-2008	Hernandez, Rigoberto/0000-0001-8526-7414; Quirk, Stephen/0000-0002-4497-1023	US NSF [CHE 1112067]; Purdue Dell PowerEdge Linux Cluster (Steele) [TG-CTS090079]; Department of Education GAANN program [P200A120190]; Kimberly-Clark Corporation; Direct For Mathematical & Physical Scien [1112067] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); Purdue Dell PowerEdge Linux Cluster (Steele); Department of Education GAANN program(US Department of Education); Kimberly-Clark Corporation; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	RH was funded through US NSF grant CHE 1112067. The computing resources necessary for this research were provided in part by the National Science Foundation through TeraGrid resources provided by the Purdue Dell PowerEdge Linux Cluster (Steele) under grant number TG-CTS090079. The remainder of the computational studies were performed on a cluster purchased through US NSF grant CHE 1112067. HRB was supported by the Department of Education GAANN program entirely through grant no. P200A120190 for this work. Kimberly-Clark Corporation provided support in the form of salaries for author SQ while he was doing a sabbatical in RH's laboratory, but Kimberly-Clark Corporation did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of SQ are articulated in the "author contributions" section.	Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Bratzel G, 2012, J MECH BEHAV BIOMED, V7, P30, DOI 10.1016/j.jmbbm.2011.07.012; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen J, 2008, PHYS CHEM CHEM PHYS, V10, P471, DOI 10.1039/b714141f; Crooks GE, 1998, J STAT PHYS, V90, P1481, DOI 10.1023/A:1023208217925; Do TN, 2013, J CHEM THEORY COMPUT, V9, P1720, DOI 10.1021/ct3009914; Echeverria I, 2012, J PHYS CHEM B, V116, P10986, DOI 10.1021/jp300527q; Echeverria I, 2010, PROTEINS, V78, P1302, DOI 10.1002/prot.22649; Feig M, 2004, CURR OPIN STRUC BIOL, V14, P217, DOI 10.1016/j.sbi.2004.03.009; Forrod B, 1995, BIOCH BIOPHYS COMMUN, V211, P7, DOI 10.1006/bbrc.1995.1770; FUJIE A, 1973, MAKROMOL CHEM, V169, P301; Guttenberg N, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4724301; Hazel A, 2014, J CHEM THEORY COMPUT, V10, P2836, DOI 10.1021/ct5002076; Ho BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013068; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Juneja A, 2013, J CHEM THEORY COMPUT, V9, P834, DOI 10.1021/ct300941v; Lin ZX, 2013, J CHEM THEORY COMPUT, V9, P1328, DOI 10.1021/ct3010497; Lu ND, 1999, J CHEM PHYS, V111, P4414, DOI 10.1063/1.479206; Luchko T, 2010, J CHEM THEORY COMPUT, V6, P607, DOI 10.1021/ct900460m; MacFadyen J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2000242; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Moradi M, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3481087; NategholEslam M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021114; Ngo VA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036702; Oberhofer H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061106; Ozer G, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4891807; Ozer G, 2012, J CHEM THEORY COMPUT, V8, P4837, DOI 10.1021/ct300709u; Ozer G, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4725183; Ozer G, 2010, J CHEM THEORY COMPUT, V6, P3026, DOI 10.1021/ct100320g; Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Paramore S, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2463306; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qin Z, 2011, J MOL MODEL, V17, P37, DOI 10.1007/s00894-010-0696-6; Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Reddy AS, 2010, BIOPHYS J, V98, P443, DOI 10.1016/j.bpj.2009.10.029; Roe DR, 2007, J PHYS CHEM B, V111, P1846, DOI 10.1021/jp066831u; Scheraga HA, 2002, BIOPHYS CHEM, V101, P255, DOI 10.1016/S0301-4622(02)00175-8; Spek EJ, 1999, J AM CHEM SOC, V121, P5571, DOI 10.1021/ja990056x; Torras J, 2009, J CHEM THEORY COMPUT, V5, P37, DOI 10.1021/ct800236d; Wu D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1992483; Wu D, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1906209; Wu D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2011391; Yang S, 2007, J PHYS CHEM B, V111, P605, DOI 10.1021/jp0649091; Zagrovic B, 2001, J MOL BIOL, V313, P151, DOI 10.1006/jmbi.2001.5033; Zhou RH, 2003, PROTEINS, V53, P148, DOI 10.1002/prot.10483	52	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127034	10.1371/journal.pone.0127034	http://dx.doi.org/10.1371/journal.pone.0127034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970521	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200144
J	Pentheroudakis, G; Raptou, G; Kotoula, V; Wirtz, RM; Vrettou, E; Karavasilis, V; Gourgioti, G; Gakou, C; Syrigos, KN; Bournakis, E; Rallis, G; Varthalitis, I; Galani, E; Lazaridis, G; Papaxoinis, G; Pectasides, D; Aravantinos, G; Makatsoris, T; Kalogeras, KT; Fountzilas, G				Pentheroudakis, George; Raptou, Georgia; Kotoula, Vassiliki; Wirtz, Ralph M.; Vrettou, Eleni; Karavasilis, Vasilios; Gourgioti, Georgia; Gakou, Chryssa; Syrigos, Konstantinos N.; Bournakis, Evangelos; Rallis, Grigorios; Varthalitis, Ioannis; Galani, Eleni; Lazaridis, Georgios; Papaxoinis, George; Pectasides, Dimitrios; Aravantinos, Gerasimos; Makatsoris, Thomas; Kalogeras, Konstantine T.; Fountzilas, George			Immune Response Gene Expression in Colorectal Cancer Carries Distinct Prognostic Implications According to Tissue, Stage and Site: A Prospective Retrospective Translational Study in the Context of a Hellenic Cooperative Oncology Group Randomised Trial	PLOS ONE			English	Article							COLON-CANCER; ESTROGEN; EPIDEMIOLOGY; LOCALIZATION; METHYLATION; CELLS	Background Although host immune response is an emerging prognostic factor for colorectal cancer, there is no consensus on the optimal methodology, surrogate markers or tissue for study. Patients and Methods Tumour blocks were prospectively collected from 344 patients with stage II/III colorectal cancer (CRC) treated with adjuvant chemotherapy. Whole section lymphocytic infiltration was studied along with mRNA expression of CD3Z, CD8, CD4, CXCL9, CXCL13, IGHM, FOXP3, SNAI2 and ESR1 by qRT-qPCR in tissue microarray (TMA) cores from the centre of tumour, invasive margin and adjacent normal mucosa. Results Lymphocytic infiltration, deficient MMR (10.9%), KRAS (40.7%) and BRAF (4.9%) mutations or single mRNA gene expression were not prognostic. Tumour ESR1 gene expression (Hazard Ratio [HR] for relapse 2.33, 95% CI 1.35-4.02; HR for death 1.74, 95% CI 1.02-2.97) and absence of necrosis (HR for relapse 1.71, 95% CI 1.05-2.71; HR for death 1.98, 95% CI 1.14-3.43) were adverse prognostic features. We used CD3Z and CD8 expression in order to devise the mRNA-based Immune Score (mIS) and proceeded to partitioning analysis in 267 patients, with age, stage, tumour site (Right vs Left CRC), KRAS mutation and tumour mIS as input factors. Only in patients with stage III right-sided colon cancer, a low immune response was associated with inferior disease-free survival (mIS-low, HR for relapse 2.28, 95% CI 1.05-8.02). No prognostic significance was seen for tumour mIS in any other stage or site of CRC, or for a similar mIS score derived from adjacent normal mucosa. Independent adverse prognostic significance was retained in multivariable analysis for absence of necrosis, tumour ESR1 expression in all patients and low tumour mIS in stage III right-sided CRC. Conclusions In localised CRC, mRNA-based CD3Z/CD8 profiling of tumour immune response may have stage, site and tissue-specific prognostic significance, along with ESR1 expression.	[Pentheroudakis, George] Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece; [Raptou, Georgia; Kotoula, Vassiliki; Vrettou, Eleni] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Raptou, Georgia; Kotoula, Vassiliki; Gakou, Chryssa; Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Hellen Fdn Canc Res, Mol Oncol Lab, GR-54006 Thessaloniki, Greece; [Wirtz, Ralph M.] STRATIFYER Mol Pathol GmbH, Cologne, Germany; [Karavasilis, Vasilios; Rallis, Grigorios; Kalogeras, Konstantine T.] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Sch Med, Dept Med Oncol, GR-54006 Thessaloniki, Greece; [Gourgioti, Georgia] Data Off, Hellen Cooperat Oncol Grp, Biostat Sect, Athens, Greece; [Syrigos, Konstantinos N.] Sotiria Gen Hosp, Athens Sch Med, Oncol Unit GPP, Athens, Greece; [Bournakis, Evangelos] Univ Athens, Alexandra Hosp, Sch Med, Dept Clin Therapeut, Athens, Greece; [Varthalitis, Ioannis] Gen Hosp Chania, Dept Oncol, Iraklion, Greece; [Galani, Eleni] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Papaxoinis, George; Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece; [Aravantinos, Gerasimos] Agii Anargiri Canc Hosp, Dept Med Oncol 2, Athens, Greece; [Makatsoris, Thomas] Univ Patras, Univ Hosp, Sch Med, Dept Med,Div Oncol, Patras, Greece; [Kalogeras, Konstantine T.] Data Off, Hellen Cooperat Oncol Grp, Translat Res Sect, Athens, Greece	University Hospital Ioannina; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Stratifyer Molecular Pathology GmbH; Aristotle University of Thessaloniki; Papageorgiou Hospital; Hellenic Cooperative Oncology Group; Athens Medical School; National & Kapodistrian University of Athens; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Hippokration General Hospital; University of Patras; Hellenic Cooperative Oncology Group	Pentheroudakis, G (corresponding author), Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece.	gpenther@otenet.gr	Syrigos, Kostas/AAE-8045-2019; Fountzilas, George/ABF-2139-2020; Bournakis, Evangelos/ABE-9202-2020	Aravantinos, Gerasimos/0000-0002-2106-1713; Fountzilas, George/0000-0001-8045-2186; Karavasilis, Vasilis/0000-0002-5806-9399	Hellenic Foundation for Cancer Research (HeFCR); Hellenic Cooperative Oncology Group (HeCOG) [HER6C05]	Hellenic Foundation for Cancer Research (HeFCR); Hellenic Cooperative Oncology Group (HeCOG)	This research project was supported by an unrestricted research grant from the Hellenic Foundation for Cancer Research (HeFCR) and the Hellenic Cooperative Oncology Group (HeCOG) (HER6C05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalay I, 2013, CANCER RES, V73, P2418, DOI 10.1158/0008-5472.CAN-12-2432; Belshaw NJ, 2008, BRIT J CANCER, V99, P136, DOI 10.1038/sj.bjc.6604432; Bendardaf R, 2008, ANTICANCER RES, V28, P3865; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bindea G, 2011, SEMIN IMMUNOPATHOL, V33, P335, DOI 10.1007/s00281-011-0264-x; Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572; Boissiere-Michot F, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29256; Caiazza F, 2007, BIOCHEM BIOPH RES CO, V359, P102, DOI 10.1016/j.bbrc.2007.05.059; Di Caro G, 2014, CLIN CANCER RES, V20, P2147, DOI 10.1158/1078-0432.CCR-13-2590; Fang YJ, 2012, TUMOR BIOL, V33, P2227, DOI 10.1007/s13277-012-0484-2; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fu KI, 2005, WORLD J GASTROENTERO, V11, P6863, DOI 10.3748/wjg.v11.i43.6863; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-1; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Kaz AM, 2014, EPIGENETICS-US, V9, P492, DOI 10.4161/epi.27650; Koudougou C, 2013, ALIMENT PHARM THER, V38, P3, DOI 10.1111/apt.12337; Marquez-Garban DC, 2011, STEROIDS, V76, P910, DOI 10.1016/j.steroids.2011.04.015; Mei Z, 2014, BRIT J CANCER, V110, P1595, DOI 10.1038/bjc.2014.46; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Pectasides DG, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.3617; Priyanka HP, 2013, MOL IMMUNOL, V56, P328, DOI 10.1016/j.molimm.2013.05.226; Rudiger T, 2002, AM J SURG PATHOL, V26, P873, DOI 10.1097/00000478-200207000-00005; Salem Mohamed Labib, 2004, Current Drug Targets - Inflammation and Allergy, V3, P97, DOI 10.2174/1568010043483944; Sanz-Pamplona R, 2011, CLIN CANCER RES, V17, P7303, DOI 10.1158/1078-0432.CCR-11-1570; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Schneider NI, 2014, CANCER MANAG RES, V6, P291, DOI 10.2147/CMAR.S38827; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Singh PB, 2008, EUR J CANCER, V44, P928, DOI 10.1016/j.ejca.2008.02.051; Tsiambas E, 2011, MED ONCOL, V28, P934, DOI 10.1007/s12032-010-9554-8; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414	35	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124612	10.1371/journal.pone.0124612	http://dx.doi.org/10.1371/journal.pone.0124612			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970543	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200044
J	Hong, BJ; Biertz, F; Raab, P; Scheinichen, D; Ertl, P; Grosshennig, A; Nakamura, M; Hermann, EJ; Lang, JM; Lanfermann, H; Krauss, JK				Hong, Bujung; Biertz, Frank; Raab, Peter; Scheinichen, Dirk; Ertl, Philipp; Grosshennig, Anika; Nakamura, Makoto; Hermann, Elvis J.; Lang, Josef M.; Lanfermann, Heinrich; Krauss, Joachim K.			Normobaric Hyperoxia for Treatment of Pneumocephalus after Posterior Fossa Surgery in the Semisitting Position: A Prospective Randomized Controlled Trial	PLOS ONE			English	Article							TENSION PNEUMOCEPHALUS; SITTING POSITION; OXYGEN-THERAPY; COMPLICATION; CRANIOTOMY; NEUROSURGERY; SLEEPINESS; DELIVERY	Background Supratentorial pneumocephalus after posterior fossa surgery in the semisitting position may lead to decreased alertness and other symptoms. We here aimed to prove the efficacy of normobaric hyperoxia on the absorption of postoperative pneumocephalus according to a standardized treatment protocol. Methods and Findings We enrolled 44 patients with postoperative supratentorial pneumocephalus (>30 ml) after posterior fossa surgery in a semisitting position. After randomisation procedure, patients received either normobaric hyperoxia at FiO(2) 100% over an endotracheal tube for 3 hours (treatment arm) or room air (control arm). Routine cranial CT scans were performed immediately (CT1) and 24 hours (CT2) after completion of surgery and were rated without knowledge of the therapy arm. Two co-primary endpoints were assessed: (i) mean change of pneumocephalus volume, and (ii) air resorption rate in 24 hours. Secondary endpoints were subjective alertness (Stanford Sleepiness Scale) postoperatively and attention (Stroop test), which were evaluated preoperatively and 24 hours after surgery. The mean change in pneumocephalus volume was higher in patients in the treatment arm as compared to patients in the control arm (p = 0.001). The air resorption rate was higher in patients in the treatment arm as compared to patients in the control arm (p = 0.0015). Differences were more pronounced in patients aged 52 years and older. No difference between patients in treatment arm and control arm was observed for the Stroop test. The distribution of scores in the Stanford Sleepiness Scale differed in the treatment arm as compared to the control arm, and there was a difference in mean values (p = 0.015). Conclusions Administration of normobaric hyperoxia at FiO(2) 100% via an endotracheal tube for 3 hours is safe and efficacious in the treatment of pneumocephalus after posterior fossa surgery in the semisitting position. Largest benefit was found in elderly patients and particularly in older men.	[Hong, Bujung; Ertl, Philipp; Nakamura, Makoto; Hermann, Elvis J.; Lang, Josef M.; Krauss, Joachim K.] Hannover Med Sch, Dept Neurosurg, Hannover, Germany; [Biertz, Frank; Grosshennig, Anika] Hannover Med Sch, Inst Biostat, Hannover, Germany; [Raab, Peter; Lanfermann, Heinrich] Hannover Med Sch, Inst Diagnost & Intervent Neuroradiol, Hannover, Germany; [Scheinichen, Dirk] Hannover Med Sch, Dept Anaesthesiol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Hong, BJ (corresponding author), Hannover Med Sch, Dept Neurosurg, Hannover, Germany.	hong.bujung@mh-hannover.de	Lanfermann, Heinrich/AAR-4069-2021					Acioly MA, 2011, ACTA NEUROCHIR, V153, P1077, DOI 10.1007/s00701-011-0960-2; Bardin H, 1970, QUANTITATIVE METHOD; BECKETT WS, 1988, J APPL PHYSIOL, V64, P1683, DOI 10.1152/jappl.1988.64.4.1683; Biyani N, 2007, PEDIATR NEUROSURG, V43, P414, DOI 10.1159/000106394; Burkhart JE, 1998, CLEV CLIN J MED, V65, P200, DOI 10.3949/ccjm.65.4.200; Chanques G, 2013, MINERVA ANESTESIOL, V79, P1344; DEMENT WC, 1982, SLEEP, V5, pS56, DOI 10.1093/sleep/5.S2.S56; Desmarquest P, 1998, RESP MED, V92, P951, DOI 10.1016/S0954-6111(98)90195-0; Dexter F, 1996, ANESTHESIOLOGY, V84, P442, DOI 10.1097/00000542-199602000-00024; DILORENZO N, 1986, ACTA NEUROCHIR, V83, P112, DOI 10.1007/BF01402388; Eigelsreiter H, 1986, INT Z ANGEW PHYSL EI, V26, P13; Friese KI, 2011, VISUAL COMPUT, V27, P129, DOI 10.1007/s00371-010-0539-6; Gore PA, 2008, J NEUROSURG, V108, P926, DOI 10.3171/JNS/2008/108/5/0926; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HULSMANN H, 1982, ANAESTHESIST, V31, P595; JACKSON RM, 1985, CHEST, V88, P900, DOI 10.1378/chest.88.6.900; Jenkinson S G, 1993, New Horiz, V1, P504; KITAHATA LM, 1976, ANESTHESIOLOGY, V44, P448, DOI 10.1097/00000542-197605000-00022; LUNSFORD LD, 1979, J NEUROSURG, V50, P525, DOI 10.3171/jns.1979.50.4.0525; MACGILLIVRAY RG, 1982, ANAESTHESIA, V37, P722, DOI 10.1111/j.1365-2044.1982.tb01309.x; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Muehstedt SG, 2001, SURGERY, V130, P602, DOI 10.1067/msy.2001.117105; POP PM, 1982, J COMPUT ASSIST TOMO, V6, P894, DOI 10.1097/00004728-198210000-00005; Porter JM, 1999, BRIT J ANAESTH, V82, P117, DOI 10.1093/bja/82.1.117; REASONER DK, 1994, ANESTHESIOLOGY, V80, P1008, DOI 10.1097/00000542-199405000-00009; Sadeghian H, 2000, ARCH NEUROL-CHICAGO, V57, P1366, DOI 10.1001/archneur.57.9.1366; Sloan T, 2010, J NEUROSURG ANESTH, V22, P59, DOI 10.1097/ANA.0b013e3181ba99a7; STANDEFER M, 1984, NEUROSURGERY, V14, P649, DOI 10.1227/00006123-198406000-00001; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suri A, 2000, CHILD NERV SYST, V16, P196, DOI 10.1007/s003810050495; Tiruvoipati R, 2010, J CRIT CARE, V25, P463, DOI 10.1016/j.jcrc.2009.06.050; TOUNG TJK, 1986, ANESTH ANALG, V65, P65	32	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125710	10.1371/journal.pone.0125710	http://dx.doi.org/10.1371/journal.pone.0125710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992622	gold, Green Published, Green Submitted			2022-12-27	WOS:000354921400043
J	Witwicka, H; Jia, H; Kutikov, A; Reyes-Gutierrez, P; Li, XD; Odgren, PR				Witwicka, Hanna; Jia, Hong; Kutikov, Artem; Reyes-Gutierrez, Pablo; Li, Xiangdong; Odgren, Paul R.			TRAFD1 (FLN29) Interacts with Plekhm1 and Regulates Osteoclast Acidification and Resorption	PLOS ONE			English	Article							MEDIATED EXTRACELLULAR ACIDIFICATION; RUFFLED BORDER FORMATION; VESICULAR TRAFFICKING; BONE-RESORPTION; CATHEPSIN-K; OSTEOPETROSIS; PROTEIN; GENE; MUTATION; PATHWAY	Plekhm1 is a large, multi-modular, adapter protein implicated in osteoclast vesicle trafficking and bone resorption. In patients, inactivating mutations cause osteopetrosis, and gain-of-function mutations cause osteopenia. Investigations of potential Plekhm1 interaction partners by mass spectrometry identified TRAFD1 (FLN29), a protein previously shown to suppress toll-like receptor signaling in monocytes/macrophages, thereby dampening inflammatory responses to innate immunity. We mapped the binding domains to the TRAFD1 zinc finger (aa 37-60), and to the region of Plekhm1 between its second pleckstrin homology domain and its C1 domain (aa 784-986). RANKL slightly increased TRAFD1 levels, particularly in primary osteoclasts, and the co-localization of TRAFD1 with Plekhm1 also increased with RANKL treatment. Stable knockdown of TRAFD1 in RAW 264.7 cells inhibited resorption activity proportionally to the degree of knockdown, and inhibited acidification. The lack of acidification occurred despite the presence of osteoclast acidification factors including carbonic anhydrase II, a3-V-ATPase, and the ClC7 chloride channel. Secretion of TRAP and cathepsin K were also markedly inhibited in knockdown cells. Truncated Plekhm1 in ia/ia osteopetrotic rat cells prevented vesicle localization of Plekhm1 and TRAFD1. We conclude that TRAFD1, in association with Plekhm1/Rab7-positive late endosomes-early lysosomes, has a previously unknown role in vesicle trafficking, acidification, and resorption in osteoclasts.	[Witwicka, Hanna; Jia, Hong; Kutikov, Artem; Reyes-Gutierrez, Pablo; Li, Xiangdong; Odgren, Paul R.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Odgren, PR (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA.	paul.odgren@umassmed.edu			US National Institute of Dental and Craniofacial Research [DE007444]; US National Institute of Arthritis, Musculoskeletal and Skin Diseases [AR061504]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE007444] Funding Source: NIH RePORTER	US National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); US National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Grant number DE007444 to PRO from US National Institute of Dental and Craniofacial Research. Grant number AR061504 to PRO from the US National Institute of Arthritis, Musculoskeletal and Skin Diseases.	Aker M, 2012, J MED GENET, V49, P221, DOI 10.1136/jmedgenet-2011-100520; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Barak B, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00149; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; Bone HG, 2014, OSTEOPOROSIS INT; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004; Cremasco V, 2012, J BONE MINER RES, V27, P2452, DOI 10.1002/jbmr.1701; Del Fattore A, 2008, J BONE MINER RES, V23, P380, DOI 10.1359/JBMR.071107; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kloet SL, 2012, MOL CELL BIOL, V32, P3358, DOI 10.1128/MCB.00416-12; Lee KS, 2010, J BIOL CHEM, V285, P33779, DOI 10.1074/jbc.M110.124255; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Mashima R, 2005, J BIOL CHEM, V280, P41289, DOI 10.1074/jbc.M508221200; McEwan DG, 2015, CELL HOST MICROBE, V17, P58, DOI 10.1016/j.chom.2014.11.011; Megarbane A, 2013, EUR J MED GENET, V56, P32, DOI 10.1016/j.ejmg.2012.10.010; Ng PY, 2013, J BONE MINER RES, V28, P119, DOI 10.1002/jbmr.1725; Odgren PR, 1996, J CELL SCI, V109, P2253; Pangrazio A, 2013, J BONE MINER RES, V28, P1041, DOI 10.1002/jbmr.1849; Rajapurohitam V, 2001, BONE, V28, P513, DOI 10.1016/S8756-3282(01)00416-1; Reinholt FP, 1999, EXP CELL RES, V251, P477, DOI 10.1006/excr.1999.4585; Sanada T, 2008, J BIOL CHEM, V283, P33858, DOI 10.1074/jbc.M806923200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sobacchi C, 2013, NAT REV ENDOCRINOL, V9, P522, DOI 10.1038/nrendo.2013.137; Stenbeck G, 2004, J CELL SCI, V117, P827, DOI 10.1242/jcs.00935; Stenbeck G, 2002, SEMIN CELL DEV BIOL, V13, P285, DOI 10.1016/S1084952102000587; Stenbeck G, 2014, CURR OPIN PHARMACOL, V16, P7, DOI 10.1016/j.coph.2014.01.003; Tabata K, 2010, MOL BIOL CELL, V21, P4162, DOI 10.1091/mbc.E10-06-0495; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Witwicka H, 2014, STRUCTURE BONE; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yang DQ, 2012, J BONE MINER RES; Yang MH, 2006, BLOOD, V107, P2262, DOI 10.1182/blood-2005-08-3365; Ye SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027285; Zhao HB, 2012, TRAFFIC, V13, P1307, DOI 10.1111/j.1600-0854.2012.01395.x; Zhu C, 2012, J CELL BIOCHEM, V113, P1608, DOI 10.1002/jcb.24029	44	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127537	10.1371/journal.pone.0127537	http://dx.doi.org/10.1371/journal.pone.0127537			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992615	Green Published, Green Submitted, gold			2022-12-27	WOS:000354918600065
J	McLean, CS; Mielke, C; Cordova, JM; Langlais, PR; Bowen, B; Miranda, D; Coletta, DK; Mandarino, LJ				McLean, Carrie S.; Mielke, Clinton; Cordova, Jeanine M.; Langlais, Paul R.; Bowen, Benjamin; Miranda, Danielle; Coletta, Dawn K.; Mandarino, Lawrence J.			Gene and MicroRNA Expression Responses to Exercise; Relationship with Insulin Sensitivity	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ENCODED MITOCHONDRIAL GENES; MESSENGER-RNA EXPRESSION; ENDURANCE EXERCISE; DIFFERENTIAL REGULATION; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; RESISTANCE EXERCISE; INCREASES; EGR-1	Background Healthy individuals on the lower end of the insulin sensitivity spectrum also have a reduced gene expression response to exercise for specific genes. The goal of this study was to determine the relationship between insulin sensitivity and exercise-induced gene expression in an unbiased, global manner. Methods and Findings Euglycemic clamps were used to measure insulin sensitivity and muscle biopsies were done at rest and 30 minutes after a single acute exercise bout in 14 healthy participants. Changes in mRNA expression were assessed using microarrays, and miRNA analysis was performed in a subset of 6 of the participants using sequencing techniques. Following exercise, 215 mRNAs were changed at the probe level (Bonferroni-corrected P<0.00000115). Pathway and Gene Ontology analysis showed enrichment in MAP kinase signaling, transcriptional regulation and DNA binding. Changes in several transcription factor mRNAs were correlated with insulin sensitivity, including MYC, r=0.71; SNF1LK, r=0.69; and ATF3, r=0.61 (5 corrected for false discovery rate). Enrichment in the 5'-UTRs of exercise-responsive genes suggested regulation by common transcription factors, especially EGR1. miRNA species of interest that changed after exercise included miR-378, which is located in an intron of the PPARGC1B gene. Conclusions These results indicate that transcription factor gene expression responses to exercise depend highly on insulin sensitivity in healthy people. The overall pattern suggests a coordinated cycle by which exercise and insulin sensitivity regulate gene expression in muscle.	[Mandarino, Lawrence J.] Arizona State Univ, Sch Sci Hlth Care Delivery, Tempe, AZ 85281 USA; [McLean, Carrie S.; Mielke, Clinton; Cordova, Jeanine M.; Bowen, Benjamin; Coletta, Dawn K.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Langlais, Paul R.; Miranda, Danielle] Mayo Clin Arizona, Scottsdale, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix	Mandarino, LJ (corresponding author), Arizona State Univ, Sch Sci Hlth Care Delivery, Tempe, AZ 85281 USA.	Lawrence.mandarino@asu.edu	Coletta, Dawn/G-6382-2016		National Institute of Diabetes, Digestive and Kidney Diseases [R01DK066483, R01DK047936, F32 DK084705]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084705, R01DK047936, R01DK098493, R01DK066483] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was received from the National Institute of Diabetes, Digestive and Kidney Diseases; R01DK066483 and R01DK047936 (LJM); and F32 DK084705 (CSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Christ-Roberts CY, 2004, METABOLISM, V53, P1233, DOI 10.1016/j.metabol.2004.03.022; Coletta DK, 2011, AM J PHYSIOL-ENDOC M, V301, pE749, DOI 10.1152/ajpendo.00363.2011; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007; Dela F, 2010, AM J PHYSIOL-ENDOC M, V299, pE80, DOI 10.1152/ajpendo.00765.2009; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; GOODYEAR LJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE987, DOI 10.1152/ajpendo.1995.268.5.E987; Irrcher I, 2004, J APPL PHYSIOL, V97, P2207, DOI 10.1152/japplphysiol.00388.2004; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Jozsi AC, 2000, MECH AGEING DEV, V120, P45, DOI 10.1016/S0047-6374(00)00178-0; Koval JA, 1999, MED SCI SPORT EXER, V31, P998, DOI 10.1097/00005768-199907000-00012; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; LIM RW, 1995, BBA-MOL CELL RES, V1266, P91, DOI 10.1016/0167-4889(94)00226-5; Liu LX, 2000, BLOOD, V96, P1772, DOI 10.1182/blood.V96.5.1772.h8001772_1772_1781; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McKenzie MJ, 2007, MED SCI SPORT EXER, V39, P1515, DOI 10.1249/mss.0b013e318074c256; Nilsson MI, 2010, AM J PHYSIOL-ENDOC M, V299, pE466, DOI 10.1152/ajpendo.00118.2010; Pagel JI, 2012, INT J MOL SCI, V13, P13104, DOI 10.3390/ijms131013104; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Roberts MD, 2010, J STRENGTH COND RES, V24, P1161, DOI 10.1519/JSC.0b013e3181da786f; Rowlands DS, 2011, PHYSIOL GENOMICS, V43, P1004, DOI 10.1152/physiolgenomics.00073.2011; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Schmutz S, 2006, PFLUG ARCH EUR J PHY, V451, P678, DOI 10.1007/s00424-005-1497-0; Stepto NK, 2009, MED SCI SPORT EXER, V41, P546, DOI 10.1249/MSS.0b013e31818c6be9; Tan LJ, 2012, HUM GENET, V131, P1, DOI 10.1007/s00439-011-1040-7; Tangen SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084002; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	41	38	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127089	10.1371/journal.pone.0127089	http://dx.doi.org/10.1371/journal.pone.0127089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984722	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300090
J	Henriques, AC; De Marco, P				Henriques, Ana C.; De Marco, Paolo			Methanesulfonate (MSA) Catabolic Genes from Marine and Estuarine Bacteria	PLOS ONE			English	Article							DIMETHYL-SULFOXIDE; ACID; SULFUR; OXIDATION; MONOOXYGENASE; METABOLISM; GENOME; IDENTIFICATION; PURIFICATION; UTILIZERS	Quantitatively, methanesulfonate (MSA) is a very relevant compound in the global biogeochemical sulfur cycle. Its utilization by bacteria as a source of carbon and energy has been described and a specific enzyme, methanesulfonate monooxygenase (MSAMO), has been found to perform the first catabolic step of its oxidation. Other proteins seemingly involved in the import of MSA into bacterial cells have been reported. In this study, we obtained novel sequences of genes msmA and msmE from marine, estuary and soil MSA-degraders (encoding the large subunit of the MSAMO enzyme and the periplasmic component of the import system, respectively). We also obtained whole-genome sequences of two novel marine Filomicrobium strains, Y and W, and annotated two full msm operons in these genomes. Furthermore, msmA and msmE sequences were amplified from North Atlantic seawater and analyzed. Good conservation of the MsmA deduced protein sequence was observed in both cultured strains and metagenomic clones. A long spacer sequence in the Rieske-type [2Fe-2S] cluster-binding motif within MsmA was found to be conserved in all instances, supporting the hypothesis that this feature is specific to the large (a) subunit of the MSAMO enzyme. The msmE gene was more difficult to amplify, from both cultivated isolates and marine metagenomic DNA. However, 3 novel msmE sequences were obtained from isolated strains and one directly from seawater. With both genes, our results combined with previous metagenomic analyses seem to imply that moderate to high-GC strains are somehow favored during enrichment and isolation of MSA-utilizing bacteria, while the majority of msm genes obtained by cultivation-independent methods have low levels of GC%, which is a clear example of the misrepresentation of natural populations that culturing, more often than not, entails. Nevertheless, the data obtained in this work show that MSA-degrading bacteria are abundant in surface seawater, which suggests ecological relevance for this metabolic group of bacteria.	[Henriques, Ana C.; De Marco, Paolo] CESPU, Inst Invest & Formacao Avancada Ciencias & Tecnol, P-4585116 Paredes, Portugal		De Marco, P (corresponding author), CESPU, Inst Invest & Formacao Avancada Ciencias & Tecnol, Rua Cent Gandra 1317, P-4585116 Paredes, Portugal.	paolo.marco@iscsn.cespu.pt	Henriques, Ana/AAB-6368-2022; De Marco, Paolo/ABI-4126-2020	Henriques, Ana/0000-0002-4951-792X; De Marco, Paolo/0000-0002-9322-6986	Competitiveness Factors Operational Program (COMPETE) [PTDC/BIA-MIC/3623/2012, FCOMP-01-0124-FEDER-028330]	Competitiveness Factors Operational Program (COMPETE)	This work was supported by the following sources of funding: PTDC/BIA-MIC/3623/2012 (http://www.fct.pt/) and FCOMP-01-0124-FEDER-028330 Competitiveness Factors Operational Program (COMPETE) (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREAE MO, 1986, ROLE AIR SEA EXCHANG, P331, DOI DOI 10.1007/978-94-009-4738-2_14; BAKER SC, 1991, NATURE, V350, P627, DOI 10.1038/350627a0; Barnes I, 2006, CHEM REV, V106, P940, DOI 10.1021/cr020529+; Baxter NJ, 2002, APPL ENVIRON MICROB, V68, P289, DOI 10.1128/AEM.68.1.289-296.2002; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Chen XK, 2010, J PHYS CHEM B, V114, P15546, DOI 10.1021/jp1078339; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; De Marco P, 1999, J BACTERIOL, V181, P2244, DOI 10.1128/JB.181.7.2244-2251.1999; De Marco P, 2004, FEMS MICROBIOL LETT, V234, P75, DOI 10.1111/j.1574-6968.2004.tb09515.x; De Marco P, 2000, ARCH MICROBIOL, V173, P146, DOI 10.1007/s002039900124; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Denger K, 2008, MICROBIOL-SGM, V154, P256, DOI 10.1099/mic.0.2007/011650-0; Friedrich CG, 2008, MICROBIAL SULFUR METABOLISM, P139, DOI 10.1007/978-3-540-72682-1_12; Gifford SM, 2013, ISME J, V7, P281, DOI 10.1038/ismej.2012.96; Gondwe M., 2003, GLOBAL BIOGEOCHEM CY, V17; Higgins TP, 1997, J BACTERIOL, V179, P1974, DOI 10.1128/jb.179.6.1974-1979.1997; Holmes AJ, 1997, ARCH MICROBIOL, V167, P46, DOI 10.1007/s002030050415; HYNES AJ, 1986, J PHYS CHEM-US, V90, P4148, DOI 10.1021/j100408a062; Jamshad M, 2006, APPL ENVIRON MICROB, V72, P276, DOI 10.1128/AEM.72.1.276-283.2006; Jamshad M, 2007, PROTEIN EXPRES PURIF, V52, P472, DOI 10.1016/j.pep.2006.11.001; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Kang I, 2013, P NATL ACAD SCI USA, V110, P12343, DOI 10.1073/pnas.1219930110; Kelly DP, 1999, ARCH MICROBIOL, V172, P341, DOI 10.1007/s002030050770; KELLY DP, 1990, FEMS MICROBIOL LETT, V87, P241, DOI 10.1111/j.1574-6968.1990.tb04919.x; KELLY DP, 1994, MICROBIOL-SGM, V140, P1419, DOI 10.1099/00221287-140-6-1419; Kittichotirat W, 2011, J BACTERIOL, V193, P4541, DOI 10.1128/JB.05331-11; KOGA S, 1993, J ATMOS CHEM, V17, P201, DOI 10.1007/BF00694398; LANGNER J, 1991, J ATMOS CHEM, V13, P225, DOI 10.1007/BF00058134; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEGRAND M, 1991, GEOPHYS RES LETT, V18, P187, DOI 10.1029/90GL02784; Leitao E, 2009, J BASIC MICROB, V49, pS24, DOI 10.1002/jobm.200800223; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; MIHALOPOULOS N, 1992, J ATMOS CHEM, V14, P459, DOI 10.1007/BF00115251; Moosvi SA, 2005, ENVIRON MICROBIOL, V7, P22, DOI 10.1111/j.1462-2920.2004.00661.x; Murrell JC, 1996, NATO ASI SER SER I, V39, P243; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Oh HM, 2010, J BACTERIOL, V192, P3240, DOI 10.1128/JB.00347-10; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reichenbecher W, 1999, ARCH MICROBIOL, V172, P387, DOI 10.1007/s002030050775; Reichenbecher W, 1999, ARCH MICROBIOL, V171, P430, DOI 10.1007/s002030050730; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sayers EW, 2010, NUCL ACIDS RES S1, V39, P38; THOMPSON AS, 1995, APPL ENVIRON MICROB, V61, P2388, DOI 10.1128/AEM.61.6.2388-2393.1995; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vogt M, 2009, GEOPHYS MONOGR SER, V187, P197, DOI 10.1029/2008GM000790; von Glasow R, 2004, ATMOS CHEM PHYS, V4, P589, DOI 10.5194/acp-4-589-2004; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; WHUNG PY, 1994, J GEOPHYS RES-ATMOS, V99, P1147, DOI 10.1029/93JD02732	48	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125735	10.1371/journal.pone.0125735	http://dx.doi.org/10.1371/journal.pone.0125735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978049	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100035
J	Liu, Y; Li, JY; Liu, XY; Liu, XD; Khawar, WQ; Zhang, XY; Wang, F; Chen, XX; Sun, Z				Liu, Yao; Li, Jianying; Liu, Xiaoyong; Liu, Xudong; Khawar, Waqaar; Zhang, Xinyan; Wang, Fan; Chen, Xiaoxin; Sun, Zheng			Quantitative Risk Stratification of Oral Leukoplakia with Exfoliative Cytology	PLOS ONE			English	Article							POTENTIALLY MALIGNANT DISORDERS; DNA-IMAGE-CYTOMETRY; EARLY-DIAGNOSIS; BRUSH BIOPSIES; CANCER; LESIONS; CARCINOMA; CLASSIFICATION; TRANSFORMATION; DYSPLASIA	Exfoliative cytology has been widely used for early diagnosis of oral squamous cell carcinoma (OSCC). Test outcome is reported as "negative", "atypical" (defined as abnormal epithelial changes of uncertain diagnostic significance), and "positive" (defined as definitive cellular evidence of epithelial dysplasia or carcinoma). The major challenge is how to properly manage the "atypical" patients in order to diagnose OSCC early and prevent OSCC. In this study, we collected exfoliative cytology data, histopathology data, and clinical data of normal subjects (n=102), oral leukoplakia (OLK) patients (n=82), and OSCC patients (n= 93), and developed a data analysis procedure for quantitative risk stratification of OLK patients. This procedure involving a step called expert-guided data transformation and reconstruction (EdTAR) which allows automatic data processing and reconstruction and reveals informative signals for subsequent risk stratification. Modern machine learning techniques were utilized to build statistical prediction models on the reconstructed data. Among the several models tested using resampling methods for parameter pruning and performance evaluation, Support Vector Machine (SVM) was found to be optimal with a high sensitivity (median>0.98) and specificity (median>0.99). With the SVM model, we constructed an oral cancer risk index (OCRI) which may potentially guide clinical follow-up of OLK patients. One OLK patient with an initial OCRI of 0.88 developed OSCC after 40 months of follow-up. In conclusion, we have developed a statistical method for qualitative risk stratification of OLK patients. This method may potentially improve cost-effectiveness of clinical follow-up of OLK patients, and help design clinical chemoprevention trial for highrisk populations.	[Liu, Yao; Liu, Xiaoyong; Sun, Zheng] Capital Med Univ, Beijing Stomatol Hosp, Dept Oral Med, Beijing, Peoples R China; [Li, Jianying] Euclados Bioinformat Solut, Cary, NC USA; [Liu, Xudong] Queens Univ, Ongwandada Resource Ctr, Kingston, ON, Canada; [Khawar, Waqaar] Ross Univ, Sch Med, Miramar, FL USA; [Zhang, Xinyan] Capital Med Univ, Sch Stomatol, Beijing Inst Dent Res, Beijing, Peoples R China; [Wang, Fan] Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Cent Hosp, Xiangyang, Hubei Province, Peoples R China; [Chen, Xiaoxin] N Carolina Cent Univ, Canc Res Program, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA	Capital Medical University; Queens University - Canada; Capital Medical University; Hubei University of Arts & Science; University of North Carolina; North Carolina Central University	Chen, XX (corresponding author), N Carolina Cent Univ, Canc Res Program, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA.	lchen@nccu.edu; zhengsun12@vip.126.com			Beijing Municipal Administration of Hospitals Key Medical Project [ZYLX201407]; National Natural Science Foundation of China [81372897]	Beijing Municipal Administration of Hospitals Key Medical Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This article was partially supported by Beijing Municipal Administration of Hospitals Key Medical Project (ZYLX201407) and a grant from National Natural Science Foundation of China (81372897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2009, ANN DIAGN PATHOL, V13, P140, DOI 10.1016/j.anndiagpath.2008.12.003; Anantharaman D, 2011, ORAL ONCOL, V47, P725, DOI 10.1016/j.oraloncology.2011.05.004; [Anonymous], 2014, R LANG ENV STAT COMP; Arpino G, 2013, BREAST, V22, P109, DOI 10.1016/j.breast.2013.01.016; Awan KH, 2011, ORAL ONCOL, V47, P274, DOI 10.1016/j.oraloncology.2011.02.001; Barnes L, 2005, PATHOLOGY GENETICS H, P177; Barnes L., 2005, WHO CLASSIFICATION T; Brouns ER, 2013, MED ORAL PATOL ORAL, V18, pE19, DOI 10.4317/medoral.18756; Cervigne NK, 2014, HUM MOL GENET, V23, P2618, DOI 10.1093/hmg/ddt657; Chaturvedi P, 2010, J CANCER RES THER, V6, P497, DOI 10.4103/0973-1482.77097; COEN H, 1992, ANAL CELL PATHOL, V4, P273; Di Narzo AF, 2014, JNCI-J NATL CANCER I, P106, DOI [10.1093/jncimonographs/lgu003, DOI 10.1093/JNCIM0N0GRAPHS/LGU003]; Domany E, 2014, CANCER RES, V74, P4612, DOI 10.1158/0008-5472.CAN-13-3338; Gomez I, 2009, EUR J ORAL SCI, V117, P541, DOI 10.1111/j.1600-0722.2009.00672.x; GUPTA PC, 1980, COMMUNITY DENT ORAL, V8, P287, DOI 10.1111/j.1600-0528.1980.tb01302.x; Jadhav K, 2011, J CYTOL, V28, P7, DOI 10.4103/0970-9371.76941; Kammerer PW, 2013, ORAL ONCOL, V49, P420, DOI 10.1016/j.oraloncology.2012.12.006; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kim DJ, 2004, J CLIN EPIDEMIOL, V57, P332, DOI 10.1016/j.jclinepi.2003.08.013; Kuhn MJ, 2013, KJELL APPL PREDICTIV; Lee JJ, 2006, ORAL SURG ORAL MED O, V101, P472, DOI 10.1016/j.tripleo.2005.07.024; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034773; Lohavanichbutr P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046575; Ma JM, 2014, EUR ARCH OTO-RHINO-L, V271, P3291, DOI 10.1007/s00405-014-2935-4; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Maraki D, 2006, J ORAL PATHOL MED, V35, P227, DOI 10.1111/j.1600-0714.2006.00401.x; Maraki D, 2006, J ORAL PATHOL MED, V35, P58, DOI 10.1111/j.1600-0714.2005.00333.x; Maraki D, 2004, J ORAL PATHOL MED, V33, P398, DOI 10.1111/j.1600-0714.2004.0235.x; Mehrotra R, 2009, J ORAL PATHOL MED, V38, P161, DOI 10.1111/j.1600-0714.2008.00709.x; Messadi DV, 2013, INT J ORAL SCI, V5, P59, DOI 10.1038/ijos.2013.24; Nagao T, 2005, J ORAL PATHOL MED, V34, P532, DOI 10.1111/j.1600-0714.2005.00349.x; Pektas ZO, 2006, J ORAL MAXIL SURG, V64, P628, DOI 10.1016/j.joms.2005.12.010; Pentenero M, 2009, ORAL ONCOL, V45, P887, DOI 10.1016/j.oraloncology.2009.03.008; Pickering CR, 2014, CLIN CANCER RES, V20, P3842, DOI 10.1158/1078-0432.CCR-14-0565; Ramshankar V, 2014, ASIAN PAC J CANCER P, V15, P8351, DOI 10.7314/APJCP.2014.15.19.8351; Remmerbach TW, 2003, ANAL CELL PATHOL, V25, P159, DOI 10.1155/2003/305151; Remmerbach TW, 2003, ANAL CELL PATHOL, V25, P139, DOI 10.1155/2003/647685; Rhodus Nelson L, 2014, Dent Clin North Am, V58, P315, DOI 10.1016/j.cden.2013.12.004; Saintigny P, 2011, CANCER PREV RES, V4, P218, DOI 10.1158/1940-6207.CAPR-10-0155; Scheifele C, 2004, ORAL ONCOL, V40, P824, DOI 10.1016/j.oraloncology.2004.02.004; Sciubba JJ, 1999, J AM DENT ASSOC, V130, P1445, DOI 10.14219/jada.archive.1999.0055; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silverman S, 2001, J AM DENT ASSOC, V132, p7S, DOI 10.14219/jada.archive.2001.0382; Stelow Edward B, 2005, Am J Clin Pathol, V124 Suppl, pS96; van der Waal I, 2014, MED ORAL PATOL ORAL, V19, pE386, DOI 10.4317/medoral.20205; Vijayavel T, 2013, J Oral Maxillofac Pathol, V17, P169, DOI 10.4103/0973-029X.119747; Wand MPJ, 2000, KERNEL SMOOTHING; Warnakulasuriya S, 2008, J ORAL PATHOL MED, V37, P127, DOI 10.1111/j.1600-0714.2007.00584.x; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Zhang SK, 2015, CHINESE J CANCER RES, V27, P44, DOI 10.3978/j.issn.1000-9604.2015.01.03	51	5	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126760	10.1371/journal.pone.0126760	http://dx.doi.org/10.1371/journal.pone.0126760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978541	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100098
J	Lonnqvist, JE; Hennig-Schmidt, H; Walkowitz, G				Loennqvist, Jan-Erik; Hennig-Schmidt, Heike; Walkowitz, Gari			Ethnicity- and Sex-Based Discrimination and the Maintenance of Self-Esteem	PLOS ONE			English	Article							SOCIAL IDENTITY THEORY; INTERGROUP DISCRIMINATION; LABOR-MARKET; BEHAVIOR; GENDER; CATEGORIZATION; ECONOMICS; SELECTION; BIAS; VALIDATION	The psychological underpinnings of labor market discrimination were investigated by having participants from Israel, the West Bank and Germany (N = 205) act as employers in a stylized employment task in which they ranked, set wages, and imposed a minimum effort level on applicants. State self-esteem was measured before and after the employment task, in which applicant ethnicity and sex were salient. The applicants were real people and all behavior was monetarily incentivized. Supporting the full self-esteem hypothesis of the social identity approach, low self-esteem in women was associated with assigning higher wages to women than to men, and such behavior was related to the maintenance of self-esteem. The narrower hypothesis that successful intergroup discrimination serves to protect self-esteem received broader support. Across all participants, both ethnicity- and sex-based discrimination of out-groups were associated with the maintenance of self-esteem, with the former showing a stronger association than the latter.	[Loennqvist, Jan-Erik] Univ Helsinki, Swedish Sch Social Sci, Helsinki, Finland; [Hennig-Schmidt, Heike; Walkowitz, Gari] Univ Bonn, Lab Expt Econ, Bonn, Germany; [Hennig-Schmidt, Heike] Univ Oslo, Oslo, Norway; [Walkowitz, Gari] Univ Cologne, Dept Corp Dev & Business Eth, D-50931 Cologne, Germany	University of Helsinki; University of Bonn; University of Oslo; University of Cologne	Walkowitz, G (corresponding author), Univ Cologne, Dept Corp Dev & Business Eth, D-50931 Cologne, Germany.	gari.walkowitz@uni-koeln.de	Hennig-Schmidt, Heike/L-2924-2017; Walkowitz, Gari/L-6016-2017	Hennig-Schmidt, Heike/0000-0002-2841-4657; Lonnqvist, Jan-Erik/0000-0001-8292-6090	Deutsche Forschungsgemeinschaft [SE 137/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Financial support is gratefully acknowledged by Deutsche Forschungsgemeinschaft (SE 137/3-1).	Aberson CL, 2000, PERS SOC PSYCHOL REV, V4, P157, DOI 10.1207/S15327957PSPR0402_04; Akerlof GA, 2002, J ECON LIT, V40, P1167, DOI 10.1257/002205102762203585; Akerlof GA, 2005, J ECON PERSPECT, V19, P9, DOI 10.1257/0895330053147930; Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; AKERLOF GA, 1982, Q J ECON, V97, P543, DOI 10.2307/1885099; Altonji J.G., 1999, HDB LABOR EC, VVol.3, P3143; ARROW KJ, 1972, PHILOS PUBLIC AFF, V1, P343; BECKETT NE, 1995, PERS SOC PSYCHOL B, V21, P21, DOI 10.1177/0146167295211004; Benabou R, 2011, Q J ECON, V126, P805, DOI 10.1093/qje/qjr002; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Billig M, 1995, BANAL NATL; BRANSCOMBE NR, 1994, EUR J SOC PSYCHOL, V24, P641, DOI 10.1002/ejsp.2420240603; Brown R, 2000, EUR J SOC PSYCHOL, V30, P745, DOI 10.1002/1099-0992(200011/12)30:6<745::AID-EJSP24>3.0.CO;2-O; Charness G, 2007, AM ECON REV, V97, P1340, DOI 10.1257/aer.97.4.1340; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Cohen GL, 2005, J PERS SOC PSYCHOL, V89, P566, DOI 10.1037/0022-3514.89.4.566; Crisp RJ, 2011, PERSONALITY SOCIAL P, V27, P76; CROCKER J, 1987, J PERS SOC PSYCHOL, V52, P907, DOI 10.1037/0022-3514.52.5.907; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; Eckel CC, 2005, J ECON BEHAV ORGAN, V58, P371, DOI 10.1016/j.jebo.2004.01.003; Falk A, 2006, AM ECON REV, V96, P1611, DOI 10.1257/aer.96.5.1611; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fehr E, 1998, EUR ECON REV, V42, P1, DOI 10.1016/S0014-2921(96)00051-7; Fein S, 1997, J PERS SOC PSYCHOL, V73, P31, DOI 10.1037/0022-3514.73.1.31; Fershtman C, 2001, Q J ECON, V116, P351, DOI 10.1162/003355301556338; GUTEK BA, 1991, J APPL PSYCHOL, V76, P560, DOI 10.1037/0021-9010.76.4.560; Hagendoorn L., 2002, GROUP PROCESS INTERG, V5, P285; Halperin E, 2010, J PEACE RES, V47, P59, DOI 10.1177/0022343309350013; HAMPTON MB, 1993, IND LABOR RELAT REV, V47, P36, DOI 10.2307/2524230; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Hoff K, 2006, AM ECON REV, V96, P206, DOI 10.1257/000282806777212611; Hogg M. A., 2000, EUR REV SOC PSYCHOL, V11, P223, DOI DOI 10.1080/14792772043000040; HOGG MA, 1985, BRIT J SOC PSYCHOL, V24, P267, DOI 10.1111/j.2044-8309.1985.tb00690.x; HOGG MA, 1987, BRIT J SOC PSYCHOL, V26, P325, DOI 10.1111/j.2044-8309.1987.tb00795.x; Hornsey MJ, 2008, SOC PERSONAL PSYCHOL, V2, P204, DOI 10.1111/j.1751-9004.2007.00066.x; Hunter JA, 1996, EUR J SOC PSYCHOL, V26, P631, DOI 10.1002/(SICI)1099-0992(199607)26:4<631::AID-EJSP783>3.0.CO;2-V; Leary, 2005, EUROPEAN REV SOCIAL, V16, P75, DOI [10.1080/10463280540000007, DOI 10.1080/10463280540000007]; LEMYRE L, 1985, J PERS SOC PSYCHOL, V49, P660, DOI 10.1037/0022-3514.49.3.660; Lonnqvist JE, 2011, PERS INDIV DIFFER, V50, P300, DOI 10.1016/j.paid.2010.10.009; Lyness KS, 2006, J APPL PSYCHOL, V91, P777, DOI 10.1037/0021-9010.91.4.777; Marlowe CM, 1996, J APPL PSYCHOL, V81, P11, DOI 10.1037/0021-9010.81.1.11; McCrae RR, 2011, PERS SOC PSYCHOL REV, V15, P28, DOI 10.1177/1088868310366253; MEINDL JR, 1984, J PERS SOC PSYCHOL, V47, P71, DOI 10.1037/0022-3514.47.1.71; Mummendey A., 1998, EUROPEAN REV SOCIAL, V9, P107, DOI [10.1080/14792779843000063, DOI 10.1080/14792779843000063]; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; OAKES PJ, 1980, EUR J SOC PSYCHOL, V10, P295, DOI 10.1002/ejsp.2420100307; Pager D, 2009, AM SOCIOL REV, V74, P777, DOI 10.1177/000312240907400505; Rensmann Lars, 2004, COLLECTIVE GUILT INT, P169, DOI DOI 10.1017/CBO9781139106931.012; Richard FD, 2003, REV GEN PSYCHOL, V7, P331, DOI 10.1037/1089-2680.7.4.331; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Rubin M, 1998, Pers Soc Psychol Rev, V2, P40, DOI 10.1207/s15327957pspr0201_3; Scheepers D., 2009, PERSONALITY SOCIAL P, V35, P505; Schmader T, 2010, CURR DIR PSYCHOL SCI, V19, P14, DOI 10.1177/0963721409359292; Sheskin D.J., 1997, HDB PARAMETRIC NONPA; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Slonim R, 2008, EXP ECON, V11, P134, DOI 10.1007/s10683-007-9162-4; Slonim R, 2010, J ECON BEHAV ORGAN, V76, P385, DOI 10.1016/j.jebo.2010.06.016; Tajfel, 1978, DIFFERENTIATION SOCI, P101; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Tajfel H, 1971, SOCIAL PSYCHOL INTER, P33; TESSER A, 1991, J EXP SOC PSYCHOL, V27, P501, DOI 10.1016/0022-1031(91)90023-Y; Tomaskovic-Devey D, 2005, AM J SOCIOL, V111, P58, DOI 10.1086/431779; Turner J. C., 1982, SOCIAL IDENTITY INTE, P15; Turner J.C., 1987, REDISCOVERING SOCIAL; TURNER JC, 1979, EUR J SOC PSYCHOL, V9, P187, DOI 10.1002/ejsp.2420090207; TURNER JC, 1980, EUR J SOC PSYCHOL, V10, P131, DOI 10.1002/ejsp.2420100203; Turner JC., 1999, SOCIAL IDENTITY CONT, P6; Umphress EE, 2008, J APPL PSYCHOL, V93, P982, DOI 10.1037/0021-9010.93.5.982; Vanbeselaere, 1991, EUROPEAN REV SOCIAL, V2, P247, DOI DOI 10.1080/14792779143000088; Vanbeselaere N, 1996, EUR J SOC PSYCHOL, V26, P75, DOI 10.1002/(SICI)1099-0992(199601)26:1<75::AID-EJSP738>3.0.CO;2-Q; Verkuyten M, 2007, J APPL SOC PSYCHOL, V37, P486, DOI 10.1111/j.1559-1816.2007.00170.x; WAGNER U, 1986, BRIT J SOC PSYCHOL, V25, P15, DOI 10.1111/j.2044-8309.1986.tb00697.x; Zanna M.P., 1982, CONSISTENCY SOCIAL B, P283; Ziegert JC, 2005, J APPL PSYCHOL, V90, P553, DOI 10.1037/0021-9010.90.3.553	77	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124622	10.1371/journal.pone.0124622	http://dx.doi.org/10.1371/journal.pone.0124622			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978646	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000354916100017
J	Tosello, B; Dany, L; Betremieux, P; Le Coz, P; Auquier, P; Gire, C; Einaudi, MA				Tosello, Barthelemy; Dany, Lionel; Betremieux, Pierre; Le Coz, Pierre; Auquier, Pascal; Gire, Catherine; Einaudi, Marie-Ange			Barriers in Referring Neonatal Patients to Perinatal Palliative Care: A French Multicenter Survey	PLOS ONE			English	Article							FETAL ANOMALIES; ETHICAL ASPECTS; MEDICINE; DIAGNOSIS; TERMINATION; MANAGEMENT; PREGNANCY; NEWBORN; LIFE	Background When an incurable fetal condition is detected, some women (or couples) would rather choose to continue with the pregnancy than opt for termination of pregnancy for medical reasons, which, in France, can be performed until full term. Such situations are frequently occurring and sometimes leading to the implementation of neonatal palliative care. The objectives of this study were to evaluate the practices of perinatal care french professionals in this context; to identify the potential obstacles that might interfere with the provision of an appropiate neonatal palliative care; and, from an opposite perspective, to determine the criteria that led, in some cases, to offer this type of care for prenatally diagnosed lethal abnormality. Methods We used an email survey sent to 434 maternal-fetal medicine specialists (MFMs) and fetal care pediatric specialists (FCPs) at 48 multidisciplinary centers for prenatal diagnosis (MCPD). Results Forty-two multidisciplinary centers for prenatal diagnosis (87.5%) took part. In total, 102 MFMs and 112 FCPs completed the survey, yielding response rate of 49.3%. One quarter of professionals (26.2%) estimated that over 20% of fetal pathologies presenting in MCPD could correspond to a diagnosis categorized as lethal (FCPs versus MFMs: 24% vs 17.2%, p = 0.04). The mean proportion of fetal abnormalities eligible for palliative care at birth was estimated at 19.30% (+/- 2.4) (FCPs versus MFMs: 23.4% vs 15.2%, p = 0.029). The degree of diagnostic certainty appears to be the most influencing factor (98.1%, n = 207) in the information provided to the pregnant woman with regard to potential neonatal palliative care. The vast majority of professionals, 92.5%, supported considering the practice of palliative care as a regular option to propose antenatally. Conclusions Our study reveals the clear need for training perinatal professionals in perinatal palliative care and for the standardization of practices in this field.	[Tosello, Barthelemy; Le Coz, Pierre; Einaudi, Marie-Ange] Aix Marseille Univ, EFS, CNRS, UMR 7268,ADES,Espace Eth Mediterraneen, F-13005 Marseille, France; [Tosello, Barthelemy; Gire, Catherine] Hosp Nord, AP HP, Dept Neonatol, F-13015 Marseille, France; [Dany, Lionel] Aix Marseille Univ, LPS EA 849, F-13621 Aix En Provence, France; [Dany, Lionel] Hosp La Timone, AP HP, Dept Oncol, F-13005 Marseille, France; [Betremieux, Pierre] Univ Hosp Ctr, Hosp Sud, Dept Neonatol, Multidisciplinary Ctr Prenatal Diag, F-35000 Rennes, France; [Auquier, Pascal] Aix Marseille Univ, EA 3279, Self Perceived Hlth Assessment Res Unit, F-13005 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Rennes; UDICE-French Research Universities; Aix-Marseille Universite	Tosello, B (corresponding author), Aix Marseille Univ, EFS, CNRS, UMR 7268,ADES,Espace Eth Mediterraneen, F-13005 Marseille, France.	barthelemy.tosello@ap-hm.fr		Tosello, Barthelemy/0000-0002-1801-9944; Dany, Lionel/0000-0003-2350-4300				[Anonymous], 2012, RAPP MED SCI ASS MED; Aubry R., 2011, ETAT LIEUX DEV SOINS; Aubry R, 2011, PREMIER ETAT LIEUX R; Azria E, 2008, GYNECOL OBSTET FERTI, V36, P476, DOI 10.1016/j.gyobfe.2008.02.014; Balaguer A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-25; Betremieux P, 2010, ARCH PEDIATRIE, V17, P413, DOI 10.1016/j.arcped.2010.01.016; Betremieux P, 2009, ARCH PEDIATRIE, V16, P603, DOI 10.1016/S0929-693X(09)74083-7; Betremieux P, 2010, PRENATAL DIAG, V30, P1112, DOI 10.1002/pd.2621; Bijma HH, 2004, PRENATAL DIAG, V24, P890, DOI 10.1002/pd.883; Breeze ACG, 2013, SEMIN FETAL NEONAT M, V18, P68, DOI 10.1016/j.siny.2012.09.004; Dageville C, 2008, GYNECOL OBSTET FERTI, V36, P571, DOI 10.1016/j.gyobfe.2008.04.003; de Rooy L, 2012, EARLY HUM DEV, V88, P73, DOI 10.1016/j.earlhumdev.2011.12.009; Dommergues M, 2000, J PEDIAT PUERICULT, P67; Dommergues M, 2010, PRENATAL DIAG, V30, P531, DOI 10.1002/pd.2510; Houfflin-Debarge V, 2013, J GYNECOL OBST BIO R, V42, P966, DOI 10.1016/j.jgyn.2013.09.018; International Society of Ultrasound in Obstetrics and Gynecology, 2014, STAND GUID; Leuthner SR, 2004, CLIN PERINATOL, V31, P649, DOI 10.1016/j.clp.2004.04.018; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; McMahon SR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e299; McNamara, 2013, PERINATAL PALLIATIVE; Ralston SJ, 2011, PEDIATRICS, V128, pE473, DOI 10.1542/peds.2011-1570; Simeoni U, 2007, ARCH PEDIATRIE, V14, P1171, DOI 10.1016/j.arcped.2007.07.003; Tosello B, 2013, GYNECOL OBSTET FERTI, V41, P251, DOI 10.1016/j.gyobfe.2013.02.013; Tosello B, 2014, J PALLIAT MED, V17, P924, DOI 10.1089/jpm.2014.0023; Whitworth M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007058.pub2; Wilkinson D, 2014, SEMIN FETAL NEONAT M, V19, P306, DOI 10.1016/j.siny.2014.08.007; Wool C, 2013, JOGNN-J OBST GYN NEO, V42, P372, DOI 10.1111/1552-6909.12034; Wool C, 2013, JOGNN-J OBST GYN NEO, V42, P48, DOI 10.1111/j.1552-6909.2012.01432.x	28	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126861	10.1371/journal.pone.0126861	http://dx.doi.org/10.1371/journal.pone.0126861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978417	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100110
J	Wang, H; Li, M; Deng, L; Wang, BH				Wang, Hui; Li, Ming; Deng, Lin; Wang, Bing-Hong			Percolation on Networks with Conditional Dependence Group	PLOS ONE			English	Article							FAILURES	Recently, the dependence group has been proposed to study the robustness of networks with interdependent nodes. A dependence group means that a failed node in the group can lead to the failures of the whole group. Considering the situation of real networks that one failed node may not always break the functionality of a dependence group, we study a cascading failure model that a dependence group fails only when more than a fraction beta of nodes of the group fail. We find that the network becomes more robust with the increasing of the parameter beta. However, the type of percolation transition is always first order unless the model reduces to the classical network percolation model, which is independent of the degree distribution of the network. Furthermore, we find that a larger dependence group size does not always make the networks more fragile. We also present exact solutions to the size of the giant component and the critical point, which are in agreement with the simulations well.	[Wang, Hui; Deng, Lin] Hefei Univ Technol, Sch Comp & Informat, Hefei 230009, Anhui, Peoples R China; [Wang, Hui; Li, Ming; Wang, Bing-Hong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Wang, Hui; Deng, Lin] Hefei Univ Technol, Informat Construct & Dev Ctr, Hefei 230009, Anhui, Peoples R China; [Wang, Hui] Anhui Univ, Ctr Informat Support & Assurance Technol, Hefei 230601, Anhui, Peoples R China	Hefei University of Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Hefei University of Technology; Anhui University	Li, M (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China.	minglichn@ustc.edu.cn; bhwang@ustc.edu.cn	Li, Ming/G-3911-2015	Li, Ming/0000-0002-8545-0726	National Natural Science Foundation of China [11275186]; Joint Laboratory of Flight Vehicle Ocean-based Measurement and Control [FOM2014OF001]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Laboratory of Flight Vehicle Ocean-based Measurement and Control; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is funded by the National Natural Science Foundation of China (Grant No.: 11275186) and the Open Funding Programme of Joint Laboratory of Flight Vehicle Ocean-based Measurement and Control (Grant No.: FOM2014OF001). ML is also supported by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bashan A, 2013, NAT PHYS, V9, P667, DOI 10.1038/NPHYS2727; Bashan A, 2011, J STAT PHYS, V145, P686, DOI 10.1007/s10955-011-0333-5; Bashan A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051127; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bollobas B., 1985, RANDOM GRAPHS; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; D'Agostino G, 2014, UNDERST COMPLEX SYST, pVII; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Li M, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/56002; Li M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/093013; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016132, 10.1103/PhysRevE.64.026118]; Parshani R, 2011, P NATL ACAD SCI USA, V108, P1007, DOI 10.1073/pnas.1008404108; Son SW, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/16006; Son SW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.195702; Zhou D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066103; Zhou D, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012803	21	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126674	10.1371/journal.pone.0126674	http://dx.doi.org/10.1371/journal.pone.0126674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978634	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100088
J	Kumar, P; Gullberg, U; Olsson, I; Ajore, R				Kumar, Parveen; Gullberg, Urban; Olsson, Inge; Ajore, Ram			Myeloid Translocation Gene-16 Co-Repressor Promotes Degradation of Hypoxia-Inducible Factor 1	PLOS ONE			English	Article							OXYGEN-DEPENDENT DEGRADATION; ACUTE MYELOGENOUS LEUKEMIA; CANCER-CELL METABOLISM; FUSION TRANSCRIPT; TUMOR-SUPPRESSOR; ETO HOMOLOGS; FAMILY; T(8-21); T(8/21); PARTNER	The myeloid translocation gene 16 (MTG16) co-repressor down regulates expression of multiple glycolytic genes, which are targets of the hypoxia-inducible factor 1 (HIF1) heterodimer transcription factor that is composed of oxygen-regulated labile HIF1 alpha and stable HIF1 beta subunits. For this reason, we investigated whether MTG16 might regulate HIF1 negatively contributing to inhibition of glycolysis and stimulation of mitochondrial respiration. A doxycycline Tet-On system was used to control levels of MTG16 in B-lymphoblastic Raji cells. Results from co-association studies revealed MTG16 to interact with HIF1 alpha. The co-association required intact N-terminal MTG16 residues including Nervy Homology Region 1 (NHR1). Furthermore, electrophoretic mobility shift assays demonstrated an association of MTG16 with hypoxia response elements (HREs) in PFKFB3, PFKFB4 and PDK1 promoters in-vitro. Results from chromatin immunoprecipitation assays revealed co-occupancy of these and other glycolytic gene promoters by HIF1 alpha, HIF1 beta and MTG16 in agreement with possible involvement of these proteins in regulation of glycolytic target genes. In addition, MTG16 interacted with prolyl hydroxylase D2 and promoted ubiquitination and proteasomal degradation of HIF1 alpha. Our findings broaden the area of MTG co-repressor functions and reveal MTG16 to be part of a protein complex that controls the levels of HIF1 alpha.	[Kumar, Parveen; Gullberg, Urban; Olsson, Inge; Ajore, Ram] Lund Univ, Dept Hematol, Lund, Sweden	Lund University	Ajore, R (corresponding author), Lund Univ, Dept Hematol, Lund, Sweden.	Ram.Ajore@med.lu.se			Swedish Research Council [K2011-11546]; Swedish Cancer Foundation [11 0450]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This work was supported by grants to UG from the Swedish Research Council (# K2011-11546, www.vr.se/) and by a grant to IO from the Swedish Cancer Foundation (# 11 0450, www.cancerfonden.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajore R, 2010, BMC MOL BIOL, V11, P15, DOI [10.1186/1471-2199-11-15, DOI 10.1186/1471-2199-11-15]; Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DOWNING JR, 1993, BLOOD, V81, P2860; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; ERICKSON P, 1992, BLOOD, V80, P1825; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Gamou T, 1998, BLOOD, V91, P4028, DOI 10.1182/blood.V91.11.4028.411a45_4028_4037; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Guastadisegni MC, 2010, LEUKEMIA, V24, P1516, DOI 10.1038/leu.2010.106; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hildebrand D, 2001, J BIOL CHEM, V276, P9889, DOI 10.1074/jbc.M010582200; Hoogeveen AT, 2002, ONCOGENE, V21, P6703, DOI 10.1038/sj.onc.1205882; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hunt A, 2011, MOL CELL BIOL, V31, P2544, DOI 10.1128/MCB.01458-10; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kitabayashi I, 1998, MOL CELL BIOL, V18, P846, DOI 10.1128/MCB.18.2.846; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068502; Lindberg SR, 2003, EUR J HAEMATOL, V71, P439, DOI 10.1046/j.0902-4441.2003.00166.x; Lindberg SR, 2005, EXP HEMATOL, V33, P189, DOI 10.1016/j.exphem.2004.10.011; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Minchenko O, 2004, FEBS LETT, V576, P14, DOI 10.1016/j.febslet.2004.08.053; Minchenko O, 2003, FEBS LETT, V554, P264, DOI 10.1016/S0014-5793(03)01179-7; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; NISSON PE, 1992, CANCER GENET CYTOGEN, V63, P81, DOI 10.1016/0165-4608(92)90384-K; Olsson A, 2008, BBA-GENE REGUL MECH, V1779, P590, DOI 10.1016/j.bbagrm.2008.06.001; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; PULVERTAFT RJV, 1964, LANCET, V1, P238; Rossetti S, 2004, GENOMICS, V84, P1, DOI 10.1016/j.ygeno.2004.02.011; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei YF, 2007, NAT STRUCT MOL BIOL, V14, P653, DOI 10.1038/nsmb1258	53	14	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0123725	10.1371/journal.pone.0123725	http://dx.doi.org/10.1371/journal.pone.0123725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974097	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600007
J	Yao, XL; Liu, H; Zhang, XH; Zhang, L; Li, X; Wang, CH; Sun, SR				Yao, Xiaoli; Liu, Hua; Zhang, Xinghua; Zhang, Liang; Li, Xiang; Wang, Changhua; Sun, Shengrong			Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; COOH-TERMINAL DOMAIN; GROWTH-FACTOR-BETA; TUMOR-CELLS; MONOCLONAL-ANTIBODY; SIGNALING PATHWAY; APOPTOSIS; CHAPERONE; LIGATION; INHIBITOR	High levels of cell surface glucose regulated protein 78 (sGRP78) have been implicated in cancer growth, survival, metastasis, and chemotherapy resistance. However, the underlying mechanism remains largely unknown. Here we report that the level of sGRP78 expression in human breast tumors gradually increases during cancer progression. Overexpression of GRP78 significantly enhanced its membrane distribution in human MCF7 breast cancer cells, but had no effect on endoplasmic reticulum (ER) stress. High levels of sGRP78 facilitated cell proliferation and migration, as well as suppressed cell apoptosis. Neutralization of sGRP78 by a specific antibody against GRP78 alleviated sGRP78-induced cell growth and migration. Importantly, high phosphorylation levels of the signal transducer and activator of transcription 3 (STAT3) were found in human breast tumors that express sGRP78 and MCF-7 cells infected with adenovirus encoding human GRP78. Pre-treatment with a GRP78 antibody suppressed STAT3 phosphorylation. Furthermore, genetic and pharmacological inhibition of STAT3 reversed the impacts of GRP78 on cell proliferation, apoptosis, and migration. These findings indicate that STAT3 mediates sGRP78-promoted breast cancer cell growth and migration.	[Yao, Xiaoli; Zhang, Liang; Li, Xiang; Sun, Shengrong] Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan 430060, Hubei Province, Peoples R China; [Liu, Hua] First Peoples Hosp Lianyungang, Dept Clin Pathol, Lianyungang 222000, Jiangsu, Peoples R China; [Liu, Hua; Wang, Changhua] Wuhan Univ, Sch Basic Med Sci, Dept Pathophysiol, Wuhan 430071, Hubei Province, Peoples R China; [Zhang, Xinghua] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan 430060, Hubei Province, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Sun, SR (corresponding author), Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan 430060, Hubei Province, Peoples R China.	sun137@sina.com			National Nature Science Foundation of China [81170790/H0718]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was partially supported by a National Nature Science Foundation of China grant to Dr. Changhua Wang (Grant NO: 81170790/H0718). http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. Dr Wang analyzed the data for this manuscript. The additional funding has come from the authors' internal research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banhegyi G, 2007, ANN NY ACAD SCI, V1113, P58, DOI 10.1196/annals.1391.007; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Hart JR, 2011, P NATL ACAD SCI USA, V108, P13247, DOI 10.1073/pnas.1110486108; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199; Li ZW, 2013, INT J BIOCHEM CELL B, V45, P987, DOI 10.1016/j.biocel.2013.02.002; Li ZW, 2012, BBA-REV CANCER, V1826, P13, DOI 10.1016/j.bbcan.2012.02.001; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu R, 2013, CLIN CANCER RES, V19, P6802, DOI 10.1158/1078-0432.CCR-13-1106; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Messmer UK, 2001, BRIT J PHARMACOL, V133, P467, DOI 10.1038/sj.bjp.0704093; Misra UK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051735; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088373; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Mukhopadhyay R, 1999, CLIN EXP METASTAS, V17, P325; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Roller C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00010; Satoh T, 2000, J NEUROCHEM, V75, P1092, DOI 10.1046/j.1471-4159.2000.0751092.x; Scriven P, 2009, BRIT J CANCER, V101, P1692, DOI 10.1038/sj.bjc.6605365; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shravah Jayant, 2014, JAKSTAT, V3, pe29554, DOI 10.4161/jkst.29554; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Vogt PK, 2011, CANCER DISCOV, V1, P481, DOI 10.1158/2159-8290.CD-11-0218; Wang XH, 2011, NEOPLASMA, V58, P158, DOI 10.4149/neo_2011_02_158; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Yeung BHY, 2008, ONCOGENE, V27, P6782, DOI 10.1038/onc.2008.290; Zhang XX, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/917296; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080071; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhu S, 2013, ASIAN PAC J CANCER P, V14, P5687, DOI 10.7314/APJCP.2013.14.10.5687	48	45	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125634	10.1371/journal.pone.0125634	http://dx.doi.org/10.1371/journal.pone.0125634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973748	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600023
J	Barr, PJ; Scholl, I; Bravo, P; Faber, MJ; Elwyn, G; McAllister, M				Barr, Paul J.; Scholl, Isabelle; Bravo, Paulina; Faber, Marjan J.; Elwyn, Glyn; McAllister, Marion			Assessment of Patient Empowerment - A Systematic Review of Measures	PLOS ONE			English	Review							HEALTH-PROMOTION INTERVENTIONS; CONSUMER-CONSTRUCTED SCALE; SHARED DECISION-MAKING; METHODOLOGICAL QUALITY; PSYCHOMETRIC PROPERTIES; SELF-MANAGEMENT; QUESTIONNAIRE; VALIDITY; INSTRUMENTS; RELIABILITY	Background Patient empowerment has gained considerable importance but uncertainty remains about the best way to define and measure it. The validity of empirical findings depends on the quality of measures used. This systematic review aims to provide an overview of studies assessing psychometric properties of questionnaires purporting to capture patient empowerment, evaluate the methodological quality of these studies and assess the psychometric properties of measures identified. Methods Electronic searches in five databases were combined with reference tracking of included articles. Peer-reviewed articles reporting psychometric testing of empowerment measures for adult patients in French, German, English, Portuguese and Spanish were included. Study characteristics, constructs operationalised and psychometric properties were extracted. The quality of study design, methods and reporting was assessed using the COSMIN checklist. The quality of psychometric properties was assessed using Terwee's 2007 criteria. Findings 30 studies on 19 measures were included. Six measures are generic, while 13 were developed for a specific condition (N=4) or specialty (N=9). Most studies tested measures in English (N=17) or Swedish (N=6). Sample sizes of included studies varied from N=35 to N=8261. A range of patient empowerment constructs was operationalised in included measures. These were classified into four domains: patient states, experiences and capacities; patient actions and behaviours; patient self-determination within the healthcare relationship and patient skills development. Quality assessment revealed several flaws in methodological study quality with COSMIN scores mainly fair or poor. The overall quality of psychometric properties of included measures was intermediate to positive. Certain psychometric properties were not tested for most measures. Discussion Findings provide a basis from which to develop consensus on a core set of patient empowerment constructs and for further work to develop a (set of) appropriately validated measure (s) to capture this. The methodological quality of psychometric studies could be improved by adhering to published quality criteria.	[Barr, Paul J.; Elwyn, Glyn] Dartmouth Coll, Lebanon, NH 03756 USA; [Scholl, Isabelle] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Bravo, Paulina; McAllister, Marion] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Bravo, Paulina] Pontificia Univ Catolica Chile, Santiago, Chile; [Faber, Marjan J.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands	Dartmouth College; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cardiff University; Pontificia Universidad Catolica de Chile; Radboud University Nijmegen	McAllister, M (corresponding author), Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales.	mcallistermf@cardiff.ac.uk	Meinders, Marjan J/L-4302-2015; Scholl, Isabelle/AAN-9450-2020; Elwyn, G./L-4292-2015; McAllister, Marion/A-9245-2012; Elwyn, Glyn/B-4798-2009	Meinders, Marjan J/0000-0001-6491-7035; Scholl, Isabelle/0000-0002-7639-0880; McAllister, Marion/0000-0001-7188-9255; Elwyn, Glyn/0000-0002-0917-6286; Bravo, Paulina/0000-0001-7378-6487	National Institute for Social Care & Health Research (UK, Wales) through an Academic Health Sciences Collaboration Clinical Research Time Fellowship	National Institute for Social Care & Health Research (UK, Wales) through an Academic Health Sciences Collaboration Clinical Research Time Fellowship	MMcA's time contribution was funded by the National Institute for Social Care & Health Research (UK, Wales) through an Academic Health Sciences Collaboration Clinical Research Time Fellowship. The contributions that PJB, IS, PB, MF and GE made to the study were unfunded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Al-Janabi H, 2012, QUAL LIFE RES, V21, P167, DOI 10.1007/s11136-011-9927-2; Anderson R, 2000, NAT HIST, V109, P23; Anderson RM, 2005, PATIENT EDUC COUNS, V57, P153, DOI 10.1016/j.pec.2004.05.008; [Anonymous], 2012, LANCET, V379, P1677, DOI 10.1016/S0140-6736(12)60699-0; [Anonymous], 1997, OCCAS PAP R COLL GEN; Arvidsson S, 2012, MUSCULOSKELET CARE, V10, P101, DOI 10.1002/msc.1005; Bann CM, 2010, J ALTERN COMPLEM MED, V16, P745, DOI 10.1089/acm.2009.0381; Berkenstadt M, 1999, AM J MED GENET, V82, P53, DOI 10.1002/(SICI)1096-8628(19990101)82:1<53::AID-AJMG11>3.0.CO;2-#; Bulsara C, 2006, J PSYCHOSOC ONCOL, V24, P1, DOI 10.1300/J077v24n02_01; Chen MF, 2011, J ADV NURS, V67, P204, DOI 10.1111/j.1365-2648.2010.05486.x; Corrigan PW, 1999, SCHIZOPHR RES, V38, P77, DOI 10.1016/S0920-9964(98)00180-7; Coulter A, 1999, BRIT MED J, V318, P318, DOI 10.1136/bmj.318.7179.318; Darzi A, 2008, HOGH QUAL CAR ALL NH; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Elwyn G, 2014, PATIENT EDUC COUNS, V97, P158, DOI 10.1016/j.pec.2014.07.027; Faulkner M, 2001, J ADV NURS, V34, P676, DOI 10.1046/j.1365-2648.2001.01797.x; Guadagnoli E, 1998, SOC SCI MED, V47, P329, DOI 10.1016/S0277-9536(98)00059-8; Hansson L, 2005, SCAND J CARING SCI, V19, P32, DOI 10.1111/j.1471-6712.2004.00310.x; Herbert Rosemary J, 2009, Res Theory Nurs Pract, V23, P107; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Holmstrom I, 2010, PATIENT EDUC COUNS, V79, P167, DOI 10.1016/j.pec.2009.08.008; Johnson MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045692; Joseph-Williams N, 2011, HEALTH EXPECT, V14, P59, DOI 10.1111/j.1369-7625.2010.00621.x; Keeley T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085287; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kim S C, 2001, Clin Nurs Res, V10, P314; Kim SC, 2008, MIL MED, V173, P85, DOI 10.7205/MILMED.173.1.85; Leksell J, 2007, SCAND J CARING SCI, V21, P247, DOI 10.1111/j.1471-6712.2007.00463.x; Lopez JE, 2010, AM J GERIAT PSYCHIAT, V18, P21, DOI 10.1097/JGP.0b013e3181b2090b; Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; McAllister M, 2011, CLIN GENET, V79, P413, DOI 10.1111/j.1399-0004.2011.01636.x; McAllister M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-157; McCrae RR, 2011, PERS SOC PSYCHOL REV, V15, P28, DOI 10.1177/1088868310366253; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mokkink LB, 2009, QUAL LIFE RES, V18, P313, DOI 10.1007/s11136-009-9451-9; Oades LG, 2011, J EVAL CLIN PRACT, V17, P1102, DOI 10.1111/j.1365-2753.2010.01474.x; Ortiz G, 2012, PATIENT, V5, P163, DOI 10.2165/11630940-000000000-00000; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Persson EK, 2007, SCAND J CARING SCI, V21, P118, DOI 10.1111/j.1471-6712.2007.00442.x; Pope Thaddeus Mason, 2013, J Clin Ethics, V24, P70; Rogers A, 2008, MED J AUSTRALIA, V189, pS21; Rogers ES, 2010, PSYCHIAT SERV, V61, P933, DOI 10.1176/ps.2010.61.9.933; Rogers ES, 1997, PSYCHIATR SERV, V48, P1042; Scherbaum CA, 2006, EDUC PSYCHOL MEAS, V66, P1047, DOI 10.1177/0013164406288171; Scholl I, 2011, Z EVIDENZ FORTBILD Q, V105, P313, DOI 10.1016/j.zefq.2011.04.012; Seckin G, 2011, SUPPORT CARE CANCER, V19, P2057, DOI 10.1007/s00520-011-1249-y; Shiu Ann T Y, 2006, Psychol Health Med, V11, P198, DOI 10.1080/13548500500286845; Shiu ATY, 2003, DIABETES CARE, V26, P2817, DOI 10.2337/diacare.26.10.2817; Sigurdardottir AK, 2008, SCAND J CARING SCI, V22, P284, DOI 10.1111/j.1471-6712.2007.00506.x; Small N, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-263; Svedberg P, 2007, J PSYCHIATR MENT HLT, V14, P566, DOI 10.1111/j.1365-2850.2007.01129.x; Svedberg P, 2008, INT J MENT HEALTH NU, V17, P171, DOI 10.1111/j.1447-0349.2008.00527.x; Tacconelli E., 2010, SYSTEMATIC REV CRDS, V10, P226; te Boveldt N, 2014, PSYCHO-ONCOLOGY, V23, P1203, DOI 10.1002/pon.3573; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tol A, 2012, IRAN RED CRESCENT ME, V14, P305; Valderas JM, 2008, VALUE HEALTH, V11, P700, DOI 10.1111/j.1524-4733.2007.00309.x; Wallerstein N., 2006, WHAT IS EV EFFECTIVE; Webb DG, 2001, INT J STD AIDS, V12, P103, DOI 10.1258/0956462011916875; Wowra SA, 1999, PSYCHIATR SERV, V50, P959, DOI 10.1176/ps.50.7.959; Yamada S, 2007, PSYCHIAT CLIN NEUROS, V61, P594, DOI 10.1111/j.1440-1819.2007.01723.x	67	113	117	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126553	10.1371/journal.pone.0126553	http://dx.doi.org/10.1371/journal.pone.0126553			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZP	25970618	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200117
J	Cemma, M; Lam, GY; Stockil, M; Higgins, DE; Brumell, JH				Cemma, Marija; Lam, Grace Y.; Stoeckil, Martina; Higgins, Darren E.; Brumell, John H.			Strain-Specific Interactions of Listeria monocytogenes with the Autophagy System in Host Cells	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; MAMMALIAN-CELLS; ACTA; INFECTION; BACTERIA; PATHOGENESIS; REPLICATION; RECOGNITION; MACROPHAGES; EXPRESSION	Listeria monocytogenes is an intracellular bacterial pathogen that can replicate in the cytosol of host cells. These bacteria undergo actin-based motility in the cytosol via expression of ActA, which recruits host actin-regulatory proteins to the bacterial surface. L. monocytogenes is thought to evade killing by autophagy using ActA-dependent mechanisms. ActA-independent mechanisms of autophagy evasion have also been proposed, but remain poorly understood. Here we examined autophagy of non-motile (Delta actA) mutants of L. monocytogenes strains 10403S and EGD-e, two commonly studied strains of this pathogen. The Delta actA mutants displayed accumulation of ubiquitinated proteins and p62/SQSTM1 on their surface. However, only strain EGD-e Delta actA displayed colocalization with the autophagy marker LC3 at 8 hours post infection. A bacteriostatic agent (chloramphenicol) was required for LC3 recruitment to 10403S Delta actA, suggesting that these bacteria produce a factor for autophagy evasion. Internalin K was proposed to block autophagy of L. monocytogenes in the cytosol of host cells. However, deletion of inlK in either the wild-type or Delta actA background of strain 10403S had no impact on autophagy evasion by bacteria, indicating it does not play an essential role in evading autophagy. Replication of Delta actA mutants of strain EGD-e and 10403S was comparable to their parent wild-type strain in macrophages. Thus,Delta actA mutants of L. monocytogenes can block killing by autophagy at a step downstream of protein ubiquitination and, in the case of strain EGD-e, downstream of LC3 recruitment to bacteria. Our findings highlight the strain-specific differences in the mechanisms that L. monocytogenes uses to evade killing by autophagy in host cells.	[Cemma, Marija; Lam, Grace Y.; Brumell, John H.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Cemma, Marija; Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Lam, Grace Y.; Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Stoeckil, Martina; Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Harvard University; Harvard Medical School	Brumell, JH (corresponding author), Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada.	john.brumell@sickkids.ca		Lam, Grace/0000-0002-7366-193X	Arthritis Society of Canada [RG11/013]; National Institutes of Health [Al053669]; Canadian Foundation for Innovation; Ontario Innovation Trust; Canadian Institutes of Health Research; NSERC PGS-D scholarship; CIHR Training Fellowship [TGF-53877]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053669] Funding Source: NIH RePORTER	Arthritis Society of Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC PGS-D scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Training Fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by operating grants from The Arthritis Society of Canada (to J.H.B., #RG11/013) and a United States Public Health Service grant (Al053669) from the National Institutes of Health (to D.E.H.). J.H. B. holds the Pitblado Chair in Cell Biology. Infrastructure for the Brumell Laboratory was provided by a New Opportunities Fund from the Canadian Foundation for Innovation and the Ontario Innovation Trust. G.Y.L. was supported by a M.D./Ph.D Studentship and Canadian Graduate Scholarship Doctoral Research Award from the Canadian Institutes of Health Research. M.C. was supported by NSERC PGS-D scholarship and CIHR Training Fellowship (TGF-53877). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; Becavin C, 2014, MBIO, V5, DOI 10.1128/mBio.00969-14; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Bruno JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015138; Cemma M, 2012, CURR BIOL, V22, pR540, DOI 10.1016/j.cub.2012.06.001; Dortet L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002168; EDMAN DC, 1968, J BACTERIOL, V96, P352, DOI 10.1128/JB.96.2.352-357.1968; Freitag NE, 1999, INFECT IMMUN, V67, P1844; Glaser P, 2001, SCIENCE, V294, P849; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Meyer-Morse N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008610; Mitchell G, 2015, INFECT IMMUN, V83, P2175, DOI 10.1128/IAI.00110-15; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Rocourt Jocelyne, 1997, World Health Statistics Quarterly, V50, P67; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Xayarath B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023502; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967	31	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125856	10.1371/journal.pone.0125856	http://dx.doi.org/10.1371/journal.pone.0125856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970638	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200087
J	Evans, AB; Acosta, ML; Bolstad, KS				Evans, Aaron B.; Acosta, Monica L.; Bolstad, Kathrin S.			Retinal Development and Ommin Pigment in the Cranchiid Squid Teuthowenia pellucida (Cephalopoda: Oegopsida)	PLOS ONE			English	Article							ADAPTATION; MIGRATION	The cranchiid Teuthowenia pellucida, like many deep-sea squid species, possesses large eyes that maximise light sensitivity in a nearly aphotic environment. To assess ontogenetic changes in the visual system, we conducted morphometric and histological analyses of the eyes using specimens from New Zealand collections. While the ratio between eye diameter and mantle length maintained a linear relationship throughout development, histological sections of the retina revealed that the outer photoreceptor layer became proportionally longer as the animal aged, coincident with a habitat shift into deeper, darker ocean strata. Other retinal layers maintained the same absolute thickness as was observed in paralarvae. Granules of the pigment ommin, normally located in the screening layer positioned at the base of the photoreceptors, were also observed at the outer end of the photoreceptor segments throughout the retina in young and mid-sized specimens. Early developmental stages of this species, dwelling in shallow waters, may therefore rely on migratory ommin to help shield photoreceptors from excess light and prevent over-stimulation. The oldest, deeper-dwelling specimens of T. pellucida examined had longer photoreceptors, and little or no migrated ommin was observed; we suggest therefore that short-term adaptive mechanisms for bright light conditions may be used primarily during epipelagic, early life stages in this species.	[Evans, Aaron B.; Bolstad, Kathrin S.] Auckland Univ Technol, Inst Appl Ecol New Zealand, Auckland, New Zealand; [Acosta, Monica L.] Dept Optometry & Vis Sci, Auckland, New Zealand; [Acosta, Monica L.] Univ Auckland, New Zealand Natl Eye Ctr, Auckland 1, New Zealand	Auckland University of Technology; University of Auckland	Evans, AB (corresponding author), Auckland Univ Technol, Inst Appl Ecol New Zealand, Auckland, New Zealand.	aaevans@aut.ac.nz	Acosta, Monica/H-2700-2019	Acosta, Monica/0000-0002-5018-339X				ARNOLD JM, 1965, BIOL BULL, V128, P24, DOI 10.2307/1539386; ARNOLD JM, 1984, J EXP ZOOL, V232, P187, DOI 10.1002/jez.1402320206; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; BRAEKEVELT CR, 1990, ANAT ANZEIGER, V171, P351; Collin SP, 1996, J FISH BIOL, V49, P157, DOI 10.1111/j.1095-8649.1996.tb06073.x; DAW NW, 1974, J GEN PHYSIOL, V63, P22, DOI 10.1085/jgp.63.1.22; DILLY PN, 1972, NATURE, V237, P403, DOI 10.1038/237403a0; Evans AB, 2013, THESIS AUCKLAND U TE; GLEADALL IG, 1993, J EXP BIOL, V185, P1; IMBER MJ, 1978, NEW ZEAL J ZOOL, V5, P445, DOI 10.1080/03014223.1978.10428331; Johnson B, 2000, VAMPYROTEUTHIS INFER; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Mathger LM, 2009, J EXP BIOL, V212, P2133, DOI 10.1242/jeb.020800; MATSUI S, 1988, J GEN PHYSIOL, V92, P55, DOI 10.1085/jgp.92.1.55; Muntz W.R.A., 1999, P467; Nilsson DE, 2012, CURR BIOL, V22, P683, DOI 10.1016/j.cub.2012.02.031; Seibel BA, 2004, J EXP MAR BIOL ECOL, V313, P375, DOI 10.1016/j.jembe.2004.08.015; Stavenga DG, 1989, FACETS VISION, P152; Sweeney AM, 2007, INTEGR COMP BIOL, V47, P808, DOI 10.1093/icb/icm092; VOSS NA, 1985, B MAR SCI, V36, P1; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; YOUNG J. Z., 1963, PROC ZOOL SOC LONDON, V140, P255	22	3	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123453	10.1371/journal.pone.0123453	http://dx.doi.org/10.1371/journal.pone.0123453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970484	Green Submitted, gold, Green Published			2022-12-27	WOS:000354544200013
J	Qvist, SA; Brook, BW				Qvist, Staffan A.; Brook, Barry W.			Potential for Worldwide Displacement of Fossil-Fuel Electricity by Nuclear Energy in Three Decades Based on Extrapolation of Regional Deployment Data	PLOS ONE			English	Article							POWER	There is an ongoing debate about the deployment rates and composition of alternative energy plans that could feasibly displace fossil fuels globally by mid-century, as required to avoid the more extreme impacts of climate change. Here we demonstrate the potential for a large-scale expansion of global nuclear power to replace fossil-fuel electricity production, based on empirical data from the Swedish and French light water reactor programs of the 1960s to 1990s. Analysis of these historical deployments show that if the world built nuclear power at no more than the per capita rate of these exemplar nations during their national expansion, then coal- and gas-fired electricity could be replaced worldwide in less than a decade. Under more conservative projections that take into account probable constraints and uncertainties such as differing relative economic output across regions, current and past unit construction time and costs, future electricity demand growth forecasts and the retiring of existing aging nuclear plants, our modelling estimates that the global share of fossil-fuel-derived electricity could be replaced within 25-34 years. This would allow the world to meet the most stringent greenhouse-gas mitigation targets.	[Qvist, Staffan A.] Uppsala Univ, Dept Phys & Astrophys, Uppsala, Sweden; [Brook, Barry W.] Univ Tasmania, Fac Sci Engn & Technol, Hobart, Tas, Australia	Uppsala University; University of Tasmania	Qvist, SA (corresponding author), Uppsala Univ, Dept Phys & Astrophys, Uppsala, Sweden.	staffan.qvist@physics.uu.se	Brook, Barry W./G-2686-2011	Brook, Barry W./0000-0002-2491-1517; Qvist, Staffan/0000-0001-7838-6482				[Anonymous], 2012, WORLD NUCL NEWS; Boden TA, 2012, TECHNICAL REPORT; Brook BW, 2012, ENERG POLICY, V42, P4, DOI 10.1016/j.enpol.2011.11.041; D'haeseleer WD, 2013, TECHNICAL REPORT; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; EIA, 2013, INT EN OUTL 2013; Energimyndigheten (Swedish Energy Agency), 2012, EN SIFFR; Escobar Rangel L, 2013, TECHNICAL REPORT; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Forsgren N., 1994, FRAN INGENTING ALLS; Fox Business News, 2012, FOX BUSINESS NEWS; Hannum W.H., 1997, PROGR NUCL ENERGY, V31; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Idaho National Laboratory, 2000, PROV PRINC HIST ID N; Intergovernmental Panel on Climate Change, 2009, 5 ASS REP; International Atomic Energy Agency, 2004, PRIS DAT; Ion S, 2007, PHILOS T R SOC A, V365, P935, DOI 10.1098/rsta.2006.1958; IPCC, 2011, SPEC REP REN EN SOUR; Kessides IN, 2010, ENERG POLICY, V38, P3849, DOI 10.1016/j.enpol.2010.03.005; Sailor WC, 2000, SCIENCE, V288, P1177, DOI 10.1126/science.288.5469.1177; SwedPower, 1985, NUCL POW SWED; UNFCC, 2014, STAT RAT CONV; University of Pennsylvania, 2012, PENN WORLD TABL 7 1; Wiens J, 2011, ECOL APPL, V21, P1085, DOI 10.1890/09-0673.1; World Bank, 2014, DAT WORLD BANK	25	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124074	10.1371/journal.pone.0124074	http://dx.doi.org/10.1371/journal.pone.0124074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970621	Green Submitted, Green Published, gold			2022-12-27	WOS:000354544200026
J	Peng, H; Zhu, QS; Zhong, SP; Levy, D				Peng, Hui; Zhu, Qin-shi; Zhong, Shuping; Levy, Daniel			Transcription of the Human Microsomal Epoxide Hydrolase Gene (EPHX1) Is Regulated by PARP-1 and Histone H1.2. Association with Sodium-Dependent Bile Acid Transport	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; RAT-LIVER; C/EBP-ALPHA; EXPRESSION; PROTEIN; DNA; HYPERCHOLANEMIA; TAUROCHOLATE; HEPATOCYTES; CELLS	Microsomal epoxide hydrolase (mEH) is a bifunctional protein that plays a central role in the metabolism of numerous xenobiotics as well as mediating the sodium-dependent transport of bile acids into hepatocytes. These compounds are involved in cholesterol homeostasis, lipid digestion, excretion of xenobiotics and the regulation of several nuclear receptors and signaling transduction pathways. Previous studies have demonstrated the critical role of GATA-4, a C/EBP alpha-NF/Y complex and an HNF-4 alpha/CAR/RXR/PSF complex in the transcriptional regulation of the mEH gene (EPHX1). Studies also identified heterozygous mutations in human EPHX1 that resulted in a 95% decrease in mEH expression levels which was associated with a decrease in bile acid transport and severe hypercholanemia. In the present investigation we demonstrate that EPHX1 transcription is significantly inhibited by two heterozygous mutations observed in the Old Order Amish population that present numerous hypercholanemic subjects in the absence of liver damage suggesting a defect in bile acid transport into the hepatocyte. The identity of the regulatory proteins binding to these sites, established using biotinylated oligonucleotides in conjunction with mass spectrometry was shown to be poly(ADP-ribose) polymerase-1 (PARP-1) bound to the EPHX1 proximal promoter and a linker histone complex, H1.2/Aly, bound to a regulatory intron 1 site. These sites exhibited 71% homology and may represent potential nucleosome positioning domains. The high frequency of the H1.2 site polymorphism in the Amish population results in a potential genetic predisposition to hypercholanemia and in conjunction with our previous studies, further supports the critical role of mEH in mediating bile acid transport into hepatocytes.	[Peng, Hui; Zhu, Qin-shi; Zhong, Shuping; Levy, Daniel] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	Levy, D (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	dlevy@usc.edu	Levy, Daniel/ABB-2752-2021		National Institutes of Health [R01 DK025836]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	R01 DK025836 National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose HE, 2007, ONCOGENE, V26, P6244, DOI 10.1038/sj.onc.1210434; ANANTHANARAYANAN M, 1988, J BIOL CHEM, V263, P8338; ANANTHANARAYANAN M, 1991, AM J PHYSIOL, V261, pG810, DOI 10.1152/ajpgi.1991.261.5.G810; Anderson SP, 2004, J BIOL CHEM, V279, P52390, DOI 10.1074/jbc.M409347200; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Carlton VEH, 2003, NAT GENET, V34, P91, DOI 10.1038/ng1147; Cortessis V, 2001, CANCER RES, V61, P2381; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0; Hagenbuch B, 1996, BIOCHEM J, V316, P901, DOI 10.1042/bj3160901; Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002; HARDIKAR W, 1995, J BIOL CHEM, V270, P20841, DOI 10.1074/jbc.270.35.20841; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; HONSCHA W, 1995, BIOCHEM J, V311, P975, DOI 10.1042/bj3110975; Hrycay E, 2014, MOL CELL BIOCHEM, V389, P119, DOI 10.1007/s11010-013-1933-y; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Kok T, 2003, BIOCHEM J, V369, P539, DOI 10.1042/BJ20020981; Kosters A, 2008, XENOBIOTICA, V38, P1043, DOI [10.1080/00498250802040584, 10.1080/00498250802040584 ]; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Meerman L, 1999, GASTROENTEROLOGY, V117, P696, DOI 10.1016/S0016-5085(99)70464-6; Mertz JA, 2007, J VIROL, V81, P3503, DOI 10.1128/JVI.02253-06; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Morton DH, 2000, GASTROENTEROLOGY, V119, P188, DOI 10.1053/gast.2000.8547; Murray JW, 2011, AM J PHYSIOL-GASTR L, V301, pG60, DOI 10.1152/ajpgi.00035.2011; Osinalde N, 2013, MOL CELL PROTEOMICS, V12, P1087, DOI 10.1074/mcp.M112.024158; Peng H, 2013, BBA-GENE REGUL MECH, V1829, P1000, DOI 10.1016/j.bbagrm.2013.05.003; Reed R, 2001, NAT CELL BIOL, V3, pE201, DOI 10.1038/ncb0901-e201; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Shan L, 2014, ONCOGENE, V31, P3711; Shneider BL, 1997, HEPATOLOGY, V25, P1176, DOI 10.1002/hep.510250521; SUCHY FJ, 1986, AM J PHYSIOL, V251, pG655, DOI 10.1152/ajpgi.1986.251.5.G665; SUCHY FJ, 1982, PEDIATR RES, V16, P282, DOI 10.1203/00006450-198204000-00007; SUCHY FJ, 1985, AM J PHYSIOL, V248, pG648, DOI 10.1152/ajpgi.1985.248.6.G648; Takasuka TE, 2010, NUCLEIC ACIDS RES, V38, P5672, DOI 10.1093/nar/gkq279; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Vaz FM, 2015, HEPATOLOGY, V61, P260, DOI 10.1002/hep.27240; von Dippe P, 2003, BIOCHEM BIOPH RES CO, V309, P804, DOI 10.1016/j.bbrc.2003.08.074; VONDIPPE P, 1993, AM J PHYSIOL, V264, pG528, DOI 10.1152/ajpgi.1993.264.3.G528; VONDIPPE P, 1990, J BIOL CHEM, V265, P14812; VONDIPPE P, 1983, J BIOL CHEM, V258, P8896; VONDIPPE P, 1983, J BIOL CHEM, V258, P8890; vonDippe P, 1996, J BIOL CHEM, V271, P18176, DOI 10.1074/jbc.271.30.18176; VONDIPPE P, 1990, J BIOL CHEM, V265, P5942; White IR, 2003, PROTEOMICS, V3, P505, DOI 10.1002/pmic.200390064; Wolkoff AW, 2003, AM J PHYSIOL-GASTR L, V284, pG175, DOI 10.1152/ajpgi.00409.2002; Xiao BT, 2012, MOL BIOL CELL, V23, P4864, DOI 10.1091/mbc.E12-07-0518; Yin H, 2006, J BIOL CHEM, V281, P11496, DOI 10.1074/jbc.M511138200; Zhu QS, 1999, J BIOL CHEM, V274, P27898, DOI 10.1074/jbc.274.39.27898; Zhu QS, 2004, J BIOL CHEM, V279, P29902, DOI 10.1074/jbc.M400438200; Zhu QS, 2004, BBA-GENE STRUCT EXPR, V1676, P251, DOI 10.1016/j.bbaexp.2004.01.002; Zhu QS, 2003, BBA-MOL BASIS DIS, V1638, P208, DOI 10.1016/S0925-4439(03)00085-1	53	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125318	10.1371/journal.pone.0125318	http://dx.doi.org/10.1371/journal.pone.0125318			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992604	Green Submitted, Green Published, gold			2022-12-27	WOS:000354921400032
J	Zhang, L; Dong, L; Lin, L; Feng, LM; Yan, F; Wang, LX; Guo, XM; Luo, AD				Zhang, Li; Dong, Lu; Lin, Liu; Feng, Limin; Yan, Fan; Wang, Lanxin; Guo, Xianming; Luo, Aidong			Asian Elephants in China: Estimating Population Size and Evaluating Habitat Suitability	PLOS ONE			English	Article							NATIONAL NATURE-RESERVE; GENETIC DIVERSITY; MICROSATELLITE LOCI; MITOCHONDRIAL-DNA; MAXIMUS; CONSERVATION; AFRICANA; YUNNAN; SELECTION; ECOLOGY	We monitored the last remaining Asian elephant populations in China over the past decade. Using DNA tools and repeat genotyping, we estimated the population sizes from 654 dung samples collected from various areas. Combined with morphological individual identifications from over 6,300 elephant photographs taken in the wild, we estimated that the total Asian elephant population size in China is between 221 and 245. Population genetic structure and diversity were examined using a 556-bp fragment of mitochondrial DNA, and 24 unique haplotypes were detected from DNA analysis of 178 individuals. A phylogenetic analysis revealed two highly divergent clades of Asian elephants, alpha and beta, present in Chinese populations. Four populations (Mengla, Shangyong, Mengyang, and Pu'Er) carried mtDNA from the a clade, and only one population (Nangunhe) carried mtDNA belonging to the a clade. Moreover, high genetic divergence was observed between the Nangunhe population and the other four populations; however, genetic diversity among the five populations was low, possibly due to limited gene flow because of habitat fragmentation. The expansion of rubber plantations, crop cultivation, and villages along rivers and roads had caused extensive degradation of natural forest in these areas. This had resulted in the loss and fragmentation of elephant habitats and had formed artificial barriers that inhibited elephant migration. Using Geographic Information System, Global Positioning System, and Remote Sensing technology, we found that the area occupied by rubber plantations, tea farms, and urban settlements had dramatically increased over the past 40 years, resulting in the loss and fragmentation of elephant habitats and forming artificial barriers that inhibit elephant migration. The restoration of ecological corridors to facilitate gene exchange among isolated elephant populations and the establishment of cross-boundary protected areas between China and Laos to secure their natural habitats are critical for the survival of Asian elephants in this region.	[Zhang, Li; Dong, Lu; Feng, Limin; Yan, Fan] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China; [Lin, Liu] Hainan Normal Univ, Coll Life Sci, Haikou 571158, Peoples R China; [Wang, Lanxin; Guo, Xianming; Luo, Aidong] Res Inst Xishuangbanna Natl Nat Reserve, Jinghong 666100, Peoples R China	Beijing Normal University; Hainan Normal University	Zhang, L (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China.	asterzhang@bnu.edu.cn; lxwang1968@163.com	Feng, Limin/G-9539-2014	Feng, Limin/0000-0001-9526-1681	National Nature Science Foundation of China [31172108]; US Fish and Wildlife Service Asian Elephant Conservation Fund [98201-8-G565]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); US Fish and Wildlife Service Asian Elephant Conservation Fund	This work was supported by the National Nature Science Foundation of China (31172108) and the US Fish and Wildlife Service Asian Elephant Conservation Fund (98201-8-G565). The funders had no role in study design, data collection and anaysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2011, CONSERV GENET, V12, P413, DOI 10.1007/s10592-010-0148-y; [Anonymous], FRONTIERS BIOL CHINA, DOI DOI 10.1007/s11515-008-0003-4; Archie EA, 2003, MOL ECOL NOTES, V3, P244, DOI 10.1046/j.1471-8286.2003.00412.x; Cai Qingxiu, 2008, Acta Theriologica Sinica, V28, P126; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Codron J, 2006, J MAMMAL, V87, P27, DOI 10.1644/05-MAMM-A-017R1.1; Comstock KE, 2002, MOL ECOL, V11, P2489, DOI 10.1046/j.1365-294X.2002.01615.x; Eggert LS, 2000, MOL ECOL, V9, P2223, DOI 10.1046/j.1365-294X.2000.105336.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feng Limin, 2005, Acta Theriologica Sinica, V25, P229; Feng Limin, 2010, Acta Theriologica Sinica, V30, P1; Fernando P, 2000, HEREDITY, V84, P362, DOI 10.1046/j.1365-2540.2000.00674.x; Fernando P, 2001, MOL ECOL NOTES, V1, P325, DOI 10.1046/j.1471-8278 .2001.00083.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Institute of Zoology of Yunnan, 1976, CHINESE J ZOOLOGY, V2, P38; ISHWARAN N, 1993, J TROP ECOL, V9, P169, DOI 10.1017/S0266467400007148; Lei R, 2012, J ZOOL, V286, P38, DOI 10.1111/j.1469-7998.2011.00851.x; Li C., 1999, CHINESE WILDLIFE, V20, P8; Li Zhang, 2011, Gajah, V35, P43; Lin L, 2008, ACTA THERIOL, V53, P365, DOI 10.1007/BF03195197; Lin Liu, 2014, Acta Ecologica Sinica, V34, P1725; Lin Liu, 2011, Acta Theriologica Sinica, V31, P226; Ma L, 2004, THESIS BEIJING NORMA; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Mitas L., 1999, GEOGRAPHICAL INFORM, V8, P481; Nyakaana S, 2005, MOL ECOL NOTES, V5, P223, DOI 10.1111/j.1471-8286.2005.00885.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; SANTIAPILLAI C, 1990, ASIAN ELEPHANT ACTIO, P1; SUKUMAR R, 1990, J TROP ECOL, V6, P33, DOI 10.1017/S0266467400004004; Sukumar R., 2003, LIVING ELEPHANTS EVO, P310; Vidya TNC, 2005, ANIM CONSERV, V8, P377, DOI 10.1017/S1367943005002428; Vidya TNC, 2005, HEREDITY, V94, P71, DOI 10.1038/sj.hdy.6800568; Yang Fan, 2012, Acta Theriologica Sinica, V32, P90; Yuan Zhiqiang, 2006, Acta Theriologica Sinica, V26, P359; Zhang L, 2003, BIOL CONSERV, V112, P453, DOI 10.1016/S0006-3207(02)00335-X; Zhang Li, 2003, Acta Theriologica Sinica, V23, P185; Zhang L, 2006, INTEGR ZOOL, V1, P179, DOI 10.1111/j.1749-4877.2006.00031.x	38	31	38	11	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0124834	10.1371/journal.pone.0124834	http://dx.doi.org/10.1371/journal.pone.0124834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992617	Green Submitted, Green Published, gold			2022-12-27	WOS:000354918600011
J	Cheng, ZW; Dong, K; Ge, P; Bian, YW; Dong, LW; Deng, X; Li, XH; Yan, YM				Cheng, Zhiwei; Dong, Kun; Ge, Pei; Bian, Yanwei; Dong, Liwei; Deng, Xiong; Li, Xiaohui; Yan, Yueming			Identification of Leaf Proteins Differentially Accumulated between Wheat Cultivars Distinct in Their Levels of Drought Tolerance	PLOS ONE			English	Article							COMPARATIVE PROTEOMIC ANALYSIS; RESPONSIVE PROTEINS; WATER-STRESS; BREAD WHEAT; SEEDLING LEAVES; DRAFT GENOME; SALT STRESS; CELL-DEATH; PLANT; EXPRESSION	The drought-tolerant 'Ningchun 47' (NC47) and drought-sensitive 'Chinese Spring' (CS) wheat (Triticum aestivum L.) cultivars were treated with different PEG6000 concentrations at the three-leaf stage. An analysis on the physiological and proteomic changes of wheat seedling in response to drought stress was performed. In total, 146 differentially accumulated protein (DAP) spots were separated and recognised using two-dimensional gel electrophoresis. In total, 101 DAP spots representing 77 unique proteins were identified by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. These proteins were allocated to 10 groups according to putative functions, which were mainly involved in carbon metabolism (23.4%), photosynthesis/respiration (22.1%) and stress/defence/detoxification (18.2%). Some drought stress-related proteins in NC47, such as enolase, 6-phosphogluconate dehydrogenase, Oxygen-evolving enhancer protein 2, fibrillin-like protein, 2-Cys peroxiredoxin BAS1 and 70-kDa heat shock protein, were more upregulated than those in CS. Multivariate principal components analysis revealed obvious differences between the control and treatments in both NC47 and CS, while cluster analysis showed that the DAPs displayed five and six accumulation patterns in NC47 and CS, respectively. Protein-protein interaction network analysis showed that some key DAPs, such as 2-Cys peroxiredoxin BAS1, RuBisCO large subunit-binding protein, 50S ribosomal protein L1, 6-phosphogluconate dehydrogenase, glyceraldehyde 3-phosphate dehydrogenase isoenzyme and 70-kDa heat shock protein, with upregulated accumulation in NC47, had complex interactions with other proteins related to amino acid metabolism, carbon metabolism, energy pathway, signal transduction, stress/defence/detoxification, protein folding and nucleotide metabolism. These proteins could play important roles in drought-stress tolerance and contribute to the relatively stronger drought tolerance of NC47.	[Cheng, Zhiwei; Dong, Kun; Ge, Pei; Bian, Yanwei; Dong, Liwei; Deng, Xiong; Li, Xiaohui; Yan, Yueming] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Yan, Yueming] HCICGI, Jingzhou 434025, Peoples R China	Capital Normal University	Yan, YM (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China.	yanym@cnu.edu.cn			International Cooperation Project from the Chinese Ministry of Science and Technology [2013DFG30530]; National Key Project for Transgenic Crops in China [2014ZX08009-003]	International Cooperation Project from the Chinese Ministry of Science and Technology; National Key Project for Transgenic Crops in China	This research was financially supported by the grants from the International Cooperation Project from the Chinese Ministry of Science and Technology (2013DFG30530) and the National Key Project for Transgenic Crops in China (2014ZX08009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi FM, 2004, PROTEOMICS, V4, P2072, DOI 10.1002/pmic.200300741; Alcazar R, 2010, PLANTA, V231, P1237, DOI 10.1007/s00425-010-1130-0; Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Amini F, 2007, RUSS J PLANT PHYSL+, V54, P464, DOI 10.1134/S102144370704005X; Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Baerenfaller K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.39; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; Bowne JB, 2012, MOL PLANT, V5, P418, DOI 10.1093/mp/ssr114; Caruso G, 2008, ANAL BIOANAL CHEM, V391, P381, DOI 10.1007/s00216-008-2008-x; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chen Z, 2006, PLANT PHYSIOL, V142, P775, DOI 10.1104/pp.106.085506; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Deeba F, 2012, PLANT PHYSIOL BIOCH, V53, P6, DOI 10.1016/j.plaphy.2012.01.002; Dupont FM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-39; Echevarria-Zomeno S, 2009, J PLANT PHYSIOL, V166, P233, DOI 10.1016/j.jplph.2008.05.008; Ergen NZ, 2009, FUNCT INTEGR GENOMIC, V9, P377, DOI 10.1007/s10142-009-0123-1; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fu ZY, 2011, BIOL PLANTARUM, V55, P196, DOI 10.1007/s10535-011-0030-x; Ge P, 2012, ANAL BIOANAL CHEM, V402, P1297, DOI 10.1007/s00216-011-5532-z; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Hao PC, 2015, PROTEOMICS, V15, P1544, DOI 10.1002/pmic.201400179; Harris D., 2002, DIRECT SEEDING RES S, P231; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jorge I, 2006, PROTEOMICS, V6, pS207, DOI 10.1002/pmic.200500364; KamalEldin A, 1997, J AM OIL CHEM SOC, V74, P375, DOI 10.1007/s11746-997-0093-1; Kaya MD, 2006, EUR J AGRON, V24, P291, DOI 10.1016/j.eja.2005.08.001; Keown JR, 2013, J BIOL CHEM, V288, P20607, DOI 10.1074/jbc.M113.466383; Kido EA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S1-S7; Kluge C, 2003, MOL MEMBR BIOL, V20, P171, DOI 10.1080/0968768031000084154; Kosova K, 2013, J PROTEOME RES, V12, P4830, DOI 10.1021/pr400600g; Kranner I, 2006, FREE RADICAL BIO MED, V40, P2155, DOI 10.1016/j.freeradbiomed.2006.02.013; Kristiansen LC, 2010, PROTEOMICS, V10, P1721, DOI 10.1002/pmic.200900318; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lv DW, 2014, J PROTEOME RES, V13, P2381, DOI 10.1021/pr401184v; Majoul T, 2004, PROTEOMICS, V4, P505, DOI 10.1002/pmic.200300570; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Moeder W, 2007, PLANT MOL BIOL, V63, P273, DOI 10.1007/s11103-006-9087-x; Mohammadi PP, 2012, AMINO ACIDS, V43, P2137, DOI 10.1007/s00726-012-1299-6; Nam MH, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-25; Pirzad A, 2011, J MED PLANTS RES, V5, P2483; Plomion C, 2006, PROTEOMICS, V6, P6509, DOI 10.1002/pmic.200600362; Pulido P, 2010, J EXP BOT, V61, P4043, DOI 10.1093/jxb/erq218; Rabello AR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-485; Ratajczak R, 2000, BBA-BIOMEMBRANES, V1465, P17, DOI 10.1016/S0005-2736(00)00129-2; Riccardi F, 1998, PLANT PHYSIOL, V117, P1253, DOI 10.1104/pp.117.4.1253; Sairam RK, 2004, CURR SCI INDIA, V86, P407; Scranton MA, 2012, J BIOL CHEM, V287, P18408, DOI 10.1074/jbc.M111.309500; Shanker AK, 2014, FUNCT INTEGR GENOMIC, V14, P11, DOI 10.1007/s10142-013-0356-x; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; Wang HG, 2007, J INTEGR PLANT BIOL, V49, P1455, DOI 10.1111/j.1672-9072.2007.00553.x; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yoda H, 2006, PLANT PHYSIOL, V142, P193, DOI 10.1104/pp.106.080515; Zhang M, 2014, J PROTEOMICS, V109, P290, DOI 10.1016/j.jprot.2014.07.010; Zhang X, 2003, GUANGXI ZHIWU, V24, P570; Zhao CF, 2005, PROTEOMICS, V5, P961, DOI 10.1002/pmic.200401131	67	61	66	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125302	10.1371/journal.pone.0125302	http://dx.doi.org/10.1371/journal.pone.0125302			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984726	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300016
J	Bates, MA; Brandenberger, C; Langohr, I; Kumagai, K; Harkema, JR; Holian, A; Pestka, JJ				Bates, Melissa A.; Brandenberger, Christina; Langohr, Ingeborg; Kumagai, Kazuyoshi; Harkema, Jack R.; Holian, Andrij; Pestka, James J.			Silica Triggers Inflammation and Ectopic Lymphoid Neogenesis in the Lungs in Parallel with Accelerated Onset of Systemic Autoimmunity and Glomerulonephritis in the Lupus-Prone NZBWF1 Mouse	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CONNECTIVE-TISSUE DISEASE; STAGE RENAL-DISEASE; T-CELL-ACTIVATION; TNF-ALPHA; OCCUPATIONAL SILICA; SCAVENGER RECEPTOR; CRYSTALLINE SILICA; IMMUNE-COMPLEXES	Genetic predisposition and environmental factors influence the development of human autoimmune disease. Occupational exposure to crystalline silica (cSiO(2)) has been etiologically linked to increased incidence of autoimmunity, including systemic lupus erythematosus (SLE), but the underlying mechanisms are poorly understood. The purpose of this study was to test the hypothesis that early repeated short-term cSiO(2) exposure will modulate both latency and severity of autoimmunity in the lupus-prone female NZBWF1 mouse. Weekly intranasal exposure to cSiO(2) (0.25 and 1.0 mg) for 4 wk beginning at 9 wk of age both reduced latency and increased intensity of glomerulonephritis. cSiO(2) elicited robust inflammatory responses in the lungs as evidenced by extensive perivascular and peribronchial lymphoplasmacytic infiltration consisting of IgG-producing plasma cells, and CD45R+ and CD3+ lymphocytes that were highly suggestive of ectopic lymphoid tissue (ELT). In addition, there were elevated concentrations of immunoglobulins and the cytokines MCP-1, TNF-alpha and IL-6 in bronchoalveolar lavage fluid. cSiO(2)-associated kidney and lung effects paralleled dose-dependent elevations of autoantibodies and proinflammatory cytokines in plasma. Taken together, cSiO2-induced pulmonary inflammation and ectopic lymphoid neogenesis in the NZBWF1 mouse corresponded closely to systemic inflammatory and autoimmune responses as well as the early initiation of pathological outcomes in the kidney. These findings suggest that following airway exposure to crystalline silica, inmice genetically prone to SLE, the lung serves as a platform for triggering systemic autoimmunity and glomerulonephritis.	[Bates, Melissa A.; Pestka, James J.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Bates, Melissa A.; Kumagai, Kazuyoshi; Harkema, Jack R.; Pestka, James J.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA; [Brandenberger, Christina; Kumagai, Kazuyoshi; Harkema, Jack R.] Michigan State Univ, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [Brandenberger, Christina] Hannover Med Sch, Funct & Appl Anat, Hannover, Germany; [Langohr, Ingeborg] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Studies, Baton Rogue, LA USA; [Holian, Andrij] Univ Montana, Ctr Environm Hlth Sci, Missoula, MT 59812 USA	Michigan State University; Michigan State University; Michigan State University; Hannover Medical School; Louisiana State University School of Veterinary Medicine; Louisiana State University System; University of Montana System; University of Montana	Pestka, JJ (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	pestka@msu.edu	Langohr, Ingeborg M/H-5570-2019	Langohr, Ingeborg M/0000-0001-7366-4391; Holian, Andrij/0000-0003-0072-4538	National Institute of Environmental Health Sciences [ES021265]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021265] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Environmental Health Sciences (ES021265) to JP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujam B, 2013, LUPUS, V22, P614, DOI 10.1177/0961203313484977; Albuquerque De Castro H, 2003, J BRAS PNEUMOL, V30, P201; Barbado J, 2012, CYTOKINE, V60, P583, DOI 10.1016/j.cyto.2012.07.009; Beamer CA, 2005, AM J PHYSIOL-LUNG C, V289, pL186, DOI 10.1152/ajplung.00474.2004; Beamer CA, 2010, J LEUKOCYTE BIOL, V88, P547, DOI 10.1189/jlb.0210108; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Berthier CC, 2012, J IMMUNOL, V189, P988, DOI 10.4049/jimmunol.1103031; Bombardieri M, 2012, J IMMUNOL, V189, P3767, DOI 10.4049/jimmunol.1201216; Brandenberger C, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-26; Brown Jared M, 2005, J Immunotoxicol, V1, P177, DOI 10.1080/15476910490911922; Brown JM, 2005, AM J PHYSIOL-LUNG C, V289, pL990, DOI 10.1152/ajplung.00078.2005; Brown JM, 2004, INHAL TOXICOL, V16, P133, DOI 10.1080/08958370490270936; Brown JM, 2003, CLIN EXP IMMUNOL, V131, P415, DOI 10.1046/j.1365-2249.2003.02094.x; Calvert GM, 1997, JAMA-J AM MED ASSOC, V277, P1219, DOI 10.1001/jama.277.15.1219; CHEN F, 1995, BIOCHEM BIOPH RES CO, V214, P985, DOI 10.1006/bbrc.1995.2383; Chouchakova N, 2001, J IMMUNOL, V166, P5193, DOI 10.4049/jimmunol.166.8.5193; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Conrad K, 1996, LUPUS, V5, P62, DOI 10.1177/096120339600500112; Cooper Glinda S, 2004, Curr Rheumatol Rep, V6, P367, DOI 10.1007/s11926-004-0011-6; Davas EM, 1999, CLIN RHEUMATOL, V18, P17, DOI 10.1007/s100670050045; Davis Gerald S., 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P81; Davis Gerald S., 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P53; DAVIS GS, 1993, CHEST, V103, pS120; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; DOLL NJ, 1981, J ALLERGY CLIN IMMUN, V68, P281; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ferreira TPT, 2013, J IMMUNOL, V191, P5220, DOI 10.4049/jimmunol.1203551; Finckh A, 2006, ARTHRITIS RHEUM-US, V54, P3648, DOI 10.1002/art.22210; Gabay C, 1997, J RHEUMATOL, V24, P303; Gonzalez ML, 2000, J IMMUNOL, V164, P1071, DOI 10.4049/jimmunol.164.2.1071; Gossart S, 1996, J IMMUNOL, V156, P1540; Grogan JL, 2012, EUR J IMMUNOL, V42, P2255, DOI 10.1002/eji.201242656; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; Hamilton RF, 2006, J BIOL CHEM, V281, P34218, DOI 10.1074/jbc.M605229200; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Holian A, 1997, ENVIRON HEALTH PERSP, V105, P1139, DOI 10.2307/3433522; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Iyer R, 1996, TOXICOL APPL PHARM, V141, P84, DOI 10.1006/taap.1996.0263; JOHNSON KJ, 1974, J CLIN INVEST, V54, P349, DOI 10.1172/JCI107770; Lacher SE, 2010, INHAL TOXICOL, V22, P77, DOI 10.3109/08958370902929969; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Lentsch AB, 1998, AM J PATHOL, V152, P1327; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Maeda K, 2010, BLOOD, V115, P4699, DOI 10.1182/blood-2009-07-230631; Makol A, 2011, AM J IND MED, V54, P255, DOI 10.1002/ajim.20917; Migliaccio CT, 2005, TOXICOL APPL PHARM, V205, P168, DOI 10.1016/j.taap.2004.11.005; Mohan C, 1999, J IMMUNOL, V162, P6492; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; National Institute for Occupational Safety and Health, 2002, HLTH EFF OCC EXP RES; National Institute of Allergy and Infectious Diseases (NIAID). Autoimmune Diseases Coordinating Committee, 2005, NIAID REP C; Nowling TK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3528; Parks CG, 2002, ARTHRITIS RHEUM-US, V46, P1840, DOI 10.1002/art.10368; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Pestka JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100255; Pestka JJ, 2010, PROSTAG LEUKOTR ESS, V82, P251, DOI 10.1016/j.plefa.2010.02.013; Pfau JC, 2004, TOXICOLOGY, V195, P167, DOI 10.1016/j.tox.2003.09.011; Pfau JC, 2008, J IMMUNOTOXICOL, V5, P129, DOI 10.1080/15476910802085756; PIGUET PF, 1990, NATURE, V344, P245, DOI 10.1038/344245a0; Rocha-Parise M, 2014, INT J HYG ENVIR HEAL, V217, P586, DOI 10.1016/j.ijheh.2013.11.002; Rosenman KD, 1999, AM J IND MED, V35, P375, DOI 10.1002/(SICI)1097-0274(199904)35:4<375::AID-AJIM8>3.0.CO;2-I; ROVIN BH, 1995, KIDNEY INT, V48, P1263, DOI 10.1038/ki.1995.410; Rudofsky UH, 1999, ENVIRON HEALTH PERSP, V107, P713, DOI 10.2307/3434332; RUDOFSKY UH, 1993, LAB INVEST, V68, P419; RYFFEL B, 1994, AM J PATHOL, V144, P927; Sabry A, 2006, CYTOKINE, V35, P148, DOI 10.1016/j.cyto.2006.07.023; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Sang A, 2012, PROG MOL BIOL TRANSL, V105, P321, DOI 10.1016/B978-0-12-394596-9.00010-X; SATRIANO J, 1994, J CLIN INVEST, V94, P1629, DOI 10.1172/JCI117505; SCHEULE RK, 1989, AM J RESP CELL MOL, V1, P313, DOI 10.1165/ajrcmb/1.4.313; Schiffer L, 2009, NEPHROL DIAL TRANSPL, V24, P3708, DOI 10.1093/ndt/gfp343; Singh B, 2005, CLIN EXP IMMUNOL, V141, P223, DOI 10.1111/j.1365-2249.2005.02841.x; Speck-Hernandez CA, 2012, ARTHRITIS, V2012, P1; Steenland K, 2002, SCAND J WORK ENV HEA, V28, P439, DOI 10.5271/sjweh.696; Steenland K, 2001, EPIDEMIOLOGY, V12, P405, DOI 10.1097/00001648-200107000-00010; Steenland K, 2005, AM J IND MED, V48, P16, DOI 10.1002/ajim.20181; STEENLAND NK, 1990, AM J PUBLIC HEALTH, V80, P153, DOI 10.2105/AJPH.80.2.153; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Su WF, 2003, SEMIN NEPHROL, V23, P564, DOI 10.1053/S0270-9295(03)00135-9; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Thakur SA, 2009, TOXICOL SCI, V108, P462, DOI 10.1093/toxsci/kfp011; Vupputuri S, 2012, RENAL FAILURE, V34, P40, DOI 10.3109/0886022X.2011.623496; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Wengner AM, 2007, ARTHRITIS RHEUM-US, V56, P3271, DOI 10.1002/art.22939; Yan D, 1998, TOXICOL APPL PHARM, V148, P261, DOI 10.1006/taap.1997.8326; Zaghi G, 2010, RHEUMATOL INT, V30, P1071, DOI 10.1007/s00296-009-1116-z; Zebedeo CN, 2014, TOXICOL APPL PHARM, V275, P257, DOI 10.1016/j.taap.2014.01.018; Zheng L, 2008, J HISTOCHEM CYTOCHEM, V56, P517, DOI 10.1369/jhc.7A7368.2008	88	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125481	10.1371/journal.pone.0125481	http://dx.doi.org/10.1371/journal.pone.0125481			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978333	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100028
J	Landler, L; Painter, MS; Youmans, PW; Hopkins, WA; Phillips, JB				Landler, Lukas; Painter, Michael S.; Youmans, Paul W.; Hopkins, William A.; Phillips, John B.			Spontaneous Magnetic Alignment by Yearling Snapping Turtles: Rapid Association of Radio Frequency Dependent Pattern of Magnetic Input with Novel Surroundings	PLOS ONE			English	Article							PHOTORECEPTOR-BASED MAGNETORECEPTION; LOGGERHEAD SEA-TURTLES; COMPASS ORIENTATION; LIGHT; BIRDS; MODEL; CRYPTOCHROME; FIELDS; BIOPHYSICS; NAVIGATION	We investigated spontaneous magnetic alignment (SMA) by juvenile snapping turtles using exposure to low-level radio frequency (RF) fields at the Larmor frequency to help characterize the underlying sensory mechanism. Turtles, first introduced to the testing environment without the presence of RF aligned consistently towards magnetic north when subsequent magnetic testing conditions were also free of RF ('RF off -> RF off'), but were disoriented when subsequently exposed to RF ('RF off -> RF on'). In contrast, animals initially introduced to the testing environment with RF present were disoriented when tested without RF ('RF on -> RF off'), but aligned towards magnetic south when tested with RF ('RF on -> RF on'). Sensitivity of the SMA response of yearling turtles to RF is consistent with the involvement of a radical pair mechanism. Furthermore, the effect of RF appears to result from a change in the pattern of magnetic input, rather than elimination of magnetic input altogether, as proposed to explain similar effects in other systems/organisms. The findings show that turtles first exposed to a novel environment form a lasting association between the pattern of magnetic input and their surroundings. However, under natural conditions turtles would never experience a change in the pattern of magnetic input. Therefore, if turtles form a similar association of magnetic cues with the surroundings each time they encounter unfamiliar habitat, as seems likely, the same pattern of magnetic input would be associated with multiple sites/localities. This would be expected from a sensory input that functions as a global reference frame, helping to place multiple locales (i.e., multiple local landmark arrays) into register to form a global map of familiar space.	[Landler, Lukas; Painter, Michael S.; Youmans, Paul W.; Phillips, John B.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Hopkins, William A.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Phillips, JB (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	jphillip@vt.edu	Landler, Lukas/D-6428-2013	Landler, Lukas/0000-0002-5638-7924	Fralin Life Science Institute; Virginia Tech: Graduate Research and Development Program; National Science Foundation [IOS 07-48175, IOS 13-49515]; Open Access Subvention Fund (Virginia Tech)	Fralin Life Science Institute; Virginia Tech: Graduate Research and Development Program; National Science Foundation(National Science Foundation (NSF)); Open Access Subvention Fund (Virginia Tech)	Support for this research was provided by grants from Fralin Life Science Institute and the Virginia Tech: Graduate Research and Development Program (to LL), and from the National Science Foundation, IOS 07-48175 and IOS 13-49515 (to JBP). Support for open access publishing fees were provided by the Open Access Subvention Fund (Virginia Tech). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey MJ, 2002, FEBS LETT, V513, P169, DOI 10.1016/S0014-5793(02)02276-7; Becker G., 1964, Zeitschrift fuer Angewandte Entomologie, V54, P75; Begall S., 2011, J COMP PHYSIOL A SEN, P1; Begall S, 2008, P NATL ACAD SCI USA, V105, P13451, DOI 10.1073/pnas.0803650105; Begall S, 2013, MAMM BIOL, V78, P10, DOI 10.1016/j.mambio.2012.05.005; Burda H, 2009, P NATL ACAD SCI USA, V106, P5708, DOI 10.1073/pnas.0811194106; CARTWRIGHT BA, 1983, J COMP PHYSIOL, V151, P521, DOI 10.1007/BF00605469; Cerveny J, 2011, BIOL LETTERS, V7, P355, DOI 10.1098/rsbl.2010.1145; COLLETT TS, 1992, PHILOS T R SOC B, V337, P295, DOI 10.1098/rstb.1992.0107; COLLETT TS, 1994, NATURE, V368, P137, DOI 10.1038/368137a0; Deutschlander ME, 1999, J EXP BIOL, V202, P891; Diego-Rasilla FJ, 2013, J COMP PHYSIOL A SEN, V199, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1007/S00359-013-0811-0; Dodson CA, 2013, TRENDS BIOCHEM SCI, V38, P435, DOI 10.1016/j.tibs.2013.07.002; Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Hart V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051100; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; Hopkins BC, 2013, ENVIRON SCI TECHNOL, V47, P2416, DOI 10.1021/es304261s; Hopkins BC, 2013, ENVIRON POLLUT, V177, P164, DOI 10.1016/j.envpol.2013.02.018; Keary N, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-25; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Kirschvink JL, 2010, J R SOC INTERFACE, V7, pS179, DOI 10.1098/rsif.2009.0491.focus; Lau JCS, 2012, J R SOC INTERFACE, V9, P3329, DOI 10.1098/rsif.2012.0374; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; LIGHT P, 1993, J EXP BIOL, V182, P1; LOHMANN KJ, 1993, BIOL BULL, V185, P149, DOI 10.2307/1542138; LOHMANN KJ, 1991, J EXP BIOL, V155, P37; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; MARDIA KV, 1967, J ROY STAT SOC B, V29, P320; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; MATHIS A, 1988, ETHOLOGY, V78, P265; Mazzotta G, 2013, P NATL ACAD SCI USA, V110, P6163, DOI 10.1073/pnas.1212317110; MOORE BR, 1980, BIOMETRIKA, V67, P175; Muheim R, 2006, LEARN BEHAV, V34, P366, DOI 10.3758/BF03193201; Muheim R, 2006, SCIENCE, V313, P837, DOI 10.1126/science.1129709; Munro U, 1997, NATURWISSENSCHAFTEN, V84, P26, DOI 10.1007/s001140050343; Niessner C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0638; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; Painter MS, 2013, J EXP BIOL, V216, P1307, DOI 10.1242/jeb.077404; Phillips JB, 2002, J EXP BIOL, V205, P3903; PHILLIPS JB, 1986, SCIENCE, V233, P765, DOI 10.1126/science.3738508; PHILLIPS JB, 1993, J COMP PHYSIOL A, V172, P303, DOI 10.1007/BF00216612; PHILLIPS JB, 1994, J EXP BIOL, V188, P275; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; PHILLIPS JB, 1992, ETHOL ECOL EVOL, V4, P33, DOI 10.1080/08927014.1992.9525348; PHILLIPS JB, 1986, J COMP PHYSIOL A, V158, P103, DOI 10.1007/BF00614524; PHILLIPS JB, 1995, ANIM BEHAV, V50, P855, DOI 10.1016/0003-3472(95)80146-4; Phillips JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073112; Phillips JB, 2010, J EXP BIOL, V213, P3247, DOI 10.1242/jeb.020792; Phillips JB, 2010, J R SOC INTERFACE, V7, pS241, DOI 10.1098/rsif.2009.0459.focus; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2004, NATURE, V38, P435; Ritz T, 2011, PROCEDIA CHEM, V3, DOI 10.1016/j.proche.2011.08.034; Ritz T, 2010, J R SOC INTERFACE, V7, pS135, DOI 10.1098/rsif.2009.0456.focus; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; RUBENS SM, 1945, REV SCI INSTRUM, V16, P243, DOI 10.1063/1.1770378; Solovyov IA, 2011, CHEM COMPASS BIRD NA; Stoneham AM, 2012, BIOPHYS J, V102, P961, DOI 10.1016/j.bpj.2012.01.007; Thalau P, 2006, J R SOC INTERFACE, V3, P583, DOI 10.1098/rsif.2006.0130; Vacha M, 2004, J EXP BIOL, V207, P1241, DOI 10.1242/jeb.00874; Vacha M, 2008, J COMP PHYSIOL A, V194, P853, DOI 10.1007/s00359-008-0356-9; Vacha M, 2009, J EXP BIOL, V212, P3473, DOI 10.1242/jeb.028670; Walker MM, 2008, J THEOR BIOL, V250, P85, DOI 10.1016/j.jtbi.2007.09.030; Wang YN, 2007, P R SOC B, V274, P2901, DOI 10.1098/rspb.2007.0904; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2008, J EXP BIOL, V211, P3344, DOI 10.1242/jeb.020313; Wiltschko R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-5; Wiltschko R, 2007, HFSP J, V1, P41, DOI [10.2976/1.2714294, 10.2976/1.2714294/10.2976/1]; Wiltschko R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1103; Wiltschko R, 2010, J R SOC INTERFACE, V7, pS163, DOI 10.1098/rsif.2009.0367.focus; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wiltschko W, 2006, P R SOC B, V273, P2815, DOI 10.1098/rspb.2006.3651; Wiltschko W, 2011, PROCEDIA CHEM, V3, DOI 10.1016/j.proche.2011.08.035; Winklhofer M, 2010, J R SOC INTERFACE, V7, pS273, DOI 10.1098/rsif.2009.0435.focus; Xu BM, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042711	76	28	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124728	10.1371/journal.pone.0124728	http://dx.doi.org/10.1371/journal.pone.0124728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978736	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100018
J	Lovewell, TRJ; McDonagh, AJ; Messenger, AG; Azzouz, M; Tazi-Ahnini, R				Lovewell, Thomas R. J.; McDonagh, Andrew J.; Messenger, Andrew G.; Azzouz, Mimoun; Tazi-Ahnini, Rachid			The AIRE-230Y Polymorphism Affects AIRE Transcriptional Activity: Potential Influence on AIRE Function in the Thymus	PLOS ONE			English	Article							AUTOIMMUNE REGULATOR AIRE; EPITHELIAL-CELLS; ALOPECIA-AREATA; GENE; PROMOTER; EXPRESSION; ANTIGENS	Background The autoimmune regulator (AIRE) is expressed in the thymus, particularly in thymic medullary epithelial cells (mTECs), and is required for the ectopic expression of a diverse range of peripheral tissue antigens by mTECs, facilitating their ability to perform negative selection of auto-reactive immature T-cells. The expression profile of peripheral tissue antigens is affected not only by AIRE deficiency but also with variation of AIRE activity in the thymus. Method and Results Therefore we screened 591bp upstream of the AIRE transcription start site including AIRE minimal promoter for single nucleotide polymorphism (SNPs) and identified two SNPs -655R (rs117557896) and -230Y (rs751032) respectively. To study the effect of these variations on AIRE promoter activity we generated a Flp-In host cell line which was stably transfected with a single copy of the reporter vector. Relative promoter activity was estimated by comparing the luciferase specific activity for lysates of the different reporter AIRE promoter-reporter gene constructs including AIRE-655G AIRE-230C, AIRE-655G AIRE-230T and AIRE-655A AIRE-230C. The analysis showed that the commonest haplotype AIRE-655G AIRE-230C has the highest luciferase specific activity (p<0.001).Whereas AIRE-655G AIRE-230T has a luciferase specific activity value that approaches null. Both AIRE promoter polymorphic sites have one allele that forms a CpG methylation site which we determined can be methylated in methylation assays using the M.SssI CpG methyltransferase. Conclusion AIRE-230Y is in a conserved region of the promoter and is adjacent to a predicted WT1 transcription factor binding site, suggesting that AIRE-230Y affects AIRE expression by influencing the binding of biochemical factors to this region. Our findings show that AIRE-655GAIRE-230T haplotype could dramatically alter AIRE transcription and so have an effect on the process of negative selection and affect susceptibility to autoimmune conditions.	[Lovewell, Thomas R. J.; Tazi-Ahnini, Rachid] Univ Sheffield, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [McDonagh, Andrew J.; Messenger, Andrew G.] Royal Hallamshire Hosp, Dept Dermatol, Sheffield S10 2JF, S Yorkshire, England; [Azzouz, Mimoun] Univ Sheffield, Sch Med & Biomed Sci, Dept Neurosci, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Tazi-Ahnini, R (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England.	r.taziahnini@sheffield.ac.uk	Messenger, Andrew/J-1240-2019; Azzouz, Mimoun/B-3979-2009	Messenger, Andrew/0000-0003-1424-8069; Shaw, Pamela/0000-0002-8925-2567; Azzouz, Mimoun/0000-0001-6564-5967	Muscular Dystrophy Association (AFM)	Muscular Dystrophy Association (AFM)	Funding: The Muscular Dystrophy Association (AFM) has supported this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Betterle C, 1998, J CLIN ENDOCR METAB, V83, P1049, DOI 10.1210/jc.83.4.1049; Betterle Corrado, 2003, Acta Biomed, V74, P9; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; Finnish-German A.C., 1997, NAT GENET, V17, P399, DOI DOI 10.1038/NG1297-399; Karimi M, 2009, EUR J HUM GENET, V17, P1454, DOI 10.1038/ejhg.2009.80; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kont V, 2008, MOL IMMUNOL, V45, P25, DOI 10.1016/j.molimm.2007.05.014; Kont V, 2011, MOL IMMUNOL, V49, P518, DOI 10.1016/j.molimm.2011.09.022; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Loots GG, 2005, NUCLEIC ACIDS RES, V33, pW56, DOI 10.1093/nar/gki355; Murumagi A, 2003, J BIOL CHEM, V278, P19784, DOI 10.1074/jbc.M210437200; Murumagi A, 2006, BIOCHEM BIOPH RES CO, V348, P768, DOI 10.1016/j.bbrc.2006.07.135; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Oliveira EH, 2013, IMMUNOBIOLOGY, V218, P96, DOI 10.1016/j.imbio.2012.02.005; Tazi-Ahnini R, 2008, BRIT J DERMATOL, V159, P591, DOI 10.1111/j.1365-2133.2008.08718.x; Tazi-Ahnini R, 2002, TISSUE ANTIGENS, V60, P489, DOI 10.1034/j.1399-0039.2002.600604.x; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; Wengraf DA, 2008, TISSUE ANTIGENS, V71, P206, DOI 10.1111/j.1399-0039.2007.00992.x	20	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127476	10.1371/journal.pone.0127476	http://dx.doi.org/10.1371/journal.pone.0127476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978041	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000354916100147
J	Negulescu, H; Guo, YZ; Garner, TP; Goodwin, OY; Henderson, G; Laine, RA; Macnaughtan, MA				Negulescu, Horia; Guo, Youzhong; Garner, Thomas P.; Goodwin, Octavia Y.; Henderson, Gregg; Laine, Roger A.; Macnaughtan, Megan A.			A Kazal-Type Serine Protease Inhibitor from the Defense Gland Secretion of the Subterranean Termite Coptotermes formosanus Shiraki	PLOS ONE			English	Article							GENE-EXPRESSION; FRONTAL GLAND; ISOPTERA; RHINOTERMITIDAE; TRYPSIN; DOMAIN; SPECIFICITY; COMPONENTS; COLONIES; DATABASE	Coptotermes formosanus is an imported, subterranean termite species with the largest economic impact in the United States. The frontal glands of the soldier caste termites comprising one third of the body mass, contain a secretion expelled through a foramen in defense. The small molecule composition of the frontal gland secretion is well-characterized, but the proteins remain to be identified. Herein is reported the structure and function of one of several proteins found in the termite defense gland secretion. TFP4 is a 6.9 kDa, non-classical group 1 Kazal-type serine protease inhibitor with activity towards chymotrypsin and elastase, but not trypsin. The 3-dimensional solution structure of TFP4 was solved with nuclear magnetic resonance spectroscopy, and represents the first structure from the taxonomic family, Rhinotermitidae. Based on the structure of TFP4, the protease inhibitor active loop (Cys(8) to Cys(16)) was identified.	[Goodwin, Octavia Y.; Laine, Roger A.; Macnaughtan, Megan A.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Negulescu, Horia; Goodwin, Octavia Y.; Laine, Roger A.; Macnaughtan, Megan A.] A&M Coll, Baton Rouge, LA 70803 USA; [Negulescu, Horia; Laine, Roger A.] Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA; [Henderson, Gregg] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Macnaughtan, MA (corresponding author), Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA.	macnau@lsu.edu	Laine, Roger A/B-9434-2014; Guo, Youzhong/AAW-3010-2021; Laine, Roger/ABE-2473-2020	Laine, Roger A/0000-0001-5984-4409; Macnaughtan, Megan/0000-0003-4626-0062	United States Department of Agriculture-Agricultural Research Service New Orleans [58-6435-8-084]	United States Department of Agriculture-Agricultural Research Service New Orleans	RAL and GH received funding from the United States Department of Agriculture-Agricultural Research Service New Orleans, specific cooperative agreement 58-6435-8-084, (http://www.ars.usda.gov/main/site_main.htm?modecode=64-35-00-00).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aramini JM, 2007, PROTEINS, V68, P789, DOI 10.1002/prot.21450; Augustin R, 2009, DEV COMP IMMUNOL, V33, P830, DOI 10.1016/j.dci.2009.01.009; Bergmeyer HU, 1974, ENZYMES AS BIOCHEMIC; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BIETH J, 1974, BIOCHEM MED METAB B, V11, P350, DOI 10.1016/0006-2944(74)90134-3; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campos ITN, 2012, ACTA CRYSTALLOGR D, V68, P695, DOI 10.1107/S0907444912009067; Chen J, 1999, J CHEM ECOL, V25, P817, DOI 10.1023/A:1020844817492; Chen J, 1998, J AGR FOOD CHEM, V46, P2337, DOI 10.1021/jf9709717; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Da Silva P, 2003, PROTEIN SCI, V12, P438, DOI 10.1110/ps.0228303; Eswar N, 2006, COMPARATIVE PROTEIN; Hemmi H, 2005, BIOCHEMISTRY-US, V44, P9626, DOI 10.1021/bi0472806; Hemmi H, 2003, BIOCHEMISTRY-US, V42, P2524, DOI 10.1021/bi026727c; Hojo M, 2005, INSECT BIOCHEM MOLEC, V35, P347, DOI 10.1016/j.ibmb.2005.01.007; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; Jeng WY, 2012, ACTA CRYSTALLOGR D, V68, P829, DOI 10.1107/S0907444912013224; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Kato I, 1978, REGULATORY PROTEOLYT; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; Khademi S, 2002, ACTA CRYSTALLOGR D, V58, P653, DOI 10.1107/S0907444902002366; KING EG, 1975, ANN ENTOMOL SOC AM, V68, P355, DOI 10.1093/aesa/68.2.355; KREJCI K, 1976, FEBS LETT, V64, P152, DOI 10.1016/0014-5793(76)80271-2; Laskowski Jr M, 1971, THE ENZYMES, P375; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lax AR, 2003, PEST MANAG SCI, V59, P788, DOI 10.1002/ps.721; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maynes JT, 2005, ACTA CRYSTALLOGR D, V61, P580, DOI 10.1107/S0907444905004889; Miura T, 1999, P NATL ACAD SCI USA, V96, P13874, DOI 10.1073/pnas.96.24.13874; Moore BP, 1969, BIOCHEMICAL STUDIES; Mullins AJ, 2011, J ECON ENTOMOL, V104, P1687, DOI 10.1603/EC11036; Nakajima S, 1964, FACULTY AGRIC BULL, V9, P222; Ohta M, 2007, J LIPID RES, V48, P656, DOI 10.1194/jlr.M600387-JLR200; Osbrink WLA, 2001, ENVIRON ENTOMOL, V30, P443, DOI 10.1603/0046-225X-30.2.443; OZAWA K, 1966, J BIOL CHEM, V241, P3955; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; PRESTWICH GD, 1984, ANNU REV ENTOMOL, V29, P201, DOI 10.1146/annurev.en.29.010184.001221; Qasim MA, 1999, BIOCHEMISTRY-US, V38, P7142, DOI 10.1021/bi990265u; QUENNEDEY A, 1975, INSECT SOC, V22, P243, DOI 10.1007/BF02223076; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Santi L, 2010, FUNGAL BIOL-UK, V114, P312, DOI 10.1016/j.funbio.2010.01.006; Scharf ME, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r62; Schlott B, 2002, J MOL BIOL, V318, P533, DOI 10.1016/S0022-2836(02)00014-1; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Su NY, 1999, SOCIOBIOLOGY, V33, P185; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945	60	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125376	10.1371/journal.pone.0125376	http://dx.doi.org/10.1371/journal.pone.0125376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978745	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100025
J	Wang, HL; Wang, SS; Song, WH; Pan, Y; Yu, HP; Si, TG; Liu, Y; Cui, XN; Guo, Z				Wang, Hai-long; Wang, Shao-shan; Song, Wen-hui; Pan, Yi; Yu, Hai-peng; Si, Tong-guo; Liu, Yong; Cui, Xiao-nan; Guo, Zhi			Expression of Prostate-Specific Membrane Antigen in Lung Cancer Cells and Tumor Neovasculature Endothelial Cells and Its Clinical Significance	PLOS ONE			English	Article							INTERNALIZATION; TRANSCRIPTION; ANGIOGENESIS; ANTIBODIES; MARKER	Background Prostate-specific membrane antigen (PSMA) has been found in tumor neovasculature endothelial cells (NECs) of non-prostate cancers and may become the most promising target for anti-tumor therapy. To study the value of PSMA as a potential new target for lung cancer treatment, PSMA expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) tissues and its relationship with clinicopathology were investigated in the current study. Methods Immunohistochemistry was used to detect PSMA expression in a total of 150 lung specimens of patients with lung cancer. The data were analyzed using univariate and multivariate statistical analyses. Results The percentages of NSCLC patients who had PSMA (+) tumor cells and PSMA (+) NECs were 54.02% and 85.06%, respectively. The percentage of patients younger than 60 years old who had PSMA (+) tumor cells was 69.05%, which was significantly greater than the percentage of patients aged 60 years or older (40.00%, p<0.05). A significant difference was observed in the percentage of NSCLC patients with PMSA (+) NECs and stage I or II cancer (92.98%) and those patients with stage III or IV cancer (76.77%). In the SCLC tissues, NEC PSMA expression (70.00%) did not differ significantly from NSCLC. SCLC tumor cells and normal lung tissues cells were all negative. There was no significant correlation between the presence of PSMA (+) NECs in SCLC patients and the observed clinicopathological parameters. Conclusions PSMA is expressed not only in NECs of NSCLC and SCLC but also in tumor cells of most NSCLC patients. The presence of PSMA (+) tumor cells and PSMA (+) NECs in NSCLC was negatively correlated with age and the clinicopathological stage of the patients, respectively.	[Wang, Hai-long; Yu, Hai-peng; Si, Tong-guo; Guo, Zhi] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Lab Canc Prevent & Therapy,Dept Intervent Treatme, Tianjin, Peoples R China; [Wang, Hai-long; Wang, Shao-shan] Dagang Hosp Binhai New Area, Dept Oncol, Tianjin, Peoples R China; [Song, Wen-hui] Tianjin First Ctr Hosp, Dept Urol, Tianjin, Peoples R China; [Pan, Yi] Tianjin Med Univ, Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China; [Liu, Yong] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Cui, Xiao-nan] Dalian Med Univ, Affiliate Hosp 1, Dept Oncol, Dalian, Peoples R China	Tianjin Medical University; Tianjin Medical University; University of Arkansas System; University of Arkansas Medical Sciences; Dalian Medical University	Liu, Y (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA.	yong.liu210@hotmail.com; cxn23@sina.com; cjr.guozhi@vip.163.com			Project of Binhai New Area Bureau of Health of Tianjin, China [2012BWKZ006]; China Scholarship Council; National Natural Science Foundation of China [81173615]	Project of Binhai New Area Bureau of Health of Tianjin, China; China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The design and conduct of this research was funded by Hai-long Wang, the host of the Project of Binhai New Area Bureau of Health of Tianjin, China (2012BWKZ006), and Xiao-nan Cui, the host of the China Scholarship Council and the National Natural Science Foundation of China (No. 81173615). Hail-ong Wang is the first author of this manuscript who designed the study, performed the experiments, contributed to data analysis, and was also responsible for writing the manuscript. Xiao-nan Cui is one of the corresponding authors who conceived the study, participated in its design and coordination, and helped to draft the manuscript.	Baccala A, 2007, UROLOGY, V70, P385, DOI 10.1016/j.urology.2007.03.025; Chang Sam S, 2004, Rev Urol, V6 Suppl 10, pS13; Chang SS, 1999, CANCER RES, V59, P3192; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; Denekamp J, 1998, ADV ENZYME REGUL, V38, P281, DOI 10.1016/S0065-2571(97)00015-0; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Godeiro Katyanne Dantas, 2006, J Carcinog, V5, P21, DOI 10.1186/1477-3163-5-21; Gordon IO, 2008, MODERN PATHOL, V21, P1421, DOI 10.1038/modpathol.2008.143; Haffner MC, 2009, HUM PATHOL, V40, P1754, DOI 10.1016/j.humpath.2009.06.003; HOROSZEWICZ JS, 1987, ANTICANCER RES, V7, P927; ISRAELI RS, 1994, CANCER RES, V54, P6306; LEEK J, 1995, BRIT J CANCER, V72, P583, DOI 10.1038/bjc.1995.377; Liu H, 1998, CANCER RES, V58, P4055; Liu JH, 2009, MOL PHARMACEUT, V6, P959, DOI 10.1021/mp8002682; LOPES AD, 1990, CANCER RES, V50, P6423; Mhawech-Fauceglia P, 2008, CANCER EPIDEM BIOMAR, V17, P571, DOI 10.1158/1055-9965.EPI-07-0511; Noss KR, 2002, GENE, V285, P247, DOI 10.1016/S0378-1119(02)00397-9; O'Keefe DS, 1998, BBA-GENE STRUCT EXPR, V1443, P113; Pasqualini R, 2002, TRENDS MOL MED, V8, P563, DOI 10.1016/S1471-4914(02)02429-2; PLATE KH, 1995, GLIA, V15, P339, DOI 10.1002/glia.440150313; Rajasekaran SA, 2003, MOL BIOL CELL, V14, P4835, DOI 10.1091/mbc.E02-11-0731; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; TROYER JK, 1995, INT J CANCER, V62, P552, DOI 10.1002/ijc.2910620511; Wernicke AG, 2011, ARCH PATHOL LAB MED, V135, P1486, DOI 10.5858/arpa.2010-0740-OA	25	65	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125924	10.1371/journal.pone.0125924	http://dx.doi.org/10.1371/journal.pone.0125924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978404	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100039
J	Smaldone, G; Pirone, L; Balasco, N; Di Gaetano, S; Pedone, EM; Vitagliano, L				Smaldone, Giovanni; Pirone, Luciano; Balasco, Nicole; Di Gaetano, Sonia; Pedone, Emilia Maria; Vitagliano, Luigi			Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins	PLOS ONE			English	Article							UBIQUITIN LIGASE; HISTONE DEACETYLASE; INSIGHTS; ADAPTERS; FAMILY; SUPPRESSOR; DYNAMICS	Cullin 3 (Cul3) recognition by BTB domains is a key process in protein ubiquitination. Among Cul3 binders, a great attention is currently devoted to KCTD proteins, which are implicated in fundamental biological processes. On the basis of the high similarity of BTB domains of these proteins, it has been suggested that the ability to bind Cul3 could be a general property among all KCTDs. In order to gain new insights into KCTD functionality, we here evaluated and/or quantified the binding of Cul3 to the BTB of KCTD proteins, which are known to be involved either in cullin-independent (KCTD12 and KCTD15) or in cullin-mediated (KCTD6 and KCTD11) activities. Our data indicate that KCTD6(BTB) and KCTD11(BTB) bind Cul3 with high affinity forming stable complexes with 4: 4 stoichiometries. Conversely, KCTD12(BTB) and KCTD15(BTB) do not interact with Cul3, despite the high level of sequence identity with the BTB domains of cullin binding KCTDs. Intriguingly, comparative sequence analyses indicate that the capability of KCTD proteins to recognize Cul3 has been lost more than once in distinct events along the evolution. Present findings also provide interesting clues on the structural determinants of Cul3-KCTD recognition. Indeed, the characterization of a chimeric variant of KCTD11 demonstrates that the swapping of alpha 2 beta 3 loop between KCTD11(BTB) and KCTD12(BTB) is sufficient to abolish the ability of KCTD11(BTB) to bind Cul3. Finally, present findings, along with previous literature data, provide a virtually complete coverage of Cul3 binding ability of the members of the entire KCTD family.	[Smaldone, Giovanni; Balasco, Nicole; Di Gaetano, Sonia; Pedone, Emilia Maria; Vitagliano, Luigi] CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy; [Pirone, Luciano] CNR, Inst Crystallog, I-70126 Bari, Italy; [Balasco, Nicole] Univ Naples 2, I-81100 Caserta, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Universita della Campania Vanvitelli	Di Gaetano, S (corresponding author), CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy.	digaetan@unina.it; empedone@unina.it; luigi.vitagliano@unina.it	Pedone, Emilia/HDN-2342-2022; Smaldone, Giovanni/K-8782-2016; Smaldone, Giovanni/AAA-8034-2020; Pedone, Emilia Maria/K-2229-2015; Pirone, Luciano/G-7256-2015; Pirone, Luciano/ABG-2892-2020	Pedone, Emilia/0000-0003-0203-8611; Smaldone, Giovanni/0000-0002-1989-4740; Pedone, Emilia Maria/0000-0003-0203-8611; Pirone, Luciano/0000-0002-7014-4689; Pirone, Luciano/0000-0002-7014-4689; Di Gaetano, Sonia/0000-0001-5523-3619; Balasco, Nicole/0000-0001-7862-9448	Italian Ministry of Education and Research (MIUR) [RBAP114AMK_006]	Italian Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was funded by the Italian Ministry of Education and Research (MIUR) for financial support [grants for fundamental research FIRB project "Integrated Network for Nano-Medicine (RINAME)" RBAP114AMK_006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelfinger L, 2014, BIOCHEM PHARMACOL, V91, P369, DOI 10.1016/j.bcp.2014.07.013; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Balasco N, 2014, BBA-PROTEINS PROTEOM, V1844, P1289, DOI 10.1016/j.bbapap.2014.04.006; Bartoi T, 2010, J BIOL CHEM, V285, P20625, DOI 10.1074/jbc.M109.049700; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Birerdinc A, 2010, TUMOR BIOL, V31, P33, DOI 10.1007/s13277-009-0005-0; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Correale S, 2013, J MOL RECOGNIT, V26, P488, DOI 10.1002/jmr.2291; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; de Paola I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121149; De Smaele E, 2011, NEOPLASIA, V13, P374, DOI 10.1593/neo.101630; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Ding XF, 2009, J CELL BIOCHEM, V106, P285, DOI 10.1002/jcb.22002; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Gallo R, 2002, J CELL BIOL, V158, P731, DOI 10.1083/jcb.200202024; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lange S, 2012, MOL BIOL CELL, V23, P2490, DOI 10.1091/mbc.E12-01-0052; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Merlino A, 2002, BIOPOLYMERS, V65, P274, DOI 10.1002/bip.10225; Pfeiffenberger C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003003; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pirone L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/162674; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Skoblov M, 2013, BIOESSAYS, V35, P586, DOI 10.1002/bies.201300002; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Turecek R, 2014, NEURON, V82, P1032, DOI 10.1016/j.neuron.2014.04.015; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zarelli VE, 2013, P NATL ACAD SCI USA, V110, P2870, DOI 10.1073/pnas.1300203110	34	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126808	10.1371/journal.pone.0126808	http://dx.doi.org/10.1371/journal.pone.0126808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974686	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600081
J	Quinney, A; Mays, C; Stilwell, JD; Zelenitsky, DK; Therrien, F				Quinney, Annie; Mays, Chris; Stilwell, Jeffrey D.; Zelenitsky, Darla K.; Therrien, Francois			The Range of Bioinclusions and Pseudoinclusions Preserved in a New Turonian (similar to 90 Ma) Amber Occurrence from Southern Australia	PLOS ONE			English	Article							CRETACEOUS FOREST; TESTATE AMEBAS; FOSSIL RESINS; EARLY EOCENE; NEW-ZEALAND; MICROORGANISMS; INCLUSIONS; TAPHONOMY; PROTISTS; PALEOECOLOGY	A new Turonian amber occurrence, representing the oldest in situ amber locality in Australia and the southern-most locality in Gondwana, has recently been discovered in the Otway Basin of Victoria. The amber was collected from petroleum cores and many pieces contain a range of inclusions that can provide information on the depositional history of the resin. To date, one species of fern spore (Cyathidites minor) and one species of lycophyte spore (Kraeuselisporites sp?) have been conclusively identified in the amber, along with filamentous microorganisms and degraded plant matter. Several samples are also rife with pseudoinclusions as reported recently in other ambers. The abundance of preserved particulate debris and wind dispersed spores suggest that the Otway amber formed subaerially. Furthermore, based on the range of bioinclusions and forms of pseudoinclusions preserved within a single piece of amber, the locus of hardening for individual samples is variably interpreted as occurring in the tree tops, on the tree trunk or on the ground surface. Notably, specific inclusion assemblages are associated with certain colours of amber. By extension, and in accordance with recent studies, amber colour may be indicative of depositional environment. Variation in the environment of solidification may, therefore, be sufficient to account for the broad range of morphological characteristics preserved in a single amber deposit.	[Quinney, Annie; Mays, Chris; Stilwell, Jeffrey D.] Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic 3800, Australia; [Zelenitsky, Darla K.] Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada; [Therrien, Francois] Royal Tyrrell Museum Palaeontol, Drumheller, AB T0J 0Y0, Canada	Monash University; University of Calgary	Quinney, A (corresponding author), Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic 3800, Australia.	ann.quinney@monash.edu		Mays, Chris/0000-0002-5416-2289; Stilwell, Jeffrey Darl/0000-0002-9853-1322; Therrien, Francois/0000-0002-2652-908X	Australian Research Council [ARC-DP1412515-Assoc]; Origin Energy grant; Natural Sciences and Engineering Research Council Graduate Scholarship [PGSD3 426805-2012]; Australian Postgraduate Award; International Postgraduate Research Scholarship	Australian Research Council(Australian Research Council); Origin Energy grant; Natural Sciences and Engineering Research Council Graduate Scholarship; Australian Postgraduate Award(Australian Government); International Postgraduate Research Scholarship(Australian Government)	The following funding agencies provided financial support to this research project: 1. Australian Research Council Discovery Project; grant number: ARC-DP1412515-Assoc. Prof. Jeffrey D Stilwell; URL: arc.gov.au; received by J.S. 2. Origin Energy grant; no grant number; URL: http://www.originfoundation.com.au/about-us/grant-program; received by J.S. 3. Natural Sciences and Engineering Research Council Graduate Scholarship; application number: PGSD3 426805-2012; URL: http://www.nserc-crsng.gc.ca; received by A.Q. 4. Australian Postgraduate Award; no grant number; URL: https://education.gov.au/australian-postgraduate-awards; received by A.Q. 5. International Postgraduate Research Scholarship; no grant number; URL: https://education.gov.au/international-postgraduate-research-scholarships; received by A.Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KB, 1992, ORG GEOCHEM, V18, P829, DOI 10.1016/0146-6380(92)90051-X; [Anonymous], 2001, E AUSTR BAS S REF EN; Aquilina L, 2013, PALAEOGEOGR PALAEOCL, V369, P220, DOI 10.1016/j.palaeo.2012.10.023; Ascaso C, 2003, J INF, V77; Ashton PS, FLORA MALESIANA, P237; Backhouse j, 1988, GEOL SURV W AUST B, V135, P1; BALME BE, 1995, REV PALAEOBOT PALYNO, V87, P85; Balme BE, 1957, SPORES POLLEN GRAINS, V25, P1; Bauer H, 2002, ANAL CHEM, V74, P91, DOI 10.1021/ac010331+; Beimforde C., 2011, ADV STROMATOLITE GEO, V131, P391; BHP, 1994, WELL COMPL REP; Bickel Daniel J., 2009, Denisia, P35; Bindschedler S, 2010, GEOL SOC SPEC PUBL, V336, P225, DOI 10.1144/SP336.11; Brasier M, 2009, J GEOL SOC LONDON, V166, P989, DOI 10.1144/0016-76492008-158; Breton G, 2005, CR PALEVOL, V4, P31, DOI 10.1016/j.crpv.2004.11.004; Breton G, 2007, CR PALEVOL, V6, P125, DOI 10.1016/j.crpv.2006.09.002; Camargo Joao M.F., 2000, American Museum Novitates, V3293, P1, DOI 10.1206/0003-0082(2000)293<0001:TEFOSB>2.0.CO;2; Couper R.A., 1958, PALAEONTOGR ABT B, V103, P75; Couper R. A., 1953, NZ GEOLOGICAL SURVEY, V22, P1; Dettmann M.E., 1963, R SOC VICTORIA, V77, P1; DETTMANN ME, 1987, BRIT ANTARCT SURV B, P13; Erdtman G., 1947, SVENSK BOT TIDSKR, V41, P104; Evans P., 1970, AUSTR BUREAU MINERAL, V116, P65; Geary GC, 1998, HYDROCARBON PROSPECT, P118; Girard V, 2008, P NATL ACAD SCI USA, V105, P17426, DOI 10.1073/pnas.0804980105; Girard Vincent, 2012, Protistology, V7, P90; Girard V, 2011, EUR J PROTISTOL, V47, P59, DOI 10.1016/j.ejop.2010.12.003; Girard V, 2009, J PALEOLIMNOL, V42, P437, DOI 10.1007/s10933-008-9287-2; Girard V, 2009, GEOLOGY, V37, P83, DOI 10.1130/G25009A.1; Girard V, 2009, GEODIVERSITAS, V31, P153, DOI 10.5252/g2009n1a14; Gomez B, 2002, LETHAIA, V35, P300, DOI 10.1080/002411602320790625; GRIMALDI D, 1990, B AM MUS NAT HIST, P5; Grimaldi D., 1996, AMBER WINDOW; Grimaldi D, 2000, STUDIES FOSSILS AMBE, V1, P76; Grimaldi David, 1994, American Museum Novitates, V3097, P1; Hand Suzanne, 2010, P69; HENWOOD A, 1992, Palaios, V7, P203, DOI 10.2307/3514931; HENWOOD AA, 1992, PALAEONTOLOGY, V35, P901; Hower JC, 2010, INT J COAL GEOL, V83, P64, DOI 10.1016/j.coal.2010.04.003; Knox EM, 1950, T P BOT SOC EDINBURG, V35, P207; Krassay AA, 2004, PETROL EXPLOR SOC AU; Lambert J., 1993, GEOARCHAEOLOGY, V8, P141, DOI DOI 10.1002/GEA.3340080206; Lambert JB, 2002, ACCOUNTS CHEM RES, V35, P628, DOI 10.1021/ar0001970; LANGENHEIM RL, 1960, GEOL SOC AM BULL, V71, P1345, DOI 10.1130/0016-7606(1960)71[1345:CAFTAC]2.0.CO;2; Markwick PJ, 1999, LATE CRETACEOUS CENO; Martin-Gonzalez A, 2008, PROTIST, V159, P251, DOI 10.1016/j.protis.2007.08.006; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; Mays C, 2013, REV PALAEOBOT PALYNO, V192, P79, DOI 10.1016/j.revpalbo.2012.12.008; McKellar RC, 2008, CAN J EARTH SCI, V45, P1061, DOI 10.1139/E08-049; MEUZELAAR HLC, 1991, FUEL PROCESS TECHNOL, V28, P119, DOI 10.1016/0378-3820(91)90044-D; Mitchell EAD, 2000, MICROB ECOL, V39, P290; MURRAY AP, 1994, GEOCHIM COSMOCHIM AC, V58, P3049, DOI 10.1016/0016-7037(94)90178-3; Nascimbene P, 2000, STUDIES FOSSILS AMBE; Natural Resources and Environment, 1964, WELL COMPL REP SHERB; Norvick M, 2001, APPEA, V41, P129; Origin Energy, 2003, WELL COMPL REP THYL; Paijmans K, 1976, NEW GUINEAS VEGETATI; Penalver Enrique, 2010, P236; Perrichot V., 2004, Geologica Acta, V2, P9; Poinar G. O. Jr., 2000, Acta Geologica Hispanica, V35, P171; POINAR GO, 1993, SCIENCE, V259, P222, DOI 10.1126/science.259.5092.222; POINAR GO, 1985, J BALTIC STUD, V16, P222, DOI 10.1080/01629778500000141; POINAR GO, 1991, FUEL PROCESS TECHNOL, V28, P135, DOI 10.1016/0378-3820(91)90045-E; Poinar GO., 1992, LIFE AMBER; Poinar HN, 1996, EXPERIENTIA, V52, P387, DOI 10.1007/BF01919546; Pole MS, 1998, AUST J EARTH SCI, V45, P979, DOI 10.1080/08120099808728452; Ragazzi E., 2011, ENCY GEOBIOLOGY, P24, DOI [DOI 10.1007/978-1-4020-9212-1_9, 10.1007/978-1-4020-9212-1_9]; Raine JI, 2008, ALCHERINGA, V32, P99, DOI 10.1080/03115510801916440; Rikkinen J, 2001, MYCOL RES, V105, P890, DOI 10.1017/S0953756201004324; Rikkinen J, 2000, MYCOL RES, V104, P7, DOI 10.1017/S0953756299001884; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Saint Martin S, 2012, CRETACEOUS RES, V35, P217, DOI 10.1016/j.cretres.2012.01.003; SCHEURING BW, 1974, REV PALAEOBOT PALYNO, V17, P187, DOI 10.1016/0034-6667(74)90100-6; Schmidt AR, 2007, P NATL ACAD SCI USA, V104, P16581, DOI 10.1073/pnas.0707949104; Schmidt AR, 2010, J EUKARYOT MICROBIOL, V57, P245, DOI 10.1111/j.1550-7408.2010.00471.x; Schmidt AR, 2010, P NATL ACAD SCI USA, V107, P7329, DOI 10.1073/pnas.1000948107; Schmidt AR, 2004, PALAEONTOLOGY, V47, P185, DOI 10.1111/j.0031-0239.2004.00368.x; Schonborn W, 1999, J EUKARYOT MICROBIOL, V46, P571, DOI 10.1111/j.1550-7408.1999.tb05133.x; Sonibare OO, 2014, AUST J EARTH SCI, V61, P979, DOI 10.1080/08120099.2014.960897; SPICER RA, 1992, GEOL MAG, V129, P169, DOI 10.1017/S0016756800008268; TSOAR H, 1987, SEDIMENTOLOGY, V34, P139, DOI 10.1111/j.1365-3091.1987.tb00566.x; Watson JC, 1925, RECORDS GEOLOGICAL S, V4, P483; Western Underground Gas Storage Pty. Ltd, 1999, WELL COMPL REP LON 4, V1; White LT, 2013, GONDWANA RES, V24, P984, DOI 10.1016/j.gr.2013.06.009; Wier A, 2002, P NATL ACAD SCI USA, V99, P1410, DOI 10.1073/pnas.022643899; Woodside, 2007, WELL COMPL REP THA01; Zherikhin VV, 1999, ESTUD MUS CIENC NAT, V14; [No title captured]	88	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0121307	10.1371/journal.pone.0121307	http://dx.doi.org/10.1371/journal.pone.0121307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970501	Green Submitted, Green Published, gold			2022-12-27	WOS:000354544200003
J	Soldati, GT; Hanazaki, N; Crivos, M; Albuquerque, UP				Soldati, Gustavo Taboada; Hanazaki, Natalia; Crivos, Marta; Albuquerque, Ulysses Paulino			Does Environmental Instability Favor the Production and Horizontal Transmission of Knowledge regarding Medicinal Plants? A Study in Southeast Brazil	PLOS ONE			English	Article							CULTURAL TRANSMISSION; ETHNOBOTANICAL KNOWLEDGE; ADAPTIVE MEMORY; COMMUNITY; EVOLUTION; ANIMALS; FACE; BIAS	Greater socio-environmental instability favors the individual production of knowledge because innovations are adapted to new circumstances. Furthermore, instability stimulates the horizontal transmission of knowledge because this mechanism disseminates adapted information. This study investigates the following hypothesis: Greater socio-environmental instability favors the production of knowledge (innovation) to adapt to new situations, and socio-environmental instability stimulates the horizontal transmission of knowledge, which is a mechanism that diffuses adapted information. In addition, the present study describes "how", "when", "from whom" and the "stimulus/context", in which knowledge regarding medicinal plants is gained or transferred. Data were collected through semi-structured interviews from three groups that represented different levels of socio-environmental instability. Socio-environmental instability did not favor individual knowledge production or any cultural transmission modes, including vertical to horizontal, despite increasing the frequency of horizontal pathways. Vertical transmission was the most important knowledge transmission strategy in all of the groups in which mothers were the most common models (knowledge sources). Significantly, childhood was the most important learning stage, although learning also occurred throughout life. Direct teaching using language was notable as a knowledge transmission strategy. Illness was the main stimulus that triggered local learning. Learning modes about medicinal plants were influenced by the knowledge itself, particularly the dynamic uses of therapeutic resources.	[Soldati, Gustavo Taboada] Univ Fed Juiz de Fora, Juiz De Fora, MG, Brazil; [Hanazaki, Natalia] Univ Fed Santa Catarina, Lab Ecol Humana & Etnobot, Florianopolis, SC, Brazil; [Crivos, Marta] Univ Nacl La Plata, Lab Etnog Aplicada, RA-1900 La Plata, Buenos Aires, Argentina; [Albuquerque, Ulysses Paulino] Univ Fed Rural Pernambuco, Lab Etnobiol Aplicada & Teor, Recife, PE, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal de Santa Catarina (UFSC); National University of La Plata; Universidade Federal Rural de Pernambuco (UFRPE)	Soldati, GT (corresponding author), Univ Fed Juiz de Fora, Juiz De Fora, MG, Brazil.	gtsoldati@gmail.com; upa@db.ufrpe.br	Hanazaki, Natalia/AAT-3830-2021; Soldati, Gustavo/AAO-2162-2020; Albuquerque, Ulysses P/I-5037-2012	Hanazaki, Natalia/0000-0002-7876-6044; Albuquerque, Ulysses P/0000-0002-8131-8429; Soldati, Gustavo/0000-0002-0173-8440	National Council of Scientific and Technologic Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq); Foundation for Research of the State of Minas Gerais (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG)	National Council of Scientific and Technologic Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research of the State of Minas Gerais (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG)	The authors received specific funding for this work from National Council of Scientific and Technologic Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq). The authors received specific funding to publish this work from Foundation for Research of the State of Minas Gerais (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG).	ABSABER Aziz, 2003, DOMINIOS NATUREZA BR; Albuquerque UP, 2013, METHODOS TECHINIQUES, P1; Aunger R, 2000, ETHOS, V28, P445, DOI 10.1525/eth.2000.28.3.445; Boyd R, 2005, ORIGINS EVOLUTION HU; Boyd R, 1996, HUMAN NATURE BIOL SO, P355; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Collard M, 2005, EVOLUTION CULTURAL D, P110; Crivos M, 2001, CAMINOS TERAPEUTICOS, P87; Crivos M, 2004, CONTRIBUCION ESTUDIO; Csibra G, 2006, ATTENTION PERFORM, P249; de Medeiros PM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/807452; Demps K, 2012, EVOL HUM BEHAV, V33, P460, DOI 10.1016/j.evolhumbehav.2011.12.008; Duque-Brasil R, 2007, REV BRAS BIOCIENCIAS, V5, P864; Durham WH, 1992, ANNU REV ANTHROPOL, V19, P187; Ellen R., 2013, UNDERSTANDING CULTUR, P1; Eyssartier C, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-25; Frazao-Moreira A, 1997, ED SOC CULTURAS, V7, P75, DOI [10.5056/jnm14040, DOI 10.5056/JNM14040]; Garcia GSC, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-39; Gurven M, 2006, J HUM EVOL, V51, P454, DOI 10.1016/j.jhevol.2006.05.003; Henrich J, 2011, PHILOS T R SOC B, V366, P1139, DOI 10.1098/rstb.2010.0323; Hewlett BS, 2011, PHILOS T R SOC B, V366, P1168, DOI 10.1098/rstb.2010.0373; HEWLETT BS, 1986, AM ANTHROPOL, V88, P922; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Holden C, 2005, EVOLUTION CULTURAL D, P13; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Ladio AH, 2004, BIODIVERS CONSERV, V13, P1153, DOI 10.1023/B:BIOC.0000018150.79156.50; Laland KN, 2004, LEARN BEHAV, V32, P4; Leonti M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00092; Leonti M, 2011, J ETHNOPHARMACOL, V134, P542, DOI 10.1016/j.jep.2011.01.017; Lozada M, 2006, ECON BOT, V60, P374, DOI 10.1663/0013-0001(2006)60[374:CTOEKI]2.0.CO;2; Mathez-Stiefel SL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/959285; McDade TW, 2007, P NATL ACAD SCI USA, V104, P6134, DOI 10.1073/pnas.0609123104; McElreath R, 2008, CURR ANTHROPOL, V49, P307, DOI 10.1086/524364; Mesoudi A, 2004, EVOLUTION, V58, P1; Mesoudi A., 2011, CULTURAL EVOLUTION D; Mesoudi A, 2008, EVOL HUM BEHAV, V29, P350, DOI 10.1016/j.evolhumbehav.2008.04.005; Mesoudi A, 2006, BEHAV BRAIN SCI, V29, P329, DOI 10.1017/S0140525X06009083; Nairne JS, 2008, J MEM LANG, V59, P377, DOI 10.1016/j.jml.2008.06.001; Nairne JS, 2008, PSYCHOL SCI, V19, P176, DOI 10.1111/j.1467-9280.2008.02064.x; Ndhlala AR, 2011, S AFR J BOT, V77, P830, DOI 10.1016/j.sajb.2011.09.002; Ohmagari K, 1997, HUM ECOL, V25, P197, DOI 10.1023/A:1021922105740; Perez-Ojeda del Arco M., 2011, Bioremediation, Biodiversity and Bioavailability, V5, P92; Pieroni A, 2007, ETHNOBIOLOGY, V7; Reyes-Garcia V, 2008, EVOL HUM BEHAV, V29, P275, DOI 10.1016/j.evolhumbehav.2008.02.002; Reyes-Garcia V, 2009, EVOL HUM BEHAV, V30, P274, DOI 10.1016/j.evolhumbehav.2009.02.001; Richerson P.J, 1988, CULTURE EVOLUTIONARY; Setalaphruk C, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-33; Srithi K, 2009, J ETHNOPHARMACOL, V123, P335, DOI 10.1016/j.jep.2009.02.035; Takahasi K, 1998, J THEOR BIOL, V190, P147, DOI 10.1006/jtbi.1997.0541; Tehrani J., 2013, UNDERSTANDING CULTUR, P148; Tehrani JJ, 2009, EVOL HUM BEHAV, V30, P286, DOI 10.1016/j.evolhumbehav.2009.03.002; Wyndham FS, 2010, HUM ECOL, V38, P87, DOI 10.1007/s10745-009-9287-5; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zarger RK, 2004, CURR ANTHROPOL, V45, P413, DOI 10.1086/420908; Zarger RK, 2002, ETHNOBIOLOGY AND BIOCULTURAL DIVERSITY, PROCEEDINGS, P593; Zent S., 2001, BIOCULTURAL DIVERSIT, P190	56	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126389	10.1371/journal.pone.0126389	http://dx.doi.org/10.1371/journal.pone.0126389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7CV	25992578	Green Published, gold			2022-12-27	WOS:000354921400062
J	Her, YF; Nelson-Holte, M; Maher, LJ				Her, Yeng F.; Nelson-Holte, Molly; Maher, Louis James, III			Oxygen Concentration Controls Epigenetic Effects in Models of Familial Paraganglioma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROLYL HYDROXYLASE REACTION; SUCCINATE-DEHYDROGENASE; SDH MUTATIONS; HEREDITARY PARAGANGLIOMA; GENE-MUTATIONS; COMPLEX-II; MALIGNANT PHEOCHROMOCYTOMAS; IDH2 MUTATIONS; CAROTID-BODY	Familial paraganglioma (PGL) is a rare neuroendocrine cancer associated with defects in the genes encoding the subunits of succinate dehydrogenase (SDH), a tricarboxylic acid (TCA) cycle enzyme. For unknown reasons, a higher prevalence of PGL has been reported for humans living at higher altitude, with increased disease aggressiveness and morbidity. In this study, we evaluate the effects of oxygen on epigenetic changes due to succinate accumulation in three SDH loss cell culture models. We test the hypothesis that the mechanism of alpha-ketoglutarate (alpha-KG)-dependent dioxygenase enzymes explains the inhibitory synergy of hypoxia and succinate accumulation. We confirm that SDH loss leads to profound succinate accumulation. We further show that hypoxia and succinate accumulation synergistically inhibit alpha-KG-dependent dioxygenases leading to increased stabilization of transcription factor HIF1 alpha, HIF2 alpha, and hypermethylation of histones and DNA. Increasing oxygen suppresses succinate inhibition of alpha-KG-dependent dioxygenases. This result provides a possible explanation for the association between hypoxia and PGL, and suggests hyperoxia as a potential novel therapy.	[Her, Yeng F.; Nelson-Holte, Molly; Maher, Louis James, III] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Her, Yeng F.] Mayo Clin, Mayo Med Sch, Mayo Grad Sch, Med Scientist Training Program, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Maher, LJ (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	maher@mayo.edu			Mayo Foundation; Paradifference Foundation; National Institutes of Health [CA166025, 1F31CA180698, 5T32GM065841]; NATIONAL CANCER INSTITUTE [F31CA180698, R01CA166025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK100469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055252, T32GM065841] Funding Source: NIH RePORTER	Mayo Foundation; Paradifference Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was received from the Mayo Foundation (no grant number), The Paradifference Foundation (no grant number), and from the National Institutes of Health (grant numbers CA166025, 1F31CA180698, and 5T32GM065841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; Akbay EA, 2014, GENE DEV, V28, P479, DOI 10.1101/gad.231233.113; Amar L, 2007, J CLIN ENDOCR METAB, V92, P3822, DOI 10.1210/jc.2007-0709; ARIASSTELLA J, 1976, ARCH PATHOL LAB MED, V100, P636; Astrom K, 2003, HUM GENET, V113, P228, DOI 10.1007/s00439-003-0969-6; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Ayala-Ramirez M, 2010, J TRAVEL MED, V17, P424, DOI 10.1111/j.1708-8305.2010.00463.x; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bancos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056827; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Cerecer-Gil NY, 2010, CLIN CANCER RES, V16, P4148, DOI 10.1158/1078-0432.CCR-10-0637; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DiGiusto DL, 2010, SCI TRANSL MED, P2, DOI DOI 10.1126/SCITRANSLMED.3000931; Favier J, 2010, BEST PRACT RES CL EN, V24, P957, DOI 10.1016/j.beem.2010.10.004; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; FOLGER GM, 1964, CIRCULATION, V29, P750, DOI 10.1161/01.CIR.29.5.750; Gill AJ, 2010, HUM PATHOL, V41, P805, DOI 10.1016/j.humpath.2009.12.005; Gimenez-Roqueplo AP, 2003, CANCER RES, V63, P5615; Gimenez-Roqueplo AP, 2002, J CLIN ENDOCR METAB, V87, P4771, DOI 10.1210/jc.2002-020525; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kasaliwal R, 2014, ENDOCR PRACT, V20, pE80, DOI 10.4158/EP13408.CR; KHAN Q, 1988, INT J BIOMETEOROL, V32, P254, DOI 10.1007/BF01080024; Killian JK, 2013, CANCER DISCOV, V3, P648, DOI 10.1158/2159-8290.CD-13-0092; King KS, 2011, J CLIN ONCOL, V29, P4137, DOI 10.1200/JCO.2011.34.6353; Kita T, 2003, HYPERTENS RES, V26, P433, DOI 10.1291/hypres.26.433; Koek MM, 2006, ANAL CHEM, V78, P1272, DOI 10.1021/ac051683+; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Kumar P, 2012, COMPR PHYSIOL, V2, P141, DOI 10.1002/cphy.c100069; Lendvai N, 2014, ENDOCRINOLOGY, V155, P27, DOI 10.1210/en.2013-1549; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; Maxwell PH, 2005, CANCER CELL, V8, P91, DOI 10.1016/j.ccr.2005.07.012; Miest T, 2009, METHODS, V47, P298, DOI 10.1016/j.ymeth.2008.11.001; MYLLYLA R, 1977, EUR J BIOCHEM, V80, P349, DOI 10.1111/j.1432-1033.1977.tb11889.x; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Opotowsky AR, 2015, J CLIN ENDOCR METAB; Peters JP, 2013, NUCLEIC ACIDS RES, V41, P10593, DOI 10.1093/nar/gkt808; Pollard PJ, 2006, J CLIN ENDOCR METAB, V91, P4593, DOI 10.1210/jc.2006-0920; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Qin N, 2014, INT J CANCER, V135, P2054, DOI 10.1002/ijc.28868; Qin Y, 2009, HORM METAB RES, V41, P664, DOI 10.1055/s-0029-1215590; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Richter S, 2014, J CLIN ENDOCR METAB, V99, P3903, DOI 10.1210/jc.2014-2151; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Rodriguez-Cuevas S, 1998, HEAD NECK-J SCI SPEC, V20, P374, DOI 10.1002/(SICI)1097-0347(199808)20:5<374::AID-HED3>3.0.CO;2-V; SALDANA MJ, 1973, HUM PATHOL, V4, P251, DOI 10.1016/S0046-8177(73)80012-7; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Sandhu J, 2009, J CHROMATOGR B, V877, P1957, DOI 10.1016/j.jchromb.2009.05.032; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; SRIDHAR KS, 1983, CANCER RES, V43, P4629; Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250; TEVETHIA MJ, 1984, VIROLOGY, V137, P414, DOI 10.1016/0042-6822(84)90234-4; TUDERMAN L, 1977, EUR J BIOCHEM, V80, P341, DOI 10.1111/j.1432-1033.1977.tb11888.x; van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0; Whalen WJ, 1970, STROKE, V1, P194, DOI 10.1161/01.STR.1.3.194; WOLFLE D, 1985, EUR J BIOCHEM, V151, P299, DOI 10.1111/j.1432-1033.1985.tb09100.x; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018	76	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127471	10.1371/journal.pone.0127471	http://dx.doi.org/10.1371/journal.pone.0127471			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985299	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300126
J	Hong, BY; Araujo, MVF; Strausbaugh, LD; Terzi, E; Ioannidou, E; Diaz, PI				Hong, Bo-Young; Araujo, Michel V. Furtado; Strausbaugh, Linda D.; Terzi, Evimaria; Ioannidou, Effie; Diaz, Patricia I.			Microbiome Profiles in Periodontitis in Relation to Host and Disease Characteristics	PLOS ONE			English	Article							SUBGINGIVAL MICROBIOTA; GUT MICROBIOTA	Periodontitis is an inflammatory condition that affects the supporting tissues surrounding teeth. The occurrence of periodontitis is associated with shifts in the structure of the communities that inhabit the gingival sulcus. Although great inter-subject variability in the subgingival microbiome has been observed in subjects with periodontitis, it is unclear whether distinct community types exist and if differences in microbial signatures correlate with host characteristics or with the variable clinical presentations of periodontitis. Therefore, in this study we explored the existence of different community types in periodontitis and their relationship with host demographic, medical and disease-related clinical characteristics. Clustering analyses of microbial abundance profiles suggested two types of communities (A and B) existed in the 34 subjects with periodontitis evaluated. Type B communities harbored greater proportions of certain periodontitis-associated taxa, including species historically associated with the disease, such as Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola, and taxa recently linked to periodontitis. In contrast, subjects with type A communities had increased proportions of different periodontitis-associated species, and were also enriched for health-associated species and core taxa (those equally prevalent in health and periodontitis). Periodontitis subgingival clusters were not associated with demographic, medical or disease-specific clinical parameters other than periodontitis extent (proportion of sites affected), which positively correlated with the total proportion of cluster B signature taxa. In conclusion, two types of microbial communities were detected in subjects with periodontitis. Host demographics and underlying medical conditions did not correlate with these profiles, which instead appeared to be related to periodontitis extent, with type B communities present in more widespread disease cases. The two identified periodontitis profiles may represent distinct dysbiotic processes potentially requiring community-tailored therapeutic interventions.	[Hong, Bo-Young; Araujo, Michel V. Furtado; Ioannidou, Effie; Diaz, Patricia I.] Univ Connecticut, Ctr Hlth, Dept Oral Hlth & Diagnost Sci, Div Periodontol, Farmington, CT 06030 USA; [Strausbaugh, Linda D.] Univ Connecticut, Ctr Appl Genet & Technol, Dept Mol & Cell Biol, Storrs, CT USA; [Terzi, Evimaria] Boston Univ, Dept Comp Sci, Boston, MA 02215 USA	University of Connecticut; University of Connecticut; Boston University	Diaz, PI (corresponding author), Univ Connecticut, Ctr Hlth, Dept Oral Hlth & Diagnost Sci, Div Periodontol, Farmington, CT 06030 USA.	pdiaz@uchc.edu	Hong, Bo-young/AAQ-1679-2021; Ioannidou, Effie/P-4068-2014	Ioannidou, Effie/0000-0003-1954-5900; Hong, Bo-young/0000-0001-5055-0893	National Institute of Dental and Craniofacial Research, National Institutes of Health [K23DE018689]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K23DE018689] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was partially supported by grant K23DE018689 from the National Institute of Dental and Craniofacial Research, National Institutes of Health, to EI. There are no additional funding sources for this study.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BURBIDGE JB, 1988, J AM STAT ASSOC, V83, P123, DOI 10.2307/2288929; Delima SL, 2010, J CLIN MICROBIOL, V48, P2344, DOI 10.1128/JCM.01821-09; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Haffajee AD, 2004, J CLIN PERIODONTOL, V31, P996, DOI 10.1111/j.1600-051X.2004.00597.x; HAFFAJEE AD, 1992, J CLIN PERIODONTOL, V19, P84, DOI 10.1111/j.1600-051X.1992.tb00445.x; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Ioannidou E, 2011, J DENT RES, V90, P730, DOI 10.1177/0022034511402209; LOESCHE WJ, 1985, J PERIODONTOL, V56, P447, DOI 10.1902/jop.1985.56.8.447; Offenbacher S, 2007, J PERIODONTOL, V78, P1911, DOI 10.1902/jop.2007.060465; Perez-Chaparro PJ, 2014, J DENT RES, V93, P846, DOI 10.1177/0022034514542468; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Teles RP, 2010, J CLIN PERIODONTOL, V37, P313, DOI 10.1111/j.1600-051X.2010.01534.x; Teles RP, 2000, PERIODONTOL, V2000, P180, DOI DOI 10.1111/J.1600-0757.2006.00192.X; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; Wang BY, 2009, J CLIN MICROBIOL, V47, P3902, DOI 10.1128/JCM.00072-09; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xie H, 2012, J PERIODONTAL RES, V47, P578, DOI 10.1111/j.1600-0765.2012.01469.x; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516; Zhou YJ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r66	35	69	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127077	10.1371/journal.pone.0127077	http://dx.doi.org/10.1371/journal.pone.0127077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984952	Green Submitted, Green Published, gold			2022-12-27	WOS:000354917300086
J	Pei, S; Muchnik, L; Tang, ST; Zheng, ZM; Makse, HA				Pei, Sen; Muchnik, Lev; Tang, Shaoting; Zheng, Zhiming; Makse, Hernan A.			Exploring the Complex Pattern of Information Spreading in Online Blog Communities	PLOS ONE			English	Article							SOCIAL NETWORKS; DIFFUSION; INFLUENTIALS; BEHAVIOR	Information spreading in online social communities has attracted tremendous attention due to its utmost practical values in applications. Despite that several individual-level diffusion data have been investigated, we still lack the detailed understanding of the spreading pattern of information. Here, by comparing information flows and social links in a blog community, we find that the diffusion processes are induced by three different spreading mechanisms: social spreading, self-promotion and broadcast. Although numerous previous studies have employed epidemic spreading models to simulate information diffusion, we observe that such models fail to reproduce the realistic diffusion pattern. In respect to users behaviors, strikingly, we find that most users would stick to one specific diffusion mechanism. Moreover, our observations indicate that the social spreading is not only crucial for the structure of diffusion trees, but also capable of inducing more subsequent individuals to acquire the information. Our findings suggest new directions for modeling of information diffusion in social systems, and could inform design of efficient propagation strategies based on users behaviors.	[Pei, Sen; Tang, Shaoting; Zheng, Zhiming] Beihang Univ, Lab Math Informat & Behav Semant, Beijing 100191, Peoples R China; [Pei, Sen; Tang, Shaoting; Zheng, Zhiming] Beihang Univ, Sch Math & Syst Sci, Beijing 100191, Peoples R China; [Pei, Sen; Makse, Hernan A.] CUNY York Coll, Levich Inst & Phys Dept, New York, NY USA; [Muchnik, Lev] Hebrew Univ Jerusalem, Sch Business Adm, IL-91905 Jerusalem, Israel	Beihang University; Beihang University; City University of New York (CUNY) System; Hebrew University of Jerusalem	Pei, S (corresponding author), Beihang Univ, Lab Math Informat & Behav Semant, Beijing 100191, Peoples R China.	peisen@buaa.edu.cn	Pei, Sen/AAN-8662-2020	Pei, Sen/0000-0002-7072-2995; Muchnik, Lev/0000-0002-5011-8336	NIH; NSF; ARL [W911NF-09-2-0053]; NSFC [11290141, 11201018]; Fundamental Research of Civil Aircraft [MJ-F-2012-04];  [2010DFR00700]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ARL(United States Department of DefenseUS Army Research Laboratory (ARL)); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research of Civil Aircraft; 	HAM thanks NIH, NSF and ARL, under Cooperative Agreement Number W911NF-09-2-0053 for financial support. SP, ST and ZZ are supported by NSFC (No. 11290141, 11201018), International Cooperation Project No. 2010DFR00700 and Fundamental Research of Civil Aircraft No. MJ-F-2012-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral S., 2013, NETW SCI, V1, P125, DOI [10.1017/nws.2013.6, DOI 10.1017/NWS.2013.6]; Aral S, 2014, MANAGE SCI, V60, P1352, DOI 10.1287/mnsc.2014.1936; Backstrom L, 2006, P 12 ACM SIGKDD INT, P44, DOI DOI 10.1145/1150402.1150412; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis N.A., 2009, CONNECTED SURPRISING; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gallos LK, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031014; Goel S., P 13 ACM C EL COMM, P623, DOI DOI 10.1145/2229012.2229058; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Gruhl Daniel, 2004, P 13 INT C WORLD WID, P491, DOI DOI 10.1145/988672.988739; Guille A, 2013, SIGMOD REC, V42, P17; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kleinberg J, 2007, ALGORITHMIC GAME THEORY, P613; Kolari P., 2006, P INT C WORLD WID WE, P22; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Li WH, 2014, PHYSICA A, V397, P121, DOI 10.1016/j.physa.2013.11.021; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Liben-Nowell D, 2008, P NATL ACAD SCI USA, V105, P4633, DOI 10.1073/pnas.0708471105; Liu C, 2014, COMMUN NONLINEAR SCI, V19, P896, DOI 10.1016/j.cnsns.2013.08.028; Lu LY, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123005; Iribarren JL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038702; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Muchnik L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01783; Myers Seth A., 2012, P 18 ACM SIGKDD INT, P33, DOI DOI 10.1145/2339530.2339540; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pastor-Satorras R., 2014, EPIDEMIC PROCESSES C; Pei S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124848; Pei S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05547; Pei S, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12002; Rogers E.M., 1995, DIFFUSION INNOVATION; Van den Bulte C, 2007, MARKET SCI, V26, P400, DOI 10.1287/mksc.1060.0224; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Watts DJ, 2007, HARVARD BUS REV, V85, P22; Yan S, 2013, PHYSICA A, V392, P3846, DOI 10.1016/j.physa.2013.04.018; Zhu YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103007	41	32	34	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126894	10.1371/journal.pone.0126894	http://dx.doi.org/10.1371/journal.pone.0126894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BG	25985081	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300061
J	Barra, MM; Richards, DM; Hofer, AC; Delacher, M; Feuerer, M				Barra, Melanie M.; Richards, David M.; Hofer, Ann-Cathrin; Delacher, Michael; Feuerer, Markus			Premature Expression of Foxp3 in Double-Negative Thymocytes	PLOS ONE			English	Article							REGULATORY T-CELLS; LINEAGE SPECIFICATION; DIFFERENTIATION; TCF-1; INVOLVEMENT; SELECTION; CORTEX; CD4	Peripheral immune regulation depends on the generation of thymic-derived regulatory T (tT(reg)) cells to maintain self-tolerance and to counterbalance overshooting immune responses. The expression of the T-reg lineage defining transcription factor Foxp3 in developing tT(reg) cells depends on TCR signaling during the thymic selection process of these T cells. In this study, we surprisingly identify Foxp3(+) immature thymocytes at the double-negative (DN) stage in transcription factor 7 (Tcf7)-deficient mice. These Foxp3+ cells did not express a TCR (beta or gamma delta chains), CD3 or CD5 and therefore these cells were true DN cells. Further investigation of this phenomenon in a transgenic TCR model showed that Foxp3-expressing DN cells could not respond to TCR stimulation in vivo. These data suggest that Foxp3 expression in these DN cells occurred independently of TCR signaling. Interestingly, these Foxp3+ DN cells were located in a transition state between DN1 and DN2 (CD4(-)CD8(-)CD3(-)TCR(-)CD44(high)CD25(low)). Our results indicate that Tcf7 is involved in preventing the premature expression of Foxp3 in DN thymocytes.	[Barra, Melanie M.; Richards, David M.; Hofer, Ann-Cathrin; Delacher, Michael; Feuerer, Markus] German Canc Res Ctr, Immune Tolerance Tumor Immunol Program, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Feuerer, M (corresponding author), German Canc Res Ctr, Immune Tolerance Tumor Immunol Program, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.feuerer@dkfz-heidelberg.de	Delacher, Michael/AAA-5224-2019; Delacher, Michael/AAM-9710-2021		Helmholtz Association of German Research Centers (HGF) [HZ-NG-505]; HGF-PhD-fellowship; Cooperation Program in Cancer Research of the DKFZ; Israel's Ministry of Science, Technology and Space (MOST); German-Israeli Helmholtz Research School in Cancer Biology	Helmholtz Association of German Research Centers (HGF)(Helmholtz Association); HGF-PhD-fellowship; Cooperation Program in Cancer Research of the DKFZ; Israel's Ministry of Science, Technology and Space (MOST); German-Israeli Helmholtz Research School in Cancer Biology	Funding: This work was supported by grants from the Helmholtz Association of German Research Centers (HGF; HZ-NG-505) to M.F.; M.M.B. was supported by a HGF-PhD-fellowship. A.C.H. was supported by the Cooperation Program in Cancer Research of the DKFZ and Israel's Ministry of Science, Technology and Space (MOST). M.D. was supported by the German-Israeli Helmholtz Research School in Cancer Biology.	Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Lee HM, 2009, J IMMUNOL, V183, P2261, DOI 10.4049/jimmunol.0901304; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liston A, 2007, J EXP MED, V204, P475, DOI 10.1084/jem.20062465; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; Peaudecerf L, 2011, MUCOSAL IMMUNOL, V4, P93, DOI 10.1038/mi.2010.47; Peaudecerf L, 2012, J EXP MED, V209, P1401, DOI 10.1084/jem.20120845; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schilham MW, 1998, J IMMUNOL, V161, P3984; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Triulzi T, 2013, J CELL PHYSIOL, V228, P30, DOI 10.1002/jcp.24125; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127038	10.1371/journal.pone.0127038	http://dx.doi.org/10.1371/journal.pone.0127038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978037	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100123
J	Fischer, KE; Gelfond, JAL; Soto, VY; Han, C; Someya, S; Richardson, A; Austad, SN				Fischer, Kathleen E.; Gelfond, Jonathan A. L.; Soto, Vanessa Y.; Han, Chul; Someya, Shinichi; Richardson, Arlan; Austad, Steven N.			Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life	PLOS ONE			English	Article							MAMMALIAN TARGET; EXTENDS LIFE; INSULIN-RESISTANCE; AMYLOID-BETA; HEARING-LOSS; TOR PATHWAY; SPAN; MICE; MTOR; INHIBITION	Rapamycin, an mTOR inhibitor, has been shown to extend lifespan in a range of model organisms. It has been reported to extend lifespan in multiple strains of mice, administered chronically or acutely early or late in life. The ability of rapamycin to extend health (healthspan) as opposed to life is less well documented. To assess the effects chronic rapamycin treatment on healthspan, enteric rapamycin was given to male and female C57BL/6J mice starting at 4 months of age and continued throughout life. Repeated, longitudinal assessments of health in individual animals were made starting at 16 months of age (= 12 months of treatment) until death. A number of health parameters were improved (female grip strength, female body mass and reduced sleep fragmentation in both sexes), others showed no significant difference, while at least one (male rotarod performance) was negatively affected. Rapamycin treatment affected many measures of health in a highly sex-specific manner. While sex-specific phenotypic effects of rapamycin treatment have been widely reported, in this study we document sex differences in the direction of phenotypic change. Rapamycin-fed males and females were both significantly different from controls; however the differences were in the opposite direction in measures of body mass, percent fat and resting metabolic rate, a pattern not previously reported.	[Fischer, Kathleen E.; Soto, Vanessa Y.; Richardson, Arlan; Austad, Steven N.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Fischer, Kathleen E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Gelfond, Jonathan A. L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Han, Chul; Someya, Shinichi] Univ Florida, Dept Aging, Gainesville, FL USA; [Han, Chul; Someya, Shinichi] Univ Florida, Dept Geriatr Res, Gainesville, FL USA; [Richardson, Arlan; Austad, Steven N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Health San Antonio	Fischer, KE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.	fischerk@uab.edu			San Antonio Nathan Shock Aging Center [P30-AG13319]; National Institutes of Health RC2 Grand Opportunity grant [AG 036613]; NIH [T32 AG 021890]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG050886, RC2AG036613, P30AG013319, T32AG021890, P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC011840, R01DC014437, R01DC012552] Funding Source: NIH RePORTER	San Antonio Nathan Shock Aging Center; National Institutes of Health RC2 Grand Opportunity grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Financial Support was provided by the San Antonio Nathan Shock Aging Center to AR (P30-AG13319) (http://www.nia.nih.gov/research/dab/nathan-shock-centers-excellence), National Institutes of Health RC2 Grand Opportunity grant to AR (AG 036613) (http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-004.html), and NIH training grant (T32 AG 021890) to SNA (http://www.nia.nih.gov/research/dea/institutional-training-grants).	Aigouy B, 2013, NAT METHODS, V10, P1048, DOI 10.1038/nmeth.2692; Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Dickinson JM, 2011, J NUTR, V141, P856, DOI 10.3945/jn.111.139485; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Flynn JM, 2013, AGING CELL, V12, P851, DOI 10.1111/acel.12109; Fok WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083988; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Halloran J, 2012, NEUROSCIENCE, V223, P102, DOI 10.1016/j.neuroscience.2012.06.054; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hinojosa CA, 2012, EXP GERONTOL, V47, P958, DOI 10.1016/j.exger.2012.08.013; Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510; Judge JO, 1996, J GERONTOL A-BIOL, V51, pM303, DOI 10.1093/gerona/51A.6.M303; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2009, NATURE, V460, P331, DOI 10.1038/460331a; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Katewa SD, 2011, EXP GERONTOL, V46, P382, DOI 10.1016/j.exger.2010.11.036; Komarova EA, 2012, AGING-US, V4, P709, DOI 10.18632/aging.100498; Lamming DW, 2013, AGING CELL, V12, P712, DOI 10.1111/acel.12097; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Larsen JL, 2006, TRANSPLANTATION, V82, P466, DOI 10.1097/01.tp.0000229384.22217.15; Livi CB, 2013, AGING-US, V5, P100, DOI 10.18632/aging.100533; Majumder S, 2012, AGING CELL, V11, P326, DOI 10.1111/j.1474-9726.2011.00791.x; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Pakala R, 2005, J CARDIOVASC PHARM, V46, P481, DOI 10.1097/01.fjc.0000177985.14305.15; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Schellinck HM, 2010, ADV STUD BEHAV, V41, P255, DOI 10.1016/S0065-3454(10)41007-4; Smith JM, 2003, PEDIATR CLIN N AM, V50, P1283, DOI 10.1016/S0031-3955(03)00121-4; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Spong A, 2012, CELL CYCLE, V11, P845, DOI 10.4161/cc.11.5.19607; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Turner AP, 2011, AM J TRANSPLANT, V11, P613, DOI 10.1111/j.1600-6143.2010.03407.x; Welzl K, 2014, GERONTOLOGY, V60, P229, DOI 10.1159/000356020; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang YQ, 2014, J GERONTOL A-BIOL, V69, P119, DOI 10.1093/gerona/glt056	46	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126644	10.1371/journal.pone.0126644	http://dx.doi.org/10.1371/journal.pone.0126644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978367	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100085
J	Guo, CG; Ji, R; Li, YQ				Guo, Chuan-Guo; Ji, Rui; Li, Yan-Qing			Accuracy of i-Scan for Optical Diagnosis of Colonic Polyps: A Meta-Analysis	PLOS ONE			English	Article							COMPUTED VIRTUAL CHROMOENDOSCOPY; NARROW-BAND; HIGH-DEFINITION; WHITE-LIGHT; COLORECTAL POLYPS; REAL-TIME; CONVENTIONAL COLONOSCOPY; HISTOLOGICAL PREDICTION; DIFFERENTIAL-DIAGNOSIS; INDIGO CARMINE	Background i-Scan is a novel virtual chromoendoscopy system designed to enhance surface and vascular patterns to improve optical diagnostic performance. Numerous prospective studies have been done to evaluate the accuracy of i-Scan in differentiating colonic neoplasms from non-neoplasms. i-Scan could be an effective endoscopic technique for optical diagnosis of colonic polyps. Objective Our aim of this study was to perform a meta-analysis of published data to establish the diagnostic accuracy of i-Scan for optical diagnosis of colonic polyps. Methods We searched PubMed, Medline, Elsevier ScienceDirect and Cochrane Library databases. We used a bivariate meta-analysis following a random effects model to summarize the data and plotted hierarchical summary receiver-operating characteristic (HSROC) curves. The area under the HSROC curve (AUC) serves as an indicator of the diagnostic accuracy. Results The meta-analysis included a total of 925 patients and 2312 polyps. For the overall studies, the area under the HSROC curve was 0.96. The summary sensitivity was 90.4% (95% CI 85%-94.1%) and specificity was 90.9% (95% CI 84.3%-94.9%). In 11 studies predicting polyps histology in real-time, the summary sensitivity and specificity was 91.5% (95% CI 85.7%-95.1%) and 92.1% (95% CI 84.5%-96.1%), respectively, with the AUC of 0.97. For three different diagnostic criteria (Kudo, NICE, others), the sensitivity was 86.3%, 93.0%, 85.0%, respectively and specificity was 84.8%, 94.4%, 91.8%, respectively. Conclusions Endoscopic diagnosis with i-Scan has accurate optical diagnostic performance to differentiate neoplastic from non-neoplastic polyps with an area under the HSROC curve exceeding 0.90. Both the sensitivity and specificity for diagnosing colonic polyps are over 90%.	[Guo, Chuan-Guo; Ji, Rui; Li, Yan-Qing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Shandong, Peoples R China	Shandong University	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Shandong, Peoples R China.	liyanqing@sdu.edu.cn		Guo, Chuan-Guo/0000-0002-0657-473X	National Natural Science Foundation of China [81330012, 81300284]; Shandong Province Science and Technology Commitee [2013GSF11833]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Science and Technology Commitee	This study was funded by National Natural Science Foundation of China (grant number 81330012, 81300284) and the Shandong Province Science and Technology Commitee (grant number 2013GSF11833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2009, GASTROENTEROLOGY, V136, P410, DOI 10.1053/j.gastro.2008.10.022; Basford PJ, 2014, GASTROINTEST ENDOSC, V79, P111, DOI 10.1016/j.gie.2013.06.013; Bouwens MWE, 2013, WORLD J GASTROENTERO, V19, P4334, DOI 10.3748/wjg.v19.i27.4334; Chan JL, 2012, WORLD J GASTROENTERO, V18, P5905, DOI 10.3748/wjg.v18.i41.5905; Chiu HM, 2007, GUT, V56, P373, DOI 10.1136/gut.2006.099614; Chung SJ, 2010, GASTROINTEST ENDOSC, V72, P136, DOI 10.1016/j.gie.2010.01.055; De Palma GD, 2006, WORLD J GASTROENTERO, V12, P2402; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Fu KI, 2004, ENDOSCOPY, V36, P1089, DOI 10.1055/s-2004-826039; Gupta N, 2012, GASTROINTEST ENDOSC, V75, P1022, DOI 10.1016/j.gie.2012.01.020; Han ML, 2012, INT J COLORECTAL DIS, V27, P337, DOI 10.1007/s00384-011-1319-0; Hassan C, 2010, CLIN GASTROENTEROL H, V8, P865, DOI 10.1016/j.cgh.2010.05.018; Hayashi N, 2013, GASTROINTEST ENDOSC, V78, P625, DOI 10.1016/j.gie.2013.04.185; Hewett DG, 2013, GASTROENTEROL CLIN N, V42, P443, DOI 10.1016/j.gtc.2013.05.015; Hoffman A, 2010, ENDOSCOPY, V42, P827, DOI 10.1055/s-0030-1255713; Hoffman A, 2010, DIGEST LIVER DIS, V42, P45, DOI 10.1016/j.dld.2009.04.005; Hong SN, 2012, GASTROINTEST ENDOSC, V75, P1011, DOI 10.1016/j.gie.2011.11.040; Ignjatovic A, 2009, LANCET ONCOL, V10, P1171, DOI 10.1016/S1470-2045(09)70329-8; Kaltenbach T, 2008, GUT, V57, P1406, DOI 10.1136/gut.2007.137984; Kodashima S, 2010, WORLD J GASTROENTERO, V16, P1043, DOI 10.3748/wjg.v16.i9.1043; Kudo S, 2001, ENDOSCOPY, V33, P367; KUDO S, 1994, J CLIN PATHOL, V47, P880, DOI 10.1136/jcp.47.10.880; Lee CK, 2011, GASTROINTEST ENDOSC, V74, P603, DOI 10.1016/j.gie.2011.04.049; Liu YX, 2008, CHINESE MED J-PEKING, V121, P977, DOI 10.1097/00029330-200806010-00004; Longcroft-Wheaton G, 2012, GUT, V61, pA329, DOI 10.1136/gutjnl-2012-302514d.79; Longcroft-Wheaton GR, 2011, EUR J GASTROEN HEPAT, V23, P903, DOI 10.1097/MEG.0b013e328349e276; McGill SK, 2013, GUT, V62, P1704, DOI 10.1136/gutjnl-2012-303965; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Neumann H, 2013, GASTROINTEST ENDOSC, V78, P115, DOI 10.1016/j.gie.2013.02.001; Pigo F, 2013, INT J COLORECTAL DIS, V28, P399, DOI 10.1007/s00384-012-1583-7; Pohl J, 2009, GUT, V58, P73, DOI 10.1136/gut.2008.153601; Pohl J, 2008, AM J GASTROENTEROL, V103, P562, DOI 10.1111/j.1572-0241.2007.01670.x; Rastogi A, 2009, AM J GASTROENTEROL, V104, P2422, DOI 10.1038/ajg.2009.403; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rex DK, 2007, GASTROENTEROLOGY, V133, P42, DOI 10.1053/j.gastro.2007.04.029; Rex DK, 2011, GASTROINTEST ENDOSC, V73, P419, DOI 10.1016/j.gie.2011.01.023; Rex DK, 2009, LANCET ONCOL, V10, P1135, DOI 10.1016/S1470-2045(09)70342-0; Robles-Medranda C, 2013, GASTROINTEST ENDOSC, V77, pAB463; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Su MY, 2006, AM J GASTROENTEROL, V101, P2711, DOI 10.1111/j.1572-0241.2006.00932.x; Tanaka S, 2011, DIGEST ENDOSC, V23, P131, DOI 10.1111/j.1443-1661.2011.01106.x; Tribonias G, 2010, COLORECTAL DIS, V12, pE260, DOI 10.1111/j.1463-1318.2009.02145.x; Uraoka T, 2008, J GASTROEN HEPATOL, V23, P1810, DOI 10.1111/j.1440-1746.2008.05635.x; Wanders LK, 2013, LANCET ONCOL, V14, P1337, DOI 10.1016/S1470-2045(13)70509-6; Wang F, 2008, STAT MED, V27, P243, DOI 10.1002/sim.2828; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126237	10.1371/journal.pone.0126237	http://dx.doi.org/10.1371/journal.pone.0126237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978459	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100057
J	Jalilian, I; Heu, C; Cheng, H; Freittag, H; Desouza, M; Stehn, JR; Bryce, NS; Whan, RM; Hardeman, EC; Fath, T; Schevzov, G; Gunning, PW				Jalilian, Iman; Heu, Celine; Cheng, Hong; Freittag, Hannah; Desouza, Melissa; Stehn, Justine R.; Bryce, Nicole S.; Whan, Renee M.; Hardeman, Edna C.; Fath, Thomas; Schevzov, Galina; Gunning, Peter W.			Cell Elasticity Is Regulated by the Tropomyosin Isoform Composition of the Actin Cytoskeleton	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; DISTINCT MICROFILAMENT POPULATIONS; MECHANICAL-PROPERTIES; MYOSIN-II; FILAMENT NETWORKS; STRESS FIBERS; SHAPE; FIBROBLASTS; RECRUITMENT; STIFFNESS	The actin cytoskeleton is the primary polymer system within cells responsible for regulating cellular stiffness. While various actin binding proteins regulate the organization and dynamics of the actin cytoskeleton, the proteins responsible for regulating the mechanical properties of cells are still not fully understood. In the present study, we have addressed the significance of the actin associated protein, tropomyosin (Tpm), in influencing the mechanical properties of cells. Tpms belong to a multi-gene family that form a co-polymer with actin filaments and differentially regulate actin filament stability, function and organization. Tpm isoform expression is highly regulated and together with the ability to sort to specific intracellular sites, result in the generation of distinct Tpm isoform-containing actin filament populations. Nanomechanical measurements conducted with an Atomic Force Microscope using indentation in Peak Force Tapping in indentation/ramping mode, demonstrated that Tpm impacts on cell stiffness and the observed effect occurred in a Tpm isoform-specific manner. Quantitative analysis of the cellular filamentous actin (F-actin) pool conducted both biochemically and with the use of a linear detection algorithm to evaluate actin structures revealed that an altered F-actin pool does not absolutely predict changes in cell stiffness. Inhibition of non-muscle myosin II revealed that intracellular tension generated by myosin II is required for the observed increase in cell stiffness. Lastly, we show that the observed increase in cell stiffness is partially recapitulated in vivo as detected in epididymal fat pads isolated from a Tpm3.1 transgenic mouse line. Together these data are consistent with a role for Tpm in regulating cell stiffness via the generation of specific populations of Tpm isoform-containing actin filaments.	[Jalilian, Iman; Heu, Celine; Desouza, Melissa; Stehn, Justine R.; Bryce, Nicole S.; Schevzov, Galina; Gunning, Peter W.] UNSW Australia, Sch Med Sci, Oncol Res Unit, Sydney, NSW 2052, Australia; [Cheng, Hong; Freittag, Hannah; Fath, Thomas] UNSW Australia, Sch Med Sci, Neurodegenerat & Repair Unit, Sydney, NSW 2052, Australia; [Heu, Celine; Whan, Renee M.] UNSW Australia, Biomed Imaging Facil, Sydney, NSW 2052, Australia; [Hardeman, Edna C.] UNSW Australia, Sch Med Sci, Neuromuscular & Regenerat Med Unit, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Gunning, PW (corresponding author), UNSW Australia, Sch Med Sci, Oncol Res Unit, Sydney, NSW 2052, Australia.	p.gunning@unsw.edu.au	Gunning, Peter W/E-9058-2010; Heu, Celine/GQB-2476-2022	Bryce, Nicole/0000-0001-9799-7393; Gunning, Peter/0000-0003-0833-3128; Hardeman, Edna/0000-0003-1649-7712; Whan, Renee/0000-0002-6664-6344; Fath, Thomas/0000-0002-6877-7567	Australian National and Medical Research Council (NHMRC) [APP1004175, APP1083209]; Kids Cancer Project	Australian National and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Kids Cancer Project	This work was supported by Project Grant APP1004175 from the Australian National and Medical Research Council (NHMRC) (P.W.G., G.S., E.C.H.), the Kids Cancer Project, and Australian National and Medical Research Council (NHMRC) Project Grant APP1083209 Thomas Fath.	Bach CTT, 2010, CELL ADHES MIGR, V4, P226, DOI 10.4161/cam.4.2.10888; Barua B, 2014, BIOCHEMISTRY-US, V53, P4015, DOI 10.1021/bi500162z; Bhadriraju K, 2002, EXP CELL RES, V278, P92, DOI 10.1006/excr.2002.5557; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Cai XF, 2010, MICRON, V41, P257, DOI 10.1016/j.micron.2009.08.011; Canetta E, 2014, ACTA BIOMATER, V10, P2043, DOI 10.1016/j.actbio.2013.12.057; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; CLARKE M, 1977, ANNU REV BIOCHEM, V46, P797, DOI 10.1146/annurev.bi.46.070177.004053; Clayton JE, 2014, MOL BIOL CELL, V25, P66, DOI 10.1091/mbc.E13-04-0200; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; Coulton AT, 2010, J CELL SCI, V123, P3235, DOI 10.1242/jcs.069971; Creed SJ, 2008, EUR J CELL BIOL, V87, P709, DOI 10.1016/j.ejcb.2008.03.004; Creed SJ, 2011, EXP CELL RES, V317, P249, DOI 10.1016/j.yexcr.2010.10.019; Curthoys NM, 2014, MOL CELL NEUROSCI, V58, P11, DOI 10.1016/j.mcn.2013.10.011; Doornaert B, 2003, EXP CELL RES, V287, P199, DOI 10.1016/S0014-4827(03)00114-9; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Geeves MA, 2015, J MUSCLE RES CELL M, V36, P147, DOI 10.1007/s10974-014-9389-6; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Haga H, 2000, ULTRAMICROSCOPY, V82, P253, DOI 10.1016/S0304-3991(99)00157-6; Heu C, 2012, J STRUCT BIOL, V178, P1, DOI 10.1016/j.jsb.2012.02.007; Hodges AR, 2012, CURR BIOL, V22, P1410, DOI 10.1016/j.cub.2012.05.035; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; JANMEY PA, 1986, J BIOL CHEM, V261, P8357; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; Ketene AN, 2012, NANOMED-NANOTECHNOL, V8, P93, DOI 10.1016/j.nano.2011.05.012; Kollins KM, 2009, DEV NEUROBIOL, V69, P279, DOI 10.1002/dneu.20704; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Lekka M, 2012, MICRON, V43, P1259, DOI 10.1016/j.micron.2012.01.019; LESSARD JL, 1988, CELL MOTIL CYTOSKEL, V10, P349, DOI 10.1002/cm.970100302; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; Martens JC, 2008, PFLUG ARCH EUR J PHY, V456, P95, DOI 10.1007/s00424-007-0419-8; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; Mendez MG, 2014, BIOPHYS J, V107, P314, DOI 10.1016/j.bpj.2014.04.050; Michelot A, 2011, CURR BIOL, V21, pR560, DOI 10.1016/j.cub.2011.06.019; Mosier AP, 2014, BIOSENSORS-BASEL, V4, P18, DOI 10.3390/bios4010018; Ngu Hai, 2008, Molecular & Cellular Biomechanics, V5, P69; Otey CA, 2003, METHOD CELL BIOL, V71, P287, DOI 10.1016/S0091-679X(03)01013-6; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; Percival JM, 2000, CELL MOTIL CYTOSKEL, V47, P189, DOI 10.1002/1097-0169(200011)47:3<189::AID-CM3>3.0.CO;2-C; PETERSEN NO, 1982, P NATL ACAD SCI-BIOL, V79, P5327, DOI 10.1073/pnas.79.17.5327; Pittenger B., 2010, BRUKER APPL NOTE AN1, V1, P1; Pogoda K, 2012, EUR BIOPHYS J BIOPHY, V41, P79, DOI 10.1007/s00249-011-0761-9; Prabhune M, 2012, MICRON, V43, P1267, DOI 10.1016/j.micron.2012.03.023; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Schafer A, 2005, ACTA BIOMATER, V1, P273, DOI 10.1016/j.actbio.2005.02.004; Schevzov G, 2005, MOL BIOL CELL, V16, P3425, DOI 10.1091/mbc.E04-10-0951; Schevzov G, 2008, J BIOL CHEM, V283, P275, DOI 10.1074/jbc.M704392200; Schevzov Galina, 2011, Bioarchitecture, V1, P135; Schevzov G, 2012, INT REV CEL MOL BIO, V298, P33, DOI 10.1016/B978-0-12-394309-5.00002-X; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Seltmann K, 2013, P NATL ACAD SCI USA, V110, P18507, DOI 10.1073/pnas.1310493110; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Vindin H, 2014, J BIOMOL SCREEN, V19, P354, DOI 10.1177/1087057113503494; Vindin H, 2013, J MUSCLE RES CELL M, V34, P261, DOI 10.1007/s10974-013-9355-8; Vlahovich N, 2009, MOL BIOL CELL, V20, P400, DOI 10.1091/mbc.E08-06-0616; WACHSSTOCK DH, 1994, BIOPHYS J, V66, P801, DOI 10.1016/S0006-3495(94)80856-2; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Weichsel J, 2010, CYTOM PART A, V77A, P52, DOI 10.1002/cyto.a.20818; Wu HW, 1998, SCANNING, V20, P389; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Yamashiro S, 2014, J BIOL CHEM, V289, P11616, DOI 10.1074/jbc.M114.555128; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Yourek G, 2007, ASAIO J, V53, P219, DOI 10.1097/MAT.0b013e31802deb2d; Zhu YX, 2011, J BIOMECH, V44, P2356, DOI 10.1016/j.jbiomech.2011.07.010	80	35	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126214	10.1371/journal.pone.0126214	http://dx.doi.org/10.1371/journal.pone.0126214			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978408	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100055
J	Juan-Albarracin, J; Fuster-Garcia, E; Manjon, JV; Robles, M; Aparici, F; Marti-Bonmati, L; Garcia-Gomez, JM				Juan-Albarracin, Javier; Fuster-Garcia, Elies; Manjon, Jose V.; Robles, Montserrat; Aparici, F.; Marti-Bonmati, L.; Garcia-Gomez, Juan M.			Automated Glioblastoma Segmentation Based on a Multiparametric Structured Unsupervised Classification	PLOS ONE			English	Article							BRAIN-TUMOR SEGMENTATION; OF-THE-ART; MR-IMAGES; ALGORITHMS	Automatic brain tumour segmentation has become a key component for the future of brain tumour treatment. Currently, most of brain tumour segmentation approaches arise from the supervised learning standpoint, which requires a labelled training dataset from which to infer the models of the classes. The performance of these models is directly determined by the size and quality of the training corpus, whose retrieval becomes a tedious and time-consuming task. On the other hand, unsupervised approaches avoid these limitations but often do not reach comparable results than the supervised methods. In this sense, we propose an automated unsupervised method for brain tumour segmentation based on anatomical Magnetic Resonance (MR) images. Four unsupervised classification algorithms, grouped by their structured or non-structured condition, were evaluated within our pipeline. Considering the non-structured algorithms, we evaluated K-means, Fuzzy K-means and Gaussian Mixture Model (GMM), whereas as structured classification algorithms we evaluated Gaussian Hidden Markov Random Field (GHMRF). An automated postprocess based on a statistical approach supported by tissue probability maps is proposed to automatically identify the tumour classes after the segmentations. We evaluated our brain tumour segmentation method with the public BRAin Tumor Segmentation (BRATS) 2013 Test and Leaderboard datasets. Our approach based on the GMM model improves the results obtained by most of the supervised methods evaluated with the Leaderboard set and reaches the second position in the ranking. Our variant based on the GHMRF achieves the first position in the Test ranking of the unsupervised approaches and the seventh position in the general Test ranking, which confirms the method as a viable alternative for brain tumour segmentation.	[Juan-Albarracin, Javier; Fuster-Garcia, Elies; Manjon, Jose V.; Robles, Montserrat; Garcia-Gomez, Juan M.] Univ Politecn Valencia, Inst Aplicac Tecnol Informac & Comunicac, Grp Informat Biomed IBIME, E-46022 Valencia, Spain; [Fuster-Garcia, Elies] Veratech Hlth SL, Valencia, Spain; [Aparici, F.] Hosp Univ & Politecn La Fe, Area Imagen Clin, Serv Radiol, Valencia, Spain; [Marti-Bonmati, L.; Garcia-Gomez, Juan M.] Hosp Univ & Politecn La Fe, Dept Radiol, Valencia, Spain; [Marti-Bonmati, L.; Garcia-Gomez, Juan M.] Hosp Univ & Politecn La Fe, GIBI230 Res Grp Biomed Imaging, Valencia, Spain	Universitat Politecnica de Valencia; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Juan-Albarracin, J (corresponding author), Univ Politecn Valencia, Inst Aplicac Tecnol Informac & Comunicac, Grp Informat Biomed IBIME, E-46022 Valencia, Spain.	jajuaal1@ibime.upv.es	Garcia-Gomez, Juan M/G-2681-2016; manjon, jose/ABE-7094-2021; Fuster-Garcia, Elies/J-6187-2012; Marti-Bonmati, Luis/AAF-7107-2020; Aparici-Robles, Fernando/AAX-8594-2021; Robles, Montserrat/A-6722-2016	Garcia-Gomez, Juan M/0000-0002-3851-1557; manjon, jose/0000-0001-6640-927X; Fuster-Garcia, Elies/0000-0002-0716-8960; Aparici-Robles, Fernando/0000-0002-1012-9073; Robles, Montserrat/0000-0002-7705-1389; Juan Albarracin, Javier/0000-0003-0680-0052	Programa Torres Quevedo, Ministerio de Educacion y Ciencia; European Social Fund [PTQ-1205693]; Red Tematica de Investigacion Cooperativa en Cancer, (RTICC) [RD12/0036/0020]; Caracterizacion de firmas biologicas de glioblastomas mediante modelos no-supervisados de prediccion estructurada basados en biomarcadores de imagen [TIN2013-43457-R]; Ministerio de Economia y Competitividad of Spain; UPV-IISLaFe: Unsupervised glioblastoma tumor components segmentation based on perfusion multiparametric MRI and spatio/temporal constraints [CON2014001]; UPV-IISLaFe: Empleo de segmentacion no supervisada multiparametrica basada en perfusion RM para la caracterizacion del edema peritumoral de gliomas y metastasis cerebrales unicas - Instituto de Investigacion Sanitaria H. Universitario y Politecnico La Fe [CON2014002]; Instituto de Aplicaciones de las Tecnologias de la Informacion y las Comunicaciones Avanzadas (ITACA)	Programa Torres Quevedo, Ministerio de Educacion y Ciencia; European Social Fund(European Social Fund (ESF)); Red Tematica de Investigacion Cooperativa en Cancer, (RTICC)(European Commission); Caracterizacion de firmas biologicas de glioblastomas mediante modelos no-supervisados de prediccion estructurada basados en biomarcadores de imagen; Ministerio de Economia y Competitividad of Spain(Spanish Government); UPV-IISLaFe: Unsupervised glioblastoma tumor components segmentation based on perfusion multiparametric MRI and spatio/temporal constraints; UPV-IISLaFe: Empleo de segmentacion no supervisada multiparametrica basada en perfusion RM para la caracterizacion del edema peritumoral de gliomas y metastasis cerebrales unicas - Instituto de Investigacion Sanitaria H. Universitario y Politecnico La Fe; Instituto de Aplicaciones de las Tecnologias de la Informacion y las Comunicaciones Avanzadas (ITACA)	EFG was supported by Programa Torres Quevedo, Ministerio de Educacion y Ciencia, co-funded by the European Social Fund (PTQ-1205693). EFG, JMGG, and JVM were supported by Red Tematica de Investigacion Cooperativa en Cancer, (RTICC) 2013-2016 (RD12/0036/0020). JMGG was supported by Project TIN2013-43457-R: Caracterizacion de firmas biologicas de glioblastomas mediante modelos no-supervisados de prediccion estructurada basados en biomarcadores de imagen, co-funded by the Ministerio de Economia y Competitividad of Spain; CON2014001 UPV-IISLaFe: Unsupervised glioblastoma tumor components segmentation based on perfusion multiparametric MRI and spatio/temporal constraints; and CON2014002 UPV-IISLaFe: Empleo de segmentacion no supervisada multiparametrica basada en perfusion RM para la caracterizacion del edema peritumoral de gliomas y metastasis cerebrales unicas, funded by Instituto de Investigacion Sanitaria H. Universitario y Politecnico La Fe. This work was partially supported by the Instituto de Aplicaciones de las Tecnologias de la Informacion y las Comunicaciones Avanzadas (ITACA). Veratech for Health S.L. provided support in the form of salaries for author EF-G, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ahmed S, 2011, IEEE T INF TECHNOL B, V15, P206, DOI 10.1109/TITB.2011.2104376; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97; Bauer S, 2011, LECT NOTES COMPUT SC, V6893, P354, DOI 10.1007/978-3-642-23626-6_44; Bezdek J. C., 1981, Pattern recognition with fuzzy objective function algorithms; Bishop CM, 1995, NEURAL NETWORKS PATT; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Diaz I, 2011, IEEE ENG MED BIO, P3934, DOI 10.1109/IEMBS.2011.6090977; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Doyle S., 2013, NCI MICCAI CHALLENGE, P18; Duda R.O., 2000, PATTERN CLASSIFICATI; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Festa J., 2013, P NCI MICCAI BRATS, V1, P23; Fletcher-Heath LM, 2001, ARTIF INTELL MED, V21, P43, DOI 10.1016/S0933-3657(00)00073-7; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gordillo N, 2013, MAGN RESON IMAGING, V31, P1426, DOI 10.1016/j.mri.2013.05.002; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hammersley JM, 1971, MARKOV FIELDS ON FIN; Jensen TR, 2009, J MAGN RESON IMAGING, V30, P481, DOI 10.1002/jmri.21878; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Komodakis N, 2008, COMPUT VIS IMAGE UND, V112, P14, DOI 10.1016/j.cviu.2008.06.007; Komodakis N, 2007, IEEE T PATTERN ANAL, V29, P1436, DOI 10.1109/TPAMI.2007.1061; Lee CH, 2008, LECT NOTES COMPUT SC, V5241, P359; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Manjon JV, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/425891; Manjon JV, 2010, MED IMAGE ANAL, V14, P784, DOI 10.1016/j.media.2010.05.010; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Meier R., 2013, MULTIMODAL BRAIN TUM, V31; Menze Bjoern H, 2015, IEEE Trans Med Imaging, V34, P1993, DOI 10.1109/TMI.2014.2377694; Nie JX, 2009, COMPUT MED IMAG GRAP, V33, P431, DOI 10.1016/j.compmedimag.2009.04.006; Plenge E, 2013, LECT NOTES COMPUT SC, V8151, P123, DOI 10.1007/978-3-642-40760-4_16; Prastawa M, 2003, ACAD RADIOL, V10, P1341, DOI 10.1016/S1076-6332(03)00506-3; Protter M, 2009, IEEE T IMAGE PROCESS, V18, P36, DOI 10.1109/TIP.2008.2008067; Reza S., 2013, P NCI MICCAI BRATS, P38; Rousseau F, 2010, MED IMAGE ANAL, V14, P594, DOI 10.1016/j.media.2010.04.005; Ruan S, 2011, I S BIOMED IMAGING, P281, DOI 10.1109/ISBI.2011.5872406; Saez C, 2014, STATISTICAL METHODS; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tustison N., 2013, P NCI MICCAI BRATS, V1, P47; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Verma R, 2008, ACAD RADIOL, V15, P966, DOI 10.1016/j.acra.2008.01.029; Vijayakumar C, 2007, COMPUT MED IMAG GRAP, V31, P473, DOI 10.1016/j.compmedimag.2007.04.004; von Deimling A, 2009, RECENT RESULTS IN CA; Wagstaff KL, 2002, THESIS CORNELL U ITH; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhu Y, 2012, ACAD RADIOL, V19, P977, DOI 10.1016/j.acra.2012.03.026	53	64	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125143	10.1371/journal.pone.0125143	http://dx.doi.org/10.1371/journal.pone.0125143			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978453	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100022
J	Kugelmann, D; Waschke, J; Radeva, MY				Kugelmann, Daniela; Waschke, Jens; Radeva, Mariya Y.			Adducin Is Involved in Endothelial Barrier Stabilization	PLOS ONE			English	Article							PROTEIN-KINASE-C; ALPHA-ADDUCIN; RHO-KINASE; EPITHELIAL-CELLS; ACTIN DYNAMICS; IN-VIVO; PHOSPHORYLATION; ORGANIZATION; DOMAIN; MICE	Adducins tightly regulate actin dynamics which is critical for endothelial barrier function. Adducins were reported to regulate epithelial junctional remodeling by controlling the assembly of actin filaments at areas of cell-cell contact. Here, we investigated the role of alpha-adducin for endothelial barrier regulation by using microvascular human dermal and myocardial murine endothelial cells. Parallel transendothelial electrical resistance (TER) measurements and immunofluorescence analysis revealed that siRNA-mediated adducin depletion impaired endothelial barrier formation and led to severe fragmentation of VE-cadherin immunostaining at cell-cell borders. To further test whether the peripheral localization of alpha-adducin is functionally linked with the integrity of endothelial adherens junctions, junctional remodeling was induced by a Ca2+-switch assay. Ca2+-depletion disturbed both linear vascular endothelial (VE)-cadherin and adducin location along cell junctions, whereas their localization was restored following Ca2+-repletion. Similar results were obtained for alpha-adducin phosphorylated at a site typical for PKA (pSer481). To verify that endothelial barrier properties and junction reorganization can be effectively modulated by altering Ca2+-concentration, TER measurements were performed. Thus, Ca2+-depletion drastically reduced TER, whereas Ca2+-repletion led to recovery of endothelial barrier properties resulting in increased TER. Interestingly, the Ca2+-dependent increase in TER was also significantly reduced after efficient alpha-adducin downregulation. Finally, we report that inflammatory mediator-induced endothelial barrier breakdown is associated with loss of alpha-adducin from the cell membrane. Taken together, our results indicate that alpha-adducin is involved in remodeling of endothelial adhesion junctions and thereby contributes to endothelial barrier regulation.	[Kugelmann, Daniela; Waschke, Jens; Radeva, Mariya Y.] Univ Munich, Inst Anat & Cell Biol, Dept 1, Munich, Germany	University of Munich	Waschke, J (corresponding author), Univ Munich, Inst Anat & Cell Biol, Dept 1, Munich, Germany.	jens.waschke@med.uni-muenchen.de; mariya.radeva@med.uni-muenchen.de						Abdi KM, 2008, MOL BIOL CELL, V19, P536, DOI 10.1091/mbc.E07-08-0818; Adamson RH, 2002, J PHYSIOL-LONDON, V539, P295, DOI 10.1113/jphysiol.2001.013117; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Cappuzzello C, 2007, CARDIOVASC RES, V75, P608, DOI 10.1016/j.cardiores.2007.04.020; Chen CL, 2011, TRAFFIC, V12, P1327, DOI 10.1111/j.1600-0854.2011.01245.x; Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a; DONG LQ, 1995, J BIOL CHEM, V270, P25534, DOI 10.1074/jbc.270.43.25534; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; JOSHI R, 1991, J CELL BIOL, V115, P665, DOI 10.1083/jcb.115.3.665; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Naydenov Nayden G, 2011, Bioarchitecture, V1, P186; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Radeva MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106733; Robledo RF, 2008, BLOOD, V112, P4298, DOI 10.1182/blood-2008-05-156000; Robledo RF, 2012, GENESIS, V50, P882, DOI 10.1002/dvg.22342; Rotzer V, 2014, J BIOL CHEM, V289, P14925, DOI 10.1074/jbc.M113.527127; Schlegel N, 2014, CELL TISSUE RES, V355, P587, DOI 10.1007/s00441-013-1755-y; Schlegel N, 2009, CRIT CARE MED, V37, P1735, DOI 10.1097/CCM.0b013e31819deb6a; Schlegel N, 2009, MICROCIRCULATION, V16, P521, DOI 10.1080/10739680902967427; Spindler V, 2011, ANN ANAT, V193, P177, DOI 10.1016/j.aanat.2011.02.003; Spindler V, 2011, MICROCIRCULATION, V18, P118, DOI 10.1111/j.1549-8719.2010.00072.x; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273; Waschke J, 2005, AM J PHYSIOL-HEART C, V288, pH1296, DOI 10.1152/ajpheart.00687.2004; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003	35	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126213	10.1371/journal.pone.0126213	http://dx.doi.org/10.1371/journal.pone.0126213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978380	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100054
J	Lay, LAR; Corredor, MB; Villalba, MC; Frometa, SS; Wong, MS; Valdes, L; Samada, M; Sausy, A; Hubschen, JM; Muller, CP				Rodriguez Lay, Licel A.; Corredor, Marite B.; Villalba, Maria C.; Frometa, Susel S.; Wong, Meilin S.; Valdes, Lidunka; Samada, Marcia; Sausy, Aurelie; Huebschen, Judith M.; Muller, Claude P.			Genetic Diversity of the Hepatitis B Virus Strains in Cuba: Absence of West-African Genotypes despite the Transatlantic Slave Trade	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANT; HBV; VARIABILITY; VARIANTS; SUBTYPES; SUBGENOTYPES; POPULATION; INFECTION; ADMIXTURE	Cuba is an HBsAg low-prevalence country with a high coverage of anti-hepatitis B vaccine. Its population is essentially the result of the population mix of Spanish descendants and former African slaves. Information about genetic characteristics of hepatitis B virus (HBV) strains circulating in the country is scarce. The HBV genotypes/subgenotypes, serotypes, mixed infections, and S gene mutations of 172 Cuban HBsAg and HBV-DNA positive patients were determined by direct sequencing and phylogenetic analysis. Phylogenetic analysis of HBV S gene sequences showed a predominance of genotype A (92.4%), subgenotype A2 (84.9%) and A1 (7.6%). Genotype D (7.0%) and subgenotype C1 (0.6%) were also detected but typical (sub) genotypes of contemporary West-Africa (E, A3) were conspicuously absent. All genotype A, D, and C strains exhibited sequence characteristics of the adw2, ayw2, and adrq serotypes, respectively. Thirty-three (19.1%) patients showed single, double, or multiple point mutations inside the Major Hydrophilic domain associated with vaccine escape; eighteen (10.5%) patients had mutations in the T-cell epitope (amino acids 28-51), and there were another 111 point mutations downstream of the S gene. One patient had an HBV A1/A2 mixed infection. This first genetic study of Cuban HBV viruses revealed only strains that were interspersed with strains from particularly Europe, America, and Asia. The absence of genotype E supports previous hypotheses about an only recent introduction of this genotype into the general population in Africa. The presence of wellknown vaccine escape (3.5%) and viral resistance mutants (2.9%) warrants strain surveillance to guide vaccination and treatment strategies.	[Rodriguez Lay, Licel A.; Villalba, Maria C.; Frometa, Susel S.; Wong, Meilin S.; Valdes, Lidunka] Pedro Kouri Inst Trop Med, Havana, Cuba; [Corredor, Marite B.; Samada, Marcia] CIMEQ, Havana, Cuba; [Sausy, Aurelie; Huebschen, Judith M.; Muller, Claude P.] Luxembourg Inst Hlth, Esch Sur Alzette, Immunol Lab, Grand Duchy, Luxembourg	Luxembourg Institute of Health	Muller, CP (corresponding author), Luxembourg Inst Hlth, Esch Sur Alzette, Immunol Lab, Grand Duchy, Luxembourg.	Claude.Muller@LiH.lu	Hübschen, Judith/ABA-7931-2021; Hübschen, Judith/AAF-5113-2020	Hübschen, Judith/0000-0002-5001-2128; Sausy, Aurelie/0000-0003-2090-7198	Ministry of Foreign Affairs; former Centre de Recherche Public de la Sante	Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy)); former Centre de Recherche Public de la Sante	For the work done in Luxembourg we acknowledge the financial support of the Ministry of Foreign Affairs and the former Centre de Recherche Public de la Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Cintado A, 2009, ANN HUM BIOL, V36, P350, DOI 10.1080/03014460902817984; Cooksley WGE, 2010, J VIRAL HEPATITIS, V17, P601, DOI 10.1111/j.1365-2893.2010.01326.x; Echevarria JM, 2005, J MED VIROL, V76, P176, DOI 10.1002/jmv.20341; Gorry C, 2011, MEDICC REV, V13, P5, DOI 10.37757/MR2011V13.N2.3; Hubschen JM, 2011, CLIN MICROBIOL INFEC, V17, P88, DOI 10.1111/j.1469-0691.2010.03205.x; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Hubschen JM, 2009, J MED VIROL, V81, P435, DOI 10.1002/jmv.21412; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Magnius LO, 1995, INTERVIROLOGY, V38, P24, DOI 10.1159/000150411; Teruel BM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-43; Matthews GV, 2006, AIDS, V20, P863, DOI 10.1097/01.aids.0000218550.85081.59; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Pumpens P, 2002, INTERVIROLOGY, V45, P218, DOI 10.1159/000067915; Roque-Afonso AM, 2007, ANTIVIR THER, V12, P1255; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Su WJ, 2010, LIVER TRANSPLANT, V16, P215, DOI 10.1002/lt.21980; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Torresi J, 2002, VIROLOGY, V299, P88, DOI 10.1006/viro.2002.1448; Ustariz C, 2011, REV CUBANA HEMATOL I, V27; Utsumi T, 2010, AM J TROP MED HYG, V83, P189, DOI 10.4269/ajtmh.2010.09-0589; Wu CC, 2010, J GEN VIROL, V91, P483, DOI 10.1099/vir.0.012740-0; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125052	10.1371/journal.pone.0125052	http://dx.doi.org/10.1371/journal.pone.0125052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978398	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100021
J	Song, JB; Shu, XX; Shen, Q; Li, BW; Song, J; Yang, ZM				Song, Jian Bo; Shu, Xia Xia; Shen, Qi; Li, Bo Wen; Song, Jun; Yang, Zhi Min			Altered Fruit and Seed Development of Transgenic Rapeseed (Brassica napus) Over-Expressing MicroRNA394	PLOS ONE			English	Article							OIL PRODUCTION; ORGAN SIZE; AUXIN; ARABIDOPSIS; TARGETS; IDENTIFICATION; DEHISCENCE; CANOLA; MIRNAS; SET	Fruit and seed development in plants is a complex biological process mainly involved in input and biosynthesis of many storage compounds such as proteins and oils. Although the basic biochemical pathways for production of the storage metabolites in plants are well characterized, their regulatory mechanisms are not fully understood. In this study, we functionally identified rapeseed (Brassica napus) miR394 with its target gene Brassica napus LEAF CURLING RESPONSIVENESS (BnLCR) to dissect a role of miR394 during the fruit and seed development. Transgenic rapeseed plants over-expressing miR394 under the control of the cauliflower mosaic virus 35S promoter were generated. miR394 over-expression plants exhibited a delayed flowering time and enlarged size of plants, leaf blade, pods and seed body, but developed seeds with higher contents of protein and glucosinolates (GLS) and lower levels of oil accumulation as compared to wild-type. Over-expression of miR394 altered the fatty acid (FA) composition by increasing several FA species such as C16: 0 and C18:0 and unsaturated species of C20:1 and C22:1 but lowering C18: 3. This change was accompanied by induction of genes coding for transcription factors of FA synthesis including LEAFY COTYLEDON1 (BnLEC1), BnLEC2, and FUSCA3 (FUS3). Because the phytohormone auxin plays a crucial role in fruit development and seed patterning, the DR5-GUS reporter was used for monitoring the auxin response in Arabidopsis siliques and demonstrated that the DR5 gene was strongly expressed. These results suggest that BnmiR394 is involved in rapeseed fruit and seed development.	[Song, Jian Bo; Shu, Xia Xia; Li, Bo Wen; Song, Jun; Yang, Zhi Min] Nanjing Agr Univ, Coll Life Sci, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Shen, Qi] Rapeseed Inst Guizhou Prov, Guiyang, Peoples R China; [Song, Jian Bo] Jiangxi Agr Univ, Coll Life Sci, Dept Biochem & Mol Biol, Nanchang, Peoples R China	Nanjing Agricultural University; Jiangxi Agricultural University	Yang, ZM (corresponding author), Nanjing Agr Univ, Coll Life Sci, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China.	zmyang@njau.edu.cn	Shen, Qirong/AAB-6531-2020	Song, Jianbo/0000-0003-0158-2527	National Natural Science Foundation of China [31071343]; Priority Academic Program Development of Jiangsu Higher Education Institutions [200910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by the National Natural Science Foundation of China (31071343) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (200910).	Barthet V. J., 2002, Journal of Oleo Science, V51, P589; Broun P, 1999, ANNU REV NUTR, V19, P197, DOI 10.1146/annurev.nutr.19.1.197; Carvalho MS, 2012, J BRAZIL CHEM SOC, V23, P763, DOI 10.1590/S0103-50532012000400023; Chauvaux N, 1997, J EXP BOT, V48, P1423, DOI 10.1093/jxb/48.7.1423; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Crawford BCW, 2011, DEVELOPMENT, V138, P2999, DOI 10.1242/dev.067793; Elhiti M, 2012, J EXP BOT, V63, P4447, DOI 10.1093/jxb/ers125; Ferrandiz C, 2002, J EXP BOT, V53, P2031, DOI 10.1093/jxb/erf082; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Gonzalez-Reig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003020; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gu Q, 1998, DEVELOPMENT, V125, P1509; Hao XY, 2004, J PLANT NUTR SOIL SC, V167, P214, DOI 10.1002/jpln.200320355; Huang DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-140; Huang SQ, 2010, PLANT BIOTECHNOL J, V8, P887, DOI 10.1111/j.1467-7652.2010.00517.x; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Knauer S, 2013, DEV CELL, V24, P125, DOI 10.1016/j.devcel.2012.12.009; Korbes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050663; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Ludwig-Muller J, 2009, PHYTOCHEM REV, V8, P135, DOI 10.1007/s11101-008-9096-2; Luerssen K, 1998, PLANT J, V15, P755, DOI 10.1046/j.1365-313X.1998.00259.x; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Nesi N, 2008, CR BIOL, V331, P763, DOI 10.1016/j.crvi.2008.07.018; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Ren ZX, 2011, J EXP BOT, V62, P2815, DOI 10.1093/jxb/erq455; Seefried WF, 2014, PLANT PHYSIOL, V165, P670, DOI 10.1104/pp.114.240846; Shen Q, 2011, PLANT CELL ENVIRON, V34, P752, DOI 10.1111/j.1365-3040.2011.02279.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Song JB, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-210; Song JB, 2012, PLANT CELL PHYSIOL, V53, P1283, DOI 10.1093/pcp/pcs080; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Sun C, 2013, PLANT CELL TISS ORG, V112, P343, DOI 10.1007/s11240-012-0241-7; Tan HL, 2011, PLANT PHYSIOL, V156, P1577, DOI 10.1104/pp.111.175000; Verma SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086648; Wang L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002172; Wang XF, 2010, EUPHYTICA, V173, P17, DOI 10.1007/s10681-009-0062-x; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Xia T, 2013, PLANT CELL, V25, P3347, DOI 10.1105/tpc.113.115063; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang YC, 2013, NAT BIOTECHNOL, V31, P848, DOI 10.1038/nbt.2646; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136	48	16	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125427	10.1371/journal.pone.0125427	http://dx.doi.org/10.1371/journal.pone.0125427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978066	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100027
J	Hwang, GB; Heo, KJ; Yun, JH; Lee, JE; Lee, HJ; Nho, CW; Bae, GN; Jung, JH				Hwang, Gi Byoung; Heo, Ki Joon; Yun, Ji Ho; Lee, Jung Eun; Lee, Hee Ju; Nho, Chu Won; Bae, Gwi-Nam; Jung, Jae Hee			Antimicrobial Air Filters Using Natural Euscaphis japonica Nanoparticles	PLOS ONE			English	Article							SILVER NANOPARTICLES; CARBON NANOTUBES; INDUCED INACTIVATION; INDOOR AIR; STAPHYLOCOCCUS; ANTIBACTERIAL; BIOAEROSOLS; EPIDERMIDIS; TEMPERATURE; WORKPLACE	Controlling bioaerosols has become more important with increasing participation in indoor activities. Treatments using natural-product nanomaterials are a promising technique because of their relatively low toxicity compared to inorganic nanomaterials such as silver nanoparticles or carbon nanotubes. In this study, antimicrobial filters were fabricated from natural Euscaphis japonica nanoparticles, which were produced by nebulizing E. japonica extract. The coated filters were assessed in terms of pressure drop, antimicrobial activity, filtration efficiency, major chemical components, and cytotoxicity. Pressure drop and antimicrobial activity increased as a function of nanoparticle deposition time (590, 855, and 1150 mu g/cm2(filter) at 3-, 6-, and 9-min depositions, respectively). In filter tests, the antimicrobial efficacy was greater against Staphylococcus epidermidis than Micrococcus luteus; similar to 61, similar to 73, and similar to 82% of M. luteus cells were inactivated on filters that had been coated for 3, 6, and 9 min, respectively, while the corresponding values were similar to 78, similar to 88, and similar to 94% with S. epidermidis. Although statistically significant differences in filtration performance were not observed between samples as a function of deposition time, the average filtration efficacy was slightly higher for S. epidermidis aerosols (similar to 97%) than for M. luteus aerosols (similar to 95%). High-performance liquid chromatography (HPLC) and electrospray ionization-tandem mass spectrometry (ESI/MS) analyses confirmed that the major chemical compounds in the E. japonica extract were 1(beta)-O-galloyl pedunculagin, quercetin-3-O-glucuronide, and kaempferol-3-O-glucoside. In vitro cytotoxicity and disk diffusion tests showed that E. japonica nanoparticles were less toxic and exhibited stronger antimicrobial activity toward some bacterial strains than a reference soluble nickel compound, which is classified as a human carcinogen. This study provides valuable information for the development of a bioaerosol control system that is environmental friendly and suitable for use in indoor environments.	[Hwang, Gi Byoung; Heo, Ki Joon; Bae, Gwi-Nam; Jung, Jae Hee] Korea Univ Sci & Technol UST, Korea Inst Sci & Technol, Dept Energy & Environm Engn, Ctr Environm Hlth & Welf Res, Seoul, South Korea; [Yun, Ji Ho; Lee, Hee Ju; Nho, Chu Won] Korea Inst Sci & Technol, KIST Gangneung Inst, Funct Food Ctr, Kangnung, Gangwon Do, South Korea; [Heo, Ki Joon] Konkuk Univ, Coll Engn, Aerosol & Bioengn Lab, Seoul, South Korea; [Hwang, Gi Byoung] UCL, Mat Chem Res Ctr, Dept Chem, London, England; [Lee, Jung Eun] Natl Inst Environm Res, Han River Environm Res Ctr, Yangpyeong Gun, Gyeonggi Do, South Korea	Korea Institute of Science & Technology (KIST); University of Science & Technology (UST); Korea Institute of Science & Technology (KIST); Konkuk University; University of London; University College London; National Institute of Environmental Research (NIER), Republic of Korea	Jung, JH (corresponding author), Korea Univ Sci & Technol UST, Korea Inst Sci & Technol, Dept Energy & Environm Engn, Ctr Environm Hlth & Welf Res, Seoul, South Korea.	jaehee@kist.re.kr	Hwang, Gi Byoung/AAB-9733-2022	Jung, Jae Hee/0000-0001-6402-0252; Hwang, Gi Byoung/0000-0003-0874-8390; Heo, Ki Joon/0000-0002-7288-9203	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2013K000386]; Railway Technology Research Project - Ministry of Land, Infrastructure and Transport, Republic of Korea [14RTRP-B081249-01]; KIST Institutional Program [2E24652]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Railway Technology Research Project - Ministry of Land, Infrastructure and Transport, Republic of Korea; KIST Institutional Program(Korea Institute of Science & Technology (KIST))	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2013K000386), the Railway Technology Research Project funded by the Ministry of Land, Infrastructure and Transport (14RTRP-B081249-01), Republic of Korea, and was partially supported by the KIST Institutional Program (2E24652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akroum S., 2009, American-Eurasian Journal of Scientific Research, V4, P93; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Atha DH, 2012, ENVIRON SCI TECHNOL, V46, P1819, DOI 10.1021/es202660k; Bai Y, 2011, CARBON, V49, P3663, DOI 10.1016/j.carbon.2011.05.002; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Banes-Marshall L, 2001, BRIT J BIOMED SCI, V58, P139; Bouillard L, 2005, ANN AGR ENV MED, V12, P187; Cantos E, 2002, J AGR FOOD CHEM, V50, P5691, DOI 10.1021/jf0204102; Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006; Chen L, 2005, J CLIN MICROBIOL, V43, P3574, DOI 10.1128/JCM.43.7.3574-3575.2005; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Chong ES, 2013, SCI TOTAL ENVIRON, V444, P110, DOI 10.1016/j.scitotenv.2012.11.075; Chung BS, 1990, DICT KOREAN FOLK MED; Cockcroft DW, 1997, CLIN EXP ALLERGY, V7, P503; COUMANS WJ, 1994, DRY TECHNOL, V12, P99, DOI 10.1080/07373939408959951; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Donaldson K, 2006, TOXICOL SCI, V92, P5, DOI 10.1093/toxsci/kfj130; Dubas ST, 2006, COLLOID SURFACE A, V289, P105, DOI 10.1016/j.colsurfa.2006.04.012; Fan FRF, 2002, J PHYS CHEM B, V106, P279, DOI 10.1021/jp012548d; Fiegel J, 2006, DRUG DISCOV TODAY, V11, P51, DOI 10.1016/S1359-6446(05)03687-1; Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7; Fung F., 2010, APPL OCCUPATIONAL EN, V18, P533; Greenblatt CL, 2004, MICROBIAL ECOL, V48, P120, DOI 10.1007/s00248-003-2016-5; Guo L, 2007, CHEM MATER, V19, P3472, DOI 10.1021/cm062691p; Hinds W. C, 1998, AEROSOL TECHNOLOGY P; Hwang GB, 2012, SCI TOTAL ENVIRON, V421, P273, DOI 10.1016/j.scitotenv.2012.01.060; Hwang GB, 2010, SCI TOTAL ENVIRON, V408, P5903, DOI 10.1016/j.scitotenv.2010.08.016; Ji JH, 2007, INHAL TOXICOL, V19, P857, DOI 10.1080/08958370701432108; Alonso-Castro AJ, 2011, J ETHNOPHARMACOL, V133, P945, DOI 10.1016/j.jep.2010.11.055; Jung JH, 2011, AEROSOL SCI TECH, V45, P1510, DOI 10.1080/02786826.2011.602763; Jung JH, 2011, LANGMUIR, V27, P10256, DOI 10.1021/la201851r; Jung JH, 2009, SCI TOTAL ENVIRON, V407, P4723, DOI 10.1016/j.scitotenv.2009.05.008; Jung JH, 2009, APPL ENVIRON MICROB, V75, P2742, DOI 10.1128/AEM.01790-08; Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Kuroyanagi M, 1999, J NAT PROD, V62, P1595, DOI 10.1021/np990051d; Lee BU, 2008, J MICROBIOL BIOTECHN, V18, P176; Lee MK, 2007, PLANTA MED, V73, P782, DOI 10.1055/s-2007-981551; Lee MK, 2009, J ENZYM INHIB MED CH, V24, P1276, DOI 10.3109/14756360902829709; Lin CY, 2002, AEROSOL SCI TECH, V36, P474, DOI 10.1080/027868202753571296; Lindsay J, 2008, STAPHYLOCOCCUS MOL G; Maeda H, 2009, CHEM PHARM BULL, V57, P421, DOI 10.1248/cpb.57.421; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Matheson MC, 2005, THORAX, V60, P645, DOI 10.1136/thx.2004.035170; MENG Z-M, 1990, Shoyakugaku Zasshi, V44, P225; MITCHELL RG, 1967, J APPL BACTERIOL, V30, P251, DOI 10.1111/j.1365-2672.1967.tb00296.x; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Oller AR, 2002, ENVIRON HEALTH PERSP, V110, P841, DOI 10.1289/ehp.02110s5841; Panyala NR, 2008, J APPL BIOMED, V6, P117, DOI 10.32725/jab.2008.015; Peccia J, 2004, J OCCUP ENVIRON HYG, V1, P430, DOI 10.1080/15459620490458495; Peccia J, 2001, AEROSOL SCI TECH, V35, P728, DOI 10.1080/02786820152546770; Pettibone JM, 2008, NANOTOXICOLOGY, V2, P189, DOI 10.1080/17435390802398291; Pibiri M. C., 2006, International Journal of Aromatherapy, V16, P149, DOI 10.1016/j.ijat.2006.10.002; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Pyankov OV, 2008, CLEAN-SOIL AIR WATER, V36, P609, DOI 10.1002/clen.200700191; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Ramyadevi J, 2012, MATER LETT, V71, P114, DOI 10.1016/j.matlet.2011.12.055; Reineccius VGA, 1988, SPRAY DRYING FOOD FL; Rios JL, 2005, J ETHNOPHARMACOL, V100, P80, DOI 10.1016/j.jep.2005.04.025; ROJAS A, 1992, J ETHNOPHARMACOL, V35, P275, DOI 10.1016/0378-8741(92)90025-M; Romeas V, 1999, IND ENG CHEM RES, V38, P3878, DOI 10.1021/ie990326k; Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Sim KM, 2014, AEROSOL SCI TECH, V48, P324, DOI 10.1080/02786826.2013.870660; Thomas D, 2001, CHEM ENG SCI, V56, P3549, DOI 10.1016/S0009-2509(01)00041-0; Verdenelli MC, 2003, J APPL MICROBIOL, V94, P9, DOI 10.1046/j.1365-2672.2003.01820.x; Wang YM, 2008, ADV FUNCT MATER, V18, P1131, DOI 10.1002/adfm.200701120	70	33	34	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126481	10.1371/journal.pone.0126481	http://dx.doi.org/10.1371/journal.pone.0126481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974109	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600054
J	Letendre, K; Donnadieu, E; Moses, ME; Cannon, JL				Letendre, Kenneth; Donnadieu, Emmanuel; Moses, Melanie E.; Cannon, Judy L.			Bringing Statistics Up to Speed with Data in Analysis of Lymphocyte Motility	PLOS ONE			English	Article							T-CELL MOTILITY; DENDRITIC CELLS; MYOSIN-IIA; MIGRATION; DYNAMICS	Two-photon (2P) microscopy provides immunologists with 3D video of the movement of lymphocytes in vivo. Motility parameters extracted from these videos allow detailed analysis of lymphocyte motility in lymph nodes and peripheral tissues. However, standard parametric statistical analyses such as the Student's t-test are often used incorrectly, and fail to take into account confounds introduced by the experimental methods, potentially leading to erroneous conclusions about T cell motility. Here, we compare the motility of WT T cell versus PKC theta-/-, CARMA1-/-, CCR7-/-, and PTX-treated T cells. We show that the fluorescent dyes used to label T cells have significant effects on T cell motility, and we demonstrate the use of factorial ANOVA as a statistical tool that can control for these effects. In addition, researchers often choose between the use of "cell-based" parameters by averaging multiple steps of a single cell over time (e.g. cell mean speed), or "step-based" parameters, in which all steps of a cell population (e.g. instantaneous speed) are grouped without regard for the cell track. Using mixed model ANOVA, we show that we can maintain cell-based analyses without losing the statistical power of step-based data. We find that as we use additional levels of statistical control, we can more accurately estimate the speed of T cells as they move in lymph nodes as well as measure the impact of individual signaling molecules on T cell motility. As there is increasing interest in using computational modeling to understand T cell behavior in in vivo, these quantitative measures not only give us a better determination of actual T cell movement, they may prove crucial for models to generate accurate predictions about T cell behavior.	[Letendre, Kenneth; Cannon, Judy L.] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Letendre, Kenneth; Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Donnadieu, Emmanuel] Univ Paris 05, Sorbonne Paris Cite, Inst Cochin, INSERM,U1016, Paris, France; [Moses, Melanie E.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Moses, Melanie E.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of New Mexico; University of New Mexico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of New Mexico; The Santa Fe Institute	Cannon, JL (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	jucannon@salud.unm.edu	Donnadieu, Emmanuel/P-4566-2017		National Institutes of Health Grant [5R01AI097202]; NSF EF [1038682]; DARPA CRASH [P-1070-113237]; Spatiotemporal Modeling Center (STMC) at the University of New Mexico [NIH P50GM085273]; Center for Evolutionary and Theoretical Immunology (CETI) at the University of New Mexico [NIH 5P20GM103452]; James S McDonnell Foundation; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452, P50GM085273] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF EF(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); DARPA CRASH; Spatiotemporal Modeling Center (STMC) at the University of New Mexico; Center for Evolutionary and Theoretical Immunology (CETI) at the University of New Mexico; James S McDonnell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a National Institutes of Health Grant 5R01AI097202 (J.L.C.) and NSF EF #1038682 (M.E.M.) and DARPA CRASH #P-1070-113237 (M.E.M.). Postdoctoral support was received from the Spatiotemporal Modeling Center (STMC NIH P50GM085273) and Center for Evolutionary and Theoretical Immunology (CETI NIH 5P20GM103452) at the University of New Mexico (F.A.B.). Funding was also received from James S McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Cannon JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078940; Celli S, 2012, BLOOD, V120, P3945, DOI 10.1182/blood-2012-01-408260; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; Fricke G.M., 2013, P ECAL 2013 12 EUR C, P1009; Gerard A, 2014, CELL, V158, P492, DOI 10.1016/j.cell.2014.05.044; Gong C, 2013, J THEOR BIOL, V335, P169, DOI 10.1016/j.jtbi.2013.06.016; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Linderman JJ, 2010, J IMMUNOL, V184, P2873, DOI 10.4049/jimmunol.0903117; Matheu MP, 2007, J IMMUNOL, V1, P2261; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller M, 1986, ANOVA BASICS APPL ST; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Norman GR, 2008, BIOSTATISTICS BARE E, V3rd; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Textor J, 2014, GECCO'14: PROCEEDINGS OF THE 2014 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P129, DOI 10.1145/2576768.2598331; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Vaux DL, 2012, NATURE, V492, P180, DOI 10.1038/492180a; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126333	10.1371/journal.pone.0126333	http://dx.doi.org/10.1371/journal.pone.0126333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973755	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600047
J	Baker, MB; Venugopal, PD; Lamp, WO				Baker, Mitchell B.; Venugopal, P. Dilip; Lamp, William O.			Climate Change and Phenology: Empoasca fabae (Hemiptera: Cicadellidae) Migration and Severity of Impact	PLOS ONE			English	Article							POTATO LEAFHOPPER HOMOPTERA; HARRIS HOMOPTERA; LONG-TERM; ALFALFA; BUTTERFLIES; PATTERNS; TRENDS; SURVIVORSHIP; ANIMALS; FLIGHT	Climate change can benefit individual species, but when pest species are enhanced by warmer temperatures agricultural productivity may be placed at greater risk. We analyzed the effects of temperature anomaly on arrival date and infestation severity of potato leafhopper, Empoasca fabae Harris, a classic new world long distance migrant, and a significant pest in several agricultural crops. We compiled E. fabae arrival dates and infestation severity data at different states in USA from existing literature reviews and agricultural extension records from 1951-2012, and examined the influence of temperature anomalies at each target state or overwintering range on the date of arrival and severity of infestation. Average E. fabae arrival date at different states reveal a clear trend along the south-north axis, with earliest arrival closest to the overwintering range. E. fabae arrival has advanced by 10 days over the last 62 years. E. fabae arrived earlier in warmer years in relation to each target state level temperature anomaly (3.0 days / degrees C increase in temperature anomaly). Increased temperature had a significant and positive effect on the severity of infestation, and arrival date had a marginal negative effect on severity. These relationships suggest that continued warming could advance the time of E. fabae colonization and increase their impact on affected crops.	[Baker, Mitchell B.] CUNY, Queens Coll, Dept Biol, Flushing, NY 11367 USA; [Venugopal, P. Dilip; Lamp, William O.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	City University of New York (CUNY) System; Queens College NY (CUNY); University System of Maryland; University of Maryland College Park	Venugopal, PD (corresponding author), Univ Maryland, Dept Entomol, 4112 Plant Sci Bldg, College Pk, MD 20742 USA.	dilip@umd.edu	Lamp, William/G-6081-2015	Lamp, William/0000-0002-8565-1560; Venugopal, Dilip/0000-0001-6339-5087	PSC-CUNY [43- 65677]; Hatch Act Formula Grant [MD-ENTM-1016]; UMD Libraries Open Access Publishing Fund	PSC-CUNY; Hatch Act Formula Grant; UMD Libraries Open Access Publishing Fund	This research was supported by PSC-CUNY award 43- 65677, https://www.rfcuny.org/rfwebsite/research/content.aspx?catID=1190 (MB), and by Hatch Act Formula Grant MD-ENTM-1016, http://www.csrees.usda.gov/business/awards/formula/hatch.html (WL). Funding for Open Access provided by the UMD Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barton K., 2013, MUMIN MULTI MODEL IN; Bell JR, 2015, J ANIM ECOL, V84, P21, DOI 10.1111/1365-2656.12282; Bentz JA, 1999, ENVIRON ENTOMOL, V28, P456, DOI 10.1093/ee/28.3.456; Brower LP, 2012, INSECT CONSERV DIVER, V5, P95, DOI 10.1111/j.1752-4598.2011.00142.x; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; CARLSON JD, 1992, AGR FOREST METEOROL, V59, P183, DOI 10.1016/0168-1923(92)90092-I; Chasen EM, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM13014; Christensen R. H. B., 2014, ORDINAL REGRESSION M; Christensen RHB, 2014, TUTORIAL FITTING CUM; Cocu N, 2005, J BIOGEOGR, V32, P615, DOI 10.1111/j.1365-2699.2005.01190.x; CUPERUS GW, 1986, J KANSAS ENTOMOL SOC, V59, P246; Daly C, 2012, J APPL METEOROL CLIM, V51, P242, DOI 10.1175/2010JAMC2536.1; DeLong DM, 1938, 618 USDA EC RES SERV; Ellwood ER, 2012, OECOLOGIA, V168, P1161, DOI 10.1007/s00442-011-2160-4; Forister ML, 2003, GLOBAL CHANGE BIOL, V9, P1130, DOI 10.1046/j.1365-2486.2003.00643.x; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Gordo O, 2005, OECOLOGIA, V146, P484, DOI 10.1007/s00442-005-0240-z; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P933, DOI 10.1111/j.1365-2486.2007.01318.x; HEINRICH B, 1977, AM NAT, V111, P623, DOI 10.1086/283196; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hogg D.B., 1989, Miscellaneous Publications of the Entomological Society of America, P26; Hondula DM, 2011, CLIM RES, V46, P121, DOI 10.3354/cr00971; Huseth AS, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14009; Karl T. R., 2009, Global climate change impacts in the United States; Kossin JP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036012; LAMP WO, 1994, J KANSAS ENTOMOL SOC, V67, P354; LAMP WO, 1991, ENVIRON ENTOMOL, V20, P118, DOI 10.1093/ee/20.1.118; LAMP WO, 1991, J ECON ENTOMOL, V84, P610, DOI 10.1093/jee/84.2.610; Maredia KM, 1998, GREAT LAKES ENTOMOL, V31, P73; Medler J. T., 1962, Verhandlungen XI Internationaler Kongress fuer Entomologie Wien 1960 Vienna (Symp), V3, P30; MEDLER JT, 1957, J ECON ENTOMOL, V50, P493, DOI 10.1093/jee/50.4.493; Menendez Rosa, 2007, Tijdschrift voor Entomologie, V150, P355; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Noetzel DM, 1985, AGBU2415 U MINN I AG; Ovaskainen O, 2013, P NATL ACAD SCI USA, V110, P13434, DOI 10.1073/pnas.1305533110; Pachauri R.K, 2007, CLIMATE CHANGE 2007, P104; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; PIENKOWSKI R. L., 1964, ANN ENTOMOL SOC AMER, V57, P588, DOI 10.1093/aesa/57.5.588; PIENKOWSKI RL, 1962, J ECON ENTOMOL, V55, P973, DOI 10.1093/jee/55.6.973; Pinheiro J, 2000, MIXED EFFECTS MODELS; Pinheiro J, 2013, R CORE NLME LINEAR N; PORTER JH, 1991, AGR FOREST METEOROL, V57, P221, DOI 10.1016/0168-1923(91)90088-8; RCore Team, 2020, R LANG ENV STAT COMP; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; SCHROEDER PC, 1988, J ECON ENTOMOL, V81, P927, DOI 10.1093/jee/81.3.927; Shields EJ, 1999, AGR FOREST METEOROL, V97, P317, DOI 10.1016/S0168-1923(99)00075-1; Sidumo AJ, 2005, J ECON ENTOMOL, V98, P757, DOI 10.1603/0022-0493-98.3.757; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Sulc RM, 2014, J ECON ENTOMOL, V107, P2077, DOI 10.1603/EC14205; TAYLOR F, 1981, AM NAT, V117, P1, DOI 10.1086/283683; TAYLOR PS, 1995, ENVIRON ENTOMOL, V24, P1115, DOI 10.1093/ee/24.5.1115; TAYLOR PS, 1995, ENVIRON ENTOMOL, V24, P1086, DOI 10.1093/ee/24.5.1086; TAYLOR PS, 1995, ENVIRON ENTOMOL, V24, P1096, DOI 10.1093/ee/24.5.1096; TAYLOR RAJ, 1986, J ANIM ECOL, V55, P1103, DOI 10.2307/4436; Weart SR, 2010, WIRES CLIM CHANGE, V1, P67, DOI 10.1002/wcc.6	60	16	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124915	10.1371/journal.pone.0124915	http://dx.doi.org/10.1371/journal.pone.0124915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970705	Green Published, gold			2022-12-27	WOS:000354544200055
J	Jen, CP; Amstislavskaya, TG; Chen, KF; Chen, YH				Jen, Chun-Ping; Amstislavskaya, Tamara G.; Chen, Kuan-Fu; Chen, Yu-Hung			Sample Preconcentration Utilizing Nanofractures Generated by Junction Gap Breakdown Assisted by Self-Assembled Monolayer of Gold Nanoparticles	PLOS ONE			English	Article							NANOFLUIDIC CHANNELS; PROTEINS; DEVICE; GLASS	The preconcentration of proteins with low concentrations can be used to increase the sensitivity and accuracy of detection. A nonlinear electrokinetic flow is induced in a nanofluidic channel due to the overlap of electrical double layers, resulting in the fast accumulation of proteins, referred to as the exclusion-enrichment effect. The proposed chip for protein preconcentration was fabricated using simple standard soft lithography with a polydimethylsiloxane replica. This study extends our previous paper, in which gold nanoparticles were manually deposited onto the surface of a protein preconcentrator. In the present work, nanofractures were formed by utilizing the self-assembly of gold-nanoparticle-assisted electric breakdown. This reliable method for nanofracture formation, involving self-assembled monolayers of nanoparticles at the junction gap between microchannels, also decreases the required electric breakdown voltage. The experimental results reveal that a high concentration factor of 1.5x10(4) for a protein sample with an extremely low concentration of 1 nM was achieved in 30 min by using the proposed chip, which is faster than our previously proposed chip at the same conditions. Moreover, an immunoassay of bovine serum albumin (BSA) and anti-BSA was carried out to demonstrate the applicability of the proposed chip.	[Jen, Chun-Ping; Chen, Kuan-Fu] Natl Chung Cheng Univ, Dept Mech Engn, Chiayi, Taiwan; [Jen, Chun-Ping; Chen, Kuan-Fu] Natl Chung Cheng Univ, Adv Inst Mfg High Tech Innovat, Chiayi, Taiwan; [Amstislavskaya, Tamara G.] Sci Res Inst Physiol & Basic Med, Lab Expt Models Emot Pathol, Novosibirsk, Russia; [Chen, Yu-Hung] Natl Cheng Kung Univ, Dept Med, Tainan 70101, Taiwan; [Chen, Yu-Hung] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan	National Chung Cheng University; National Chung Cheng University; Research Institute for Neurosciences & Medicine; National Cheng Kung University; National Cheng Kung University	Jen, CP (corresponding author), Natl Chung Cheng Univ, Dept Mech Engn, Chiayi, Taiwan.	imecpj@ccu.edu.tw; second@mail.ncku.edu.tw	Jen, Chun-Ping/P-3275-2018; Chen, Yu-Hung/GLU-7365-2022; Amstislavskaya, Tamara G/K-4149-2018; Chen, Yu-Hung/F-4167-2010	Jen, Chun-Ping/0000-0001-5558-5817; Chen, Yu-Hung/0000-0003-3524-629X; 	National Science Council of the Republic of China, Taiwan [NSC 101-2221-E-194-027, NSC 102-2221-E-194-001, NSC 103-2221-E-194 -001 -]; Scientific Research Institute of Physiology and Basic Medicine [053]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); Scientific Research Institute of Physiology and Basic Medicine	The authors would like to thank the National Science Council of the Republic of China, Taiwan, for its financial support of this research under grants NSC 101-2221-E-194-027, NSC 102-2221-E-194-001 and NSC 103-2221-E-194 -001 -. This study was also partially supported by the budget project No. 053 of the Scientific Research Institute of Physiology and Basic Medicine.	Chiang PJ, 2014, MICROELECTRON ENG, V115, P39, DOI 10.1016/j.mee.2013.10.024; Chun HG, 2010, ANAL CHEM, V82, P6287, DOI 10.1021/ac101297t; Duan CH, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4794973; GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008; Hofmann O, 1999, ANAL CHEM, V71, P678, DOI 10.1021/ac9806660; Jen CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102050; Jung B, 2006, ANAL CHEM, V78, P2319, DOI 10.1021/ac051659w; Kim SM, 2006, ANAL CHEM, V78, P4779, DOI 10.1021/ac060031y; Kim SJ, 2008, ANAL CHEM, V80, P3507, DOI 10.1021/ac800157q; Ko SH, 2011, LAB CHIP, V11, P1351, DOI 10.1039/c0lc00349b; Lee JH, 2008, LAB CHIP, V8, P596, DOI 10.1039/b717900f; Lee JH, 2007, ANAL CHEM, V79, P6868, DOI 10.1021/ac071162h; Lin CC, 2011, MICROFLUID NANOFLUID, V10, P481, DOI 10.1007/s10404-010-0661-9; Liu V, 2010, LAB CHIP, V10, P1485, DOI 10.1039/b923214a; Mao P, 2005, LAB CHIP, V5, P837, DOI 10.1039/b502809d; Pu QS, 2004, NANO LETT, V4, P1099, DOI 10.1021/nl0494811; Ross D, 2002, ANAL CHEM, V74, P2556, DOI 10.1021/ac025528w; Song S, 2004, ANAL CHEM, V76, P4589, DOI 10.1021/ac0497151; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Wang YC, 2005, ANAL CHEM, V77, P4293, DOI 10.1021/ac050321z; Wu DP, 2009, LAB CHIP, V9, P1890, DOI 10.1039/b823409d; Yu H, 2008, LAB CHIP, V8, P1496, DOI 10.1039/b802778a	22	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126641	10.1371/journal.pone.0126641	http://dx.doi.org/10.1371/journal.pone.0126641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970592	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200125
J	Pimentel, M; Morales, W; Rezaie, A; Marsh, E; Lembo, A; Mirocha, J; Leffler, DA; Marsh, Z; Weitsman, S; Chua, KS; Barlow, GM; Bortey, E; Forbes, W; Yu, A; Chang, C				Pimentel, Mark; Morales, Walter; Rezaie, Ali; Marsh, Emily; Lembo, Anthony; Mirocha, James; Leffler, Daniel A.; Marsh, Zachary; Weitsman, Stacy; Chua, Kathleen S.; Barlow, Gillian M.; Bortey, Enoch; Forbes, William; Yu, Allen; Chang, Christopher			Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human Subjects	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; RAT MODEL; BACTERIAL OVERGROWTH; MOLECULAR MIMICRY; VINCULIN; DIAGNOSIS; DISEASE; GASTROENTERITIS; PREVALENCE; SYMPTOMS	Diarrhea-predominant irritable bowel syndrome (IBS) is diagnosed through clinical criteria after excluding "organic" conditions, and can be precipitated by acute gastroenteritis. Cytolethal distending toxin B (CdtB) is produced by bacteria that cause acute gastroenteritis, and a post-infectious animal model demonstrates that host antibodies to CdtB cross-react with vinculin in the host gut, producing an IBS-like phenotype. Therefore, we assessed circulating anti-CdtB and anti-vinculin antibodies as biomarkers for D-IBS in human subjects. Subjects with D-IBS based on Rome criteria (n=2375) were recruited from a large-scale multicenter clinical trial for D-IBS (TARGET 3). Subjects with inflammatory bowel disease (IBD) (n=142), subjects with celiac disease (n=121), and healthy controls (n=43) were obtained for comparison. Subjects with IBD and celiac disease were recruited based on the presence of intestinal complaints and histologic confirmation of chronic inflammatory changes in the colon or small intestine. Subjects with celiac disease were also required to have an elevated tTG and biopsy. All subjects were aged between 18 and 65 years. Plasma levels of anti-CdtB and anti-vinculin antibodies were determined by ELISA, and compared between groups. Anti-CdtB titers were significantly higher in D-IBS subjects compared to IBD, healthy controls and celiac disease (P<0.001). Anti-vinculin titers were also significantly higher in IBS (P<0.001) compared to the other groups. The area-under-the-receiver operating curves (AUCs) were 0.81 and 0.62 for diagnosis of D-IBS against IBD for anti-CdtB and anti-vinculin, respectively. Both tests were less specific in differentiating IBS from celiac disease. Optimization demonstrated that for anti-CdtB (optical density >= 2.80) the specificity, sensitivity and likelihood ratio were 91.6%, 43.7 and 5.2, respectively, and for anti-vinculin (OD >= 1.68) were 83.8%, 32.6 and 2.0, respectively. These results confirm that anti-CdtB and anti-vinculin antibodies are elevated in D-IBS compared to non-IBS subjects. These biomarkers may be especially helpful in distinguishing D-IBS from IBD in the workup of chronic diarrhea.	[Pimentel, Mark; Morales, Walter; Rezaie, Ali; Marsh, Emily; Marsh, Zachary; Weitsman, Stacy; Chua, Kathleen S.; Barlow, Gillian M.; Yu, Allen; Chang, Christopher] Cedars Sinai Med Ctr, GI Motil Program, Los Angeles, CA 90048 USA; [Lembo, Anthony; Leffler, Daniel A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Mirocha, James] Cedars Sinai Med Ctr, Dept Biostat, Los Angeles, CA 90048 USA; [Bortey, Enoch; Forbes, William] Salix Pharmaceut Inc, Raleigh, NC USA	Cedars Sinai Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Cedars Sinai Medical Center	Pimentel, M (corresponding author), Cedars Sinai Med Ctr, GI Motil Program, Los Angeles, CA 90048 USA.	pimentelm@cshs.org	Rezaie, Ali/AAI-1659-2021; Pimentel, Mark/AAH-7073-2021	Rezaie, Ali/0000-0002-0106-372X; Pimentel, Mark/0000-0002-0619-5115; Barlow, Gillian/0000-0002-0487-048X	Beatrice and Samuel A. Seaver Foundation; Salix Pharmaceuticals; National Institutes of Health [5R03DK095937]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK095937] Funding Source: NIH RePORTER	Beatrice and Samuel A. Seaver Foundation; Salix Pharmaceuticals; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The biomarkers in this study were discovered through basic research conducted by authors MP and CC at Cedars-Sinai Medical Center, which was funded in part by the Beatrice and Samuel A. Seaver Foundation. Performing the test on samples from subjects in the TARGET 3 trial was funded by Salix Pharmaceuticals. Salix Pharmaceuticals provided support in the form of salaries for authors EB & WF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are described in the 'author contributions' section. DL's work is supported by a grant from the National Institutes of Health (5R03DK095937).	Cash BD, 2004, ALIMENT PHARM THER, V19, P1235, DOI 10.1111/j.1365-2036.2004.02001.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DeMali KA, 2004, TRENDS BIOCHEM SCI, V29, P565, DOI 10.1016/j.tibs.2004.09.001; DROSSMAN DA, 1982, GASTROENTEROLOGY, V83, P529; Frisk A, 2001, MICROB PATHOGENESIS, V30, P313, DOI 10.1006/mpat.2000.0436; Halpin SJ, 2012, AM J GASTROENTEROL, V107, P1474, DOI 10.1038/ajg.2012.260; Halvorson HA, 2006, AM J GASTROENTEROL, V101, P1894, DOI 10.1111/j.1572-0241.2006.00654.x; Hill ID, 2005, GASTROENTEROLOGY, V128, pS25, DOI 10.1053/j.gastro.2005.02.012; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Jee SR, 2010, WORLD J GASTROENTERO, V16, P3680, DOI 10.3748/wjg.v16.i29.3680; Ji S, 2005, J GASTROEN HEPATOL, V20, P381, DOI 10.1111/j.1440-1746.2005.03574.x; KRUIS W, 1984, GASTROENTEROLOGY, V87, P1; Leffler DA, 2007, CLIN GASTROENTEROL H, V5, P445, DOI 10.1016/j.cgh.2006.12.006; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; Mearin F, 2005, GASTROENTEROLOGY, V129, P98, DOI 10.1053/j.gastro.2005.04.012; Mooiweer E, 2015, J CROHNS COLITIS, V9, P50, DOI 10.1093/ecco-jcc/jju003; Morales W, 2013, GASTROENTEROLOGY, V144; Morales W, 2011, DIGEST DIS SCI, V56, P2575, DOI 10.1007/s10620-011-1662-6; 박재명, 2006, Journal of Neurogastroenterology and Motility (JNM), V12, P35; Okhuysen PC, 2004, AM J GASTROENTEROL, V99, P1774, DOI 10.1111/j.1572-0241.2004.30435.x; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; Pimentel M, 2013, SCAND J GAS IN PRESS; Pimentel M, 2014, DIG DIS SCI; Pimentel M, 2008, DIGEST DIS SCI, V53, P982, DOI 10.1007/s10620-007-9977-z; Pimentel M, 2013, GASTROENTEROLOGY, V144, pE1, DOI 10.1053/j.gastro.2013.04.049; Pokkunuri V, 2012, J NEUROGASTROENTEROL, V18, P434, DOI 10.5056/jnm.2012.18.4.434; Porter CK, 2013, MIL MED, V178, P452, DOI 10.7205/MILMED-D-12-00510; Posserud I, 2007, GUT, V56, P802, DOI 10.1136/gut.2006.108712; Pyleris E, 2012, DIGEST DIS SCI, V57, P1321, DOI 10.1007/s10620-012-2033-7; Rome Foundation, 2006, J Gastrointestin Liver Dis, V15, P307; Shah ED, 2012, J NEUROGASTROENTEROL, V18, P200, DOI 10.5056/jnm.2012.18.2.200; Shah ED, 2010, DIGEST DIS SCI, V55, P2441, DOI 10.1007/s10620-010-1276-4; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; Stanisic V, 2014, EXPERT REV GASTROENT, V8, P139, DOI 10.1586/17474124.2014.876361; Thabane M, 2007, ALIMENT PHARM THER, V26, P535, DOI 10.1111/j.1365-2036.2007.03399.x; Thompson WG, 1999, GUT, V45, P43; Thompson WG., 1989, GASTROENTEROL INT, V2, P92; Tibble JA, 2002, GASTROENTEROLOGY, V123, P450, DOI 10.1053/gast.2002.34755; TSUCHIYA N, 1992, WESTERN J MED, V157, P133; Varon C, 2014, J INFECT DIS, V209, P588, DOI 10.1093/infdis/jit539; Vitoria JC, 1999, J PEDIATR GASTR NUTR, V29, P571, DOI 10.1097/00005176-199911000-00018; Xu WM, 1998, DEVELOPMENT, V125, P327; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0	47	63	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126438	10.1371/journal.pone.0126438	http://dx.doi.org/10.1371/journal.pone.0126438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970536	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200114
J	Bollfrass, A; Shaver, A				Bollfrass, Alexander; Shaver, Andrew			The Effects of Temperature on Political Violence: Global Evidence at the Subnational Level	PLOS ONE			English	Article							CLIMATE-CHANGE; CIVIL-WAR; CONFLICT; VARIABILITY; RISK	A number of studies have demonstrated an empirical relationship between higher ambient temperatures and substate violence, which have been extrapolated to make predictions about the security implications of climate change. This literature rests on the untested assumption that the mechanism behind the temperature-conflict link is that disruption of agricultural production provokes local violence. Using a subnational-level dataset, this paper demonstrates that the relationship: (1) obtains globally, (2) exists at the substate levelprovinces that experience positive temperature deviations see increased conflict; and (3) occurs even in regions without significant agricultural production. Diminished local farm output resulting from elevated temperatures is unlikely to account for the entire increase in substate violence. The findings encourage future research to identify additional mechanisms, including the possibility that a substantial portion of the variation is brought about by the well-documented direct effects of temperature on individuals' propensity for violence or through macroeconomic mechanisms such as food price shocks.	[Bollfrass, Alexander; Shaver, Andrew] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Shaver, A (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.	ashaver@princeton.edu		Bollfrass, Alexander/0000-0002-1635-1898				Anderson CA, 2000, ADV EXP SOC PSYCHOL, V32, P63, DOI 10.1016/S0065-2601(00)80004-0; Arezki Rabah., 2011, IMF WORKING PAPERS, V2011, DOI [10.5089/9781455221066.001, DOI 10.5089/9781455221066.001]; Bellanger M., 2012, 2012 5 INT S COMM CO, P1; Buhaug H, 2010, P NATL ACAD SCI USA, V107, pE186, DOI 10.1073/pnas.1015796108; Buhaug H, 2010, P NATL ACAD SCI USA, V107, P16477, DOI 10.1073/pnas.1005739107; Burke M, 2010, CLIMATE CIVIL WAR IS; Burke MB, 2010, P NATL ACAD SCI USA, V107, pE185, DOI 10.1073/pnas.1014879107; Burke MB, 2010, P NATL ACAD SCI USA, V107, pE103, DOI 10.1073/pnas.1005748107; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Collier P, 2004, J PEACE RES, V41, P253, DOI 10.1177/0022343304043769; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Dodge RW, 1980, CRIME SEASONALITY; Executive Office of the President, 2013, TECHNICAL REPORT; Fearon JD, 2003, AM POLIT SCI REV, V97, P75, DOI 10.1017/S0003055403000534; Feng SZ, 2010, P NATL ACAD SCI USA, V107, P14257, DOI 10.1073/pnas.1002632107; Gelman A., 2007, DATA ANAL USING REGR; Gleditsch NP, 2012, J PEACE RES, V49, P3, DOI 10.1177/0022343311431288; Hallberg JD, 2012, CONFLICT MANAG PEACE, V29, P219, DOI 10.1177/0738894211433168; Hendrix CS, 2013, STABILITY, V2, DOI 10.5334/sta.bm; Hendrix CS, 2012, J PEACE RES, V49, P35, DOI 10.1177/0022343311426165; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Hsiang SM, 2010, P NATL ACAD SCI USA, V107, P15367, DOI 10.1073/pnas.1009510107; Jones Benjamin F., 2010, CLIMATE SHOCKS EXPOR; King G., 1997, SOLUTION ECOLOGICAL; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; Neyman J, 1948, ECONOMETRICA, V16, P1, DOI 10.2307/1914288; Raleigh C, 2012, J PEACE RES, V49, P51, DOI 10.1177/0022343311427754; Salehyan I, 2006, INT ORGAN, V60, P335, DOI 10.1017/S0020818306060103; Shaver AC, 2013, TERRAIN RUGGEDNESS L; Sutton AE, 2010, P NATL ACAD SCI USA, V107, pE102, DOI 10.1073/pnas.1005278107; Theisen OM, 2012, J PEACE RES, V49, P81, DOI 10.1177/0022343311425842; Tollefsen AF, 2012, J PEACE RES, V49, P363, DOI 10.1177/0022343311431287; Wucherpfennig J, 2011, CONFLICT MANAG PEACE, V28, P423, DOI 10.1177/0738894210393217	34	27	27	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0123505	10.1371/journal.pone.0123505	http://dx.doi.org/10.1371/journal.pone.0123505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7CV	25992616	Green Published, gold			2022-12-27	WOS:000354921400011
J	Downs, CJ; Stewart, KM; Dick, BL				Downs, Cynthia J.; Stewart, Kelley M.; Dick, Brian L.			Investment in Constitutive Immune Function by North American Elk Experimentally Maintained at Two Different Population Densities	PLOS ONE			English	Article							LIFE-HISTORY STRATEGIES; REPRODUCTIVE EFFORT; TRADE-OFFS; TEMPORAL VARIATION; MULE DEER; RUMP FAT; COSTS; RESPONSES; DYNAMICS; TRANSMISSION	Natural selection favors individuals that respond with effective and appropriate immune responses to macro or microparasites. Animals living in populations close to ecological carrying capacity experience increased intraspecific competition, and as a result are often in poor nutritional condition. Nutritional condition, in turn, affects the amount of endogenous resources that are available for investment in immune function. Our objective was to understand the relationship between immune function and density dependence mediated by trade-offs between immune function, nutritional condition, and reproduction. To determine how immune function relates to density-dependent processes, we quantified bacteria killing ability, hemolytic-complement activity, and nutritional condition of North American elk (Cervus elaphus) from populations maintained at experimentally high-and low-population densities. When compared with elk from the low-density population, those from the high-density population had higher bacteria killing ability and hemolytic-complement activity despite their lower nutritional condition. Similarly, when compared with adults, yearlings had higher bacteria killing ability, higher hemolytic-complement activity, and lower nutritional condition. Pregnancy status and lactational status did not change either measure of constitutive immunity. Density-dependent processes affected both nutritional condition and investment in constitutive immune function. Although the mechanism for how density affects immunity is ambiguous, we hypothesize two possibilities: (i) individuals in higher population densities and in poorer nutritional condition invested more into constitutive immune defenses, or (ii) had higher parasite loads causing higher induced immune responses. Those explanations are not mutually exclusive, and might be synergistic, but overall our results provide stronger support for the hypothesis that animals in poorer nutritional condition invest more in constitutive immune defenses then animals in better nutritional condition. This intriguing hypothesis should be investigated further within the larger framework of the cost and benefit structure of immune responses.	[Downs, Cynthia J.; Stewart, Kelley M.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Dick, Brian L.] US Forest Serv, Pacific NW Res Stn, La Grande, OR USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of Agriculture (USDA); United States Forest Service	Downs, CJ (corresponding author), Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA.	cdowns@unr.edu	Downs, Cynthia J/K-3758-2012; Stewart, Kelley M/F-5897-2012	Downs, Cynthia J/0000-0001-9435-0623; 	Nevada Agriculture Experimental Station; University of Nevada Reno; US Forest Service	Nevada Agriculture Experimental Station; University of Nevada Reno; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This study was supported by a Hatch grant awarded by Nevada Agriculture Experimental Station and funding from the University of Nevada Reno, and US Forest Service grant awarded to KMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R. M., 1979, Population dynamics. (20th Symposium of the British Ecological Society, London, 1978)., P245; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], 1997, STARKEY PROJECT HIST; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; Ardia DR, 2005, J ANIM ECOL, V74, P517, DOI 10.1111/j.1365-2656.2005.00950.x; Ardia DR, 2003, P ROY SOC B-BIOL SCI, V270, P1679, DOI 10.1098/rspb.2003.2424; Armitage SAO, 2003, J EVOLUTION BIOL, V16, P1038, DOI 10.1046/j.1420-9101.2003.00551.x; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Arsnoe DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022633; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; Bardsen BJ, 2011, OIKOS, V120, P245, DOI 10.1111/j.1600-0706.2010.18597.x; Bardsen BJ, 2010, OECOLOGIA, V162, P627, DOI 10.1007/s00442-009-1537-0; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Beldomenico Pablo M, 2010, Trends Ecol Evol, V25, P21, DOI 10.1016/j.tree.2009.06.015; Brunner FS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0128; Caughley G., 1979, P2; CHANDRA RK, 1991, AM J CLIN NUTR, V53, P1087, DOI 10.1093/ajcn/53.5.1087; Clutton-Brock, 2003, SOAY SHEEP DYNAMICS; Cook RC, 2010, J WILDLIFE MANAGE, V74, P880, DOI 10.2193/2009-031; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Demas G., 2012, ECOIMMUNOLOGY; Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631; Demas GE, 2011, J ANIM ECOL, V80, P710, DOI 10.1111/j.1365-2656.2011.01813.x; Derting TL, 2003, PHYSIOL BIOCHEM ZOOL, V76, P744, DOI 10.1086/375662; Downs CJ, 2014, INTEGR COMP BIOL, V54, P340, DOI 10.1093/icb/icu082; Downs CJ, 2014, CALIF FISH GAME, V100, P371; DRENT RH, 1980, ARDEA, V68, P225; DWYER G, 1991, ECOLOGY, V72, P559, DOI 10.2307/2937196; Flies AS, 2012, ECOLOGY IMMUNE FUNCT; French SS, 2007, FUNCT ECOL, V21, P1115, DOI 10.1111/j.1365-2435.2007.01311.x; French SS, 2007, AM NAT, V170, P79, DOI 10.1086/518569; French SS, 2010, HORM BEHAV, V58, P792, DOI 10.1016/j.yhbeh.2010.08.001; French SS, 2009, P ROY SOC B-BIOL SCI, V276, P4003, DOI 10.1098/rspb.2009.1199; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hadley GL, 2007, J ANIM ECOL, V76, P448, DOI 10.1111/j.1365-2656.2007.01219.x; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; HIRTH DH, 1985, SOUTHWEST NAT, V30, P297, DOI 10.2307/3670743; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; Institute S, 2010, SAS SYST WIND; Iseri VJ, 2013, DEV COMP IMMUNOL, V40, P248, DOI 10.1016/j.dci.2013.02.005; Keech MA, 1998, ALCES-N AM MOOSE CON, V34, P173; Kie John G., 2003, P296, DOI 10.1017/CBO9780511615757.010; Klasing K.C., 1999, OSTRICH, V69, P32; Klasing KC, 1998, POULTRY SCI, V77, P1119, DOI 10.1093/ps/77.8.1119; Koski KG, 2001, ANNU REV NUTR, V21, P297, DOI 10.1146/annurev.nutr.21.1.297; Landete-Castillejos T, 2002, BIOL REPROD, V67, P1613, DOI 10.1095/biolreprod.102.004507; Liebl AL, 2009, FUNCT ECOL, V23, P1091, DOI 10.1111/j.1365-2435.2009.01592.x; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lochmiller RL, 1996, OIKOS, V76, P594, DOI 10.2307/3546356; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; MAUTZ W W, 1978, Wildlife Society Bulletin, V6, P88; Mayer M.M., 1948, EXPT IMMUNOCHEMISTRY; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCullough D.R., 1979, GEORGE RESERVE DEER; McCullough DR, 1999, J MAMMAL, V80, P1130, DOI 10.2307/1383164; Millet S, 2007, DEV COMP IMMUNOL, V31, P188, DOI 10.1016/j.dci.2006.05.013; Monteith KL, 2014, WILDLIFE MONOGR, V186, P1, DOI 10.1002/wmon.1011; Monteith KL, 2013, J ANIM ECOL, V82, P377, DOI 10.1111/1365-2656.12016; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Morano S, 2013, J MAMMAL, V94, P162, DOI 10.1644/12-MAMM-A-074.1; Muehlenbein M.P., 2010, HUMAN EVOLUTIONARY B, P459; Murphy K., 2007, JANEWAYS IMMUNOBIOLO; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; NORRIS K, 1994, J ANIM ECOL, V63, P601, DOI 10.2307/5226; Noyes JH, 1997, WILDLIFE SOC B, V25, P695; Nussey D. H., 2014, Proceedings of the Royal Society B. Biological Sciences, V281, P20132931, DOI 10.1098/rspb.2013.2931; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Raberg L, 2003, EVOLUTION, V57, P1670, DOI 10.1554/02-417; SAETHER BE, 1983, J MAMMAL, V64, P226, DOI 10.2307/1380552; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; SCHWARTZ CC, 1993, J WILDLIFE MANAGE, V57, P454, DOI 10.2307/3809270; SCOTT ME, 1987, PARASITOLOGY, V95, P111, DOI 10.1017/S0031182000057590; Scrimshaw Nevin S., 1997, American Journal of Clinical Nutrition, V66, p464S; Scrimshaw NS, 1968, INTERACTIONS NUTR IN; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sinclair JA, 2000, CAN J ZOOL, V78, P254, DOI 10.1139/cjz-78-2-254; Stearns S.C., 1992, pi; Stephenson TR, 2002, WILDLIFE SOC B, V30, P557; Stephenson TR, 1998, CAN J ZOOL, V76, P717, DOI 10.1139/cjz-76-4-717; Stewart KM, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)167[1:HOBNAE]2.0.CO;2; Stewart KM, 2005, OECOLOGIA, V143, P85, DOI 10.1007/s00442-004-1785-y; Stewart KM, 2002, J MAMMAL, V83, P229, DOI 10.1644/1545-1542(2002)083&lt;0229:TDOEMD&gt;2.0.CO;2; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Wilson K, 2008, PHENOTYPIC PLASTICIT, V1, P381; Wobeser GA, 2007, DIS WILD ANIMALS INV; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zysling DA, 2009, FUNCT ECOL, V23, P979, DOI 10.1111/j.1365-2435.2009.01572.x	96	18	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125586	10.1371/journal.pone.0125586	http://dx.doi.org/10.1371/journal.pone.0125586			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992627	gold, Green Published, Green Submitted			2022-12-27	WOS:000354921400036
J	Polioudakis, D; Abell, NS; Iyer, VR				Polioudakis, Damon; Abell, Nathan S.; Iyer, Vishwanath R.			MiR-191 Regulates Primary Human Fibroblast Proliferation and Directly Targets Multiple Oncogenes	PLOS ONE			English	Article							BREAST-CANCER; WIDE IDENTIFICATION; ENRICHMENT ANALYSIS; GENE-EXPRESSION; STEM-CELLS; MICRORNA; REVEALS; SITES; HSA-MIR-191; INTEGRATION	miRNAs play a central role in numerous pathologies including multiple cancer types. miR-191 has predominantly been studied as an oncogene, but the role of miR-191 in the proliferation of primary cells is not well characterized, and the miR-191 targetome has not been experimentally profiled. Here we utilized RNA induced silencing complex immunoprecipitations as well as gene expression profiling to construct a genome wide miR-191 target profile. We show that miR-191 represses proliferation in primary human fibroblasts, identify multiple proto-oncogenes as novel miR-191 targets, including CDK9, NOTCH2, and RPS6KA3, and present evidence that miR-191 extensively mediates target expression through coding sequence (CDS) pairing. Our results provide a comprehensive genome wide miR-191 target profile, and demonstrate miR-191's regulation of primary human fibroblast proliferation.	[Polioudakis, Damon; Abell, Nathan S.; Iyer, Vishwanath R.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Iyer, VR (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.	vishy.iyer@gmail.com			National Institutes of Health (NIH) [CA130075]; Cancer Prevention and Research Institute of Texas [RP120194]; NATIONAL CANCER INSTITUTE [R01CA130075] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by grants from the National Institutes of Health (NIH) (CA130075) and the Cancer Prevention and Research Institute of Texas (RP120194) to V.R.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brizova H, 2010, VIRCHOWS ARCH, V456, P671, DOI 10.1007/s00428-010-0922-8; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Di Leva G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003311; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He YH, 2011, NEOPLASIA, V13, P841, DOI 10.1593/neo.11698; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Lena AM, 2012, BIOCHEM BIOPH RES CO, V423, P509, DOI 10.1016/j.bbrc.2012.05.153; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Li Yu, 2012, Genomics Proteomics & Bioinformatics, V10, P246, DOI 10.1016/j.gpb.2012.07.005; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nagpal N, 2013, CARCINOGENESIS, V34, P1889, DOI 10.1093/carcin/bgt107; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Qin S, 2014, NEOPLASMA, V61, P27, DOI 10.4149/neo_2014_005; Romano G, 2008, CELL CYCLE, V7, P3664, DOI 10.4161/cc.7.23.7122; Shi XJ, 2011, ACTA BIOCH BIOPH SIN, V43, P849, DOI 10.1093/abbs/gmr084; Smith JA, 2005, CANCER RES, V65, P1027; Sun X, 2014, ONCOGENE, V33, P4967, DOI [10.1038/onc.2013.492, 10.1038/onc.2014.224]; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tan PH, 2005, MODERN PATHOL, V18, P374, DOI 10.1038/modpathol.3800254; Tzachanis D, 2004, LEUKEMIA LYMPHOMA, V45, P1959, DOI 10.1080/1042819042000219494; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8	46	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126535	10.1371/journal.pone.0126535	http://dx.doi.org/10.1371/journal.pone.0126535			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992613	Green Submitted, Green Published, gold			2022-12-27	WOS:000354921400066
J	Beauchet, O; Launay, CP; Fantino, B; Allali, G; Annweiler, C				Beauchet, Olivier; Launay, Cyrille P.; Fantino, Bruno; Allali, Gilles; Annweiler, Cedric			Respective and Combined Effects of Impairments in Sensorimotor Systems and Cognition on Gait Performance: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							HIGHER-LEVEL GAIT; MOTOR IMAGERY; EXECUTIVE FUNCTION; POSTURAL CONTROL; WALKING SPEED; OLDER PERSONS; FALLS; DISORDERS; VARIABILITY; MEMORY	Background Respective and combined effects of impairments in sensorimotor systems and cognition on gait performance have not been fully studied. This study aims to describe the respective effects of impairments in muscle strength, distance vision, lower-limb proprioception and cognition on the Timed Up & Go (TUG) scores (i.e., performed TUG [pTUG], imagined TUG [iTUG] and the time difference between these two tests [delta TUG]) in older community-dwellers; and to examine their combined effects on TUG scores. Methods Based on a cross-sectional design, 1792 community-dwellers (70.2 +/- 4.8 years; 53.6% female) were recruited. Gait performance was assessed using pTUG, iTUG and delta TUG. Participants were divided into healthy individuals and 15 subgroups of individuals according to the presence of impairment in one or more subsystems involved in gait control (i.e., muscle strength and/or distance vision and/or lower-limb proprioception and/or cognition [episodic memory and executive performance]). Impairment in muscle strength, distance vision and lower-limb proprioception was defined as being in the lowest tertile of performance. Impairment in cognition was defined as abnormal episodic memory and executive tests. Results A total of 191 (10.7%) exhibited impairment in muscle strength, 188 (10.5%) in distance vision, 302 (16.9%) in lower-limb proprioception, and 42 (2.3%) in cognition. Linear regressions showed that cognitive impairment as well as dual combinations of impairments were associated with increased pTUG (P<0.02). Impairment in lower-limb proprioception was associated with decreased iTUG (P=0.015). All combinations of impairments, except those including muscle strength and the combinations of the 4 subsystems, were associated with increased delta TUG (P<0.04). Conclusion Cognitive integrity is central for efficient gait control and stability, whereas lower-limb proprioception seems to be central for gait imagery.	[Beauchet, Olivier; Launay, Cyrille P.; Fantino, Bruno; Annweiler, Cedric] Angers Univ Hosp, Div Geriatr Med, Dept Neurosci, Angers, France; [Allali, Gilles] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; [Allali, Gilles] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Allali, Gilles] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurol, Div Cognit & Motor Aging, Bronx, NY USA; [Annweiler, Cedric] Univ Western Ontario, Robarts Res Inst, Dept Med Biophys, Schulich Sch Med & Dent, London, ON, Canada	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Geneva; University of Geneva; Yeshiva University; Albert Einstein College of Medicine; Western University (University of Western Ontario)	Beauchet, O (corresponding author), Angers Univ Hosp, Div Geriatr Med, Dept Neurosci, Angers, France.	olbeauchet@chu-angers.fr	Allali, Gilles/D-1500-2009; Beauchet, Olivier/AAP-8108-2020	Allali, Gilles/0000-0002-4455-6719; Annweiler, Cedric/0000-0002-7199-8109				Allali G, 2012, EUR NEUROL, V67, P116, DOI 10.1159/000334394; Allan LM, 2005, J AM GERIATR SOC, V53, P1681, DOI 10.1111/j.1532-5415.2005.53552.x; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; Beauchet O, 2013, J NUTR HEALTH AGING, V17, P235, DOI 10.1007/s12603-012-0394-4; Beauchet O, 2011, NEUROLOGY, V76, P1617, DOI 10.1212/WNL.0b013e318219fb08; Beauchet O, 2011, J NUTR HEALTH AGING, V15, P79, DOI 10.1007/s12603-011-0016-6; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Beauchet O, 2008, GAIT POSTURE, V27, P156, DOI 10.1016/j.gaitpost.2006.12.017; Beauchet O, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-66; Beauchet O, 2014, DRUG AGING, V31, P363, DOI 10.1007/s40266-014-0175-3; Beauchet O, 2014, BRAIN TOPOGR, V27, P293, DOI 10.1007/s10548-013-0293-y; Beauchet O, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-12; Beauchet O, 2011, J AM GERIATR SOC, V59, P1973, DOI 10.1111/j.1532-5415.2011.03610_9.x; Beauchet O, 2010, J NEUROL SCI, V294, P102, DOI 10.1016/j.jns.2010.03.021; Beauchet Olivier, 2008, Neuropsychiatr Dis Treat, V4, P155; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Doumas M, 2008, EXP BRAIN RES, V187, P275, DOI 10.1007/s00221-008-1302-3; Dubost V, 2005, PHYS THER, V85, P404, DOI 10.1093/ptj/85.5.404; Gandevia SC, 2002, ADV EXP MED BIOL, V508, P61; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Haubois G, 2013, EUR J NEUROL, V20, P588, DOI 10.1111/j.1468-1331.2012.03830.x; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hsiao-Wecksler ET, 2003, J BIOMECH, V36, P1327, DOI 10.1016/S0021-9290(03)00153-2; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Killane I, 2013, IEEE ENG MED BIO, P6921, DOI 10.1109/EMBC.2013.6611149; Kressig RW, 2006, AGING CLIN EXP RES, V18, P174, DOI 10.1007/BF03327437; Lallart E, 2012, PSYCHIAT RES, V198, P366, DOI 10.1016/j.psychres.2011.12.013; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; LORD SR, 1991, J GERONTOL, V46, pM69, DOI 10.1093/geronj/46.3.M69; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; Muir SW, 2013, J NUTR HEALTH AGING, V17, P661, DOI 10.1007/s12603-013-0045-4; NUTT JG, 1993, NEUROLOGY, V43, P268, DOI 10.1212/WNL.43.2.268; Oh-Park M, 2010, J AM GERIATR SOC, V58, P1512, DOI 10.1111/j.1532-5415.2010.02962.x; Oliver D, 2000, J AM GERIATR SOC, V48, P1679, DOI 10.1111/j.1532-5415.2000.tb03883.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Robertson MC, 2002, J AM GERIATR SOC, V50, P905, DOI 10.1046/j.1532-5415.2002.50218.x; Rossat A, 2010, J NUTR HEALTH AGING, V14, P787, DOI 10.1007/s12603-010-0089-7; Rosso AL, 2014, GAIT POSTURE; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Shah A, 1997, AGE AGEING, V26, P217, DOI 10.1093/ageing/26.3.217; Shimada H, 2013, GAIT POSTURE, V38, P203, DOI 10.1016/j.gaitpost.2012.11.008; Snijders AH, 2007, LANCET NEUROL, V6, P63, DOI 10.1016/S1474-4422(06)70678-0; Stevens JA, 2005, COGNITION, V95, P329, DOI 10.1016/j.cognition.2004.02.008; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; van der Meulen M, 2014, HUM BRAIN MAPP, V35, P455, DOI 10.1002/hbm.22192; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Watson NL, 2010, J GERONTOL A-BIOL, V65, P1093, DOI 10.1093/gerona/glq111; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zimmerman ME, 2009, BRAIN RES, V1291, P73, DOI 10.1016/j.brainres.2009.07.043	54	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0125102	10.1371/journal.pone.0125102	http://dx.doi.org/10.1371/journal.pone.0125102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BT	25992567	Green Published, gold, Green Submitted			2022-12-27	WOS:000354918600013
J	Korn, M; Schmidpeter, J; Dahl, M; Muller, S; Voll, LM; Koch, C				Korn, Martin; Schmidpeter, Johannes; Dahl, Marlis; Mueller, Susanne; Voll, Lars M.; Koch, Christian			A Genetic Screen for Pathogenicity Genes in the Hemibiotrophic Fungus Colletotrichum higginsianum Identifies the Plasma Membrane Proton Pump Pma2 Required for Host Penetration	PLOS ONE			English	Article							TUMEFACIENS-MEDIATED TRANSFORMATION; CHITIN-TRIGGERED IMMUNITY; KELCH REPEAT PROTEIN; H+-ATPASE; MAGNAPORTHE-ORYZAE; APPRESSORIUM DEVELOPMENT; INSERTIONAL MUTAGENESIS; PURINE BIOSYNTHESIS; BOTRYTIS-CINEREA; VIRULENCE GENES	We used insertional mutagenesis by Agrobacterium tumefaciens mediated transformation (ATMT) to isolate pathogenicity mutants of Colletotrichum higginsianum. From a collection of 7200 insertion mutants we isolated 75 mutants with reduced symptoms. 19 of these were affected in host penetration, while 17 were affected in later stages of infection, like switching to necrotrophic growth. For 16 mutants the location of T-DNA insertions could be identified by PCR. A potential plasma membrane H+-ATPase Pma2 was targeted in five independent insertion mutants. We genetically inactivated the Ku80 component of the non-homologous end-joining pathway in C. higginsianum to establish an efficient gene knockout protocol. Chpma2 deletion mutants generated by homologous recombination in the Delta Chku80 background form fully melanized appressoria but entirely fail to penetrate the host tissue and are non-pathogenic. The ChPMA2 gene is induced upon appressoria formation and infection of A. thaliana. Pma2 activity is not important for vegetative growth of saprophytically growing mycelium, since the mutant shows no growth penalty under these conditions. Colletotrichum higginsianum codes for a closely related gene (ChPMA1), which is highly expressed under most growth conditions. ChPMA1 is more similar to the homologous yeast genes for plasma membrane pumps. We propose that expression of a specific proton pump early during infection may be common to many appressoria forming fungal pathogens as we found ChPMA2 orthologs in several plant pathogenic fungi.	[Korn, Martin; Schmidpeter, Johannes; Dahl, Marlis; Mueller, Susanne; Voll, Lars M.; Koch, Christian] Univ Erlangen Nurnberg, Dept Biol, Div Biochem, D-91058 Erlangen, Germany	University of Erlangen Nuremberg	Koch, C (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Div Biochem, Staudtstr 5, D-91058 Erlangen, Germany.	christian.koch@fau.de			University of Erlangen	University of Erlangen	This work was supported by the University of Erlangen. The authors received no other specific funding for this work.	Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Blaise F, 2007, FUNGAL GENET BIOL, V44, P123, DOI 10.1016/j.fgb.2006.07.006; Chen ZJ, 2004, MYCOLOGIA, V96, P1199, DOI 10.2307/3762135; Choquer M, 2008, FEMS MICROBIOL LETT, V289, P225, DOI 10.1111/j.1574-6968.2008.01388.x; Covert SF, 2001, MYCOL RES, V105, P259, DOI 10.1017/S0953756201003872; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Denisov Y, 2005, EUR J PLANT PATHOL, V112, P293, DOI 10.1007/s10658-005-2771-x; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Enyenihi AH, 2003, GENETICS, V163, P47; Eraso P, 2006, BBA-BIOMEMBRANES, V1758, P164, DOI 10.1016/j.bbamem.2006.01.010; Fernandez J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02398; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Ferrol N, 2000, CURR GENET, V37, P112, DOI 10.1007/s002940050017; Flowers JL, 2005, CURR GENET, V48, P380, DOI 10.1007/s00294-005-0034-1; Franck WL, 2013, MOL CELL PROTEOMICS, V12, P2249, DOI 10.1074/mcp.M112.025874; Giesbert S, 2012, MOL PLANT MICROBE IN, V25, P481, DOI 10.1094/MPMI-07-11-0199; Gilbert RD, 1996, PHYSIOL MOL PLANT P, V48, P335, DOI 10.1006/pmpp.1996.0027; Giraldo MC, 2013, NAT REV MICROBIOL, V11, P800, DOI 10.1038/nrmicro3119; Green MR, 2012, MOL CLONING LAB MANU, V1; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Hoi JWS, 2007, MOL MICROBIOL, V64, P68, DOI 10.1111/j.1365-2958.2007.05639.x; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Huser A, 2009, MOL PLANT MICROBE IN, V22, P143, DOI 10.1094/MPMI-22-2-0143; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kleemann J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002643; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Latunde-Dada AO, 2001, MOL PLANT PATHOL, V2, P187, DOI 10.1046/j.1464-6722.2001.00069.x; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Lee WS, 2014, MOL PLANT MICROBE IN, V27, P236, DOI 10.1094/MPMI-07-13-0201-R; Li Y, 2010, MOL PLANT MICROBE IN, V23, P317, DOI 10.1094/MPMI-23-3-0317; Liu LP, 2013, MICROB PATHOGENESIS, V64, P6, DOI 10.1016/j.micpath.2013.06.001; Ludwig N, 2014, MOL PLANT MICROBE IN, V27, P315, DOI 10.1094/MPMI-09-13-0267-R; MATHUR RS, 1950, PHYTOPATHOLOGY, V40, P104; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Meng Y, 2007, FUNGAL GENET BIOL, V44, P1050, DOI 10.1016/j.fgb.2007.04.002; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Michielse CB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r4; MONEY NP, 1989, PLANT PHYSIOL, V91, P766, DOI 10.1104/pp.91.2.766; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Munch S, 2011, MOL PLANT PATHOL, V12, P43, DOI 10.1111/j.1364-3703.2010.00651.x; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; O'Connell R, 2004, MOL PLANT MICROBE IN, V17, P272, DOI 10.1094/MPMI.2004.17.3.272; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; OCONNELL RJ, 1985, PHYSIOL PLANT PATHOL, V27, P75, DOI 10.1016/0048-4059(85)90058-X; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Park SM, 2004, BIOTECHNOL BIOPROC E, V9, P217, DOI 10.1007/BF02942296; Paz Z, 2011, FUNGAL GENET BIOL, V48, P677, DOI 10.1016/j.fgb.2011.02.003; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philips J, 1998, J CELL BIOL, V143, P375, DOI 10.1083/jcb.143.2.375; Remy E, 2008, FUNGAL GENET BIOL, V45, P1122, DOI 10.1016/j.fgb.2008.04.008; Requena N, 2003, PLANT PHYSIOL, V132, P1540, DOI 10.1104/pp.102.019042; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Sakaguchi A, 2008, EUKARYOT CELL, V7, P102, DOI 10.1128/EC.00227-07; Sakaguchi A, 2010, MOL PLANT MICROBE IN, V23, P103, DOI 10.1094/MPMI-23-1-0103; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Sharon A., 2010, MOL CELL BIOL METHOD; Shimada C, 2006, MOL PLANT MICROBE IN, V19, P270, DOI 10.1094/MPMI-19-0270; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Singer K, 2012, PLANT PHYSIOL, V160, P511, DOI 10.1104/pp.112.200212; Takahara H., 2012, Mycology - An International Journal on Fungal Biology, V3, P54; Tadashi T, 2006, MOL GENET GENOMICS, V275, P460, DOI 10.1007/s00438-006-0104-1; Talhinhas P, 2008, MOL BIOTECHNOL, V39, P57, DOI 10.1007/s12033-007-9028-1; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; TIMMERMAN B, 1988, J MOL BIOL, V203, P373, DOI 10.1016/0022-2836(88)90005-8; Tsuji G, 2003, MOL PLANT MICROBE IN, V16, P315, DOI 10.1094/MPMI.2003.16.4.315; Ushimaru T, 2010, MOL GENET GENOMICS, V284, P357, DOI 10.1007/s00438-010-0572-1; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Veneault-Fourrey C, 2005, APPL ENVIRON MICROB, V71, P4761, DOI 10.1128/AEM.71.8.4761-4770.2005; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Voll LM, 2012, NEW PHYTOL, V195, P189, DOI 10.1111/j.1469-8137.2012.04129.x; Walton FJ, 2006, MOL BIOL CELL, V17, P3768, DOI 10.1091/mbc.E06-02-0125; Wang ET, 2014, PLANT CELL, V26, P1818, DOI 10.1105/tpc.113.120527; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weld RJ, 2006, CELL RES, V16, P31, DOI 10.1038/sj.cr.7310006	88	25	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0125960	10.1371/journal.pone.0125960	http://dx.doi.org/10.1371/journal.pone.0125960			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992547	Green Published, gold, Green Submitted			2022-12-27	WOS:000354918600023
J	Barros, MHM; Segges, P; Vera-Lozada, G; Hassan, R; Niedobitek, G				Barros, Mario H. M.; Segges, Priscilla; Vera-Lozada, Gabriela; Hassan, Rocio; Niedobitek, Gerald			Macrophage Polarization Reflects T Cell Composition of Tumor Microenvironment in Pediatric Classical Hodgkin Lymphoma and Has Impact on Survival	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; GENE-EXPRESSION; HUMAN MONOCYTES; CD163-POSITIVE MACROPHAGES; PROGNOSTIC RELEVANCE; ACTIVATED MACROPHAGE; C-MAF; SUBSETS; PLASTICITY; CANCER	Macrophages have been implicated in the pathogenesis of classical Hodgkin lymphoma (cHL) and have been suggested to have a negative impact on outcome. Most studies addressing the role of macrophages in cHL have relied on identification of macrophages by generic macrophage antigens, e.g., CD68. We have therefore conducted an in situ analysis of macrophage polarization in a series of 100 pediatric cHL (pcHL) cases using double staining immunohistochemistry, combining CD68 or CD163 with pSTAT1 (M1-like) or CMAF (M2-like). M1-or M2-polarised microenvironment was defined by an excess of one population over the other (>1.5). Expression of STAT1 and LYZ genes was also evaluated by RT-qPCR. Patients <14 years and EBV+ cases displayed higher numbers of CD68+pSTAT1+ cells than older children and EBV-cases, respectively (P=0.01 and P=0.02). A cytotoxic tumor microenvironment, defined by a CD8+/FOXP3+ratio >1.5 was associated with higher numbers of CD68+ pSTAT1+ (P=0.025) and CD163+pSTAT1+ macrophages (P<0.0005). Levels of STAT1 and LYZ expression were associated with the numbers of CD68+ pSTAT1+ macrophages. EBV+ cHL cases disclosed a predominant M1 polarized microenvironment similar to Th1 mediated inflammatory disorders, while EBV-cHL showed a predominant M2 polarized microenvironment closer to Th2 mediated inflammatory diseases. Better overall-survival (OS) was observed in cases with higher numbers of CD163+pSTAT1+ macrophages (P=0.02) while larger numbers of CD163+CMAF+ macrophages were associated with worse progression-free survival (PFS) (P=0.02). Predominant M1-like polarization as disclosed by CD163+pSTAT1+/CD163+CMAF+ratio >1.5 was associated with better OS (P=0.037). In conclusion, macrophage polarization in pcHL correlates with prevalent local T cell response and may be influenced by the EBV-status of neoplastic cells. Besides, M1-like and M2-like macrophages displayed differential effects on outcome in pcHL.	[Barros, Mario H. M.; Segges, Priscilla; Niedobitek, Gerald] Unfallkrankenhaus Berlin, Inst Pathol, Berlin, Germany; [Segges, Priscilla; Vera-Lozada, Gabriela; Hassan, Rocio] Bone Marrow Transplantat Ctr, Inst Nacl Canc INCA, Rio De Janeiro, Brazil; [Niedobitek, Gerald] Sana Klinikum Lichtenberg, Inst Pathol, Berlin, Germany	National Cancer Institute (Inca)	Barros, MHM (corresponding author), Unfallkrankenhaus Berlin, Inst Pathol, Berlin, Germany.	mariohenrique.barros@gmail.com	; Barros, Mario/G-1842-2014	Niedobitek, Gerald/0000-0003-4474-1882; Hassan, Rocio/0000-0003-3782-3580; Barros, Mario/0000-0001-6826-9565	Wilhelm Sander Foundation [2012.029.1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475969/2013-8]; INCT para Controle do Cancer, Brazil [CNPq 573806/2008-0, FAPERJ E26/170.026/2008]; Science without Borders sandwich PhD fellowship (CNPq, Brazil); Alexander von Humboldt Foundation	Wilhelm Sander Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT para Controle do Cancer, Brazil; Science without Borders sandwich PhD fellowship (CNPq, Brazil); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Wilhelm Sander Foundation (2012.029.1); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grant 475969/2013-8 and INCT para Controle do Cancer, Brazil (Grants CNPq 573806/2008-0 and FAPERJ E26/170.026/2008). Priscilla Segges was a recipient of a Science without Borders sandwich PhD fellowship (CNPq, Brazil); Dr. Mario Barros was supported by Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Baiocchi OCG, 2008, LEUKEMIA LYMPHOMA, V49, P2031, DOI 10.1080/10428190802517799; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Barros MHM, 2012, CLIN CANCER RES, V18, P3762, DOI 10.1158/1078-0432.CCR-12-0129; Barros MHM, 2012, INT J CANCER, V131, P1142, DOI 10.1002/ijc.27314; Barros MHM, 2011, HEMATOL ONCOL, V29, P190, DOI 10.1002/hon.984; Barros MHM, 2010, LEUKEMIA LYMPHOMA, V51, P1513, DOI 10.3109/10428194.2010.489243; Bartlett JA, 2001, CLIN DIAGN LAB IMMUN, V8, P740, DOI 10.1128/CDLI.8.4.740-746.2001; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bonilla FA, 2010, J ALLERGY CLIN IMMUN, V125, pS33, DOI 10.1016/j.jaci.2009.09.017; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Faria AM, 2008, NEUROIMMUNOMODULAT, V15, P365, DOI 10.1159/000156478; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Diehl V, 2010, NAT REV CLIN ONCOL, V7, P301, DOI 10.1038/nrclinonc.2010.71; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; ERKELLERYUKSEL FM, 1992, J PEDIATR-US, V120, P216, DOI 10.1016/S0022-3476(05)80430-5; Fiorcari S, 2015, HAEMATOLOGICA, V100, P253, DOI 10.3324/haematol.2014.113217; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Fujii N, 2012, J ORAL PATHOL MED, V41, P444, DOI 10.1111/j.1600-0714.2012.01127.x; Gjuvsland AB, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-57; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greaves P, 2013, BLOOD, V122, P2856, DOI 10.1182/blood-2013-06-508044; Harris JA, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-12; HELDRUP J, 1992, ACTA PAEDIATR, V81, P125, DOI 10.1111/j.1651-2227.1992.tb12187.x; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Hogger P, 1998, J IMMUNOL, V161, P1883; Hohaus S, 2009, LEUKEMIA RES, V33, P1352, DOI 10.1016/j.leukres.2009.01.009; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jakovic LR, 2011, LEUKEMIA LYMPHOMA, V52, P1913, DOI 10.3109/10428194.2011.580026; Jarrett RF, 2005, BLOOD, V106, P2444, DOI 10.1182/blood-2004-09-3759; JIANG SL, 1995, J CLIN INVEST, V95, P1253, DOI 10.1172/JCI117775; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Luebke RW, 2006, J TOXICOL ENV HEAL A, V69, P811, DOI 10.1080/15287390600591496; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Roussel Y, 2007, VACCINE, V25, P2919, DOI 10.1016/j.vaccine.2006.07.013; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sanchez-Espiridion B, 2009, CLIN CANCER RES, V15, P1367, DOI 10.1158/1078-0432.CCR-08-1119; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schoof N, 2013, ONCOLOGIST, V18, P80, DOI 10.1634/theoncologist.2012-0291; Scott DW, 2014, NAT REV CANCER, V14, P517, DOI 10.1038/nrc3774; Scott DW, 2013, J CLIN ONCOL, V31, P692, DOI 10.1200/JCO.2012.43.4589; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; SLIVNICK DJ, 1990, SEMIN ONCOL, V17, P673; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Swerdlow SH, 2008, WHO CLASSIFICATION O, DOI [10.1016/j.anndiagpath.2012.05.004, DOI 10.1016/J.ANNDIAGPATH.2012.05.004]; Tzankov A, 2010, PATHOBIOLOGY, V77, P301, DOI 10.1159/000321567; Vakkila J, 2005, PEDIATR DEVEL PATHOL, V8, P43, DOI 10.1007/s10024-004-5045-2; van den Bosch MWM, 2014, J BIOL CHEM, V289, P22980, DOI 10.1074/jbc.M114.573089; Vassilakopoulos TP, 2001, HAEMATOLOGICA, V86, P274; Vera-Lozada G, 2014, EXP MOL PATHOL, V97, P433, DOI 10.1016/j.yexmp.2014.09.014; Verbeke CS, 2000, CLIN EXP IMMUNOL, V120, P294, DOI 10.1046/j.1365-2249.2000.01181.x; Waddell A, 2011, J IMMUNOL, V186, P5993, DOI 10.4049/jimmunol.1003844; Wager CML, 2014, J IMMUNOL, V193, P4060, DOI 10.4049/jimmunol.1400318; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; WARREN KS, 1976, ANN NY ACAD SCI, V278, P7, DOI 10.1111/j.1749-6632.1976.tb47011.x; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yoon DH, 2012, EUR J HAEMATOL, V88, P292, DOI 10.1111/j.1600-0609.2011.01731.x; Zaki MAA, 2011, VIRCHOWS ARCH, V459, P361, DOI 10.1007/s00428-011-1140-8; Zhang YM, 2014, INFLAMMATION, V37, P1240, DOI 10.1007/s10753-014-9851-z	76	41	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124531	10.1371/journal.pone.0124531	http://dx.doi.org/10.1371/journal.pone.0124531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978381	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100014
J	Chen, QF; Arai, D; Kawakami, K; Sawada, T; Jing, XF; Miyajima, M; Hirai, S; Sakaguchi, K; Furushima, K				Chen, Qingfa; Arai, Daiki; Kawakami, Kazuki; Sawada, Takahiro; Jing, Xuefeng; Miyajima, Masayasu; Hirai, Syu-ichi; Sakaguchi, Kazushige; Furushima, Kenryo			EphA4 Regulates the Balance between Self-Renewal and Differentiation of Radial Glial Cells and Intermediate Neuronal Precursors in Cooperation with FGF Signaling	PLOS ONE			English	Article							NEURAL STEM-CELLS; PROGENITOR-CELL; CORTICAL-NEURONS; CEREBRAL-CORTEX; PROLIFERATION; RECEPTOR; MIGRATION; FRS2-ALPHA; SUBTYPE; COMPLEX	In mouse cerebral corticogenesis, neurons are generated from radial glial cells (RGCs) or from their immediate progeny, intermediate neuronal precursors (INPs). The balance between self-renewal of these neuronal precursors and specification of cell fate is critical for proper cortical development, but the signaling mechanisms that regulate this progression are poorly understood. EphA4, a member of the receptor tyrosine kinase superfamily, is expressed in RGCs during embryogenesis. To illuminate the function of EphA4 in RGC cell fate determination during early corticogenesis, we deleted Epha4 in cortical cells at E11.5 or E13.5. Loss of EphA4 at both stages led to precocious in vivo RGC differentiation toward neurogenesis. Cortical cells isolated at E14.5 and E15.5 from both deletion mutants showed reduced capacity for neurosphere formation with greater differentiation toward neurons. They also exhibited lower phosphorylation of ERK and FRS2a in the presence of FGF. The size of the cerebral cortex at P0 was smaller than that of controls when Epha4 was deleted at E11.5 but not when it was deleted at E13.5, although the cortical layers were formed normally in both mutants. The number of PAX6-positive RGCs decreased at later developmental stages only in the E11.5 Epha4 deletion mutant. These results suggest that EphA4, in cooperation with an FGF signal, contributes to the maintenance of RGC self-renewal and repression of RGC differentiation through the neuronal lineage. This function of EphA4 is especially critical and uncompensated in early stages of corticogenesis, and thus deletion at E11.5 reduces the size of the neonatal cortex.	[Chen, Qingfa; Arai, Daiki; Kawakami, Kazuki; Sawada, Takahiro; Jing, Xuefeng; Sakaguchi, Kazushige; Furushima, Kenryo] Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama 6418509, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama 6418509, Japan; [Hirai, Syu-ichi] Wakayama Med Univ, Dept Biol, Wakayama 6410011, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University	Furushima, K (corresponding author), Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	bunshi@wakayama-med.ac.jp	Chen, Qingfa/AAG-1036-2020		Wakayama Medical University	Wakayama Medical University	This work was supported by a Research Grant on Priority Areas from Wakayama Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Clifford MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-21; Dufour A, 2006, DEVELOPMENT, V133, P4415, DOI 10.1242/dev.02623; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Furushima K, 2007, DEV BIOL, V306, P480, DOI 10.1016/j.ydbio.2007.03.028; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Greferath U, 2002, MECH DEVELOP, V119, pS231, DOI 10.1016/S0925-4773(03)00122-9; Herrmann JE, 2010, GENESIS, V48, P101, DOI 10.1002/dvg.20587; Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006; Hu MC, 2013, SEMIN NEPHROL, V33, P118, DOI 10.1016/j.semnephrol.2012.12.013; Hu Y, 2014, NEUROSCI BULL, V30, P425, DOI 10.1007/s12264-013-1404-1; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kang WF, 2009, J NEUROSCI, V29, P14571, DOI 10.1523/JNEUROSCI.3844-09.2009; Khodosevich K, 2011, J CELL SCI, V124, P1268, DOI 10.1242/jcs.076059; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; NIETO MA, 1992, DEVELOPMENT, V116, P1137; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; North HA, 2009, DEVELOPMENT, V136, P2467, DOI 10.1242/dev.034405; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012; Rash BG, 2011, J NEUROSCI, V31, P15604, DOI 10.1523/JNEUROSCI.4439-11.2011; Sato T, 2010, STEM CELLS, V28, P1660, DOI 10.1002/stem.488; Satoh Y, 2011, J NEUROSCI, V31, P1149, DOI 10.1523/JNEUROSCI.2243-10.2011; Sawada T, 2010, GENES CELLS, V15, P297, DOI 10.1111/j.1365-2443.2010.01391.x; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Stevens HE, 2010, J NEUROSCI, V30, P5590, DOI 10.1523/JNEUROSCI.5837-09.2010; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yamamoto S, 2005, P NATL ACAD SCI USA, V102, P15983, DOI 10.1073/pnas.0507961102; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhou XF, 2001, J NEUROSCI RES, V66, P1054, DOI 10.1002/jnr.10029.abs	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126942	10.1371/journal.pone.0126942	http://dx.doi.org/10.1371/journal.pone.0126942			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978062	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100115
J	Liu, YC; Yang, H; Chen, TX; Luo, YB; Xu, ZY; Li, Y; Yang, JH				Liu, Yanchun; Yang, Hui; Chen, Tianxing; Luo, Yongbin; Xu, Zheyuan; Li, Ying; Yang, Jiahui			Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NEVER SMOKERS; ANTIGEN ROR1; CANCER; MUTATIONS; EXPRESSION; APOPTOSIS; FAMILY; PSEUDOKINASE; MECHANISMS	Receptor tyrosine kinase ROR1, an embryonic protein involved in organogenesis, is expressed in certain hematological malignancies and solid tumors, but is generally absent in adult tissues. This makes the protein an ideal drug target for cancer therapy. In order to assess the suitability of ROR1 as a cell surface antigen for targeted therapy of lung adenocarcinoma, we carried out a comprehensive analysis of ROR1 protein expression in human lung adenocarcinoma tissues and cell lines. Our data show that ROR1 protein is selectively expressed on lung adenocarcinoma cells, but do not support the hypothesis that expression levels of ROR1 are associated with aggressive disease. However silencing of ROR1 via siRNA treatment significantly down-regulates the activity of the PI3K/AKT/mTOR signaling pathway. This is associated with significant apoptosis and anti-proliferation of tumor cells. We found ROR1 protein expressed in lung adenocarcinoma but almost absent in tumor-adjacent tissues of the patients. The finding of ROR1-mediated proliferation signals in both tyrosine kinase inhibitor (TKI)-sensitive and -resistant tumor cells provides encouragement to develop ROR1-directed targeted therapy in lung adenocarcinoma, especially those with TKI resistance.	[Liu, Yanchun; Luo, Yongbin; Yang, Jiahui] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Yang, Hui; Chen, Tianxing; Li, Ying] First Peoples Hosp Yunnan Prov, Dept Pathol, Kunming, Yunnan, Peoples R China; [Xu, Zheyuan] First Peoples Hosp Yunnan Prov, Dept Thorac Surg, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Yang, JH (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.	yangjiahui@mail.kib.ac.cn			National Natural Science Foundation of China [81401904]; Outstanding Talent Projects of Kunming Institute of Botany, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Talent Projects of Kunming Institute of Botany, Chinese Academy of Sciences	Funding: This work was supported by the grant from the National Natural Science Foundation of China (No. 81401904, www.nsfc.gov.cn) and the Outstanding Talent Projects of Kunming Institute of Botany, Chinese Academy of Sciences. J. Yang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgeer M, 2013, CURR OPIN PHARMACOL, V13, P394, DOI 10.1016/j.coph.2013.03.010; Bainbridge TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102695; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Beau-Faller M, 2014, ANN ONCOL, V25, P126, DOI 10.1093/annonc/mdt418; Bichev SN, 2015, CELL ONCOL, V38, P145, DOI 10.1007/s13402-014-0211-7; Broome HE, 2011, LEUKEMIA RES, V35, P1390, DOI 10.1016/j.leukres.2011.06.021; Cadranel J, 2013, CRIT REV ONCOL HEMAT, V88, P477, DOI 10.1016/j.critrevonc.2013.06.009; Choudhury A, 2010, BRIT J HAEMATOL, V151, P327, DOI 10.1111/j.1365-2141.2010.08362.x; Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007; Daneshmanesh AH, 2012, LEUKEMIA, V26, P1348, DOI 10.1038/leu.2011.362; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Daneshmanesh AH, 2015, BRIT J HAEMATOL, V169, P455, DOI 10.1111/bjh.13228; Daneshmanesh AH, 2013, LEUKEMIA LYMPHOMA, V54, P843, DOI 10.3109/10428194.2012.731599; Gentile A, 2014, INT J CANCER, V135, P2305, DOI 10.1002/ijc.28879; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hojjat-Farsangi M, 2014, SEMIN CANCER BIOL, V29, P21, DOI 10.1016/j.semcancer.2014.07.005; Hojjat-Farsangi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078339; Hojjat-Farsangi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061167; Hrustanovic G, 2013, CANCER BIOL THER, V14, P304, DOI 10.4161/cbt.23627; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karachaliou N, 2014, TRANSL LUNG CANCER R, V3, P122, DOI 10.3978/j.issn.2218-6751.2014.03.02; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma Li-ju, 2012, Chinese Journal of Pathology, V41, P335, DOI 10.3760/cma.j.issn.0529-5807.2012.05.011; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Shabani M, 2008, LEUKEMIA LYMPHOMA, V49, P1360, DOI 10.1080/10428190802124000; Shabani M, 2007, TUMOR BIOL, V28, P318, DOI 10.1159/000121405; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Trigka EA, 2013, ONCOL REP, V30, P623, DOI 10.3892/or.2013.2512; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Widhopf GF, 2014, P NATL ACAD SCI USA, V111, P793, DOI 10.1073/pnas.1308374111; Xu J, 2014, NAT PROD COMMUN, V9, P215; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yamazaki S, 2014, J PHARMACOL EXP THER, V351, P67, DOI 10.1124/jpet.114.217141; Yang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021018; Zhang HL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05811; Zhang SP, 2012, AM J PATHOL, V181, P1903, DOI 10.1016/j.ajpath.2012.08.024; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; Zhao YL, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-103	51	20	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127092	10.1371/journal.pone.0127092	http://dx.doi.org/10.1371/journal.pone.0127092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978653	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100128
J	Chen, SL; Huang, LX; Sun, KY; Wu, DX; Li, MR; Li, MY; Zhong, BH; Chen, MH; Zhang, SH				Chen, Shuling; Huang, Lixia; Sun, Kaiyu; Wu, Dexi; Li, Minrui; Li, Manying; Zhong, Bihui; Chen, Minhu; Zhang, Shenghong			Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GROUP PROTEIN EZH2; GASTRIC-CANCER; BREAST-CANCER; HIGH EXPRESSION; POOR-PROGNOSIS; THERAPEUTIC TARGET; TUMOR PROGRESSION; PROSTATE-CANCER; E-CADHERIN	Background Novel biomarkers are of particular interest for predicting cancer prognosis. This study aimed to explore the associations between enhancer of zeste homolog 2 (EZH2) and patient survival in various cancers. Methods Relevant literature was retrieved from PubMed and Web of Science databases. Pooled hazard ratios (HRs), odds ratios (ORs), and 95% confidence intervals (CIs) were calculated. Results Forty-nine studies (8,050 patients) were included. High EZH2 expression was significantly associated with shorter overall (hazard ratio [HR] 1.74, 95% CI: 1.46-2.07), disease-free (HR 1.59, 95% CI: 1.27-1.99), metastasis-free (HR 2.19, 95% CI: 1.38-3.47), progression-free (HR 2.53, 95% CI: 1.52-4.21), cancer-specific (HR 3.13, 95% CI: 1.70-5.74), and disease-specific (HR 2.29, 95% CI: 1.56-3.35) survival, but not recurrence-free survival (HR 1.38, 95% CI: 0.93-2.06). Moreover, EZH2 expression significantly correlated with distant metastasis (OR 3.25, 95% CI: 1.07-9.87) in esophageal carcinoma; differentiation (OR 3.00, 95% CI: 1.37-6.55) in non-small cell lung cancer; TNM stage (OR 3.18, 95% CI: 2.49-4.08) in renal cell carcinoma; and histological grade (OR 4.50, 95% CI: 3.33-6.09), estrogen receptor status (OR 0.15, 95% CI: 0.11-0.20) and progesterone receptor status (OR 0.30, 95% CI: 0.23-0.39) in breast cancer. Conclusions Our results suggested that EZH2 might be an independent prognostic factor for multiple survival measures in different cancers.	[Chen, Shuling; Li, Minrui; Li, Manying; Zhong, Bihui; Chen, Minhu; Zhang, Shenghong] Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Lixia] Sun Yat Sen Univ, Affiliated Hosp 1, Div Respirat, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Kaiyu] Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastrointestinal Surg, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Dexi] Sun Yat Sen Univ, Affiliated Hosp 1, Div Cardiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, MH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	chenminhu@vip.163.com; shenghongzhang@163.com	Chen, Shu/Z-2943-2019		Natural Scientific Foundation of Guangdong Province [S2012040007685]; Doctoral Program Foundation of Institutions of Higher Education of China [20120171120090]; National Natural Science Foundation of China [81301769]; Outstanding Youth Talent Supporting Grand of the First Affiliated Hospital of Sun Yat-sen University	Natural Scientific Foundation of Guangdong Province; Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Talent Supporting Grand of the First Affiliated Hospital of Sun Yat-sen University	This work was supported by the Natural Scientific Foundation of Guangdong Province (S2012040007685), Doctoral Program Foundation of Institutions of Higher Education of China (20120171120090), National Natural Science Foundation of China (81301769) and Outstanding Youth Talent Supporting Grand of the First Affiliated Hospital of Sun Yat-sen University for SZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford SH, 2012, BREAST CANCER RES TR, V132, P429, DOI 10.1007/s10549-011-1591-2; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Athanassiadou AM, 2011, ACTA CYTOL, V55, P180, DOI 10.1159/000320790; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behrens C, 2013, CLIN CANCER RES, V19, P6556, DOI 10.1158/1078-0432.CCR-12-3946; Cao W, 2012, CANCER-AM CANCER SOC, V118, P2858, DOI 10.1002/cncr.26575; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Changchien YC, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-216; Choi JH, 2010, APMIS, V118, P196, DOI 10.1111/j.1600-0463.2009.02579.x; Chokunonga E, 2013, INT J CANCER, V133, P721, DOI 10.1002/ijc.28063; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Crea F, 2012, ANN ONCOL, V23, P1207, DOI 10.1093/annonc/mdr387; De Brot M, 2012, PATHOLOGY, V44, P303, DOI 10.1097/PAT.0b013e3283534bcb; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fluge O, 2009, BRIT J CANCER, V101, P1282, DOI 10.1038/sj.bjc.6605333; Gong Y, 2011, CANCER-AM CANCER SOC, V117, P5476, DOI 10.1002/cncr.26179; Guo L, 2014, TUMOR BIOL, V35, P6649, DOI 10.1007/s13277-014-1888-y; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Ha SY, 2012, PATHOL RES PRACT, V208, P462, DOI 10.1016/j.prp.2012.05.012; Hayashi A, 2014, VIRCHOWS ARCH, V464, P463, DOI 10.1007/s00428-014-1541-6; He LR, 2010, INT J CANCER, V127, P138, DOI 10.1002/ijc.25031; He LJ, 2012, ASIAN PAC J CANCER P, V13, P3173, DOI 10.7314/APJCP.2012.13.7.3173; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huqun, 2012, CANCER-AM CANCER SOC, V118, P1599, DOI 10.1002/cncr.26441; Hussein YR, 2012, HUM PATHOL, V43, P1638, DOI 10.1016/j.humpath.2011.12.004; Hwang CF, 2012, INT J RADIAT ONCOL, V82, P597, DOI 10.1016/j.ijrobp.2010.11.062; Kidani K, 2009, ORAL ONCOL, V45, P39, DOI 10.1016/j.oraloncology.2008.03.016; Kikuchi J, 2010, CANCER-AM CANCER SOC, V116, P3015, DOI 10.1002/cncr.25128; Knudsen ES, 2013, CELL CYCLE, V12, P2042, DOI 10.4161/cc.25065; Laitinen S, 2008, INT J CANCER, V122, P595, DOI 10.1002/ijc.23145; Lee HW, 2012, PATHOL INT, V62, P735, DOI 10.1111/pin.12001; Lee H, 2012, HUM PATHOL, V43, P1704, DOI 10.1016/j.humpath.2011.12.019; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Li ZW, 2013, ONCOTARGET, V4, P2532, DOI 10.18632/oncotarget.1503; Liu DC, 2011, PATHOL RES PRACT, V207, P472, DOI 10.1016/j.prp.2011.05.010; Liu L, 2014, BJU INT IN PRESS; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081484; Liu Xiao-dong, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1029; Liu YY, 2014, INT J GYNECOL PATHOL, V33, P218, DOI 10.1097/PGP.0b013e31829c6574; Marchesi I, 2012, CELL CYCLE, V11, P3828, DOI 10.4161/cc.22025; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Mimori K, 2005, EJSO-EUR J SURG ONC, V31, P376, DOI 10.1016/j.ejso.2004.11.001; Nakagawa S, 2013, ANN SURG ONCOL, V20, pS667, DOI 10.1245/s10434-013-3135-y; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Sakurai T, 2012, BIOCHEM BIOPH RES CO, V422, P607, DOI 10.1016/j.bbrc.2012.05.035; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vekony H, 2008, J CLIN PATHOL, V61, P744, DOI 10.1136/jcp.2007.054262; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Wang C, 2013, MOL CARCINOGEN, V52, P229, DOI 10.1002/mc.21848; Wang CG, 2010, WORLD J GASTROENTERO, V16, P2421, DOI 10.3748/wjg.v16.i19.2421; Wang H, 2012, UROL ONCOL-SEMIN ORI, V30, P428, DOI 10.1016/j.urolonc.2010.09.005; Wang Haoran, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P99; Xing XB, 2013, INT J CANCER, V132, P2589, DOI 10.1002/ijc.27947; Xu B, 2013, ARCH PATHOL LAB MED, V137, P1326, DOI 10.5858/arpa.2012-0525-OA; Yamada A, 2011, INT J ONCOL, V38, P345, DOI 10.3892/ijo.2010.868; Yamaga K, 2008, MOL MED REP, V1, P633, DOI 10.3892/mmr_00000004; Yonemitsu Y, 2009, HUM PATHOL, V40, P1304, DOI 10.1016/j.humpath.2009.01.017; Zhou J, 2013, GYNECOL ONCOL, V128, P344, DOI 10.1016/j.ygyno.2012.07.128	65	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125480	10.1371/journal.pone.0125480	http://dx.doi.org/10.1371/journal.pone.0125480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974088	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600017
J	De Pascalis, R; Mittereder, L; Chou, AY; Kennett, NJ; Elkins, KL				De Pascalis, Roberto; Mittereder, Lara; Chou, Alicia Y.; Kennett, Nikki J.; Elkins, Karen L.			Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice	PLOS ONE			English	Article							STRAIN INFECTION; HUMORAL IMMUNITY; ANTIBODIES; TULAREMIA; LVS; IMMUNIZATION; VIRULENCE; LIPOPOLYSACCHARIDE; SUSCEPTIBILITY; IDENTIFICATION	In the last decade several new vaccines against Francisella tularensis, which causes tularemia, have been characterized in animal models. Whereas many of these vaccine candidates showed promise, it remains critical to bridge the preclinical studies to human subjects, ideally by taking advantage of correlates of protection. By combining in vitro intramacrophage LVS replication with gene expression data through multivariate analysis, we previously identified and quantified correlative T cell immune responses that discriminate vaccines of different efficacy. Further, using C57BL/6J mice, we demonstrated that the relative levels of gene expression vary according to vaccination route and between cell types from different organs. Here, we extended our studies to the analysis of T cell functions of BALB/cByJ mice to evaluate whether our approach to identify correlates of protection also applies to a Th2 dominant mouse strain. BALB/cByJ mice had higher survival rates than C57BL/6J mice when they were immunized with suboptimal vaccines and challenged. However, splenocytes derived from differentially vaccinated BALB/cByJ mice controlled LVS intramacrophage replication in vitro in a pattern that reflected the hierarchy of protection observed in C57BL/6J mice. In addition, gene expression of selected potential correlates revealed similar patterns in splenocytes of BALB/cByJ and C57BL/6J mice. The different survival patterns were related to B cell functions, not necessarily to specific antibody production, which played an important protective role in BALB/cByJ mice when vaccinated with suboptimal vaccines. Our studies therefore demonstrate the range of mechanisms that operate in the most common mouse strains used for characterization of vaccines against F. tularensis, and illustrate the complexity necessary to define a comprehensive set of correlates.	[De Pascalis, Roberto; Mittereder, Lara; Chou, Alicia Y.; Kennett, Nikki J.; Elkins, Karen L.] US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	De Pascalis, R (corresponding author), US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	roberto.depascalis@fda.hhs.gov			CBER/FDA (U.S. government)	CBER/FDA (U.S. government)	This work was funded by internal CBER/FDA (U.S. government) operating funds.	Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Cowley SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00026; Crane DD, 2013, J IMMUNOL, V190, P2756, DOI 10.4049/jimmunol.1202697; De Pascalis R, 2014, MBIO, V5, DOI 10.1128/mBio.00936-13; De Pascalis R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002494; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins Karen L, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1425s93; Elkins KL, 1999, INFECT IMMUN, V67, P6002, DOI 10.1128/IAI.67.11.6002-6007.1999; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Fulop M, 2001, VACCINE, V19, P4465, DOI 10.1016/S0264-410X(01)00189-X; Hickey AJ, 2011, VACCINE, V29, P6941, DOI 10.1016/j.vaccine.2011.07.075; Hornick RB, 1966, BACTERIOL REV, V30, P49; Ireland PM, 2011, MICROBIOL-SGM, V157, P3172, DOI 10.1099/mic.0.052902-0; Kirimanjeswara GS, 2007, J IMMUNOL, V179, P532, DOI 10.4049/jimmunol.179.1.532; Klimpel GR, 2008, VACCINE, V26, P6874, DOI 10.1016/j.vaccine.2008.09.077; KOSKELA P, 1982, INFECT IMMUN, V36, P983, DOI 10.1128/IAI.36.3.983-989.1982; KOSKELA P, 1985, J CLIN MICROBIOL, V22, P973, DOI 10.1128/JCM.22.6.973-979.1985; Kubelkova K, 2012, MICROB PATHOGENESIS, V53, P259, DOI 10.1016/j.micpath.2012.07.006; Kurtz SL, 2013, INFECT IMMUN, V81, P585, DOI 10.1128/IAI.01249-12; Lavine CL, 2007, EUR J IMMUNOL, V37, P3007, DOI 10.1002/eji.200737620; Lu Z, 2007, IMMUNOL LETT, V112, P92, DOI 10.1016/j.imlet.2007.07.006; Lu ZH, 2014, CLIN VACCINE IMMUNOL, V21, P227, DOI 10.1128/CVI.00626-13; Mara-Koosham G, 2011, INFECT IMMUN, V79, P1770, DOI 10.1128/IAI.00605-10; Marohn ME, 2013, VACCINE, V31, P3485, DOI 10.1016/j.vaccine.2013.05.096; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Melillo AA, 2014, INFECT IMMUN, V82, P1477, DOI 10.1128/IAI.01545-13; Melillo AA, 2013, J LEUKOCYTE BIOL, V93, P657, DOI 10.1189/jlb.1012485; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; SANDSTORM G, 1994, J CHEM TECHNOL BIOT, V59, P315, DOI 10.1002/jctb.280590402; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Saslaw S, 1961, ARCH INTERN MED, V107, P134, DOI DOI 10.1001/ARCHINTE.1961.03620050068007; Snoy PJ, 2010, VET PATHOL, V47, P774, DOI 10.1177/0300985810372506; TARNVIK A, 1989, REV INFECT DIS, V11, P440; TIGERTT WD, 1962, BACTERIOL REV, V26, P354, DOI 10.1128/MMBR.26.3.354-373.1962; Twine S, 2012, VACCINE, V30, P3634, DOI 10.1016/j.vaccine.2012.03.036; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008; Twine SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010000; WAAG DM, 1995, CLIN DIAGN LAB IMMUN, V2, P143, DOI 10.1128/CDLI.2.2.143-148.1995	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126570	10.1371/journal.pone.0126570	http://dx.doi.org/10.1371/journal.pone.0126570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973794	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600060
J	Dimitrova, DV; Stowe, LA; Hoeks, JCJ				Dimitrova, Diana V.; Stowe, Laurie A.; Hoeks, John C. J.			When Correction Turns Positive: Processing Corrective Prosody in Dutch	PLOS ONE			English	Article							PITCH ACCENTS; LANGUAGE COMPREHENSION; INFORMATION STATUS; H-ASTERISK; P600; POTENTIALS; CONTOURS; WORDS	Current research on spoken language does not provide a consistent picture as to whether prosody, the melody and rhythm of speech, conveys a specific meaning. Perception studies show that English listeners assign meaning to prosodic patterns, and, for instance, associate some accents with contrast, whereas Dutch listeners behave more controversially. In two ERP studies we tested how Dutch listeners process words carrying two types of accents, which either provided new information (new information accents) or corrected information (corrective accents), both in single sentences (experiment 1) and after corrective and new information questions (experiment 2). In both experiments corrective accents elicited a sustained positivity as compared to new information accents, which started earlier in context than in single sentences. The positivity was not modulated by the nature of the preceding question, suggesting that the underlying neural mechanism likely reflects the construction of an interpretation to the accented word, either by identifying an alternative in context or by inferring it when no context is present. Our experimental results provide strong evidence for inferential processes related to prosodic contours in Dutch.	[Dimitrova, Diana V.] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Dimitrova, Diana V.] Radboud Univ Nijmegen, Ctr Language Studies, NL-6525 ED Nijmegen, Netherlands; [Stowe, Laurie A.; Hoeks, John C. J.] Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands; [Stowe, Laurie A.; Hoeks, John C. J.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; University of Groningen	Dimitrova, DV (corresponding author), Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	d.dimitrova@donders.ru.nl		Hoeks, John/0000-0002-6874-1126	Centre for Language and Cognition Groningen	Centre for Language and Cognition Groningen	This work has been supported by an Ubbo Emmius PhD Grant awarded to Diana Dimitrova by the Centre for Language and Cognition Groningen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann S, 2012, LANG SPEECH, V55, P361, DOI 10.1177/0023830911422184; Beckman M. E., 1997, OSU RES FDN; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Braun B, 2010, LANG COGNITIVE PROC, V25, P1024, DOI 10.1080/01690960903036836; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Cutler A, 1977, 13 REG M CHIC LING S, P104; Dennison HY, 2010, P SPEECH PROS; Dimitrova DV, 2012, J COGNITIVE NEUROSCI, V24, P2400, DOI 10.1162/jocn_a_00302; Dimitrova DV, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P999; Fraundorf SH, 2010, J MEM LANG, V63, P367, DOI 10.1016/j.jml.2010.06.004; Friedrich CK, 2001, NEUROREPORT, V12, P3189, DOI 10.1097/00001756-200110290-00009; Frisch S, 2002, COGNITION, V85, pB83, DOI 10.1016/S0010-0277(02)00126-9; Gotzner N, 2013, 35 ANN M COGN SCI SO; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Gussenhoven C, 1997, J ACOUST SOC AM, V102, P3009, DOI 10.1121/1.420355; Gussenhoven C, 2000, LANG SPEECH, V43, P183, DOI 10.1177/00238309000430020301; Gussenhoven C., 2005, PROSODIC TYPOLOGY PH, P118, DOI [10.1093/acprof:oso/9780199249633.003.0005, DOI 10.1093/ACPROF:OSO/9780199249633.003.0005]; Hanssen J, 2008, P SPEECH PROS; Heim S, 2006, ACTA NEUROBIOL EXP, V66, P55; Hoeks J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073549, DOI 10.1371/JOURNAL.PONE.0073549]; Hoeks J., 2014, OXFORD HDB LANGUAGE, P365, DOI [DOI 10.1093/OXFORDHB/9780199838639.013.024, 10.1093/oxfordhb/9780199838639.013.024]; Hoeks JCJ, 2004, COGNITIVE BRAIN RES, V19, P59, DOI 10.1016/j.cogbrainres.2003.10.022; Hruska C., 2004, INFORM STRUCTURE THE, P211, DOI DOI 10.1515/9783110905892.211; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Krahmer E, 2002, SPEECH COMMUN, V36, P133, DOI 10.1016/S0167-6393(01)00030-9; Krahmer E, 1999, ETRW DIALOGUE PROSOD; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Ladd DR, 2000, J ACOUST SOC AM, V107, P2685, DOI 10.1121/1.428654; Magne C, 2005, J COGNITIVE NEUROSCI, V17, P740, DOI 10.1162/0898929053747667; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; NAATANEN R, 1995, EAR HEARING, V16, P6; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; OSTERHOUT L, 1993, LANG COGNITIVE PROC, V8, P413, DOI 10.1080/01690969308407584; PIERREHUMBERT J, 1990, SYS DEV FDN, P271; Pierrehumbert J., 1980, THESIS MASSACHUSETTS; Schumacher PB, 2010, NEUROREPORT, V21, P618, DOI 10.1097/WNR.0b013e328339874a; Sedivy JC, 2002, J MEM LANG, V46, P341, DOI 10.1006/jmla.2001.2812; Selkirk E, 2002, P SPEECH PROS; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; Steube A, 2001, THEOR LINGUIST, V27, P215, DOI 10.1515/thli.2001.27.2-3.215; Swerts M, 2002, J PHONETICS, V30, P629, DOI 10.1006/jpho.2002.0178; Swerts M, 2001, P EUR, P383; Swerts M., 2000, P INT C SPOK LANG PR; Toepel U, 2005, MPI SERIES, V66; Umbach Carla., 2004, J SEMANT, V21, P1; van Leeuwen TM, 2014, NEUROPSYCHOLOGIA, V58, P64, DOI 10.1016/j.neuropsychologia.2014.03.017; Wang L, 2011, NEUROPSYCHOLOGIA, V49, P813, DOI 10.1016/j.neuropsychologia.2010.12.035; Watson DG, 2008, COGNITIVE SCI, V32, P1232, DOI 10.1080/03640210802138755; Weber A, 2006, LANG SPEECH, V49, P367, DOI 10.1177/00238309060490030301; Zimmermann M, 2011, LINGUA, V121, P1651, DOI 10.1016/j.lingua.2011.06.002	52	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126299	10.1371/journal.pone.0126299	http://dx.doi.org/10.1371/journal.pone.0126299			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CI2AC	25973607	gold, Green Published			2022-12-27	WOS:000354545600046
J	Kelly, MS; Smieja, M; Luinstra, K; Wirth, KE; Goldfarb, DM; Steenhoff, AP; Arscott-Mills, T; Cunningham, CK; Boiditswe, S; Sethomo, W; Shah, SS; Finalle, R; Feemster, KA				Kelly, Matthew S.; Smieja, Marek; Luinstra, Kathy; Wirth, Kathleen E.; Goldfarb, David M.; Steenhoff, Andrew P.; Arscott-Mills, Tonya; Cunningham, Coleen K.; Boiditswe, Sefelani; Sethomo, Warona; Shah, Samir S.; Finalle, Rodney; Feemster, Kristen A.			Association of Respiratory Viruses with Outcomes of Severe Childhood Pneumonia in Botswana	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; HOSPITALIZED CHILDREN; TRACT INFECTIONS; VIRAL ETIOLOGY; SOUTH-AFRICA; INFANTS; MULTICENTER; FAILURE	Background The highest incidence of childhood acute lower respiratory tract infection (ALRI) is in lowand middle-income countries. Few studies examined whether detection of respiratory viruses predicts ALRI outcomes in these settings. Methods We conducted prospective cohort and case-control studies of children 1-23 months of age in Botswana. Cases met clinical criteria for pneumonia and were recruited within six hours of presentation to a referral hospital. Controls were children without pneumonia matched to cases by primary care clinic and date of enrollment. Nasopharyngeal specimens were tested for respiratory viruses using polymerase chain reaction. We compared detection rates of specific viruses in matched case-control pairs. We examined the effect of respiratory syncytial virus (RSV) and other respiratory viruses on pneumonia outcomes. Results Between April 2012 and August 2014, we enrolled 310 cases, of which 133 had matched controls. Median ages of cases and controls were 6.1 and 6.4 months, respectively. One or more viruses were detected from 75% of cases and 34% of controls. RSV and human metapneumovirus were more frequent among cases than controls, but only enterovirus/rhinovirus was detected from asymptomatic controls. Compared with non-RSV viruses, RSV was associated with an increased risk of treatment failure at 48 hours [risk ratio (RR): 1.85; 95% confidence interval (CI): 1.20, 2.84], more days of respiratory support [mean difference (MD): 1.26 days; 95% CI: 0.30, 2.22 days], and longer duration of hospitalization [MD: 1.35 days; 95% CI: 0.20, 2.50 days], but lower in-hospital mortality [RR: 0.09; 95% CI: 0.01, 0.80] in children with pneumonia. Conclusions Respiratory viruses were detected from most children hospitalized with ALRI in Botswana, but only RSV and human metapneumovirus were more frequent than among children without ALRI. Detection of RSV from children with ALRI predicted a protracted illness course but lower mortality compared with non-RSV viruses.	[Kelly, Matthew S.; Goldfarb, David M.; Steenhoff, Andrew P.; Arscott-Mills, Tonya; Boiditswe, Sefelani] Botswana UPenn Partnership, Gaborone, Botswana; [Kelly, Matthew S.; Steenhoff, Andrew P.; Finalle, Rodney; Feemster, Kristen A.] Childrens Hosp Philadelphia, Global Hlth Ctr, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.; Feemster, Kristen A.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Kelly, Matthew S.; Cunningham, Coleen K.] Duke Univ, Med Ctr, Div Pediat Infect Dis, Durham, NC USA; [Smieja, Marek; Luinstra, Kathy; Goldfarb, David M.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Wirth, Kathleen E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Steenhoff, Andrew P.; Arscott-Mills, Tonya; Finalle, Rodney; Feemster, Kristen A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Goldfarb, David M.; Sethomo, Warona] Univ Botswana, Sch Med, Gaborone, Botswana; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Div Hosp Med & Infect Dis, Cincinnati, OH 45229 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; McMaster University; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Botswana; Cincinnati Children's Hospital Medical Center	Kelly, MS (corresponding author), Botswana UPenn Partnership, Gaborone, Botswana.	matthew.kelly@duke.edu	Goldfarb, David/ABD-4623-2021	Goldfarb, David/0000-0003-0835-9504; Wirth, Kathleen/0000-0002-7468-851X	Early Career Award from the Thrasher Research Fund; Children's Hospital of Philadelphia; Pincus Family Foundation; Penn Center for AIDS Research; NIH [P30-AI045008]; CIPHER grant from the International AIDS Society; ViiV Healthcare; National Institutes of Health [T32 HD060558]; Duke Center for AIDS Research [P30-AI064518]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020939] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, P30AI045008] Funding Source: NIH RePORTER	Early Career Award from the Thrasher Research Fund; Children's Hospital of Philadelphia; Pincus Family Foundation; Penn Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIPHER grant from the International AIDS Society; ViiV Healthcare; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Center for AIDS Research; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by an Early Career Award from the Thrasher Research Fund (to MSK), by the Children's Hospital of Philadelphia (to APS and KAF) and Pincus Family Foundation, and through core services and support from the Penn Center for AIDS Research, an NIH-funded program (P30-AI045008). Funding for this project was also made possible in part by a CIPHER grant from the International AIDS Society, supported by ViiV Healthcare. The views expressed in this publication do not necessarily reflect the official policies of the International AIDS Society or ViiV Healthcare. MSK received financial support from a National Institutes of Health training grant (T32 HD060558), and CKC was supported through the Duke Center for AIDS Research (P30-AI064518).	Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; da Silva ER, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-41; Falkenstein-Hagander K, 2014, ACTA PAEDIATR, V103, P625, DOI 10.1111/apa.12623; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jartti T, 2013, PAEDIATR RESPIR REV, V14, P38, DOI 10.1016/j.prrv.2012.04.002; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Kelly MS, J PEDIAT INFECT DIS; Levin D, 2010, PEDIATR CRIT CARE ME, V11, P390, DOI 10.1097/PCC.0b013e3181b809c5; Luchsinger V, 2014, J CLIN VIROLOGY OFFI; Garcia-Garcia ML, 2012, PEDIATR INFECT DIS J, V31, P808, DOI 10.1097/INF.0b013e3182568c67; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Mahony JB, 2009, J CLIN MICROBIOL, V47, P2812, DOI 10.1128/JCM.00556-09; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Mathisen M, 2011, PEDIATR INFECT DIS J, V30, P1032, DOI 10.1097/INF.0b013e31822f845f; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Oosterheert JJ, 2005, CLIN INFECT DIS, V41, P1438, DOI 10.1086/497134; Ouedraogo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110435; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Purcell K, 2002, ARCH PEDIAT ADOL MED, V156, P322, DOI 10.1001/archpedi.156.4.322; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Schulert Grant S, 2014, Hosp Pediatr, V4, P372, DOI 10.1542/hpeds.2014-0018; Schulert GS, 2013, PEDIATR INFECT DIS J, V32, P467, DOI 10.1097/INF.0b013e318284b146; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Tchetgen ET, 2013, INT J BIOSTAT, V9, P251, DOI 10.1515/ijb-2013-0007; The United Nations Joint Programme on HIV/AIDS, 2014, BOTSW GLOB AIDS REP; Venter M, 2011, J MED VIROL, V83, P1458, DOI 10.1002/jmv.22120; Webb C, 2012, PEDIATR INFECT DIS J, V31, pE152, DOI 10.1097/INF.0b013e3182638012; Wishaupt JO, 2011, PEDIATRICS, V128, pE1113, DOI 10.1542/peds.2010-2779; World Health Organization, BOTSW COUNTR PROF; World Health Organization, 2013, POCK BOOK HOSP CAR C	35	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126593	10.1371/journal.pone.0126593	http://dx.doi.org/10.1371/journal.pone.0126593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973924	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600063
J	Li, PP; Qiu, TM; Qin, C				Li, Pingping; Qiu, Tangmeng; Qin, Chao			Efficacy of Acupuncture for Bell's Palsy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							POLYMERASE-CHAIN-REACTION; HERPES-SIMPLEX-VIRUS; DNA	Acupuncture has emerged as an alternative therapy for Bell's palsy in both adults and children. However, the use of acupuncture is controversial. We conducted a systematic review and meta-analysis to assess the efficacy of acupuncture for Bell's palsy. We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials, irrespective of any language restrictions. Randomized controlled trials comparing acupuncture with other therapies for Bell's palsy in adults or children were included. Fourteen randomized controlled trials involving 1541 individuals were included in this meta-analysis. Significant association was observed in acupuncture with a higher effective response rate for Bell's palsy (relative risk, 1.14; 95% confidence interval, 1.04-1.25; P = 0.005) but there was a heterogeneity among the studies (I-2 = 87%). An assessment of the included studies revealed a high risk of bias in methodological quality. An evaluation of the incidence of complications was not available, owing to incomplete data. Acupuncture seems to be an effective therapy for Bell's palsy, but there was insufficient evidence to support the efficacy and safety of acupuncture. However, the results should be interpreted cautiously, because of the poor quality and heterogeneity of the included studies.	[Li, Pingping; Qiu, Tangmeng; Qin, Chao] Guangxi Med Univ, Affiliated Hosp 1, Dept Neurol, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Qin, C (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Neurol, Nanning, Guangxi, Peoples R China.	qc6699@yeah.net	Li, Ping/GYV-4914-2022					ADOUR KK, 1975, JAMA-J AM MED ASSOC, V233, P527, DOI 10.1001/jama.233.6.527; Ahn CB, 2011, J ACUPUNCT MERIDIAN, V4, P29, DOI 10.1016/S2005-2901(11)60005-8; [Anonymous], 2007, J SICHUAN TRADIT CHI, P109; [Anonymous], 2005, CHINESE J REHABILITA, V11, P1037; [Anonymous], 2004, J CLIN ACUPUNCTURE M, V20, P26; [Anonymous], 2009, ZHEJIANG J TRADIT CH, P444; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BURGESS LPA, 1984, LARYNGOSCOPE, V94, P1472; Chen Ning, 2010, Cochrane Database Syst Rev, pCD002914, DOI 10.1002/14651858.CD002914.pub5; Chen XQ, 2009, CONTEMP CLIN TRIALS, V30, P347, DOI 10.1016/j.cct.2009.02.006; Cumberworth A, 2012, INT J SURG, V10, P310, DOI 10.1016/j.ijsu.2012.04.019; Du LZ, 2013, WORLD J ACUPUNCTURE, P42; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fu Xiao-hu, 2007, Zhongguo Zhen Jiu, V27, P494; Furuta Y, 1997, J MED VIROL, V52, P316, DOI 10.1002/(SICI)1096-9071(199707)52:3&lt;316::AID-JMV13&gt;3.0.CO;2-G; Gilden DH, 2004, NEW ENGL J MED, V351, P1323, DOI 10.1056/NEJMcp041120; Grogan PM, 2001, NEUROLOGY, V56, P830, DOI 10.1212/WNL.56.7.830; Harwood-Nuss A, 2009, HARWOOD NUSS CLIN PR; HAUSER WA, 1971, MAYO CLIN PROC, V46, P258; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Holland NJ, 2004, BMJ-BRIT MED J, V329, P553, DOI 10.1136/bmj.329.7465.553; Jiangping L., 2005, CHINESE CLIN MED RES, V11, P1715; Kim JI, 2012, CHIN J INTEGR MED, V18, P48, DOI 10.1007/s11655-011-0861-5; Kwon HJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-71; Lee Cham Kyul, 2013, Journal of Acupuncture Research, V30, P51, DOI 10.13045/acupunct.2013005; Li J, 2005, CHINESE CLIN MED RES, P1715; Li Y, 2004, CHINESE MED J-PEKING, V117, P1502; Li Y, 2011, ZHONGGUO ZHEN JIU, P289; Li Y, 2011, WOODHEAD PUBL MATER, P1; Liang Fanrong, 2006, J Tradit Chin Med, V26, P3; Liu Li-An, 2012, Zhongguo Zhen Jiu, V32, P587; Liu M., 1996, J CLIN ACUPUNCT MOXI, P56; Ma Z, 2004, SNANGHAI J ACUPUNCTU, P19; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morris AM, 2002, NEUROEPIDEMIOLOGY, V21, P255, DOI 10.1159/000065645; Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005; PEITERSEN E, 1982, AM J OTOL, V4, P107; Qi Qi-Hua, 2013, Zhongguo Zhen Jiu, V33, P965; Qu Yong, 2005, Zhongguo Zhen Jiu, V25, P545; Reheman Ainiwan, 2009, Zhongguo Zhen Jiu, V29, P17; Schirm J, 1997, APMIS, V105, P815, DOI 10.1111/j.1699-0463.1997.tb05089.x; Shannon S, 2003, J FAM PRACTICE, V52, P156; Shao SF, 1999, NEW MED, P16; Stjernquist-Desatnik A, 2006, ANN OTO RHINOL LARYN, V115, P306, DOI 10.1177/000348940611500410; Teixeira LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006283.pub3; Theil D, 2001, BRAIN PATHOL, V11, P408, DOI 10.1111/j.1750-3639.2001.tb00408.x; Tong FM, 2009, ACUPUNCT MED, V27, P169, DOI 10.1136/aim.2009.000638; Uchino K, 2013, ANN INTERN MED, V159, DOI 10.7326/0003-4819-159-10-201311190-02008; Wang HW, 2013, ZHONGGUO ZHEN JIU, P306; White A, 2001, BRIT MED J, V323, P485, DOI 10.1136/bmj.323.7311.485; Wong XH ZL, 2004, ZHONGHUA LINCHUANG K, V8, P616; Xia Feng, 2011, Trials, V12, P158, DOI 10.1186/1745-6215-12-158; Xu SB, 2013, CAN MED ASSOC J, V185, P473, DOI 10.1503/cmaj.121108; Xuan LH WL, 2007, CHIN J TRADIT MED SC, P6; Yang C, 2006, SCI TECH INFO GANSU, V35, P240; Yang G, 2001, J ACUPUNCTURE MOXIBU, P28; Yang SB, 2012, ZHONGGUO ZHEN JIU, P21; Yang SB, 2013, WORLD J ACUPUNCTURE, P15; Yu Y., 1999, SHANGHAI J ACUPUNCTU, P26; Zhang CY, 2011, ZHEN CI YAN JIU, P433; Zhao JP, 2010, J TRADIT CHIN MED, V30, P118, DOI 10.1016/S0254-6272(10)60026-X; Zhao Y, 2005, CHINESE J CLIN REHAB, P41; Zhou M, 2009, J ALTERN COMPLEM MED, V15, P759, DOI 10.1089/acm.2008.0179; Zhu HQ, 2004, CHINESE J PAIN MED; Zhu L., 2006, SHANGHAI J ACUPUNCT, V25, P17	66	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0121880	10.1371/journal.pone.0121880	http://dx.doi.org/10.1371/journal.pone.0121880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974022	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600005
J	Zhang, Q; Zhu, F; Liu, L; Zheng, CW; Wang, DH; Hou, ZC; Ning, ZH				Zhang, Quan; Zhu, Feng; Liu, Long; Zheng, Chuan Wei; Wang, De He; Hou, Zhuo Cheng; Ning, Zhong Hua			Integrating Transcriptome and Genome Re-Sequencing Data to Identify Key Genes and Mutations Affecting Chicken Eggshell Qualities	PLOS ONE			English	Article							UTERINE FLUID; ORGANIC MATRIX; AVIAN EGGSHELL; SHELL GLAND; FUNCTIONAL-CHARACTERIZATION; PROTEIN; EGG; TRAITS; MINERALIZATION; IDENTIFICATION	Eggshell damages lead to economic losses in the egg production industry and are a threat to human health. We examined 49-wk-old Rhode Island White hens (Gallus gallus) that laid eggs having shells with significantly different strengths and thicknesses. We used HiSeq 2000 (Illumina) sequencing to characterize the chicken transcriptome and whole genome to identify the key genes and genetic mutations associated with eggshell calcification. We identified a total of 14,234 genes expressed in the chicken uterus, representing 89% of all annotated chicken genes. A total of 889 differentially expressed genes were identified by comparing low eggshell strength (LES) and normal eggshell strength (NES) genomes. The DEGs are enriched in calcification-related processes, including calcium ion transport and calcium signaling pathways as reveled by gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis. Some important matrix proteins, such as OC-116, LTF and SPP1, were also expressed differentially between two groups. A total of 3,671,919 single-nucleotide polymorphisms (SNPs) and 508,035 Indels were detected in protein coding genes by whole-genome re-sequencing, including 1775 non-synonymous variations and 19 frame-shift Indels in DEGs. SNPs and Indels found in this study could be further investigated for eggshell traits. This is the first report to integrate the transcriptome and genome re-sequencing to target the genetic variations which decreased the eggshell qualities. These findings further advance our understanding of eggshell calcification in the chicken uterus.	[Hou, Zhuo Cheng] China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China; China Agr Univ, Minist Agr, Dept Anim Genet & Breeding, Key Lab Anim Genet & Breeding, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Hou, ZC (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.	zchou@cau.edu.cn; ningzhh@cau.edu.cn		Zhang, Quan/0000-0002-6123-9512	Chinese Agricultural Research System [CARS-41]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; Fundamental Research Funds for the Central Universities [2011JS003]; National Scientific Supporting Projects of China [2011BAD28B03]	Chinese Agricultural Research System; Program for Changjiang Scholar and Innovation Research Team in University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Scientific Supporting Projects of China	This work was supported by the Chinese Agricultural Research System (CARS-41), Program for Changjiang Scholar and Innovation Research Team in University (IRT1191), the Fundamental Research Funds for the Central Universities (2011JS003) and the National Scientific Supporting Projects of China (2011BAD28B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ARAD Z, 1989, AM J PHYSIOL, V257, pR732, DOI 10.1152/ajpregu.1989.257.4.R732; ARIAS JL, 1993, INT REV CYTOL, V145, P217, DOI 10.1016/S0074-7696(08)60428-3; Bar A, 2009, J POULT SCI, V46, P267, DOI 10.2141/jpsa.46.267; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Britton FC, 2005, J BIOL CHEM, V280, P25871, DOI 10.1074/jbc.M502826200; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chitwood JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-350; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Dunn IC, 2009, GEN COMP ENDOCR, V163, P225, DOI 10.1016/j.ygcen.2009.03.006; Dunn IC, 2009, ANIM GENET, V40, P110, DOI 10.1111/j.1365-2052.2008.01794.x; EDWARDS NA, 1977, BRIT POULTRY SCI, V18, P641, DOI 10.1080/00071667708416415; ELJACK MH, 1967, J REPROD FERTIL, V13, P127, DOI 10.1530/jrf.0.0130127; Fan WL, 2013, GENOME BIOL EVOL, V5, P1376, DOI 10.1093/gbe/evt097; Fan YF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-90; Gautron J, 2001, CONNECT TISSUE RES, V42, P255, DOI 10.3109/03008200109016840; Gautron J, 2001, J BIOL CHEM, V276, P39243, DOI 10.1074/jbc.M104543200; Gautron J, 1997, CONNECT TISSUE RES, V36, P195, DOI 10.3109/03008209709160220; HIMPENS B, 1995, J VASC RES, V32, P207, DOI 10.1159/000159095; Hincke MT, 2008, J HISTOCHEM CYTOCHEM, V56, P467, DOI 10.1369/jhc.2008.950576; Hincke MT, 1999, J BIOL CHEM, V274, P32915, DOI 10.1074/jbc.274.46.32915; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZM, 2009, J MOL CELL CARDIOL, V47, P121, DOI 10.1016/j.yjmcc.2009.04.008; Jonchere Vincent, 2012, BMC Physiology, V12, P10, DOI 10.1186/1472-6793-12-10; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Laiho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061558; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann K, 2002, MATRIX BIOL, V21, P383, DOI 10.1016/S0945-053X(02)00031-8; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MONGIN P, 1970, CR ACAD SCI D NAT, V270, P1715; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakada T, 1990, JAPANESE POULTRY SCI, P27; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Nys Y, 1999, POULT AVIAN BIOL REV, V10, P143; NYS Y, 1991, POULTRY SCI, V70, P1236, DOI 10.3382/ps.0701236; Nys Y, 2011, IMPROVING THE SAFETY; Panheleux M, 1999, BRIT POULTRY SCI, V40, P632, DOI 10.1080/00071669987025; Panheleux M, 1999, BRIT POULTRY SCI, V40, P240, DOI 10.1080/00071669987665; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Sasaki O, 2004, ANIM GENET, V35, P188, DOI 10.1111/j.1365-2052.2004.01133.x; SAUVEUR B, 1971, ANN BIOL ANIM BIOCH, V11, P213, DOI 10.1051/rnd:19710203; Sauveur B, 1988, POULTRY REPRODUCTION, VXXI; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Solomon SE, 1997, EGG EGGSHELL QUALITY, V1st; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vetter AE, 2005, J EXP BIOL, V208, P479, DOI 10.1242/jeb.01409; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD438, DOI 10.1093/nar/gki092; Wang XQ, 2010, J PHYS CHEM B, V114, P5301, DOI 10.1021/jp1008237; Wardecka Barbara, 2002, Journal of Applied Genetics, V43, P319; Wright D, 2006, ANIM GENET, V37, P529, DOI 10.1111/j.1365-2052.2006.01515.x; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Yao JF, 2010, POULTRY SCI, V89, P883, DOI 10.3382/ps.2009-00613; Zhang Y, 2011, POULTRY SCI, V90, P2718, DOI 10.3382/ps.2011-01751	62	22	25	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125890	10.1371/journal.pone.0125890	http://dx.doi.org/10.1371/journal.pone.0125890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974068	gold, Green Submitted, Green Published			2022-12-27	WOS:000354545600030
J	Zhao, YH; Zhang, K; Li, GQ; Zhang, XY; Shi, DL				Zhao, Yinghao; Zhang, Kun; Li, Guangquan; Zhang, Xingyi; Shi, Donglei			Expression of GITR Enhances Multiple Myeloma Cell Sensitivity to Bortezomib	PLOS ONE			English	Article							NEUROBLASTOMA; APOPTOSIS; DELETION; 1P36	Recently tumor necrosis factor receptor super family member 18 (TNFRSF18, also called GITR) has been identified as a novel tumor suppressor gene in Multiple Myeloma (MM), undergoing aberrant DNA methylation-mediated gene expression silencing. Furthermore, the expression of GITR blocks canonical NF-kappa B activation in MM cells in response to TNF alpha. Bortezomib, a proteasome inhibitor, can induce NF-kappa B activation, which may significantly influence the drug response in MM patients. In this study, we aim to elucidate if GITR status is associated with response to Bortezomib in MM cells through regulating GITR mediated NF-kappa B blockade. We found that GITR was significantly downregulated in MM patients and cell lines. Overexpression of GITR inhibited non-canonical NF-kappa B activation induced by TNF alpha. Moreover, NF-kappa B inhibitor induced apoptosis in GITR-deficient MM cells in response to TNF alpha. In addition, overexpression of GITR could inhibit Bortezomib-induced NF-kappa B activation and enhance the cytotoxicity of Bortezomib in GITR-deficient MM cell line (MM1.S). In contrast, knockdown of GITR attenuated the cytotoxic effect of Bortezomib on GITR proficient MM (RPMI) cell line and increased NF-kappa B activation. Finally, overexpression of GITR enhanced the sensitivity to Bortezomib in co-culture with bone marrow stromal cells and significantly reduced the tumor growth in MM1.S xenograft mice. In conclusion, we demonstrated that GITR expression can enhance the sensitivity to Bortezomib by inhibiting Bortezomib-induced NF-kappa B activation.	[Zhao, Yinghao; Zhang, Xingyi; Shi, Donglei] Jilin Univ, Hosp 2, Dept Thorac Surg, Changchun 130023, Peoples R China; [Zhang, Kun; Li, Guangquan] Jilin Univ, Hosp 2, Centralab, Changchun 130023, Peoples R China	Jilin University; Jilin University	Shi, DL (corresponding author), Jilin Univ, Hosp 2, Dept Thorac Surg, Changchun 130023, Peoples R China.	dongleis@hotmail.com			National Natural Science Foundation of China [NSFC81272472]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China grant NSFC81272472. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059756; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; BIEGEL JA, 1993, AM J HUM GENET, V52, P176; Collette Y, 2003, TRENDS IMMUNOL, V24, P387, DOI 10.1016/S1471-4906(03)00166-2; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Fabre C, 2012, CLIN CANCER RES, V18, P4669, DOI 10.1158/1078-0432.CCR-12-0779; Feinman Rena, 2004, Clin Adv Hematol Oncol, V2, P162; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Jia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032584; Katzenberger T, 2009, BLOOD, V113, P1053, DOI 10.1182/blood-2008-07-168682; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066982; Maiso P, 2011, BLOOD, V118, P6860, DOI 10.1182/blood-2011-03-342394; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Nomoto S, 2000, GENE CHROMOSOME CANC, V28, P342, DOI 10.1002/1098-2264(200007)28:3<342::AID-GCC13>3.0.CO;2-A; Piperdi B, 2011, MOL CANCER THER, V10, P2029, DOI 10.1158/1535-7163.MCT-11-0745; Poetsch M, 2002, ONCOGENE, V21, P3038, DOI 10.1038/sj.onc.1205457; Rapino F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.440; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Schreiber TH, 2012, J IMMUNOL, V189, P3311, DOI 10.4049/jimmunol.1200597; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Xing SS, 2014, BIOCHEM BIOPH RES CO, V445, P375, DOI 10.1016/j.bbrc.2014.02.008	23	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127334	10.1371/journal.pone.0127334	http://dx.doi.org/10.1371/journal.pone.0127334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973846	Green Submitted, gold, Green Published			2022-12-27	WOS:000354545600109
J	Cheseto, X; Kuate, SP; Tchouassi, DP; Ndung'u, M; Teal, PEA; Torto, B				Cheseto, Xavier; Kuate, Serge Philibert; Tchouassi, David P.; Ndung'u, Mary; Teal, Peter E. A.; Torto, Baldwyn			Potential of the Desert Locust Schistocerca gregaria (Orthoptera: Acrididae) as an Unconventional Source of Dietary and Therapeutic Sterols	PLOS ONE			English	Article							PLANT STEROLS; BIOSYNTHESIS; METABOLISM; INSECTS; GRASSHOPPER; MECHANISMS; NUTRITION; ECDYSONE; ENZYMES	Insects are increasingly being recognized not only as a source of food to feed the ever growing world population but also as potential sources of new products and therapeutic agents, among which are sterols. In this study, we sought to profile sterols and their derivatives present in the desert locust, Schistocerca gregaria, focusing on those with potential importance as dietary and therapeutic components for humans. Using coupled gas chromatography-mass spectrometry (GC-MS), we analyzed and compared the quantities of sterols in the different sections of the gut and tissues of the locust. In the gut, we identified 34 sterols which showed a patchy distribution, but with the highest composition in the foregut (55%) followed by midgut (31%) and hindgut (14%). Fed ad libitum on wheat seedlings, five sterols unique to the insect were detected. These sterols were identified as 7-dehydrocholesterol, desmosterol, fucosterol, (3 beta, 5 alpha) cholesta-8, 14, 24-trien-3-ol, 4, 4-dimethyl, and (3 beta, 20R) cholesta-5, 24-dien-3, 20-diol with the first three having known health benefits in humans. Incubation of the fore-, mid- and hindgut with cholesterol-[4-C-13] yielded eight derivatives, three of these were detected in the gut of the desert locust after it had consumed the vegetative diet but were not detected in the diet. Our study shows that the desert locust ingests phytosterols from a vegetative diet and, amplifies and metabolizes them into derivatives with potential salutary benefits and we discuss our findings in this context.	[Cheseto, Xavier; Kuate, Serge Philibert; Tchouassi, David P.; Torto, Baldwyn] Int Ctr Insect Physiol & Ecol Icipe, Behav & Chem Ecol Dept, Nairobi, Kenya; [Cheseto, Xavier; Ndung'u, Mary] Jomo Kenyatta Univ Agr & Technol, Dept Chem, Nairobi, Kenya; [Teal, Peter E. A.] USDA ARS, Chem Res Unit, Ctr Med Agr & Vet Entomol, Gainesville, FL USA	International Centre of Insect Physiology & Ecology (ICIPE); Jomo Kenyatta University of Agriculture & Technology; United States Department of Agriculture (USDA)	Torto, B (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, Behav & Chem Ecol Dept, Nairobi, Kenya.	btorto@icipe.org		Cheseto, Xavier/0000-0002-9779-0357	icipe-Dissertation Research Internship Program (DRIP); USDA/ARS-CMAVE	icipe-Dissertation Research Internship Program (DRIP); USDA/ARS-CMAVE	Support from icipe-Dissertation Research Internship Program (DRIP) and USDA/ARS-CMAVE is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANG ENV STAT COMP; Behmer ST, 2011, FUNCT ECOL, V25, P484, DOI 10.1111/j.1365-2435.2010.01810.x; Behmer ST, 1999, ARCH INSECT BIOCHEM, V42, P13, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;13::AID-ARCH3&gt;3.0.CO;2-P; Behmer ST, 2003, ADV INSECT PHYSIOL, V31, P1, DOI 10.1016/S0065-2806(03)31001-X; BLASQUEZ JRE, 2012, FOOD NUTR SCI, V3, P164, DOI DOI 10.4236/FNS.2012.32025; Briscoe J, 2005, DEV CELL, V8, P143, DOI 10.1016/j.devcel.2005.01.008; Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343; CAMPBELL BC, 1983, J INSECT PHYSIOL, V29, P149, DOI 10.1016/0022-1910(83)90138-5; Chakravorty J, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-5; CHERBAS L, 1970, BIOL BULL, V138, P115, DOI 10.2307/1540196; Dettner K., 1997, V130, P337; FAO, 2015, WORLD AGR 2015 2030; FAO, 2014, DES LOC SIT UPD; FAO, 2012, DES LOC SAH, P4; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; GRIENEISEN ML, 1994, INSECT BIOCHEM MOLEC, V24, P115, DOI 10.1016/0965-1748(94)90078-7; GUO DA, 1995, LIPIDS, V30, P203, DOI 10.1007/BF02537823; Heupel RC, 1989, ANAL STEROLS OTHER B, P1; HINKS CF, 1986, ENTOMOL EXP APPL, V42, P39, DOI 10.1007/BF00186156; Illgner P, 2000, GEOGR J, V166, P336, DOI 10.1111/j.1475-4959.2000.tb00035.x; KAPPLER C, 1988, J STEROID BIOCHEM, V31, P891, DOI 10.1016/0022-4731(88)90330-5; Loizou S, 2010, MOL NUTR FOOD RES, V54, P551, DOI 10.1002/mnfr.200900012; Marinangeli CPF, 2006, J NUTR BIOCHEM, V17, P217, DOI 10.1016/j.jnutbio.2005.09.003; Ochieng-Odero JPR, 1994, EFFECTIVE NETWORKING, P33; OLFERT O, 1990, Journal of Agricultural Entomology, V7, P275; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Patel MD, 2006, ATHEROSCLEROSIS, V186, P12, DOI 10.1016/j.atherosclerosis.2005.10.026; Patterson GW, 1994, PHYLOGENETIC DISTRIB, P5; Pemberton RW, 1999, J ETHNOPHARMACOL, V65, P207, DOI 10.1016/S0378-8741(98)00209-8; Piironen V, 2000, J SCI FOOD AGR, V80, P939, DOI [10.1002/(SICI)1097-0010(20000515)80:7<939::AID-JSFA644>3.0.CO;2-C, 10.1002/(SICI)1097-0010(20000515)80:7&lt;939::AID-JSFA644&gt;3.0.CO;2-C]; Pinstrup-Andersen P, 2002, AM J AGR ECON, V84, P1201, DOI 10.1111/1467-8276.00381; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Svoboda JA, 1999, CRIT REV BIOCHEM MOL, V34, P49, DOI 10.1080/10409239991209183; Svoboda JA, 1994, EVOLUTIONARY ASPECTS, P126; Thompson SN, 1999, ANNU REV ENTOMOL, V44, P561, DOI 10.1146/annurev.ento.44.1.561; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; Uvarov B, 1966, HDB GEN ACRIDOLOGY; van Huis A, 2011, ANNU REV ENTOMOL, V58, P563; WEIRICH GF, 1984, ARCH INSECT BIOCHEM, V1, P311, DOI 10.1002/arch.940010403; Woyengo TA, 2009, EUR J CLIN NUTR, V63, P813, DOI 10.1038/ejcn.2009.29; YhoungAree J, 1997, ECOL FOOD NUTR, V36, P133, DOI 10.1080/03670244.1997.9991511	41	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127171	10.1371/journal.pone.0127171	http://dx.doi.org/10.1371/journal.pone.0127171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970517	gold, Green Submitted, Green Published			2022-12-27	WOS:000354544200154
J	Ekblom-Bak, E; Olsson, G; Ekblom, O; Ekblom, B; Bergstrom, G; Borjesson, M				Ekblom-Bak, Elin; Olsson, Gustav; Ekblom, Orjan; Ekblom, Bjorn; Bergstrom, Goran; Borjesson, Mats			The Daily Movement Pattern and Fulfilment of Physical Activity Recommendations in Swedish Middle-Aged Adults: The SCAPIS Pilot Study	PLOS ONE			English	Article							SEDENTARY TIME; UNITED-STATES; HEALTH; BREAKING; PRESCRIPTION; INACTIVITY; MONITORS; RISK	Different aspects of the daily movement pattern-sitting, light intensity physical activity, and moderate-and vigorous intensity physical activity-have each independently been associated with health and longevity. Previous knowledge of the amount and distribution of these aspects in the general Swedish population, as well as the fulfilment rate of physical activity recommendations, mainly relies on self-reported data. More detailed data assessed with objective methods is needed. The aim of the study was to present descriptive data on the daily movement pattern in a middle-aged Swedish population assessed by hip-worn accelerometers. The cohort consisted of 948 participants (51% women), aged 50 to 64 years, from the Swedish CArdioPulmonary bioImage pilot Study. In the total sample, 60.5% of accelerometer wear time was spent sitting, 35.2% in light physical activity and 3.9% in moderate- and vigorous physical activity. Men and participants with high educational level spent a larger proportion of time sitting, compared to women and participants with low educational level. Men and participants with a high educational level spent more time, and the oldest age-group spent less time, in moderate-and vigorous physical activity. Only 7.1% of the study population met the current national physical activity recommendations, with no gender, age or education level differences. Assessment of all three components of the daily movement pattern is of high clinical relevance and should be included in future research. As the fulfilment of national physical activity recommendations is very low and sitting time is very high in our middle-aged population, the great challenge remains to enhance the implementation of methods to increase the level of physical activity in this population.	[Ekblom-Bak, Elin; Olsson, Gustav; Ekblom, Orjan; Ekblom, Bjorn; Borjesson, Mats] Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden; [Bergstrom, Goran] Sahlgrens Univ Hosp, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden; [Bergstrom, Goran] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden; [Borjesson, Mats] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden	Swedish School of Sport & Health Sciences; Sahlgrenska University Hospital; University of Gothenburg; Karolinska Institutet; Karolinska University Hospital	Ekblom-Bak, E (corresponding author), Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden.	eline@gih.se	Ekblom-Bak, Elin/AFR-0681-2022	Ekblom-Bak, Elin/0000-0002-3901-7833; Borjesson, Mats/0000-0002-8786-0438; Bergstrom, Goran/0000-0003-4289-5722; Ekblom, Orjan/0000-0001-6058-4982; Olsson, Sven/0000-0003-3591-5123	Swedish Heart and Lung Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council; VINNOVA; Sahlgrenska Academy at Gothenburg University; ALF/LUA in Western Sweden; Swedish Research Council for Health, Working Life and Welfare	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); Sahlgrenska Academy at Gothenburg University; ALF/LUA in Western Sweden; Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The Swedish CArdioPulmonary bioImage Study (SCAPIS) is supported by the Swedish Heart and Lung Foundation (www.hjart-lungfonden.se), the Knut and Alice Wallenberg Foundation (www.wallenberg.com/kaw/en), the Swedish Research Council (www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) and VINNOVA (www.vinnova.se/en/). The SCAPIS pilot study also received funding from the Sahlgrenska Academy at Gothenburg University (http://sahlgrenska.gu.se/english) and strategic grants from ALF/LUA in Western Sweden (www.fou.nu/is/alfgbg). Author EEB has received funding from the Swedish Research Council for Health, Working Life and Welfare (www.forte.se/en/) and the Swedish Heart and Lung Foundation (www.hjart-lungfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Government, 2014, AUSTR PHYS ACT SED B; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bennie JA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-107; Bergstrom G, 2015, J INTERN ME IN PRESS; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Duvivier BMFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055542; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; European Commission, 2013, SPEC EUR 412, V412; Hagstromer M, 2014, J SCI MED S IN PRESS; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Kallings LV, 2008, SCAND J MED SCI SPOR, V18, P154, DOI 10.1111/j.1600-0838.2007.00678.x; Kallings LV, 2009, EUR J CARDIOV PREV R, V16, P80, DOI 10.1097/HJR.0b013e32831e953a; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118078; Larsen RN, 2014, NUTR METAB CARDIOVAS, V24, P976, DOI 10.1016/j.numecd.2014.04.011; Latouche C, 2013, J APPL PHYSIOL, V114, P453, DOI 10.1152/japplphysiol.00978.2012; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lyden K, 2012, MED SCI SPORT EXER, V44, P2243, DOI 10.1249/MSS.0b013e318260c477; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Owen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Parry S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-296; Robusto KM, 2012, J SPORT SCI, V30, P1429, DOI 10.1080/02640414.2012.710761; SWEDISH NATIONAL BOARD OF HEALTH AND WELFARE, 2011, NAT GUID METH PREV D; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	36	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126336	10.1371/journal.pone.0126336	http://dx.doi.org/10.1371/journal.pone.0126336			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970580	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200104
J	Spittle, AJ; Lee, KJ; Spencer-Smith, M; Lorefice, LE; Anderson, PJ; Doyle, LW				Spittle, Alicia J.; Lee, Katherine J.; Spencer-Smith, Megan; Lorefice, Lucy E.; Anderson, Peter J.; Doyle, Lex W.			Accuracy of Two Motor Assessments during the First Year of Life in Preterm Infants for Predicting Motor Outcome at Preschool Age	PLOS ONE			English	Article							DEVELOPMENTAL COORDINATION DISORDER; LOW-BIRTH-WEIGHT; CEREBRAL-PALSY; PREVENTIVE CARE; CHILDREN BORN; SCALE; RELIABILITY; ABILITIES; MOVEMENT; VALIDITY	Aim The primary aim of this study was to investigate the accuracy of the Alberta Infant Motor Scale (AIMS) and Neuro-Sensory Motor Developmental Assessment (NSMDA) over the first year of life for predicting motor impairment at 4 years in preterm children. The secondary aims were to assess the predictive value of serial assessments over the first year and when using a combination of these two assessment tools in follow-up. Method Children born <30 weeks' gestation were prospectively recruited and assessed at 4, 8 and 12 months' corrected age using the AIMS and NSMDA. At 4 years' corrected age children were assessed for cerebral palsy (CP) and motor impairment using the Movement Assessment Battery for Children 2nd-edition (MABC-2). We calculated accuracy of the AIMS and NSMDA for predicting CP and MABC-2 scores <= 15th (at-risk of motor difficulty) and <= 5th centile (significant motor difficulty) for each test (AIMS and NSMDA) at 4, 8 and 12 months, for delay on one, two or all three of the time points over the first year, and finally for delay on both tests at each time point. Results Accuracy for predicting motor impairment was good for each test at each age, although false positives were common. Motor impairment on the MABC-2 (scores <= 5th and <= 15th) was most accurately predicted by the AIMS at 4 months, whereas CP was most accurately predicted by the NSMDA at 12 months. In regards to serial assessments, the likelihood ratio for motor impairment increased with the number of delayed assessments. When combining both the NSMDA and AIMS the best accuracy was achieved at 4 months, although results were similar at 8 and 12 months. Interpretation Motor development during the first year of life in preterm infants assessed with the AIMS and NSMDA is predictive of later motor impairment at preschool age. However, false positives are common and therefore it is beneficial to follow-up children at high risk of motor impairment at more than one time point, or to use a combination of assessment tools.	[Spittle, Alicia J.; Lee, Katherine J.; Spencer-Smith, Megan; Lorefice, Lucy E.; Anderson, Peter J.; Doyle, Lex W.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Spittle, Alicia J.; Lee, Katherine J.; Anderson, Peter J.; Doyle, Lex W.] Univ Melbourne, Melbourne, Vic, Australia; [Spittle, Alicia J.; Doyle, Lex W.] Royal Womens Hosp, Melbourne, Vic, Australia; [Spencer-Smith, Megan] Monash Univ, Melbourne, Vic 3004, Australia; [Lorefice, Lucy E.] Royal Childrens Hosp, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; Monash University; Royal Children's Hospital Melbourne	Spittle, AJ (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	alicia.spittle@mcri.edu.au	Lee, Katherine J/A-2519-2016; Anderson, Peter John/O-5302-2019; Doyle, Lex/AAJ-5205-2021	Anderson, Peter John/0000-0001-7430-868X; Doyle, Lex/0000-0002-7667-7312; Spittle, Alicia/0000-0002-6535-661X; Spencer-Smith, Megan/0000-0002-1047-0829	National Health and Medical Council [284512, 1053767, 628371]; Cerebral Palsy Alliance; Murdoch Childrens Research Institute; Myer Foundation; Allens Arthur Robinson, Thyne Reid Foundation; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Council; Cerebral Palsy Alliance; Murdoch Childrens Research Institute; Myer Foundation; Allens Arthur Robinson, Thyne Reid Foundation; Victorian Government's Operational Infrastructure Support Program	This study was funded by grants from the National Health and Medical Council (Project Grant ID 284512, Early Career Fellowship (AJS) ID 1053767, Senior Research Fellowship (PJA) ID 628371), the Cerebral Palsy Alliance (Project Grant), Murdoch Childrens Research Institute, Myer Foundation, Allens Arthur Robinson, Thyne Reid Foundation and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa Vanessa M., 2003, Physical & Occupational Therapy in Pediatrics, V23, P7, DOI 10.1300/J006v23n03_02; Barbosa Vanessa Maziero, 2007, Pediatr Phys Ther, V19, P28, DOI 10.1097/PEP.0b013e31802f65f9; Bosanquet M, 2013, DEV MED CHILD NEUROL, V55, P418, DOI 10.1111/dmcn.12140; Brown T, 2009, PHYS OCCUP THER PEDI, V29, P86, DOI 10.1080/01942630802574908; Burns Y, 2004, EARLY HUM DEV, V80, P19, DOI 10.1016/j.earlhumdev.2004.05.003; Burns Y R, 1989, Aust J Physiother, V35, P141, DOI 10.1016/S0004-9514(14)60503-1; BURNS YR, 1989, AUST PAEDIATR J, V25, P215; Danks M, 2012, EARLY HUM DEV, V88, P637, DOI 10.1016/j.earlhumdev.2012.01.010; Darrah J, 1998, EARLY HUM DEV, V52, P169, DOI 10.1016/S0378-3782(98)00028-0; Darrah J, 2014, DEV MED CHILD NEUROL, V56, P877, DOI 10.1111/dmcn.12452; Darrah J, 2009, INFANT BEHAV DEV, V32, P72, DOI 10.1016/j.infbeh.2008.10.001; Edwards J, 2011, J DEV BEHAV PEDIATR, V32, P678, DOI 10.1097/DBP.0b013e31822a396a; Fallang B, 2005, NEURAL PLAST, V12, P263; Fallang Bjorg, 2005, Neural Plasticity, V12, P175, DOI 10.1155/NP.2005.175; Ferrari F, 2012, J MATERN-FETAL NEO M, V25, P2154, DOI 10.3109/14767058.2012.696164; Fleuren KMW, 2007, ACTA PAEDIATR, V96, P424, DOI 10.1111/j.1651-2227.2007.00111.x; Goyen TA, 2002, EARLY HUM DEV, V70, P103, DOI 10.1016/S0378-3782(02)00094-4; Heineman KR, 2008, J DEV BEHAV PEDIATR, V29, P315, DOI 10.1097/DBP.0b013e318182a4ea; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Himpens E, 2008, DEV MED CHILD NEUROL, V50, P334, DOI 10.1111/j.1469-8749.2008.02047.x; Jeng SF, 2000, PHYS THER, V80, P168, DOI 10.1093/ptj/80.2.168; Nuysink J, 2013, EARLY HUM DEV, V89, P693, DOI 10.1016/j.earlhumdev.2013.04.016; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pin TW, 2010, EARLY HUM DEV, V86, P573, DOI 10.1016/j.earlhumdev.2010.07.008; Pin TW, 2009, DEV MED CHILD NEUROL, V51, P739, DOI 10.1111/j.1469-8749.2009.03265.x; Piper M., 1994, MOTOR ASSESSMENT DEV; Reid SM, 2011, DEV MED CHILD NEUROL, V53, P907, DOI 10.1111/j.1469-8749.2011.04039.x; Rosenbaum P, 2006, EARLY HUM DEV, V82, P167, DOI 10.1016/j.earlhumdev.2006.01.007; Spencer-Smith MM, 2012, PEDIATRICS, V130, P1094, DOI 10.1542/peds.2012-0426; Spittle A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub3; Spittle A, 2011, DEV MED CHILD NEUROL, V53, P681, DOI 10.1111/j.1469-8749.2011.04034.x; Spittle AJ, 2008, DEV MED CHILD NEUROL, V50, P254, DOI 10.1111/j.1469-8749.2008.02025.x; Spittle AJ, 2013, DEV MED CHILD NEUROL, V55, P448, DOI 10.1111/dmcn.12049; Spittle AJ, 2010, PEDIATRICS, V126, pE171, DOI 10.1542/peds.2009-3137; Spittle AJ, 2014, SEMIN FETAL NEONAT M, V19, P84, DOI 10.1016/j.siny.2013.11.005; Valentini NC, 2012, PHYS THER, V92, P440, DOI 10.2522/ptj.20110036; Van Haastert IC, 2006, J PEDIATR-US, V149, P617, DOI 10.1016/j.jpeds.2006.07.025; Wang CJ, 2006, PEDIATRICS, V117, P2080, DOI 10.1542/peds.2005-1904	38	24	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125854	10.1371/journal.pone.0125854	http://dx.doi.org/10.1371/journal.pone.0125854			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZP	25970619	gold, Green Published, Green Submitted			2022-12-27	WOS:000354544200086
J	Ge, XM; Tian, Y; Tang, LZ				Ge, Xiaomin; Tian, Ye; Tang, Luozhong			Nutrient Distribution Indicated Whole-Tree Harvesting as a Possible Factor Restricting the Sustainable Productivity of a Poplar Plantation System in China	PLOS ONE			English	Article							FINE-ROOT PRODUCTION; USE EFFICIENCY; BIOMASS PRODUCTION; FOREST ECOSYSTEMS; RAIN-FOREST; STAND; THROUGHFALL; GROWTH; FIR; ACCUMULATION	We evaluated the biomass and contents of five major macronutrients (N, P, K, Ca and Mg) in 10-year-old poplar trees (Populus deltoids Bartr. cv. "Lux"), and determined their nutrient use efficiencies (NUEs) at Zhoushan Forestry Farm (32 degrees 200'N, 119 degrees 40' E), Jiangsu province, in eastern China. The above-and below-ground biomass of poplar trees was 161.7 t ha(-1), of which 53.3% was stemwood. The nutrient contents in the aboveground part were as follows: 415.1 kg N ha(-1), 29.7 kg P ha(-1), 352.0 kg K ha(-1), 1083.0 kg Ca ha(-1), and 89.8 kg Mg ha(-1). The highest nutrient contents were in stembark, followed by branches, roots, stemwood, and foliage. The NUEs of the aboveground parts of poplar for N, P, K, Ca and Mg were 0.313, 4.377, 0.369, 0.120, 1.448 t dry biomass kg(-1) nutrient, respectively, while those of stemwood were 1.294, 33.154, 1.253, 0.667, and 3.328 t dry biomass kg(-1), respectively. The cycling coefficients, defined as the percentage of annual nutrient return in annual nutrient uptake, of N, P, K, Ca and Mg for the aboveground part were 87, 95, 69, 92, and 84%, respectively. Based on the NUE and nutrient cycling characteristics, shifting from whole-tree harvesting to stemwood-only harvesting and appropriately extending the harvest rotation could prevent site deterioration and support sustainable productivity of poplar plantation systems.	[Ge, Xiaomin; Tian, Ye; Tang, Luozhong] Nanjing Forestry Univ, Coll Forestry, Nanjing 210037, Jiangsu, Peoples R China	Nanjing Forestry University	Tang, LZ (corresponding author), Nanjing Forestry Univ, Coll Forestry, 159 Longpan Rd, Nanjing 210037, Jiangsu, Peoples R China.	luozhongtang@njfu.edu.cn			International Science and Technology Cooperation Program of China [2011DFA30490]; National Natural Science Foundation of China [31170566, 31370618]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Student Research and Innovation Program in Universities of Jiangsu Province [CXZZ13_0550]	International Science and Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Student Research and Innovation Program in Universities of Jiangsu Province	This work was supported by the International Science and Technology Cooperation Program of China (No. 2011DFA30490), the National Natural Science Foundation of China (No. 31170566 and No. 31370618), as well as the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Graduate Student Research and Innovation Program in Universities of Jiangsu Province (No. CXZZ13_0550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto L, 2000, ANN FOREST SCI, V57, P313; Block RMA, 2006, AGROFOREST SYST, V67, P73, DOI 10.1007/s10457-005-2002-7; Chen ZZ, 2005, LECT NOTES COMPUT SC, V3514, P115; Chuyong GB, 2004, BIOGEOCHEMISTRY, V67, P73, DOI 10.1023/B:BIOG.0000015316.90198.cf; Dezzeo N, 2006, FOREST ECOL MANAG, V234, P218, DOI 10.1016/j.foreco.2006.07.003; Fang Sheng-zuo, 2008, Yingyong Shengtai Xuebao, V19, P2308; Fang YT, 2011, J FOREST RES-JPN, V16, P341, DOI 10.1007/s10310-011-0267-4; Feng ZW, 1999, BIOMASS PRODUCTIVITY, P8; Finer L, 1989, ACTA FOR FENN, V208, P63; Finer L, 2011, FOREST ECOL MANAG, V262, P2008, DOI 10.1016/j.foreco.2011.08.042; Guo LB, 2002, BIORESOURCE TECHNOL, V85, P273, DOI 10.1016/S0960-8524(02)00118-9; He DZ, 2009, PROT FOR SCI TECHNOL, V2, P32; Hogberg P, 2007, NATURE, V447, P781, DOI 10.1038/447781a; Kavvadias VA, 2001, FOREST ECOL MANAG, V144, P113, DOI 10.1016/S0378-1127(00)00365-0; Kimaro AA, 2007, AGROFOREST SYST, V71, P175, DOI 10.1007/s10457-007-9061-x; KUBIN E, 1983, ANN BOT FENN, V20, P361; Kumar BM, 1998, FOREST ECOL MANAG, V112, P145, DOI 10.1016/S0378-1127(98)00325-9; Laclau JP, 2010, FOREST ECOL MANAG, V259, P1771, DOI 10.1016/j.foreco.2009.06.010; Li PZ, 2001, CHINESE J APPL ECOLO, V12, P829; Li XY, 2011, J LIAONING FOR SCI T, V6, P39; Liu FD, 2005, THESIS SHANGDONG AGR; Lukac M, 2010, PLANT SOIL, V331, P505, DOI 10.1007/s11104-009-0271-z; Ma XiangQing, 1997, Journal of Nanjing Forestry University, V21, P77; Ma XQ, 2007, FOREST ECOL MANAG, V243, P61, DOI 10.1016/j.foreco.2007.02.018; Majdi H, 2005, ECOSYSTEMS, V8, P191, DOI 10.1007/s10021-004-0246-0; McLaughlin JW, 2011, FOREST ECOL MANAG, V261, P649, DOI 10.1016/j.foreco.2010.11.019; MEIRESONNE L, 2007, CAN J FOREST RES, V37, P141, DOI DOI 10.1139/X06-205; Meng XY, 2008, FOREST MENSURATION, P197; Morhart C, 2013, FORESTS, V4, P471, DOI 10.3390/f4020471; Palviainen M, 2012, EUR J FOREST RES, V131, P945, DOI 10.1007/s10342-011-0567-4; Perez D, 2008, J TROP FOR SCI, V20, P66; Ponette Q, 2001, FOREST ECOL MANAG, V142, P109, DOI 10.1016/S0378-1127(00)00345-5; RANGER J, 1995, FOREST ECOL MANAG, V72, P167, DOI 10.1016/0378-1127(94)03469-D; Safou-Matondo R, 2005, FOREST ECOL MANAG, V210, P193, DOI 10.1016/j.foreco.2005.02.049; Scheer MB, 2011, J FOREST RES-JPN, V16, P76, DOI 10.1007/s10310-010-0222-9; Shammas K, 2003, BIOL FERT SOILS, V38, P228, DOI 10.1007/s00374-003-0654-x; Sheng WT, 2005, LONG TERM PRODUCTIVI, P124; Shujauddin N, 2003, FOREST ECOL MANAG, V180, P135, DOI 10.1016/S0378-1127(02)00609-6; Son Y, 2004, ECOL RES, V19, P21, DOI 10.1111/j.1440-1703.2003.00617.x; Sun CuiLing, 1995, Scientia Silvae Sinicae, V31, P506; Sverdrup H, 2006, BIOGEOCHEMISTRY, V81, P219, DOI 10.1007/s10533-006-9038-2; Tang LuoZhong, 2004, Journal of Nanjing Forestry University (Natural Sciences Edition), V28, P1; Tumer J, 2008, FOREST ECOL MANAG, V255, P1701, DOI 10.1016/j.foreco.2007.11.038; Vanninen P, 1996, TREES-STRUCT FUNCT, V10, P231, DOI 10.1007/BF02185674; Wall A, 2012, FOREST ECOL MANAG, V282, P175, DOI 10.1016/j.foreco.2012.07.012; WANG D, 1991, FOREST ECOL MANAG, V46, P1, DOI 10.1016/0378-1127(91)90241-M; Wang Hua-Tian, 2011, Chinese Journal of Plant Ecology, V35, P214, DOI 10.3724/SP.J.1258.2011.00214; Xia JB, 2009, AFR J BIOTECHNOL, V8, P5415; Xiang WH, 2006, ACTA PHYTOECOL SIN, V26, P89; Xie YingXin, 2010, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V18, P897, DOI 10.3724/SP.J.1011.2010.00897; Yang Shi-hua, 2013, Forest Research, V26, P1; Zhai MingPu, 2002, Journal of Beijing Forestry University, V24, P39; [钟继洪 Zhong Jihong], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P45; 李跃林, 2001, 生态学报, V21, P1734	54	9	10	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125303	10.1371/journal.pone.0125303	http://dx.doi.org/10.1371/journal.pone.0125303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992549	Green Published, Green Submitted, gold			2022-12-27	WOS:000354921400031
J	Stewart, JR; Jacobi, RM				Stewart, John R.; Jacobi, Roger M.			The Long Term Response of Birds to Climate Change: New Results from a Cold Stage Avifauna in Northern England	PLOS ONE			English	Article							LATE PLEISTOCENE; POTENTIAL IMPACTS; GLACIAL SURVIVAL; LAGOPUS-LAGOPUS; CRESWELL CRAGS; BOREAL TREES; BODY-SIZE; REFUGIA; MIDDLE; ECOLOGY	The early MIS 3 (55-40 Kyr BP associated with Middle Palaeolithic archaeology) bird remains from Pin Hole, Creswell Crags, Derbyshire, England are analysed in the context of the new dating of the site's stratigraphy. The analysis is restricted to the material from the early MIS 3 level of the cave because the upper fauna is now known to include Holocene material as well as that from the Late Glacial. The results of the analysis confirm the presence of the taxa, possibly unexpected for a Late Pleistocene glacial deposit including records such as Alpine swift, demoiselle crane and long-legged buzzard with southern and/or eastern distributions today. These taxa are accompanied by more expected ones such as willow ptarmigan /red grouse and rock ptarmigan living today in northern and montane areas. Finally, there are temperate taxa normally requiring trees for nesting such as wood pigeon and grey heron. Therefore, the result of the analysis is that the avifauna of early MIS 3 in England included taxa whose ranges today do not overlap making it a non-analogue community similar to the many steppe-tundra mammalian faunas of the time. The inclusion of more temperate and woodland taxa is discussed in the light that parts of northern Europe may have acted as cryptic northern refugia for some such taxa during the last glacial. These records showing former ranges of taxa are considered in the light of modern phylogeographic studies as these often assume former ranges without considering the fossil record of those taxa. In addition to the anomalous combination of taxa during MIS 3 living in Derbyshire, the individuals of a number of the taxa are different in size and shape to members of the species today probably due to the high carrying capacity of the steppe-tundra.	[Stewart, John R.] Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England; [Jacobi, Roger M.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Bournemouth University; Natural History Museum London	Stewart, JR (corresponding author), Bournemouth Univ, Fac Sci & Technol, Talbot Campus, Poole BH12 5BB, Dorset, England.	jstewart@bournemouth.ac.uk	Stewart, John R./C-1075-2011	Stewart, John R./0000-0002-3506-5264	Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	This work was funded by the Leverhulme Trust funded Ancient Human Occupation of Britain Project.	ANDERSSON M, 1976, J ANIM ECOL, V45, P537, DOI 10.2307/3890; ANDERSSON M, 1980, OIKOS, V35, P63, DOI 10.2307/3544727; Armstrong A. L, 1932, P PREHISTORIC SOC E, V6, P330; Armstrong AL, 1925, J R ANTHROPOL INST G, V55, P146, DOI 10.2307/2843698; Armstrong AL, 1939, MEMOIRS P MANCHESTER, V83, P87; Armstrong AL, 1956, SHEFFIELD ITS REGION, P90; Armstrong AL, 1926, T HUNTER ARCHAEOLOGI, V3, P116; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; Bacher A., 1967, VERLEICHEND MORPHOLO; Barnosky AD, 2008, CLIMATIC CHANGE, V86, P29, DOI 10.1007/s10584-007-9333-5; Baumel J. J., 1979, NOMINA ANATOMICA AVI; Bell GF, 1969, NEW PHYTOL, V68, P913; Birks HH, 2012, SCIENCE, V338, DOI 10.1126/science.1225345; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Bochenski Z, 1974, PTAKI MLODSZEGO CZWA, P204; Bramwell D, 1984, SHADOW EXTINCTION QU; Burger J, 2004, MOL PHYLOGENET EVOL, V30, P841, DOI 10.1016/j.ympev.2003.07.020; Butkauskas Dalius, 2008, Acta Zoologica Lituanica, V18, P77, DOI 10.2478/v10043-008-0011-2; Caseldine CJ, 2008, J QUATERNARY SCI, V23, P193, DOI 10.1002/jqs.1121; Cassoli P.F., 1972, Quaternaria, V16, P225; COOMBS F, 1978, CROWS STUDY CORVIDS; Coope GR, 2000, J QUATERNARY SCI, V15, P779; Cowles G.S., 1981, Bulletin of the British Ornithologists' Club, V101, P383; Cramp S., 1994, HDB BIRDS EUROPE MID, V8; Cramp S., 1985, HDB BIRDS EUROPE MID, VIV; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Cramp S., 1980, HDB BIRDS EUROPE MID, VII; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; Davis MB, 2000, ANNU REV EARTH PL SC, V28, P1, DOI 10.1146/annurev.earth.28.1.1; DAVIS SJM, 1981, PALEOBIOLOGY, V7, P101, DOI 10.1017/S0094837300003821; Driesch A. von den, 1976, PEABODY MUSEUM B, V1; Feare C.J., 1984, STARLING; Feurdean A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071797; Fick O. K. W., 1974, VERGLEICHEND MORPHOL; FITZGERALD GR, 1980, CAN J EARTH SCI, V17, P1593, DOI 10.1139/e80-168; Geist V, 1986, CAN J ZOOL, V65, P1035, DOI [10.1139/z87-164, DOI 10.1139/Z87-164]; Germonpre Mietje, 2004, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V74, P175; Graham R.W., 1985, Acta Zoologica Fennica, P181; Graham RW, 1996, SCIENCE, V272, P1601; GRAHAM RW, 1985, COMMUNITY ECOLOGY, P300; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Gruber A, 1990, VERGLEICHEND MORPHOL; Guthrie D., 2000, HUNTERS GOLDEN AGE M, V31, P13; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Guthrie R. Dale, 1990, P42; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; Guthrie RD, 1984, CARNEGIE MUS NAT HIS, V8, P482; Harrison C.J.O., 1988, Proceedings Spelaeological Society (Bristol), V18, P258; Harrison C.J.O., 1980, Bulletin of the British Museum (Natural History) Geology, V33, P91; Harrison CJO, 1999, UK ENGLISH HERITAGE, V16; Harrison CJO., 1982, ATLAS BIRDS W PALAEA; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hofreiter M, 2012, QUATERNARY SCI REV, V33, P1, DOI 10.1016/j.quascirev.2011.11.018; Hoglund J, 2013, BIOL J LINN SOC, V110, P77, DOI 10.1111/bij.12109; Holder K, 1999, EVOLUTION, V53, P1936, DOI 10.1111/j.1558-5646.1999.tb04574.x; Holder K, 2000, MOL ECOL, V9, P1265, DOI 10.1046/j.1365-294x.2000.01005.x; Holm SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094021; HUNTLEY B, 1991, ANN BOT-LONDON, V67, P15, DOI 10.1093/oxfordjournals.aob.a088205; HUNTLEY B, 1990, J VEG SCI, V1, P507, DOI 10.2307/3235785; Huntley B, 2003, QUATERNARY RES, V59, P195, DOI 10.1016/S0033-5894(02)00016-9; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Jacobi RM, 2006, J QUATERNARY SCI, V21, P557, DOI 10.1002/jqs.1037; Jacobi RM, 1998, J QUATERNARY SCI, V13, P29, DOI 10.1002/(SICI)1099-1417(199801/02)13:1<29::AID-JQS346>3.3.CO;2-Y; Janossy D., 1972, Anthropos, V20, P35; Janossy D, 1983, HUMERI CENTRAL EUROP, V11, P85; Kellner M, 1986, VERGLEICHEND MORPHOL; Kraft E., 1972, VERGLEICHEND MORPHOL; KurtUn B., 1968, PLEISTOCENE MAMMALS; LANGER G, 1980, VERGLEICHEND MORPHOL; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Lister A., 1987, T P TORQUAY NATURAL, V19, P189; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; LISTER AM, 1995, NATURE, V378, P23, DOI 10.1038/378023a0; LISTER AM, 1992, QUATERNARY SCI REV, V11, P329, DOI 10.1016/0277-3791(92)90004-R; Lockley, 1954, SEA BIRDS; Lowe J. J., 1997, RECONSTRUCTING QUATE; Markova AK, 2002, QUATERNARY RES, V57, P391, DOI 10.1006/qres.2002.2336; Markova Anastasia K., 1997, Paleontologia i Evolucio, V28-29, P5; Marthinsen G, 2009, CONSERV GENET, V10, P923, DOI 10.1007/s10592-008-9581-6; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Meiri S, 2007, GLOBAL ECOL BIOGEOGR, V16, P788, DOI 10.1111/j.1466-8238.2007.00330.x; Mikkola H., 2020, OWLS, P97; Moss Stephen, 1998, British Birds, V91, P307; Mourer-Chauvire C., 1975, DOCUMENTS LAB GEOLOG, V64; Mourer-Chauvire C, 2004, GEOBIOS-LYON, V37, pS97, DOI 10.1016/S0016-6995(04)80010-X; Musil R, 1985, ACTA MUSEI NATL PRAG, VXLI B, P1; Neves VC, 2010, EUR J WILDLIFE RES, V56, P95, DOI 10.1007/s10344-009-0316-x; Olson S.L., 1985, Avian Biology, V8, P79; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Omland KE, 2000, P ROY SOC B-BIOL SCI, V267, P2475, DOI 10.1098/rspb.2000.1308; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parslow J. L F, 1972, BIRDS BRITAIN EUROPE; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Pruett CL, 2008, CLIMATIC CHANGE, V86, P23, DOI 10.1007/s10584-007-9332-6; Pruett CL, 2005, CLIMATIC CHANGE, V68, P219, DOI 10.1007/s10584-005-1584-4; Quintela M, 2010, MOL ECOL, V19, P2380, DOI 10.1111/j.1365-294X.2010.04648.x; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Schmidt-Burger P., 1982, VERGLEICHEND MORPHOL; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Smith SE, 2013, DIVERS DISTRIB, V19, P352, DOI 10.1111/ddi.12025; Solti B., 1981, Vertebrata Hungarica, V20, P75; Solti B, 1996, FOLIA HIST NAT MUSEI, V21, P5; Stafford TW, 1999, GEOLOGY, V27, P903, DOI 10.1130/0091-7613(1999)027<0903:FAMSCD>2.3.CO;2; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Stewart J.R., 1996, DEVON E CORNWALL FIE; Stewart J. R., 2002, P 5 S SOC AV PAL EV, P261; Stewart John R., 2007, Acta Zoologica Cracoviensia Ser. A - Vertebrata, V50A, P93, DOI 10.3409/000000007783995372; Stewart JR, 2008, CLIMATIC CHANGE, V86, P19, DOI 10.1007/s10584-007-9366-9; Stewart JR, 2010, QUATERN INT, V228, P72, DOI 10.1016/j.quaint.2010.07.025; Stewart John R., 2005, Documenta Archaeobiologiae, V3, P43; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart John R., 2002, Acta Zoologica Cracoviensia, V45, P167; Stewart John R., 2007, British Birds, V100, P481; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Stewart JR, 2005, QUATERN INT, V137, P35, DOI 10.1016/j.quaint.2004.11.018; Stewart JR, 1999, SM C PALEOB, P159; Stewart JR, 1997, INT J OSTEOARCHAEOL, V7, P364, DOI 10.1002/(SICI)1099-1212(199707/08)7:4<364::AID-OA377>3.0.CO;2-P; Stewart JR, 1992, THESIS N LONDON THAM; Stewart JR, 2007, BRIT ARCHAEOLOGICAL; Stewart JR, 2003, NEANDERTHALS MODERN, P103; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; STUART AJ, 1991, BIOL REV, V66, P453, DOI 10.1111/j.1469-185X.1991.tb01149.x; Sutherland S, 1984, SHADOW EXTINCTION QU; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tomek T., 2000, COMP OSTEOLOGY EUROP; Tyrberg T., 1991, Ornithologische Verhandlungen, V25, P29; Tyrberg T, 1998, PUBL NUTTAL ORNIT CL, V27; Tyrberg Tommy, 1995, Courier Forschungsinstitut Senckenberg, V181, P275; Tzedakis PC, 2013, TRENDS ECOL EVOL, V28, P696, DOI 10.1016/j.tree.2013.09.001; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Webb WC, 2011, MOL ECOL, V20, P2390, DOI 10.1111/j.1365-294X.2011.05095.x; Wiklund CG, 1999, AMBIO, V28, P281; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; WINKLER H, 1992, IBIS, V134, P21; Woelfle E., 1967, VERGLEICHEND MORPHOL, P257; Woolfenden G. E., 1961, FLORIDA STATE MUS B, V6, P1; Yom-Tov Y, 2001, P ROY SOC B-BIOL SCI, V268, P947, DOI 10.1098/rspb.2001.1592	146	9	10	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0122617	10.1371/journal.pone.0122617	http://dx.doi.org/10.1371/journal.pone.0122617			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992609	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000354921400007
J	Lark, DS; Kang, L; Lustig, ME; Bonner, JS; James, FD; Neufer, PD; Wasserman, DH				Lark, Daniel S.; Kang, Li; Lustig, Mary E.; Bonner, Jeffrey S.; James, Freyja D.; Neufer, P. Darrell; Wasserman, David H.			Enhanced Mitochondrial Superoxide Scavenging Does Not Improve Muscle Insulin Action in the High Fat-Fed Mouse	PLOS ONE			English	Article							HYPERINSULINEMIC-EUGLYCEMIC CLAMPS; GLUCOSE-HOMEOSTASIS; DISMUTASE PROTECTS; H2O2 EMISSION; CELL-DEATH; OVEREXPRESSION; RESISTANCE; ANTIOXIDANT; TISSUES	Improving mitochondrial oxidant scavenging may be a viable strategy for the treatment of insulin resistance and diabetes. Mice overexpressing the mitochondrial matrix isoform of superoxide dismutase (sod2(tg) mice) and/or transgenically expressing catalase within the mitochondrial matrix (mcat(tg) mice) have increased scavenging of O-2(.-) and H2O2, respectively. Furthermore, muscle insulin action is partially preserved in high fat (HF)-fed mcat(tg) mice. The goal of the current study was to test the hypothesis that increased O-2(._) scavenging alone or in combination with increased H2O2 scavenging (mtAO mice) enhances in vivo muscle insulin action in the HF-fed mouse. Insulin action was examined in conscious, unrestrained and unstressed wild type (WT), sod2(tg), mcattg and mtAO mice using hyperinsulinemic-euglycemic clamps (insulin clamps) combined with radioactive glucose tracers following sixteen weeks of normal chow or HF (60% calories from fat) feeding. Glucose infusion rates, whole body glucose disappearance, and muscle glucose uptake during the insulin clamp were similar in chow- and HF-fed WT and sod2(tg) mice. Consistent with our previous work, HF-fed mcat(tg) mice had improved muscle insulin action, however, an additive effect was not seen in mtAO mice. Insulin-stimulated Akt phosphorylation in muscle from clamped mice was consistent with glucose flux measurements. These results demonstrate that increased O-2(._) scavenging does not improve muscle insulin action in the HF-fed mouse alone or when coupled to increased H2O2 scavenging.	[Lark, Daniel S.; Kang, Li; Lustig, Mary E.; Bonner, Jeffrey S.; James, Freyja D.; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA; [Neufer, P. Darrell] E Carolina Univ, Dept Physiol, Greenville, NC USA; [Neufer, P. Darrell] E Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC USA; [Wasserman, David H.] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37235 USA	Vanderbilt University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Lark, DS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37235 USA.	daniel.lark@vanderbilt.edu		Kang, Li/0000-0002-6990-1996; Lark, Daniel/0000-0001-8386-8478	National Institutes of Health [DK054902, DK059637, DK007061, DK073488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R56DK054902, P30DK020593, T32DK007061, R01DK054902, R01DK073488, U24DK059637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK054902 (to D.H.W.), DK059637 (Vanderbilt-NIDDK Mouse Metabolic Phenotyping Center), DK007061 (to D.S.L.) and DK073488 (to P.D.N.). The authors would also like to acknowledge the Diabetes Research and Training Center (DK20593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Archuleta TL, 2009, FREE RADICAL BIO MED, V47, P1486, DOI 10.1016/j.freeradbiomed.2009.08.014; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Boden MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE798, DOI 10.1152/ajpendo.00577.2011; Chiang YF, 2011, BRIT J NUTR, V105, P1311, DOI 10.1017/S0007114510005039; Chung SS, 2009, MOL CELL BIOL, V29, P20, DOI 10.1128/MCB.00544-08; Dasgupta J, 2006, ANTIOXID REDOX SIGN, V8, P1295, DOI 10.1089/ars.2006.8.1295; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Higaki Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE889, DOI 10.1152/ajpendo.00150.2007; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hughey CC, 2014, MAMM GENOME, V25, P522, DOI 10.1007/s00335-014-9533-z; Ibrahim W, 2000, FREE RADICAL BIO MED, V28, P397, DOI 10.1016/S0891-5849(99)00253-1; Kane DA, 2011, AM J PHYSIOL-ENDOC M, V300, pE528, DOI 10.1152/ajpendo.00389.2010; Kang L, 2012, J APPL PHYSIOL, DOI [10.1152/japplphysiol.01344.2011, DOI 10.1152/JAPPLPHYSIOL.O1344.2011]; Kang L, 2014, DIABETES, V63, P3699, DOI 10.2337/db13-1845; Kim H, 2001, BBA-MOL CELL RES, V1540, P137, DOI 10.1016/S0167-4889(01)00131-8; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Liu YH, 2013, BIOCHEM BIOPH RES CO, V438, P78, DOI 10.1016/j.bbrc.2013.07.029; Livingstone C, 2002, CLIN SCI, V102, P151, DOI 10.1042/cs1020151; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Motoori S, 2001, CANCER RES, V61, P5382; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; STEELE R, 1956, AM J PHYSIOL, V187, P25, DOI 10.1152/ajplegacy.1956.187.1.25; Venkataraman S, 2005, ONCOGENE, V24, P77, DOI 10.1038/sj.onc.1208145; WISPE JR, 1992, J BIOL CHEM, V267, P23937; Zhang ZJ, 2002, J PSYCHIAT RES, V36, P317, DOI 10.1016/S0022-3956(02)00007-9	31	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126732	10.1371/journal.pone.0126732	http://dx.doi.org/10.1371/journal.pone.0126732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992608	Green Published, Green Submitted, gold			2022-12-27	WOS:000354918600041
J	Monk, RL; Heim, D; Qureshi, A; Price, A				Monk, Rebecca Louise; Heim, Derek; Qureshi, Adam; Price, Alan			"I Have No Clue What I Drunk Last Night" Using Smartphone Technology to Compare In-Vivo and Retrospective Self-Reports of Alcohol Consumption	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; ENVIRONMENTAL CONTEXT; OUTCOME EXPECTANCIES; DRINKING; MEMORY; SMOKING; QUESTIONS	Aim This research compared real-time measurements of alcohol consumption with retrospective accounts of alcohol consumption to examine possible discrepancies between, and contextual influences on, the different accounts. Method Building on previous investigations, a specifically designed Smartphone technology was utilized to measure alcohol consumption and contextual influences in de facto real-time. Realtime data (a total of 10,560 data points relating to type and number of drinks and current social / environmental context) were compared with daily and weekly retrospective accounts of alcohol consumption. Results Participants reported consuming more alcoholic drinks during real-time assessment than retrospectively. For daily accounts a higher number of drinks consumed in real-time was related to a higher discrepancy between real-time and retrospective accounts. This effect was found across all drink types but was not shaped by social and environmental contexts. Higher in-vivo alcohol consumption appeared to be related to a higher discrepancy in retrospectively reported weekly consumption for alcohol beverage types other than wine. When including contextual factors into the statistical models, being with two or more friends (as opposed to being alone) decreased the discrepancy between real-time and retrospective reports, whilst being in the pub (relative to being at home) was associated with greater discrepancies. Conclusions Overall, retrospective accounts may underestimate the amount of actual, real-time alcohol consumed. Increased consumption may also exacerbate differences between real-time and retrospective accounts. Nonetheless, this is not a global effect as environmental and social contexts interact with the type of alcohol consumed and the time frame given for reporting (weekly vs. daily retrospective). A degree of caution therefore appears warranted with regards to the use of retrospective self-report methods of recording alcohol consumption. Whilst real-time sampling is unlikely to be completely error free, it may be better able to account for social and environmental influences on self-reported consumption.	[Monk, Rebecca Louise; Heim, Derek; Qureshi, Adam; Price, Alan] Edge Hill Univ, Dept Psychol, Ormskirk, Lancs, England	Edge Hill University	Monk, RL (corresponding author), Edge Hill Univ, Dept Psychol, Ormskirk, Lancs, England.	monkre@edgehill.ac.uk		Qureshi, Adam/0000-0002-7698-2691; Price, Alan/0000-0002-3208-7214; Monk, Rebecca/0000-0002-3554-9007	Alcohol Research UK	Alcohol Research UK	This research was funded by Alcohol Research UK, http://alcoholresearchuk.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi SM, 2013, ADDICTION, V108, P900, DOI 10.1111/add.12093; Borsari B, 2001, J SUBST ABUSE, V13, P391, DOI 10.1016/S0899-3289(01)00098-0; BRADBURN NM, 1987, SCIENCE, V236, P157, DOI 10.1126/science.3563494; Buckingham SA, 2013, PSYCHOL ADDICT BEHAV, V27, P1132, DOI 10.1037/a0032480; Cadigan JM, 2013, ADDICT RES THEORY, V21, P507, DOI 10.3109/16066359.2012.754884; Collins RL, 1998, EXP CLIN PSYCHOPHARM, V6, P306, DOI 10.1037/1064-1297.6.3.306; Collins RL, 2003, EXP CLIN PSYCHOPHARM, V11, P73, DOI 10.1037/1064-1297.11.1.73; Davies JB, 1996, PSYCHOL HEALTH, V11, P291, DOI 10.1080/08870449608400258; Del Boca FK, 2000, ADDICTION, V95, pS347; Fjaer EG, 2012, J YOUTH STUD, V15, P995, DOI 10.1080/13676261.2012.693594; Foster JH, 2014, ALCOHOL ALCOHOLISM, V49, P213, DOI 10.1093/alcalc/agt135; Gabbert F, 2003, APPL COGNITIVE PSYCH, V17, P533, DOI 10.1002/acp.885; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325, DOI 10.1111/j.2044-8295.1975.tb01468.x; Greenfield TK, 2008, ADDICTION, V103, P1082, DOI 10.1111/j.1360-0443.2008.02197.x; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Katz J., 2002, PERPETUAL CONTACT MO; Kuntsche E, 2014, ADDICTION, V109, P1052, DOI 10.1111/add.12540; Lau-Barraco C, 2014, ADDICT RES THEORY, V22, P57, DOI 10.3109/16066359.2013.772585; Lau-Barraco C, 2009, ADDICT RES THEORY, V17, P306, DOI 10.1080/16066350802346201; Leigh BC., 1993, PSYCHOL ASSESS, V5, P216, DOI [DOI 10.1037/1040-3590.5.2.216, 10.1037/1040-3590.5.2.216]; LEMMENS P, 1992, J STUD ALCOHOL, V53, P476, DOI 10.15288/jsa.1992.53.476; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Monk RL, 2014, ALCOHOL CLIN EXP RES, V38, P2454, DOI 10.1111/acer.12504; Monk RL, 2013, PSYCHOL ADDICT BEHAV, V27, P814, DOI 10.1037/a0033948; Monk RL, 2013, EXP CLIN PSYCHOPHARM, V21, P1, DOI 10.1037/a0030772; Monk RL, 2013, SUBST USE MISUSE, V48, P539, DOI 10.3109/10826084.2013.787097; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Norell M, 1995, STOCKH BRUTUSO STLIN; Palmblad M, 2004, QUAL LIFE RES, V13, P1199, DOI 10.1023/B:QURE.0000037501.92374.e1; Piasecki TM, 2011, J ABNORM PSYCHOL, V120, P557, DOI 10.1037/a0023033; ROBINSON P, 1995, LANG LEARN, V45, P283, DOI 10.1111/j.1467-1770.1995.tb00441.x; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Shiffman S, 1997, J CONSULT CLIN PSYCH, V65, P292, DOI 10.1037/0022-006X.65.2.292.a; Shiffman S, 2002, J ABNORM PSYCHOL, V111, P531, DOI 10.1037/0021-843X.111.4.531; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Smyth Joshua M, 2003, J HAPPINESS STUD, V4, P35, DOI [10.1023/A:1023657221954, DOI 10.1023/A:1023657221954]; Sobell LC, 2001, SUBST USE MISUSE, V36, P313, DOI 10.1081/JA-100102628; STEELE CM, 1990, AM PSYCHOL, V45, P921, DOI 10.1037/0003-066X.45.8.921; Stone AA, 2002, ANN BEHAV MED, V24, P236, DOI 10.1207/S15324796ABM2403_09; Toll BA, 2005, PSYCHOL ADDICT BEHAV, V19, P291, DOI 10.1037/0893-164X.19.3.291; Verster Joris C, 2012, Curr Drug Abuse Rev, V5, P169; WALKER DW, 1978, NEUROPSYCHOLOGIA, V16, P545, DOI 10.1016/0028-3932(78)90082-9; Wall AM, 2001, PSYCHOL ADDICT BEHAV, V15, P219, DOI 10.1037/0893-164X.15.3.219; Wall AM, 2000, PSYCHOL ADDICT BEHAV, V14, P367, DOI 10.1037/0893-164X.14.4.367; Weissenborn R, 2003, PSYCHOPHARMACOLOGY, V165, P306, DOI 10.1007/s00213-002-1281-1	47	71	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126209	10.1371/journal.pone.0126209	http://dx.doi.org/10.1371/journal.pone.0126209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BT	25992573	Green Submitted, Green Published, gold			2022-12-27	WOS:000354918600030
J	Park, JY; Kim, MH; Han, SS; Cho, H; Kim, H; Ryu, DR; Kim, H; Lee, H; Lee, JP; Lim, CS; Kim, KH; Joo, KW; Kim, YS; Kim, DK				Park, Jae Yoon; Kim, Myoung-Hee; Han, Seung Seok; Cho, Hyunjeong; Kim, Ho; Ryu, Dong-Ryeol; Kim, Hyunwook; Lee, Hajeong; Lee, Jung Pyo; Lim, Chun-Soo; Kim, Kyoung Hoon; Joo, Kwon Wook; Kim, Yon Su; Kim, Dong Ki		Clin Res Ctr End Stage Renal Dis	Recalibration and Validation of the Charlson Comorbidity Index in Korean Incident Hemodialysis Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; DIALYSIS PATIENTS; RISK ADJUSTMENT; MORTALITY; PREDICTORS; SURVIVAL; POPULATION; MORBIDITY; OUTCOMES; SCORE	Background Weights assigned to comorbidities to predict mortality may vary based on the type of index disease and advances in the management of comorbidities. We aimed to develop a modified Charlson comorbidity index (CCI) in incident hemodialysis patients (mCCI-IHD), thereby improving risk stratification for mortality. Methods Data on 24,738 Koreans who received their first hemodialysis treatment between 2005 and 2008 were obtained from the Korean Health Insurance dataset. The mCCI-IHD score were calculated by summing up the weights which were assigned to individual comorbidities according to their relative prognostic significance determined by multivariate Cox proportional hazards model. The modified index was validated in an independent nationwide prospective cohort (n=1,100). Results The Cox proportional hazards model revealed that all comorbidities in the CCI except ulcers significantly predicted mortality. Thus, the mCCI-IHD included 14 comorbidities with reassigned severity weights. In the validation cohort, both the CCI and the mCCI-IHD were correlated with mortality. However, the mCCI-IHD showed modest but significant increases in c statistics compared with the CCI at 6 months and 1 year. The analyses using continuous net reclassification improvement revealed that the mCCI-IHD improved net mortality risk reclassification by 24.6% (95% CI, 2.5-46.7; P=0.03), 26.2% (95% CI, 1.0-51.4; P=0.04) and 42.8%(95% CI, 4.9-80.8; P=0.03) with respect to the CCI at 6 months and 1 and 2 years, respectively. Conclusions The mCCI-IHD facilitates better risk stratification for mortality in incident hemodialysis patients compared with the CCI, suggesting that it may be a preferred index for use in clinical practice and the statistical analysis of epidemiological studies.	[Park, Jae Yoon; Han, Seung Seok; Cho, Hyunjeong; Joo, Kwon Wook; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Myoung-Hee] Eulji Univ, Coll Hlth Sci, Dept Dent Hyg, Taejon, Gyeonggi Do, South Korea; [Kim, Ho] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Seoul, South Korea; [Ryu, Dong-Ryeol] Ewha Womans Univ, Dept Internal Med, Seoul, South Korea; [Ryu, Dong-Ryeol] Ewha Womans Univ, Sch Med, Ewha Med Res Inst, Seoul, South Korea; [Kim, Hyunwook] Wonkwang Univ, Dept Internal Med, Coll Med Sanbon Hosp, Iksan Si, Gyeonggi Do, South Korea; [Lee, Jung Pyo; Lim, Chun-Soo] Seoul Natl Univ, Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Kyoung Hoon] Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea	Seoul National University (SNU); Eulji University; Seoul National University (SNU); Ewha Womans University; Ewha Womans University; Wonkwang University; Seoul National University (SNU); Korea University	Kim, DK (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	dkkim73@gmail.com	Han, Seung Seok/HGD-2825-2022; Kim, Ho/AAS-2402-2021; Kim, Dong Ki/J-5389-2012	Kim, Ho/0000-0001-7472-3752; Kim, Dong Ki/0000-0002-5195-7852; Cho, Hyunjeong/0000-0002-6005-3484; Ryu, Dong-Ryeol/0000-0002-5309-7606; Park, Jung Tak/0000-0002-2325-8982	Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea [HI10C2020]	Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea	This work was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (HI10C2020).	[Anonymous], 1997, P AM STAT ASS BIOM S; Athienites NV, 2000, SEMIN DIALYSIS, V13, P320, DOI 10.1046/j.1525-139x.2000.00095.x; Beddhu S, 2000, AM J MED, V108, P609, DOI 10.1016/S0002-9343(00)00371-5; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; Hall SF, 2006, J CLIN EPIDEMIOL, V59, P849, DOI 10.1016/j.jclinepi.2005.11.013; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Jin DC, 2014, KIDNEY RES CLIN PRAC, V33, P9, DOI 10.1016/j.krcp.2014.01.002; KHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J; Khan IH, 1998, NEPHROL DIAL TRANSPL, V13, P76, DOI 10.1093/ndt/13.suppl_1.76; KOPPLE JD, 1994, AM J KIDNEY DIS, V24, P1002, DOI 10.1016/S0272-6386(12)81075-4; Kopple JD, 1999, KIDNEY INT, V56, P1136, DOI 10.1046/j.1523-1755.1999.00615.x; Leavey SF, 1998, AM J KIDNEY DIS, V31, P997, DOI 10.1053/ajkd.1998.v31.pm9631845; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; Longenecker JC, 2000, J AM SOC NEPHROL, V11, P520, DOI 10.1681/ASN.V113520; Miskulin D, 2005, PERITON DIALYSIS INT, V25, P320; Miskulin D, 2009, CLIN J AM SOC NEPHRO, V4, P1818, DOI 10.2215/CJN.00640109; Miskulin DC, 2001, KIDNEY INT, V60, P1498, DOI 10.1046/j.1523-1755.2001.00954.x; Miskulin DC, 2004, NEPHROL DIAL TRANSPL, V19, P413, DOI 10.1093/ndt/gfg571; Miskulin DC, 2002, AM J KIDNEY DIS, V39, P324, DOI 10.1053/ajkd.2002.30552; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2012, STAT MED, V31, P101, DOI 10.1002/sim.4348; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Radovanovic D, 2014, HEART, V100, P288, DOI 10.1136/heartjnl-2013-304588; Reyes C, 2014, OSTEOPOROSIS INT, V25, P1751, DOI 10.1007/s00198-014-2682-9; Selim G, 2015, INT UROL NEPHROL, V47, P153, DOI 10.1007/s11255-014-0794-y; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916; Wallen MD, 2001, CLIN NEPHROL, V55, P101; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Wu PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061930	40	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127240	10.1371/journal.pone.0127240	http://dx.doi.org/10.1371/journal.pone.0127240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984790	Green Submitted, Green Published, gold			2022-12-27	WOS:000354917300104
J	Shao, MW; Wei, ZZ; Hu, MJ; Zhang, GJ				Shao, Mingwei; Wei, Zhenzhong; Hu, Mengjie; Zhang, Guangjun			Correction Method for Line Extraction in Vision Measurement	PLOS ONE			English	Article							3-D OBJECT RETRIEVAL; DETECTOR; RECOGNITION; SCALE; MODEL	Over-exposure and perspective distortion are two of the main factors underlying inaccurate feature extraction. First, based on Steger's method, we propose a method for correcting curvilinear structures (lines) extracted from over-exposed images. A new linemodel based on the Gaussian line profile is developed, and its description in the scale space is provided. The line position is analytically determined by the zero crossing of its first-order derivative, and the bias due to convolution with the normal Gaussian kernel function is eliminated on the basis of the related description. The model considers over-exposure features and is capable of detecting the line position in an over-exposed image. Simulations and experiments show that the proposed method is not significantly affected by the exposure level and is suitable for correcting lines extracted from an over-exposed image. In our experiments, the corrected result is found to bemore precise than the uncorrected result by around 45.5%. Second, we analyze perspective distortion, which is inevitable during line extraction owing to the projective camera model. The perspective distortion can be rectified on the basis of the bias introduced as a function of related parameters. The properties of the proposed model and its application to vision measurement are discussed. In practice, the proposed model can be adopted to correct line extraction according to specific requirements by employing suitable parameters.	[Shao, Mingwei; Wei, Zhenzhong; Hu, Mengjie; Zhang, Guangjun] Beihang Univ, Key Lab Precis Optomech Technol, Minist Educ, Beijing 100191, Peoples R China	Beihang University	Wei, ZZ (corresponding author), Beihang Univ, Key Lab Precis Optomech Technol, Minist Educ, Beijing 100191, Peoples R China.	zhenzhongwei@buaa.edu.cn			National Natural Science Foundation of China [61340054]; Natural Science Foundation of Beijing [3142012]; National Key Scientific Instrument and Equipment Development Project [2012YQ140032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); National Key Scientific Instrument and Equipment Development Project	This work is supported by the National Natural Science Foundation of China (61340054) (http://www.nsfc.gov.cn/) with Grant Recipient: Zhenzhong Wei, the Natural Science Foundation of Beijing (3142012) (http://www.bjnsf.org/) with Grant Recipient: Zhenzhong Wei and the National Key Scientific Instrument and Equipment Development Project (2012YQ140032) (http://www.most.gov.cn/) with Grant Recipient: Guangjun Zhang. Zhenzhong Wei received his PhD degree from the School of Automation Science and Electrical Engineering at Beihang University, China, in 2003. He is now a professor in the School of Instrumentation Science and Opto-electronics Engineering Beihang University, China. His research interests are machine vision and artificial intelligence. Guangjun Zhang received his PhD degree from the Department of Precision Instrument Engineering of Tianjin University, China, in 1991. He was a visiting professor at North Dakota State University, USA, from 1997 to 1998. He was a Yangtze River Scholar Award Program Professor in 2000. He is currently a professor in the School of Instrumentation Science and Opto-electronics Engineering, Beihang University China and an academician of CAE. His research interests are laser precision measurement, machine vision, optical sensing, and artificial intelligence.	[Anonymous], 2012, INT J COMPUT VISION, DOI DOI 10.1007/s11263-011-0472-9; Fleming M. G., 1999, SKIN RES TECHNOL, V5, P42; Fleming MG, 1998, COMPUT MED IMAG GRAP, V22, P375, DOI 10.1016/S0895-6111(98)00048-2; FLORACK LMJ, 1992, IMAGE VISION COMPUT, V10, P376, DOI 10.1016/0262-8856(92)90024-W; Gao Y, 2014, IEEE T IND ELECTRON, V61, P2088, DOI 10.1109/TIE.2013.2262760; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Guan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098806; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Guan T, 2011, IEEE COMPUT GRAPH, V31, P56, DOI 10.1109/MCG.2010.23; Guo D, 2010, PROC CVPR IEEE, P515, DOI 10.1109/CVPR.2010.5540170; Hedman K., 2010, STAT FUSION MULTIASP, V654; Heikkila J, 1997, COMPUTER VISION PATT; Hinz S, 2004, PHOTOGRAMM ENG REM S, V70, P1457, DOI 10.14358/PERS.70.12.1457; Hinz S, 2003, ISPRS J PHOTOGRAMM, V58, P83, DOI 10.1016/S0924-2716(03)00019-4; Hinz S, 2009, ISPRS J PHOTOGRAMM, V64, P297, DOI 10.1016/j.isprsjprs.2008.10.006; Jang JH, 2002, PATTERN RECOGN, V35, P807, DOI 10.1016/S0031-3203(01)00073-5; Jeon BK, 2002, IEEE T GEOSCI REMOTE, V40, P22, DOI 10.1109/36.981346; Lemaitre C, 2007, LECT NOTES COMPUT SC, V4673, P686; Nuydens R, 2000, APOPTOSIS, V5, P43, DOI 10.1023/A:1009685609275; Press W. H., 1992, ART SCI COMPUTING; Stanford DC, 2000, IEEE T PATTERN ANAL, V22, P601, DOI 10.1109/34.862198; Steger C, 1998, IEEE T PATTERN ANAL, V20, P113, DOI 10.1109/34.659930; Steger C, 2013, COMPUT VIS IMAGE UND, V117, P97, DOI 10.1016/j.cviu.2012.08.007; Sun JH, 2006, SENSOR ACTUAT A-PHYS, V132, P460, DOI 10.1016/j.sna.2006.02.048; Tseng HY, 2008, ICHIT 2008: INTERNATIONAL CONFERENCE ON CONVERGENCE AND HYBRID INFORMATION TECHNOLOGY, PROCEEDINGS, P176, DOI 10.1109/ICHIT.2008.231; Wei ZZ, 2005, SENSOR ACTUAT A-PHYS, V120, P527, DOI 10.1016/j.sna.2004.12.007; Wessel B., 2006, AUTOMATISCHE EXTRAKT, V600; Wong AKC, 2005, COMPUT VIS IMAGE UND, V98, P398, DOI 10.1016/j.cviu.2004.09.003; Xiong GL, 2006, CYTOM PART A, V69A, P494, DOI 10.1002/cyto.a.20296; Yang X, OPTOELECTRONIC ENG, V31, P46; Zhang GJ, 2003, MEAS SCI TECHNOL, V14, P1420, DOI 10.1088/0957-0233/14/8/331; Zhang Y, 2007, NEUROIMAGE, V36, P346, DOI 10.1016/j.neuroimage.2007.02.044	34	0	0	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127068	10.1371/journal.pone.0127068	http://dx.doi.org/10.1371/journal.pone.0127068			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984762	Green Submitted, Green Published, gold			2022-12-27	WOS:000354917300084
J	Lee, J; Maslove, DM; Dubin, JA				Lee, Joon; Maslove, David M.; Dubin, Joel A.			Personalized Mortality Prediction Driven by Electronic Medical Data and a Patient Similarity Metric	PLOS ONE			English	Article							CARE; SYSTEMS; SCORE	Background Clinical outcome prediction normally employs static, one-size-fits-all models that perform well for the average patient but are sub-optimal for individual patients with unique characteristics. In the era of digital healthcare, it is feasible to dynamically personalize decision support by identifying and analyzing similar past patients, in a way that is analogous to personalized product recommendation in e-commerce. Our objectives were: 1) to prove that analyzing only similar patients leads to better outcome prediction performance than analyzing all available patients, and 2) to characterize the trade-off between training data size and the degree of similarity between the training data and the index patient for whom prediction is to be made. Methods and Findings We deployed a cosine-similarity-based patient similarity metric (PSM) to an intensive care unit (ICU) database to identify patients that are most similar to each patient and subsequently to custom-build 30-day mortality prediction models. Rich clinical and administrative data from the first day in the ICU from 17,152 adult ICU admissions were analyzed. The results confirmed that using data from only a small subset of most similar patients for training improves predictive performance in comparison with using data from all available patients. The results also showed that when too few similar patients are used for training, predictive performance degrades due to the effects of small sample sizes. Our PSM-based approach outperformed well-known ICU severity of illness scores. Although the improved prediction performance is achieved at the cost of increased computational burden, Big Data technologies can help realize personalized data-driven decision support at the point of care. Conclusions The present study provides crucial empirical evidence for the promising potential of personalized data-driven decision support systems. With the increasing adoption of electronic medical record (EMR) systems, our novel medical data analytics contributes to meaningful use of EMR data.	[Lee, Joon; Dubin, Joel A.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Maslove, David M.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Maslove, David M.] Queens Univ, Crit Care Program, Kingston, ON, Canada; [Dubin, Joel A.] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo; Queens University - Canada; Queens University - Canada; University of Waterloo	Lee, J (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada.	joon.lee@uwaterloo.ca	Maslove, David M/H-4645-2019	Maslove, David M/0000-0002-0765-7158; Lee, Joon/0000-0001-8593-9321	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04743, RGPIN-2014-05911]; University of Waterloo; Queen's University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Waterloo; Queen's University	Funding: JL (RGPIN-2014-04743) and JD (RGPIN-2014-05911) were partially supported by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). JL and JD were otherwise supported by the University of Waterloo as faculty members. DM was fully supported by Queen's University as a faculty member. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Bakhshi-Raiez F, 2007, CRIT CARE MED, V35, P2553, DOI 10.1097/01.CCM.0000288123.29559.5A; Breese J. S., 1998, Uncertainty in Artificial Intelligence. Proceedings of the Fourteenth Conference (1998), P43; Celi LA, 2012, J PERS MED, V2, P138, DOI 10.3390/jpm2040138; Celi LA, 2013, AM J RESP CRIT CARE, V187, P1157, DOI 10.1164/rccm.201212-2311ED; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Kramer AA, 2015, CRIT CARE MED, V43, P261, DOI 10.1097/CCM.0000000000000694; LEGALL JR, 1983, LANCET, V2, P741; Nahm U.Y., 2002, P AAAI 2002 SPRING S; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; Schneeweiss S, 2014, NEW ENGL J MED, V370, P2161, DOI 10.1056/NEJMp1401111; Silver N., 2003, BASEBALL PROSPECTUS, V2003, P507; Sun J, 2012, ACM SIGKDD EXPLORATI, V14, P16, DOI DOI 10.1145/2408736.2408740; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; 2014, MIT TECHNOL REV, V117, P1	18	33	33	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127428	10.1371/journal.pone.0127428	http://dx.doi.org/10.1371/journal.pone.0127428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978419	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100144
J	Schneider, RR; Bayne, EM				Schneider, Richard R.; Bayne, Erin M.			Reserve Design under Climate Change: From Land Facets Back to Ecosystem Representation	PLOS ONE			English	Article							CHANGE ADAPTATION; SPECIES DISTRIBUTION; ASSISTED MIGRATION; CONSERVATION; BIODIVERSITY; MICROREFUGIA; STRATEGIES; MANAGEMENT; VEGETATION; REFUGIA	Ecosystem distributions are expected to shift as a result of global warming, raising concerns about the long-term utility of reserve systems based on coarse-filter ecosystem representation. We tested the extent to which proportional ecosystem representation targets would be maintained under a changing climate by projecting the distribution of the major ecosystems of Alberta, Canada, into the future using bioclimatic envelope models and then calculating the composition of reserves in successive periods. We used the Marxan conservation planning software to generate the suite of reserve systems for our test, varying the representation target and degree of reserve clumping. Our climate envelope projections for the 2080s indicate that virtually all reserves will, in time, be comprised of different ecosystem types than today. Nevertheless, our proportional targets for ecosystem representation were maintained across all time periods, with only minor exceptions. We hypothesize that this stability in representation arises because ecosystems may be serving as proxies for land facets, the stable abiotic landscape features that delineate major arenas of biological activity. The implication is that accommodating climate change may not require abandoning the conventional ecosystem-based approach to reserve design in favour of a strictly abiotic approach, since the two approaches may be largely synonymous.	[Schneider, Richard R.; Bayne, Erin M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Schneider, RR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	rnschnei@ualberta.ca		Bayne, Erin/0000-0002-0679-4521	Climate Change and Emission Management Corporation	Climate Change and Emission Management Corporation	This report was funded by the Climate Change and Emission Management Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Camacho A, 2010, 20124 UC IRV SCH LAW; Craig RK, 2010, HARVARD ENVIRON LAW, V34, P9; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Doerr VAJ, 2011, J APPL ECOL, V48, P143, DOI 10.1111/j.1365-2664.2010.01899.x; Dunlop M, 2013, CLIMATE READY CONSER; FULLER LG, 1993, CAN J SOIL SCI, V73, P613, DOI 10.4141/cjss93-059; Game ET, 2011, GLOBAL CHANGE BIOL, V17, P3150, DOI 10.1111/j.1365-2486.2011.02457.x; Game ET, 2008, MARXAN USER MANUAL M; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Hauer G, 2010, NET PRESENT VALUE MO; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; HOGG EH, 1994, CAN J FOREST RES, V24, P1835, DOI 10.1139/x94-237; Holmes Keith R., 2013, Diversity-Basel, V5, P352; Huggett RJ, 1998, CATENA, V32, P155, DOI 10.1016/S0341-8162(98)00053-8; Hunter M, 2010, CONSERV BIOL, V24, P1169, DOI 10.1111/j.1523-1739.2010.01569.x; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; KLIJN F, 1994, LANDSCAPE ECOL, V9, P89, DOI 10.1007/BF00124376; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lemieux CJ, 2005, CAN GEOGR-GEOGR CAN, V49, P384, DOI 10.1111/j.0008-3658.2005.00103.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meidinger D., 1991, ECOSYSTEMS BRIT COLU; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Natural Regions Committee, 2006, NAT REG SUBR ALB; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pedlar JH, 2011, FOREST CHRON, V87, P766, DOI 10.5558/tfc2011-093; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Roberts DR, 2012, ECOGRAPHY, V35, P792, DOI 10.1111/j.1600-0587.2011.07147.x; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Rowe J. S., 1972, Publication, Canadian Forestry Service, pmap; Schneider R.R., 2013, ALBERTAS NATURAL SUB; Schneider RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023254; Schneider RR, 2009, CAN J FOREST RES, V39, P1001, DOI 10.1139/X09-033; Schneider RR, 2014, CONSERVING ALBERTAS; Scott D, 2005, FOREST CHRON, V81, P696, DOI 10.5558/tfc81696-5; Staudt A, 2013, FRONT ECOL ENVIRON, V11, P494, DOI 10.1890/120275; Strong WL, 2005, J BIOGEOGR, V32, P1043, DOI 10.1111/j.1365-2699.2004.01223.x; Tingley MW, 2014, ANN NY ACAD SCI, V1322, P92, DOI 10.1111/nyas.12484; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Watson J.E.M., 2011, CONSERVATION BIOGEOG, P136, DOI [DOI 10.1002/9781444390001.CH6, 10.1002/9781444390001.ch6]; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Woodward FI, 1997, GLOBAL ECOL BIOGEOGR, V6, P413, DOI 10.2307/2997350	54	3	3	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126918	10.1371/journal.pone.0126918	http://dx.doi.org/10.1371/journal.pone.0126918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978759	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100114
J	Xiao, YH; van Hijum, SAFT; Abee, T; Wells-Bennik, MHJ				Xiao, Yinghua; van Hijum, Sacha A. F. T.; Abee, Tjakko; Wells-Bennik, Marjon H. J.			Genome-Wide Transcriptional Profiling of Clostridium perfringens SM101 during Sporulation Extends the Core of Putative Sporulation Genes and Genes Determining Spore Properties and Germination Characteristics	PLOS ONE			English	Article							BACILLUS-SUBTILIS; DIPICOLINIC ACID; BACTERIAL-SPORES; HEAT-RESISTANCE; SER/THR KINASE; KILLING FACTOR; IDENTIFICATION; DIFFICILE; PROTEINS; SEQUENCE	The formation of bacterial spores is a highly regulated process and the ultimate properties of the spores are determined during sporulation and subsequent maturation. A wide variety of genes that are expressed during sporulation determine spore properties such as resistance to heat and other adverse environmental conditions, dormancy and germination responses. In this study we characterized the sporulation phases of C. perfringens enterotoxic strain SM101 based on morphological characteristics, biomass accumulation (OD600), the total viable counts of cells plus spores, the viable count of heat resistant spores alone, the pH of the supernatant, enterotoxin production and dipicolinic acid accumulation. Subsequently, whole-genome expression profiling during key phases of the sporulation process was performed using DNA microarrays, and genes were clustered based on their time-course expression profiles during sporulation. The majority of previously characterized C. perfringens germination genes showed upregulated expression profiles in time during sporulation and belonged to two main clusters of genes. These clusters with up-regulated genes contained a large number of C. perfringens genes which are homologs of Bacillus genes with roles in sporulation and germination; this study therefore suggests that those homologs are functional in C. perfringens. A comprehensive homology search revealed that approximately half of the upregulated genes in the two clusters are conserved within a broad range of sporeforming Firmicutes. Another 30% of upregulated genes in the two clusters were found only in Clostridium species, while the remaining 20% appeared to be specific for C. perfringens. These newly identified genes may add to the repertoire of genes with roles in sporulation and determining spore properties including germination behavior. Their exact roles remain to be elucidated in future studies.	[Xiao, Yinghua; van Hijum, Sacha A. F. T.; Wells-Bennik, Marjon H. J.] NIZO Food Res, Ede, Netherlands; [Xiao, Yinghua; van Hijum, Sacha A. F. T.; Abee, Tjakko; Wells-Bennik, Marjon H. J.] Top Inst Food & Nutr, Wageningen, Netherlands; [van Hijum, Sacha A. F. T.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Xiao, Yinghua; Abee, Tjakko] Wageningen Univ, Food Microbiol Lab, NL-6700 AP Wageningen, Netherlands	NIZO Food Research; Top Institute Food & Nutrition; Radboud University Nijmegen; Wageningen University & Research	Wells-Bennik, MHJ (corresponding author), NIZO Food Res, Ede, Netherlands.	marjon.wells-bennik@nizo.com	van Hijum, Sacha/F-6445-2014	van Hijum, Sacha/0000-0003-0741-2991	TI Food and Nutrition; NIZO food research	TI Food and Nutrition; NIZO food research	Funding: The project is funded by TI Food and Nutrition, a public-private partnership on pre-competitive research in food and nutrition. The public partners are responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The private partners have contributed to the project through regular discussion. NIZO food research provided support in the form of salaries for authors Yinghua Xiao, Sacha A.F.T. van Hijum and Marjon H.J. Wells-Bennik, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abecasis AB, 2013, J BACTERIOL, V195, P2101, DOI 10.1128/JB.02110-12; Adams CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003165; Akhtar S, 2009, FOOD MICROBIOL, V26, P272, DOI 10.1016/j.fm.2008.12.011; Al-Hinai MA, 2015, MICROBIOL MOL BIOL R, V79, P19, DOI 10.1128/MMBR.00025-14; Allenby NEE, 2006, J BACTERIOL, V188, P5299, DOI 10.1128/JB.00084-06; Alsaker KV, 2005, J BACTERIOL, V187, P7103, DOI 10.1128/JB.187.20.7103-7118.2005; Banawas S, 2013, J BACTERIOL, V195, P5084, DOI 10.1128/JB.00901-13; Bassi D, 2013, FOOD MICROBIOL, V33, P11, DOI 10.1016/j.fm.2012.08.004; Burns DA, 2011, J MICROBIOL METH, V87, P133, DOI 10.1016/j.mimet.2011.07.017; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Durre P, 2011, MOL MICROBIOL, V80, P584, DOI 10.1111/j.1365-2958.2011.07628.x; DUNCAN CL, 1973, J BACTERIOL, V113, P932, DOI 10.1128/JB.113.2.932-936.1973; Durre P, 2009, CLOSTRIDIA MOL BIOL, DOI [10.1016/j.ijpara.2008.10.001, DOI 10.1016/J.IJPARA.2008.10.001]; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Eichenberger P, 2012, BACILLUS: CELLULAR AND MOLECULAR BIOLOGY, SECOND EDITION, P319; Ermolaeva MD, 2000, J MOL BIOL, V301, P27, DOI 10.1006/jmbi.2000.3836; Fimlaid KA, 2015, CURR OPIN MICROBIOL, V24, P88, DOI 10.1016/j.mib.2015.01.006; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Hassan KA, 2011, GENOMES OF FOODBORNE AND WATERBORNE PATHOGENS, P213; Jones SW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r114; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kirk DG, 2012, APPL ENVIRON MICROB, V78, P4590, DOI 10.1128/AEM.00304-12; Kort R, 2005, APPL ENVIRON MICROB, V71, P3556, DOI 10.1128/AEM.71.7.3556-3564.2005; Kumazawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P884, DOI 10.1271/bbb.60511; Kuwana R, 2006, J BIOCHEM, V139, P887, DOI 10.1093/jb/mvj096; LABBE RG, 1979, APPL ENVIRON MICROB, V37, P1196, DOI 10.1128/AEM.37.6.1196-1200.1979; Lamsa A, 2012, MOL MICROBIOL, V84, P486, DOI 10.1111/j.1365-2958.2012.08038.x; Leimena MM, 2012, APPL ENVIRON MICROB, V78, P4141, DOI 10.1128/AEM.00470-12; Li Guojun, 2009, Journal of Bioinformatics and Computational Biology, V7, P19, DOI 10.1142/S0219720009003984; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Masayama A, 2006, GENES GENET SYST, V81, P227, DOI 10.1266/ggs.81.227; McClane BA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P698, DOI 10.1007/0-387-30744-3_22; McClane BA, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P423; Morales P, 2013, PRODUCTION RESPONSE; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Orsburn B, 2009, FEMS MICROBIOL LETT, V291, P188, DOI 10.1111/j.1574-6968.2008.01454.x; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Paredes-Sabja D, 2008, MICROBIOL-SGM, V154, P2241, DOI 10.1099/mic.0.2008/016592-0; Paredes-Sabja D, 2008, J BACTERIOL, V190, P1190, DOI 10.1128/JB.01748-07; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Paredes-Sabja D, 2009, MICROBIOL-SGM, V155, P3464, DOI 10.1099/mic.0.030965-0; Paredes-Sabja D, 2009, APPL ENVIRON MICROB, V75, P3813, DOI 10.1128/AEM.00048-09; Paredes-Sabja D, 2009, J BACTERIOL, V191, P2711, DOI 10.1128/JB.01832-08; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Sarker MR, 1999, MOL MICROBIOL, V33, P946, DOI 10.1046/j.1365-2958.1999.01534.x; Sarker MR., 2007, BANGLADESH J MICROBI, V24, P1; Setlow B, 2006, J BACTERIOL, V188, P3740, DOI 10.1128/JB.00212-06; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shah IM, 2010, MOL MICROBIOL, V75, P1232, DOI 10.1111/j.1365-2958.2010.07046.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Stevens MJA, 2010, MICROBIOL-SGM, V156, P695, DOI 10.1099/mic.0.034165-0; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Ooiij C, 2004, J BACTERIOL, V186, P4441, DOI 10.1128/JB.186.14.4441-4448.2004; Wernersson R, 2007, NAT PROTOC, V2, P2677, DOI 10.1038/nprot.2007.370; Westers H, 2005, APPL ENVIRON MICROB, V71, P1899, DOI 10.1128/AEM.71.4.1899-1908.2005; Xiao YH, 2012, APPL ENVIRON MICROB, V78, P7060, DOI 10.1128/AEM.01486-12; Xiao YH, 2011, FOOD MICROBIOL, V28, P266, DOI 10.1016/j.fm.2010.03.016	64	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127036	10.1371/journal.pone.0127036	http://dx.doi.org/10.1371/journal.pone.0127036			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978838	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100122
J	Zhao, ZH; Yang, L; Yang, GH; Zhuang, Y; Qian, XF; Zhou, X; Xiao, DJ; Shen, YF				Zhao, Zhenhua; Yang, Lei; Yang, Guohua; Zhuang, Yun; Qian, Xifeng; Zhou, Xin; Xiao, Dajiang; Shen, Yunfeng			Contributions of T Lymphocyte Abnormalities to Therapeutic Outcomes in Newly Diagnosed Patients with Immune Thrombocytopenia	PLOS ONE			English	Article							INTRAVENOUS GAMMA-GLOBULIN; DENDRITIC CELLS; MEDIATED CYTOTOXICITY; PURPURA ITP; B-CELLS; IMMUNOGLOBULIN; ADULTS; EXPANSION; PROSTAGLANDIN-E2; PLATELETS	T cell abnormalities have been reported to play an important role in pathogenesis of immune thrombocytopenia (ITP) besides specific autoantibodies towards platelet. The aim of this study was to explore the clinical importance of T lymphocyte subsets in adult patients with newly diagnosed ITP before and after first-line treatment. Elderly ITP patients were also studied and we tried to analyze the relationships between these items and therapeutic outcomes. The patients were treated with intravenous immunoglobulin (IVIG) plus corticosteroids and therapeutic responses were evaluated. As a result, compared with the controls, absolute lymphocyte counts in ITP patients decreased significantly before treatment. After treatment, lymphocyte counts restored to control level regardless of their treatment outcomes. In addition, we observed increased IgG and CD19(+) cell expression and decreased CD4(+)/CD8(+) cell ratio in both whole ITP group and elderly group before treatment. After treatment, the increased IgG and CD19(+) cell expression could be reduced in both respond and non-respond group regardless of patient age, while CD4(+)/CD8(+) cell ratio could not be corrected in non-respond ITP patients. In non-respond ITP patients, increased CD8(+) cell expression was noticed and could not be corrected by first-line treatment. Furthermore, even lower NK cell expression was found in non-respond elderly patients after treatment when compared with that in controls. Our findings suggest that ITP patients usually had less numbers of peripheral lymphocytes and patients with higher levels of CD8(+) cells or lower levels of CD4(+)/CD8(+) cell ratio were less likely to respond to first-line treatment. Lower levels of NK cells made therapies in elderly ITP patients even more difficult.	[Zhao, Zhenhua; Xiao, Dajiang] Nanjing Med Univ, Dept Otolaryngol, Affiliated Wuxi Hosp 2, Wuxi 214002, Jiangsu, Peoples R China; [Yang, Lei; Yang, Guohua; Zhuang, Yun; Qian, Xifeng; Zhou, Xin; Shen, Yunfeng] Nanjing Med Univ, Dept Hematol, Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China	Nanjing Medical University; Jiangnan University; Nanjing Medical University	Xiao, DJ (corresponding author), Nanjing Med Univ, Dept Otolaryngol, Affiliated Wuxi Hosp 2, Wuxi 214002, Jiangsu, Peoples R China.	dajiang2125@163.com; yfshen21cn2012@hotmail.com			National Natural Science Foundation of China [81300382]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (No. 81300382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2010, PEDIATR BLOOD CANCER, V55, P508, DOI 10.1002/pbc.22570; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Bahoush G, 2014, MINERVA PEDIAT; Bayry J, 2012, J RHEUMATOL, V39, P450, DOI 10.3899/jrheum.111123; Bennett D, 2011, ADV THER, V28, P1096, DOI 10.1007/s12325-011-0084-3; Bizzoni L, 2006, EUR J HAEMATOL, V76, P210, DOI 10.1111/j.1600-0609.2005.00602.x; Rocha AMC, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-28; Chow L, 2010, BLOOD, V115, P1247, DOI 10.1182/blood-2009-09-244772; Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; CORTELAZZO S, 1991, BLOOD, V77, P31; Deel MD, 2013, PEDIATR BLOOD CANCER, V60, P1967, DOI 10.1002/pbc.24628; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; FEHR J, 1982, NEW ENGL J MED, V306, P1254, DOI 10.1056/NEJM198205273062102; Feudjo-Tepie M A, 2009, Adv Hematol, V2009, P963506, DOI 10.1155/2009/963506; GEORGE JN, 1994, NEW ENGL J MED, V331, P1207, DOI 10.1056/NEJM199411033311807; Guhr T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021246; Hu MH, 2014, ANN HEMATOL, V93, P1023, DOI 10.1007/s00277-014-2014-3; Jacobi C, 2009, CLIN IMMUNOL, V133, P393, DOI 10.1016/j.clim.2009.09.006; Johansson U, 2004, BRIT J HAEMATOL, V125, P400, DOI 10.1111/j.1365-2141.2004.04896.x; Karpatkin S, 1997, LANCET, V349, P1531, DOI 10.1016/S0140-6736(96)12118-8; Lazarus Alan H, 2013, Semin Hematol, V50 Suppl 1, pS68, DOI 10.1053/j.seminhematol.2013.03.012; Leontyev D, 2012, TRANSFUSION, V52, P1799, DOI 10.1111/j.1537-2995.2011.03517.x; Lopez-Karpovitch X, 2008, ARCH MED RES, V39, P541, DOI 10.1016/j.arcmed.2008.04.004; Lutz HU, 2004, BLOOD, V103, P465, DOI 10.1182/blood-2003-05-1530; Maddur MS, 2015, CELL MOL IMMUNOL, V12, P650, DOI 10.1038/cmi.2014.117; Maddur MS, 2013, J CLIN IMMUNOL, V33, pS62, DOI 10.1007/s10875-012-9752-6; Maddur MS, 2011, AUTOIMMUN REV, V11, P154, DOI 10.1016/j.autrev.2011.08.004; Maddur MS, 2011, AUTOIMMUN REV, V10, P809, DOI 10.1016/j.autrev.2011.02.007; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Michel M, 2011, AM J HEMATOL, V86, P980, DOI 10.1002/ajh.22170; Neylon AJ, 2003, BRIT J HAEMATOL, V122, P966, DOI 10.1046/j.1365-2141.2003.04547.x; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Pamuk GE, 2002, ANN HEMATOL, V81, P436, DOI 10.1007/s00277-002-0488-x; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Sakakura M, 2007, THROMB RES, V120, P187, DOI 10.1016/j.thromres.2006.09.008; Schwab I, 2012, EUR J IMMUNOL, V42, P826, DOI 10.1002/eji.201142260; Segal JB, 2006, J THROMB HAEMOST, V4, P2377, DOI 10.1111/j.1538-7836.2006.02147.x; Seite JF, 2014, J ALLERGY CLIN IMMUN, V133, P181, DOI 10.1016/j.jaci.2013.08.042; Semple JW, 2010, CURR OPIN HEMATOL, V17, P590, DOI 10.1097/MOH.0b013e32833eaef3; SEMPLE JW, 1991, AM J HEMATOL, V37, P258, DOI 10.1002/ajh.2830370409; Semple JW, 2003, TRANSFUS APHER SCI, V28, P237, DOI 10.1016/S1473-0502(03)00041-7; SEMPLE JW, 1994, BLOOD, V83, P870; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Talaat RM, 2014, CLIN EXP IMMUNOL, V176, P291, DOI 10.1111/cei.12279; Toltl LJ, 2011, SEMIN THROMB HEMOST, V37, P631, DOI 10.1055/s-0031-1291373; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; von Gunten S, 2014, NAT REV IMMUNOL, V14, P349, DOI 10.1038/nri3401-c1; Wang L, 2007, CRIT REV ONCOL HEMAT, V64, P83, DOI 10.1016/j.critrevonc.2007.05.007; Wei R, 2014, BLOOD COAGUL FIBRIN, V25, P816, DOI 10.1097/MBC.0000000000000155; Xu RL, 2014, EXP THER MED, V7, P149, DOI 10.3892/etm.2013.1386; Yang L, 2010, BLOOD, V116, P4307, DOI 10.1182/blood-2010-02-267435; Yazdanbakhsh Karina, 2013, Semin Hematol, V50 Suppl 1, pS63, DOI 10.1053/j.seminhematol.2013.03.011; Yu J, 2008, BLOOD, V112, P1325, DOI 10.1182/blood-2008-01-135335; Zhang F, 2006, EUR J HAEMATOL, V76, P427, DOI 10.1111/j.1600-0609.2005.00622.x; Zhao CH, 2008, HAEMATOL-HEMATOL J, V93, P1428, DOI 10.3324/haematol.12889	58	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126601	10.1371/journal.pone.0126601	http://dx.doi.org/10.1371/journal.pone.0126601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978334	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100084
J	Buckeridge, E; LeVangie, MC; Stetter, B; Nigg, SR; Nigg, BM				Buckeridge, Erica; LeVangie, Marc C.; Stetter, Bernd; Nigg, Sandro R.; Nigg, Benno M.			An On-Ice Measurement Approach to Analyse the Biomechanics of Ice Hockey Skating	PLOS ONE			English	Article							3-DIMENSIONAL KINEMATICS; SPEED; TREADMILL; SURFACE	Skating is a fundamental movement in ice hockey; however little research has been conducted within the field of hockey skating biomechanics due to the difficulties of on-ice data collection. In this study a novel on-ice measurement approach was tested for reliability, and subsequently implemented to investigate the forward skating technique, as well as technique differences across skill levels. Nine high caliber (High) and nine low caliber (Low) hockey players performed 30m forward skating trials. A 3D accelerometer was mounted to the right skate for the purpose of stride detection, with the 2nd and 6th strides defined as acceleration and steady-state, respectively. The activity of five lower extremity muscles was recorded using surface electromyography. Biaxial electro-goniometers were used to quantify hip and knee angles, and in-skate plantar force was measured using instrumented insoles. Reliability was assessed with the coefficient of multiple correlation, which demonstrated moderate (r>0.65) to excellent (r>0.95) scores across selected measured variables. Greater plantar-flexor muscle activity and hip extension were evident during acceleration strides, while steady state strides exhibited greater knee extensor activity and hip abduction range of motion (p<0.05). High caliber exhibited greater hip range of motion and forefoot force application (p<0.05). The successful implementation of this on-ice mobile measurement approach offers potential for athlete monitoring, biofeedback and training advice.	[Buckeridge, Erica; LeVangie, Marc C.; Stetter, Bernd; Nigg, Sandro R.; Nigg, Benno M.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	University of Calgary	Buckeridge, E (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	ebuckeri@ucalgary.ca		Stetter, Bernd/0000-0002-5291-4299	Natural Sciences and Engineering Research Council of Canada (NSERC), [1025673]	Natural Sciences and Engineering Research Council of Canada (NSERC),(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), RSO number: 1025673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CCM funded this research and also provided the skates that were used in the testing. However, the results presented in this paper do not in any way represent a bias toward CCM products over other brands.	Buckeridge EM, SCANDINAVIAN J MED S; DEKONING JJ, 1991, J BIOMECH, V24, P137, DOI 10.1016/0021-9290(91)90358-T; DEKONING JJ, 1995, MED SCI SPORT EXER, V27, P1703; Garofalo P, 2009, MED BIOL ENG COMPUT, V47, P475, DOI 10.1007/s11517-009-0454-z; German RZ, 2008, INTEGR COMP BIOL, V48, P283, DOI 10.1093/icb/icn022; Goudreault R, 2002, 4 WORLD C BIOM CALG; Houdijk H, 2000, MED SCI SPORT EXER, V32, P635, DOI 10.1097/00005768-200003000-00013; International Ice Hockey Federation, 2007, SKAT; Lafontaine D, 2007, SPORT BIOMECH, V6, P391, DOI 10.1080/14763140701491427; Neptune RR, 2005, J EXP BIOL, V208, P799, DOI 10.1242/jeb.01435; Nigg BM, 2001, CLIN J SPORT MED, V11, P2, DOI 10.1097/00042752-200101000-00002; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; Nobes KJ, 2003, CAN J APPL PHYSIOL, V28, P1, DOI 10.1139/h03-001; Pearsall D, 2001, KINEMATICS FOOT ANKL; Stidwill TJ, 2010, SPORT BIOMECH, V9, P57, DOI 10.1080/14763141003690237; Upjohn T, 2008, SPORT BIOMECH, V7, P206, DOI 10.1080/14763140701841621; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4	18	40	40	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127324	10.1371/journal.pone.0127324	http://dx.doi.org/10.1371/journal.pone.0127324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973775	Green Published, gold			2022-12-27	WOS:000354545600108
J	Kachalo, S; Naveed, H; Cao, YF; Zhao, JL; Liang, J				Kachalo, Sema; Naveed, Hammad; Cao, Youfang; Zhao, Jieling; Liang, Jie			Mechanical Model of Geometric Cell and Topological Algorithm for Cell Dynamics from Single-Cell to Formation of Monolayered Tissues with Pattern	PLOS ONE			English	Article							LATERAL INHIBITION; STEM-CELL; ASYMMETRIC DIVISION; AUTOMATON MODEL; SCALE CELLS; DROSOPHILA; APOPTOSIS; MORPHOGENESIS; NOTCH; MICROTUBULES	Geometric and mechanical properties of individual cells and interactions among neighboring cells are the basis of formation of tissue patterns. Understanding the complex interplay of cells is essential for gaining insight into embryogenesis, tissue development, and other emerging behavior. Here we describe a cell model and an efficient geometric algorithm for studying the dynamic process of tissue formation in 2D (e.g. epithelial tissues). Our approach improves upon previous methods by incorporating properties of individual cells as well as detailed description of the dynamic growth process, with all topological changes accounted for. Cell size, shape, and division plane orientation are modeled realistically. In addition, cell birth, cell growth, cell shrinkage, cell death, cell division, cell collision, and cell rearrangements are now fully accounted for. Different models of cell-cell interactions, such as lateral inhibition during the process of growth, can be studied in detail. Cellular pattern formation for monolayered tissues from arbitrary initial conditions, including that of a single cell, can also be studied in detail. Computational efficiency is achieved through the employment of a special data structure that ensures access to neighboring cells in constant time, without additional space requirement. We have successfully generated tissues consisting of more than 20,000 cells starting from 2 cells within 1 hour. We show that our model can be used to study embryogenesis, tissue fusion, and cell apoptosis. We give detailed study of the classical developmental process of bristle formation on the epidermis of D. melanogaster and the fundamental problem of homeostatic size control in epithelial tissues. Simulation results reveal significant roles of solubility of secreted factors in both the bristle formation and the homeostatic control of tissue size. Our method can be used to study broad problems in monolayered tissue formation. Our software is publicly available.	[Kachalo, Sema; Naveed, Hammad; Cao, Youfang; Zhao, Jieling; Liang, Jie] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Naveed, Hammad] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal, Saudi Arabia	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; King Abdullah University of Science & Technology	Liang, J (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	jliang@uic.edu	Zhao, Jieling/AAQ-7755-2020	Zhao, Jieling/0000-0002-9801-2434; Naveed, Hammad/0000-0002-1867-974X	NIH [GM079804, GM086145]; NSF [DMS-0800257, DBI 1062328]; University of Illinois at Chicago Research Open Access Article Publishing (ROAAP) Fund; Fulbright Scholarship; Higher Education Commission of Pakistan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM086145, R01GM079804, R01GM081682] Funding Source: NIH RePORTER; Direct For Biological Sciences [1062328] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Illinois at Chicago Research Open Access Article Publishing (ROAAP) Fund; Fulbright Scholarship; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NIH GM079804 and GM086145, NSF DMS-0800257 and DBI 1062328, and the University of Illinois at Chicago Research Open Access Article Publishing (ROAAP) Fund. H.N. was supported by a Fulbright Scholarship and the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BIGNONE FA, 1993, J THEOR BIOL, V161, P231, DOI 10.1006/jtbi.1993.1052; Bock IR, 1972, STUDIES IN GENETICS, V7; Brakke KA, 1994, SURFACE EVOLVER MANU; Brezavscek AH, 2012, BIOPHYS J, V103, P1069, DOI 10.1016/j.bpj.2012.07.018; Brill A, 1999, J ASSIST REPROD GEN, V16, P512, DOI 10.1023/A:1020541019347; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Bruce A., 2002, MOL BIOL CELL, V4th ed.; BURNSIDE B, 1971, DEV BIOL, V26, P416, DOI 10.1016/0012-1606(71)90073-X; Cao Y, 2013, C P IEEE ENG MED BIO, V2013; CAO Y, 2012, C P IEEE ENG MED BIO, V2012, P5502, DOI DOI 10.1109/EMBC.2012.6347240; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chen N, 2007, COMPUT PHYS COMMUN, V176, P670, DOI 10.1016/j.cpc.2007.03.007; Christley S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-107; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Craiu RV, 2006, IEEE T IMAGE PROCESS, V15, P1718, DOI 10.1109/TIP.2006.873472; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Delgado-Benarroch L, 2009, PLANT SIGNAL BEHAV, V4, P814, DOI 10.4161/psb.4.9.9394; DOMNINA LV, 1985, J CELL SCI, V74, P267; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Farhadifar R, 2009, DYNAMICS CELL PACKIN; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; FEDOROFF S, 1967, CAN J GENET CYTOL, V9, P412, DOI 10.1139/g67-045; French V, 1998, J INSECT PHYSIOL, V44, P1081, DOI 10.1016/S0022-1910(98)00061-4; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Galant R, 1998, CURR BIOL, V8, P807, DOI 10.1016/S0960-9822(98)70322-7; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; HADLEY NF, 1986, SCI AM, V255, P104, DOI 10.1038/scientificamerican0786-104; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; HELD LI, 1991, BIOESSAYS, V13, P633, DOI 10.1002/bies.950131203; Hilbert D, 1922, GEOMETRY IMAGINATION; Hilgenfeldt S, 2008, P NATL ACAD SCI USA, V105, P907, DOI 10.1073/pnas.0711077105; Hoehme S, 2010, BIOINFORMATICS, V26, P2641, DOI 10.1093/bioinformatics/btq437; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; HONDA H, 1990, DEVELOPMENT, V110, P1349; Honda H, 2000, ACTA BIOTHEOR, V48, P121, DOI 10.1023/A:1002796601050; Hotani H, 1990, Adv Biophys, V26, P135, DOI 10.1016/0065-227X(90)90010-Q; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; HYAFIL F, 1981, CELL, V26, P447, DOI 10.1016/0092-8674(81)90214-2; Isenberg C., 1992, SCI SOAP FILMS SOAP; Jamali Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012097; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jr LIH, 1984, CELL INTERACTIONS CO, P291; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; KAPLAN DR, 1991, BIOSCIENCE, V41, P693, DOI 10.2307/1311764; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Li YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086725; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043108; Li YZ, 2011, IEEE ENG MED BIO, P178, DOI 10.1109/IEMBS.2011.6089923; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Lo WC, 2009, MATH BIOSCI ENG, V6, P59, DOI 10.3934/mbe.2009.6.59; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Luthi PO, 1998, PHYSICA D, V118, P151, DOI 10.1016/S0167-2789(98)00008-6; Macdowell EC, 1915, J EXP ZOOL, V19, P61, DOI 10.1002/jez.1400190106; MADREPERLA SA, 1989, DEV BIOL, V131, P149, DOI 10.1016/S0012-1606(89)80046-6; Madzvamuse A, 2002, MATH J, V32, P325; MAINSTER MA, 1992, EYE, V6, P420, DOI 10.1038/eye.1992.88; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Maree AFM, 2007, SINGLE CELL BASED MO, P107, DOI DOI 10.1007/978-3-7643-8123-3_5; Mayer A. G., 1896, Bulletin of the Museum at Harvard College, Vxxix, P209; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; MIZUSHIMASUGANO J, 1983, BIOCHIM BIOPHYS ACTA, V755, P257, DOI 10.1016/0304-4165(83)90212-X; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; NAGAI T, 1988, J PHYS SOC JPN, V57, P2221, DOI 10.1143/JPSJ.57.2221; Nagai T, 2001, PHILOS MAG B, V81, P699, DOI 10.1080/13642810110055328; Nagai T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061903; Narui Y, 2013, BIOPHYS J, V105, P2655, DOI 10.1016/j.bpj.2013.11.012; Naveed H, 2010, IEEE ENG MED BIO, P3808, DOI 10.1109/IEMBS.2010.5627601; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; ORENIC TV, 1993, DEVELOPMENT, V118, P9; OSTER GF, 1988, MATH BIOSCI, V90, P265, DOI 10.1016/0025-5564(88)90070-3; OVERTON J, 1966, J CELL BIOL, V29, P293, DOI 10.1083/jcb.29.2.293; Palmari J, 1997, ANAL CELL PATHOL, V14, P75, DOI 10.1155/1997/183028; Parks AL, 1997, MECH DEVELOP, V63, P61, DOI 10.1016/S0925-4773(97)00675-8; Perez-Pomares JM, 2006, BIOESSAYS, V28, P809, DOI 10.1002/bies.20442; Plahte E, 2001, J MATH BIOL, V43, P411, DOI 10.1007/s002850100105; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Ray HJ, 2012, DEVELOPMENT, V139, P1701, DOI 10.1242/dev.068338; Reed RD, 2004, DEV GENES EVOL, V214, P43, DOI 10.1007/s00427-003-0366-0; Rejniak KA, 2007, J THEOR BIOL, V247, P186, DOI 10.1016/j.jtbi.2007.02.019; RICHARDS AG, 1951, INTEGUMENT ARTHROPOD; Roeder I, 2006, STEM CELL REV, V2, P171, DOI 10.1007/s12015-006-0045-4; Sekimura T, 2000, P ROY SOC B-BIOL SCI, V267, P851, DOI 10.1098/rspb.2000.1081; SIMPSON P, 1990, DEVELOPMENT, V109, P509; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Snyman J., 2005, PRACTICAL MATH OPTIM; SPRAGUE GF, 1983, ANNU REV MICROBIOL, V37, P623, DOI 10.1146/annurev.mi.37.100183.003203; Staple DB, 2010, EUR PHYS J E, V33, P117, DOI 10.1140/epje/i2010-10677-0; STERN C., 1954, Proceedings 9th int. Congr. Genet., P355; STERN CURT, 1954, AMER SCI, V42, P213; SULLIVAN SL, 1964, AICHE J, V10, P848, DOI 10.1002/aic.690100614; Toledano H, 2008, MECH REGULATING STEM; Tomasetti C, 2010, P NATL ACAD SCI USA, V107, P16766, DOI 10.1073/pnas.1007726107; Tsukaya H, 2003, CURR OPIN PLANT BIOL, V6, P57, DOI 10.1016/S1369526602000055; Tsukaya H, 2002, INT REV CYTOL, V217, P1; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Viens D, 2007, J BIOMECH ENG-T ASME, V129, P651, DOI 10.1115/1.2768375; Weaire D., 1999, PHYS FOAMS; WEILER K, 1985, IEEE COMPUT GRAPH, V5, P21, DOI 10.1109/MCG.1985.276271; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; WELIKY M, 1990, DEVELOPMENT, V109, P373; WIGGLESWORTH V B, 1972, P827; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhao Feng, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P304; Zhao Feng, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P820; Zhou SH, 2012, CURR BIOL, V22, P668, DOI 10.1016/j.cub.2012.02.065	119	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126484	10.1371/journal.pone.0126484	http://dx.doi.org/10.1371/journal.pone.0126484			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974182	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600055
J	Matsumura, K; Miyatake, T				Matsumura, Kentarou; Miyatake, Takahisa			Differences in Attack Avoidance and Mating Success between Strains Artificially Selected for Dispersal Distance in Tribolium castaneum	PLOS ONE			English	Article							TRADE-OFF; SEXUAL SELECTION; WING DIMORPHISM; REPRODUCTIVE-PERFORMANCE; PREDATION RISK; EVOLUTION; MALES; MIGRATION; FECUNDITY; FEMALE	Individuals of both dispersal and non-dispersal types (disperser and non-disperser) are found in a population, suggesting that each type has both costs and benefits for fitness. However, few studies have examined the trade-off between the costs and benefits for the types. Here, we artificially selected for walking distance, i.e., an indicator of dispersal ability, in the red flour beetle Tribolium castaneum and established strains with longer (L-strains) or shorter (S-strains) walking distances. We then compared the frequency of predation by the assassin bug Amphibolus venator and the mating frequency of the selected strains. L-strain beetles suffered higher predation risk, than did S-strain beetles. L-strain males had significantly increased mating success compared to S-strain males, but females did not show a significant difference between the strains. The current results showed the existence of a trade-off between predation avoidance and mating success associated with dispersal types at a genetic level only in males. This finding can help to explain the maintenance of variation in dispersal ability within a population.	[Matsumura, Kentarou; Miyatake, Takahisa] Okayama Univ, Grad Sch Environm & Life Sci, Lab Evolutionary Ecol, Okayama, Japan	Okayama University	Miyatake, T (corresponding author), Okayama Univ, Grad Sch Environm & Life Sci, Lab Evolutionary Ecol, Okayama, Japan.	miyatake@cc.okayama-u.ac.jp	Miyatake, Takahisa/B-6580-2017	Miyatake, Takahisa/0000-0002-5476-0676	Japan Society for the Promotion of Science KAKENHI [26291091]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI 26291091. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2007, J EXP MAR BIOL ECOL, V347, P77, DOI 10.1016/j.jembe.2007.03.010; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Aukema BH, 2004, ECOL ENTOMOL, V29, P129, DOI 10.1111/j.0307-6946.2004.00594.x; Bitume EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026927; Bloch MC, 1996, ANN ENTOMOL SOC AM, V89, P892, DOI 10.1093/aesa/89.6.892; Boake CRB, 1994, QUANTITATIVE GENETIC; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Crnokrak P, 1995, ANIM BEHAV, V50, P1475, DOI 10.1016/0003-3472(95)80004-2; Crnokrak P, 1998, EVOLUTION, V52, P1111, DOI 10.1111/j.1558-5646.1998.tb01838.x; Crnokrak P, 1998, ANIM BEHAV, V56, P433, DOI 10.1006/anbe.1998.0741; Demont M, 2014, EVOL BIOL, V41, P62, DOI 10.1007/s11692-013-9246-3; Dingle H, 2006, J ORNITHOL, V147, P212, DOI 10.1007/s10336-005-0052-2; FAIRBAIRN DJ, 1992, BIOL J LINN SOC, V45, P167, DOI 10.1111/j.1095-8312.1992.tb00637.x; Falconer D. S., 1996, Introduction to quantitative genetics.; Fedina TY, 2008, BIOL REV, V83, P151, DOI 10.1111/j.1469-185X.2008.00037.x; GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051; Gatehouse AG, 1997, ANNU REV ENTOMOL, V42, P475, DOI 10.1146/annurev.ento.42.1.475; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; Grazer VM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-21; Hiddink JG, 2002, MAR BIOL, V140, P1149, DOI 10.1007/s00227-002-0794-9; Hiddink JG, 2002, MAR ECOL PROG SER, V233, P117, DOI 10.3354/meps233117; HILL WG, 1992, ANNU REV ECOL SYST, V23, P287, DOI 10.1146/annurev.es.23.110192.001443; Huberty AF, 2006, OECOLOGIA, V148, P226, DOI 10.1007/s00442-006-0371-x; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Korb J, 2002, INSECT SOC, V49, P264, DOI 10.1007/s00040-002-8312-0; Kotrschal A, 2013, CURR BIOL, V23, P168, DOI 10.1016/j.cub.2012.11.058; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Langellotto GA, 2000, ECOLOGY, V81, P865, DOI 10.1890/0012-9658(2000)081[0865:ATOBFC]2.0.CO;2; Lewis SM, 2012, J EVOLUTION BIOL, V25, P438, DOI 10.1111/j.1420-9101.2011.02408.x; LEWIS SM, 1994, BEHAV ECOL, V5, P219; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lynch Michael, 1998; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Michalczyk L, 2011, EVOLUTION, V65, P713, DOI 10.1111/j.1558-5646.2010.01174.x; Miyatake T, 2008, ANIM BEHAV, V75, P113, DOI 10.1016/j.anbehav.2007.04.019; Nakayama S, 2010, POPUL ECOL, V52, P329, DOI 10.1007/s10144-009-0188-7; Nakayama S, 2010, BIOL LETTERS, V6, P18, DOI 10.1098/rsbl.2009.0494; Nilsson T, 2002, EVOLUTION, V56, P111, DOI 10.1111/j.0014-3820.2002.tb00853.x; NOVOTNY V, 1995, ENTOMOL EXP APPL, V76, P233, DOI 10.1007/BF02382989; Park T, 1933, J EXP ZOOL, V65, P17, DOI 10.1002/jez.1400650103; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; PRAY LA, 1995, EVOLUTION, V49, P176, DOI 10.2307/2410303; Reaney LT, 2007, BEHAV ECOL, V18, P521, DOI 10.1093/beheco/arm014; Roderick TH, 1976, GENETIC MANIPULATION, P143; Roff DA, 1999, J EVOLUTION BIOL, V12, P535, DOI 10.1046/j.1420-9101.1999.00051.x; ROFF DA, 1984, OECOLOGIA, V63, P30, DOI 10.1007/BF00379781; Roff DA, 1996, HEREDITY, V76, P178, DOI 10.1038/hdy.1996.25; Roff DA, 2003, J EVOLUTION BIOL, V16, P744, DOI 10.1046/j.1420-9101.2003.00570.x; Roff DA, 2007, BIOSCIENCE, V57, P155, DOI 10.1641/B570210; Saastamoinen M, 2007, OECOLOGIA, V153, P569, DOI 10.1007/s00442-007-0772-5; Sack C, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.4501; Sbilordo SH, 2014, BIOL J LINN SOC, V112, P67, DOI 10.1111/bij.12262; SCHMITT J, 1985, AM NAT, V126, P570, DOI 10.1086/284439; Sokoloff A, 1974, BIOL TRIBOLIUM SPECI; Srygley RB, 2004, P ROY SOC B-BIOL SCI, V271, P589, DOI 10.1098/rspb.2003.2627; Stevens VM, 2014, ECOL LETT, V17, P1039, DOI 10.1111/ele.12303; Stirling G, 2001, EVOL ECOL RES, V3, P157; Takahashi Keiichi, 2001, Japanese Journal of Entomology New Series, V4, P91; Tamaki, 1991, REARING METHODS INSE, P251; Thornhill R., 1979, SEXUAL SELECTION REP, P417; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Tregenza T, 2009, BEHAV ECOL SOCIOBIOL, V63, P817, DOI 10.1007/s00265-009-0716-7	63	21	21	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127042	10.1371/journal.pone.0127042	http://dx.doi.org/10.1371/journal.pone.0127042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970585	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200145
J	Salganik, MJ; Levy, KEC				Salganik, Matthew J.; Levy, Karen E. C.			Wiki Surveys: Open and Quantifiable Social Data Collection	PLOS ONE			English	Article							QUESTIONS; FUTURE; IDEA	In the social sciences, there is a longstanding tension between data collection methods that facilitate quantification and those that are open to unanticipated information. Advances in technology now enable new, hybrid methods that combine some of the benefits of both approaches. Drawing inspiration from online information aggregation systems like Wikipedia and from traditional survey research, we propose a new class of research instruments called wiki surveys. Just as Wikipedia evolves over time based on contributions from participants, we envision an evolving survey driven by contributions from respondents. We develop three general principles that underlie wiki surveys: they should be greedy, collaborative, and adaptive. Building on these principles, we develop methods for data collection and data analysis for one type of wiki survey, a pairwise wiki survey. Using two proof-of-concept case studies involving our free and open-source website www.allourideas.org, we show that pairwise wiki surveys can yield insights that would be difficult to obtain with other methods.	[Salganik, Matthew J.] Princeton Univ, Dept Sociol, Ctr Informat Technol Policy, Princeton, NJ 08544 USA; [Salganik, Matthew J.] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Levy, Karen E. C.] NYU, Informat Law Inst, New York, NY USA; [Levy, Karen E. C.] NYU, Dept Media Culture & Commun, New York, NY USA; [Levy, Karen E. C.] Data & Soc Res Inst, New York, NY USA	Princeton University; Princeton University; New York University; New York University	Salganik, MJ (corresponding author), Princeton Univ, Dept Sociol, Ctr Informat Technol Policy, Princeton, NJ 08544 USA.	mjs3@princeton.edu		Levy, Karen/0000-0003-3806-9161	Google (Faculty Research Award); Google (People and Innovation Lab); Google (Summer of Code); Princeton University Center for Information Technology Policy; Princeton University Committee on Research in the Humanities and Social Sciences; National Science Foundation [CNS-0905086]; National Institutes of Health [R24 HD047879]; Microsoft Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	Google (Faculty Research Award)(Google Incorporated); Google (People and Innovation Lab)(Google Incorporated); Google (Summer of Code)(Google Incorporated); Princeton University Center for Information Technology Policy; Princeton University Committee on Research in the Humanities and Social Sciences; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microsoft Research(Microsoft); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grants from Google (Faculty Research Award, the People and Innovation Lab, and Summer of Code 2010); Princeton University Center for Information Technology Policy; Princeton University Committee on Research in the Humanities and Social Sciences; the National Science Foundation (grant number CNS-0905086); and the National Institutes of Health (grant number R24 HD047879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some of this research was carried out while MJS was an employee of Microsoft Research. Microsoft Research provided support in the form of salary for author MJS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Anderson C., 2006, LONG TAIL WHY FUTURE; [Anonymous], 2008, CROWDSOURCING WHY PO; [Anonymous], 2014, R LANG ENV STAT COMP; Baker R, 2010, PUBLIC OPIN QUART, V74, P711, DOI 10.1093/poq/nfq048; BALASUBRAMANIAN SK, 1989, J MARKETING RES, V26, P311, DOI 10.2307/3172903; Bates D, 2011, MATRIX SPARSE DENSE; Bengtsson H, 2013, MATRIXSTATS METHODS; BENKLER Y, 2006, WEALTH NETWORKS; Brick JM, 2011, PUBLIC OPIN QUART, V75, P872, DOI 10.1093/poq/nfr045; Chen KA, 2010, PROC INT CONF DATA, P321, DOI 10.1109/ICDE.2010.5447832; Conrad FG, 2008, WILEY SER SURV METH, P1; Converse J., 1984, PUBLIC OPIN QUART, V48, P267, DOI [DOI 10.1086/268825, DOI 10.1093/POQ/48.1B.267]; Converse JM, 2009, SURVEY RES US ROOTS; Couper M. P., 2008, DESIGNING EFFECTIVE; Couper MP, 2011, PUBLIC OPIN QUART, V75, P889, DOI 10.1093/poq/nfr046; Couper MP, 2008, PUBLIC OPIN QUART, V72, P831, DOI 10.1093/poq/nfn066; Dillman DA, 2002, PUBLIC OPIN QUART, V66, P473, DOI 10.1086/342184; Dzyabura D, 2011, MARKET SCI, V30, P801, DOI 10.1287/mksc.1110.0660; Fowler F.J, 1995, IMPROVING SURVEY QUE; Gal D, 2011, J MARKETING RES, V48, P185, DOI 10.1509/jmkr.48.1.185; Gelman A., 2003, BAYESIAN DATA ANAL; Girotra K, 2010, MANAGE SCI, V56, P591, DOI 10.1287/mnsc.1090.1144; Glickman ME, 2005, J STAT PLAN INFER, V127, P279, DOI 10.1016/j.jspi.2003.09.022; Goel S, 2010, J PERS SOC PSYCHOL, V99, P611, DOI 10.1037/a0020697; Gollapudi S., 2010, P 3 ACM INT C WEB SE, P21, DOI DOI 10.1145/1718487.171849; Groves RM, 2006, J R STAT SOC A STAT, V169, P439, DOI 10.1111/j.1467-985X.2006.00423.x; Groves RM, 2011, PUBLIC OPIN QUART, V75, P861, DOI 10.1093/poq/nfr057; Hacker S, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1207; Kane MJ, 2011, BIGMEMORY MANAGE MAS; Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537; Lazarsfeld PF, 1944, PUBLIC OPIN QUART, V8, P38, DOI 10.1086/265666; Lewry F, 2007, KITTENWAR MAY CUTEST; LINDLEY DV, 1956, ANN MATH STAT, V27, P986, DOI 10.1214/aoms/1177728069; Luon Y., 2012, MOBILE COMPUTING APP, P20, DOI [DOI 10.1007/978-3-642-3232012, 10.1007/978-3-642-3232012]; Mao A, 2013, CAPTURING COGNITIVE; MERTON RK, 1987, PUBLIC OPIN QUART, V51, P550, DOI 10.1086/269057; Merton RK, 1946, AM J SOCIOL, V51, P541, DOI 10.1086/219886; MITOFSKY WJ, 1989, PUBLIC OPIN QUART, V53, P446, DOI 10.1093/poq/53.3.446; Montgomery JM, 2013, POLIT ANAL, V21, P172, DOI 10.1093/pan/mps060; MOSTELLER F, 1951, PSYCHOMETRIKA, V16, P3, DOI DOI 10.1007/BF02289116; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Newport F, 2011, PUBLIC OPIN QUART, V75, P593, DOI 10.1093/poq/nfr027; Nielsen M., 2012, REINVENTING DISCOVER; Noveck BS, 2009, WIKI GOVERNMENT: HOW TECHNOLOGY CAN MAKE GOVERNMENT BETTER, DEMOCRACY STRONGER, AND CITIZENS MORE POWERFUL, P1; Pfeiffer T., 2012, 26 AAAI C ART INT; PRESSER S, 1990, SOC FORCES, V68, P856, DOI 10.2307/2579357; Presser S, 2004, PUBLIC OPIN QUART, V68, P109, DOI 10.1093/poq/nfh008; Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103; Salesses P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068400; Salganik MJ, 2009, TOP COGN SCI, V1, P439, DOI 10.1111/j.1756-8765.2009.01030.x; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SCHUMAN H, 1987, SCIENCE, V236, P957, DOI 10.1126/science.236.4804.957; SCHUMAN H, 1979, AM SOCIOL REV, V44, P692, DOI 10.2307/2094521; Schuman H., 2008, METHOD MEANING POLLS; Shah D, 2009, THESIS PRINCETON U; SINGH J, 1990, J MARKETING RES, V27, P304, DOI 10.2307/3172588; Smyth JD, 2009, PUBLIC OPIN QUART, V73, P325, DOI 10.1093/poq/nfp029; STERN H, 1990, BIOMETRIKA, V77, P265, DOI 10.1093/biomet/77.2.265; SULLIVAN JL, 1979, AM POLIT SCI REV, V73, P781, DOI 10.2307/1955404; Thurstone L L., 1927, J ABNORMAL SOCIAL PS, V21, P384, DOI DOI 10.1037/H0065439; Toubia O, 2007, MARKET SCI, V26, P342, DOI 10.1287/mksc.1070.0273; Trautmann H, 2011, TRUNCNORM TRUNCATED; Turner C. F., 1984, SURVEYING SUBJECTIVE; Urbanek S, 2011, MULTICORE PARALLEL P; van de Rijt A, 2014, P NATL ACAD SCI USA, V111, P6934, DOI 10.1073/pnas.1316836111; von Ahn L, 2008, COMMUN ACM, V51, P58, DOI 10.1145/1378704.1378719; Weinstein JR, 2009, THESIS PRINCETON U; Wickham H, 2011, R J, V3, P5; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wilkinson DM, 2008, EC'08: PROCEEDINGS OF THE 2008 ACM CONFERENCE ON ELECTRONIC COMMERCE, P302; Wu M, 2008, DAILY PRINCETONIAN; Zhu H., 2012, P SIGCHI C HUMAN FAC, P2257	72	53	54	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0123483	10.1371/journal.pone.0123483	http://dx.doi.org/10.1371/journal.pone.0123483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7CV	25992565	gold, Green Submitted, Green Published			2022-12-27	WOS:000354921400010
J	Schalinski, I; Teicher, MH				Schalinski, Inga; Teicher, Martin H.			Type and Timing of Childhood Maltreatment and Severity of Shutdown Dissociation in Patients with Schizophrenia Spectrum Disorder	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SEXUAL-ABUSE; SENSITIVE PERIODS; PERSISTENT DISSOCIATION; PHYSICAL ABUSE; PSYCHOTIC SYMPTOMS; TRAUMA; EXPERIENCES; WOMEN; PSYCHOPATHOLOGY	Dissociation, particularly the shutting down of sensory, motor and speech systems, has been proposed to emerge in susceptible individuals as a defensive response to traumatic stress. In contrast, other individuals show signs of hyperarousal to acute threat. A key question is whether exposure to particular types of stressful events during specific stages of development can program an individual to have a strong dissociative response to subsequent stressors. Vulnerability to ongoing shutdown dissociation was assessed in 75 inpatients (46M/29F, M = 31 +/- 10 years old) with schizophrenia spectrum disorder and related to number of traumatic events experienced or witnessed during childhood or adulthood. The Maltreatment and Abuse Chronology of Exposure (MACE) scale was used to collect retrospective recall of exposure to ten types of maltreatment during each year of childhood. Severity of shutdown dissociation was related to number of childhood but not adult traumatic events. Random forest regression with conditional trees indicated that type and timing of childhood maltreatment could predictably account for 31% of the variance (p < 0.003) in shutdown dissociation, with peak vulnerability occurring at 13-14 years of age and with exposure to emotional neglect followed by various forms of emotional abuse. These findings suggest that there may be windows of vulnerability to the development of shutdown dissociation. Results support the hypothesis that experienced events are more important than witnessed events, but challenge the hypothesis that "life-threatening" events are a critical determinant.	[Schalinski, Inga] Univ Constance, Dept Psychol, Clin Psychol, Constance, Germany; [Teicher, Martin H.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Teicher, Martin H.] McLean Hosp, Dev Biopsychiat Res Program, Belmont, MA 02178 USA	University of Konstanz; Harvard University; Harvard Medical School; Harvard University; McLean Hospital	Schalinski, I (corresponding author), Univ Constance, Dept Psychol, Clin Psychol, Constance, Germany.	inga.schalinski@uni-konstanz.de	Teicher, Martin H/P-3906-2017	Teicher, Martin H/0000-0002-6036-0177; Schalinski, Inga/0000-0003-1665-7640	University of Konstanz; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017846] Funding Source: NIH RePORTER	University of Konstanz; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project was supported by the University of Konstanz.	Aas M, 2012, SCHIZOPHR RES, V137, P73, DOI 10.1016/j.schres.2012.01.035; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; [Anonymous], 1994, DIAGN STAT MAN MENT; Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567; Bebbington PE, 2004, BRIT J PSYCHIAT, V185, P220, DOI 10.1192/bjp.185.3.220; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Bracha HS, 2004, CNS SPECTRUMS, V9, P679, DOI 10.1017/S1092852900001954; Braehler C, 2013, PSYCHIAT RES, V210, P36, DOI 10.1016/j.psychres.2013.05.033; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; Briere J, 2005, AM J PSYCHIAT, V162, P2295, DOI 10.1176/appi.ajp.162.12.2295; Brunner R, 2000, J NERV MENT DIS, V188, P71, DOI 10.1097/00005053-200002000-00002; Campbell MLC, 2007, BEHAV RES THER, V45, P1579, DOI 10.1016/j.brat.2006.11.009; Cardena Etzel, 1994, P15; Choi J, 2012, NEUROIMAGE, V59, P1071, DOI 10.1016/j.neuroimage.2011.09.033; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Chu JA, 1999, AM J PSYCHIAT, V156, P749; Colins O, 2009, DRUG ALCOHOL DEPEN, V100, P39, DOI 10.1016/j.drugalcdep.2008.08.013; Elbert T ., 2011, NARRATIVE EXPOSURE T, P80; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fiess J, 2013, Z KL PSYCH PSYCHOTH, V42, P24, DOI 10.1026/1616-3443/a000183; Fisher HL, 2011, SCHIZOPHRENIA BULL, V37, P546, DOI 10.1093/schbul/sbp103; Friedman MJ, 2013, J TRAUMA STRESS, V26, P548, DOI 10.1002/jts.21840; Ginzburg Karni, 2006, J Trauma Dissociation, V7, P7, DOI 10.1300/J229v07n02_02; GOFF DC, 1991, PSYCHIAT RES, V37, P73, DOI 10.1016/0165-1781(91)90107-Z; Goodman LA, 1999, J TRAUMA STRESS, V12, P587, DOI 10.1023/A:1024708916143; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; GREENFIELD SF, 1994, BRIT J PSYCHIAT, V164, P831, DOI 10.1192/bjp.164.6.831; Heidt JM, 2005, BEHAV RES THER, V43, P1157, DOI 10.1016/j.brat.2004.08.005; Heim CM, 2013, AM J PSYCHIAT, V170, P616, DOI 10.1176/appi.ajp.2013.12070950; Holmes EA, 2005, CLIN PSYCHOL REV, V25, P1, DOI 10.1016/j.cpr.2004.08.006; Holowka DW, 2003, SCHIZOPHR RES, V60, P87, DOI 10.1016/S0920-9964(02)00296-7; Hoy K, 2012, SCHIZOPHRENIA BULL, V38, P1162, DOI 10.1093/schbul/sbr085; Isele D, 2014, Z KL PSYCH PSYCHOTH, V43, P121, DOI 10.1026/1616-3443/a000257; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Khan A, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00042; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; Lange A, 1999, J NERV MENT DIS, V187, P150, DOI 10.1097/00005053-199903000-00004; Lanius RA, 2010, EUR J PSYCHOTRAUMATO, V1, DOI 10.3402/ejpt.v1i0.5467; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Meyer IH, 1996, CHILD ABUSE NEGLECT, V20, P213, DOI 10.1016/S0145-2134(95)00137-9; Moskowitz A, 2011, J TRAUMA DISSOCIATIO, V12, P347, DOI 10.1080/15299732.2011.573770; Mulder RT, 1998, AM J PSYCHIAT, V155, P806; Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363; Nijenhuis ERS, 1996, J NERV MENT DIS, V184, P688, DOI 10.1097/00005053-199611000-00006; Nijenhuis ERS, 1998, J TRAUMA STRESS, V11, P711, DOI 10.1023/A:1024493332751; Panasetis P, 2003, J TRAUMA STRESS, V16, P563, DOI 10.1023/B:JOTS.0000004079.74606.ba; Pechtel P, 2014, NEUROIMAGE, V97, P236, DOI 10.1016/j.neuroimage.2014.04.025; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Read J, 2003, PSYCHOL PSYCHOTHER-T, V76, P1, DOI 10.1348/14760830260569210; Read J., 2008, CLIN SCHIZOPHRENIA R, V2, P235, DOI [https://doi.org/10.3371/CSRP.2.3.5, DOI 10.3371/CSRP.2.3.5]; Rockstroh B, 2010, INT J PSYCHOPHYSIOL, V78, P14, DOI 10.1016/j.ijpsycho.2010.01.012; Romans SE, 1999, AM J PSYCHIAT, V156, P1080; ROSS CA, 1994, HOSP COMMUNITY PSYCH, V45, P489; Ross CA, 2004, J TRAUMA DISSOCIATIO, V5, P69, DOI DOI 10.1300/J229V05N03_05; Sar V., 2014, J SCHIZOPHR RES, V1, P2; Sar V, 2010, PSYCHOPATHOLOGY, V43, P33, DOI 10.1159/000255961; Schafer I, 2012, COMPR PSYCHIAT, V53, P364, DOI 10.1016/j.comppsych.2011.05.010; Schafer I, 2006, J NERV MENT DIS, V194, P135, DOI 10.1097/01.nmd.0000198199.57512.84; Schalinski I, 2013, PSYCHOPHYSIOLOGY, V50, P691, DOI 10.1111/psyp.12051; Schalinski I, 2015, PSYCHIAT RE IN PRESS; Schalinski I, 2015, EUR J PSYCH IN PRESS; Schalinski I, 2011, J TRAUMA STRESS, V24, P235, DOI 10.1002/jts.20631; Schauer M, 2010, Z PSYCHOL, V218, P109, DOI 10.1027/0044-3409/a000018; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Shaffer A, 2008, CHILD ABUSE NEGLECT, V32, P682, DOI 10.1016/j.chiabu.2007.09.010; Shevlin M, 2011, SOC PSYCH PSYCH EPID, V46, P1203, DOI 10.1007/s00127-010-0296-x; Spitzer C, 2006, WORLD PSYCHIATRY, V5, P82; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Teicher MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117423; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Teicher MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028852; Teicher MH, 2002, PSYCHIAT CLIN N AM, V25, P397, DOI 10.1016/S0193-953X(01)00003-X; Tomoda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052528; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; van der Hart O, 2004, AUST NZ J PSYCHIAT, V38, P906, DOI 10.1080/j.1440-1614.2004.01480.x; Vermetten E, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-013-0434-8; Vogel M, 2011, PSYCHIAT RES, V189, P121, DOI 10.1016/j.psychres.2011.01.008; Vogel M, 2009, PSYCHOPATHOLOGY, V42, P124, DOI 10.1159/000204763; Werner KB, 2012, J TRAUMA STRESS, V25, P401, DOI 10.1002/jts.21725; Whitfield CL, 2005, CHILD ABUSE NEGLECT, V29, P797, DOI 10.1016/j.chiabu.2005.01.004; WILLIAMS LM, 1994, J CONSULT CLIN PSYCH, V62, P1167, DOI 10.1037//0022-006X.63.3.343; World Health Organization, 1992, CLIN DESCR DIAGN GUI, V10th	88	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127151	10.1371/journal.pone.0127151	http://dx.doi.org/10.1371/journal.pone.0127151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BT	25992568	Green Published, Green Submitted, gold			2022-12-27	WOS:000354918600051
J	Maree, HJ; Pirie, MD; Oosthuizen, K; Bester, R; Rees, DJG; Burger, JT				Maree, Hans J.; Pirie, Michael D.; Oosthuizen, Kristin; Bester, Rachelle; Rees, D. Jasper G.; Burger, Johan T.			Phylogenomic Analysis Reveals Deep Divergence and Recombination in an Economically Important Grapevine Virus	PLOS ONE			English	Article							SEQUENCE; VARIABILITY; DENDROSCOPE; ALGORITHM; VINEYARDS; VARIANTS; ISOLATE	The evolutionary history of the exclusively grapevine (Vitis spp.) infecting, grapevine leafroll-associated virus 3 (GLRaV-3) has not been studied extensively, partly due to limited available sequence data. In this study we trace the evolutionary history of GLRaV-3, focussing on isolate GH24, a newly discovered variant. GH24 was discovered through the use of next-generation sequencing (NGS) and the whole genome sequence determined and validated with Sanger sequencing. We assembled an alignment of all 13 available whole genomes of GLRaV-3 isolates and all other publicly available GLRaV-3 sequence data. Using multiple recombination detection methods we identified a clear signal for recombination in one whole genome sequence and further evidence for recombination in two more, including GH24. We inferred phylogenetic trees and networks and estimated the ages of common ancestors of GLRaV-3 clades by means of relaxed clock models calibrated with asynchronous sampling dates. Our results generally confirm previously identified variant groups as well as two new groups (VII and VIII). Higher order groups were defined as supergroups designated A to D. Supergroup A includes variant groups I-V and supergroup B group VI and its related unclassified isolates. Supergroups C and D are less well known, including the newly identified groups VII (including isolate GH24) and VIII respectively. The inferred node ages suggest that the origins of the major groups of GLRaV-3, including isolate GH24, may have occurred prior to worldwide cultivation of grapevines, whilst the current diversity represents closely related isolates that diverged from common ancestors within the last century.	[Maree, Hans J.] Agr Res Council, Infruitec Nietvoorbij Fruit Vine & Wine Inst, ZA-7599 Stellenbosch, South Africa; [Maree, Hans J.; Oosthuizen, Kristin; Bester, Rachelle; Burger, Johan T.] Univ Stellenbosch, Dept Genet, ZA-7602 Matieland, South Africa; [Pirie, Michael D.] Johannes Gutenberg Univ Mainz, Inst Spezielle Bot, D-55099 Mainz, Germany; [Pirie, Michael D.] Johannes Gutenberg Univ Mainz, Bot Garten, D-55099 Mainz, Germany; [Pirie, Michael D.] Univ Stellenbosch, Dept Biochem, ZA-7602 Matieland, South Africa; [Rees, D. Jasper G.] Agr Res Council, Biotechnol Platform, ZA-0110 Onderstepoort, South Africa	Agricultural Research Council of South Africa; Institute for Deciduous Fruit, Vines & Wine, Agricultural Research Council; Stellenbosch University; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Stellenbosch University; Agricultural Research Council of South Africa	Maree, HJ (corresponding author), Agr Res Council, Infruitec Nietvoorbij Fruit Vine & Wine Inst, Private Bag X5026, ZA-7599 Stellenbosch, South Africa.	hjmaree@sun.ac.za	Maree, Hans J/F-5846-2012; Bester, Rachelle/AAZ-2127-2020; Rees, David Jasper Gilbert/AAZ-8073-2020; Bester, Rachelle/AAY-2621-2020; Pirie, Michael/A-3067-2008	Maree, Hans J/0000-0001-9639-4558; Bester, Rachelle/0000-0002-2226-0968; Rees, David Jasper Gilbert/0000-0003-3321-1325; Pirie, Michael/0000-0003-0403-4470	Winetech; National Research Foundation (NRF)	Winetech; National Research Foundation (NRF)	This research was supported in part by a grant to JTB and HJM by Winetech. The financial assistance of the National Research Foundation (NRF) towards a student bursary for RB is also acknowledged. Opinions expressed and conclusions arrived at are those of the authors and are not necessarily to be attributed to the NRF or Winetech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bester R, 2012, ARCH VIROL, V157, P1815, DOI 10.1007/s00705-012-1333-8; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Chooi KM, 2013, ARCH VIROL, V158, P1597, DOI 10.1007/s00705-013-1631-9; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Engel EA, 2008, VIRUS GENES, V37, P110, DOI 10.1007/s11262-008-0241-1; Figueiral I, 2010, J ARCHAEOL SCI, V37, P139, DOI 10.1016/j.jas.2009.09.024; Fuchs M, 2009, PLANT DIS, V93, P395, DOI 10.1094/PDIS-93-4-0395; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gouveia P, 2011, ARCH VIROL, V156, P413, DOI 10.1007/s00705-010-0878-7; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jooste AEC, 2010, ARCH VIROL, V155, P1997, DOI 10.1007/s00705-010-0793-y; KARASEV AV, 1995, VIROLOGY, V208, P511, DOI 10.1006/viro.1995.1182; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Maddison WP, 2001, MESQUITE A MODULAR S; Maree HJ, 2008, ARCH VIROL, V153, P755, DOI 10.1007/s00705-008-0040-y; Maree HJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00082; Martelli GP, 2012, J PLANT PATHOL, V94, P7; Martelli GP, 2014, J PLANT PATHOL, V96, P1; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McGovern PE, 2003, ANCIENT WINE THE SEA; Meng BZ, 2005, VIRUS GENES, V31, P31, DOI 10.1007/s11262-004-2197-0; MORRIS TJ, 1979, PHYTOPATHOLOGY, V69, P854, DOI 10.1094/Phyto-69-854; Nei M, 2000, MOLECULAR EVOLUTION; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pirie MD, 2008, MOL PHYLOGENET EVOL, V48, P1106, DOI 10.1016/j.ympev.2008.05.030; Pirie MD, 2009, SYST BIOL, V58, P612, DOI 10.1093/sysbio/syp068; Seah YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-235; Sharma AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026227; SMITH JM, 1992, J MOL EVOL, V34, P126; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turturo C, 2005, J GEN VIROL, V86, P217, DOI 10.1099/vir.0.80395-0; Valamoti SM, 2007, ANTIQUITY, V81, P54, DOI 10.1017/S0003598X00094837; Visser JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050631; Wang JB, 2011, PHYTOPATHOLOGY, V101, P445, DOI 10.1094/PHYTO-07-10-0173; White Elizabeth J., 2008, Biotechnology Journal, V3, P1424, DOI 10.1002/biot.200800207; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001	48	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126819	10.1371/journal.pone.0126819	http://dx.doi.org/10.1371/journal.pone.0126819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992606	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300054
J	Ahmad, A; Niwa, Y; Goto, S; Ogawa, T; Shimizu, M; Suzuki, A; Kobayashi, K; Kobayashi, H				Ahmad, Aftab; Niwa, Yasuo; Goto, Shingo; Ogawa, Takeshi; Shimizu, Masanori; Suzuki, Akane; Kobayashi, Kyoko; Kobayashi, Hirokazu			bHLH106 Integrates Functions of Multiple Genes through Their G-Box to Confer Salt Tolerance on Arabidopsis	PLOS ONE			English	Article							PLANT CRATEROSTIGMA-PLANTAGINEUM; TRANSCRIPTION FACTOR FAMILY; DNA-BINDING SPECIFICITY; LOOP-HELIX PROTEINS; MEDIATED TRANSFORMATION; COMPARATIVE GENOMICS; MOLECULAR RESPONSES; CRYSTAL-STRUCTURE; STRESS-RESPONSE; CALCIUM SENSOR	An activation-tagging methodology was applied to dedifferentiated calli of Arabidopsis to identify new genes involved in salt tolerance. This identified salt tolerant callus 8 (stc8) as a gene encoding the basic helix-loop-helix transcription factor bHLH106. bHLH106-knockout (KO) lines were more sensitive to NaCl, KCl, LiCl, ABA, and low temperatures than the wild-type. Back-transformation of the KO line rescued its phenotype, and over-expression (OX) of bHLH106 in differentiated plants exhibited tolerance to NaCl. Green fluorescent protein (GFP) fused with bHLH106 revealed that it was localized to the nucleus. Prepared bHLH106 protein was subjected to electrophoresis mobility shift assays against E-box sequences (5'-CANNTG-3'). The G-box sequence 5'-CACGTG-3' had the strongest interaction with bHLH106. bHLH106-OX lines were transcriptomically analyzed, and resultant up-and down-regulated genes selected on the criterion of presence of a G-box sequence. There were 198 genes positively regulated by bHLH106 and 36 genes negatively regulated; these genes possessed one or more G-box sequences in their promoter regions. Many of these genes are known to be involved in abiotic stress response. It is concluded that bHLH106 locates at a branching point in the abiotic stress response network by interacting directly to the G-box in genes conferring salt tolerance on plants.	[Ahmad, Aftab; Niwa, Yasuo; Goto, Shingo; Ogawa, Takeshi; Shimizu, Masanori; Suzuki, Akane; Kobayashi, Kyoko; Kobayashi, Hirokazu] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Plant Mol Improvement, Suruga, Shizuoka 4228526, Japan	University of Shizuoka	Kobayashi, H (corresponding author), Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Plant Mol Improvement, 1-52 Yada, Suruga, Shizuoka 4228526, Japan.	hirokoba@u-shizuoka-ken.ac.jp	Ahmad, Aftab/L-9718-2015; Goto, Shingo/AAU-4777-2021; Kobayashi, Hirokazu/E-7903-2010	Ahmad, Aftab/0000-0002-2792-9771; Goto, Shingo/0000-0002-2298-7016; Kobayashi, Hirokazu/0000-0002-8040-0826	COE Program in the 21st Century from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Salt Science Research Foundation; University of Shizuoka; University of Shizuoka Grants for Scientific and Educational Research; MEXT; Global COE Program	COE Program in the 21st Century from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Salt Science Research Foundation; University of Shizuoka; University of Shizuoka Grants for Scientific and Educational Research; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Grants-in-Aid, COE Program in the 21st Century (2002-2007) and from the Global COE Program (2007-2012) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, http://www.mext.go.jp/english/), Project Research Grant of the Salt Science Research Foundation (http://www.saltscience.or.jp/english.html), Goto Research Grant from the University of Shizuoka, and the University of Shizuoka Grants for Scientific and Educational Research. AA was a recipient of a scholarship for foreign research students from MEXT. AA and MS were postdoctoral fellows supported by the Global COE Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bastola DR, 1998, PLANT MOL BIOL, V38, P1123, DOI 10.1023/A:1006081926699; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Castilhos G, 2014, PLANT SCI, V223, P1, DOI 10.1016/j.plantsci.2014.02.010; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; CHURCH GM, 1985, NATURE, V313, P798, DOI 10.1038/313798a0; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng X, 2002, PLANT MOL BIOL, V49, P601, DOI 10.1023/A:1015501205303; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Furini A, 1997, EMBO J, V16, P3599, DOI 10.1093/emboj/16.12.3599; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Isono K, 1997, P NATL ACAD SCI USA, V94, P14948, DOI 10.1073/pnas.94.26.14948; Ito Y, 2001, GENESIS, V30, P231, DOI 10.1002/gene.1069; Iturriaga G, 1996, PLANT MOL BIOL, V32, P707, DOI 10.1007/BF00020211; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Kim J, 2006, BBA-GENE STRUCT EXPR, V1759, P191, DOI 10.1016/j.bbaexp.2006.03.002; Kiribuchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P1042, DOI 10.1271/bbb.69.1042; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Littlewood TD., 1998, HELIX LOOP HELIX TRA; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Liu YG, 2005, METH MOL B, V286, P341; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Marsch-Martinez N, 2002, PLANT PHYSIOL, V129, P1544, DOI 10.1104/pp.003327; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nair SK, 2000, NATURE, V404, P715, DOI 10.1038/35008182; Niwa Y, 2006, PLANT CELL PHYSIOL, V47, P319, DOI 10.1093/pcp/pci242; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Niwa Y., 2003, PLANT BIOTECHNOL-NAR, V20, P1, DOI [10.5511/plantbiotechnology.20.1, DOI 10.5511/PLANTBIOTECHNOLOGY.20.1]; Quail PH, 2000, SEMIN CELL DEV BIOL, V11, P457, DOI 10.1006/scdb.2000.0199; Quan RD, 2007, PLANT CELL, V19, P1415, DOI 10.1105/tpc.106.042291; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schwechheimer C, 1998, ANNU REV PLANT PHYS, V49, P127, DOI 10.1146/annurev.arplant.49.1.127; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sonnenfeld M, 2005, DEV GENES EVOL, V215, P221, DOI 10.1007/s00427-004-0462-9; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tsugane K, 1999, PLANT CELL, V11, P1195, DOI 10.1105/tpc.11.7.1195; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Wang YJ, 2003, THEOR APPL GENET, V107, P1402, DOI 10.1007/s00122-003-1378-x; Waterston RH, 2002, P NATL ACAD SCI USA, V99, P3712, DOI 10.1073/pnas.042692499; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Weigel D., 2002, ARABIDOPSIS LAB MANU; Zahaf O, 2012, MOL PLANT, V5, P1068, DOI 10.1093/mp/sss009; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941	63	28	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126872	10.1371/journal.pone.0126872	http://dx.doi.org/10.1371/journal.pone.0126872			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978450	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100111
J	Chatkin, R; Chatkin, JM; Spanemberg, L; Casagrande, D; Wagner, M; Mottin, C				Chatkin, Raquel; Chatkin, Jose Miguel; Spanemberg, Lucas; Casagrande, Daniela; Wagner, Mario; Mottin, Claudio			Smoking Is Associated with More Abdominal Fat in Morbidly Obese Patients	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; CIGARETTE-SMOKING; BODY-WEIGHT; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; GENERAL-POPULATION; BARIATRIC SURGERY; MEN; ADIPOSITY; MORTALITY	Introduction While the association between cigarette smoking and abdominal fat has been well studied in normal and overweight patients, data regarding the influence of tobacco use in patients with morbid obesity remain scarce. The aim of this study is to evaluate body fat distribution in morbidly obese smokers. Methods We employed a cross-sectional study and grouped severely obese patients (body mass index [BMI] >40 kg/m(2) or >35 kg/m(2) with comorbidities) according to their smoking habits (smokers or non-smokers). We next compared the anthropometrical measurements and body composition data (measured by electric bioimpedance) of both groups. We analyzed the effect of smoking on body composition variables using univariate and multiple linear regression (MLR); differences are presented as regression coefficients (b) and their respective 95% confidence intervals. Results We included 536 morbidly obese individuals, 453 (84.5%) non-smokers and 83 (15.5%) smokers. Male smokers had a higher BMI (b=3.28 kg/m(2), p=0.036), larger waist circumference (b=6.07 cm, p=0.041) and higher percentage of body fat (b=2.33%, p=0.050) than non-smokers. These differences remained significant even after controlling for confounding factors. For females, the only significant finding in MLR was a greater muscle mass among smokers (b=1.34kg, p=0.028). No associations were found between tobacco load measured in pack-years and anthropometric measures or body composition. Discussion Positive associations between smoking and BMI, and waist circumference and percentage of body fat, were found among male morbidly obese patients, but not among females. To the best of our knowledge, this study is the first investigation of these aspects in morbidly obese subjects. We speculate that our findings may indicate that the coexistence of morbid obesity and smoking helps to explain the more serious medical conditions, particularly cardiovascular diseases and neoplasms, seen in these patients.	[Chatkin, Raquel; Casagrande, Daniela; Mottin, Claudio] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Ctr Obes & Metab Syndrome, Porto Alegre, RS, Brazil; [Chatkin, Raquel; Chatkin, Jose Miguel; Wagner, Mario; Mottin, Claudio] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil; [Spanemberg, Lucas] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Dept Psychiat, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Chatkin, JM (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil.	jmchatkin@pucrs.br	Wagner, Mario/F-9430-2015; Spanemberg, Lucas/B-4549-2010; Chatkin, Jose M/Q-3925-2016	Wagner, Mario/0000-0002-3661-4851; Spanemberg, Lucas/0000-0001-6789-7420; Chatkin, Jose M/0000-0002-4343-025X	Brazilian Ministry of Education CAPES	Brazilian Ministry of Education CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors state that they have not received any grant for this study. RC received a PhD scholarship from the Brazilian Ministry of Education CAPES. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action on Smoking & Health, 2012, CIG SMOK BOD MASS IN; Ahima RS, 2011, J CLIN INVEST, V121, P2076, DOI 10.1172/JCI58719; Akbartabartoori M, 2005, INT J OBESITY, V29, P236, DOI 10.1038/sj.ijo.0802827; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P1; Amorim P., 2000, REV BRAS PSIQUIATR, V22, P106, DOI DOI 10.1590/S1516-44462000000300003; [Anonymous], 2000, PRACT GUID ID EV TRE; Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Banka G, 2012, ARCH SURG-CHICAGO, V147, P550, DOI 10.1001/archsurg.2012.195; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bidulescu A, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-9; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; Centers for Disease Control and Prevention (CDC), 2009, NAT HLTH INT SURV NH; Chatkin Raquel, 2007, J. bras. pneumol., V33, P712, DOI 10.1590/S1806-37132007000600016; Chatkin R, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-61; Chen H, 2005, NEUROPSYCHOPHARMACOL, V30, P713, DOI 10.1038/sj.npp.1300597; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Clair C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-23; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Davis MM, 2006, ARCH SURG-CHICAGO, V141, P71, DOI 10.1001/archsurg.141.1.71; Despres JP, 2006, EUR HEART J SUPPL, V8, pB4, DOI 10.1093/eurheartj/sul002; Faria CD, 2012, J BRAS PNEUMOL, V38, P356, DOI 10.1590/S1806-37132012000300011; Faria SL, 2014, OBES SURG, V24, P1476, DOI 10.1007/s11695-014-1190-5; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Freedman DM, 2006, AM J PREV MED, V31, P355, DOI 10.1016/j.amepre.2006.07.022; Global Health Observatory (GHO), 2014, OBESITY; Goldman L., 2012, GOLDMANS CECIL MED E; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Health Canada, 2014, HLTH CONC TERM; Hintze LJ, 2012, REV CIENC MED, V20, P87; Kasteridis P, 2012, HEALTH SERV RES, V47, P1580, DOI 10.1111/j.1475-6773.2012.01380.x; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045815; Kitahara CM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001673; Komiya H, 2006, TOHOKU J EXP MED, V208, P123, DOI 10.1620/tjem.208.123; Koster A, 2008, AM J CLIN NUTR, V88, P1206, DOI 10.3945/ajcn.2008.26298; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Melo ME, 2009, REV BRAS MED, V66, P100; Miyatake N, 2006, INTERNAL MED, V45, P1039, DOI 10.2169/internalmedicine.45.1850; Mizuno O, 2005, J ATHEROSCLER THROMB, V12, P199, DOI 10.5551/jat.12.199; Nakanishi N, 2005, IND HEALTH, V43, P295, DOI 10.2486/indhealth.43.295; Nigro E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/658913; Padwal RS, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-54; Patel K, 2011, AM J HEALTH BEHAV, V35, P627; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pisinger C, 2007, PREV MED, V44, P283, DOI 10.1016/j.ypmed.2006.11.014; Rasky E, 1996, INT J EPIDEMIOL, V25, P1208, DOI 10.1093/ije/25.6.1208; Saami SE, 2009, AM J PUBLIC HEALTH, V99, P348, DOI 10.2105/AJPH.2007.123851; Schuster DP, 2010, DIABETES METAB SYNDR, V3, P253, DOI 10.2147/DMSO.S7354; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Tamura U, 2010, J ATHEROSCLER THROMB, V17, P12, DOI 10.5551/jat.1800; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2014, OB OV; Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006; World Obesity Federation, 2012, AB OB; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126146	10.1371/journal.pone.0126146	http://dx.doi.org/10.1371/journal.pone.0126146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978682	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100050
J	de Melo, MB; Mandal, AK; Tavares, IM; Ali, MH; Kabra, M; de Vasconcellos, JPC; Senthil, S; Sallum, JMF; Kaur, I; Betinjane, AJ; Moura, CR; Paula, JS; Costa, KA; Sarfarazi, M; Della Paolera, M; Finzi, S; Ferraz, VEF; Costa, VP; Belfort, R; Chakrabarti, S				de Melo, Monica Barbosa; Mandal, Anil K.; Tavares, Ivan M.; Ali, Mohammed Hasnat; Kabra, Meha; Cabral de Vasconcellos, Jose Paulo; Senthil, Sirisha; Sallum, Juliana M. F.; Kaur, Inderjeet; Betinjane, Alberto J.; Moura, Christiane R.; Paula, Jayter S.; Costa, Karita A.; Sarfarazi, Mansoor; Della Paolera, Mauricio; Finzi, Simone; Ferraz, Victor E. F.; Costa, Vital P.; Belfort, Rubens, Jr.; Chakrabarti, Subhabrata			Genotype-Phenotype Correlations in CYP1B1-Associated Primary Congenital Glaucoma Patients Representing Two Large Cohorts from India and Brazil	PLOS ONE			English	Article							CYTOCHROME P4501B1 CYP1B1; MOLECULAR-GENETICS; JAPANESE PATIENTS; UNITED-STATES; LTBP2 GENE; MUTATIONS; POPULATION; FAMILIES; LOCUS; BUPHTHALMOS	Background Primary congenital glaucoma (PCG), occurs due to the developmental defects in the trabecular meshwork and anterior chamber angle in children. PCG exhibits genetic heterogeneity and the CYP1B1 gene has been widely implicated worldwide. Despite the diverse mutation spectra, the clinical implications of these mutations are yet unclear. The present study attempted to delineate the clinical profile of PCG in the background of CYP1B1 mutations from a large cohort of 901 subjects from India (n=601) and Brazil (n=300). Methods Genotype-phenotype correlations was undertaken on clinically well characterized PCG cases from India (n=301) and Brazil (n=150) to assess the contributions of CYP1B1 mutation on a set of demographic and clinical parameters. The demographic (gender, and history of consanguinity) and quantitative clinical (presenting intraocular pressure [IOP] and corneal diameter [CD]) parameters were considered as binary and continuous variables, respectively, for PCG patients in the background of the overall mutation spectra and also with respect to the prevalent mutations in India (R368H) and Brazil (4340delG). All these variables were fitted in a multivariate logistic regression model using the Akaike Information Criterion (AIC) to estimate the adjusted odds ratio (OR) using the R software (version 2.14.1). Results The overall mutation spectrum were similar across the Indian and Brazilian PCG cases, despite significantly higher number of homozygous mutations in the former (p=0.024) and compound heterozygous mutations in the later (p=0.012). A wide allelic heterogeneity was observed and only 6 mutations were infrequently shared between these two populations. The adjusted ORs for the binary (demographic) and continuous (clinical) variables did not indicate any susceptibility to the observed mutations (p>0.05). Conclusions The present study demonstrated a lack of genotype-phenotype correlation of the demographic and clinical traits to CYP1B1 mutations in PCG at presentation. However, the susceptibility of these mutations to the long-term progression of these traits are yet to be deciphered.	[de Melo, Monica Barbosa] Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Campinas, SP, Brazil; [Mandal, Anil K.; Senthil, Sirisha] LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, Andhra Pradesh, India; [Tavares, Ivan M.; Sallum, Juliana M. F.; Moura, Christiane R.; Costa, Karita A.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, SP, Brazil; [Ali, Mohammed Hasnat] LV Prasad Eye Inst, Ctr Clin Epidemiol & Biostat, Hyderabad, Andhra Pradesh, India; [Kabra, Meha; Kaur, Inderjeet; Chakrabarti, Subhabrata] LV Prasad Eye Inst, Kallam Anji Reddy Mol Genet Lab, Hyderabad, Andhra Pradesh, India; [Cabral de Vasconcellos, Jose Paulo; Costa, Vital P.] Univ Estadual Campinas, Fac Med Sci, Dept Ophthalmol, Campinas, SP, Brazil; [Betinjane, Alberto J.; Finzi, Simone] Univ Sao Paulo, Sch Med, Dept Ophthalmol, Sao Paulo, SP, Brazil; [Paula, Jayter S.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Ophthalmol, BR-14049 Ribeirao Preto, SP, Brazil; [Sarfarazi, Mansoor] Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT USA; [Della Paolera, Mauricio] Irmandade Santa Casa de Misericordia Sao Paulo, Sch Med Sci, Dept Ophthalmol, Sao Paulo, SP, Brazil; [Ferraz, Victor E. F.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil	Universidade Estadual de Campinas; L. V. Prasad Eye Institute; Universidade Federal de Sao Paulo (UNIFESP); L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Connecticut; Universidade de Sao Paulo	Chakrabarti, S (corresponding author), LV Prasad Eye Inst, Kallam Anji Reddy Mol Genet Lab, Hyderabad, Andhra Pradesh, India.	subho@lvpei.org	de Moura, Christiane R Rolim/P-2489-2015; Tavares, Ivan/F-6766-2010; PAULA, JAYTER S/D-1249-2013; Mandal, Anil/AAY-4809-2020; Kaur, Inderjeet/ABD-1833-2021; Sallum, Juliana Maria Ferraz/AAL-4000-2020; Ferraz, Victor EF/A-8774-2013; Chakrabarti, Subhabrata/F-2468-2015	de Moura, Christiane R Rolim/0000-0002-0636-8100; Tavares, Ivan/0000-0003-2220-7603; PAULA, JAYTER S/0000-0002-8111-3810; Sallum, Juliana Maria Ferraz/0000-0002-7206-4447; Ferraz, Victor EF/0000-0003-0337-4588; Chakrabarti, Subhabrata/0000-0003-3717-4963	Department of Science and Technology, Government of India [DST/INT/BRAZIL/RPO-01/2008]; Brazilian Academy of Sciences-CNPq, Government of Brazil [EU475687/20094]	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Brazilian Academy of Sciences-CNPq, Government of Brazil	Funding: This study was supported through a bilateral Indo-Brazil grant from the Department of Science and Technology (DST/INT/BRAZIL/RPO-01/2008) to SC, Government of India and Brazilian Academy of Sciences-CNPq (Grant EU475687/20094), Government of Brazil to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2011, MOL VIS, V17, P2911; Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; Al-Haddad C, 2014, OPHTHALMIC GENET, V18, P1; Alfadhli S, 2006, AM J OPHTHALMOL, V141, P512, DOI 10.1016/j.ajo.2005.11.001; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Anderson D R, 1981, Trans Am Ophthalmol Soc, V79, P458; Bagiyeva S, 2007, MOL VIS, V13, P1458; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; Belmouden A, 2002, CLIN GENET, V62, P334, DOI 10.1034/j.1399-0004.2002.620415.x; Campos-Mollo E, 2009, MOL VIS, V15, P417; Chakrabarti S, 2006, INVEST OPHTH VIS SCI, V47, P43, DOI 10.1167/iovs.05-0912; Chakrabarti S, 2010, HUM MOL GENET, V19, P4083, DOI 10.1093/hmg/ddq309; Chavarria-Soley G, 2006, MOL VIS, V12, P523; Chen YH, 2008, ARCH OPHTHALMOL-CHIC, V126, P1443, DOI 10.1001/archopht.126.10.1443; Chitsazian F, 2007, J MOL DIAGN, V9, P382, DOI 10.2353/jmoldx.2007.060157; Choudhary D, 2009, XENOBIOTICA, V39, P606, DOI 10.1080/00498250903000198; Colomb E, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9197; Dandona L, 1998, ARCH OPHTHALMOL-CHIC, V116, P545, DOI 10.1001/archopht.116.4.514; Della Paolera M, 2010, J GLAUCOMA, V19, P176, DOI 10.1097/IJG.0b013e3181a98bae; Dimasi DP, 2007, CLIN GENET, V72, P255, DOI 10.1111/j.1399-0004.2007.00864.x; El-Ashry MF, 2007, J GLAUCOMA, V16, P104, DOI 10.1097/01.ijg.0000212288.00917.e1; Firasat S, 2008, MOL VIS, V14, P1659; FRANCOIS J, 1980, OPHTHALMOLOGICA, V181, P61, DOI 10.1159/000309028; Geyer O, 2011, AM J OPHTHALMOL, V151, P263, DOI 10.1016/j.ajo.2010.08.038; Hollander David A, 2006, Trans Am Ophthalmol Soc, V104, P183; Hollander DA, 2006, AM J OPHTHALMOL, V142, P993, DOI 10.1016/j.ajo.2006.07.054; Khan AO, 2011, CURR OPIN OPHTHALMOL, V22, P347, DOI 10.1097/ICU.0b013e32834922d2; Lim SH, 2013, AM J OPHTHALMOL, V155, P508, DOI 10.1016/j.ajo.2012.09.012; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Mandal AK, 2006, PEDIAT GLAUCOMAS, P119; Mashima Y, 2001, INVEST OPHTH VIS SCI, V42, P2211; Milla E, 2013, MOL VIS, V19, P1707; Mohanty K, 2013, MOL VIS, V19, P78; Moore DB, 2013, SURV OPHTHALMOL, V58, P278, DOI 10.1016/j.survophthal.2012.11.003; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; Ohtake Y, 2003, BRIT J OPHTHALMOL, V87, P302, DOI 10.1136/bjo.87.3.302; Ou Y, 2012, DEV OPHTHALMOL, V50, P157, DOI 10.1159/000334798; Panicker SG, 2004, INVEST OPHTH VIS SCI, V45, P1149, DOI 10.1167/iovs.03-0404; Plasilova M, 1999, J MED GENET, V36, P290; Reddy ABM, 2004, MOL VIS, V10, P696; Sarfarazi M, 2000, EYE, V14, P422, DOI 10.1038/eye.2000.126; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; Sarfarazi Mansoor, 2003, Ophthalmol Clin North Am, V16, P543, DOI 10.1016/S0896-1549(03)00062-2; Sena DF, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010777; Sharafieh R, 2013, OPHTHALMIC GENET, V34, P14, DOI 10.3109/13816810.2012.716486; Sheikh SA, 2014, MOL VIS, V20, P991; Sitorus R, 2003, J Med Genet, V40, pe9, DOI 10.1136/jmg.40.1.e9; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; STOILOV I, 2002, INVEST OPHTH VIS SCI, V43, P3015; Stoilov IR, 2002, INVEST OPHTH VIS SCI, V43, P1820; Suh W, 2012, BRIT J OPHTHALMOL, V96, P1372, DOI 10.1136/bjophthalmol-2012-301517; Vasilou V, 2008, ANN REV PHARM TOXICO, V48, P131	53	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127147	10.1371/journal.pone.0127147	http://dx.doi.org/10.1371/journal.pone.0127147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978063	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100131
J	Elfwing, M; Natt, D; Goerlich-Jansson, VC; Persson, M; Hjelm, J; Jensen, P				Elfwing, Magnus; Natt, Daniel; Goerlich-Jansson, Vivian C.; Persson, Mia; Hjelm, Jonas; Jensen, Per			Early Stress Causes Sex-Specific, Life-Long Changes in Behaviour, Levels of Gonadal Hormones, and Gene Expression in Chickens	PLOS ONE			English	Article							RED JUNGLEFOWL; MATERNAL-CARE; GALLUS-GALLUS; INHERITANCE; GROWTH; BRAIN; TRANSMISSION; MECHANISMS; RESPONSES; FOWL	Early stress can have long-lasting phenotypic effects. Previous research shows that male and female chickens differ in many behavioural aspects, and respond differently to chronic stress. The present experiment aimed to broadly characterize long-term sex differences in responses to brief events of stress experienced during the first weeks of life. Chicks from a commercial egg-laying hybrid were exposed to stress by inducing periods of social isolation during their first three weeks of life, followed by a broad behavioural, physiological and genomic characterization throughout life. Early stressed males, but not females, where more anxious in an open field-test, stayed shorter in tonic immobility and tended to have delayed sexual maturity, as shown by a tendency for lower levels of testosterone compared to controls. While early stressed females did not differ from non-stressed in fear and sexual maturation, they were more socially dominant than controls. The differential gene expression profile in hypothalamus was significantly correlated from 28 to 213 days of age in males, but not in females. In conclusion, early stress had a more pronounced long-term effect on male than on female chickens, as evidenced by behavioral, endocrine and genomic responses. This may either be attributed to inherent sex differences due to evolutionary causes, or possibly to different stress related selection pressures on the two sexes during commercial chicken breeding.	[Elfwing, Magnus; Natt, Daniel; Goerlich-Jansson, Vivian C.; Persson, Mia; Hjelm, Jonas; Jensen, Per] Linkoping Univ, AVIAN Behav Genom & Physiol Grp, IFM Biol, S-58183 Linkoping, Sweden	Linkoping University	Jensen, P (corresponding author), Linkoping Univ, AVIAN Behav Genom & Physiol Grp, IFM Biol, S-58183 Linkoping, Sweden.	perje@ifm.liu.se	Natt, Daniel/AAR-3928-2021	Natt, Daniel/0000-0001-9182-9401; Persson, Mia/0000-0002-6115-7517	Swedish Research Council [2008-14496-59340-36]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS [221-2007-838]; European Research Council (ERC) [322206 GENEWELL]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS(Swedish Research Council Formas); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by the Swedish Research Council (www.vr.se) (2008-14496-59340-36), The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS (www.formas.se) (221-2007-838), and the European Research Council (www.erc.europa.eu) (ERC grant 322206 GENEWELL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnvall B, 2014, ANIMAL, P1; Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Appleby M.C., 2004, POULTRY BEHAV WELFAR; Bangasser DA, 2014, FRONT NEUROENDOCRIN, V35, P303, DOI 10.1016/j.yfrne.2014.03.008; Braastad BO, 1998, APPL ANIM BEHAV SCI, V61, P159, DOI 10.1016/S0168-1591(98)00188-9; Brown GR, 2013, NEUROSCIENCE, V249, P115, DOI 10.1016/j.neuroscience.2012.12.016; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Collias NE, 1996, ANIM BEHAV, V51, P1337, DOI 10.1006/anbe.1996.0137; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; de Margerie E, 2013, DEV PSYCHOBIOL, V55, P256, DOI 10.1002/dev.21019; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Fresard L, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-16; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Goerlich VC, 2012, HORM BEHAV, V61, P711, DOI 10.1016/j.yhbeh.2012.03.006; Huang DW, 2008, NATURE PROTOCOLS; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jensen P, 2013, PROG BIOPHYS MOL BIO, V113, P447, DOI 10.1016/j.pbiomolbio.2013.01.001; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; Joseph NS, 2003, J APPL POULTRY RES, V12, P7, DOI 10.1093/japr/12.1.7; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Lenz KM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00026; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Madison FN, 2008, GEN COMP ENDOCR, V155, P566, DOI 10.1016/j.ygcen.2007.08.014; MCBRIDE G., 1969, Anim. Behav. Monogrs., V2, P125; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Naguib M, 2006, P ROY SOC B-BIOL SCI, V273, P1901, DOI 10.1098/rspb.2006.3526; Natt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096376; Provencal N, 2012, J NEUROSCI, V32, P15626, DOI 10.1523/JNEUROSCI.1470-12.2012; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Schlichting CD, 2014, EVOLUTION, V68, P656, DOI 10.1111/evo.12348; Schutz KE, 2004, BEHAV GENET, V34, P121, DOI 10.1023/B:BEGE.0000009481.98336.fc; SHARP PJ, 1977, J ENDOCRINOL, V74, P467, DOI 10.1677/joe.0.0740467; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	37	23	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125808	10.1371/journal.pone.0125808	http://dx.doi.org/10.1371/journal.pone.0125808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978318	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100036
J	Ludidi, S; Jonkers, D; Elamin, E; Pieters, HJ; Schaepkens, E; Bours, P; Kruimel, J; Conchillo, J; Masclee, A				Ludidi, Samefko; Jonkers, Daisy; Elamin, Elhaseen; Pieters, Harm-Jan; Schaepkens, Esther; Bours, Paul; Kruimel, Joanna; Conchillo, Jose; Masclee, Ad			The Intestinal Barrier in Irritable Bowel Syndrome: Subtype-Specific Effects of the Systemic Compartment in an In Vitro Model	PLOS ONE			English	Article							SERINE-PROTEASE ACTIVITY; ACTIVATED RECEPTOR-2; IMMUNE ACTIVATION; PREDOMINANT IBS; ABDOMINAL-PAIN; PERMEABILITY; EXPRESSION; CELLS; ENDOTOXIN; TRYPTASE	Background Irritable bowel syndrome (IBS) is a disorder with multifactorial pathophysiology. Intestinal barrier may be altered, especially in diarrhea-predominant IBS (IBS-D). Several mediators may contribute to increased intestinal permeability in IBS. Aim We aimed to assess effects of tryptase and LPS on in vitro permeability using a 3dimensional cell model after basolateral cell exposure. Furthermore, we assessed the extent to which these mediators in IBS plasma play a role in intestinal barrier function. Materials and Methods Caco-2 cells were grown in extracellular matrix to develop into polarized spheroids and were exposed to tryptase (10 - 50 mU), LPS (1 - 50 ng/mL) and two-fold diluted plasma samples of 7 patients with IBS-D, 7 with constipation-predominant IBS (IBS-C) and 7 healthy controls (HC). Barrier function was assessed by the flux of FITC-dextran (FD4) using live cell imaging. Furthermore, plasma tryptase and LPS were determined. Results Tryptase (20 and 50 mU) and LPS (6.25 - 50 ng/ mL) significantly increased Caco-2 permeability versus control (all P<0.05). Plasma of IBS-D only showed significantly elevated median tryptase concentrations (7.1 [3.9 - 11.0] vs. 4.2 [2.2 - 7.0] vs. 4.2 [2.5 - 5.9] mu g/mL; P<0.05) and LPS concentrations (3.65 [3.00 - 6.10] vs. 3.10 [2.60-3.80] vs. 2.65 [2.40 - 3.40] EU/ml; P<0.05) vs. IBS-C and HC. Also, plasma of IBS-D increased Caco-2 permeability versus HC (0.14450 +/- 0.00472 vs. 0.00021 +/- 0.00003; P < 0.001), which was attenuated by selective inhibition of tryptase and LPS (P<0.05). Conclusion Basolateral exposure of spheroids to plasma of IBS-D patients resulted in a significantly increased FD4 permeation, which was partially abolished by selective inhibition of tryptase and LPS. These findings point to a role of systemic tryptase and LPS in the epithelial barrier alterations observed in patients with IBS-D.	[Ludidi, Samefko; Jonkers, Daisy; Elamin, Elhaseen; Pieters, Harm-Jan; Schaepkens, Esther; Bours, Paul; Kruimel, Joanna; Conchillo, Jose; Masclee, Ad] Maastricht Univ, Med Ctr, Div Gastroenterol Hepatol, Dept Internal Med,NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Ludidi, S (corresponding author), Maastricht Univ, Med Ctr, Div Gastroenterol Hepatol, Dept Internal Med,NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands.	S.Ludidi@maastrichtuniversity.nl	Kruimel, J.W./H-7307-2019	Kruimel, J.W./0000-0001-7102-1720				Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Annahazi A, 2013, AM J GASTROENTEROL, V108, P1322, DOI 10.1038/ajg.2013.152; Azpiroz F, 2007, NEUROGASTROENT MOTIL, V19, P62, DOI 10.1111/j.1365-2982.2006.00875.x; Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Barbara G, 2006, AM J GASTROENTEROL, V101, P1295, DOI 10.1038/ajg2006242; Benoit R, 1998, SHOCK, V10, P43, DOI 10.1097/00024382-199807000-00008; Bertiaux-Vandaele N, 2011, AM J GASTROENTEROL, V106, P2165, DOI 10.1038/ajg.2011.257; Bohm SK, 1996, BIOCHEM J, V314, P1009; Camilleri M, 2012, AM J PHYSL GASTROINT; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; Cuéllar Adriana, 2004, Biomed., V24, P413; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Elamin E, 2013, ALCOHOL CLIN EXP RES; Elamin E, 2014, AM J PHYSIOL-GASTR L, V306, pG677, DOI 10.1152/ajpgi.00236.2013; Elamin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058561; Elamin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035008; Ge YM, 2000, J INFECT DIS, V182, P873, DOI 10.1086/315784; Gecse K, 2008, GUT, V57, P591, DOI 10.1136/gut.2007.140210; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Hanson PJ, 2007, INNATE IMMUN; Juuti-Uusitalo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022967; Keszthelyi D, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-121; Keszthelyi D, 2012, DIGEST DIS SCI, V57, P2487, DOI 10.1007/s10620-012-2339-5; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Lee H, 2013, J NEUROGASTROENTEROL, V19, P244, DOI 10.5056/jnm.2013.19.2.244; Lee JW, 2010, DIGEST DIS SCI, V55, P2922, DOI 10.1007/s10620-009-1094-8; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Maltman DJ, 2010, BIOCHEM SOC T, V38, P1072, DOI 10.1042/BST0381072; Marshall JK, 2004, ALIMENT PHARM THER, V20, P1317, DOI 10.1111/j.1365-2036.2004.02284.x; Matricon J, 2012, ALIMENT PHARM THER, V36, P1009, DOI 10.1111/apt.12080; MERTZ H, 1995, GASTROENTEROLOGY, V109, P40, DOI 10.1016/0016-5085(95)90267-8; ODWYER ST, 1988, ARCH SURG-CHICAGO, V123, P1459; Ohmori T, 1998, EXP CELL RES, V245, P350, DOI 10.1006/excr.1998.4261; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; Ringel Y, 2013, AM J PHYSIOL-GASTR L, V305, pG529, DOI 10.1152/ajpgi.00207.2012; Roka R, 2007, CLIN GASTROENTEROL H, V5, P550, DOI 10.1016/j.cgh.2006.12.004; Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; Taira M, 2002, J ASTHMA, V39, P315, DOI 10.1081/JAS-120002288; Wilcz-Villega EM, 2013, AM J GASTROENTEROL, V108, P1140, DOI 10.1038/ajg.2013.92; Zhou QQ, 2010, GUT, V59, P775, DOI 10.1136/gut.2009.181834; Zhou QQ, 2009, PAIN, V146, P41, DOI 10.1016/j.pain.2009.06.017	45	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0123498	10.1371/journal.pone.0123498	http://dx.doi.org/10.1371/journal.pone.0123498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978614	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100008
J	Guadamuz, TE; Cheung, DH; Wei, CY; Koe, S; Lim, SH				Guadamuz, Thomas E.; Cheung, Doug H.; Wei, Chongyi; Koe, Stuart; Lim, Sin How			Young, Online and in the Dark: Scaling Up HIV Testing among MSM in ASEAN	PLOS ONE			English	Article							MALE SEX WORKERS; MEN MSM; ANAL INTERCOURSE; RISK; PREVENTION; BEHAVIOR; BARRIERS; SAMPLE	Background Poor HIV testing uptake by MSM may be attributable to unique challenges that are localized in Southeast Asia. Objective To characterize MSM who never tested for HIV, to identify correlates of never testing, and to elucidate the perceived barriers to HIV testing. Methods The present study used data from the Asian Internet MSM Sex Survey (AIMSS) and restricted the analysis to 4,310 MSM from the ten member countries of the Association of South East Asian Nations (ASEAN). Results Among MSM participants from ASEAN in our sample, 1290 (29.9%) reported having never been tested for HIV, 471 (10.9%) tested for HIV more than 2 years ago, and 2186 (50.7%) reported their last test date was between 6 months and two years ago, with only 363 (8.4%) of these men having been tested in the past 6 months. In multivariable logistic regression, younger MSM (age 15-22 years old [AOR: 4.60, 95% CI: 3.04-6.96]), MSM with lower education (secondary school or lower [AOR: 1.37, 95% CI: 1.03-1.83]), MSM who identify as bisexual or heterosexual (compared to gay-identified) (AOR: 1.94, 95% CI: 1.60-2.35), and MSM who had never used a condom with male partners (AOR: 1.61, 95% CI: 1.32-1.97) had higher odds of never been HIV tested. Main reason for not being tested was a low risk perception of HIV exposure (n = 390, 30.2%). Conclusion Current HIV prevention response must not leave MSM "in the dark," but instead meet them where they are by utilizing the Internet creatively through social media and smart phones. As ASEAN Economic Community (AEC) is quickly becoming a reality, so must there be an equally fast and united response to slowing down the HIV epidemics among MSM in ASEAN.	[Guadamuz, Thomas E.] Mahidol Univ, Fac Social Sci & Humanities, Dept Hlth & Soc, Nakhon Pathom, Thailand; [Guadamuz, Thomas E.; Cheung, Doug H.] Mahidol Univ, Fac Social Sci & Humanities, Ctr Hlth Policy Studies, Nakhon Pathom, Thailand; [Cheung, Doug H.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wei, Chongyi] Univ Calif San Francisco, Dept Epidemiol & Biostat & Global Hlth Sci, San Francisco, CA 94143 USA; [Koe, Stuart] ICM Pharma Pte Ltd, Singapore, Singapore; [Lim, Sin How] Univ Malaya, Ctr Excellence Res AIDS, Kuala Lumpur, Malaysia	Mahidol University; Mahidol University; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Universiti Malaya	Guadamuz, TE (corresponding author), Mahidol Univ, Fac Social Sci & Humanities, Dept Hlth & Soc, Nakhon Pathom, Thailand.	tguadamu@hotmail.com	Lim, Sin How/AAC-8004-2020; Ji, Kyungyang/J-9304-2013	Ji, Kyungyang/0000-0002-8014-1342; Koe, Stuart/0000-0001-7577-8624	U.S. National Institute of Mental Health [MH085567, MH093201]; IAS-NIDA Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH093201, K01MH085567, K99MH093201] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); IAS-NIDA Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Thomas E. Guadamuz and Chongyi Wei were supported by grants from the U.S. National Institute of Mental Health (MH085567, MH093201, respectively). Sin How Lim was supported by IAS-NIDA Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PCG, 2009, JAIDS-J ACQ IMM DEF, V52, pS143, DOI 10.1097/QAI.0b013e3181baf111; [Anonymous], 2013, ASEAN DECL COMM GETT; Arreola S, 2015, AIDS BEHAV, V19, P227, DOI 10.1007/s10461-014-0869-x; Asia Pacific Coalition On Male Sexual Health (APCOM), 2014, REG REP MSM HIV COUN; Aung T, 2013, AIDS BEHAV, V17, P1386, DOI 10.1007/s10461-012-0232-z; Beyrer C, 2011, 3 M TECHN ADV GROUP; Biello KB, 2014, AIDS BEHAV, V18, P1264, DOI 10.1007/s10461-013-0632-8; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Do TD, 2005, AIDS EDUC PREV, V17, P540, DOI 10.1521/aeap.2005.17.6.540; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Guadamuz TE, 2014, AIDS BEHAV, V18, P2089, DOI 10.1007/s10461-014-0826-8; Guadamuz T. E., 2013, NEW PUBLIC HLTH STD, P251; Herrick AL, 2013, AM J PUBLIC HEALTH, V103, P79, DOI 10.2105/AJPH.2012.300810; HOSMER DW, 1989, APPL LOGISTIC REGRES; Huang ZJ, 2012, AIDS BEHAV, V16, P858, DOI 10.1007/s10461-011-0119-4; Justumus P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071471; Ko NY, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2264; Landovitz RJ, 2013, J URBAN HEALTH, V90, P729, DOI 10.1007/s11524-012-9766-7; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; Lieber E, 2006, AIDS BEHAV, V10, P463, DOI 10.1007/s10461-005-9047-5; Lim SH, 2013, SEX TRANSM INFECT, V89, P642, DOI 10.1136/sextrans-2012-050995; Lim SH, 2012, AIDS BEHAV, V16, P1979, DOI 10.1007/s10461-012-0233-y; Morineau G, 2011, AIDS BEHAV, V15, P1033, DOI 10.1007/s10461-009-9590-6; Newman PA, 2012, PREV SCI, V13, P483, DOI 10.1007/s11121-012-0275-4; O'Leary A, 2013, AIDS BEHAV, V17, P1855, DOI 10.1007/s10461-012-0291-1; Raymond HF, 2008, AIDS EDUC PREV, V20, P408, DOI 10.1521/aeap.2008.20.5.408; Song Y, 2011, AIDS CARE, V23, P179, DOI 10.1080/09540121.2010.487088; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Sullivan PS, 2013, JAIDS-J ACQ IMM DEF, V63, pS102, DOI 10.1097/QAI.0b013e3182949e85; Thai National AIDS Committee, 2014, THAIL AIDS RESP PROG; Wei CY, 2014, AIDS BEHAV, V18, P1428, DOI 10.1007/s10461-013-0628-4; Wei CY, 2014, AIDS CARE, V26, P372, DOI 10.1080/09540121.2013.824538; Wimonsate W, 2011, AIDS BEHAV, V15, P693, DOI 10.1007/s10461-010-9755-3; Zhang L, 2013, SEX TRANSM DIS, V40, P235, DOI 10.1097/OLQ.0b013e31827ca6b9	36	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126658	10.1371/journal.pone.0126658	http://dx.doi.org/10.1371/journal.pone.0126658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25973907	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600074
J	Kitajima, A; Kikuchi, M				Kitajima, Akimasa; Kikuchi, Macoto			Numerous but Rare: An Exploration of Magic Squares	PLOS ONE			English	Article							ALGORITHM	How rare are magic squares? So far, the exact number of magic squares of order n is only known for n <= 5. For larger squares, we need statistical approaches for estimating the number. For this purpose, we formulated the problem as a combinatorial optimization problem and applied the Multicanonical Monte Carlo method ( MMC), which has been developed in the field of computational statistical physics. Among all the possible arrangements of the numbers 1; 2,..., n(2) in an n x n square, the probability of finding a magic square decreases faster than the exponential of n. We estimated the number of magic squares for n <= 30. The number of magic squares for n = 30 was estimated to be 6.56( 29) x 10(2056) and the corresponding probability is as small as 10(-212). Thus the MMC is effective for counting very rare configurations.	[Kitajima, Akimasa] Res & Legislat Reference Bur, Natl Diet Lib, Chiyoda Ku, Tokyo, Japan; [Kitajima, Akimasa; Kikuchi, Macoto] Osaka Univ, Grad Sch Sci, Dept Phys, Toyonaka, Osaka 560, Japan; [Kikuchi, Macoto] Osaka Univ, Cybermedia Ctr, Large Scale Computat Sci Div, Toyonaka, Osaka 560, Japan	National Diet Library; Osaka University; Osaka University	Kitajima, A (corresponding author), Res & Legislat Reference Bur, Natl Diet Lib, Chiyoda Ku, Tokyo, Japan.	a-kitaji@ndl.go.jp	Kikuchi, Macoto/K-7202-2019; Kikuchi, Macoto/GRJ-1079-2022	Kikuchi, Macoto/0000-0003-1582-8970	Global COE Program (Core Research and Engineering of Advanced Materials Interdisciplinary Education Center for Materials Science), MEXT, Japan	Global COE Program (Core Research and Engineering of Advanced Materials Interdisciplinary Education Center for Materials Science), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	AK is supported by Global COE Program (Core Research and Engineering of Advanced Materials Interdisciplinary Education Center for Materials Science), MEXT, Japan (http://www.gcoe.mp.es.osaka-u.ac.jp).	BERG BA, 1991, PHYS LETT B, V267, P249, DOI 10.1016/0370-2693(91)91256-U; Hukushima K, 2002, COMPUT PHYS COMMUN, V147, P77, DOI 10.1016/S0010-4655(02)00207-2; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; Iba Y, 2001, INT J MOD PHYS C, V12, P623, DOI 10.1142/S0129183101001912; LEE J, 1993, PHYS REV LETT, V71, P211, DOI 10.1103/PhysRevLett.71.211; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Pickover C, 2001, THE ZEN OF MAGIC SQU; Pinn K, 1998, INT J MOD PHYS C, V9, P541, DOI 10.1142/S0129183198000443; Wang FG, 2001, PHYS REV LETT, V86, P2050, DOI 10.1103/PhysRevLett.86.2050; Zhang C, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016703	10	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125062	10.1371/journal.pone.0125062	http://dx.doi.org/10.1371/journal.pone.0125062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973764	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600011
J	Koh, CL; Pan, SL; Jeng, JS; Chen, BB; Wang, YH; Hsueh, IP; Hsieh, CL				Koh, Chia-Lin; Pan, Shin-Liang; Jeng, Jiann-Shing; Chen, Bang-Bin; Wang, Yen-Ho; Hsueh, I-Ping; Hsieh, Ching-Lin			Predicting Recovery of Voluntary Upper Extremity Movement in Subacute Stroke Patients with Severe Upper Extremity Paresis	PLOS ONE			English	Article							MOTOR RECOVERY; REHABILITATION ASSESSMENT; UPPER-LIMB; INTERRATER RELIABILITY; FUNCTIONAL RECOVERY; IMPAIRMENT; STREAM; IMPACT; DEXTERITY; SCALE	Background and Objective Prediction of voluntary upper extremity (UE) movement recovery is largely unknown in patients with little voluntary UE movement at admission. The present study aimed to investigate (1) the extent and variation of voluntary UE movement recovery, and (2) the best predictive model of the recovery of voluntary UE movement by clinical variables in patients with severe UE paresis. Design Prospective cohort study. Methods 140 (out of 590) stroke patients with severe UE paresis completed all assessments. Voluntary UE movement was assessed using the UE subscale of the Stroke Rehabilitation Assessment of Movement (STREAM-UE). Two outcome measures, STREAM-UE scores at discharge (DCSTREAM-UE) and changes between admission and discharge (Delta(STREAM-UE))(,) were investigated to represent the final states and improvement of the recovery of voluntary UE movement. Stepwise regression analyses were used to investigate 19 clinical variables and to find the best predictive models of the two outcome measures. Results The participants showed wide variation in both DCSTREAM-UE and Delta(STREAM-UE). 3.6% of the participants almost fully recovered at discharge (DCSTREAM-UE > 15). A large improvement (Delta(STREAM-UE) >= 10) occurred in 16.4% of the participants, while 32.9% of the participants did not have any improvement. The four predictors for the DCSTREAM-UE (R-2 = 35.0%) were 'baseline STREAM-UE score', 'hemorrhagic stroke', 'baseline National Institutes of Health Stroke Scale (NIHSS) score', and 'cortical lesion excluding primary motor cortex'. The three predictors for the Delta(STREAM-UE) (R-2 = 22.0%) were 'hemorrhagic stroke', 'baseline NIHSS score', and 'cortical lesion excluding primary motor cortex'. Conclusions Recovery of voluntary UE movement varied widely in patients with severe UE paresis after stroke. The predictive power of clinical variables was poor. Both results indicate the complex nature of voluntary UE movement recovery in patients with severe UE paresis after stroke.	[Koh, Chia-Lin; Hsueh, I-Ping; Hsieh, Ching-Lin] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei, Taiwan; [Pan, Shin-Liang; Wang, Yen-Ho; Hsueh, I-Ping; Hsieh, Ching-Lin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Bang-Bin] Natl Taiwan Univ Hosp, Dept Med Imaging & Radiol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hsueh, IP (corresponding author), Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei, Taiwan.	iping@ntu.edu.tw	Hsieh, Ching-Lin/G-6057-2011; Koh, Chia-Lin/G-2127-2010	Hsieh, Ching-Lin/0000-0001-9468-9969; Koh, Chia-Lin/0000-0002-9927-2553; JENG, JIANN-SHING/0000-0002-1456-3686; PAN, SHIN-LIANG/0000-0001-6451-4666; CHEN, BANG-BIN/0000-0001-7058-1427; HSUEH, I-PING/0000-0002-8852-8242	National Taiwan University Hospital [UN102-069]	National Taiwan University Hospital(National Taiwan University)	This study was supported by the National Taiwan University Hospital (UN102-069).	Ahmed S, 2003, PHYS THER, V83, P617, DOI 10.1093/ptj/83.7.617; Baker K, 2011, STROKE, V42, P1787, DOI 10.1161/STROKEAHA.110.608505; Binkofski F, 2001, CEREBROVASC DIS, V11, P273, DOI 10.1159/000047650; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Daley K, 1999, PHYS THER, V79, P8, DOI 10.1093/ptj/79.1.8; Daley K, 1997, PHYSIOTHER CAN, V49, P269; DEHAAN RJ, 1995, STROKE, V26, P402, DOI 10.1161/01.STR.26.3.402; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Feys H, 2000, Physiother Res Int, V5, P1, DOI 10.1002/pri.180; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Hsueh IP, 2008, NEUROREHAB NEURAL RE, V22, P737, DOI 10.1177/1545968308315999; Kelly PJ, 2003, ARCH PHYS MED REHAB, V84, P968, DOI 10.1016/S0003-9993(03)00040-6; Kong KH, 2013, NEUROREHABILITATION, V32, P345, DOI 10.3233/NRE-130854; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Lang CE, 2013, J HAND THER, V26, P104, DOI 10.1016/j.jht.2012.06.005; Lee YC, 2010, OCCUP THER INT, V17, P152, DOI 10.1002/oti.301; Lindenberg R, 2012, HUM BRAIN MAPP, V33, P1040, DOI 10.1002/hbm.21266; Lu WS, 2008, J REHABIL MED, V40, P615, DOI 10.2340/16501977-0230; Maddala GS, 2000, APPL ECON, V32, P635, DOI 10.1080/000368400322534; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P852, DOI 10.1016/0003-9993(94)90108-2; Nijland RHM, 2010, STROKE, V41, P745, DOI 10.1161/STROKEAHA.109.572065; Pedraza S, 2012, J NEUROIMAGING, V22, P155, DOI 10.1111/j.1552-6569.2011.00588.x; Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302; Riachy M, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-24; Riley JD, 2011, STROKE, V42, P421, DOI 10.1161/STROKEAHA.110.599340; Shelton FDAP, 2001, NEUROREHAB NEURAL RE, V15, P229, DOI 10.1177/154596830101500311; Shelton FDAP, 2001, STROKE, V32, P107, DOI 10.1161/01.STR.32.1.107; Shi ZS, 2012, STROKE, V43, P1806, DOI 10.1161/STROKEAHA.111.649152; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Tsair TJ, 2010, RADIOGRAPHY, V16, P209, DOI 10.1016/j.radi.2010.04.004; van Kuijk AA, 2009, NEUROREHAB NEURAL RE, V23, P45, DOI 10.1177/1545968308317578; Wang CH, 2002, J REHABIL MED, V34, P20, DOI 10.1080/165019702317242668; Zarahn E, 2011, CEREB CORTEX, V21, P2712, DOI 10.1093/cercor/bhr047	38	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126857	10.1371/journal.pone.0126857	http://dx.doi.org/10.1371/journal.pone.0126857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973919	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600087
J	Lindlof, A; Chawade, A; Sikora, P; Olsson, O				Lindlof, Angelica; Chawade, Aakash; Sikora, Per; Olsson, Olof			Comparative Transcriptomics of Sijung and Jumli Marshi Rice during Early Chilling Stress Imply Multiple Protective Mechanisms	PLOS ONE			English	Article							ORYZA-SATIVA L.; COLD-ACCLIMATION; LOW-TEMPERATURE; ABSCISIC-ACID; GENE-EXPRESSION; ABIOTIC STRESS; PROTEIN-KINASES; FREEZING TOLERANCE; ELONGATION-FACTOR; ARABIDOPSIS	Introduction Low temperature is one of the major environmental factors that adversely affect plant growth and yield. Many cereal crops from tropical regions, such as rice, are chilling sensitive and, therefore, are affected already at < 10 degrees C. Interestingly, it has been demonstrated that chilling susceptibility varies greatly among rice varieties, which indicates differences in the underlying molecular responses. Understanding these differences is vital for continued development of rational breeding and transgenic strategies for more tolerant varieties. Thus, in this study, we conducted a comparative global gene expression profiling analysis of the chilling tolerant varieties Sijung and Jumli Marshi (spp. Japonica) during early chilling stress (< 24 h, 10 degrees C). Methods and Results Global gene expression experiments were conducted with Agilent Rice Gene Expression Microarray 4x44K. The analysed results showed that there was a relatively low ( percentage or number) overlap in differentially expressed genes in the two varieties and that substantially more genes were up-regulated in Jumli Marshi than in Sijung but the number of down-regulated genes were higher in Sijung. In broad GO annotation terms, the activated response pathways in Sijung and Jumli Marshi were coherent, as a majority of the genes belonged to the catalytic, transcription regulator or transporter activity categories. However, a more detailed analysis revealed essential differences. For example, in Sijung, activation of calcium and phosphorylation signaling pathways, as well as of lipid transporters and exocytosis-related proteins take place very early in the stress response. Such responses can be coupled to processes aimed at strengthening the cell wall and plasma membrane against disruption. On the contrary, in Jumli Marshi, sugar production, detoxification, ROS scavenging, protection of chloroplast translation, and plausibly the activation of the jasmonic acid pathway were the very first response activities. These can instead be coupled to detoxification processes. Conclusions Based on the results inferred from this study, we conclude that different, but overlapping, strategies are undertaken by the two varieties to cope with the chilling stress; in Sijung the initial molecular responses seem to be mainly targeted at strengthening the cell wall and plasma membrane, whereas in Jumli Marshi the protection of chloroplast translation and detoxification is prioritized.	[Lindlof, Angelica] Univ Skovde, Syst Biol Res Ctr, S-54128 Skovde, Sweden; [Chawade, Aakash; Olsson, Olof] Lund Univ, Dept Pure & Appl Biochem, CropTailor AB, SE-22100 Lund, Sweden; [Chawade, Aakash] Lund Univ, Dept Immunotechnol, SE-22381 Lund, Sweden; [Sikora, Per] Univ Gothenburg, Dept Biol & Environm Sci, SE-40530 Gothenburg, Sweden; [Olsson, Olof] Lund Univ, Dept Pure & Appl Biochem, SE-22100 Lund, Sweden	University of Skovde; Lund University; Lund University; University of Gothenburg; Lund University	Lindlof, A (corresponding author), Univ Skovde, Syst Biol Res Ctr, S-54128 Skovde, Sweden.	angelica.lindlof@his.se	Chawade, Aakash/G-7750-2011	Chawade, Aakash/0000-0002-6500-4139	Swedish Research School in Genomics and Bioinformatics; Swedish Farmers Supply and Crop Marketing Cooperative (SLF) [H0633164-K02]; Swedish Research Council (VR)	Swedish Research School in Genomics and Bioinformatics; Swedish Farmers Supply and Crop Marketing Cooperative (SLF); Swedish Research Council (VR)(Swedish Research Council)	This work was supported by grants from the Swedish Research School in Genomics and Bioinformatics, the Swedish Farmers Supply and Crop Marketing Cooperative (SLF, grant number H0633164-K02), and the Swedish Research Council (VR). Crop Tailor provided support in the form of salary for authors AC and AL, and also partly in the study design, data collection and analysis and preparation of the manuscript. Crop Tailor supports the decision to publish the work. The specific roles of these authors are articulated in the Author Contributions section.	Agrawal GK, 2004, BIOCHEM BIOPH RES CO, V317, P1, DOI 10.1016/j.bbrc.2004.03.020; Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Badea C, 2009, PLANT OMICS, V2, P78; Batista-Santos P, 2011, J PLANT PHYSIOL, V168, P792, DOI 10.1016/j.jplph.2010.11.013; Benedict C, 2006, PLANT PHYSIOL, V141, P1219, DOI 10.1104/pp.106.083527; Boisson-Dernier A, 2010, EXPERIMENTAL BOTANY, V62, P1581; Bonnecarrere V, 2011, PLANT SCI, V180, P726, DOI 10.1016/j.plantsci.2011.01.023; Campoli C, 2009, MOL GENET GENOMICS, V282, P141, DOI 10.1007/s00438-009-0451-9; Chawade A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081729; Chawade A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-304; Choi JY, 2011, PLANT CELL REP, V30, P867, DOI 10.1007/s00299-010-0989-3; Chung S, 2008, PLANT J, V54, P15, DOI 10.1111/j.1365-313X.2007.03399.x; Chunhui X, 1988, ACTA BOT SIN, V30, P601; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Ducruet JM, 2005, PLANTA, V221, P567, DOI 10.1007/s00425-004-1464-6; Ehlert B, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-12; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fortunato AS, 2010, J PLANT PHYSIOL, V167, P333, DOI 10.1016/j.jplph.2009.10.013; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Franz S, 2011, MOL PLANT, V4, P83, DOI 10.1093/mp/ssq064; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Ganeshan S, 2011, PLANT MOL BIOL, V75, P379, DOI 10.1007/s11103-011-9734-8; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Govindachary S, 2004, PHYSIOL PLANTARUM, V121, P322, DOI 10.1111/j.0031-9317.2004.00305.x; Gulick PJ, 2005, GENOME, V48, P913, DOI 10.1139/g05-039; Guy Charles, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P231; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hayashi T, 2011, MOL PLANT, V4, P17, DOI 10.1093/mp/ssq063; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; HENNESSEY TL, 1993, PLANTA, V189, P369, DOI 10.1007/BF00194433; HENNESSEY TL, 1991, PLANT PHYSIOL, V96, P831, DOI 10.1104/pp.96.3.831; Hurry V, 2000, PLANT J, V24, P383, DOI 10.1046/j.1365-313x.2000.00888.x; Ikeda T, 2009, THEOR APPL GENET, V118, P1477, DOI 10.1007/s00122-009-0996-3; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Janska A, 2011, FUNCT INTEGR GENOMIC, V11, P307, DOI 10.1007/s10142-011-0213-8; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kaji A, 2001, COLD SPRING HARB SYM, V66, P515, DOI 10.1101/sqb.2001.66.515; Kaniuga Z, 2008, PLANT BIOLOGY, V10, P171, DOI 10.1111/j.1438-8677.2007.00019.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kumar K, 2011, PLANT SIGNAL BEHAV, V6, P316, DOI 10.4161/psb.6.3.13063; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Liljas A, 1995, CURR OPIN STRUC BIOL, V5, P721, DOI 10.1016/0959-440X(95)80003-4; Lindlof A, 2009, BIOINFORMATICS, V25, P1345, DOI 10.1093/bioinformatics/btp172; Liu XY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-287; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lucinski R, 2006, ACTA BIOCHIM POL, V53, P693; Mackill DJ, 1997, CROP SCI, V37, P1340, DOI 10.2135/cropsci1997.0011183X003700040051x; Mai J, 2010, TREE PHYSIOL, V30, P1391, DOI 10.1093/treephys/tpq075; MANSFIELD C M, 1973, International Journal of Chronobiology, V1, P235; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mishra A, 2011, PLANT SIGNAL BEHAV, V6, P301, DOI 10.4161/psb.6.2.15278; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Monroy AF, 2007, PLANT MOL BIOL, V64, P409, DOI 10.1007/s11103-007-9161-z; Morsy MR, 2005, GENE, V344, P171, DOI 10.1016/j.gene.2004.09.033; Morsy MR, 2007, J PLANT PHYSIOL, V164, P157, DOI 10.1016/j.jplph.2005.12.004; Mulder Nicola, 2007, V396, P59; Nemoto K, 2011, PHYTOCHEMISTRY, V72, P1136, DOI 10.1016/j.phytochem.2011.02.029; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Okamoto M, 2011, PHYTOCHEMISTRY, V72, P717, DOI 10.1016/j.phytochem.2011.02.004; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Oono Youko, 2006, Functional & Integrative Genomics, V6, P212, DOI 10.1007/s10142-005-0014-z; Pearce RS, 1999, PLANT GROWTH REGUL, V29, P47, DOI 10.1023/A:1006291330661; Pennycooke JC, 2008, PLANT MOL BIOL, V67, P483, DOI 10.1007/s11103-008-9333-5; Poirier Yves, 2002, Arabidopsis Book, V1, pe0024, DOI 10.1199/tab.0024; PRASAD TK, 1994, PLANT PHYSIOL, V105, P619, DOI 10.1104/pp.105.2.619; Rassow J, 1996, CURR BIOL, V6, P115, DOI 10.1016/S0960-9822(02)00437-2; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Robinson SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-434; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sano T, 1999, PLANT CELL PHYSIOL, V40, P1, DOI 10.1093/oxfordjournals.pcp.a029464; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; Satterlee JS, 1998, J MEMBRANE BIOL, V164, P205, DOI 10.1007/s002329900406; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Shu DF, 2011, PLANT PHYSIOL BIOCH, V49, P1228, DOI 10.1016/j.plaphy.2011.04.005; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Singh BN, 2004, BIOCHEM BIOPH RES CO, V320, P523, DOI 10.1016/j.bbrc.2004.05.192; Smith FW, 2003, PLANT SOIL, V248, P71, DOI 10.1023/A:1022376332180; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tomes CN, 2004, DEV BIOL, V265, P399, DOI 10.1016/j.ydbio.2003.09.032; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	98	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125385	10.1371/journal.pone.0125385	http://dx.doi.org/10.1371/journal.pone.0125385			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973918	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600015
J	Ying, Q; Ansong, E; Diamond, AM; Lu, ZX; Yang, WC; Bie, XM				Ying, Qi; Ansong, Emmanuel; Diamond, Alan M.; Lu, Zhaoxin; Yang, Wancai; Bie, Xiaomei			Quantitative Proteomic Analysis Reveals That Anti-Cancer Effects of Selenium-Binding Protein 1 In Vivo Are Associated with Metabolic Pathways	PLOS ONE			English	Article							COLORECTAL-CANCER; CELLS; SUPPRESSION; MACROPHAGES; EXPRESSION; INTERACTS	Previous studies have shown the tumor-suppressive role of selenium-binding protein 1 (SBP1), but the underlying mechanisms are unclear. In this study, we found that induction of SBP1 showed significant inhibition of colorectal cancer cell growth and metastasis in mice. We further employed isobaric tags for relative and absolute quantitation (iTRAQ) to identify proteins that were involved in SBP1-mediated anti-cancer effects in tumor tissues. We identified 132 differentially expressed proteins, among them, 53 proteins were upregulated and 79 proteins were downregulated. Importantly, many of the differentially altered proteins were associated with lipid/glucose metabolism, which were also linked to Glycolysis, MAPK, Wnt, NF-kappa B, NOTCH and epithelial-mesenchymal transition (EMT) signaling pathways. These results have revealed a novel mechanism that SBP1-mediated cancer inhibition is through altering lipid/glucose metabolic signaling pathways.	[Ying, Qi; Lu, Zhaoxin; Bie, Xiaomei] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Ying, Qi; Yang, Wancai] Xinxiang Med Univ, Dept Pathol, Xinxiang 453003, Peoples R China; [Ying, Qi; Ansong, Emmanuel; Diamond, Alan M.; Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University; Xinxiang Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Nanjing Agricultural University	Bie, XM (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.	wyang06@uic.edu; bxm43@njau.edu.cn	Yang, Wancai/O-7655-2019	Yang, Wancai/0000-0001-7437-9197	National Natural Science Foundation of China [91229115, 81272251]; grant for the Innovative Team of Science and Technology, Henan Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); grant for the Innovative Team of Science and Technology, Henan Province, China	This work was supported in part by the grants from National Natural Science Foundation of China (grant # 91229115 and 81272251), a grant for the Innovative Team of Science and Technology, Henan Province, China.	Ansong E, 2014, MOL NUTR FOOD RES, V58, P117, DOI 10.1002/mnfr.201300543; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casado-Vela J, 2010, PROTEOMICS, V10, P343, DOI 10.1002/pmic.200900509; Chang PWG, 1997, J CELL BIOCHEM, V64, P217, DOI 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#; Chen GA, 2004, J PATHOL, V202, P321, DOI 10.1002/path.1524; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Fang WF, 2010, CARCINOGENESIS, V31, P1360, DOI 10.1093/carcin/bgq114; Harjes U, 2014, J BIOL CHEM, V289, P23168, DOI 10.1074/jbc.M114.576512; Hatziapostolou M, 2013, TRENDS ENDOCRIN MET, V24, P361, DOI 10.1016/j.tem.2013.03.002; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Huang C, 2012, CLIN CANCER RES, V18, P3042, DOI 10.1158/1078-0432.CCR-12-0183; Iwasa T, 2012, BBA-MOL BASIS DIS, V1822, P204, DOI 10.1016/j.bbadis.2011.10.013; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; Jeong JY, 2009, BIOCHEM BIOPH RES CO, V379, P583, DOI 10.1016/j.bbrc.2008.12.110; Jerome-Morais A, 2012, PROSTATE, V72, P1006, DOI 10.1002/pros.21506; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Li QK, 2013, J PROTEOME RES, V12, P3689, DOI 10.1021/pr400274w; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Liang MM, 2014, ASIAN J ANDROL, V16, P661, DOI 10.4103/1008-682X.132947; Luo YD, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-21; Mikheev AM, 2007, BIOCHEM BIOPH RES CO, V352, P675, DOI 10.1016/j.bbrc.2006.11.079; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; Niknahad H, 2003, CHEM-BIOL INTERACT, V143, P107, DOI 10.1016/S0009-2797(02)00185-0; Pal S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-23; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Park EJ, 2013, FOOD CHEM TOXICOL, V55, P424, DOI 10.1016/j.fct.2013.01.007; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; Raucci R, 2011, BBA-PROTEINS PROTEOM, V1814, P513, DOI 10.1016/j.bbapap.2011.02.006; Silvers AL, 2010, CLIN CANCER RES, V16, P2009, DOI 10.1158/1078-0432.CCR-09-2801; Sun S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096211; Tan SYE, 2014, CURR OPIN BIOTECH, V26, P1, DOI 10.1016/j.copbio.2013.08.002; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Tsujimoto S, 2013, BBA-GEN SUBJECTS, V1830, P3616, DOI 10.1016/j.bbagen.2013.03.008; Wang TP, 2010, EXP CELL RES, V316, P2893, DOI 10.1016/j.yexcr.2010.07.017; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yuan HY, 2013, CANCER RES, V73, P4349, DOI 10.1158/0008-5472.CAN-13-0322; Zhang CJ, 2013, INT J ONCOL, V42, P1620, DOI 10.3892/ijo.2013.1850	40	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126285	10.1371/journal.pone.0126285	http://dx.doi.org/10.1371/journal.pone.0126285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974208	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600044
J	Sanpa, S; Popova, M; Bankova, V; Tunkasiri, T; Eitssayeam, S; Chantawannakul, P				Sanpa, Sirikarn; Popova, Milena; Bankova, Vassya; Tunkasiri, Tawee; Eitssayeam, Sukum; Chantawannakul, Panuwan			Antibacterial Compounds from Propolis of Tetragonula laeviceps and Tetrigona melanoleuca (Hymenoptera: Apidae) from Thailand	PLOS ONE			English	Article							GARCINIA-MANGOSTANA; TERPENOID CONSTITUENTS; APIS-MELLIFERA; GC-MS; XANTHONES; BEE; CYCLOOXYGENASE; TRITERPENES; INHIBITION; ANGUSTULA	This study investigated the chemical composition and antimicrobial activity of propolis collected from two stingless bee species Tetragonula laeviceps and Tetrigona melanoleuca (Hymenoptera: Apidae). Six xanthones, one triterpene and one lignane were isolated from Tetragonula laeviceps propolis. Triterpenes were the main constituents in T. melanoleuca propolis. The ethanol extract and isolated compounds from T. laeviceps propolis showed a higher antibacterial activity than those of T. melanoleuca propolis as the constituent alpha-man-gostin exhibited the strongest activity. Xanthones were found in propolis for the first time; Garcinia mangostana (Mangosteen) was the most probable plant source. In addition, this is the first report on the chemical composition and bioactivity of propolis from T. melanoleuca.	[Sanpa, Sirikarn] Chiang Mai Univ, Grad Sch, Chiang Mai 50000, Thailand; [Sanpa, Sirikarn; Chantawannakul, Panuwan] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Popova, Milena; Bankova, Vassya] Bulgarian Acad Sci, Ctr Phytochem, Inst Organ Chem, BU-1113 Sofia, Bulgaria; [Tunkasiri, Tawee; Eitssayeam, Sukum] Chiang Mai Univ, Fac Sci, Dept Phys, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University; Bulgarian Academy of Sciences; Chiang Mai University	Chantawannakul, P (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand.	panuwan@gmail.com	Bankova, Vassya/A-8972-2010	Sanpa, Sirikarn/0000-0003-3184-0830	program of Strategic Scholarships for Frontier Research Network for the Joint Ph.D. Program Thai Doctoral degree from the Office of the Higher Education Commission, Thailand	program of Strategic Scholarships for Frontier Research Network for the Joint Ph.D. Program Thai Doctoral degree from the Office of the Higher Education Commission, Thailand	This work was supported by a grant under the program of Strategic Scholarships for Frontier Research Network for the Joint Ph.D. Program Thai Doctoral degree from the Office of the Higher Education Commission, Thailand.	Arriaga AMC, 2002, AN ACAD BRAS CIENC, V74, P415, DOI 10.1590/S0001-37652002000300004; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Burger P, 2008, THESIS; Burger P, 2009, ANAL CHIM ACTA, V648, P85, DOI 10.1016/j.aca.2009.06.022; Caligiani A, 2013, FOOD CHEM, V136, P735, DOI 10.1016/j.foodchem.2012.08.011; Chanchao C, 2013, POT HONEY, P495; Chen LG, 2008, FOOD CHEM TOXICOL, V46, P688, DOI 10.1016/j.fct.2007.09.096; Choudhari MK, 2012, J ETHNOPHARMACOL, V141, P363, DOI 10.1016/j.jep.2012.02.047; Fontanay S, 2008, J ETHNOPHARMACOL, V120, P272, DOI 10.1016/j.jep.2008.09.001; Garedew A, 2004, THERMOCHIM ACTA, V422, P115, DOI 10.1016/j.tca.2004.05.037; Gibbons S, 2004, NAT PROD REP, V21, P263, DOI 10.1039/b212695h; Jalil AH, 2014, BEESCAPE FOR MELIPON; Joycharat N, 2010, CAN J CHEM, V88, P937, DOI 10.1139/V10-085; Jung HA, 2006, J AGR FOOD CHEM, V54, P2077, DOI 10.1021/jf052649z; Kaewmuangmoon J., 2012, European Journal of Medicinal Plants, V2, P74; Kim GS, 2010, J KOREAN SOC APPL BI, V53, P417, DOI 10.3839/jksabc.2010.064; Leonhardt SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023445; Li L, 2013, PLANTA MED, V79, P646, DOI 10.1055/s-0032-1328543; Liberio SA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-108; MARTIN F.W., 1980, TROPICAL SUBTROPICAL, P407; MICHENER CD, 1988, P NATL ACAD SCI USA, V85, P6424, DOI 10.1073/pnas.85.17.6424; Miorin PL, 2003, J APPL MICROBIOL, V95, P913, DOI 10.1046/j.1365-2672.2003.02050.x; Miyauchi T, 1998, PHYTOCHEMISTRY, V47, P665, DOI 10.1016/S0031-9422(97)00458-5; Nakatani K, 2002, BIOCHEM PHARMACOL, V63, P73, DOI 10.1016/S0006-2952(01)00810-3; Nguyen LHD, 2003, PHYTOCHEMISTRY, V63, P467, DOI 10.1016/S0031-9422(02)00433-8; Norizan Ahmat, 2010, Middle East Journal of Scientific Research, V6, P123; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Penduka D, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/s12941-014-0037-1; Phongmaykin J, 2008, ARCH PHARM RES, V31, P21, DOI 10.1007/s12272-008-1115-8; Ragasa Consolacion Y., 2010, Philippine Scientist, V47, P63; Santos GG, 1997, PHYTOCHEMISTRY, V44, P1309, DOI 10.1016/S0031-9422(96)00680-2; Sawaya A.C.H.F., 2009, J APIPROD APIMED SCI, V1, P37, DOI [10.3896/IBRA.4.01.2.03, DOI 10.3896/IBRA.4.01.2.03]; Sawaya ACHF, 2006, APIDOLOGIE, V37, P398, DOI 10.1051/apido:2006011; Seger C, 2008, TETRAHEDRON LETT, V49, P4313, DOI 10.1016/j.tetlet.2008.04.109; SEN AK, 1982, PHYTOCHEMISTRY, V21, P1747, DOI 10.1016/0031-9422(82)85052-8; Suksamrarn S, 2006, CHEM PHARM BULL, V54, P301, DOI 10.1248/cpb.54.301; Suntiparapop K, 2012, J APICULT RES, V51, P45, DOI 10.3896/IBRA.1.51.1.06; Velthuis HHW., 1997, THE BIOLOGY OF STING; Xie XL, 2012, MUTAT RES-GEN TOX EN, V748, P29, DOI 10.1016/j.mrgentox.2012.06.005; Zhang YJ, 2004, J AGR FOOD CHEM, V52, P228, DOI 10.1021/jf034616u	40	43	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126886	10.1371/journal.pone.0126886	http://dx.doi.org/10.1371/journal.pone.0126886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992582	Green Submitted, gold, Green Published			2022-12-27	WOS:000354917300059
J	Turton, KB; Annis, DS; Rui, LX; Esnault, S; Mosher, DF				Turton, Keren B.; Annis, Douglas S.; Rui, Lixin; Esnault, Stephane; Mosher, Deane F.			Ratios of Four STAT3 Splice Variants in Human Eosinophils and Diffuse Large B Cell Lymphoma Cells	PLOS ONE			English	Article							TIME PCR QUANTIFICATION; GENE-EXPRESSION; RT-PCR; ISOFORMS; BETA; PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; GENERATION; INDUCTION	Signal transducer and activator of transcription 3 (STAT3) is a key mediator of leukocyte differentiation and proliferation. The 3' end of STAT3 transcripts is subject to two alternative splicing events. One results in either full-length STAT3 alpha or in STAT3 beta, which lacks part of the C-terminal transactivation domain. The other is at a tandem donor (5') splice site and results in the codon for Ser-701 being included (S) or excluded (Delta S). Despite the proximity of Ser-701 to the site of activating phosphorylation at Tyr-705, Delta S/S splicing has barely been studied. Sequencing of cDNA from purified eosinophils revealed the presence of four transcripts (S-alpha, Delta S-alpha, S-beta, and Delta S-beta) rather than the three reported in publically available databases from which Delta S-beta is missing. To gain insight into regulation of the two alternative splicing events, we developed a quantitative(q) PCR protocol to compare transcript ratios in eosinophils in which STAT3 is upregulated by cytokines, activated B cell diffuse large B cell Lymphoma (DLBCL) cells in which STAT3 is dysregulated, and in germinal center B cell-like DLBCL cells in which it is not. With the exception of one line of activated B cell DLCBL cells, the four variants were found in roughly the same ratios despite differences in total levels of STAT3 transcripts. S-alpha was the most abundant, followed by S-beta. Delta S-alpha and Delta S-beta together comprised 15.6 +/- 4.0% (mean +/- SD, n=21) of the total. The percentage of STAT3 beta variants that were Delta S was 1.5-fold greater than of STAT3 alpha variants that were Delta S. Inspection of Illumina's "BodyMap" RNA-Seq database revealed that the Delta S variant accounts for 10-26 % of STAT3 transcripts across 16 human tissues, with less variation than three other genes with the identical tandem donor splice site sequence. Thus, it seems likely that all cells contain the S-alpha, Delta S-alpha, S-beta, and Delta S-beta variants of STAT3.	[Turton, Keren B.; Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Rui, Lixin; Esnault, Stephane; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	dfmosher@wisc.edu	li, rui/GSD-4367-2022; Esnault, Stephane/AAJ-4511-2020; rui, li/GYR-3791-2022; Esnault, Stephane/AAO-4712-2020	Esnault, Stephane/0000-0001-7238-8671; Turton, Keren/0000-0001-9064-6523	National Institutes of Health-NHLBI [P01HL088584]; University of Wisconsin Carbone Cancer Center and Department of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, KL2TR000428] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER	National Institutes of Health-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Wisconsin Carbone Cancer Center and Department of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The studies were supported by a Program Project Grant on the Role of Eosinophils in Airway Inflammation and Remodeling: P01HL088584 (PI: N. Jarjour) from the National Institutes of Health-NHLBI, and intramural funds from the University of Wisconsin Carbone Cancer Center and Department of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Bortfeldt R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-202; Bradley RK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001229; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burnham ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103122; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Chakraborty A, 1996, BLOOD, V88, P2442, DOI 10.1182/blood.V88.7.2442.bloodjournal8872442; Delgoffe Greg M, 2013, JAKSTAT, V2, pe23060, DOI 10.4161/jkst.23060; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Fededa JP, 2005, MOL CELL, V19, P393, DOI 10.1016/j.molcel.2005.06.035; Glauser DA, 2011, P NATL ACAD SCI USA, V108, P20790, DOI 10.1073/pnas.1116712108; Hiller M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r65; Junk DJ, 2014, CANCERS, V6, P741, DOI 10.3390/cancers6020741; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kelly EAB, 2012, CYTOKINE, V58, P199, DOI 10.1016/j.cyto.2012.01.009; Kramarzova K, 2012, LEUKEMIA, V26, P2086, DOI 10.1038/leu.2012.76; Kramer M, 2011, GENETICS, V187, P761, DOI 10.1534/genetics.110.125096; Liu LY, 2007, J IMMUNOL, V179, P4840, DOI 10.4049/jimmunol.179.7.4840; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; Ng IHW, 2014, TRAFFIC, V15, P946, DOI 10.1111/tra.12181; Ng IHW, 2012, BIOCHEM J, V447, P125, DOI 10.1042/BJ20120941; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Too HP, 2003, MOL BRAIN RES, V114, P146, DOI 10.1016/S0169-328X(03)00169-4; Waitkus MS, 2014, MOL CELL BIOL, V34, P1800, DOI 10.1128/MCB.00034-14; Waitkus MS, 2013, J BIOL CHEM, V288, P11988, DOI 10.1074/jbc.M112.428516; Walton HS, 2007, J NEUROSCI METH, V160, P294, DOI 10.1016/j.jneumeth.2006.09.022; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Zammarchi F, 2011, P NATL ACAD SCI USA, V108, P17779, DOI 10.1073/pnas.1108482108; Zhou Z, 2013, CIRCULATION, V127, P476, DOI 10.1161/CIRCULATIONAHA.112.132126	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127243	10.1371/journal.pone.0127243	http://dx.doi.org/10.1371/journal.pone.0127243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984943	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300105
J	Clements, D; Dongre, A; Krymskaya, VP; Johnson, SR				Clements, Debbie; Dongre, Arundhati; Krymskaya, Vera P.; Johnson, Simon R.			Wild Type Mesenchymal Cells Contribute to the Lung Pathology of Lymphangioleiomyomatosis	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; TUBEROUS SCLEROSIS; CXCR4/CXCL12 AXIS; EXPRESSION; PROLIFERATION; METABOLISM; MUTATIONS; PATHWAYS; TSC2	Lymphangioleiomyomatosis (LAM) is a rare disease leading to lungs cysts and progressive respiratory failure. Cells of unknown origin accumulate in the lungs forming nodules and eventually resulting in lung cysts. These LAM cells are described as clonal with bi-allelic mutations in TSC-2 resulting in constitutive mTOR activation. However LAM nodules are heterogeneous structures containing cells of different phenotypes; we investigated whether recruited wild type cells were also present alongside mutation bearing cells. Cells were isolated from LAM lung tissue, cultured and characterised using microscopy, immunocytochemistry and western blotting. Fibroblast-like cells were identified in lung tissue using immunohistochemical markers. Fibroblast chemotaxis toward LAM cells was examined using migration assays and 3D cell culture. Fibroblast-like cells were obtained from LAM lungs: these cells had fibroblast-like morphology, actin stress fibres, full length tuberin protein and suppressible ribosomal protein S6 activity suggesting functional TSC-1/2 protein. Fibroblast Activation Protein, Fibroblast Specific Protein/S100A4 and Fibroblast Surface Protein all stained subsets of cells within LAM nodules from multiple donors. In a mouse model of LAM, tuberin positive host derived cells were also present within lung nodules of xenografted TSC-2 null cells. In vitro, LAM 621-101 cells and fibroblasts formed spontaneous aggregates over three days in 3D co-cultures. Fibroblast chemotaxis was enhanced two fold by LAM 621-101 conditioned medium (p=0.05), which was partially dependent upon LAM cell derived CXCL12. Further, LAM cell conditioned medium also halved fibroblast apoptosis under serum free conditions (p=0.03). Our findings suggest that LAM nodules contain a significant population of fibroblast-like cells. Analogous to cancer associated fibroblasts, these cells may provide a permissive environment for LAM cell growth and contribute to the lung pathology of LAM lung disease.	[Clements, Debbie; Dongre, Arundhati; Johnson, Simon R.] Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England; [Krymskaya, Vera P.] Univ Penn, Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	University of Nottingham; University of Pennsylvania; Pennsylvania Medicine	Clements, D (corresponding author), Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England.	debbie.clements@nottingham.ac.uk		Krymskaya, Vera/0000-0002-0584-4486; Johnson, Simon/0000-0002-9837-2763	LAM Action [LAM001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114085, R01HL110551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	LAM Action; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by LAM Action (lamaction.org) grant number LAM001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrinidis A, 2005, ONCOGENE, V24, P7475, DOI 10.1038/sj.onc.1209090; Badri KR, 2013, AM J RESP CRIT CARE, V187, P663, DOI 10.1164/ajrccm.187.6.663; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Chilosi M, 2009, MODERN PATHOL, V22, P161, DOI 10.1038/modpathol.2008.189; Clements D, 2010, J IMMUNOL, V185, P1812, DOI 10.4049/jimmunol.0902149; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crooks DM, 2004, P NATL ACAD SCI USA, V101, P17462, DOI 10.1073/pnas.0407971101; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Fearon DT, 2014, CANCER IMMUNOL RES, V2, P187, DOI 10.1158/2326-6066.CIR-14-0002; Finlay G, 2004, AM J PHYSIOL-LUNG C, V286, pL690, DOI 10.1152/ajplung.00311.2003; Goncharova EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003840; Hayashi T, 1997, HUM PATHOL, V28, P1071, DOI 10.1016/S0046-8177(97)90061-7; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; Henske EP, 2003, GENE CHROMOSOME CANC, V38, P376, DOI 10.1002/gcc.10252; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Johnson SR, 2002, HISTOPATHOLOGY, V40, P458, DOI 10.1046/j.1365-2559.2002.01394.x; Johnson SR, 2006, EUR RESPIR J, V27, P1056, DOI 10.1183/09031936.06.00113303; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Martinez-Outschoorn UE, 2011, INT J BIOCHEM CELL B, V43, P1045, DOI 10.1016/j.biocel.2011.01.023; Matsui K, 2000, AM J RESP CRIT CARE, V161, P1002, DOI 10.1164/ajrccm.161.3.9904009; Matsumoto Y, 1999, AM J RESP CELL MOL, V21, P327, DOI 10.1165/ajrcmb.21.3.3693; Pacheco-Rodriguez G, 2007, CANCER RES, V67, P10573, DOI 10.1158/0008-5472.CAN-07-1356; Pea M, 1997, ELECT J PATHOLOGY HI, V3, P28, DOI [10.1016/j.exer.2014.03.001, DOI 10.1016/J.EXER.2014.03.001]; Ruiz EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4175; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Strizheva GD, 2001, AM J RESP CRIT CARE, V163, P253, DOI 10.1164/ajrccm.163.1.2005004; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Valencia JC, 2015, CHEST, V147, P771, DOI 10.1378/chest.14-0380; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Yu J, 2001, AM J RESP CRIT CARE, V164, P1537, DOI 10.1164/ajrccm.164.8.2104095; Zhang J, 2013, PHARMACOL THERAPEUT, V137, P200, DOI 10.1016/j.pharmthera.2012.10.003	35	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126025	10.1371/journal.pone.0126025	http://dx.doi.org/10.1371/journal.pone.0126025			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978616	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100042
J	Furuta, Y; Konno, M; Osaki, T; Yonezawa, H; Ishige, T; Imai, M; Shiwa, Y; Shibata-Hatta, M; Kanesaki, Y; Yoshikawa, H; Kamiya, S; Kobayashi, I				Furuta, Yoshikazu; Konno, Mutsuko; Osaki, Takako; Yonezawa, Hideo; Ishige, Taichiro; Imai, Misaki; Shiwa, Yuh; Shibata-Hatta, Mari; Kanesaki, Yu; Yoshikawa, Hirofumi; Kamiya, Shigeru; Kobayashi, Ichizo			Microevolution of Virulence-Related Genes in Helicobacter pylori Familial Infection	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; SINGLE-MOLECULE; PROTEIN FAMILIES; EXPRESSION; EVOLUTION; MUTATION; HOPQ; RECOMBINATION; METHYLATION; ADHERENCE	Helicobacter pylori, a bacterial pathogen that can infect human stomach causing gastritis, ulcers and cancer, is known to have a high degree of genome/epigenome diversity as the result of mutation and recombination. The bacteria often infect in childhood and persist for the life of the host. One of the reasons of the rapid evolution of H. pylori is that it changes its genome drastically for adaptation to a new host. To investigate microevolution and adaptation of the H. pylori genome, we undertook whole genome sequencing of the same or very similar sequence type in multi-locus sequence typing (MLST) with seven genes in members of the same family consisting of parents and children in Japan. Detection of nucleotide substitutions revealed likely transmission pathways involving children. Nonsynonymous (amino acid changing) mutations were found in virulence-related genes (cag genes, vacA, hcpDX, tnfa, ggt, htrA and the collagenase gene), outer membrane protein (OMP) genes and other cell surface-related protein genes, signal transduction genes and restriction-modification genes. We reconstructed various pathways by which H. pylori can adapt to a new human host, and our results raised the possibility that the mutational changes in virulence-related genes have a role in adaptation to a child host. Changes in restriction-modification genes might remodel the methylome and transcriptome to help adaptation. This study has provided insights into H. pylori transmission and virulence and has implications for basic research as well as clinical practice.	[Furuta, Yoshikazu; Kobayashi, Ichizo] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo, Japan; [Furuta, Yoshikazu; Kobayashi, Ichizo] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Konno, Mutsuko] Sapporo Kosei Gen Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Osaki, Takako; Yonezawa, Hideo; Kamiya, Shigeru] Kyorin Univ, Sch Med, Dept Infect Dis, Mitaka, Tokyo 181, Japan; [Ishige, Taichiro; Imai, Misaki; Shiwa, Yuh; Shibata-Hatta, Mari; Kanesaki, Yu; Yoshikawa, Hirofumi] Tokyo Univ Agr, Nodai Res Inst, Genome Res Ctr, Setagaya Ku, Tokyo 1568502, Japan; [Yoshikawa, Hirofumi] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan	University of Tokyo; University of Tokyo; Sapporo Kosei General Hospital; Kyorin University; Tokyo University of Agriculture; Tokyo University of Agriculture	Kobayashi, I (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo, Japan.	ikobaya@ims.u-tokyo.ac.jp	Kobayashi, Ichizo/GVT-8377-2022; Kanesaki, Yu/J-3817-2017; Furuta, Yoshikazu/AAB-2219-2020	Kanesaki, Yu/0000-0003-3537-9789; Furuta, Yoshikazu/0000-0003-4710-1389	Japan Society for the Promotion of Science [21370001, 25291080, 24790412, 23590518, 24593166]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24113506, 24119503]; Health and Labor Sciences Research Grants for Clinical Cancer Research from Ministry of Health, Labor and Welfare, Japan; JSPS [20132033]; global COE project of Genome Information Big Bang from MEXT; Bio-oriented Technology Research Advance Institution [121205003001002100019]; Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15K08471] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grants for Clinical Cancer Research from Ministry of Health, Labor and Welfare, Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); global COE project of Genome Information Big Bang from MEXT; Bio-oriented Technology Research Advance Institution; Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This work was supported, in part, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant nos. 21370001 and 25291080 to I.K., 24790412 to Y.F., 23590518 to S.K. and 24593166 to H.Ys.); and from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (grant nos. 24113506 to I.K. and 24119503 to Y.F.); Health and Labor Sciences Research Grants for Clinical Cancer Research from the Ministry of Health, Labor and Welfare, Japan, grants for Scientific Research (grant no. 20132033 to S.K.) from JSPS; the global COE project of Genome Information Big Bang from MEXT to I.K.; Grant in Promotion of Basic Research Activities for Innovative Biosciences (grant no. 121205003001002100019) from Bio-oriented Technology Research Advance Institution to I.K.; Cooperative Research Grant of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture; and from the Takeda Science Foundation to Y.F.	Akada J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104611; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alm RA, 2000, INFECT IMMUN, V68, P4155, DOI 10.1128/IAI.68.7.4155-4168.2000; Atherton JC, 1997, GASTROENTEROLOGY, V112, P92, DOI 10.1016/S0016-5085(97)70223-3; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Burucoa C, 1999, J CLIN MICROBIOL, V37, P4071, DOI 10.1128/JCM.37.12.4071-4080.1999; Cao P, 2002, J CLIN MICROBIOL, V40, P4504, DOI 10.1128/JCM.40.12.4504-4511.2002; Cao QZ, 2015, GUT, V64, P554, DOI 10.1136/gutjnl-2014-307345; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Didelot X, 2013, P NATL ACAD SCI USA, V110, P13880, DOI 10.1073/pnas.1304681110; Donahue JP, 2002, FEMS MICROBIOL LETT, V208, P295, DOI 10.1111/j.1574-6968.2002.tb11097.x; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Furuta Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004272; Furuta Yoshikazu, 2012, Mob Genet Elements, V2, P292; Furuta Y, 2012, NUCLEIC ACIDS RES, V40, P9218, DOI 10.1093/nar/gks681; Furuta Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018819; Gong M, 2010, GASTROENTEROLOGY, V139, P564, DOI 10.1053/j.gastro.2010.03.050; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Kawai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-104; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Krebes J, 2014, INT J MED MICROBIOL, V304, P1135, DOI 10.1016/j.ijmm.2014.08.007; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042303; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linz B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5165; Linz B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082187; Loh JT, 2008, FEMS MICROBIOL LETT, V289, P53, DOI 10.1111/j.1574-6968.2008.01368.x; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110; Ohno T, 2011, J INFECT DIS, V203, P726, DOI 10.1093/infdis/jiq090; Osaki T, 2015, J MED MICROBIOL, V64, P67, DOI 10.1099/jmm.0.080507-0; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Pinto AC, 2011, GENET MOL RES, V10, P1707, DOI 10.4238/vol10-3gmr1554; Rimbara E, 2013, MICROBIOL IMMUNOL, V57, P665, DOI 10.1111/1348-0421.12089; Roschitzki B, 2011, CURR MICROBIOL, V63, P239, DOI 10.1007/s00284-011-9969-2; Senkovich OA, 2011, INFECT IMMUN, V79, P3106, DOI 10.1128/IAI.01275-10; Sicinschi LA, 2012, HELICOBACTER, V17, P96, DOI 10.1111/j.1523-5378.2011.00919.x; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027569; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suganuma M, 2012, CANCER LETT, V322, P133, DOI 10.1016/j.canlet.2012.03.027; Takeuchi H, 2002, J INFECT DIS, V186, P1186, DOI 10.1086/343810; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Vale FF, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-193; Vitoriano I, 2013, J APPL MICROBIOL, V114, P1817, DOI 10.1111/jam.12187; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Yahara K, 2012, GENOME BIOL EVOL, V4, P628, DOI 10.1093/gbe/evs043	55	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127197	10.1371/journal.pone.0127197	http://dx.doi.org/10.1371/journal.pone.0127197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978460	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100135
J	Kamuya, DM; Theobald, SJ; Marsh, V; Parker, M; Geissler, WP; Molyneux, SC				Kamuya, Dorcas M.; Theobald, Sally J.; Marsh, Vicki; Parker, Michael; Geissler, Wenzel P.; Molyneux, Sassy C.			"The One Who Chases You Away Does Not Tell You Go": Silent Refusals and Complex Power Relations in Research Consent Processes in Coastal Kenya	PLOS ONE			English	Article							INFORMED-CONSENT; COMMUNITY ENGAGEMENT; MEDICAL-RESEARCH; RESEARCH PARTICIPATION; DECISION-MAKING; VACCINE TRIAL; HEALTH; EXPERIENCES; ETHICS; SURVEILLANCE	Consent processes have attracted significant research attention over the last decade, including in the global south. Although relevant studies suggest consent is a complex negotiated process involving multiple actors, most guidelines assume consent is a one-off encounter with a clear 'yes' or 'no' decision. In this paper we explore the concept of 'silent refusals', a situation where it is not clear whether potential participants want to join studies or those in studies want to withdraw from research, as they were not actively saying no. We draw on participant observation, in-depth interviews and group discussions conducted with a range of stakeholders in two large community based studies conducted by the KEMRI Wellcome Trust programme in coastal Kenya. We identified three broad inter-related ratio-nales for silent refusals: 1) a strategy to avoid conflicts and safeguard relations within households, - for young women in particular-to appear to conform to the wishes of elders; 2) an approach to maintain friendly, appreciative and reciprocal relationships with fieldworkers, and the broader research programme; and 3) an effort to retain study benefits, either for individuals, whole households or wider communities. That refusals and underlying ratio-nales were silent posed multiple dilemmas for fieldworkers, who are increasingly recognised to play a key interface role between researchers and communities in many settings. Silent refusals reflect and reinforce complex power relations embedded in decisions about research participation, with important implications for consent processes and broader research ethics practice. Fieldworkers need support to reflect upon and respond to the ethically charged environment they work in.	[Kamuya, Dorcas M.; Marsh, Vicki; Molyneux, Sassy C.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Kamuya, Dorcas M.; Marsh, Vicki; Parker, Michael; Molyneux, Sassy C.] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford, England; [Marsh, Vicki; Molyneux, Sassy C.] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England; [Theobald, Sally J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool L3 5QA, Merseyside, England; [Geissler, Wenzel P.] Univ Oslo, Dept Social Anthropol, Oslo, Norway; [Geissler, Wenzel P.] Univ Cambridge, Dept Social Anthropol, Cambridge, England	University of Oxford; University of Oxford; Liverpool School of Tropical Medicine; University of Liverpool; University of Oslo; University of Cambridge	Kamuya, DM (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	dkamuya@kemri-wellcome.org	Molyneux, Catherine/HGB-8464-2022	Molyneux, Catherine/0000-0001-9522-416X; Theobald, Sally/0000-0002-9053-211X	Wellcome Trust Strategic Award [084538]; Global Health Bioethics Network [096527]	Wellcome Trust Strategic Award(Wellcome Trust); Global Health Bioethics Network	Financial support for carrying out and writing this paper from Wellcome Trust Strategic Award to KEMRI-Wellcome Trust Research Programme (084538); and Global Health Bioethics Network (096527). The funders of this research had no role at all in the conception of this research, design, data collection and writing up of this manuscript.	Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Benatar SR, 2002, SOC SCI MED, V54, P1131, DOI 10.1016/S0277-9536(01)00327-6; Beskow LM, 2004, AM J MED GENET A, V130A, P424, DOI 10.1002/ajmg.a.30234; Boga M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001089; Chantler T, 2013, DEV WORLD BIOETH, V13, P30, DOI 10.1111/dewb.12023; Doumbo OK, 2005, SCIENCE, V307, P679, DOI 10.1126/science.1109773; Edwards SJL, 2005, BIOETHICS, V19, P112, DOI 10.1111/j.1467-8519.2005.00429.x; Fairhead J, 2006, SOC SCI MED, V63, P1109, DOI 10.1016/j.socscimed.2006.02.018; Geissler PW, 2008, SOC SCI MED, V67, P696, DOI 10.1016/j.socscimed.2008.02.004; Geissler PW, 2005, AFRICA, V75, P173, DOI 10.3366/afr.2005.75.2.173; Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003; Green J, 2007, QUALITATIVE METHODS; Ho A, 2008, SCAND J CARING SCI, V22, P128, DOI 10.1111/j.1471-6712.2007.00561.x; Irabor DO, 2009, DEV WORLD BIOETH, V9, P34, DOI 10.1111/j.1471-8847.2007.00198.x; Kamuya D, 2011, AM J BIOETHICS, V11, P31, DOI 10.1080/15265161.2011.583328; Kamuya DM, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-90; Kamuya DM, 2013, DEV WORLD BIOETH, V13, P1, DOI 10.1111/dewb.12009; Kandiyoti D, 1988, GENDER SOC, V2, P274, DOI 10.1177/089124388002003004; Kingori P, 2013, SOC SCI MED, V98, P361, DOI 10.1016/j.socscimed.2013.10.013; Lavery JV, 2010, TRENDS PARASITOL, V26, P279, DOI 10.1016/j.pt.2010.02.009; Lehmann U, 2013, HEALTH POLICY PLANN, V28, P358, DOI 10.1093/heapol/czs066; Lidz CW, 2002, MED CARE, V40, P55, DOI 10.1097/01.MLR.0000023956.25813.18; Long N, 1999, UNESCO BACKGROUND PA; Lukes S, 2004, POWER RADICAL VIEW; Madiega PA, 2013, DEV WORLD BIOETH, V13, P21, DOI 10.1111/dewb.12019; Marsh VM, 2011, PUBLIC HEALTH ETH-UK, V4, P26, DOI 10.1093/phe/phr007; Marsh V, 2008, SOC SCI MED, V67, P721, DOI 10.1016/j.socscimed.2008.02.007; Marsh VM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-13; Marshall PA, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-38; Masiye F, 2008, MALAWI MED J, V20, P50; McKnight C, 2006, J URBAN HEALTH, V83, pI54, DOI 10.1007/s11524-006-9102-1; Mfutso-Bengo J, 2008, MALAWI MED J, V20, P37, DOI 10.4314/mmj.v20i2.10898; Molyneux C, 2009, J INT DEV, V21, P309, DOI 10.1002/jid.1548; Molyneux CS, 2005, SOC SCI MED, V61, P1463, DOI 10.1016/j.socscimed.2004.11.073; Molyneux CS, 2004, SOC SCI MED, V59, P2547, DOI 10.1016/j.socscimed.2004.03.037; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Molyneux S, 2013, DEV WORLD BIOETH, V13, DOI 10.1111/dewb.12027; Molyneux S, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-13; Mosavel M, 2011, SOC SCI MED, V73, P145, DOI 10.1016/j.socscimed.2011.04.029; Ndebele P, 2008, THEOR MED BIOETH, V29, P331, DOI 10.1007/s11017-008-9084-y; Participants in the Community Engagement and Consent Workshop  Kilifi Kenya  March 2011, 2013, J Empir Res Hum Res Ethics, V8, P1, DOI 10.1525/jer.2013.8.4.1; Reynolds L, 2013, SOC SCI MED, V77, P118, DOI 10.1016/j.socscimed.2012.11.015; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rotimi C, 2007, COMMUNITY GENET, V10, P186, DOI 10.1159/000101761; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Simon C, 2010, AM J BIOETHICS, V10, P3, DOI 10.1080/15265160903585578; Tekola F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000482; Van Bogaert LJ, 2006, DEV WORLD BIOETH, V6, P13, DOI 10.1111/j.1471-8847.2006.00132.x; Williams B, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-59	49	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126671	10.1371/journal.pone.0126671	http://dx.doi.org/10.1371/journal.pone.0126671			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978465	gold, Green Published, Green Accepted			2022-12-27	WOS:000354916100087
J	Liang, LN; Chen, J; Zhan, LB; Lu, XG; Sun, XX; Sui, H; Zheng, LP; Xiang, H; Zhang, FL				Liang, Lina; Chen, Jing; Zhan, Libin; Lu, Xiaoguang; Sun, Xiaoxin; Sui, Hua; Zheng, Luping; Xiang, Hong; Zhang, Fuliang			Endoplasmic Reticulum Stress Impairs Insulin Receptor Signaling in the Brains of Obese Rats	PLOS ONE			English	Article							NUTRIENT HOMEOSTASIS; INHIBITS INSULIN; KAPPA-B; PHOSPHORYLATION; DEMENTIA; KINASE; RESISTANCE; DYSREGULATION; ASSOCIATION; TRANSLATION	The incidence of obesity is increasing worldwide. It was reported that endoplasmic reticulum stress (ERS) could inhibit insulin receptor signaling by activating c-Jun N-terminal kinase (JNK) in the liver. However, the relationship between ERS and insulin receptor signaling in the brain during obesity remains unclear. The aim of the current study was to assess whether ERS alters insulin receptor signaling through the hyper-activation of JNK in the hippocampus and frontal cortex in the brains of obese rats. Obesity was induced using a high fat diet (HFD). The Morris water maze test was then performed to evaluate decreases in cognitive function, and western blot was used to verify whether abnormal insulin receptor signaling was induced by ERS in HFD rats exhibiting cognitive decline. In addition, to determine whether ERS activated JNK and consequently impaired insulin receptor signaling, SH-SY5Y cells were treated with the JNK inhibitor, SP600125, followed by tunicamycin or thapsigargin, and primary rat hippocampal and cortical neurons were transfected with siRNA against IRE1 alpha and JNK. We found that the expression of phosphorylation of PKR-like kinase (PERK), phosphorylation of a subunit of translation initiation factor 2 (eIF2 alpha), and phosphorylation of inositol-requiring kinase-1 alpha (IRE-1 alpha) were increased in the brains of rats with HFD when compared with control rats. The level of serine phosphorylation of insulin receptor substrate-1 (IRS-1) was also increased, while protein kinase B (PKB/Akt) was reduced. ERS was also found to inhibit insulin receptor signaling via the activation of JNK in SH-SY5Y cells, primary rat hippocampal, and cortical neurons. These results indicate that ERS was increased, thereby resulting in impaired insulin receptor signaling in the hippocampus and frontal cortex of obese rats.	[Liang, Lina; Chen, Jing; Zhan, Libin; Sun, Xiaoxin; Sui, Hua; Zheng, Luping; Xiang, Hong] Dalian Med Univ, Coll Inst Integrat Med, Dalian, Liaoning, Peoples R China; [Zhan, Libin] Dalian Med Univ, Affiliated Hosp 2, Dept Tradit Chinese Med, Dalian, Liaoning, Peoples R China; [Lu, Xiaoguang] Dalian Univ, Zhongshan Hosp, Dept Emergency Med, Dalian 116012, Liaoning, Peoples R China; [Zhang, Fuliang] Dalian Med Univ, Inst Publ Hyg, Dalian, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian University; Dalian Medical University	Zhan, LB (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Tradit Chinese Med, Dalian, Liaoning, Peoples R China.	libinzhan@hotmail.com; dllxg@126.com		Chen, Jing/0000-0001-6751-0935	National Nature Science Foundation of China [81230084]; Program for Professor of Special Appointment in Liaoning Province; first leading talent support program of Dalian; Program for Liaoning Innovative Research Team in University [LT2014018]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment in Liaoning Province; first leading talent support program of Dalian; Program for Liaoning Innovative Research Team in University	This work was supported by the National Nature Science Foundation of China (no. 81230084), the Program for Professor of Special Appointment in Liaoning Province, the first leading talent support program of Dalian, and the Program for Liaoning Innovative Research Team in University (LT2014018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Dahl A, 2010, J GERONTOL A-BIOL, V65, P57, DOI 10.1093/gerona/glp035; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Giraud J, 2007, MOL ENDOCRINOL, V21, P2294, DOI 10.1210/me.2007-0159; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105944; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Rizzi L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/908915; Rodriguez M, 2011, J BIOL CHEM, V286, P22814, DOI 10.1074/jbc.M111.225631; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sahin K, 2007, METABOLISM, V56, P1233, DOI 10.1016/j.metabol.2007.04.021; Sari FR, 2010, J PHARMACOL SCI, V113, P325, DOI 10.1254/jphs.10047FP; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharfi H, 2008, AM J PHYSIOL-ENDOC M, V294, pE307, DOI 10.1152/ajpendo.00534.2007; Shi X, 2011, DIABETOLOGIA, V54, P1888, DOI 10.1007/s00125-011-2147-z; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wotton CJ, 2014, POSTGRAD MED J, V90, P547, DOI 10.1136/postgradmedj-2014-132571; Yi ZP, 2007, DIABETES, V56, P1508, DOI 10.2337/db06-1355; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	44	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126384	10.1371/journal.pone.0126384	http://dx.doi.org/10.1371/journal.pone.0126384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978724	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100066
J	Mourao, L; de Jesus, K; Roesler, H; Machado, LJ; Fernandes, RJ; Vilas-Boas, JP; Vaz, MAP				Mourao, Luis; de Jesus, Karla; Roesler, Helio; Machado, Leandro J.; Fernandes, Ricardo J.; Vilas-Boas, Joao Paulo; Vaz, Mario A. P.			Effective Swimmer's Action during the Grab Start Technique	PLOS ONE			English	Article							TRACK	The external forces applied in swimming starts have been often studied, but using direct analysis and simple interpretation data processes. This study aimed to develop a tool for vertical and horizontal force assessment based on the swimmers' propulsive and structural forces (passive forces due to dead weight) applied during the block phase. Four methodological pathways were followed: the experimented fall of a rigid body, the swimmers' inertia effect, the development of a mathematicalmodel to describe the outcome of the rigid body fall and its generalization to include the effects of the inertia, and the experimental swimmers' starting protocol analysed with the inclusion of the developed mathematical tool. The first three methodological steps resulted in the description and computation of the passive force components. At the fourth step, six well-trained swimmers performed three 15m maximal grab start trials and three-dimensional (3D) kinetic data were obtained using a six degrees of freedom force plate. The passive force contribution to the start performance obtained from themodel was subtracted from the experimental force due to the swimmers resulting in the swimmers' active forces. As expected, the swimmers' vertical and horizontal active forces accounted for the maximum variability contribution of the experimental forces. It was found that the active force profile for the vertical and horizontal components resembled one another. These findings should be considered in clarifying the active swimmers' force variability and the respective geometrical profile as indicators to redefine steering strategies.	[Mourao, Luis] Porto Polytech Inst, Super Sch Ind Studies & Management, Vila Do Conde, Portugal; [Mourao, Luis; de Jesus, Karla; Roesler, Helio; Machado, Leandro J.; Fernandes, Ricardo J.; Vilas-Boas, Joao Paulo] Univ Porto, Ctr Res Educ Innovat & Intervent Sport, Fac Sport, P-4100 Oporto, Portugal; [Roesler, Helio] Univ Estado Santa Catarina, Hlth & Sports Sci Ctr, Aquat Biomech Res Lab, Florianopolis, SC, Brazil; [Machado, Leandro J.; Fernandes, Ricardo J.; Vilas-Boas, Joao Paulo; Vaz, Mario A. P.] Univ Porto, Porto Biomech Lab, P-4100 Oporto, Portugal; [Vaz, Mario A. P.] Univ Porto, Inst Mech Engn & Ind Management, Fac Engn, P-4100 Oporto, Portugal	Polytechnic Institute of Porto; Universidade do Porto; Universidade do Estado de Santa Catarina; Universidade do Porto; Universidade do Porto	de Jesus, K (corresponding author), Univ Porto, Ctr Res Educ Innovat & Intervent Sport, Fac Sport, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	karla_de_jesus@yahoo.com.br	Roesler, Helio/X-5184-2018; Machado, Leandro/AAI-7714-2020; Fernandes, Ricardo J./A-1040-2012	Roesler, Helio/0000-0002-1631-6961; Machado, Leandro/0000-0001-5332-5974; Fernandes, Ricardo J./0000-0002-5811-0443; Vilas-Boas, J. Paulo/0000-0002-4109-2939; Mourao, Luis/0000-0002-7635-2219	Brazil Coordination for the Improvement of Higher Level or Education Personnel Foundation; Ministry of Education of Brazil [0761/12-5/2012-2015]; Foundation for Science and Technology of Portugal [COMPETE - EXPL/DTP-DES/2481/2013- FCOMP-01-0124-FEDER-041981]	Brazil Coordination for the Improvement of Higher Level or Education Personnel Foundation; Ministry of Education of Brazil; Foundation for Science and Technology of Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the Brazil Coordination for the Improvement of Higher Level or Education Personnel Foundation, Ministry of Education of Brazil (0761/12-5/2012-2015) and the Foundation for Science and Technology of Portugal (COMPETE - EXPL/DTP-DES/2481/2013- FCOMP-01-0124-FEDER-041981). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjanuvatra N., 2005, START RIGHT BIOMECHA; Breed RVP, 2003, J SPORT SCI, V21, P213, DOI 10.1080/0264041031000071047; de Jesus K, 2011, INT J SPORTS MED, V32, P546, DOI 10.1055/s-0031-1273688; Elipot M, 2009, J BIOMECH, V42, P1367, DOI 10.1016/j.jbiomech.2009.03.032; Galbraith H, 2008, J APPL BIOMECH, V24, P307, DOI 10.1123/jab.24.4.307; Guimaraes A., 1985, INT J SPORT BIOMECHA, V1, P25, DOI DOI 10.1123/IJSB.1.1.25; Holfelder B, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077185, DOI 10.1371/J0URNAL.P0NE.0077185]; Mason B., 2012, 30 INT C BIOM SPORTS, P249; NASA, 1978, ANTHROPOMETRIC SOURC, V1024; Preatoni E, 2013, SPORT BIOMECH, V12, P69, DOI 10.1080/14763141.2012.738700; Seifert L, 2010, J STRENGTH COND RES, V24, P507, DOI 10.1519/JSC.0b013e3181c06a0e; Slawson SE, 2013, J SPORT SCI, V31, P468, DOI 10.1080/02640414.2012.736631; Vantorre J, 2010, INT J SPORTS MED, V31, P887, DOI 10.1055/s-0030-1265150; Vantorre J, 2010, INT J SPORTS MED, V31, P16, DOI 10.1055/s-0029-1241208; Vilas-Boas J. P., 2003, 9 BIOM MED SWIMM, P249	15	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0123001	10.1371/journal.pone.0123001	http://dx.doi.org/10.1371/journal.pone.0123001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978370	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100005
J	Spencer, MJ; Nayagam, DAX; Clarey, JC; Paolini, AG; Meffin, H; Burkitt, AN; Grayden, DB				Spencer, Martin J.; Nayagam, David A. X.; Clarey, Janine C.; Paolini, Antonio G.; Meffin, Hamish; Burkitt, Anthony N.; Grayden, David B.			Broadband Onset Inhibition Can Suppress Spectral Splatter in the Auditory Brainstem	PLOS ONE			English	Article							VENTRAL COCHLEAR NUCLEUS; SUPERIOR PARAOLIVARY NUCLEUS; OCTOPUS CELLS; LATERAL LEMNISCUS; INFERIOR COLLICULUS; NERVE FIBERS; GUINEA-PIGS; NEURONS; RESPONSES; CONDUCTANCES	In vivo intracellular responses to auditory stimuli revealed that, in a particular population of cells of the ventral nucleus of the lateral lemniscus (VNLL) of rats, fast inhibition occurred before the first action potential. These experimental data were used to constrain a leaky integrate-and-fire (LIF) model of the neurons in this circuit. The post-synaptic potentials of the VNLL cell population were characterized using a method of triggered averaging. Analysis suggested that these inhibited VNLL cells produce action potentials in response to a particular magnitude of the rate of change of their membrane potential. The LIF model was modified to incorporate the VNLL cells' distinctive action potential production mechanism. The model was used to explore the response of the population of VNLL cells to simple speech-like sounds. These sounds consisted of a simple tone modulated by a saw tooth with exponential decays, similar to glottal pulses that are the repeated impulses seen in vocalizations. It was found that the harmonic component of the sound was enhanced in the VNLL cell population when compared to a population of auditory nerve fibers. This was because the broadband onset noise, also termed spectral splatter, was suppressed by the fast onset inhibition. This mechanism has the potential to greatly improve the clarity of the representation of the harmonic content of certain kinds of natural sounds.	[Spencer, Martin J.; Meffin, Hamish; Burkitt, Anthony N.; Grayden, David B.] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia; [Spencer, Martin J.; Meffin, Hamish; Burkitt, Anthony N.; Grayden, David B.] Univ Melbourne, Dept Elect & Elect Engn, Natl ICT Australia, Melbourne, Vic, Australia; [Spencer, Martin J.; Meffin, Hamish; Burkitt, Anthony N.; Grayden, David B.] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia; [Nayagam, David A. X.; Clarey, Janine C.; Burkitt, Anthony N.; Grayden, David B.] Bion Inst, Melbourne, Vic, Australia; [Nayagam, David A. X.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Paolini, Antonio G.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia	University of Melbourne; NICTA; University of Melbourne; University of Melbourne; Bionics Institute; University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Spencer, MJ (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia.	martinjs@pgrad.unimelb.edu.au	Grayden, David B/L-5782-2018	Grayden, David B/0000-0002-5497-7234; Paolini, Antonio/0000-0002-0853-4598; Nayagam, David/0000-0002-4380-6640; Meffin, Hamish/0000-0003-4307-6841; SPENCER, MARTIN/0000-0002-2001-9054	National Health and Medical Research Council of Australia (NHMRC) [567164]; National Information and Communication Technology Australia (NICTA); Australian Research Council [DP1094830]; Australian Government; Australian Research Council through the ICT Centre of Excellence program; Victorian Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Information and Communication Technology Australia (NICTA)(NICTA); Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence program(Australian Research Council); Victorian Government	Martin Spencer acknowledges postgraduate scholarships from the National Health and Medical Research Council of Australia (NHMRC - 567164 - www.nhmrc.gov.au/) and National Information and Communication Technology Australia (NICTA - www.nicta.com.au/). The work was supported by the Australian Research Council (DP1094830 - www.arc.gov.au/). NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy (www.communications.gov.au/) and the Australian Research Council through the ICT Centre of Excellence program. The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program (http://www.business.vic.gov.au/grants-and-assistance/programs/medicalresearch-operational-infrastructure-program). We acknowledge the late Dame Elisabeth Murdoch for funding the original in vivo research on which the present manuscript is based. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 1997, AUDIT NEUROSCI, V3, P335; Aubie B, 2009, J NEUROSCI, V29, P9255, DOI 10.1523/JNEUROSCI.1085-09.2009; Benson CG, 2008, J COMP NEUROL, V510, P673, DOI 10.1002/cne.21820; Cai YD, 1997, J NEUROPHYSIOL, V78, P872, DOI 10.1152/jn.1997.78.2.872; Cai YD, 2000, J NEUROPHYSIOL, V83, P301, DOI 10.1152/jn.2000.83.1.301; Cao XJ, 2010, J NEUROPHYSIOL, V104, P2308, DOI 10.1152/jn.00451.2010; CARNEY LH, 1989, J NEUROPHYSIOL, V62, P144, DOI 10.1152/jn.1989.62.1.144; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; Ferragamo MJ, 2002, J NEUROPHYSIOL, V87, P2262, DOI 10.1152/jn.00587.2001; Gittelman JX, 2011, J NEUROSCI, V31, P2576, DOI 10.1523/JNEUROSCI.5112-10.2011; GLENDENNING KK, 1981, J COMP NEUROL, V197, P673, DOI 10.1002/cne.901970409; GODFREY DA, 1975, J COMP NEUROL, V162, P247, DOI 10.1002/cne.901620206; Golding NL, 1999, J NEUROSCI, V19, P2897; Hemmert W, 2005, LECT NOTES COMPUT SC, V3696, P583, DOI 10.1007/11550822_91; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; Kipke DR, 1997, J ACOUST SOC AM, V102, P403, DOI 10.1121/1.419762; Kuwada S, 1997, J NEUROSCI, V17, P7565; Levy KL, 1998, J ACOUST SOC AM, V103, P1940, DOI 10.1121/1.421346; Levy KL, 1997, J ACOUST SOC AM, V102, P391, DOI 10.1121/1.419761; McGinley M, 2005, 28 ANN MIDW M ASS RE; McGinley MJ, 2006, HEARING RES, V216, P52, DOI 10.1016/j.heares.2006.02.006; McGinley MJ, 2012, J NEUROSCI, V32, P9301, DOI 10.1523/JNEUROSCI.0272-12.2012; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Myoga MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4790; Nayagam DAX, 2006, J COMP NEUROL, V498, P295, DOI 10.1002/cne.21058; Nayagam DAX, 2005, J NEUROPHYSIOL, V94, P1651, DOI 10.1152/jn.00167.2005; Needham K, 2003, J NEUROSCI, V23, P6357; Oertel D, 2008, NEUROSCIENCE, V154, P77, DOI 10.1016/j.neuroscience.2008.01.085; Oertel D, 2000, P NATL ACAD SCI USA, V97, P11773, DOI 10.1073/pnas.97.22.11773; Paolini AG, 2005, EUR J NEUROSCI, V21, P1236, DOI 10.1111/j.1460-9568.2005.03958.x; Paolini AG, 2004, J NEUROPHYSIOL, V92, P2615, DOI 10.1152/jn.00327.2004; Pollak GD, 2011, HEARING RES, V273, P134, DOI 10.1016/j.heares.2010.03.083; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3083, DOI 10.1152/jn.00126.2002; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3070, DOI 10.1152/jn.00125.2002; Saldana E, 2009, NEUROSCIENCE, V163, P372, DOI 10.1016/j.neuroscience.2009.06.030; SCHOFIELD BR, 1995, J COMP NEUROL, V360, P135, DOI 10.1002/cne.903600110; Schofield BR, 1997, J COMP NEUROL, V379, P363, DOI 10.1002/(SICI)1096-9861(19970317)379:3<363::AID-CNE4>3.0.CO;2-1; Spencer MJ, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00083; Sun H, 2008, NEUROSCIENCE, V154, P257, DOI 10.1016/j.neuroscience.2007.10.055; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Tripathy SJ, 2013, P NATL ACAD SCI USA, V110, P8248, DOI 10.1073/pnas.1221214110; Zilany MSA, 2007, J ACOUST SOC AM, V122, P402, DOI 10.1121/1.2735117; Zilany MSA, 2006, J ACOUST SOC AM, V120, P1446, DOI 10.1121/1.2225512; Zilany MSA, 2009, J ACOUST SOC AM, V126, P2390, DOI 10.1121/1.3238250	45	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126500	10.1371/journal.pone.0126500	http://dx.doi.org/10.1371/journal.pone.0126500			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978772	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100074
J	Takeuchi, M; Higashino, A; Takeuchi, K; Hori, Y; Koshiba-Takeuchi, K; Makino, H; Monobe, Y; Kishida, M; Adachi, J; Takeuchi, J; Tomonaga, T; Umezawa, A; Kameoka, Y; Akagi, K				Takeuchi, Masao; Higashino, Atsunori; Takeuchi, Kikuko; Hori, Yutaro; Koshiba-Takeuchi, Kazuko; Makino, Hatsune; Monobe, Yoko; Kishida, Marina; Adachi, Jun; Takeuchi, Jun; Tomonaga, Takeshi; Umezawa, Akihiro; Kameoka, Yosuke; Akagi, Ken-ichi			Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation	PLOS ONE			English	Article							HUMAN-DIPLOID FIBROBLASTS; TUMOR-SUPPRESSOR; NEOPLASTIC TRANSFORMATION; MALIGNANT-TRANSFORMATION; CHROMOSOMAL INSTABILITY; CELLULAR ONCOGENES; EPITHELIAL-CELLS; LUNG-CANCER; GENE; P53	Comprehensive analysis of alterations in gene expression along with neoplastic transformation in human cells provides valuable information about the molecular mechanisms underlying transformation. To further address these questions, we performed whole transcriptome analysis to the human mesenchymal stem cell line, UE6E7T-3, which was immortalized with hTERT and human papillomavirus type 16 E6/E7 genes, in association with progress of transformation in these cells. At early stages of culture, UE6E7T-3 cells preferentially lost one copy of chromosome 13, as previously described; in addition, tumor suppressor genes, DNA repair genes, and apoptosis-activating genes were overexpressed. After the loss of chromosome 13, additional aneuploidy and genetic alterations that drove progressive transformation, were observed. At this stage, the cell line expressed oncogenes as well as genes related to anti-apoptotic functions, cell-cycle progression, and chromosome instability (CIN); these pro-tumorigenic changes were concomitant with a decrease in tumor suppressor gene expression. At later stages after prolong culture, the cells exhibited chromosome translocations, acquired anchorage-independent growth and tumorigenicity in nude mice, (sarcoma) and exhibited increased expression of genes encoding growth factor and DNA repair genes, and decreased expression of adhesion genes. In particular, glypican-5 (GPC5), which encodes a cell-surface proteoglycan that might be a biomarker for sarcoma, was expressed at high levels in association with transformation. Patched (Ptc1), the cell surface receptor for hedgehog (Hh) signaling, was also significantly overexpressed and co-localized with GPC5. Knockdown of GPC5 expression decreased cell proliferation, suggesting that it plays a key role in growth in U3-DT cells (transformants derived from UE6E7T-3 cells) through the Hh signaling pathway. Thus, the UE6E7T-3 cell culture model is a useful tool for assessing the functional contribution of genes showed by expression profiling to the neoplastic transformation of human fibroblasts and human mesenchymal stem cells (hMSC).	[Takeuchi, Masao; Takeuchi, Kikuko; Monobe, Yoko; Akagi, Ken-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Sect Lab Equipment, Ibaraki, Osaka, Japan; [Higashino, Atsunori] Kyoto Univ, Primate Res Inst, Ctr Human Evolut Modeling Res, Kyoto, Japan; [Hori, Yutaro; Koshiba-Takeuchi, Kazuko; Makino, Hatsune; Takeuchi, Jun] Univ Tokyo, Inst Mol & Cellular Biosci, Div Cardiovasc Regenerat, Tokyo, Japan; [Hori, Yutaro] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Makino, Hatsune; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol & Pathol, Tokyo, Japan; [Kishida, Marina; Adachi, Jun; Tomonaga, Takeshi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Proteome Res, Ibaraki, Osaka, Japan; [Takeuchi, Jun] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan; [Kameoka, Yosuke] A CLIP Inst, Cent Inst, Chiba, Japan	Kyoto University; University of Tokyo; University of Tokyo; National Center for Child Health & Development - Japan; Japan Science & Technology Agency (JST)	Takeuchi, M (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Sect Lab Equipment, Ibaraki shi, Ibaraki, Osaka, Japan.	takeuchim@nibiohn.go.jp	Adachi, Jun/H-2813-2014	Adachi, Jun/0000-0003-1220-3246; Hori, Yutaro/0000-0002-4163-4750; AKAGI, Ken-ichi/0000-0002-7051-4598	Ministry of Health, Labor, and Welfare of Japan [09158647]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the grant, No. 09158647, from the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Burns JS, 2008, HISTOL HISTOPATHOL, V23, P1229, DOI 10.14670/HH-23.1229; Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Derksen PWB, 2011, DIS MODEL MECH, V4, P347, DOI 10.1242/dmm.006395; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Filmus J, 2014, MATRIX BIOL, V35, P248, DOI 10.1016/j.matbio.2013.12.007; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Higashino A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r58; Imabayashi H, 2003, EXP CELL RES, V288, P35, DOI 10.1016/S0014-4827(03)00130-7; Israels E D, 2000, Oncologist, V5, P510, DOI 10.1634/theoncologist.5-6-510; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Jin YH, 2010, ANTICANCER RES, V30, P245; Kalitsis P, 2005, GENE CHROMOSOME CANC, V44, P29, DOI 10.1002/gcc.20215; Kendall SD, 2005, CANCER RES, V65, P9824, DOI 10.1158/0008-5472.CAN-05-1543; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kume H, 2014, MOL CELL PROTEOMICS, V13, P1471, DOI 10.1074/mcp.M113.037093; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Li RH, 2000, P NATL ACAD SCI USA, V97, P3236, DOI 10.1073/pnas.040529797; Li YF, 2011, J THORAC ONCOL, V6, P2, DOI 10.1097/JTO.0b013e3181fd6b04; Lukasik A, 2008, FEBS J, V275, P332, DOI 10.1111/j.1742-4658.2007.06203.x; Mahale AM, 2008, CANCER RES, V68, P1417, DOI 10.1158/0008-5472.CAN-07-3021; Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880; Milyavsky M, 2003, CANCER RES, V63, P7147; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Narisawa-Saito M, 2008, CANCER RES, V68, P5699, DOI 10.1158/0008-5472.CAN-07-6862; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nishiyama H, 2001, ONCOGENE, V20, P2956, DOI 10.1038/sj.onc.1204432; Rahman FA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-482; Rodriguez R, 2009, NEOPLASIA, V11, P397, DOI 10.1593/neo.81620; Roh M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002572; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ryschich E, 2004, EUR J CANCER, V40, P1418, DOI 10.1016/j.ejca.2004.01.036; Sasai K, 2011, CANCER RES, V71, P2541, DOI 10.1158/0008-5472.CAN-10-2221; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schvartzman JM, 2011, CANCER CELL, V19, P701, DOI 10.1016/j.ccr.2011.04.017; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Takeuchi M, 2007, IN VITRO CELL DEV-AN, V43, P129, DOI 10.1007/s11626-007-9021-9; Takeuchi M, 2009, IN VITRO CELL DEV-AN, V45, P290, DOI 10.1007/s11626-008-9174-1; Torres EM, 2010, COLD SH Q B, V75, P445, DOI 10.1101/sqb.2010.75.025; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Williamson D, 2007, CANCER RES, V67, P57, DOI 10.1158/0008-5472.CAN-06-1650; Yang X, 2013, CANCER LETT, V341, P265, DOI 10.1016/j.canlet.2013.08.020; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846; Zhang YN, 2014, ARCH ORAL BIOL, V59, P1172, DOI 10.1016/j.archoralbio.2014.07.009; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	63	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126562	10.1371/journal.pone.0126562	http://dx.doi.org/10.1371/journal.pone.0126562			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978455	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100080
J	Wu, YC; Chang, CY; Kao, A; Hsi, B; Lee, SH; Chen, YH; Wang, IJ				Wu, Yu-Ching; Chang, Chao-Yuan; Kao, Alex; Hsi, Brian; Lee, Shwu-Huey; Chen, Yau-Hung; Wang, I-Jong			Hypoxia-Induced Retinal Neovascularization in Zebrafish Embryos: A Potential Model of Retinopathy of Prematurity	PLOS ONE			English	Article							INTRAVITREAL BEVACIZUMAB AVASTIN; AGGRESSIVE POSTERIOR RETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; IN-VIVO ANALYSIS; GENE-EXPRESSION; MACULAR DEGENERATION; ZONE-I; ANGIOGENESIS; VEGF; RANIBIZUMAB	Retinopathy of prematurity, formerly known as a retrolental fibroplasia, is a leading cause of infantile blindness worldwide. Retinopathy of prematurity is caused by the failure of central retinal vessels to reach the retinal periphery, creating a nonperfused peripheral retina, resulting in retinal hypoxia, neovascularization, vitreous hemorrhage, vitreoretinal fibrosis, and loss of vision. We established a potential retinopathy of prematurity model by using a green fluorescent vascular endothelium zebrafish transgenic line treated with cobalt chloride (a hypoxia-inducing agent), followed by GS4012 (a vascular endothelial growth factor inducer) at 24 hours postfertilization, and observed that the number of vascular branches and sprouts significantly increased in the central retinal vascular trunks 2-4 days after treatment. We created an angiography method by using tetramethylrhodamine dextran, which exhibited severe vascular leakage through the vessel wall into the surrounding retinal tissues. The quantification of mRNA extracted from the heads of the larvae by using real-time quantitative polymerase chain reaction revealed a twofold increase in vegfaa and vegfr2 expression compared with the control group, indicating increased vascular endothelial growth factor signaling in the hypoxic condition. In addition, we demonstrated that the hypoxic insult could be effectively rescued by several antivascular endothelial growth factor agents such as SU5416, bevacizumab, and ranibizumab. In conclusion, we provide a simple, highly reproducible, and clinically relevant retinopathy of prematurity model based on zebrafish embryos; this model may serve as a useful platform for clarifying the mechanisms of human retinopathy of prematurity and its progression.	[Wu, Yu-Ching; Kao, Alex; Hsi, Brian; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chang, Chao-Yuan; Chen, Yau-Hung] Tamkang Univ, Dept Chem, New Taipei City, Taiwan; [Lee, Shwu-Huey] Cathay Gen Hosp, Dept Ophthalmol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Tamkang University; Cathay General Hospital	Chen, YH (corresponding author), Tamkang Univ, Dept Chem, New Taipei City, Taiwan.	yauhung@mail.tku.edu.tw; ijong@ms8.hinet.net	Chang, Chao-Yuan/GWZ-5431-2022	Chang, Chao-Yuan/0000-0003-0672-984X; Wang, I-Jong/0000-0002-3045-0614	National Science Council [983112B002040, 993112B002029, 992314B002039MY3]; National Taiwan University Hospital [98S-1105]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by National Science Council grants-983112B002040, 993112B002029, and 992314B002039MY3-and grants from National Taiwan University Hospital 98S-1105.	Adamis AP, 2006, OPHTHALMOLOGY, V113, P23, DOI 10.1016/j.ophtha.2005.10.012; Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; BALLARD KW, 1964, J PHYSIOL-LONDON, V173, P178, DOI 10.1113/jphysiol.1964.sp007450; Barnett JM, 2010, DOC OPHTHALMOL, V120, P3, DOI 10.1007/s10633-009-9180-y; Cannon JE, 2010, BRIT J PHARMACOL, V161, P140, DOI 10.1111/j.1476-5381.2010.00871.x; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Chawla D, 2012, INDIAN J PEDIATR, V79, P501, DOI 10.1007/s12098-010-0279-7; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chimote G, 2014, DRUG DES DEV THER, V8, P1107, DOI 10.2147/DDDT.S55621; Chung EJ, 2007, GRAEF ARCH CLIN EXP, V245, P1727, DOI 10.1007/s00417-007-0661-y; Ellis L M, 2000, Oncologist, V5 Suppl 1, P11; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferrara N, 2005, EXP SUPPL, V94, P209; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FLYNN JT, 1992, EYE, V6, P161, DOI 10.1038/eye.1992.32; FOSTER A, 1992, EYE, V6, P173, DOI 10.1038/eye.1992.34; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Haase VH, 2010, KIDNEY INT, V78, P10, DOI 10.1038/ki.2010.112; Hara A, 2006, BRAIN RES, V1109, P192, DOI 10.1016/j.brainres.2006.06.037; Hartsock A, 2014, DEV BIOL, V394, P327, DOI 10.1016/j.ydbio.2014.07.024; Jorge R, 2006, RETINA-J RET VIT DIS, V26, P1006, DOI 10.1097/01.iae.0000246884.76018.63; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lalwani GA, 2008, RETINA-J RET VIT DIS, V28, pS13, DOI 10.1097/IAE.0b013e3181644ad2; Law JC, 2010, J AAPOS, V14, P6, DOI 10.1016/j.jaapos.2009.10.011; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; Li WW, 2008, BRIT J HAEMATOL, V143, P622, DOI 10.1111/j.1365-2141.2008.07372.x; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu XH, 1999, CLIN EXP METASTAS, V17, P687, DOI 10.1023/A:1006728119549; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Los M, 2007, ONCOLOGIST, V12, P443, DOI 10.1634/theoncologist.12-4-443; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Martin DF, 2002, RETINA-J RET VIT DIS, V22, P143; Castellanos MAM, 2013, BRIT J OPHTHALMOL, V97, P816, DOI 10.1136/bjophthalmol-2012-302276; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; MINCHENKO A, 1994, LAB INVEST, V71, P374; Mintz-Hittner HA, 2008, RETINA-J RET VIT DIS, V28, P831, DOI 10.1097/IAE.0b013e318177f934; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rabinowitz R, 2012, CURR EYE RES, V37, P624, DOI 10.3109/02713683.2012.669003; Reinardy HC, 2013, AQUAT TOXICOL, V126, P224, DOI 10.1016/j.aquatox.2012.11.007; Schmucker C, 2011, BRIT J OPHTHALMOL, V95, P308, DOI 10.1136/bjo.2009.178574; Shah Parag K., 2007, Indian Journal of Ophthalmology, V55, P75; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771; Sukbuntherng J, 2001, J PHARM PHARMACOL, V53, P1629, DOI 10.1211/0022357011778232; TAILOI CL, 1992, INVEST OPHTH VIS SCI, V33, P2128; Travassos A, 2007, OPHTHAL SURG LAS IM, V38, P233, DOI 10.3928/15428877-20070501-09; Yanni SE, 2008, RETINAL AND CHOROIDAL ANGIOGENESIS, P57, DOI 10.1007/978-1-4020-6780-8_3; Yu RMK, 2012, ENVIRON SCI TECHNOL, V46, P9112, DOI 10.1021/es301758c; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	59	24	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126750	10.1371/journal.pone.0126750	http://dx.doi.org/10.1371/journal.pone.0126750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978439	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100097
J	Zhao, N; Sun, MN; Burns-Huang, K; Jiang, XJ; Ling, Y; Darby, C; Ehrt, S; Liu, G; Nathan, C				Zhao, Nan; Sun, Mingna; Burns-Huang, Kristin; Jiang, Xiuju; Ling, Yan; Darby, Crystal; Ehrt, Sabine; Liu, Gang; Nathan, Carl			Identification of Rv3852 as an Agrimophol-Binding Protein in Mycobacterium tuberculosis	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEIN; POLYPHENOLS; EXTRACTS; MODEL	Mycobacterial tuberculosis (Mtb) is able to preserve its intrabacterial pH (pH(IB)) near neutrality in the acidic phagosomes of immunologically activated macrophages and to cause lethal pathology in immunocompetent mice. In contrast, when its ability to maintain pH(IB) homeostasis is genetically compromised, Mtb dies in acidic phagosomes and is attenuated in the mouse. Compounds that phenocopy the genetic disruption of Mtb's pH(IB) homeostasis could serve as starting points for drug development in their own right or through identification of their targets. A previously reported screen of a natural product library identified a phloroglucinol, agrimophol, that lowered Mtb's pH(IB) and killed Mtb at an acidic extrabacterial pH. Inability to identify agrimophol-resistant mutants of Mtb suggested that the compound may have more than one target. Given that polyphenolic compounds may undergo covalent reactions, we attempted an affinity-based method for target identification. The structure-activity relationship of synthetically tractable polyhydroxy diphenylmethane analogs with equivalent bioactivity informed the design of a bioactive agrimophol alkyne. After click-chemistry reaction with azido-biotin and capture on streptavidin, the biotinylated agrimophol analog pulled down the Mtb protein Rv3852, a predicted membrane protein that binds DNA in vitro. A ligand-protein interaction between agrimophol and recombinant Rv3852 was confirmed by isothermal calorimetry (ITC) and led to disruption of Rv3852's DNA binding function. However, genetic deletion of rv3852 in Mtb did not phenocopy the effect of agrimophol on Mtb, perhaps because of redundancy of its function.	[Zhao, Nan; Burns-Huang, Kristin; Jiang, Xiuju; Ling, Yan; Darby, Crystal; Ehrt, Sabine; Nathan, Carl] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Sun, Mingna; Liu, Gang] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Sun, Mingna; Liu, Gang] Tsinghua Univ, Sch Med, Dept Pharmacol & Pharmaceut Sci, Beijing 100084, Peoples R China	Cornell University; Tsinghua University; Tsinghua University	Liu, G (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	gangliu27@biomed.tsinghua.edu.cn; cnathan@med.cornell.edu	Ehrt, Sabine/AAU-6449-2020; ZHAO, NAN/H-7633-2017		National Institutes of Health [RO1 AI081725]; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant RO1 AI081725. The Department of Microbiology and Immunology at Weill Cornell Medical College is supported by the William Randolph Hearst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Darby CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068942; Dashti Y, 2014, NAT PROD REP, V31, P990, DOI 10.1039/c4np00021h; Duckworth BP, 2011, CHEM BIOL, V18, P1432, DOI 10.1016/j.chembiol.2011.08.013; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Ghosh S, 2013, J BACTERIOL, V195, P1769, DOI 10.1128/JB.02081-12; Hider RC, 2001, METHOD ENZYMOL, V335, P190; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunisch R, 2012, BMC MICROBIOL, V165, P1; Le Bourvellec C, 2012, CRIT REV FOOD SCI, V52, P213, DOI 10.1080/10408398.2010.499808; Lee CY, 2013, J ORG CHEM, V78, P11221, DOI 10.1021/jo401603d; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Marques MA, 1998, NATURE, V393, P537; Park SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002264; Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774; Popovych N, 2012, J PHYS CHEM B, V116, P3650, DOI 10.1021/jp2121577; Prabhakar S., 1998, Tubercle and Lung Disease, V79, P43, DOI 10.1054/tuld.1998.0004; Sharadamma N, 2010, NUCLEIC ACIDS RES, V38, P3555, DOI 10.1093/nar/gkq064; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; WALLER JP, 1963, J MOL BIOL, V7, P483, DOI 10.1016/S0022-2836(63)80096-0; Werlang ICR, 2009, MICROBIOL-SGM, V155, P2652, DOI 10.1099/mic.0.030148-0; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yao R H, 1984, Yao Xue Xue Bao, V19, P228; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	29	9	11	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126211	10.1371/journal.pone.0126211	http://dx.doi.org/10.1371/journal.pone.0126211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978362	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100053
J	Morita, T; Ishikawa, M; Sakamoto, A				Morita, Tomonori; Ishikawa, Masashi; Sakamoto, Atsuhiro			Identical MicroRNAs Regulate Liver Protection during Anaesthetic and Ischemic Preconditioning in Rats: An animal study	PLOS ONE			English	Article							REPERFUSION INJURY; CYCLIN D1; SEVOFLURANE; EXPRESSION; PATHWAYS	Anaesthetic preconditioning (APC) and ischemic preconditioning (IPC) ameliorate liver ischemia- reperfusion (I/R) injury and are important for regulating hepatic I/R injury. MicroRNAs (miRNAs) are short, noncoding RNA molecules of 21-23 nucleotides in length, and are currently under intensive investigation regarding their ability to regulate gene expression in a wide range of species. miRNA activity is involved in controlling a wide range of biological functions and processes. We evaluated whether APC and IPC are mediated by the same miRNAs by performing comprehensive miRNA screening experiments in a rat model of hepatic I/R injury. Twenty-one rats were randomly divided into three groups (n = 7/group): control (mock preconditioning), APC, and IPC. Control rats were subjected to 60 min of hepatic ischemia followed by 4 h of reperfusion, whereas the APC and IPC groups were preconditioned with 2% sevoflurane and hepatic ischemia for 10 min prior to ischemia-reperfusion, respectively. Liver samples were collected to measure miRNA levels after 3 h of reperfusion, and gene networks and canonical pathways were identified using Ingenuity Pathway Analysis (IPA). Blood samples were collected to measure the levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Although haemodynamic parameters did not vary among the groups, AST and ALT levels were significantly higher in the control group than in the APC and IPC groups. Comprehensive miRNA screening experiments revealed that most miRNAs altered in the APC group were common to those in the IPC group. IPA identified five miRNAs related to the Akt-glycogen synthase kinase-3 beta (GSK-3 beta)-cyclin D1 pathway that were significantly affected by both preconditioning strategies. The application of either APC or IPC to ameliorate hepatic I/R injury results in expression of several common miRNAs that are related to the Akt-GSK-cyclin D1 pathway.	[Morita, Tomonori; Ishikawa, Masashi; Sakamoto, Atsuhiro] Nippon Med Sch, Grad Sch Med, Dept Anesthesiol & Pain Med, Bunkyo Ku, Tokyo 113, Japan	Nippon Medical School	Morita, T (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Anesthesiol & Pain Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	t-morit@nms.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24592318]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Science Research (C) (Project number 24592318) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht JH, 1999, CELL GROWTH DIFFER, V10, P397; Amador A, 2007, AM J TRANSPLANT, V7, P2180, DOI 10.1111/j.1600-6143.2007.01914.x; Beck-Schimmer B, 2008, ANN SURG, V248, P909, DOI 10.1097/SLA.0b013e31818f3dda; Bedirli N, 2008, ANESTH ANALG, V106, P830, DOI 10.1213/ane.0b013e3181616fc9; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Cai FG, 2006, WORLD J GASTROENTERO, V12, P2936, DOI 10.3748/wjg.v12.i18.2936; Hsieh TC, 2012, CARCINOGENESIS, V33, P670, DOI 10.1093/carcin/bgs016; Huang MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029173; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Ishida Hiroshi, 2002, J Anesth, V16, P44, DOI 10.1007/s540-002-8093-x; Ishikawa M, 2012, ANESTHESIOLOGY, V117, P1245, DOI 10.1097/ALN.0b013e3182746676; Li L, 2015, LIVER INT, V35, P1124, DOI 10.1111/liv.12441; Martinez-Pacheco M, 2014, GENE, V533, P508, DOI 10.1016/j.gene.2013.09.049; Miyamoto S, 2009, J BIOENERG BIOMEMBR, V41, P169, DOI 10.1007/s10863-009-9205-y; Obal D, 2001, BRIT J ANAESTH, V87, P905, DOI 10.1093/bja/87.6.905; Ofluoglu E, 2006, EUR SURG RES, V38, P114, DOI 10.1159/000093300; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sun GX, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-100; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070956; Weiss JBW, 2012, AM J CARDIOVASC DIS, V2, P237; Xiao YY, 2011, ANESTH ANALG, V113, P224, DOI 10.1213/ANE.0b013e3182239b71; Yamada F, 2007, J GASTROEN HEPATOL, V22, P1971, DOI 10.1111/j.1440-1746.2006.04711.x; Yang QZ, 2011, ANESTH ANALG, V112, P931, DOI 10.1213/ANE.0b013e31820bcfa4; Ye XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055615; Yu QQ, 2014, BIOMED PHARMACOTHER, V68, P155, DOI 10.1016/j.biopha.2014.01.005; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041478; Zhang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074422	32	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125866	10.1371/journal.pone.0125866	http://dx.doi.org/10.1371/journal.pone.0125866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974021	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600029
J	Qi, CM; Deng, LR; Li, DY; Wu, WH; Gong, L; Li, Y; Zhang, QD; Zhang, T; Zhang, C; Zhang, Y				Qi, Chunmei; Deng, Liangrong; Li, Dongye; Wu, Weiheng; Gong, Lei; Li, Yong; Zhang, Qingdui; Zhang, Tao; Zhang, Chao; Zhang, Yu			Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin	PLOS ONE			English	Article							INFLAMMATION; ULTRASOUND	Background Rupture of an atherosclerotic plaque is the primary cause of acute cardiovascular and cerebrovascular syndromes. Early and non-invasive detection of vulnerable atherosclerotic plaques (VP) would be significant in preventing some aspects of these syndromes. As a new contrast agent, dimercaptosuccinic acid (DMSA) modified ultra-small super paramagnetic iron oxide (USPIO) was synthesized and used to identify VP and rupture plaque by magnetic resonance imaging (MRI). Methods Atherosclerosis was induced in male New Zealand White rabbits by feeding a high cholesterol diet (n = 30). Group A with atherosclerosis plaque (n = 10) were controls. VP was established in groups B (n = 10) and C (n = 10) using balloon-induced endothelial injury of the abdominal aorta. Adenovirus-carrying p53 genes were injected into the aortic segments rich in plaques after 8 weeks. Group C was treated with atorvastatin for 8 weeks. Sixteen weeks later, all rabbits underwent pharmacological triggering, and imaging were taken daily for 5 d after DMSA-USPIO infusion. At the first day and before being killed, serum MMP-9, sCD40L, and other lipid indicators were measured. Results DMSA-USPIO particles accumulated in VP and rupture plaques. Rupture plaques appeared as areas of hyper-intensity on DMSA-USPIO enhanced MRI, especially T2*-weighted sequences, with a signal strength peaking at 96 h. The group given atorvastatin showed few DMSA-USPIO particles and had lower levels of serum indicators. MMP-9 and sCD40L levels in group B were significantly higher than in the other 2 groups (P < 0.05). Conclusion After successfully establishing a VP model in rabbits, DMSA-USPIO was used to enhance MRI for clear identification of plaque inflammation and rupture. Rupture plaques were detectable in this way probably due to an activating inflammatory process. Atorvastatin reduced the inflammatory response and stabilizing VP possibly by decreasing MMP-9 and sCD40L levels.	[Qi, Chunmei; Li, Dongye] Gen Hosp Nanjing Mil Reg, Xuzhou, Peoples R China; [Deng, Liangrong; Li, Dongye] Xuzhou Med Coll, Inst Cardiovasc Dis, Xuzhou, Peoples R China; [Qi, Chunmei; Wu, Weiheng; Gong, Lei; Li, Yong; Zhang, Qingdui] Xuzhou Med Coll, Affiliated Hosp 2, Dept Cardiol, Xuzhou, Peoples R China; [Zhang, Tao; Zhang, Chao] Xuzhou Med Coll, Affiliated Hosp 2, Dept Magnet Resonance Imaging, Xuzhou, Peoples R China; [Zhang, Yu] Southeast Univ, Lab Mol & Boimol Elect, Nanjing, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Southeast University - China	Li, DY (corresponding author), Gen Hosp Nanjing Mil Reg, Xuzhou, Peoples R China.	lidongyexinnei@126.com	李, 东野/AAY-6410-2020; Stefanadis, Christodoulos/ABH-2232-2020; 李, 东/GYA-4703-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; 	China Postdoctoral Science Foundation [2012M512177]; Xuzhou Scientific Technology Subject [XF11C103, XM13B048];  [53431002]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Xuzhou Scientific Technology Subject; 	This work was supported by grants from the Postdoctoral Subject (No. 53431002), China Postdoctoral Science Foundation Grant (2012M512177), Xuzhou Scientific Technology Subject (No. XF11C103 and No. XM13B048). The funders had roles in the data collection and analysis, decision to publish and preparation of the manuscript. The role of the funders in detail is as follows: For data collection and analysis, the funders supported the purchase of raw materials such as rabbits, rabbits' feed, triggering pharmaceuticals of Chinese Russell's viper venom and histamine, surgical instruments, general anesthetic named pentobarbital sodium, MMP-9 and sCD40L ELISA kits, histopathology and electron microscopy detection and so on. The funders supported the decision to publish by covering the publication fee. Lastly, the funders supported the preparation of the manuscript by funding language copyediting services provided by native English speakers.	Arias JL, 2006, J COLLOID INTERF SCI, V299, P599, DOI 10.1016/j.jcis.2006.03.005; Asabella AN, 2014, ANN NUCL MED, V28, P571, DOI 10.1007/s12149-014-0850-9; Bautista MC, 2005, J MAGN MAGN MATER, V293, P20, DOI 10.1016/j.jmmm.2005.01.038; Bond AR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379069; Chen WQ, 2007, AM J PHYSIOL-HEART C, V293, pH2836, DOI 10.1152/ajpheart.00472.2007; Chen WQ, 2004, CHINESE MED J-PEKING, V117, P1293; Deguchi J, 2006, CIRCULATION, V114, P55, DOI 10.1161/CIRCULATIONAHA.106.619056; Drakopoulou M, 2011, CURR PHARM DESIGN, V17, P4190, DOI 10.2174/138161211798764816; Hernandez ASM, 2007, REV CLIN ESP, V207, P418; Howarth SP, 2007, ANN SURG INNOV RES, V21, P1; Iqbal SN, 2014, AM HEART J, V167, DOI 10.1016/j.ahj.2014.01.011; Khalil A, 2014, AM J NUCL MED MOLEC, V4, P283; Klug G, 2009, FRONT BIOSCI-LANDMRK, V14, P2546, DOI 10.2741/3396; Li S, 2014, J ATHEROSCLER THROMB, V21, P648, DOI 10.5551/jat.21600; Metz S, 2011, INT J CARDIOVAS IMAG, V27, P901, DOI 10.1007/s10554-010-9736-7; Millon A, 2013, ATHEROSCLEROSIS, V228, P339, DOI 10.1016/j.atherosclerosis.2013.03.019; Morishige K, 2010, CIRCULATION, V122, P1707, DOI 10.1161/CIRCULATIONAHA.109.891804; Motomura K, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-32; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Rubba P, 2007, DRUGS, V67, P17, DOI 10.2165/00003495-200767001-00003; Shahbazi-Gahrouei D, 2013, SCI WORLD J, DOI 10.1155/2013/609151; Shen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094876; Shen WB, 2013, INT J NANOMED, V8, P4593, DOI 10.2147/IJN.S53012; Skotland T, 2012, CONTRAST MEDIA MOL I, V7, P1, DOI 10.1002/cmmi.458; Suh WM, 2011, CIRC-CARDIOVASC IMAG, V4, P169, DOI 10.1161/CIRCIMAGING.110.958777; Tsuzuki M, 2005, HEART VESSELS, V20, P245, DOI 10.1007/s00380-005-0840-x; Voros S, 2011, JACC-CARDIOVASC IMAG, V4, P537, DOI 10.1016/j.jcmg.2011.03.006; Wu YH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/22/225703; Zhao QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061140; Zhao SP, 2003, CLIN CHIM ACTA, V336, P103, DOI 10.1016/S0009-8981(03)00335-8; Zhao XC, 2013, CHINESE MED J-PEKING, V126, P2163, DOI 10.3760/cma.j.issn.0366-6999.20121030	31	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125677	10.1371/journal.pone.0125677	http://dx.doi.org/10.1371/journal.pone.0125677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973795	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600024
J	Zhang, L; Li, M; Zhan, LB; Lu, XG; Liang, LN; Su, BL; Sui, H; Gao, ZN; Li, YZ; Liu, Y; Wu, BH; Liu, QG				Zhang, Lin; Li, Meng; Zhan, Libin; Lu, Xiaoguang; Liang, Lina; Su, Benli; Sui, Hua; Gao, Zhengnan; Li, Yuzhong; Liu, Ying; Wu, Benhui; Liu, Qigui			Plasma Metabolomic Profiling of Patients with Diabetes-Associated Cognitive Decline	PLOS ONE			English	Article							SERUM URIC-ACID; METABONOMIC ANALYSIS; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; MASS-SPECTROMETRY; OXIDATIVE STRESS; RISK; MELLITUS; DEMENTIA	Diabetes related cognitive dysfunction (DACD), one of the chronic complications of diabetes, seriously affect the quality of life in patients and increase family burden. Although the initial stage of DACD can lead to metabolic alterations or potential pathological changes, DACD is difficult to diagnose accurately. Moreover, the details of the molecular mechanism of DACD remain somewhat elusive. To understand the pathophysiological changes that underpin the development and progression of DACD, we carried out a global analysis of metabolic alterations in response to DACD. The metabolic alterations associated with DACD were first investigated in humans, using plasma metabonomics based on high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and multivariate statistical analysis. The related pathway of each metabolite of interest was searched in database online. The network diagrams were established KEGGSOAP software package. Receiver operating characteristic (ROC) analysis was used to evaluate diagnostic accuracy of metabolites. This is the first report of reliable biomarkers of DACD, which were identified using an integrated strategy. The identified biomarkers give new insights into the pathophysiological changes and molecular mechanisms of DACD. The disorders of sphingolipids metabolism, bile acids metabolism, and uric acid metabolism pathway were found in T2DM and DACD. On the other hand, differentially expressed plasma metabolites offer unique metabolic signatures for T2DM and DACD patients. These are potential biomarkers for disease monitoring and personalized medication complementary to the existing clinical modalities.	[Zhang, Lin; Li, Meng; Zhan, Libin; Liang, Lina; Sui, Hua] Dalian Med Univ, Acad Integrat Med, Dalian, Liaoning, Peoples R China; [Zhan, Libin] Dalian Med Univ, Affiliated Hosp 2, Dept Tradit Chinese Med, Dalian, Liaoning, Peoples R China; [Lu, Xiaoguang] Dalian Univ, Zhongshan Hosp, Dept Emergency Med, Dalian 116012, Liaoning, Peoples R China; [Su, Benli] Dalian Univ, Dept Endocrinol, Affiliated Hosp 2, Dalian 116012, Liaoning, Peoples R China; [Gao, Zhengnan] Dalian Med Univ, Dept Endocrinol, Dalian Municipal Cent Hosp, Dalian, Liaoning, Peoples R China; [Li, Yuzhong] Dalian Med Univ, Examinat Dept, Affiliated Hosp 2, Dalian, Liaoning, Peoples R China; [Liu, Ying; Wu, Benhui] Dalian Med Univ, Med Examinat Ctr, Affiliated Hosp 2, Dalian, Liaoning, Peoples R China; [Liu, Qigui] Dalian Med Univ, Publ Hlth, Dalian, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian University; Dalian University; Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University	Zhan, LB (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Tradit Chinese Med, Dalian, Liaoning, Peoples R China.	libinzhan@hotmail.com; dllxg@126.com			Key Project of National Natural Science Foundation of China [81230084]; Research Fund for the Doctoral Program of Higher Education of China [20112105110006]; Program for Professor of Special Appointment in Liaoning Province; Program for Liaoning Innovative Research Team in University [LT2014018]	Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Professor of Special Appointment in Liaoning Province; Program for Liaoning Innovative Research Team in University	This work was supported in part by the Key Project of National Natural Science Foundation of China (no. 81230084), by the Research Fund for the Doctoral Program of Higher Education of China (no. 20112105110006), by the Program for Professor of Special Appointment in Liaoning Province, and by the Program for Liaoning Innovative Research Team in University (no. LT2014018).	Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Bentley-Lewis R, 2014, J CLIN TRANSL ENDOCR, V1, P38, DOI 10.1016/j.jcte.2014.03.003; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Blachnio-Zabielska A, 2010, HORM METAB RES, V42, P1, DOI 10.1055/s-0029-1238322; Cai S, 2009, J CHROMATOGR B, V877, P3619, DOI 10.1016/j.jchromb.2009.08.044; Cervellati C, 2014, J NEUROL SCI, V337, P156, DOI 10.1016/j.jns.2013.11.041; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Exalto LG, 2012, EXP GERONTOL, V47, P858, DOI 10.1016/j.exger.2012.07.014; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Galazis N, 2012, EUR J OBSTET GYN R B, V160, P121, DOI 10.1016/j.ejogrb.2011.11.005; Gika HG, 2008, J CHROMATOGR B, V871, P279, DOI 10.1016/j.jchromb.2008.04.020; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Katyare SS, 2005, DIABETES OBES METAB, V7, P555, DOI 10.1111/j.1463-1326.2004.00429.x; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Leichtle AB, 2013, METABOLOMICS, V9, P677, DOI 10.1007/s11306-012-0476-7; Li HK, 2007, J PROTEOME RES, V6, P1364, DOI 10.1021/pr060513q; Li J, 2010, EXP GERONTOL, V45, P331, DOI 10.1016/j.exger.2010.01.005; Lipina C, 2011, DIABETOLOGIA, V54, P1596, DOI 10.1007/s00125-011-2127-3; Liu R, 2012, J MASS SPECTROM, V47, P1341, DOI 10.1002/jms.3084; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maher PA, 2009, EXPERT REV NEUROTHER, V9, P617, DOI 10.1586/ERN.09.18; Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Miric DJ, 2013, J DIABETES COMPLICAT, V27, P171, DOI 10.1016/j.jdiacomp.2012.09.005; Morris JK, 2014, NEUROBIOL AGING, V35, P585, DOI 10.1016/j.neurobiolaging.2013.09.033; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Padberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085082; Plaa GL, 1998, TOXICOLOGY LIVER, P347; R Core Team, 2018, R LANG ENV STAT COMP; Roberts RO, 2014, NEUROLOGY, V82, P1132, DOI 10.1212/WNL.0000000000000269; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schretlen DJ, 2007, NEUROPSYCHOLOGY, V21, P136, DOI 10.1037/0894-4105.21.1.136; Shang J, 2014, J PHARMACEUT BIOMED, V92, P26, DOI 10.1016/j.jpba.2013.12.019; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Zhang J, 2009, ANAL CHIM ACTA, V650, P16, DOI 10.1016/j.aca.2009.02.027; Zhao LC, 2012, J ETHNOPHARMACOL, V142, P647, DOI 10.1016/j.jep.2012.05.031	49	13	15	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126952	10.1371/journal.pone.0126952	http://dx.doi.org/10.1371/journal.pone.0126952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974350	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600091
J	Tzeng, YM; Kao, LT; Kao, S; Lin, HC; Tsai, MC; Lee, CZ				Tzeng, Ya-Mei; Kao, Li-Ting; Kao, Senyeong; Lin, Herng-Ching; Tsai, Ming-Chieh; Lee, Cha-Ze			An Appendectomy Increases the Risk of Rheumatoid Arthritis: A Five-Year Follow-Up Study	PLOS ONE			English	Article							HUMAN VERMIFORM APPENDIX; POPULATION-BASED COHORT; ULCERATIVE-COLITIS; CROHNS-DISEASE; CLAVULANIC-ACID; TONSILLECTOMY; SURGERY	Many studies have reported a possible association of an appendectomy with rheumatoid arthritis (RA). However, findings of the relationship between an appendectomy and RA remain inconsistent. Furthermore, all such studies were conducted in Western societies, and relevant studies on the relationship between an appendectomy and RA in Asian countries are still lacking. In this study, we investigated the relationship between an appendectomy and the subsequent risk of RA using a population-based dataset. We retrieved data for this retrospective cohort study from the Taiwan "Longitudinal Health Insurance Database 2005". We included 4,294 subjects who underwent an appendectomy in the study cohort and 12,882 matched subjects in the comparison cohort. We individually tracked each subject for a 5-year period from their index date to identify those who developed RA. A stratified Cox proportional hazard regression was performed to calculate the hazard ratio (HR) and its corresponding 95% confidence interval (CI) for the subsequent development of RA during the 5-year follow-up period between subjects who underwent an appendectomy and comparison subjects. Of the sampled subjects, 93 (0.54%) received a diagnosis of RA during the 5-year follow-up period: 33 from the study cohort (0.77% of subjects who underwent an appendectomy) and 60 from the comparison cohort (0.47% of comparison subjects) (p<0.001). After censoring individuals who died during the follow-up period and adjusting for subjects' monthly income and geographic region, the HR of RA during the 5-year follow-up period was 1.61 (95% CI = 1.05 similar to 2.48) for subjects who underwent an appendectomy compared to comparison subjects. We found that among females, the adjusted HR of RA was 1.76 (95% CI = 1.04 similar to 2.96) for subjects who underwent an appendectomy compared to comparison subjects. However, there was no increased hazard of RA for males who underwent an appendectomy compared to comparison subjects. We concluded that female subjects who undergo an appendectomy have a higher risk of RA than comparison female subjects.	[Tzeng, Ya-Mei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting; Kao, Senyeong] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Lee, Cha-Ze] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Defense Medical Center; National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; Cathay General Hospital; National Taiwan University; National Taiwan University Hospital	Lee, CZ (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	czl@ntu.edu.tw	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408; Kao, Senyeong/0000-0002-0209-240X				Andersson RE, 2003, GASTROENTEROLOGY, V124, P40, DOI 10.1053/gast.2003.50021; Ansaloni L, 2009, EUR SURG RES, V43, P67, DOI 10.1159/000219236; Berry RJA, 1900, J ANAT PHYSIOL, V35, P83; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Cosnes J, 2002, GUT, V51, P803, DOI 10.1136/gut.51.6.803; Di Saverio S, 2014, ANN SURG, V260, P109, DOI 10.1097/SLA.0000000000000560; Eftekharian MM, 2013, MARMARA MED J, V26, P30, DOI 10.5472/MMJ.2012.02644.1; FERNANDEZMADRID F, 1985, J RHEUMATOL, V12, P43; GOTTLIEB NL, 1979, J RHEUMATOL, V6, P316; Hallas J, 2004, EPIDEMIOLOGY, V15, P173, DOI 10.1097/01.ede.0000112208.22339.4a; Janszky I, 2011, EUR HEART J, V32, P2290, DOI 10.1093/eurheartj/ehr137; Kaplan GG, 2007, GUT, V56, P1387, DOI 10.1136/gut.2007.121467; Lai SW, 2014, EUR J CLIN MICROBIOL, V33, P1573, DOI 10.1007/s10096-014-2112-0; Laurin M, 2011, ANAT REC, V294, P567, DOI 10.1002/ar.21357; LINOS AD, 1986, J RHEUMATOL, V13, P707; Ludvigsson JF, 2006, DIGEST LIVER DIS, V38, P823, DOI 10.1016/j.dld.2006.06.041; MOENS HB, 1994, CLIN RHEUMATOL, V13, P483; PATEL SB, 1983, J RHEUMATOL, V10, P313; Radford-Smith GL, 2002, GUT, V51, P808, DOI 10.1136/gut.51.6.808; Shames RS, 2002, J ADOLESCENT HEALTH, V30, P59, DOI 10.1016/S1054-139X(01)00382-2; Svensson JF, 2014, ANN SURG; ter Borg EJ, 1999, CLIN RHEUMATOL, V18, P1, DOI 10.1007/s100670050042; Vons C, 2011, LANCET, V377, P1573, DOI 10.1016/S0140-6736(11)60410-8	23	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126816	10.1371/journal.pone.0126816	http://dx.doi.org/10.1371/journal.pone.0126816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970542	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200134
J	Squires, JE; Shivakumar, P; Mourya, R; Bessho, K; Walters, S; Bezerra, JA				Squires, James E.; Shivakumar, Pranavkumar; Mourya, Reena; Bessho, Kazuhiko; Walters, Stephanie; Bezerra, Jorge A.			Natural Killer Cells Promote Long-Term Hepatobiliary Inflammation in a Low-Dose Rotavirus Model of Experimental Biliary Atresia	PLOS ONE			English	Article							REGULATORY T-CELLS; BILE-DUCT INJURY; GENE-EXPRESSION; EPITHELIAL INJURY; HEPATIC CD8(+); MURINE MODEL; LYMPHOCYTES; OBSTRUCTION; LIVER; MICE	Biliary atresia is a rapidly progressive obstructive cholangiopathy of infants. Mechanistic studies in the mouse model of Rhesus rotavirus (RRV)-induced biliary atresia have linked the importance of effector lymphocytes to the pathogenesis of extrahepatic bile duct (EHBD) injury and obstruction in experimental biliary atresia; however, studies of the progressive liver injury have been limited by early death of newborn mice. Here, we aimed to determine 1) if a lower inoculum of RRV induces obstruction of EHBDs while allowing for ongoing liver inflammation, and 2) if NK cells regulate intrahepatic injury. The administration of 0.25x10(6) fluorescence forming units of RRV induced an obstructive extrahepatic cholangiopathy, but allowed for restoration of the duct epithelium, increased survival, and the development of a progressive intrahepatic inflammatory injury with molecular and cellular signatures equivalent to the traditional infectious model. Investigating the mechanisms of liver injury, we found that NK cell depletion at the onset of jaundice decreased liver inflammation, suppressed the expression of fibrosis and inflammation/immunity genes, lowered plasma ALT and bilirubin and improved survival. Conclusions Lower inoculation of RRV-induced progressive liver injury and fibrosis via NK cells. These findings point to the potential use of NK cell-depleting strategies to block progression of liver disease in biliary atresia.	[Squires, James E.; Shivakumar, Pranavkumar; Mourya, Reena; Walters, Stephanie; Bezerra, Jorge A.] Univ Cincinnati, Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45220 USA; [Squires, James E.; Shivakumar, Pranavkumar; Mourya, Reena; Walters, Stephanie; Bezerra, Jorge A.] Cincinnati Childrens Hosp Med Ctr, Pediat Liver Care Ctr, Cincinnati, OH 45229 USA; [Bessho, Kazuhiko] Osaka Univ, Div Pediat, Osaka, Japan	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Osaka University	Bezerra, JA (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45220 USA.	jorge.bezerra@cchmc.org	Shivakumar, Pranav/A-4229-2011	Mourya, Reena/0000-0003-4525-0196; Shivakumar, Pranavkumar/0000-0002-2095-0623	American Liver Foundation/American Association; Faculty Transition; National Institutes of Health [DK83781, DK078392];  [T32 -DK007727]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007727, R01DK083781, P30DK078392] Funding Source: NIH RePORTER	American Liver Foundation/American Association; Faculty Transition; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by two grants from the American Liver Foundation/American Association for Postdoctoral Research (to J.E.S.) and Faculty Transition (to P.S.), and by the National Institutes of Health grants DK83781 (to J.A.B.), DK078392 (Gene and Protein Expression Core and the Integrative Morphology Core of the Digestive Disease Research Center in Cincinnati; to J.A.B.), and the T32 -DK007727 (to J.E.S.).	Bessho K, 2014, HEPATOLOGY, V60, P211, DOI 10.1002/hep.27045; Bessho K, 2011, ANNU REV MED, V62, P171, DOI 10.1146/annurev-med-042909-093734; Carvalho E, 2005, GASTROENTEROLOGY, V129, P713, DOI 10.1053/j.gastro.205.05.052; Feldman AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073644; Guo CB, 2012, PEDIATR RES, V71, P638, DOI 10.1038/pr.2012.17; Lages CS, 2012, HEPATOLOGY, V56, P219, DOI 10.1002/hep.25662; Leonhardt J, 2006, PEDIATR SURG INT, V22, P84, DOI 10.1007/s00383-005-1589-0; Li J, 2011, J CLIN INVEST, V121, P4244, DOI 10.1172/JCI57728; Locaputo S, 1999, HEPATOLOGY, V29, P1106, DOI 10.1002/hep.510290434; Mack CL, 2005, CLIN IMMUNOL, V115, P200, DOI 10.1016/j.clim.2005.01.012; MCINTYRE KW, 1986, J EXP MED, V164, P1667, DOI 10.1084/jem.164.5.1667; Miethke AG, 2010, J HEPATOL, V52, P718, DOI 10.1016/j.jhep.2009.12.027; Okamura A, 2013, J CLIN PATHOL, V66, P99, DOI 10.1136/jclinpath-2012-201097; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; Petersen C, 2012, SEMIN PEDIATR SURG, V21, P185, DOI 10.1053/j.sempedsurg.2012.05.002; Qiu YR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004011; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Saxena V, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002069; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Shivakumar P, 2007, GASTROENTEROLOGY, V133, P268, DOI 10.1053/j.gastro.2007.04.031; Shivakumar P, 2014, J HEPATOL, V60, P370, DOI 10.1016/j.jhep.2013.09.021; Shivakumar P, 2009, J CLIN INVEST, V119, P2281, DOI 10.1172/JCI38879; Sira MM, 2012, EUR J GASTROEN HEPAT, V24, P1227, DOI 10.1097/MEG.0b013e328356aee4; Sokol RJ, 2001, SEMIN LIVER DIS, V21, P517, DOI 10.1055/s-2001-19032	25	6	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127191	10.1371/journal.pone.0127191	http://dx.doi.org/10.1371/journal.pone.0127191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992581	gold, Green Published, Green Submitted			2022-12-27	WOS:000354918600053
J	Riofrio-Lazo, M; Paez-Rosas, D				Riofrio-Lazo, Marjorie; Paez-Rosas, Diego			Feeding Habits of Introduced Black Rats, Rattus rattus, in Nesting Colonies of Galapagos Petrel on San Cristobal Island, Galapagos	PLOS ONE			English	Article							STABLE-ISOTOPES; PTERODROMA-PHAEOPYGIA; CARBON ISOTOPES; DIET; SEABIRDS; CONSERVATION; DELTA-C-13; PREDATORS; IMPACTS; BIOLOGY	Introduced rodents are responsible for ecosystem changes in islands around the world. In the Galapagos archipelago, their effects on the native flora and fauna are adverse, including the extinction of endemic rodents in some islands and the reduction in the reproductive success of the Galapagos petrel (Pterodroma phaeopygia) in its nesting zones. Understanding the feeding behavior of introduced rodents and their trophic interactions with native and non-native species on islands, can assist in the design of management strategies and conservation plans of invasive and endemic species respectively. Four petrel nesting colonies were monitored during June 2013 on San Cristobal Island (El Platano, El Junco, San Joaquin, and La Comuna). The feeding habits of black rats were evaluated by analyzing stomach contents and stable isotopes in hair. Three species of introduced rodents were captured. Rattus rattus was the most abundant at all sites (n=43, capture success (CS) = 55.8%), followed by the house mouse, Mus musculus (n = 17, CS = 37.8%), and the Norwegian rat, R. norvegicus (n = 4, CS = 4.5%), captured only at La Comuna. The omnivorous black rat ate mostly plants (98%) and arthropods (2%). Intact seeds of Miconia robinsoniana were the main food at all sites (relative abundance=72.1%, present in 95% of the analyzed stomachs), showing the black rats' possible role in the archipelago as endemic seed dispersers. There was no evidence of petrel's intake; however, its possible consumption is not discarded at all. The delta N-15 and delta C-13 analysis corroborated the primarily herbivorous diet of black rats. The isotopic signatures of the three rodent species reflect the inter-and intra-specific differential use of food resources. Black rat showed a wider diet in La Comuna, which was related to a lower availability of its primary prey and its ability to adapt to the available resources in its habitat.	[Riofrio-Lazo, Marjorie; Paez-Rosas, Diego] USFQ, Galapagos Sci Ctr, San Cristobal Isl, Galapagos, Ecuador; [Paez-Rosas, Diego] Unidad Tecn Operat San Cristobal, Direcc Parque Nacl Galapagos, San Cristobal Isl, Galapagos, Ecuador		Riofrio-Lazo, M (corresponding author), USFQ, Galapagos Sci Ctr, San Cristobal Isl, Galapagos, Ecuador.	marjorieriofrio@gmail.com	Riofrío-Lazo, Marjorie/AAG-8510-2022; Páez-Rosas, Diego/X-3047-2019; Riofrío-Lazo, Marjorie/AFL-8440-2022	Riofrío-Lazo, Marjorie/0000-0003-4431-3458; Páez-Rosas, Diego/0000-0002-2446-9888; Riofrío-Lazo, Marjorie/0000-0003-4431-3458	Galapagos Science Center; Galapagos National Park	Galapagos Science Center; Galapagos National Park	This work was funded and supported by the Galapagos Science Center and the Galapagos National Park respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Tetsuto, 2007, Pacific Conservation Biology, V13, P213; Angel A, 2009, BIOL INVASIONS, V11, P1743, DOI 10.1007/s10530-008-9401-4; Atkinson I.A.E., 1985, International Council for Bird Preservation Technical Publication, P35; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Caut S, 2008, J APPL ECOL, V45, P428, DOI 10.1111/j.1365-2664.2007.01438.x; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; CLARK DA, 1982, ECOLOGY, V63, P763, DOI 10.2307/1936797; CLARK DA, 1981, BIOTROPICA, V13, P182, DOI 10.2307/2388123; Cole F. Russell, 2000, Pacific Science, V54, P313; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Cruz F., 1987, Vida Silvestre Neotropical, V1, P3; CRUZ JB, 1987, BIOL CONSERV, V42, P303, DOI 10.1016/0006-3207(87)90074-7; Cruz-Delgado F, 2010, BIRD CONSERV INT, V20, P306, DOI 10.1017/S095927091000002X; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Grant-Hoffman MN, 2010, BIOL INVASIONS, V12, P805, DOI 10.1007/s10530-009-9503-7; Grocke DR, 1997, EARTH PLANET SC LETT, V153, P279, DOI 10.1016/S0012-821X(97)00189-1; Harper GA, 2010, BIOL INVASIONS, V12, P1449, DOI 10.1007/s10530-009-9560-y; Harper GA, 2007, WILDLIFE RES, V34, P443, DOI 10.1071/WR07037; Harper GA, 2006, NEW ZEAL J ECOL, V30, P321; Hervias S, 2014, ZOOLOGY, V117, P171, DOI 10.1016/j.zool.2013.12.003; Hobson KA, 2003, OECOLOGIA, V136, P302, DOI 10.1007/s00442-003-1271-y; Jaramillo P, 2012, RAPID IDENTIFICATION; Key G, 1994, P 16 VERT PEST C U C, P118; Key Gillian, 1996, Proceedings of the Vertebrate Pest Conference, V17, P172; KORNER C, 1988, OECOLOGIA, V74, P623, DOI 10.1007/BF00380063; Major HL, 2007, J ZOOL, V271, P463, DOI 10.1111/j.1469-7998.2006.00230.x; Mariotti A., 1980, Catena, V7, P293, DOI 10.1016/0341-8162(80)90014-4; Mulder CPH, 2009, BIOL INVASIONS, V11, P1671, DOI 10.1007/s10530-008-9396-x; PATTON JL, 1975, SYST ZOOL, V24, P296, DOI 10.2307/2412717; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rodriguez MA, 2013, OECOLOGIA, V171, P537, DOI 10.1007/s00442-012-2423-8; Ruffino L, 2011, POPUL ECOL, V53, P535, DOI 10.1007/s10144-011-0265-6; Shiels AB, 2014, PAC SCI, V68, P145, DOI 10.2984/68.2.1; Shiels AB, 2013, BIOL INVASIONS, V15, P1037, DOI 10.1007/s10530-012-0348-0; Shiels AB, 2011, BIOL INVASIONS, V13, P883, DOI 10.1007/s10530-010-9876-7; Shiels AB, 2011, BIOL INVASIONS, V13, P781, DOI 10.1007/s10530-010-9868-7; Sweetapple PJ, 2007, NEW ZEAL J ECOL, V31, P186; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Williams PA, 2000, AUSTRAL ECOL, V25, P523, DOI 10.1046/j.1442-9993.2000.01078.x; YABE T, 1979, Japanese Journal of Ecology, V29, P235; Yabe Tatsuo, 2009, Marine Ornithology, V37, P293	45	17	18	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127901	10.1371/journal.pone.0127901	http://dx.doi.org/10.1371/journal.pone.0127901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984724	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300136
J	Ku, CY; Wang, YR; Lin, HY; Lu, SC; Lin, JY				Ku, Chung-Yu; Wang, Ying-Ren; Lin, Hsuan-Yuan; Lu, Shao-Chun; Lin, Jung-Yaw			Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway	PLOS ONE			English	Article							SIGNAL TRANSDUCER; GROWTH; CANCER; ANGIOGENESIS; PROLIFERATION; METASTASIS; ACTIVATION; MEDICINE; VEGF	Inhibition of VEGFR2 activity has been proposed as an important strategy for the clinical treatment of hepatocellular carcinoma (HCC). In this study, we identified corosolic acid (CA), which exists in the root of Actinidia chinensis, as having a significant anti-cancer effect on HCC cells. We found that CA inhibits VEGFR2 kinase activity by directly interacting with the ATP binding pocket. CA down-regulates the VEGFR2/Src/FAK/cdc42 axis, subsequently decreasing F-actin formation and migratory activity in vitro. In an in vivo model, CA exhibited an effective dose (5 mg/kg/day) on tumor growth. We further demonstrate that CA has a synergistic effect with sorafenib within a wide range of concentrations. In conclusion, this research elucidates the effects and molecular mechanism for CA on HCC cells and suggests that CA could be a therapeutic or adjuvant strategy for patients with aggressive HCC.	[Ku, Chung-Yu; Wang, Ying-Ren; Lin, Hsuan-Yuan; Lu, Shao-Chun; Lin, Jung-Yaw] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 100, Taiwan; [Lin, Hsuan-Yuan; Lin, Jung-Yaw] Natl Taiwan Normal Univ, Dept Life Sci, Taipei 11623, Taiwan	National Taiwan University; National Taiwan Normal University	Lu, SC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 100, Taiwan.	lsc@ntu.edu.tw; linjy@ntu.edu.tw	Lin, Jung-Yaw/AGW-9336-2022	Lin, Jung-Yaw/0000-0002-6341-1160	Ministry of Health and Welfare of the Republic of China [CCMP 102-RD-006]; Ministry of Science and Technology of the Republic of China [MOST103-2320-B-003-001-MY3]	Ministry of Health and Welfare of the Republic of China; Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Health and Welfare of the Republic of China (CCMP 102-RD-006), and the Ministry of Science and Technology of the Republic of China (MOST103-2320-B-003-001-MY3). The funders had no role in study design, data collection and analysis, or decision to publish of the manuscript.	Asnaghi L, 2010, ONCOGENE, V29, P2760, DOI 10.1038/onc.2010.39; Bennett SM, 2013, J VIROL, V87, P8843, DOI 10.1128/JVI.00664-13; Bergelin N, 2010, ENDOCRINOLOGY, V151, P2994, DOI [10.1210/en.2009-1387, 10.1210//en.2009-1387]; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Fan Y, 2013, J CHEMOTHERAPY, V25, P298, DOI 10.1179/1973947813Y.0000000079; Fife CM, 2014, BR J PHARM; Fujiwara Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/348539; Fujiwara Y, 2013, ONCOL LETT, V6, P1619, DOI 10.3892/ol.2013.1591; Fujiwara Y, 2011, CANCER SCI, V102, P206, DOI 10.1111/j.1349-7006.2010.01772.x; Gottwein JM, 2013, ANTIMICROB AGENTS CH, V57, P1291, DOI 10.1128/AAC.02164-12; Horlad H, 2013, MOL NUTR FOOD RES, V57, P1046, DOI 10.1002/mnfr.201200610; Jiang MA, 2010, PLANTA MED, V76, P2048, DOI 10.1055/s-0030-1250456; Kim JH, 2014, FOOD CHEM TOXICOL, V67, P87, DOI 10.1016/j.fct.2014.02.019; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lee K, 2010, EUR J MED CHEM, V45, P5420, DOI 10.1016/j.ejmech.2010.09.002; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lord R, 2011, INT J CLIN PRACT, V65, P182, DOI 10.1111/j.1742-1241.2010.02545.x; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Olsen Sonja K, 2010, Therap Adv Gastroenterol, V3, P55, DOI 10.1177/1756283X09346669; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park M, 2014, J ELECTROCHEM SCI TE, V5, P1, DOI 10.5229/JECST.2014.5.1.1; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Saraswati S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-82; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Shum WW, 2011, AM J PHYSIOL-CELL PH, V301, pC31, DOI 10.1152/ajpcell.00198.2010; Singh S, 2014, NAT REV GASTRO HEPAT, V11, P45, DOI 10.1038/nrgastro.2013.143; Tsubouchi T, 2013, CELL, V152, P873, DOI 10.1016/j.cell.2013.01.012; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; Wang SC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/409823; Wang Zhaoxia, 2013, TEXTILE APPAREL ED, V02, P8, DOI DOI 10.1371/J0URNAL.P0NE.0068566; Youns Mahmoud, 2010, Curr Drug Discov Technol, V7, P37; Zhang L, 2012, MOL BIOL REP, V39, P5085, DOI 10.1007/s11033-011-1304-2; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30; Zhu WJ, 2013, ANTI-CANCER AGENT ME, V13, P195, DOI 10.2174/1871520611313020002; Zuo LL, 2012, INT J MOL SCI, V13, P5506, DOI 10.3390/ijms13055506	37	37	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126725	10.1371/journal.pone.0126725	http://dx.doi.org/10.1371/journal.pone.0126725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978354	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100093
J	Poletti, V; Carri, AD; Tagliazucchi, GM; Faedo, A; Petiti, L; Mazza, EMC; Peano, C; De Bellis, G; Bicciato, S; Miccio, A; Cattaneo, E; Mavilio, F				Poletti, Valentina; Carri, Alessia Delli; Tagliazucchi, Guidantonio Malagoli; Faedo, Andrea; Petiti, Luca; Mazza, Emilia Maria Cristina; Peano, Clelia; De Bellis, Gianluca; Bicciato, Silvio; Miccio, Annarita; Cattaneo, Elena; Mavilio, Fulvio			Genome-Wide Definition of Promoter and Enhancer Usage during Neural Induction of Human Embryonic Stem Cells	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; CHROMATIN; MOUSE; PROTEIN; IDENTIFICATION; METHYLATION; STRATEGIES; DIVERSITY; DISTINCT	Genome-wide mapping of transcriptional regulatory elements is an essential tool for understanding the molecular events orchestrating self-renewal, commitment and differentiation of stem cells. We combined high-throughput identification of transcription start sites with genome-wide profiling of histones modifications to map active promoters and enhancers in embryonic stem cells (ESCs) induced to neuroepithelial-like stem cells (NESCs). Our analysis showed that most promoters are active in both cell types while approximately half of the enhancers are cell-specific and account for most of the epigenetic changes occurring during neural induction, and most likely for the modulation of the promoters to generate cell-specific gene expression programs. Interestingly, the majority of the promoters activated or up-regulated during neural induction have a "bivalent" histone modification signature in ESCs, suggesting that developmentally-regulated promoters are already poised for transcription in ESCs, which are apparently pre-committed to neuroectodermal differentiation. Overall, our study provides a collection of differentially used enhancers, promoters, transcription starts sites, protein-coding and non-coding RNAs in human ESCs and ESC-derived NESCs, and a broad, genome-wide description of promoter and enhancer usage and of gene expression programs characterizing the transition from a pluripotent to a neural-restricted cell fate.	[Poletti, Valentina] Ist Sci San Raffaele, Div Genet & Cell Biol, Milan, Italy; [Poletti, Valentina; Mavilio, Fulvio] Genethon, Evry, France; [Carri, Alessia Delli; Faedo, Andrea; Cattaneo, Elena] Univ Milan, Dept Biosci, Milan, Italy; [Tagliazucchi, Guidantonio Malagoli; Petiti, Luca; Mazza, Emilia Maria Cristina; Bicciato, Silvio; Miccio, Annarita; Mavilio, Fulvio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Peano, Clelia; De Bellis, Gianluca] CNR, Inst Biomed Technol, Milan, Italy; [Miccio, Annarita] Imagine Inst, Paris, France	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Universita di Modena e Reggio Emilia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); UDICE-French Research Universities; Universite Paris Cite	Mavilio, F (corresponding author), Genethon, Evry, France.	fmavilio@genethon.fr	Tagliazucch, Guidantonio Malagoli/E-5026-2018; Bicciato, Silvio/C-9825-2009; Mazza, Emilia Maria Cristina/HHZ-8915-2022; Miccio, Annarita/H-9585-2017; faedo, andrea/AAA-4319-2021; Peano, Clelia/C-4015-2018; Poletti, Venerino/K-8821-2016; De Bellis, Gianluca/H-9725-2013	Tagliazucch, Guidantonio Malagoli/0000-0001-5581-4851; Bicciato, Silvio/0000-0002-1944-7078; Mazza, Emilia Maria Cristina/0000-0003-2424-3640; Miccio, Annarita/0000-0002-3409-9665; Peano, Clelia/0000-0001-7055-3629; CATTANEO, ELENA/0000-0002-0755-4917; Poletti, Venerino/0000-0002-8634-2284; De Bellis, Gianluca/0000-0002-1622-4477; Mavilio, Fulvio/0000-0003-0459-4320; Faedo, Andrea/0000-0002-2227-0656	European Research Council [FM; ERC-2010AdG]; Italian Ministry of Education, University and Research (MIUR) FIRB [AM; RBFR10OS4G]	European Research Council(European Research Council (ERC)European Commission); Italian Ministry of Education, University and Research (MIUR) FIRB(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the European Research Council (FM; ERC-2010AdG, GT-SKIN; URL: http://erc.europa.eu/;), and the Italian Ministry of Education, University and Research (MIUR) FIRB project (AM; RBFR10OS4G; URL:http://futuroinricerca.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bianco C, 2010, AM J PATHOL, V177, P532, DOI 10.2353/ajpath.2010.100102; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Carninci P, 1997, DNA Res, V4, P61, DOI 10.1093/dnares/4.1.61; Carri AD, 2013, STEM CELL REV REP, V9, P461, DOI 10.1007/s12015-013-9441-8; Chan YS, 2013, STEM CELLS, V31, P682, DOI 10.1002/stem.1307; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Hahne JC, 2008, MINI-REV MED CHEM, V8, P1095, DOI 10.2174/138955708785909934; Harmston N, 2013, NUCLEIC ACIDS RES, V41, P7185, DOI 10.1093/nar/gkt499; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacox E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012274; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch P, 2012, AM J PATHOL, V180, P2404, DOI 10.1016/j.ajpath.2012.02.012; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Lai F, 2014, CURR OPIN GENET DEV, V25, P38, DOI 10.1016/j.gde.2013.11.017; Langmead Christopher James, 2009, Journal of Bioinformatics and Computational Biology, V7, P323, DOI 10.1142/S0219720009004084; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; Mousavi K, 2014, RNA BIOL, V11, P106, DOI 10.4161/rna.27950; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nivard MG, 2014, GENES BRAIN BEHAV, V13, P195, DOI 10.1111/gbb.12095; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Plessy C, 2012, GENOME RES, V22, P486, DOI 10.1101/gr.126201.111; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ren B, 2010, NATURE, V465, P173, DOI 10.1038/465173a; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shabalina SA, 2014, NUCLEIC ACIDS RES, V42, P7132, DOI 10.1093/nar/gku342; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Simoes-Costa M, 2014, GENOME RES, V24, P281, DOI 10.1101/gr.161182.113; Stappert L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059011, 10.1371/annotation/b03fbc42-8f70-4873-9cce-854e48249a13]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5; Zhang D, 2007, TEXT RES J, V77, P3, DOI [10.1177/0040517507081409, 10.1177/0033688206076154]; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zwart R, 1996, MECH DEVELOP, V54, P185, DOI 10.1016/0925-4773(95)00472-6	68	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126590	10.1371/journal.pone.0126590	http://dx.doi.org/10.1371/journal.pone.0126590			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978676	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100082
J	Zhu, Z; Puliga, M; Cerina, F; Chessa, A; Riccaboni, M				Zhu, Zhen; Puliga, Michelangelo; Cerina, Federica; Chessa, Alessandro; Riccaboni, Massimo			Global Value Trees	PLOS ONE			English	Article							VALUE CHAINS; PRODUCTION NETWORKS; TRADE; GROWTH	The fragmentation of production across countries has become an important feature of the globalization in recent decades and is often conceptualized by the term "global value chains" (GVCs). When empirically investigating the GVCs, previous studies are mainly interested in knowing how global the GVCs are rather than how the GVCs look like. From a complex networks perspective, we use the World Input-Output Database (WIOD) to study the evolution of the global production system. We find that the industry-level GVCs are indeed not chain-like but are better characterized by the tree topology. Hence, we compute the global value trees (GVTs) for all the industries available in the WIOD. Moreover, we compute an industry importance measure based on the GVTs and compare it with other network centrality measures. Finally, we discuss some future applications of the GVTs.	[Zhu, Zhen; Puliga, Michelangelo; Chessa, Alessandro; Riccaboni, Massimo] IMT Inst Adv Studies Lucca, Lucca, Italy; [Puliga, Michelangelo; Cerina, Federica; Chessa, Alessandro] Complex Syst Computat Lab, Linkalab, Cagliari, Italy; [Cerina, Federica] Univ Cagliari, Dept Phys, Cagliari, Italy; [Riccaboni, Massimo] Katholieke Univ Leuven, Dept Managerial Econ Strategy & Innovat, Leuven, Belgium	IMT School for Advanced Studies Lucca; University of Cagliari; KU Leuven	Zhu, Z (corresponding author), IMT Inst Adv Studies Lucca, Lucca, Italy.	zhen.zhu@imtlucca.it	Zhu, Zhen/AAN-9861-2020; puliga, michelangelo/AAS-9954-2020	Zhu, Zhen/0000-0003-0258-1454; RICCABONI, Massimo/0000-0003-4979-8933	Ministry of Education, Universities and Research (MIUR)-the Basic Research Investment Fund (FIRB) [RBFR12BA3Y]; "ViWaN: The Global Virtual Water Network" project; Future Emerging Technologies (FET) [MULTIPLEX 317532, SIMPOL 610704]; National Research Project (PNR) project CRISIS Lab; Sardinia Regional Government; Linkalab	Ministry of Education, Universities and Research (MIUR)-the Basic Research Investment Fund (FIRB)(Ministry of Education, Universities and Research (MIUR)); "ViWaN: The Global Virtual Water Network" project; Future Emerging Technologies (FET); National Research Project (PNR) project CRISIS Lab; Sardinia Regional Government(Regione Sardegna); Linkalab	MR and ZZ acknowledge funding from the Ministry of Education, Universities and Research (MIUR)-the Basic Research Investment Fund (FIRB) project RBFR12BA3Y and from the "ViWaN: The Global Virtual Water Network" project. All authors acknowledge support from the Future Emerging Technologies (FET) projects MULTIPLEX 317532 and SIMPOL 610704 and the National Research Project (PNR) project CRISIS Lab. FC acknowledges Sardinia Regional Government for the financial support of her PhD scholarship (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013-Axis IV Human Resources, Objective l.3, Line of Activity l.3.1.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Linkalab provided support in the form of salaries for authors MP, FC, and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amador J, 2014, J EC SURV, DOI [10.1111/joes.12097, DOI 10.1111/J0ES.12097]; Antras P, 2012, AM ECON REV, V102, P412, DOI 10.1257/aer.102.3.412; Backer K, 2013, TECHNICAL REPORT; Baldwin R, 2006, TECHNICAL REPORT; Baldwin R., 2014, WORLD EC; Baldwin R, 2013, J INT ECON, V90, P245, DOI 10.1016/j.jinteco.2013.02.005; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Blair P. D., 2009, INPUT OUTPUT ANAL FD, DOI DOI 10.1017/CBO9780511626982; Caldarelli G, 2013, NAT PHYS, V9, P125, DOI 10.1038/nphys2580; Caldarelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047278; Cerina F, 2014, ARXIV14070225; Chessa A, 2013, SCIENCE, V339, P650, DOI 10.1126/science.1227970; Coe NM, 2008, J ECON GEOGR, V8, P271, DOI 10.1093/jeg/lbn002; Coe NM, 2004, T I BRIT GEOGR, V29, P468, DOI 10.1111/j.0020-2754.2004.00142.x; Costinot A, 2013, REV ECON STUD, V80, P109, DOI 10.1093/restud/rds023; D'Agostino G, 2014, UNDERST COMPLEX SYST, pVII; Dedrick J, 2010, IND CORP CHANGE, V19, P81, DOI 10.1093/icc/dtp032; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Feenstra RC, 1999, Q J ECON, V114, P907, DOI 10.1162/003355399556179; Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604; Grossman GA, 2008, AM ECON REV, V98, P1978, DOI 10.1257/aer.98.5.1978; Hummels D, 2001, J INT ECON, V54, P75, DOI 10.1016/S0022-1996(00)00093-3; Johnson RC, 2014, J ECON PERSPECT, V28, P119, DOI 10.1257/jep.28.2.119; Johnson RC, 2012, J INT ECON, V86, P224, DOI 10.1016/j.jinteco.2011.10.003; Kitsak M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036117; Leontief WW, 1936, REV ECON STATISTICS, V18, P105, DOI 10.2307/1927837; Los B., 2014, J REGIONAL SCI; Pammolli F, 2002, SMALL BUS ECON, V19, P205, DOI 10.1023/A:1019682612073; Riccaboni M, 2013, J ECON INTERACT COOR, V8, P33, DOI 10.1007/s11403-012-0101-x; Riccaboni M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/2/023003; Shi PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098247; Sturgeon T, 2008, J ECON GEOGR; Sturgeon TJ, 2001, IDS BULL-I DEV STUD, V32, P9, DOI 10.1111/j.1759-5436.2001.mp32003002.x; Timmer M., 2012, TECHNICAL REPORT; Timmer MP, 2014, J ECON PERSPECT, V28, P99, DOI 10.1257/jep.28.2.99; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105496	36	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126699	10.1371/journal.pone.0126699	http://dx.doi.org/10.1371/journal.pone.0126699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978067	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000354916100091
J	Ansah, JP; Malhotra, R; Lew, N; Chiu, CT; Chan, A; Bayer, S; Matchar, DB				Ansah, John P.; Malhotra, Rahul; Lew, Nicola; Chiu, Chi-Tsun; Chan, Angelique; Bayer, Steffen; Matchar, David B.			Projection of Young-Old and Old-Old with Functional Disability: Does Accounting for the Changing Educational Composition of the Elderly Population Make a Difference?	PLOS ONE			English	Article							HEALTH-CARE EXPENDITURES; SOCIOECONOMIC-STATUS; SERVICE UTILIZATION; PHYSICAL HEALTH; LIFE EXPECTANCY; TRANSITIONS; PREVALENCE; PEOPLE; AGE; CAREGIVERS	This study compares projections, up to year 2040, of young-old (aged 60-79) and old-old (aged 80+) with functional disability in Singapore with and without accounting for the changing educational composition of the Singaporean elderly. Two multi-state population models, with and without accounting for educational composition respectively, were developed, parameterized with age-gender-(education)-specific transition probabilities (between active, functional disability and death states) estimated from two waves (2009 and 2011) of a nationally representative survey of community-dwelling Singaporeans aged >= 60 years (N=4,990). Probabilistic sensitivity analysis with the bootstrap method was used to obtain the 95% confidence interval of the transition probabilities. Not accounting for educational composition overestimated the young-old with functional disability by 65 percent and underestimated the old-old by 20 percent in 2040. Accounting for educational composition, the proportion of old-old with functional disability increased from 40.8 percent in 2000 to 64.4 percent by 2040; not accounting for educational composition, the proportion in 2040 was 49.4 percent. Since the health profiles, and hence care needs, of the old-old differ from those of the young-old, health care service utilization and expenditure and the demand for formal and informal caregiving will be affected, impacting health and long-term care policy.	[Ansah, John P.; Malhotra, Rahul; Lew, Nicola; Chiu, Chi-Tsun; Chan, Angelique; Bayer, Steffen; Matchar, David B.] Duke NUS Grad Med Sch, Signature Program Hlth Serv & Syst Res, Singapore, Singapore; [Chan, Angelique] Natl Univ Singapore, Dept Sociol, Singapore 117548, Singapore; [Matchar, David B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Duke University	Ansah, JP (corresponding author), Duke NUS Grad Med Sch, Signature Program Hlth Serv & Syst Res, Singapore, Singapore.	john.ansah@duke-nus.edu.sg	Matchar, David/M-3951-2019; Malhotra, Rahul/I-7818-2019	Malhotra, Rahul/0000-0002-9978-4276; Bayer, Steffen/0000-0002-7872-467X; ansah, john/0000-0001-9157-4218; Matchar, David/0000-0003-3020-2108	Singapore Ministry of Health's National Medical Research Council under its STaR Award Grant [NMRC\STaR\0005\2009]	Singapore Ministry of Health's National Medical Research Council under its STaR Award Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	This work was supported by the Singapore Ministry of Health's National Medical Research Council under its STaR Award Grant (grant number NMRC vertical bar STaR vertical bar 0005 vertical bar 2009) as part of the project "Establishing a Practical and Theoretical Foundation for Comprehensive and Integrated Community, Policy and Academic Efforts to Improve Dementia Care in Singapore." DM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WL, 2011, J DISABIL POLICY STU, V21, P230, DOI 10.1177/1044207310391407; Arksey H, 2008, SOC POLICY ADMIN, V42, P1, DOI 10.1111/j.1467-9515.2007.00587.x; Berlau DJ, 2009, INT J GERIATR PSYCH, V24, P1217, DOI 10.1002/gps.2248; Bharmal MF, 2012, AM J GERIAT PSYCHIAT, V20, P73, DOI 10.1097/JGP.0b013e318209dce4; Bolin K, 2008, J HEALTH ECON, V27, P718, DOI 10.1016/j.jhealeco.2007.10.004; Boscoe FP, 2008, AM J PUBLIC HEALTH, V98, P1167, DOI 10.2105/AJPH.2008.133900; Chou KL, 2005, INT J GERIATR PSYCH, V20, P41, DOI 10.1002/gps.1246; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Corrada MM, 2010, ANN NEUROL, V67, P114, DOI 10.1002/ana.21915; CRIMMINS EM, 1993, J ING HLTH, V0005; Cummins RA, 2001, J INTELLECT DEV DIS, V26, P83, DOI 10.1080/13668250020032787; de Meijer C, 2011, J HEALTH ECON, V30, P425, DOI 10.1016/j.jhealeco.2010.12.010; Department of Statistics Singapore, STAT LAT DAT; FIELD D, 1988, J GERONTOL, V43, pP100, DOI 10.1093/geronj/43.4.P100; Finlayson M, 2002, GERONTOLOGIST, V42, P443, DOI 10.1093/geront/42.4.443; Freedman VA, 1999, DEMOGRAPHY, V36, P461, DOI 10.2307/2648084; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; Galenkamp H, 2013, J GERONTOLOGY B; GERDTHAM UG, 1993, HEALTH POLICY, V24, P1, DOI 10.1016/0168-8510(93)90083-2; Giles LC, 2003, MED J AUSTRALIA, V179, P130, DOI 10.5694/j.1326-5377.2003.tb05470.x; Gonzalez-Gonzalez C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-192; Grundy E, 2000, AGE AGEING, V29, P149, DOI 10.1093/ageing/29.2.149; Hidajat MM, 2007, POPUL RES POLICY REV, V26, P219, DOI 10.1007/s11113-007-9025-x; Jacobs JM, 2012, GERONTOLOGY, V58, P313, DOI 10.1159/000335238; Jagger C, 2007, INT J EPIDEMIOL, V36, P358, DOI 10.1093/ije/dyl307; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Kaneda T, 2007, J CROSS-CULT GERONTO, V22, P303, DOI 10.1007/s10823-007-9041-7; KUNKEL SR, 1992, J GERONTOL, V47, pS253, DOI 10.1093/geronj/47.5.S253; Lau RS, 2012, ASIA-PAC J PUBLIC HE, V24, P195, DOI 10.1177/1010539510376663; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Lee W K, 1999, J Aging Soc Policy, V10, P73; Lim V., 2003, EMPL RELAT, V25, P330, DOI [10.1108/0142545031048336, DOI 10.1108/01425450310483361]; Lim YH., 2014, MYPAPER         0117; Liu K, 2000, J GERONTOL B-PSYCHOL, V55, pS245, DOI 10.1093/geronb/55.4.S245; Lubitz J, 2001, HEALTH AFFAIR, V20, P19, DOI 10.1377/hlthaff.20.2.19; Lutz W., 2014, WORLD POPULATION HUM; Lynch SM, 2009, INT HDB POPULATION A; Malhotra R, 2010, HYPERTENS RES, V33, P1223, DOI 10.1038/hr.2010.177; MANTON KG, 1985, MILBANK FUND Q, V63, P206, DOI 10.2307/3349881; Melzer D, 2001, J GERONTOL B-PSYCHOL, V56, pS294, DOI 10.1093/geronb/56.5.S294; Metti AL, 2014, J AM GERIATR SOC, V62, P662, DOI 10.1111/jgs.12739; Ministry of Education Singapore, OUR ED SYST; MORROWHOWELL N, 1987, GERONTOLOGIST, V27, P17, DOI 10.1093/geront/27.1.17; MULLINS LC, 1982, DEATH EDUC, V6, P75, DOI 10.1080/07481188208252117; Nie JX, 2008, J EVAL CLIN PRACT, V14, P1044, DOI 10.1111/j.1365-2753.2008.00952.x; Nie JX, 2010, J EVAL CLIN PRACT, V16, P825, DOI 10.1111/j.1365-2753.2009.01218.x; NPTD Singstat MHA ICA, 2013, POP BRIEF 2013; Nuttall SR, 1994, J I ACTUARIES, V121, P1, DOI DOI 10.1017/S0020268100020084; Paganini-Hill A, 2013, J HOUS ELDER, V27, P191, DOI 10.1080/02763893.2012.754822; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P3166, DOI 10.1167/iovs.10-6210; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126, DOI 10.1093/geronb/62.2.P126; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rickayzen B.D., 2002, BRIT ACTUARIAL J, V8, P341, DOI [DOI 10.1017/S1357321700003755, 10.1017/S1357321700003755]; Sakari R, 2013, MOBILITY ITS DECLINE; Samir KC, 2010, VIENNA YB POPUL RES, V8, P201, DOI DOI 10.1553/POPULATIONYEARBOOK2010S201; SAW SH, 1986, J BIOSOC SCI, V18, P395; SOLDO BJ, 1985, MILBANK FUND Q, V63, P286, DOI 10.2307/3349882; Spillman BC, 2004, MILBANK Q, V82, P157, DOI 10.1111/j.0887-378X.2004.00305.x; Spillman BC, 2000, MILBANK Q, V78, P347, DOI 10.1111/1468-0009.00177; Sulander T, 2006, INT J EPIDEMIOL, V35, P1255, DOI 10.1093/ije/dyl183; Taylor MG, 2010, J GERONTOL B-PSYCHOL, V65, P733, DOI 10.1093/geronb/gbq018; TEO P, 1994, AGEING SOC, V14, P405, DOI 10.1017/S0144686X00001653; Thompson JP, 2014, SYST RES BEHAV SCI, V31, P227, DOI 10.1002/sres.2202; United Nations, ESAPWP228 UN; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33; Vilpert S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-344; Vogelsang EM, 2014, THE JOURNALS OF GERO; Wen WK, 2013, J FUTURES STUD, V17, P81; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Wittenberg R., 1998, DEMAND LONG TERM CAR; Wu CY, 2013, ARCH GERONTOL GERIAT, V57, P177, DOI 10.1016/j.archger.2013.04.011; Yaffe K, 2011, ARCH NEUROL-CHICAGO, V68, P631, DOI 10.1001/archneurol.2011.82; Yang Z, 2003, J GERONTOL B-PSYCHOL, V58, pS2, DOI 10.1093/geronb/58.1.S2; Yong V, 2012, J GERONTOL B-PSYCHOL, V67, P343, DOI 10.1093/geronb/gbs029; Zimmer Z, 1998, DEMOGRAPHY, V35, P361, DOI 10.2307/3004043; Zimmer Z, 2003, INT J EPIDEMIOL, V32, P1089, DOI 10.1093/ije/dyg254	79	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126471	10.1371/journal.pone.0126471	http://dx.doi.org/10.1371/journal.pone.0126471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25974069	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600053
J	Chen, SZ; Zhu, YF; Liu, ZF; Gao, ZY; Li, BY; Zhang, DQ; Zhang, ZC; Jiang, XW; Liu, ZF; Meng, LQ; Yang, Y; Shi, BK				Chen, Shouzhen; Zhu, Yaofeng; Liu, Zhifeng; Gao, Zhaoyun; Li, Baoying; Zhang, Dongqing; Zhang, Zhaocun; Jiang, Xuewen; Liu, Zhengfang; Meng, Lingquan; Yang, Yue; Shi, Benkang			Grape Seed Proanthocyanidin Extract Ameliorates Diabetic Bladder Dysfunction via the Activation of the Nrf2 Pathway	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; OXIDATIVE STRESS; APOPTOSIS; CYSTOPATHY; MUSCLE; CONTRACTILE; BERBERINE; PROTECTS; DECREASE; RECEPTOR	Diabetes Mellitus (DM)-induced bladder dysfunction is predominantly due to the long-term oxidative stress caused by hyperglycemia. Grape seed proanthocyanidin extract (GSPE) has been reported to possess a broad spectrum of pharmacological and therapeutic properties against oxidative stress. However, its protective effects against diabetic bladder dysfunction have not been clarified. This study focuses on the effects of GSPE on bladder dysfunction in diabetic rats induced by streptozotocin. After 8 weeks of GSPE administration, the bladder function of the diabetic rats was improved significantly, as indicated by both urodynamics analysis and histopathological manifestation. Moreover, the disordered activities of antioxidant enzymes (SOD and GSH-Px) and abnormal oxidative stress levels were partly reversed by treatment with GSPE. Furthermore, the level of apoptosis in the bladder caused by DM was decreased following the administration of GSPE according to the Terminal Deoxynucleotidyl Transferase (TdT)-mediated dUTP Nick-End Labeling (TUNEL) assay. Additionally, GSPE affected the expression of apoptosis-related proteins such as Bax, Bcl-2 and cleaved caspase-3. Furthermore, GSPE showed neuroprotective effects on the bladder of diabetic rats, as shown by the increased expression of nerve growth factor (NGF) and decreased expression of the precursor of nerve growth factor (proNGF). GSPE also activated nuclear erythroid2-related factor2 (Nrf2), which is a key antioxidative transcription factor, with the concomitant elevation of downstream hemeoxygenase-1 (HO-1). These findings suggested that GSPE could ameliorate diabetic bladder dysfunction and decrease the apoptosis of the bladder in diabetic rats, a finding that may be associated with its antioxidant activity and ability to activate the Nrf2 defense pathway.	[Chen, Shouzhen; Zhu, Yaofeng; Liu, Zhifeng; Zhang, Dongqing; Zhang, Zhaocun; Jiang, Xuewen; Liu, Zhengfang; Meng, Lingquan; Yang, Yue; Shi, Benkang] Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China; [Liu, Zhifeng] Cent Hosp Taian, Dept Urol, Tai An, Shandong, Peoples R China; [Gao, Zhaoyun] Peoples Hosp Yinan Cty, Dept Urol, Yinan, Shandong, Peoples R China; [Li, Baoying] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Shi, BK (corresponding author), Shandong Univ, Qilu Hosp, Dept Urol, Wenhua Xi Rd, Jinan 250100, Shandong, Peoples R China.	benkangshi@126.com		liu, zhifeng/0000-0001-5124-9824	National Natural Science Foundation of China [81470987, 81170702]; Science and Technology Development Project of Shandong Province [2014GSF118054]; Natural Science Foundation of Shandong Province [ZR2014HQ062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	The work was supported by the following: 1. National Natural Science Foundation of China (Grant 81470987 to B. Shi and Y. Zhu; Grant 81170702 to B. Shi) http://www.nsfc.gov.cn/; 2. Science and Technology Development Project of Shandong Province (Grant 2014GSF118054 to B. Shi) http://jihlx.sdstc.gov.cn/STDPMS/GG/Default.aspx; and 3. Natural Science Foundation of Shandong Province (Grant ZR2014HQ062 to Y. Zhu) http://www.sdnsf.gov.cn/portal/.	Ali TK, 2011, DIABETOLOGIA, V54, P657, DOI 10.1007/s00125-010-1935-1; Arrellano-Valdez F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-549; Bagchi D, 1997, RES COMMUN MOL PATH, V95, P179; Changolkar AK, 2005, J UROLOGY, V173, P309, DOI 10.1097/01.ju.0000141583.31183.7a; Chen SZ, 2014, UROL INT, V93, P344, DOI 10.1159/000355711; Chowdhury SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113663; Cu XP, 2008, J NUTR SCI VITAMINOL, V54, P321; Daneshgari F, 2009, J UROLOGY, V182, pS18, DOI 10.1016/j.juro.2009.08.070; Devi SA, 2011, EXP GERONTOL, V46, P958, DOI 10.1016/j.exger.2011.08.006; Ferreira D, 2000, NAT PROD REP, V17, P193, DOI 10.1039/a705728h; FRIMODTMOLLER C, 1978, DAN MED BULL, V25, P49; Gao ZL, 2014, MOL MED REP, V9, P801, DOI 10.3892/mmr.2014.1883; Geetha T, 2013, J BIOL CHEM, V288, P23807, DOI 10.1074/jbc.M112.436279; Ha US, 2013, NEUROUROL URODYNAM, V32, P493, DOI 10.1002/nau.22334; Hsu YY, 2013, TOXICOL APPL PHARM, V272, P787, DOI 10.1016/j.taap.2013.08.008; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Jiang X, 2014, TOXICOL APPL PHARM, V279, P198, DOI 10.1016/j.taap.2014.06.009; Kanika ND, 2011, BJU INT, V107, P1676, DOI 10.1111/j.1464-410X.2010.09655.x; Kaplan S A, 1988, J Diabet Complications, V2, P133, DOI 10.1016/S0891-6632(88)80024-2; Kirschner-Hermanns R, 2012, NEUROUROL URODYNAM, V31, P359, DOI 10.1002/nau.22228; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kumar Subash V, 2013, J Nat Sci Biol Med, V4, P57, DOI 10.4103/0976-9668.107261; Langdale CL, 2014, AUTON NEUROSCI-BASIC, V185, P59, DOI 10.1016/j.autneu.2014.06.007; Li J, 2010, AM J CHINESE MED, V38, P569, DOI 10.1142/S0192415X10008068; Li WJ, 2010, NEUROUROL URODYNAM, V29, P1332, DOI 10.1002/nau.20869; Li YZ, 2011, INT UROL NEPHROL, V43, P109, DOI 10.1007/s11255-010-9747-2; Liu CM, 2013, J AGR FOOD CHEM, V61, P1146, DOI 10.1021/jf304562b; Liu GM, 2014, CHINESE MED J-PEKING, V127, P1357, DOI 10.3760/cma.j.issn.0366-6999.20132407; Liu P, 2011, J ALZHEIMERS DIS, V26, P657, DOI 10.3233/JAD-2011-110383; Lu M, 2010, J NUTR SCI VITAMINOL, V56, P87, DOI 10.3177/jnsv.56.87; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Mimura J, 2011, J BIOCHEM, V150, P209, DOI 10.1093/jb/mvr065; Moller C F, 1976, Dan Med Bull, V23, P291; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Ren LM, 2013, J ETHNOPHARMACOL, V150, P1128, DOI 10.1016/j.jep.2013.10.039; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Sasaki K, 2002, J UROLOGY, V168, P1259, DOI 10.1016/S0022-5347(05)64636-8; Sato M, 2001, FREE RADICAL BIO MED, V31, P729, DOI 10.1016/S0891-5849(01)00626-8; Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5; Song Q, 2014, J ORTHOP SCI; Su L, 2011, TOXICOL MECH METHOD, V21, P487, DOI 10.3109/15376516.2011.556156; Fasulo CTL, 2013, CELL DEATH DIFFER, V20, P1017, DOI 10.1038/cdd.2013.22; Torimoto K, 2005, J UROLOGY, V173, P1027, DOI 10.1097/01.ju.0000146268.45662.36; Ulusoy S, 2014, LIFE SCI, V103, P101, DOI 10.1016/j.lfs.2014.03.030; Ulusoy S, 2013, AM J NEPHROL, V38, P368, DOI 10.1159/000355537; Ustuner MC, 2010, UROLOGY, V75, P902, DOI 10.1016/j.urology.2009.06.003; Vinson JA, 2002, MOL CELL BIOCHEM, V240, P99, DOI 10.1023/A:1020611925819; Wang D, 2010, INT UROL NEPHROL, V42, P401, DOI 10.1007/s11255-009-9610-5; Whitman SA, 2013, EXP CELL RES, V319, P2673, DOI 10.1016/j.yexcr.2013.07.015; Yu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052541; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003	53	29	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126457	10.1371/journal.pone.0126457	http://dx.doi.org/10.1371/journal.pone.0126457			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974036	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600052
J	Fadini, RF; Cintra, R				Fadini, Rodrigo F.; Cintra, Renato			Modeling Occupancy of Hosts by Mistletoe Seeds after Accounting for Imperfect Detectability	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; METAPOPULATION DYNAMICS; EPIPHYTE METAPOPULATION; PARAMETER-ESTIMATION; DEPOSITION PATTERNS; AMAZONIAN SAVANNA; NATIONAL-FOREST; DISPERSAL; INFERENCE; COLONIZATION	The detection of an organism in a given site is widely used as a state variable in many meta-population and epidemiological studies. However, failure to detect the species does not necessarily mean that it is absent. Assessing detectability is important for occupancy (presence-absence) surveys; and identifying the factors reducing detectability may help improve survey precision and efficiency. A method was used to estimate the occupancy status of host trees colonized by mistletoe seeds of Psittacanthus plagiophyllus as a function of host co-variates: host size and presence of mistletoe infections on the same or on the nearest neighboring host (the cashew tree Anacardium occidentale). The technique also evaluated the effect of taking detectability into account for estimating host occupancy by mistletoe seeds. Individual host trees were surveyed for presence of mistletoe seeds with the aid of two or three observers to estimate detectability and occupancy. Detectability was, on average, 17% higher in focal-host trees with infected neighbors, while decreased about 23 to 50% from smallest to largest hosts. The presence of mistletoe plants in the sample tree had negligible effect on detectability. Failure to detect hosts as occupied decreased occupancy by 2.5% on average, with maximum of 10% for large and isolated hosts. The method presented in this study has potential for use with metapopulation studies of mistletoes, especially those focusing on the seed stage, but also as improvement of accuracy in occupancy models estimates often used for metapopulation dynamics of tree-dwelling plants in general.	[Fadini, Rodrigo F.] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, BR-69067375 Manaus, Amazonas, Brazil; [Cintra, Renato] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, BR-69067375 Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Fadini, RF (corresponding author), Univ Fed Oeste, Inst Biodiversidade & Florestas, Rua Vera Paz, BR-68035110 Santarem, PA, Brazil.	rodrigo.fadini@ufopa.edu.br	Fadini, Rodrigo/C-7574-2013	Fadini, Rodrigo/0000-0002-6873-1438	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Edital Universal [479130/2006-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - fellowship; Instituto Internacional de Educacao do Brasil - IEB - Programa BECA - fellowship [B/2007/01/DEP/07]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Edital Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - fellowship; Instituto Internacional de Educacao do Brasil - IEB - Programa BECA - fellowship	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) - Edital Universal - grant Number 479130/2006-0. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (capes.gov.br) - fellowship to RF. Instituto Internacional de Educacao do Brasil - IEB - Programa BECA - fellowship to RF - number B/2007/01/DEP/07 - http://www.iieb.org.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukema JE, 2003, FRONT ECOL ENVIRON, V1, P212, DOI 10.1890/1540-9295(2003)001[0212:VVAVMA]2.0.CO;2; Aukema JE, 2002, ECOLOGY, V83, P3489, DOI 10.1890/0012-9658(2002)083[3489:WDAFEB]2.0.CO;2; Aukema JE, 2002, ECOGRAPHY, V25, P139, DOI 10.1034/j.1600-0587.2002.250202.x; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cintra R, 1997, STUD NEOTROP FAUNA E, V32, P17, DOI 10.1076/snfe.32.1.17.13459; Daugherty CM, 2003, WEST N AM NATURALIST, V63, P382; DelRio CM, 1996, ECOLOGY, V77, P912, DOI 10.2307/2265511; Fadini RF, 2012, BIOTROPICA, V44, P27, DOI 10.1111/j.1744-7429.2011.00773.x; Fadini RF, 2011, ACTA BOT BRAS, V25, P337, DOI 10.1590/S0102-33062011000200010; Fadini RF, 2009, AUST J BOT, V57, P640, DOI 10.1071/BT09013; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; GEILS BW, 1990, FOREST SCI, V36, P955; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guerra TJ, 2014, BIOTROPICA, V46, P285, DOI 10.1111/btp.12112; Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; HELLER RC, 1973, J FOREST, V71, P18; Hines JE., 2006, PRESENCESOFTWARE EST; Johansson V, 2012, ECOLOGY, V93, P235, DOI 10.1890/11-0760.1; Kery M, 2003, J ECOL, V91, P265, DOI 10.1046/j.1365-2745.2003.00759.x; Kuijt J., 2009, MONOGRAPH PSITTACANT, P361; Laine AL, 2005, J EVOLUTION BIOL, V18, P930, DOI 10.1111/j.1420-9101.2005.00933.x; Lobel S, 2006, J ECOL, V94, P856, DOI 10.1111/j.1365-2745.2006.01114.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacKenzie DI, 2006, OCCUPANCY ESTIMATION, P344; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Mathiasen RL, 1996, GREAT BASIN NAT, V56, P129; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCarthy MA, 2013, OIKOS, V122, P717, DOI 10.1111/j.1600-0706.2012.20781.x; Mccullagh P., 1989, GEN LINEAR MODELS, P532, DOI DOI 10.1007/978-1-4899-3242-6; Medel R, 2004, ECOLOGY, V85, P120, DOI 10.1890/03-0261; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Moilanen A, 1999, ECOLOGY, V80, P1031, DOI 10.1890/0012-9658(1999)080[1031:POMOMD]2.0.CO;2; MONTEIRO RF, 1992, J TROP ECOL, V8, P307, DOI 10.1017/S026646740000657X; Muir J. A., 2002, General Technical Report - Rocky Mountain Research Station, USDA Forest Service, P67; OVERTON JM, 1994, J ECOL, V82, P711, DOI 10.2307/2261437; Rawsthorne J, 2012, J AVIAN BIOL, V43, P9, DOI 10.1111/j.1600-048X.2011.05515.x; Roxburgh L, 2005, FUNCT ECOL, V19, P865, DOI 10.1111/j.1365-2435.2005.01036.x; Roxburgh L, 2008, PLANT ECOL, V195, P21, DOI 10.1007/s11258-007-9295-8; Royle JA, 2005, OIKOS, V110, P353, DOI 10.1111/j.0030-1299.2005.13534.x; Shaw David, 2000, Western Journal of Applied Forestry, V15, P8; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Teodoro GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065836; ter Braak CJF, 1998, ENVIRONM INTELL UNIT, P167; Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; Ward MJ, 2007, AUSTRAL ECOL, V32, P113, DOI 10.1111/j.1442-9993.2006.01668.x; Zartman CE, 2012, J ECOL, V100, P980, DOI 10.1111/j.1365-2745.2012.01969.x	53	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127004	10.1371/journal.pone.0127004	http://dx.doi.org/10.1371/journal.pone.0127004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973754	Green Published, gold			2022-12-27	WOS:000354545600095
J	Kilby, MC; Molenaar, PCM; Newell, KM				Kilby, Melissa C.; Molenaar, Peter C. M.; Newell, Karl M.			Models of Postural Control: Shared Variance in Joint and COM Motions	PLOS ONE			English	Article							INVERTED PENDULUM MODEL; CENTER-OF-MASS; QUIET STANCE; LEG STANCE; ANKLE; BALANCE; HIP; STRATEGIES; STABILITY; SELECTION	This paper investigated the organization of the postural control system in human upright stance. To this aim the shared variance between joint and 3D total body center of mass (COM) motions was analyzed using multivariate canonical correlation analysis (CCA). The CCA was performed as a function of established models of postural control that varied in their joint degrees of freedom (DOF), namely, an inverted pendulum ankle model (2DOF), ankle-hip model (4DOF), ankle-knee-hip model (5DOF), and ankle-knee-hip-neck model (7DOF). Healthy young adults performed various postural tasks (two-leg and one-leg quiet stances, voluntary AP and ML sway) on a foam and rigid surface of support. Based on CCA model selection procedures, the amount of shared variance between joint and 3D COM motions and the cross-loading patterns we provide direct evidence of the contribution of multi-DOF postural control mechanisms to human balance. The direct model fitting of CCA showed that incrementing the DOFs in the model through to 7DOF was associated with progressively enhanced shared variance with COM motion. In the 7DOF model, the first canonical function revealed more active involvement of all joints during more challenging one leg stances and dynamic posture tasks. Furthermore, the shared variance was enhanced during the dynamic posture conditions, consistent with a reduction of dimension. This set of outcomes shows directly the degeneracy of multivariate joint regulation in postural control that is influenced by stance and surface of support conditions.	[Kilby, Melissa C.; Newell, Karl M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Molenaar, Peter C. M.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; [Kilby, Melissa C.; Newell, Karl M.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia	Kilby, MC (corresponding author), Penn State Univ, Dept Kinesiol, 23 Recreat Bldg, University Pk, PA 16802 USA.	mck18@uga.edu						Accornero N, 1997, ELECTROMYOGR MOTOR C, V105, P213, DOI 10.1016/S0924-980X(97)96567-X; Alexandrov AV, 2005, BIOL CYBERN, V93, P309, DOI [10.1007/s00422-005-0004-1, 10.1007/s00422-005-0004-l]; AlKandari NM, 1997, COMMUN STAT-SIMUL C, V26, P873, DOI 10.1080/03610919708813416; Aramaki Y, 2001, EXP BRAIN RES, V136, P463, DOI 10.1007/s002210000603; Bardy BG, 1999, J EXP PSYCHOL HUMAN, V25, P1284, DOI 10.1037/0096-1523.25.5.1284; Batschelet E, 1981, CIRCULAR STAT BIOL; Bernstein NA., 1967, COORDINATION REGULAT; Brillinger D. R., 1975, TIME SERIES DATA ANA; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; Di Giulio I, 2013, J APPL PHYSIOL, V114, P1717, DOI 10.1152/japplphysiol.01299.2012; Federolf P, 2013, J BIOMECH, V46, P2626, DOI 10.1016/j.jbiomech.2013.08.008; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; Haibach PS, 2007, EXP BRAIN RES, V177, P471, DOI 10.1007/s00221-006-0703-4; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hettich G, 2014, HUM MOVEMENT SCI, V37, P123, DOI 10.1016/j.humov.2014.07.004; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Iqbal K, 2000, J BIOMECH, V33, P1619, DOI 10.1016/S0021-9290(00)00129-9; Johnson RA., 2007, APPL MULTIVARIATE ST; Kennedy MW, 2014, GAIT POSTURE, V40, P134, DOI 10.1016/j.gaitpost.2014.03.011; Kilby MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108905; Ko JH, 2013, EXP BRAIN RES, V226, P183, DOI 10.1007/s00221-013-3424-5; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Kuznetsov NA, 2012, J MOTOR BEHAV, V44, P241, DOI 10.1080/00222895.2012.688894; Lakie M, 2006, J PHYSIOL-LONDON, V577, P403, DOI 10.1113/jphysiol.2006.116772; Masani K, 2006, GAIT POSTURE, V23, P164, DOI 10.1016/j.gaitpost.2005.01.006; MURRAY MP, 1975, J BONE JOINT SURG AM, VA 57, P510, DOI 10.2106/00004623-197557040-00012; Noble R, 2004, ENVIRONMETRICS, V15, P291, DOI 10.1002/env.641; Park E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041583; Pinter IJ, 2008, J NEUROPHYSIOL, V100, P3197, DOI 10.1152/jn.01312.2007; Qu XD, 2012, COMPUT METHOD BIOMEC, V15, P1053, DOI 10.1080/10255842.2011.570339; Riemann BL, 2003, ARCH PHYS MED REHAB, V84, P90, DOI 10.1053/apmr.2003.50004; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; de Freitas SMSF, 2010, J BIOMECH, V43, P775, DOI 10.1016/j.jbiomech.2009.10.033; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Sternad D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000751; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Wang Z, 2014, GAIT POSTURE, V39, P909, DOI 10.1016/j.gaitpost.2013.11.017; Wang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106078; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334	44	30	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126379	10.1371/journal.pone.0126379	http://dx.doi.org/10.1371/journal.pone.0126379			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973896	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600049
J	Shang, WF; Ning, Y; Xu, X; Li, ML; Guo, SM; Han, M; Zeng, R; Ge, SW; Xu, G				Shang, Weifeng; Ning, Yong; Xu, Xiu; Li, Menglan; Guo, Shuiming; Han, Min; Zeng, Rui; Ge, Shuwang; Xu, Gang			Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; WEGENERS-GRANULOMATOSIS; FOLLOW-UP; RISK; CYCLOPHOSPHAMIDE; POLYANGIITIS; MALIGNANCIES; LYMPHOMA; DISEASES; THERAPY	Objective The purpose of this paper is to examine cancer incidence in patients with ANCA-associated vasculitis (AASV) derived from population-based cohort studies by means of meta-analysis. Methods Relevant electronic databases were searched for studies characterizing the associated risk of overall malignancy in patients with AASV. Standardized incidence rates (SIRs) with 95% confidence intervals (CIs) were used to evaluate the strength of association. We tested for publication bias and heterogeneity and stratified for site-specific cancers. Results Six studies (n = 2,578) were eventually identified, of which six provided the SIR for overall malignancy, five reported the SIR for non-melanoma skin cancer (NMSC), four for leukemia, five for bladder cancer, three for lymphoma, three for liver cancer, four for lung cancer, three for kidney cancer, four for prostate cancer, four for colon cancer and four for breast cancer. Overall, the pooled SIR of cancer in AASV patients was 1.74 (95% CI = 1.37-2.21), with moderate heterogeneity among these studies (I-2 = 65.8%, P = 0.012). In sub-analyses for site-specific cancers, NMSC, leukemia and bladder cancer were more frequently observed in patients with AASV with SIR of 5.18 (95% CI = 3.47-7.73), 4.89 (95% CI = 2.93-8.16) and 3.84 (95% CI = 2.72-5.42) respectively. There was no significant increase in the risk of kidney cancer (SIR = 2.12, 95% CI = 0.66-6.85), prostate cancer (SIR = 1.45, 95% CI = 0.87-2.42), colon cancer (SIR = 1.26, 95% CI = 0.70-2.27), and breast cancer (SIR = 0.95, 95% CI = 0.50-1.79). Among these site-specific cancers, only NMSC showed moderate heterogeneity (I-2 = 55.8%, P = 0.06). No publication bias was found by using the Begg's test and Egger's test. Conclusions This meta-analysis shows that AASV patients treatment with cyclophosphamide (CYC) are at increased risk of late-occurring malignancies, particularly of the NMSC, leukemia and bladder cancer. However, there is no significant association between AASV and kidney cancer, prostate cancer, colon cancer and breast cancer. These findings emphasize monitoring and preventative management in AASV patients after cessation of CYC therapy is momentous.	[Shang, Weifeng; Ning, Yong; Xu, Xiu; Li, Menglan; Guo, Shuiming; Han, Min; Zeng, Rui; Ge, Shuwang; Xu, Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan, Hunan, Peoples R China	Huazhong University of Science & Technology	Ge, SW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan, Hunan, Peoples R China.	geshuwang@tjh.tjmu.edu.cn; xugang@tjh.tjmu.edu.cn	Zeng, RUI/AAF-7238-2019; Zeng, Rui/GRY-0646-2022	Zeng, Rui/0000-0003-1188-3198	National Nature Science Foundation of China (NSFC) [81200531, 81470948, 81270770]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (NSFC) (No. 81200531 for Shuwang Ge; No. 81470948 and 81270770 for Gang Xu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berden A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e26; Bosch X, 2007, JAMA-J AM MED ASSOC, V298, P655, DOI 10.1001/jama.298.6.655; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FAUCI AS, 1983, ANN INTERN MED, V98, P76, DOI 10.7326/0003-4819-98-1-76; Faurschou M, 2008, J RHEUMATOL, V35, P100; Flossmann O, 2011, ANN RHEUM DIS, V70, P488, DOI 10.1136/ard.2010.137778; Fortin Paul R., 1996, Current Opinion in Rheumatology, V8, P30, DOI 10.1097/00002281-199601000-00005; Heijl C, 2011, ANN RHEUM DIS, V70, P1415, DOI 10.1136/ard.2010.145250; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Holle JU, 2011, ARTHRITIS RHEUM-US, V63, P257, DOI 10.1002/art.27763; Ioannidis JPA, 2014, ANN ONCOL, V25, P16, DOI 10.1093/annonc/mdt372; Jennette JC, 2013, ANNU REV PATHOL-MECH, V8, P139, DOI 10.1146/annurev-pathol-011811-132453; Keogh KA, 2006, AM J RESP CRIT CARE, V173, P180, DOI 10.1164/rccm.200507-1144OC; Knight A, 2002, INT J CANCER, V100, P82, DOI 10.1002/ijc.10444; Le Guenno G, 2011, ARTHRITIS RHEUM-US, V63, P1435, DOI 10.1002/art.30296; Mahr A, 2013, BEST PRACT RES CL RH, V27, P45, DOI 10.1016/j.berh.2012.12.003; MANTEL N, 1959, J NATL CANCER I, V22, P719; Monach PA, 2010, ARTHRITIS RHEUM-US, V62, P9, DOI 10.1002/art.25061; Nath R, 2007, ARTHRIT RHEUM-ARTHR, V57, P619, DOI 10.1002/art.22667; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; PEDERSENBJERGAARD J, 1987, LANCET, V2, P83, DOI 10.1016/S0140-6736(87)92744-9; Roussou M, 2008, UROLOGY, V71, DOI 10.1016/j.urology.2007.11.046; Scott DGI, 2013, CLIN EXP NEPHROL, V17, P607, DOI 10.1007/s10157-013-0830-8; Silva F, 2011, ARTHRITIS RHEUM-US, V63, P2495, DOI 10.1002/art.30394; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TalarWilliams C, 1996, ANN INTERN MED, V124, P477, DOI 10.7326/0003-4819-124-5-199603010-00003; Westman KWA, 1998, J AM SOC NEPHROL, V9, P842; Weyand CM, 2006, ARTHRITIS RHEUM, V54, P685, DOI 10.1002/art.21674; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337; Zycinska K, 2013, ADV EXP MED BIOL, V788, P349, DOI 10.1007/978-94-007-6627-3_47	34	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126016	10.1371/journal.pone.0126016	http://dx.doi.org/10.1371/journal.pone.0126016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973882	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600037
J	Zaveska Drabkova, L; Dobrev, PI; Motyka, V				Zaveska Drabkova, Lenka; Dobrev, Petre I.; Motyka, Vaclav			Phytohormone Profiling across the Bryophytes	PLOS ONE			English	Article							PLANT-GROWTH REGULATORS; AUXIN METABOLISM; EVOLUTIONARY PATTERNS; PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; CYTOKININS; LAND; PHYLOGENY; MOSSES; MITOCHONDRIAL	Background Bryophytes represent a very diverse group of non-vascular plants such as mosses, liver-worts and hornworts and the oldest extant lineage of land plants. Determination of endogenous phytohormone profiles in bryophytes can provide substantial information about early land plant evolution. In this study, we screened thirty bryophyte species including six liver-worts and twenty-four mosses for their phytohormone profiles in order to relate the hormo-nome with phylogeny in the plant kingdom. Methodology Samples belonging to nine orders (Pelliales, Jungermanniales, Porellales, Sphagnales, Tetraphidales, Polytrichales, Dicranales, Bryales, Hypnales) were collected in Central and Northern Bohemia. The phytohormone content was analysed with a high performance liquid chromatography electrospray tandem-mass spectrometry (HPLC-ESI-MS/MS). Principal Findings As revealed for growth hormones, some common traits such as weak conjugation of both cytokinins and auxins, intensive production of cisZ-type cytokinins and strong oxidative degradation of auxins with abundance of a major primary catabolite 2-oxindole-3-acetic acid were pronounced in all bryophytes. Whereas apparent dissimilarities in growth hormones profiles between liverworts and mosses were evident, no obvious trends in stress hormone levels (abscisic acid, jasmonic acid, salicylic acid) were found with respect to the phylogeny. Conclusion The apparent differences in conjugation and/or degradation strategies of growth hormones between liverworts and mosses might potentially show a hidden link between vascular plants and liverworts. On the other hand, the complement of stress hormones in bryophytes probably correlate rather with prevailing environmental conditions and plant survival strategy than with plant evolution.	[Zaveska Drabkova, Lenka] Acad Sci Czech Republ, Inst Bot, Dept Taxon, CS-25243 Pruhonice, Czech Republic; [Dobrev, Petre I.; Motyka, Vaclav] Acad Sci Czech Republ, Inst Expt Bot, Lab Hormonal Regulat Plants, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Motyka, V (corresponding author), Acad Sci Czech Republ, Inst Expt Bot, Lab Hormonal Regulat Plants, Prague, Czech Republic.	vmotyka@ueb.cas.cz	Motyka, Vaclav/F-6115-2014; Drabkova, Lenka Zaveska/F-6999-2012	Motyka, Vaclav/0000-0001-7878-7788; Drabkova, Lenka Zaveska/0000-0003-1140-6607	Czech Science Foundation [P506/11/0774]	Czech Science Foundation(Grant Agency of the Czech Republic)	This research was supported by the Czech Science Foundation (P506/11/0774), PI Vaclav Motyka, CoPI Lenka Zaveska Drabkova.	Adam KP, 1996, ARCH BIOCHEM BIOPHYS, V332, P352, DOI 10.1006/abbi.1996.0352; Adam KP, 1998, PHYTOCHEMISTRY, V49, P475, DOI 10.1016/S0031-9422(97)00741-3; Alaba S, 2015, NEW PHYTOL, V206, P352, DOI 10.1111/nph.13220; Asakawa Y., 1995, PROGR CHEM ORGANIC N; ASHTON NW, 1985, PLANTA, V164, P142, DOI 10.1007/BF00391040; Atzorn R, 1992, PHYSL BIOCH CYTOKINI, P215; Auer CA, 1997, PLANT GROWTH REGUL, V23, P17, DOI 10.1023/A:1005998307340; Bajguz A, 2009, PHYTOCHEMISTRY, V70, P957, DOI 10.1016/j.phytochem.2009.05.006; Bopp M., 1990, Bryophyte development: physiology and biochemistry., P55; Chang Y, 2011, AM J BOT, V98, P839, DOI 10.3732/ajb.0900384; Cho SH, 2009, ANNU PLANT REV, V36, P282, DOI 10.1111/b.9781405181891.2009.000011.x; Cooke TJ, 2002, PLANT MOL BIOL, V49, P319, DOI 10.1023/A:1015242627321; Cox CJ, 2000, BRYOLOGIST, V103, P224, DOI 10.1639/0007-2745(2000)103[0224:PRATDA]2.0.CO;2; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Davis EC, 2004, MONOG SYST BOTAN, V98, P61; Decker EL, 2006, PLANT BIOLOGY, V8, P397, DOI 10.1055/s-2006-923952; Djilianov DL, 2013, J PLANT GROWTH REGUL, V32, P564, DOI 10.1007/s00344-013-9323-y; Dobrev Petre I, 2012, Methods Mol Biol, V913, P251, DOI 10.1007/978-1-61779-986-0_17; DUCKETT JG, 1995, ANN BOT-LONDON, V76, P405, DOI 10.1006/anbo.1995.1114; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; GERHAUSER D, 1990, J PLANT PHYSIOL, V135, P714, DOI 10.1016/S0176-1617(11)80885-0; Groth-Malonek M, 2005, TAXON, V54, P293, DOI 10.2307/25065358; Johri M. M., 2008, Physiology and Molecular Biology of Plants, V14, P23, DOI 10.1007/s12298-008-0003-5; Kaminek M, 2000, PLANT GROWTH REGUL, V32, P253, DOI 10.1023/A:1010743522048; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lindner AC, 2014, J EXP BOT, V65, P2533, DOI 10.1093/jxb/eru142; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Ludwig-Muller J, 2009, NEW PHYTOL, V181, P323, DOI 10.1111/j.1469-8137.2008.02677.x; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Novak O, 2012, PLANT J, V72, P523, DOI 10.1111/j.1365-313X.2012.05085.x; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Pencik A, 2013, PLANT CELL, V25, P3858, DOI 10.1105/tpc.113.114421; Qiu YL, 2007, INT J PLANT SCI, V168, P691, DOI 10.1086/513474; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Sabovljevic Marko, 2014, Botanica Serbica, V38, P99; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schulz P, 2000, J PLANT PHYSIOL, V156, P768, DOI 10.1016/S0176-1617(00)80246-1; Shaw J, 2004, AM J BOT, V91, P1557, DOI 10.3732/ajb.91.10.1557; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; Stirk WA, 2010, PLANT GROWTH REGUL, V62, P101, DOI 10.1007/s10725-010-9481-x; Stirk WA, 2014, ADV BOT RES, V71, P125, DOI 10.1016/B978-0-12-408062-1.00005-6; Stirk WA, 2013, J PHYCOL, V49, P459, DOI 10.1111/jpy.12061; Suire C, 2000, PLANT PHYSIOL, V124, P971, DOI 10.1104/pp.124.3.971; Sztein AE, 1999, AM J BOT, V86, P1544, DOI 10.2307/2656792; Sztein AE, 2000, INT J PLANT SCI, V161, P849, DOI 10.1086/317566; Tarakhovskaya ER, 2007, RUSS J PLANT PHYSL+, V54, P163, DOI 10.1134/S1021443707020021; Vankova R, 1999, ADVANCES IN REGULATION OF PLANT GROWTH AND DEVELOPMENT, P67; Verpoorte R., 2000, METABOLIC ENG PLANT, P1; von Schwartzenberg K, 2006, PLANT BIOLOGY, V8, P382, DOI 10.1055/s-2006-923962; von Schwartzenberg K, 2007, PLANT PHYSIOL, V145, P786, DOI 10.1104/pp.107.103176; von Schwartzenberg K, 2009, ANNU PLANT REV, V36, P246, DOI 10.1111/b.9781405181891.2009.000010.x; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Yevdakova NA, 2008, J PLANT GROWTH REGUL, V27, P271, DOI 10.1007/s00344-008-9053-8	54	50	52	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125411	10.1371/journal.pone.0125411	http://dx.doi.org/10.1371/journal.pone.0125411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974061	Green Submitted, gold, Green Published			2022-12-27	WOS:000354545600016
J	Isaksson, S; Funcke, A; Envall, I; Enquist, M; Lindenfors, P				Isaksson, Sven; Funcke, Alexander; Envall, Ida; Enquist, Magnus; Lindenfors, Patrik			A Novel Method to Analyze Social Transmission in Chronologically Sequenced Assemblages, Implemented on Cultural Inheritance of the Art of Cooking	PLOS ONE			English	Article								Here we present an analytical technique for the measurement and evaluation of changes in chronologically sequenced assemblages. To illustrate the method, we studied the cultural evolution of European cooking as revealed in seven cook books dispersed over the past 800 years. We investigated if changes in the set of commonly used ingredients were mainly gradual or subject to fashion fluctuations. Applying our method to the data from the cook books revealed that overall, there is a clear continuity in cooking over the ages - cooking is knowledge that is passed down through generations, not something (re-) invented by each generation on its own. Looking at three main categories of ingredients separately (spices, animal products and vegetables), however, disclosed that all ingredients do not change according to the same pattern. While choice of animal products was very conservative, changing completely sequentially, changes in the choices of spices, but also of vegetables, were more unbounded. We hypothesize that this may be due a combination of fashion fluctuations and changes in availability due to contact with the Americas during our study time period. The presented method is also usable on other assemblage type data, and can thus be of utility for analyzing sequential archaeological data from the same area or other similarly organized material.	[Isaksson, Sven; Funcke, Alexander; Envall, Ida; Enquist, Magnus; Lindenfors, Patrik] Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden; [Isaksson, Sven] Stockholm Univ, Archaeol Res Lab, S-10691 Stockholm, Sweden; [Funcke, Alexander] Univ Penn, Philosophy Polit & Econ, Philadelphia, PA 19104 USA; [Lindenfors, Patrik] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University; University of Pennsylvania; Stockholm University	Lindenfors, P (corresponding author), Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden.	patrik.lindenfors@zoologi.su.se	Lindenfors, Patrik/G-6401-2011; Lindenfors, Patrik/N-2801-2019	Lindenfors, Patrik/0000-0003-3245-0850; Lindenfors, Patrik/0000-0003-3245-0850				Acerbi A, 2014, EVOL HUM BEHAV, V35, P228, DOI 10.1016/j.evolhumbehav.2014.02.003; Andrews B, 1999, VAR KOKBOK; [Anonymous], 2010, J NORDIC ARCHAEOLOGI, V17, P3; Banegas Lopez RA, 2010, FOOD HIST, V8, P63; Beheim BA, 2014, EVOL HUM BEHAV, V35, P351, DOI 10.1016/j.evolhumbehav.2014.04.001; Crittenden AN, 2011, FOOD FOODWAYS, V19, P257, DOI 10.1080/07409710.2011.630618; Currie TE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1622; Davidson A., 2014, OXFORD COMPANION FOO, DOI 10.1093/acref/9780199677337.001.0001; Eidlitz K., 1971, FODA NODFODA HUR MAN; Envall I, CULTURAL EV IN PRESS; Fransen K, 1976, KAJSAS KOKBOK; Goldstein Darra, 2005, CULINARY CULTURES EU; Grewe R, 2001, LIBELLUS ARTE CONQUI; Grignon C, 1999, Food Foodways, V8, P151, DOI 10.1080/07409710.1999.9962086; Hagdahl CE, 2004, KOK KONSTEN SOM VETE; Hieatt CB, 1985, CURYE INGLYSCH MIDDL; Katz S. H., 2003, ENCY FOOD CULTURE, V2; Kiple KF, 2000, WORLD HIST FOOD, V2; Kiple KF, 2000, CAMBRIDGE WORLD HIST; Lentz Carola, 1991, FOOD FOODWAYS, V5, P1, DOI 10.1080/07409710.1991.996198; Locher JL, 2005, FOOD FOODWAYS, V13, P273, DOI 10.1080/07409710500334509; Milham Mary Ella, 1998, PLATINA RIGHT PLEASU; Montanari M, 1994, THE CULTURE OF FOOD; Neuhaus J., 2003, MANLY MEALS MOMS HOM; Nyberg A., 1989, TEKNIKEN KVINNORNAS; Perreault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045150; Ross E.B., 1987, FOOD EVOLUTION THEOR, P57; Searles E., 2002, FOOD FOODWAYS, V10:1-2, P55, DOI [10.1080/07409710212485, DOI 10.1080/07409710212485, DOI 10.21237/C7CLIO7131139]; Sobal J, 2005, FOOD FOODWAYS, V13, P135, DOI 10.1080/07409710590915409; Stahle L, 2011, WILD ENVIRON MED, V22, P202, DOI 10.1016/j.wem.2011.02.018; Symons M, 2009, FOOD FOODWAYS, V17, P215, DOI 10.1080/07409710903356307; Wahlund PE, 1990, GAMMAL SVENSK KOKBOK; Wikstrom K, 2007, MARTA STURES HUSHALL	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0122092	10.1371/journal.pone.0122092	http://dx.doi.org/10.1371/journal.pone.0122092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970578	Green Submitted, Green Published, gold			2022-12-27	WOS:000354544200004
J	Reeder, C; Closser, M; Poh, HM; Sandhu, K; Wichterle, H; Gifford, D				Reeder, Christopher; Closser, Michael; Poh, Huay Mei; Sandhu, Kuljeet; Wichterle, Hynek; Gifford, David			High Resolution Mapping of Enhancer-Promoter Interactions	PLOS ONE			English	Article							CHROMATIN; DIFFERENTIATION; EXPRESSION; PRINCIPLES; LANDSCAPE	RNA Polymerase II ChIA-PET data has revealed enhancers that are active in a profiled cell type and the genes that the enhancers regulate through chromatin interactions. The most commonly used computational method for analyzing ChIA-PET data, the ChIA-PET Tool, discovers interaction anchors at a spatial resolution that is insufficient to accurately identify individual enhancers. We introduce Germ, a computational method that estimates the likelihood that any two narrowly defined genomic locations are jointly occupied by RNA Polymerase II. Germ takes a blind deconvolution approach to simultaneously estimate the likelihood of RNA Polymerase II occupation as well as a model of the arrangement of read alignments relative to locations occupied by RNA Polymerase II. Both types of information are utilized to estimate the likelihood that RNA Polymerase II jointly occupies any two genomic locations. We apply Germ to RNA Polymerase II ChIA-PET data from embryonic stem cells to identify the genomic locations that are jointly occupied along with transcription start sites. We show that these genomic locations align more closely with features of active enhancers measured by ChIP-Seq than the locations identified using the ChIA-PET Tool. We also apply Germ to RNA Polymerase II ChIA-PET data from motor neuron progenitors. Based on the Germ results, we observe that a combination of cell type specific and cell type independent regulatory interactions are utilized by cells to regulate gene expression.	[Reeder, Christopher; Gifford, David] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Closser, Michael; Wichterle, Hynek] Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Pathol & Cell Bi, New York, NY USA; [Closser, Michael; Wichterle, Hynek] Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Neurol, New York, NY USA; [Closser, Michael; Wichterle, Hynek] Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Neurosci, New York, NY USA; [Poh, Huay Mei] Genome Inst Singapore, Singapore, Singapore; [Sandhu, Kuljeet] Indian Inst Sci Educ & Res, Dept Biol Sci, Knowledge City, Mohali, India	Massachusetts Institute of Technology (MIT); Columbia University; Columbia University; Columbia University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Indian Institute of Science Education & Research (IISER) - Mohali	Gifford, D (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gifford@mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Sandhu, Kuljeet/0000-0001-7632-6339; Wichterle, Hynek/0000-0002-7817-0080	National Institutes of Health [1U01HG007037]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this work was provided by the National Institutes of Health grant 1U01HG007037 to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Busser BW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002531; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ensini M, 1998, DEVELOPMENT, V125, P969; FISH DA, 1995, J OPT SOC AM A, V12, P58, DOI 10.1364/JOSAA.12.000058; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Girgis HZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-25; Gonzalez S, 2012, BIOINFORMATICS, V28, P763, DOI 10.1093/bioinformatics/bts024; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Meireles ACA, 2009, CURR OPIN GENET DEV, V19, P565, DOI 10.1016/j.gde.2009.10.006; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Reeder Christopher, 2013, Research in Computational Molecular Biology. 17th Annual International Conference (RECOMB 2013). Proceedings, P186, DOI 10.1007/978-3-642-37195-0_16; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; RUDEMO M, 1982, SCAND J STAT, V9, P65; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Won KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005501; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	42	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0122420	10.1371/journal.pone.0122420	http://dx.doi.org/10.1371/journal.pone.0122420			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970635	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200006
J	Sehgal, D; Skot, L; Singh, R; Srivastava, RK; Das, SP; Taunk, J; Sharma, PC; Pal, R; Raj, B; Hash, CT; Yadav, RS				Sehgal, Deepmala; Skot, Leif; Singh, Richa; Srivastava, Rakesh Kumar; Das, Sankar Prasad; Taunk, Jyoti; Sharma, Parbodh C.; Pal, Ram; Raj, Bhasker; Hash, Charles T.; Yadav, Rattan S.			Exploring Potential of Pearl Millet Germplasm Association Panel for Association Mapping of Drought Tolerance Traits	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; SINGLE-NUCLEOTIDE POLYMORPHISMS; L. R. BR.; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; TERMINAL DROUGHT; CANDIDATE GENES; GRAIN-YIELD; STRESS TOLERANCE; CORE COLLECTION	A pearl millet inbred germplasm association panel (PMiGAP) comprising 250 inbred lines, representative of cultivated germplasm from Africa and Asia, elite improved open-pollinated cultivars, hybrid parental inbreds and inbred mapping population parents, was recently established. This study presents the first report of genetic diversity in PMiGAP and its exploitation for association mapping of drought tolerance traits. For diversity and genetic structure analysis, PMiGAP was genotyped with 37 SSR and CISP markers representing all seven linkage groups. For association analysis, it was phenotyped for yield and yield components and morpho-physiological traits under both well-watered and drought conditions, and genotyped with SNPs and InDels from seventeen genes underlying a major validated drought tolerance (DT) QTL. The average gene diversity in PMiGAP was 0.54. The STRUCTURE analysis revealed six subpopulations within PMiGAP. Significant associations were obtained for 22 SNPs and 3 InDels from 13 genes under different treatments. Seven SNPs associations from 5 genes were common under irrigated and one of the drought stress treatments. Most significantly, an important SNP in putative acetyl CoA carboxylase gene showed constitutive association with grain yield, grain harvest index and panicle yield under all treatments. An InDel in putative chlorophyll a/b binding protein gene was significantly associated with both stay-green and grain yield traits under drought stress. This can be used as a functional marker for selecting high yielding genotypes with 'stay green' phenotype under drought stress. The present study identified useful marker-trait associations of important agronomics traits under irrigated and drought stress conditions with genes underlying a major validated DT-QTL in pearl millet. Results suggest that PMiGAP is a useful panel for association mapping. Expression patterns of genes also shed light on some physiological mechanisms underlying pearl millet drought tolerance.	[Sehgal, Deepmala; Skot, Leif; Singh, Richa; Das, Sankar Prasad; Taunk, Jyoti; Sharma, Parbodh C.; Pal, Ram; Yadav, Rattan S.] Aberystwyth Univ, Inst Biol Environm & Biol Sci IBERS, Aberystwyth, Ceredigion, Wales; [Singh, Richa; Taunk, Jyoti] Chaudhary Charan Singh Haryana Agr Univ, Dept Mol Biol & Biotechnol, Hisar, Haryana, India; [Srivastava, Rakesh Kumar; Raj, Bhasker] Int Crops Res Inst Semi Arid Trop, Patancheru, Andhra Pradesh, India; [Das, Sankar Prasad] Tripura Ctr, ICAR Res Complex NEH Reg, Lembucherra, India; [Sharma, Parbodh C.] CSSRI, Karnal, India; [Pal, Ram] Natl Res Ctr Orchids, Darjeeling, India; [Hash, Charles T.] ICRISAT Sahelian Ctr, Niamey, Niger	Aberystwyth University; CCS Haryana Agricultural University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; Indian Council of Agricultural Research (ICAR); ICAR - Central Soil Salinity Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Orchids; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Yadav, RS (corresponding author), Aberystwyth Univ, Inst Biol Environm & Biol Sci IBERS, Aberystwyth, Ceredigion, Wales.	rsy@aber.ac.uk		Yadav, Professor Rattan/0000-0001-6132-4541; Skot, Leif/0000-0003-4301-9468; Srivastava, Rakesh K/0000-0001-6715-0386	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F004133/1]; Department for International Development (DFID) [BB/F004133/1]; Biotechnology and Biological Sciences Research Council [BB/F004133/1, BB/H53166X/1] Funding Source: researchfish; BBSRC [BB/H53166X/1, BB/F004133/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for International Development (DFID); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors wish to acknowledge Biotechnology and Biological Sciences Research Council (BBSRC) and Department for International Development (DFID) for funding the work via grant number BB/F004133/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu M. O., 2011, Journal of Agricultural and Biological Science, V6, P16; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Akey JM, 2003, MOL BIOL EVOL, V20, P232, DOI 10.1093/molbev/msg032; Akkasaeng Chutipong, 2007, Pak J Biol Sci, V10, P1611, DOI 10.3923/pjbs.2007.1611.1617; Amadou I, 2013, EMIR J FOOD AGR, V25, P501, DOI 10.9755/ejfa.v25i7.12045; Belknap WR, 1996, TRENDS PLANT SCI, V1, P331; Bhattacharjee R, 2007, EUPHYTICA, V155, P35, DOI 10.1007/s10681-006-9298-x; Bhosale SU, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-32; Bidinger FR, 2007, CROP SCI, V47, P969, DOI 10.2135/cropsci2006.07.0465; Boccalandro HE, 2003, PLANT PHYSIOL, V133, P1539, DOI 10.1104/pp.103.029579; Boggs JZ, 2010, PLANT GROWTH REGUL, V60, P77, DOI 10.1007/s10725-009-9427-3; Budak H, 2003, CROP SCI, V43, P2284, DOI 10.2135/cropsci2003.2284; Chen YE, 2013, J EXP BOT, V64, P1167, DOI 10.1093/jxb/ert002; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Chung E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066056; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; Edae EA, 2013, PLANT GEN, V6, P2, DOI DOI 10.3835/PLANTGEN0ME2013.04.0010; EJETA G, 1987, P NATL ACAD SCI USA, V84, P6016, DOI 10.1073/pnas.84.17.6016; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; GOSWAMI AK, 1969, BRIT J NUTR, V23, P913, DOI 10.1079/BJN19690102; Govindaraj M, 2013, CROP SCI, V53, P507, DOI 10.2135/cropsci2012.08.0477; Gulia S.K., 2007, CROP PRODUCTION STRE; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Haussmann BIG, 2012, J AGRON CROP SCI, V198, P327, DOI 10.1111/j.1439-037X.2012.00526.x; HILL GM, 1990, J ANIM SCI, V68, P2061; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Ikeda H, 2009, GENETICS, V182, P603, DOI 10.1534/genetics.109.102152; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; JONES ES, 1995, THEOR APPL GENET, V91, P448, DOI 10.1007/BF00222972; Jones ES, 2002, CROP SCI, V42, P1316, DOI 10.2135/cropsci2002.1316; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kholova J, 2013, FUNCT PLANT BIOL, V40, P44, DOI 10.1071/FP12181; Kholova J, 2011, ENVIRON EXP BOT, V71, P99, DOI 10.1016/j.envexpbot.2010.11.001; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; LI WW, 1994, PLANT PHYSIOL, V106, P963, DOI 10.1104/pp.106.3.963; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; Magorokosho C, 2004, AFRIC CROP SCI J, V11, P151; Mao, 1999, POPGENE VERSION 1 3; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Mariac C, 2006, THEOR APPL GENET, V114, P49, DOI 10.1007/s00122-006-0409-9; Matthies IE, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-77; Nepolean T, 2006, INT SORGHUM MILLETS, V47, P149; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Oumar I, 2008, THEOR APPL GENET, V117, P489, DOI 10.1007/s00122-008-0793-4; Ozias-Akins P, 1998, P NATL ACAD SCI USA, V95, P5127, DOI 10.1073/pnas.95.9.5127; Parry MAJ, 2011, J EXP BOT, V62, P453, DOI 10.1093/jxb/erq304; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Paulsen H, 2010, ADV PHOTOSYNTH RESP, V31, P231; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; Rawsthorne S, 2002, PROG LIPID RES, V41, P182, DOI 10.1016/S0163-7827(01)00023-6; Rharrabti Y, 2001, J AGR FOOD CHEM, V49, P3802, DOI 10.1021/jf001139w; Rotundo JL, 2009, FIELD CROP RES, V112, P90, DOI 10.1016/j.fcr.2009.02.004; Saidou AA, 2009, GENETICS, V182, P899, DOI 10.1534/genetics.109.102756; SAWAYA WN, 1984, QUAL PLANT, V34, P117, DOI 10.1007/BF01094839; Schliebner I, 2008, CURR GENOMICS, V9, P184, DOI 10.2174/138920208784340740; Schneider K, 2007, THEOR APPL GENET, V115, P601, DOI 10.1007/s00122-007-0591-4; Sehgal D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-9; Sehgal D, 2010, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, SECOND EDITION, P207, DOI 10.1007/978-90-481-2967-6_9; Setter TL, 2011, J EXP BOT, V62, P701, DOI 10.1093/jxb/erq308; Sokolskaya SV, 2003, FUNCT PLANT BIOL, V30, P1249, DOI 10.1071/FP03013; Stich B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-216; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tan CM, 2013, INT J MOL SCI, V14, P20204, DOI 10.3390/ijms141020204; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; THOMAS H, 1993, ANN APPL BIOL, V123, P193, DOI 10.1111/j.1744-7348.1993.tb04086.x; Upadhyaya HD, 2009, CROP SCI, V49, P573, DOI 10.2135/cropsci2008.06.0378; Vahdatirad A., 2013, Journal of Biological Sciences, V13, P250, DOI 10.3923/jbs.2013.250.256; Varshney RK, 2007, THEOR APPL GENET, V114, P1105, DOI 10.1007/s00122-007-0504-6; Velu G, 2007, PLANT BREEDING, V126, P182, DOI 10.1111/j.1439-0523.2007.01322.x; Gonzalez CV, 2012, PLANT CELL ENVIRON, V35, P1958, DOI 10.1111/j.1365-3040.2012.02529.x; Wan XR, 2011, J BIOSCI BIOENG, V111, P478, DOI 10.1016/j.jbiosc.2010.11.021; Wilson JP, 2004, CROP PROT, V23, P865, DOI 10.1016/j.cropro.2004.01.006; Xia Yanshi, 2012, PLoS One, V7, pe37573, DOI 10.1371/journal.pone.0037573; Xing Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-43; Yadav RS, 2011, J EXP BOT, V62, P397, DOI 10.1093/jxb/erq265; Yadav RS, 2004, EUPHYTICA, V136, P265, DOI 10.1023/B:EUPH.0000032711.34599.3a; Yadav RS, 2002, THEOR APPL GENET, V104, P67, DOI 10.1007/s001220200008; Yan WK, 2008, CROP SCI, V48, P417, DOI 10.2135/cropsci2007.05.0254; Yao J, 2009, GENETICA, V137, P67, DOI 10.1007/s10709-009-9351-5; Yu XQ, 2013, J EXP BOT, V64, P1537, DOI 10.1093/jxb/ert018; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	89	51	52	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0122165	10.1371/journal.pone.0122165	http://dx.doi.org/10.1371/journal.pone.0122165			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970600	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000354544200005
J	Sjogren, B; Swaney, S; Neubig, RR				Sjoegren, Benita; Swaney, Steven; Neubig, Richard R.			FBXO44-Mediated Degradation of RGS2 Protein Uniquely Depends on a Cullin 4B/DDB1 Complex	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; SMALL-MOLECULE INHIBITORS; UP-REGULATION; REGULATORS; EXPRESSION; END; BOX; TARGETS; LIGASE; G-PROTEIN-SIGNALING-2	The ubiquitin-proteasome system for protein degradation plays a major role in regulating cell function and many signaling proteins are tightly controlled by this mechanism. Among these, Regulator of G Protein Signaling 2 (RGS2) is a target for rapid proteasomal degradation, however, the specific enzymes involved are not known. Using a genomic siRNA screening approach, we identified a novel E3 ligase complex containing cullin 4B (CUL4B), DNA damage binding protein 1 (DDB1) and F-box protein 44 (FBXO44) that mediates RGS2 protein degradation. While the more typical F-box partners CUL1 and Skp1 can bind FBXO44, that E3 ligase complex does not bind RGS2 and is not involved in RGS2 degradation. These observations define an unexpected DDB1/CUL4B-containing FBXO44 E3 ligase complex. Pharmacological targeting of this mechanism provides a novel therapeutic approach to hypertension, anxiety, and other diseases associated with RGS2 dysregulation.	[Sjoegren, Benita; Neubig, Richard R.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Swaney, Steven] Univ Michigan, Ctr Chem Genom, Ann Arbor, MI 48109 USA	Michigan State University; University of Michigan System; University of Michigan	Sjogren, B (corresponding author), Michigan State Univ, Dept Pharmacol & Toxicol, 1355 Bogue St, E Lansing, MI 48824 USA.	sjogren1@msu.edu		Neubig, Richard/0000-0003-0501-0008; Sjogren, Benita/0000-0003-1460-1045	NIH [R01 DA023252]; Life Sciences Institute Screening Pilot Grant (University of Michigan); Swedish Heart-and Lung Foundation; American Heart Association [15SDG21630002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Institute Screening Pilot Grant (University of Michigan); Swedish Heart-and Lung Foundation(Swedish Heart-Lung Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH R01 DA023252 and the Life Sciences Institute Screening Pilot Grant (University of Michigan) to R.R.N., the Swedish Heart-and Lung Foundation International Research Fellowship and the American Heart Association (15SDG21630002) to B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Arya AK, 2010, BRIT J CANCER, V103, P186, DOI 10.1038/sj.bjc.6605739; Blazer LL, 2011, BIOCHEMISTRY-US, V50, P3181, DOI 10.1021/bi1019622; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Chen C, 2006, MOL CANCER RES, V4, P695, DOI 10.1158/1541-7786.MCR-06-0182; Cho H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P107, DOI 10.2174/1568008043339938; Ciechanover A, 2002, HEPATOLOGY, V35, P3, DOI 10.1053/jhep.2002.30316; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Ding QJ, 2013, J MED CHEM, V56, P5979, DOI 10.1021/jm400487c; Doupnik CA, 2001, BBA-GENE STRUCT EXPR, V1522, P97, DOI 10.1016/S0167-4781(01)00342-6; Druey KM, 2003, EXPERT OPIN THER TAR, V7, P475, DOI 10.1517/14728222.7.4.475; Geurts M, 2003, BIOCHEM PHARMACOL, V66, P1163, DOI 10.1016/S0006-2952(03)00447-7; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hahntow IN, 2009, AM J HYPERTENS, V22, P80, DOI 10.1038/ajh.2008.310; He FJ, 2013, BBA-MOL BASIS DIS, V1832, P595, DOI 10.1016/j.bbadis.2013.01.015; Herrmann J, 2004, CARDIOVASC RES, V61, P11, DOI 10.1016/j.cardiores.2003.09.033; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Ilyin GP, 2002, GENE, V296, P11, DOI 10.1016/S0378-1119(02)00867-3; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Li X, 2011, J BIOL CHEM, V286, P32344, DOI 10.1074/jbc.M111.249003; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Lu YZ, 2012, J BIOL CHEM, V287, P41014, DOI 10.1074/jbc.M112.407106; Lyu JH, 2015, J CELL BIOCHEM, V116, P260, DOI 10.1002/jcb.24964; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nunn C, 2010, CELL SIGNAL, V22, P1231, DOI 10.1016/j.cellsig.2010.03.015; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Otowa T, 2011, AM J MED GENET B, V156B, P430, DOI 10.1002/ajmg.b.31178; Park EJ, 2013, ANTI-CANCER DRUG, V24, P260, DOI 10.1097/CAD.0b013e32835c0311; Patterson C, 2007, CIRCULATION, V115, P1456, DOI 10.1161/CIRCULATIONAHA.106.649863; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Sjogren B, 2012, MOL PHARMACOL, V82, P500, DOI 10.1124/mol.112.079293; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Sjogren B, 2010, MOL PHARMACOL, V78, P550, DOI 10.1124/mol.110.065219; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sugimoto K, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/196307; Sun DQ, 2014, J MED CHEM, V57, P1454, DOI 10.1021/jm401753e; Tsang Sharon, 2010, Front Biosci (Schol Ed), V2, P547; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Turner EM, 2012, ACS MED CHEM LETT, V3, P146, DOI 10.1021/ml200263y; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Yoshida Y, 2011, BIOCHEM BIOPH RES CO, V410, P24, DOI 10.1016/j.bbrc.2011.05.098; Zhang W, 2006, J BIOL CHEM, V281, P5811, DOI 10.1074/jbc.M507871200; Zhao YJ, 2013, J MED CHEM, V56, P5553, DOI 10.1021/jm4005708; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	64	16	18	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123581	10.1371/journal.pone.0123581	http://dx.doi.org/10.1371/journal.pone.0123581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970626	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200016
J	Miranda, A; Carvalho, LM; Dionisio, F				Miranda, Antonio; Carvalho, Luis M.; Dionisio, Francisco			Lower Within-Community Variance of Negative Density Dependence Increases Forest Diversity	PLOS ONE			English	Article							PLANT-SOIL FEEDBACK; SPECIES COEXISTENCE; SEEDLING MORTALITY; TROPICAL FORESTS; FREQUENCY-DEPENDENCE; RELATIVE ABUNDANCE; RAIN-FOREST; TREE; PATHOGENS; PATTERNS	Local abundance of adult trees impedes growth of conspecific seedlings through host-specific enemies, a mechanism first proposed by Janzen and Connell to explain plant diversity in forests. While several studies suggest the importance of this mechanism, there is still little information of how the variance of negative density dependence (NDD) affects diversity of forest communities. With computer simulations, we analyzed the impact of strength and variance of NDD within tree communities on species diversity. We show that stronger NDD leads to higher species diversity. Furthermore, lower range of strengths of NDD within a community increases species richness and decreases variance of species abundances. Our results show that, beyond the average strength of NDD, the variance of NDD is also crucially important to explain species diversity. This can explain the dissimilarity of biodiversity between tropical and temperate forest: highly diverse forests could have lower NDD variance. This report suggests that natural enemies and the variety of the magnitude of their effects can contribute to the maintenance of biodiversity.	[Miranda, Antonio; Carvalho, Luis M.; Dionisio, Francisco] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, P-1749016 Lisbon, Portugal; [Dionisio, Francisco] Univ Lisbon, Fac Ciencias, Dept Plant Biol, P-1749016 Lisbon, Portugal; [Miranda, Antonio; Dionisio, Francisco] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Gulbenkian de Ciencia	Dionisio, F (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, P-1749016 Lisbon, Portugal.	dionisio@fc.ul.pt	Carvalho, Luis M/A-8820-2010; Dionisio, Francisco/A-2129-2009	Carvalho, Luis M/0000-0003-4918-6160; Dionisio, Francisco/0000-0002-3653-1511	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/33859/2009, SFRH/BPD/33633/2009]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	AM received a PhD grant (SFRH/BD/33859/2009) from Fundacao para a Ciencia e a Tecnologia, Portugal http://www.fct.pt. LMC received a post-doc grant (SFRH/BPD/33633/2009) from Fundacao para a Ciencia e a Tecnologia, Portugal http://www.fct.pt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Banitz T, 2008, THEOR ECOL-NETH, V1, P231, DOI 10.1007/s12080-008-0023-3; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Bonanomi G, 2005, OIKOS, V111, P311, DOI 10.1111/j.0030-1299.2005.13975.x; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chisholm RA, 2011, THEOR ECOL-NETH, V4, P241, DOI 10.1007/s12080-011-0119-z; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; CONNELL J H, 1971, P298; Freckleton RP, 2006, P R SOC B, V273, P2909, DOI 10.1098/rspb.2006.3660; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kobe RK, 2011, ECOL LETT, V14, P503, DOI 10.1111/j.1461-0248.2011.01612.x; Mack KML, 2014, J ECOL, V102, P1195, DOI 10.1111/1365-2745.12269; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Metz MR, 2010, ECOLOGY, V91, P3675, DOI 10.1890/08-2323.1; Molofsky J, 1999, THEOR POPUL BIOL, V55, P270, DOI 10.1006/tpbi.1998.1404; Molofsky J, 2002, ECOLOGY, V83, P21; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Sedio BE, 2013, ECOL LETT, V16, P995, DOI 10.1111/ele.12130; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; VALENCIA R, 1994, BIODIVERS CONSERV, V3, P21, DOI 10.1007/BF00115330; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	29	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127260	10.1371/journal.pone.0127260	http://dx.doi.org/10.1371/journal.pone.0127260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992631	Green Published, gold, Green Submitted			2022-12-27	WOS:000354921400103
J	Li, YC; Sun, R; Zhang, B; Wang, YC; Li, HY				Li, Yongcheng; Sun, Rong; Zhang, Bin; Wang, Yuechao; Li, Hongyi			Application of Hierarchical Dissociated Neural Network in Closed-Loop Hybrid System Integrating Biological and Mechanical Intelligence	PLOS ONE			English	Article							PLASTICITY; DYNAMICS; DEVICES; BURSTS	Neural networks are considered the origin of intelligence in organisms. In this paper, a new design of an intelligent system merging biological intelligence with artificial intelligence was created. It was based on a neural controller bidirectionally connected to an actual mobile robot to implement a novel vehicle. Two types of experimental preparations were utilized as the neural controller including 'random' and '4Q' (cultured neurons artificially divided into four interconnected parts) neural network. Compared to the random cultures, the '4Q' cultures presented absolutely different activities, and the robot controlled by the '4Q' network presented better capabilities in search tasks. Our results showed that neural cultures could be successfully employed to control an artificial agent; the robot performed better and better with the stimulus because of the short-term plasticity. A new framework is provided to investigate the bidirectional biological-artificial interface and develop new strategies for a future intelligent system using these simplified model systems.	[Li, Yongcheng; Wang, Yuechao; Li, Hongyi] Univ Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang, Liaoning, Peoples R China; [Sun, Rong; Zhang, Bin] Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; University of Chinese Academy of Sciences, CAS	Li, HY (corresponding author), Univ Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang, Liaoning, Peoples R China.	hli@sia.cn		Sun, Rong/0000-0002-0950-1480	Fundation of State Key Laboratory of Robotics [2013Z05]; National Natural Science Foundation of China [51305438]	Fundation of State Key Laboratory of Robotics; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work has been supported by the Fundation of State Key Laboratory of Robotics (grant No. 2013Z05) and the National Natural Science Foundation of China (grant No. 51305438, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkum DJ, 2008, J NEURAL ENG, V5, P310, DOI 10.1088/1741-2560/5/3/004; Barkan U, 2006, NEUROCOMPUTING, V69, P1108, DOI 10.1016/j.neucom.2005.12.121; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; DiGiovanna J., 2010, J AUTOMATIC CONTROL, V20, P27, DOI DOI 10.2298/JAC10; Erickson J, 2008, J NEUROSCI METH, V175, P1, DOI 10.1016/j.jneumeth.2008.07.023; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Jun SB, 2007, J NEUROSCI METH, V160, P317, DOI 10.1016/j.jneumeth.2006.09.009; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; le Feber J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008871; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; MAEDA E, 1995, J NEUROSCI, V15, P6834; Novellino A, 2007, Comput Intell Neurosci, P12725, DOI 10.1155/2007/12725; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Patil PG, 2008, NEUROTHERAPEUTICS, V5, P137, DOI 10.1016/j.nurt.2007.11.002; Pizzi RMR, 2009, BIOSYSTEMS, V95, P137, DOI 10.1016/j.biosystems.2008.09.006; Potter A, 2004, PEDIAT ENDOCRINOLOGY, P1; Rachmuth G, 2011, P NATL ACAD SCI USA, V108, pE1266, DOI 10.1073/pnas.1106161108; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Raichman N, 2006, NEUROCOMPUTING, V69, P1150, DOI 10.1016/j.neucom.2005.12.064; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Tessadori J, 2012, FRONT NEURAL CIRCUIT, V6, P1, DOI [10.3389/fncir.2012.00001, DOI 10.3389/FNCIR.2012.00001]; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Vishwanathan A, 2011, LAB CHIP, V11, P1081, DOI [10.1039/c0lc00450b, 10.1039/c01c00450b]; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Warwick K, 2010, DEFENCE SCI J, V60, P5, DOI 10.14429/dsj.60.11; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613	34	1	1	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127452	10.1371/journal.pone.0127452	http://dx.doi.org/10.1371/journal.pone.0127452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992579	gold, Green Published, Green Submitted			2022-12-27	WOS:000354918600064
J	Pan, CS; Liu, YH; Liu, YY; Zhang, Y; He, K; Yang, XY; Hu, BH; Chang, X; Wang, MX; Wei, XH; Fan, JY; Wu, XM; Han, JY				Pan, Chun-Shui; Liu, Ying-Hua; Liu, Yu-Ying; Zhang, Yu; He, Ke; Yang, Xiao-Yuan; Hu, Bai-He; Chang, Xin; Wang, Ming-Xia; Wei, Xiao-Hong; Fan, Jing-Yu; Wu, Xin-Min; Han, Jing-Yan			Salvianolic Acid B Ameliorates Lipopolysaccharide-Induced Albumin Leakage from Rat Mesenteric Venules through Src-Regulated Transcelluar Pathway and Paracellular Pathway	PLOS ONE			English	Article							INDUCED MICROCIRCULATORY DISTURBANCE; TIGHT JUNCTION; ENDOTHELIAL PERMEABILITY; VASCULAR-PERMEABILITY; VE-CADHERIN; TRANSPORT; ISCHEMIA; KINASE; CELL; PHOSPHORYLATION	Lipopolysaccharide (LPS) causes microvascular barrier disruption, leading to albumin leakage from microvessels resulting in a range of disastrous sequels. Salvianolic acid B (SalB) is a major water-soluble component derived from Salvia miltiorrhiza. Previous studies showed its potential to attenuate microvascular barrier dysfunction, but the underlying mechanism is not fully understood. The present study was intended to investigate the impact of SalB on endothelial cell barrier in vivo in rat mesenteric venules as well as in vitro in human umbilical vein endothelial cells (HUVECs), aiming at disclosing the mechanism thereof, particularly the role of Src in its action. Male Wistar rats were challenged by infusion of LPS (2 mg/kg/h) through left femoral vein for 90 min. SalB (5 mg/kg/h) was administrated either simultaneously with LPS or 30 min after LPS infusion through the left jugular vein. Vesicles in venular walls were observed by electron microscopy. HUVECs were incubated with LPS with or without SalB. The expression of Zonula occluden-1 (ZO-1), VE-cadherin, caveolin-1 and Src in HUVECs was assessed by Western blot and confocal microscopy, binding of SalB to Src was measured using Surface Plasmon Resonance and BioLayer Interferometry. Treatment with SalB inhibited albumin leakage from rat mesenteric venules and inhibited the increase of vesicle number in venular endothelial cells induced by LPS. In addition, SalB inhibited the degradation of ZO-1, the phosphorylation and redistribution of VE-cadherin, the expression and phosphorylation of caveolin-1, and phosphoirylation of Src in HUVECs exposed to LPS. Furthermore, SalB was found able to bind to Src. This study demonstrates that protection of SalB against microvascular barrier disruption is a process involving both para- and trans-endothelial cell pathway, and highly suggests Src as the key enzyme for SalB to work.	[Pan, Chun-Shui; Liu, Yu-Ying; Hu, Bai-He; Chang, Xin; Wang, Ming-Xia; Wei, Xiao-Hong; Fan, Jing-Yu; Han, Jing-Yan] Peking Univ, Hlth Sci Ctr, Tasly Microcirculat Res Ctr, Beijing 100871, Peoples R China; [Liu, Ying-Hua; Wu, Xin-Min] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China; [Wei, Xiao-Hong] Peking Univ, Sch Basic Med Sci, Dept Integrat Tradit Chinese & Western Med, Beijing 100871, Peoples R China; [Pan, Chun-Shui; Liu, Yu-Ying; Zhang, Yu; He, Ke; Yang, Xiao-Yuan; Hu, Bai-He; Chang, Xin; Wang, Ming-Xia; Han, Jing-Yan] State Adm Tradit Chinese Med Peoples Republ China, Key Lab Microcirculat, Beijing, Peoples R China; [Pan, Chun-Shui; Liu, Yu-Ying; Zhang, Yu; He, Ke; Yang, Xiao-Yuan; Hu, Bai-He; Chang, Xin; Han, Jing-Yan] State Adm Tradit Chinese Med Peoples Republ China, Key Lab Stasis & Phlegm, Beijing, Peoples R China	Peking University; Peking University; Peking University	Han, JY (corresponding author), Peking Univ, Hlth Sci Ctr, Tasly Microcirculat Res Ctr, Beijing 100871, Peoples R China.	hanjingyan@bjmu.edu.cn	LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022		Production of New Medicine Program of Ministry of the Science and Technology of the People's Republic of China [2008ZX09401]	Production of New Medicine Program of Ministry of the Science and Technology of the People's Republic of China	This project was supported by the Production of New Medicine Program of Ministry of the Science and Technology of the People's Republic of China [2008ZX09401], in the study design, data collection and analysis, decision to publish.	Al-Sadi R, 2010, AM J PATHOL, V177, P2310, DOI 10.2353/ajpath.2010.100371; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Ding M, 2007, J PHARM PHARMACOL, V59, P1027, DOI 10.1211/jpp.59.7.0016; Fischbarg J, 2010, PHYSIOL REV, V90, P1271, DOI 10.1152/physrev.00025.2009; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Guo J, 2008, SHOCK, V29, P205, DOI 10.1097/SHK.0b013e318070c61a; Hailstones D, 1998, J LIPID RES, V39, P369; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Han JY, 2007, WORLD J GASTROENTERO, V13, P3581, DOI 10.3748/wjg.v13.i26.3581; Ho JHC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-30; Hu GC, 2008, CHEM-BIOL INTERACT, V171, P177, DOI 10.1016/j.cbi.2007.08.006; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lin F, 2013, SHOCK, V39, P317, DOI 10.1097/SHK.0b013e318283773e; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Shen Q, 2009, CELL HEALTH CYTOSKEL, V1, P43; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Shiels IA, 2000, MED HYPOTHESES, V54, P193, DOI 10.1054/mehy.1999.0017; Singh AK, 2007, TOXICOL MECH METHOD, V17, P331, DOI 10.1080/15376510601077029; Sperl B, 2009, BIOORG MED CHEM LETT, V19, P3305, DOI 10.1016/j.bmcl.2009.04.083; Wang MX, 2010, WORLD J GASTROENTERO, V16, P5306, DOI 10.3748/wjg.v16.i42.5306; Wei XH, 2013, MICROCIRCULATION, V20, P17, DOI 10.1111/micc.12002; Zhang Y, 2014, AM J PHYSIOL-GASTR L, V306, pG289, DOI 10.1152/ajpgi.00168.2013; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	31	14	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126640	10.1371/journal.pone.0126640	http://dx.doi.org/10.1371/journal.pone.0126640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992563	Green Submitted, Green Published, gold			2022-12-27	WOS:000354918600037
J	Checconi, P; Salzano, S; Bowler, L; Mullen, L; Mengozzi, M; Hanschmann, EM; Lillig, CH; Sgarbanti, R; Panella, S; Nencioni, L; Palamara, AT; Ghezzi, P				Checconi, Paola; Salzano, Sonia; Bowler, Lucas; Mullen, Lisa; Mengozzi, Manuela; Hanschmann, Eva-Maria; Lillig, Christopher Horst; Sgarbanti, Rossella; Panella, Simona; Nencioni, Lucia; Palamara, Anna Teresa; Ghezzi, Pietro			Redox Proteomics of the Inflammatory Secretome Identifies a Common Set of Redoxins and Other Glutathionylated Proteins Released in Inflammation, Influenza Virus Infection and Oxidative Stress	PLOS ONE			English	Article							HUMAN MONONUCLEAR-CELLS; TUMOR-NECROSIS-FACTOR; PEROXIREDOXIN FAMILY; INNATE IMMUNITY; FREE-RADICALS; A VIRUS; THIOREDOXIN; DISEASE; MICE; DEFICIENCY	Protein cysteines can form transient disulfides with glutathione (GSH), resulting in the production of glutathionylated proteins, and this process is regarded as a mechanism by which the redox state of the cell can regulate protein function. Most studies on redox regulation of immunity have focused on intracellular proteins. In this study we have used redox proteomics to identify those proteins released in glutathionylated form by macrophages stimulated with lipopolysaccharide (LPS) after pre-loading the cells with biotinylated GSH. Of the several proteins identified in the redox secretome, we have selected a number for validation. Proteomic analysis indicated that LPS stimulated the release of peroxiredoxin (PRDX) 1, PRDX2, vimentin (VIM), profilin1 (PFN1) and thioredoxin 1 (TXN1). For PRDX1 and TXN1, we were able to confirm that the released protein is glutathionylated. PRDX1, PRDX2 and TXN1 were also released by the human pulmonary epithelial cell line, A549, infected with influenza virus. The release of the proteins identified was inhibited by the anti-inflammatory glucocorticoid, dexamethasone (DEX), which also inhibited tumor necrosis factor (TNF)-alpha release, and by thiol antioxidants (N-butanoyl GSH derivative, GSH-C4, and N-acetylcysteine (NAC), which did not affect TNF-alpha production. The proteins identified could be useful as biomarkers of oxidative stress associated with inflammation, and further studies will be required to investigate if the extracellular forms of these proteins has immunoregulatory functions.	[Checconi, Paola] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, I-00185 Rome, Italy; [Checconi, Paola; Salzano, Sonia; Mullen, Lisa; Mengozzi, Manuela; Ghezzi, Pietro] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Bowler, Lucas] Univ Brighton, Pharm & Biomol Sci, Brighton, E Sussex, England; [Hanschmann, Eva-Maria; Lillig, Christopher Horst] Ernst Moritz Arndt Univ Greifswald, Univ Med, Inst Med Biochem & Mol Biol, Greifswald, Germany; [Sgarbanti, Rossella; Panella, Simona; Palamara, Anna Teresa] Telemat Univ, IRCSS San Raffaele Pisana, Rome, Italy; [Panella, Simona; Nencioni, Lucia; Palamara, Anna Teresa] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; University of Brighton; University of Sussex; University of Brighton; Ernst Moritz Arndt Universitat Greifswald; IRCCS San Raffaele Pisana; Fondazione Cenci Bolognetti; Sapienza University Rome	Ghezzi, P (corresponding author), Brighton & Sussex Med Sch, Brighton, E Sussex, England.	p.ghezzi@bsms.ac.uk	Nencioni, Lucia/K-5988-2016; Hanschmann, Eva-Maria/AAS-9261-2021; Lillig, Christopher Horst/AAD-7098-2019; Checconi, Paola/K-6655-2016; Checconi, Paola/AAH-1985-2019	Nencioni, Lucia/0000-0003-4427-4823; Lillig, Christopher Horst/0000-0003-2509-5117; Checconi, Paola/0000-0001-7518-5730; Checconi, Paola/0000-0001-7518-5730; Mullen, Lisa/0000-0001-8278-2226; PALAMARA, ANNA TERESA/0000-0001-8330-4381; Mengozzi, Manuela/0000-0003-4466-395X; Ghezzi, Pietro/0000-0003-0911-8358; Bowler, Lucas/0000-0002-7004-8021; Sgarbanti, Rossella/0000-0002-8028-0027	RM Phillips Charitable Trust; European Development Fund; Interreg Project Peptide Research Network of Excellence, Perene; EU COST action EU-ROS; Deutsche Forschungsgemeinschaft (DFG) [SFB593-N01]; von Behring-Rontgen Foundation; Italian Ministry of Instruction, University and Research [PON 0101802]; Institute Pasteur/Cenci-Bolognetti Foundation, Rome	RM Phillips Charitable Trust; European Development Fund; Interreg Project Peptide Research Network of Excellence, Perene; EU COST action EU-ROS; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); von Behring-Rontgen Foundation; Italian Ministry of Instruction, University and Research(Ministry of Education, Universities and Research (MIUR)); Institute Pasteur/Cenci-Bolognetti Foundation, Rome	This work was supported by the RM Phillips Charitable Trust (to PG), European Development Fund, Interreg Project Peptide Research Network of Excellence, Perene (to PG), the EU COST action EU-ROS (to PG), the Deutsche Forschungsgemeinschaft (DFG SFB593-N01 to CHL), the von Behring-Rontgen Foundation (to CHL), the Italian Ministry of Instruction, University and Research (grant number PON 0101802 to ATP). PC was supported by a fellowship from the Institute Pasteur/Cenci-Bolognetti Foundation, Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1990, J CLIN INVEST, V85, P739, DOI 10.1172/JCI114499; Amatore D, 2015, CELL MICROBIOL, V17, P131, DOI 10.1111/cmi.12343; Andersen JF, 1997, BIOCHEMISTRY-US, V36, P13979, DOI 10.1021/bi971004s; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; BIANCHI M, 1993, CYTOKINE, V5, P525, DOI 10.1016/1043-4666(93)90045-7; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Chang JW, 2005, FEBS LETT, V579, P2873, DOI 10.1016/j.febslet.2005.04.028; Checconi P, 2013, INT J MOL SCI, V14, P4148, DOI 10.3390/ijms14024148; Coppo L, 2011, BIOCHEM SOC T, V39, P1268, DOI 10.1042/BST0391268; Cuello F, 2014, MOL CELL PROTEOMICS, V13, P2545, DOI 10.1074/mcp.M114.039446; Davis DA, 1997, J BIOL CHEM, V272, P25935, DOI 10.1074/jbc.272.41.25935; El Eter E, 2014, CELL STRESS CHAPERON, V19, P173, DOI 10.1007/s12192-013-0442-y; ERROI A, 1992, AGENTS ACTIONS, V36, P66, DOI 10.1007/BF01991230; FAHEY RC, 1977, J MOL EVOL, V10, P155, DOI 10.1007/BF01751808; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Geiben-Lynn R, 2003, J BIOL CHEM, V278, P1569, DOI 10.1074/jbc.M209964200; Ghezzi P, 2013, BBA-GEN SUBJECTS, V1830, P3165, DOI 10.1016/j.bbagen.2013.02.009; Go YM, 2013, J BIOL CHEM, V288, P26512, DOI 10.1074/jbc.R113.464131; Godoy JR, 2011, BBA-GEN SUBJECTS, V1810, P2, DOI 10.1016/j.bbagen.2010.05.006; HENNET T, 1992, J GEN VIROL, V73, P39, DOI 10.1099/0022-1317-73-1-39; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; Huang HW, 2008, J MED INVESTIG, V55, P133, DOI 10.2152/jmi.55.133; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Klein-Scory S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-70; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Laragione T, 2006, BIOL CHEM, V387, P1371, DOI 10.1515/BC.2006.172; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meza J.E., 2004, IMPROVED TRYPTIC DIG; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Mullen L, 2015, MOL MED, V21, DOI 10.2119/molmed.2015.00033; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P2688, DOI 10.1073/pnas.041624998; Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje; Nencioni L, 2011, CURR PHARM DESIGN, V17, P3898, DOI 10.2174/138161211798357728; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Palamara Anna Teresa, 2004, Antiviral Chemistry & Chemotherapy, V15, P83; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Rossi L, 2012, BLOOD, V120, P2365, DOI 10.1182/blood-2012-04-422378; Sahaf B, 2000, ANTIOXID REDOX SIGN, V2, P717, DOI 10.1089/ars.2000.2.4-717; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schweigert Florian J, 2004, Proteome Sci, V2, P5, DOI 10.1186/1477-5956-2-5; Sgarbanti R, 2011, ANTIOXID REDOX SIGN, V15, P593, DOI 10.1089/ars.2010.3512; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; STAAL FJT, 1992, LANCET, V339, P909, DOI 10.1016/0140-6736(92)90939-Z; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; THOR H, 1982, J BIOL CHEM, V257, P2419; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Thuy TBP, 2011, MICROBIOL IMMUNOL, V55, P874, DOI 10.1111/j.1348-0421.2011.00396.x; Tilleman K, 2008, RHEUMATOLOGY, V47, P597, DOI 10.1093/rheumatology/ken077; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	71	52	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127086	10.1371/journal.pone.0127086	http://dx.doi.org/10.1371/journal.pone.0127086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985305	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000354917300089
J	Pereira-Azevedo, N; Carrasquinho, E; de Oliveira, EC; Cavadas, V; Osorio, L; Fraga, A; Castelo-Branco, M; Roobol, MJ				Pereira-Azevedo, Nuno; Carrasquinho, Eduardo; de Oliveira, Eduardo Cardoso; Cavadas, Vitor; Osorio, Luis; Fraga, Avelino; Castelo-Branco, Miguel; Roobol, Monique J.			mHealth in Urology: A Review of Experts' Involvement in App Development	PLOS ONE			English	Review							SOCIAL MEDIA; SMARTPHONE APPLICATION	Introduction Smartphones are increasingly playing a role in healthcare and previous studies assessing medical applications (apps) have raised concerns about lack of expert involvement and low content accuracy. However, there are no such studies in Urology. We reviewed Urology apps with the aim of assessing the level of participation of healthcare professionals (HCP) and scientific Urology associations in their development. Material and Methods A systematic search was performed on PubMed, Apple's App Store and Google's Play Store, for Urology apps, available in English. Apps were reviewed by three graders to determine the app's platform, target customer, developer, app type, app category, price and the participation of a HCP or a scientific Urology association in the development. Results The search yielded 372 apps, of which 150 were specific for Urology. A fifth of all apps had no HCP involvement (20.7%) and only a third had been developed with a scientific Urology association (34.7%). The lowest percentage of HCP (13.4%) and urological association (1.9%) involvement was in apps designed for the general population. Furthermore, there was no contribution from an Urology society in "Electronic Medical Record" nor in "Patient Information" apps. A limitation of the study is that only Android and iOS apps were reviewed. Conclusions Despite the increasing Mobile Health (mHealth) market, this is the first study that demonstrates the lack of expert participation in the design of Urology apps, particularly in apps designed for the general public. Until clear regulation is enforced, the urological community should help regulate app development. Maintaining a register of certified apps or issuing an official scientific seal of approval could improve overall app quality. We propose that urologists become stakeholders in mHealth, shaping future app design and promoting peer-review app validation.	[Pereira-Azevedo, Nuno; Castelo-Branco, Miguel] Univ Beira Interior, Fac Hlth Sci, Covilha, Portugal; [Carrasquinho, Eduardo; de Oliveira, Eduardo Cardoso] Espirito Santo Hosp, Dept Urol, Evora, Portugal; [Pereira-Azevedo, Nuno; Cavadas, Vitor; Osorio, Luis; Fraga, Avelino] Porto Hosp Ctr, Dept Urol, Porto, Portugal; [Roobol, Monique J.] Erasmus Univ, Erasmus Med Ctr, Rotterdam, Netherlands	Universidade da Beira Interior; Erasmus University Rotterdam; Erasmus MC	Pereira-Azevedo, N (corresponding author), Univ Beira Interior, Fac Hlth Sci, Covilha, Portugal.	nuno@pereira-azevedo.com	Castelo-Branco, Miguel/F-3866-2019; Sousa, Miguel Castelo-branco/F-7869-2010	Castelo-Branco, Miguel/0000-0003-4364-6373; Sousa, Miguel Castelo-branco/0000-0002-6191-5912; Pereira Azevedo, Nuno/0000-0002-0442-6565; Ferreira, Avelino/0000-0002-2999-0963				American Urological Association, SOCIAL MEDIA BEST PR; Ang WJJ, 2014, OPER NEUROSURG, V10, P57, DOI 10.1227/NEU.0000000000000010; Bahsoun AN, 2013, J SURG EDUC, V70, P161, DOI 10.1016/j.jsurg.2012.08.008; Boxall NE, 2014, EMERG MED J, V31, P608, DOI 10.1136/emermed-2014-203809; Brewer AC, 2013, JAMA DERMATOL, V149, P1300, DOI 10.1001/jamadermatol.2013.5517; Buijink Arthur Willem Gerard, 2013, Evid Based Med, V18, P90, DOI 10.1136/eb-2012-100885; Cantudo-Cuenca Ma R, 2014, Farm Hosp, V38, P112; Carter T, 2013, ANN VASC SURG, V27, P804, DOI 10.1016/j.avsg.2012.10.013; de la Vega R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101312; Food and Drug Administration, 2011, FDA PROPOSES HEALTH; Gaglani SM, 2014, ACAD MED, V89, P1207, DOI 10.1097/ACM.0000000000000361; Greene JA, 2010, NEW ENGL J MED, V363, P2087, DOI 10.1056/NEJMp1004986; Hsi RS, 2013, J SEX MED, V10, P1867, DOI 10.1111/jsm.12136; Johnson EK, 2014, J UROLOGY, V192, P908, DOI 10.1016/j.juro.2014.03.099; Kiranantawat K, 2014, PLAST RECONSTR SURG, V134, P130, DOI 10.1097/PRS.0000000000000276; Kwok Roberta, 2013, Nature, V498, P395; Lin YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098312; Matta R, 2014, J UROLOGY, V192, P494, DOI 10.1016/j.juro.2014.02.043; McCartney M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1811; Mobasheri MH, 2014, BREAST, V23, P683, DOI 10.1016/j.breast.2014.07.006; Murphy DG, 2014, BJU INT, V114, P9, DOI 10.1111/bju.12788; Pellegrini CA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1041; Research2Guidance, 2013, THE MOBILE HEALTH GL, V3; Roupret M, 2014, EUR UROL, V66, P628, DOI 10.1016/j.eururo.2014.06.046; Visvanathan A, 2012, CLIN MICROBIOL INFEC, V18, pE218, DOI 10.1111/j.1469-0691.2012.03892.x; Wolf JA, 2013, JAMA DERMATOL, V149, P422, DOI 10.1001/jamadermatol.2013.2382; World Health Organization, 2011, GLOBAL OBSERVATORY F, V3	27	27	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125547	10.1371/journal.pone.0125547	http://dx.doi.org/10.1371/journal.pone.0125547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984916	gold, Green Published, Green Submitted			2022-12-27	WOS:000354917300020
J	Warif, NMA; Stoitzner, P; Leggatt, GR; Mattarollo, SR; Frazer, IH; Hibma, MH				Warif, Nor Malia Abd; Stoitzner, Patrizia; Leggatt, Graham R.; Mattarollo, Stephen R.; Frazer, Ian H.; Hibma, Merilyn H.			Langerhans Cell Homeostasis and Activation Is Altered in Hyperplastic Human Papillomavirus Type 16 E7 Expressing Epidermis	PLOS ONE			English	Article							DERMAL DENDRITIC CELLS; CERVICAL INTRAEPITHELIAL NEOPLASIA; REGULATORY T-CELLS; IN-VIVO; COSTIMULATORY MOLECULES; DOWN-REGULATION; SKIN; ANTIGEN; CARCINOMA; MIGRATION	It has previously been shown that expression of human papillomavirus type 16 (HPV) E7 in epidermis causes hyperplasia and chronic inflammation, characteristics of pre-malignant lesions. Importantly, E7-expressing epidermis is strongly immune suppressed and is not rejected when transplanted onto immune competent mice. Professional antigen presenting cells are considered essential for initiation of the adaptive immune response that results in graft rejection. Langerhans cells (LC) are the only antigen presenting cells located in normal epidermis and altered phenotype and function of these cells may contribute to the immune suppressive microenvironment. Here, we show that LC are atypically activated as a direct result of E7 expression in the epidermis, and independent of the presence of lymphocytes. The number of LC was significantly increased and the LC are functionally impaired, both in migration and in antigen uptake. However when the LC were extracted from K14E7 skin and matured in vitro they were functionally competent to present and cross-present antigen, and to activate T cells. The ability of the LC to present and cross-present antigen following maturation supports retention of full functional capacity when removed from the hyperplastic skin microenvironment. As such, opportunities are afforded for the development of therapies to restore normal LC function in hyperplastic skin.	[Warif, Nor Malia Abd; Leggatt, Graham R.; Mattarollo, Stephen R.; Frazer, Ian H.] Univ Queensland, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld 4102, Australia; [Stoitzner, Patrizia] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria; [Hibma, Merilyn H.] Univ Otago, Dept Pathol, Dunedin, New Zealand	University of Queensland; Medical University of Innsbruck; University of Otago	Frazer, IH (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia.	ian.frazer@tri.edu.au	Leggatt, Graham/G-1924-2010; Frazer, Ian/A-1137-2007	Leggatt, Graham/0000-0002-4078-5653; stoitzner, patrizia/0000-0002-8488-6704; Frazer, Ian/0000-0002-8002-4680	NIH [5U01CA141583]; National Health and Medical Research Council of Australia [569938]; Australian Research Council; Cancer Council Queensland; Australian Cancer Research Foundation; Cancer Society of New Zealand; Health Research Council of New Zealand; Ministry of Higher Education Malaysia; NATIONAL CANCER INSTITUTE [U01CA141583] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cancer Council Queensland(Cancer Council Queensland); Australian Cancer Research Foundation; Cancer Society of New Zealand; Health Research Council of New Zealand(Health Research Council of New Zealand); Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NIH (5U01CA141583), National Health and Medical Research Council of Australia (569938), Australian Research Council, Cancer Council Queensland, Australian Cancer Research Foundation, Cancer Society of New Zealand and the Health Research Council of New Zealand. Nor Malia Abd Warif is the recipient of a Ppostgraduate Sscholarship from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA S, 1990, J IMMUNOL, V145, P2791; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bellette BM, 2003, IMMUNOLOGY, V110, P466, DOI 10.1111/j.1365-2567.2003.01759.x; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Campaner AB, 2007, ACTA OBSTET GYN SCAN, V86, P361, DOI 10.1080/00016340601133871; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Douillard P, 2005, J INVEST DERMATOL, V125, P983, DOI 10.1111/j.0022-202X.2005.23951.x; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gosmann C, 2014, J INVEST DERMATOL, V134, P2562, DOI 10.1038/jid.2014.201; Gueiros LA, 2012, OR SURG OR MED OR PA, V113, P661, DOI 10.1016/j.oooo.2011.12.008; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Koch F, 2001, METH MOLEC MED, V64, P43, DOI 10.1385/1-59259-150-7:43; Tran LS, 2014, J INVEST DERMATOL, V134, P2438, DOI 10.1038/jid.2014.186; Lim W, 2005, J IMMUNOL, V175, P5690, DOI 10.4049/jimmunol.175.9.5690; Luckashenak N, 2013, J IMMUNOL, V190, P27, DOI 10.4049/jimmunol.1201082; Mattarollo SR, 2010, J IMMUNOL, V184, P1242, DOI 10.4049/jimmunol.0902191; Matthews K, 2003, J VIROL, V77, P8378, DOI 10.1128/JVI.77.15.8378-8385.2003; MCARDLE JP, 1986, AM J OBSTET GYNECOL, V154, P509, DOI 10.1016/0002-9378(86)90592-2; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001; Nishibu A, 2006, J INVEST DERMATOL, V126, P787, DOI 10.1038/sj.jid.5700107; Noordegraaf M, 2010, J INVEST DERMATOL, V130, P2752, DOI 10.1038/jid.2010.223; Obhrai JS, 2008, J INVEST DERMATOL, V128, P1950, DOI 10.1038/jid.2008.52; Ozawa H, 1996, J INVEST DERMATOL, V106, P441, DOI 10.1111/1523-1747.ep12343589; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; ROMANI N, 1989, J INVEST DERMATOL, V93, P600, DOI 10.1111/1523-1747.ep12319727; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Schuller E, 2001, ARCH DERMATOL RES, V293, P448, DOI 10.1007/s004030100263; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sparber F, 2010, IMMUNOBIOLOGY, V215, P770, DOI 10.1016/j.imbio.2010.05.014; Stoitzner P, 1999, J LEUKOCYTE BIOL, V66, P462, DOI 10.1002/jlb.66.3.462; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; TEUNISSEN MBM, 1990, J INVEST DERMATOL, V94, P166, DOI 10.1111/1523-1747.ep12874439; Tindle RW, 2001, J VIROL, V75, P5985, DOI 10.1128/JVI.75.13.5985-5997.2001; van Kempen LCL, 2002, DIFFERENTIATION, V70, P610, DOI 10.1046/j.1432-0436.2002.700914.x; Wang B, 1999, J IMMUNOL, V162, P277	45	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127155	10.1371/journal.pone.0127155	http://dx.doi.org/10.1371/journal.pone.0127155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992642	gold, Green Submitted, Green Published			2022-12-27	WOS:000354917300095
J	Ahmad, A; Niwa, Y; Goto, S; Kobayashi, K; Shimizu, M; Ito, S; Usui, Y; Nakayama, T; Kobayashi, H				Ahmad, Aftab; Niwa, Yasuo; Goto, Shingo; Kobayashi, Kyoko; Shimizu, Masanori; Ito, Sohei; Usui, Yumiko; Nakayama, Tsutomu; Kobayashi, Hirokazu			Genome-Wide Screening of Salt Tolerant Genes by Activation-Tagging Using Dedifferentiated Calli of Arabidopsis and Its Application to Finding Gene for Myo-Inositol-1-P-Synthase	PLOS ONE			English	Article							PHYTIC-ACID; HIGH-SALINITY; MEDIATED TRANSFORMATION; MYOINOSITOL METABOLISM; COMPATIBLE SOLUTES; STRESS TOLERANCE; CALCIUM SENSOR; THALIANA; PLANTS; DROUGHT	Salinity represents a major abiotic stress factor that can adversely limit the production, quality and geographical distribution of crops. In this study we focused on dedifferentiated calli with fundamental cell functions, the salt tolerance of which had not been previously examined. The experimental approach was based on activation tagging without regeneration of plants for the identification of salt-tolerant mutants of Arabidopsis. Among 62,000 transformed calli that were screened, 18 potential mutants resistant to 150 mM NaCl were obtained. Thermal asymmetric interlaced (TAIL)-PCR was performed to determine the location of T-DNA integration in the genome. In one line, referred to as salt tolerant callus 1 (stc1), expression of a gene [At4g39800: myo-inositol-1-P-synthase 1 (MIPS1)] was considerably enhanced in calli. Plants regenerated from calli showed tolerance to salt in germination and subsequent growth. Retransformation of wild-type Arabidopsis with MIPS1 conferred salt tolerance, indicating that MIPS1 is the causal gene. The over-expression of MIPS1 increased the content of total inositol. The involvement of MIPS1 in salt tolerance through the fundamental cell growth has been proved in Arabidopsis.	[Ahmad, Aftab; Niwa, Yasuo; Goto, Shingo; Kobayashi, Kyoko; Shimizu, Masanori; Kobayashi, Hirokazu] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Plant Mol Improvement, Suruga Ku, Shizuoka 4228529, Japan; [Ito, Sohei] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Prot Engn, Suruga Ku, Shizuoka 4228529, Japan; [Usui, Yumiko; Nakayama, Tsutomu] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Mol Fooineering, Suruga Ku, Shizuoka 4228529, Japan	University of Shizuoka; University of Shizuoka; University of Shizuoka	Kobayashi, H (corresponding author), Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Plant Mol Improvement, Suruga Ku, 52-1 Yada, Shizuoka 4228529, Japan.	hirokoba@u-shizuoka-ken.ac.jp	Kobayashi, Hirokazu/E-7903-2010; Goto, Shingo/AAU-4777-2021; Ito, Sohei/M-5930-2019; Ahmad, Aftab/L-9718-2015	Kobayashi, Hirokazu/0000-0002-8040-0826; Goto, Shingo/0000-0002-2298-7016; Ito, Sohei/0000-0002-9937-3100; Ahmad, Aftab/0000-0002-2792-9771	COE Program [20022007]; Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [20072012]; Salt Science Research Foundation; University of Shizuoka; University of Shizuoka Grants for Scientific and Educational Research; MEXT; Global COE Program	COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Salt Science Research Foundation; University of Shizuoka; University of Shizuoka Grants for Scientific and Educational Research; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Grants-in-Aid, COE Program in the 21st Century (20022007) and from the Global COE Program (20072012) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, http://www.mext.go.jp/english/), Project Research Grant of the Salt Science Research Foundation (http://www.saltscience.or.jp/english.html), Goto Research Grant from the University of Shizuoka, and the University of Shizuoka Grants for Scientific and Educational Research. AA was a recipient of a scholarship for foreign research students from MEXT. AA and MS were postdoctoral fellows supported by the Global COE Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2001, FEBS LETT, V508, P438, DOI 10.1016/S0014-5793(01)03123-4; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Biswas B B, 1984, Subcell Biochem, V10, P237; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Chalfun A, 2003, FEBS LETT, V555, P459, DOI 10.1016/S0014-5793(03)01300-0; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hatzack F, 2001, BIOCHEM J, V354, P473, DOI 10.1042/0264-6021:3540473; HAYASHI H, 1992, SCIENCE, V258, P1350, DOI 10.1126/science.1455228; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Ishitani M, 1996, PLANT J, V9, P537, DOI 10.1046/j.1365-313X.1996.09040537.x; Isono K, 1997, P NATL ACAD SCI USA, V94, P14948, DOI 10.1073/pnas.94.26.14948; Ito Y, 2001, GENESIS, V30, P231, DOI 10.1002/gene.1069; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Larson SR, 1998, THEOR APPL GENET, V97, P141, DOI 10.1007/s001220050878; Larson SR, 2000, CROP SCI, V40, P1397, DOI 10.2135/cropsci2000.4051397x; Lee CW, 2009, PLANT CELL, V21, P2948, DOI 10.1105/tpc.108.064576; LEE KY, 1988, EMBO J, V7, P1241, DOI 10.1002/j.1460-2075.1988.tb02937.x; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Liu YG, 2005, METH MOL B, V286, P341; Loewus F. A., 1982, Encyclopedia of plant physiology. New series. Volume 13 A. Plant carbohydrates.I. Intracellular carbohydrates [Loewus, R.A.; Tanner, W. (Editors)], P193; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; Lott J.N.A., 1995, SEED DEV GERMINATION, P215; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; MAGA JA, 1982, J AGR FOOD CHEM, V30, P1, DOI 10.1021/jf00109a001; Majee M, 2004, J BIOL CHEM, V279, P28539, DOI 10.1074/jbc.M310138200; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; MUNNS R, 1993, PLANT CELL ENVIRON, V16, P15, DOI 10.1111/j.1365-3040.1993.tb00840.x; Nelson DE, 1998, PLANT CELL, V10, P753; Niwa Y, 2006, PLANT CELL PHYSIOL, V47, P319, DOI 10.1093/pcp/pci242; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Quan RD, 2007, PLANT CELL, V19, P1415, DOI 10.1105/tpc.106.042291; RABOY V, 1987, PLANT PHYSIOL, V85, P841, DOI 10.1104/pp.85.3.841; Raboy V, 2001, J PLANT PHYSIOL, V158, P489, DOI 10.1078/0176-1617-00361; Raboy V, 2000, PLANT PHYSIOL, V124, P355, DOI 10.1104/pp.124.1.355; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; SERRANO R, 1994, CRIT REV PLANT SCI, V13, P121, DOI 10.1080/713608057; Shen B, 1997, PLANT PHYSIOL, V115, P527, DOI 10.1104/pp.115.2.527; Shen B, 1997, PLANT PHYSIOL, V113, P1177, DOI 10.1104/pp.113.4.1177; Sheveleva E, 1997, PLANT PHYSIOL, V115, P1211, DOI 10.1104/pp.115.3.1211; Shi JR, 2005, PLANT J, V42, P708, DOI 10.1111/j.1365-313X.2005.02412.x; Smart CC, 1997, PLANT MOL BIOL, V33, P811, DOI 10.1023/A:1005754425440; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Stein AJ, 2002, J BIOL CHEM, V277, P9484, DOI 10.1074/jbc.M109371200; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; TARCZYNSKI MC, 1993, SCIENCE, V259, P508, DOI 10.1126/science.259.5094.508; THOMAS JC, 1995, PLANT CELL ENVIRON, V18, P801, DOI 10.1111/j.1365-3040.1995.tb00584.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsugane K, 1999, PLANT CELL, V11, P1195, DOI 10.1105/tpc.11.7.1195; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wilcox JR, 2000, CROP SCI, V40, P1601, DOI 10.2135/cropsci2000.4061601x; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	61	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0115502	10.1371/journal.pone.0115502	http://dx.doi.org/10.1371/journal.pone.0115502			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978457	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100001
J	Cheong, WC; Kang, HR; Yoon, H; Kang, SJ; Ting, JPY; Song, MJ				Cheong, Woo-Chang; Kang, Hye-Ri; Yoon, Hyunyee; Kang, Suk-Jo; Ting, Jenny P. -Y.; Song, Moon Jung			Influenza A Virus NS1 Protein Inhibits the NLRP3 Inflammasome	PLOS ONE			English	Article							PRE-MESSENGER-RNAS; NF-KAPPA-B; ADAPTIVE IMMUNITY; HUMAN MACROPHAGES; NUCLEAR EXPORT; CELL-DEATH; IN-VIVO; INTERFERON; INNATE; GENE	The inflammasome is a molecular platform that stimulates the activation of caspase-1 and the processing of pro-interleukin (IL)-1 beta and pro-IL-18 for secretion. The NOD-like receptor family, pyrin domain containing 3 (NLRP3) protein is activated by diverse molecules and pathogens, leading to the formation of the NLRP3 inflammasome. Recent studies showed that the NLRP3 inflammasome mediates innate immunity against influenza A virus (IAV) infection. In this study, we investigated the function of the IAV non-structural protein 1 (NS1) in the modulation of NLRP3 inflammasome. We found that NS1 proteins derived from both highly pathogenic and low pathogenic strains efficiently decreased secretion of IL-1 alpha and IL-18 from THP-1 cells treated with LPS and ATP. NS1 overexpression significantly impaired the transcription of proinflammatory cytokines by inhibiting transactivation of the nuclear factor-kappa B (NF-kappa B), a major transcription activator. Furthermore, NS1 physically interacted with endogenous NLRP3 and activation of the NLRP3 inflammasome was abrogated in NS1-expressing THP-1 cells. These findings suggest that NS1 downregulates NLRP3 inflammasome activation by targeting NLRP3 as well as NF-kappa B, leading to a reduction in the levels of inflammatory cytokines as a viral immune evasion strategy.	[Cheong, Woo-Chang; Kang, Hye-Ri; Yoon, Hyunyee; Song, Moon Jung] Korea Univ, Coll Life Sci & Biotechnol, Dept Biosyst & Biotechnol, Virus Host Interact Lab,Div Biotechnol, Seoul 136713, South Korea; [Yoon, Hyunyee] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Prot Immunol, Seoul 110744, South Korea; [Kang, Suk-Jo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Dept Genet, Chapel Hill, NC 27599 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Inflammatory Dis Inst, Chapel Hill, NC 27599 USA	Korea University; Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Song, MJ (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Dept Biosyst & Biotechnol, Virus Host Interact Lab,Div Biotechnol, Seoul 136713, South Korea.	moonsong@korea.ac.kr	Kang, Suk-Jo/C-1796-2011	Song, Moon Jung/0000-0003-3649-6987	National Research Foundation - Korean Government [NRF-2012R1A1A2004532]; Korean Ministry of Science, ICT and future planning (MSIP) [NRF-2011-0020334, NRF-2012M3A9B4027955]; NIH [AI109965, AI109784, AI067798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, U19AI109965, U19AI109784] Funding Source: NIH RePORTER	National Research Foundation - Korean Government(Korean Government); Korean Ministry of Science, ICT and future planning (MSIP); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Research Foundation Grants funded by the Korean Government (NRF-2012R1A1A2004532 to M.J.S.), by the Korean Ministry of Science, ICT and future planning (MSIP) (NRF-2011-0020334 and NRF-2012M3A9B4027955 to S-J.K.), and by NIH U19 grants (AI109965, AI109784 and AI067798 to J.P.Y.T.).	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brodsky IE, 2009, SEMIN IMMUNOL, V21, P199, DOI 10.1016/j.smim.2009.05.007; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Chua MA, 2013, CELL REP, V3, P23, DOI 10.1016/j.celrep.2012.12.010; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Fernandez-Sesma A., 2007, Infectious Disorders - Drug Targets, V7, P336, DOI 10.2174/187152607783018754; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gao SJ, 2012, CELL MICROBIOL, V14, P1849, DOI 10.1111/cmi.12005; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Kang HR, 2014, J VIROL, V88, P6832, DOI 10.1128/JVI.03460-13; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Li YZ, 2001, RNA, V7, P920, DOI 10.1017/S1355838201010226; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Wu NC, 2013, J VIROL, V87, P1193, DOI 10.1128/JVI.01658-12	47	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126456	10.1371/journal.pone.0126456	http://dx.doi.org/10.1371/journal.pone.0126456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978411	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100069
J	Kenez, A; Kulcsar, A; Kluge, F; Benbelkacem, I; Hansen, K; Locher, L; Meyer, U; Rehage, J; Danicke, S; Huber, K				Kenez, Akos; Kulcsar, Anna; Kluge, Franziska; Benbelkacem, Idir; Hansen, Kathrin; Locher, Lena; Meyer, Ulrich; Rehage, Juergen; Daenicke, Sven; Huber, Korinna			Changes of Adipose Tissue Morphology and Composition during Late Pregnancy and Early Lactation in Dairy Cows	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; FAT-CELL TURNOVER; LIPID-METABOLISM; ENERGY-INTAKE; TRANSITION PERIOD; BODY CONDITION; GENETIC MERIT; DEPOTS; LIVER; PHOSPHORYLATION	Dairy cows mobilize large amounts of body fat during early lactation to overcome negative energy balance which typically arises in this period. As an adaptation process, adipose tissues of cows undergo extensive remodeling during late pregnancy and early lactation. The objective of the present study was to characterize this remodeling to get a better understanding of adaptation processes in adipose tissues, affected by changing metabolic conditions including lipid mobilization and refilling as a function of energy status. This was done by determining adipocyte size in histological sections of subcutaneous and retroperitoneal adipose tissue biopsy samples collected from German Holstein cows at 42 days prepartum, and 1, 21, and 100 days postpartum. Characterization of cell size changes was extended by the analysis of DNA, triacylglycerol, and protein content per gram tissue, and beta-actin protein expression in the same samples. In both adipose tissue depots cell size was becoming smaller during the course of the study, suggesting a decrease in cellular triacylglycerol content. Results of DNA, triacylglycerol, and protein content, and beta-actin protein expression could only partially explain the observed differences in cell size. The retroperitoneal adipose tissue exhibited a greater extent of time-related differences in cell size, DNA, and protein content, suggesting greater dynamics and metabolic flexibility for this abdominal depot compared to the investigated subcutaneous depot.	[Kenez, Akos; Hansen, Kathrin; Huber, Korinna] Univ Vet Med, Dept Physiol, Hannover, Germany; [Kulcsar, Anna; Kluge, Franziska] Szent Istvan Univ, Fac Vet Sci, Dept Physiol & Biochem, Budapest, Hungary; [Benbelkacem, Idir] Higher Natl Vet Sch, Algiers, Algeria; [Locher, Lena] Univ Munich, Ctr Vet Clin Med, Clin Ruminants Ambulatory & Herd Hlth Serv, Oberschleissheim, Germany; [Meyer, Ulrich; Daenicke, Sven] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Germany; [Rehage, Juergen] Univ Vet Med, Clin Cattle, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Hungarian University of Agriculture & Life Sciences; University of Munich; Friedrich Loeffler Institute; University of Veterinary Medicine Hannover, Foundation	Huber, K (corresponding author), Univ Vet Med, Dept Physiol, Hannover, Germany.	korinna.huber@tiho-hannover.de	Kenéz, Ákos/AAX-4134-2020	Kenéz, Ákos/0000-0002-9041-3452	German Research Foundation (DFG) [DA 558/6-1]; German Academic Exchange Service (DAAD)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Funding: This study was funded by the German Research Foundation (DFG, www.dfg.de), grant number: DA 558/6-1. The PhD studies of AK were funded by the German Academic Exchange Service (DAAD, www.daad.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CJ, 1981, J HISTOCHEM CYTOCHEM, V29, P326, DOI 10.1177/29.2.7252122; Akter SH, 2011, J DAIRY SCI, V94, P2871, DOI 10.3168/jds.2010-3868; Albrecht E, 2015, MEAT SCI, V100, P237, DOI 10.1016/j.meatsci.2014.10.012; Drackley JK, 2005, ITAL J ANIM SCI, V4, P323, DOI 10.4081/ijas.2005.323; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Goff JP, 1997, J DAIRY SCI, V80, P1260, DOI 10.3168/jds.S0022-0302(97)76055-7; Haussler S, 2013, RES VET SCI, V95, P1142, DOI 10.1016/j.rvsc.2013.07.004; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; Koltes DA, 2011, J DAIRY SCI, V94, P1839, DOI 10.3168/jds.2010-3769; Locher LF, 2012, J DAIRY SCI, V95, P2497, DOI 10.3168/jds.2011-4830; Locher LF, 2011, J DAIRY SCI, V94, P4514, DOI 10.3168/jds.2011-4145; Loor JJ, 2013, ANIM PROD SCI, V53, P931, DOI 10.1071/AN12344; MCNAMARA JP, 1986, J DAIRY SCI, V69, P3032, DOI 10.3168/jds.S0022-0302(86)80766-4; MCNAMARA JP, 1986, J LIPID RES, V27, P150; McNamara JP, 1995, J DAIRY SCI, V78, P2782, DOI 10.3168/jds.S0022-0302(95)76909-0; MCNAMARA JP, 1991, J DAIRY SCI, V74, P706, DOI 10.3168/jds.S0022-0302(91)78217-9; MCNAMARA JP, 1994, J NUTR, V124, pS1383, DOI 10.1093/jn/124.suppl_8.1383S; Pires JAA, 2013, J DAIRY SCI, V96, P6423, DOI 10.3168/jds.2013-6801; REID IM, 1986, ANIM PROD, V43, P7, DOI 10.1017/S0003356100018298; ROBELIN J, 1986, LIVEST PROD SCI, V14, P349, DOI 10.1016/0301-6226(86)90014-X; Rocco SM, 2013, J DAIRY SCI, V96, P3108, DOI 10.3168/jds.2012-6097; SMITH SB, 1984, J NUTR, V114, P792, DOI 10.1093/jn/114.4.792; SMITH TR, 1990, J DAIRY SCI, V73, P772, DOI 10.3168/jds.S0022-0302(90)78730-9; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tamminga S, 1997, LIVEST PROD SCI, V52, P31, DOI 10.1016/S0301-6226(97)00115-2; Vernon RG, 2005, J DAIRY RES, V72, P460, DOI 10.1017/S0022029905001299; Vernon RG, 1981, LIPID METAB RUMIN AN, V1, P279; von Soosten D, 2011, J DAIRY SCI, V94, P2859, DOI 10.3168/jds.2010-3851; WALTNER SS, 1994, J DAIRY SCI, V77, P2570, DOI 10.3168/jds.S0022-0302(94)77198-8	29	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127208	10.1371/journal.pone.0127208	http://dx.doi.org/10.1371/journal.pone.0127208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978720	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100137
J	Palhares, RM; Drummond, MG; Brasil, BDAF; Cosenza, GP; Brandao, MDL; Oliveira, G				Palhares, Rafael Melo; Drummond, Marcela Goncalves; Alves Figueiredo Brasil, Bruno dos Santos; Cosenza, Gustavo Pereira; Lins Brandao, Maria das Gracas; Oliveira, Guilherme			Medicinal Plants Recommended by the World Health Organization: DNA Barcode Identification Associated with Chemical Analyses Guarantees Their Quality	PLOS ONE			English	Article							AUTHENTICATION; CONSERVATION; PRODUCTS	Medicinal plants are used throughout the world, and the regulations defining their proper use, such as identification of the correct species and verification of the presence, purity and concentration of the required chemical compounds, are widely recognized. Herbal medicines are made from vegetal drugs, the processed products of medicinal species. These processed materials present a number of challenges in terms of botanical identification, and according to the World Health Organization (WHO), the use of incorrect species is a threat to consumer safety. The samples used in this study consisted of the dried leaves, flowers and roots of 257 samples from 8 distinct species approved by the WHO for the production of medicinal herbs and sold in Brazilian markets. Identification of the samples in this study using DNA barcoding (matK, rbcL and ITS2 regions) revealed that the level of substitutions may be as high as 71%. Using qualitative and quantitative chemical analyses, this study identified situations in which the correct species was being sold, but the chemical compounds were not present. Even more troubling, some samples identified as substitutions using DNA barcoding contained the chemical compounds from the correct species at the minimum required concentration. This last situation may lead to the use of unknown species or species whose safety for human consumption remains unknown. This study concludes that DNA barcoding should be used in a complementary manner for species identification with chemical analyses to detect and quantify the required chemical compounds, thus improving the quality of this class of medicines.	[Palhares, Rafael Melo] Univ Fed Minas Gerais, Programa Posgrad Genet, Belo Horizonte, MG, Brazil; [Palhares, Rafael Melo] Univ Fed Minas Gerais, Programa Posgrad Genet, Belo Horizonte, MG, Brazil; [Palhares, Rafael Melo; Drummond, Marcela Goncalves] Myleus Biotechnol Res Team, Belo Horizonte, MG, Brazil; [Palhares, Rafael Melo; Oliveira, Guilherme] Fiocruz MS, Ctr Pesquisa Rene Rachou, Grp Genom & Biol Computac, Belo Horizonte, MG, Brazil; [Alves Figueiredo Brasil, Bruno dos Santos] EMBRAPA Agroenergia, Brasilia, DF, Brazil; [Cosenza, Gustavo Pereira; Lins Brandao, Maria das Gracas] Univ Fed Minas Gerais, Fac Farm, Lab Farmacognosia, Belo Horizonte, MG, Brazil; [Lins Brandao, Maria das Gracas] Univ Fed Minas Gerais, CEPLAMT, Museu Hist Nat & Jardim Bot, Belo Horizonte, MG, Brazil; [Lins Brandao, Maria das Gracas] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Palhares, RM (corresponding author), Univ Fed Minas Gerais, Programa Posgrad Genet, Belo Horizonte, MG, Brazil.	rafael.melopalhares@gmail.com	Brasil, Bruno S. A. F./E-8817-2012; Oliveira, Guilherme/E-2624-2014	Brasil, Bruno S. A. F./0000-0002-8690-2157; Lins Brandao, Maria das Gracas/0000-0003-0351-8625; Oliveira, Guilherme/0000-0003-0054-3438; Palhares, Rafael/0000-0003-2512-8273	CNPq (Conselho Nacional de Pesquisa - Brasil) [INCT 573899/2008-8]; CAPES; FAPEMIG (Fundacao de apoio a pesquisa do Estado de Minas Gerais Brasil) [INCT APQ-0084/08]; CNPQ [300702/2012-4, 143127/2011-0]	CNPq (Conselho Nacional de Pesquisa - Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG (Fundacao de apoio a pesquisa do Estado de Minas Gerais Brasil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: This project was funded by CNPq (Conselho Nacional de Pesquisa - Brasil) (INCT 573899/2008-8), CAPES and FAPEMIG (Fundacao de apoio a pesquisa do Estado de Minas Gerais Brasil) (INCT APQ-0084/08). MGD is grateful to CNPQ for the research fellowship provided (process number 300702/2012-4). RMP is grateful to CNPQ for the research fellowship provided (process number 143127/2011-0). The funding agencies played no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberton M, 2002, REV BRAS FARMACOGNO, V12, P3; ANVISA. Agencia Nacional de Vigilancia Sanitaria (Brasil), 2008, INSTR NORM N 5 11 DE; Aslanargun P, 2012, J ANESTH, V26, P39, DOI 10.1007/s00540-011-1265-6; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Begossi A, 2002, HUM ECOL, V30, P281, DOI 10.1023/A:1016564217719; Brandao MGL, 2010, ENVIRON MONIT ASSESS, V164, P369, DOI 10.1007/s10661-009-0899-4; Brower V, 2008, J NATL CANCER I, V100, P838, DOI 10.1093/jnci/djn199; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; Butnariu M, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-35; Carvalho D, 2008, REV BRAS REPROD ANIM, V32, P5; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chuang H, 2011, BOT STUD, V52, P13; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; da Silva JB, 2011, INT J MOL SCI, V12, P8993, DOI 10.3390/ijms12128993; Dalmacio LMM, 2011, BENEF MICROBES, V2, P273, DOI 10.3920/BM2011.0017; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Doulaty B, 2007, J HORTIC SCI, V82, P8; Drummond M, 2013, FOOD CONTROL, V29, P7; Eschricher W, 1988, PULVER ATLAS DROGEN; Fajardo V, 2010, TRENDS FOOD SCI TECH, V21, P408, DOI 10.1016/j.tifs.2010.06.002; Ferri G, 2015, FORENSIC SCI INT-GEN, V15, P131, DOI 10.1016/j.fsigen.2014.10.005; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Grassi F, 2006, PLANT BIOSYST, V140, P17, DOI 10.1080/11263500500500747; Guo XR, 2011, BIOL PHARM BULL, V34, P1198, DOI 10.1248/bpb.34.1198; Gurib-Fakim A., 2006, MOL ASPECTS MED, V27, P1, DOI [10.1016/j.mam.2005.07.008, DOI 10.1016/J.MAM.2005.07.008]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanlidou E, 2004, J ETHNOPHARMACOL, V91, P281, DOI 10.1016/j.jep.2004.01.007; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HERENDEEN PS, 1995, ADV LEGUM SYSTEMAT, P123; Heubl G, 2010, PLANTA MED, V76, P1963, DOI 10.1055/s-0030-1250519; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Ibrahim MA, 2013, P NATL ACAD SCI USA, V110, P16832, DOI 10.1073/pnas.1311528110; Kumar P, 2009, PLANT OMICS, V2, P23; Laiou A, 2013, ZOOKEYS, P197, DOI 10.3897/zookeys.365.5670; Langhammer L, 1989, BILDATLAS MIKROSCOPI; Lima N, 2002, SCI AGR, V1, P20; Brandao MDL, 2013, ENVIRON MONIT ASSESS, V185, P7013, DOI 10.1007/s10661-013-3081-y; Little DP, 2014, MOL ECOL RESOUR, V14, P437, DOI 10.1111/1755-0998.12194; Little DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081008; Mahadani P, 2013, DNA BARCODES, V4; Mane B, 2009, FOOD CHEM, V116, P5; Mankga LT, 2013, ZOOKEYS, P215, DOI 10.3897/zookeys.365.5730; Ministerio do Meio Ambiente, 2008, INSTR NORM SET 2008; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Newmaster SG, 2009, INT J COMPUT APPL T, V35, P50, DOI 10.1504/IJCAT.2009.024595; Nithaniyal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107669; Oliveira F, 1991, FARMACOGNOSIA; Palhares RM, 2014, J ETHNOPHARMACOL, V155, P815, DOI 10.1016/j.jep.2014.06.040; Prosdocimi Francisco, 2004, Genet Mol Res, V3, P483; Purushothaman N, 2014, GEN MOL RES, V13, P10; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Seethapathy GS, 2014, INT J LEGAL MED; Shanley P, 2003, BIOSCIENCE, V53, P12; Shikha Srivastava, 2009, Journal of Chemical and Pharmaceutical Research, V1, P1; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Sucher NJ, 2008, PLANTA MED, V74, P603, DOI 10.1055/s-2008-1074517; Surh I, 2013, TOXICOL PATHOL, V41, P770, DOI 10.1177/0192623312464304; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor D.A., 2008, ENVIRON HEALTH PERSP, V116, P21, DOI DOI 10.1289/EHP.10663; Verma SK, 2014, FORENSIC SCI INT, V241, P183, DOI 10.1016/j.forsciint.2014.05.016; Voeks R, 2004, ECON BOT, V58, P13; Wagner H., 1996, PLANT DRUG ANAL THIN; Wallace L, 2012, FOOD RES INT, V49, P8; WHO (World Health Organization), 2010, MON SEL MED PLANTS, V5; WHO (World Health Organization), 2003, MON SEL MED PLANTS, V2; WHO (World Health Organization), 2009, MON SEL MED PLANTS, V4; WHO (World Health Organization), 2007, WHO GUID GOOD AGR CO; WHO (World Health Organization), 1999, MON SEL MED PLANTS, V1; WHO (World Health Organization), 2004, MED PLANTS GUID PROM; WHO (World Health Organization), 2011, TACKL ANT RES FOOD S, V3, P1; WHO (World Health Organization), 2007, MON SEL MED PLANTS, V3; WHO (World Health Organization), 2005, QUAL CONTR METH MED; World Health Organization, 1998, QUAL CONTR METH MED; Zeraik M, 2010, REV BRAS FARMACOGNO, V20, P13; Zheng XW, 2012, FOOD MICROBIOL, V31, P293, DOI 10.1016/j.fm.2012.03.008; Zuccolotto T, 1999, REV INST ADOLFO LUTZ, V58, P1	78	85	90	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127866	10.1371/journal.pone.0127866	http://dx.doi.org/10.1371/journal.pone.0127866			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978064	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100155
J	Altmann, LJP; Stegemoller, E; Hazamy, AA; Wilson, JP; Okun, MS; McFarland, NR; Shukla, AW; Hass, CJ				Altmann, Lori J. P.; Stegemoeller, Elizabeth; Hazamy, Audrey A.; Wilson, Jonathan P.; Okun, Michael S.; McFarland, Nikolaus R.; Shukla, Aparna Wagle; Hass, Chris J.			Unexpected Dual Task Benefits on Cycling in Parkinson Disease and Healthy Adults: A Neuro-Behavioral Model	PLOS ONE			English	Article							GAIT; PERFORMANCE; INTERFERENCE; ATTENTION; WALKING; PEOPLE; MECHANISMS; DISORDERS; EXERCISE; AROUSAL	Background When performing two tasks at once, a dual task, performance on one or both tasks typically suffers. People with Parkinson's disease (PD) usually experience larger dual task decrements on motor tasks than healthy older adults (HOA). Our objective was to investigate the decrements in cycling caused by performing cognitive tasks with a range of difficulty in people with PD and HOAs. Methods Twenty-eight participants with Parkinson's disease and 20 healthy older adults completed a baseline cycling task with no secondary tasks and then completed dual task cycling while performing 12 tasks from six cognitive domains representing a wide range of difficulty. Results Cycling was faster during dual task conditions than at baseline, and was significantly faster for six tasks (all p<.02) across both groups. Cycling speed improved the most during the easiest cognitive tasks, and cognitive performance was largely unaffected. Cycling improvement was predicted by task difficulty (p<.001). People with Parkinson's disease cycled slower (p<.03) and showed reduced dual task benefits (p<.01) than healthy older adults. Conclusions Unexpectedly, participants' motor performance improved during cognitive dual tasks, which cannot be explained in current models of dual task performance. To account for these findings, we propose a model integrating dual task and acute exercise approaches which posits that cognitive arousal during dual tasks increases resources to facilitate motor and cognitive performance, which is subsequently modulated by motor and cognitive task difficulty. This model can explain both the improvement observed on dual tasks in the current study and more typical dual task findings in other studies.	[Altmann, Lori J. P.; Hazamy, Audrey A.; Wilson, Jonathan P.] Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL 32611 USA; [Stegemoeller, Elizabeth; Hass, Chris J.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Okun, Michael S.; McFarland, Nikolaus R.; Shukla, Aparna Wagle] Univ Florida, Dept Neurol & Neurosurg, Gainesville, FL USA; [Altmann, Lori J. P.; Stegemoeller, Elizabeth; Hazamy, Audrey A.; Wilson, Jonathan P.; Okun, Michael S.; McFarland, Nikolaus R.; Shukla, Aparna Wagle; Hass, Chris J.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Stegemoeller, Elizabeth] Iowa State Univ, Dept Kinesiol, Ames, IA USA; [Wilson, Jonathan P.] Midwestern Univ, Dept Speech Language Pathol, Downers Grove, IL 60515 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Iowa State University; Midwestern University	Altmann, LJP (corresponding author), Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL 32611 USA.	laltmann@ufl.edu	Shukla, Aparna Wagle/AAN-1344-2020; McFarland, Nikolaus R/I-4209-2017	McFarland, Nikolaus R/0000-0002-8699-8857; Altmann, Lori/0000-0002-4935-3574; WAGLE SHUKLA, APARNA/0000-0002-9757-9973; Okun, Michael/0000-0002-6247-9358	National Institue on Aging at the National Institutes of Health [R21AG0033284-1A2]; National Parkinson Foundation Center of Excellence located at the University of Florida; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033284] Funding Source: NIH RePORTER	National Institue on Aging at the National Institutes of Health; National Parkinson Foundation Center of Excellence located at the University of Florida; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant R21AG0033284-1A2 from the National Institue on Aging at the National Institutes of Health to LJA, CJH, and MSO. This project was also supported by the National Parkinson Foundation Center of Excellence located at the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Audiffren M., 2009, EXERCISE COGNITIVE F, P3, DOI DOI 10.1002/9780470740668.CH1; Bland W, 2006, AUDACITY FREE DIGITA; BLOEM BR, 1992, CLIN NEUROL NEUROSUR, V94, pS41; Bonanni L, 2010, NEUROL SCI, V31, P751, DOI 10.1007/s10072-010-0403-5; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; COOPER CJ, 1973, ERGONOMICS, V16, P601, DOI 10.1080/00140137308924551; de la Fuente-Fernandez- R, 2002, TRENDS NEUROSCI, V25, P302, DOI 10.1016/S0166-2236(02)02181-1; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Duncan RP, 2011, DISABIL REHABIL, V33, P1440, DOI 10.3109/09638288.2010.533245; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galletly R, 2005, AUST J PHYSIOTHER, V51, P175, DOI 10.1016/S0004-9514(05)70024-6; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Hass CJ, 2005, ARCH PHYS MED REHAB, V86, P2172, DOI 10.1016/j.apmr.2005.05.013; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jarvis B, 2006, DIRECTRT; Kahneman D, 1970, ATTENTION PERFORM, P118; Kelly VE, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/918719, 10.1073/pnas.1207553109]; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Mattis S, 1988, DEMENTIA RATING SCAL; McDowd J., 2000, HDB AGING COGNITION, P221; McMorris T, 2009, INT J PSYCHOPHYSIOL, V73, P334, DOI 10.1016/j.ijpsycho.2009.05.004; Morris ME, 2000, PHYS THER, V80, P578, DOI 10.1093/ptj/80.6.578; Neider MB, 2011, PSYCHOL AGING, V26, P260, DOI 10.1037/a0021566; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Plummer-D'Amato P, 2011, GAIT POSTURE, V33, P233, DOI 10.1016/j.gaitpost.2010.11.011; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; Puglisi-Allegra S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00031; Rochester L, 2014, NEUROSCIENCE, V265, P83, DOI 10.1016/j.neuroscience.2014.01.041; Rogers MW, 1996, CLIN GERIATR MED, V12, P825; Smith EE, 2001, P NATL ACAD SCI USA, V98, P2095, DOI 10.1073/pnas.98.4.2095; Snijders AH, 2012, J NEUROL NEUROSUR PS, V83, P578, DOI 10.1136/jnnp-2011-300375; Snijders AH, 2011, MOVEMENT DISORD, V26, P367, DOI 10.1002/mds.23530; Szot P, 2011, ETIOLOGY PATHOPHYSIO, P247; Tabachnik B. G., 2001, USING MULTIVARIATE S; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Yogev-Seligmann G, 2013, EXP BRAIN RES, V226, P81, DOI 10.1007/s00221-013-3412-9	45	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125470	10.1371/journal.pone.0125470	http://dx.doi.org/10.1371/journal.pone.0125470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970607	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200075
J	Holbrook, SJ; Schmitt, RJ; Messmer, V; Brooks, AJ; Srinivasan, M; Munday, PL; Jones, GP				Holbrook, Sally J.; Schmitt, Russell J.; Messmer, Vanessa; Brooks, Andrew J.; Srinivasan, Maya; Munday, Philip L.; Jones, Geoffrey P.			Reef Fishes in Biodiversity Hotspots Are at Greatest Risk from Loss of Coral Species	PLOS ONE			English	Article							CLIMATE-CHANGE; MARINE BIODIVERSITY; HABITAT; EXTINCTION; DIVERSITY; COMMUNITY; WINNERS; SPECIALIZATION; CONSERVATION; RECRUITMENT	Coral reef ecosystems are under a variety of threats from global change and anthropogenic disturbances that are reducing the number and type of coral species on reefs. Coral reefs support upwards of one third of all marine species of fish, so the loss of coral habitat may have substantial consequences to local fish diversity. We posit that the effects of habitat degradation will be most severe in coral regions with highest biodiversity of fishes due to greater specialization by fishes for particular coral habitats. Our novel approach to this important but untested hypothesis was to conduct the same field experiment at three geographic locations across the Indo-Pacific biodiversity gradient (Papua New Guinea; Great Barrier Reef, Australia; French Polynesia). Specifically, we experimentally explored whether the response of local fish communities to identical changes in diversity of habitat-providing corals was independent of the size of the regional species pool of fishes. We found that the proportional reduction (sensitivity) in fish biodiversity to loss of coral diversity was greater for regions with larger background species pools, reflecting variation in the degree of habitat specialization of fishes across the Indo-Pacific diversity gradient. This result implies that habitat-associated fish in diversity hotspots are at greater risk of local extinction to a given loss of habitat diversity compared to regions with lower species richness. This mechanism, related to the positive relationship between habitat specialization and regional biodiversity, and the elevated extinction risk this poses for biodiversity hotspots, may apply to species in other types of ecosystems.	[Holbrook, Sally J.; Schmitt, Russell J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Holbrook, Sally J.; Schmitt, Russell J.; Brooks, Andrew J.] Univ Calif Santa Barbara, Inst Marine Sci, Coastal Res Ctr, Santa Barbara, CA 93106 USA; [Messmer, Vanessa; Srinivasan, Maya; Munday, Philip L.; Jones, Geoffrey P.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld 4811, Australia; [Srinivasan, Maya; Munday, Philip L.; Jones, Geoffrey P.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; James Cook University; James Cook University	Holbrook, SJ (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	holbrook@lifesci.ucsb.edu	Munday, Philip L/F-5443-2011; Jones, Geoffrey P./E-9306-2010; Srinivasan, Maya/B-6269-2015	Munday, Philip L/0000-0001-9725-2498; Jones, Geoffrey P./0000-0002-6244-1245; Srinivasan, Maya/0000-0002-8035-3417	United States National Science Foundation [OCE 12-36905]; United States National Science Foundation (Moorea Coral Reef LTER); Australian Research Council (ARC Centre of Excellence for Coral Reef Studies); Ian Potter Foundation Fellowship at the Australian Museum's Lizard Island Research Station; Gordon and Betty Moore Foundation; Division Of Ocean Sciences [1236905] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); United States National Science Foundation (Moorea Coral Reef LTER); Australian Research Council (ARC Centre of Excellence for Coral Reef Studies)(Australian Research Council); Ian Potter Foundation Fellowship at the Australian Museum's Lizard Island Research Station; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Work was supported by funds from the United States National Science Foundation (OCE 12-36905 and earlier awards, Moorea Coral Reef LTER; www.nsf.gov), the Australian Research Council (ARC Centre of Excellence for Coral Reef Studies, www.arc.gov.au), an Ian Potter Foundation Fellowship at the Australian Museum's Lizard Island Research Station (www.lizardisland.com.au) and the Gordon and Betty Moore Foundation (www.moore.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Best RJ, 2014, ECOLOGY, V95, P1308, DOI 10.1890/13-1480.1; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Brooks AJ, 2015, PLOS ONE, DOI [10.6073/pasta/0745bc0e052daa76fe5383616855a74b, DOI 10.6073/PASTA/0745BC0E052DAA76FE5383616855A74B]; Bruno JF, 2014, SCIENCE, V345, P879, DOI 10.1126/science.1258556; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Feary DA, 2007, MAR ECOL PROG SER, V333, P243, DOI 10.3354/meps333243; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holbrook SJ, 2008, MAR ECOL PROG SER, V371, P263, DOI 10.3354/meps07690; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P1045, DOI 10.1071/MF02063; Holbrook SJ, 2000, OECOLOGIA, V122, P109, DOI 10.1007/PL00008826; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hughes TP, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.037; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kindt R., 2005, WORLD; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2012, P NATL ACAD SCI USA, V109, P17734, DOI 10.1073/pnas.1215836109; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Messmer V, 2011, ECOLOGY, V92, P2285, DOI 10.1890/11-0037.1; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Newbold T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1371; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pratchett MS, 2012, ECOL EVOL, V2, P2168, DOI 10.1002/ece3.321; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; R Core Team, 2013, LANG ENV STAT COMP; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Schmitt RJ, 2000, ECOLOGY, V81, P3479, DOI 10.1890/0012-9658(2000)081[3479:HLROCR]2.0.CO;2; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stier AC, 2014, ECOLOGY, V95, P1294, DOI 10.1890/12-1441.1; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Venables WN., 2002, MODERN APPL STAT S 4; Veron J. E., 2000, CORALS WORLD, V1; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wilson SK, 2010, J EXP BIOL, V213, P894, DOI 10.1242/jeb.037895; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x	53	35	35	3	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124054	10.1371/journal.pone.0124054	http://dx.doi.org/10.1371/journal.pone.0124054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970588	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200025
J	Zhang, YJ; Li, D; Sun, BY				Zhang, Yijuan; Li, Ding; Sun, Bingyun			Do Housekeeping Genes Exist?	PLOS ONE			English	Article							RNA-SEQ; SEQUENCING TECHNOLOGIES; EXPRESSION; GENOME; IDENTIFICATION; MICROARRAY; MOUSE; TRANSCRIPTOME; INTEGRATION; SELECTION	The searching of human housekeeping (HK) genes has been a long quest since the emergence of transcriptomics, and is instrumental for us to understand the structure of genome and the fundamentals of biological processes. The resolved genes are frequently used in evolution studies and as normalization standards in quantitative gene-expression analysis. Within the past 20 years, more than a dozen HK-gene studies have been conducted, yet none of them sampled human tissues completely. We believe an integration of these results will help remove false positive genes owing to the inadequate sampling. Surprisingly, we only find one common gene across 15 examined HK-gene datasets comprising 187 different tissue and cell types. Our subsequent analyses suggest that it might not be appropriate to rigidly define HK genes as expressed in all tissue types that have diverse developmental, physiological, and pathological states. It might be beneficial to use more robustly identified HK functions for filtering criteria, in which the representing genes can be a subset of genome. These genes are not necessarily the same, and perhaps need not to be the same, everywhere in our body.	[Sun, Bingyun] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Sun, BY (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	bingyun_sun@sfu.ca			China Scholarship Council; Mitacs Globalink program; Simon Fraser University; Compute Canada; Stem Cell Networks of Canada	China Scholarship Council(China Scholarship Council); Mitacs Globalink program; Simon Fraser University; Compute Canada; Stem Cell Networks of Canada	Y. Z. and D. L. would like to acknowledge the financial support from China Scholarship Council and Mitacs Globalink program. This work is supported by Simon Fraser University startup fund, Compute Canada, and Stem Cell Networks of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; BOHM SK, 1995, BIOCHEM J, V311, P835; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Bonner John Tyler, 1998, Integrative Biology, V1, P27; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Chen ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054082; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; COHEN PTW, 1973, NATURE-NEW BIOL, V241, P229; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Eichenlaub-Ritter U, 2002, HUM REPROD UPDATE, V8, P21, DOI 10.1093/humupd/8.1.21; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Eksi R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003314; Eller CD, 2007, GENE, V390, P153, DOI 10.1016/j.gene.2006.09.018; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hitzemann R, 2013, GENES BRAIN BEHAV, V12, P1, DOI 10.1111/gbb.12007; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hurd PJ, 2009, BRIEFINGS FUNCTIONAL; Jain M, 2007, NUCLEIC ACIDS RES, V35, P2074, DOI 10.1093/nar/gkm081; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jin P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-55; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kemphues K, 2005, ESSENTIAL GENES; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li HD, 2014, TRENDS GENET, V30, P340, DOI 10.1016/j.tig.2014.05.005; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; McGettigan PA, 2013, CURR OPIN CHEM BIOL, V17, P4, DOI 10.1016/j.cbpa.2012.12.008; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Murphy RM, 2003, PHYSIOL GENOMICS, V12, P163, DOI 10.1152/physiolgenomics.00060.2002; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; Podder S, 2009, GENE, V439, P11, DOI 10.1016/j.gene.2009.03.005; Ponjavic J, 2007, BIOESSAYS, V29, P1077, DOI 10.1002/bies.20669; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Reinertsen T, 2012, APMIS, V120, P558, DOI 10.1111/j.1600-0463.2011.02865.x; Reverter A, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-8; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; Sharma VK, 2007, PHYSIOL GENOMICS, V31, P96, DOI 10.1152/physiolgenomics.00183.2006; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sollazzo V, 2011, INT J PERIODONT REST, V31, pE17; Steele BK, 2002, ANAL BIOCHEM, V307, P341, DOI 10.1016/S0003-2697(02)00045-3; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Watson JD, 1965, MOL BIOL GENE, V1; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	93	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123691	10.1371/journal.pone.0123691	http://dx.doi.org/10.1371/journal.pone.0123691			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970694	Green Submitted, Green Published, gold			2022-12-27	WOS:000354544200017
J	Ahmed, SS; Oviedo-Orta, E; Mekaru, SR; Freifeld, CC; Tougas, G; Brownstein, JS				Ahmed, S. Sohail; Oviedo-Orta, Ernesto; Mekaru, Sumiko R.; Freifeld, Clark C.; Tougas, Gervais; Brownstein, John S.			Surveillance for Neisseria meningitidis Disease Activity and Transmission Using Information Technology	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; HEALTHMAP; OUTBREAKS; VACCINES	Background While formal reporting, surveillance, and response structures remain essential to protecting public health, a new generation of freely accessible, online, and real-time informatics tools for disease tracking are expanding the ability to raise earlier public awareness of emerging disease threats. The rationale for this study is to test the hypothesis that the HealthMap informatics tools can complement epidemiological data captured by traditional surveillance monitoring systems for meningitis due to Neisseria meningitides (N. meningitides) by highlighting severe transmissible disease activity and outbreaks in the United States. Methods Annual analyses of Neisseria meningitides disease alerts captured by HealthMap were compared to epidemiological data captured by the Centers for Disease Control's Active Bacterial Core surveillance (ABCs) for Neisseria meningitides. Morbidity and mortality case reports were measured annually from 2010 to 2013 (HealthMap) and 2005 to 2012 (ABCs). Findings HealthMap Neisseria meningitides monitoring captured 80-90% of alerts as diagnosed Neisseria meningitides, 5-20% of alerts as suspected cases, and 5-10% of alerts as related news articles. HealthMap disease alert activity for emerging disease threats related to Neisseria meningitides were in agreement with patterns identified historically using traditional surveillance systems. HealthMap's strength lies in its ability to provide a cumulative "snapshot" of weak signals that allows for rapid dissemination of knowledge and earlier public awareness of potential outbreak status while formal testing and confirmation for specific serotypes is ongoing by public health authorities. Conclusions The underreporting of disease cases in internet-based data streaming makes inadequate any comparison to epidemiological trends illustrated by the more comprehensive ABCs network published by the Centers for Disease Control. However, the expected delays in compiling confirmatory reports by traditional surveillance systems (at the time of writing, ABCs data for 2013 is listed as being provisional) emphasize the helpfulness of real-time internet-based data streaming to quickly fill gaps including the visualization of modes of disease transmission in outbreaks for better resource and action planning. HealthMap can also contribute as an internet-based monitoring system to provide real-time channel for patients to report intervention-related failures.	[Ahmed, S. Sohail; Oviedo-Orta, Ernesto] Novartis Vaccines Srl, Global Clin Sci, Siena, Italy; [Mekaru, Sumiko R.; Freifeld, Clark C.; Brownstein, John S.] Harvard Mit Div Hlth Sci & Technol, Computat Epidemiol Grp, Childrens Hosp, Informat Program, Boston, MA USA; [Tougas, Gervais] Novartis Pharma AG, Drug Safety & Epidemiol, Basel, Switzerland; [Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston Childrens Hosp, Boston, MA 02115 USA	Novartis; Harvard University; Boston Children's Hospital; Novartis; Harvard University; Boston Children's Hospital; Harvard Medical School	Ahmed, SS (corresponding author), GSK, Global Clin Sci, Siena, Italy.	sohail.q.ahmed@gsk.com	OVIEDO-ORTA, Ernesto/L-4846-2018	OVIEDO-ORTA, Ernesto/0000-0003-1323-3316; Mekaru, Sumiko/0000-0002-9782-3833	National Library of Medicine [5 R01 LM010812-04]; Novartis; NATIONAL LIBRARY OF MEDICINE [R01LM010812] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Novartis(Novartis); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Drs. Brownstein, Mekaru, and Freifeld are supported by grant 5 R01 LM010812-04 from the National Library of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other sources of funding have supported this work. Novartis provided support in the form of salaries for authors (SSA, EOO, GT), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Bilukha O, 2007, PEDIATR INFECT DIS J, V26, P371, DOI 10.1097/01.inf.0000259996.95965.ef; Bona G, 2012, CLIN MANAG ISSUES, V6, P59, DOI 10.7175/cmi.v6i2.627; Brooks R, 2006, CLIN INFECT DIS, V43, P49, DOI 10.1086/504804; Brownstein J., 2007, EUROSURVEILLANCE, V12, DOI DOI 10.2807/ESW.12.48.03322-EN5; Brownstein John S, 2006, AMIA Annu Symp Proc, P866; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Brownstein JS, 2007, GLOBAL INFECT DIS SU, DOI [10.1371/journal.pone.0006954, DOI 10.1371/J0URNAL.P0NE.0006954]; Centers for Disease Control and Prevention, 2013, ACT BACT COR SURV RE; Centers for Disease Control and Prevention, 2014, MEN DIS UPD; Centers for Disease Control and Prevention, 1998, MMWR-MORBID MORTAL W, V47, P833; Centers for Disease Control and Prevention, 2013, SANT BARB MEN DIS OU; Centers for Disease Control and Prevention, 2012, MEN DIS EP PREV VACC, P193; Chacon-Cruz E, 2011, EMERG INFECT DIS, V17, P543, DOI 10.3201/eid1703.101254; Chunara R, 2012, PARASITOLOGY, V139, P1843, DOI 10.1017/S0031182012000923; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Erickson LJ, 2001, CLIN INFECT DIS, V33, P737, DOI 10.1086/322587; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Freifeld CC, 2014, DRUG SAFETY, V37, P343, DOI 10.1007/s40264-014-0155-x; Freifeld CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000376; Hartley Dm, 2010, Emerg Health Threats J, V3, pe3, DOI 10.3134/ehtj.10.003; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Jackson LA, 1996, PEDIATR INFECT DIS J, V15, P992, DOI 10.1097/00006454-199611000-00012; Magee M, 2013, MENINGITIS WARNING S; Mandal S, 2013, CLIN INFECT DIS, V57, P344, DOI 10.1093/cid/cit243; SAFADI MA, 2012, EPIDEMIOL INFECT, P1, DOI DOI 10.1017/S0950268812002245; Salvadori MI, 2011, PAED CHILD HEALT-CAN, V16, P485, DOI 10.1093/pch/16.8.485; Scales David, 2013, Emerg Health Threats J, V6, P21621, DOI 10.3402/ehtj.v6i0.21621; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]	31	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127406	10.1371/journal.pone.0127406	http://dx.doi.org/10.1371/journal.pone.0127406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992552	Green Published, gold, Green Submitted			2022-12-27	WOS:000354921400115
J	Bauman, AG; Guest, JR; Dunshea, G; Low, J; Todd, PA; Steinberg, PD				Bauman, Andrew G.; Guest, James R.; Dunshea, Glenn; Low, Jeffery; Todd, Peter A.; Steinberg, Peter D.			Coral Settlement on a Highly Disturbed Equatorial Reef System	PLOS ONE			English	Article							SCLERACTINIAN CORALS; CARIBBEAN CORAL; POSTSETTLEMENT MORTALITY; LARVAL SETTLEMENT; SPATIAL-PATTERNS; RECRUITMENT; SURVIVAL; REPRODUCTION; ABUNDANCE; SEDIMENT	Processes occurring early in the life stages of corals can greatly influence the demography of coral populations, and successful settlement of coral larvae that leads to recruitment is a critical life history stage for coral reef ecosystems. Although corals in Singapore persist in one the world's most anthropogenically impacted reef systems, our understanding of the role of coral settlement in the persistence of coral communities in Singapore remains limited. Spatial and temporal patterns of coral settlement were examined at 7 sites in the southern islands of Singapore, using settlement tiles deployed and collected every 3 months from 2011 to 2013. Settlement occurred year round, but varied significantly across time and space. Annual coral settlement was low (similar to 54.72 spat m(-2) yr(-1)) relative to other equatorial regions, but there was evidence of temporal variation in settlement rates. Peak settlement occurred between March-May and September-November, coinciding with annual coral spawning periods (March-April and October), while the lowest settlement occurred from December-February during the northeast monsoon. A period of high settlement was also observed between June and August in the first year (2011/12), possibly due to some species spawning outside predicted spawning periods, larvae settling from other locations or extended larval settlement competency periods. Settlement rates varied significantly among sites, but spatial variation was relatively consistent between years, suggesting the strong effects of local coral assemblages or environmental conditions. Pocilloporidae were the most abundant coral spat (83.6%), while Poritidae comprised only 6% of the spat, and Acroporidae <1%. Other, unidentifiable families represented 10% of the coral spat. These results indicate that current settlement patterns are reinforcing the local adult assemblage structure ('others'; i.e. sediment-tolerant coral taxa) in Singapore, but that the replenishment capacity of Singapore's reefs appears relatively constrained, which could lead to less resilient reefs.	[Bauman, Andrew G.; Guest, James R.; Steinberg, Peter D.] Nanyang Technol Univ, Nanyang Environm & Water Res Inst, Adv Environm Biotechnol Ctr, Singapore 639798, Singapore; [Guest, James R.; Steinberg, Peter D.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Guest, James R.; Steinberg, Peter D.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Dunshea, Glenn] Ecol Marine Serv, Burnett Heads, Qld, Australia; [Low, Jeffery] Natl Pk Board, Natl Biodivers Ctr, Singapore, Singapore; [Todd, Peter A.] Natl Univ Singapore, Dept Biol Sci, Expt Marine Ecol Lab, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of New South Wales Sydney; University of New South Wales Sydney; National University of Singapore	Bauman, AG (corresponding author), Natl Univ Singapore, Dept Biol Sci, Expt Marine Ecol Lab, Singapore 117548, Singapore.	andrew.bauman@nus.edu.sg	Todd, Peter A/H-8410-2012; Guest, James/D-5179-2011	Guest, James/0000-0002-9714-9009; Steinberg, Peter/0000-0002-1781-0726; Dunshea, Glenn/0000-0002-8683-0181; Bauman, Andrew/0000-0001-9260-2153	Advanced Environmental Biotechnology Centre; Nanyang Technological University; Centre for Marine Bio-Innovation, University of New South Wales	Advanced Environmental Biotechnology Centre; Nanyang Technological University(Nanyang Technological University); Centre for Marine Bio-Innovation, University of New South Wales	This work was funded by the Advanced Environmental Biotechnology Centre, Nanyang Technological University and the Centre for Marine Bio-Innovation, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson A, 2005, MAR POLLUT BULL, V50, P576, DOI 10.1016/j.marpolbul.2005.02.021; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Babcock R, 1985, P 5 INT COR REEF S, V4, P355; Babcock RC, 2003, ZOOL STUD, V42, P211; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2012, 12 INT COR REEF S CA, P5; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Bauman AG, 2014, MAR ECOL PROG SER, V499, P115, DOI 10.3354/meps10662; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Carey G, 2012, P 12 INT COR REEF S; Chen M, 2005, J COASTAL RES, V21, P960, DOI 10.2112/04-0412.1; Chia L.S., 1988, ICLARM TECHNICAL REP; Chong-Seng KM, 2014, CORAL REEFS, V33, P449, DOI 10.1007/s00338-014-1137-2; Chou L. M., 1996, Galaxea, V13, P85; Chuang SH, 1977, P 3 INT COR REEF S M, V1, P545; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Dikou A, 2006, MAR POLLUT BULL, V52, P7, DOI 10.1016/j.marpolbul.2005.07.021; Eagle Janelle V., 2012, Galaxea - Tokyo, V14, P5; Edmunds PJ, 2001, MAR BIOL, V139, P981; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferse SCA, 2013, RESTOR ECOL, V21, P745, DOI 10.1111/rec.12004; FISK DA, 1990, MAR BIOL, V107, P485, DOI 10.1007/BF01313433; Foster NL, 2007, J ANIM ECOL, V76, P384, DOI 10.1111/j.1365-2656.2006.01207.x; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gilmour J, 1999, MAR BIOL, V135, P451, DOI 10.1007/s002270050645; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gin KYH, 2000, J PLANKTON RES, V22, P1465, DOI 10.1093/plankt/22.8.1465; Glassom D, 2004, MAR BIOL, V144, P641, DOI 10.1007/s00227-003-1243-0; Golbuu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050998; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Guest JR, 2012, CORAL REEFS, V31, P705, DOI 10.1007/s00338-012-0881-4; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Guest JR, 2005, INVERTEBR REPROD DEV, V48, P207, DOI 10.1080/07924259.2005.9652186; Guest JR, 2005, CORAL REEFS, V24, P112, DOI 10.1007/s00338-004-0433-7; Harriott VJ, 1999, B MAR SCI, V65, P881; Harrison P.L., 1990, P133; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Huang DW, 2009, RAFFLES B ZOOL, P69; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Mangubhai S, 2007, MAR ECOL PROG SER, V348, P149, DOI 10.3354/meps07090; MILICICH MJ, 1994, MAR ECOL PROG SER, V110, P135, DOI 10.3354/meps110135; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; R Core Team, 2021, R LANGUAGE ENV STAT; Richmond Robert H., 1997, P175; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROMATZKI S, 2009, CONTRIBUTIONS REEF R; Sawall Y, 2013, MAR POLLUT BULL, V74, P374, DOI 10.1016/j.marpolbul.2013.06.022; Sin LC, 2012, EFFECT BENTHIC MACRO, P89; SMITH SR, 1992, AM ZOOL, V32, P663; Soong K, 2003, CORAL REEFS, V22, P224, DOI 10.1007/s00338-003-0311-8; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Tay YC, 2012, AQUAT BIOL, V15, P283, DOI 10.3354/ab00433; Tay YC, 2011, J EXP MAR BIOL ECOL, V409, P324, DOI 10.1016/j.jembe.2011.09.013; Tebben J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087545; Todd PA, 2004, MAR ECOL PROG SER, V271, P167, DOI 10.3354/meps271167; Tomascik T, 1996, CORAL REEFS, V15, P169, DOI 10.1007/s003380050038; Tun K., 2012, THESIS NATL U SINGAP; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; WALLACE CC, 1985, MAR ECOL PROG SER, V21, P289, DOI 10.3354/meps021289; Willis B. L., 1985, P 5 INT COR REEF C, P343; Zuur Alain F., 2009, P1	89	36	36	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127874	10.1371/journal.pone.0127874	http://dx.doi.org/10.1371/journal.pone.0127874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992562	Green Published, gold			2022-12-27	WOS:000354921400139
J	Hernandez-Montero, JR; Saldana-Vazquez, RA; Galindo-Gonzalez, J; Sosa, VJ				Hernandez-Montero, Jesus R.; Saldana-Vazquez, Romeo A.; Galindo-Gonzalez, Jorge; Sosa, Vinicio J.			Bat-Fruit Interactions Are More Specialized in Shaded-Coffee Plantations than in Tropical Mountain Cloud Forest Fragments	PLOS ONE			English	Article							BIODIVERSITY; LANDSCAPES; FRUGIVORY; BIRDS	Forest disturbance causes specialization of plant-frugivore networks and jeopardizes mutualistic interactions through reduction of ecological redundancy. To evaluate how simplification of a forest into an agroecosystem affects plant-disperser mutualistic interactions, we compared bat-fruit interaction indexes of specialization in tropical montane cloud forest fragments (TMCF) and shaded-coffee plantations (SCP). Bat-fruit interactions were surveyed by collection of bat fecal samples. Bat-fruit interactions were more specialized in SCP (mean H-2'= 0.55) compared to TMCF fragments (mean H-2' = 0.27), and were negatively correlated to bat abundance in SCP (R = -0.35). The number of shared plant species was higher in the TMCF fragments (mean = 1) compared to the SCP (mean = 0.51) and this was positively correlated to the abundance of frugivorous bats (R=0.79). The higher specialization in SCP could be explained by lower bat abundance and lower diet overlap among bats. Coffee farmers and conservation policy makers must increase the proportion of land assigned to TMCF within agroecosystem landscapes in order to conserve frugivorous bats and their invaluable seed dispersal service.	[Hernandez-Montero, Jesus R.; Galindo-Gonzalez, Jorge] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa 91090, Veracruz, Mexico; [Saldana-Vazquez, Romeo A.] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Lab Ecol Paisajes Fragmentados, Morelia 58190, Michoacan, Mexico; [Hernandez-Montero, Jesus R.; Sosa, Vinicio J.] Inst Ecol AC Apdo, Red Ecol Func, Xalapa 91000, Veracruz, Mexico	Universidad Veracruzana; Universidad Nacional Autonoma de Mexico; Instituto de Ecologia - Mexico	Saldana-Vazquez, RA (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Lab Ecol Paisajes Fragmentados, Antigua Carretera Patzcuaro 8701, Morelia 58190, Michoacan, Mexico.	romeo.saldana@gmail.com	Hernández-Montero, Jesús Rafael/E-9581-2011; Saldaña-Vázquez, Romeo A./AAD-2784-2019; Saldaña-Vázquez, Romeo A./R-7154-2019; Galindo-González, Jorge/M-2585-2014; VJ, Sosa/Q-6888-2018	Hernández-Montero, Jesús Rafael/0000-0001-9778-0768; Saldaña-Vázquez, Romeo A./0000-0002-6442-772X; Galindo-González, Jorge/0000-0003-2583-2754; VJ, Sosa/0000-0002-4712-3900	Programa para el Mejoramiento del Profesorado (PROMEP) of the Secretaria de Educacion Publica; CONACYT-SEMARNAT [BIOCAFE 2002-01-C01-00194]; FORDECYT [139378]	Programa para el Mejoramiento del Profesorado (PROMEP) of the Secretaria de Educacion Publica; CONACYT-SEMARNAT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FORDECYT	JRH-M acknowledges scholarship support from the Programa para el Mejoramiento del Profesorado (PROMEP) of the Secretaria de Educacion Publica. RAS-V and VJS were funded by CONACYT-SEMARNAT (grant BIOCAFE 2002-01-C01-00194) and FORDECYT (grant 139378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro-Luna AA, 2012, MAMM BIOL, V77, P32, DOI 10.1016/j.mambio.2011.06.009; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Caras T, 2009, J TROP ECOL, V25, P97, DOI 10.1017/S0266467408005671; Chama L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054956; Colwell RK, 2013, ESTIMATE S STATISTIC; Cortes-Delgado N, 2014, BIOTROPICA, V46, P624, DOI 10.1111/btp.12142; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Dormann C.F., 2008, R NEWS, V8, P8; Forget PM, 2011, ACTA OECOL, V37, P517, DOI 10.1016/j.actao.2011.09.008; Galindo-Gonzalez J, 2009, J TROP ECOL, V25, P205, DOI 10.1017/S0266467409005859; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Gorchov DL, 1995, OIKOS, V74, P235, DOI 10.2307/3545653; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Kelm DH, 2008, J COMP PHYSIOL B, V178, P985, DOI 10.1007/s00360-008-0287-3; Lobova TA, 2009, SEED DISPERSAL BY BA; MacGregor-Fors I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056794; McCune B, 2002, ANALYSIS OF ECOLOGIC; Medellin R, 2008, IDENTIFICACION DE LO; Menke S, 2012, OIKOS, V121, P1553, DOI 10.1111/j.1600-0706.2011.20210.x; Meyer CFJ, 2011, J APPL ECOL, V48, P777, DOI 10.1111/j.1365-2664.2011.01976.x; Muniz-Castro MA, 2006, J TROP ECOL, V22, P431, DOI 10.1017/S0266467406003221; Munoz-Villers LE, 2008, INT J REMOTE SENS, V29, P71, DOI 10.1080/01431160701280967; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Philpott SM, 2008, CONSERV BIOL, V22, P1093, DOI 10.1111/j.1523-1739.2008.01029.x; R Development Core Team S, 2012, R A LANGUAGE AND ENV, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rex K, 2010, ECOSCIENCE, V17, P37, DOI 10.2980/17-1-3294; Mello MAR, 2011, OECOLOGIA, V167, P131, DOI 10.1007/s00442-011-1984-2; Mello MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017395; Saldana-Vazquez RA, 2014, MAMMAL REV, V44, P215, DOI 10.1111/mam.12024; Saldana-Vazquez RA, 2013, MAMM BIOL, V78, P216, DOI 10.1016/j.mambio.2012.08.004; Saldana-Vazquez RA, 2010, BIODIVERS CONSERV, V19, P2111, DOI 10.1007/s10531-010-9829-6; Sanchez MS, 2012, MAMM BIOL, V77, P22, DOI 10.1016/j.mambio.2011.06.002; Soto-Esparza M, 1990, ATLAS CLIMATICO DEL; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; STONE L, 1992, OECOLOGIA, V91, P419, DOI 10.1007/BF00317632; Straube FC, 2002, CHIRO NEOTR, V8, P150, DOI DOI 10.1017/CB09781107415324.004; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Valiente-Banuet A, 2013, FRONT ECOL ENVIRON, V11, P408, DOI 10.1890/130002; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Wagner H., 2013, VEGAN	41	9	12	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126084	10.1371/journal.pone.0126084	http://dx.doi.org/10.1371/journal.pone.0126084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992550	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300034
J	Oguchi, T; Ota, M; Ito, T; Hamano, H; Arakura, N; Katsuyama, Y; Meguro, A; Kawa, S				Oguchi, Takaya; Ota, Masao; Ito, Tetsuya; Hamano, Hideaki; Arakura, Norikazu; Katsuyama, Yoshihiko; Meguro, Akira; Kawa, Shigeyuki			Investigation of Susceptibility Genes Triggering Lachrymal/Salivary Gland Lesion Complications in Japanese Patients with Type 1 Autoimmune Pancreatitis	PLOS ONE			English	Article							SCLEROSING PANCREATITIS; TRANSCRIPTION FACTORS; IGG4 CONCENTRATIONS; FERM DOMAIN; FAMILY; POLYMORPHISMS; ASSOCIATION; POPULATION; DISEASE; BENIGN	Autoimmune pancreatitis (AIP) is a unique form of chronic pancreatitis characterized by high serum IgG4 concentration and a variety of complicating extra-pancreatic lesions. In particular, lachrymal/salivary gland lesions tend to manifest in a highly active AIP disease state, and several genes are speculated to be associated with the onset of this complication. We therefore searched for candidate susceptibility genes related to lachrymal/salivary gland lesions in a genome-wide association study (GWAS) with the GeneChip Human Mapping 500k Array Set (Affymetrix, CA) that was followed by fine mapping of additional single nucleotide polymorphisms (SNPs) in strongly significant genes with TaqMan assays. Venous blood samples were obtained from 50 type 1 AIP patients with lachrymal/salivary gland lesions (A group) and 53 type 1 AIP patients without (B group). The mean values of IgG and IG4 were both significantly different (P<0.05) between the groups. SNPs that showed a significant association with the A group at the genome-wide level (P<0.0001) were identified and subsequently used in fine SNP mapping of candidate genes. In total, five SNPs had a positive association with complicated AIP (most notably rs2284932 [P=0.0000021]) and five SNPs possessed a negative association (particularly rs9371942 [P=0.00000039]). Among them, KLF7, FRMD4B, LOC101928923, and MPPED2 were further examined for complication susceptibility using additional SNPs that were not included in the GWAS. Individual genotyping of KLF7 rs2284932 revealed that the frequency of the minor C allele was significantly increased (P=0.00062, Pc=0.0018, OR=2.98, 95% CI=1.58-5.65) in group A. The minor T allele of rs4473559 in FRMD4 demonstrated a significant association in the A group (P=0.00015, OR=3.38, 95% CI=1.77-7.65). In the LOC101928923 gene, the frequency of the minor C allele of rs4379306 was significantly decreased in group A in both TaqMan and GWAS analyses. Lastly, the minor C allele of MPPED2 rs514644 carried a significantly increased risk of complications. These four genes may be linked with the onset of lachrymal/salivary gland lesions in type 1 AIP patients and require further study.	[Oguchi, Takaya; Ito, Tetsuya; Hamano, Hideaki] Shinshu Univ, Sch Med, Dept Gastroenterol, Matsumoto, Nagano 390, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Arakura, Norikazu] Shinshu Univ Hosp, Endoscop Examinat Ctr, Matsumoto, Nagano, Japan; [Katsuyama, Yoshihiko] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano, Japan; [Meguro, Akira] Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa 232, Japan; [Kawa, Shigeyuki] Shinshu Univ, Ctr Hlth Safety & Environm Management, Matsumoto, Nagano 390, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University; Yokohama City University; Shinshu University	Ota, M (corresponding author), Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan.	otamasao@shinshu-u.ac.jp		Ota, Masao/0000-0002-6400-5658	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23591012]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by a research grant from the Ministry of Health, Labor, and Welfare of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23591012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Erkelens GW, 1999, LANCET, V354, P43, DOI 10.1016/S0140-6736(99)00603-0; Finn SP, 2007, VIRCHOWS ARCH, V450, P249, DOI 10.1007/s00428-006-0348-5; Fujinaga Y, 2010, EUR J RADIOL, V76, P228, DOI 10.1016/j.ejrad.2009.06.010; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hamano H, 2006, J GASTROENTEROL, V41, P1197, DOI 10.1007/s00535-006-1908-9; Hirano K, 2009, J GASTROENTEROL, V44, P799, DOI 10.1007/s00535-009-0080-4; Kamisawa T, 2003, GUT, V52, P683, DOI 10.1136/gut.52.5.683; Kamisawa T, 2013, GUT LIVER, V7, P394, DOI 10.5009/gnl.2013.7.4.394; Kanazawa A, 2005, DIABETOLOGIA, V48, P1315, DOI 10.1007/s00125-005-1797-0; Kanno A, 2012, PANCREAS, V41, P835, DOI 10.1097/MPA.0b013e3182480c99; Kawa S, 2002, GASTROENTEROLOGY, V122, P1264, DOI 10.1053/gast.2002.33022; Kawa S, 2013, AUTOIMMUNE DIS, P935; Klarlund JK, 2001, J BIOL CHEM, V276, P40065, DOI 10.1074/jbc.M105260200; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Liguori L, 2012, CELL CYCLE, V11, P569, DOI 10.4161/cc.11.3.19063; Mazzanti C, 2004, CANCER RES, V64, P2898, DOI 10.1158/0008-5472.CAN-03-3811; Moleirinho S, 2013, BIOCHEM J, V452, P183, DOI 10.1042/BJ20121642; Nakazawa T, 2001, HEPATO-GASTROENTEROL, V48, P625; Ota M, 2007, IMMUNOGENETICS, V59, P45, DOI 10.1007/s00251-006-0178-2; Ota M, 2011, DIS MARKERS, V31, P223, DOI [10.3233/DMA-2011-0820, 10.1155/2011/264747]; Park DH, 2008, GASTROENTEROLOGY, V134, P440, DOI 10.1053/j.gastro.2007.11.023; Schuettpelz LG, 2012, BLOOD, V120, P2981, DOI 10.1182/blood-2012-02-409839; Seitz S, 2006, GENE CHROMOSOME CANC, V45, P612, DOI 10.1002/gcc.20325; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P474, DOI 10.1093/ndt/gfg477; Taniguchi T, 2004, GUT, V53, P770; Umemura T, 2006, GUT, V55, P1367, DOI 10.1136/gut.2006.095059; Umemura T, 2008, AM J GASTROENTEROL, V103, P588, DOI 10.1111/j.1572-0241.2007.01750.x; Umemura T, 2009, HUM IMMUNOL, V70, P742, DOI 10.1016/j.humimm.2009.05.009; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yamamoto M, 2004, SCAND J RHEUMATOL, V33, P432, DOI 10.1080/03009740410006439; Zabel DP, 2009, EUR J ENDOCRINOL, V160, P603, DOI 10.1530/EJE-08-0688	42	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127078	10.1371/journal.pone.0127078	http://dx.doi.org/10.1371/journal.pone.0127078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985088	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300087
J	Van Dycke, KCG; Pennings, JLA; van Oostrom, CTM; van Kerkhof, LWM; van Steeg, H; van der Horst, GTJ; Rodenburg, W				Van Dycke, Kirsten C. G.; Pennings, Jeroen L. A.; van Oostrom, Conny T. M.; van Kerkhof, Linda W. M.; van Steeg, Harry; van der Horst, Gijsbertus T. J.; Rodenburg, Wendy			Biomarkers for Circadian Rhythm Disruption Independent of Time of Day	PLOS ONE			English	Article							CHRONIC JET-LAG; BODY TIME; CD36; EXPRESSION; RISK; DENSITY; PLASMA; HEALTH; WORK	Frequent shift work causes disruption of the circadian rhythm and might on the long-term result in increased health risk. Current biomarkers evaluating the presence of circadian rhythm disturbance (CRD), including melatonin, cortisol and body temperature, require 24hr ("around the clock") measurements, which is tedious. Therefore, these markers are not eligible to be used in large-scale (human) studies. The aim of the present study was to identify universal biomarkers for CRD independent of time of day using a transcriptomics approach. Female FVB mice were exposed to six shifts in a clockwise (CW) and counterclockwise (CCW) CRD protocol and sacrificed at baseline and after 1 shift, 6 shifts, 5 days recovery and 14 days recovery, respectively. At six time-points during the day, livers were collected for mRNA microarray analysis. Using a classification approach, we identified a set of biomarkers able to classify samples into either CRD or non-disrupted based on the hepatic gene expression. Furthermore, we identified differentially expressed genes 14 days after the last shift compared to baseline for both CRD protocols. Non-circadian genes differentially expressed upon both CW and CCW protocol were considered useful, universal markers for CRD. One candidate marker i. e. CD36 was evaluated in serum samples of the CRD animals versus controls. These biomarkers might be useful to measure CRD and can be used later on for monitoring the effectiveness of intervention strategies aiming to prevent or minimize chronic adverse health effects.	[Van Dycke, Kirsten C. G.; Pennings, Jeroen L. A.; van Oostrom, Conny T. M.; van Kerkhof, Linda W. M.; van Steeg, Harry; Rodenburg, Wendy] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands; [Van Dycke, Kirsten C. G.; van der Horst, Gijsbertus T. J.] Erasmus Univ, Med Ctr, Ctr Biomed Genet, Dept Genet, Rotterdam, Netherlands; [van Steeg, Harry] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rodenburg, W (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands.	wendy.rodenburg@rivm.nl	van der Horst, Gijsbertus TJ/E-3661-2015	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Pennings, Jeroen L.A./0000-0002-9188-6358				BARTON J, 1994, OCCUP ENVIRON MED, V51, P749, DOI 10.1136/oem.51.11.749; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boquet A, 2004, AVIAT SPACE ENVIR MD, V75, P898; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; DeFilippis RA, 2012, CANCER DISCOV, V2, P826, DOI 10.1158/2159-8290.CD-12-0107; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Fritschi L, 2011, MED HYPOTHESES, V77, P430, DOI 10.1016/j.mehy.2011.06.002; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Kubo T, 2011, OCCUP ENVIRON MED, V68, P327, DOI 10.1136/oem.2009.054445; McGowan Niall M, 2013, J Mol Psychiatry, V1, P7, DOI 10.1186/2049-9256-1-7; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Mirick DK, 2008, CANCER EPIDEM BIOMAR, V17, P3306, DOI 10.1158/1055-9965.EPI-08-0605; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Neil-Sztramko SE, 2014, SCAND J WORK ENV HEA, V40, P543, DOI 10.5271/sjweh.3445; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pennings JLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018866; Reynolds P, 2002, CANCER CAUSE CONTROL, V13, P317, DOI 10.1023/A:1015284014563; Rifkin R, 2003, SIAM REV, V45, P706, DOI 10.1137/S0036144502411986; Schernhammer ES, 2006, EPIDEMIOLOGY, V17, P108, DOI 10.1097/01.ede.0000190539.03500.c1; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tucker P, 2000, OCCUP ENVIRON MED, V57, P678, DOI 10.1136/oem.57.10.678; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P11227, DOI 10.1073/pnas.0401882101; Uray IP, 2004, CANCER LETT, V207, P101, DOI 10.1016/j.canlet.2003.10.021; van der Veen JW, 2013, TOXICOL IN VITRO, V27, P314, DOI 10.1016/j.tiv.2012.08.023; Vandebriel RJ, 2010, TOXICOL SCI, V117, P81, DOI 10.1093/toxsci/kfq182; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Wang F, 2014, OBES REV, V15, P709, DOI 10.1111/obr.12194; Wang F, 2013, ANN ONCOL, V24, P2724, DOI 10.1093/annonc/mdt283; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	33	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127075	10.1371/journal.pone.0127075	http://dx.doi.org/10.1371/journal.pone.0127075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25984797	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300085
J	Lantschner, MV; Corley, JC				Victoria Lantschner, M.; Corley, Juan C.			Spatial Pattern of Attacks of the Invasive Woodwasp Sirex noctilio, at Landscape and Stand Scales	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; HYMENOPTERA-SIRICIDAE; SPATIOTEMPORAL PATTERNS; FABRICIUS HYMENOPTERA; OUTBREAK POPULATIONS; BIOLOGICAL-CONTROL; SPREAD; PEST; INFESTATIONS; AGGREGATION	Invasive insect pests are responsible for important damage to native and plantation forests, when population outbreaks occur. Understanding the spatial pattern of attacks by forest pest populations is essential to improve our understanding of insect population dynamics and for predicting attack risk by invasives or planning pest management strategies. The woodwasp Sirex noctilio is an invasive woodwasp that has become probably the most important pest of pine plantations in the Southern Hemisphere. Our aim was to study the spatial dynamics of S. noctilio populations in Southern Argentina. Specifically we describe: (1) the spatial patterns of S. noctilio outbreaks and their relation with environmental factors at a landscape scale; and (2) characterize the spatial pattern of attacked trees at the stand scale. We surveyed the spatial distribution of S. noctilio outbreaks in three pine plantation landscapes, and we assessed potential associations with topographic variables, habitat characteristics, and distance to other outbreaks. We also looked at the spatial distribution of attacked trees in 20 stands with different levels of infestation, and assessed the relationship of attacks with stand composition and management. We found that the spatial pattern of pine stands with S. noctilio outbreaks at the landscape scale is influenced mainly by the host species present, slope aspect, and distance to other outbreaks. At a stand scale, there is strong aggregation of attacked trees in stands with intermediate infestation levels, and the degree of attacks is influenced by host species and plantation management. We conclude that the pattern of S. noctilio damage at different spatial scales is influenced by a combination of both inherent population dynamics and the underlying patterns of environmental factors. Our results have important implications for the understanding and management of invasive insect outbreaks in forest systems.	[Victoria Lantschner, M.] INTA EEA Bariloche, CONICET, San Carlos De Bariloche, Rio Negro, Argentina; INTA EEA Bariloche, Grp Ecol Poblaciones Insectos, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Lantschner, MV (corresponding author), INTA EEA Bariloche, CONICET, San Carlos De Bariloche, Rio Negro, Argentina.	lantschner.v@inta.gob.ar	Lantschner, María/GNH-1740-2022	Lantschner, María/0000-0002-2012-1366	UCAR-Ministerio de Agricultura [SaFo-109]; Ganaderia y Pesca, Argentina; Agencia Nacional para la Promocion Cientifica y Tecnologica, Argentina [PICT-2013-0557]	UCAR-Ministerio de Agricultura; Ganaderia y Pesca, Argentina; Agencia Nacional para la Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	Funding came from SaFo-109 - UCAR-Ministerio de Agricultura, Ganaderia y Pesca, Argentina (http://www.ucar.gob.ar/) and PICT-2013-0557 - Agencia Nacional para la Promocion Cientifica y Tecnologica, Argentina to JC (http://www.agencia.mincyt.gob.ar/). Both grants provided funding for study design, data collection and analysis, and preparation of the manuscript.	ASTER GDEM Validation Team, 2009, ASTER GLOB DEM VAL S; Aukema BH, 2004, ECOL ENTOMOL, V29, P129, DOI 10.1111/j.0307-6946.2004.00594.x; Aukema BH, 2008, ECOGRAPHY, V31, P348, DOI 10.1111/j.0906-7590.2007.05453.x; Barros VR, 1983, CARTAS PRECIPITACION; BEERS TW, 1966, J FOREST, V64, P691; Berryman A.A., 1987, P3; Bonneau Laurent R., 1999, Biological Invasions, V1, P255, DOI 10.1023/A:1010021629127; Bordeaux JM, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P31, DOI 10.1007/978-94-007-1960-6_3; Bouchard M, 2014, LANDSCAPE ECOL, V29, P111, DOI 10.1007/s10980-013-9966-x; Bruzzone OA, 2009, J EXP BIOL, V212, P731, DOI 10.1242/jeb.022517; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Carnegie Angus J., 2005, New Zealand Journal of Forestry Science, V35, P3; CFI-FUNDFAEP, 2009, INV BOSQ IMPL PROV N, P63; Chapman TB, 2012, ECOLOGY, V93, P2175, DOI 10.1890/11-1055.1; Corley JC, 2007, ENTOMOL EXP APPL, V125, P231, DOI 10.1111/j.1570-7458.2007.00623.x; Corley JC, 2014, J PEST SCI, V87, P551, DOI 10.1007/s10340-014-0613-3; Corley JC, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P51, DOI 10.1007/978-94-007-1960-6_4; Dodds KJ, 2006, FOREST ECOL MANAG, V231, P119, DOI 10.1016/j.foreco.2006.05.023; Eldridge R. H., 1987, Australian Forestry, V50, P24; Eldridge RH, 1989, FOREST PROTECTION SE; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Fernandez Ajo AA, J APPL ENTO IN PRESS; Fettig CJ, 2007, FOREST ECOL MANAG, V238, P24, DOI 10.1016/j.foreco.2006.10.011; FITZGERALD JW, 1994, J ECON ENTOMOL, V87, P417, DOI 10.1093/jee/87.2.417; Ford TE, 2009, EMERG INFECT DIS, V15, P1341, DOI 10.3201/eid1509.081334; Hatala JA, 2010, REMOTE SENS ENVIRON, V114, P375, DOI 10.1016/j.rse.2009.09.008; Haugen DA, 1990, AUSTR FOREST GROWER, V132, P1; Hoebeke E. R., 2005, Newsletter of the Michigan Entomological Society, V50, P24; Hurley BP, 2007, AGR FOREST ENTOMOL, V9, P159, DOI 10.1111/j.1461-9563.2007.00340.x; Iede E. T., 1998, P C TRAIN CONTR SIR, P45, DOI DOI 10.5962/BHL.TITLE.150181; Iede ET, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P217, DOI 10.1007/978-94-007-1960-6_16; Johnson DM, 2004, ECOL LETT, V7, P967, DOI 10.1111/j.1461-0248.2004.00659.x; Kessler A., 2012, INSECT OUTBREAKS REV, P89; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Liebhold Andrew M., 2012, P113; Logan JA, 1998, THEOR POPUL BIOL, V53, P236, DOI 10.1006/tpbi.1997.1350; Madden J. L., 1968, Proceedings of the Ecological Society of Australia, V3, P147; Madden J.L., 1988, P407; Mermoz M, 2005, ECOLOGY, V86, P2705, DOI 10.1890/04-1850; MITCHELL RG, 1991, FOREST SCI, V37, P1390; Orwig DA, 2002, J BIOGEOGR, V29, P1475, DOI 10.1046/j.1365-2699.2002.00765.x; Aparicio JP, 2013, MATH BIOSCI ENG, V10, P1265, DOI 10.3934/mbe.2013.10.1265; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; Powell J, 1998, J THEOR BIOL, V194, P49, DOI 10.1006/jtbi.1998.0742; Powers JS, 1999, LANDSCAPE ECOL, V14, P105, DOI 10.1023/A:1008017711917; Ryan K, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P15, DOI 10.1007/978-94-007-1960-6_2; SAFRANYIK L, 1992, J APPL ENTOMOL, V113, P441, DOI 10.1111/j.1439-0418.1992.tb00687.x; *SAGPYA, 2001, INV NAC PLANT FOR; Slippers B, 2012, SIREX WOODSWASP ITS; SPRADBERY JP, 1978, B ENTOMOL RES, V68, P341, DOI 10.1017/S0007485300009330; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; TALBOT PHB, 1977, ANNU REV PHYTOPATHOL, V15, P41, DOI 10.1146/annurev.py.15.090177.000353; Tribe GD, 1995, AFR ENTOMOL, V3, P215; Tribe GD, 2004, AFR ENTOMOL, V12, P9; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; TURCHIN P, 1989, ECOLOGY, V70, P1008, DOI 10.2307/1941369; Lantschner MV, 2014, BIOL INVASIONS, V16, P329, DOI 10.1007/s10530-013-0521-0; Villacide JM, 2012, INT J PEST MANAGE, V58, P249, DOI 10.1080/09670874.2012.701022; Wichmann L, 2001, FOREST ECOL MANAG, V148, P31, DOI 10.1016/S0378-1127(00)00477-1; Yemshanov D, 2011, J ENVIRON MANAGE, V92, P205, DOI 10.1016/j.jenvman.2010.09.002	61	20	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127099	10.1371/journal.pone.0127099	http://dx.doi.org/10.1371/journal.pone.0127099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992640	Green Published, gold, Green Submitted			2022-12-27	WOS:000354917300091
J	Zhang, LH; Li, Y; Dai, K; Wen, XT; Wu, R; Huang, XB; Jin, J; Xu, K; Yan, QG; Huang, Y; Ma, XP; Wen, YP; Cao, SJ				Zhang, Luhua; Li, Ying; Dai, Ke; Wen, Xintian; Wu, Rui; Huang, Xiaobo; Jin, Jin; Xu, Kui; Yan, Qigui; Huang, Yong; Ma, Xiaoping; Wen, Yiping; Cao, Sanjie			Establishment of a Successive Markerless Mutation System in Haemophilus parasuis through Natural Transformation	PLOS ONE			English	Article							SERUM-RESISTANCE; SC096 STRAIN; GENETIC MANIPULATION; PROTEIN; INVASION; EXPRESSION; ADHERENCE; VIRULENCE; ADHESION; SEQUENCE	Haemophilus parasuis, belonging to the family Pasteurellaceae, is the causative agent of Glasser's disease leading to serious economic losses. In this study, a successive markerless mutation system for H. parasuisusing two sequential steps of natural transformation was developed. By the first homologous recombination, the target genes were replaced by a cassette carrying kanamycin resistance gene and sacB (which confers sensitivity to sucrose) gene using kanamycin selection, followed by the second reconstruction to remove the selection cassette, with application of sucrose to further screen unmarked mutants. To improve DNA transformation frequency, several parameters have been analyzed further in this work. With this method, two unmarked deletions in one strain have been generated successfully. It is demonstrated that this system can be employed to construct multi-gene scarless deletions, which is of great help for developing live attenuated vaccines for H. parasuis.	[Zhang, Luhua; Li, Ying; Dai, Ke; Wen, Xintian; Wu, Rui; Huang, Xiaobo; Jin, Jin; Xu, Kui; Yan, Qigui; Huang, Yong; Ma, Xiaoping; Wen, Yiping; Cao, Sanjie] Sichuan Agr Univ, Coll Vet Med, Porcine Dis Res Ctr, Chengdu 611130, Peoples R China	Sichuan Agricultural University	Wen, YP (corresponding author), Sichuan Agr Univ, Coll Vet Med, Porcine Dis Res Ctr, Chengdu 611130, Peoples R China.	yueliang5189@163.com; csanjie@gmail.com		Zhang, Luhua/0000-0001-6458-3530	Special Fund for Agro-scientific Research in the Public Interest [201303034]	Special Fund for Agro-scientific Research in the Public Interest	This work was supported by Special Fund for Agro-scientific Research in the Public Interest, grant 201303034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes N, 2003, FEMS MICROBIOL LETT, V220, P41, DOI 10.1016/S0378-1097(03)00064-8; Bigas A, 2005, VET MICROBIOL, V105, P223, DOI 10.1016/j.vetmic.2004.10.015; Bosse JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111252; Brockmeier SL, 2013, CLIN VACCINE IMMUNOL, V20, P1466, DOI 10.1128/CVI.00168-13; Cai XW, 2005, VET MICROBIOL, V111, P231, DOI 10.1016/j.vetmic.2005.07.007; Chen LP, 2012, VET MICROBIOL, V155, P310, DOI 10.1016/j.vetmic.2011.08.020; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Feng SX, 2014, VET J, V202, P191, DOI 10.1016/j.tvjl.2014.05.045; Fu SL, 2012, RES VET SCI, V93, P57, DOI 10.1016/j.rvsc.2011.07.006; Huang XH, 2013, CLIN VACCINE IMMUNOL, V20, P912, DOI 10.1128/CVI.00621-12; Ishikawa M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-86; Kuehn JS, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00739-13; Li JY, 2013, PROCEEDINGS OF THE 2013 INTERNATIONAL CONFERENCE ON ENERGY, P1; Li YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068350; Mullins MA, 2011, STAND GENOMIC SCI, V5, P61, DOI 10.4056/sigs.2245029; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Wang XR, 2013, VET MICROBIOL, V164, P184, DOI 10.1016/j.vetmic.2013.01.037; Wang Y, 2006, MICROBIOL-SGM, V152, P3319, DOI 10.1099/mic.0.29018-0; Xu CG, 2013, VET J, V195, P200, DOI 10.1016/j.tvjl.2012.06.017; Xu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019631; Yuan FY, 2012, RES VET SCI, V93, P51, DOI 10.1016/j.rvsc.2011.04.020; Zhang B, 2014, MICROB PATHOGENESIS, V74, P33, DOI 10.1016/j.micpath.2014.07.006; Zhang B, 2013, VET MICROBIOL, V162, P713, DOI 10.1016/j.vetmic.2012.09.021; Zhang B, 2012, VET MICROBIOL, V157, P237, DOI 10.1016/j.vetmic.2011.12.002; Zhang B, 2012, MICROB PATHOGENESIS, V52, P117, DOI 10.1016/j.micpath.2011.11.002; Zhang B, 2012, FEMS MICROBIOL LETT, V326, P109, DOI 10.1111/j.1574-6968.2011.02433.x; Zhang LH, 2014, VET MICROBIOL, V173, P395, DOI 10.1016/j.vetmic.2014.10.001; Zhang L, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-38; Zhou MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032580; Zou Y, 2013, VET MICROBIOL, V162, P278, DOI 10.1016/j.vetmic.2012.08.006	31	18	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127393	10.1371/journal.pone.0127393	http://dx.doi.org/10.1371/journal.pone.0127393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985077	Green Submitted, Green Published, gold			2022-12-27	WOS:000354917300122
J	Gauthier, TW; Mohan, SS; Gross, TS; Harris, FL; Guidot, DM; Brown, LAS				Gauthier, Theresa W.; Mohan, Sowmya S.; Gross, Teresa S.; Harris, Frank L.; Guidot, David M.; Brown, Lou Ann S.			Placental Fatty Acid Ethyl Esters Are Elevated with Maternal Alcohol Use in Pregnancies Complicated by Prematurity	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; MECONIUM; EXPOSURE; ETHANOL; CONSUMPTION; BIOMARKERS; HAIR; GLUCURONIDE; DRINKING; SULFATE	The accumulation of fatty acid ethyl esters (FAEEs) in meconium of term newborns has been described as one potential biomarker of maternal alcohol use during pregnancy. FAEEs accumulate in multiple alcohol-exposed fetal tissues and in the placenta. Limited research has focused on the identification of the premature newborn exposed to alcohol in utero. We hypothesized that maternal alcohol use occurs in a significant proportion of premature deliveries and that this exposure can be detected as elevated placental FAEEs. The goals of this study were to 1) determine the prevalence of maternal alcohol use in the premature newborn and 2) investigate whether placental FAEEs could identify those newborns with fetal alcohol exposure. This prospective observational study evaluated 80 placentas from 80 women after premature delivery. Subjects were interviewed for alcohol intake and placental FAEEs were quantified via GC/MS. Receiver Operator Characteristic (ROC) Curves were generated to evaluate the ability of placental FAEEs to predict maternal drinking during pregnancy. Adjusted ROC curves were generated to adjust for gestational age, maternal smoking, and illicit drug use. 30% of the subjects admitted to drinking alcohol during pregnancy and approximately 14% answered questions indicative of problem drinking (designated AUDIT+). The specific FAEEs ethyl stearate and linoleate, as well as combinations of oleate + linoleate + linolenate (OLL) and of OLL + stearate, were significantly (p<0.05) elevated in placentas from AUDIT+ pregnancies. Adjusted ROC Curves generated areas under the curve ranging from 88-93% with negative predictive values of 97% for AUDIT+ pregnancies. We conclude that nearly one third of premature pregnancies were alcohol-exposed, and that elevated placental FAEEs hold great promise to accurately determine maternal alcohol use, particularly heavy use, in pregnancies complicated by premature delivery.	[Gauthier, Theresa W.; Mohan, Sowmya S.; Gross, Teresa S.; Harris, Frank L.; Brown, Lou Ann S.] Emory Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA; [Guidot, David M.] Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA USA	Emory University; Emory University	Gauthier, TW (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA.	tgauthi@emory.edu			National Institutes of Health [P50 AA-135757, TL1TR000456]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; Cancer Tissue and Pathology Shared Resource of the Winship Cancer Institute of Emory University [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, TL1TR000456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Cancer Tissue and Pathology Shared Resource of the Winship Cancer Institute of Emory University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by National Institutes of Health P50 AA-135757 (TWG, DMG, LAS), the National Center for Advancing Translational Sciences of the National Institutes of Health UL1TR000454, the National Institutes of Health TL1TR000456 (TSG) and by the Cancer Tissue and Pathology Shared Resource of the Winship Cancer Institute of Emory University (P30CA138292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvik A, 2006, ALCOHOL CLIN EXP RES, V30, P510, DOI 10.1111/j.1530-0277.2006.00055.x; Bakdash A, 2010, ANAL BIOANAL CHEM, V396, P2469, DOI 10.1007/s00216-010-3474-5; BEARER CF, 1992, PEDIATR RES, V31, P492, DOI 10.1203/00006450-199205000-00017; Bearer CF, 2005, J PEDIATR-US, V146, P824, DOI 10.1016/j.jpeds.2005.01.048; Bearer CF, 2003, J PEDIATR-US, V143, P463, DOI 10.1067/S0022-3476(03)00442-6; Bearer CF, 2015, ALCOHOL CLIN EXP RES, V39, P413, DOI 10.1111/acer.12675; Best CA, 2003, FRONT BIOSCI-LANDMRK, V8, pE202, DOI 10.2741/931; Bradley KA, 1998, JAMA-J AM MED ASSOC, V280, P166, DOI 10.1001/jama.280.2.166; Brien JF, 2006, THER DRUG MONIT, V28, P345, DOI 10.1097/01.ftd.0000211819.35182.82; Chan D, 2004, J PHARMACOL EXP THER, V310, P75, DOI 10.1124/jpet.104.066597; Chan D, 2004, J PEDIATR-US, V144, P692, DOI 10.1016/j.jpeds.2004.01.062; DUBROVIN LC, 1992, AM J PHYSIOL, V263, pL42, DOI 10.1152/ajplung.1992.263.1.L42; ERNHART CB, 1988, ALCOHOL CLIN EXP RES, V12, P506, DOI 10.1111/j.1530-0277.1988.tb00233.x; Ethen M, 2009, MATERN CHILD HLTH J, V13, P274, DOI 10.1007/s10995-008-0328-2; Gareri Joey, 2009, Paediatr Drugs, V11, P26; Gauthier TW, 2005, ALCOHOL CLIN EXP RES, V29, P1035, DOI 10.1097/01.ALC.0000167956.28160.5E; Grant TM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.871; Guidot DM, 2000, ALCOHOL CLIN EXP RES, V24, P1070, DOI 10.1097/00000374-200007000-00019; Kulaga V, 2006, ALCOHOL ALCOHOLISM, V41, P534, DOI 10.1093/alcalc/agl048; Kulaga V, 2010, ALCOHOL, V44, P615, DOI 10.1016/j.alcohol.2010.04.001; Kulaga V, 2009, THER DRUG MONIT, V31, P261, DOI 10.1097/FTD.0b013e31819c33b8; LANGE LG, 1981, J BIOL CHEM, V256, P2968; Lange S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-127; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; Lester BM, 2001, PEDIATRICS, V107, P309, DOI 10.1542/peds.107.2.309; Min MO, 2015, J PEDIAT; Mohan SS, 2015, ALCOHOL CLIN EXP RES, V39, P434, DOI 10.1111/acer.12647; Morini L, 2010, FORENSIC SCI INT, V196, P74, DOI 10.1016/j.forsciint.2009.12.035; Morini L, 2011, ANAL BIOCHEM, V418, P30, DOI 10.1016/j.ab.2011.06.038; O'Leary CM, 2009, BJOG-INT J OBSTET GY, V116, P390, DOI 10.1111/j.1471-0528.2008.02058.x; Parazzini F, 2003, EUR J CLIN NUTR, V57, P1345, DOI 10.1038/sj.ejcn.1601690; Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x; Pichini S, 2009, BIRTH DEFECTS RES A, V85, P230, DOI 10.1002/bdra.20559; Russo D, 2004, ALCOHOL, V32, P37, DOI 10.1016/j.alcohol.2004.01.003; Schendel DE, 1996, JAMA-J AM MED ASSOC, V276, P1805, DOI 10.1001/jama.276.22.1805; Sokol RJ, 2007, ALCOHOL CLIN EXP RES, V31, P1031, DOI 10.1111/j.1530-0277.2007.00384.x; Tarcomnicu I, 2010, FORENSIC SCI INT, V196, P121, DOI 10.1016/j.forsciint.2009.12.043; Velasquez A, 2002, ALCOHOL CLIN EXP RES, V26, P1245, DOI 10.1097/01.ALC.0000024269.05402.97; YEARGINALLSOPP M, 1992, PEDIATRICS, V89, P624; Zelner I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059168; Zelner I, 2012, ALCOHOL CLIN EXP RES, V36, P1497, DOI 10.1111/j.1530-0277.2012.01763.x; Zelner I, 2010, THER DRUG MONIT, V32, P305, DOI 10.1097/FTD.0b013e3181dca381	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126552	10.1371/journal.pone.0126552	http://dx.doi.org/10.1371/journal.pone.0126552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978403	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100079
J	Park, M; Lee, JS; Lee, JH; Oh, SH; Park, MK				Park, Mina; Lee, Ji Sung; Lee, Jun Ho; Oh, Seung Ha; Park, Moo Kyun			Prevalence and Risk Factors of Chronic Otitis Media: The Korean National Health and Nutrition Examination Survey 2010-2012	PLOS ONE			English	Article							MIDDLE-EAR; HEARING IMPAIRMENT; ALLERGIC RHINITIS; YOUNG-CHILDREN; EFFUSION; REFLUX; INFANTS; DISEASE; ADULTS	Background The performance of nationwide studies of chronic otitis media (COM) in adults has been insufficient in Korea. We evaluated the prevalence and risk factors of COM in Korea. Methods This study was conducted using data from the fifth Korean National Health and Nutrition Examination Survey (n = 23,621). After excluding the subjects under 20 year old and suffered from cancers, 16,063 patients were evaluated for COM. Participants underwent a medical interview, physical examination, endoscopic examination, and blood and urine test. COM was diagnosed by trained residents in the Department of Otorhinolaryngology using an ear, nose, and throat questionnaire and otoendoscopy findings. Data on the presence and absence of COM were collected. Multivariate logistic regression analyses were performed to identify its risk factors. Results Of the 16,063 participants aged above 20 year old, the weighted prevalence of COM was 3.8%. In the multivariate analyses, the following factors showed high odds ratios (ORs) for COM: pulmonary tuberculosis (adjusted OR, 1.78; 95% confidence interval [CI], 1.06-3.01), chronic rhinosinusitis (adjusted OR, 1.87; 95% CI, 1.17-2.98), mild hearing impairment (adjusted OR, 1.95; 95% CI, 1.34-2.85), moderate hearing impairment (adjusted OR, 4.00; 95% CI, 2.21-7.22), tinnitus (adjusted OR, 1.82; 95% CI, 1.34-2.49), increased hearing thresholds in pure tone audiometry in the right ear (adjusted OR, 1.02; 95% CI, 1.01-1.03), and left ear (adjusted OR, 1.03; 95% CI, 1.02-1.04). The following factors showed low odds ratios for COM: hepatitis B (adjusted OR, 0.28; 95% CI, 0.08-0.94) and rhinitis (adjusted OR, 0.60; 95% CI, 0.42-0.88). In addition, high levels of vitamin D, lead, and cadmium, EQ-5D index; and low red blood cell counts were associated with development of COM (Student's t-test, P < 0.01). Conclusions Our population-based study showed that COM is not rare in Korea, and its development may be associated with various host and environmental factors. Further research on its relationships and the pathogenesis are needed.	[Park, Mina; Lee, Jun Ho; Oh, Seung Ha; Park, Moo Kyun] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Lee, Ji Sung] Asan Med Ctr, Clin Res Ctr, Seoul, South Korea; [Lee, Jun Ho; Oh, Seung Ha; Park, Moo Kyun] Seoul Natl Univ, Med Res Ctr, Sensory Organ Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Samsung; University of Ulsan; Asan Medical Center; Seoul National University (SNU)	Park, MK (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	aspetic@snu.ac.kr		Park, Moo Kyun/0000-0002-8635-797X	Korean Ministry of the Environment, "The Environmental Health Action Program"; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A1013003]	Korean Ministry of the Environment, "The Environmental Health Action Program"; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This study was supported by the Korean Ministry of the Environment as part of "The Environmental Health Action Program" and the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A1013003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuin J, 2004, CHILD ADOLESCENT HLT; Ah-Tye C, 2001, PEDIATRICS, V107, P1251, DOI 10.1542/peds.107.6.1251; Austin DF, 2009, LARYNGOSCOPE, V119, P1788, DOI 10.1002/lary.20570; Bainbridge KE, 2010, DIABETES CARE, V33, P811, DOI 10.2337/dc09-1193; Bakhshaee M, 2011, EUR ARCH OTO-RHINO-L, V268, P87, DOI 10.1007/s00405-010-1290-3; Choo J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003954; DALY K, 1988, PEDIATR INFECT DIS J, V7, P471, DOI 10.1097/00006454-198807000-00004; Doner F, 2004, J INVEST ALLERG CLIN, V14, P154; Doyle WJ, 2002, CURR OPIN ALLERGY CL, V2, P21, DOI 10.1097/00130832-200202000-00004; Engel J, 2001, INT J PEDIATR OTORHI, V57, P137, DOI 10.1016/S0165-5876(00)00462-6; Engel JAM, 2005, INT J PEDIATR OTORHI, V69, P533, DOI 10.1016/j.ijporl.2004.11.026; FLISS DM, 1991, PEDIATR INFECT DIS J, V10, P895, DOI 10.1097/00006454-199112000-00003; Gozal D, 2008, SLEEP MED, V9, P549, DOI 10.1016/j.sleep.2007.08.002; Ilicali OC, 2001, LARYNGOSCOPE, V111, P163, DOI 10.1097/00005537-200101000-00028; Ito K, 2007, ACTA OTO-LARYNGOL, V127, P24, DOI 10.1080/03655230701595279; Kakarlapudi V, 2003, OTOL NEUROTOL, V24, P382, DOI 10.1097/00129492-200305000-00006; KALM O, 1994, INT J PEDIATR OTORHI, V30, P151, DOI 10.1016/0165-5876(94)90198-8; Keles B, 2004, ACTA OTO-LARYNGOL, V124, P1178, DOI 10.1080/00016480410017134; Kim Chong Sun, 1993, Journal of Korean Medical Science, V8, P34; Kim CS, 1981, KORENA J OTOL, V24, P505; Lasisi AO, 2007, INT J PEDIATR OTORHI, V71, P1549, DOI 10.1016/j.ijporl.2007.06.005; Lin YS, 2009, OTOLARYNG HEAD NECK, V140, P165, DOI 10.1016/j.otohns.2008.10.020; Luong A, 2008, OTOLARYNG CLIN N AM, V41, P311, DOI 10.1016/j.otc.2007.11.004; Nadol JB, 2006, OTOLARYNG CLIN N AM, V39, P723, DOI 10.1016/j.otc.2006.05.003; Nelson HM, 2011, PHYSIOL BEHAV, V102, P511, DOI 10.1016/j.physbeh.2011.01.002; Nguyen LHP, 2004, J OTOLARYNGOL, V33, P345, DOI 10.2310/7070.2004.03073; Pagella F, 2010, Int J Immunopathol Pharmacol, V23, P38; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Park RJ, 2014, CLIN OTOLARYNGOL, V39, P89, DOI 10.1111/coa.12232; Poelmans J, 2001, OTOL NEUROTOL, V22, P447, DOI 10.1097/00129492-200107000-00005; SMITH TL, 1995, LARYNGOSCOPE, V105, P236, DOI 10.1288/00005537-199503000-00002; Sone M, 2013, OTOL NEUROTOL, V34, P1013, DOI 10.1097/MAO.0b013e318299aa52; STAHLBERG MR, 1986, PEDIATR INFECT DIS J, V5, P30, DOI 10.1097/00006454-198601000-00006; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; WACKYM PA, 1986, AM J OTOL, V7, P176; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yeo SG, 2007, AM J OTOLARYNG, V28, P148, DOI 10.1016/j.amjoto.2006.07.011; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086397	38	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125905	10.1371/journal.pone.0125905	http://dx.doi.org/10.1371/journal.pone.0125905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978376	Green Submitted, gold, Green Published			2022-12-27	WOS:000354916100038
J	Pichler, U; Hauser, M; Wolf, M; Bernardi, ML; Gadermaier, G; Weiss, R; Ebner, C; Yokoi, H; Takai, T; Didierlaurent, A; Rafaiani, C; Briza, P; Mari, A; Behrendt, H; Wallner, M; Ferreira, F				Pichler, Ulrike; Hauser, Michael; Wolf, Martin; Bernardi, Maria Livia; Gadermaier, Gabriele; Weiss, Richard; Ebner, Christof; Yokoi, Hidenori; Takai, Toshiro; Didierlaurent, Alain; Rafaiani, Chiara; Briza, Peter; Mari, Adriano; Behrendt, Heidrun; Wallner, Michael; Ferreira, Fatima			Pectate Lyase Pollen Allergens: Sensitization Profiles and Cross-Reactivity Pattern	PLOS ONE			English	Article							JAPANESE CEDAR POLLEN; CRY-J-I; MAJOR ALLERGEN; CYPRESS POLLEN; ENZYME-ACTIVITY; RAGWEED POLLEN; BANANA FRUIT; CLONING; AMB	Background Pollen released by allergenic members of the botanically unrelated families of Asteraceae and Cupressaceae represent potent elicitors of respiratory allergies in regions where these plants are present. As main allergen sources the Asteraceae species ragweed and mugwort, as well as the Cupressaceae species, cypress, mountain cedar, and Japanese cedar have been identified. The major allergens of all species belong to the pectate lyase enzyme family. Thus, we thought to investigate cross-reactivity pattern as well as sensitization capacities of pectate lyase pollen allergens in cohorts from distinct geographic regions. Methods The clinically relevant pectate lyase pollen allergens Amb a 1, Art v 6, Cup a 1, Jun a 1, and Cry j 1 were purified from aqueous pollen extracts, and patients' sensitization pattern of cohorts from Austria, Canada, Italy, and Japan were determined by IgE ELISA and cross-inhibition experiments. Moreover, we performed microarray experiments and established a mouse model of sensitization. Results In ELISA and ELISA inhibition experiments specific sensitization pattern were discovered for each geographic region, which reflected the natural allergen exposure of the patients. We found significant cross-reactivity within Asteraceae and Cupressaceae pectate lyase pollen allergens, which was however limited between the orders. Animal experiments showed that immunization with Asteraceae allergens mainly induced antibodies reactive within the order, the same was observed for the Cupressaceae allergens. Cross-reactivity between orders was minimal. Moreover, Amb a 1, Art v 6, and Cry j 1 showed in general higher immunogenicity. Conclusion We could cluster pectate lyase allergens in four categories, Amb a 1, Art v 6, Cup a 1/Jun a 1, and Cry j 1, respectively, at which each category has the potential to sensitize predisposed individuals. The sensitization pattern of different cohorts correlated with pollen exposure, which should be considered for future allergy diagnosis and therapy.	[Pichler, Ulrike; Hauser, Michael; Wolf, Martin; Gadermaier, Gabriele; Wallner, Michael; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Bernardi, Maria Livia; Rafaiani, Chiara; Mari, Adriano] Associated Ctr Mol Allergol, Rome, Italy; [Bernardi, Maria Livia; Rafaiani, Chiara; Mari, Adriano] IDI IRCCS, Ctr Allergol Mol, Rome, Italy; [Weiss, Richard; Briza, Peter] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Ebner, Christof] Allergieambulatorium Reumanpl, Vienna, Austria; [Yokoi, Hidenori] Kyorin Univ, Sch Med, Dept Otolaryngol, Tokyo, Japan; [Takai, Toshiro] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan; [Didierlaurent, Alain] Stallergenes SA, Antony, France; [Behrendt, Heidrun] Ctr Allergy & Environm, ZAUM, Munich, Germany	Salzburg University; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Salzburg University; Kyorin University; Juntendo University; Stallergenes Greer	Ferreira, F (corresponding author), Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.	fatima.ferreira@sbg.ac.at	Wolf, Martin/AGX-0301-2022; Gadermaier, Gabriele/L-5997-2015; Ferreira, Fatima/AAB-4321-2019; Weiss, Richard/N-7279-2013; Wallner, Michael/L-5437-2015; Wolf, Martin/L-3116-2015; Ferreira, Fatima/E-4889-2011; Hauser, Michael/P-6148-2017; Briza, Peter/D-7309-2012; Takai, Toshiro/K-5690-2013	Wolf, Martin/0000-0002-4795-8086; Gadermaier, Gabriele/0000-0002-4886-417X; Ferreira, Fatima/0000-0003-0989-2335; Weiss, Richard/0000-0003-3185-7253; Wallner, Michael/0000-0001-6568-7892; Wolf, Martin/0000-0002-4795-8086; Ferreira, Fatima/0000-0003-0989-2335; Hauser, Michael/0000-0001-6558-755X; Briza, Peter/0000-0002-4941-6782; Takai, Toshiro/0000-0001-8363-0355	CK-CARE AG Individual Project, Davos, Switzerland [2009-02]; Biomay AG, Vienna Austria; Christian Doppler Research Association, Vienna, Austria; Grants-in-Aid for Scientific Research [25461711] Funding Source: KAKEN	CK-CARE AG Individual Project, Davos, Switzerland; Biomay AG, Vienna Austria; Christian Doppler Research Association, Vienna, Austria; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CK-CARE AG Individual Project 2009-02, Davos, Switzerland; Biomay AG, Vienna Austria; Christian Doppler Research Association, Vienna, Austria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceituno E, 2000, CLIN EXP ALLERGY, V30, P1750, DOI 10.1046/j.1365-2222.2000.00949.x; Akei HS, 2006, J ALLERGY CLIN IMMUN, V118, P62, DOI 10.1016/j.jaci.2006.04.046; Asero R, 2014, ANN ALLERGY ASTHMA I; Beck Lisa A., 2000, Journal of Allergy and Clinical Immunology, V106, pS258; Bernardi ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027856; Charpin D, 2005, ALLERGY, V60, P293, DOI 10.1111/j.1398-9995.2005.00731.x; Erler A, 2011, PROTEOMICS, V11, P1486, DOI 10.1002/pmic.201000624; Ferreira F, 2014, TREE POLLEN ALLERGEN; Gadermaier G, 2014, METHODS, V66, P55, DOI 10.1016/j.ymeth.2013.06.014; Hartl A, 2004, METHODS, V32, P328, DOI 10.1016/j.ymeth.2003.08.014; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; Himly M, 2009, ALLERGY; Jahn-Schmid B, 2012, J IMMUNOL, V188, P1559, DOI 10.4049/jimmunol.1102445; Marin-Rodriguez MC, 2003, PLANT MOL BIOL, V51, P851, DOI 10.1023/A:1023057202847; Midoro-Horiuti T, 1999, J ALLERGY CLIN IMMUN, V104, P608, DOI 10.1016/S0091-6749(99)70331-3; Mitsumoto K, 2010, AEROBIOLOGIA, V26, P99, DOI 10.1007/s10453-009-9147-1; Payasi A, 2004, PLANT PHYSIOL BIOCH, V42, P861, DOI 10.1016/j.plaphy.2004.10.011; Payasi A, 2003, PHYTOCHEMISTRY, V63, P243, DOI 10.1016/S0031-9422(03)00027-X; RAFNAR T, 1991, J BIOL CHEM, V266, P1229; SONE T, 1994, BIOCHEM BIOPH RES CO, V199, P619, DOI 10.1006/bbrc.1994.1273; Sposato B, 2014, J INVEST ALLERG CLIN, V24, P23; TANIAI M, 1988, FEBS LETT, V239, P329, DOI 10.1016/0014-5793(88)80945-1; TANIGUCHI Y, 1995, ALLERGY, V50, P90, DOI 10.1111/j.1398-9995.1995.tb02489.x; Thomas WR, 2013, CLIN EXP ALLERGY, V43, P152, DOI 10.1111/j.1365-2222.2012.04059.x; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; WING RA, 1990, PLANT MOL BIOL, V14, P17, DOI 10.1007/BF00015651; Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188; Yoshida K, 2013, ALLERGY, V68, P757, DOI 10.1111/all.12164	28	33	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0120038	10.1371/journal.pone.0120038	http://dx.doi.org/10.1371/journal.pone.0120038			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978036	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100003
J	Nguyen, VT; Nguyen, HT; Nguyen, QC; Duong, PTB; West, G				Van Thu Nguyen; Huyen Thanh Nguyen; Quoc Cuong Nguyen; Phuong Thi Bich Duong; West, Gary			Expenditure Analysis of HIV Testing and Counseling Services Using the Cascade Framework in Vietnam	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; COST-EFFECTIVENESS; STRATEGIES; CARE	Objectives Currently, HIV testing and counseling (HTC) services in Vietnam are primarily funded by international sources. However, international funders are now planning to withdraw their support and the Government of Vietnam (GVN) is seeking to identify domestic funding and generate client fees to continue services. A clear understanding of the cost to sustain current HTC services is becoming increasingly important to facilitate planning that can lead to making HTC and other HIV services more affordable and sustainable in Vietnam. The objectives of this analysis were to provide a snapshot of current program costs to achieve key program outcomes including 1) testing and identifying PLHIV unaware of their HIV status and 2) successfully enrolling HIV (+) clients in care. Methods We reviewed expenditure data reported by 34 HTC sites in nine Vietnamese provinces over a one-year period from October 2012 to September 2013. Data on program outcomes were extracted from the HTC database of 42,390 client records. Analysis was carried out from the service providers' perspective. Results The mean expenditure for a single client provided HTC services (testing, receiving results and referral for care/treatment) was US $7.6. The unit expenditure per PLHIV identified through these services varied widely from US $22.8 to $741.5 (median: $131.8). Excluding repeat tests, the range for expenditure to newly diagnose a PLHIV was even wider (from US $30.8 to $1483.0). The mean expenditure for one successfully referred HIV client to care services was US $466.6. Personnel costs contributed most to the total cost. Conclusions Our analysis found a wide range of expenditures by site for achieving the same outcomes. Re-designing systems to provide services at the lowest feasible cost is essential to making HIV services more affordable and treatment for prevention programs feasible in Vietnam. The analysis also found that understanding the determinants and reasons for variance in service costs by site is an important enhancement to the cascade of HIV services framework now adapted for and extensively used in Vietnam for planning and evaluation.	[Van Thu Nguyen; Huyen Thanh Nguyen; Quoc Cuong Nguyen; Phuong Thi Bich Duong; West, Gary] FHI 360 Vietnam, Hanoi, Vietnam		Nguyen, VT (corresponding author), FHI 360 Vietnam, 7th Floor,Hanoi Tourist Bldg,18 Ly Thuong Kiet St, Hanoi, Vietnam.	thuvan@fhi360.org			Sustainable Management of HIV/AIDS Responses and Transition to Technical Assistance (SMART TA) Project - U.S. Agency for International Development (USAID) [AID-486-A-11-00011]	Sustainable Management of HIV/AIDS Responses and Transition to Technical Assistance (SMART TA) Project - U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	This work was supported through the Cooperative Agreement #AID-486-A-11-00011 "Sustainable Management of HIV/AIDS Responses and Transition to Technical Assistance (SMART TA) Project" funded by the U.S. Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this paper are the sole responsibility of the authors and do not represent the views or opinions of USAID nor FHI 360.	[Anonymous], 2012, VIETN AIDS RESP PROG; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Hien NT, 2004, AIDS EDUC PREV, V16, P137, DOI 10.1521/aeap.16.3.5.137.35527; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Izazola-Licea JA, 2009, JAIDS-J ACQ IMM DEF, V52, pS119, DOI 10.1097/QAI.0b013e3181baeeda; Joint United Nation programme on HIV/AIDS, 2014, VIETN NAT AIDS SPEND; Minh Hoang Van, 2012, Value Health Reg Issues, V1, P36, DOI 10.1016/j.vhri.2012.03.012; Ministry of Health, 2014, SUMM ACT RESP HIV AI; Mulogo EM, 2013, AFR HEALTH SCI, V13, P423, DOI 10.4314/ahs.v13i2.32; Obure CD, 2012, SEX TRANSM INFECT, V88, P498, DOI 10.1136/sextrans-2012-050544; Siapka M, 2014, B WORLD HEALTH ORGAN, V92, P499, DOI 10.2471/BLT.13.127639; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; The Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, VIETN NAT AIDS SPEND; The World Bank, 2014, OFF EXCH RAT; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; Vietnam Authority for HIV/AIDS Control, 2013, VIETN HIV AIDS EST P; Vietnam Authority of HIV/AIDS Control, 2014, REP HIV AIDS PREV CO	18	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126659	10.1371/journal.pone.0126659	http://dx.doi.org/10.1371/journal.pone.0126659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978427	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100086
J	Dinat, N; Marinda, E; Moch, S; Rice, ASC; Kamerman, PR				Dinat, Natalya; Marinda, Edmore; Moch, Shirra; Rice, Andrew S. C.; Kamerman, Peter R.			Randomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory Neuropathy	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; PERIPHERAL NEUROPATHY; RISK-FACTORS; PHARMACOLOGICAL-TREATMENT; IMMPACT RECOMMENDATIONS; ANTIRETROVIRAL THERAPY; CLINICAL-TRIALS; RHYTHMICITY; PREVALENCE; PREGABALIN	We conducted a randomized, double-blind, placebo-controlled, crossover study at a single center in South Africa, to ascertain whether amitriptyline is an effective analgesic for painful HIV-associated sensory neuropathy of moderate to severe intensity in: i) antiretroviral drug naive individuals, and ii) antiretroviral drug users. 124 HIV-infected participants (antiretroviral drug naive = 62, antiretroviral drug users = 62) who met the study criteria for painful HIV-associated sensory neuropathy were randomized to once-daily oral amitriptyline (titrated to a median: interquartile range of 50: 25-50 mg) or placebo for six weeks, followed by a three-week washout period and subsequent treatment crossover. The primary outcome measure was change from baseline in worst pain intensity of the feet (measured by participant self-report using an 11-point numerical pain rating scale) after six weeks of treatment. 122 of 124 participants completed all study visits and were included in the analysis of the primary outcome. In the antiretroviral drug-naive group (n = 61) there was no significant difference in the mean change in pain score from baseline after six weeks of treatment with placebo or amitriptyline [amitriptyline: 2.8 (SD 3.3) vs. placebo: 2.8 (3.4)]. Similarly, there was no significant difference in the change in pain score after six weeks of treatment with placebo or amitriptyline in the antiretroviral drug-user group (n = 61) [amitriptyline: 2.7 (3.3) vs. placebo: 2.1 (2.8)]. Controlling for period effects and treatment order effects did not alter the outcome of the analyses. Nor did analyzing the intention-to-treat cohort (missing data interpolated using baseline observation carried forward) alter the outcome of the analyses. In summary, amitriptyline, at the doses used here, was no more effective than an inactive placebo at reducing pain intensity in individuals with painful HIV-associated sensory neuropathy of moderate to severe intensity, irrespective of whether they were on antiretroviral therapy or not.	[Dinat, Natalya] Univ Witwatersrand, Fac Hlth Sci, Ctr Palliat Care, Johannesburg, South Africa; [Marinda, Edmore] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Moch, Shirra] Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Div Pharmacol, Johannesburg, South Africa; [Rice, Andrew S. C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Pain Res, London, England; [Rice, Andrew S. C.] Chelsea & Westminster Hosp NHS Fdn Trust, Pain Med, London, England; [Kamerman, Peter R.] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Imperial College London; Imperial College London; University of Witwatersrand	Kamerman, PR (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa.	peter.kamerman@wits.ac.za	Kamerman, Peter/L-8645-2015	Kamerman, Peter/0000-0002-3103-5295	Diana Princess of Wales Memorial Fund	Diana Princess of Wales Memorial Fund	The study was supported by a grant to ND from the Diana Princess of Wales Memorial Fund (http://www.dianaprincessofwalesmemorialfund.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The amitriptyline and placebo were purchased.	Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Cepeda MS, 2012, PAIN MED, V13, P575, DOI 10.1111/j.1526-4637.2012.01340.x; Cherry CL, 2012, FUTURE VIROL, V7, P849, DOI 10.2217/FVL.12.77; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; Clifford DB, 2012, JAIDS-J ACQ IMM DEF, V59, P126, DOI 10.1097/QAI.0b013e31823e31f7; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Fontaine A, 1999, J PAIN SYMPTOM MANAG, V18, P263, DOI 10.1016/S0885-3924(99)00078-0; Gilron I, 2014, CURR OPIN SUPPORT PA, V8, P429, DOI 10.1097/SPC.0000000000000085; Gilron I, 2013, CLIN J PAIN, V29, P755, DOI 10.1097/AJP.0b013e318275f287; Gilron I, 2009, LANCET, V374, P1252, DOI 10.1016/S0140-6736(09)61081-3; Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1; James M, 2011, GOODMAN GILMANS PHAR, P397; Jensen KB, 2012, P NATL ACAD SCI USA, V109, P15959, DOI 10.1073/pnas.1202056109; Kamerman PR, 2015, PAIN, V156, P793, DOI 10.1097/01.j.pain.0000460356.94374.a1; Kamerman PR, 2012, CURR PAIN HEADACHE R, V16, P226, DOI 10.1007/s11916-012-0257-z; Kamerman PR, 2012, J PERIPHER NERV SYST, V17, P19, DOI 10.1111/j.1529-8027.2012.00373.x; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kieburtz K, 1998, NEUROLOGY, V51, P1682, DOI 10.1212/WNL.51.6.1682; Maritz J, 2010, MUSCLE NERVE, V41, P599, DOI 10.1002/mus.21535; Mehta SA, 2011, CLIN INFECT DIS, V53, P490, DOI 10.1093/cid/cir432; Moore RA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008242.pub2; Mphahlele N, 2008, J PAIN SYMPTOM MANAG, V36, P396, DOI 10.1016/j.jpainsymman.2007.10.020; Phillips TJC, 2014, PAIN, V155, P1846, DOI 10.1016/j.pain.2014.06.014; Phillips TJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014433; Rakel DP, 2009, FAM MED, V41, P494; Shlay JC, 1998, JAMA-J AM MED ASSOC, V280, P1590, DOI 10.1001/jama.280.18.1590; Simpson DM, 2010, NEUROLOGY, V74, P413, DOI 10.1212/WNL.0b013e3181ccc6ef; Simpson DM, 2014, PAIN, V155, P1943, DOI 10.1016/j.pain.2014.05.027; Simpson DM, 2003, NEUROLOGY, V60, P1508, DOI 10.1212/01.WNL.0000063304.88470.D9; Smyth K, 2007, HIV MED, V8, P367, DOI 10.1111/j.1468-1293.2007.00478.x; South African National Department of Health, 2012, STAND TREATM GUID ES; Wadley AL, 2011, J PAIN SYMPTOM MANAG, V41, P700, DOI 10.1016/j.jpainsymman.2010.07.006; WHO, 2004, POL LAB MAN, P1; World Health Organization, 2013, WHO MOD LIST ESS MED; World Health Organization, 2010, UN ACC SCAL PRIOR HI	40	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126297	10.1371/journal.pone.0126297	http://dx.doi.org/10.1371/journal.pone.0126297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974287	gold, Green Published, Green Submitted			2022-12-27	WOS:000354545600045
J	Lin, WC; Hsu, TW; Chen, CL; Lu, CH; Chen, HL; Cheng, YF				Lin, Wei-Che; Hsu, Tun-Wei; Chen, Chao-Long; Lu, Cheng-Hsien; Chen, Hsiu-Ling; Cheng, Yu-Fan			Resting State-fMRI with ReHo Analysis as a Non-Invasive Modality for the Prognosis of Cirrhotic Patients with Overt Hepatic Encephalopathy	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; REGIONAL HOMOGENEITY; GLUCOSE-METABOLISM; BRAIN ACTIVITY; NEURAL SYNCHRONIZATION; AMMONIA METABOLISM; LIVER-DISEASE; CORTEX	Background To investigate the relationships among regional activity abnormalities, clinical disease severity, and prognosis in cirrhotic patients with overt hepatic encephalopathy (OHE) using resting-state functional magnetic resonance imaging (rs-fMRI). Methods Regional homogeneity (ReHo) values of 12 cirrhotic patients with OHE and 12 age-and sex-matched healthy volunteers were calculated from rs-fMRI. Two-sample t-test was performed on individual ReHo maps between the two groups. The relationships between ReHo variation, disease severity, and prognosis were analyzed. Results Cirrhotic patients with OHE had significantly low ReHo values in the left middle cingulum, bilateral superior temporal, left inferior orbito-frontal, right calcarine, left inferior frontal gyrus, left post-central, left inferior temporal, and left lingual areas, and high ReHo in the right superior frontal, right inferior temporal, right caudate, and cerebellum. There was significant group difference in the right superior temporal lobe (p=0.016) and crus1 of the left cerebellum (p=0.015) between survivors and non-survivors in the OHE group. Worse Glasgow Coma Scale was associated with increased local connectivity in the left cerebellar crus I (r=-0.868, p=0.001). Conclusions Information on the functional activity of cirrhotic patients with OHE suggests the use of rsfMRI with ReHo analysis as a non-invasive prognosticating modality.	[Lin, Wei-Che; Chen, Hsiu-Ling; Cheng, Yu-Fan] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Lin, Wei-Che; Chen, Chao-Long; Lu, Cheng-Hsien; Cheng, Yu-Fan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hsu, Tun-Wei; Chen, Hsiu-Ling] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Hsu, Tun-Wei] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lin, WC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan.	u64lin@yahoo.com.tw		Hsu, Tun-Wei/0000-0002-4614-6449	Chang Gung Medical Research Project [CMRPG870482]; National Science Council [NSC 97-2314-B-182A-104-MY3]	Chang Gung Medical Research Project; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Medical Research Project CMRPG870482 to W-C Lin and National Science Council, NSC 97-2314-B-182A-104-MY3 to W-C Lin.	Ahl B, 2004, HEPATOLOGY, V40, P73, DOI 10.1002/hep.20290; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Chalela JA, 2013, NEUROCRIT CARE, V18, P398, DOI 10.1007/s12028-013-9836-z; Chen HJ, 2013, RADIOLOGY, V266, P261, DOI 10.1148/radiol.12120026; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Cordoba J, 1996, SEMIN LIVER DIS, V16, P271, DOI 10.1055/s-2007-1007240; Di X, 2013, CEREB CORTEX, V23, P255, DOI 10.1093/cercor/bhs001; Flamm Steven L, 2011, Therap Adv Gastroenterol, V4, P199, DOI 10.1177/1756283X11401774; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; GUPTA RK, 1993, AM J GASTROENTEROL, V88, P670; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Huang ZR, 2014, HUM BRAIN MAPP, V35, P5368, DOI 10.1002/hbm.22556; Kale RA, 2006, HEPATOLOGY, V43, P698, DOI 10.1002/hep.21114; Kato A, 2000, HEPATOL RES, V17, P237, DOI 10.1016/S1386-6346(99)00080-7; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Lin WC, 2014, J CEREBR BLOOD F MET, V34, P1877, DOI 10.1038/jcbfm.2014.143; Lin WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105887; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036986; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; Lockwood AH, 2002, METAB BRAIN DIS, V17, P29, DOI 10.1023/A:1014000313824; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P337, DOI 10.1038/jcbfm.1991.67; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lv XF, 2013, LIVER INT, V33, P375, DOI 10.1111/liv.12096; Mashour GA, 2006, ANESTH ANALG, V103, P975, DOI 10.1213/01.ane.0000232442.69757.4a; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; Norenberg MD, 1996, SEMIN LIVER DIS, V16, P245, DOI 10.1055/s-2007-1007237; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saksena S, 2008, J GASTROEN HEPATOL, V23, pE111, DOI 10.1111/j.1440-1746.2007.05158.x; Schiff S, 2006, CLIN NEUROPHYSIOL, V117, P1728, DOI 10.1016/j.clinph.2006.04.020; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Thomason ME, 2007, HUM BRAIN MAPP, V28, P59, DOI 10.1002/hbm.20241; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Timmermann L, 2005, METAB BRAIN DIS, V20, P337, DOI 10.1007/s11011-005-7916-2; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; VANNUCCI RC, 1988, STROKE, V19, P245, DOI 10.1161/01.STR.19.2.245; VERGOTE G, 1992, NEURORADIOLOGY, V34, P215, DOI 10.1007/BF00596339; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yuan R, 2013, MAGN RESON IMAGING, V31, P1492, DOI 10.1016/j.mri.2013.07.005; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	50	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126834	10.1371/journal.pone.0126834	http://dx.doi.org/10.1371/journal.pone.0126834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973853	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600085
J	Yasunami, M; Nakamura, H; Agematsu, K; Nakamura, A; Yazaki, M; Kishida, D; Yachie, A; Toma, T; Masumoto, J; Ida, H; Koga, T; Kawakami, A; Eguchi, K; Furukawa, H; Nakamura, T; Nakamura, M; Migita, K				Yasunami, Michio; Nakamura, Hitomi; Agematsu, Kazunaga; Nakamura, Akinori; Yazaki, Masahide; Kishida, Dai; Yachie, Akihiro; Toma, Tomoko; Masumoto, Junya; Ida, Hiroaki; Koga, Tomohiro; Kawakami, Atsushi; Eguchi, Katsumi; Furukawa, Hiroshi; Nakamura, Tadashi; Nakamura, Minoru; Migita, Kiyoshi			Identification of Disease-Promoting HLA Class I and Protective Class II Modifiers in Japanese Patients with Familial Mediterranean Fever	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; BEHCETS-DISEASE; RHEUMATOID-ARTHRITIS; ASSOCIATION; MEFV; SUSCEPTIBILITY; SPONDYLARTHROPATHIES; COLCHICINE; DIAGNOSIS; ALLELES	Objectives The genotype-phenotype correlation of MEFV remains unclear for the familial Mediterranean fever (FMF) patients, especially without canonical MEFV mutations in exon 10. The risk of FMF appeared to be under the influence of other factors in this case. The contribution of HLA polymorphisms to the risk of FMF was examined as strong candidates of modifier genes. Methods Genotypes of HLA-B and -DRB1 loci were determined for 258 mutually unrelated Japanese FMF patients, who satisfied modified Tel-Hashomer criteria, and 299 healthy controls. The effects of carrier status were evaluated for the risk of FMF by odds ratio (OR). The HLA effects were also assessed for clinical forms of FMF, subsets of FMF with certain MEFV genotypes and responsiveness to colchicine treatment. Results The carriers of B*39:01 were increased in the patients (OR = 3.25, p = 0.0012), whereas those of DRB1*15:02 were decreased (OR = 0.45, p = 0.00050), satisfying Bonferroni's correction for multiple statistical tests (n = 28, p<0.00179). The protective effect of DRB1*15:02 was completely disappeared in the co-existence of B*40:01. The HLA effects were generally augmented in the patients without a canonical MEFV variant allele M694I, in accordance with the notion that the lower penetrance of the mutations is owing to the larger contribution of modifier genes in the pathogenesis, with a few exceptions. Further, 42.9% of 14 colchicine-resistant patients and 13.5% of 156 colchicine-responders possessed B*35:01 allele, giving OR of 4.82 (p = 0.0041). Conclusions The differential effects of HLA class I and class II polymorphisms were identified for Japanese FMF even in those with high-penetrance MEFV mutations.	[Yasunami, Michio; Nakamura, Hitomi] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Agematsu, Kazunaga] Shinshu Univ, Grad Sch Med, Dept Infect & Host Def, Matsumoto, Nagano 390, Japan; [Nakamura, Akinori; Yazaki, Masahide; Kishida, Dai] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 390, Japan; [Yachie, Akihiro; Toma, Tomoko] Kanazawa Univ, Dept Pediat, Kanazawa, Ishikawa, Japan; [Masumoto, Junya] Ehime Univ, Grad Sch Med, Dept Pathogen, To On, Japan; [Ida, Hiroaki] Kurume Univ, Sch Med, Dept Rheumatol, Kurume, Fukuoka 830, Japan; [Koga, Tomohiro; Kawakami, Atsushi] Nagasaki Univ, Dept Internal Med 1, Sch Med, Nagasaki 852, Japan; [Eguchi, Katsumi] Sasebo City Gen Hosp, Dept Rheumatol, Sasebo, Japan; [Furukawa, Hiroshi] Sagamihara Hosp, Natl Hosp Org, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Nakamura, Tadashi] Kumamoto Shinto Gen Hosp, Dept Rheumatol, Kumamoto, Japan; [Nakamura, Minoru; Migita, Kiyoshi] Nagasaki Med Ctr, Natl Hosp Org, Clin Res Ctr, Omura, Japan	Nagasaki University; Shinshu University; Shinshu University; Kanazawa University; Ehime University; Kurume University; Nagasaki University	Yasunami, M (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan.	yasunami@nagasaki-u.ac.jp	Koga, Tomohiro/V-9397-2019; Koga, Tomohiro/AAU-9697-2020	Koga, Tomohiro/0000-0003-2077-4428	Japan Society for the Promotion of Science (JSPS) [26293076]; Ministry of Health, Labour and Welfare of Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study supported in part by the Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS), (#26293076, granted to M. Yasunami) and the Grant-in- Aid for Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan, (granted to KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4154; Atagunduz P, 2003, CLIN EXP RHEUMATOL, V21, pS35; Ben-Chetrit E, 2002, J RHEUMATOL, V29, P530; Ben-Chetrit E, 2008, CLIN EXP RHEUMATOL, V26, pS49; Ben-Chetrit E, 1998, LANCET, V351, P659, DOI 10.1016/S0140-6736(97)09408-7; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Bravo MJ, 2003, J RHEUMATOL, V30, P1051; Brown MA, 1996, ANN RHEUM DIS, V55, P268, DOI 10.1136/ard.55.4.268; Chae JJ, 2009, BRIT J HAEMATOL, V146, P467, DOI 10.1111/j.1365-2141.2009.07733.x; Cosan F, 2010, ARTHRITIS RHEUM-US, V62, P3232, DOI 10.1002/art.27683; Furukawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087792; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Kirino Y, 2013, P NATL ACAD SCI USA, V110, P8134, DOI 10.1073/pnas.1306352110; Kone-Paut I, 2009, RHEUMATOLOGY, V48, P840, DOI 10.1093/rheumatology/kep121; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Migita K, 2012, MEDICINE, V91, P337, DOI 10.1097/MD.0b013e318277cf75; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Oka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099453; Ozen S, 2014, NAT REV RHEUMATOL, V10, P135, DOI 10.1038/nrrheum.2013.174; ROBINSON WP, 1989, ARTHRITIS RHEUM-US, V32, P1135, DOI 10.1002/anr.1780320912; Sobao Y, 1999, ARTHRITIS RHEUM, V42, P175, DOI 10.1002/1529-0131(199901)42:1<175::AID-ANR21>3.0.CO;2-7; Terao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040067; Tokunaga K, 1997, IMMUNOGENETICS, V46, P199, DOI 10.1007/s002510050262; Touitou I, 2013, J MED GENET, V50, P349, DOI 10.1136/jmedgenet-2013-101577; Touitou I, 2000, HUM MUTAT, V16, DOI 10.1002/1098-1004(200009)16:3<271::AID-HUMU16>3.0.CO;2-A; Tufan A, 2007, J RHEUMATOL, V34, P1540; Ueda S, 2014, J CLIN ENDOCR METAB, V99, pE379, DOI 10.1210/jc.2013-2841; Wei JCC, 2004, RHEUMATOLOGY, V43, P839, DOI 10.1093/rheumatology/keh193; Yague J, 2000, J EXP MED, V191, P2083, DOI 10.1084/jem.191.12.2083; YAMAGUCHI A, 1995, ARTHRITIS RHEUM-US, V38, P1672, DOI 10.1002/art.1780381120	32	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125938	10.1371/journal.pone.0125938	http://dx.doi.org/10.1371/journal.pone.0125938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974247	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600033
J	Courtney, R; Sachlikidis, N; Jones, R; Seymour, J				Courtney, Robert; Sachlikidis, Nik; Jones, Rhondda; Seymour, Jamie			Prey Capture Ecology of the Cubozoan Carukia barnesi	PLOS ONE			English	Article							JELLYFISH TRIPEDALIA-CYSTOPHORA; AUSTRALIAN BOX JELLYFISH; CNIDARIA; CUBOMEDUSAN; PATTERNS; OCELLI; MORPHOLOGY; SCYPHOZOA; BEHAVIOR; VISION	Adult Carukia barnesi medusae feed predominantly on larval fish; however, their mode of prey capture seems more complex than previously described. Our findings revealed that during light conditions, this species extends its tentacles and 'twitches' them frequently. This highlights the lure-like nematocyst clusters in the water column, which actively attract larval fish that are consequently stung and consumed. This fishing behavior was not observed during dark conditions, presumably to reduce energy expenditure when they are not luring visually oriented prey. We found that larger medusae have longer tentacles; however, the spacing between the nematocyst clusters is not dependent on size, suggesting that the spacing of the nematocyst clusters is important for prey capture. Additionally, larger specimens twitch their tentacles more frequently than small specimens, which correlate with their recent ontogenetic prey shift from plankton to larval fish. These results indicate that adult medusae of C. barnesi are not opportunistically grazing in the water column, but instead utilize sophisticated prey capture techniques to specifically target larval fish.	[Courtney, Robert; Seymour, Jamie] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia; [Sachlikidis, Nik] NGS Aquat, Kota Kinabalu, Saga, Malaysia; [Jones, Rhondda] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Courtney, R (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia.	Robert.Courtney@my.jcu.edu.au	; Jones, Rhondda/E-4853-2013	Courtney, Robert/0000-0002-3914-1551; Jones, Rhondda/0000-0002-1031-2863	NGS aquatic	NGS aquatic	NGS aquatic provided support in the form of salaries for author NS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arai MN, 1997, FUNCTIONAL BIOL SCYP; BARNES J. H., 1966, SYMP ZOOL SOC LONDON, V16, P307; Barnes J. H., 1964, Medical Journal of Australia, V1, P897; Bentlage B, 2012, J NAT HIST, V46, P2595, DOI 10.1080/00222933.2012.717645; Blumer MJF, 1995, ZOOMORPHOLOGY, V115, P221, DOI 10.1007/BF00393802; BREWER RH, 1989, BIOL BULL, V176, P272, DOI 10.2307/1541985; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Carrette TJ, 2012, DIVING HYPERB MED, V42, P214; Chaousis S, 2014, TOXICON, V80, P17, DOI 10.1016/j.toxicon.2014.01.007; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; Colin SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056393; D'Ambra I, 2001, HYDROBIOLOGIA, V451, P223, DOI 10.1023/A:1011832222174; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2007, J COMP PHYSIOL A, V193, P547, DOI 10.1007/s00359-007-0211-4; Garm A, 2012, BIOL BULL-US, V222, P35, DOI 10.1086/BBLv222n1p35; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Gordon MR, 2009, HYDROBIOLOGIA, V616, P87, DOI 10.1007/s10750-008-9594-7; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Grossowicz M, 2012, MAR BIODIVERS, V42, P65, DOI 10.1007/s12526-011-0093-0; Haddock SHD, 2005, SCIENCE, V309, P263, DOI 10.1126/science.1110441; HAMNER WM, 1981, LIMNOL OCEANOGR, V26, P414; Hamner WM, 1995, MAR FRESHWATER RES, V46, P985, DOI 10.1071/MF9950985; Hartwick R, HYDROBIOLOGIA, V216, P181; Hunter J. R, 1980, FISH BEHAV ITS USE C, V5, P287; Kingsford MJ, 2012, HYDROBIOLOGIA, V690, P257, DOI 10.1007/s10750-012-1041-0; Kinsey BE, 1988, MORE BARNES BO UNPUB; Land MF, 2012, OPHTHAL PHYSL OPT, V32, P449, DOI 10.1111/j.1475-1313.2012.00941.x; Mapstone GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087737; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Matsumoto GI, 1995, MAR FRESHW BEHAV PHY, V26, P139, DOI 10.1080/10236249509378935; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504; PEARSE JS, 1978, SCIENCE, V199, P458, DOI 10.1126/science.22934; Pereira P, 2010, CLIN TOXICOL, V48, P390, DOI 10.3109/15563651003662675; PIATIGORSKY J, 1989, J COMP PHYSIOL A, V164, P577, DOI 10.1007/BF00614500; Pugh PR, 2010, J MAR BIOL ASSOC UK, V90, P1119, DOI 10.1017/S0025315409990543; PURCELL JE, 1980, SCIENCE, V209, P1045, DOI 10.1126/science.209.4460.1045; PURCELL JE, 1981, MAR BIOL, V65, P83, DOI 10.1007/BF00397071; Puvanendran V, 2002, AQUACULTURE, V214, P131, DOI 10.1016/S0044-8486(02)00045-5; SEBENS KP, 1977, MAR BIOL, V43, P247, DOI 10.1007/BF00402317; Seymour JE, 2004, MED J AUSTRALIA, V181, P707, DOI 10.5694/j.1326-5377.2004.tb06529.x; Shorten M, 2005, J ZOOL, V267, P371, DOI 10.1017/S0952836905007600; SINGLA CL, 1974, CELL TISSUE RES, V149, P413; Sorek M, MAR GENOM, V214, P47, DOI [10.1016/j.mqren.2014.01.003, DOI 10.1016/J.MQREN.2014.01.003]; SOUTHCOTT R. V., 1967, AUST J ZOOL, V15, P651, DOI 10.1071/ZO9670651; Stewart SE, 1996, MAR FRESHW BEHAV PHY, V27, P175, DOI 10.1080/10236249609378963; Underwood AH, 2007, TOXICON, V49, P1073, DOI 10.1016/j.toxicon.2007.01.014; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Yamasu T., 1973, Publications Seto Mar Biol Lab, V20, P757; YAMASU T, 1976, CELL TISSUE RES, V170, P325, DOI 10.1007/BF00219415	51	12	12	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124256	10.1371/journal.pone.0124256	http://dx.doi.org/10.1371/journal.pone.0124256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970583	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200034
J	Saucedo, L; Buffa, GN; Rosso, M; Guillardoy, T; Gongora, A; Munuce, MJ; Vazquez-Levin, MH; Marin-Briggiler, C				Saucedo, Lucia; Buffa, Gabriela N.; Rosso, Marina; Guillardoy, Tomas; Gongora, Adrian; Munuce, Maria J.; Vazquez-Levin, Monica H.; Marin-Briggiler, Clara			Fibroblast Growth Factor Receptors (FGFRs) in Human Sperm: Expression, Functionality and Involvement in Motility Regulation	PLOS ONE			English	Article							PROGESTERONE-RECEPTORS; EPITHELIAL CADHERIN; ACROSOME REACTION; CELL; FAMILY; LOCALIZATION; ACTIVATION; INHIBITOR; PROTEINS; PATHWAY	Fibroblast growth factors receptors (FGFRs) have been widely characterized in somatic cells, but there is scarce evidence of their expression and function in mammalian gametes. The objective of the present study was to evaluate the expression of FGFRs in human male germ cells, to determine sperm FGFR activation by the FGF2 ligand and their participation in the regulation of sperm motility. The expression of FGFR1, 2, 3 and 4 mRNAs and proteins in human testis and localization of these receptors in germ cells of the seminiferous epithelium was demonstrated. In ejaculated sperm, FGFRs were localized to the acrosomal region and flagellum. Sperm exposure to FGF2 caused an increase in flagellar FGFR phosphorylation and activation of extracellular signal-regulated kinase (ERK) and protein kinase B (PKB or Akt) signaling pathways. Incubation with FGF2 led to a significant increase in the percentage of total and progressive sperm motility, as well as in sperm kinematics. All responses were prevented by sperm preincubation with BGJ398, a specific inhibitor of FGFR tyrosine kinase activity. In addition to confirming the expression of FGFRs in germ cells of the human testis, our study describes for the first time the presence, localization and functionality of human sperm FGFRs, and provides evidence of the beneficial effect of FGF2 upon sperm motility.	[Saucedo, Lucia; Buffa, Gabriela N.; Rosso, Marina; Guillardoy, Tomas; Gongora, Adrian; Vazquez-Levin, Monica H.; Marin-Briggiler, Clara] Consejo Nacl Invest Cient & Tecn, FIBYME, Inst Biol & Med Expt IBYME, RA-1033 Buenos Aires, DF, Argentina; [Munuce, Maria J.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Lab Med Reprod, Area Bioquim Clin, RA-2000 Rosario, Santa Fe, Argentina; [Munuce, Maria J.] Sanatorio Britan Rosario, Reprolab, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; National University of Rosario	Marin-Briggiler, C (corresponding author), Consejo Nacl Invest Cient & Tecn, FIBYME, Inst Biol & Med Expt IBYME, RA-1033 Buenos Aires, DF, Argentina.	clarisamarin@gmail.com	Rosso, Marina/A-7886-2018	Rosso, Marina/0000-0002-1077-3088	Fundacion Florencio Fiorini; National Agency to Promote Science and Technology (ANPCyT; PICT) [627]; National Research Council of Argentina (CONICET) [PIP 2008 2120, 2012 740]; Reprolab	Fundacion Florencio Fiorini; National Agency to Promote Science and Technology (ANPCyT; PICT); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Reprolab	This study was supported by the Fundacion Florencio Fiorini and the National Agency to Promote Science and Technology (ANPCyT; PICT 2013 # 627) to CMB, as well as the National Research Council of Argentina (CONICET) (grant PIP 2008 2120 to MHVL and 2012 740 to MHVL and CMB). Reprolab provided support in the form of salaries for author MJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; Breitbart H, 2010, MOL CELL ENDOCRINOL, V314, P234, DOI 10.1016/j.mce.2009.06.009; Cancilla B, 2000, J ENDOCRINOL, V164, P149, DOI 10.1677/joe.0.1640149; Cerliani JP, 2011, CANCER RES, V71, P3720, DOI 10.1158/0008-5472.CAN-10-3074; Chaves RN, 2012, REPROD FERT DEVELOP, V24, P905, DOI 10.1071/RD11318; Cotton L, 2006, J CELL SCI, V119, P75, DOI 10.1242/jcs.02704; Cotton LM, 2008, ENDOCR REV, V29, P193, DOI 10.1210/er.2007-0028; de Lamirande E, 2002, MOL HUM REPROD, V8, P124, DOI 10.1093/molehr/8.2.124; de Lamirande E, 2008, BBA-PROTEINS PROTEOM, V1784, P106, DOI 10.1016/j.bbapap.2007.08.024; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ewen KA, 2013, INT J DEV BIOL, V57, P141, DOI 10.1387/ijdb.130022er; Gabler C, 1997, J REPROD FERTIL, V109, P213, DOI 10.1530/jrf.0.1090213; Giulianelli S, 2008, INT J CANCER, V123, P2518, DOI 10.1002/ijc.23802; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; Groth C, 2002, INT J DEV BIOL, V46, P393; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jiang X, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/489095; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kamura S, 2010, BRIT J CANCER, V103, P370, DOI 10.1038/sj.bjc.6605775; Koppers AJ, 2011, BIOCHEM J, V436, P687, DOI 10.1042/BJ20110114; Lapyckyj L, 2010, J CELL PHYSIOL, V222, P596, DOI 10.1002/jcp.21974; LEHTOLA L, 1992, INT J CANCER, V50, P598, DOI 10.1002/ijc.2910500419; Li Shengqiang, 2014, J Reprod Infertil, V15, P122; Luconi M, 2001, HUM REPROD, V16, P1931, DOI 10.1093/humrep/16.9.1931; Luconi M, 1998, BIOL REPROD, V58, P1476, DOI 10.1095/biolreprod58.6.1476; Maher PA, 1996, J CELL BIOL, V134, P529, DOI 10.1083/jcb.134.2.529; Malamitsi-Puchner A, 2001, FERTIL STERIL, V76, P98, DOI 10.1016/S0015-0282(01)01854-4; Marin-Briggiler CI, 2010, INT J ANDROL, V33, pE228, DOI 10.1111/j.1365-2605.2009.00999.x; Marin-Briggiler CI, 2008, MOL HUM REPROD, V14, P561, DOI 10.1093/molehr/gan053; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Ornitz DM, 2001, GENOME BIOL, V2; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Sagare-Patil V, 2012, INT J ANDROL, V35, P633, DOI 10.1111/j.1365-2605.2012.01291.x; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; St Bernard R, 2005, ENDOCRINOLOGY, V146, P1145, DOI 10.1210/en.2004-1134; Steger K, 1998, HISTOCHEM CELL BIOL, V110, P57, DOI 10.1007/s004180050265; Sugihara K, 2013, FEBS LETT, V587, P3195, DOI 10.1016/j.febslet.2013.07.056; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tardif S, 2014, HUM REPROD, V29, P2123, DOI 10.1093/humrep/deu196; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; von Kopylow K, 2012, HISTOCHEM CELL BIOL, V138, P759, DOI 10.1007/s00418-012-0991-7; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Xu WJ, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111245; Yan D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3441; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116	53	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127297	10.1371/journal.pone.0127297	http://dx.doi.org/10.1371/journal.pone.0127297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970615	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200157
J	Higgins, D; Rohrlach, AB; Kaidonis, J; Townsend, G; Austin, JJ				Higgins, Denice; Rohrlach, Adam B.; Kaidonis, John; Townsend, Grant; Austin, Jeremy J.			Differential Nuclear and Mitochondrial DNA Preservation in Post-Mortem Teeth with Implications for Forensic and Ancient DNA Studies	PLOS ONE			English	Article							HUMAN IDENTIFICATION; EXTRACTION; DEGRADATION; BONES; PCR; MULTIPLEX; SEQUENCE; REMAINS; QUALITY; DAMAGE	Major advances in genetic analysis of skeletal remains have been made over the last decade, primarily due to improvements in post-DNA-extraction techniques. Despite this, a key challenge for DNA analysis of skeletal remains is the limited yield of DNA recovered from these poorly preserved samples. Enhanced DNA recovery by improved sampling and extraction techniques would allow further advancements. However, little is known about the post-mortem kinetics of DNA degradation and whether the rate of degradation varies between nuclear and mitochondrial DNA or across different skeletal tissues. This knowledge, along with information regarding ante-mortem DNA distribution within skeletal elements, would inform sampling protocols facilitating development of improved extraction processes. Here we present a combined genetic and histological examination of DNA content and rates of DNA degradation in the different tooth tissues of 150 human molars over short-medium post-mortem intervals. DNA was extracted from coronal dentine, root dentine, cementum and pulp of 114 teeth via a silica column method and the remaining 36 teeth were examined histologically. Real time quantification assays based on two nuclear DNA fragments (67 bp and 156 bp) and one mitochondrial DNA fragment (77 bp) showed nuclear and mitochondrial DNA degraded exponentially, but at different rates, depending on postmortem interval and soil temperature. In contrast to previous studies, we identified differential survival of nuclear and mtDNA in different tooth tissues. Futhermore histological examination showed pulp and dentine were rapidly affected by loss of structural integrity, and pulp was completely destroyed in a relatively short time period. Conversely, cementum showed little structural change over the same time period. Finally, we confirm that targeted sampling of cementum from teeth buried for up to 16 months can provide a reliable source of nuclear DNA for STR-based genotyping using standard extraction methods, without the need for specialised equipment or large-volume demineralisation steps.	[Higgins, Denice; Austin, Jeremy J.] Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Higgins, Denice; Austin, Jeremy J.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Rohrlach, Adam B.] Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia; [Kaidonis, John; Townsend, Grant] Univ Adelaide, Sch Dent, Adelaide, SA 5005, Australia	University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide	Higgins, D (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia.	denice.higgins@adelaide.edu.au	Austin, Jeremy J/F-8729-2010; Rohrlach, Adam B/H-8415-2017; Rohrlach, Adam/AAD-2530-2019; Higgins, Denice/AAF-1011-2020	Austin, Jeremy J/0000-0003-4244-2942; Rohrlach, Adam B/0000-0002-4204-5018; Rohrlach, Adam/0000-0002-4204-5018; Higgins, Denice/0000-0001-7780-243X	Australian Dental Research Foundation [47/2010]; Australian Dental Industry Association; Australian Federal Police; Forensic Science South Australia; Australian Research Council [FT100100108]	Australian Dental Research Foundation; Australian Dental Industry Association; Australian Federal Police; Forensic Science South Australia; Australian Research Council(Australian Research Council)	This work was supported by Australian Dental Research Foundation, www.adia.org.au/adrf No: 47/2010 (DH, JK, GT); Australian Dental Industry Association, www.adia.org.au/ (DH, JK, GT); Australian Federal Police (DH); Forensic Science South Australia (DH); Australian Research Council Future Fellowship, www.arc.gov.au/, FT100100108 JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CJ, 2011, J ARCHAEOL SCI, V38, P956, DOI 10.1016/j.jas.2010.11.010; Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Amory S, 2012, FORENSIC SCI INT-GEN, V6, P398, DOI 10.1016/j.fsigen.2011.08.004; [Anonymous], 2012, R PACKAGE VERSION 0; Avery JK, 2006, ESSENTIALS FO ORAL H; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Burger J, 1999, ELECTROPHORESIS, V20, P1722; Butler J M, 2012, Forensic Sci Rev, V24, P15; Deagle BE, 2006, FRONTIERS IN ZOOLOGY, V3; Dobberstein RC, 2008, FORENSIC SCI INT, V179, P181, DOI 10.1016/j.forsciint.2008.05.017; Edson S M, 2004, Forensic Sci Rev, V16, P63; Fondevila M, 2013, FORENSIC SCI INT-GEN, V7, P63, DOI 10.1016/j.fsigen.2012.06.007; Foran DR, 2006, J FORENSIC SCI, V51, P766, DOI 10.1111/j.1556-4029.2006.00176.x; Garcia AA, 1996, INT J LEGAL MED, V109, P125, DOI 10.1007/BF01369671; Gilbert MTP, 2005, J ARCHAEOL SCI, V32, P785, DOI 10.1016/j.jas.2004.12.008; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; HAGELBERG E, 1991, PHILOS T ROY SOC B, V333, P399, DOI 10.1098/rstb.1991.0090; Higgins D, 2013, SCI JUSTICE; Holland MM, 2003, CROAT MED J, V44, P264; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Kayser M, 2012, NATURE, V12, P179; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Loreille OM, 2007, FORENSIC SCI INT-GEN, V1, P191, DOI 10.1016/j.fsigen.2007.02.006; Malaver PC, 2003, CROAT MED J, V44, P306; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Milos A, 2007, CROAT MED J, V48, P486; Mundorff AZ, 2009, J FORENSIC SCI, V54, P739, DOI 10.1111/j.1556-4029.2009.01045.x; Musgrave-Brown E, 2007, FORENSIC SCI INT-GEN, V1, P186, DOI 10.1016/j.fsigen.2007.01.004; Niederstatter H, 2007, FORENSIC SCI INT-GEN, V1, P29, DOI 10.1016/j.fsigen.2006.10.007; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Pereira R, 2009, ELECTROPHORESIS, V30, P3682, DOI 10.1002/elps.200900274; Phillips C, 2013, ELECTROPHORESIS, V34, P1151, DOI 10.1002/elps.201200621; Pinchi V, 2007, J Forensic Odontostomatol, V25, P1; Pinchi V, 2011, FORENSIC SCI INT, V204, P111, DOI 10.1016/j.forsciint.2010.05.010; Prado VF, 1997, GENET ANAL-BIOMOL E, V14, P41, DOI 10.1016/S1050-3862(97)00004-1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rudbeck L, 2005, AM J PHYS ANTHROPOL, V128, P424, DOI 10.1002/ajpa.20294; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; SCHWARTZ TR, 1991, J FORENSIC SCI, V36, P979; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Swango KL, 2006, FORENSIC SCI INT, V158, P14, DOI 10.1016/j.forsciint.2005.04.034; Tvedebrink T, 2012, FORENSIC SCI INT-GEN, V6, P523, DOI 10.1016/j.fsigen.2011.12.006; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005	46	47	48	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126935	10.1371/journal.pone.0126935	http://dx.doi.org/10.1371/journal.pone.0126935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BT	25992635	Green Published, gold, Green Submitted			2022-12-27	WOS:000354918600045
J	Thatcher, LF; Kamphuis, LG; Hane, JK; Onate-Sanchez, L; Singh, KB				Thatcher, Louise F.; Kamphuis, Lars G.; Hane, James K.; Onate-Sanchez, Luis; Singh, Karam B.			The Arabidopsis KH-Domain RNA-Binding Protein ESR1 Functions in Components of Jasmonate Signalling, Unlinking Growth Restraint and Resistance to Stress	PLOS ONE			English	Article							PLANT-DISEASE RESISTANCE; RESPONSIVE GENE-REGULATION; PRE-MESSENGER-RNA; FUSARIUM-OXYSPORUM; DIFFERENTIAL GENE; DEPENDENT DEFENSE; ANALYSIS TOOLKIT; GENOME ANALYSIS; EXPRESSION; THALIANA	Glutathione S-transferases (GSTs) play important roles in the protection of cells against toxins and oxidative damage where one Arabidopsis member, GSTF8, has become a commonly used marker gene for early stress and defense responses. A GSTF8 promoter fragment fused to the luciferase reporter gene was used in a forward genetic screen for Arabidopsis mutants with up-regulated GSTF8 promoter activity. This identified the esr1-1 (enhanced stress response 1) mutant which also conferred increased resistance to the fungal pathogen Fusarium oxysporum. Through positional cloning, the ESR1 gene was found to encode a KH-domain containing RNA-binding protein (At5g53060). Whole transcriptome sequencing of esr1-1 identified altered expression of genes involved in responses to biotic and abiotic stimuli, hormone signaling pathways and developmental processes. In particular was an overall significant enrichment for jasmonic acid (JA) mediated processes in the esr1-1 down-regulated dataset. A subset of these genes were tested for MeJA inducibility and we found the expression of some but not all were reduced in esr1-1. The esr1-1 mutant was not impaired in other aspects of JA-signalling such as JA-sensitivity or development, suggesting ESR1 functions in specific components of the JA-signaling pathway. Examination of salicylic acid (SA) regulated marker genes in esr1-1 showed no increase in basal or SA induced expression suggesting repression of JA-regulated genes is not due to antagonistic SA-JA crosstalk. These results define new roles for KH-domain containing proteins with ESR1 unlinking JA-mediated growth and defense responses.	[Thatcher, Louise F.; Kamphuis, Lars G.; Hane, James K.; Onate-Sanchez, Luis; Singh, Karam B.] CSIRO, Agr Flagship, Ctr Environm & Life Sci, Wembley, WA, Australia; [Kamphuis, Lars G.; Singh, Karam B.] Univ Western Australia, Inst Agr, Crawley, WA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia	Thatcher, LF (corresponding author), CSIRO, Agr Flagship, Ctr Environm & Life Sci, Wembley, WA, Australia.	Louise.Thatcher@csiro.au	Kamphuis, Lars/X-3458-2019; Oñate-Sánchez, Luis J/C-6274-2017; Kamphuis, Lars/GVU-9293-2022; Kamphuis, Lars G/B-5360-2011; Singh, Karam B/C-3235-2012; Hane, James/A-7062-2011; Thatcher, Louise F/A-1302-2010	Kamphuis, Lars/0000-0002-9042-0513; Oñate-Sánchez, Luis J/0000-0001-7047-5739; Kamphuis, Lars G/0000-0002-9042-0513; Singh, Karam B/0000-0002-2777-7448; Hane, James/0000-0002-7651-0977; Thatcher, Louise F/0000-0001-7622-6610	Australian Government	Australian Government(Australian GovernmentCGIAR)	We thank Roger Shivas for the F. oxysporum (Fo5176), Kemal Kazan for the A. brassicicola (UQ4273) and the ABRC for seeds of Arabidopsis mutants. We also thank Elaine Smith and Hayley Casarotto for excellent technical assistance, Angela Williams for bioinformatic assistance, and Drs Jonathan Anderson and Rhonda Foley for critical reading of the manuscript and useful discussions. This research was undertaken with the assistance of resources provided at the NCI Specialised Facility in Bioinformatics at The University of Queensland and the Pawsey Supercomputing Centre through the National Computational Merit Allocation Scheme supported by the Australian Government.	Adio AM, 2011, PLANT CELL, V23, P3303, DOI 10.1105/tpc.111.088989; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ambrosone A, 2012, PLANT SCI, V182, P12, DOI 10.1016/j.plantsci.2011.02.004; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chen T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003875; Chen WQ, 1996, PLANT J, V10, P955, DOI 10.1046/j.1365-313X.1996.10060955.x; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Curtin SJ, 2008, FEBS LETT, V582, P2753, DOI 10.1016/j.febslet.2008.07.004; De Coninck B, 2013, FUNGAL BIOL REV, V26, P109, DOI 10.1016/j.fbr.2012.10.002; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Derksen H, 2013, PLANT SCI, V207, P79, DOI 10.1016/j.plantsci.2013.03.004; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Epple P, 1997, PLANT CELL, V9, P509, DOI 10.1105/tpc.9.4.509; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Foley RC, 2006, PLANT PHYSIOL, V142, P245, DOI 10.1104/pp.106.079509; Foley RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056814; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Fujisaki K, 2008, VIROLOGY, V380, P402, DOI 10.1016/j.virol.2008.07.033; Gao LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-521; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gleason C, 2011, P NATL ACAD SCI USA, V108, P10768, DOI 10.1073/pnas.1016060108; Grant MR, 2013, MICROB BIOTECHNOL, V6, P212, DOI 10.1111/1751-7915.12017; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; Guan QM, 2013, MOL PLANT, V6, P386, DOI 10.1093/mp/sss119; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huh SU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00397; Jeong IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080509; Jiang JF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003625; Jones AME, 2004, PHYTOCHEMISTRY, V65, P1805, DOI 10.1016/j.phytochem.2004.04.005; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee HJ, 2012, PLANT PHYSIOL BIOCH, V60, P46, DOI 10.1016/j.plaphy.2012.07.020; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Perl-Treves R, 2004, MOL PLANT MICROBE IN, V17, P70, DOI 10.1094/MPMI.2004.17.1.70; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Qi YP, 2010, MOL PLANT MICROBE IN, V23, P1573, DOI 10.1094/MPMI-05-10-0106; Ripoll JJ, 2006, DEV BIOL, V289, P346, DOI 10.1016/j.ydbio.2005.10.037; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Thatcher LF, 2005, FUNCT PLANT BIOL, V32, P1, DOI 10.1071/FP04135; Thatcher LF, 2007, J BIOL CHEM, V282, P28915, DOI 10.1074/jbc.M702207200; Thatcher LF, 2012, PLANT PHYSIOL, V160, P407, DOI 10.1104/pp.112.199067; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Veerappan V, 2012, PLANTA, V236, P1, DOI 10.1007/s00425-012-1630-1; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Wasternack C, 2014, BIOTECHNOL ADV, V32, P31, DOI 10.1016/j.biotechadv.2013.09.009; Woloshen V, 2011, J PATHOG, V2011, DOI 10.4061/2011/278697; Yadeta KA, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00086, 10.3389/fpls.2013.00097]; Zhou XJ, 2002, PLANT SCI, V162, P629, DOI 10.1016/S0168-9452(02)00002-X	84	36	39	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126978	10.1371/journal.pone.0126978	http://dx.doi.org/10.1371/journal.pone.0126978			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25985302	Green Published, Green Submitted, gold			2022-12-27	WOS:000354917300071
J	de Diego, LG; Cuervo, M; Martinez, JA				Garcia de Diego, Laura; Cuervo, Marta; Alfredo Martinez, J.			Development of a Learning-Oriented Computer Assisted Instruction Designed to Improve Skills in the Clinical Assessment of the Nutritional Status: A Pilot Evaluation	PLOS ONE			English	Article							QUALITY-OF-LIFE; CORONARY-HEART-DISEASE; COMMON GENETIC-VARIANTS; CHIP-CHILD EDITION; SPANISH VERSION; HEALTH-STATUS; CARDIOVASCULAR-DISEASE; SHORT-FORM; CONSTRUCT-VALIDITY; METABOLIC SYNDROME	Computer assisted instruction (CAI) is an effective tool for evaluating and training students and professionals. In this article we will present a learning-oriented CAI, which has been developed for students and health professionals to acquire and retain new knowledge through the practice. A two-phase pilot evaluation was conducted, involving 8 nutrition experts and 30 postgraduate students, respectively. In each training session, the software developed guides users in the integral evaluation of a patient's nutritional status and helps them to implement actions. The program includes into the format clinical tools, which can be used to recognize possible patient's needs, to improve the clinical reasoning and to develop professional skills. Among them are assessment questionnaires and evaluation criteria, cardiovascular risk charts, clinical guidelines and photographs of various diseases. This CAI is a complete software package easy to use and versatile, aimed at clinical specialists, medical staff, scientists, educators and clinical students, which can be used as a learning tool. This application constitutes an advanced method for students and health professionals to accomplish nutritional assessments combining theoretical and empirical issues, which can be implemented in their academic curriculum.	[Garcia de Diego, Laura; Cuervo, Marta; Alfredo Martinez, J.] Univ Navarra, Dept Food Sci & Physiol, E-31080 Pamplona, Spain; [Cuervo, Marta; Alfredo Martinez, J.] Inst Hlth Carlos III, ISCIII, CIBERobn, Pathophysiol Obes & Nutr, Madrid, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Martinez, JA (corresponding author), Univ Navarra, Dept Food Sci & Physiol, E-31080 Pamplona, Spain.	jalfmtz@unav.es	Stefanadis, Christodoulos/ABH-2232-2020; Cuervo, Marta/B-8752-2017; Martinez Hernandez, J Alfredo/K-8709-2014	Stefanadis, Christodoulos/0000-0001-5974-6454; Cuervo, Marta/0000-0003-2082-224X; Martinez Hernandez, J Alfredo/0000-0001-5218-6941				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alonso J, 1997, EUR HEART J, V18, P414; Alvarez J, 2008, NUTR HOSP, V23, P536; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 2000, CLASSIFICATION TRAST; Appleton A, 2012, MED TEACH, V34, P176, DOI 10.3109/0142159X.2012.644838; Aranceta J, 2004, MED CLIN-BARCELONA, V123, P686, DOI 10.1016/S0025-7753(04)75331-2; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Babor TF., 1992, GUIDELINES USE PRIMA; Badia X, 2002, CLIN THER, V24, P2137, DOI 10.1016/S0149-2918(02)80103-5; Badia X, 1997, EUR UROL, V31, P129; Badia X, 2000, Med Clin (Barc), V114 Suppl 3, P68; Baile JI, 2003, MED CLIN-BARCELONA, V121, P173; Balkau B, 2002, DIABETES METAB, V28, P364; Bare LA, 2007, GENET MED, V9, P682, DOI 10.1097/GIM.0b013e318156fb62; Berman NB, 2008, ADV HEALTH SCI EDUC, V13, P373, DOI 10.1007/s10459-006-9041-3; Boeker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082328; Bond WF, 2012, J GEN INTERN MED, V27, P213, DOI 10.1007/s11606-011-1804-8; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Burgos R, 2012, NUTR HOSP, V27, P2048, DOI 10.3305/nh.2012.27.6.6100; Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023; Castro J., 1991, EVALUACIONPSICOLOGIC, V7, P175; CHANG RWS, 1984, CLIN NUTR, V3, P67, DOI 10.1016/0261-5614(84)90033-5; Choban P, 2013, JPEN-PARENTER ENTER, V37, P714, DOI 10.1177/0148607113499374; Chren MM, 1997, ARCH DERMATOL, V133, P1433, DOI 10.1001/archderm.133.11.1433; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Costa DSJ, 2013, EXPERT REV PHARM OUT, V13, P631, DOI 10.1586/14737167.2013.838024; Cuervo M, 2009, ARCH GERONTOL GERIAT, V49, P69, DOI 10.1016/j.archger.2008.05.003; DCCT Res Grp, 1988, DIABETES CARE, V11, P725; de Castro MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103354; de Gracia M, 2007, PSICOTHEMA, V19, P646; de la Iglesia JM, 2001, MED CLIN-BARCELONA, V117, P129; DEHAES JCJM, 1990, BRIT J CANCER, V62, P1034, DOI 10.1038/bjc.1990.434; DEJONG PCM, 1985, CLIN NUTR, V4, P61, DOI 10.1016/0261-5614(85)90043-3; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Dour CA, 2013, J NUTR EDUC BEHAV, V45, P288, DOI 10.1016/j.jneb.2012.10.001; Dupuy H.J., 1984, ASSESSMENT QUALITY L, P170; Duquette MP, 2008, J OBSTET GYNAECOL CA, V30, P29, DOI 10.1016/S1701-2163(16)32710-4; Edwards MS, 2006, J NUTR EDUC BEHAV, V38, P386, DOI 10.1016/j.jneb.2006.05.023; Elia M., 2003, DEV USE MALNUTRITION; ESTEVE-VIVES J, 1991, Revista Espanola de Reumatologia, V18, P258; Ferguson M, 1999, NUTRITION, V15, P458, DOI 10.1016/S0899-9007(99)00084-2; Ferrer M, 1999, MED CLIN-BARCELONA, V113, P250; Garcia CG, 2014, NUTR HOSP, V30, P678, DOI 10.3305/nh.2014.30.3.7627; de Diego LG, 2013, NUTR HOSP, V28, P1622, DOI 10.3305/nh.2013.28.5.6622; Garcia JB, 2000, PSICOTHEMA, V12, P107; Garcia-Campayo J, 2005, J PSYCHOSOM RES, V59, P51, DOI 10.1016/j.jpsychores.2004.06.005; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; GASSULL MA, 1984, HUM NUTR-CLIN NUTR, V38C, P419; Gavin JR, 1997, DIABETES CARE, V20, P1183; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Greenhalgh T, 2001, BRIT MED J, V322, P40, DOI 10.1136/bmj.322.7277.40; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; GUYATT G, 1989, GASTROENTEROLOGY, V96, P804, DOI 10.1016/0016-5085(89)90905-0; Haddad M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078493; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; He MA, 2010, ARTERIOSCL THROM VAS, V30, P327, DOI 10.1161/ATVBAHA.109.196196; Henry BW, 2010, J NUTR EDUC BEHAV, V42, P57, DOI 10.1016/j.jneb.2008.12.005; Holmes S., 1995, ENDOCRINOL METAB, V2, P63; HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5; INGENBLEEK Y, 1985, INT J VITAM NUTR RES, V55, P91; Issler L, 2007, METHOD INFORM MED, V46, P641, DOI 10.3414/ME0428; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kelleher CJ, 1997, BRIT J OBSTET GYNAEC, V104, P1374, DOI 10.1111/j.1471-0528.1997.tb11006.x; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuykendall DH, 1998, J CLIN EPIDEMIOL, V51, P99, DOI 10.1016/S0895-4356(97)00245-X; Laillou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101159; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LEE EW, 1993, ARCH INTERN MED, V153, P34, DOI 10.1001/archinte.153.1.34; Leung SF, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-9; Lluis-Ganella C, 2010, REV ESP CARDIOL, V63, P925, DOI 10.1016/S0300-8932(10)70204-9; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; LOPEZ RR, 1991, MED CLIN-BARCELONA, V96, P196; LOVE JR, 1992, J CLIN GASTROENTEROL, V14, P15, DOI 10.1097/00004836-199201000-00005; MAHONEY F I, 1965, Md State Med J, V14, P61; Marrugat J, 2003, REV ESP CARDIOL, V56, P253, DOI 10.1157/13043951; Marti A, 2005, Nutr. Hosp., V20, P157; Martin-Albo J, 2007, SPAN J PSYCHOL, V10, P458, DOI 10.1017/S1138741600006727; Mc Laren DS, 1981, COLOUR ATLAS NUTR DI; MCKENNA SP, 1992, HEALTH POLICY, V22, P321, DOI 10.1016/0168-8510(92)90005-V; MORALES JM, 1995, ALZ DIS ASSOC DIS, V9, P105, DOI 10.1097/00002093-199509020-00008; Morejon AJV, 2007, ACTAS ESP PSIQUIATRI, V35, P309; MORLEY JE, 1989, J AM GERIATR SOC, V37, P184, DOI 10.1111/j.1532-5415.1989.tb05881.x; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; MULLEN JL, 1979, SURG FORUM, V30, P80; Nielsen J., 1995, CONDUCT HEURISTIC EV, V1, P1; Nikolaus T, 1995, ANN NUTR METAB, V39, P340, DOI 10.1159/000177883; Norton D., 1962, INVESTIGATION GERIAT, P193; *NUTR SCREEN IN, 1991, NUTR SCREEN MAN PROF; Nykanen P, 2011, INT J MED INFORM, V80, P815, DOI 10.1016/j.ijmedinf.2011.08.004; Otles S, 2014, ACTA SCI POLON-TECHN, V13, P89, DOI 10.17306/J.AFS.2014.1.8; Palacios S, 2004, MED CLIN-BARCELONA, V122, P205, DOI 10.1157/13058170; Panagiotakos DB, 2006, COMPUT METH PROG BIO, V83, P73, DOI 10.1016/j.cmpb.2006.05.003; Pinero NC, 2002, ACTAS ESP PSIQUIATRI, V30, P7; POSNER BM, 1993, AM J PUBLIC HEALTH, V83, P972, DOI 10.2105/AJPH.83.7.972; Puri R, 2010, J AM DIET ASSOC, V110, P892, DOI 10.1016/j.jada.2010.03.022; Qi Q, 2010, DIABETOLOGIA, V53, P2163, DOI 10.1007/s00125-010-1826-5; Raich R.M., 1996, CLIN SALUD, V7, P51; RAIDL MA, 1995, J AM DIET ASSOC, V95, P868, DOI 10.1016/S0002-8223(95)00241-3; Ramirez-Rodrigo J, 2013, J EVAL CLIN PRACT, V19, P277, DOI 10.1111/j.1365-2753.2012.01819.x; RAMOSBRIEVA JA, 1988, J PSYCHIATR RES, V22, P21, DOI 10.1016/0022-3956(88)90024-6; Reid GT, 2009, PUBLIC HEALTH GENOMI, V12, P73, DOI 10.1159/000160667; Riley AW, 2004, MED CARE, V42, P221, DOI 10.1097/01.mlr.0000114910.46921.73; RIVAS T, 2004, PSICOLOGIA CONDUCTUA, V12, P447; ROCACUSACHS A, 1992, MED CLIN-BARCELONA, V98, P486; Rodriguez MC, 1997, MED EDUC, V31, P229, DOI 10.1111/j.1365-2923.1997.tb02572.x; Rosen KR, 2008, J CRIT CARE, V23, P157, DOI 10.1016/j.jcrc.2007.12.004; Rubin J., 2008, HDB USABILITY TESTIN; Ruiz M. A., 1993, EUROPEAN J PSYCHOL A, V9, P19; Rusin M, 2013, INT J MED INFORM, V82, P653, DOI 10.1016/j.ijmedinf.2013.01.007; Ryan Frances, 2007, Br J Nurs, V16, P738; Schifferdecker KE, 2012, MED EDUC, V46, P1063, DOI 10.1111/j.1365-2923.2012.04350.x; Schwarz EB, 2012, J GEN INTERN MED, V27, P831, DOI 10.1007/s11606-012-1991-y; SELTZER MH, 1979, JPEN-PARENTER ENTER, V3, P157, DOI 10.1177/0148607179003003157; Shaw MJ, 2001, AM J GASTROENTEROL, V96, P52; Shi JJ, 2010, AM J EPIDEMIOL, V172, P244, DOI 10.1093/aje/kwq129; SMILKSTEIN G, 1978, J FAM PRACTICE, V6, P1231; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; Stern S, 2008, PERSPECT BIOL MED, V51, P22, DOI 10.1353/pbm.2008.0014; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tejero A., 1986, REV DEP PSIQUIATRIA, V13, P233; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; Travale Irene L, 2007, J Contin Educ Nurs, V38, P132; Turner RE, 2000, J AM DIET ASSOC, V100, P183, DOI 10.1016/S0002-8223(00)00059-6; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; van Dierendonck D, 2004, PERS INDIV DIFFER, V36, P629, DOI 10.1016/S0191-8869(03)00122-3; Vila Coll MA, 1997, ATEN PRIM, V19, P121; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weaver TE, 1997, SLEEP, V20, P835; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WILLIFORD WO, 1991, NEW ENGL J MED, V325, P525; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolbrink TA, 2014, PEDIATR CRIT CARE ME, V15, P197, DOI 10.1097/PCC.0000000000000051; Wood D, 1998, EUR HEART J, V19, P1434; WU AW, 1991, MED CARE, V29, P786, DOI 10.1097/00005650-199108000-00011; Yiannakouris N, 2006, EUR J EPIDEMIOL, V21, P859, DOI 10.1007/s10654-006-9070-5; Younossi ZM, 1999, GUT, V45, P295, DOI 10.1136/gut.45.2.295	154	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126345	10.1371/journal.pone.0126345	http://dx.doi.org/10.1371/journal.pone.0126345			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7AU	25978456	Green Published, gold			2022-12-27	WOS:000354916100064
J	Lu, YR; Li, LX; Yang, X; Yang, YX				Lu, Yanrong; Li, Lixiang; Yang, Xing; Yang, Yixian			Robust Biometrics Based Authentication and Key Agreement Scheme for Multi-Server Environments Using Smart Cards	PLOS ONE			English	Article							IMPROVEMENT	Biometrics authenticated schemes using smart cards have attracted much attention in multi-server environments. Several schemes of this type where proposed in the past. However, many of them were found to have some design flaws. This paper concentrates on the security weaknesses of the three-factor authentication scheme by Mishra et al. After careful analysis, we find their scheme does not really resist replay attack while failing to provide an efficient password change phase. We further propose an improvement of Mishra et al.'s scheme with the purpose of preventing the security threats of their scheme. We demonstrate the proposed scheme is given to strong authentication against several attacks including attacks shown in the original scheme. In addition, we compare the performance and functionality with other multi-server authenticated key schemes.	[Lu, Yanrong; Li, Lixiang; Yang, Xing; Yang, Yixian] Beijing Univ Posts & Telecommun, State Key Lab Networking & Switching Technol, Informat Secur Ctr, Beijing 100876, Peoples R China; [Lu, Yanrong; Li, Lixiang; Yang, Xing; Yang, Yixian] Beijing Univ Posts & Telecommun, Natl Engn Lab Disaster Backup & Recovery, Beijing 100876, Peoples R China	Beijing University of Posts & Telecommunications; Beijing University of Posts & Telecommunications	Li, LX (corresponding author), Beijing Univ Posts & Telecommun, State Key Lab Networking & Switching Technol, Informat Secur Ctr, Beijing 100876, Peoples R China.	li_lixiang2006@163.com	Li, lixiang/G-6222-2011	Li, lixiang/0000-0001-9949-8731; Li, Lixiang/0000-0001-8541-308X	National Natural Science Foundation of China [61121061]; Beijing Natural Science Foundation [4142016]; Asia Foresight Program under NSFC Grant [61411146001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Asia Foresight Program under NSFC Grant	This work was supported by National Natural Science Foundation of China (grant no. 61121061), the Beijing Natural Science Foundation (grant no. 4142016), and the Asia Foresight Program under NSFC Grant (grant no. 61411146001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURROWS M, 1990, ACM T COMPUT SYST, V8, P18, DOI [10.1145/77648.77649, 10.1145/74851.74852]; Chuang MC, 2014, EXPERT SYST APPL, V41, P1411, DOI 10.1016/j.eswa.2013.08.040; Das AK., 2013, NETWORKING SCI, V2, P12, DOI DOI 10.1007/S13119-012-0009-8; Das AK, 2012, INFORM SCIENCES, V209, P80, DOI 10.1016/j.ins.2012.04.036; Du WB, 2013, PHYSICA A, V392, P3505, DOI 10.1016/j.physa.2013.03.032; LAMPORT L, 1981, COMMUN ACM, V24, P770, DOI 10.1145/358790.358797; Lee CC, 2011, EXPERT SYST APPL, V38, P13863, DOI 10.1016/j.eswa.2011.04.190; Li CS, 2011, J STAT COMPUT SIM, V81, P1081, DOI 10.1080/00949651003677410; Li X, 2013, MATH COMPUT MODEL, V58, P85, DOI 10.1016/j.mcm.2012.06.033; Liao YP, 2009, COMPUT STAND INTER, V31, P24, DOI 10.1016/j.csi.2007.10.007; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Lu RX, 2012, IEEE T INTELL TRANSP, V13, P127, DOI 10.1109/TITS.2011.2164068; Lu RX, 2012, IEEE T PARALL DISTR, V23, P32, DOI 10.1109/TPDS.2011.95; Lu YR, 2015, INT J DISTRIB SENS N, DOI [10.1109/ISSNIP.2015.7106965, 10.1007/s10766-015-0386-1, 10.1155/2015/635890]; Lu YR, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/894549; Lu YR, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0221-7; Lu YR, 2015, SECURITY COMMUNICATI; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; Mishra D, 2014, EXPERT SYST APPL, V41, P8129, DOI 10.1016/j.eswa.2014.07.004; Stallings W., 2003, CRYPTOGRAPHY NETWORK; Sun DZ, 2009, IEEE T IND ELECTRON, V56, P2284, DOI 10.1109/TIE.2009.2016508; Tsai JL, 2008, COMPUT SECUR, V27, P115, DOI 10.1016/j.cose.2008.04.001; Wang Z, 2010, BMC EMERG MED, V10, DOI [10.1186/1471-227X-10-1, 10.1186/1471-2458-10-487]; Xue KP, 2014, J COMPUT SYST SCI, V80, P195, DOI 10.1016/j.jcss.2013.07.004; Zhao DW, 2014, WIRELESS PERS COMMUN, V78, P247, DOI 10.1007/s11277-014-1750-y; Zhao DW, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/896187	26	66	68	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126323	10.1371/journal.pone.0126323	http://dx.doi.org/10.1371/journal.pone.0126323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978373	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100062
J	Murphy, R; Thornley, S; de Zoysa, J; Stamp, LK; Dalbeth, N; Merriman, TR				Murphy, Rinki; Thornley, Simon; de Zoysa, Janak; Stamp, Lisa K.; Dalbeth, Nicola; Merriman, Tony R.			Sugar Sweetened Beverage Consumption among Adults with Gout or Type 2 Diabetes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTHY-YOUNG MEN; CARDIOVASCULAR-DISEASE; FRUCTOSE CONSUMPTION; INSULIN SENSITIVITY; METABOLIC SYNDROME; WEIGHT-GAIN; LIFE-STYLE; RISK; SUCROSE	Background Current guidelines for the management of type 2 diabetes and gout recommend that people with these conditions limit their sugar sweetened beverage (SSB) intake. We examined self-reported SSB intake among New Zealand adults with gout or type 2 diabetes, including those on hemodialysis. Method 1023 adults with gout and 580 adults (including 206 receiving hemodialysis) with type 2 diabetes, participated in this study of between 2009 and 2012. Participants completed an interviewer- administered SSB intake question " how many sugar sweetened drinks (including fruit juice), but not including diet drinks, do you normally drink per day?" SSB consumption was recorded as a circled number 0, 1, 2, 3, 4, 5, or >5, cans or large glasses (300mL) per day. Results Consuming one or more SSB per day was reported by 64% (622/1023) of subjects with gout, 49% (176/374) with type 2 diabetes without dialysis, and 47% (96/206) with diabetes on dialysis. Consuming four or more SSBs per day was reported by 18% (179/1023), 9% (31/374) and 9% (18/206), respectively. Such high consumers of SSB were characterized after multivariable analysis to be more likely to be male (adjusted odds ratio (OR) 1.8; 95% confidence interval 1.1-2.9), younger in age (40 vs 65 years: 1.6; 1.1-2.3), current smoker (5.2; 2.7-10.1), obese (BMI 41 vs 26kg/m(2): 1.4; 1-1.9), and report Maori (1.8; 1.2-2.8) or Pacific (1.6; 1.1-2.5) ancestry, compared to Caucasian. People with gout were more likely to report heavy SSB intake compared to people with diabetes (OR 2.4, 95% CI 1.5-3.9). Heavy SSB consumption reported by people with diabetes was similar if they did or did not require dialysis. Conclusion A high proportion of patients with gout and type 2 diabetes, including those on haemodialysis, are not responding to health messages to abstain from SSB consumption.	[Murphy, Rinki; de Zoysa, Janak; Dalbeth, Nicola] Univ Auckland, Dept Med, Fac Med & Hlth Sci, Auckland, New Zealand; [Murphy, Rinki] Maurice Wilkins Ctr Biodiscovery, Auckland, New Zealand; [Thornley, Simon] Counties Manukau Dist Hlth Board, Populat Hlth Directorate, Auckland, New Zealand; [de Zoysa, Janak] Waitemata Dist Hlth Board, Dept Renal Med, Auckland, New Zealand; [Stamp, Lisa K.] Univ Otago, Dept Med, Christchurch, New Zealand; [Merriman, Tony R.] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Auckland; University of Otago; University of Otago	Murphy, R (corresponding author), Univ Auckland, Dept Med, Fac Med & Hlth Sci, Auckland, New Zealand.	R.Murphy@auckland.ac.nz		Merriman, Tony/0000-0003-0844-8726	Health Research Council of New Zealand; Arthritis New Zealand; New Zealand Lottery Health; University of Otago and Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); Arthritis New Zealand; New Zealand Lottery Health; University of Otago and Auckland	This work was supported by the Health Research Council of New Zealand, Arthritis New Zealand, New Zealand Lottery Health and the University of Otago and Auckland.	Aeberli I, 2013, DIABETES CARE, V36, P150, DOI 10.2337/dc12-0540; Aeberli I, 2011, AM J CLIN NUTR, V94, P479, DOI 10.3945/ajcn.111.013540; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Batt C, 2013, ANN RHEUM DIS; Bleich SN, 2011, DIABETES CARE, V34, P551, DOI 10.2337/dc10-1687; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Dalbeth N, 2013, ANN RHEUM DIS, V72, P1868, DOI 10.1136/annrheumdis-2012-202732; de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; Deshmukh-Taskar P, 2007, J AM DIET ASSOC, V107, P223, DOI 10.1016/j.jada.2006.11.004; Eyre H, 2004, DIABETES CARE, V27, P1812, DOI 10.2337/diacare.27.7.1812; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; Harnack L, 1999, AM J HEALTH PROMOT, V13, P233, DOI 10.4278/0890-1171-13.4.233; [Health UoOaMo Mo Health], 2011, FOC NUTR KEY FIND 20; Hollis-Moffatt JE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3816; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Le MT, 2012, METABOLISM, V61, P641, DOI 10.1016/j.metabol.2011.09.013; Lv N, 2004, J AM DIET ASSOC, V104, P771, DOI 10.1016/j.jada.2004.02.032; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Park SY, 2005, PUBLIC HEALTH NUTR, V8, P904, DOI 10.1079/PHN2005740; Peart N, 2000, N Z Bioeth J, V1, P3; Sorensen LB, 2005, AM J CLIN NUTR, V82, P421, DOI 10.1093/ajcn/82.2.421; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Thompson FE, 2009, J AM DIET ASSOC, V109, P1376, DOI 10.1016/j.jada.2009.05.002; Thornley S, 2012, JOURNAL OF BIOMETRIC, V3, P6; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; West DS, 2006, OBESITY, V14, P1825, DOI 10.1038/oby.2006.210; Yang EJ, 2007, J AM DIET ASSOC, V107, P942, DOI 10.1016/j.jada.2007.03.005	37	8	8	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125543	10.1371/journal.pone.0125543	http://dx.doi.org/10.1371/journal.pone.0125543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978428	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100030
J	Rao, HL; Begum, VU; Khadka, D; Mandal, AK; Senthil, S; Garudadri, CS				Rao, Harsha L.; Begum, Viquar U.; Khadka, Deepa; Mandal, Anil K.; Senthil, Sirisha; Garudadri, Chandra S.			Comparing Glaucoma Progression on 24-2 and 10-2 Visual Field Examinations	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CATARACT-EXTRACTION; AUTOMATED PERIMETRY; INDEX	Purpose To compare the rate of mean deviation (MD) change on 24-2 versus 10-2 VFs in treated glaucomatous eyes with 5 or more examinations. Methods In a retrospective study, 24-2 and 10-2 VFs of 131 glaucoma patients (167 eyes) who had undergone at least 5 VFs examinations during their follow-up were analyzed. All these patients had VF defects both on 24-2 and 10-2 VFs. Rates of MD change were calculated using best linear unbiased predictions (BLUP). Results Median age, MD on 24-2 VF at baseline, number of VFs performed during follow-up and follow-up duration were 55 years, -16.9 dB, 9 and 9 years respectively. Median rate of MD change was significantly greater (p<0.001) on 10-2 VF (-0.26 dB/year; interquartile range [IQR]: -0.47, -0.11) compared to 24-2 VFs (-0.19 dB/year; IQR: -0.41, -0.03). Comparing the rates of MD change in eyes with different severities of VF loss (early [MD better than -6 dB], moderate [-6 dB to -12 dB], advanced [-12 to -20 dB] and severe [MD worse than -20 dB]) at baseline (based on the MD on 24-2 VF), median rate of MD change was comparable between 10-2 and 24-2 VFs in mild (-0.45 dB/year vs. -0.40 dB/year, P = 0.42) and moderate (-0.32 dB/year vs. -0.40 dB/year, P = 0.26) VF loss categories, while the same were significantly greater on 10-2 VFs in advanced (-0.28 dB/year vs. -0.21 dB/year, P = 0.04) and severe (-0.18 dB/year vs. -0.06 dB/year, P<0.001) VF loss categories. Conclusions In patients with VF defects both on 24-2 and 10-2 VFs, evaluating the rate of MD change on 10-2 VFs may help in better estimation of glaucoma progression, especially so in eyes with advanced glaucoma at baseline.	[Rao, Harsha L.; Begum, Viquar U.; Khadka, Deepa; Mandal, Anil K.; Senthil, Sirisha; Garudadri, Chandra S.] VST Glaucoma Ctr, LV Prasad Eye Inst, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute	Rao, HL (corresponding author), VST Glaucoma Ctr, LV Prasad Eye Inst, Hyderabad, Andhra Pradesh, India.	harshalaxmanarao@gmail.com	Mandal, Anil/AAY-4809-2020	Rao, Harsha/0000-0001-5866-9856	Allergan; Merck; Alcon	Allergan(AbbVieAllergan); Merck(Merck & Company); Alcon(Novartis)	Funding: The authors declare funding from the following sources: Rao HL: Allergan (C); Begum VU: none; Khadka D: none; Mandal AK: none; Senthil S: none; Garudadri CS: Allergan (C), Merck (C), Alcon (C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 1999, AUTOMATED STATIC PER; Arnalich-Montiel F, 2009, GRAEF ARCH CLIN EXP, V247, P391, DOI 10.1007/s00417-008-0986-1; Beckett LA, 2004, STAT MED, V23, P231, DOI 10.1002/sim.1712; Bengtsson B, 2008, AM J OPHTHALMOL, V145, P343, DOI 10.1016/j.ajo.2007.09.038; Carrillo MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P929, DOI 10.1001/archopht.123.7.929; Fitzke FW, 1996, BRIT J OPHTHALMOL, V80, P40, DOI 10.1136/bjo.80.1.40; Gardiner SK, 2002, INVEST OPHTH VIS SCI, V43, P1400; Heijl A, 2012, FIELD ANAL PRIMER EF; HUDSON C, 1994, INVEST OPHTH VIS SCI, V35, P268; JOHNSON CA, 1988, APPL OPTICS, V27, P1030, DOI 10.1364/AO.27.001030; Koucheki B, 2004, AM J OPHTHALMOL, V138, P1022, DOI 10.1016/j.ajo.2004.08.006; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Medeiros FA, 2012, J GLAUCOMA, V21, P147, DOI 10.1097/IJG.0b013e31820bd1fd; Medeiros FA, 2010, OPHTHALMOLOGY, V117, P2061, DOI 10.1016/j.ophtha.2010.02.015; Medeiros FA, 2010, AM J OPHTHALMOL, V149, P908, DOI 10.1016/j.ajo.2010.01.010; Nevalainen J, 2008, GRAEF ARCH CLIN EXP, V246, P1331, DOI 10.1007/s00417-008-0828-1; Nevalainen J, 2009, GRAEF ARCH CLIN EXP, V247, P1659, DOI 10.1007/s00417-009-1134-2; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Park S.U., 2013, INT J CHEM, V2, P10, DOI DOI 10.3201/EID2011.140888; Rao HL, 2011, OPHTHALMOLOGY, V118, P249, DOI 10.1016/j.ophtha.2010.05.027; Rao HL, 2013, J GLAUCOMA, V22, P164, DOI 10.1097/IJG.0b013e31822e8e37; Robinson G.K., 1991, STAT SCI, P15, DOI DOI 10.1214/SS/1177011926; Schiefer U, 2003, ARCH OPHTHALMOL-CHIC, V121, P458, DOI 10.1001/archopht.121.4.458; Siddiqui MAR, 2007, J GLAUCOMA, V16, P205, DOI 10.1097/IJG.0b013e31802dfc35; Spry PGD, 2005, EYE, V19, P643, DOI 10.1038/sj.eye.6701605; Stewart WC, 2000, AM J OPHTHALMOL, V130, P274, DOI 10.1016/S0002-9394(00)00487-6; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; Vesti E, 2003, INVEST OPHTH VIS SCI, V44, P3873, DOI 10.1167/iovs.02-1171; WERNER EB, 1988, ARCH OPHTHALMOL-CHIC, V106, P619; WILD JM, 1991, ACTA OPHTHALMOL, V69, P210	31	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127233	10.1371/journal.pone.0127233	http://dx.doi.org/10.1371/journal.pone.0127233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978316	gold, Green Submitted, Green Published			2022-12-27	WOS:000354916100140
J	Saini, S; Zakaria, N; Rohaya, D; Rambli, A; Sulaiman, S				Saini, Sanjay; Zakaria, Nordin; Rohaya, Dayang; Rambli, Awang; Sulaiman, Suziah			Markerless Human Motion Tracking Using Hierarchical Multi-Swarm Cooperative Particle Swarm Optimization	PLOS ONE			English	Article							BODY MOTION; CAPTURE	The high-dimensional search space involved in markerless full-body articulated human motion tracking from multiple-views video sequences has led to a number of solutions based on metaheuristics, the most recent form of which is Particle Swarm Optimization (PSO). However, the classical PSO suffers from premature convergence and it is trapped easily into local optima, significantly affecting the tracking accuracy. To overcome these drawbacks, we have developed a method for the problem based on Hierarchical Multi-Swarm Cooperative Particle Swarm Optimization (H-MCPSO). The tracking problem is formulated as a non-linear 34-dimensional function optimization problem where the fitness function quantifies the difference between the observed image and a projection of the model configuration. Both the silhouette and edge likelihoods are used in the fitness function. Experiments using Brown and HumanEva-II dataset demonstrated that H-MCPSO performance is better than two leading alternative approaches-Annealed Particle Filter (APF) and Hierarchical Particle Swarm Optimization (HPSO). Further, the proposed tracking method is capable of automatic initialization and self-recovery from temporary tracking failures. Comprehensive experimental results are presented to support the claims.	[Saini, Sanjay; Zakaria, Nordin; Rohaya, Dayang; Rambli, Awang; Sulaiman, Suziah] Univ Teknol PETRONAS, Dept Comp & Informat Sci, Tronoh, Perak, Malaysia	Universiti Teknologi Petronas	Saini, S (corresponding author), Univ Teknol PETRONAS, Dept Comp & Informat Sci, Tronoh, Perak, Malaysia.	sanjay.1987saini@gmail.com	Saini, Sanjay/M-6034-2015	Saini, Sanjay/0000-0001-9399-5788	ERGS - Government of Malaysia [ERGS/1/2013/ICT07/UTP/02/03]	ERGS - Government of Malaysia	Funding: This work is supported by ERGS grant (ERGS/1/2013/ICT07/UTP/02/03), funded by the Government of Malaysia.	Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Balaei A. T., 2007, CVPR, P1; Balan A. O., 2005, Proceedings. 2nd Joint IEEE International Workshop on Visual Surveillance and Performance Evaluation of Tracking and Surveillance (VS-PETS) (IEEE Cat. No. 05EX1178), P349; Bergh FVD, 2006, ANAL PARTICLE SWARM; Carranza J, 2003, ACM T GRAPHIC, V22, P569, DOI 10.1145/882262.882309; Chang IC, 2010, PATTERN RECOGN, V43, P3621, DOI 10.1016/j.patcog.2010.05.003; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Deutscher J, 2005, INT J COMPUT VISION, V61, P185, DOI 10.1023/B:VISI.0000043757.18370.9c; Fleischmann P, 2012, LECT NOTES COMPUT SC, V7517, P479, DOI 10.1007/978-3-642-33140-4_42; Gall J, 2010, INT J COMPUT VISION, V87, P75, DOI 10.1007/s11263-008-0173-1; Goh CK, 2010, EUR J OPER RES, V202, P42, DOI 10.1016/j.ejor.2009.05.005; Isard M, 1998, INT J COMPUT VISION, V29, P5, DOI 10.1023/A:1008078328650; Ivekovic S, 2006, IEEE C EVOL COMPUTAT, P1241; Jan B., 2008, P 19 BRIT MACH VIS C, P1; John M., 2000, LECT NOTES COMPUTER, P3, DOI DOI 10.1007/3-540-45053-X1; John V, 2010, P BMVC 2010 UK POSTG, P41; John V, 2010, IMAGE VISION COMPUT, V28, P1530, DOI 10.1016/j.imavis.2010.03.008; Kehl R, 2005, PROC CVPR IEEE, P129; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Krzeszowski T, 2011, ADV INTEL SOFT COMPU, V95, P297; Kwolek B, 2012, LECT NOTES COMPUT SC, V7378, P92, DOI 10.1007/978-3-642-31567-1_9; Kwolek B, 2011, LECT NOTES COMPUT SC, V6915, P115, DOI 10.1007/978-3-642-23687-7_11; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; Li Y, 2012, COMM COM INF SC, V321, P153; Lozano M, 2011, SOFT COMPUT, V15, P2085, DOI 10.1007/s00500-010-0639-2; MacCormick J, 2000, INT J COMPUT VISION, V39, P57, DOI 10.1023/A:1008122218374; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Multon F, 2009, COMPUT ANIMAT VIRT W, V20, P491, DOI 10.1002/cav.281; Niu B, 2007, APPL MATH COMPUT, V185, P1050, DOI 10.1016/j.amc.2006.07.026; Poli R, 2007, ANAL PUBLICATIONS PA; Prati A, 2003, IEEE T PATTERN ANAL, V25, P918, DOI 10.1109/TPAMI.2003.1206520; Robertson C., 2006, BMVC 2006, P999; Saini S., 2012, 2012 Proceedings of International Conference on Computer & Information Science (ICCIS 2012), P55, DOI 10.1109/ICCISci.2012.6297212; Shen SA, 2008, PATTERN RECOGN LETT, V29, P1877, DOI 10.1016/j.patrec.2008.06.014; Shi Y., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P1945, DOI 10.1109/CEC.1999.785511; Sigal L, 2012, INT J COMPUT VISION, V98, P15, DOI 10.1007/s11263-011-0493-4; Sminchisescu C, 2002, WSCG'2002, VOLS I AND II, CONFERENCE PROCEEDINGS, P413; van den Bergh F, 2004, IEEE T EVOLUT COMPUT, V8, P225, DOI [10.1109/TEVC.2004.826069, 10.1109/tevc.2004.826069]; Wang P., 2006, P IEEE C COMP VIS PA, V1, P790; Yeguas-Bolivar E, 2014, APPL SOFT COMPUT, V17, P153, DOI 10.1016/j.asoc.2014.01.007; Zhang JZ, 2011, ENG APPL ARTIF INTEL, V24, P958, DOI 10.1016/j.engappai.2011.05.010; Zhang Z, 2010, HDB SWARM INTELLIGEN, P201; Zhang Z, 2013, IEEE T MULTIMEDIA, V15, P106, DOI 10.1109/TMM.2012.2225040	45	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127833	10.1371/journal.pone.0127833	http://dx.doi.org/10.1371/journal.pone.0127833			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978493	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100153
J	Vaseghi, B; Zoghi, M; Jaberzadeh, S				Vaseghi, Bita; Zoghi, Maryam; Jaberzadeh, Shapour			A Meta-Analysis of Site-Specific Effects of Cathodal Transcranial Direct Current Stimulation on Sensory Perception and Pain	PLOS ONE			English	Article							MOTOR CORTEX EXCITABILITY; SOMATOSENSORY CORTEX; DC-STIMULATION; METHODOLOGICAL QUALITY; MAGNETIC STIMULATION; PEDRO SCALE; MODULATION; MECHANISMS; RESPONSES; INSULA	The primary aim of our meta-analysis was to evaluate the effects of cathodal transcranial direct current stimulation (c-tDCS) on sensory and pain thresholds (STh and PTh) in healthy individuals and pain level (PL) in patients with chronic pain. Electronic databases were searched for c-tDCS studies. Methodological quality was evaluated using the PEDro and Downs and Black (D&B) assessment tools. C-tDCS of the primary motor cortex (S1) increases both STh (P<0.001, effect size of 26.84%) and PTh (P<0.001, effect size of 11.62%). In addition, c-tDCS over M1 led to STh increase (P<0.005, effect size of 30.44%). Likewise, PL decreased significantly in the patient group following application of c-tDCS. The small number of studies precluded subgroup analysis. Nevertheless, meta-analysis showed that in all groups (except c-tDCS of S1) active c-tDCS and sham stimulation produced significant differences in STh/PTh in healthy and PL in patient group. This review provides evidence for the site-specific effectiveness of c-tDCS in increasing STh/PTh in healthy individuals and decreasing PL in patients with chronic pain. However, due to small sample sizes in the included studies, our results should be interpreted with caution. Given that the level of blinding was not considered in the inclusion criteria, the results of the current study should be interpreted with caution.	[Vaseghi, Bita; Jaberzadeh, Shapour] Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Zoghi, Maryam] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne	Vaseghi, B (corresponding author), Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia.	bita.vaseghi@monash.edu.au	, Zoghi/AAF-9536-2019	, Zoghi/0000-0002-1819-6895; jaberzadeh, shapour/0000-0003-2957-4510				Amer Assoc Electrodiagnost Med, 2004, MUSCLE NERVE, V29, P734, DOI 10.1002/mus.20053; Antal A, 2008, PERCEPTION, V37, P367, DOI 10.1068/p5872; Antal A, 2008, CLIN J PAIN, V24, P56, DOI 10.1097/AJP.0b013e318157233b; Antal A, 2011, CEPHALALGIA, V31, P820, DOI 10.1177/0333102411399349; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Ardolino G, 2005, J PHYSIOL-LONDON, V568, P653, DOI 10.1113/jphysiol.2005.088310; Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Bax L, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-40; Bingel U, 2004, NEUROIMAGE, V23, P224, DOI 10.1016/j.neuroimage.2004.05.021; Bolton JE, 1998, J MANIP PHYSIOL THER, V21, P1; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Csifcsak G, 2009, PAIN MED, V10, P122, DOI 10.1111/j.1526-4637.2008.00508.x; de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1; Debanne D, 2003, J PHYSIOLOGY-PARIS, V97, P403, DOI 10.1016/j.jphysparis.2004.01.004; Soler MD, 2010, BRAIN, V133, P2565, DOI 10.1093/brain/awq184; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Fernandez-de-las-Penas C, 2010, ARTHRIT CARE RES, V62, P1055, DOI 10.1002/acr.20189; Fregni F, 2007, LANCET NEUROL, V6, P188, DOI 10.1016/S1474-4422(07)70032-7; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; FULLER GN, 1989, J NEUROL NEUROSUR PS, V52, P810, DOI 10.1136/jnnp.52.6.810-a; Furubayashi T, 2008, EXP BRAIN RES, V185, P279, DOI 10.1007/s00221-007-1149-z; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; Grundmann L, 2011, BRAIN STIMUL, V4, P253, DOI 10.1016/j.brs.2010.12.002; Hansen N, 2011, CEPHALALGIA, V31, P661, DOI 10.1177/0333102410390394; Higgins J., 2011, COCHRANE HDB SYST RE; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; ISLAM N, 1995, BRAIN RES, V684, P206, DOI 10.1016/0006-8993(95)00434-R; Joseph A., 2011, PLOT DIGITIZER 2 5 1; Kanda M, 2000, BRAIN RES, V853, P282, DOI 10.1016/S0006-8993(99)02274-X; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Kinkelin I, 2000, NEUROSCI LETT, V283, P149, DOI 10.1016/S0304-3940(00)00944-7; Kulkarni B, 2005, EUR J NEUROSCI, V21, P3133, DOI 10.1111/j.1460-9568.2005.04098.x; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Laurent B, 2000, REV NEUROL-FRANCE, V156, P341; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Loeb GE, 1986, ELECTROMYOGRAPHY FOR; Luedtke K, 2012, CLIN J PAIN, V28, P452, DOI 10.1097/AJP.0b013e31823853e3; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Mendonca ME, 2011, J PAIN, V12, P610, DOI 10.1016/j.jpain.2010.12.015; Moseley AM, 2002, AUST J PHYSIOTHER, V48, P43, DOI 10.1016/S0004-9514(14)60281-6; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; NETZER R, 1993, EUR J PHARMACOL, V238, P209, DOI 10.1016/0014-2999(93)90849-D; Nitsche MA, 2004, NEUROPSYCHOPHARMACOL, V29, P1573, DOI 10.1038/sj.npp.1300517; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; O'Connell NE, 2011, EUR J PHYS REHAB MED, V47, P309; Oliviero A, 2005, CLIN NEUROPHYSIOL, V116, P1072, DOI 10.1016/j.clinph.2004.12.003; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Palm U, 2013, BRAIN STIMUL, V6, P690, DOI 10.1016/j.brs.2013.01.005; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Reidler JS, 2012, J PAIN, V13, P450, DOI 10.1016/j.jpain.2012.01.005; Rogalewski A, 2004, EUR J NEUROSCI, V20, P313, DOI 10.1111/j.0953-816X.2004.03450.x; Roizenblatt Suely, 2007, Pain Pract, V7, P297, DOI 10.1111/j.1533-2500.2007.00152.x; Russo R, 2013, BRAIN STIMUL, V6, P946, DOI 10.1016/j.brs.2013.05.009; Sawamoto N, 2000, J NEUROSCI, V20, P7438; Smith BH, 2001, FAM PRACT, V18, P292, DOI 10.1093/fampra/18.3.292; STOLLBERG J, 1988, J CELL BIOL, V107, P1397, DOI 10.1083/jcb.107.4.1397; Summers J, 2004, NEUROSCI LETT, V368, P197, DOI 10.1016/j.neulet.2004.07.008; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Terney D, 2008, J PAIN SYMPTOM MANAG, V36, P79, DOI 10.1016/j.jpainsymman.2007.08.014; Vaseghi B, 2014, CLIN NEUROPHYSIOL; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	70	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0123873	10.1371/journal.pone.0123873	http://dx.doi.org/10.1371/journal.pone.0123873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978673	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100009
J	Xin, Y; Liu, SY				Xin, Yang; Liu, Shuying			Quantitative Assessment of the Influence of Rhizoma Zingiberis on the Level of Aconitine in Rat Gut Sacs and Qualitative Analysis of the Major Influencing Components of Rhizoma Zingiberis on Aconitine Using UPLC/MS	PLOS ONE			English	Article							IN-VITRO; INTESTINAL-ABSORPTION; LATERALIS-PREPARATA; MASS-SPECTROMETRY; GINGER; CHROMATOGRAPHY; ALKALOIDS; MODEL; CARDIOMYOCYTES; GLYCOPROTEIN	This study attempted to clarify the material basis for the detoxification of Rhizoma Zingiberis (RZ) on aconitine, an analgesic drug, by quantitatively assessing the influence of RZ on the in vitro intestinal concentration of aconitine using an everted gut sac model and by qualitatively identifying the components in the RZ extract. To quantify aconitine in rat everted gut sacs, both an accurate processing method and a sensitive detection method were required. We developed a three-step sample processing method to protect the components from decomposition and applied ultra-performance liquid chromatography coupled with triple quadrupole mass spectrometry (UPLC/TQMS) to quantify aconitine, glucose and digoxin. In addition, ultra-performance liquid chromatography coupled with linear ion trap mass spectrometry (UPLC/ITMS) was applied to detect the potential antidotal components in the RZ extract. Finally, the RZ extract reduced the level of aconitine in everted gut sacs, and eleven gingerols were successfully identified, which could be considered potential antidotal components for aconitine. This study demonstrated the application of two UPLC/MS methods for analyzing the material basis for the reciprocity between Chinese medicine components in everted gut sacs.	[Xin, Yang] Qiqihar Univ, Coll Chem & Chem Engn, Qiqihar 161006, Peoples R China; [Xin, Yang; Liu, Shuying] Chinese Acad Sci, Changchun Ctr Mass Spectrometry, Changchun 130022, Peoples R China; [Xin, Yang; Liu, Shuying] Chinese Acad Sci, Biol Chem Lab, Changchun Inst Appl Chem, Changchun 130022, Peoples R China; [Xin, Yang; Liu, Shuying] Changchun Univ Chinese Med, Changchun 130117, Peoples R China	Qiqihar University; Chinese Academy of Sciences; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Changchun University of Chinese Medicine	Liu, SY (corresponding author), Chinese Acad Sci, Changchun Ctr Mass Spectrometry, Changchun 130022, Peoples R China.	syliu@ciac.ac.cn			National Natural Science Foundation of China [81403067, 21175127, 21475012]; Heilongjiang Province Science and Technology Department [12541874]; Qiqihar Science and Technology Bureau [SFZD-2012087]; Program for Young Teachers Scientific Research in Qiqihar University [2012k-Z04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Science and Technology Department; Qiqihar Science and Technology Bureau; Program for Young Teachers Scientific Research in Qiqihar University	This research was supported by National Natural Science Foundation of China (Nos. 81403067, 21175127, 21475012), Heilongjiang Province Science and Technology Department (No. 12541874), Qiqihar Science and Technology Bureau (No. SFZD-2012087), and Program for Young Teachers Scientific Research in Qiqihar University (No. 2012k-Z04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahui MLB, 2008, INT IMMUNOPHARMACOL, V8, P1626, DOI 10.1016/j.intimp.2008.07.009; Araya JJ, 2011, PHYTOCHEMISTRY, V72, P935, DOI 10.1016/j.phytochem.2011.03.007; Arellano C, 2010, J CHROMATOGR B, V878, P645, DOI 10.1016/j.jchromb.2010.01.019; Chan K, 2006, J ETHNOPHARMACOL, V103, P425, DOI 10.1016/j.jep.2005.08.020; Cornaire G, 2004, INT J PHARMACEUT, V278, P119, DOI 10.1016/j.ijpharm.2004.03.001; Fu M, 2008, BIOCHEM PHARMACOL, V75, P2147, DOI 10.1016/j.bcp.2008.02.027; Fu M, 2007, BIOCHEM BIOPH RES CO, V354, P929, DOI 10.1016/j.bbrc.2007.01.082; Han TJ, 2011, ACTA CHIM SINICA, V69, P1795; He XG, 1998, J CHROMATOGR A, V796, P327, DOI 10.1016/S0021-9673(97)01013-3; Kim EC, 2005, BIOCHEM BIOPH RES CO, V335, P300, DOI 10.1016/j.bbrc.2005.07.076; Klinck JS, 2011, AQUAT TOXICOL, V102, P58, DOI 10.1016/j.aquatox.2010.12.009; Li YF, 2010, J ETHNOPHARMACOL, V131, P187, DOI 10.1016/j.jep.2010.06.025; Lin MW, 2008, NEUROPHARMACOLOGY, V54, P912, DOI 10.1016/j.neuropharm.2008.01.009; Liou SS, 2005, J ETHNOPHARMACOL, V99, P379, DOI 10.1016/j.jep.2005.02.014; Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743; Ono Takiyoshi, 2009, Legal Medicine, V11, P132, DOI 10.1016/j.legalmed.2008.11.001; Perez R, 2010, SMALL RUMINANT RES, V93, P103, DOI 10.1016/j.smallrumres.2010.05.010; Qian JY, 2010, TOXICOL IN VITRO, V24, P960, DOI 10.1016/j.tiv.2009.12.027; Shaheen F, 2005, PHYTOCHEMISTRY, V66, P935, DOI 10.1016/j.phytochem.2005.02.010; Shen XY, 2011, J ETHNOPHARMACOL, V134, P399, DOI 10.1016/j.jep.2010.12.033; Smalley J, 2007, J CHROMATOGR B, V854, P260, DOI 10.1016/j.jchromb.2007.04.030; Solazzo M, 2006, EXP CELL RES, V312, P4070, DOI 10.1016/j.yexcr.2006.09.005; Takano M, 2006, PHARMACOL THERAPEUT, V109, P137, DOI 10.1016/j.pharmthera.2005.06.005; Xu SJ, 2006, LISHIZHEN MED MAT ME, V17, P518; Yue Hao, 2007, Yaoxue Xuebao, V42, P201; Yue H, 2007, CHINESE J ANAL CHEM, V35, P959; ZAMORA JM, 1988, MOL PHARMACOL, V33, P454; Zhou YQ, 2010, ENVIRON TOXICOL PHAR, V29, P229, DOI 10.1016/j.etap.2010.01.004	28	3	3	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0124110	10.1371/journal.pone.0124110	http://dx.doi.org/10.1371/journal.pone.0124110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978042	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100011
J	Lampa, S; Mihoub, JB; Gruber, B; Klenke, R; Henle, K				Lampa, Simone; Mihoub, Jean-Baptiste; Gruber, Bernd; Klenke, Reinhard; Henle, Klaus			Non-Invasive Genetic Mark-Recapture as a Means to Study Population Sizes and Marking Behaviour of the Elusive Eurasian Otter (Lutra lutra)	PLOS ONE			English	Article							MINK MUSTELA-VISON; GENOTYPING ERRORS; AMERICAN MINK; SPATIAL-ORGANIZATION; SCENT MARKING; DNA; SEX; SPRAINTS; PROGRAM; IDENTIFICATION	Quantifying population status is a key objective in many ecological studies, but is often difficult to achieve for cryptic or elusive species. Here, non-invasive genetic capture-mark-recapture (CMR) methods have become a very important tool to estimate population parameters, such as population size and sex ratio. The Eurasian otter (Lutra lutra) is such an elusive species of management concern and is increasingly studied using faecal-based genetic sampling. For unbiased sex ratios or population size estimates, the marking behaviour of otters has to be taken into account. Using 2132 otter faeces of a wild otter population in Upper Lusatia (Saxony, Germany) collected over six years (2006-2012), we studied the marking behaviour and applied closed population CMR models accounting for genetic mis-identification to estimate population sizes and sex ratios. We detected a sex difference in the marking behaviour of otters with jelly samples being more often defecated by males and placed actively exposed on frequently used marking sites. Since jelly samples are of higher DNA quality, it is important to not only concentrate on this kind of samples or marking sites and to invest in sufficiently high numbers of repetitions of non-jelly samples to ensure an unbiased sex ratio. Furthermore, otters seemed to increase marking intensity due to the handling of their spraints, hence accounting for this behavioural response could be important. We provided the first precise population size estimate with confidence intervals for Upper Lusatia (for 2012: (N) over cap = 20 +/- 2.1, 95% CI = 16-25) and showed that spraint densities are not a reliable index for abundances. We further demonstrated that when minks live in sympatry with otters and have comparably high densities, a non-negligible number of supposed otter samples are actually of mink origin. This could severely bias results of otter monitoring if samples are not genetically identified.	[Lampa, Simone; Mihoub, Jean-Baptiste; Klenke, Reinhard; Henle, Klaus] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, D-04318 Leipzig, Germany; [Lampa, Simone] Univ Jena, Inst Ecol, D-07743 Jena, Germany; [Gruber, Bernd] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Gruber, Bernd] Univ Canberra, Collaborat Res Network Murray Darling Basin Futur, Canberra, ACT 2601, Australia	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; University of Canberra; University of Canberra	Lampa, S (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Permoserstr 15, D-04318 Leipzig, Germany.	simone.lampa@ufz.de	Mihoub, Jb/B-7708-2015; Henle, Klaus/I-6837-2013; Klenke, Reinhard/J-4686-2013	Mihoub, Jb/0000-0002-5354-850X; Henle, Klaus/0000-0002-6647-5362; Klenke, Reinhard/0000-0002-6860-8085; Gruber, Bernd/0000-0003-0078-8179	Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE); German Science Foundation (DFG) [GR 1960/2-1]	Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE); German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE; http://www.ufz.de/higrade/index.php?en=14662). SL was funded by the German Science Foundation (DFG; http://www.dfg.de/), grant GR 1960/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge H, 1997, MAMM BIOL, V62, P142; Ansorge Hermann, 1994, Saeugetierkundliche Informationen, V3, P617; Arrendal J, 2007, CONSERV GENET, V8, P1097, DOI 10.1007/s10592-006-9266-y; Balestrieri A, 2011, NATURWISSENSCHAFTEN, V98, P23, DOI 10.1007/s00114-010-0737-0; Bohnert W, 1996, ANAL BEWERTUNG LANDS; Bonesi L, 2004, OIKOS, V106, P509, DOI 10.1111/j.0030-1299.2004.13034.x; Bonesi L, 2004, OIKOS, V106, P9, DOI 10.1111/j.0030-1299.2004.13138.x; Bonesi L, 2006, BIOL CONSERV, V130, P268, DOI 10.1016/j.biocon.2005.12.021; Bonesi L, 2013, ACTA THERIOL, V58, P157, DOI 10.1007/s13364-012-0118-5; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Brzezinski M, 2006, MAMMALIA, V70, P58, DOI 10.1515/MAMM.2006.019; Bueno F, 1996, ACTA THERIOL, V41, P149, DOI 10.4098/AT.arch.96-14; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calzada J, 2010, ECOL INDIC, V10, P560, DOI 10.1016/j.ecolind.2009.06.012; Chanin P., 2003, MONITORING OTTER LUT; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Dallas JF, 1998, MOL ECOL, V7, P1248; Dallas JF, 2003, MOL ECOL, V12, P275, DOI 10.1046/j.1365-294X.2003.01712.x; Dallas JF, 2002, CONSERV GENET, V3, P15, DOI 10.1023/A:1014259218632; Dallas John F., 2000, Conservation Genetics, V1, P181, DOI 10.1023/A:1026551510861; Dunstone N., 1993, MINK; ERLINGE S, 1968, OIKOS, V19, P81, DOI 10.2307/3564733; Garcia-Diaz P, 2011, FOLIA ZOOL, V60, P37; Guter A, 2008, ECOL INDIC, V8, P462, DOI 10.1016/j.ecolind.2007.04.009; Hajkova P, 2006, MOL ECOL NOTES, V6, P559, DOI 10.1111/j.1471-8286.2006.01269.x; Hajkova P, 2009, CONSERV GENET, V10, P1667, DOI 10.1007/s10592-008-9745-4; Harrington LA, 2010, EUR J WILDLIFE RES, V56, P377, DOI 10.1007/s10344-009-0328-6; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Hauer S, 2002, BIOL J LINN SOC, V77, P329, DOI 10.1046/j.1095-8312.2002.00097.x; Hedmark E, 2004, CONSERV GENET, V5, P405, DOI 10.1023/B:COGE.0000031224.88778.f5; HOLM S, 1979, SCAND J STAT, V6, P65; HOSS M, 1992, NATURE, V359, P199, DOI 10.1038/359199a0; Hothorn T, EXACT DISTRIBUTION R; Hung CM, 2004, ANIM CONSERV, V7, P301, DOI 10.1017/S1367943004001453; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Janssens X, 2008, ECOGRAPHY, V31, P176, DOI 10.1111/j.0906-7590.2008.4936.x; Kalz B, 2006, MAMM BIOL, V71, P321, DOI 10.1016/j.mambio.2006.02.010; Kean EF, 2011, CHEM SENSES, V36, P555, DOI 10.1093/chemse/bjr025; Klenke R, 1996, ARTENSCHUTZPROGRAMM, P12; Koelewijn HP, 2010, CONSERV GENET, V11, P601, DOI 10.1007/s10592-010-0051-6; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; KRUUK H, 1989, BIOL CONSERV, V49, P241, DOI 10.1016/0006-3207(89)90046-3; KRUUK H, 1991, J ZOOL, V224, P41, DOI 10.1111/j.1469-7998.1991.tb04787.x; KRUUK H, 1992, BEHAV ECOL, V3, P133, DOI 10.1093/beheco/3.2.133; KRUUK H, 1986, BIOL CONSERV, V35, P187, DOI 10.1016/0006-3207(86)90050-9; Kruuk H., 2006, OTTERS ECOLOGY BEHAV; Lampa S, PLOS ONE; Lampa S, 2008, CONSERV GENET, V9, P201, DOI 10.1007/s10592-007-9328-9; Lampa S, 2013, J WILDLIFE MANAGE, V77, P1490, DOI 10.1002/jwmg.604; Lanszki J, 2008, MAMM BIOL, V73, P40, DOI 10.1016/j.mambio.2007.08.005; Lanszki J, 2010, MAMM BIOL, V75, P447, DOI 10.1016/j.mambio.2009.09.006; Lukacs PM, 2005, MOL ECOL, V14, P3909, DOI 10.1111/j.1365-294X.2005.02717.x; Lukacs PM, 2005, J WILDLIFE MANAGE, V69, P396, DOI 10.2193/0022-541X(2005)069<0396:EPSFDC>2.0.CO;2; MACDONALD SM, 1987, ACTA THERIOL, V32, P449, DOI 10.4098/AT.arch.87-31; Marucco F, 2011, EUR J WILDLIFE RES, V57, P1, DOI 10.1007/s10344-010-0477-7; MASON CF, 1987, BIOL CONSERV, V41, P167, DOI 10.1016/0006-3207(87)90100-5; McDonald RA, 2007, DIVERS DISTRIB, V13, P92, DOI 10.1111/j.1366-9516.2006.00303.x; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Mysiak J, 2013, HUMAN WILDLIFE CONFL, P141; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Prigioni C, 2006, J MAMMAL, V87, P855, DOI 10.1644/05-MAMM-A-294R1.1; R Core Team, R LANG ENV STAT COMP; Remonti L, 2011, ANN ZOOL FENN, V48, P287, DOI 10.5735/086.048.0503; Reuther Claus, 2000, Habitat, V12, P1; Rostain RR, 2004, ANIM BEHAV, V68, P703, DOI 10.1016/j.anbehav.2003.10.027; Ruiz-Olmo J, 2001, J ZOOL, V253, P359, DOI 10.1017/S0952836901000334; Ruiz-Olmo J, 2008, LUTRA LUTRA; Ruiz-Olmo J, 2011, EUR J WILDLIFE RES, V57, P827, DOI 10.1007/s10344-011-0495-0; SIDOROVICH VE, 1991, ACTA THERIOL, V36, P153, DOI 10.4098/AT.arch.91-12; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Sulkava R, 2007, WILDLIFE BIOL, V13, P208, DOI 10.2981/0909-6396(2007)13[208:STARMF]2.0.CO;2; TABERLET P, 1992, NATURE, V358, P197, DOI 10.1038/358197a0; Trowbridge BJ, 1983, OLFACTORY COMMUNICAT; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Yamaguchi N, 2003, J MAMMAL, V84, P1341, DOI 10.1644/1545-1542(2003)084<1341:TBOCIR>2.0.CO;2	78	23	24	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125684	10.1371/journal.pone.0125684	http://dx.doi.org/10.1371/journal.pone.0125684			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973884	gold, Green Submitted, Green Published			2022-12-27	WOS:000354545600025
J	Li, HX; Zheng, JF; Luo, JY; Zeng, R; Feng, N; Zhu, N; Feng, Q				Li, Huixia; Zheng, Jianfei; Luo, Jiayou; Zeng, Rong; Feng, Na; Zhu, Na; Feng, Qi			Congenital Anomalies in Children Exposed to Antithyroid Drugs In-Utero: A Meta-Analysis of Cohort Studies	PLOS ONE			English	Article							BIRTH-DEFECTS PREVENTION; APLASIA-CUTIS-CONGENITA; METHIMAZOLE EXPOSURE; MATERNAL HYPERTHYROIDISM; COMPLICATING PREGNANCY; FAMILY-HISTORY; MEDICATION USE; 1ST TRIMESTER; RISK; PROPYLTHIOURACIL	Background Hyperthyroidism affects about 0.2%-2.7% of all pregnancies, and is commonly managed with antithyroid drugs (ATDs). However, previous studies about the effects of ATDs on congenital anomalies are controversial. Therefore, the present meta-analysis was performed to explore the risk of congenital anomalies in children exposed to ATDs in-utero. Methods Embase, Pubmed, Web of Knowledge, and BIOSIS Citation Index were searched to find out studies about congenital anomalies in children exposed to ATDs in-utero reported up to May 2014. The references cited by the retrieved articles were also searched. The relative risks (RRs) and confidence intervals (CIs) for the individual studies were pooled by fixed effects models, and heterogeneity was analyzed by chi-square and I-2 tests. Results Eight studies met the inclusion criteria. Exposure to propylthiouracil (PTU), methimazole/carbimazole (MMI/CMZ), and PTU & MMI/CMZ was investigated in 7, 7 and 2 studies, respectively. The pooled RR was 1.20 (95% CI: 1.02-1.42), 1.64 (95% CI: 1.39-1.92), and 1.83 (95% CI: 1.30-2.56) for congenital anomalies after exposure to PTU, MMI/CMZ, and PTU & MMI/CMZ, respectively. Conclusions The meta-analysis suggests that exposure to ATDs in-utero increases the risk of congenital anomalies. The use of ATDs in pregnancy should be limited when possible. Further research is needed to delineate the exact teratogenic risk for particular congenital anomaly.	[Li, Huixia; Luo, Jiayou; Feng, Na; Zhu, Na; Feng, Qi] Cent S Univ, Sch Publ Hlth, Dept Maternal & Children Hlth, Changsha, Hunan, Peoples R China; [Zheng, Jianfei] Cent S Univ, Xiangya Hosp 2, Dept Emergency & Intens Care Med, Changsha, Hunan, Peoples R China; [Zeng, Rong] Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Luo, JY (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Maternal & Children Hlth, Changsha, Hunan, Peoples R China.	jiayouluo@126.com		Luo, Jiayou/0000-0003-1612-5951	National Natural Science Foundation of China [81172680]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the funding of National Natural Science Foundation of China (NO. 81172680). JYL received the funding [http://www.nsfc.gov.cn/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2013, J CLIN ENDOCR METAB, V98, P4373, DOI 10.1210/jc.2013-2831; Azizi F, 2011, EUR J ENDOCRINOL, V164, P871, DOI 10.1530/EJE-10-1030; Banhidy F, 2011, J MATERN-FETAL NEO M, V24, P305, DOI 10.3109/14767058.2010.487142; Barbero P, 2008, AM J MED GENET A, V146A, P2390, DOI 10.1002/ajmg.a.32497; Bowman P, 2011, J THROID RES, V2011, DOI 10.4061/2011/235130; Brittain EH, 2012, BIOSTATISTICS, V13, P637, DOI 10.1093/biostatistics/kxs006; Canaku Dorina, 2014, Mater Sociomed, V26, P158, DOI 10.5455/msm.2014.26.158-162; Cassina M, 2012, BIRTH DEFECTS RES A, V94, P612, DOI 10.1002/bdra.23012; Chen CH, 2011, BJOG-INT J OBSTET GY, V118, P1365, DOI 10.1111/j.1471-0528.2011.03019.x; Chootrakool H, 2011, STAT MED, V30, P1183, DOI 10.1002/sim.4143; Clementi M, 2010, J CLIN ENDOCR METAB, V95, pE337, DOI 10.1210/jc.2010-0652; Di Gianantonio E, 2001, TERATOLOGY, V64, P262, DOI 10.1002/tera.1072; Drews K, 2011, CURR PHARM BIOTECHNO, V12, P774, DOI 10.2174/138920111795470895; Dwarakanath C. S., 1999, SMJ, V40, P70; Ferraris S, 2003, BIRTH DEFECTS RES A, V67, P989, DOI 10.1002/bdra.10098; Green RF, 2008, GENET MED, V10, P37, DOI 10.1097/GIM.0b013e31815f1def; Hackmon R, 2012, J OBSTET GYNAECOL CA, V34, P1077, DOI 10.1016/S1701-2163(16)35438-X; Karg E, 2004, PEDIATR DERMATOL, V21, P491, DOI 10.1111/j.0736-8046.2004.21417.x; Koenig D, 2010, ANN ENDOCRINOL-PARIS, V71, P535, DOI 10.1016/j.ando.2010.07.001; Korelitz JJ, 2013, THYROID, V23, P758, DOI 10.1089/thy.2012.0488; KRIPLANI A, 1994, EUR J OBSTET GYN R B, V54, P159, DOI 10.1016/0028-2243(94)90276-3; Laurberg P, 2014, EUR J ENDOCRINOL, V171; Lian Xiao-lan, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P511; Luo YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081369; Mestman JH, 2004, BEST PRACT RES CL EN, V18, P267, DOI 10.1016/j.beem.2004.03.005; MOMOTANI N, 1984, CLIN ENDOCRINOL, V20, P695, DOI 10.1111/j.1365-2265.1984.tb00119.x; Mortimer RH, 1997, J CLIN ENDOCR METAB, V82, P3099, DOI 10.1210/jc.82.9.3099; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; Rodriguez-Garcia C, 2011, PEDIATR DERMATOL, V28, P743, DOI 10.1111/j.1525-1470.2011.01572.x; Romitti PA, 2007, PEDIATRICS, V120, pS71, DOI 10.1542/peds.2007-1010F; Rosenfeld H, 2009, BRIT J CLIN PHARMACO, V68, P609, DOI 10.1111/j.1365-2125.2009.03495.x; Stoltenberg C, 1997, AM J EPIDEMIOL, V145, P439; Stoltenberg C, 1999, AM J MED GENET, V82, P423, DOI 10.1002/(SICI)1096-8628(19990219)82:5<423::AID-AJMG12>3.3.CO;2-3; SUGRUE D, 1980, BRIT J OBSTET GYNAEC, V87, P970, DOI 10.1111/j.1471-0528.1980.tb04460.x; Ting YH, 2013, BIRTH DEFECTS RES A, V97, P225, DOI 10.1002/bdra.23117; Van Zutphen AR, 2014, OBSTET GYNECOL, V123, P309, DOI 10.1097/AOG.0000000000000103; Vinceti M, 2014, EUR J EPIDEMIOL, V29, P411, DOI 10.1007/s10654-014-9913-4; Wang WW, 2011, EUR J ENDOCRINOL, V164, P263, DOI 10.1530/EJE-10-0660; WING DA, 1994, AM J OBSTET GYNECOL, V170, P90; Yoshihara A, 2012, J CLIN ENDOCR METAB, V97, P2396, DOI 10.1210/jc.2011-2860; Zhou HH, 2007, PHARMACOLOGY	42	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126610	10.1371/journal.pone.0126610	http://dx.doi.org/10.1371/journal.pone.0126610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974033	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600065
J	Chen, TH; Shih, CY; Hsu, WL; Chou, TC				Chen, Tso-Hsiao; Shih, Ching-Yu; Hsu, Wen-Lin; Chou, Tz-Chong			Mechanisms of Nifedipine-Downregulated CD40L/sCD40L Signaling in Collagen Stimulated Human Platelets	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CD40 LIGAND; ANTIPLATELET ACTIVITY; MATRIX METALLOPROTEINASE-2; HSP27 PHOSPHORYLATION; CD40/CD40 LIGAND; SOLUBLE CD40L; INHIBITION; ATHEROSCLEROSIS; RELEASE	The platelet-derived soluble CD40L (sCD40L) release plays a critical role in the development of atherosclerosis. Nifedipine, a dihydropyridine-based L-type calcium channel blocker (CCB), has been reported to have an anti-atherosclerotic effect beyond its blood pressure-lowering effect, but the molecular mechanisms remain unclear. The present study was designed to investigate whether nifedipine affects sCD40L release from collagen-stimulated human platelets and to determine the potential role of peroxisome proliferator-activated receptor-beta/-gamma (PPAR-beta/-gamma).We found that treatment with nifedipine significantly inhibited the platelet surface CD40L expression and sCD40L release in response to collagen, while the inhibition was markedly reversed by blocking PPAR-beta/-gamma activity with specific antagonist such as GSK0660 and GW9662. Meanwhile, nifedipine also enhanced nitric oxide (NO) and cyclic GMP formation in a PPAR-beta/-gamma-dependent manner. When the NO/cyclic GMP pathway was suppressed, nifedipine-mediated inhibition of sCD40L release was abolished significantly. Collagen-induced phosphorylation of p38MAPK, ERK1/2 and HSP27, matrix metalloproteinase-2 (MMP-2) expression/ activity and reactive oxygen species (ROS) formation were significantly inhibited by nifedipine, whereas these alterations were all attenuated by co-treatment with PPAR-beta/-gamma antagonists. Collectively, these results demonstrate that PPAR-beta/-gamma-dependent pathways contribute to nifedipine-mediated downregulation of CD40L/sCD40L signaling in activated platelets through regulation of NO/p38MAPK/ERK1/2/HSP27/MMP-2 signalings and provide a novel mechanismregarding the anti-atherosclerotic effect of nifedipine.	[Chen, Tso-Hsiao] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Shih, Ching-Yu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hsu, Wen-Lin] Tzu Chi Univ, Sch Med, Dept Radiat Oncol, Buddhist Tzu Chi Gen Hosp, Hualien, Taiwan; [Chou, Tz-Chong] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chou, Tz-Chong] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chou, Tz-Chong] China Med Univ, China Med Univ Hosp, Taichung, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; National Defense Medical Center; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chou, TC (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	tcchou48@mail.tcu.edu.tw	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Science Council of Taiwan, Republic of China [NSC 97-2320-B-016-008-MY3]	National Science Council of Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from the National Science Council of Taiwan, Republic of China (NSC 97-2320-B-016-008-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Alarayyed NA, 2002, PLATELETS, V13, P267, DOI 10.1080/0953770021000007203; Ali FY, 2006, FASEB J, V20, P326, DOI 10.1096/fj.05-4395fje; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; BorschHaubold AG, 1997, EUR J BIOCHEM, V245, P751, DOI 10.1111/j.1432-1033.1997.t01-1-00751.x; Chakrabarti S, 2005, ARTERIOSCL THROM VAS, V25, P2428, DOI 10.1161/01.ATV.0000184765.59207.f3; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Enomoto Y, 2010, ATHEROSCLEROSIS, V209, P415, DOI 10.1016/j.atherosclerosis.2009.10.024; Ferroni P, 2007, CURR MED CHEM, V14, P2170; Granger DN, 2004, HYPERTENSION, V43, P924, DOI 10.1161/01.HYP.0000123070.31763.55; Hammwohner M, 2007, EXP BIOL MED, V232, P581; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Inwald DP, 2003, CIRC RES, V92, P1041, DOI 10.1161/01.RES.0000070111.98158.6C; Kato H, 2008, ARCH BIOCHEM BIOPHYS, V475, P80, DOI 10.1016/j.abb.2008.04.023; Kato H, 2010, THROMB RES, V126, P39, DOI 10.1016/j.thromres.2009.12.003; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Lai YS, 2010, J AGR FOOD CHEM, V58, P8596, DOI 10.1021/jf101518p; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Marx N, 2003, CIRCULATION, V107, P1954, DOI 10.1161/01.CIR.0000069272.06194.91; Nomura S, 2007, J HUM HYPERTENS, V21, P38, DOI 10.1038/sj.jhh.1002100; PARK AJ, 1991, J BIOL CHEM, V266, P1584; Reinboldt S, 2009, PLATELETS, V20, P441, DOI 10.1080/09537100903096684; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Saglam F, 2012, RENAL FAILURE, V34, P95, DOI 10.3109/0886022X.2011.623498; Schwarz UR, 2000, BIOCHEM PHARMACOL, V60, P1399, DOI 10.1016/S0006-2952(00)00452-4; Shih CY, 2014, BRIT J PHARMACOL, V171, P1490, DOI 10.1111/bph.12523; Shih CY, 2014, J HYPERTENS, V32, P181, DOI 10.1097/HJH.0000000000000007; Shih CY, 2012, BIOCHEM PHARMACOL, V84, P793, DOI 10.1016/j.bcp.2012.06.022; Spinelli SL, 2008, PPAR RES, V2008, DOI 10.1155/2008/328172; Sweeney NV, 2004, CARDIOVASC RES, V63, P625, DOI 10.1016/j.cardiores.2004.05.008; Thijs T, 2010, CLIN CHEM LAB MED, V48, pS3, DOI 10.1515/CCLM.2010.363; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yamagishi S, 2006, CURR PHARM DESIGN, V12, P1543, DOI 10.2174/138161206776389877; Yessoufou A, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13071; Zhang HJ, 2002, J BIOL CHEM, V277, P20919, DOI 10.1074/jbc.M109801200; Zhu WG, 2010, IMMUNOL CELL BIOL, V88, P305, DOI 10.1038/icb.2009.100	39	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127054	10.1371/journal.pone.0127054	http://dx.doi.org/10.1371/journal.pone.0127054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970603	gold, Green Published, Green Submitted			2022-12-27	WOS:000354544200146
J	Ghorashi, SA; Kanci, A; Noormohammadi, AH				Ghorashi, Seyed A.; Kanci, Anna; Noormohammadi, Amir H.			Evaluation of the Capacity of PCR and High-Resolution Melt Curve Analysis for Identification of Mixed Infection with Mycoplasma gallisepticum Strains	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; POLYMERASE-CHAIN-REACTION; HOUSE FINCHES; GENE; DNA; DIFFERENTIATION; SYNOVIAE; POULTRY; SINGLE	Pathogenicity and presentation of Mycoplasma gallisepticum (MG) infection may differ from one strain to another and this may have implications on control measures. Infection of individual birds with more than one MG strain has been reported. A PCR followed by high resolution melt (HRM) curve analysis has been developed in our laboratory and routinely used for detection and differentiation of MG strains. However the potential of this test for identification of MG strains in a mixed specimen has not been evaluated. In the present study, the capability of PCR-HRM curve analysis technique, targeting vlhA and pvpA genes was assessed for identification of individual MG strains in a mixed population. Different DNA ratios of two MG strains from 1 to 10(-4) ng were tested with some generated conventional and normalized curves distinct from those of individual strains alone. Using genotype confidence percentages (GCP) generated from HRM curve analysis, it was found that vlhA PCR-HRM was more consistent than pvpA PCR-HRM for the detection of MG ts-11 vaccine strain mixed with any of the MG strains 6/85, F, S6 or a field isolate. The potential of vlhA PCR-HRM to detect mixed MG strains in a specimen was found to be primarily dependent on quantity and proportion of the target DNAs in the mixture. This is the first study examining the capacity of PCR-HRM technique for identification of individual MG strains in a mixed strain population.	[Ghorashi, Seyed A.; Noormohammadi, Amir H.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Werribee, Vic 3030, Australia; [Kanci, Anna] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Ghorashi, SA (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Werribee, Vic 3030, Australia.	aghorashi@csu.edu.au	Ghorashi, Seyed A/C-1529-2016	Ghorashi, Seyed A/0000-0002-9820-5308; NOORMOHAMMADI, AMIR/0000-0003-3459-2692; Kanci, Anna/0000-0003-0110-1594	Australian Poultry Cooperative Research Center	Australian Poultry Cooperative Research Center(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding for this project was provided by the Australian Poultry Cooperative Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER H. E., 1957, AVIAN DIS, V1, P19, DOI 10.2307/1587542; ADLER HE, 1957, AM J VET RES, V18, P655; BENCINA D, 1992, J CLIN MICROBIOL, V30, P407, DOI 10.1128/JCM.30.2.407-410.1992; BRADBURY JM, 1982, J CLIN MICROBIOL, V16, P314, DOI 10.1128/JCM.16.2.314-318.1982; Carpenter T E, 1979, Proc Annu Meet U S Anim Health Assoc, P364; Cherry JJ, 2006, J WILDLIFE DIS, V42, P421, DOI 10.7589/0090-3558-42.2.421; Chou LS, 2005, AM J CLIN PATHOL, V124, P330, DOI 10.1309/BF3MLJN8J527MWQY; EVANS RA, 1992, IEEE T RELIAB, V41, P1; Ferguson NA, 2003, AVIAN DIS, V47, P523, DOI 10.1637/6059; Ferguson NM, 2005, MICROBIOL-SGM, V151, P1883, DOI 10.1099/mic.0.27642-0; Ferguson-Noel N, 2009, AAAP AVMA SYMPOSIUM; Ghorashi SA, 2013, VET MICROBIOL, V167, P440, DOI 10.1016/j.vetmic.2013.09.032; Ghorashi SA, 2010, MICROBIOL-SGM, V156, P1019, DOI 10.1099/mic.0.031351-0; Hong Y, 2005, AVIAN DIS, V49, P43, DOI 10.1637/7254-080504R; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Jiang HX, 2009, AVIAN DIS, V53, P124, DOI 10.1637/8338-042908-ResNote.1; JORDAN FTW, 1980, RES VET SCI, V28, P96, DOI 10.1016/S0034-5288(18)32780-2; Kirkpatrick NC, 2009, AVIAN PATHOL, V38, P13, DOI 10.1080/03079450802596053; Kiss I, 1997, VET MICROBIOL, V58, P23, DOI 10.1016/S0378-1135(97)81568-4; Kleven SH, 1998, AVIAN DIS, V42, P300, DOI 10.2307/1592480; KLEVEN SH, 1990, AVIAN DIS, V34, P984, DOI 10.2307/1591393; Landman WJM, 2014, AVIAN PATHOL, V43, P2, DOI 10.1080/03079457.2014.881049; Levesque S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016167; LEVISOHN S, 1987, AVIAN DIS, V31, P1, DOI 10.2307/1590765; Luttrell MP, 2001, AVIAN DIS, V45, P321, DOI 10.2307/1592971; Lysnyansky I, 2005, AVIAN DIS, V49, P238, DOI 10.1637/7285-10020R; Morrow CJ, 1998, AVIAN DIS, V42, P667, DOI 10.2307/1592700; O'Connor RJ, 1999, AVIAN DIS, V43, P640, DOI 10.2307/1592732; Raviv Z, 2008, VET MICROBIOL, V129, P179, DOI 10.1016/j.vetmic.2007.11.017; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Stallknecht DE, 1998, AVIAN DIS, V42, P352, DOI 10.2307/1592485; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; WHITHEAR KG, 1990, AUST VET J, V67, P159, DOI 10.1111/j.1751-0813.1990.tb07745.x; Wijesurendra DS, 2015, AVIAN PATHOL, V44, P35, DOI 10.1080/03079457.2014.992390	34	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126824	10.1371/journal.pone.0126824	http://dx.doi.org/10.1371/journal.pone.0126824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970590	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200135
J	Inskip, SA; Taylor, GM; Zakrzewski, SR; Mays, SA; Pike, AWG; Llewellyn, G; Williams, CM; Lee, OYC; Wu, HHT; Minnikin, DE; Besra, GS; Stewart, GR				Inskip, Sarah A.; Taylor, G. Michael; Zakrzewski, Sonia R.; Mays, Simon A.; Pike, Alistair W. G.; Llewellyn, Gareth; Williams, Christopher M.; Lee, Oona Y-C; Wu, Houdini H. T.; Minnikin, David E.; Besra, Gurdyal S.; Stewart, Graham R.			Osteological, Biomolecular and Geochemical Examination of an Early Anglo-Saxon Case of Lepromatous Leprosy	PLOS ONE			English	Article							MYCOBACTERIUM-LEPRAE; ISOTOPIC COMPOSITION; MEDIEVAL; TUBERCULOSIS; SAMPLES; TANDEM; AMS; PRETREATMENT; PHOSPHATE; STRONTIUM	We have examined a 5th to 6th century inhumation from Great Chesterford, Essex, UK. The incomplete remains are those of a young male, aged around 21-35 years at death. The remains show osteological evidence of lepromatous leprosy (LL) and this was confirmed by lipid biomarker analysis and ancient DNA (aDNA) analysis, which provided evidence for both multi-copy and single copy loci from the Mycobacterium leprae genome. Genotyping showed the strain belonged to the 3I lineage, but the Great Chesterford isolate appeared to be ancestral to 3I strains found in later medieval cases in southern Britain and also continental Europe. While a number of contemporaneous cases exist, at present, this case of leprosy is the earliest radiocarbon dated case in Britain confirmed by both aDNA and lipid biomarkers. Importantly, Strontium and Oxygen isotope analysis suggest that the individual is likely to have originated from outside Britain. This potentially sheds light on the origins of the strain in Britain and its subsequent spread to other parts of the world, including the Americas where the 3I lineage of M. leprae is still found in some southern states of America.	[Inskip, Sarah A.] Leiden Univ, Fac Archaeol, NL-2311 BE Leiden, Netherlands; [Taylor, G. Michael; Stewart, Graham R.] Univ Surrey, Sch Biosci & Med, Dept Microbial & Cellular Sci, Guildford GU2 7TE, Surrey, England; [Zakrzewski, Sonia R.; Pike, Alistair W. G.] Univ Southampton, Dept Archaeol, Southampton SO17 1BF, Hants, England; [Mays, Simon A.] English Heritage Ctr Archaeol, Ancient Monuments Lab, Portsmouth PO4 9LD, Hants, England; [Llewellyn, Gareth; Williams, Christopher M.] Swansea Univ, Coll Med, Inst Mass Spectrometry, EPSRC Natl Mass Spectrometry Facil, Swansea SA2 8PP, W Glam, Wales; [Lee, Oona Y-C; Wu, Houdini H. T.; Minnikin, David E.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England	Leiden University; Leiden University - Excl LUMC; University of Surrey; University of Southampton; English Heritage; Swansea University; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Birmingham	Inskip, SA (corresponding author), Leiden Univ, Fac Archaeol, NL-2311 BE Leiden, Netherlands.	s.a.inskip@arch.leidenuniv.nl	Zakrzewski, Sonia/AAA-9200-2022	Zakrzewski, Sonia/0000-0003-1796-065X; Inskip, Sarah/0000-0001-7424-2094; Stewart, Graham/0000-0002-6867-6248; Besra, Gurdyal/0000-0002-5605-0395; Pike, Alistair/0000-0002-5610-8948; Williams, Christopher/0000-0002-0964-2048	Leverhulme Trust [F/00 094/BL]; UK Medical Research Council; UK Engineering and Physical Sciences Research Council (EPSRC); MRC [MR/K012118/1] Funding Source: UKRI; Medical Research Council [MR/K012118/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	No specific grant was available to fund this study but Mycolic Acid analysis was covered by The Leverhulme Trust Project Grant F/00 094/BL (OY-CL, DEM, GSB). GSB was supported by a Personal Research Chair from Mr. James Bardrick and the UK Medical Research Council. The UK Engineering and Physical Sciences Research Council (EPSRC) funded the UK National Mass Spectrometry Facility at Swansea University (GL, CMW). We would like to acknowledge Vera Evison's excellent work at Great Chesterford that made this research possible.	Andersen J.G., 1992, INT J OSTEOARCHAEOL, V2, P121, DOI [10.1002/oa.1390020204, DOI 10.1002/OA.1390020204]; Andersen J.G., 1994, INT J OSTEOARCHAEOL, V4, P21, DOI [10.1002/oa.1390040105, DOI 10.1002/OA.1390040105]; Arcini C., 1993, ARKEOLOGI SVERIGE, V2, P55; Bayliss A, 2004, J ARCHAEOL SCI, V31, P563, DOI 10.1016/j.jas.2003.10.004; Beavan N, 2013, SOC MEDIEV ARCH MGR, V33, P101; Blau S, 2005, AM J PHYS ANTHROPOL, V126, P150, DOI 10.1002/ajpa.20121; Boldsen JL, 2008, AM J PHYS ANTHROPOL, V135, P301, DOI 10.1002/ajpa.20744; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Brothwell D. R., 1961, J R ANTHR I, V91, P318; Brothwell D.R., 1981, DIGGING BONES EXCAVA; Brothwell DR, 2000, BRITANNIA MONOGRAPH, V17, P132; Budd P, 2004, ANTIQUITY, V78, P127, DOI 10.1017/S0003598X0009298X; Buikstra J.E., 1994, STANDARDS DATA COLLE, DOI 10.1002/ajhb.1310070519; Chenery CA, 2011, FITZPATRICK, P185; Chenery CA, 2012, RAPID COMMUN MASS SP, V26, P309, DOI 10.1002/rcm.5331; Darling WG, 2003, HYDROL EARTH SYST SC, V7, P163, DOI 10.5194/hess-7-163-2003; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; De Jong H, 2010, ANTHR ISOTOPIE DNA B, V3, P53; De Jong HN, 2013, THESIS U BRISTOL; Donoghue HD, 2005, P ROY SOC B-BIOL SCI, V272, P389, DOI 10.1098/rspb.2004.2966; Duhig C, 2003, P CAMBRIDGE ANTIQUAR, V92, P95; DZIERZYKRAYROGALSKI T, 1980, J HUM EVOL, V9, P71, DOI 10.1016/0047-2484(80)90044-5; Economou C, 2013, J ARCHAEOL SCI, V40, P465, DOI 10.1016/j.jas.2012.07.005; Evans JA, 2012, J ANAL ATOM SPECTROM, V27, P754, DOI 10.1039/c2ja10362a; Evans JA, 2010, J GEOL SOC LONDON, V167, P1, DOI 10.1144/0016-76492009-090; Evison V. I., 1996, 103 COUNC BRIT ARCH; Evison V.I, 1994, 91 CBA; Ford DK, 1989, ARTHRITIS ALLIED CON, P944; Frei KM, 2011, APPL GEOCHEM, V26, P325, DOI 10.1016/j.apgeochem.2010.12.006; Gyorgy P, 2014, AM J PHYS ANTHROPOL, V153, P213; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; JONES CE, 1994, GEOCHIM COSMOCHIM AC, V58, P3061, DOI 10.1016/0016-7037(94)90179-1; Katzenberg M.A., 1989, CAN SOC FORENSIC SCI, V22, P7, DOI DOI 10.1080/00085030.1989.10757414; Kettering JM, 1996, SEMIN ROENTGENOL, V31, P220, DOI 10.1016/S0037-198X(96)80030-7; Kjellstrom A, 2012, INT J OSTEOARCHAEOL, V22, P261, DOI 10.1002/oa.1204; Lanting J. N., 1998, J IRISH ARCHAEOLOGY, V9, P151; Lee OYC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041923; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; MANCHESTER K, 1981, J ARCHAEOL SCI, V8, P205, DOI 10.1016/0305-4403(81)90025-X; Matheson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008319; Mays S, 2011, J ARCHAEOL SCI, V38, P1571, DOI 10.1016/j.jas.2011.02.022; Mendum TA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-270; Minnikin DE, 2012, UNDERSTANDING TUBERCULOSIS - DECIPHERING THE SECRET LIFE OF THE BACILLI, P3; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P2013; MINNIKIN DE, 1993, ANN SOC BELG MED TR, V73, P25; Minnikin DE, 2011, YB MUMMY STUDIES, V1, P109; Moller-Christensen V., 1961, BONE CHANGES LEPROSY; Moller-Christensen V., 1962, MAN, V287, P177; Molleson T, 1993, DORSET NATURAL HIST, V11, P142; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Naysmith P, 2010, RADIOCARBON, V52, P263, DOI 10.1017/S003382220004529X; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Ramsey CB, 2004, RADIOCARBON, V46, P25; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Rawcliffe C., 2006, LEPROSY MEDIEVAL ENG; READER R, 1974, J ARCHAEOL SCI, V1, P205, DOI 10.1016/0305-4403(74)90043-0; Roberts C, 1993, NOTTINGHAM ARCHAEOLO, P58; Rogers J., 1995, FIELD GUIDE JOINT DI; Rubini M, 2014, INT J OSTEOARCHAEOL, V24, P570, DOI 10.1002/oa.2242; Rubini M, 2014, HOMO, V65, P13, DOI 10.1016/j.jchb.2013.07.006; Scheuer L., 2000, DEV JUVENILE OSTEOLO; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schuenemann VJ, 2013, SCIENCE, V341, P179, DOI 10.1126/science.1238286; SLOTA PJ, 1987, RADIOCARBON, V29, P303; Spigelman M, 2001, AM J PHYS ANTHROPOL, V114, P92, DOI 10.1002/1096-8644(200101)114:1<92::AID-AJPA1008>3.0.CO;2-V; Taylor GM, 2006, J ARCHAEOL SCI, V33, P1569, DOI 10.1016/j.jas.2006.02.008; Taylor GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062406; Taylor GM, 2011, MICROBES INFECT, V13, P923, DOI 10.1016/j.micinf.2011.05.003; Taylor GM, 2009, J ARCHAEOL SCI, V36, P2408, DOI 10.1016/j.jas.2009.06.026; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; Vandeputte K, 1996, ANAL LETT, V29, P2761; Wells C, 1962, MED HIST, V6, P382; West SG, 1997, RHEUMATOLOGY SECRETS, P568	74	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124282	10.1371/journal.pone.0124282	http://dx.doi.org/10.1371/journal.pone.0124282			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970602	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000354544200035
J	Kohan, HG; Kaur, K; Jamali, F				Kohan, Hamed Gilzad; Kaur, Kamaljit; Jamali, Fakhreddin			Synthesis and Characterization of a New Peptide Prodrug of Glucosamine with Enhanced Gut Permeability	PLOS ONE			English	Article							INTESTINAL-ABSORPTION; KNEE OSTEOARTHRITIS; DOUBLE-BLIND; SULFATE; PHARMACOKINETICS; PROGRESSION; ACYCLOVIR	The aim of this study was to synthesize a peptide prodrug of glucosamine (GlcN) with increased gut permeability through the gut peptide transporter 1 (PepT1). Glycine-Valine ester derivative of GlcN (GVG) was synthesised using solid phase synthesis followed by characterization and evaluation of its physicochemical and intestinal stability. In addition, GVG was evaluated for its ability to be biotransformed to GlcN in the liver homogenate. In vitro absorption of the new prodrug through everted rat gut was also assessed. GVG demonstrated significant and meaningful increased gut permeability as compared with GlcN. It showed favorable stability in the gut and a quick cleavage to GlcN after exposure to the liver homogenate. In conclusion, a novel prodrug of glucosamine with superior gut permeability compared to GlcN was developed and successfully tested in vitro.	[Kohan, Hamed Gilzad; Kaur, Kamaljit; Jamali, Fakhreddin] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada; [Kohan, Hamed Gilzad] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY USA; [Kaur, Kamaljit] Chapman Univ, CUSP, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA USA	University of Alberta; Albany College of Pharmacy & Health Sciences; Chapman University System; Chapman University	Kohan, HG (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.	Hamed.Kohan@acphs.edu		Gilzad Kohan, Mojtaba/0000-0002-3956-444X; Gilzad Kohan, Mohammadhossein/0000-0002-8028-0481	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) (FJ), http://www.nserc-crsng.gc.ca/index_eng.asp. Canada Foundation for Innovation (CFI) is also acknowledged (FJ), http://www.innovation.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agahzadeh-Habashi A, J PHARM SCI, V103, P760, DOI [10.1002/jps.23819, DOI 10.1002/JPS.23819]; Aghazadeh-Habashi A, J PHARM PHARM SCI, V14, P264; Amblard M, MOL BIOTECHNOL, V33, P239; Anand BS, J PHARM EXP THER, V311, P659; Bailey PD, CHEM COMMUN CAMB, V21, P323; Barthe L, 1999, FUND CLIN PHARMACOL, V13, P154, DOI 10.1111/j.1472-8206.1999.tb00334.x; Gilzad-Kohan MH, EUR J PHARM SCI, V47, P387; Gouze JN, 2002, FEBS LETT, V510, P166, DOI 10.1016/S0014-5793(01)03255-0; Han HK, AAPS PHARMSCI, V2, pE6; Herrero-Beaumont G, ARTHRITIS RHEUM, V56, P555; Hoekstra WJ, CURR MED CHEM, V8, P715; Hua J, INFLAMM RES, V54, P127; Ibrahim A, 2012, J PHARM SCI-US, V101, P2574, DOI 10.1002/jps.23145; Jackson CG, 2010, OSTEOARTHR CARTILAGE, V18, P297, DOI 10.1016/j.joca.2009.10.013; Jamali F, J PHARM PHARM SCI, V13, P128; Jamali F, Glucosamine Prodrugs, Patent No. [US 20130196897 A1, 20130196897]; Korda A, AMINO ACIDS, V30, P95; Noack W, OSTEOARTHRITIS CARTI, V2, P51; Oke S, EQUINE VET J, V38, P93; Pang KS, DRUG METAB DISPOS, V31, P1507; Pavelka K, 2002, ARCH INTERN MED, V162, P2113, DOI 10.1001/archinte.162.18.2113; Persiani S, OSTEOARTHRITIS CARTI, V15, P764; Purifoy DJ, J MED VIROL S, V1, P139; Reginster JY, 2001, LANCET, V357, P251, DOI 10.1016/S0140-6736(00)03610-2; Rovati LC, ADV MUSCULOSKELET DI, V4, P167, DOI [10.1177/1759720X12437753, DOI 10.1177/1759720X12437753]; Russell AS, J RHEUMATOL, V29, P2407; Sherman AL, 2012, PM&R, V4, pS110, DOI 10.1016/j.pmrj.2012.02.021; Soliman W, J MED CHEM, V54, P2399; Szczech GM, CLIN INFECT DIS, V22, P355; Talluri RS, INT J PHARM, V1, P118; Thieriet N, ORG LETT, V2, P1815; Wang SX, ARTHRITIS RHEUM, V56, P1537; Weller S, CLIN PHARM THER, V54, P595; Wen ZH, 2010, OSTEOARTHR CARTILAGE, V18, P1192, DOI 10.1016/j.joca.2010.05.012; Yu LX, ADV DRUG DELIV REV, V19, P359	35	11	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126786	10.1371/journal.pone.0126786	http://dx.doi.org/10.1371/journal.pone.0126786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978315	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100100
J	Mitchell, CL; Yeager, RD; Johnson, ZJ; D'Annunzio, SE; Vogel, KR; Werner, T				Mitchell, Chelsea L.; Yeager, Roger D.; Johnson, Zachary J.; D'Annunzio, Stephanie E.; Vogel, Kara R.; Werner, Thomas			Long-Term Resistance of Drosophila melanogaster to the Mushroom Toxin Alpha-Amanitin	PLOS ONE			English	Article							CROSS-RESISTANCE; INSECTICIDE-RESISTANCE; MYCOPHAGOUS DROSOPHILA; CYTOCHROME-P450 GENE; FITNESS COSTS; BODY-SIZE; BACILLUS-THURINGIENSIS; ADAPTIVE-CHANGES; OVER-EXPRESSION; DDT RESISTANCE	Insect resistance to toxins exerts not only a great impact on our economy, but also on the ecology of many species. Resistance to one toxin is often associated with cross-resistance to other, sometimes unrelated, chemicals. In this study, we investigated mushroom toxin resistance in the fruit fly Drosophila melanogaster (Meigen). This fruit fly species does not feed on mushrooms in nature and may thus have evolved cross-resistance to a-amanitin, the principal toxin of deadly poisonous mushrooms, due to previous pesticide exposure. The three Asian D. melanogaster stocks used in this study, Ama-KTT, Ama-MI, and Ama-KLM, acquired a-amanitin resistance at least five decades ago in their natural habitats in Taiwan, India, and Malaysia, respectively. Here we show that all three stocks have not lost the resistance phenotype despite the absence of selective pressure over the past half century. In response to a-amanitin in the larval food, several signs of developmental retardation become apparent in a concentration-dependent manner: higher pre-adult mortality, prolonged larva-to-adult developmental time, decreased adult body size, and reduced adult longevity. In contrast, female fecundity nearly doubles in response to higher a-amanitin concentrations. Our results suggest that a-amanitin resistance has no fitness cost, which could explain why the resistance has persisted in all three stocks over the past five decades. If pesticides caused a-amanitin resistance in D. melanogaster, their use may go far beyond their intended effects and have long-lasting effects on ecosystems.	[Mitchell, Chelsea L.; Yeager, Roger D.; Johnson, Zachary J.; D'Annunzio, Stephanie E.; Werner, Thomas] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; [Vogel, Kara R.] Washington State Univ, Dept Expt & Syst Pharmacol, Spokane, WA USA	Michigan Technological University; Washington State University	Werner, T (corresponding author), Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.	twerner@mtu.edu			Michigan Technological University	Michigan Technological University	Funding: This work was funded by a start-up and a seed grant from Michigan Technological University to T.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 1999, ANIM BEHAV, V57, P117, DOI 10.1006/anbe.1998.0999; Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x; Begun DJ, 2000, HEREDITY, V85, P184, DOI 10.1046/j.1365-2540.2000.00729.x; Benjamin DR, 1995, MUSHROOMS POISONS PA; BLOOMQUIST JR, 1994, ARCH INSECT BIOCHEM, V26, P69, DOI 10.1002/arch.940260106; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Chevillon C, 1997, GENET RES, V70, P195, DOI 10.1017/S0016672397003029; Cordts R, 1996, ANIM BEHAV, V52, P269, DOI 10.1006/anbe.1996.0172; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345; Eritja R, 1999, J MED ENTOMOL, V36, P41, DOI 10.1093/jmedent/36.1.41; Fellowes MDE, 1999, J EVOLUTION BIOL, V12, P123, DOI 10.1046/j.1420-9101.1999.00018.x; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Gassmann AJ, 2006, J ECON ENTOMOL, V99, P920, DOI 10.1603/0022-0493-99.3.920; GRIMALDI D, 1984, ECOLOGY, V65, P1113, DOI 10.2307/1938319; Hallen HE, 2002, S AFR J BOT, V68, P322, DOI 10.1016/S0254-6299(15)30393-8; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; JAENIKE J, 1985, EVOLUTION, V39, P1295, DOI [10.2307/2408786, 10.1111/j.1558-5646.1985.tb05695.x]; JAENIKE J, 1983, SCIENCE, V221, P165, DOI 10.1126/science.221.4606.165; JAENIKE J, 1983, EVOLUTION, V37, P1023, DOI 10.1111/j.1558-5646.1983.tb05630.x; JAENIKE J, 1989, EVOLUTION, V43, P1467, DOI 10.1111/j.1558-5646.1989.tb02597.x; Javois J, 2004, ANIM BEHAV, V68, P249, DOI 10.1016/j.anbehav.2003.10.022; Kalajdzic P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040296; Karan D, 1998, J THERM BIOL, V23, P301, DOI 10.1016/S0306-4565(98)00021-7; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Leips J, 2000, GENETICS, V155, P1773; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Liu NN, 2000, J ECON ENTOMOL, V93, P1269, DOI 10.1603/0022-0493-93.4.1269; Liu ZW, 2006, PEST MANAG SCI, V62, P279, DOI 10.1002/ps.1169; McCart C, 2005, CURR BIOL, V15, pR587, DOI 10.1016/j.cub.2005.07.054; McCart C, 2008, PEST MANAG SCI, V64, P639, DOI 10.1002/ps.1567; Mitchell CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093489; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Norry FM, 2002, J EVOLUTION BIOL, V15, P775, DOI 10.1046/j.1420-9101.2002.00438.x; Norry FM, 2002, EVOLUTION, V56, P299, DOI 10.1111/j.0014-3820.2002.tb01340.x; PARTRIDGE L, 1994, EVOLUTION, V48, P1269, DOI 10.1111/j.1558-5646.1994.tb05311.x; Perlman SJ, 2003, EVOLUTION, V57, P544, DOI 10.1111/j.0014-3820.2003.tb01546.x; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; PETERS TM, 1977, ANNU REV ENTOMOL, V22, P431, DOI 10.1146/annurev.en.22.010177.002243; PHILLIPS JP, 1982, CAN J GENET CYTOL, V24, P151, DOI 10.1139/g82-014; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Raymond B, 2005, P ROY SOC B-BIOL SCI, V272, P1519, DOI 10.1098/rspb.2005.3103; SMITH JM, 1958, J EXP BIOL, V35, P832; Spencer CC, 2003, AGING CELL, V2, P123, DOI 10.1046/j.1474-9728.2003.00044.x; Spicer GS, 1996, EVOLUTION, V50, P2328, DOI 10.1111/j.1558-5646.1996.tb03620.x; Stump AD, 2011, ENVIRON ENTOMOL, V40, P1604, DOI 10.1603/EN11136; TABASHNIK BE, 1994, APPL ENVIRON MICROB, V60, P4627, DOI 10.1128/AEM.60.12.4627-4629.1994; Tuno N, 2007, J CHEM ECOL, V33, P311, DOI 10.1007/s10886-006-9228-3; Vetter J, 1998, TOXICON, V36, P13, DOI 10.1016/S0041-0101(97)00074-3; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Walton JD, 2010, BIOPOLYMERS, V94, P659, DOI 10.1002/bip.21416; Webster JP, 1999, P ROY SOC B-BIOL SCI, V266, P391, DOI 10.1098/rspb.1999.0650; Wei YP, 2001, PEST MANAG SCI, V57, P1055, DOI 10.1002/ps.383	62	4	5	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127569	10.1371/journal.pone.0127569	http://dx.doi.org/10.1371/journal.pone.0127569			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978397	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100150
J	Pacitti, D; Lawan, MM; Sweetman, J; Martin, SAM; Feldmann, J; Secombes, CJ				Pacitti, Davide; Lawan, Muhammad M.; Sweetman, John; Martin, Samuel A. M.; Feldmann, Jorg; Secombes, Christopher J.			Selenium Supplementation in Fish: A Combined Chemical and Biomolecular Study to Understand Sel-Plex Assimilation and Impact on Selenoproteome Expression in Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; INORGANIC SELENIUM; DIETARY; TOXICITY; YEAST; SELENOMETHIONINE; BIOAVAILABILITY; REQUIREMENT; SPECIATION; SYSTEM	Background Selenium (Se) is an essential oligonutrient, as a component of several Se-containing proteins (selenoproteins), which exert important biological functions within an organism. In livestock, Se-enriched products have been proposed as dietary supplements to be included into functional feeds for animal preventive health care. To this end, it is important to understand the optimal range of concentrations for supplementation and how long it takes to be assimilated into the organism. Methods In this study, rainbow trout (Oncorhynchus mykiss) were fed a control diet containing 0.9 g Kg(-1) Se or the same diet supplemented with a Se-Yeast product (Sel-Plex) to achieve Se concentrations ranging from 1.5-8.9 g Kg(-1) for a period of ten weeks. Fish were sampled every two weeks for analysis. The kinetics of Se bioaccumulation and the effects on fish selenoprotein expression was determined in different tissues combining chemical and bimolecular techniques. Results The Sel-Plex enriched diets did not have any effect on survival and growth performance. The highest Se levels were found in liver and kidney followed by muscle and blood cells. Analysis of the Se concentration factor showed that liver is able to initially regulate the amount of Se accumulated. However, with higher dietary Se level (4.8 and 8.9 g Kg(-1)) and longer times of exposure (10 weeks), regulation is ineffective and the Se tissue concentration increases. The expression of the selected trout selenoprotein transcripts showed an inverse correlation with Sel-Plex augmentation in most cases. In liver, kidney and blood cells the highest up-regulation of the trout selenoprotein genes was seen mostly in the group fed the diet enriched with the lowest concentration of Sel-Plex (0.5 g Kg(-1)) for 10 weeks. Conclusion Sel-Plex may represent an excellent Se supplement to deliver a high level of Se without provoking harm to the fish and to guarantee the maximal absorption of the element. According to our results, a dietary supplementation of Sel-Plex between 0.5 and 4 g Kg(-1) may allow maximal benefits, whereas 8 g Kg(-1) may be excessive for the purpose of supplementation.	[Pacitti, Davide; Martin, Samuel A. M.; Secombes, Christopher J.] Univ Aberdeen, Inst Biol & Environm Sci, Scottish Fish Immunol Res Ctr, Aberdeen, Scotland; [Lawan, Muhammad M.; Feldmann, Jorg] Univ Aberdeen, Dept Chem, Trace Element Speciat Lab, Aberdeen, Scotland; [Sweetman, John] Alltech Biosci Ctr, Dunboyne, Country Meath, Ireland	University of Aberdeen; University of Aberdeen	Secombes, CJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Scottish Fish Immunol Res Ctr, Aberdeen, Scotland.	c.secombes@abdn.ac.uk	Lawan, Mohammed Musa/GLN-3167-2022; Lawan, Muhammad/GQZ-2057-2022; Feldmann, Jörg/AAT-3703-2020	Lawan, Mohammed Musa/0000-0002-1392-657X; Feldmann, Joerg/0000-0002-0524-8254; Lawan, Dr. Mohammed Musa/0000-0003-2759-442X; Martin, Samuel/0000-0003-0289-6317	Alltech [ZY002 RGF0258]; University of Aberdeen [BL900. ROQ0061]; Alltech Biosciences Centre	Alltech; University of Aberdeen; Alltech Biosciences Centre	Funding: Funding from Alltech (ZY002 RGF0258) supported the feeding trial and the bimolecular analysis, whereas the Principal's Interdisciplinary Fund at the University of Aberdeen (award BL900. ROQ0061) provided support for the chemical analysis. Alltech Biosciences Centre provided support in the form of a salary for author Davide Pacitti, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Bierla K, 2012, TRAC-TREND ANAL CHEM, V41, P122, DOI 10.1016/j.trac.2012.08.006; Ciardullo S, 2008, J AGR FOOD CHEM, V56, P2442, DOI 10.1021/jf703572t; Dumont E, 2006, ANAL BIOANAL CHEM, V385, P1304, DOI 10.1007/s00216-006-0529-8; Hefnawy AE, 2010, SMALL RUMINANT RES, V89, P185, DOI 10.1016/j.smallrumres.2009.12.042; Fairweather-Tait SJ, 1999, FRESEN J ANAL CHEM, V363, P536, DOI 10.1007/s002160051242; GATLIN DM, 1984, J NUTR, V114, P627, DOI 10.1093/jn/114.3.627; Griffiths JC, 2006, INT J TOXICOL, V25, P477, DOI 10.1080/10915810600959667; Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hawkes WC, 2010, BIOL TRACE ELEM RES, V134, P235, DOI 10.1007/s12011-010-8656-7; HILTON JW, 1980, J NUTR, V110, P2527, DOI 10.1093/jn/110.12.2527; HODSON PV, 1983, ECOL BULL, P335; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Jovanovic A, 1997, CRIT REV FOOD SCI, V37, P443, DOI 10.1080/10408399709527783; Kieliszek M, 2013, NUTRITION, V29, P713, DOI 10.1016/j.nut.2012.11.012; Kohrle J, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P205, DOI 10.1007/978-1-4614-1025-6_16; KOLLER LD, 1986, CAN J VET RES, V50, P297; Kucukbay FZ, 2009, AQUACULT NUTR, V15, P569, DOI 10.1111/j.1365-2095.2008.00624.x; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; McKenzie RC, 2002, ANTIOXID REDOX SIGN, V4, P339, DOI 10.1089/152308602753666398; Morera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026998; Morera D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-89; Pacitti D, 2014, DEV COMP IMMUNOL, V42, P261, DOI 10.1016/j.dci.2013.09.013; Pacitti D, 2013, AQUAT TOXICOL, V130, P97, DOI 10.1016/j.aquatox.2012.12.020; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2004, BRIT J NUTR, V92, P557, DOI 10.1079/BJN20041251; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Rider SA, 2009, AQUACULTURE, V295, P282, DOI 10.1016/j.aquaculture.2009.07.003; Schrauzer GN, 2006, PURE APPL CHEM, V78, P105, DOI 10.1351/pac200678010105; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; Sunde RA, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P137, DOI 10.1007/978-1-4614-1025-6_11; Sweetman JW, 2010, AQUAC RES, V41, P345, DOI 10.1111/j.1365-2109.2009.02196.x; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P134, DOI 10.1016/S0753-3322(03)00035-0; Thiry C, 2012, FOOD CHEM, V130, P767, DOI 10.1016/j.foodchem.2011.07.102; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wang CL, 1997, AQUACULTURE, V152, P223, DOI 10.1016/S0044-8486(96)01523-2; WOOD CM, 2011, FISH PHYSL A, V31, P1, DOI DOI 10.1016/S1546-5098(11)31001-1; Zavacki AM, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P369, DOI 10.1007/978-1-4614-1025-6_29; Zhou XX, 2009, AQUACULTURE, V291, P78, DOI 10.1016/j.aquaculture.2009.03.007	41	48	50	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127041	10.1371/journal.pone.0127041	http://dx.doi.org/10.1371/journal.pone.0127041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978314	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100124
J	Park, SY; Park, YK; Cho, KH; Choi, HJ; Han, JH; Han, KD; Han, BD; Yoon, YJ; Kim, YH				Park, Si-Young; Park, Yong-Kyu; Cho, Kyung-Hwan; Choi, Hee-Jeong; Han, Jee-Hye; Han, Kyung-Do; Han, Byung-Duck; Yoon, Yeo-Joon; Kim, Yang-Hyun			Normal Range Albuminuria and Metabolic Syndrome in South Korea: The 2011-2012 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-GRADE ALBUMINURIA; CARDIOVASCULAR RISK; GENERAL-POPULATION; RENAL-FUNCTION; MICROALBUMINURIA; EXCRETION; ASSOCIATION; DEFINITION; PREVALENCE	Background It is well-known that there is a close relationship between metabolic syndrome (MetS) and microalbuminuria. However, some recent studies have found that even normal range albuminuria was associated with MetS and cardiometabolic risk factors. The purpose of this study is to analyze the relationship between MetS and normal range albuminuria and to calculate the cutoff value for albuminuria that correlates with MetS in the representative fraction of Korean population. Methods Data were obtained from the 2011-2012 Korea National Health and Nutrition Examination Survey and included 9,650 subjects aged >= 19 years. We measured metabolic parameters: fasting blood glucose, waist circumference, blood pressure, and lipids, and albumin-to-creatinine ratio (ACR). The optimal ACR cutoff points for MetS were examined by the receiver operating characteristic curve. Multivariate logistic regression was used to obtain the prevalence of MetS and its components according to the ACR levels. Results The first cutoff value of ACR were 4.8 mg/g for subjects with >= 3 components of MetS. There was a graded association between ACR and prevalence of MetS and its components. If ACR was <4 mg/g, there was no significant increase in the prevalence of MetS or its components. From the ACR level of 4-5 mg/g, the prevalence of MetS significantly increased after adjusting for age, sex, body mass index, smoking, alcohol intake, exercise, and medications for diabetes mellitus and hypertension (odds ratio; 95% confidence intervals = 1.416; 1.041-1.926). Conclusions Albuminuria within the normal range (around 5 mg/g) was associated with prevalence of MetS in the Korean population.	[Park, Si-Young; Choi, Hee-Jeong; Han, Jee-Hye] Eulji Univ, Coll Med, Dept Family Med, Taejon, South Korea; [Park, Yong-Kyu; Han, Kyung-Do] Catholic Univ, Coll Med, Dept Med Stat, Seoul, South Korea; [Cho, Kyung-Hwan; Han, Byung-Duck; Yoon, Yeo-Joon; Kim, Yang-Hyun] Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea	Eulji University; Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine)	Kim, YH (corresponding author), Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea.	mrchir@naver.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Kim, Yang-Hyun/0000-0003-3548-8758				Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Choi HS, 2006, NEPHRON CLIN PRACT, V104, pC85, DOI 10.1159/000093995; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Clausen P, 2001, CIRCULATION, V103, P1869; Cubeddu LX, 2003, AM J HYPERTENS, V16, P343, DOI 10.1016/S0895-7061(03)00057-8; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Gerstein HC, 2000, DIABETES CARE, V23, pB35; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; HUTCHISON AS, 1988, CLIN CHEM, V34, P2019; Janssen WMT, 2000, CLIN CHEM LAB MED, V38, P1107, DOI 10.1515/CCLM.2000.165; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Klausen KP, 2007, J INTERN MED, V262, P470, DOI 10.1111/j.1365-2796.2007.01839.x; Klausen KP, 2005, HYPERTENSION, V46, P33, DOI 10.1161/01.HYP.0000169153.78459.50; Konta T, 2006, KIDNEY INT, V70, P751, DOI 10.1038/sj.ki.5001504; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Li MF, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-110; Nicholl DDM, 2012, AM J PHYSIOL-RENAL, V302, pF526, DOI 10.1152/ajprenal.00458.2011; Oh CM, 2014, MATURITAS, V77, P149, DOI 10.1016/j.maturitas.2013.10.013; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Park S, 2013, SPACE, P18; Ritz E, 2010, DIABETOLOGIA, V53, P49, DOI 10.1007/s00125-009-1577-3; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1717, DOI 10.1681/ASN.2012030252; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-6; TUCKER BJ, 1992, KIDNEY INT, V42, P1160, DOI 10.1038/ki.1992.400; Vyssoulis G, 2010, J CLIN HYPERTENS, V12, P597, DOI 10.1111/j.1751-7176.2010.00306.x; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065597	31	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125615	10.1371/journal.pone.0125615	http://dx.doi.org/10.1371/journal.pone.0125615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978637	gold, Green Published, Green Submitted			2022-12-27	WOS:000354916100032
J	Zhao, F; Wang, Z; Lang, HX; Liu, XY; Zhang, DB; Wang, XL; Zhang, T; Wang, R; Shi, P; Pang, XN				Zhao, Feng; Wang, Zhe; Lang, Hongxin; Liu, Xiaoyu; Zhang, Dianbao; Wang, Xiliang; Zhang, Tao; Wang, Rui; Shi, Ping; Pang, Xining			Dynamic Expression of Novel MiRNA Candidates and MiRNA-34 Family Members in Early- to Mid-Gestational Fetal Keratinocytes Contributes to Scarless Wound Healing by Targeting the TGF-beta Pathway	PLOS ONE			English	Article							DEEP-SEQUENCING DATA; GROWTH-FACTOR BETA-1; GENE-EXPRESSION; SKIN FIBROBLASTS; CANCER CELLS; STEM-CELLS; MICRORNAS; REGENERATION; MIR-34A; RNA	Background Early- to mid-gestational fetal mammalian skin wounds heal rapidly and without scarring. Keratinocytes (KCs) have been found to exert important effects on the regulation of fibroblasts. There may be significant differences of gestational fetal KCs at different ages. The advantages in early-to mid-gestational fetal KCs could lead to fetal scarless wound healing. Methods KCs from six human fetal skin samples were divided into two groups: a mid-gestation group (less than 28 weeks of gestational age) and a late-gestation group (more than 28 weeks of gestational age). RNA extracted from KCs was used to prepare a library of small RNAs for next-generation sequencing (NGS). To uncover potential novel microRNA (miRNAs), the mirTools 2.0 web server was used to identify candidate novel human miRNAs from the NGS data. Other bioinformatical analyses were used to further validate the novel miRNAs. The expression levels of the miRNAs were further confirmed by real-time quantitative RTPCR. Results A total of 61.59 million reads were mapped to 1,170 known human miRNAs in miRBase. Among a total of 202 potential novel miRNAs uncovered, 106 candidates have a higher probability of being novel human miRNAs. A total of 110 miRNAs, including 22 novel miRNA candidates, were significantly differently expressed between mid-and late-gestational fetal KCs. Thirty-three differentially expressed miRNAs and miR-34 family members are correlated with the transforming growth factor-beta (TGF-beta) pathway. Conclusions Taken together, our results provide compelling evidence supporting the existence of 106 novel miRNAs and the dynamic expression of miRNAs that extensively targets the TGF-beta pathway at different gestational ages in fetal KCs. MiRNAs showing altered expression at different gestational ages in fetal KCs may contribute to scarless wound healing in early-to mid-gestational fetal KCs, and thus may be new targets for potential scar prevention and reduction therapies.	[Zhao, Feng; Lang, Hongxin; Liu, Xiaoyu; Zhang, Dianbao; Wang, Xiliang; Zhang, Tao; Wang, Rui; Pang, Xining] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Stem Cells & Regenerat Med, Shenyang 110013, Liaoning Provin, Peoples R China; [Zhao, Feng; Lang, Hongxin; Liu, Xiaoyu; Zhang, Dianbao; Wang, Xiliang; Zhang, Tao; Wang, Rui; Pang, Xining] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Shenyang 110013, Liaoning Provin, Peoples R China; [Wang, Zhe] China Med Univ, Shengjing Hosp, Dept Blood Transfus, Shenyang 110004, Liaoning Provin, Peoples R China; [Shi, Ping] China Med Univ, Hosp 1, Dept Gen Practice, Shenyang 110001, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Pang, XN (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Stem Cells & Regenerat Med, 77 Puhe St, Shenyang 110013, Liaoning Provin, Peoples R China.	pangxining@126.com	Dianbao, Zhang/F-3608-2011	Dianbao, Zhang/0000-0001-7063-7742	Program for National Basic Research Program of China [2012CB518103]; National Science Foundation of China [81450017]; Doctoral Fund of Ministry of Education of China [20132104110020]; Science and Technology Planning Project of Liaoning Province [2012225080]; Science and Technology Planning Project of Shenyang City [F11-262-9-01]; National Science Foundation of China Program [81370883]	Program for National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Science and Technology Planning Project of Liaoning Province; Science and Technology Planning Project of Shenyang City; National Science Foundation of China Program	XP was supported by the Program for National Basic Research Program of China (No. 2012CB518103), National Science Foundation of China (No. 81450017), Doctoral Fund of Ministry of Education of China (No. 20132104110020), Science and Technology Planning Project of Liaoning Province (No. 2012225080), and Science and Technology Planning Project of Shenyang City (No. F11-262-9-01). PS was supported by the National Science Foundation of China Program (No. 81370883). Study design and data collection was supported by the Program No. 2012CB518103, No. 81450017 and No. 2012225080. Data analysis was supported by the Program No. 20132104110020 and No. F11-262-9-01. Program No. 81370883 was used for the decision to publish and preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartkova J, 2003, ARCH ORAL BIOL, V48, P125, DOI 10.1016/S0003-9969(02)00202-9; Bernardo BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090337; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bielefeld KA, 2013, CELL MOL LIFE SCI, V70, P2059, DOI 10.1007/s00018-012-1152-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen W, 2005, WOUND REPAIR REGEN, V13, P68, DOI 10.1111/j.1067-1927.2005.130109.x; Cheng J, 2010, TOHOKU J EXP MED, V221, P203, DOI 10.1620/tjem.221.203; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070372; Cowin AJ, 2001, EUR J DERMATOL, V11, P424; Dang C, 2003, CLIN PLAST SURG, V30, P13, DOI 10.1016/S0094-1298(02)00067-6; Ellis IR, 1998, CYTOKINE, V10, P281, DOI 10.1006/cyto.1997.0294; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hahn JM, 2013, WOUND REPAIR REGEN, V21, P530, DOI 10.1111/wrr.12060; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Jung HJ, 2012, CURR GENOMICS, V13, P548, DOI 10.2174/138920212803251436; Kim NH, 2013, CELL CYCLE, V12, P1578, DOI 10.4161/cc.24739; King A, 2013, J PEDIATR SURG, V48, P1211, DOI 10.1016/j.jpedsurg.2013.03.014; Kishi K, 1999, BRIT J PLAST SURG, V52, P579, DOI 10.1054/bjps.1999.3163; Kishi Kazuo, 2012, Keio Journal of Medicine, V61, P101, DOI 10.2302/kjm.2011-0002-IR; Klass BR, 2009, POSTGRAD MED J, V85, P9, DOI 10.1136/pgmj.2008.069831; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WQ, 2011, FEBS J, V278, P1522, DOI 10.1111/j.1742-4658.2011.08075.x; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Liu XY, 2013, INT J MOL MED, V31, P407, DOI 10.3892/ijmm.2012.1199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074563; Mathelier A, 2010, BIOINFORMATICS, V26, P2226, DOI 10.1093/bioinformatics/btq329; Peurala H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026122; Rolfe KJ, 2007, WOUND REPAIR REGEN, V15, P897, DOI 10.1111/j.1524-475X.2007.00314.x; Ryu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016403; Samuels P, 1999, J OTOLARYNGOL, V28, P296; Swaminathan S, 2013, BIOCHEM BIOPH RES CO, V434, P228, DOI 10.1016/j.bbrc.2013.03.046; Walraven M, 2014, WOUND REPAIR REGEN, V22, P3, DOI 10.1111/wrr.12098; Wang X, 2013, INT J MOL SCI, V14, P20459, DOI 10.3390/ijms141020459; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Wu JY, 2013, RNA BIOL, V10, P1087, DOI 10.4161/rna.25193; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068209; Xia J, 2012, CURR DRUG TARGETS, V13, P1750, DOI 10.2174/138945012804545597; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Yeh J, 2009, WOUND REPAIR REGEN, V17, P639, DOI 10.1111/j.1524-475X.2009.00535.x; Zuliani T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070408	51	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126087	10.1371/journal.pone.0126087	http://dx.doi.org/10.1371/journal.pone.0126087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978377	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100046
J	Gevaert, T; Lopez, XM; Sagaert, X; Libbrecht, L; Roskams, T; Rorive, S; Decaestecker, C; Salmon, I; De Ridder, D				Gevaert, Thomas; Lopez, Xavier Moles; Sagaert, Xavier; Libbrecht, Louis; Roskams, Tania; Rorive, Sandrine; Decaestecker, Christine; Salmon, Isabelle; De Ridder, Dirk			Morphometric and Quantitative Immunohistochemical Analysis of Disease-Related Changes in the Upper (Suburothelial) Lamina Propria of the Human Bladder Dome	PLOS ONE			English	Article							INTERSTITIAL-CELLS; RECEPTOR EXPRESSION; OVERACTIVE BLADDER; MYOFIBROBLASTS; IDENTIFICATION; ANGIOGENESIS; MARKERS	The upper (suburothelial) lamina propria (ULP) is a distinct region in the human bladder with dense populations of interstitial cells (IC), fine vascular networks and variable development of muscularis mucosae (MM). It is more and more obvious that the ULP plays an important role in bladder physiology and bladder disease, and in the present study we have quantified changes in the cellular key players of the ULP in bladders from patients with carcinoma in situ (CIS), multiple sclerosis (MS) and bladder pain syndrome (BPS). Tissue samples for the different patient groups were obtained from radical cystectomy-specimens. Standardized immunohistochemistry with a panel of specific cell markers was used to characterise the ULP cellular structures, followed by digitalised morphometry and quantitative staining analysis. Alterations in the ULP area were most pronounced in MS bladders, but also present in BPS and CIS bladders. We observed an increased thickness and increased variability in thickness of the ULP IC area in MS and BPS bladders; a significantly increased development of MM in MS bladders; a changed organization of vascular plexuses in the lamina propria in most pathologic bladders and a changed phenotype of ULP IC: a significantly decreased expression of progesterone receptor in MS bladders and a trend towards decreased expression of alpha-smooth muscle actin in BPS bladders. We show here for the first time the presence of disease-specific changes in organisation and/or phenotype of the different key players of the ULP area in human bladder. The present findings further support the hypothesis that the ULP area is involved and altered in different bladder diseases.	[Gevaert, Thomas; De Ridder, Dirk] Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Expt Urol, Leuven, Belgium; [Gevaert, Thomas; Sagaert, Xavier; Roskams, Tania] Katholieke Univ Leuven, Translat Cell & Tissue Res, Dept Imaging & Pathol, Leuven, Belgium; [Gevaert, Thomas] AZ Klina, Dept Pathol, Brasschaat, Belgium; [Lopez, Xavier Moles; Rorive, Sandrine; Decaestecker, Christine; Salmon, Isabelle] Univ Libre Bruxelles, DIAPath Ctr Microscopy & Mol Imaging, Gosselies, Belgium; [Lopez, Xavier Moles; Rorive, Sandrine; Salmon, Isabelle] Univ Libre Bruxelles, Dept Pathol, Erasme Hosp, Brussels, Belgium; [Libbrecht, Louis] Univ Ghent, Dept Pathol, B-9000 Ghent, Belgium; [Libbrecht, Louis] Ghent Univ Hosp, Ghent, Belgium; [Decaestecker, Christine] Univ Libre Bruxelles, Brussels Sch Engn, Labs Image Signal Proc & Acoust, Brussels, Belgium	KU Leuven; KU Leuven; Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Ghent University; Ghent University; Ghent University Hospital; Universite Libre de Bruxelles	Gevaert, T (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Expt Urol, Leuven, Belgium.	Thomas.gevaert@med.kuleuven.be		Roskams, Tania/0000-0002-2816-1530; Decaestecker, Christine/0000-0002-5495-1931	Research Foundation Flanders (FWO) [G.0500.6N]; Research Council of the KU Leuven Grant [EF/95/010]; Astellas; Televie program of the Fonds National de la Recherche Scientifique; Foundation Yvonne Boel (Brussels, Belgium); European Regional Development Fund; Walloon Region	Research Foundation Flanders (FWO)(FWO); Research Council of the KU Leuven Grant; Astellas(Astellas Pharmaceuticals); Televie program of the Fonds National de la Recherche Scientifique; Foundation Yvonne Boel (Brussels, Belgium); European Regional Development Fund(European Commission); Walloon Region	This study was supported by Research Foundation Flanders (FWO) Grants G.0500.6N and Research Council of the KU Leuven Grant EF/95/010 and an unrestricted educational grant by Astellas. Dirk De Ridder is a clinical-fundamental researcher of the FWO Vlaanderen. This work was also supported by the Televie program of the Fonds National de la Recherche Scientifique (XML) and by the Foundation Yvonne Boel (Brussels, Belgium). CD is a senior research associate with the Fonds National de la Recherche Scientifique (Brussels, Belgium). The CMMI is supported by the European Regional Development Fund and the Walloon Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2014, NEUROUROL URODYNAM, V33, P9, DOI 10.1002/nau.22465; Blakeman PJ, 2000, BJU INT, V86, P32, DOI 10.1046/j.1464-410x.2000.00724.x; Cardozo L, 2004, ACTA OBSTET GYN SCAN, V83, P892, DOI 10.1111/j.0001-6349.2004.00581.x; Chidlow JH, 2007, AM J PHYSIOL-GASTR L, V293, pG5, DOI 10.1152/ajpgi.00107.2007; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; Decaestecker C, 2009, PROTEOMICS, V9, P4478, DOI 10.1002/pmic.200800936; DIXON JS, 1983, J ANAT, V136, P265; Fry CH, 2012, AM J PHYSIOL-RENAL, V302, pF1447, DOI 10.1152/ajprenal.00436.2011; Gevaert T, 2014, J UROLOGY, V192, P1555, DOI 10.1016/j.juro.2014.05.096; Gevaert T, 2014, NEUROUROL URODYNAM, V33, P461, DOI 10.1002/nau.22415; Gevaert T, 2012, J CELL MOL MED, V16, P2085, DOI 10.1111/j.1582-4934.2011.01504.x; Gevaert T, 2011, J CELL MOL MED, V15, P2586, DOI 10.1111/j.1582-4934.2011.01262.x; Grol S, 2009, BJU INT, V104, P398, DOI 10.1111/j.1464-410X.2009.08423.x; Kiuchi H, 2009, BJU INT, V104, P826, DOI 10.1111/j.1464-410X.2009.08467.x; Miodonski AJ, 1999, ANAT REC, V254, P375, DOI 10.1002/(SICI)1097-0185(19990301)254:3<375::AID-AR8>3.3.CO;2-I; Monaghan KP, 2012, J UROLOGY, V188, P639, DOI 10.1016/j.juro.2012.03.117; Mukerji G, 2006, J UROLOGY, V176, P367, DOI 10.1016/S0022-5347(06)00563-5; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Roosen A, 2009, EUR UROL, V55, P1440, DOI 10.1016/j.eururo.2008.11.009; Sui GP, 2006, BJU INT, V97, P1327, DOI 10.1111/j.1464-410X.2006.06200.x; Tincello DG, 2009, J UROLOGY, V181, P1474, DOI 10.1016/j.juro.2008.10.104; Vannucchi MG, 2014, J CELL MOL MED, V18, P2000, DOI 10.1111/jcmm.12375; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Wiseman OJ, 2003, BJU INT, V91, P89, DOI 10.1046/j.1464-410X.2003.03802.x; Yu WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048897	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127020	10.1371/journal.pone.0127020	http://dx.doi.org/10.1371/journal.pone.0127020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973881	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600097
J	Hao, XX; Wei, XL; Huang, F; Wei, YQ; Zeng, H; Xu, LW; Zhou, QJ; Feng, R				Hao, Xiaoxiao; Wei, Xiaolei; Huang, Fen; Wei, Yongqiang; Zeng, Hong; Xu, Linwei; Zhou, Qinjun; Feng, Ru			The Expression of CD30 Based on Immunohistochemistry Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							CHEMOTHERAPY PLUS RITUXIMAB; ELDERLY-PATIENTS; CHOP; PROGNOSIS; SURVIVAL	The prognostic value of CD30 expression indiffuse large B-cell lymphoma (DLBCL) remains controversial. Herein, we performed this retrospective study to investigate the clinical and prognostic significance of CD30 expression in patients with DLBCL. Among all the 146 patients, the expression of CD30 was observed in 23 cases (15.7%). The DLBCL patients with CD30 expression showed more likely to present B symptoms, bone marrow involvement, non-germinal centre B-cell-like (Non-GCB) DLBCL, BCL-2 and Ki-67overexpression (p<0.05). Patients with CD30 expression showed significantly poor overall and event-free survivalcompared with CD30 negative patients(p = 0.031 and 0.041, respectively), especially those with the high intermediate/high-risk international prognostic index (IPI)(p = 0.001 and 0.007, respectively). The prognostic value of CD30expression retained in DLBCL patients treated with eitherCHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) or R-CHOP(rituximab+CHOP). The multivariate analysisrevealed that the expression of CD30 remained an unfavorable factor for both overall and event-free survival (p = 0.001 and 0.002, respectively). In conclusion, these data suggest that CD30 is expressed predominantly in Non-GCBDLBCL. The expression of CD30 implied poor outcomein DLBCL patientstreated with either CHOP or R-CHOP, especially those with the high intermediate/high-risk IPI, possibly indicating that anti-CD30 monoclonal antibody could be of clinical interest.	[Hao, Xiaoxiao; Wei, Xiaolei; Huang, Fen; Wei, Yongqiang; Zeng, Hong; Xu, Linwei; Zhou, Qinjun; Feng, Ru] Southern Med Univ, Dept Hematol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Feng, R (corresponding author), Southern Med Univ, Dept Hematol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	ruth1626@hotmail.com			Science and Technology Project of Guangdong Province [2010B050700020]; Science and Technology Project of Guangzhou City [12C22121553]; Natural Science Foundation of Guangdong Province [S2011010003790]	Science and Technology Project of Guangdong Province; Science and Technology Project of Guangzhou City; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the Science and Technology Project of Guangdong Province (Grant No. 2010B050700020), the Science and Technology Project of Guangzhou City (Grant No. 12C22121553) and the Natural Science Foundation of Guangdong Province (Grant No. S2011010003790).	Al-Shamkhani A, 2004, CURR OPIN PHARMACOL, V4, P355, DOI 10.1016/j.coph.2004.02.007; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Brown JR, 2013, BLOOD, V122; Campuzano-Zuluaga G, 2013, LEUKEMIA LYMPHOMA, V54, P2405, DOI 10.3109/10428194.2013.778407; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; de Leval L, 2010, HAEMATOL-HEMATOL J, V95, P1627, DOI 10.3324/haematol.2010.029256; Deutsch YE, 2011, LEUKEMIA LYMPHOMA, V52, P1641, DOI 10.3109/10428194.2011.574761; Durkop H, 2000, J PATHOL, V190, P613; Facchetti F., 2008, WHO CLASSIFICATION T, V4th ed; FALINI B, 1995, BLOOD, V85, P1; GRUSS HJ, 1994, BLOOD, V83, P2045; Gutierrez-Garcia G, 2011, BLOOD, V117, P4836, DOI 10.1182/blood-2010-12-322362; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hu SM, 2013, BLOOD, V121, P2715, DOI 10.1182/blood-2012-10-461848; Iqbal J, 2011, CLIN CANCER RES, V17, P7785, DOI 10.1158/1078-0432.CCR-11-0267; Jin X, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-51; Li XY, 2015, ANN HEMATOL, V94, P57, DOI 10.1007/s00277-014-2167-0; Mounier N, 2003, BLOOD, V101, P4279, DOI 10.1182/blood-2002-11-3442; Park S, 2007, BLOOD, V110, P972, DOI 10.1182/blood-2007-01-067769; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Saito B, 2007, LEUKEMIA, V21, P2563, DOI 10.1038/sj.leu.2404844; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Sehn LH, 2012, HEMATOL-AM SOC HEMAT, P402, DOI 10.1182/asheducation-2012.1.402; Sehn LH, 2011, J CLIN ONCOL, V29, P1452, DOI 10.1200/JCO.2010.33.3419; Shipra Gandhi, 2013, BLOOD, V122, P5024; Wei XL, 2014, LEUKEMIA RES, V38, P694, DOI 10.1016/j.leukres.2014.03.013; Yoon DH, 2010, EUR J HAEMATOL, V85, P149, DOI 10.1111/j.1600-0609.2010.01467.x; Zhou D, 2013, ASIAN PAC J CANCER P, V14, P929, DOI 10.7314/APJCP.2013.14.2.929; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493	31	14	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126615	10.1371/journal.pone.0126615	http://dx.doi.org/10.1371/journal.pone.0126615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25974110	Green Submitted, gold, Green Published			2022-12-27	WOS:000354545600067
J	Narimatsu, H; Nakata, Y; Nakamura, S; Sato, H; Sho, R; Otani, K; Kawasaki, R; Kubota, I; Ueno, Y; Kato, T; Yamashita, H; Fukao, A; Kayama, T				Narimatsu, Hiroto; Nakata, Yoshinori; Nakamura, Sho; Sato, Hidenori; Sho, Ri; Otani, Katsumi; Kawasaki, Ryo; Kubota, Isao; Ueno, Yoshiyuki; Kato, Takeo; Yamashita, Hidetoshi; Fukao, Akira; Kayama, Takamasa			Applying Data Envelopment Analysis to Preventive Medicine: A Novel Method for Constructing a Personalized Risk Model of Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ANALYSIS; JAPANESE POPULATION; PHYSICAL-ACTIVITY; EFFICIENCY; ASSOCIATION; NUTRITION; COHORT; ENVIRONMENT; WOMEN	Data envelopment analysis (DEA) is a method of operations research that has not yet been applied in the field of obesity research. However, DEA might be used to evaluate individuals' susceptibility to obesity, which could help establish effective risk models for the onset of obesity. Therefore, we conducted this study to evaluate the feasibility of applying DEA to predict obesity, by calculating efficiency scores and evaluating the usefulness of risk models. In this study, we evaluated data from the Takahata study, which was a population-based cohort study (with a follow-up study) of Japanese people who are >40 years old. For our analysis, we used the input-oriented Charnes-Cooper-Rhodes model of DEA, and defined the decision-making units (DMUs) as individual subjects. The inputs were defined as (1) exercise (measured as calories expended) and (2) the inverse of food intake (measured as calories ingested). The output was defined as the inverse of body mass index (BMI). Using the beta coefficients for the participants' single nucleotide polymorphisms, we then calculated their genetic predisposition score (GPS). Both efficiency scores and GPS were available for 1,620 participants from the baseline survey, and for 708 participants from the follow-up survey. To compare the strengths of the associations, we used models of multiple linear regressions. To evaluate the effects of genetic factors and efficiency score on body mass index (BMI), we used multiple linear regression analysis, with BMI as the dependent variable, GPS and efficiency scores as the explanatory variables, and several demographic controls, including age and sex. Our results indicated that all factors were statistically significant (p < 0.05), with an adjusted R-2 value of 0.66. Therefore, it is possible to use DEA to predict environmentally driven obesity, and thus to establish a well-fitted model for risk of obesity.	[Narimatsu, Hiroto; Sho, Ri; Otani, Katsumi; Kawasaki, Ryo; Fukao, Akira] Yamagata Univ, Grad Sch Med, Dept Publ Hlth, Yamagata 990, Japan; [Nakata, Yoshinori] Teikyo Univ, Dept Healthcare Management, Grad Sch Publ Hlth, Tokyo 173, Japan; [Nakamura, Sho] Yamagata Univ, Dept Clin Oncol, Fac Med, Yamagata 990, Japan; [Sato, Hidenori] Yamagata Univ, Fac Med, Inst Promot Med Sci Res, Genome Informat Unit, Yamagata 990, Japan; [Kubota, Isao] Yamagata Univ, Fac Med, Dept Internal Med 1, Yamagata 990, Japan; [Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Internal Med 2, Yamagata 990, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Internal Med 3, Yamagata 990, Japan; [Yamashita, Hidetoshi] Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata 990, Japan; [Kayama, Takamasa] Yamagata Univ, Fac Med, Dept Neurosurg, Yamagata 990, Japan	Yamagata University; Teikyo University; Yamagata University; Yamagata University; Yamagata University; Yamagata University; Yamagata University; Yamagata University; Yamagata University	Narimatsu, H (corresponding author), Yamagata Univ, Grad Sch Med, Dept Publ Hlth, Yamagata 990, Japan.	hiroto-narimatsu@umin.org	Ueno, Yoshiyuki/R-9242-2019; Kawasaki, Ryo/H-9716-2019; Kawasaki, Ryo/B-7266-2009; Narimatsu, Hiroto/ABC-9150-2021; Nakamura, Sho/O-2107-2014	Ueno, Yoshiyuki/0000-0001-5623-4250; Kawasaki, Ryo/0000-0002-7492-6303; Narimatsu, Hiroto/0000-0002-5302-5872; Nakamura, Sho/0000-0002-5378-9477	JSPS KAKENHI [25560363]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant-in-Aid for Challenging Exploratory Research) Grant Number 25560363 to Dr. Narimatsu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alburquerque-Sendin F, 2012, BRAZ J PHYS THER, V16, P328, DOI 10.1590/S1413-35552012005000025; [Anonymous], 2005, INTRO EFFICIENCY PRO, DOI DOI 10.1007/B136381; BANKER RD, 1986, MANAGE SCI, V32, P30, DOI 10.1287/mnsc.32.1.30; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bogetoft P, 2011, BENCHMARKING DEA SFA, P81, DOI [10.1007/978-1-4419-7961-2_4, DOI 10.1007/978-1-4419-7961-2_4]; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Cooper W.W., 2007, DATA ENVELOPMENT ANA, P21, DOI [10.1007/978-0-387-45283-8, DOI 10.1007/978-0-387-45283-8]; Cooper W. W, 2007, DATA ENVELOPMENT ANA, P114; Daimon M, 2008, BIOCHEM BIOPH RES CO, V365, P466, DOI 10.1016/j.bbrc.2007.10.180; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Funatogawa I, 2009, INT J EPIDEMIOL, V38, P83, DOI 10.1093/ije/dyn182; Graff M, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.20; Graff M, 2013, HUM MOL GENET, V22, P3597, DOI 10.1093/hmg/ddt205; Hollingsworth B, 2008, HEALTH ECON, V17, P1107, DOI 10.1002/hec.1391; Karasawa S, 2010, ENDOCR J, V57, P293, DOI 10.1507/endocrj.K09E-305; Kohno K, 2014, EUR J HAEMATOL, V92, P298, DOI 10.1111/ejh.12250; Konta T, 2006, KIDNEY INT, V70, P751, DOI 10.1038/sj.ki.5001504; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Lu YC, 2013, GENOME MED, V5, DOI 10.1186/gm459; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Miyabara Y, 2007, J BONE MINER METAB, V25, P414, DOI 10.1007/s00774-007-0780-x; Narimatsu H, 2013, J HUM GENET, V58, P54, DOI 10.1038/jhg.2012.128; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Sasaki S, 1998, J Epidemiol, V8, P203; SHERMAN HD, 1984, MED CARE, V22, P922, DOI 10.1097/00005650-198410000-00005; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thanassoulis E., 2008, MEASUREMENT PRODUCTI, P251, DOI [10.1093/acprof:oso/9780195183528.003.0003, DOI 10.1093/ACPROF:OSO/9780195183528.003.0003]; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; Yoo C, 2014, INT NEUROUROL J, V18, P50, DOI 10.5213/inj.2014.18.2.50	33	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126443	10.1371/journal.pone.0126443	http://dx.doi.org/10.1371/journal.pone.0126443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973987	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600051
J	Olszewski, M; Balsewicz, J; Nowak, M; Maciejewska, N; Cyranka-Czaja, A; Zalewska-Piatek, B; Piatek, R; Kur, J				Olszewski, Marcin; Balsewicz, Jan; Nowak, Marta; Maciejewska, Natalia; Cyranka-Czaja, Anna; Zalewska-Piatek, Beata; Piatek, Rafal; Kur, Jozef			Characterization of a Single-Stranded DNA-Binding-Like Protein from Nanoarchaeum equitans-A Nucleic Acid Binding Protein with Broad Substrate Specificity	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; SSB; IDENTIFICATION; GENOME; INSIGHTS; MODES	Background SSB (single-stranded DNA-binding) proteins play an essential role in all living cells and viruses, as they are involved in processes connected with ssDNA metabolism. There has recently been an increasing interest in SSBs, since they can be applied in molecular biology techniques and analytical methods. Nanoarchaeum equitans, the only known representative of Archaea phylum Nanoarchaeota, is a hyperthermophilic, nanosized, obligatory parasite/symbiont of Ignicoccus hospitalis. Results This paper reports on the ssb-like gene cloning, gene expression and characterization of a novel nucleic acid binding protein from Nanoarchaeum equitans archaeon (NeqSSB-like protein). This protein consists of 243 amino acid residues and one OB fold per monomer. It is biologically active as a monomer like as SSBs from some viruses. The NeqSSB-like protein displays a low sequence similarity to the Escherichia coli SSB, namely 10% identity and 29% similarity, and is the most similar to the Sulfolobus solfataricus SSB (14% identity and 32% similarity). The NeqSSB-like protein binds to ssDNA, although it can also bind mRNA and, surprisingly, various dsDNA forms, with no structure-dependent preferences as evidenced by gel mobility shift assays. The size of the ssDNA binding site, which was estimated using fluorescence spectroscopy, is 7 +/- 1 nt. No salt-dependent binding mode transition was observed. NeqSSB-like protein probably utilizes a different model for ssDNA binding than the SSB proteins studied so far. This protein is highly thermostable; the half-life of the ssDNA binding activity is 5 min at 100 degrees C and melting temperature (T-m) is 100.2 degrees C as shown by differential scanning calorimetry (DSC) analysis. Conclusion NeqSSB-like protein is a novel highly thermostable protein which possesses a unique broad substrate specificity and is able to bind all types of nucleic acids.	[Olszewski, Marcin; Balsewicz, Jan; Nowak, Marta; Maciejewska, Natalia; Zalewska-Piatek, Beata; Piatek, Rafal; Kur, Jozef] Gdansk Univ Technol, Fac Chem, Dept Mol Biotechnol & Microbiol, PL-80233 Gdansk, Poland; [Cyranka-Czaja, Anna] Univ Wroclaw, Fac Biotechnol, Dept Prot Engn, PL-50138 Wroclaw, Poland	Fahrenheit Universities; Gdansk University of Technology; University of Wroclaw	Olszewski, M (corresponding author), Gdansk Univ Technol, Fac Chem, Dept Mol Biotechnol & Microbiol, PL-80233 Gdansk, Poland.	molszewski@pg.gda.pl	Olszewski, Marcin/HFZ-9682-2022	Olszewski, Marcin/0000-0002-5116-2793; Zalewska-Piatek, Beata/0000-0003-1654-1218; Maciejewska, Natalia/0000-0001-7728-0598; Piatek, Rafal/0000-0003-3808-6906	Polish State Committee for Scientific Research [N302 439439, N302 116636]	Polish State Committee for Scientific Research(Polish State Committee for Scientific Research)	This study was partially supported by the Polish State Committee for Scientific Research grants N302 439439 to J.K. and N302 116636 to M.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Capp C, 2010, J BIOL CHEM, V285, P39637, DOI 10.1074/jbc.M110.173989; Choi JJ, 2008, APPL ENVIRON MICROB, V74, P6563, DOI 10.1128/AEM.00624-08; Choi JJ, 2006, J MOL BIOL, V356, P1093, DOI 10.1016/j.jmb.2005.12.036; CURTH U, 1993, BIOCHEMISTRY-US, V32, P2585, DOI 10.1021/bi00061a016; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Ehn M, 2001, PROTEIN EXPRES PURIF, V22, P120, DOI 10.1006/prep.2001.1426; Filipkowski P, 2007, ACTA BIOCHIM POL, V54, P79, DOI 10.18388/abp.2007_3272; Filipkowski P, 2006, ARCH MICROBIOL, V186, P129, DOI 10.1007/s00203-006-0128-2; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Greipel J., 1989, PROTEIN NUCL ACID IN, P61, DOI [10.1007/978-1-349-09871-2_4, DOI 10.1007/978-1-349-09871-2_4]; Haseltine CA, 2002, MOL MICROBIOL, V43, P1505, DOI 10.1046/j.1365-2958.2002.02807.x; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Kelly TJ, 1998, P NATL ACAD SCI USA, V95, P14634, DOI 10.1073/pnas.95.25.14634; Kerr ID, 2003, EMBO J, V22, P2561, DOI 10.1093/emboj/cdg272; Komori K, 2001, J BIOL CHEM, V276, P25654, DOI 10.1074/jbc.M102423200; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Olszewski M, 2008, ARCH MICROBIOL, V190, P79, DOI 10.1007/s00203-008-0366-6; Olszewski M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-260; PORTER RD, 1990, BIO-TECHNOL, V8, P47, DOI 10.1038/nbt0190-47; Purnapatre K, 1999, EUR J BIOCHEM, V264, P591, DOI 10.1046/j.1432-1327.1999.00684.x; Randau L, 2005, P NATL ACAD SCI USA, V102, P17934, DOI 10.1073/pnas.0509197102; Reddy MS, 2001, J BIOL CHEM, V276, P45959, DOI 10.1074/jbc.M103523200; Rodrigues JV, 2008, J BIOL INORG CHEM, V13, P219, DOI 10.1007/s00775-007-0313-z; Rolfsmeier ML, 2010, J MOL BIOL, V397, P31, DOI 10.1016/j.jmb.2010.01.004; SCHWARZ G, 1983, J MOL BIOL, V163, P467, DOI 10.1016/0022-2836(83)90069-4; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; WEINER JH, 1975, J BIOL CHEM, V250, P1972; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	35	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126563	10.1371/journal.pone.0126563	http://dx.doi.org/10.1371/journal.pone.0126563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973760	Green Submitted, gold, Green Published			2022-12-27	WOS:000354545600059
J	Zhang, TH; Li, HJ; Stone, WS; Woodberry, KA; Seidman, LJ; Tang, YY; Guo, Q; Zhuo, KM; Qian, ZY; Cui, HR; Zhu, YK; Jiang, LJ; Chow, A; Tang, YX; Li, CB; Jiang, KD; Yi, ZH; Xiao, ZP; Wang, JJ				Zhang, TianHong; Li, HuiJun; Stone, William S.; Woodberry, Kristen A.; Seidman, Larry J.; Tang, YingYing; Guo, Qian; Zhuo, KaiMing; Qian, ZhenYing; Cui, HuiRu; Zhu, YiKang; Jiang, LiJuan; Chow, Annabelle; Tang, YunXiang; Li, ChunBo; Jiang, KaiDa; Yi, ZhengHui; Xiao, ZePing; Wang, JiJun			Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing RBANS Performance	PLOS ONE			English	Article							CLINICAL HIGH-RISK; ULTRA-HIGH RISK; QUALITY-OF-LIFE; REPEATABLE BATTERY; NEUROCOGNITIVE DEFICITS; OLFACTORY IDENTIFICATION; COGNITIVE IMPAIRMENT; SCREENING-TEST; VERBAL MEMORY; SCHIZOPHRENIA	Background Cognitive deficits are observed throughout all developmental phases of psychosis. However, prior studies have usually focused on a limited illness period and used a wide variety of cognitive instruments. Therefore, it has been difficult to characterize or highlight cognitive functioning in different stages of psychosis. Method We administered the RBANS (Repeatable Battery for the Assessment of Neuropsychological Status) tests to 4 participant subgroups, including healthy volunteers (controls, HC, n = 28), subjects at high risk for clinical psychosis (prodrome, CHR, n = 27), first-episode schizophrenia patients (FE-Sz, n = 26), and mid-term and long-term chronic schizophrenia patients (Ch-Sz, n = 147). Comparison, correlation, and regression analyses of RBANS index scores were assessed among groups. We examined clinical outcomes over 2 years between the CHR and HC subjects, and RBANS domains were used as possible predictors for conversion to psychosis. Results Performance on all RBANS domains was significantly impaired during a post-onset stage of psychosis (FE-Sz and Ch-Sz), and RBANS scores declined along with disease progression. Regression analyses showed that for CHR and HC subjects, baseline impairment in delayed memory (DM) significantly predicted conversion to psychosis. Additionally, partial correlations showed that for FE-Sz and Ch-Sz subjects, DM was the only correlate with a later stage of psychosis. Conclusions Cognitive deficits broadly emerged, and diminished functioning followed along with disease progression. Impairment in DM is perhaps one domain that helps us understand the development of psychosis. A critical need is to monitor and treat memory functioning for psychotic patients throughout all phases of the disease.	[Zhang, TianHong; Tang, YingYing; Guo, Qian; Zhuo, KaiMing; Qian, ZhenYing; Cui, HuiRu; Zhu, YiKang; Jiang, LiJuan; Li, ChunBo; Jiang, KaiDa; Yi, ZhengHui; Xiao, ZePing; Wang, JiJun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China; [Li, HuiJun] Florida A&M Univ, Dept Psychol, Tallahassee, FL 32307 USA; [Li, HuiJun; Stone, William S.; Woodberry, Kristen A.; Seidman, Larry J.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02115 USA; [Chow, Annabelle] Changi Gen Hosp, Dept Psychol Med, Singapore, Singapore; [Tang, YunXiang] Second Mil Med Univ, Fac Mental Hlth, Dept Med Psychol, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; State University System of Florida; Florida A&M University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Changi General Hospital; Naval Medical University	Yi, ZH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China.	jijunwang27@gmail.com; xiaozeping88@163.com; yi_zhenghui@163.com			National Natural Science Foundation of China [81201043, 81171267, 81171280, 81372122, 81261120410, 81361120403]; Shanghai Municipal Natural Science Foundation [12ZR1448400]; National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health) [2011-873]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine [BXJ 201345]; Shanghai Jiao Tong University Foundation [14JCRY04, YG2014MS40]; Fogarty and National Institutes of Mental Health from the USA [1R21 MH093294-01A1]; OMAMH [2011-873]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH102358] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health); Shanghai Key Laboratory of Psychotic Disorders; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University Foundation; Fogarty and National Institutes of Mental Health from the USA; OMAMH; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by National Natural Science Foundation of China (81201043, 81171267, 81171280, 81372122, 81261120410, 81361120403) (nsfc.gov.cn) (the study design, data collection and analysis), Shanghai Municipal Natural Science Foundation (12ZR1448400) (stcsm.gov.cn) (preparation of the manuscript), National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health, 2011-873; OMAMH, 2011-873) (www.smhc.org.cn) (revised the manuscript), Shanghai Key Laboratory of Psychotic Disorders (13dz2260500) (www.smhc.org.cn) (revised the manuscript), Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine (BXJ 201345) (sjtu.edu.cn) (decision to publish), Shanghai Jiao Tong University Foundation (14JCRY04, YG2014MS40) (sjtu.edu.cn) (revised the manuscript) and by a Fogarty and National Institutes of Mental Health grant (1R21 MH093294-01A1) (www.nih.gov) (preparation of the manuscript) from the USA.	Addington J, 2012, SCHIZOPHR RES, V142, P77, DOI 10.1016/j.schres.2012.09.012; Bahorik AL, 2014, SCHIZOPHRENIA BULL, V40, P856, DOI 10.1093/schbul/sbt099; Barbato M, 2013, PSYCHIAT RES, V206, P195, DOI 10.1016/j.psychres.2012.10.013; Beatty WW, 2003, J CLIN EXP NEUROPSYC, V25, P1065, DOI 10.1076/jcen.25.8.1065.16732; Becker HE, 2010, PSYCHOL MED, V40, P1599, DOI 10.1017/S0033291710000048; Becker HE, 2010, EUR PSYCHIAT, V25, P105, DOI 10.1016/j.eurpsy.2009.08.003; Bora E, 2014, ACTA PSYCHIAT SCAND, V130, P1, DOI 10.1111/acps.12261; Brewer WJ, 2003, AM J PSYCHIAT, V160, P1790, DOI 10.1176/appi.ajp.160.10.1790; Brewer WJ, 2005, AM J PSYCHIAT, V162, P71, DOI 10.1176/appi.ajp.162.1.71; Chang WC, 2013, J CLIN PSYCHIAT, V74, pE1046, DOI 10.4088/JCP.13m08355; Cheng Y, 2011, ARCH MED SCI, V7, P850, DOI 10.5114/aoms.2011.25561; Compton MT, 2006, SCHIZOPHR RES, V86, P154, DOI 10.1016/j.schres.2006.06.007; Dougherty DM, 1998, PSYCHIAT RES, V79, P255, DOI 10.1016/S0165-1781(98)00040-7; Fioravanti M, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-64; Frommann I, 2011, SCHIZOPHRENIA BULL, V37, P861, DOI 10.1093/schbul/sbp155; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Giuliano AJ, 2012, CURR PHARM DESIGN, V18, P399; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hobart MP, 1999, AM J PSYCHIAT, V156, P1951; Irani F, 2012, AM J GERIAT PSYCHIAT, V20, P41, DOI 10.1097/JGP.0b013e3182051a7d; Jahshan C, 2010, NEUROPSYCHOLOGY, V24, P109, DOI 10.1037/a0016791; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2006, SCHIZOPHR RES, V88, P26, DOI 10.1016/j.schres.2006.06.041; Leeson VC, 2009, PSYCHOL MED, V39, P1799, DOI 10.1017/S0033291709005935; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Loughland CM, 2007, SCHIZOPHR RES, V89, P232, DOI 10.1016/j.schres.2006.08.022; Malla A, 2005, SCHIZOPHRENIA BULL, V31, P650, DOI 10.1093/schbul/sbi031; McGlashan T, 2010, THE PSYCHOSIS RISK S; Meyer EC, 2014, SCHIZOPHRENIA BULL, V40, P1452, DOI 10.1093/schbul/sbt235; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Niendam TA, 2006, SCHIZOPHR RES, V84, P100, DOI 10.1016/j.schres.2006.02.005; Patel MX, 2013, SCHIZOPHR RES, V149, P141, DOI 10.1016/j.schres.2013.06.030; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Sigaudo M, 2014, SCHIZOPHR RES, V153, P196, DOI 10.1016/j.schres.2014.01.013; Sumiyoshi C, 2014, SCHIZOPHR RES, V152, P421, DOI 10.1016/j.schres.2013.12.009; Torgalsboen AK, 2014, PSYCHIAT RES, V216, P1, DOI 10.1016/j.psychres.2014.01.031; Torniainen M, 2013, PSYCHOL MED, V43, P2361, DOI 10.1017/S0033291713000032; Toulopoulou T, 2004, BIOL PSYCHIAT, V56, P447, DOI 10.1016/j.biopsych.2004.06.026; Toulopoulouand Timothea, 2004, Expert Rev Neurother, V4, P43, DOI 10.1586/14737175.4.1.43; van Veelen NMJ, 2010, SCHIZOPHR RES, V120, P191, DOI 10.1016/j.schres.2010.04.011; Vingerhoets Wilhelmina A M, 2013, Front Psychiatry, V4, P157, DOI 10.3389/fpsyt.2013.00157; Wang JH, 2009, SHANGHAI ARCH PSYCHI, V21, P265, DOI DOI 10.5114/AOMS.2011.25561; Woodberry KA, 2013, SCHIZOPHR RES, V146, P87, DOI 10.1016/j.schres.2013.01.017; Wu JQ, 2014, SCHIZOPHR RES, V152, P210, DOI 10.1016/j.schres.2013.11.010; Yung AR, 2008, SCHIZOPHR RES, V105, P10, DOI 10.1016/j.schres.2008.07.012; [张保华 ZHANG BaoHua], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P865; Zhang TH, 2014, SCHIZOPHR RES, V152, P391, DOI 10.1016/j.schres.2013.11.039; Zhang XY, 2013, PSYCHOL MED, V43, P1651, DOI 10.1017/S0033291712002590; [郑丽娜 Zheng Lina], 2012, [中国心理卫生杂志, Chinese Mental Health Journal], V26, P571; Zhong N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074258	52	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125784	10.1371/journal.pone.0125784	http://dx.doi.org/10.1371/journal.pone.0125784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25973925	gold, Green Submitted, Green Published			2022-12-27	WOS:000354545600027
J	Lau, EYY; Wong, ML; Lau, KNT; Hui, FWY; Tseng, CH				Lau, Esther Yuet Ying; Wong, Mark Lawrence; Kristy Nga Ting Lau; Hui, Florence Wai Ying; Tseng, Chia-huei			Rapid-Eye-Movement-Sleep (REM) Associated Enhancement of Working Memory Performance after a Daytime Nap	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PSYCHOMOTOR VIGILANCE; QUALITY INDEX; BRAIN; CONSOLIDATION; ACTIVATION; HEALTH; TASK	The main objective was to study the impact of a daytime sleep opportunity on working memory and the mechanism behind such impact. This study adopted an experimental design in a sleep research laboratory. Eighty healthy college students (Age: 17-23, 36 males) were randomized to either have a polysomnography-monitored daytime sleep opportunity (Napgroup, n=40) or stay awake (Wake-group, n=40) between the two assessment sessions. All participants completed a sleep diary and wore an actigraph-watch for 5 days before and one day after the assessment sessions. They completed the state-measurement of sleepiness and affect, in addition to a psychomotor vigilance test and a working memory task before and after the nap/wake sessions. The two groups did not differ in their sleep characteristics prior to and after the lab visit. The Nap-group had higher accuracy on the working memory task, fewer lapses on the psychomotor vigilance test and lower state-sleepiness than the Wake-group. Within the Nap-group, working memory accuracy was positively correlated with duration of rapid eye movement sleep (REM) and total sleep time during the nap. Our findings suggested that "sleep gain" during a daytime sleep opportunity had significant positive impact on working memory performance, without affecting subsequent nighttime sleep in young adult, and such impact was associated with the duration of REM. While REM abnormality has long been noted in pathological conditions (e.g. depression), which are also presented with cognitive dysfunctions (e.g. working memory deficits), this was the first evidence showing working memory enhancement associated with REM in daytime napping in college students, who likely had habitual short sleep duration but were otherwise generally healthy.	[Lau, Esther Yuet Ying; Wong, Mark Lawrence; Kristy Nga Ting Lau; Hui, Florence Wai Ying] Univ Hong Kong, Sleep Lab, Hong Kong, Hong Kong, Peoples R China; [Lau, Esther Yuet Ying; Wong, Mark Lawrence; Kristy Nga Ting Lau; Tseng, Chia-huei] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Lau, Esther Yuet Ying] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Lau, EYY (corresponding author), Univ Hong Kong, Sleep Lab, Hong Kong, Hong Kong, Peoples R China.	eyylau@hku.hk	Wong, Lawrence/ABE-1483-2020	Wong, Mark Lawrence/0000-0003-4297-5597	HKU Seed Funding Program for Basic Research	HKU Seed Funding Program for Basic Research(University of Hong Kong)	This study was supported by the HKU Seed Funding Program for Basic Research. This is not an industry-supported study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks S, 2007, J CLIN SLEEP MED, V3, P519; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Beebe DW, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-9; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; BROWMAN CP, 1986, SLEEP, V9, P183, DOI 10.1093/sleep/9.1.183; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chung KF, 2000, J PSYCHOSOM RES, V49, P367, DOI 10.1016/S0022-3999(00)00186-0; Corsi-Cabrera M, 2008, BRAIN RES, V1235, P82, DOI 10.1016/j.brainres.2008.06.052; Debarnot U, 2011, COGN AFFECT BEHAV NE, V11, P541, DOI 10.3758/s13415-011-0052-z; Delazer M, 2011, NEUROPSYCHOLOGY, V25, P477, DOI 10.1037/a0022357; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Drummond SPA, 2013, SLEEP, V36, P1307, DOI 10.5665/sleep.2952; Ficca G, 2010, SLEEP MED REV, V14, P249, DOI 10.1016/j.smrv.2009.09.005; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Gujar N, 2011, CEREB CORTEX, V21, P115, DOI 10.1093/cercor/bhq064; Hoddes E, 1973, PSYCHOPHYSIOLOGY, V10, P114; Hofle N, 1997, J NEUROSCI, V17, P4800; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kubota Y, 2011, BRAIN RES, V1389, P83, DOI 10.1016/j.brainres.2011.02.061; Lau EYY, 2010, J INT NEUROPSYCH SOC, V16, P1077, DOI 10.1017/S1355617710000901; Lau EYY., 2013, J SLEEP DISORD, V2, P3; Lau H, 2010, NEUROBIOL LEARN MEM, V93, P554, DOI 10.1016/j.nlm.2010.02.003; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Moussa MT., 2001, PSYCHOMETRIC PROPERT; Mu QW, 2005, SLEEP, V28, P433, DOI 10.1093/sleep/28.4.433; Mu QW, 2005, SLEEP, V28, P55, DOI 10.1093/sleep/28.1.55; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Nofzinger EA, 2005, SEMIN NEUROL, V25, P9, DOI 10.1055/s-2005-867070; Nofzinger EA, 1997, BRAIN RES, V770, P192, DOI 10.1016/S0006-8993(97)00807-X; Pribram K., 1960, PLANS STRUCTURE BEHA; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Smith ME, 2002, SLEEP, V25, P784; Smith SS, 2007, SLEEP BIOL RHYTHMS, V5, P117, DOI 10.1111/j.1479-8425.2007.00261.x; Thorne DR, 2005, BEHAV RES METHODS, V37, P111, DOI 10.3758/BF03206404; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wilhelm I, 2011, J COGNITIVE NEUROSCI, V23, P3703, DOI 10.1162/jocn_a_00093; Wong ML, 2013, J PSYCHOSOM RES, V74, P271, DOI 10.1016/j.jpsychores.2012.08.014	44	26	27	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125752	10.1371/journal.pone.0125752	http://dx.doi.org/10.1371/journal.pone.0125752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZP	25970511	Green Published, gold			2022-12-27	WOS:000354544200083
J	Zha, QB; Zhang, XY; Lin, QR; Xu, LH; Zhao, GX; Pan, H; Zhou, D; Ouyang, DY; Liu, ZH; He, XH				Zha, Qing-Bing; Zhang, Xiao-Yu; Lin, Qiu-Ru; Xu, Li-Hui; Zhao, Gao-Xiang; Pan, Hao; Zhou, Dan; Ouyang, Dong-Yun; Liu, Ze-Huan; He, Xian-Hui			Cucurbitacin E Induces Autophagy via Downregulating mTORC1 Signaling and Upregulating AMPK Activity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ACTIN AGGREGATION; PHOSPHORYLATION; COFILIN; GROWTH; CELLS; INHIBITOR; MECHANISM; APOPTOSIS; UPSTREAM	Cucurbitacins, the natural triterpenoids possessing many biological activities, have been reported to suppress the mTORC1/p70S6K pathway and to induce autophagy. However, the correlation between such activities is largely unknown. In this study, we addressed this issue in human cancer cells in response to cucurbitacin E (CuE) treatment. Our results showed that CuE induced autophagy as evidenced by the formation of LC3-II and colocalization of punctate LC3 with the lysosomal marker LAMP2 in HeLa and MCF7 cells. However, CuE induced much lower levels of autophagy in ATG5-knocked down cells and failed to induce autophagy in DU145 cells lacking functional ATG5 expression, suggesting the dependence of CuE-induced autophagy on ATG5. Consistent with autophagy induction, mTORC1 activity (as reflected by p70S6K and ULK1S758 phosphorylation) was inhibited by CuE treatment. The suppression of mTORC1 activity was further confirmed by reduced recruitment of mTOR to the lysosome, which is the activation site of mTORC1. In contrast, CuE rapidly activated AMPK leading to increased phosphorylation of its substrates. AMPK activation contributed to CuE-induced suppression of mTORC1/p70S6K signaling and autophagy induction, since AMPK knockdown diminished these effects. Collectively, our data suggested that CuE induced autophagy in human cancer cells at least partly via down-regulation of mTORC1 signaling and upregulation of AMPK activity.	[Zha, Qing-Bing; Zhang, Xiao-Yu; Lin, Qiu-Ru; Xu, Li-Hui; Zhao, Gao-Xiang; Pan, Hao; Zhou, Dan; Ouyang, Dong-Yun; Liu, Ze-Huan; He, Xian-Hui] Jinan Univ, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China; [Zha, Qing-Bing] Jinan Univ, Affiliated Hosp 1, Dept Fetal Med, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Liu, ZH (corresponding author), Jinan Univ, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China.	Ezhliu@jnu.edu.cn; thexh@jnu.edu.cn	潘, 浩/AAZ-6693-2020; Ouyang, dong-yun/GSD-5233-2022; Zhang, xiaoyu/GXA-3206-2022; Ouyang, Dong-Yun/P-7305-2019; He, Xian-Hui/H-3153-2019; Liu, Zehuan/G-1711-2013	潘, 浩/0000-0002-2049-1842; Ouyang, Dong-Yun/0000-0002-4743-942X; He, Xian-Hui/0000-0001-7433-7392; Liu, Zehuan/0000-0001-5080-1015; Xu, Li-hui/0000-0002-2633-9999	National Natural Science Foundation of China [81173604, 81373423]; Major State Basic Research Development Program of China (973 Program) [2010CB833603]; Fundamental Research Funds for the Central Universities [21612411, 21609403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by grants from the National Natural Science Foundation of China (No. 81173604 and 81373423), the Major State Basic Research Development Program of China (973 Program) (No. 2010CB833603), and the Fundamental Research Funds for the Central Universities (No. 21612411 and 21609403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaskovich MA, 2003, CANCER RES, V63, P1270; Boykin C, 2011, BRIT J CANCER, V104, P781, DOI 10.1038/bjc.2011.10; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gabrielsen M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-58; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He J, 2013, INT IMMUNOPHARMACOL, V16, P27, DOI 10.1016/j.intimp.2013.03.013; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knecht DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014039; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Lee DH, 2011, CANCER LETT, V306, P161, DOI 10.1016/j.canlet.2011.03.001; Ma J, 2014, EUR J PHARMACOL, V723, P46, DOI 10.1016/j.ejphar.2013.12.005; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakashima S, 2010, BIOORG MED CHEM LETT, V20, P2994, DOI 10.1016/j.bmcl.2010.02.062; Ouyang DY, 2013, AUTOPHAGY, V9, P20, DOI 10.4161/auto.22397; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qiao J, 2013, INFLAMM RES, V62, P461, DOI 10.1007/s00011-013-0598-z; Ren S, 2012, CANCER CHEMOTH PHARM, V70, P415, DOI 10.1007/s00280-012-1921-z; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yuan G, 2014, J BIOL CHEM, V289, P10607, DOI 10.1074/jbc.M113.528760; Zhang T, 2012, BREAST CANCER RES TR, V135, P445, DOI 10.1007/s10549-012-2175-5; Zhang T, 2012, AUTOPHAGY, V8, P559, DOI 10.4161/auto.18867; Zhang YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093547; Zhang YT, 2013, J CELL BIOCHEM, V114, P2415, DOI 10.1002/jcb.24587; Zhang YT, 2011, ACTA BIOCH BIOPH SIN, V43, P556, DOI 10.1093/abbs/gmr042; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	45	28	29	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124355	10.1371/journal.pone.0124355	http://dx.doi.org/10.1371/journal.pone.0124355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970614	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200036
J	Korterink, JJ; Diederen, K; Benninga, MA; Tabbers, MM				Korterink, Judith J.; Diederen, Kay; Benninga, Marc A.; Tabbers, Merit M.			Epidemiology of Pediatric Functional Abdominal Pain Disorders: A Meta-Analysis	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; HELICOBACTER-PYLORI INFECTION; GASTROINTESTINAL DISORDERS; RECURRENT PAIN; DEPRESSIVE SYMPTOMS; SOMATIC SYMPTOMS; SCHOOL-CHILDREN; ROME II; PREVALENCE; ADOLESCENTS	Objective We aimed to review the literature regarding epidemiology of functional abdominal pain disorders in children and to assess its geographic, gender and age distribution including associated risk factors of developing functional abdominal pain. Methods The Cochrane Library, MEDLINE, EMBASE, CINAHL and PsychInfo databases were systematically searched up to February 2014. Study selection criteria included: (1) studies of birth cohort, school based or general population samples (2) containing data concerning epidemiology, prevalence or incidence (3) of children aged 4-18 years (4) suffering from functional abdominal pain. Quality of studies was rated by a self-made assessment tool. A random-effect meta-analysis model was used to estimate the prevalence of functional abdominal pain in childhood. Results A total of 58 articles, including 196,472 children were included. Worldwide pooled prevalence for functional abdominal pain disorders was 13.5%(95% CI 11.8-15.3), of which irritable bowel syndrome was reported most frequently (8.8%, 95% CI 6.2-11.9). The prevalence across studies ranged widely from 1.6% to 41.2%. Higher pooled prevalence rates were reported in South America (16.8%) and Asia (16.5%) compared to Europe (10.5%). And a higher pooled prevalence was reported when using the Rome III criteria (16.4%, 95% CI 13.5-19.4). Functional abdominal pain disorders are shown to occur significantly more in girls (15.9% vs. 11.5%, pooled OR 1.5) and is associated with the presence of anxiety and depressive disorders, stress and traumatic life events. Conclusion Functional abdominal pain disorders are a common problem worldwide with irritable bowel syndrome as most encountered abdominal pain-related functional gastrointestinal disorder. Female gender, psychological disorders, stress and traumatic life events affect prevalence.	[Korterink, Judith J.; Diederen, Kay; Benninga, Marc A.; Tabbers, Merit M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Gastroenterol & Nutr, Emmas Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Korterink, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat Gastroenterol & Nutr, Emmas Childrens Hosp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.korterink@amc.nl		Tabbers, Merit/0000-0001-9744-7308				ABUARAFEH I, 1995, ARCH DIS CHILD, V72, P413, DOI 10.1136/adc.72.5.413; Alfven G, 2008, J PSYCHOSOM RES, V65, P381, DOI 10.1016/j.jpsychores.2008.07.004; APLEY J, 1958, ARCH DIS CHILD, V33, P165, DOI 10.1136/adc.33.168.165; Bakoula C, 2006, ACTA PAEDIATR, V95, P947, DOI 10.1080/08035250600684453; Bode G, 2003, J PSYCHOSOM RES, V54, P417, DOI 10.1016/S0022-3999(02)00459-2; Boey CCM, 1999, J PAEDIATR CHILD H, V35, P303, DOI 10.1046/j.1440-1754.1999.00366.x; Boey CCM, 2003, J PAEDIATR CHILD H, V39, P352, DOI 10.1046/j.1440-1754.2003.00173.x; Boey CCM, 2001, DIGEST LIVER DIS, V33, P140, DOI 10.1016/S1590-8658(01)80069-4; Boey CCM, 2001, J GASTROEN HEPATOL, V16, P154, DOI 10.1046/j.1440-1746.2001.02434.x; Boyle MH, 1998, EVID-BASED MENT HEAL, V1, P37; Chitkara DK, 2005, AM J GASTROENTEROL, V100, P1868, DOI 10.1111/j.1572-0241.2005.41893.x; Christensen M F, 1984, Ugeskr Laeger, V146, P2690; Cuvellier JC, 2009, REV NEUROL-FRANCE, V165, P521, DOI 10.1016/j.neurol.2008.10.011; Dahl-Larsen Rasmus, 2005, Ugeskr Laeger, V167, P1848; De Giacomo C, 2002, HELICOBACTER, V7, P356, DOI 10.1046/j.1523-5378.2002.00109.x; Demirceken FG, 2010, J PEDIATR GASTR NUTR, V50, pE122; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devanarayana N, 2012, J GASTROEN HEPATOL, V27, P383; Devanarayana NM, 2008, J PAEDIATR CHILD H, V44, P195, DOI 10.1111/j.1440-1754.2008.01295.x; Devanarayana NM, 2008, J TROP PEDIATRICS, V54, P178, DOI 10.1093/tropej/fmm114; Devanarayana NM, 2011, J PEDIATR GASTR NUTR, V53, P659, DOI 10.1097/MPG.0b013e3182296033; Devanarayana NM, 2011, J TROP PEDIATRICS, V57, P34, DOI 10.1093/tropej/fmq039; Dhroove G, 2010, J PEDIATR GASTR NUTR, V51, P579, DOI 10.1097/MPG.0b013e3181de0639; Di Lorenzo C, 2005, J PEDIATR GASTR NUTR, V40, P249, DOI 10.1097/01.MPG.0000154661.39488.AC; Di Lorenzo C, 2001, J PEDIATR-US, V139, P838, DOI 10.1067/mpd.2001.118883; Dong L, 2005, PEDIATRICS, V116, pE393, DOI 10.1542/peds.2004-2764; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Endo Y, 2011, J GASTROEN HEPATOL, V26, P106, DOI 10.1111/j.1440-1746.2011.06637.x; FAULL C, 1986, J CHILD PSYCHOL PSYC, V27, P251; Gieteling MJ, 2008, J PEDIATR GASTR NUTR, V47, P316, DOI 10.1097/MPG.0b013e31815bc1c1; Groholt EK, 2003, EUR J EPIDEMIOL, V18, P965, DOI 10.1023/A:1025889912964; Gulewitsch MD, 2013, EUR J GASTROEN HEPAT, V25, P1223, DOI 10.1097/MEG.0b013e328364b55d; Harma AM, 2002, SCAND J PRIM HEALTH, V20, P92, DOI 10.1080/713796398; Helgeland H, 2010, J PSYCHOSOM RES, V68, P359, DOI 10.1016/j.jpsychores.2009.10.010; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hotopf M, 1998, BRIT MED J, V316, P1196, DOI 10.1136/bmj.316.7139.1196; Hyams JS, 1996, J PEDIATR-US, V129, P220, DOI 10.1016/S0022-3476(96)70246-9; Iovino P, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01303.x; Kmet LM, 2004, STANDARD QUALITY ASS; Kokkonen J, 2004, ACTA PAEDIATR, V93, P880, DOI [10.1080/08035250410024907, 10.1111/j.1651-2227.2004.tb02684.x]; Koloski NA, 2012, GUT, V61, P1284, DOI 10.1136/gutjnl-2011-300474; Korterink JJ, 2014, ARCH DIS CHILD, P1, DOI [10.1136/archdischild-2014-307251, DOI 10.1136/ARCHDISCHILD-2014-307251]; Kroner-Herwig B, 2009, CLIN J PAIN, V25, P58, DOI 10.1097/AJP.0b013e31817fc62d; Krogsgaard LR, 2014, CLIN GASTROENTEROL H; Li Ding-guo, 2007, Zhonghua Nei Ke Za Zhi, V46, P99; Liu JS, 2011, J GASTROEN HEPATOL, V26, P88, DOI 10.1111/j.1440-1746.2011.06641.x; LUNDBY L, 1990, Ugeskrift for Laeger, V152, P2851; Luntamo T, 2012, EUR CHILD ADOLES PSY, V21, P301, DOI 10.1007/s00787-012-0261-1; Malaty HM, 2007, ACTA PAEDIATR, V96, P572, DOI 10.1111/j.1651-2227.2007.00230.x; Mayer EA, 2008, GUT, V57, DOI 10.1136/gut.2006.101675; Mayer EA, 2011, ANNU REV MED, V62, P381, DOI 10.1146/annurev-med-012309-103958; Meleine M, 2014, WORLD J GASTROENTERO, V20, P6725, DOI 10.3748/wjg.v20.i22.6725; MORTIMER MJ, 1993, DEV MED CHILD NEUROL, V35, P243; Mugie SM, 2011, BEST PRACT RES CL GA, V25, P3, DOI 10.1016/j.bpg.2010.12.010; ODonohoe JM, 1996, ACTA PAEDIATR, V85, P961, DOI 10.1111/j.1651-2227.1996.tb14194.x; Oh M C, 2004, Ann Acad Med Singap, V33, pS10; Ostberg V, 2006, ACTA PAEDIATR, V95, P929, DOI 10.1080/08035250600636545; Park H, 2011, GASTROENTEROL NURS, V34, P450, DOI 10.1097/SGA.0b013e318237eb43; Park JW, 2013, GUT LIVER, V7, P668, DOI 10.5009/gnl.2013.7.6.668; Perquin CW, 2000, PAIN, V87, P51, DOI 10.1016/S0304-3959(00)00269-4; Petersen S, 2003, SCAND J PUBLIC HEALT, V31, P367, DOI 10.1080/14034940210165064; Phavichitr Nopaorn, 2012, J Med Assoc Thai, V95 Suppl 5, pS42; Rask CU, 2009, EUR J EPIDEMIOL, V24, P625, DOI 10.1007/s10654-009-9366-3; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Rasquin-Weber A, 1999, GUT, V45, P60, DOI 10.1136/gut.45.2008.ii60; Reshetnikov O V, 2001, Int J Circumpolar Health, V60, P253; Romero-Acosta K, 2013, J MENT HEALTH, V22, P33, DOI 10.3109/09638237.2012.734655; Roth-Isigkeit A, 2004, ACTA PAEDIATR, V93, P258, DOI 10.1080/08035250310022577; Sagawa T, 2013, J GASTROEN HEPATOL, V28, P285, DOI 10.1111/j.1440-1746.2012.07257.x; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Saps M, 2014, J PEDIATR-US, V164, P542, DOI 10.1016/j.jpeds.2013.10.088; SHARRER VW, 1991, J SCHOOL HEALTH, V61, P86, DOI 10.1111/j.1746-1561.1991.tb03243.x; Silva AA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-486; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Sinniah B, 2014, TROP BIOMED, V31, P190; Sohrabi S, 2010, J PEDIATR GASTR NUTR, V51, P41, DOI 10.1097/MPG.0b013e3181d1b23e; Son YJ, 2009, INT J NURS STUD, V46, P77, DOI 10.1016/j.ijnurstu.2008.07.006; Song SW, 2012, J KOREAN MED SCI, V27, P1398, DOI 10.3346/jkms.2012.27.11.1398; Spee LAA, 2013, SCAND J PRIM HEALTH, V31, P197, DOI 10.3109/02813432.2013.844405; Stanford EA, 2008, PAIN, V138, P11, DOI 10.1016/j.pain.2007.10.032; Sundblad GMB, 2007, EUR J PAIN, V11, P171, DOI 10.1016/j.ejpain.2006.02.006; Sundblad GMB, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-276; Telmesani Abdulwahab M A, 2009, Saudi J Gastroenterol, V15, P100, DOI 10.4103/1319-3767.45359; Tindberg Y, 2005, J PEDIATR GASTR NUTR, V41, P33, DOI 10.1097/01.MPG.0000163734.84518.9E; Uc A, 2006, J PEDIATR GASTR NUTR, V42, P270, DOI 10.1097/01.mpg.0000189371.29911.68; Walker LS, 2007, J PEDIATR PSYCHOL, V32, P206, DOI 10.1093/jpepsy/jsj124; Walker LS, 2012, PAIN, V153, P1798, DOI 10.1016/j.pain.2012.03.026; Wang Y, 2008, EXP MECH, V48, P107, DOI 10.1007/s11340-007-9067-3; WHITEHEAD WE, 1990, GASTROENTEROLOGY, V98, P1485, DOI 10.1016/0016-5085(90)91079-L; Wise EA, 2002, PAIN, V96, P335, DOI 10.1016/S0304-3959(01)00473-0; Youssef NN, 2008, CLIN GASTROENTEROL H, V6, P329, DOI 10.1016/j.cgh.2007.12.019; Zheng SC, 2012, J CLIN GASTROENTEROL, V46, P345, DOI 10.1097/MCG.0b013e31824712d0; Zhou H, 2010, CHILD CARE HLTH DEV, V36, P781, DOI 10.1111/j.1365-2214.2010.01120.x; Zhou HQ, 2012, SLEEP BREATH, V16, P1211, DOI 10.1007/s11325-011-0635-5; [周惠清 ZHOU Hui-qing], 2009, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V29, P581; Zhou HQ, 2011, J PEDIATR GASTR NUTR, V53, P168, DOI 10.1097/MPG.0b013e3182125388; Zhu JZ, 2014, J GASTROEN HEPATOL, V29, P1595, DOI 10.1111/jgh.12609	98	233	241	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126982	10.1371/journal.pone.0126982	http://dx.doi.org/10.1371/journal.pone.0126982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992621	Green Published, Green Submitted, gold			2022-12-27	WOS:000354921400088
J	Godar, AS; Varanasi, VK; Nakka, S; Prasad, PVV; Thompson, CR; Mithila, J				Godar, Amar S.; Varanasi, Vijaya K.; Nakka, Sridevi; Prasad, P. V. Vara; Thompson, Curtis R.; Mithila, J.			Physiological and Molecular Mechanisms of Differential Sensitivity of Palmer Amaranth (Amaranthus palmeri) to Mesotrione at Varying Growth Temperatures	PLOS ONE			English	Article							RELATIVE-HUMIDITY; GENE-EXPRESSION; RAPID EVOLUTION; HERBICIDE RESISTANCE; GLYPHOSATE; ARABIDOPSIS; STRESS; TOLERANCE; TOXICITY; ATRAZINE	Herbicide efficacy is known to be influenced by temperature, however, underlying mechanism(s) are poorly understood. A marked alteration in mesotrione [a 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor] efficacy on Palmer amaranth (Amaranthus palmeri S. Watson) was observed when grown under low- (LT, 25/15 degrees C, day/night temperatures) and high (HT, 40/30 degrees C) temperature compared to optimum (OT, 32.5/22.5 degrees C) temperature. Based on plant height, injury, and mortality, Palmer amaranth was more sensitive to mesotrione at LT and less sensitive at HT compared to OT (ED50 for mortality; 18.5, 52.3, and 63.7 g ai ha(-1), respectively). Similar responses were observed for leaf chlorophyll index and photochemical efficiency of PSII (F-v/F-m). Furthermore, mesotrione translocation and metabolism, and HPPD expression data strongly supported such variation. Relatively more mesotrione was translocated to meristematic regions at LT or OT than at HT. Based on T-50 values (time required to metabolize 50% of the C-14 mesotrione), plants at HT metabolized mesotrione faster than those at LT or OT (T-50; 13, 21, and 16.5 h, respectively). The relative HPPD: CPS (carbamoyl phosphate synthetase) or HPPD:beta-tubulin expression in mesotrione-treated plants increased over time in all temperature regimes; however, at 48 HAT, the HPPD:beta-tubulin expression was exceedingly higher at HT compared to LT or OT (18.4-, 3.1-, and 3.5-fold relative to untreated plants, respectively). These findings together with an integrated understanding of other interacting key environmental factors will have important implications for a predictable approach for effective weed management.	[Godar, Amar S.; Varanasi, Vijaya K.; Nakka, Sridevi; Prasad, P. V. Vara; Thompson, Curtis R.; Mithila, J.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA	Kansas State University	Mithila, J (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	mithila@ksu.edu	Prasad, P.V. Vara/B-3835-2012	Prasad, P.V. Vara/0000-0001-6632-3361	Kansas State Research and Extension [14-359-J]; Department of Agronomy	Kansas State Research and Extension; Department of Agronomy	This research was supported by funds from Department of Agronomy and Kansas State Research and Extension (KAES-contribution # 14-359-J).	Ahrens H, 2013, ANGEW CHEM INT EDIT, V52, P9388, DOI 10.1002/anie.201302365; Almsick A. van, 2009, Outlooks on Pest Management, V20, P27, DOI 10.1564/20feb09; ANDERSON DM, 1993, WEED RES, V33, P139, DOI 10.1111/j.1365-3180.1993.tb01927.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Beaudegnies R, 2009, BIOORGAN MED CHEM, V17, P4134, DOI 10.1016/j.bmc.2009.03.015; Beckie HJ, 2012, CROP PROT, V35, P15, DOI 10.1016/j.cropro.2011.12.018; Burgos NR, 2001, PEST MANAG SCI, V57, P449, DOI 10.1002/ps.308; Busi R, 2009, HEREDITY, V103, P318, DOI 10.1038/hdy.2009.64; Busi R, 2013, EVOL APPL, V6, P231, DOI 10.1111/j.1752-4571.2012.00282.x; Culpepper AS, 2006, WEED SCI, V54, P620, DOI 10.1614/WS-06-001R.1; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Dat JF, 1998, PLANT PHYSIOL, V118, P1455, DOI 10.1104/pp.118.4.1455; Devine MD, 1993, PHYSL HERBICIDE ACTI, P67; Fausey JC, 2001, WEED SCI, V49, P668, DOI 10.1614/0043-1745(2001)049[0668:EEOCAF]2.0.CO;2; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; GOSSETT BJ, 1992, WEED TECHNOL, V6, P587, DOI 10.1017/S0890037X00035843; Gressel J, 2011, PEST MANAG SCI, V67, P253, DOI 10.1002/ps.2071; HAMMERTON JL, 1967, WEEDS-U, V15, P330, DOI 10.2307/4041001; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Hatzios K. K., 1982, Metabolism of herbicides in higher plants.; Hawkes TR, 2001, BCPC CONFERENCE - WEEDS 2001, VOLS 1 AND 2, P563; Heap I, 2014, INT SURVEY HERBICIDE; Johnson BC, 2002, WEED SCI, V50, P157, DOI 10.1614/0043-1745(2002)050[0157:IOTARH]2.0.CO;2; JORDAN TN, 1977, WEED SCI, V25, P448, DOI 10.1017/S004317450003383X; Joy M, 2009, WEED SCI, V57, P563, DOI 10.1614/WS-09-041.1; KLINGAMAN TE, 1994, WEED SCI, V42, P523, DOI 10.1017/S0043174500076888; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Leister D, 2005, GENE, V354, P110, DOI 10.1016/j.gene.2005.03.039; Ma R, 2013, PLANT PHYSIOL, V163, P363, DOI 10.1104/pp.113.223156; Manalil S, 2011, WEED SCI, V59, P210, DOI 10.1614/WS-D-10-00111.1; Massinga RA, 2001, WEED SCI, V49, P202, DOI 10.1614/0043-1745(2001)049[0202:IOPAIC]2.0.CO;2; Matringe M, 2005, PEST MANAG SCI, V61, P269, DOI 10.1002/ps.997; McCurdy JD, 2008, J AGR FOOD CHEM, V56, P9133, DOI 10.1021/jf801574u; MCWHORTER CG, 1978, WEED SCI, V26, P605, DOI 10.1017/S004317450006464X; McWhorter CG, 1981, WEED SCI, V29, P235; MILLER SD, 1981, WEED SCI, V29, P33, DOI 10.1017/S0043174500025790; Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E; Nandula VK, 2012, WEED SCI, V60, P179, DOI 10.1614/WS-D-11-00157.1; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Neve P, 2005, THEOR APPL GENET, V110, P1154, DOI 10.1007/s00122-005-1947-2; Neve P, 2005, HEREDITY, V95, P485, DOI 10.1038/sj.hdy.6800751; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Patterson DT, 1999, CLIMATIC CHANGE, V43, P711, DOI 10.1023/A:1005549400875; Ramel F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-450; Ricker DB, 2007, THESIS VIRGINIA POLY, P73; Riechers DE, 1996, J AGR FOOD CHEM, V44, P1558, DOI 10.1021/jf950544y; RITTER RL, 1981, WEED SCI, V29, P480, DOI 10.1017/S0043174500040030; Rossel JB, 2002, PLANT PHYSIOL, V130, P1109, DOI 10.1104/pp.005595; Ruiz-Sola M Aguila, 2012, Arabidopsis Book, V10, pe0158, DOI 10.1199/tab.0158; SAUER J, 1957, EVOLUTION, V11, P11, DOI 10.2307/2405808; Senseman S., 2007, HERBICIDE HDB, V9th, P458; Stephenson DO, 2004, WEED TECHNOL, V18, P1111, DOI 10.1614/WT-03-260R1; Sulmon C, 2004, PLANT SCI, V167, P913, DOI 10.1016/j.plantsci.2004.05.036; Sutton P, 2002, PEST MANAG SCI, V58, P981, DOI 10.1002/ps.554; Turner NC, 2004, J EXP BOT, V55, P2413, DOI 10.1093/jxb/erh154; Waltz AL, 2004, WEED TECHNOL, V18, P931, DOI 10.1614/WT-03-123R3; Ward SM, 2013, WEED TECHNOL, V27, P12, DOI 10.1614/WT-D-12-00113.1; Webster TM, 2012, WEED SCI, V60, P145, DOI 10.1614/WS-D-11-00092.1; Zhang SR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0227	61	50	51	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126731	10.1371/journal.pone.0126731	http://dx.doi.org/10.1371/journal.pone.0126731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992558	gold, Green Submitted, Green Published			2022-12-27	WOS:000354918600040
J	Oztemur, Y; Bekmez, T; Aydos, A; Yulug, IG; Bozkurt, B; Dedeoglu, BG				Oztemur, Yasemin; Bekmez, Tufan; Aydos, Alp; Yulug, Isik G.; Bozkurt, Betul; Dedeoglu, Bala Gur			A Ranking-Based Meta-Analysis Reveals Let-7 Family as a Meta-Signature for Grade Classification in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; MICRORNAS; GROWTH; DIFFERENTIATION; METASTASIS	Breast cancer is one of the most important causes of cancer-related deaths worldwide in women. In addition to gene expression studies, the progressing work in the miRNA area including miRNA microarray studies, brings new aspects to the research on the cancer development and progression. Microarray technology has been widely used to find new biomarkers in research and many transcriptomic microarray studies are available in public databases. In this study, the breast cancer miRNA and mRNA microarray studies were collected according to the availability of their data and clinical information, and combined by a newly developed ranking-based meta-analysis approach to find out candidate miRNA biomarkers (meta-miRNAs) that classify breast cancers according to their grades and explain the relation between miRNAs and mRNAs. This approach provided meta-miRNAs specific to breast cancer grades, pointing out let-7 family members as grade classifiers. The qRT-PCR studies performed with independent breast tumors confirmed the potential biomarker role of let-7 family members (meta-miRNAs). The concordance between the meta-mRNAs and miRNA target genes specific to tumor grade (common genes) supported the idea of mRNAs as miRNA targets. The pathway analysis results showed that most of the let-7 family miRNA targets, and also common genes, were significantly taking part in cancer-related pathways. The qRT-PCR studies, together with bioinformatic analyses, confirmed the results of meta-analysis approach, which is dynamic and allows combining datasets from different platforms.	[Oztemur, Yasemin; Aydos, Alp; Dedeoglu, Bala Gur] Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey; [Bekmez, Tufan] Gazi Univ, Fac Dent, Ankara, Turkey; [Yulug, Isik G.] Bilkent Univ, Mol Biol & Genet Dept, Ankara, Turkey; [Bozkurt, Betul] Ankara Numune Training & Res Hosp, Dept Gen Surg, Ankara, Turkey	Ankara University; Gazi University; Ihsan Dogramaci Bilkent University; Ankara Numune Training & Research Hospital	Dedeoglu, BG (corresponding author), Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey.	gurbala@yahoo.com	Dedeoglu, Bala Gur/ABC-2436-2020; Aydos, Alp/AAH-5316-2020; Dedeoglu, Bala Gur/O-1604-2014; ıslakoglu, yasemin oztemur/AAY-7401-2020	Dedeoglu, Bala Gur/0000-0002-4320-5685; Aydos, Alp/0000-0002-8670-3393; Dedeoglu, Bala Gur/0000-0002-4320-5685; ıslakoglu, yasemin oztemur/0000-0001-7792-7777; Yulug, Isik/0000-0002-7577-2502	Scientific and Technological Research Council of Turkey [112T679]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by The Scientific and Technological Research Council of Turkey, http://www.tubitak.gov.tr/, grant no. 112T679. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Campain A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-408; Chang L, 2013, META ANALYSIS METHOD; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Findlay VJ, 2010, OPEN CANC J, V3, P55, DOI DOI 10.2174/1874079001003010055; Gery S, 2005, CLIN CANCER RES, V11, P7243, DOI 10.1158/1078-0432.CCR-05-0231; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gur-Dedeoglu B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-396; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Hu YS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093310, 10.1371/journal.pone.0093425, 10.1371/journal.pone.0092099]; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Li QY, 2012, BIOCHEM BIOPH RES CO, V424, P28, DOI 10.1016/j.bbrc.2012.06.028; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mulrane L, 2014, EXPERT REV MOL DIAGN, V14, P347, DOI 10.1586/14737159.2014.901153; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Oliveros JC, 2007, AN INTERACTIVE TOOL; Ouzounova M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-139; Phan JH, 2012, SCI WORLD J, DOI 10.1100/2012/989637; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Romero-Cordoba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031904; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Serpico D, 2014, CANCER TREAT REV, V40, P595, DOI 10.1016/j.ctrv.2013.11.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simon R, 2007, CANCER INFORM, V3, P11; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tang ZQ, 2014, INT J CANCER, V134, P306, DOI 10.1002/ijc.28371; Van Laere S, 2008, CLIN CANCER RES, V14, P7452, DOI 10.1158/1078-0432.CCR-08-1077; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhang N, 2014, ONCOGENE, V33, P3119, DOI 10.1038/onc.2013.286	50	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126837	10.1371/journal.pone.0126837	http://dx.doi.org/10.1371/journal.pone.0126837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978727	Green Submitted, Green Published, gold			2022-12-27	WOS:000354916100105
J	Solah, VA; Meng, XQ; Wood, S; Gahler, RJ; Kerr, DA; James, AP; Pal, S; Fenton, HK; Johnson, SK				Solah, Vicky A.; Meng, Xingqiong; Wood, Simon; Gahler, Roland J.; Kerr, Deborah A.; James, Anthony P.; Pal, Sebely; Fenton, Haelee K.; Johnson, Stuart K.			Effect of Training on the Reliability of Satiety Evaluation and Use of Trained Panellists to Determine the Satiety Effect of Dietary Fibre: A Randomised Controlled Trial	PLOS ONE			English	Article							ENERGY-INTAKE; GENETIC-VARIATION; APPETITE; REPRODUCIBILITY; SCALE; OVERWEIGHT; VALIDITY; GLUCOSE; FOODS	Background The assessment of satiety effects on foods is commonly performed by untrained volunteers marking their perceived hunger or fullness on line scales, marked with pre-set descriptors. The lack of reproducibility of satiety measurement using this approach however results in the tool being unable to distinguish between foods that have small, but possibly important, differences in their satiety effects. An alternate approach is used in sensory evaluation; panellists can be trained in the correct use of the assessment line-scale and brought to consensus on the meanings of descriptors used for food quality attributes to improve the panel reliability. The effect of training on the reliability of a satiety panel has not previously been reported. Method In a randomised controlled parallel intervention, the effect of training in the correct use of a satiety labelled magnitude scale (LMS) was assessed versus no-training. The test-retest precision and reliability of two hour postprandial satiety evaluation after consumption of a standard breakfast was compared. The trained panel then compared the satiety effect of two breakfast meals containing either a viscous or a non-viscous dietary fibre in a crossover trial. Results A subgroup of the 23 panellists (n = 5) improved their test re-test precision after training. Panel satiety area under the curve, "after the training" intervention was significantly different to "before training" (p < 0.001). Reliability of the panel determined by intraclass correlation (ICC) of test and retest showed improved strength of the correlation from 0.70 pre-intervention to 0.95 post intervention. The trained "satiety expert panel" determined that a standard breakfast with 5g of viscous fibre gave significantly higher satiety than with 5g non-viscous fibre (area under curve (AUC) of 478.2, 334.4 respectively) (p <= 0.002). Conclusion Training reduced between panellist variability. The improved strength of test-retest ICC as a result of the training intervention suggests that training satiety panellists can improve the discriminating power of satiety evaluation.	[Solah, Vicky A.; Meng, Xingqiong; Wood, Simon; Kerr, Deborah A.; James, Anthony P.; Pal, Sebely; Fenton, Haelee K.; Johnson, Stuart K.] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Nutr Dietet & Food Sci, Perth, WA 6845, Australia; [Wood, Simon] Univ British Columbia, Food Nutr & Hlth Program, Vancouver, BC V5Z 1M9, Canada; [Wood, Simon] InovoBiol Inc, Calgary, AB, Canada; [Gahler, Roland J.] Factors Grp R&D, Burnaby, BC, Canada; [Meng, Xingqiong] Flinders Univ S Australia, Flinders Ctr Innovat Canc, Adelaide, SA 5001, Australia	Curtin University; University of British Columbia; Flinders University South Australia	Solah, VA (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Nutr Dietet & Food Sci, Perth, WA 6845, Australia.	v.solah@curtin.edu.au	Kerr, Deborah A/F-3356-2012; James, Anthony P/A-2241-2008; Kerr, Deborah A/N-8599-2019; Fenton, Haelee/S-5571-2019; Johnson, Stuart/B-5174-2012	Kerr, Deborah A/0000-0002-1094-1299; James, Anthony P/0000-0002-0873-3714; Kerr, Deborah A/0000-0002-1094-1299; Solah, Vicky/0000-0003-4029-5977; Meng, Xingqiong/0000-0001-8935-358X; Fenton, Haelee/0000-0002-1476-4816; Johnson, Stuart/0000-0001-8357-797X	InovoBiologic, Inc.	InovoBiologic, Inc.	Financial support for the study and supply of PGX(r) were provided by InovoBiologic, Inc. SW receives consulting fees from InovoBiologic, Inc. VAS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GH, 2004, J NUTR, V134, p974S, DOI 10.1093/jn/134.4.974S; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Benelam B, 2009, NUTR BULL, V34, P126, DOI 10.1111/j.1467-3010.2009.01753.x; Bi J, 2012, J SENS STUD, V27, P352, DOI 10.1111/j.1745-459X.2012.00399.x; Blundell J, 2010, OBES REV, V11, P251, DOI 10.1111/j.1467-789X.2010.00714.x; Bornet FRJ, 2007, APPETITE, V49, P535, DOI 10.1016/j.appet.2007.04.006; Brunstrom JM, 2008, APPETITE, V51, P604, DOI 10.1016/j.appet.2008.04.017; Cardello A, 2008, FOOD QUAL PREFER, V19, P473, DOI 10.1016/j.foodqual.2008.02.003; Cardello AV, 2004, J SENS STUD, V19, P341, DOI 10.1111/j.1745-459X.2004.tb00152.x; CROSS HR, 1978, FOOD TECHNOL-CHICAGO, V32, P48; Duffy VB, 2000, J AM DIET ASSOC, V100, P647, DOI 10.1016/S0002-8223(00)00191-7; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Flood-Obbagy JE, 2009, APPETITE, V52, P416, DOI 10.1016/j.appet.2008.12.001; Food Standards Australia and New Zealand, NUTR PAN CALC; Gerstein DE, 2004, J AM DIET ASSOC, V104, P1151, DOI 10.1016/j.jada.2004.04.027; Hayes JE, 2013, FOOD QUAL PREFER, V28, P36, DOI 10.1016/j.foodqual.2012.07.012; Holt SHA, 2001, J AM DIET ASSOC, V101, P767, DOI 10.1016/S0002-8223(01)00192-4; Horner KM, 2014, APPETITE, V81, P116, DOI 10.1016/j.appet.2014.06.025; Ip EH, 2011, CONTEMP CLIN TRIALS, V32, P225, DOI 10.1016/j.cct.2010.11.001; Kreutzmann S, 2007, FOOD QUAL PREFER, V18, P482, DOI 10.1016/j.foodqual.2006.05.009; Lawless H. T., 1998, SENSORY EVALUATION F; Lawless HT, 2010, FOOD QUAL PREFER, V21, P4, DOI 10.1016/j.foodqual.2009.06.009; Mattes RD, 2007, PHYSIOL BEHAV, V90, P705, DOI 10.1016/j.physbeh.2006.12.009; Pal S, 2010, BRIT J NUTR, V104, P1241, DOI 10.1017/S0007114510001911; Pereira MA, 2001, PEDIATR CLIN N AM, V48, P969, DOI 10.1016/S0031-3955(05)70351-5; RABEN A, 1995, BRIT J NUTR, V73, P517, DOI 10.1079/BJN19950056; Reichert RG, 2013, BIOTECHNOL GENET ENG, V29, P221, DOI 10.1080/02648725.2013.801229; Schifferstein HNJ, 2012, FOOD QUAL PREFER, V26, P151, DOI 10.1016/j.foodqual.2012.04.016; Schuring E, 2012, APPETITE, V59, P601, DOI 10.1016/j.appet.2012.07.003; Slavin J, 2007, NUTR BULL, V32, P32, DOI 10.1111/j.1467-3010.2007.00603.x; Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018; Solah VA, 2014, APPETITE, V77, P72, DOI 10.1016/j.appet.2014.02.021; Solah VA, 2010, APPETITE, V54, P485, DOI 10.1016/j.appet.2010.01.019; Stubbs RJ, 2000, BRIT J NUTR, V84, P405, DOI 10.1017/S0007114500001719; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Zalifah MK, 2008, FOOD QUAL PREFER, V19, P574, DOI 10.1016/j.foodqual.2008.03.001	36	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126202	10.1371/journal.pone.0126202	http://dx.doi.org/10.1371/journal.pone.0126202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978321	Green Published, gold			2022-12-27	WOS:000354916100052
J	Subramenium, GA; Viszwapriya, D; Iyer, PM; Balamurugan, K; Pandian, SK				Subramenium, Ganapathy Ashwinkumar; Viszwapriya, Dharmaprakash; Iyer, Prasanth Mani; Balamurugan, Krishnaswamy; Pandian, Shunmugiah Karutha			covR Mediated Antibiofilm Activity of 3-Furancarboxaldehyde Increases the Virulence of Group A Streptococcus	PLOS ONE			English	Article							HYALURONIC-ACID CAPSULE; BIOFILM FORMATION; M-PROTEIN; REGULATES EXPRESSION; GENE-EXPRESSION; PYOGENES; 2-COMPONENT; RESISTANCE; SYSTEM; IDENTIFICATION	Background Group A streptococcus (GAS, Streptococcus pyogenes), a multi-virulent, exclusive human pathogen responsible for various invasive and non-invasive diseases possesses biofilm forming phenomenon as one of its pathogenic armaments. Recently, antibiofilm agents have gained prime importance, since inhibiting the biofilm formation is expected to reduce development of antibiotic resistance and increase their susceptibility to the host immune cells. Principal Findings The current study demonstrates the antibiofilm activity of 3Furancarboxaldehyde (3FCA), a floral honey derived compound, against GAS biofilm, which was divulged using crystal violet assay, light microscopy, and confocal laser scanning microscopy. The report is extended to study its effect on various aspects of GAS (morphology, virulence, aggregation) at its minimal biofilm inhibitory concentration (132 mu g/ml). 3FCA was found to alter the growth pattern of GAS in solid and liquid medium and increased the rate of auto-aggregation. Electron microscopy unveiled the increase in extra polymeric substances around cell. Gene expression studies showed down-regulation of covR gene, which is speculated to be the prime target for the antibiofilm activity. Increased hyaluronic acid production and down regulation of srtBgene is attributed to the enhanced rate of auto-aggregation. The virulence genes (srv, mga, luxS and hasA) were also found to be over expressed, which was manifested with the increased susceptibility of the model organism Caenorhabditis elegans to 3FCA treated GAS. The toxicity of 3FCA was ruled out with no adverse effect on C. elegans. Significance Though 3FCA possess antibiofilm activity against GAS, it was also found to increase the virulence of GAS. This study demonstrates that, covR mediated antibiofilm activity may increase the virulence of GAS. This also emphasizes the importance to analyse the acclimatization response and virulence of the pathogen in the presence of antibiofilm compounds prior to their clinical trials.	[Subramenium, Ganapathy Ashwinkumar; Viszwapriya, Dharmaprakash; Iyer, Prasanth Mani; Balamurugan, Krishnaswamy; Pandian, Shunmugiah Karutha] Alagappa Univ, Dept Biotechnol, Karaikkudi, Tamil Nadu, India	Alagappa University	Pandian, SK (corresponding author), Alagappa Univ, Dept Biotechnol, Sci Campus, Karaikkudi, Tamil Nadu, India.	sk_pandian@rediffmail.com	Shunmugiah, Karutha Pandian/B-6765-2018; Pandian, Shunmugiah Karutha/AAV-2803-2020; Ganapathy, Ashwinkumar Subramenium/AAA-8198-2022	Shunmugiah, Karutha Pandian/0000-0003-2925-0575; Pandian, Shunmugiah Karutha/0000-0003-2925-0575; Balamurugan, Prof. Dr. Krishnaswamy/0000-0001-9316-8141; Ganapathy, Ashwinkumar Subramenium/0000-0001-5254-9431	Indian Council for Medical Research, New Delhi [58/20/2011-BMS]; Department of Biotechnology, Government of India [BT/BI/25/015/2012(BIF)]; Department of Science and Technology, Government of India through PURSE [SR/S9Z-23/2010/42(G)]; Department of Science and Technology, Government of India through FIST [SR-FST/LSI-087/2008]; University Grants Commission, New Delhi through SAP-DRS1 [F.3-28/2011(SAP-II)]	Indian Council for Medical Research, New Delhi(Indian Council of Agricultural Research (ICAR)Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India through PURSE(Department of Science & Technology (India)); Department of Science and Technology, Government of India through FIST(Department of Science & Technology (India)); University Grants Commission, New Delhi through SAP-DRS1(University Grants Commission, India)	Funding: The authors would like to thank Indian Council for Medical Research, New Delhi (Sanction number 58/20/2011-BMS dated 19.03.2012) for having funded for the study. The authors also thankfully acknowledge the computational facility provided by the Bioinformatics Infrastructure Facility funded by Department of Biotechnology, Government of India (Grant No. BT/BI/25/015/2012(BIF)). The Instrumentation Facility provided by Department of Science and Technology, Government of India through PURSE [Grant No. SR/S9Z-23/2010/42(G)] & FIST (Grant No. SR-FST/LSI-087/2008) and University Grants Commission, New Delhi through SAP-DRS1 [Grant No. F.3-28/2011(SAP-II)] is greatly acknowledged.	Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06; Benyelles B, 2014, J SAUDI CHEM SOC, V18, P972, DOI 10.1016/j.jscs.2011.12.001; Bianchi F, 2005, FOOD CHEM, V89, P527, DOI 10.1016/j.foodchem.2004.03.009; Bugrysheva JV, 2010, RNA BIOL, V7, P569, DOI 10.4161/rna.7.5.13097; CAPARON MG, 1987, P NATL ACAD SCI USA, V84, P8677, DOI 10.1073/pnas.84.23.8677; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; CLEARY PP, 1979, J BACTERIOL, V140, P1090, DOI 10.1128/JB.140.3.1090-1097.1979; Conley J, 2003, J CLIN MICROBIOL, V41, P4043, DOI 10.1128/JCM.41.9.4043-4048.2003; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2006, J BACTERIOL, V188, P77, DOI 10.1128/JB.188.1.77-85.2006; Darmstadt GL, 2000, INFECT IMMUN, V68, P1215, DOI 10.1128/IAI.68.3.1215-1221.2000; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dengg Marlene, 2004, Journal of Pharmacological and Toxicological Methods, V50, P209, DOI 10.1016/j.vascn.2004.04.002; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Fiedler T, 2010, FUTURE MICROBIOL, V5, P1675, DOI [10.2217/fmb.10.128, 10.2217/FMB.10.128]; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Green AE, 2012, FEMS MICROBIOL LETT, V333, P54, DOI 10.1111/j.1574-6968.2012.02598.x; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040319; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Kang SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037367; Kim S, 2004, J ANTIMICROB CHEMOTH, V54, P447, DOI 10.1093/jac/dkh363; Kimura KR, 2012, J BACTERIOL, V194, P804, DOI 10.1128/JB.06283-11; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreth J, 2011, J BACTERIOL, V193, P4153, DOI 10.1128/JB.00061-11; Krzysciak W, 2013, EUR J CLIN MICROBIOL, V32, P1361, DOI 10.1007/s10096-013-1914-9; Landini P, 2010, APPL MICROBIOL BIOT, V86, P813, DOI 10.1007/s00253-010-2468-8; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Lin P, 2003, FLAVOUR FRAG J, V18, P539, DOI 10.1002/ffj.1264; Marouni MJ, 2003, INFECT IMMUN, V71, P5633, DOI 10.1128/IAI.71.10.5633-5639.2003; Mayfield JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100698; Moses AE, 1997, INFECT IMMUN, V65, P64, DOI 10.1128/IAI.65.1.64-71.1997; Nozal MJ, 2001, J CHROMATOGR A, V917, P95, DOI 10.1016/S0021-9673(01)00702-6; PATENGE N, 2013, HOST PATHOGEN INTERA, V368, P111, DOI DOI 10.1007/82_2012_296; Perez-Trallero E, 1999, EMERG INFECT DIS, V5, P235, DOI 10.3201/eid0502.990207; Pino J, 2004, J ESSENT OIL RES, V16, P302, DOI 10.1080/10412905.2004.9698727; Ribardo DA, 2004, INFECT IMMUN, V72, P3668, DOI 10.1128/IAI.72.6.3668-3673.2004; Roberts AL, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-3; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Schmidt KH, 1996, MED MICROBIOL IMMUN, V184, P169, DOI 10.1007/PL00008248; SEPPALA H, 1992, NEW ENGL J MED, V326, P292, DOI 10.1056/NEJM199201303260503; Tan JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096800; Tatsuno Ichiro, 2014, BMC Res Notes, V7, P189, DOI 10.1186/1756-0500-7-189; Terao Y, 2012, J ORAL BIOSCI, V54, P96, DOI 10.1016/j.job.2012.02.004; Thenmozhi R, 2011, J BASIC MICROB, V51, P196, DOI 10.1002/jobm.201000006; Torretta S, 2012, OTOLARYNG HEAD NECK, V146, P991, DOI 10.1177/0194599812438169; WILSON AT, 1959, J EXP MED, V109, P257, DOI 10.1084/jem.109.3.257; York MK, 1999, J CLIN MICROBIOL, V37, P1727, DOI 10.1128/JCM.37.6.1727-1731.1999	53	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0127210	10.1371/journal.pone.0127210	http://dx.doi.org/10.1371/journal.pone.0127210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978065	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100139
J	Vadasz, Z; Rainis, T; Nakhleh, A; Haj, T; Bejar, J; Halasz, K; Toubi, E				Vadasz, Zahava; Rainis, Tova; Nakhleh, Afif; Haj, Tharwat; Bejar, Jacob; Halasz, Katty; Toubi, Elias			The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)	PLOS ONE			English	Article							REGULATORY T-CELLS; IL-17; TH17	Background and Aims Immune semaphorins are a large family of proteins involved in the pathogenesis of inflammatory diseases through the regulation of immune homeostasis and tissue inflammation. We aim to assess the possible involvement of semaphorin3A (sema3A) and 4A (sema4A) in peripheral immune responses and bowel tissue inflammation of patients suffering from Crohn's disease (CD) and ulcerative colitis (UC). Patients and Methods Twenty-seven CD patients and 10 UC patients were studied and compared to 10 patients followed for acute diverticulitis (disease control) and 12 healthy individuals. All were evaluated for sema3A expression on T regulatory cells (Tregs), serum levels of sema3A and sema4A, and tissue expression of sema3A and sema4A in bowel biopsies. Results The percentage (%) of T regulatory cells (Tregs) expressing sema3A in patients with active CD (64.5% +/- 14.49%) and active UC (49.8% +/- 16.45%) was significantly lower when compared to that of healthy controls (88.7% +/- 3.6%, p< 0.001 and p< 0.0001, respectively). This expression was seen to be in negative correlation with CD activity. Serum levels of Sema4A were significantly lower in patients with CD and UC when compared to that of controls (5.69 +/- 1.48ng\ml for CD, 5.26 +/- 1.23 ng/ml for UC patients vs 9.74 +/- 2.73ng/ml for normal controls, P<0.001). Sema4A was highly expressed in lymphocytes of the lamina propria of CD and UC patients but absent in patients with diverticulitis or in normal individuals. Conclusions Altered % of Tregs expressing sema3A in patients with inflammatory bowel diseases (IBD) is partially responsible for their failure in preventing CD4+ effector T cell induced inflammation in IBD in peripheral blood. The increased expression of sema4A in bowel biopsies from CD and UC patients is suggestive of its central role in regulating local tissue inflammation in the bowel.	[Vadasz, Zahava; Nakhleh, Afif; Haj, Tharwat; Halasz, Katty; Toubi, Elias] Technion Israel Inst Technol, Bnai Zion Med Ctr, Div Allergy & Clin Immunol, Haifa, Israel; [Rainis, Tova] Technion Israel Inst Technol, Bnai Zion Med Ctr, Div Gastroenterol, Haifa, Israel; [Bejar, Jacob] Technion Israel Inst Technol, Bnai Zion Med Ctr, Dept Pathol, Haifa, Israel	Bnai Zion Medical Center; Technion Israel Institute of Technology; Bnai Zion Medical Center; Technion Israel Institute of Technology; Bnai Zion Medical Center; Technion Israel Institute of Technology	Toubi, E (corresponding author), Technion Israel Inst Technol, Bnai Zion Med Ctr, Div Allergy & Clin Immunol, Haifa, Israel.	elias.toubi@b-zion.org.il	Nakhleh, Afif/AAF-6986-2019	Nakhleh, Afif/0000-0003-1206-1516				Baker RL, 2012, EUR J IMMUNOL, V42, P672, DOI 10.1002/eji.201142071; Catalano A, 2010, J IMMUNOL, V185, P6373, DOI 10.4049/jimmunol.0903527; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Kelsen J, 2005, CLIN EXP IMMUNOL, V141, P549, DOI 10.1111/j.1365-2249.2005.02876.x; Khan WN, 2013, IMMUNOL RES, V57, P335, DOI 10.1007/s12026-013-8466-z; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lepelletier Y, 2006, EUR J IMMUNOL, V36, P1782, DOI 10.1002/eji.200535601; Morihana T, 2013, J CLIN IMMUNOL, V33, P200, DOI 10.1007/s10875-012-9798-5; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5688, DOI 10.3748/wjg.v18.i40.5688; Nkyimbeng-Takwi EH, 2012, MUCOSAL IMMUNOL, V5, P409, DOI 10.1038/mi.2012.18; Nkyimbeng-Takwi E, 2011, IMMUNOL RES, V50, P10, DOI 10.1007/s12026-010-8201-y; Okou DT, 2014, J PEDIATR GASTR NUTR, V58, P561, DOI 10.1097/MPG.0000000000000302; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Ueno A, 2013, INFLAMM BOWEL DIS, V19, P2522, DOI 10.1097/MIB.0b013e3182a85709; Vadasz Z, 2011, LUPUS, V20, P1466, DOI 10.1177/0961203311417034; Vadasz Z, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3881; Walters TD, 2011, INFLAMM BOWEL DIS, V17, P1547, DOI 10.1002/ibd.21524; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053; Yuan XM, 2014, IMMUNOL REV, V259, P103, DOI 10.1111/imr.12163	22	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125860	10.1371/journal.pone.0125860	http://dx.doi.org/10.1371/journal.pone.0125860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978359	Green Submitted, gold, Green Published			2022-12-27	WOS:000354916100037
J	Zhao, M; Bai, YJ; Xie, WK; Shi, X; Li, FT; Yang, F; Sun, YY; Huang, LZ; Li, XX				Zhao, Min; Bai, Yujing; Xie, Wankun; Shi, Xuan; Li, Fangting; Yang, Fei; Sun, Yaoyao; Huang, Lvzhen; Li, Xiaoxin			Interleukin-1 beta Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV)	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; CELL-DEATH; INFLAMMATION; ACTIVATION; DRUSEN; CYTOKINES; SYSTEM; EYE; CLASSIFICATION; INFLAMMASOMES	Purpose To examine the expression of pro-interleukin-1 beta (pro-IL-1 beta) and interleukin-1 beta (IL-1 beta) in the vitreous body of patients with neovascular age-related macular degeneration(nAMD), polypoidal choroidal vasculopathy (PCV), proliferative diabetic retinopathy (PDR), retinal vein occlusion (RVO) or Eales' disease to further elucidate the role of IL-1 beta and inflammation in the pathogenesis of neovascular retinal disease. Design Prospective clinical laboratory investigation study. Methods All patients enrolled had vitreous hemorrhage due to nAMD, PCV, PDR, RVO or Eales' disease that required vitrectomy. Patients were excluded for any history of active intraocular inflammation, or other ophthalmic surgery besides vitrectomy. Control samples were obtained from patients with idiopathic macular epiretinal membrane. A total of fifty vitreous samples were collected from patient during vitrectomy. Pro-IL-1 beta and IL-1 beta expression were measured by enzyme-linked immunosorbent assay (ELISA). Results were analyzed statistically using nonparametric tests. Results Expression of pro-IL-1 beta protein was increased by 2.83-fold and 9.19-fold in PCV and nAMD vitreous samples relative to control, respectively. Expression of IL-beta protein was increased by 10-fold and 4.83-fold in PCV and nAMD vitreous samples relative to control, respectively. Conclusions Our results demonstrate that expression of pro-IL-1 beta and IL-1 beta proteins is higher in PCV and nAMD. The roles of pro-IL-1 beta and IL-1 beta as inflammatory mediators in the development of PCV and nAMD may be associated with photoreceptor degeneration and neovascularization which necessitates further study.	[Zhao, Min; Bai, Yujing; Xie, Wankun; Shi, Xuan; Li, Fangting; Yang, Fei; Sun, Yaoyao; Huang, Lvzhen; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Zhao, Min; Bai, Yujing; Xie, Wankun; Shi, Xuan; Li, Fangting; Yang, Fei; Sun, Yaoyao; Huang, Lvzhen; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Zhao, Min; Bai, Yujing; Xie, Wankun; Shi, Xuan; Li, Fangting; Yang, Fei; Sun, Yaoyao; Huang, Lvzhen; Li, Xiaoxin] Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China	Peking University	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drlixiaoxin@163.com	Xie, Wankun/K-8623-2017	Xie, Wankun/0000-0003-0178-3361; Zhao, Min/0000-0003-0521-9186	National Basic Research Program of China (973 Program) [2011CB510200]; Peking University People's Hospital Research and Development Funds [RDB2013-21, 2118000540]; Beijing Nova Program [Z131102000413004]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Peking University People's Hospital Research and Development Funds; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	Xiaoxin Li was supported by National Basic Research Program of China (973 Program, 2011CB510200). Min Zhao was supported by Peking University People's Hospital Research and Development Funds (RDB2013-21, 2118000540). Yujing Bai was supported by Beijing Nova Program (Z131102000413004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cackett P, 2009, RETINA-J RET VIT DIS, V29, P187, DOI 10.1097/IAE.0b013e318188c839; Campbell M, 2013, J MOL MED, V91, P1059, DOI 10.1007/s00109-013-1050-0; Colak E, 2012, BIOCHEM MEDICA, V22, P39; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dong N, 2013, MOL VIS, V19, P1734; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; El-Asrar Ahmed M Abu, 2011, Mol Vis, V17, P1829; Feng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068149; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; Hou J, 2011, GRAEF ARCH CLIN EXP, V249, P975, DOI 10.1007/s00417-010-1575-7; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kaarniranta K, 2009, J MOL MED, V87, P117, DOI 10.1007/s00109-008-0418-z; Kikuchi M, 2007, OPHTHALMOLOGY, V114, P1722, DOI 10.1016/j.ophtha.2006.12.021; Klein R, 2014, JAMA OPHTHALMOL, V132, P446, DOI 10.1001/jamaophthalmol.2013.7671; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Leal SM, 2012, CYTOKINE, V58, P107, DOI 10.1016/j.cyto.2011.12.022; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Murugeswari P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107551; Okumura Chikara, 2013, Nihon Rinsho, V71, P1497; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Rosenbaum JT, 2012, NEW ENGL J MED, V367, P768, DOI 10.1056/NEJMcibr1204973; Stanton CM, 2014, ADV EXP MED BIOL, V801, P251, DOI 10.1007/978-1-4614-3209-8_32; Stefansson E, 2011, PROG RETIN EYE RES, V30, P72, DOI 10.1016/j.preteyeres.2010.09.003; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Xie WK, 2011, MOL VIS, V17, P3512; Xu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-54	41	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125150	10.1371/journal.pone.0125150	http://dx.doi.org/10.1371/journal.pone.0125150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978536	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100023
J	Zhao, YL; Li, HL; Wu, RQ; Li, SH; Wang, P; Wang, HT; Wang, J; Zhou, JG				Zhao, Yali; Li, Hailiang; Wu, Ruiqin; Li, Shanhu; Wang, Peng; Wang, Hongtao; Wang, Jian; Zhou, Jianguang			Antitumor Effects of Oncolytic Adenovirus-Carrying siRNA Targeting Potential Oncogene EphA3	PLOS ONE			English	Article							AUTOPHAGIC CELL-DEATH; TUMOR-CELLS; RECEPTORS; EPHRINS	Conditionally replicating adenoviruses (CRAds) armed with antitumor transgenes hold promise for cancer treatment. In previous studies, we showed that the 1504-siRNA targeting potential oncogene EphA3 was an efficient therapeutic transgene and that the telomerase reverse transcriptase promoter (TERTp) driving the CRAd was a more advanced generation of CRAd. Therefore, we combined Ad-TERTp-E1A-1504 by inserting 1504-siRNA into the CRAd to study its antitumor effects and mechanism of action, using Ad-TERTp-E1A-NC and nonreplicating adenovirus carrying 1504-siRNA as controls. Cell viability assays and ED50 studies of growth inhibition confirmed that Ad-TERTp-E1A-1504 has 3.5- and 1,400-fold greater ability to kill EphA3- and TERT-expressing tumor cells compared to Ad-TERTp-E1A-NC and Ad-Delta E1A-1504, respectively. Also, Ad-TERTp-E1A-1504 had little effect on cells that modestly expressed EphA3 and TERT such as 2BS. The antitumor efficacy of Ad-TERTp-E1A-1504 was also validated in vivo. Furthermore, the virus yield of Ad-TERTp-E1A-1504 in C4-2B was similar to 1,000 times greater than that in 2BS. No obvious differences were observed between Ad-TERTp-E1A-1504 and Ad-TERTp-E1A-NC. Both acridine orange staining and Beclin1 protein measurements indicated that autophagy with Ad-TERTp-E1A-1504 at 5 and 10 MOI was higher than that of Ad-TERTp-E1A-NC. Finally, the classical negatively regulated autophagy signaling pathway, PI3K/AKT/mTOR, was suppressed (reduced phosphorylated form) in contrast to NC, and that this was mediated by 1504-siRNA. Thus, Ad-TERTp-E1A-1504 does not harm normal cells but has dual inhibiting and killing effects on TERT-and EphA3-positive tumor cells, and this effect is mediated by the AKT/mTOR signaling pathway via induction of autophagy. These data may offer a foundation for novel antitumor therapies targeting this mechanism.	[Li, Hailiang; Wu, Ruiqin; Li, Shanhu; Wang, Peng; Wang, Hongtao; Wang, Jian; Zhou, Jianguang] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China; [Zhao, Yali] Astronaut Res & Training Ctr China, Beijing, Peoples R China; [Li, Hailiang] Southern Med Univ, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Wang, J (corresponding author), Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China.	zhou.jianguang@aliyun.com; newgeno2003@aliyun.com			National Natural Science Foundation of China [81172445, 81372740, 81372770]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The source of funding for this study was the National Natural Science Foundation of China, grant numbers are 81172445, 81372740 (JW) and 81372770 (JZ), the website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hu ZB, 2008, CANCER GENE THER, V15, P173, DOI 10.1038/sj.cgt.7701105; Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liu HY, 2009, J VIROL METHODS, V162, P8, DOI 10.1016/j.jviromet.2009.07.011; Logue SE, 2008, BIOCHEM SOC T, V36, P1, DOI 10.1042/BST0360001; Meerani S, 2010, EUROPEAN J SCI RES, V40, P156; Nihira K, 2014, CANCER SCI, V105, P568, DOI 10.1111/cas.12396; NybergHoffman C, 1997, NAT MED, V3, P808, DOI 10.1038/nm0797-808; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Smith LM, 2004, EXP CELL RES, V292, P295, DOI 10.1016/j.yexcr.2003.08.021; Vearing C, 2005, CANCER RES, V65, P6745, DOI 10.1158/0008-5472.CAN-05-0758; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Wu RQ, 2014, ONCOL REP, V32, P2657, DOI 10.3892/or.2014.3482; Yokoyama T, 2008, GENE THER, V15, P1233, DOI 10.1038/gt.2008.98; Yu ST, 2009, INT J ONCOL, V35, P329, DOI 10.3892/ijo_00000344; [赵亚丽 Zhao Yali], 2012, [军事医学, Military Medical Sciences], V36, P272; Zhao YL, 2012, LETT BIOTECH, V23, P503; Zhuang GL, 2012, JNCI-J NATL CANCER I, V104, P1182, DOI 10.1093/jnci/djs297; Zou WG, 2004, ONCOGENE, V23, P457, DOI 10.1038/sj.onc.1207033	22	9	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0126726	10.1371/journal.pone.0126726	http://dx.doi.org/10.1371/journal.pone.0126726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25978371	Green Published, gold, Green Submitted			2022-12-27	WOS:000354916100094
J	Brunmair, B; Lehner, Z; Stadlbauer, K; Adorjan, I; Frobel, K; Scherer, T; Luger, A; Bauer, L; Furnsinn, C				Brunmair, Barbara; Lehner, Zsuzsanna; Stadlbauer, Karin; Adorjan, Immanuel; Frobel, Klaus; Scherer, Thomas; Luger, Anton; Bauer, Leonhardt; Fuernsinn, Clemens			55P0110, a Novel Synthetic Compound Developed from a Plant Derived Backbone Structure, Shows Promising Anti-Hyperglycaemic Activity in Mice	PLOS ONE			English	Article							PEPTIDASE-IV INHIBITORS; HIGH-FAT DIET; DIABETIC MICE; QUINOLIZIDINE ALKALOIDS; HYPOGLYCEMIA; SULFONYLUREAS; DRUGS; RATS	Starting off with a structure derived from the natural compound multiflorine, a derivatisation program aimed at the discovery and initial characterisation of novel compounds with antidiabetic potential. Design and discovery of the structures was guided by oral bioactivities obtained in oral glucose tolerance tests in mice. 55P0110, one among several new compounds with distinct anti-hyperglycaemic activity, was further examined to characterise its pharmacology and mode of action. Whereas a single oral dose of 55P0110 did not affect basal glycaemia, it markedly improved the glucose tolerance of healthy and diabetic mice (peak blood glucose in glucose tolerance test, mmol/l: healthy mice with 90 mg/kg 55P0110, 17.0 +/- 1.2 vs. 10.1 +/- 1.1; diabetic mice with 180 mg/kg 55P0110, 23.1 +/- 0.9 vs. 11.1 +/- 1.4; p<0.001 each). Closer examination argued against retarded glucose resorption from the gut, increased glucose excretion in urine, acute insulin-like or insulin sensitising properties, and direct inhibition of dipeptidyl peptidase-4 as the cause of glucose lowering. Hence, 55P0110 seems to act via a target not exploited by any drug presently approved for the treatment of diabetes mellitus. Whereas the insulinotropic sulfonylurea gliclazide (16 mg/ kg) distinctly increased the circulating insulin-per-glucose ratio under basal conditions, 55P0110 (90 mg/kg) lacked such an effect (30 min. after dosing, nmol/mol: vehicle, 2.49 +/- 0.27; 55P0110, 2.99 +/- 0.35; gliclazide, 8.97 +/- 0.49; p<0.001 each vs. gliclazide). Under an exogenous glucose challenge, however, 55P0110 increased this ratio to the same extent as gliclazide (20 min. after glucose feeding: vehicle, 2.53 +/- 0.41; 55P0110, 3.80 +/- 0.46; gliclazide, 3.99 +/- 0.26; p<0.05 each vs. vehicle). By augmenting the glucose stimulated increase in plasma insulin, 55P0110 thus shows distinct anti-hyperglycaemic action in combination with low risk for fasting hypoglycaemia in mice. In summary, we have discovered a novel class of fully synthetic substituted quinazolidines with an attractive pharmacological profile that recommends the structures for further evaluation as candidates for the treatment of diabetes mellitus.	[Brunmair, Barbara; Lehner, Zsuzsanna; Stadlbauer, Karin; Scherer, Thomas; Luger, Anton; Fuernsinn, Clemens] Med Univ Vienna, Div Endocrinol & Metab, Dept Med 3, Vienna, Austria; [Adorjan, Immanuel; Frobel, Klaus; Bauer, Leonhardt] 55pharma Drug Discovery & Dev AG, Vienna, Austria	Medical University of Vienna	Furnsinn, C (corresponding author), Med Univ Vienna, Div Endocrinol & Metab, Dept Med 3, Vienna, Austria.	clemens.fuernsinn@meduniwien.ac.at		Scherer, Thomas/0000-0003-4980-706X	Austrian Research Promotion Agency [BRIDGE 812095-SCK/SAI]; 55pharma Drug Discovery Development AG	Austrian Research Promotion Agency; 55pharma Drug Discovery Development AG	This work was supported by The Austrian Research Promotion Agency (https://www.ffg.at/en; Grant No. BRIDGE 812095-SCK/SAI to BB). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. "55pharma Drug Discovery & Development AG" provided additional support in the form of salaries for authors IA, KF, and LB and consultancy fees for CF, but did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the "author contributions" section.	Ahmed R. T., 1993, Egyptian Journal of Pharmaceutical Sciences, V34, P565; Bailey CJ, 2011, TRENDS PHARMACOL SCI, V32, P63, DOI 10.1016/j.tips.2010.11.011; Bobkiewicz-Kozlowska T, 2007, EUR J PHARMACOL, V565, P240, DOI 10.1016/j.ejphar.2007.02.032; Cryer PE, 2014, DIABETES, V63, P2188, DOI 10.2337/db14-0059; Deacon CF, 2006, INT J BIOCHEM CELL B, V38, P831, DOI 10.1016/j.biocel.2005.09.011; Farghaly AA, 2012, EUR REV MED PHARMACO, V16, P126; Gurrola-Diaz CM, 2008, INSULIN SECRETION EF, P484; Hargrove DM, 1996, METABOLISM, V45, P404, DOI 10.1016/S0026-0495(96)90297-8; Holstein A, 2003, EXP CLIN ENDOCR DIAB, V111, P405, DOI 10.1055/s-2003-44287; Kubo H, 2000, BIOL PHARM BULL, V23, P1114, DOI 10.1248/bpb.23.1114; Kubo H, 2006, BIOL PHARM BULL, V29, P2046, DOI 10.1248/bpb.29.2046; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Lopez PMG, 2004, EUR J PHARMACOL, V504, P139, DOI 10.1016/j.ejphar.2004.09.008; Matsui Y, 2010, BIOL PHARM BULL, V33, P963, DOI 10.1248/bpb.33.963; Matsuyama-Yokono A, 2009, METABOLISM, V58, P379, DOI 10.1016/j.metabol.2008.10.012; Mehranjani M. S., 2007, Indian Journal of Pharmaceutical Sciences, V69, P768; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Schopman JE, 2014, DIABETES-METAB RES, V30, P11, DOI 10.1002/dmrr.2470; Tahara A, 2011, EUR J PHARMACOL, V655, P108, DOI 10.1016/j.ejphar.2011.01.015; Waget A, 2011, ENDOCRINOLOGY, V152, P3018, DOI 10.1210/en.2011-0286; Wilding JPH, 2014, METABOLISM, V63, P1228, DOI 10.1016/j.metabol.2014.06.018	22	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126847	10.1371/journal.pone.0126847	http://dx.doi.org/10.1371/journal.pone.0126847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973898	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600086
J	Choi, SH; Hong, HK; Cho, YB; Lee, WY; Yoo, HY				Choi, Seung Ho; Hong, Hye Kyung; Cho, Yong Beom; Lee, Woo Yong; Yoo, Hae Yong			Identification of Sestrin3 Involved in the In vitro Resistance of Colorectal Cancer Cells to Irinotecan	PLOS ONE			English	Article							MTOR; RAS; PROTEIN; STRESS; AKT	Irinotecan, an analogue of camptothecin, is frequently used as a single agent or in combination with other anticancer drugs for the treatment of colorectal cancer. However, the drug resistance of tumors is a major obstacle to successful cancer treatment. In this study, we established that cells acquire chronic resistance to irinotecan. We profiled their differential gene expression using microarray. After gene ontology (GO) and KEGG pathway analysis of the microarray data, we specifically investigated whether Sestrin3 could decrease irinotecan resistance. Our results revealed that Sestrin3 enhanced the anticancer effect of irinotecan in vitro in LoVo cells that had acquired resistance to irinotecan. Irinotecan-resistant LoVo cells showed lower reactive oxygen species (ROS) production than their irinotecan-sensitive parental cells. ROS production was increased by Sestrin3 knockdown in irinotecan-resistant LoVo cells. Our results indicate that Sestrin3 might be a good target to develop therapeutics that can help to overcome resistance to irinotecan.	[Choi, Seung Ho; Cho, Yong Beom; Yoo, Hae Yong] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Choi, Seung Ho; Yoo, Hae Yong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst,Res Inst Future Med, Seoul, South Korea; [Hong, Hye Kyung; Cho, Yong Beom; Lee, Woo Yong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Yoo, HY (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea.	hyoo@skku.edu	Cho, Yong Beom/F-4606-2014		Korea Health technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3418]; National Research Foundation of Korea [NRF-2013R1A1A2060410]; Samsung Medical Center grant	Korea Health technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea); Samsung Medical Center grant(Samsung)	This study was supported by grants from the Korea Health technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3418), the National Research Foundation of Korea (NRF-2013R1A1A2060410) and Samsung Medical Center grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2011, ANTIOXID REDOX SIGN, V15, P1679, DOI 10.1089/ars.2010.3530; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Mayer RJ, 2009, NEW ENGL J MED, V360, P623, DOI 10.1056/NEJMe0809343; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pouyet L, 2010, TRANSGENIC RES, V19, P155, DOI 10.1007/s11248-009-9308-6; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Xu Y, 2002, ANN ONCOL, V13, P1841, DOI 10.1093/annonc/mdf337	23	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126830	10.1371/journal.pone.0126830	http://dx.doi.org/10.1371/journal.pone.0126830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973791	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600084
J	Critchley, HD; Nicotra, A; Chiesa, PA; Nagai, Y; Gray, MA; Minati, L; Bernardi, L				Critchley, Hugo D.; Nicotra, Alessia; Chiesa, Patrizia A.; Nagai, Yoko; Gray, Marcus A.; Minati, Ludovico; Bernardi, Luciano			Slow Breathing and Hypoxic Challenge: Cardiorespiratory Consequences and Their Central Neural Substrates	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CHEMOREFLEX RESPONSE; BRAIN; FMRI; REGIONS; HUMANS; BOLD; BREATHLESSNESS; ORGANIZATION; INSPIRATION	Controlled slow breathing (at 6/min, a rate frequently adopted during yoga practice) can benefit cardiovascular function, including responses to hypoxia. We tested the neural substrates of cardiorespiratory control in humans during volitional controlled breathing and hypoxic challenge using functional magnetic resonance imaging (fMRI). Twenty healthy volunteers were scanned during paced (slow and normal rate) breathing and during spontaneous breathing of normoxic and hypoxic (13% inspired O-2) air. Cardiovascular and respiratory measures were acquired concurrently, including beat-to-beat blood pressure from a subset of participants (N = 7). Slow breathing was associated with increased tidal ventilatory volume. Induced hypoxia raised heart rate and suppressed heart rate variability. Within the brain, slow breathing activated dorsal pons, periaqueductal grey matter, cerebellum, hypothalamus, thalamus and lateral and anterior insular cortices. Blocks of hypoxia activated mid pons, bilateral amygdalae, anterior insular and occipitotemporal cortices. Interaction between slow breathing and hypoxia was expressed in ventral striatal and frontal polar activity. Across conditions, within brainstem, dorsal medullary and pontine activity correlated with tidal volume and inversely with heart rate. Activity in rostroventral medulla correlated with beat-to-beat blood pressure and heart rate variability. Widespread insula and striatal activity tracked decreases in heart rate, while subregions of insular cortex correlated with momentary increases in tidal volume. Our findings define slow breathing effects on central and cardiovascular responses to hypoxic challenge. They highlight the recruitment of discrete brainstem nuclei to cardiorespiratory control, and the engagement of corticostriatal circuitry in support of physiological responses that accompany breathing regulation during hypoxic challenge.	[Critchley, Hugo D.; Nagai, Yoko] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Critchley, Hugo D.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Nicotra, Alessia] Imperial Coll Healthcare NHS Trust, London, England; [Chiesa, Patrizia A.] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Chiesa, Patrizia A.] Univ Queensland, Ghermann Lab, Brisbane, Qld 4072, Australia; [Gray, Marcus A.] Fdn Santa Lucia, IRCCS, Rome, Italy; [Minati, Ludovico] Fdn Neurol Carlo Besta, IRCCS, Milan, Italy; [Bernardi, Luciano] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy; [Bernardi, Luciano] Fdn IRCCS Policlin San Matteo, Pavia, Italy	University of Brighton; University of Sussex; University of Sussex; Imperial College London; Sapienza University Rome; University of Queensland; IRCCS Santa Lucia; IRCCS Istituto Neurologico Besta; University of Pavia; IRCCS Fondazione San Matteo	Critchley, HD (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England.	h.critchley@bsms.ac.uk	Minati, Ludovico/R-1076-2017; critchley, hugo d/G-9267-2011; Gray, Marcus/F-6521-2013	Minati, Ludovico/0000-0002-2532-1674; critchley, hugo d/0000-0002-2445-9284; CHIESA, PATRIZIA ANDREA/0000-0002-1606-9008; Gray, Marcus/0000-0001-8671-6939	Dr Mortimer and Theresa Sackler Foundation though the Sackler Centre for Consciousness Science; European Research Council [AdG324150]; Wellcome Trust; University of Sussex	Dr Mortimer and Theresa Sackler Foundation though the Sackler Centre for Consciousness Science; European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); University of Sussex	HDC is supported by the Dr Mortimer and Theresa Sackler Foundation though the Sackler Centre for Consciousness Science, University of Sussex, and by a European Research Council Advanced Grant AdG324150. YN is supported by a fellowship from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banzett RB, 2000, NEUROREPORT, V11, P2117, DOI 10.1097/00001756-200007140-00012; Beissner F, 2014, NEUROIMAGE, V86, P91, DOI 10.1016/j.neuroimage.2013.07.081; Benarroch EE, 2008, NEUROLOGY, V71, P1733, DOI 10.1212/01.wnl.0000335246.93495.92; Bernardi L, 2006, EUR RESPIR J, V27, P165, DOI 10.1183/09031936.06.00015805; Bernardi L, 2002, CIRCULATION, V105, P143, DOI 10.1161/hc0202.103311; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Bernardi L, 2001, BRIT MED J, V323, P1446, DOI 10.1136/bmj.323.7327.1446; Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Brooks JCW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00623; Costa KM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00302; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duong TQ, 2007, BRAIN RES, V1135, P186, DOI 10.1016/j.brainres.2006.11.097; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; Evans KC, 1999, J PHYSIOL-LONDON, V520, P383, DOI 10.1111/j.1469-7793.1999.00383.x; Feinstein JS, 2013, NAT NEUROSCI, V16, P270, DOI 10.1038/nn.3323; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fink GR, 1996, J APPL PHYSIOL, V81, P1295, DOI 10.1152/jappl.1996.81.3.1295; Gianaros PJ, 2012, HUM BRAIN MAPP, V33, P1700, DOI 10.1002/hbm.21315; Golanov EV, 2001, J NEUROSCI, V21, P4032, DOI 10.1523/JNEUROSCI.21-11-04032.2001; GOZAL D, 1995, P NATL ACAD SCI USA, V92, P6607, DOI 10.1073/pnas.92.14.6607; Harrison NA, 2010, J NEUROSCI, V30, P12878, DOI 10.1523/JNEUROSCI.1725-10.2010; Harrison NA, 2009, SOC NEUROSCI-UK, V4, P233, DOI 10.1080/17470910802553508; Joseph CN, 2005, HYPERTENSION, V46, P714, DOI 10.1161/01.HYP.0000179581.68566.7d; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Macefield VG, 2010, HUM BRAIN MAPP, V31, P539, DOI 10.1002/hbm.20885; McKay LC, 2003, J APPL PHYSIOL, V95, P1170, DOI 10.1152/japplphysiol.00641.2002; Mckay LC, 2008, NEUROIMAGE, V40, P1824, DOI 10.1016/j.neuroimage.2008.01.058; Mckay LC, 2010, NEUROIMAGE, V49, P2526, DOI 10.1016/j.neuroimage.2009.11.007; Morel A, 2013, NEUROSCIENCE, V236, P117, DOI 10.1016/j.neuroscience.2012.12.076; Mourya M, 2009, J ALTERN COMPLEM MED, V15, P711, DOI 10.1089/acm.2008.0609; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Pattinson KTS, 2009, NEUROIMAGE, V44, P295, DOI 10.1016/j.neuroimage.2008.09.007; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85, DOI 10.1113/jphysiol.1993.sp019503; Reniers RLEP, 2014, SOC NEUROSCI-UK, V9, P50, DOI 10.1080/17470919.2013.861360; ROSTRUP E, 1995, NMR BIOMED, V8, P41, DOI 10.1002/nbm.1940080109; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Spicuzza L, 2000, LANCET, V356, P1495, DOI 10.1016/S0140-6736(00)02881-6; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025	44	51	52	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0127082	10.1371/journal.pone.0127082	http://dx.doi.org/10.1371/journal.pone.0127082			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973923	Green Published, Green Accepted, gold			2022-12-27	WOS:000354545600099
J	Dalaba, MA; Akweongo, P; Aborigo, RA; Saronga, HP; Williams, J; Blank, A; Kaltschmidt, J; Sauerborn, R; Loukanova, S				Dalaba, Maxwell Ayindenaba; Akweongo, Patricia; Aborigo, Raymond Akawire; Saronga, Happiness Pius; Williams, John; Blank, Antje; Kaltschmidt, Jens; Sauerborn, Rainer; Loukanova, Svetla			Cost-Effectiveness of Clinical Decision Support System in Improving Maternal Health Care in Ghana	PLOS ONE			English	Article							PHYSICIAN ORDER ENTRY; CONSEQUENCES; MORBIDITY	Objective This paper investigated the cost-effectiveness of a computer-assisted Clinical Decision Support System (CDSS) in the identification of maternal complications in Ghana. Methods A cost-effectiveness analysis was performed in a before- and after-intervention study. Analysis was conducted from the provider's perspective. The intervention area was the Kassena- Nankana district where computer-assisted CDSS was used by midwives in maternal care in six selected health centres. Six selected health centers in the Builsa district served as the non-intervention group, where the normal Ghana Health Service activities were being carried out. Results Computer-assisted CDSS increased the detection of pregnancy complications during antenatal care (ANC) in the intervention health centres (before-intervention= 9 /1,000 ANC attendance; after-intervention= 12/1,000 ANC attendance; P-value= 0.010). In the intervention health centres, there was a decrease in the number of complications during labour by 1.1%, though the difference was not statistically significant (before-intervention = 107/1,000 labour clients; after-intervention= 96/1,000 labour clients; P-value= 0.305). Also, at the intervention health centres, the average cost per pregnancy complication detected during ANC (cost -effectiveness ratio) decreased from US$ 17,017.58 (before-intervention) to US$ 15,207.5 (after-intervention). Incremental cost -effectiveness ratio (ICER) was estimated at US$ 1,142. Considering only additional costs (cost of computer-assisted CDSS), cost per pregnancy complication detected was US$ 285. Conclusions Computer -assisted CDSS has the potential to identify complications during pregnancy and marginal reduction in labour complications. Implementing computer-assisted CDSS is more costly but more effective in the detection of pregnancy complications compared to routine maternal care, hence making the decision to implement CDSS very complex. Policy makers should however be guided by whether the additional benefit is worth the additional cost.	[Dalaba, Maxwell Ayindenaba; Saronga, Happiness Pius; Sauerborn, Rainer; Loukanova, Svetla] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Dalaba, Maxwell Ayindenaba; Aborigo, Raymond Akawire; Williams, John] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Akweongo, Patricia] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Saronga, Happiness Pius] Muhimbili Univ Hlth & Allied Sci, Dept Behav Sci, Sch Publ Hlth & Social Sci, Dar Es Salaam, Tanzania; [Blank, Antje; Kaltschmidt, Jens] Univ Heidelberg Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Navrongo Health Research Center; University of Ghana; Muhimbili University of Health & Allied Sciences; Ruprecht Karls University Heidelberg	Dalaba, MA (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.	madalaba@yahoo.com	Saronga, Happiness/AGP-6824-2022	Saronga, Happiness/0000-0002-1946-4855; Blank, Antje/0000-0001-8743-5194; Dalaba, Maxwell/0000-0002-7101-769X; AKWEONGO, PATRICIA/0000-0001-6728-3365	European Union [22982]	European Union(European Commission)	The project was funded as part of the 7th Framework Programme of the European Union (grant agreement 22982). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FWJ, 2007, MATERN CHILD HLTH J, V11, P395, DOI 10.1007/s10995-006-0173-0; Assarag B, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-225; Awoonor-Williams JK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S3; Baker U, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-31; Bang HJ, 2012, J STAT THEORY PRACT, V6, P428, DOI 10.1080/15598608.2012.695571; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; Bodri M, 2006, ANTIVIR THER, V11, P63; Builsa-DHMT, 2011, BUILS DHMT 2010 ANN; Candidate S, 2014, ARCH IRAN MED, V17, P198, DOI 0141703/AIM.0011; Dalaba MA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0659-1; Dalaba MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106416; Dalaba MA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-287; Dinye, 2013, J SCI TECHNOL GHANA, V33, P59, DOI [DOI 10.4314/JUST.V33I2.6, http://doi.org/10.4314/just.v33i2.6]; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Edejer T, 2003, MAKING CHOICES HLTH; Field TS, 2008, J AM MED INFORM ASSN, V15, P466, DOI 10.1197/jamia.M2589; Galanter WL, 2005, J AM MED INFORM ASSN, V12, P269, DOI 10.1197/jamia.M1727; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Ghana Health Service, 2008, NAT SAF MOTH SERV PR; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Jabir M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-11; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kirigia Joses M, 2006, Afr J Health Sci, V13, P86; KNE-DHMT, 2011, KNE DHMT 2010 ANN RE; Koblinsky M, 2012, J HEALTH POPUL NUTR, V30, P124, DOI 10.3329/jhpn.v30i2.11294; Maine D, 2005, INT J GYNECOL OBSTET, V89, P218, DOI 10.1016/j.ijgo.2005.01.039; Mills S, 2008, MATERN CHILD HLTH J, V12, P577, DOI 10.1007/s10995-007-0289-x; NDPC, 2012, ACH MDGS EQ GHAN; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Ofori-Adjei David, 2007, Ghana Med J, V41, P94; Osheroff JA, 2007, J AM MED INFORM ASSN, V14, P141, DOI 10.1197/jamia.M2334; Pearson L, 2006, CHILDBIRTH CARE; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Services TG to CP, COMM GUID SUMM A CAR; Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828; Tuncalp O, 2013, INT J GYNECOL OBSTET, V123, P58, DOI 10.1016/j.ijgo.2013.06.003; van Hoek AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047511; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	40	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125920	10.1371/journal.pone.0125920	http://dx.doi.org/10.1371/journal.pone.0125920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25974093	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600031
J	Kim, DH; Choi, E; Lee, JS; Lee, NR; Baek, SY; Gu, A; Kim, DH; Kim, IS				Kim, Do Hyung; Choi, Eugene; Lee, Ji-Sook; Lee, Na Rae; Baek, Seung Yeop; Gu, Ayoung; Kim, Da Hye; Kim, In Sik			House Dust Mite Allergen Regulates Constitutive Apoptosis of Normal and Asthmatic Neutrophils via Toll-Like Receptor 4	PLOS ONE			English	Article							PATHOGENESIS; S100A8/A9; PATHWAYS	House dust mites (HDMs) induce allergic diseases such as asthma. Neutrophil apoptosis is an important process of innate immunity, and its dysregulation is associated with asthma. In this study, we examined the effects of HDM on constitutive apoptosis of normal and asthmatic neutrophils. Extract of Dermatophagoides pteronissinus (DP) inhibited neutrophil apoptosis, but Dermatophagoides farinae extract had no effect. Anti-apoptotic signaling mediated by DP involves in TLR4, Lyn, PI3K, Akt, ERK, and NF-kappa B in normal neutrophils. DP delayed cleavage of procaspase 9 and procaspase 3 and the decrease in Mcl-1 expression. Supernatant collected from DP-treated normal neutrophils inhibited the constitutive apoptosis of normal neutrophils, and S100A8 and S100A9 were identified as anti-apoptotic proteins in the supernatant. S100A8 and S100A9 transduced the anti-apoptotic signal via TLR4, Lyn, PI3K, Akt, ERK, and NF-kappa B. DP also suppressed asthmatic neutrophil apoptosis and induced secretion of S100A8 and S100A9, which delayed the constitutive apoptosis. The anti-apoptotic effects of DP, S100A8 and S100A9 in asthmatic neutrophils are associated with TLR4, Lyn, PI3K, Akt, ERK, and NF-kappa B. The concentrations of S100A8 and S100A9 were significantly elevated in asthmatic bronchoalveolar lavage fluid (BALF) when compared to normal BALF (p<0.01), but not in serum. S100A8 concentration in BALF was positively correlated with the number of BALF neutrophils and negatively correlated with FEV1(%). These findings improve our understanding of the role of HDM in regulation of neutrophil apoptosis in normal individuals and asthmatics and will enable elucidation of asthma pathogenesis.	[Kim, Do Hyung; Lee, Na Rae; Kim, In Sik] Eulji Univ, Sch Med, Dept Biomed Lab Sci, Taejon 301768, South Korea; [Choi, Eugene] Konyang Univ, Dept Resp Internal Med, Coll Med, Taejon 302718, South Korea; [Lee, Ji-Sook] Wonkwang Hlth Sci Univ, Dept Clin Lab Sci, Iksan 570750, South Korea; [Baek, Seung Yeop; Gu, Ayoung; Kim, Da Hye; Kim, In Sik] Eulji Univ, Grad Sch, Plus Program BK21, Dept Senior Healthcare, Taejon 301746, South Korea	Eulji University; Konyang University; Konyang University Hospital; Eulji University	Kim, IS (corresponding author), Eulji Univ, Sch Med, Dept Biomed Lab Sci, Taejon 301768, South Korea.	orientree@eulji.ac.kr			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education.	Atallah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029333; Berry M, 2007, THORAX, V62, P1043, DOI 10.1136/thx.2006.073429; Cui YB, 2013, MOL BIOL REP, V40, P681, DOI 10.1007/s11033-012-2108-8; Gaffin JM, 2009, CURR OPIN ALLERGY CL, V9, P128, DOI 10.1097/ACI.0b013e32832678b0; Gopal R, 2013, AM J RESP CRIT CARE, V188, P1137, DOI 10.1164/rccm.201304-0803OC; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Halayko AJ, 2009, CAN J PHYSIOL PHARM, V87, P743, DOI 10.1139/Y09-054; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Kato T, 2009, ALLERGY, V64, P1366, DOI 10.1111/j.1398-9995.2009.02023.x; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kim EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105814; Kuipers MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068694; Liu CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075983; Louis R, 2006, CLIN EXP ALLERGY, V36, P563, DOI 10.1111/j.1365-2222.2006.02493.x; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Scheel-Toellner D, 2004, BIOCHEM SOC T, V32, P461, DOI 10.1042/BST0320461; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Stremnitzer C, 2014, ALLERGY, V69, P741, DOI 10.1111/all.12399; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tsai JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023249; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Yang EJ, 2012, J CELL PHYSIOL, V227, P2567, DOI 10.1002/jcp.22995; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009	32	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125983	10.1371/journal.pone.0125983	http://dx.doi.org/10.1371/journal.pone.0125983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI2AC	25973752	Green Submitted, Green Published, gold			2022-12-27	WOS:000354545600035
J	Kudesia, RS; Baer, M; Elfenbein, HA				Kudesia, Ravi S.; Baer, Markus; Elfenbein, Hillary Anger			A Wandering Mind Does Not Stray Far from Home: The Value of Metacognition in Distant Search	PLOS ONE			English	Article							MINDFULNESS; GENERATION; ACTIVATION	When faced with a problem, how do individuals search for potential solutions? In this article, we explore the cognitive processes that lead to local search (i.e., identifying options closest to existing solutions) and distant search (i.e., identifying options of a qualitatively different nature than existing solutions). We suggest that mind wandering is likely to lead to local search because it operates by spreading activation from initial ideas to closely associated ideas. This reduces the likelihood of accessing a qualitatively different solution. However, instead of getting lost in thought, individuals can also step back and monitor their thoughts from a detached perspective. Such mindful metacognition, we suggest, is likely to lead to distant search because it redistributes activation away from initial ideas to other, less strongly associated, ideas. This hypothesis was confirmed across two studies. Thus, getting lost in thoughts is helpful when one is on the right track and needs only a local search whereas stepping back from thoughts is helpful when one needs distant search to produce a change in perspective.	[Kudesia, Ravi S.; Baer, Markus; Elfenbein, Hillary Anger] Washington Univ, Dept Org Behav, Olin Business Sch, St Louis, MO 63130 USA	Washington University (WUSTL)	Kudesia, RS (corresponding author), Washington Univ, Dept Org Behav, Olin Business Sch, St Louis, MO 63130 USA.	rskudesia@wustl.edu	Kudesia, Ravi S./AAD-3568-2019	Kudesia, Ravi S./0000-0003-0561-8857	Olin Business School	Olin Business School	The authors would like to thank the Olin Business School for its generous financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird B, 2012, PSYCHOL SCI, V23, P1117, DOI 10.1177/0956797612446024; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Cropley M, 2007, ADDICTION, V102, P989, DOI 10.1111/j.1360-0443.2007.01832.x; Cyert R. M., 1963, BEHAV THEORY FIRM; Dodds R. A., 2003, CREATIVITY RES HDB, V3; Gavetti G, 2000, ADMIN SCI QUART, V45, P113, DOI 10.2307/2666981; GUILFORD JP, 1956, PSYCHOL BULL, V53, P267, DOI 10.1037/h0040755; Hayes SC, 2011, ANNU REV CLIN PSYCHO, V7, P141, DOI 10.1146/annurev-clinpsy-032210-104449; Kudesia R.S., 2015, MINDFULNESS ORG FDN, P190, DOI DOI 10.1017/CBO9781107587793.010; Kudesia RS, 2015, MINDFULNESS, V6, P910, DOI 10.1007/s12671-014-0337-8; March JG., 1958, ORGANIZATIONS; Markman KD, 2007, PERS SOC PSYCHOL B, V33, P312, DOI 10.1177/0146167206296106; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Nijstad B. A., 2003, GROUP CREATIVITY INN, P137, DOI DOI 10.1093/ACPROF:OSO/9780195147308.003.0007; Ohlsson S., 2011, DEEP LEARNING MIND O; Ohlsson S., 1992, ADV PSYCHOL THINKING, V1, DOI DOI 10.1017/CB09780511780295; Ostafin BD, 2012, CONSCIOUS COGN, V21, P1031, DOI 10.1016/j.concog.2012.02.014; PERFETTO GA, 1987, B PSYCHONOMIC SOC, V25, P151; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Sio UN, 2009, PSYCHOL BULL, V135, P94, DOI 10.1037/a0014212; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; TEASDALE JD, 1995, BEHAV RES THER, V33, P25, DOI 10.1016/0005-7967(94)E0011-7; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tripsas M, 2000, STRATEGIC MANAGE J, V21, P1147, DOI 10.1002/1097-0266(200010/11)21:10/11<1147::AID-SMJ128>3.0.CO;2-R; Wells A, 2011, METACOGNITIVE THERAP; YANIV I, 1987, J EXP PSYCHOL LEARN, V13, P187, DOI 10.1037/0278-7393.13.2.187	30	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0126865	10.1371/journal.pone.0126865	http://dx.doi.org/10.1371/journal.pone.0126865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25974164	Green Published, Green Submitted, gold			2022-12-27	WOS:000354545600089
J	Wang, F; Li, S; Bai, XW; Ren, XP; Rao, LL; Li, JZ; Liu, H; Liu, HZ; Wu, B; Zheng, R				Wang, Fei; Li, Shu; Bai, Xin-Wen; Ren, Xiao-Peng; Rao, Li-Lin; Li, Jin-Zhen; Liu, Huan; Liu, Hong-Zhi; Wu, Bin; Zheng, Rui			Town Mouse or Country Mouse: Identifying a Town Dislocation Effect in Chinese Urbanization	PLOS ONE			English	Article							SCIENTIFIC STATUS; PLACE ATTACHMENT; PROSPECT-THEORY; PERCEPTION; POLICY; CITY; REGRESSION; MEDIATION; QUALITY; FOODS	Understanding urbanization and evaluating its impact are vital for formulating global sustainable development. The results obtained from evaluating the impact of urbanization, however, depend on the kind of measurement used. With the goal of increasing our understanding of the impact of urbanization, we developed direct and indirect subjective indicators to measure how people assess their living situation. The survey revealed that the projected endorsements and perceived social ambiance of people toward living in different types of settlements did not improve along with the urbanization level in China. The assessment scores from the city dwellers were not significantly different from those from the country areas and, more surprisingly, both were significantly higher than the assessment scores of the town dwellers, which we had expected to fall between the assessment scores of the country and city dwellers. Instead their scores were the lowest. We dubbed this V-shaped relationship the "town dislocation effect." When searching for a potential explanation for this effect, we found additional town dislocation effects in social support, loss aversion, and receptivity toward genetically modified food. Further analysis showed that only social support mediated the relationship between the three tiers of settlements (cities, country areas, and towns) and the subjective indicator. The projected endorsements yielded significant subjective assessments that could enhance our understanding of Chinese urbanization. Towns posed specific problems that require special attention.	[Wang, Fei; Li, Shu; Bai, Xin-Wen; Ren, Xiao-Peng; Rao, Li-Lin; Li, Jin-Zhen; Liu, Huan; Liu, Hong-Zhi; Wu, Bin; Zheng, Rui] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Wang, Fei] Xiamen Univ, Sch Journalism & Commun, Xiamen, Peoples R China; [Li, Shu] Jinan Univ, Sch Management, Guangzhou, Guangdong, Peoples R China; [Liu, Huan] Nanchang Univ, Ctr Mental Hlth, Nanchang, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Xiamen University; Jinan University; Nanchang University	Zheng, R (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zhengrui@psych.ac.cn	Xinwen, Bai/A-3827-2014	Xinwen, Bai/0000-0002-4750-4164; Wu, Bin/0000-0002-4904-5686; li, shu/0000-0003-4402-1674; Wang, Fei/0000-0002-1987-060X	Science and Technology (ST) [2009FY110100]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-YW-R-130]; National Natural Science Foundation of China [70871110]; Special Fund for Beijing Key Discipline Construction; Project for Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences [O8CX025002, O9CX104010]	Science and Technology (ST); Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Beijing Key Discipline Construction; Project for Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences	This study was partially supported by the Science and Technology (S&T) basic work (2009FY110100), the Knowledge Innovation Project of the Chinese Academy of Sciences (No. KSCX2-YW-R-130), the National Natural Science Foundation of China (No. 70871110), the Special Fund for Beijing Key Discipline Construction, and the Project for Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences (O8CX025002, O9CX104010). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; ANDERSON JC, 1978, J MARKETING RES, V15, P644, DOI 10.2307/3150638; Bloom DE, 2008, SCIENCE, V319, P772, DOI 10.1126/science.1153057; BLUMENTHAL JA, 1987, PSYCHOSOM MED, V49, P331, DOI 10.1097/00006842-198707000-00002; Bogac C, 2009, J ENVIRON PSYCHOL, V29, P267, DOI 10.1016/j.jenvp.2009.01.001; Bohnet I, 2008, LANDSCAPE URBAN PLAN, V88, P1, DOI 10.1016/j.landurbplan.2008.07.002; Bonaiuto M, 1999, J ENVIRON PSYCHOL, V19, P331, DOI 10.1006/jevp.1999.0138; Cai Y., 2005, THEOR OBS, V34, P73; Cattell RB, 1944, CHARACT PERSON, V12, P177; Chang JH-Y, 2005, PAPER PRESENTED AT T; Chang JH-Y, 2002, PAPER PRESENTED AT T; Chen AM, 2006, MOD CHINA, V32, P99, DOI 10.1177/0097700405283503; Civerolo K, 2007, ATMOS ENVIRON, V41, P1803, DOI 10.1016/j.atmosenv.2006.10.076; Donoghue S., 2000, J CONSUM SCI, V28, P47, DOI 10.4314/jfecs.v28i1.52784; Dye C, 2008, SCIENCE, V319, P766, DOI 10.1126/science.1150198; Fang X., 2003, J CHANGSHA SOC WORK, V3, P1, DOI [10.3969/j.issn.1671-5136.2003.03.001, DOI 10.3969/J.ISSN.1671-5136.2003.03.001]; Gaskell G, 2004, RISK ANAL, V24, P185, DOI 10.1111/j.0272-4332.2004.00421.x; Gaskell G, 1999, SCIENCE, V285, P384, DOI 10.1126/science.285.5426.384; Gillies RR, 2003, REMOTE SENS ENVIRON, V86, P411, DOI 10.1016/S0034-4257(03)00082-8; Goldberg DP, 1978, MANUAL OF THE GENERA; Habitat U., 2013, STATE OF THE WORLDS; Hagerty MR, 2001, SOC INDIC RES, V55, P1, DOI 10.1023/A:1010811312332; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; Helmstadter GC, 1964, PRINCIPLES OF PSYCHO; Hibbard S, 2003, J PERS ASSESS, V80, P260, DOI 10.1207/S15327752JPA8003_05; JONES PD, 1990, NATURE, V347, P169, DOI 10.1038/347169a0; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; KARACA M, 1995, ATMOS ENVIRON, V29, P3411, DOI 10.1016/1352-2310(95)00085-D; Kline P., 1983, PERSONALITY MEASUREM; Knight J, 2010, J DEV STUD, V46, P506, DOI 10.1080/00220380903012763; Knight J, 2010, WORLD DEV, V38, P113, DOI 10.1016/j.worlddev.2009.03.002; Kobberling V, 2005, J ECON THEORY, V122, P119, DOI 10.1016/j.jet.2004.03.009; Kozlov MV, 1997, ACTA OECOL, V18, P13, DOI 10.1016/S1146-609X(97)80076-8; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Li Qiang, 2012, SOCIAL SCI CHINA, V7, P82; Lilienfeld SO, 2000, PSYCHOL SCI, P27, DOI 10.1111/1529-1006.002; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Mesch GS, 1998, ENVIRON BEHAV, V30, P504, DOI 10.1177/001391659803000405; Moser G, 2002, ENVIRON BEHAV, V34, P122, DOI 10.1177/0013916502034001009; NBS-DPES, 2008, CHINA POPULATION AND; Nijs KAND, 2006, BRIT MED J, V332, P1180, DOI 10.1136/bmj.38825.401181.7C; Nunnally J, 1978, PSYCHOMETRIC METHODS; Onodera S, 2008, SCI TOTAL ENVIRON, V404, P401, DOI 10.1016/j.scitotenv.2008.08.003; Ott R. Lyman, 1993, AN INTRODUCTION TO S; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Peterson C., 2006, PRIMER POSITIVE PSYC, DOI DOI 10.1016/j.compedu.2004.08.013; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Qiu J, 2008, NATURE, V455, P850, DOI 10.1038/455850a; Rollero C, 2010, J ENVIRON PSYCHOL, V30, P198, DOI 10.1016/j.jenvp.2009.12.003; Rose S, 2007, J HYDROL, V341, P42, DOI 10.1016/j.jhydrol.2007.04.019; Scannell L, 2010, J ENVIRON PSYCHOL, V30, P1, DOI 10.1016/j.jenvp.2009.09.006; Scopelliti M, 2010, ENVIRON BEHAV; Seasons A, 2007, MORALITY IS NOT THE; SHIN DC, 1980, SOC INDIC RES, V8, P199, DOI 10.1007/BF00286477; Simonis UE, 1981, NEW ASIA COLLEGE ACA, V18, P221; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026856; Starr CG, 1971, THE ANCIENT ROMANS; State Statistical Bureau, 2008, STATISTICAL YEARBOOK; Stone R, 2008, SCIENCE, V321, P1279, DOI 10.1126/science.321.5894.1279; Survey research center, 1964 ELECTION STUDY, P196; Tonkaz T, 2007, J ARID ENVIRON, V68, P143, DOI 10.1016/j.jaridenv.2006.03.020; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; UN Habitat, 2008, STATE OF THE WORLDS; UNDP, 1990, HUMAN DEVELOPMENT RE; Veenhoven R, 2002, SOC INDIC RES, V58, P33, DOI 10.1023/A:1015723614574; Veenhoven R, 2007, SOCIOLOGISTS IN A GL; Vieider FM, 2009, ACTA PSYCHOL, V132, P96, DOI 10.1016/j.actpsy.2009.05.006; Wakker PP, 2002, EUR ECON REV, V46, P1253, DOI 10.1016/S0014-2921(01)00141-6; Wang CX, 2005, CHIN J POPUL RESOUR, V3, P55, DOI 10.1080/10042857.2005.10677416; Webster D, 2004, EAST ASIA INFRASTRUC, V8; Wissing M. P., 2013, WELL BEING RES S AFR, P415; Zhu Y., 2005, J ANHUI AGR U SOC SC, V14, P84, DOI [10.3969/j.issn.1009-2463.2005.05.023, DOI 10.3969/J.ISSN.1009-2463.2005.05.023]	75	4	7	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2015	10	5							e0125821	10.1371/journal.pone.0125821	http://dx.doi.org/10.1371/journal.pone.0125821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI2AC	25973960	Green Published, gold, Green Submitted			2022-12-27	WOS:000354545600028
J	Kuo, YH; Chen, PF; Wang, JH; Chang, KC; Kee, KM; Tsai, MC; Lin, CY; Lin, SC; Tsai, LS; Chen, SC; Lu, SN				Kuo, Yuan-Hung; Chen, Pao-Fei; Wang, Jing-Houng; Chang, Kuo-Chin; Kee, Kwong-Ming; Tsai, Ming-Chao; Lin, Chun-Yin; Lin, Sheng-Che; Tsai, Lin-San; Chen, Shu-Chuan; Lu, Sheng-Nan			Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; DIABETES-MELLITUS; ASIAN PATIENTS; ENDEMIC AREA; VIRUS; RIBAVIRIN; HBV; SEROPOSITIVITY; INTERFERON	To elucidate the results of post-screening care stratagems for anti-hepatitis C virus (HCV)-positive subjects in the community. Part I methods: The intervention program: A total of 151,790 subjects underwent a large-scale healthcare screening. Subjects aged less than 65 years, with anti-HCV-positive and alanine aminotransferase (ALT) level more than 80 IU/L were followed-up to answer a structured questionnaire. Those responders who met the reimbursement criteria of Taiwan's National Health Insurance for anti-HCV treatment were referred for treatment. Part II: The accessible medical care program: In Yujing township, 271 HCV residents who have been screened before were invited to a bi-weekly hepatitis clinic in Yujing health center. Part-I results: A total of 907 anti-HCV-positive subjects responded and 197(21.7%) were advised the treatment, but only 83(9.2%) did. Finally, 47 patients achieved a sustained virological response (SVR). After this intervention program, 96(10.6%) additional patients were encouraged to be referred, 33(3.6%) received treatment and 20 obtained a SVR. Part II: A total of 140(51.7%) subjects responded and 112 were anti-HCV-positive including 31(27.7%) HCV RNA-negative, 49(43.8%) HCV RNA-positive plus ALT less than 40 IU/L and 32(28.5%) HCV RNA-positive plus ALT more than 40 IU/L. During the follow-up, 14 of 49 patients had ALT more than 40 IU/L. Among 46 eligible HCV patients, 15 (32.6%) received treatment and 10 achieved a SVR. Simple notification only made 9.2% of the screened HCV patients treat. Active referral could encourage additional 3.6% to be treated. Additionally, accessible medical care program could result in treatment of 32.6% elderly eligible patients.	[Kuo, Yuan-Hung; Wang, Jing-Houng; Chang, Kuo-Chin; Kee, Kwong-Ming; Tsai, Ming-Chao; Lu, Sheng-Nan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Kuo, Yuan-Hung; Wang, Jing-Houng; Chang, Kuo-Chin; Kee, Kwong-Ming; Tsai, Ming-Chao; Lu, Sheng-Nan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Pao-Fei] Hlth Ctr Yanpu Township, Pingtung, Taiwan; [Lin, Chun-Yin] Hlth Ctr Yujing Dist, Tainan, Taiwan; [Lin, Sheng-Che; Tsai, Lin-San; Chen, Shu-Chuan] Tainan City Govt, Dept Hlth, Tainan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lu, SN (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	juten@ms17.hinet.net	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051	Delivery Hope project of Bristol-Myers Squibb Foundation	Delivery Hope project of Bristol-Myers Squibb Foundation	This study was funded by a grant from Delivery Hope project of Bristol-Myers Squibb Foundation to Dr. Sheng-Nan Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, THE REIMBURSEMENT CR; Boettler T, 2014, J HEPATOL, V61, P696, DOI 10.1016/j.jhep.2014.05.016; Chang KC, 2012, J ANTIMICROB CHEMOTH, V67, P2766, DOI 10.1093/jac/dks269; Chen CT, 2013, KAOHSIUNG J MED SCI, V29, P451, DOI 10.1016/j.kjms.2012.12.006; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen JY, 2010, J GASTROEN HEPATOL, V25, P1763, DOI 10.1111/j.1440-1746.2010.06300.x; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hagan LM, 2013, LIVER INT, V33, P68, DOI 10.1111/liv.12063; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Liu JL, 2012, J GASTROEN HEPATOL, V27, P1688, DOI 10.1111/j.1440-1746.2012.07212.x; Liver Disease Prevention and Treatment Research Foundation, 2005, LIVER DISEASE PREVEN, V28, P11; McCaughan GW, 2007, J GASTROEN HEPATOL, V22, P615, DOI 10.1111/j.1440-1746.2007.04883.x; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Nguyen LH, 2013, ALIMENT PHARM THER, V37, P921, DOI 10.1111/apt.12300; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; The reimbursement criteria of anti-HCV treatment, 2009, THE REIMBURSEMENT CR; Tsai MC, 2007, J GASTROEN HEPATOL, V22, P92, DOI 10.1111/j.1440-1746.2006.04489.x; Tung HD, 2010, AM J GASTROENTEROL, V105, P624, DOI 10.1038/ajg.2009.711; Wang JH, 2010, J GASTROEN HEPATOL, V25, P964, DOI 10.1111/j.1440-1746.2009.06194.x; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Zhu Y, 2013, WORLD J GASTROENTERO, V19, P8963, DOI 10.3748/wjg.v19.i47.8963; Zhuang LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061361	26	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126031	10.1371/journal.pone.0126031	http://dx.doi.org/10.1371/journal.pone.0126031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970487	Green Submitted, Green Published, gold			2022-12-27	WOS:000354544200093
J	Mantyla, T; Mantere, O; Raij, TT; Kieseppa, T; Laitinen, H; Leiviska, J; Torniainen, M; Tuominen, L; Vaarala, O; Suvisaari, J				Mantyla, Teemu; Mantere, Outi; Raij, Tuukka T.; Kieseppa, Tuula; Laitinen, Hanna; Leiviska, Jaana; Torniainen, Minna; Tuominen, Lauri; Vaarala, Outi; Suvisaari, Jaana			Altered Activation of Innate Immunity Associates with White Matter Volume and Diffusion in First-Episode Psychosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MACROPHAGE-DERIVED CHEMOKINE; VOXEL-BASED MORPHOMETRY; 1ST EPISODE PSYCHOSIS; BIPOLAR DISORDER; INFLAMMATORY MEDIATORS; CORTICAL THICKNESS; MOOD DISORDERS; SCHIZOPHRENIA; BRAIN	First-episode psychosis (FEP) is associated with inflammatory and brain structural changes, but few studies have investigated whether systemic inflammation associates with brain structural changes in FEP. Thirty-seven FEP patients (median 27 days on antipsychotic medication), and 19 matched controls were recruited. Serum levels of 38 chemokines and cytokines, and cardiovascular risk markers were measured at baseline and 2 months later. We collected T1-and diffusion-weighted MRIs with a 3 T scanner from the patients at baseline. We analyzed the association of psychosis-related inflammatory markers with gray and white matter (WM) volume using voxel-based morphometry and WM diffusion using tract-based spatial statistics with whole-brain and region-of-interest (ROI) analyses. FEP patients had higher CCL22 and lower TGFa, CXCL1, CCL7, IFN-alpha 2 and ApoA-I than controls. CCL22 decreased significantly between baseline and 2 months in patients but was still higher than in controls. The association between inflammatory markers and FEP remained significant after adjusting for age, sex, smoking and BMI. We did not observe a correlation of inflammatory markers with any symptoms or duration of antipsychotic treatment. Baseline CCL22 levels correlated negatively with WM volume and positively with mean diffusivity and radial diffusivity bilaterally in the frontal lobes in ROI analyses. Decreased serum lan association between circulating chemokine levels and WM in FEP patients. Interestingly, CCL22 has been previously implicated in autoimmune diseases associated with WM pathology. The results suggest that an altered activation of innate immunity may contribute to WM damage in psychotic disorders.evel of ApoA-I was associated with smaller volume of the medial temporal WM. In whole-brain analyses, CCL22 correlated positively with mean diffusivity and radial diffusivity, and CXCL1 associated negatively with fractional anisotropy and positively with mean diffusivity and radial diffusivity in several brain regions. This is the first report to demonstrate	[Mantyla, Teemu; Mantere, Outi; Kieseppa, Tuula; Torniainen, Minna; Suvisaari, Jaana] Natl Inst Hlth & Welf, Mental Hlth Unit, Helsinki, Finland; [Mantyla, Teemu; Kieseppa, Tuula] Aalto Univ, Sch Sci, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland; [Mantyla, Teemu; Raij, Tuukka T.] Aalto Univ, Sch Sci, Adv Magnet Imaging Ctr Aalto NeuroImaging, Espoo, Finland; [Mantyla, Teemu] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Mantere, Outi; Raij, Tuukka T.; Kieseppa, Tuula] Univ Helsinki, Dept Psychiat, Cent Hosp, SF-00180 Helsinki, Finland; [Mantere, Outi] Univ Helsinki, Dept Psychiat, Inst Clin Med, SF-00180 Helsinki, Finland; [Laitinen, Hanna] Natl Inst Hlth & Welf, Vaccinat Programme Unit, Helsinki, Finland; [Leiviska, Jaana] Natl Inst Hlth & Welf, Genom & Biomarkers Unit, Helsinki, Finland; [Torniainen, Minna] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Tuominen, Lauri] Univ Turku, Turku PET Ctr, Turku, Finland; [Tuominen, Lauri] Univ Turku, Dept Psychiat, Turku, Finland; [Vaarala, Outi] AstraZeneca R&D, Resp Inflammatory & Autoimmun Innovat Med, Molndal, Sweden; [Vaarala, Outi] Univ Helsinki, Inst Clin Med, Helsinki, Finland	Finland National Institute for Health & Welfare; Aalto University; Aalto University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Karolinska Institutet; University of Turku; University of Turku; AstraZeneca; University of Helsinki	Suvisaari, J (corresponding author), Natl Inst Hlth & Welf, Mental Hlth Unit, Helsinki, Finland.	jaana.suvisaari@thl.fi	Linnaranta, Outi/AAU-1855-2021; Mäntylä, Teemu J.S./C-2358-2019; Mantere, Outi/J-8524-2019	Mantere, Outi/0000-0002-0383-7215; Suvisaari, Jaana/0000-0001-7167-0990; Mantyla, Teemu/0000-0002-1645-2883	Sigrid Juselius Foundation; Finnish Cultural Foundation; Helsinki University Central Hospital; ERC [232946]; University of Helsinki; Academy of Finland [251155, 278171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009784] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki University Central Hospital; ERC(European Research Council (ERC)European Commission); University of Helsinki; Academy of Finland(Academy of Finland); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by Sigrid Juselius Foundation (JS), the Finnish Cultural Foundation (JS and TM), the Helsinki University Central Hospital (OM), ERC Advanced Grant #232946 to Riitta Hari (TTR, TM) University of Helsinki (TR, OM), the Academy of Finland (TTR #251155, JS #278171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. OV is an employee of AstraZeneca R & D Molndal, Sweden from 1 Aug 2014, AstraZenca provided support in the form of salaries for OV, but did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Acharjee S, 2013, BRAIN BEHAV IMMUN, V33, P164, DOI 10.1016/j.bbi.2013.07.003; Aiello G, 2012, PSYCHONEUROENDOCRINO, V37, P1600, DOI 10.1016/j.psyneuen.2012.05.003; Al-Ayadhi LY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-72; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Babor TF., 2001, AUDIT ALCOHOL USE DI; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Beumer W, 2012, PSYCHONEUROENDOCRINO, V37, P1901, DOI 10.1016/j.psyneuen.2012.04.001; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Bora E, 2012, PSYCHOL MED, V42, P295, DOI 10.1017/S0033291711001450; Borovcanin M, 2013, SCHIZOPHR RES, V147, P103, DOI 10.1016/j.schres.2013.03.027; Borovcanin M, 2012, J PSYCHIATR RES, V46, P1421, DOI 10.1016/j.jpsychires.2012.08.016; Brambilla P, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.46; Cannon TD, 2015, BIOL PSYCHIAT, V77, P147, DOI 10.1016/j.biopsych.2014.05.023; Cappellano Giuseppe, 2013, Am J Neurodegener Dis, V2, P89; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Chiang SSW, 2013, PSYCHIAT CLIN NEUROS, V67, P228, DOI 10.1111/pcn.12040; Columba-Cabezas S, 2002, J NEUROIMMUNOL, V130, P10, DOI 10.1016/S0165-5728(02)00170-4; Concha L, 2014, NEUROSCIENCE, V276, P14, DOI 10.1016/j.neuroscience.2013.09.004; de Boer WI, 2007, CELL BIOCHEM BIOPHYS, V47, P131; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Dimitrov DH, 2013, SCHIZOPHR RES, V151, P29, DOI 10.1016/j.schres.2013.10.019; Diniz BS, 2014, MOL PSYCHIA IN PRESS; Dogan RNE, 2011, J LEUKOCYTE BIOL, V89, P93, DOI 10.1189/jlb.0810442; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; Drexhage RC, 2011, INT REV NEUROBIOL, V101, P169, DOI 10.1016/B978-0-12-387718-5.00007-9; Drexhage RC, 2011, INT J NEUROPSYCHOPH, V14, P746, DOI 10.1017/S1461145710001653; Drexhage RC, 2010, EXPERT REV NEUROTHER, V10, P59, DOI [10.1586/ern.09.144, 10.1586/ERN.09.144]; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fillman SG, 2013, MOL PSYCHIATR, V18, P206, DOI 10.1038/mp.2012.110; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Foa EB, 1998, PSYCHOL ASSESSMENT, V10, P206, DOI 10.1037/1040-3590.10.3.206; Foley DL, 2011, ARCH GEN PSYCHIAT, V68, P609, DOI 10.1001/archgenpsychiatry.2011.2; Fulkerson PC, 2004, J IMMUNOL, V173, P7565, DOI 10.4049/jimmunol.173.12.7565; Fusar-Poli P, 2012, SCHIZOPHRENIA BULL, V38, P1297, DOI 10.1093/schbul/sbr134; Galimberti D, 2008, MULT SCLER, V14, P547, DOI 10.1177/1352458507084268; Hayes LN, 2014, SCHIZOPHRENIA BULL, V40, P963, DOI 10.1093/schbul/sbu052; Horvath S, 2014, BIOL PSYCHIAT, V75, P316, DOI 10.1016/j.biopsych.2013.06.010; Huang JTJ, 2008, MOL PSYCHIATR, V13, P1118, DOI 10.1038/sj.mp.4002108; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kan AA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-207; Kerstetter AE, 2009, EXP NEUROL, V220, P44, DOI 10.1016/j.expneurol.2009.07.010; Kvajo M, 2012, NEUROSCIENCE, V211, P136, DOI 10.1016/j.neuroscience.2011.07.051; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Li HYS, 2014, IMMUNOL REV, V261, P84, DOI 10.1111/imr.12198; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mantovani A, 2000, J LEUKOCYTE BIOL, V68, P400; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Miralbell J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.020; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Mondelli V, 2011, J CLIN PSYCHIAT, V72, P1677, DOI 10.4088/JCP.10m06745; Mori S., 2005, MRI ATLAS HUMAN WHIT; Muller N, 2012, PSYCHIAT RES, V198, P341, DOI 10.1016/j.psychres.2011.12.049; Munkholm K, 2013, J PSYCHIATR RES, V47, P1119, DOI 10.1016/j.jpsychires.2013.05.018; Najjar S, 2015, SCHIZOPHR RES, V161, P102, DOI 10.1016/j.schres.2014.04.041; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Natarajan R, 2013, MULTIPLE SCLEROSIS I, V2013, P10; Olabi B, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-104; Ormstad H, 2011, J NEUROL, V258, P677, DOI 10.1007/s00415-011-6006-0; Owens GC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-56; Pasternak O, 2012, J NEUROSCI, V32, P17365, DOI 10.1523/JNEUROSCI.2904-12.2012; Penna G, 2002, HUM IMMUNOL, V63, P1164, DOI 10.1016/S0198-8859(02)00755-3; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Poppensieker K, 2012, P NATL ACAD SCI USA, V109, P3897, DOI 10.1073/pnas.1114153109; Prasad KM, 2015, SCHIZOPHR RES, V161, P119, DOI 10.1016/j.schres.2014.09.043; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rosano C, 2012, AGING DIS, V3, P16; Samartzis L, 2014, J NEUROIMAGING, V24, P101, DOI 10.1111/j.1552-6569.2012.00779.x; Savitz J, 2013, BRAIN BEHAV IMMUN, V31, P161, DOI 10.1016/j.bbi.2012.10.007; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Schwarz E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.3; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soderlund J, 2009, MOL PSYCHIATR, V14, P1069, DOI 10.1038/mp.2009.52; Sommer IE, 2012, J CLIN PSYCHIAT, V73, P414, DOI 10.4088/JCP.10r06823; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Suvisaari Jaana, 2013, Infectious Disorders - Drug Targets, V13, P59; Suvisaari J, 2011, PSYCHIAT RES, V189, P305, DOI 10.1016/j.psychres.2011.07.006; Takano A, 2010, INT J NEUROPSYCHOPH, V13, P943, DOI 10.1017/S1461145710000313; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tarricone I, 2010, PSYCHOL MED, V40, P187, DOI 10.1017/S0033291709990407; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Upthegrove R, 2014, SCHIZOPHR RES, V155, P101, DOI 10.1016/j.schres.2014.03.005; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; van Venrooij JAEM, 2012, SCHIZOPHRENIA BULL, V38, P272, DOI 10.1093/schbul/sbq062; Vancampfort D, 2013, AM J PSYCHIAT, V170, P265, DOI 10.1176/appi.ajp.2012.12050620; VENTURA J, 1993, INT J METH PSYCH RES, V3, P221; Verstynen TD, 2013, NEUROIMAGE, V79, P129, DOI 10.1016/j.neuroimage.2013.04.075; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Ward MA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00029; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Williamson PC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00184; Yao L, 2013, PROG NEURO-PSYCHOPH, V45, P100, DOI 10.1016/j.pnpbp.2013.04.019; Yao YR, 2008, J PSYCHIATR RES, V42, P639, DOI 10.1016/j.jpsychires.2007.07.011; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	111	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125112	10.1371/journal.pone.0125112	http://dx.doi.org/10.1371/journal.pone.0125112			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970596	Green Published, Green Submitted, gold			2022-12-27	WOS:000354544200065
J	Sierra, S; Dybowski, JN; Pironti, A; Heider, D; Guney, L; Thielen, A; Reuter, S; Esser, S; Fatkenheuer, G; Lengauer, T; Hoffmann, D; Pfister, H; Jensen, B; Kaiser, R				Sierra, Saleta; Dybowski, J. Nikolai; Pironti, Alejandro; Heider, Dominik; Gueney, Lisa; Thielen, Alex; Reuter, Stefan; Esser, Stefan; Faetkenheuer, Gerd; Lengauer, Thomas; Hoffmann, Daniel; Pfister, Herbert; Jensen, Bjeorn; Kaiser, Rolf			Parameters Influencing Baseline HIV-1 Genotypic Tropism Testing Related to Clinical Outcome in Patients on Maraviroc	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; CORECEPTOR USAGE; TYPE-1 TROPISM; VIROLOGICAL RESPONSE; SELECTIVE PRESSURE; INFECTION; SENSITIVITY; RESISTANCE; EVOLUTION; TROFILE	Objectives We analysed the impact of different parameters on genotypic tropism testing related to clinical outcome prediction in 108 patients on maraviroc (MVC) treatment. Methods 87 RNA and 60 DNA samples were used. The viral tropism was predicted using the geno2pheno([coreceptor]) and T-CUP tools with FPR cut-offs ranging from 1%-20%. Additionally, 27 RNA and 28 DNA samples were analysed in triplicate, 43 samples with the ESTA assay and 45 with next-generation sequencing. The influence of the genotypic susceptibility score (GSS) and 16 MVC-resistance mutations on clinical outcome was also studied. Results Concordance between single-amplification testing compared to ESTA and to NGS was in the order of 80%. Concordance with NGS was higher at lower FPR cut-offs. Detection of baseline R5 viruses in RNA and DNA samples by all methods significantly correlated with treatment success, even with FPR cut-offs of 3.75%-7.5%. Triple amplification did not improve the prediction value but reduced the number of patients eligible for MVC. No influence of the GSS or MVC-resistance mutations but adherence to treatment, on the clinical outcome was detected. Conclusions Proviral DNA is valid to select candidates for MVC treatment. FPR cut-offs of 5%-7.5% and single amplification from RNA or DNA would assure a safe administration of MVC without excluding many patients who could benefit from this drug. In addition, the new prediction system T-CUP produced reliable results.	[Sierra, Saleta; Gueney, Lisa; Pfister, Herbert; Kaiser, Rolf] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Dybowski, J. Nikolai; Heider, Dominik; Hoffmann, Daniel] Univ Duisburg Essen, Dept Bioinformat, Essen, Germany; [Pironti, Alejandro; Thielen, Alex; Lengauer, Thomas] Max Planck Inst Informat, Computat Biol & Appl Algorithm, D-66123 Saarbrucken, Germany; [Reuter, Stefan; Jensen, Bjeorn] Univ Hosp Dusseldorf, Dept Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Esser, Stefan] Univ Duisburg Essen, Dept Dermatol, Essen, Germany; [Faetkenheuer, Gerd] Univ Cologne, Dept Internal Med 1, Cologne, Germany	University of Cologne; University of Duisburg Essen; Max Planck Society; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Duisburg Essen; University of Cologne	Sierra, S (corresponding author), Univ Cologne, Inst Virol, D-50931 Cologne, Germany.	saleta.sierra-aragon@uk-koeln.de	Jensen, Björn/HIK-2559-2022; Hoffmann, Daniel/P-5624-2019; gailly, frederik/H-4813-2019; Hoffmann, Daniel/B-1314-2018; Heider, Dominik/F-8545-2010	Hoffmann, Daniel/0000-0003-2973-7869; gailly, frederik/0000-0003-0481-9745; Hoffmann, Daniel/0000-0003-2973-7869; Lengauer, Thomas/0000-0003-3801-2640; Heider, Dominik/0000-0002-3108-8311	RESINA Project [BMG IIA5-2010-2510AUK361]; CHAIN Project [EU-223131]; EURESIST project [IST-4-027173]; MedSys HIV cell entry project [BMBF-0315489C]; CORUS Project [BMBF 01ES0712]	RESINA Project; CHAIN Project; EURESIST project; MedSys HIV cell entry project; CORUS Project	This work was supported by the RESINA Project (BMG IIA5-2010-2510AUK361), CHAIN Project (EU-223131), EURESIST project (IST-4-027173), MedSys HIV cell entry project (BMBF-0315489C) and CORUS Project (BMBF 01ES0712). The funding sources of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Baroncelli S, 2012, J ANTIMICROB CHEMOTH, V67, P1479, DOI 10.1093/jac/dks055; Battaglioli-DeNero AM, 2007, J ASSOC NURSE AIDS C, V18, pS17, DOI 10.1016/j.jana.2006.11.020; Braun P, 2007, EUR J MED RES, V12, P463; Brieu N, 2011, BLOOD, V117, P2073, DOI 10.1182/blood-2010-10-311860; Brumme CJ, 2011, RELATIVE PERFORMANCE; Brumme CJ, 2010, J INT AIDS SOC, DOI [10.1186/ 1758- 2652- 13- 7, DOI 10.1186/1758-2652-13-7]; Cabral GB, 2012, AIDS RES HUM RETROV, V28, P734, DOI [10.1089/aid.2011.0251, 10.1089/AID.2011.0251]; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; D'Aquila RT, 1998, J INFECT DIS, V177, P1549, DOI 10.1086/515307; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Eberle J., 2014, EMPFEHLUNGEN BESTIMM; Edo-Matas D, 2012, VIROLOGY, V422, P70, DOI 10.1016/j.virol.2011.10.005; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Harrigan P.R., 2013, CLIN INFECT DIS; Harrigan PR, 2010, INFLUENCE PCR AMPLIC; Jiao YM, 2011, IMMUNOL INVEST, V40, P597, DOI 10.3109/08820139.2011.569673; KLEIN MR, 1994, J INFECT DIS, V169, P1244, DOI 10.1093/infdis/169.6.1244; Klimkait T, 2012, INTERVIROLOGY, V55, P118, DOI 10.1159/000332003; Knapp DJHF, 2013, J CLIN MICROBIOL, V51, P444, DOI 10.1128/JCM.00739-12; McGovern R, 2010, POPULATION BASED SEQ; McGovern RA, 2012, JAIDS-J ACQ IMM DEF, V61, P279, DOI 10.1097/QAI.0b013e31826249cf; Menendez-Arias L., 2013, ANTIVIRAL RES; Mortier V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080259; Nakayama EE, 2000, J VIROL, V74, P5452, DOI 10.1128/JVI.74.12.5452-5459.2000; Obermeier M, 2010, REV ANTIVIR THER; Obermeier M, 2012, CURR OPIN HIV AIDS, V7, P470, DOI 10.1097/COH.0b013e328356eaa7; Portsmouth S, 2010, J INT AIDS SOC S4, V13, P128; Portsmouth S, 2013, ANTIVIR RES, V97, P60, DOI 10.1016/j.antiviral.2012.11.002; Pou C, 2010, HIGH RESOLUTION TROP; Poveda E, 2010, AIDS REV, V12, P135; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Reuter S, 2010, EUR J MED RES, V15, P231, DOI 10.1186/2047-783X-15-6-231; Sander O, 2007, PLOS COMPUT BIOL, V3, P555, DOI 10.1371/journal.pcbi.0030058; Saracino A, 2010, JAIDS-J ACQ IMM DEF, V53, P550, DOI 10.1097/QAI.0b013e3181ba46a6; Schapiro JM, 2011, ANTIVIR THER, V16, P395, DOI 10.3851/IMP1759; Sierra S, 2011, JOVE-J VIS EXP, V58, P3624; Soulie C, 2012, CURR OPIN HIV AIDS, V7, P450, DOI 10.1097/COH.0b013e328356e9c2; Svicher V, 2010, NEW MICROBIOL, V33, P195; Swenson LC, 2010, J INT AIDS SOC; Swenson LC, 2012, CURR OPIN HIV AIDS, V7, P478, DOI 10.1097/COH.0b013e328356e9da; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Symons J, 2011, CLIN MICROBIOL INFEC; Thielen A, 2014, ANTIVIR THER, V19, pA78; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Verhofstede C, 2011, HIV MED, V12, P544, DOI 10.1111/j.1468-1293.2011.00922.x; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Wirden M, 2013, J ANTIMICROB CHEMOTH, V68, P188, DOI 10.1093/jac/dks362	51	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125502	10.1371/journal.pone.0125502	http://dx.doi.org/10.1371/journal.pone.0125502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970632	Green Published, gold, Green Submitted			2022-12-27	WOS:000354544200077
J	Lin, CK; Hung, CC; Peng, CY; Chao, E; Lee, TSH				Lin, Chao-Kuang; Hung, Chia-Chun; Peng, Ching-Yi; Chao, En; Lee, Tony Szu-Hsien			Factors Associated with Methadone Treatment Duration: A Cox Regression Analysis	PLOS ONE			English	Article							HEROIN USERS; MAINTENANCE TREATMENT; DRUG-USERS; FOLLOW-UP; RETENTION; PREDICTORS; MORTALITY; THERAPY; COHORT	This study examined retention rates and associated predictors of methadone maintenance treatment (MMT) duration among 128 newly admitted patients in Taiwan. A semi-structured questionnaire was used to obtain demographic and drug use history. Daily records of methadone taken and test results for HIV, HCV, and morphine toxicology were taken from a computerized medical registry. Cox regression analyses were performed to examine factors associated with MMT duration. MMT retention rates were 80.5%, 68.8%, 53.9%, and 41.4% for 3, 6, 12, and 18 months, respectively. Excluding 38 patients incarcerated during the study period, retention rates were 81.1%, 73.3%, 61.1%, and 48.9% for 3 months, 6 months, 12 months, and 18 months, respectively. No participant seroconverted to HIV and 1 died during the 18-months follow-up. Results showed that being female, imprisonment, a longer distance from house to clinic, having a lower methadone dose after 30 days, being HCV positive, and in the New Taipei city program predicted early patient dropout. The findings suggest favorable MMT outcomes of HIV seroincidence and mortality. Results indicate that the need to minimize travel distance and to provide programs that meet women's requirements justify expansion of MMT clinics in Taiwan.	[Lin, Chao-Kuang] Natl Yang Ming Univ, Educ Ctr Humanities & Social Sci, Taipei 112, Taiwan; [Hung, Chia-Chun] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Peng, Ching-Yi; Chao, En; Lee, Tony Szu-Hsien] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Taiwan Normal University	Lee, TSH (corresponding author), Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan.	tonylee@ntnu.edu.tw	Hung, chiachun/AAV-7181-2020; Popescu, Sorin C/D-5981-2015	Popescu, Sorin C/0000-0002-8155-8801; Tsogt, Khongor/0000-0003-0431-2688; Lee, Tony Szu-Hsien/0000-0003-2574-3372; Hung, Chia Chun/0000-0003-1118-8187; Lin, Chinsu/0000-0002-4513-8674; Chao, En/0000-0002-2117-2886	Taiwan Ministry of Health and Welfare [DOH97-NNB-1044, DOH98-NNB-1032, DOH99-FDA-61501]; National Taiwan Normal University (NTNU), Taiwan, ROC	Taiwan Ministry of Health and Welfare; National Taiwan Normal University (NTNU), Taiwan, ROC	This study was funded by the Taiwan Ministry of Health and Welfare (DOH97-NNB-1044, DOH98-NNB-1032 and DOH99-FDA-61501). The funders of the study had no role in study design, data collection, data analysis, data interpretation, and writing of the report. This article was subsidized by the National Taiwan Normal University (NTNU), Taiwan, ROC.	Borisova NN, 2004, J SUBST ABUSE TREAT, V26, P345, DOI 10.1016/S0740-5472(03)00157-0; Deck D, 2005, J BEHAV HEALTH SER R, V32, P43, DOI 10.1007/BF02287327; Dolan KA, 2005, ADDICTION, V100, P820, DOI 10.1111/j.1360-0443.2005.01050.x; Hartel DM, 1999, PUBLIC HEALTH, V113, P107; Hser YI, 2004, PSYCHIAT SERV, V55, P767, DOI 10.1176/appi.ps.55.7.767; Huang YF, 2011, ADDICTION, V106, P1437, DOI 10.1111/j.1360-0443.2011.03443.x; Kelly SM, 2011, DRUG ALCOHOL DEPEN, V117, P170, DOI 10.1016/j.drugalcdep.2011.01.008; Kerr T, 2005, DRUG ALCOHOL DEPEN, V80, P329, DOI 10.1016/j.drugalcdep.2005.05.002; Lee TSH, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-6; Lee TSH, 2006, TAIWAN J PUBLIC HLTH, V25, P214; Liao DL, 2013, J PSYCHIATR RES, V47, P1530, DOI 10.1016/j.jpsychires.2013.07.001; Lin HC, 2013, J ADDICT DIS, V32, P140, DOI 10.1080/10550887.2013.795466; Magura S, 1998, ADDICTION, V93, P51, DOI 10.1046/j.1360-0443.1998.931516.x; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; Peles E, 2006, DRUG ALCOHOL DEPEN, V82, P211, DOI 10.1016/j.drugalcdep.2005.09.004; Qian HZ, 2008, J SUBST ABUSE TREAT, V34, P391, DOI 10.1016/j.jsat.2007.07.002; SIMPSON DD, 1981, ARCH GEN PSYCHIAT, V38, P875; UNODC, 2002, COMTEMPORARY DRUG AB; Villafranca SW, 2006, DRUG ALCOHOL DEPEN, V83, P218, DOI 10.1016/j.drugalcdep.2005.11.020; Wang PW, 2012, AM J DRUG ALCOHOL AB, V38, P213, DOI 10.3109/00952990.2011.649222; Wong KH, 2003, J SUBST ABUSE TREAT, V24, P233, DOI 10.1016/S0740-5472(03)00029-1; World Health Organization, 2012, WHO UNODC UNAIDS TEC, DOI [10.1016/j.drugpo.2007.12.002, DOI 10.1016/J.DRUGPO.2007.12.002]; Yang F, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-3; Zhang ZW, 2003, ADDICTION, V98, P673, DOI 10.1046/j.1360-0443.2003.00354.x	24	57	59	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123687	10.1371/journal.pone.0123687	http://dx.doi.org/10.1371/journal.pone.0123687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EB	25875531	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700038
J	Lin, CS; Popescu, SC; Thomson, G; Tsogt, K; Chang, CI				Lin, Chinsu; Popescu, Sorin C.; Thomson, Gavin; Tsogt, Khongor; Chang, Chein-I			Classification of Tree Species in Overstorey Canopy of Subtropical Forest Using QuickBird Images	PLOS ONE			English	Article							HIGH-RESOLUTION; LIDAR DATA; VEGETATION; KAPPA; IDENTIFICATION; PREVALENCE; ALGORITHMS; DENSITY; SYSTEM; CROWNS	This paper proposes a supervised classification scheme to identify 40 tree species (2 coniferous, 38 broadleaf) belonging to 22 families and 36 genera in high spatial resolution QuickBird multispectral images (HMS). Overall kappa coefficient (OKC) and species conditional kappa coefficients (SCKC) were used to evaluate classification performance in training samples and estimate accuracy and uncertainty in test samples. Baseline classification performance using HMS images and vegetation index (VI) images were evaluated with an OKC value of 0.58 and 0.48 respectively, but performance improved significantly (up to 0.99) when used in combination with an HMS spectral-spatial texture image (SpecTex). One of the 40 species had very high conditional kappa coefficient performance (SCKC >= 0.95) using 4-band HMS and 5-band VIs images, but, only five species had lower performance (0.68 <= SCKC <= 0.94) using the SpecTex images. When SpecTex images were combined with a Visible Atmospherically Resistant Index (VARI), there was a significant improvement in performance in the training samples. The same level of improvement could not be replicated in the test samples indicating that a high degree of uncertainty exists in species classification accuracy which may be due to individual tree crown density, leaf greenness (inter-canopy gaps), and noise in the background environment (intra-canopy gaps). These factors increase uncertainty in the spectral texture features and therefore represent potential problems when using pixel-based classification techniques for multi-species classification.	[Lin, Chinsu; Tsogt, Khongor] Natl Chiayi Univ, Dept Forestry & Nat Resources, Chiayi 60004, Taiwan; [Popescu, Sorin C.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA; [Thomson, Gavin] Natl Formosa Univ, Dept Appl Foreign Languages, Huwei Township 63201, Yunlin, Taiwan; [Chang, Chein-I] Univ Maryland Baltimore Cty, Dept Comp Sci & Elect Engn, Baltimore, MD 21250 USA	National Chiayi University; Texas A&M University System; Texas A&M University College Station; National Formosa University; University System of Maryland; University of Maryland Baltimore County	Lin, CS (corresponding author), Natl Chiayi Univ, Dept Forestry & Nat Resources, 300 Univ Rd, Chiayi 60004, Taiwan.	chinsu@mail.ncyu.edu.tw	Hung, chiachun/AAV-7181-2020; Popescu, Sorin C/D-5981-2015	Popescu, Sorin C/0000-0002-8155-8801; Tsogt, Khongor/0000-0003-0431-2688; Lee, Tony Szu-Hsien/0000-0003-2574-3372; Hung, Chia Chun/0000-0003-1118-8187; Lin, Chinsu/0000-0002-4513-8674; Chao, En/0000-0002-2117-2886				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081478; Boschetti M, 2007, INT J REMOTE SENS, V28, P1251, DOI 10.1080/01431160600928542; Brandtberg T, 1998, MACH VISION APPL, V11, P64, DOI 10.1007/s001380050091; CHAVEZ PS, 1991, PHOTOGRAMM ENG REM S, V57, P295; Chinsu Lin, 2015, Information Processing in Agriculture, V2, P25, DOI 10.1016/j.inpa.2015.01.003; Chytry M, 2011, APPL VEG SCI, V14, P435, DOI 10.1111/j.1654-109X.2011.01154.x; Cochrane MA, 2000, INT J REMOTE SENS, V21, P2075, DOI 10.1080/01431160050021303; Du YZ, 2004, OPT ENG, V43, P1777, DOI 10.1117/1.1766301; Duro DC, 2012, REMOTE SENS ENVIRON, V118, P259, DOI 10.1016/j.rse.2011.11.020; Dwivedi Ravi Shankar, 2009, P73; Feilhauer H, 2012, REMOTE SENS-BASEL, V4, P2057, DOI 10.3390/rs4072057; Frampton CM, 2001, ENVIRON MONIT ASSESS, V72, P227, DOI 10.1023/A:1012049205475; Franklin SE, 2000, INT J REMOTE SENS, V21, P61, DOI 10.1080/014311600210993; Gaikwad RN, 2006, ISPRS ARCH 4, VXXXVI; Gairola S, 2013, INT J REMOTE SENS, V34, P2006, DOI 10.1080/01431161.2012.730161; Ghiyamat A, 2010, INT J REMOTE SENS, V31, P1837, DOI 10.1080/01431160902926681; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Gougeon F.A., 1995, CANADIAN J REMOTE SE, V21, P274, DOI [DOI 10.1080/07038992.1995.10874622, 10.1080/07038992.1995.10874622]; Hantson W, 2012, APPL VEG SCI, V15, P536, DOI 10.1111/j.1654-109X.2012.01194.x; Hill RA, 2010, APPL VEG SCI, V13, P86, DOI 10.1111/j.1654-109X.2009.01053.x; Hill RA, 2005, INT J REMOTE SENS, V26, P3763, DOI 10.1080/01431160500114706; Hoare D, 2004, APPL VEG SCI, V7, P19, DOI 10.1111/j.1654-109X.2004.tb00591.x; Holmgren J, 2008, INT J REMOTE SENS, V29, P1537, DOI 10.1080/01431160701736471; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Ishihama F, 2012, APPL VEG SCI, V15, P383, DOI 10.1111/j.1654-109X.2012.01184.x; Jensen JR., 2004, INTRO DIGITAL IMAGE, V3; Jones TG, 2010, INT J REMOTE SENS, V31, P1121, DOI 10.1080/01431160903349040; Kang JY, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL III, PROCEEDINGS, P315, DOI 10.1109/IITA.2008.269; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; Ke Y, REMOTE SENSING ENV, V114, P1141; Krause K., 2005, RADIOMETRIC USE QUIC; KRUSE FA, 1993, AIP CONF PROC, P192, DOI 10.1016/0034-4257(93)90013-N; Larcher W, 2003, PHYSL PLANT ECOLOGY; Leckie DG, 2005, CAN J REMOTE SENS, V31, P175, DOI 10.5589/m05-004; LEE JS, 1980, IEEE T PATTERN ANAL, V2, P165, DOI 10.1109/TPAMI.1980.4766994; Li CF, 2012, S E AS FLOR ROL FORM; Lin C, 2015, BIOGEOSCIENCES, V12, P49, DOI 10.5194/bg-12-49-2015; Lin C, 2003, J NATL CHIAYI U, V75, P181; Lin C., 2011, J EARTH SCI ENG, V1, P35; Lin C, 2005, Q J CHINESE FORESTRY, V38, P163; Lin C, 2011, P 4 INT C IM SIGN PR, V3, P1633; Lin CS, 2012, J ENVIRON MANAGE, V113, P440, DOI 10.1016/j.jenvman.2012.09.001; Lin CS, 2011, PHOTOGRAMM ENG REM S, V77, P241, DOI 10.14358/PERS.77.3.241; Lin Chinsu, 1999, Taiwan Journal of Forest Science, V14, P289; Lo CS, 2013, IEEE T GEOSCI REMOTE, V51, P2216, DOI 10.1109/TGRS.2012.2211023; Hernandez-Stefanoni JL, 2009, APPL VEG SCI, V12, P398, DOI 10.1111/j.1654-109X.2009.01044.x; McDanold RI, 2007, APPL VEG SCI, V10, P193; Ouyang ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067315; Pu RL, 2009, INT J REMOTE SENS, V30, P2759, DOI 10.1080/01431160802555820; Reitberger J, 2008, INT J REMOTE SENS, V29, P1407, DOI 10.1080/01431160701736448; Richards J.A., 1999, REMOTE SENSING DIGIT, DOI [DOI 10.1007/978-3-642-30062-2, 10.1007/978-3-662-03978-6, DOI 10.1007/978-3-662-03978-6]; Rocchini D, 2007, APPL VEG SCI, V10, P325, DOI 10.1111/j.1654-109X.2007.tb00431.x; Schowengerdt R. A., 1997, REMOTE SENSING MODEL; Stehman SV, 1996, PHOTOGRAMM ENG REM S, V62, P401; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Vach W, 2005, J CLIN EPIDEMIOL, V58, P655, DOI 10.1016/j.jclinepi.2004.02.021; Vina A, 2004, AGRON J, V96, P1139, DOI 10.2134/agronj2004.1139; Wang L, 2009, INT J REMOTE SENS, V30, P1267, DOI 10.1080/01431160802474014; Wu TF, 2004, J MACH LEARN RES, V5, P975	62	57	59	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125554	10.1371/journal.pone.0125554	http://dx.doi.org/10.1371/journal.pone.0125554			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25875531	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100031
